|
Name |
Accession |
Description |
Interval |
E-value |
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
1058-3599 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 2132.16 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1058 PVSSAQKRIYVLQQLD-EGVAYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSgADDEPVQRIHTEVPFTL--- 1133
Cdd:PRK12467 51 PLSYAQERQWFLWQLDpDSAAYNIPTALRLRGELDVSALRRAFDALVARHESLRTRFVQ-DEEGFRQVIDASLSLTIpld 129
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1134 --------SKETTIEGFV-----RPFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYANR---- 1196
Cdd:PRK12467 130 dlaneqgrARESQIEAYIneevaRPFDLANGPLLRVRLLRLADDEHVLVVTLHHIISDGWSMRVLVEELVQLYSAYsqgr 209
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1197 --QLKPLRIQYKDYAVWQQKFKKGDSYQKQETYWQQQFSGDLPILELPTDKRRPAERQFIGGKVTFQLDKEITARIKRLA 1274
Cdd:PRK12467 210 epSLPALPIQYADYAIWQRSWLEAGERERQLAYWQEQLGGEHTVLELPTDRPRPAVPSYRGARLRVDLPQALSAGLKALA 289
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1275 HKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPHADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQTALEAY 1354
Cdd:PRK12467 290 QREGVTLFMVLLASFQTLLHRYSGQSDIRIGVPNANRNRVETERLIGFFVNTQVLKAEVDPQASFLELLQQVKRTALGAQ 369
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1355 EHQDYPFEELVDKLGVQREMSRNPLFDTTLVLQNMEQ-----QKLKMNDVQLQWNDLEHPISKFDISLYVTEHDSELFCQ 1429
Cdd:PRK12467 370 AHQDLPFEQLVEALQPERSLSHSPLFQVMFNHQNTATggrdrEGAQLPGLTVEELSWARHTAQFDLALDTYESAQGLWAA 449
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1430 FEYSTALFEKETIQRWASLFTTLVEHTAASPETELDNIPILTKEEERDFIESCHLfEETGYSmNQTLHYALEQQAEKTPD 1509
Cdd:PRK12467 450 FTYATDLFEATTIERLATHWRNLLEAIVAEPRRRLGELPLLDAEERARELVRWNA-PATEYA-PDCVHQLIEAQARQHPE 527
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1510 QAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLED 1589
Cdd:PRK12467 528 RPALVFGEQVLSYAELNRQANRLAHVLIAAGVGPDVLVGIAVERSIEMVVGLLAVLKAGGAYVPLDPEYPQDRLAYMLDD 607
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1590 SGTNILLLQSAGL-HVPEFTG-EIVYLNQTNSGLAHRLS-NPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNS 1666
Cdd:PRK12467 608 SGVRLLLTQSHLLaQLPVPAGlRSLCLDEPADLLCGYSGhNPEVALDPDNLAYVIYTSGSTGQPKGVAISHGALANYVCV 687
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1667 LQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHiky 1746
Cdd:PRK12467 688 IAERLQLAADDSMLMVSTFAFDLGVTELFGALASGATLHLLPPDCARDAEAFAALMADQGVTVLKIVPSHLQALLQA--- 764
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1747 rSVPIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFDCPPHEK-LERIPIGKPVHHVRLYLLN 1825
Cdd:PRK12467 765 -SRVALPRPQRALVCGGEALQVDLLARVRALGPGARLINHYGPTETTVGVSTYELSDEERdFGNVPIGQPLANLGLYILD 843
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1826 QNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYP-GERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRI 1904
Cdd:PRK12467 844 HYLNPVPVGVVGELYIGGAGLARGYHRRPALTAERFVPDPFGAdGGRLYRTGDLARYRADGVIEYLGRMDHQVKIRGFRI 923
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1905 EPGEIEAALRSIEGVREAAVTVRTDSGEPELCAYVEGLQ----------RNEVRAQLERLLPGYMVPAYMIEMEQWPVTP 1974
Cdd:PRK12467 924 ELGEIEARLLAQPGVREAVVLAQPGDAGLQLVAYLVPAAvadgaehqatRDELKAQLRQVLPDYMVPAHLLLLDSLPLTP 1003
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1975 SGKLDRNALPAPGGAADAETYTAPRNVTEMKLSQLWEDVLKNGPVGIHDNFFDRGGHSLKATALVSRITKEFDVQVPLKD 2054
Cdd:PRK12467 1004 NGKLDRKALPKPDASAVQATFVAPQTELEKRLAAIWADVLKVERVGLTDNFFELGGHSLLATQVISRVRQRLGIQVPLRT 1083
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2055 VFAHPTVEGLATVIREGTDSPYEAIKPAEKQETYPVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQEL 2134
Cdd:PRK12467 1084 LFEHQTLAGFAQAVAAQQQGAQPALPDVDRDQPLPLSYAQERQWFLWQLEPGSAAYHIPQALRLKGPLDIEALERSFDAL 1163
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2135 IKRHESLRTSFEQdEGGDPVQRIHDEVPFTL-QTTVLGARTEQEAAAAFI-----KPFDLSQAPLFRAQIVKVSDERHLL 2208
Cdd:PRK12467 1164 VARHESLRTTFVQ-EDGRTRQVIHPVGSLTLeEPLLLAADKDEAQLKVYVeaearQPFDLEQGPLLRVGLLRLAADEHVL 1242
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2209 LVDMHHIISDGVSVNILIQEFGELY------NNRKLPALRIQYKDYAVWQEGFKTGDAYKMQEAYWLKQLEGELPVLDLP 2282
Cdd:PRK12467 1243 VLTLHHIVSDGWSMQVLVDELVALYaaysqgQSLQLPALPIQYADYAVWQRQWMDAGERARQLAYWKAQLGGEQPVLELP 1322
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2283 ADHARPPVRSFAGDKVSFTLEPEVASGLHKLARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHKDLEPILGM 2362
Cdd:PRK12467 1323 TDRPRPAVQSHRGARLAFELPPALAEGLRALARREGVTLFMLLLASFQTLLHRYSGQDDIRVGVPIANRNRAETEGLIGF 1402
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2363 FVNTLALRTRPEGGKPFVQYLQEVRETALEAFEHQNYPFEELVDKLELTRDMSRNPVFDAMLVVQNNDYEPLH-LHDLQM 2441
Cdd:PRK12467 1403 FVNTQVLRAEVDGQASFQQLLQQVKQAALEAQAHQDLPFEQLVEALQPERSLSHSPLFQVMFNHQRDDHQAQAqLPGLSV 1482
|
1450 1460 1470 1480 1490 1500 1510 1520
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2442 KPAQVSHLVSKFDLTLQASEGDGNIHFLFEYSTALFEKTTIERWASHLTNVLSIIGKNPKVTLNHIDILTQEERHQLLNE 2521
Cdd:PRK12467 1483 ESLSWESQTAQFDLTLDTYESSEGLQASLTYATDLFEASTIERLAGHWLNLLQGLVADPERRLGELDLLDEAERRQILEG 1562
|
1530 1540 1550 1560 1570 1580 1590 1600
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2522 FNTGQANQYGVQTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASIL 2601
Cdd:PRK12467 1563 WNATHTGYPLARLVHQLIEDQAAATPEAVALVFGEQELTYGELNRRANRLAHRLIALGVGPEVLVGIAVERSLEMVVGLL 1642
|
1610 1620 1630 1640 1650 1660 1670 1680
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2602 GVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMTiNEADLGVLADFEG-EILTIES----VEEDDKSPLPQMSSAHHLA 2676
Cdd:PRK12467 1643 AILKAGGAYVPLDPEYPRERLAYMIEDSGIELLLT-QSHLQARLPLPDGlRSLVLDQeddwLEGYSDSNPAVNLAPQNLA 1721
|
1690 1700 1710 1720 1730 1740 1750 1760
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2677 YIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAI 2756
Cdd:PRK12467 1722 YVIYTSGSTGRPKGAGNRHGALVNRLCATQEAYQLSAADVVLQFTSFAFDVSVWELFWPLINGARLVIAPPGAHRDPEQL 1801
|
1770 1780 1790 1800 1810 1820 1830 1840
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2757 KHQLSRQRITHMIIVPVLYRALLDVV-QPEDVKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTENSVATT--VM 2833
Cdd:PRK12467 1802 IQLIERQQVTTLHFVPSMLQQLLQMDeQVEHPLSLRRVVCGGEALEVEALRPWLERLPDTGLFNLYGPTETAVDVThwTC 1881
|
1850 1860 1870 1880 1890 1900 1910 1920
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2834 RH--MEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPF-KPEARMYRTGDA 2910
Cdd:PRK12467 1882 RRkdLEGRDSVPIGQPIANLSTYILDASLNPVPIGVAGELYLGGVGLARGYLNRPALTAERFVADPFgTVGSRLYRTGDL 1961
|
1930 1940 1950 1960 1970 1980 1990 2000
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2911 ARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQtELSAYVVTK----------PGLST 2980
Cdd:PRK12467 1962 ARYRADGVIEYLGRIDHQVKIRGFRIELGEIEARLREQGGVREAVVIAQDGANGK-QLVAYVVPTdpglvdddeaQVALR 2040
|
2010 2020 2030 2040 2050 2060 2070 2080
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2981 NAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGALPKPVYNhEGERPFLPPSSKMEQILADIWKEVLGAEKIGTAD 3060
Cdd:PRK12467 2041 AILKNHLKASLPEYMVPAHLVFLARMPLTPNGKLDRKALPAPDAS-ELQQAYVAPQSELEQRLAAIWQDVLGLEQVGLHD 2119
|
2090 2100 2110 2120 2130 2140 2150 2160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3061 SFFELGGDSIKALQVSARLHRIGKQMAVKDLFSHPTIQELAAYIRDSDTSSS--QAAVEGDVQWSPVQKWFLSQDIKEKH 3138
Cdd:PRK12467 2120 NFFELGGDSIISIQVVSRARQAGIRFTPKDLFQHQTVQSLAAVAQEGDGTVSidQGPVTGDLPLLPIQQMFFADDIPERH 2199
|
2170 2180 2190 2200 2210 2220 2230 2240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3139 HFNQSVMLHRSTSVQEDALRKTLKAITCHHDALRMVFTQnEQGKWDQYNR-PLSHSDDALYGLQMIDLSApdgtdgnrpY 3217
Cdd:PRK12467 2200 HWNQSVLLEPREALDAELLEAALQALLVHHDALRLGFVQ-EDGGWSAMHRaPEQERRPLLWQVVVADKEE---------L 2269
|
2250 2260 2270 2280 2290 2300 2310 2320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3218 EPLikrhVLDIQQKMDLKNGPLLQAGLFHTIDGD-FLFLSAHHLVVDGISWRVLLEDLALGYRQAAGGEDIKLPPKTSSF 3296
Cdd:PRK12467 2270 EAL----CEQAQRSLDLEEGPLLRAVLATLPDGSqRLLLVIHHLVVDGVSWRILLEDLQTAYRQLQGGQPVKLPAKTSAF 2345
|
2330 2340 2350 2360 2370 2380 2390 2400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3297 KAYAKKLSDYAESQQLMKQLKYWREAEEYQTEALPFDQIDGTRAHEgQRSTISFTLNDKETAALLKDANSAYNTDTQDML 3376
Cdd:PRK12467 2346 KAWAERLQTYAASAALADELGYWQAQLQGASTELPCDHPQGGLQRR-HAASVTTHLDSEWTRRLLQEAPAAYRTQVNDLL 2424
|
2410 2420 2430 2440 2450 2460 2470 2480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3377 LASVILALRHWTNQSAFKLSLEGHGREDVLKGIDVSRTIGWFTAIYPLLIKLNADLPDSeesmvhvLKTTKDTLRRVPDK 3456
Cdd:PRK12467 2425 LTALARVIARWTGQASTLIQLEGHGREDLFDEIDLTRTVGWFTSLYPVKLSPTASLATS-------IKTIKEQLRAVPNK 2497
|
2490 2500 2510 2520 2530 2540 2550 2560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3457 GFGYGVIKYL-TPPGKKDINFTGAPEISFNYLGQFESGRTAevpEEDAFsFSPLG--AGGDISTTWNREQSLDISAIAAE 3533
Cdd:PRK12467 2498 GLGFGVLRYLgSEAARQTLQALPVPRITFNYLGQFDGSFDA---EKQAL-FVPSGefSGAEQSEEAPLGNWLSINGQVYG 2573
|
2570 2580 2590 2600 2610 2620 2630
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 3534 GKLTVNMTYDNARFQRKTIEQLSETCRQFLLQLIEHCQNKSETEKTISDFDDQELTED-------ALQEIADM 3599
Cdd:PRK12467 2574 GELNLGWTFSQEMFDEATIQRLADAYAEELRALIEHCCSNDQRGVTPSDFPLAGLSQEqldrlpvAVGDIEDI 2646
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
465-3593 |
0e+00 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 1907.98 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 465 IHAMfEKQAEKTPDAHAVI------DQACSLTYRELNKAANRLARHLRMKGVVRQEPVaIMMERSAAFITGVLGILKAGG 538
Cdd:PRK05691 12 VQAL-QRRAAQTPDRLALRfladdpGEGVVLSYRDLDLRARTIAAALQARASFGDRAV-LLFPSGPDYVAAFFGCLYAGV 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 539 AIVPVDP------HYpADRIRYILHDCGCSHVVSQAHLPSSLEDNYIITHPEDIES-KVDGSNIKSVNN-------ADDL 604
Cdd:PRK05691 90 IAVPAYPpesarrHH-QERLLSIIADAEPRLLLTVADLRDSLLQMEELAAANAPELlCVDTLDPALAEAwqepalqPDDI 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 605 LYMIYTSGTTGKPKGVQFEHRNM-AN--LLKFEYthsGIDFEADvlqfatpsfDVcyqeIFSAL-------LKGGTLhiv 674
Cdd:PRK05691 169 AFLQYTSGSTALPKGVQVSHGNLvANeqLIRHGF---GIDLNPD---------DV----IVSWLplyhdmgLIGGLL--- 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 675 pEAIKRDVPQLFafinkhQTNIVFL--PTAFIKMIFSERELANSFPDGVKHLI------AAGEQLMIS------------ 734
Cdd:PRK05691 230 -QPIFSGVPCVL------MSPAYFLerPLRWLEAISEYGGTISGGPDFAYRLCservseSALERLDLSrwrvaysgsepi 302
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 735 -----DLFQDVLRKRGIHLHNH---YGPSE-THVVSTYTihPGDPIPEL-------------PPIGKPIGCTDLYILNH- 791
Cdd:PRK05691 303 rqdslERFAEKFAACGFDPDSFfasYGLAEaTLFVSGGR--RGQGIPALeldaealarnraePGTGSVLMSCGRSQPGHa 380
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 792 -------QKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKpdvIMYRTGDLARrLEDGNIEYIGRADNQVKI 864
Cdd:PRK05691 381 vlivdpqSLEVLGDNRVGEIWASGPSIAHGYWRNPEASAKTFVEHDGR---TWLRTGDLGF-LRDGELFVTGRLKDMLIV 456
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 865 RGYRIEPQEIEVTLMNHPDISE----AAILIwqDQNGEHEL---CAYYCSVQKLNTID-----LRSYMASELPEymIPAK 932
Cdd:PRK05691 457 RGHNLYPQDIEKTVEREVEVVRkgrvAAFAV--NHQGEEGIgiaAEISRSVQKILPPQaliksIRQAVAEACQE--APSV 532
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 933 WIWVD--SIPLTPNGKVDRAA---------------LPEPDASISGNPYTAPRNLlEAKLSQLFEDVLKNGHIGIQDNFF 995
Cdd:PRK05691 533 VLLLNpgALPKTSSGKLQRSAcrlrladgsldsyalFPALQAVEAAQTAASGDEL-QARIAAIWCEQLKVEQVAADDHFF 611
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 996 DNGGHSLKATVLMSRIAKEFHVQVSLKDIFAHPTVEGLALIIREAEQN---LYAAIEPAEKRDTYPVSSAQKRIYVLQQL 1072
Cdd:PRK05691 612 LLGGNSIAATQVVARLRDELGIDLNLRQLFEAPTLAAFSAAVARQLAGggaAQAAIARLPRGQALPQSLAQNRLWLLWQL 691
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1073 D-EGVAYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSgADDEPVQRIHTEVPFTL----------SKETTIEG 1141
Cdd:PRK05691 692 DpQSAAYNIPGGLHLRGELDEAALRASFQRLVERHESLRTRFYE-RDGVALQRIDAQGEFALqridlsdlpeAEREARAA 770
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1142 FVR------PFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYANR------QLKPLRIQYKDYA 1209
Cdd:PRK05691 771 QIReeearqPFDLEKGPLLRVTLVRLDDEEHQLLVTLHHIVADGWSLNILLDEFSRLYAAAcqgqtaELAPLPLGYADYG 850
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1210 VWQQKFKKGDSYQKQETYWQQQFSGDLPILELPTDKRRPAERQFIGGKVTFQLDKEITARIKRLAHKNRSTLYMTLLALY 1289
Cdd:PRK05691 851 AWQRQWLAQGEAARQLAYWKAQLGDEQPVLELATDHPRSARQAHSAARYSLRVDASLSEALRGLAQAHQATLFMVLLAAF 930
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1290 SAFLSRLSGQDDIVIGSPIAGRPHADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQTALEAYEHQDYPFEELVDKLG 1369
Cdd:PRK05691 931 QALLHRYSGQGDIRIGVPNANRPRLETQGLVGFFINTQVLRAQLDGRLPFTALLAQVRQATLGAQAHQDLPFEQLVEALP 1010
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1370 VQREMSrnpLFDttlVLQNMEQQKLK-------MNDVQLQWNDLEhpiSKFDISLYVTE-HDSELFCQFEYSTALFEKET 1441
Cdd:PRK05691 1011 QAREQG---LFQ---VMFNHQQRDLSalrrlpgLLAEELPWHSRE---AKFDLQLHSEEdRNGRLTLSFDYAAELFDAAT 1081
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1442 IQRWASLFTTLVEHTAASPETELDNIPILTKEEERDFIESCHLfeeTGYSMNQTLHYALEQQAEKTPDQAAVIFEDGVMT 1521
Cdd:PRK05691 1082 IERLAEHFLALLEQVCEDPQRALGDVQLLDAAERAQLAQWGQA---PCAPAQAWLPELLNEQARQTPERIALVWDGGSLD 1158
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1522 YKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLLQSAG 1601
Cdd:PRK05691 1159 YAELHAQANRLAHYLRDKGVGPDVCVAIAAERSPQLLVGLLAILKAGGAYVPLDPDYPAERLAYMLADSGVELLLTQSHL 1238
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1602 L-HVPEFTGEIVYLNQTNSGLAHRLSNPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIM 1680
Cdd:PRK05691 1239 LeRLPQAEGVSAIALDSLHLDSWPSQAPGLHLHGDNLAYVIYTSGSTGQPKGVGNTHAALAERLQWMQATYALDDSDVLM 1318
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1681 HKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHikyrsvPIKTN--RLKR 1758
Cdd:PRK05691 1319 QKAPISFDVSVWECFWPLITGCRLVLAGPGEHRDPQRIAELVQQYGVTTLHFVPPLLQLFIDE------PLAAActSLRR 1392
|
1450 1460 1470 1480 1490 1500 1510 1520
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1759 VFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFDCPPHEKlERIPIGKPVHHVRLYLLNQNQRMLPVGCIGE 1838
Cdd:PRK05691 1393 LFSGGEALPAELRNRVLQRLPQVQLHNRYGPTETAINVTHWQCQAEDG-ERSPIGRPLGNVLCRVLDAELNLLPPGVAGE 1471
|
1530 1540 1550 1560 1570 1580 1590 1600
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1839 LYIAGAGVARGYLNRPALTEERFLEDPF-YPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIE 1917
Cdd:PRK05691 1472 LCIGGAGLARGYLGRPALTAERFVPDPLgEDGARLYRTGDRARWNADGALEYLGRLDQQVKLRGFRVEPEEIQARLLAQP 1551
|
1610 1620 1630 1640 1650 1660 1670 1680
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1918 GVREAAVTVRTDSGEPELCAYVEGL-----QRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNALPAPGGaaDA 1992
Cdd:PRK05691 1552 GVAQAAVLVREGAAGAQLVGYYTGEagqeaEAERLKAALAAELPEYMVPAQLIRLDQMPLGPSGKLDRRALPEPVW--QQ 1629
|
1690 1700 1710 1720 1730 1740 1750 1760
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1993 ETYTAPRNVTEMKLSQLWEDVLKNGPVGIHDNFFDRGGHSLKATALVSRITKEFDVQVPLKDVFAHPTVEGLATVIR--- 2069
Cdd:PRK05691 1630 REHVEPRTELQQQIAAIWREVLGLPRVGLRDDFFALGGHSLLATQIVSRTRQACDVELPLRALFEASELGAFAEQVAriq 1709
|
1770 1780 1790 1800 1810 1820 1830 1840
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2070 -EGTDSPYEAIKPAEKQETYPVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQD 2148
Cdd:PRK05691 1710 aAGERNSQGAIARVDRSQPVPLSYSQQRMWFLWQMEPDSPAYNVGGMARLSGVLDVDRFEAALQALILRHETLRTTFPSV 1789
|
1850 1860 1870 1880 1890 1900 1910 1920
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2149 eGGDPVQRIHDEVPFTLQTTVLGA--------RTEQEAAAAFIKPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGV 2220
Cdd:PRK05691 1790 -DGVPVQQVAEDSGLRMDWQDFSAlpadarqqRLQQLADSEAHQPFDLERGPLLRACLVKAAEREHYFVLTLHHIVTEGW 1868
|
1930 1940 1950 1960 1970 1980 1990 2000
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2221 SVNILIQEFGELY----NNRKLP--ALRIQYKDYAVWQEGFKTGDAYKMQEAYWLKQLEGELPVLDLPADHARPPVRSFA 2294
Cdd:PRK05691 1869 AMDIFARELGALYeaflDDRESPlePLPVQYLDYSVWQRQWLESGERQRQLDYWKAQLGNEHPLLELPADRPRPPVQSHR 1948
|
2010 2020 2030 2040 2050 2060 2070 2080
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2295 GDKVSFTLEPEVASGLHKLARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHKDLEPILGMFVNTLALRTRPE 2374
Cdd:PRK05691 1949 GELYRFDLSPELAARVRAFNAQRGLTLFMTMTATLAALLYRYSGQRDLRIGAPVANRIRPESEGLIGAFLNTQVLRCQLD 2028
|
2090 2100 2110 2120 2130 2140 2150 2160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2375 GGKPFVQYLQEVRETALEAFEHQNYPFEELVDKLELTRDMSRNPVFDAMLVVQNNDYEplhlHDLQMKPAQVSHLV---- 2450
Cdd:PRK05691 2029 GQMSVSELLEQVRQTVIEGQSHQDLPFDHLVEALQPPRSAAYNPLFQVMCNVQRWEFQ----QSRQLAGMTVEYLVndar 2104
|
2170 2180 2190 2200 2210 2220 2230 2240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2451 -SKFDLTLQASEGDGNIHFLFEYSTALFEKTTIERWASHLTNVLSIIGKNPKVTLNHIDILTQEERHQLLNEFNTGQANQ 2529
Cdd:PRK05691 2105 aTKFDLNLEVTDLDGRLGCCLTYSRDLFDEPRIARMAEHWQNLLEALLGDPQQRLAELPLLAAAEQQQLLDSLAGEAGEA 2184
|
2250 2260 2270 2280 2290 2300 2310 2320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2530 YGVQTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGC 2609
Cdd:PRK05691 2185 RLDQTLHGLFAAQAARTPQAPALTFAGQTLSYAELDARANRLARALRERGVGPQVRVGLALERSLEMVVGLLAILKAGGA 2264
|
2330 2340 2350 2360 2370 2380 2390 2400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2610 YVPIDPEYPKERKRYILSDSGTKLLmtineadLGVLADFE--GEI---LTIESVEED-------DKSPLPQMSSAHHLAY 2677
Cdd:PRK05691 2265 YVPLDPEYPLERLHYMIEDSGIGLL-------LSDRALFEalGELpagVARWCLEDDaaalaaySDAPLPFLSLPQHQAY 2337
|
2410 2420 2430 2440 2450 2460 2470 2480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2678 IIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEE--AKDILa 2755
Cdd:PRK05691 2338 LIYTSGSTGKPKGVVVSHGEIAMHCQAVIERFGMRADDCELHFYSINFDAASERLLVPLLCGARVVLRAQGQwgAEEIC- 2416
|
2490 2500 2510 2520 2530 2540 2550 2560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2756 ikhQLSR-QRITHMIIVPVLYRALLD-VVQPEDVKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTEnsvaTTVM 2833
Cdd:PRK05691 2417 ---QLIReQQVSILGFTPSYGSQLAQwLAGQGEQLPVRMCITGGEALTGEHLQRIRQAFAPQLFFNAYGPTE----TVVM 2489
|
2570 2580 2590 2600 2610 2620 2630 2640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2834 --------RHMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKPEA-RM 2904
Cdd:PRK05691 2490 placlapeQLEEGAASVPIGRVVGARVAYILDADLALVPQGATGELYVGGAGLAQGYHDRPGLTAERFVADPFAADGgRL 2569
|
2650 2660 2670 2680 2690 2700 2710 2720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2905 YRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQtELSAYVVTKPGLSTN--- 2981
Cdd:PRK05691 2570 YRTGDLVRLRADGLVEYVGRIDHQVKIRGFRIELGEIESRLLEHPAVREAVVLALDTPSGK-QLAGYLVSAVAGQDDeaq 2648
|
2730 2740 2750 2760 2770 2780 2790 2800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2982 -----AVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGALPKPvyNHEGERP-FLPPSSKMEQILADIWKEVLGAEK 3055
Cdd:PRK05691 2649 aalreALKAHLKQQLPDYMVPAHLILLDSLPLTANGKLDRRALPAP--DPELNRQaYQAPRSELEQQLAQIWREVLNVER 2726
|
2810 2820 2830 2840 2850 2860 2870 2880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3056 IGTADSFFELGGDSIKALQVSARLHRIGKQMAVKDLFSHPTIQELAAYIRDSDTSSS-QAAVEGDVQWSPVQKWFLSQDI 3134
Cdd:PRK05691 2727 VGLGDNFFELGGDSILSIQVVSRARQLGIHFSPRDLFQHQTVQTLAAVATHSEAAQAeQGPLQGASGLTPIQHWFFDSPV 2806
|
2890 2900 2910 2920 2930 2940 2950 2960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3135 KEKHHFNQSVMLHRSTSVQEDALRKTLKAITCHHDALRMVFTQNEqGKWDQYNRPLshSDDALyglqMIDLSAPDGTDGN 3214
Cdd:PRK05691 2807 PQPQHWNQALLLEPRQALDPALLEQALQALVEHHDALRLRFSQAD-GRWQAEYRAV--TAQEL----LWQVTVADFAECA 2879
|
2970 2980 2990 3000 3010 3020 3030 3040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3215 RPYEplikrhvlDIQQKMDLKNGPLLQAGLFHTIDG-DFLFLSAHHLVVDGISWRVLLEDLALGYRQAAGGEDIKLPPKT 3293
Cdd:PRK05691 2880 ALFA--------DAQRSLDLQQGPLLRALLVDGPQGqQRLLLAIHHLVVDGVSWRVLLEDLQALYRQLSAGAEPALPAKT 2951
|
3050 3060 3070 3080 3090 3100 3110 3120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3294 SSFKAYAKKLSDYAESQQLMKQLKYWREAEEYQTEALPFDQIDGTRAHEgQRSTISFTLNDKETAALLKDANSAYNTDTQ 3373
Cdd:PRK05691 2952 SAFRDWAARLQAYAGSESLREELGWWQAQLGGPRAELPCDRPQGGNLNR-HAQTVSVRLDAERTRQLLQQAPAAYRTQVN 3030
|
3130 3140 3150 3160 3170 3180 3190 3200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3374 DMLLASVILALRHWTNQSAFKLSLEGHGREDVLKGIDVSRTIGWFTAIYPL-LIKLNADLPDSEESmvhvLKTTKDTLRR 3452
Cdd:PRK05691 3031 DLLLTALARVLCRWSGQPSVLVQLEGHGREALFDDIDLTRSVGWFTSAYPLrLTPAPGDDAARGES----IKAIKEQLRA 3106
|
3210 3220 3230 3240 3250 3260 3270 3280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3453 VPDKGFGYGVIKYL-TPPGKKDINFTGAPEISFNYLGQFESGRtaevpEEDAFsFSPL----GAGGDISTTWNREQSLDI 3527
Cdd:PRK05691 3107 VPHKGLGYGVLRYLaDAAVREAMAALPQAPITFNYLGQFDQSF-----ASDAL-FRPLdepaGPAHDPDAPLPNELSVDG 3180
|
3290 3300 3310 3320 3330 3340
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 3528 SAIAaeGKLTVNMTYDNARFQRKTIEQLSETCRQFLLQLIEHCQNKSETEKTISDFDDQELTE---DAL 3593
Cdd:PRK05691 3181 QVYG--GELVLRWTYSAERYDEQTIAELAEAYLAELQALIAHCLADGAGGLTPSDFPLAQLTQaqlDAL 3247
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1048-3593 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 1760.63 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1048 IEPAEKRDTYPVSSAQKRIY---VLQQldEGVAYNMPAVLELEGaLDVAKLSAVCKELISRHEPLRTSFVSGAD-DEPVQ 1123
Cdd:PRK12316 1548 LPAGEIADIYPLSPMQQGMLfhsLYEQ--EAGDYINQLRVDVQG-LDPDRFRAAWQATVDRHEILRSGFLWQDGlEQPLQ 1624
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1124 RIHTEV--PFTLSKETTIEGFV------------RPFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREF 1189
Cdd:PRK12316 1625 VIHKQVelPFAELDWRGREDLGqaldalaqaerqKGFDLTRAPLLRLVLVRTGEGRHHLIYTNHHILMDGWSNAQLLGEV 1704
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1190 TDLYANRQLKPLRIQYKDYAVWQQKFKKGDSyqkqETYWQQQfsgdLPILELPT----DKRRPAERQfiGGKVTFQ-LDK 1264
Cdd:PRK12316 1705 LQRYAGQPVAAPGGRYRDYIAWLQRQDAAAS----EAFWKEQ----LAALEEPTrlaqAARTEDGQV--GYGDHQQlLDP 1774
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1265 EITARIKRLAHKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPhADL---EAVLGMFVNTLALRTRPAGNKTFEE 1341
Cdd:PRK12316 1775 AQTRALAEFARAQKVTLNTLVQAAWLLLLQRYTGQETVAFGATVAGRP-AELpgiEQQIGLFINTLPVIAAPRPDQSVAD 1853
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1342 FLKEVRQTALEAYEHQDYPFEELVDKLGVQREmsrnPLFDTTLVLQNME-QQKLKMN-DVQLQWNDL-EHPISKFDISLY 1418
Cdd:PRK12316 1854 WLQEVQALNLALREHEHTPLYDIQRWAGQGGE----ALFDSLLVFENYPvAEALKQGaPAGLVFGRVsNHEQTNYPLTLA 1929
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1419 VTEHDSeLFCQFEYSTALFEKETIQRWASLFTTLVEHTAASPETELDNIPILTKEEERDFIESCHLFEEtGYSMNQTLHY 1498
Cdd:PRK12316 1930 VTLGET-LSLQYSYDRGHFDAAAIERLDRHLLHLLEQMAEDAQAALGELALLDAGERQRILADWDRTPE-AYPRGPGVHQ 2007
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1499 ALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDY 1578
Cdd:PRK12316 2008 RIAEQAARAPEAIAVVFGDQHLSYAELDSRANRLAHRLRARGVGPEVRVAIAAERSFELVVALLAVLKAGGAYVPLDPNY 2087
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1579 PEERISFLLEDSGTNILLLQSAGLHVPEFTGEIVYLNQTNSG-LAHRLS-NPNVDVLPQSLAYVIYTSGSTGMPKGVEIE 1656
Cdd:PRK12316 2088 PAERLAYMLEDSGAALLLTQRHLLERLPLPAGVARLPLDRDAeWADYPDtAPAVQLAGENLAYVIYTSGSTGLPKGVAVS 2167
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1657 HRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVyLLPQGGEKEPEVIAKAIEEQKITAMHFVPSM 1736
Cdd:PRK12316 2168 HGALVAHCQAAGERYELSPADCELQFMSFSFDGAHEQWFHPLLNGARV-LIRDDELWDPEQLYDEMERHGVTILDFPPVY 2246
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1737 LHAFLEHIKYRSVPIKtnrLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFDCPPHEK--LERIPIGK 1814
Cdd:PRK12316 2247 LQQLAEHAERDGRPPA---VRVYCFGGEAVPAASLRLAWEALRPVYLFNGYGPTEAVVTPLLWKCRPQDPcgAAYVPIGR 2323
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1815 PVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPF-YPGERMYKTGDVARWLPDGNVEFLGRT 1893
Cdd:PRK12316 2324 ALGNRRAYILDADLNLLAPGMAGELYLGGEGLARGYLNRPGLTAERFVPDPFsASGERLYRTGDLARYRADGVVEYLGRI 2403
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1894 DDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDSGEPELCAYVEG-----LQRNEVRAQLERLLPGYMVPAYMIEME 1968
Cdd:PRK12316 2404 DHQVKIRGFRIELGEIEARLQAHPAVREAVVVAQDGASGKQLVAYVVPddaaeDLLAELRAWLAARLPAYMVPAHWVVLE 2483
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1969 QWPVTPSGKLDRNALPAPGGAADAETYTAPRNVTEMKLSQLWEDVLKNGPVGIHDNFFDRGGHSLKATALVSRITKEFDV 2048
Cdd:PRK12316 2484 RLPLNPNGKLDRKALPKPDVSQLRQAYVAPQEGLEQRLAAIWQAVLKVEQVGLDDHFFELGGHSLLATQVVSRVRQDLGL 2563
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2049 QVPLKDVFAHPTVEGLATVIREGTDSPYEAIKPAEKQETYPVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMD 2128
Cdd:PRK12316 2564 EVPLRILFERPTLAAFAASLESGQTSRAPVLQKVTRVQPLPLSHAQQRQWFLWQLEPESAAYHLPSALHLRGVLDQAALE 2643
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2129 RAFQELIKRHESLRTSFEQDeGGDPVQRIHDEVPFTLQ----TTVLGARTEQEAAAAFIKPFDLSQAPLFRAQIVKVSDE 2204
Cdd:PRK12316 2644 QAFDALVLRHETLRTRFVEV-GEQTRQVILPNMSLRIVledcAGVADAAIRQRVAEEIQRPFDLARGPLLRVRLLALDGQ 2722
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2205 RHLLLVDMHHIISDGVSVNILIQEFGELYNNRK------LPALRIQYKDYAVWQEGFKTGDAYKMQEAYWLKQLEGELPV 2278
Cdd:PRK12316 2723 EHVLVITQHHIVSDGWSMQVMVDELVQAYAGARrgeqptLPPLPLQYADYAAWQRAWMDSGEGARQLDYWRERLGGEQPV 2802
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2279 LDLPADHARPPVRSFAGDKVSFTLEPEVASGLHKLARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHKDLEP 2358
Cdd:PRK12316 2803 LELPLDRPRPALQSHRGARLDVALDVALSRELLALARREGVTLFMLLLASFQVLLHRYSGQSDIRVGVPIANRNRAETER 2882
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2359 ILGMFVNTLALRTRPEGGKPFVQYLQEVRETALEAFEHQNYPFEELVDKLELTRDMSRNPVFDAMLVVQNNDYEPLHLHD 2438
Cdd:PRK12316 2883 LIGFFVNTQVLRAQVDAQLAFRDLLGQVKEQALGAQAHQDLPFEQLVEALQPERSLSHSPLFQVMYNHQSGERAAAQLPG 2962
|
1450 1460 1470 1480 1490 1500 1510 1520
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2439 LQMKPAQVSHLVSKFDLTLQASEGDGNIHFLFEYSTALFEKTTIERWASHLTNVLSIIGKNPKVTLNHIDILTQEERHQL 2518
Cdd:PRK12316 2963 LHIESFAWDGAATQFDLALDTWESAEGLGASLTYATDLFDARTVERLARHWQNLLRGMVENPQRSVDELAMLDAEERGQL 3042
|
1530 1540 1550 1560 1570 1580 1590 1600
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2519 LNEFNTGQANQYGVQTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIA 2598
Cdd:PRK12316 3043 LEAWNATAAEYPLERGVHRLFEEQVERTPDAVALAFGEQRLSYAELNRRANRLAHRLIERGVGPDVLVGVAVERSLEMVV 3122
|
1610 1620 1630 1640 1650 1660 1670 1680
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2599 SILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMTINEADLGVLADFegEILTIESVEEDDKSPLPQM-SSAHHLAY 2677
Cdd:PRK12316 3123 GLLAILKAGGAYVPLDPEYPEERLAYMLEDSGAQLLLSQSHLRLPLAQGV--QVLDLDRGDENYAEANPAIrTMPENLAY 3200
|
1690 1700 1710 1720 1730 1740 1750 1760
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2678 IIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIK 2757
Cdd:PRK12316 3201 VIYTSGSTGKPKGVGIRHSALSNHLCWMQQAYGLGVGDRVLQFTTFSFDVFVEELFWPLMSGARVVLAGPEDWRDPALLV 3280
|
1770 1780 1790 1800 1810 1820 1830 1840
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2758 HQLSRQRITHMIIVPVLYRALLDVVQPEDVKTLRVVTLAGEAADRELIARSLAICPhteLANEYGPTENSVATTVMRHME 2837
Cdd:PRK12316 3281 ELINSEGVDVLHAYPSMLQAFLEEEDAHRCTSLKRIVCGGEALPADLQQQVFAGLP---LYNLYGPTEATITVTHWQCVE 3357
|
1850 1860 1870 1880 1890 1900 1910 1920
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2838 K-QAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKPEARMYRTGDAARWMAD 2916
Cdd:PRK12316 3358 EgKDAVPIGRPIANRACYILDGSLEPVPVGALGELYLGGEGLARGYHNRPGLTAERFVPDPFVPGERLYRTGDLARYRAD 3437
|
1930 1940 1950 1960 1970 1980 1990 2000
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2917 GTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVahvtASGQTELSAYVVTKPGLST--NAVRSELQNKLPVF 2994
Cdd:PRK12316 3438 GVIEYIGRVDHQVKIRGFRIELGEIEARLLEHPWVREAVVL----AVDGRQLVAYVVPEDEAGDlrEALKAHLKASLPEY 3513
|
2010 2020 2030 2040 2050 2060 2070 2080
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2995 MHPAFIEKLDSLPLSPNGKLDRGALPKPVYNhEGERPFLPPSSKMEQILADIWKEVLGAEKIGTADSFFELGGDSIKALQ 3074
Cdd:PRK12316 3514 MVPAHLLFLERMPLTPNGKLDRKALPRPDAA-LLQQDYVAPVNELERRLAAIWADVLKLEQVGLTDNFFELGGDSIISLQ 3592
|
2090 2100 2110 2120 2130 2140 2150 2160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3075 VSARLHRIGKQMAVKDLFSHPTIQELAAYIR-DSDTSSSQAAVEGDVQWSPVQKWFLSQDIKEKHHFNQSVMLHRSTSVQ 3153
Cdd:PRK12316 3593 VVSRARQAGIRFTPKDLFQHQTIQGLARVARvGGGVAVDQGPVSGETLLLPIQQQFFEEPVPERHHWNQSLLLKPREALD 3672
|
2170 2180 2190 2200 2210 2220 2230 2240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3154 EDALRKTLKAITCHHDALRMVFTQNEqGKWDQYNRPLSHSDDALYGLQMIDLSApdgtdgnrpyeplIKRHVLDIQQKMD 3233
Cdd:PRK12316 3673 AAALEAALQALVEHHDALRLRFVEDA-GGWTAEHLPVELGGALLWRAELDDAEE-------------LERLGEEAQRSLD 3738
|
2250 2260 2270 2280 2290 2300 2310 2320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3234 LKNGPLLQAGLFHTIDGD-FLFLSAHHLVVDGISWRVLLEDLALGYRQAAGGEDIKLPPKTSSFKAYAKKLSDYAESQQL 3312
Cdd:PRK12316 3739 LADGPLLRALLATLADGSqRLLLVIHHLVVDGVSWRILLEDLQQAYQQLLQGEAPRLPAKTSSFKAWAERLQEHARGEAL 3818
|
2330 2340 2350 2360 2370 2380 2390 2400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3313 MKQLKYWREAEEYQTEALPFDQIDGTRAHEGQRSTISfTLNDKETAALLKDANSAYNTDTQDMLLASVILALRHWTNQSA 3392
Cdd:PRK12316 3819 KAELAYWQEQLQGVSSELPCDHPQGALQNRHAASVQT-RLDRELTRRLLQQAPAAYRTQVNDLLLTALARVVCRWTGEAS 3897
|
2410 2420 2430 2440 2450 2460 2470 2480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3393 FKLSLEGHGREDVLKGIDVSRTIGWFTAIYPLLIKLNADLPDSeesmvhvLKTTKDTLRRVPDKGFGYGVIKYL-TPPGK 3471
Cdd:PRK12316 3898 ALVQLEGHGREDLFADIDLSRTVGWFTSLFPVRLSPVEDLGAS-------IKAIKEQLRAIPNKGIGFGLLRYLgDEESR 3970
|
2490 2500 2510 2520 2530 2540 2550 2560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3472 KDINFTGAPEISFNYLGQFESGRTAEvpeedAFSFSPLG--AGGDISTTWNREQSLDISAIAAEGKLTVNMTYDNARFQR 3549
Cdd:PRK12316 3971 RTLAGLPVPRITFNYLGQFDGSFDEE-----MALFVPAGesAGAEQSPDAPLDNWLSLNGRVYGGELSLDWTFSREMFEE 4045
|
2570 2580 2590 2600
....*....|....*....|....*....|....*....|....
gi 1678550997 3550 KTIEQLSETCRQFLLQLIEHCQNKSETEKTISDFDDQELTEDAL 3593
Cdd:PRK12316 4046 ATIQRLADDYAAELTALVEHCCDAERHGVTPSDFPLAGLDQARL 4089
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
4-2373 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 1588.44 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 4 ANSIQDIYPLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGkVNPQFFQNSINALVERHDIFRTIFISQN-VSSPQQVVLR 82
Cdd:PRK12316 1550 AGEIADIYPLSPMQQGMLFHSLYEQEAGDYINQLRVDVQG-LDPDRFRAAWQATVDRHEILRSGFLWQDgLEQPLQVIHK 1628
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 83 ERNVIVLEEDITHLNEAEQSqfIEQWKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLH 162
Cdd:PRK12316 1629 QVELPFAELDWRGREDLGQA--LDALAQAERQKGFDLTRAPLLRLVLVRTGEGRHHLIYTNHHILMDGWSNAQLLGEVLQ 1706
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 163 IYASYVNASPitlepVQPYGKYIKWLMEQDKEQAVSYWDHYLSGHEQQTVLPKQKKT--KGKSRQEHVTfSFSKEESSRL 240
Cdd:PRK12316 1707 RYAGQPVAAP-----GGRYRDYIAWLQRQDAAASEAFWKEQLAALEEPTRLAQAARTedGQVGYGDHQQ-LLDPAQTRAL 1780
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 241 SELAAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRPAEIEGIEHMVGLFINTMPVrvQGAKTPFLQL---IKDM 317
Cdd:PRK12316 1781 AEFARAQKVTLNTLVQAAWLLLLQRYTGQETVAFGATVAGRPAELPGIEQQIGLFINTLPV--IAAPRPDQSVadwLQEV 1858
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 318 QKDRLAAEAYSYHPLYEIQsRSAVKQG--LIDHILVFENYPVQQEiqmLNKQEHASDLF-QIHNFtvaDETNYSFYLMVA 394
Cdd:PRK12316 1859 QALNLALREHEHTPLYDIQ-RWAGQGGeaLFDSLLVFENYPVAEA---LKQGAPAGLVFgRVSNH---EQTNYPLTLAVT 1931
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 395 PGEEIHIKMNYDAEQHDRSFVLSVKEHLLNAVSQILNNPNLPPEEIDITtDTEKRQLIGEITDQT----PVYETIHAMFE 470
Cdd:PRK12316 1932 LGETLSLQYSYDRGHFDAAAIERLDRHLLHLLEQMAEDAQAALGELALL-DAGERQRILADWDRTpeayPRGPGVHQRIA 2010
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 471 KQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPAD 550
Cdd:PRK12316 2011 EQAARAPEAIAVVFGDQHLSYAELDSRANRLAHRLRARGVGPEVRVAIAAERSFELVVALLAVLKAGGAYVPLDPNYPAE 2090
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 551 RIRYILHDCGCSHVVSQAHL------PSSLEdNYIITHPEDIESKVDGSNIKSVNnADDLLYMIYTSGTTGKPKGVQFEH 624
Cdd:PRK12316 2091 RLAYMLEDSGAALLLTQRHLlerlplPAGVA-RLPLDRDAEWADYPDTAPAVQLA-GENLAYVIYTSGSTGLPKGVAVSH 2168
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 625 RNMANLLKFEYTHSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIkRDVPQLFAFINKHQTNIVFLPTAFI 704
Cdd:PRK12316 2169 GALVAHCQAAGERYELSPADCELQFMSFSFDGAHEQWFHPLLNGARVLIRDDEL-WDPEQLYDEMERHGVTILDFPPVYL 2247
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 705 KMIFSERELANSfPDGVKHLIAAGEQLMISDLFQDVLRKRGIHLHNHYGPSETHVVST-YTIHPGDPI-PELPPIGKPIG 782
Cdd:PRK12316 2248 QQLAEHAERDGR-PPAVRVYCFGGEAVPAASLRLAWEALRPVYLFNGYGPTEAVVTPLlWKCRPQDPCgAAYVPIGRALG 2326
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 783 CTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPF-KPDVIMYRTGDLARRLEDGNIEYIGRADNQ 861
Cdd:PRK12316 2327 NRRAYILDADLNLLAPGMAGELYLGGEGLARGYLNRPGLTAERFVPDPFsASGERLYRTGDLARYRADGVVEYLGRIDHQ 2406
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 862 VKIRGYRIEPQEIEVTLMNHPDISEAAIlIWQDQNGEHELCAYYC--SVQKLNTIDLRSYMASELPEYMIPAKWIWVDSI 939
Cdd:PRK12316 2407 VKIRGFRIELGEIEARLQAHPAVREAVV-VAQDGASGKQLVAYVVpdDAAEDLLAELRAWLAARLPAYMVPAHWVVLERL 2485
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 940 PLTPNGKVDRAALPEPDASISGNPYTAPRNLLEAKLSQLFEDVLKNGHIGIQDNFFDNGGHSLKATVLMSRIAKEFHVQV 1019
Cdd:PRK12316 2486 PLNPNGKLDRKALPKPDVSQLRQAYVAPQEGLEQRLAAIWQAVLKVEQVGLDDHFFELGGHSLLATQVVSRVRQDLGLEV 2565
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1020 SLKDIFAHPTVEGLALIIREAEQNLYAAIEPAEKRDTYPVSSAQKRIYVLQQLD-EGVAYNMPAVLELEGALDVAKLSAV 1098
Cdd:PRK12316 2566 PLRILFERPTLAAFAASLESGQTSRAPVLQKVTRVQPLPLSHAQQRQWFLWQLEpESAAYHLPSALHLRGVLDQAALEQA 2645
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1099 CKELISRHEPLRTSFVSGADD-----------EPVQRIHTEVPFTLSKETTIEGFVRPFDLSQAPLFRAGLIEVSNEKHV 1167
Cdd:PRK12316 2646 FDALVLRHETLRTRFVEVGEQtrqvilpnmslRIVLEDCAGVADAAIRQRVAEEIQRPFDLARGPLLRVRLLALDGQEHV 2725
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1168 LLVDMHHIISDGVSVQLLIREFTDLYANR------QLKPLRIQYKDYAVWQQKFKKGDSYQKQETYWQQQFSGDLPILEL 1241
Cdd:PRK12316 2726 LVITQHHIVSDGWSMQVMVDELVQAYAGArrgeqpTLPPLPLQYADYAAWQRAWMDSGEGARQLDYWRERLGGEQPVLEL 2805
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1242 PTDKRRPAERQFIGGKVTFQLDKEITARIKRLAHKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPHADLEAVLG 1321
Cdd:PRK12316 2806 PLDRPRPALQSHRGARLDVALDVALSRELLALARREGVTLFMLLLASFQVLLHRYSGQSDIRVGVPIANRNRAETERLIG 2885
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1322 MFVNTLALRTRPAGNKTFEEFLKEVRQTALEAYEHQDYPFEELVDKLGVQREMSRNPLFDTTLVLQNMEQQKLKMNDVQL 1401
Cdd:PRK12316 2886 FFVNTQVLRAQVDAQLAFRDLLGQVKEQALGAQAHQDLPFEQLVEALQPERSLSHSPLFQVMYNHQSGERAAAQLPGLHI 2965
|
1450 1460 1470 1480 1490 1500 1510 1520
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1402 QWNDLEHPISKFDISLYVTEHDSELFCQFEYSTALFEKETIQRWASLFTTLVEHTAASPETELDNIPILTKEEERDFIES 1481
Cdd:PRK12316 2966 ESFAWDGAATQFDLALDTWESAEGLGASLTYATDLFDARTVERLARHWQNLLRGMVENPQRSVDELAMLDAEERGQLLEA 3045
|
1530 1540 1550 1560 1570 1580 1590 1600
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1482 CHlFEETGYSMNQTLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGI 1561
Cdd:PRK12316 3046 WN-ATAAEYPLERGVHRLFEEQVERTPDAVALAFGEQRLSYAELNRRANRLAHRLIERGVGPDVLVGVAVERSLEMVVGL 3124
|
1610 1620 1630 1640 1650 1660 1670 1680
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1562 YGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLLQSAgLHVPEFTG-EIVYLNQTNSGLAHrlSNPNVDVLPQSLAYV 1640
Cdd:PRK12316 3125 LAILKAGGAYVPLDPEYPEERLAYMLEDSGAQLLLSQSH-LRLPLAQGvQVLDLDRGDENYAE--ANPAIRTMPENLAYV 3201
|
1690 1700 1710 1720 1730 1740 1750 1760
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1641 IYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAK 1720
Cdd:PRK12316 3202 IYTSGSTGKPKGVGIRHSALSNHLCWMQQAYGLGVGDRVLQFTTFSFDVFVEELFWPLMSGARVVLAGPEDWRDPALLVE 3281
|
1770 1780 1790 1800 1810 1820 1830 1840
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1721 AIEEQKITAMHFVPSMLHAFLEHIKYRSVPIktnrLKRVFSGGEQLGTHLVSRFYELLPnvsITNSYGPTEATVEAAFFD 1800
Cdd:PRK12316 3282 LINSEGVDVLHAYPSMLQAFLEEEDAHRCTS----LKRIVCGGEALPADLQQQVFAGLP---LYNLYGPTEATITVTHWQ 3354
|
1850 1860 1870 1880 1890 1900 1910 1920
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1801 CpPHEKLERIPIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYPGERMYKTGDVAR 1880
Cdd:PRK12316 3355 C-VEEGKDAVPIGRPIANRACYILDGSLEPVPVGALGELYLGGEGLARGYHNRPGLTAERFVPDPFVPGERLYRTGDLAR 3433
|
1930 1940 1950 1960 1970 1980 1990 2000
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1881 WLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVtvrTDSGEPELCAYV-----EGLQRNEVRAQLERLL 1955
Cdd:PRK12316 3434 YRADGVIEYIGRVDHQVKIRGFRIELGEIEARLLEHPWVREAVV---LAVDGRQLVAYVvpedeAGDLREALKAHLKASL 3510
|
2010 2020 2030 2040 2050 2060 2070 2080
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1956 PGYMVPAYMIEMEQWPVTPSGKLDRNALPAPGGAADAETYTAPRNVTEMKLSQLWEDVLKNGPVGIHDNFFDRGGHSLKA 2035
Cdd:PRK12316 3511 PEYMVPAHLLFLERMPLTPNGKLDRKALPRPDAALLQQDYVAPVNELERRLAAIWADVLKLEQVGLTDNFFELGGDSIIS 3590
|
2090 2100 2110 2120 2130 2140 2150 2160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2036 TALVSRItKEFDVQVPLKDVFAHPTVEGLATVIREGT-----DSPYEAIKP--AEKQETYPVSSAQKRIYVLQQLedggt 2108
Cdd:PRK12316 3591 LQVVSRA-RQAGIRFTPKDLFQHQTIQGLARVARVGGgvavdQGPVSGETLllPIQQQFFEEPVPERHHWNQSLL----- 3664
|
2170 2180 2190 2200 2210 2220 2230 2240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2109 gynmpavLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGDPVQRIHDEVPFTL--QTTVLGARTEQEAAAAFIKPF 2186
Cdd:PRK12316 3665 -------LKPREALDAAALEAALQALVEHHDALRLRFVEDAGGWTAEHLPVELGGALlwRAELDDAEELERLGEEAQRSL 3737
|
2250 2260 2270 2280 2290 2300 2310 2320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2187 DLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELYNNR------KLPALRIQYKDYAVWQEGFKTGDA 2260
Cdd:PRK12316 3738 DLADGPLLRALLATLADGSQRLLLVIHHLVVDGVSWRILLEDLQQAYQQLlqgeapRLPAKTSSFKAWAERLQEHARGEA 3817
|
2330 2340 2350 2360 2370 2380 2390 2400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2261 YKMQEAYWLKQLEGELPvlDLPADHARPPVRSFAGDKVSFTLEPEVASGLHKLARENGST-LYMVLLAAYTAFLSRLSGQ 2339
Cdd:PRK12316 3818 LKAELAYWQEQLQGVSS--ELPCDHPQGALQNRHAASVQTRLDRELTRRLLQQAPAAYRTqVNDLLLTALARVVCRWTGE 3895
|
2410 2420 2430
....*....|....*....|....*....|....*...
gi 1678550997 2340 EDIIVGSPIAGRPHK----DLEPILGMFVNTLALRTRP 2373
Cdd:PRK12316 3896 ASALVQLEGHGREDLfadiDLSRTVGWFTSLFPVRLSP 3933
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
12-2373 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 1576.32 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 12 PLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNvSSPQQVVLRERNVIVLEE 91
Cdd:PRK12467 51 PLSYAQERQWFLWQLDPDSAAYNIPTALRLRGELDVSALRRAFDALVARHESLRTRFVQDE-EGFRQVIDASLSLTIPLD 129
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 92 DITHLNEAEQSQFIEQWKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASYVNAS 171
Cdd:PRK12467 130 DLANEQGRARESQIEAYINEEVARPFDLANGPLLRVRLLRLADDEHVLVVTLHHIISDGWSMRVLVEELVQLYSAYSQGR 209
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 172 PITLE--PVQpYGKYI----KWLMEQDKEQAVSYWDHYLSGheQQTVL--------PKQKKTKGKSRQehvtFSFSKEES 237
Cdd:PRK12467 210 EPSLPalPIQ-YADYAiwqrSWLEAGERERQLAYWQEQLGG--EHTVLelptdrprPAVPSYRGARLR----VDLPQALS 282
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 238 SRLSELAAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRP-AEIEGiehMVGLFINTMPVRVQ-GAKTPFLQLIK 315
Cdd:PRK12467 283 AGLKALAQREGVTLFMVLLASFQTLLHRYSGQSDIRIGVPNANRNrVETER---LIGFFVNTQVLKAEvDPQASFLELLQ 359
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 316 DMQKDRLAAEAYSYHPLYEI---------QSRSAVKQGLIDHilvfenypvQQEIQMLNKQEhASDL--FQIHNFTVADE 384
Cdd:PRK12467 360 QVKRTALGAQAHQDLPFEQLvealqpersLSHSPLFQVMFNH---------QNTATGGRDRE-GAQLpgLTVEELSWARH 429
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 385 TNYsFYLMVAPGEE---IHIKMNYDAEQHDRSFVLSVKEHLLNAVSQILNNPNLPPEEIDITTDTEKRQLI--GEITDQT 459
Cdd:PRK12467 430 TAQ-FDLALDTYESaqgLWAAFTYATDLFEATTIERLATHWRNLLEAIVAEPRRRLGELPLLDAEERARELvrWNAPATE 508
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 460 PVYETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGA 539
Cdd:PRK12467 509 YAPDCVHQLIEAQARQHPERPALVFGEQVLSYAELNRQANRLAHVLIAAGVGPDVLVGIAVERSIEMVVGLLAVLKAGGA 588
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 540 IVPVDPHYPADRIRYILHDCGCSHVVSQAH------LPSSLEdNYIITHPEDIESKVDGSNIKSVNNADDLLYMIYTSGT 613
Cdd:PRK12467 589 YVPLDPEYPQDRLAYMLDDSGVRLLLTQSHllaqlpVPAGLR-SLCLDEPADLLCGYSGHNPEVALDPDNLAYVIYTSGS 667
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 614 TGKPKGVQFEHRNMANLlkFEYTHSGIDFEAD--VLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINK 691
Cdd:PRK12467 668 TGQPKGVAISHGALANY--VCVIAERLQLAADdsMLMVSTFAFDLGVTELFGALASGATLHLLPPDCARDAEAFAALMAD 745
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 692 HQTNIVFLPTAFIKMIFSERELANsfPDGVKHLIAAGEQLMIsDLFQDVLRKR-GIHLHNHYGPSETHV-VSTYTIHPGD 769
Cdd:PRK12467 746 QGVTVLKIVPSHLQALLQASRVAL--PRPQRALVCGGEALQV-DLLARVRALGpGARLINHYGPTETTVgVSTYELSDEE 822
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 770 PIPELPPIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPD-VIMYRTGDLARRLE 848
Cdd:PRK12467 823 RDFGNVPIGQPLANLGLYILDHYLNPVPVGVVGELYIGGAGLARGYHRRPALTAERFVPDPFGADgGRLYRTGDLARYRA 902
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 849 DGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIwQDQNGEHELCAYYCSVQKLNT-------IDLRSYMA 921
Cdd:PRK12467 903 DGVIEYLGRMDHQVKIRGFRIELGEIEARLLAQPGVREAVVLA-QPGDAGLQLVAYLVPAAVADGaehqatrDELKAQLR 981
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 922 SELPEYMIPAKWIWVDSIPLTPNGKVDRAALPEPDASISGNPYTAPRNLLEAKLSQLFEDVLKNGHIGIQDNFFDNGGHS 1001
Cdd:PRK12467 982 QVLPDYMVPAHLLLLDSLPLTPNGKLDRKALPKPDASAVQATFVAPQTELEKRLAAIWADVLKVERVGLTDNFFELGGHS 1061
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1002 LKATVLMSRIAKEFHVQVSLKDIFAHPTVEGLALIIREAEQNLYAAIEPAEKRDTYPVSSAQKRIYVLQQLDEG-VAYNM 1080
Cdd:PRK12467 1062 LLATQVISRVRQRLGIQVPLRTLFEHQTLAGFAQAVAAQQQGAQPALPDVDRDQPLPLSYAQERQWFLWQLEPGsAAYHI 1141
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1081 PAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSgADDEPVQRIHTEVPFTLSKET---------TIEGFV-----RPF 1146
Cdd:PRK12467 1142 PQALRLKGPLDIEALERSFDALVARHESLRTTFVQ-EDGRTRQVIHPVGSLTLEEPLllaadkdeaQLKVYVeaearQPF 1220
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1147 DLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYANR------QLKPLRIQYKDYAVWQQKFKKGDS 1220
Cdd:PRK12467 1221 DLEQGPLLRVGLLRLAADEHVLVLTLHHIVSDGWSMQVLVDELVALYAAYsqgqslQLPALPIQYADYAVWQRQWMDAGE 1300
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1221 YQKQETYWQQQFSGDLPILELPTDKRRPAERQFIGGKVTFQLDKEITARIKRLAHKNRSTLYMTLLALYSAFLSRLSGQD 1300
Cdd:PRK12467 1301 RARQLAYWKAQLGGEQPVLELPTDRPRPAVQSHRGARLAFELPPALAEGLRALARREGVTLFMLLLASFQTLLHRYSGQD 1380
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1301 DIVIGSPIAGRPHADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQTALEAYEHQDYPFEELVDKLGVQREMSRNPLF 1380
Cdd:PRK12467 1381 DIRVGVPIANRNRAETEGLIGFFVNTQVLRAEVDGQASFQQLLQQVKQAALEAQAHQDLPFEQLVEALQPERSLSHSPLF 1460
|
1450 1460 1470 1480 1490 1500 1510 1520
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1381 DTTLVLQNMEQQKL-KMNDVQLQWNDLEHPISKFDISLYVTEHDSELFCQFEYSTALFEKETIQRWASLFTTLVEHTAAS 1459
Cdd:PRK12467 1461 QVMFNHQRDDHQAQaQLPGLSVESLSWESQTAQFDLTLDTYESSEGLQASLTYATDLFEASTIERLAGHWLNLLQGLVAD 1540
|
1530 1540 1550 1560 1570 1580 1590 1600
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1460 PETELDNIPILTKEEERDFIESCHLfEETGYSMNQTLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGR 1539
Cdd:PRK12467 1541 PERRLGELDLLDEAERRQILEGWNA-THTGYPLARLVHQLIEDQAAATPEAVALVFGEQELTYGELNRRANRLAHRLIAL 1619
|
1610 1620 1630 1640 1650 1660 1670 1680
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1540 GVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLLQSAGL-HVPEFTG-EIVYLNQT 1617
Cdd:PRK12467 1620 GVGPEVLVGIAVERSLEMVVGLLAILKAGGAYVPLDPEYPRERLAYMIEDSGIELLLTQSHLQaRLPLPDGlRSLVLDQE 1699
|
1690 1700 1710 1720 1730 1740 1750 1760
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1618 NSGLA-HRLSNPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFW 1696
Cdd:PRK12467 1700 DDWLEgYSDSNPAVNLAPQNLAYVIYTSGSTGRPKGAGNRHGALVNRLCATQEAYQLSAADVVLQFTSFAFDVSVWELFW 1779
|
1770 1780 1790 1800 1810 1820 1830 1840
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1697 WPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKtnrLKRVFSGGEQLGTHLVSRFYE 1776
Cdd:PRK12467 1780 PLINGARLVIAPPGAHRDPEQLIQLIERQQVTTLHFVPSMLQQLLQMDEQVEHPLS---LRRVVCGGEALEVEALRPWLE 1856
|
1850 1860 1870 1880 1890 1900 1910 1920
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1777 LLPNVSITNSYGPTEATVEAAFFDCPPHEKLER--IPIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRP 1854
Cdd:PRK12467 1857 RLPDTGLFNLYGPTETAVDVTHWTCRRKDLEGRdsVPIGQPIANLSTYILDASLNPVPIGVAGELYLGGVGLARGYLNRP 1936
|
1930 1940 1950 1960 1970 1980 1990 2000
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1855 ALTEERFLEDPF-YPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDSGEP 1933
Cdd:PRK12467 1937 ALTAERFVADPFgTVGSRLYRTGDLARYRADGVIEYLGRIDHQVKIRGFRIELGEIEARLREQGGVREAVVIAQDGANGK 2016
|
2010 2020 2030 2040 2050 2060 2070 2080
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1934 ELCAYV-------------EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNALPAPGGAADAETYTAPRN 2000
Cdd:PRK12467 2017 QLVAYVvptdpglvdddeaQVALRAILKNHLKASLPEYMVPAHLVFLARMPLTPNGKLDRKALPAPDASELQQAYVAPQS 2096
|
2090 2100 2110 2120 2130 2140 2150 2160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2001 VTEMKLSQLWEDVLKNGPVGIHDNFFDRGGHSLKATALVSRiTKEFDVQVPLKDVFAHPTVEGLATVIREGTDSPyeAIK 2080
Cdd:PRK12467 2097 ELEQRLAAIWQDVLGLEQVGLHDNFFELGGDSIISIQVVSR-ARQAGIRFTPKDLFQHQTVQSLAAVAQEGDGTV--SID 2173
|
2170 2180 2190 2200 2210 2220 2230 2240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2081 PAEKQETYPVSSAQKRIYVLQQLEDggTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGG------DPV 2154
Cdd:PRK12467 2174 QGPVTGDLPLLPIQQMFFADDIPER--HHWNQSVLLEPREALDAELLEAALQALLVHHDALRLGFVQEDGGwsamhrAPE 2251
|
2250 2260 2270 2280 2290 2300 2310 2320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2155 QrihDEVPFTLQTTVL-GARTEQEAAAAfIKPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELY 2233
Cdd:PRK12467 2252 Q---ERRPLLWQVVVAdKEELEALCEQA-QRSLDLEEGPLLRAVLATLPDGSQRLLLVIHHLVVDGVSWRILLEDLQTAY 2327
|
2330 2340 2350 2360 2370 2380 2390 2400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2234 NNR------KLPALRIQYKDYAVWQEGFKTGDAYKMQEAYWLKQLEG---ELPVLDLPADHARPPVRSfagdkVSFTLEP 2304
Cdd:PRK12467 2328 RQLqggqpvKLPAKTSAFKAWAERLQTYAASAALADELGYWQAQLQGastELPCDHPQGGLQRRHAAS-----VTTHLDS 2402
|
2410 2420 2430 2440 2450 2460 2470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 2305 EVASGLHKLA-RENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGR----PHKDLEPILGMFVNTLALRTRP 2373
Cdd:PRK12467 2403 EWTRRLLQEApAAYRTQVNDLLLTALARVIARWTGQASTLIQLEGHGRedlfDEIDLTRTVGWFTSLYPVKLSP 2476
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
12-2376 |
0e+00 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 1311.31 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 12 PLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNvSSPQQVVLRERNVIVLEE 91
Cdd:PRK05691 677 PQSLAQNRLWLLWQLDPQSAAYNIPGGLHLRGELDEAALRASFQRLVERHESLRTRFYERD-GVALQRIDAQGEFALQRI 755
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 92 DITHLNEAEQSQFIEQWKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASYVNAS 171
Cdd:PRK05691 756 DLSDLPEAEREARAAQIREEEARQPFDLEKGPLLRVTLVRLDDEEHQLLVTLHHIVADGWSLNILLDEFSRLYAAACQGQ 835
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 172 PITLEPVQ-PYGKYI----KWLMEQDKEQAVSYWDHYLSGheQQTVLPKQKKTKGKSRQEHVTFSFSKEESSRLSE---- 242
Cdd:PRK05691 836 TAELAPLPlGYADYGawqrQWLAQGEAARQLAYWKAQLGD--EQPVLELATDHPRSARQAHSAARYSLRVDASLSEalrg 913
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 243 LAAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRP-AEIEGiehMVGLFINTMPVRVQ-GAKTPFLQLIKDMQKD 320
Cdd:PRK05691 914 LAQAHQATLFMVLLAAFQALLHRYSGQGDIRIGVPNANRPrLETQG---LVGFFINTQVLRAQlDGRLPFTALLAQVRQA 990
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 321 RLAAEAYSYHPLYEiqsrsavkqglidhilVFENYPVQQEIQ----MLNKQEHasDLFQIHNF--TVADETNY-----SF 389
Cdd:PRK05691 991 TLGAQAHQDLPFEQ----------------LVEALPQAREQGlfqvMFNHQQR--DLSALRRLpgLLAEELPWhsreaKF 1052
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 390 YLMVAPGEE----IHIKMNYDAEQHDRSFVLSVKEHLLNAVSQILNNPNLPPEEIDITTDTEKRQLIG-EITDQTPVYET 464
Cdd:PRK05691 1053 DLQLHSEEDrngrLTLSFDYAAELFDAATIERLAEHFLALLEQVCEDPQRALGDVQLLDAAERAQLAQwGQAPCAPAQAW 1132
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 465 IHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVD 544
Cdd:PRK05691 1133 LPELLNEQARQTPERIALVWDGGSLDYAELHAQANRLAHYLRDKGVGPDVCVAIAAERSPQLLVGLLAILKAGGAYVPLD 1212
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 545 PHYPADRIRYILHDCGCSHVVSQAHLPSSLEDNYIIT-------HPEDIESKVDGSNIksvnNADDLLYMIYTSGTTGKP 617
Cdd:PRK05691 1213 PDYPAERLAYMLADSGVELLLTQSHLLERLPQAEGVSaialdslHLDSWPSQAPGLHL----HGDNLAYVIYTSGSTGQP 1288
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 618 KGVQFEHRNMANLLKFEYTHSGIDfEADVL-QFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQ-TN 695
Cdd:PRK05691 1289 KGVGNTHAALAERLQWMQATYALD-DSDVLmQKAPISFDVSVWECFWPLITGCRLVLAGPGEHRDPQRIAELVQQYGvTT 1367
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 696 IVFLPtAFIKMIFSERELANSfpDGVKHLIAAGEQLMiSDLFQDVL-RKRGIHLHNHYGPSETHVVSTYTiHPGDPIPEL 774
Cdd:PRK05691 1368 LHFVP-PLLQLFIDEPLAAAC--TSLRRLFSGGEALP-AELRNRVLqRLPQVQLHNRYGPTETAINVTHW-QCQAEDGER 1442
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 775 PPIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPD-VIMYRTGDLARRLEDGNIE 853
Cdd:PRK05691 1443 SPIGRPLGNVLCRVLDAELNLLPPGVAGELCIGGAGLARGYLGRPALTAERFVPDPLGEDgARLYRTGDRARWNADGALE 1522
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 854 YIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEhELCAYYCSV--QKLNTIDLRSYMASELPEYMIPA 931
Cdd:PRK05691 1523 YLGRLDQQVKLRGFRVEPEEIQARLLAQPGVAQAAVLVREGAAGA-QLVGYYTGEagQEAEAERLKAALAAELPEYMVPA 1601
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 932 KWIWVDSIPLTPNGKVDRAALPEPDASIsgNPYTAPRNLLEAKLSQLFEDVLKNGHIGIQDNFFDNGGHSLKATVLMSRI 1011
Cdd:PRK05691 1602 QLIRLDQMPLGPSGKLDRRALPEPVWQQ--REHVEPRTELQQQIAAIWREVLGLPRVGLRDDFFALGGHSLLATQIVSRT 1679
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1012 AKEFHVQVSLKDIFAHPT----VEGLALIIREAEQNLYAAIEPAEKRDTYPVSSAQKRIYVLQQLD-EGVAYNMPAVLEL 1086
Cdd:PRK05691 1680 RQACDVELPLRALFEASElgafAEQVARIQAAGERNSQGAIARVDRSQPVPLSYSQQRMWFLWQMEpDSPAYNVGGMARL 1759
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1087 EGALDVAKLSAVCKELISRHEPLRTSFVSgADDEPVQRIHTEVPFTLSKE--TTIEGFVR--------------PFDLSQ 1150
Cdd:PRK05691 1760 SGVLDVDRFEAALQALILRHETLRTTFPS-VDGVPVQQVAEDSGLRMDWQdfSALPADARqqrlqqladseahqPFDLER 1838
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1151 APLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLY----ANRQ--LKPLRIQYKDYAVWQQKFKKGDSYQKQ 1224
Cdd:PRK05691 1839 GPLLRACLVKAAEREHYFVLTLHHIVTEGWAMDIFARELGALYeaflDDREspLEPLPVQYLDYSVWQRQWLESGERQRQ 1918
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1225 ETYWQQQFSGDLPILELPTDKRRPAERQFIGGKVTFQLDKEITARIKRLAHKNRSTLYMTLLALYSAFLSRLSGQDDIVI 1304
Cdd:PRK05691 1919 LDYWKAQLGNEHPLLELPADRPRPPVQSHRGELYRFDLSPELAARVRAFNAQRGLTLFMTMTATLAALLYRYSGQRDLRI 1998
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1305 GSPIAGRPHADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQTALEAYEHQDYPFEELVDKLGVQREMSRNPLFDTTL 1384
Cdd:PRK05691 1999 GAPVANRIRPESEGLIGAFLNTQVLRCQLDGQMSVSELLEQVRQTVIEGQSHQDLPFDHLVEALQPPRSAAYNPLFQVMC 2078
|
1450 1460 1470 1480 1490 1500 1510 1520
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1385 VLQNME-QQKLKMNDVQLQW--NDLEhpISKFDISLYVTEHDSELFCQFEYSTALFEKETIQRWASLFTTLVEHTAASPE 1461
Cdd:PRK05691 2079 NVQRWEfQQSRQLAGMTVEYlvNDAR--ATKFDLNLEVTDLDGRLGCCLTYSRDLFDEPRIARMAEHWQNLLEALLGDPQ 2156
|
1530 1540 1550 1560 1570 1580 1590 1600
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1462 TELDNIPILTKEEERDFIESchLFEETG-YSMNQTLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRG 1540
Cdd:PRK05691 2157 QRLAELPLLAAAEQQQLLDS--LAGEAGeARLDQTLHGLFAAQAARTPQAPALTFAGQTLSYAELDARANRLARALRERG 2234
|
1610 1620 1630 1640 1650 1660 1670 1680
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1541 VKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLLQSAGLhvpEFTGEIVY------L 1614
Cdd:PRK05691 2235 VGPQVRVGLALERSLEMVVGLLAILKAGGAYVPLDPEYPLERLHYMIEDSGIGLLLSDRALF---EALGELPAgvarwcL 2311
|
1690 1700 1710 1720 1730 1740 1750 1760
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1615 NQTNSGLAHRLSNPNVDV-LPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWE 1693
Cdd:PRK05691 2312 EDDAAALAAYSDAPLPFLsLPQHQAYLIYTSGSTGKPKGVVVSHGEIAMHCQAVIERFGMRADDCELHFYSINFDAASER 2391
|
1770 1780 1790 1800 1810 1820 1830 1840
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1694 LFWWPYAGASVYLLPQgGEKEPEVIAKAIEEQKITAMHFVP---SMLHAFLEHiKYRSVPIKTnrlkrVFSGGEQL-GTH 1769
Cdd:PRK05691 2392 LLVPLLCGARVVLRAQ-GQWGAEEICQLIREQQVSILGFTPsygSQLAQWLAG-QGEQLPVRM-----CITGGEALtGEH 2464
|
1850 1860 1870 1880 1890 1900 1910 1920
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1770 LvSRFYELLPNVSITNSYGPTEATVEAafFDCPPHEKLER----IPIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAG 1845
Cdd:PRK05691 2465 L-QRIRQAFAPQLFFNAYGPTETVVMP--LACLAPEQLEEgaasVPIGRVVGARVAYILDADLALVPQGATGELYVGGAG 2541
|
1930 1940 1950 1960 1970 1980 1990 2000
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1846 VARGYLNRPALTEERFLEDPFYP-GERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAV 1924
Cdd:PRK05691 2542 LAQGYHDRPGLTAERFVADPFAAdGGRLYRTGDLVRLRADGLVEYVGRIDHQVKIRGFRIELGEIESRLLEHPAVREAVV 2621
|
2010 2020 2030 2040 2050 2060 2070 2080
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1925 TVRTDSGEPELCAYVEGLQ-----------RNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNALPAPGGAADAE 1993
Cdd:PRK05691 2622 LALDTPSGKQLAGYLVSAVagqddeaqaalREALKAHLKQQLPDYMVPAHLILLDSLPLTANGKLDRRALPAPDPELNRQ 2701
|
2090 2100 2110 2120 2130 2140 2150 2160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1994 TYTAPRNVTEMKLSQLWEDVLKNGPVGIHDNFFDRGGHSLKATALVSRiTKEFDVQVPLKDVFAHPTVEGLATVIregTD 2073
Cdd:PRK05691 2702 AYQAPRSELEQQLAQIWREVLNVERVGLGDNFFELGGDSILSIQVVSR-ARQLGIHFSPRDLFQHQTVQTLAAVA---TH 2777
|
2170 2180 2190 2200 2210 2220 2230 2240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2074 SPYEAIKPAEKQETYPVSSAQKRIYVLQQLEDggTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGdp 2153
Cdd:PRK05691 2778 SEAAQAEQGPLQGASGLTPIQHWFFDSPVPQP--QHWNQALLLEPRQALDPALLEQALQALVEHHDALRLRFSQADGR-- 2853
|
2250 2260 2270 2280 2290 2300 2310 2320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2154 VQRIHDEV---PFTLQTTVLGARTEQEAAAAFIKPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFG 2230
Cdd:PRK05691 2854 WQAEYRAVtaqELLWQVTVADFAECAALFADAQRSLDLQQGPLLRALLVDGPQGQQRLLLAIHHLVVDGVSWRVLLEDLQ 2933
|
2330 2340 2350 2360 2370 2380 2390 2400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2231 ELYNNR------KLPALRIQYKDYAVWQEGFKTGDAYKMQEAYWLKQLEGelPVLDLPADHARPPVRSFAGDKVSFTLEP 2304
Cdd:PRK05691 2934 ALYRQLsagaepALPAKTSAFRDWAARLQAYAGSESLREELGWWQAQLGG--PRAELPCDRPQGGNLNRHAQTVSVRLDA 3011
|
2410 2420 2430 2440 2450 2460 2470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 2305 EVASGLHKLARENGST-LYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHK----DLEPILGMFVNTLALRTRPEGG 2376
Cdd:PRK05691 3012 ERTRQLLQQAPAAYRTqVNDLLLTALARVLCRWSGQPSVLVQLEGHGREALfddiDLTRSVGWFTSAYPLRLTPAPG 3088
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
2064-3599 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 1187.06 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2064 LATVIREGTD----SPYEAIKPAEKQetyPVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHE 2139
Cdd:PRK12316 25 LATLRGEGVDfslfPIPAGVSSAERD---RLSYAQQRMWFLWQLEPQSGAYNLPSAVRLNGPLDRQALERAFASLVQRHE 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2140 SLRTSFEQdEGGDPVQRIHDEVPFTLQ--------TTVLGARTEQEAAAAFIKPFDLSQAPLFRAQIVKVSDERHLLLVD 2211
Cdd:PRK12316 102 TLRTVFPR-GADDSLAQVPLDRPLEVEfedcsglpEAEQEARLRDEAQRESLQPFDLCEGPLLRVRLLRLGEEEHVLLLT 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2212 MHHIISDGVSVNILIQEFGELYNNR------KLPALRIQYKDYAVWQEGFKTGDAYKMQEAYWLKQLEGELPVLDLPADH 2285
Cdd:PRK12316 181 LHHIVSDGWSMNVLIEEFSRFYSAYatgaepGLPALPIQYADYALWQRSWLEAGEQERQLEYWRAQLGEEHPVLELPTDH 260
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2286 ARPPVRSFAGDKVSFTLEPEVASGLHKLARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHKDLEPILGMFVN 2365
Cdd:PRK12316 261 PRPAVPSYRGSRYEFSIDPALAEALRGTARRQGLTLFMLLLGAFNVLLHRYSGQTDIRVGVPIANRNRAEVEGLIGFFVN 340
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2366 TLALRTRPEGGKPFVQYLQEVRETALEAFEHQNYPFEELVDKLELTRDMSRNPVFDAMLVVQN--NDYEPL-HLHDLQMK 2442
Cdd:PRK12316 341 TQVLRSVFDGRTRVATLLAGVKDTVLGAQAHQDLPFERLVEALKVERSLSHSPLFQVMYNHQPlvADIEALdTVAGLEFG 420
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2443 PAQVSHLVSKFDLTLQASEGDGNIHFLFEYSTALFEKTTIERWASHLTNVLSIIGKNPKVTLNHIDILTQEERHQLLNEF 2522
Cdd:PRK12316 421 QLEWKSRTTQFDLTLDTYEKGGRLHAALTYATDLFEARTVERMARHWQNLLRGMVENPQARVDELPMLDAEERGQLVEGW 500
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2523 NTGQANQYGVQTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILG 2602
Cdd:PRK12316 501 NATAAEYPLQRGVHRLFEEQVERTPEAPALAFGEETLDYAELNRRANRLAHALIERGVGPDVLVGVAMERSIEMVVALLA 580
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2603 VWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMTinEADLGVLADFEGEILTIE------SVEEDDKSPLPQMSSAHHLA 2676
Cdd:PRK12316 581 ILKAGGAYVPLDPEYPAERLAYMLEDSGVQLLLS--QSHLGRKLPLAAGVQVLDldrpaaWLEGYSEENPGTELNPENLA 658
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2677 YIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAI 2756
Cdd:PRK12316 659 YVIYTSGSTGKPKGAGNRHRALSNRLCWMQQAYGLGVGDTVLQKTPFSFDVSVWEFFWPLMSGARLVVAAPGDHRDPAKL 738
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2757 KHQLSRQRITHMIIVPVLYRALLDVVQPEDVKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTENSV-ATTVMRH 2835
Cdd:PRK12316 739 VELINREGVDTLHFVPSMLQAFLQDEDVASCTSLRRIVCSGEALPADAQEQVFAKLPQAGLYNLYGPTEAAIdVTHWTCV 818
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2836 MEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKPEARMYRTGDAARWMA 2915
Cdd:PRK12316 819 EEGGDSVPIGRPIANLACYILDANLEPVPVGVLGELYLAGRGLARGYHGRPGLTAERFVPSPFVAGERMYRTGDLARYRA 898
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2916 DGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAhvtASGQtELSAYVV-TKPGLST-NAVRSELQNKLPV 2993
Cdd:PRK12316 899 DGVIEYAGRIDHQVKLRGLRIELGEIEARLLEHPWVREAAVLA---VDGK-QLVGYVVlESEGGDWrEALKAHLAASLPE 974
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2994 FMHPAFIEKLDSLPLSPNGKLDRGALPKPVYNhEGERPFLPPSSKMEQILADIWKEVLGAEKIGTADSFFELGGDSIKAL 3073
Cdd:PRK12316 975 YMVPAQWLALERLPLTPNGKLDRKALPAPEAS-VAQQGYVAPRNALERTLAAIWQDVLGVERVGLDDNFFELGGDSIVSI 1053
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3074 QVSARLHRIGKQMAVKDLFSHPTIQELA-AYIRDSDTSSSQAAVEGDVQWSPVQKWFLSQDIKEKHHFNQSVMLHRSTSV 3152
Cdd:PRK12316 1054 QVVSRARQAGIQLSPRDLFQHQTIRSLAlVAKAGQATAADQGPASGEVALAPVQRWFFEQAIPQRQHWNQSLLLQARQPL 1133
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3153 QEDALRKTLKAITCHHDALRMVFTQnEQGKWDQ-YNRPlsHSDDALYGLQMIDLSApdgtdgnrpyeplIKRHVLDIQQK 3231
Cdd:PRK12316 1134 DPDRLGRALERLVAHHDALRLRFRE-EDGGWQQaYAAP--QAGEVLWQRQAASEEE-------------LLALCEEAQRS 1197
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3232 MDLKNGPLLQAGLFHTIDG-DFLFLSAHHLVVDGISWRVLLEDLALGYRQAaggeDIKLPPKTSSFKAYAKKLSDYAESq 3310
Cdd:PRK12316 1198 LDLEQGPLLRALLVDMADGsQRLLLVIHHLVVDGVSWRILLEDLQRAYADL----DADLPARTSSYQAWARRLHEHAGA- 1272
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3311 qLMKQLKYWREAEEYQTEALPFDQIDGTRAHEGQRsTISFTLNDKETAALLKDANSAYNTDTQDMLLASVILALRHWTNQ 3390
Cdd:PRK12316 1273 -RAEELDYWQAQLEDAPHELPCENPDGALENRHER-KLELRLDAERTRQLLQEAPAAYRTQVNDLLLTALARVTCRWSGQ 1350
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3391 SAFKLSLEGHGREDVLKGIDVSRTIGWFTAIYPLLIKLNADLPDSeesmvhvLKTTKDTLRRVPDKGFGYGVIKYL-TPP 3469
Cdd:PRK12316 1351 ASVLVQLEGHGREDLFEDIDLSRTVGWFTSLFPVRLTPAADLGES-------IKAIKEQLRAVPDKGIGYGLLRYLaGEE 1423
|
1450 1460 1470 1480 1490 1500 1510 1520
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3470 GKKDINFTGAPEISFNYLGQF--------------ESGRTAEVPEedafsfSPLGAggdisttWnreqsLDISAIAAEGK 3535
Cdd:PRK12316 1424 AAARLAALPQPRITFNYLGQFdrqfdeaalfvpatESAGAAQDPC------APLAN-------W-----LSIEGQVYGGE 1485
|
1530 1540 1550 1560 1570 1580 1590
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 3536 LTVNMTYDNARFQRKTIEQLSETCRQFLLQLIEHCQNKSETEKTISDFDDQELTE---DAL----QEIADM 3599
Cdd:PRK12316 1486 LSLHWSFSREMFAEATVQRLADDYARELQALIEHCCDERNRGVTPSDFPLAGLSQaqlDALplpaGEIADI 1556
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
1046-2328 |
0e+00 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 1118.78 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1046 AAIEPAEKRDTYPVSSAQKRIYVLQQLDEGVAYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSGADDEPVQRI 1125
Cdd:COG1020 7 AALPPAAAAAPLPLSAAQQRLWLLLLLLLGSAAYNLALALLLLGLLLVAALLLLAALLARRRRALRTRLRTRAGRPVQVI 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1126 HTEVPFTL----------------SKETTIEGFVRPFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREF 1189
Cdd:COG1020 87 QPVVAAPLpvvvllvdlealaeaaAEAAAAAEALAPFDLLRGPLLRLLLLLLLLLLLLLLLALHHIISDGLSDGLLLAEL 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1190 TDLY------ANRQLKPLRIQYKDYAVWQQKFKKGDSYQKQETYWQQQFSGDLPILELPTDKRRPAERQFIGGKVTFQLD 1263
Cdd:COG1020 167 LRLYlaayagAPLPLPPLPIQYADYALWQREWLQGEELARQLAYWRQQLAGLPPLLELPTDRPRPAVQSYRGARVSFRLP 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1264 KEITARIKRLAHKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPHADLEAVLGMFVNTLALRTRPAGNKTFEEFL 1343
Cdd:COG1020 247 AELTAALRALARRHGVTLFMVLLAAFALLLARYSGQDDVVVGTPVAGRPRPELEGLVGFFVNTLPLRVDLSGDPSFAELL 326
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1344 KEVRQTALEAYEHQDYPFEELVDKLGVQREMSRNPLFDTTLVLQNMEQQKLKMNDVQLQWNDLEHPISKFDISLYVTEHD 1423
Cdd:COG1020 327 ARVRETLLAAYAHQDLPFERLVEELQPERDLSRNPLFQVMFVLQNAPADELELPGLTLEPLELDSGTAKFDLTLTVVETG 406
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1424 SELFCQFEYSTALFEKETIQRWASLFTTLVEHTAASPETELDNIPILTKEEERDFIESchlFEETG--YSMNQTLHYALE 1501
Cdd:COG1020 407 DGLRLTLEYNTDLFDAATIERMAGHLVTLLEALAADPDQPLGDLPLLTAAERQQLLAE---WNATAapYPADATLHELFE 483
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1502 QQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEE 1581
Cdd:COG1020 484 AQAARTPDAVAVVFGDQSLTYAELNARANRLAHHLRALGVGPGDLVGVCLERSLEMVVALLAVLKAGAAYVPLDPAYPAE 563
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1582 RISFLLEDSGTNILLLQSAGL-HVPEFTGEIVYLNQTNSGlAHRLSNPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSA 1660
Cdd:COG1020 564 RLAYMLEDAGARLVLTQSALAaRLPELGVPVLALDALALA-AEPATNPPVPVTPDDLAYVIYTSGSTGRPKGVMVEHRAL 642
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1661 VNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPSMLHAF 1740
Cdd:COG1020 643 VNLLAWMQRRYGLGPGDRVLQFASLSFDASVWEIFGALLSGATLVLAPPEARRDPAALAELLARHRVTVLNLTPSLLRAL 722
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1741 LEHikyrsVPIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFDCPPHEKL-ERIPIGKPVHHV 1819
Cdd:COG1020 723 LDA-----APEALPSLRLVLVGGEALPPELVRRWRARLPGARLVNLYGPTETTVDSTYYEVTPPDADgGSVPIGRPIANT 797
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1820 RLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPF-YPGERMYKTGDVARWLPDGNVEFLGRTDDQVK 1898
Cdd:COG1020 798 RVYVLDAHLQPVPVGVPGELYIGGAGLARGYLNRPELTAERFVADPFgFPGARLYRTGDLARWLPDGNLEFLGRADDQVK 877
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1899 IRGYRIEPGEIEAALRSIEGVREAAVTVRTD-SGEPELCAYV-----EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPV 1972
Cdd:COG1020 878 IRGFRIELGEIEAALLQHPGVREAVVVAREDaPGDKRLVAYVvpeagAAAAAALLRLALALLLPPYMVPAAVVLLLPLPL 957
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1973 TPSGKLDRNALPAPgGAADAETYTAPRNVTEMKLSQLWEDVLKNGPVGIHDNFFDRGGHSLKATALVSRITKEFDVQVPL 2052
Cdd:COG1020 958 TGNGKLDRLALPAP-AAAAAAAAAAPPAEEEEEEAALALLLLLVVVVGDDDFFFFGGGLGLLLLLALARAARLLLLLLLL 1036
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2053 KDVFAHPTVEGLATVIREGTDSPYEAIKPAEKQETYPVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQ 2132
Cdd:COG1020 1037 LLLFLAAAAAAAAAAAAAAAAAAAAPLAAAAAPLPLPPLLLSLLALLLALLLLLALLALLALLLLLLLLLLLLALLLLLA 1116
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2133 ELIKRHESLRTSF-----EQDEGGDPVQRIHDEVPFTLQTTVLGARTEQEAAAAFIKPFDLSQAPLFRAQIVKVSDERHL 2207
Cdd:COG1020 1117 LLLALLAALRARRavrqeGPRLRLLVALAAALALAALLALLLAAAAAAAELLAAAALLLLLALLLLALLLLLLLLLLLLL 1196
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2208 LLVDMHHIISDGVSVNILIQEFGELY------NNRKLPALRIQYKDYAVWQEGFKTGDAYKMQEAYWLKQLEGELPVLDL 2281
Cdd:COG1020 1197 LLLLLLLLLLLLLLLLLLLLLLLLLLllaaaaAALLALALLLALLALAALLALAALAALAAALLALALALLALALLLLAL 1276
|
1290 1300 1310 1320
....*....|....*....|....*....|....*....|....*..
gi 1678550997 2282 PADHARPPVRSFAGDKVSFTLEPEVASGLHKLARENGSTLYMVLLAA 2328
Cdd:COG1020 1277 ALLLPALARARAARTARALALLLLLALLLLLALALALLLLLLLLLAL 1323
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
2077-3386 |
0e+00 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 1089.12 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2077 EAIKPAEKQETYPVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGgDPVQR 2156
Cdd:COG1020 7 AALPPAAAAAPLPLSAAQQRLWLLLLLLLGSAAYNLALALLLLGLLLVAALLLLAALLARRRRALRTRLRTRAG-RPVQV 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2157 IHDEVPFTLQTTVL--------GARTEQEAAAAFIKPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQE 2228
Cdd:COG1020 86 IQPVVAAPLPVVVLlvdlealaEAAAEAAAAAEALAPFDLLRGPLLRLLLLLLLLLLLLLLLALHHIISDGLSDGLLLAE 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2229 FGELYN------NRKLPALRIQYKDYAVWQEGFKTGDAYKMQEAYWLKQLEGELPVLDLPADHARPPVRSFAGDKVSFTL 2302
Cdd:COG1020 166 LLRLYLaayagaPLPLPPLPIQYADYALWQREWLQGEELARQLAYWRQQLAGLPPLLELPTDRPRPAVQSYRGARVSFRL 245
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2303 EPEVASGLHKLARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHKDLEPILGMFVNTLALRTRPEGGKPFVQY 2382
Cdd:COG1020 246 PAELTAALRALARRHGVTLFMVLLAAFALLLARYSGQDDVVVGTPVAGRPRPELEGLVGFFVNTLPLRVDLSGDPSFAEL 325
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2383 LQEVRETALEAFEHQNYPFEELVDKLELTRDMSRNPVFDAMLVVQNNDYEPLHLHDLQMKPAQVSHLVSKFDLTLQASEG 2462
Cdd:COG1020 326 LARVRETLLAAYAHQDLPFERLVEELQPERDLSRNPLFQVMFVLQNAPADELELPGLTLEPLELDSGTAKFDLTLTVVET 405
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2463 DGNIHFLFEYSTALFEKTTIERWASHLTNVLSIIGKNPKVTLNHIDILTQEERHQLLNEFNTGQANQYGVQTISQLFEQQ 2542
Cdd:COG1020 406 GDGLRLTLEYNTDLFDAATIERMAGHLVTLLEALAADPDQPLGDLPLLTAAERQQLLAEWNATAAPYPADATLHELFEAQ 485
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2543 AARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERK 2622
Cdd:COG1020 486 AARTPDAVAVVFGDQSLTYAELNARANRLAHHLRALGVGPGDLVGVCLERSLEMVVALLAVLKAGAAYVPLDPAYPAERL 565
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2623 RYILSDSGTKLLMTiNEADLGVLADFEGEILTIESVE--EDDKSPLPQMSSAHHLAYIIYTSGTTGRPKGVMVEHKGIAN 2700
Cdd:COG1020 566 AYMLEDAGARLVLT-QSALAARLPELGVPVLALDALAlaAEPATNPPVPVTPDDLAYVIYTSGSTGRPKGVMVEHRALVN 644
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2701 TLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLYRALLD 2780
Cdd:COG1020 645 LLAWMQRRYGLGPGDRVLQFASLSFDASVWEIFGALLSGATLVLAPPEARRDPAALAELLARHRVTVLNLTPSLLRALLD 724
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2781 VVqPEDVKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTENSVATTVMR---HMEKQAYVSIGQPIDGTQVLILN 2857
Cdd:COG1020 725 AA-PEALPSLRLVLVGGEALPPELVRRWRARLPGARLVNLYGPTETTVDSTYYEvtpPDADGGSVPIGRPIANTRVYVLD 803
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2858 SNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFK-PEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRV 2936
Cdd:COG1020 804 AHLQPVPVGVPGELYIGGAGLARGYLNRPELTAERFVADPFGfPGARLYRTGDLARWLPDGNLEFLGRADDQVKIRGFRI 883
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2937 ETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTNA--VRSELQNKLPVFMHPAFIEKLDSLPLSPNGKL 3014
Cdd:COG1020 884 ELGEIEAALLQHPGVREAVVVAREDAPGDKRLVAYVVPEAGAAAAAalLRLALALLLPPYMVPAAVVLLLPLPLTGNGKL 963
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3015 DRGALPKPVYNHEGERPFLPPSSkmEQILADIWKEVLGAEKIGTADSFFELGGDSIKALQVSARLHRIGKQMAVKDLFSH 3094
Cdd:COG1020 964 DRLALPAPAAAAAAAAAAPPAEE--EEEEAALALLLLLVVVVGDDDFFFFGGGLGLLLLLALARAARLLLLLLLLLLLFL 1041
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3095 PTIQELAAYIRDSDTSSSQAAVEGDVQWSPVQKWFLSQDIKEKHHFNQSVMLHRSTSVQEDALRKTLKAITCHHDALRMV 3174
Cdd:COG1020 1042 AAAAAAAAAAAAAAAAAAAAPLAAAAAPLPLPPLLLSLLALLLALLLLLALLALLALLLLLLLLLLLLALLLLLALLLAL 1121
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3175 FTQNEQGKWDQYNRPLSHSDDALYGLQMIDLSAPDGTDGNRPYEPLIKRHVLDIQQKMDLKNGPLLQAGLFHTIDgdfLF 3254
Cdd:COG1020 1122 LAALRARRAVRQEGPRLRLLVALAAALALAALLALLLAAAAAAAELLAAAALLLLLALLLLALLLLLLLLLLLLL---LL 1198
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3255 LSAHHLVVDGISWRVLLEDLALGYRQAAGGEDIKLPPKTSSFKAYAKKLSDYAESQQLMKQLKYWREAEEYQTEALPFDQ 3334
Cdd:COG1020 1199 LLLLLLLLLLLLLLLLLLLLLLLLLLAAAAAALLALALLLALLALAALLALAALAALAAALLALALALLALALLLLALAL 1278
|
1290 1300 1310 1320 1330
....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 3335 IDGTRAHEGQRSTiSFTLNDKETAALLKDANSAYNTDTQDMLLASVILALRH 3386
Cdd:COG1020 1279 LLPALARARAART-ARALALLLLLALLLLLALALALLLLLLLLLALLLLALL 1329
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1047-2375 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 969.43 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1047 AIEPAEKRDtyPVSSAQKRIYVLQQLDEGV-AYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSGADDEpVQRI 1125
Cdd:PRK12316 42 AGVSSAERD--RLSYAQQRMWFLWQLEPQSgAYNLPSAVRLNGPLDRQALERAFASLVQRHETLRTVFPRGADDS-LAQV 118
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1126 HTEVPFTLSK-------ETTIEGFVR---------PFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREF 1189
Cdd:PRK12316 119 PLDRPLEVEFedcsglpEAEQEARLRdeaqreslqPFDLCEGPLLRVRLLRLGEEEHVLLLTLHHIVSDGWSMNVLIEEF 198
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1190 TDLY------ANRQLKPLRIQYKDYAVWQQKFKKGDSYQKQETYWQQQFSGDLPILELPTDKRRPAERQFIGGKVTFQLD 1263
Cdd:PRK12316 199 SRFYsayatgAEPGLPALPIQYADYALWQRSWLEAGEQERQLEYWRAQLGEEHPVLELPTDHPRPAVPSYRGSRYEFSID 278
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1264 KEITARIKRLAHKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPHADLEAVLGMFVNTLALRTRPAGNKTFEEFL 1343
Cdd:PRK12316 279 PALAEALRGTARRQGLTLFMLLLGAFNVLLHRYSGQTDIRVGVPIANRNRAEVEGLIGFFVNTQVLRSVFDGRTRVATLL 358
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1344 KEVRQTALEAYEHQDYPFEELVDKLGVQREMSRNPLFDTTLVLQNM--EQQKLK----MNDVQLQWNDlehPISKFDISL 1417
Cdd:PRK12316 359 AGVKDTVLGAQAHQDLPFERLVEALKVERSLSHSPLFQVMYNHQPLvaDIEALDtvagLEFGQLEWKS---RTTQFDLTL 435
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1418 YVTEHDSELFCQFEYSTALFEKETIQRWASLFTTLVEHTAASPETELDNIPILTKEEERDFIESCHLFEEtGYSMNQTLH 1497
Cdd:PRK12316 436 DTYEKGGRLHAALTYATDLFEARTVERMARHWQNLLRGMVENPQARVDELPMLDAEERGQLVEGWNATAA-EYPLQRGVH 514
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1498 YALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPD 1577
Cdd:PRK12316 515 RLFEEQVERTPEAPALAFGEETLDYAELNRRANRLAHALIERGVGPDVLVGVAMERSIEMVVALLAILKAGGAYVPLDPE 594
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1578 YPEERISFLLEDSGTNILLLQSAGLHVPEFTGEIVYLNQTNSGL---AHRLSNPNVDVLPQSLAYVIYTSGSTGMPKGVE 1654
Cdd:PRK12316 595 YPAERLAYMLEDSGVQLLLSQSHLGRKLPLAAGVQVLDLDRPAAwleGYSEENPGTELNPENLAYVIYTSGSTGKPKGAG 674
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1655 IEHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVP 1734
Cdd:PRK12316 675 NRHRALSNRLCWMQQAYGLGVGDTVLQKTPFSFDVSVWEFFWPLMSGARLVVAAPGDHRDPAKLVELINREGVDTLHFVP 754
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1735 SMLHAFLEHIKYRSVpiktNRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFDCpPHEKLERIPIGK 1814
Cdd:PRK12316 755 SMLQAFLQDEDVASC----TSLRRIVCSGEALPADAQEQVFAKLPQAGLYNLYGPTEAAIDVTHWTC-VEEGGDSVPIGR 829
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1815 PVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYPGERMYKTGDVARWLPDGNVEFLGRTD 1894
Cdd:PRK12316 830 PIANLACYILDANLEPVPVGVLGELYLAGRGLARGYHGRPGLTAERFVPSPFVAGERMYRTGDLARYRADGVIEYAGRID 909
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1895 DQVKIRGYRIEPGEIEAALRSIEGVREAAVTVrtdSGEPELCAYV-----EGLQRNEVRAQLERLLPGYMVPAYMIEMEQ 1969
Cdd:PRK12316 910 HQVKLRGLRIELGEIEARLLEHPWVREAAVLA---VDGKQLVGYVvleseGGDWREALKAHLAASLPEYMVPAQWLALER 986
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1970 WPVTPSGKLDRNALPAPGGAADAETYTAPRNVTEMKLSQLWEDVLKNGPVGIHDNFFDRGGHSLKATALVSRiTKEFDVQ 2049
Cdd:PRK12316 987 LPLTPNGKLDRKALPAPEASVAQQGYVAPRNALERTLAAIWQDVLGVERVGLDDNFFELGGDSIVSIQVVSR-ARQAGIQ 1065
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2050 VPLKDVFAHPTVEGLATVIREGTDSPYEAiKPAEKQetYPVSSAQKRIYvlQQLEDGGTGYNMPAVLELEGKLNPERMDR 2129
Cdd:PRK12316 1066 LSPRDLFQHQTIRSLALVAKAGQATAADQ-GPASGE--VALAPVQRWFF--EQAIPQRQHWNQSLLLQARQPLDPDRLGR 1140
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2130 AFQELIKRHESLRTSFEQDEGGdpVQRIHDEvpfTLQTTVLGART--EQEAAAAFI----KPFDLSQAPLFRAQIVKVSD 2203
Cdd:PRK12316 1141 ALERLVAHHDALRLRFREEDGG--WQQAYAA---PQAGEVLWQRQaaSEEELLALCeeaqRSLDLEQGPLLRALLVDMAD 1215
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2204 ERHLLLVDMHHIISDGVSVNILIQEFGELYNNR--KLPALRIQYKDYAVWQEGFKTGDAykMQEAYWLKQLEGELPvlDL 2281
Cdd:PRK12316 1216 GSQRLLLVIHHLVVDGVSWRILLEDLQRAYADLdaDLPARTSSYQAWARRLHEHAGARA--EELDYWQAQLEDAPH--EL 1291
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2282 PADHARPPVRSFAGDKVSFTLEPEVASGLHKLA----RENGSTLymvLLAAYTAFLSRLSGQEDIIVGSPIAGRPHK--- 2354
Cdd:PRK12316 1292 PCENPDGALENRHERKLELRLDAERTRQLLQEApaayRTQVNDL---LLTALARVTCRWSGQASVLVQLEGHGREDLfed 1368
|
1370 1380
....*....|....*....|..
gi 1678550997 2355 -DLEPILGMFVNTLALRTRPEG 2375
Cdd:PRK12316 1369 iDLSRTVGWFTSLFPVRLTPAA 1390
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
1490-3386 |
0e+00 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 927.65 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1490 YSMNQTLHYALEQQAEKTPDQAAVIF------EDGVMTYKELNEQANRIAWELIGRGVKPETTVaIIGKRSPEMLLGIYG 1563
Cdd:PRK05691 5 FELPLTLVQALQRRAAQTPDRLALRFladdpgEGVVLSYRDLDLRARTIAAALQARASFGDRAV-LLFPSGPDYVAAFFG 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1564 ILKAGGAYLPIDPdyPE-------ERISFLLEDSGTNiLLLQSAGLHVP-----EFTG----EIVYLNQTNSGLAHRLSN 1627
Cdd:PRK05691 84 CLYAGVIAVPAYP--PEsarrhhqERLLSIIADAEPR-LLLTVADLRDSllqmeELAAanapELLCVDTLDPALAEAWQE 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1628 PNVDvlPQSLAYVIYTSGSTGMPKGVEIEHRSAVNflNSLQSRY----QLKHSDMIMHKTSYSFDAS-IWELFWWPYAGA 1702
Cdd:PRK05691 161 PALQ--PDDIAFLQYTSGSTALPKGVQVSHGNLVA--NEQLIRHgfgiDLNPDDVIVSWLPLYHDMGlIGGLLQPIFSGV 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1703 SVYLL-PQGGEKEPEVIAKAIEEQKIT---AMHFVPSMLHAFLEHIKYRSVPIktNRLKRVFSGGEQLGTHLVSRFYELL 1778
Cdd:PRK05691 237 PCVLMsPAYFLERPLRWLEAISEYGGTisgGPDFAYRLCSERVSESALERLDL--SRWRVAYSGSEPIRQDSLERFAEKF 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1779 PNVSITN-----SYGPTEAT----------------VEAAFFDCPPHEKLERIPI-----GKPVHHVRLyLLNQNQRMLP 1832
Cdd:PRK05691 315 AACGFDPdsffaSYGLAEATlfvsggrrgqgipaleLDAEALARNRAEPGTGSVLmscgrSQPGHAVLI-VDPQSLEVLG 393
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1833 VGCIGELYIAGAGVARGYLNRPALTEERFLEdpfYPGERMYKTGDVArWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAA 1912
Cdd:PRK05691 394 DNRVGEIWASGPSIAHGYWRNPEASAKTFVE---HDGRTWLRTGDLG-FLRDGELFVTGRLKDMLIVRGHNLYPQDIEKT 469
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1913 L-RSIEGVREAAVTV--RTDSGEPELCAYVE---GLQR-----------NEVRAQLERLLPGYMVpayMIEMEQWPVTPS 1975
Cdd:PRK05691 470 VeREVEVVRKGRVAAfaVNHQGEEGIGIAAEisrSVQKilppqaliksiRQAVAEACQEAPSVVL---LLNPGALPKTSS 546
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1976 GKLDRNA---------------LPAPGGAADAETYTAPRNVTEMkLSQLWEDVLKNGPVGIHDNFFDRGGHSLKATALVS 2040
Cdd:PRK05691 547 GKLQRSAcrlrladgsldsyalFPALQAVEAAQTAASGDELQAR-IAAIWCEQLKVEQVAADDHFFLLGGNSIAATQVVA 625
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2041 RITKEFDVQVPLKDVFAHPTVEG----LATVIREGTDSPyEAIKPAEKQETYPVSSAQKRIYVLQQLEDGGTGYNMPAVL 2116
Cdd:PRK05691 626 RLRDELGIDLNLRQLFEAPTLAAfsaaVARQLAGGGAAQ-AAIARLPRGQALPQSLAQNRLWLLWQLDPQSAAYNIPGGL 704
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2117 ELEGKLNPERMDRAFQELIKRHESLRTSF-EQDegGDPVQRIHDEVPFTLQTTVLGA--RTEQEAAAAFIK------PFD 2187
Cdd:PRK05691 705 HLRGELDEAALRASFQRLVERHESLRTRFyERD--GVALQRIDAQGEFALQRIDLSDlpEAEREARAAQIReeearqPFD 782
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2188 LSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELYNNR------KLPALRIQYKDYAVWQEGFKTGDAY 2261
Cdd:PRK05691 783 LEKGPLLRVTLVRLDDEEHQLLVTLHHIVADGWSLNILLDEFSRLYAAAcqgqtaELAPLPLGYADYGAWQRQWLAQGEA 862
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2262 KMQEAYWLKQLEGELPVLDLPADHARPPVRSFAGDKVSFTLEPEVASGLHKLARENGSTLYMVLLAAYTAFLSRLSGQED 2341
Cdd:PRK05691 863 ARQLAYWKAQLGDEQPVLELATDHPRSARQAHSAARYSLRVDASLSEALRGLAQAHQATLFMVLLAAFQALLHRYSGQGD 942
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2342 IIVGSPIAGRPHKDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRETALEAFEHQNYPFEELVDKLELTRDMSrnpVFD 2421
Cdd:PRK05691 943 IRIGVPNANRPRLETQGLVGFFINTQVLRAQLDGRLPFTALLAQVRQATLGAQAHQDLPFEQLVEALPQAREQG---LFQ 1019
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2422 AMLVVQNNDYEPL-HLHDLQMKPAQVSHLVSKFDLTLQASEG-DGNIHFLFEYSTALFEKTTIERWASHLTNVLSIIGKN 2499
Cdd:PRK05691 1020 VMFNHQQRDLSALrRLPGLLAEELPWHSREAKFDLQLHSEEDrNGRLTLSFDYAAELFDAATIERLAEHFLALLEQVCED 1099
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2500 PKVTLNHIDILTQEERHQLLnefNTGQANQYGVQ-TISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSR 2578
Cdd:PRK05691 1100 PQRALGDVQLLDAAERAQLA---QWGQAPCAPAQaWLPELLNEQARQTPERIALVWDGGSLDYAELHAQANRLAHYLRDK 1176
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2579 GVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMTiNEADLGVLADFEGEI-LTIES 2657
Cdd:PRK05691 1177 GVGPDVCVAIAAERSPQLLVGLLAILKAGGAYVPLDPDYPAERLAYMLADSGVELLLT-QSHLLERLPQAEGVSaIALDS 1255
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2658 VEEDD-KSPLPQMS-SAHHLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTP 2735
Cdd:PRK05691 1256 LHLDSwPSQAPGLHlHGDNLAYVIYTSGSTGQPKGVGNTHAALAERLQWMQATYALDDSDVLMQKAPISFDVSVWECFWP 1335
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2736 LLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDVVQPEDVKTLRVVTLAGEAADRELIARSLAICPHT 2815
Cdd:PRK05691 1336 LITGCRLVLAGPGEHRDPQRIAELVQQYGVTTLHFVPPLLQLFIDEPLAAACTSLRRLFSGGEALPAELRNRVLQRLPQV 1415
|
1450 1460 1470 1480 1490 1500 1510 1520
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2816 ELANEYGPTENSVATTVMR-HMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFT 2894
Cdd:PRK05691 1416 QLHNRYGPTETAINVTHWQcQAEDGERSPIGRPLGNVLCRVLDAELNLLPPGVAGELCIGGAGLARGYLGRPALTAERFV 1495
|
1530 1540 1550 1560 1570 1580 1590 1600
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2895 QNPF-KPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVV 2973
Cdd:PRK05691 1496 PDPLgEDGARLYRTGDRARWNADGALEYLGRLDQQVKLRGFRVEPEEIQARLLAQPGVAQAAVLVREGAAGAQLVGYYTG 1575
|
1610 1620 1630 1640 1650 1660 1670 1680
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2974 TK-PGLSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGALPKPVYNhegERPFLPPSSKMEQILADIWKEVLG 3052
Cdd:PRK05691 1576 EAgQEAEAERLKAALAAELPEYMVPAQLIRLDQMPLGPSGKLDRRALPEPVWQ---QREHVEPRTELQQQIAAIWREVLG 1652
|
1690 1700 1710 1720 1730 1740 1750 1760
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3053 AEKIGTADSFFELGGDSIKALQVSARL-HRIGKQMAVKDLFSHPTIQELA---AYIRDSDTSSSQAAVEGDVQWSPV--- 3125
Cdd:PRK05691 1653 LPRVGLRDDFFALGGHSLLATQIVSRTrQACDVELPLRALFEASELGAFAeqvARIQAAGERNSQGAIARVDRSQPVpls 1732
|
1770 1780 1790 1800 1810 1820 1830 1840
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3126 ----QKWFLSQDIKEKHHFNQSVMLHRSTSVQEDALRKTLKAITCHHDALRMVFTQNEQGKWDQYnrplsHSDDALYgLQ 3201
Cdd:PRK05691 1733 ysqqRMWFLWQMEPDSPAYNVGGMARLSGVLDVDRFEAALQALILRHETLRTTFPSVDGVPVQQV-----AEDSGLR-MD 1806
|
1850 1860 1870 1880 1890 1900 1910 1920
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3202 MIDLSAPDGTDGNRPYEPLIKRHVldiQQKMDLKNGPLLQAGLFHTIDGD-FLFLSAHHLVVDGISWRVLLEDLALGYRQ 3280
Cdd:PRK05691 1807 WQDFSALPADARQQRLQQLADSEA---HQPFDLERGPLLRACLVKAAEREhYFVLTLHHIVTEGWAMDIFARELGALYEA 1883
|
1930 1940 1950 1960 1970 1980 1990 2000
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3281 AAGGEDIKLPPKTSSFKAYAKKLSDYAESQQLMKQLKYWRE--AEEYQTEALPFDQI-DGTRAHEGQrsTISFTLNDkET 3357
Cdd:PRK05691 1884 FLDDRESPLEPLPVQYLDYSVWQRQWLESGERQRQLDYWKAqlGNEHPLLELPADRPrPPVQSHRGE--LYRFDLSP-EL 1960
|
2010 2020
....*....|....*....|....*....
gi 1678550997 3358 AALLKDANSAYNTdTQDMLLASVILALRH 3386
Cdd:PRK05691 1961 AARVRAFNAQRGL-TLFMTMTATLAALLY 1988
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
2086-3391 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 927.64 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2086 ETYPVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGdPVQRIHDEVPFTL 2165
Cdd:PRK12467 48 ERIPLSYAQERQWFLWQLDPDSAAYNIPTALRLRGELDVSALRRAFDALVARHESLRTRFVQDEEG-FRQVIDASLSLTI 126
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2166 QTTVLGA---RTEQEAAAAFI-----KPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELY---- 2233
Cdd:PRK12467 127 PLDDLANeqgRARESQIEAYIneevaRPFDLANGPLLRVRLLRLADDEHVLVVTLHHIISDGWSMRVLVEELVQLYsays 206
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2234 NNRK--LPALRIQYKDYAVWQEGFKTGDAYKMQEAYWLKQLEGELPVLDLPADHARPPVRSFAGDKVSFTLEPEVASGLH 2311
Cdd:PRK12467 207 QGREpsLPALPIQYADYAIWQRSWLEAGERERQLAYWQEQLGGEHTVLELPTDRPRPAVPSYRGARLRVDLPQALSAGLK 286
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2312 KLARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHKDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRETAL 2391
Cdd:PRK12467 287 ALAQREGVTLFMVLLASFQTLLHRYSGQSDIRIGVPNANRNRVETERLIGFFVNTQVLKAEVDPQASFLELLQQVKRTAL 366
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2392 EAFEHQNYPFEELVDKLELTRDMSRNPVFDAMLVVQN-----NDYEPLHLHDLQMKPAQVSHLVSKFDLTLQASEGDGNI 2466
Cdd:PRK12467 367 GAQAHQDLPFEQLVEALQPERSLSHSPLFQVMFNHQNtatggRDREGAQLPGLTVEELSWARHTAQFDLALDTYESAQGL 446
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2467 HFLFEYSTALFEKTTIERWASHLTNVLSIIGKNPKVTLNHIDILTQEERHQLLNEFNTgQANQYGVQTISQLFEQQAART 2546
Cdd:PRK12467 447 WAAFTYATDLFEATTIERLATHWRNLLEAIVAEPRRRLGELPLLDAEERARELVRWNA-PATEYAPDCVHQLIEAQARQH 525
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2547 PKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYIL 2626
Cdd:PRK12467 526 PERPALVFGEQVLSYAELNRQANRLAHVLIAAGVGPDVLVGIAVERSIEMVVGLLAVLKAGGAYVPLDPEYPQDRLAYML 605
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2627 SDSGTKLLMTINE--ADLGVLADfegeiltIESVEEDDKSPLPQMSSAHH---------LAYIIYTSGTTGRPKGVMVEH 2695
Cdd:PRK12467 606 DDSGVRLLLTQSHllAQLPVPAG-------LRSLCLDEPADLLCGYSGHNpevaldpdnLAYVIYTSGSTGQPKGVAISH 678
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2696 KGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLY 2775
Cdd:PRK12467 679 GALANYVCVIAERLQLAADDSMLMVSTFAFDLGVTELFGALASGATLHLLPPDCARDAEAFAALMADQGVTVLKIVPSHL 758
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2776 RALLDVVQPEDVKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTENSVATTVMRHMEKQA---YVSIGQPIDGTQ 2852
Cdd:PRK12467 759 QALLQASRVALPRPQRALVCGGEALQVDLLARVRALGPGARLINHYGPTETTVGVSTYELSDEERdfgNVPIGQPLANLG 838
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2853 VLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKPE-ARMYRTGDAARWMADGTLEYLGRIDDQVKI 2931
Cdd:PRK12467 839 LYILDHYLNPVPVGVVGELYIGGAGLARGYHRRPALTAERFVPDPFGADgGRLYRTGDLARYRADGVIEYLGRMDHQVKI 918
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2932 RGYRVETKEIESVIRCIKGVKDAAVVAhVTASGQTELSAYVV-------TKPGLSTNAVRSELQNKLPVFMHPAFIEKLD 3004
Cdd:PRK12467 919 RGFRIELGEIEARLLAQPGVREAVVLA-QPGDAGLQLVAYLVpaavadgAEHQATRDELKAQLRQVLPDYMVPAHLLLLD 997
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3005 SLPLSPNGKLDRGALPKPVYNhEGERPFLPPSSKMEQILADIWKEVLGAEKIGTADSFFELGGDSIKALQVSARL-HRIG 3083
Cdd:PRK12467 998 SLPLTPNGKLDRKALPKPDAS-AVQATFVAPQTELEKRLAAIWADVLKVERVGLTDNFFELGGHSLLATQVISRVrQRLG 1076
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3084 KQMAVKDLFSHPTIQELAAYIRDSDTSSSQAAVEGDVQWSPV------QKWFLSQDIKEKHHFNQSVMLHRSTSVQEDAL 3157
Cdd:PRK12467 1077 IQVPLRTLFEHQTLAGFAQAVAAQQQGAQPALPDVDRDQPLPlsyaqeRQWFLWQLEPGSAAYHIPQALRLKGPLDIEAL 1156
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3158 RKTLKAITCHHDALRMVFTQNEqgkwdqyNRPLSHSDDALYGLQMIDLSAPDGTDgnrpyEPLIKRHV-LDIQQKMDLKN 3236
Cdd:PRK12467 1157 ERSFDALVARHESLRTTFVQED-------GRTRQVIHPVGSLTLEEPLLLAADKD-----EAQLKVYVeAEARQPFDLEQ 1224
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3237 GPLLQAGLFHTIDGD-FLFLSAHHLVVDGISWRVLLEDLALGYRQAAGGEDIKLPPKTSSFKAYAKKLSDYAESQQLMKQ 3315
Cdd:PRK12467 1225 GPLLRVGLLRLAADEhVLVLTLHHIVSDGWSMQVLVDELVALYAAYSQGQSLQLPALPIQYADYAVWQRQWMDAGERARQ 1304
|
1290 1300 1310 1320 1330 1340 1350
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 3316 LKYWRE--AEEYQTEALPFDQI-DGTRAHEGQRstISFTLnDKETAALLKDANSAYNTDTQDMLLASVILALRHWTNQS 3391
Cdd:PRK12467 1305 LAYWKAqlGGEQPVLELPTDRPrPAVQSHRGAR--LAFEL-PPALAEGLRALARREGVTLFMLLLASFQTLLHRYSGQD 1380
|
|
| A_NRPS_ProA |
cd17656 |
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the ... |
476-953 |
0e+00 |
|
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains gramicidin S synthase 2 (also known as ATP-dependent proline adenylase or proline activase or ProA). ProA is a multifunctional enzyme involved in synthesis of the cyclic peptide antibiotic gramicidin S and able to activate and polymerize the amino acids proline, valine, ornithine and leucine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341311 [Multi-domain] Cd Length: 479 Bit Score: 895.29 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 476 TPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYI 555
Cdd:cd17656 1 TPDAVAVVFENQKLTYRELNERSNQLARFLREKGVKKDSIVAIMMERSAEMIVGILGILKAGGAFVPIDPEYPEERRIYI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 556 LHDCGCSHVVSQAHLPSSLEDNYIITHPE-DIESKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFE 634
Cdd:cd17656 81 MLDSGVRVVLTQRHLKSKLSFNKSTILLEdPSISQEDTSNIDYINNSDDLLYIIYTSGTTGKPKGVQLEHKNMVNLLHFE 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 635 YTHSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNIVFLPTAFIKMIFSERELA 714
Cdd:cd17656 161 REKTNINFSDKVLQFATCSFDVCYQEIFSTLLSGGTLYIIREETKRDVEQLFDLVKRHNIEVVFLPVAFLKFIFSEREFI 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 715 NSFPDGVKHLIAAGEQLMISDLFQDVLRKRGIHLHNHYGPSETHVVSTYTIHPGDPIPELPPIGKPIGCTDLYILNHQKQ 794
Cdd:cd17656 241 NRFPTCVKHIITAGEQLVITNEFKEMLHEHNVHLHNHYGPSETHVVTTYTINPEAEIPELPPIGKPISNTWIYILDQEQQ 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 795 LQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPDVIMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEI 874
Cdd:cd17656 321 LQPQGIVGELYISGASVARGYLNRQELTAEKFFPDPFDPNERMYRTGDLARYLPDGNIEFLGRADHQVKIRGYRIELGEI 400
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 875 EVTLMNHPDISEAAILIWQDQNGEHELCAYYCSVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALP 953
Cdd:cd17656 401 EAQLLNHPGVSEAVVLDKADDKGEKYLCAYFVMEQELNISQLREYLAKQLPEYMIPSFFVPLDQLPLTPNGKVDRKALP 479
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
8-1288 |
0e+00 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 796.37 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 8 QDIYPLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNVSsPQQVVLRERNVI 87
Cdd:COG1020 15 AAPLPLSAAQQRLWLLLLLLLGSAAYNLALALLLLGLLLVAALLLLAALLARRRRALRTRLRTRAGR-PVQVIQPVVAAP 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 88 VLEEDITHLNEAEQSQFIEQWKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASY 167
Cdd:COG1020 94 LPVVVLLVDLEALAEAAAEAAAAAEALAPFDLLRGPLLRLLLLLLLLLLLLLLLALHHIISDGLSDGLLLAELLRLYLAA 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 168 VNASPITLEPVQPYGK-----YIKWLMEQDKEQAVSYWDHYLSGHEQQTVLP--KQKKTKGKSRQEHVTFSFSKEESSRL 240
Cdd:COG1020 174 YAGAPLPLPPLPIQYAdyalwQREWLQGEELARQLAYWRQQLAGLPPLLELPtdRPRPAVQSYRGARVSFRLPAELTAAL 253
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 241 SELAAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRPAEieGIEHMVGLFINTMPVRVQGAKTP-FLQLIKDMQK 319
Cdd:COG1020 254 RALARRHGVTLFMVLLAAFALLLARYSGQDDVVVGTPVAGRPRP--ELEGLVGFFVNTLPLRVDLSGDPsFAELLARVRE 331
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 320 DRLAAEAYSYHPLYEIQ-----SRSAVKQGLIDHILVFENYPVQQEiqmlnkqeHASDLfQIHNFTVADET-NYSFYLMV 393
Cdd:COG1020 332 TLLAAYAHQDLPFERLVeelqpERDLSRNPLFQVMFVLQNAPADEL--------ELPGL-TLEPLELDSGTaKFDLTLTV 402
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 394 AP-GEEIHIKMNYDAEQHDRSFVLSVKEHLLNAVSQILNNPNLPPEEIDITTDTEKRQLIGEITD---QTPVYETIHAMF 469
Cdd:COG1020 403 VEtGDGLRLTLEYNTDLFDAATIERMAGHLVTLLEALAADPDQPLGDLPLLTAAERQQLLAEWNAtaaPYPADATLHELF 482
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 470 EKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPA 549
Cdd:COG1020 483 EAQAARTPDAVAVVFGDQSLTYAELNARANRLAHHLRALGVGPGDLVGVCLERSLEMVVALLAVLKAGAAYVPLDPAYPA 562
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 550 DRIRYILHDCGCSHVVSQAHLPSSLEDN--YIITHPEDIESKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRNM 627
Cdd:COG1020 563 ERLAYMLEDAGARLVLTQSALAARLPELgvPVLALDALALAAEPATNPPVPVTPDDLAYVIYTSGSTGRPKGVMVEHRAL 642
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 628 ANLLkfEYTHSGIDFEAD--VLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNIVFLPTAFIK 705
Cdd:COG1020 643 VNLL--AWMQRRYGLGPGdrVLQFASLSFDASVWEIFGALLSGATLVLAPPEARRDPAALAELLARHRVTVLNLTPSLLR 720
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 706 MIFserELANSFPDGVKHLIAAGEQLMIsDLFQDVLRK-RGIHLHNHYGPSETHVVST-YTIHPGDPIPELPPIGKPIGC 783
Cdd:COG1020 721 ALL---DAAPEALPSLRLVLVGGEALPP-ELVRRWRARlPGARLVNLYGPTETTVDSTyYEVTPPDADGGSVPIGRPIAN 796
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 784 TDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFK-PDVIMYRTGDLARRLEDGNIEYIGRADNQV 862
Cdd:COG1020 797 TRVYVLDAHLQPVPVGVPGELYIGGAGLARGYLNRPELTAERFVADPFGfPGARLYRTGDLARWLPDGNLEFLGRADDQV 876
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 863 KIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCSVQKLNTID--LRSYMASELPEYMIPAKWIWVDSIP 940
Cdd:COG1020 877 KIRGFRIELGEIEAALLQHPGVREAVVVAREDAPGDKRLVAYVVPEAGAAAAAalLRLALALLLPPYMVPAAVVLLLPLP 956
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 941 LTPNGKVDRAALPEPDASISGNPYTAPRNLLEAKLSQLFEDVLKNGHIGIQDNFFDNGGHSLKATVLMSRIAKEFHVQVS 1020
Cdd:COG1020 957 LTGNGKLDRLALPAPAAAAAAAAAAPPAEEEEEEAALALLLLLVVVVGDDDFFFFGGGLGLLLLLALARAARLLLLLLLL 1036
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1021 LKDIFAHPTVEGLALIIREAEQNLYAAIEPAEKRDTYPVSSAQKRIYVLQQLDEGVAYNMPAVLELEGALDVAKLSAVCK 1100
Cdd:COG1020 1037 LLLFLAAAAAAAAAAAAAAAAAAAAPLAAAAAPLPLPPLLLSLLALLLALLLLLALLALLALLLLLLLLLLLLALLLLLA 1116
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1101 ELISRHEPLRTSFVSGADDEPVQRIHTEVPFTLS-------------KETTIEGFVRPFDLSQAPLFRAGLIEVSNEKHV 1167
Cdd:COG1020 1117 LLLALLAALRARRAVRQEGPRLRLLVALAAALALaallalllaaaaaAAELLAAAALLLLLALLLLALLLLLLLLLLLLL 1196
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1168 LLVDMHHIISDGVSVQLLIREFTDLYA------NRQLKPLRIQYKDYAVWQQKFKKGDSYQKQETYWQQQFSGDLPILEL 1241
Cdd:COG1020 1197 LLLLLLLLLLLLLLLLLLLLLLLLLLLlaaaaaALLALALLLALLALAALLALAALAALAAALLALALALLALALLLLAL 1276
|
1290 1300 1310 1320
....*....|....*....|....*....|....*....|....*..
gi 1678550997 1242 PTDKRRPAERQFIGGKVTFQLDKEITARIKRLAHKNRSTLYMTLLAL 1288
Cdd:COG1020 1277 ALLLPALARARAARTARALALLLLLALLLLLALALALLLLLLLLLAL 1323
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
4-1346 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 765.86 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 4 ANSIQDIYPLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGkVNPQFFQNSINALVERHDIFRTIFISQ-NVSSPQQVVLR 82
Cdd:PRK12467 2640 VGDIEDIYPLSPMQQGMLFHTLYEGGAGDYINQMRVDVEG-LDVERFRTAWQAVIDRHEILRSGFLWDgELEEPLQVVYK 2718
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 83 ERNVIVLEEDIThlNEAEQSQFIEQWKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLH 162
Cdd:PRK12467 2719 QARLPFSRLDWR--DRADLEQALDALAAADRQQGFDLLSAPLLRLTLVRTGEDRHHLIYTNHHILMDGWSGSQLLGEVLQ 2796
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 163 IYASYVNASPITLepvqpYGKYIKWLMEQDKEQAVSYWDHYLSGHEQQTVLP---KQKKTKGKSRQEHVTFSFSKEESSR 239
Cdd:PRK12467 2797 RYFGQPPPAREGR-----YRDYIAWLQAQDAEASEAFWKEQLAALEEPTRLAralYPAPAEAVAGHGAHYLHLDATQTRQ 2871
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 240 LSELAAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRPAEIEGIEHMVGLFINTMPVrVQG--AKTPFLQLIKDM 317
Cdd:PRK12467 2872 LIEFARRHRVTLNTLVQGAWLLLLQRFTGQDTVCFGATVAGRPAQLRGAEQQLGLFINTLPV-IASprAEQTVSDWLQQV 2950
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 318 QKDRLAAEAYSYHPLYEIQSRSA-VKQGLIDHILVFENYPVQQEIQmlnkQEHASDLfQIHNFTVADETNYSFYLMVAPG 396
Cdd:PRK12467 2951 QAQNLALREFEHTPLADIQRWAGqGGEALFDSILVFENYPISEALK----QGAPSGL-RFGAVSSREQTNYPLTLAVGLG 3025
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 397 EEIHIKMNYDAEQHDRSFVLSVKEHLLNAVSQILNNPNLPPEEIDITTDTEKRQLIGEITDQTPVY---ETIHAMFEKQA 473
Cdd:PRK12467 3026 DTLELEFSYDRQHFDAAAIERLAESFDRLLQAMLNNPAARLGELPTLAAHERRQVLHAWNATAAAYpseRLVHQLIEAQV 3105
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 474 EKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIR 553
Cdd:PRK12467 3106 ARTPEAPALVFGDQQLSYAELNRRANRLAHRLIAIGVGPDVLVGVAVERSVEMIVALLAVLKAGGAYVPLDPEYPRERLA 3185
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 554 YILHDCGCSHVVSQAH----LPSSLEDNYIITHPEDIESKVDgSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRNMAN 629
Cdd:PRK12467 3186 YMIEDSGVKLLLTQAHlleqLPAPAGDTALTLDRLDLNGYSE-NNPSTRVMGENLAYVIYTSGSTGKPKGVGVRHGALAN 3264
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 630 LLKFEYTHSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIkRDVPQLFAFINKHQTNIVFLPTAFIKMIFS 709
Cdd:PRK12467 3265 HLCWIAEAYELDANDRVLLFMSFSFDGAQERFLWTLICGGCLVVRDNDL-WDPEELWQAIHAHRISIACFPPAYLQQFAE 3343
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 710 ERELANSFPdgVKHLIAAGEQlMISDLFQDVLRK-RGIHLHNHYGPSETHVVSTYTIHPGDPIPELP--PIGKPIGCTDL 786
Cdd:PRK12467 3344 DAGGADCAS--LDIYVFGGEA-VPPAAFEQVKRKlKPRGLTNGYGPTEAVVTVTLWKCGGDAVCEAPyaPIGRPVAGRSI 3420
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 787 YILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPD-VIMYRTGDLARRLEDGNIEYIGRADNQVKIR 865
Cdd:PRK12467 3421 YVLDGQLNPVPVGVAGELYIGGVGLARGYHQRPSLTAERFVADPFSGSgGRLYRTGDLARYRADGVIEYLGRIDHQVKIR 3500
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 866 GYRIEPQEIEVTLMNHPDISEAAILIwQDQNGEHELCAYYC--SVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTP 943
Cdd:PRK12467 3501 GFRIELGEIEARLLQHPSVREAVVLA-RDGAGGKQLVAYVVpaDPQGDWRETLRDHLAASLPDYMVPAQLLVLAAMPLGP 3579
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 944 NGKVDRAALPEPDASISGNpYTAPRNLLEAKLSQLFEDVLKNGHIGIQDNFFDNGGHSLKATVLMSRIAKEFHVQVSLKD 1023
Cdd:PRK12467 3580 NGKVDRKALPDPDAKGSRE-YVAPRSEVEQQLAAIWADVLGVEQVGVTDNFFELGGDSLLALQVLSRIRQSLGLKLSLRD 3658
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1024 IFAHPTVEGLAliireaeqnlyaaiepaekrdtypvssaqkriyvlqqldegvAYNMPAVLELEGALDVAKLSAVCKELI 1103
Cdd:PRK12467 3659 LMSAPTIAELA------------------------------------------GYSPLGDVPVNLLLDLNRLETGFPALF 3696
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1104 SRHEPLRTSFvsgaDDEPVQRIhtevpftlskettiegfvrpfdlsqaplfraglieVSNEKHVLLVDMHHIISDGvsvq 1183
Cdd:PRK12467 3697 CRHEGLGTVF----DYEPLAVI-----------------------------------LEGDRHVLGLTCRHLLDDG---- 3733
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1184 llireftdlYANRQLKPLRIQYKDYAVWQQkfkkgdsyqkqetywqqqfsgdlpilelptdkrrPAERQFIGGkvtFQLD 1263
Cdd:PRK12467 3734 ---------WQDTSLQAMAVQYADYILWQQ----------------------------------AKGPYGLLG---WSLG 3767
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1264 KEITARIKRLAHKNRSTlymtllalysaflsrlsgqddivigspiagrphadlEAVLGMFVNTLALRTRPAGNKTFEEFL 1343
Cdd:PRK12467 3768 GTLARLVAELLEREGES------------------------------------EAFLGLFDNTLPLPDEFVPQAEFLELL 3811
|
...
gi 1678550997 1344 KEV 1346
Cdd:PRK12467 3812 RQL 3814
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1050-2061 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 753.72 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1050 PAEKRDTYPVSSAQKRIYVLQQLDEGVA-YNMPAVLELEGaLDVAKLSAVCKELISRHEPLRTSFV-SGADDEPVQRIH- 1126
Cdd:PRK12316 4096 LGEIEDIYPLSPMQQGMLFHSLYEQEAGdYINQMRVDVQG-LDVERFRAAWQAALDRHDVLRSGFVwQGELGRPLQVVHk 4174
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1127 -TEVPFT---LSKETTIEGFV---------RPFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLY 1193
Cdd:PRK12316 4175 qVSLPFAeldWRGRADLQAALdalaaaereRGFDLQRAPLLRLVLVRTAEGRHHLIYTNHHILMDGWSNSQLLGEVLERY 4254
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1194 ANRQLKPLRIQYKDYAVWQQKFKKGDSyqkqETYWQQQfsgdLPILELPT----DKRRPAERQFIG-GKVTFQLDKEITA 1268
Cdd:PRK12316 4255 SGRPPAQPGGRYRDYIAWLQRQDAAAS----EAFWREQ----LAALDEPTrlaqAIARADLRSANGyGEHVRELDATATA 4326
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1269 RIKRLAHKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPhADL---EAVLGMFVNTLALRTRPAGNKTFEEFLKE 1345
Cdd:PRK12316 4327 RLREFARTQRVTLNTLVQAAWLLLLQRYTGQDTVAFGATVAGRP-AELpgiEGQIGLFINTLPVIATPRAQQSVVEWLQQ 4405
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1346 VRQTALEAYEHQDYPFEELvdklgvQRE--MSRNPLFDTTLVLQN------MEQQK---LKMNDVqLQWNDLEHPiskFD 1414
Cdd:PRK12316 4406 VQRQNLALREHEHTPLYEI------QRWagQGGEALFDSLLVFENypvseaLQQGApggLRFGEV-TNHEQTNYP---LT 4475
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1415 ISLYVTEhdsELFCQFEYSTALFEKETIQRWASLFTTLVEHTAASPETELDNIPILTKEEERDFIESCHLfEETGYSMNQ 1494
Cdd:PRK12316 4476 LAVGLGE---TLSLQFSYDRGHFDAATIERLARHLTNLLEAMAEDPQRRLGELQLLEKAEQQRIVALWNR-TDAGYPATR 4551
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1495 TLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPI 1574
Cdd:PRK12316 4552 CVHQLVAERARMTPDAVAVVFDEEKLTYAELNRRANRLAHALIARGVGPEVLVGIAMERSAEMMVGLLAVLKAGGAYVPL 4631
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1575 DPDYPEERISFLLEDSGTNILLLQS---AGLHVPEFTGEIVyLNQTNSGLAHRLSNPNVDVLPQSLAYVIYTSGSTGMPK 1651
Cdd:PRK12316 4632 DPEYPRERLAYMMEDSGAALLLTQShllQRLPIPDGLASLA-LDRDEDWEGFPAHDPAVRLHPDNLAYVIYTSGSTGRPK 4710
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1652 GVEIEHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVyLLPQGGEKEPEVIAKAIEEQKITAMH 1731
Cdd:PRK12316 4711 GVAVSHGSLVNHLHATGERYELTPDDRVLQFMSFSFDGSHEGLYHPLINGASV-VIRDDSLWDPERLYAEIHEHRVTVLV 4789
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1732 FVPSMLHAFLEHIKYRSVPIktnRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFDCPPH--EKLER 1809
Cdd:PRK12316 4790 FPPVYLQQLAEHAERDGEPP---SLRVYCFGGEAVAQASYDLAWRALKPVYLFNGYGPTETTVTVLLWKARDGdaCGAAY 4866
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1810 IPIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPF-YPGERMYKTGDVARWLPDGNVE 1888
Cdd:PRK12316 4867 MPIGTPLGNRSGYVLDGQLNPLPVGVAGELYLGGEGVARGYLERPALTAERFVPDPFgAPGGRLYRTGDLARYRADGVID 4946
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1889 FLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDSGEPELCAYV-------------EGLQRNEVRAQLERLL 1955
Cdd:PRK12316 4947 YLGRVDHQVKIRGFRIELGEIEARLREHPAVREAVVIAQEGAVGKQLVGYVvpqdpaladadeaQAELRDELKAALRERL 5026
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1956 PGYMVPAYMIEMEQWPVTPSGKLDRNALPAPGGAADAETYTAPRNVTEMKLSQLWEDVLKNGPVGIHDNFFDRGGHSLKA 2035
Cdd:PRK12316 5027 PEYMVPAHLVFLARMPLTPNGKLDRKALPQPDASLLQQAYVAPRSELEQQVAAIWAEVLQLERVGLDDNFFELGGHSLLA 5106
|
1050 1060
....*....|....*....|....*.
gi 1678550997 2036 TALVSRITKEFDVQVPLKDVFAHPTV 2061
Cdd:PRK12316 5107 IQVTSRIQLELGLELPLRELFQTPTL 5132
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
1047-2253 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 730.42 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1047 AIEPAEKRDTYPVSSAQKRI--YVLQQLDEGVAYNMPAVLeLEGaLDVAKLSAVCKELISRHEPLRTSFVS-GADDEPVQ 1123
Cdd:PRK12467 2637 PVAVGDIEDIYPLSPMQQGMlfHTLYEGGAGDYINQMRVD-VEG-LDVERFRTAWQAVIDRHEILRSGFLWdGELEEPLQ 2714
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1124 RIH--TEVPFTL-------SKETTIEGFV-----RPFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREF 1189
Cdd:PRK12467 2715 VVYkqARLPFSRldwrdraDLEQALDALAaadrqQGFDLLSAPLLRLTLVRTGEDRHHLIYTNHHILMDGWSGSQLLGEV 2794
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1190 TDLYANRQLKPLRIQYKDYAVWQQKfkkgDSYQKQETYWQQQFsGDL--PILELPTDKRRPAERQFIGGKVTFQLDKEIT 1267
Cdd:PRK12467 2795 LQRYFGQPPPAREGRYRDYIAWLQA----QDAEASEAFWKEQL-AALeePTRLARALYPAPAEAVAGHGAHYLHLDATQT 2869
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1268 ARIKRLAHKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPhADL---EAVLGMFVNTLALRTRPAGNKTFEEFLK 1344
Cdd:PRK12467 2870 RQLIEFARRHRVTLNTLVQGAWLLLLQRFTGQDTVCFGATVAGRP-AQLrgaEQQLGLFINTLPVIASPRAEQTVSDWLQ 2948
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1345 EVRQTALEAYEHQDYPFEElvdklgVQREMSR--NPLFDTTLVLQNME-QQKLKMN-DVQLQWNDLE-HPISKFDISLYV 1419
Cdd:PRK12467 2949 QVQAQNLALREFEHTPLAD------IQRWAGQggEALFDSILVFENYPiSEALKQGaPSGLRFGAVSsREQTNYPLTLAV 3022
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1420 TEHDSeLFCQFEYSTALFEKETIQRWASLFTTLVEHTAASPETELDNIPILTKEEeRDFIESCHLFEETGYSMNQTLHYA 1499
Cdd:PRK12467 3023 GLGDT-LELEFSYDRQHFDAAAIERLAESFDRLLQAMLNNPAARLGELPTLAAHE-RRQVLHAWNATAAAYPSERLVHQL 3100
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYP 1579
Cdd:PRK12467 3101 IEAQVARTPEAPALVFGDQQLSYAELNRRANRLAHRLIAIGVGPDVLVGVAVERSVEMIVALLAVLKAGGAYVPLDPEYP 3180
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1580 EERISFLLEDSGTNILLLQSAGL-HVPEFTGEIVYLNQTNSGLAHRLSNPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHR 1658
Cdd:PRK12467 3181 RERLAYMIEDSGVKLLLTQAHLLeQLPAPAGDTALTLDRLDLNGYSENNPSTRVMGENLAYVIYTSGSTGKPKGVGVRHG 3260
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1659 SAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPqGGEKEPEVIAKAIEEQKITAMHFVPSMLH 1738
Cdd:PRK12467 3261 ALANHLCWIAEAYELDANDRVLLFMSFSFDGAQERFLWTLICGGCLVVRD-NDLWDPEELWQAIHAHRISIACFPPAYLQ 3339
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1739 AFLEHIKYRSVPiktnRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFDCPPHEKLE--RIPIGKPV 1816
Cdd:PRK12467 3340 QFAEDAGGADCA----SLDIYVFGGEAVPPAAFEQVKRKLKPRGLTNGYGPTEAVVTVTLWKCGGDAVCEapYAPIGRPV 3415
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1817 HHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFY-PGERMYKTGDVARWLPDGNVEFLGRTDD 1895
Cdd:PRK12467 3416 AGRSIYVLDGQLNPVPVGVAGELYIGGVGLARGYHQRPSLTAERFVADPFSgSGGRLYRTGDLARYRADGVIEYLGRIDH 3495
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1896 QVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDSGEPELCAYV-----EGLQRNEVRAQLERLLPGYMVPAYMIEMEQW 1970
Cdd:PRK12467 3496 QVKIRGFRIELGEIEARLLQHPSVREAVVLARDGAGGKQLVAYVvpadpQGDWRETLRDHLAASLPDYMVPAQLLVLAAM 3575
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1971 PVTPSGKLDRNALPAPgGAADAETYTAPRNVTEMKLSQLWEDVLKNGPVGIHDNFFDRGGHSLKATALVSRITKEFDVQV 2050
Cdd:PRK12467 3576 PLGPNGKVDRKALPDP-DAKGSREYVAPRSEVEQQLAAIWADVLGVEQVGVTDNFFELGGDSLLALQVLSRIRQSLGLKL 3654
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2051 PLKDVFAHPTVEGLATVIREGTdspyeaikpaekqetypvssaqkriyvlqqledggtgynmpavLELEGKLNPERMDRA 2130
Cdd:PRK12467 3655 SLRDLMSAPTIAELAGYSPLGD-------------------------------------------VPVNLLLDLNRLETG 3691
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2131 FQELIKRHESLRTSFEqdegGDPVQRIhdevpftlqttvlgarteqeaaaafikpfdlsqaplfraqivkVSDERHLLLV 2210
Cdd:PRK12467 3692 FPALFCRHEGLGTVFD----YEPLAVI-------------------------------------------LEGDRHVLGL 3724
|
1210 1220 1230 1240
....*....|....*....|....*....|....*....|...
gi 1678550997 2211 DMHHIISDGvsvniliqefgelYNNRKLPALRIQYKDYAVWQE 2253
Cdd:PRK12467 3725 TCRHLLDDG-------------WQDTSLQAMAVQYADYILWQQ 3754
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
4-1030 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 715.20 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 4 ANSIQDIYPLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGkVNPQFFQNSINALVERHDIFRTIFISQ-NVSSPQQVVLR 82
Cdd:PRK12316 4096 LGEIEDIYPLSPMQQGMLFHSLYEQEAGDYINQMRVDVQG-LDVERFRAAWQAALDRHDVLRSGFVWQgELGRPLQVVHK 4174
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 83 ERNVIVLEEDITHLNEAEQSqfIEQWKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLH 162
Cdd:PRK12316 4175 QVSLPFAELDWRGRADLQAA--LDALAAAERERGFDLQRAPLLRLVLVRTAEGRHHLIYTNHHILMDGWSNSQLLGEVLE 4252
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 163 IYASYVNAspitlEPVQPYGKYIKWLMEQDKEQAVSYWDHYLSGHEQQTVL----PKQKKTKGKSRQEHVTfSFSKEESS 238
Cdd:PRK12316 4253 RYSGRPPA-----QPGGRYRDYIAWLQRQDAAASEAFWREQLAALDEPTRLaqaiARADLRSANGYGEHVR-ELDATATA 4326
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 239 RLSELAAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRPAEIEGIEHMVGLFINTMPVRVQ-GAKTPFLQLIKDM 317
Cdd:PRK12316 4327 RLREFARTQRVTLNTLVQAAWLLLLQRYTGQDTVAFGATVAGRPAELPGIEGQIGLFINTLPVIATpRAQQSVVEWLQQV 4406
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 318 QKDRLAAEAYSYHPLYEIQsRSAVKQG--LIDHILVFENYPVQQEIQmlnkQEHASDLfQIHNFTVADETNYSFYLMVAP 395
Cdd:PRK12316 4407 QRQNLALREHEHTPLYEIQ-RWAGQGGeaLFDSLLVFENYPVSEALQ----QGAPGGL-RFGEVTNHEQTNYPLTLAVGL 4480
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 396 GEEIHIKMNYDAEQHDRSFVLSVKEHLLNAVSQILNNPNLPPEEIDITtDTEKRQLIGEITDQT----PVYETIHAMFEK 471
Cdd:PRK12316 4481 GETLSLQFSYDRGHFDAATIERLARHLTNLLEAMAEDPQRRLGELQLL-EKAEQQRIVALWNRTdagyPATRCVHQLVAE 4559
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 472 QAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADR 551
Cdd:PRK12316 4560 RARMTPDAVAVVFDEEKLTYAELNRRANRLAHALIARGVGPEVLVGIAMERSAEMMVGLLAVLKAGGAYVPLDPEYPRER 4639
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 552 IRYILHDCGCSHVVSQAHLPSSLE-----DNYIITHPEDIESKVDgSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRN 626
Cdd:PRK12316 4640 LAYMMEDSGAALLLTQSHLLQRLPipdglASLALDRDEDWEGFPA-HDPAVRLHPDNLAYVIYTSGSTGRPKGVAVSHGS 4718
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 627 MANLLKFEYTHSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIkRDVPQLFAFINKHQTNIVFLPTAFIKM 706
Cdd:PRK12316 4719 LVNHLHATGERYELTPDDRVLQFMSFSFDGSHEGLYHPLINGASVVIRDDSL-WDPERLYAEIHEHRVTVLVFPPVYLQQ 4797
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 707 IFSERELANSFPDgVKHLIAAGEQLMiSDLFQDVLRK-RGIHLHNHYGPSETHV-VSTYTIHPGDP-IPELPPIGKPIGC 783
Cdd:PRK12316 4798 LAEHAERDGEPPS-LRVYCFGGEAVA-QASYDLAWRAlKPVYLFNGYGPTETTVtVLLWKARDGDAcGAAYMPIGTPLGN 4875
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 784 TDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPF-KPDVIMYRTGDLARRLEDGNIEYIGRADNQV 862
Cdd:PRK12316 4876 RSGYVLDGQLNPLPVGVAGELYLGGEGVARGYLERPALTAERFVPDPFgAPGGRLYRTGDLARYRADGVIDYLGRVDHQV 4955
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 863 KIRGYRIEPQEIEVTLMNHPDISEAaILIWQDQNGEHELCAY----------YCSVQKLNTIDLRSYMASELPEYMIPAK 932
Cdd:PRK12316 4956 KIRGFRIELGEIEARLREHPAVREA-VVIAQEGAVGKQLVGYvvpqdpaladADEAQAELRDELKAALRERLPEYMVPAH 5034
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 933 WIWVDSIPLTPNGKVDRAALPEPDASISGNPYTAPRNLLEAKLSQLFEDVLKNGHIGIQDNFFDNGGHSLKATVLMSRIA 1012
Cdd:PRK12316 5035 LVFLARMPLTPNGKLDRKALPQPDASLLQQAYVAPRSELEQQVAAIWAEVLQLERVGLDDNFFELGGHSLLAIQVTSRIQ 5114
|
1050
....*....|....*...
gi 1678550997 1013 KEFHVQVSLKDIFAHPTV 1030
Cdd:PRK12316 5115 LELGLELPLRELFQTPTL 5132
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
1058-2073 |
0e+00 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 689.09 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1058 PVSSAQKRIYVLQQLD-EGVAYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSGaDDEPVQRIHTEVPFT---- 1132
Cdd:PRK10252 9 PLVAAQPGIWMAEKLSpLPSAWSVAHYVELTGELDAPLLARAVVAGLAEADTLRMRFTED-NGEVWQWVDPALTFPlpei 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1133 --LSKETTIEGFVRPF---DLSQA-------PLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYANRQ--- 1197
Cdd:PRK10252 88 idLRTQPDPHAAAQALmqaDLQQDlrvdsgkPLVFHQLIQLGDNRWYWYQRYHHLLVDGFSFPAITRRIAAIYCAWLrge 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1198 ------LKPLRIQYKDYAVWQQkfkkGDSYQKQETYWQQQFSGDLPILEL---PTDKRRPAERqFIggKVTFQLDKEITA 1268
Cdd:PRK10252 168 ptpaspFTPFADVVEEYQRYRA----SEAWQRDAAFWAEQRRQLPPPASLspaPLPGRSASAD-IL--RLKLEFTDGAFR 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1269 RIKRLAHKNRstLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPHADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQ 1348
Cdd:PRK10252 241 QLAAQASGVQ--RPDLALALVALWLGRLCGRMDYAAGFIFMRRLGSAALTATGPVLNVLPLRVHIAAQETLPELATRLAA 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1349 TALEAYEHQDYPFEELVDKLGvqREMSRNPLFDTTLVLQNMEQQkLKMNDVQLQWNDLEH-PISKFDISLYVTEhDSELF 1427
Cdd:PRK10252 319 QLKKMRRHQRYDAEQIVRDSG--RAAGDEPLFGPVLNIKVFDYQ-LDFPGVQAQTHTLATgPVNDLELALFPDE-HGGLS 394
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1428 CQFEYSTALFEKETIQRWASLFTTLVEHTAASPETELDNIPILTKEEerdfIESCHLFEETGYSM-NQTLHYALEQQAEK 1506
Cdd:PRK10252 395 IEILANPQRYDEATLIAHAERLKALIAQFAADPALLCGDVDILLPGE----YAQLAQVNATAVEIpETTLSALVAQQAAK 470
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1507 TPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFL 1586
Cdd:PRK10252 471 TPDAPALADARYQFSYREMREQVVALANLLRERGVKPGDSVAVALPRSVFLTLALHAIVEAGAAWLPLDTGYPDDRLKMM 550
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1587 LEDSgTNILLLQSAGLhVPEFTG-EIVYLNQTNSGLAHRLSNPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLN 1665
Cdd:PRK10252 551 LEDA-RPSLLITTADQ-LPRFADvPDLTSLCYNAPLAPQGAAPLQLSQPHHTAYIIFTSGSTGRPKGVMVGQTAIVNRLL 628
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1666 SLQSRYQLKHSDMIMHKTSYSFDASIWElFWWPY-AGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHI 1744
Cdd:PRK10252 629 WMQNHYPLTADDVVLQKTPCSFDVSVWE-FFWPFiAGAKLVMAEPEAHRDPLAMQQFFAEYGVTTTHFVPSMLAAFVASL 707
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1745 KYRSVPIKTNRLKRVFSGGEQLGTHLVSRFYELLpNVSITNSYGPTEATVEAAFFDCPPHEKLER----IPIGKPVHHVR 1820
Cdd:PRK10252 708 TPEGARQSCASLRQVFCSGEALPADLCREWQQLT-GAPLHNLYGPTEAAVDVSWYPAFGEELAAVrgssVPIGYPVWNTG 786
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1821 LYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIR 1900
Cdd:PRK10252 787 LRILDARMRPVPPGVAGDLYLTGIQLAQGYLGRPDLTASRFIADPFAPGERMYRTGDVARWLDDGAVEYLGRSDDQLKIR 866
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1901 GYRIEPGEIEAALRSIEGVREAAV-------TVRTDSGEPELCAYV-----EGLQRNEVRAQLERLLPGYMVPAYMIEME 1968
Cdd:PRK10252 867 GQRIELGEIDRAMQALPDVEQAVThacvinqAAATGGDARQLVGYLvsqsgLPLDTSALQAQLRERLPPHMVPVVLLQLD 946
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1969 QWPVTPSGKLDRNALPAPGGAADAETyTAPRNVTEMKLSQLWEDVLKNGPVGIHDNFFDRGGHSLKATALVSRITKEFDV 2048
Cdd:PRK10252 947 QLPLSANGKLDRKALPLPELKAQVPG-RAPKTGTETIIAAAFSSLLGCDVVDADADFFALGGHSLLAMKLAAQLSRQFAR 1025
|
1050 1060
....*....|....*....|....*
gi 1678550997 2049 QVPLKDVFAHPTVEGLATVIREGTD 2073
Cdd:PRK10252 1026 QVTPGQVMVASTVAKLATLLDAEED 1050
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
2081-3101 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 687.85 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2081 PAEKQETYPVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGkLNPERMDRAFQELIKRHESLRTSF-EQDEGGDPVQRIHD 2159
Cdd:PRK12316 4096 LGEIEDIYPLSPMQQGMLFHSLYEQEAGDYINQMRVDVQG-LDVERFRAAWQAALDRHDVLRSGFvWQGELGRPLQVVHK 4174
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2160 --EVPFTLQ----TTVLGARTEQEAAAAFIKPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELY 2233
Cdd:PRK12316 4175 qvSLPFAELdwrgRADLQAALDALAAAERERGFDLQRAPLLRLVLVRTAEGRHHLIYTNHHILMDGWSNSQLLGEVLERY 4254
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2234 NNRKLPALRIQYKDYAVWqegFKTGDAyKMQEAYWLKQLEGELPVLDLPADHARPPVRSFAG-DKVSFTLEPEVASGLHK 2312
Cdd:PRK12316 4255 SGRPPAQPGGRYRDYIAW---LQRQDA-AASEAFWREQLAALDEPTRLAQAIARADLRSANGyGEHVRELDATATARLRE 4330
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2313 LARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPH--KDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRETA 2390
Cdd:PRK12316 4331 FARTQRVTLNTLVQAAWLLLLQRYTGQDTVAFGATVAGRPAelPGIEGQIGLFINTLPVIATPRAQQSVVEWLQQVQRQN 4410
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2391 LEAFEHQNYPFEELvdklELTRDMSRNPVFDAMLVVQNNdyePLHLHDLQMKPAQV------SHLVSKFDLTLQASEGDg 2464
Cdd:PRK12316 4411 LALREHEHTPLYEI----QRWAGQGGEALFDSLLVFENY---PVSEALQQGAPGGLrfgevtNHEQTNYPLTLAVGLGE- 4482
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2465 NIHFLFEYSTALFEKTTIERWASHLTNVLSIIGKNPKVTLNHIDILTQEERHQLLNEFNTGQANQYGVQTISQLFEQQAA 2544
Cdd:PRK12316 4483 TLSLQFSYDRGHFDAATIERLARHLTNLLEAMAEDPQRRLGELQLLEKAEQQRIVALWNRTDAGYPATRCVHQLVAERAR 4562
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2545 RTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRY 2624
Cdd:PRK12316 4563 MTPDAVAVVFDEEKLTYAELNRRANRLAHALIARGVGPEVLVGIAMERSAEMMVGLLAVLKAGGAYVPLDPEYPRERLAY 4642
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2625 ILSDSGTKLLMTINEAdLGVLADFEG-EILTIESVEEDDKSPL--PQMS-SAHHLAYIIYTSGTTGRPKGVMVEHKGIAN 2700
Cdd:PRK12316 4643 MMEDSGAALLLTQSHL-LQRLPIPDGlASLALDRDEDWEGFPAhdPAVRlHPDNLAYVIYTSGSTGRPKGVAVSHGSLVN 4721
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2701 TLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAkAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLYRALL- 2779
Cdd:PRK12316 4722 HLHATGERYELTPDDRVLQFMSFSFDGSHEGLYHPLINGA-SVVIRDDSLWDPERLYAEIHEHRVTVLVFPPVYLQQLAe 4800
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2780 DVVQPEDVKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTENSVATTVMR----HMEKQAYVSIGQPIDGTQVLI 2855
Cdd:PRK12316 4801 HAERDGEPPSLRVYCFGGEAVAQASYDLAWRALKPVYLFNGYGPTETTVTVLLWKardgDACGAAYMPIGTPLGNRSGYV 4880
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2856 LNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPF-KPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGY 2934
Cdd:PRK12316 4881 LDGQLNPLPVGVAGELYLGGEGVARGYLERPALTAERFVPDPFgAPGGRLYRTGDLARYRADGVIDYLGRVDHQVKIRGF 4960
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2935 RVETKEIESVIRCIKGVKDAAVVAHVTASGQtELSAYVV--TKPGLSTNAVRSELQNKL--------PVFMHPAFIEKLD 3004
Cdd:PRK12316 4961 RIELGEIEARLREHPAVREAVVIAQEGAVGK-QLVGYVVpqDPALADADEAQAELRDELkaalrerlPEYMVPAHLVFLA 5039
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3005 SLPLSPNGKLDRGALPKPVYNHEgERPFLPPSSKMEQILADIWKEVLGAEKIGTADSFFELGGDSIKALQVSARLH-RIG 3083
Cdd:PRK12316 5040 RMPLTPNGKLDRKALPQPDASLL-QQAYVAPRSELEQQVAAIWAEVLQLERVGLDDNFFELGGHSLLAIQVTSRIQlELG 5118
|
1050
....*....|....*...
gi 1678550997 3084 KQMAVKDLFSHPTIQELA 3101
Cdd:PRK12316 5119 LELPLRELFQTPTLAAFV 5136
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
12-1535 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 677.83 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 12 PLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNVSSPQQVVLrERNVIVLEE 91
Cdd:PRK12316 51 RLSYAQQRMWFLWQLEPQSGAYNLPSAVRLNGPLDRQALERAFASLVQRHETLRTVFPRGADDSLAQVPL-DRPLEVEFE 129
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 92 DITHLNEAEQSQFIEQWKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASYVNAS 171
Cdd:PRK12316 130 DCSGLPEAEQEARLRDEAQRESLQPFDLCEGPLLRVRLLRLGEEEHVLLLTLHHIVSDGWSMNVLIEEFSRFYSAYATGA 209
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 172 PITLE--PVQpYGKYI----KWLMEQDKEQAVSYWDHYLSghEQQTVL--------PKQKKTKGKSRQehvtFSFSKEES 237
Cdd:PRK12316 210 EPGLPalPIQ-YADYAlwqrSWLEAGEQERQLEYWRAQLG--EEHPVLelptdhprPAVPSYRGSRYE----FSIDPALA 282
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 238 SRLSELAAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRP-AEIEGiehMVGLFINTMPVRVQ-GAKTPFLQLIK 315
Cdd:PRK12316 283 EALRGTARRQGLTLFMLLLGAFNVLLHRYSGQTDIRVGVPIANRNrAEVEG---LIGFFVNTQVLRSVfDGRTRVATLLA 359
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 316 DMQKDRLAAEAYSYHPLYEIQSRSAVKQGLiDHILVFEnypvqqeiQMLNKQEHASD---LFQIHNFTVAD------ETN 386
Cdd:PRK12316 360 GVKDTVLGAQAHQDLPFERLVEALKVERSL-SHSPLFQ--------VMYNHQPLVADieaLDTVAGLEFGQlewksrTTQ 430
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 387 YSFYL-MVAPGEEIHIKMNYDAEQHDRSFVLSVKEHLLNAVSQILNNPNLPPEEIDITTDTEKRQLI---GEITDQTPVY 462
Cdd:PRK12316 431 FDLTLdTYEKGGRLHAALTYATDLFEARTVERMARHWQNLLRGMVENPQARVDELPMLDAEERGQLVegwNATAAEYPLQ 510
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 463 ETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVP 542
Cdd:PRK12316 511 RGVHRLFEEQVERTPEAPALAFGEETLDYAELNRRANRLAHALIERGVGPDVLVGVAMERSIEMVVALLAILKAGGAYVP 590
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 543 VDPHYPADRIRYILHDCGCSHVVSQAHLPSSLEDNYIITHP--EDIESKVDG---SNIKSVNNADDLLYMIYTSGTTGKP 617
Cdd:PRK12316 591 LDPEYPAERLAYMLEDSGVQLLLSQSHLGRKLPLAAGVQVLdlDRPAAWLEGyseENPGTELNPENLAYVIYTSGSTGKP 670
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 618 KGVQFEHRNMANLLKFEYTHSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNIV 697
Cdd:PRK12316 671 KGAGNRHRALSNRLCWMQQAYGLGVGDTVLQKTPFSFDVSVWEFFWPLMSGARLVVAAPGDHRDPAKLVELINREGVDTL 750
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 698 FLPTAFIKMIFSERELANSFPdgVKHLIAAGEQLMiSDLFQDVLRKRGI-HLHNHYGPSETHVVSTYTIHPgDPIPELPP 776
Cdd:PRK12316 751 HFVPSMLQAFLQDEDVASCTS--LRRIVCSGEALP-ADAQEQVFAKLPQaGLYNLYGPTEAAIDVTHWTCV-EEGGDSVP 826
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 777 IGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPDVIMYRTGDLARRLEDGNIEYIG 856
Cdd:PRK12316 827 IGRPIANLACYILDANLEPVPVGVLGELYLAGRGLARGYHGRPGLTAERFVPSPFVAGERMYRTGDLARYRADGVIEYAG 906
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 857 RADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIwqdQNGEhELCAYYC--SVQKLNTIDLRSYMASELPEYMIPAKWI 934
Cdd:PRK12316 907 RIDHQVKLRGLRIELGEIEARLLEHPWVREAAVLA---VDGK-QLVGYVVleSEGGDWREALKAHLAASLPEYMVPAQWL 982
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 935 WVDSIPLTPNGKVDRAALPEPDASISGNPYTAPRNLLEAKLSQLFEDVLKNGHIGIQDNFFDNGGHSLKATVLMSRiAKE 1014
Cdd:PRK12316 983 ALERLPLTPNGKLDRKALPAPEASVAQQGYVAPRNALERTLAAIWQDVLGVERVGLDDNFFELGGDSIVSIQVVSR-ARQ 1061
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1015 FHVQVSLKDIFAHPTVEGLALIIREAEQnlyAAIEPAEKRDTYPVSSAQKRIYVlQQLDEGVAYNMPAVLELEGALDVAK 1094
Cdd:PRK12316 1062 AGIQLSPRDLFQHQTIRSLALVAKAGQA---TAADQGPASGEVALAPVQRWFFE-QAIPQRQHWNQSLLLQARQPLDPDR 1137
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1095 LSAVCKELISRHEPLRTSFVSGAD-----------DEPVQRIHTEVPFTLskETTIEGFVRPFDLSQAPLFRAGLIEVSN 1163
Cdd:PRK12316 1138 LGRALERLVAHHDALRLRFREEDGgwqqayaapqaGEVLWQRQAASEEEL--LALCEEAQRSLDLEQGPLLRALLVDMAD 1215
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1164 EKHVLLVDMHHIISDGVSVQLLIREFTDLYANRQLKpLRIQYKDYAVWQQKFKK-GDSYQKQETYWQQQFsGDLPiLELP 1242
Cdd:PRK12316 1216 GSQRLLLVIHHLVVDGVSWRILLEDLQRAYADLDAD-LPARTSSYQAWARRLHEhAGARAEELDYWQAQL-EDAP-HELP 1292
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1243 TDKRRPAERQFIGGKVTFQLDKEITARIKRLA-HKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPH----ADLE 1317
Cdd:PRK12316 1293 CENPDGALENRHERKLELRLDAERTRQLLQEApAAYRTQVNDLLLTALARVTCRWSGQASVLVQLEGHGREDlfedIDLS 1372
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1318 AVLGMFVNTLALRTRPAGNktFEEFLKEVRQTaLEAYEHQDYPFEELVDKLGVQREMSRNPLFDTTLVLQNMEQQKLKMN 1397
Cdd:PRK12316 1373 RTVGWFTSLFPVRLTPAAD--LGESIKAIKEQ-LRAVPDKGIGYGLLRYLAGEEAAARLAALPQPRITFNYLGQFDRQFD 1449
|
1450 1460 1470 1480 1490 1500 1510 1520
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1398 DVQL---------QWNDLEHPISKFdISLYVTEHDSELFCQFEYSTALFEKETIQRWASLFT----TLVEHTAASP---- 1460
Cdd:PRK12316 1450 EAALfvpatesagAAQDPCAPLANW-LSIEGQVYGGELSLHWSFSREMFAEATVQRLADDYArelqALIEHCCDERnrgv 1528
|
1530 1540 1550 1560 1570 1580 1590 1600
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1461 -----------ETELDNIPILTKEEERDFIESchlfeetgySMNQTL--HYALEQQAEKTPDQAAVIFEDgvmtykeLNE 1527
Cdd:PRK12316 1529 tpsdfplaglsQAQLDALPLPAGEIADIYPLS---------PMQQGMlfHSLYEQEAGDYINQLRVDVQG-------LDP 1592
|
....*...
gi 1678550997 1528 QANRIAWE 1535
Cdd:PRK12316 1593 DRFRAAWQ 1600
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
12-1460 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 668.59 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 12 PLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNVSSPQQVVLRERNVIVLEE 91
Cdd:PRK12316 2604 PLSHAQQRQWFLWQLEPESAAYHLPSALHLRGVLDQAALEQAFDALVLRHETLRTRFVEVGEQTRQVILPNMSLRIVLED 2683
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 92 DITHLNEAeqsqfIEQWKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASYVNAS 171
Cdd:PRK12316 2684 CAGVADAA-----IRQRVAEEIQRPFDLARGPLLRVRLLALDGQEHVLVITQHHIVSDGWSMQVMVDELVQAYAGARRGE 2758
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 172 PITLEPVQ-PYGKYIKWLME----QDKEQAVSYWDHYLSGHEQQTVLPKQKKTKGKS--RQEHVTFSFSKEESSRLSELA 244
Cdd:PRK12316 2759 QPTLPPLPlQYADYAAWQRAwmdsGEGARQLDYWRERLGGEQPVLELPLDRPRPALQshRGARLDVALDVALSRELLALA 2838
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 245 AREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRpaEIEGIEHMVGLFINTMPVRVQ-GAKTPFLQLIKDMQKDRLA 323
Cdd:PRK12316 2839 RREGVTLFMLLLASFQVLLHRYSGQSDIRVGVPIANR--NRAETERLIGFFVNTQVLRAQvDAQLAFRDLLGQVKEQALG 2916
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 324 AEAYSYHPLYEIQS-----RSAVKQGLIDHILVFENYPVQQeiqmlnKQEHASDLFQIHNFTVADETNYSFYLMVAPgEE 398
Cdd:PRK12316 2917 AQAHQDLPFEQLVEalqpeRSLSHSPLFQVMYNHQSGERAA------AQLPGLHIESFAWDGAATQFDLALDTWESA-EG 2989
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 399 IHIKMNYDAEQHDRSFVLSVKEHLLNAVSQILNNPNLPPEEIDITTDTEKRQLIGEITDQTPVYET---IHAMFEKQAEK 475
Cdd:PRK12316 2990 LGASLTYATDLFDARTVERLARHWQNLLRGMVENPQRSVDELAMLDAEERGQLLEAWNATAAEYPLergVHRLFEEQVER 3069
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 476 TPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYI 555
Cdd:PRK12316 3070 TPDAVALAFGEQRLSYAELNRRANRLAHRLIERGVGPDVLVGVAVERSLEMVVGLLAILKAGGAYVPLDPEYPEERLAYM 3149
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 556 LHDCGCSHVVSQAHLPSSLEDNYIITHPEDIESKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEY 635
Cdd:PRK12316 3150 LEDSGAQLLLSQSHLRLPLAQGVQVLDLDRGDENYAEANPAIRTMPENLAYVIYTSGSTGKPKGVGIRHSALSNHLCWMQ 3229
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 636 THSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNivfLPTAFIKMIFSERELAN 715
Cdd:PRK12316 3230 QAYGLGVGDRVLQFTTFSFDVFVEELFWPLMSGARVVLAGPEDWRDPALLVELINSEGVD---VLHAYPSMLQAFLEEED 3306
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 716 SFPDGVKHLIAAGEQLMISDLFQDVLrkRGIHLHNHYGPSETHVVSTyTIHPGDPIPELPPIGKPIGCTDLYILNHQKQL 795
Cdd:PRK12316 3307 AHRCTSLKRIVCGGEALPADLQQQVF--AGLPLYNLYGPTEATITVT-HWQCVEEGKDAVPIGRPIANRACYILDGSLEP 3383
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 796 QPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPDVIMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIE 875
Cdd:PRK12316 3384 VPVGALGELYLGGEGLARGYHNRPGLTAERFVPDPFVPGERLYRTGDLARYRADGVIEYIGRVDHQVKIRGFRIELGEIE 3463
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 876 VTLMNHPDISEAAILiwqDQNGEhELCAYYCSVQKLNTI--DLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALP 953
Cdd:PRK12316 3464 ARLLEHPWVREAVVL---AVDGR-QLVAYVVPEDEAGDLreALKAHLKASLPEYMVPAHLLFLERMPLTPNGKLDRKALP 3539
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 954 EPDASISGNPYTAPRNLLEAKLSQLFEDVLKNGHIGIQDNFFDNGGHSLKATVLMSRiAKEFHVQVSLKDIFAHPTVEGL 1033
Cdd:PRK12316 3540 RPDAALLQQDYVAPVNELERRLAAIWADVLKLEQVGLTDNFFELGGDSIISLQVVSR-ARQAGIRFTPKDLFQHQTIQGL 3618
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1034 ALIIReaeqnlyaaIEPAEKRDTYPVSSAQKRIYVLQQ-LDEGVA----YNMPAVLELEGALDVAKLSAVCKELISRHEP 1108
Cdd:PRK12316 3619 ARVAR---------VGGGVAVDQGPVSGETLLLPIQQQfFEEPVPerhhWNQSLLLKPREALDAAALEAALQALVEHHDA 3689
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1109 LRTSFVSGADDEPVQRIHTEVPFTL----------SKETTIEGFVRPFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISD 1178
Cdd:PRK12316 3690 LRLRFVEDAGGWTAEHLPVELGGALlwraelddaeELERLGEEAQRSLDLADGPLLRALLATLADGSQRLLLVIHHLVVD 3769
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1179 GVSVQLLIREFTDLYANR------QLKPLRIQYKDYAVWQQKFKKGDSYQKQETYWQQQFSGDLPilELPTDKRRPAERQ 1252
Cdd:PRK12316 3770 GVSWRILLEDLQQAYQQLlqgeapRLPAKTSSFKAWAERLQEHARGEALKAELAYWQEQLQGVSS--ELPCDHPQGALQN 3847
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1253 FIGGKVTFQLDKEITARIKRLA-HKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPH----ADLEAVLGMFVNTL 1327
Cdd:PRK12316 3848 RHAASVQTRLDRELTRRLLQQApAAYRTQVNDLLLTALARVVCRWTGEASALVQLEGHGREDlfadIDLSRTVGWFTSLF 3927
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1328 ALRTRPAGN-----KTFEEFLKEVRQTALEAYEHQDYPFEELVDKLGV--QREMSRNPL--FDTTLvlqNMEQQKL-KMN 1397
Cdd:PRK12316 3928 PVRLSPVEDlgasiKAIKEQLRAIPNKGIGFGLLRYLGDEESRRTLAGlpVPRITFNYLgqFDGSF---DEEMALFvPAG 4004
|
1450 1460 1470 1480 1490 1500
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 1398 DVQLQWNDLEHPISKFdISLYVTEHDSELFCQFEYSTALFEKETIQR----WASLFTTLVEHTAASP 1460
Cdd:PRK12316 4005 ESAGAEQSPDAPLDNW-LSLNGRVYGGELSLDWTFSREMFEEATIQRladdYAAELTALVEHCCDAE 4070
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
2078-3112 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 650.69 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2078 AIKPAEKQETYPVSSAQKRIyVLQQLEDGGTG-YNMPAVLELEGkLNPERMDRAFQELIKRHESLRTSF-EQDEGGDPVQ 2155
Cdd:PRK12467 2637 PVAVGDIEDIYPLSPMQQGM-LFHTLYEGGAGdYINQMRVDVEG-LDVERFRTAWQAVIDRHEILRSGFlWDGELEEPLQ 2714
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2156 RIHD--EVPFTLQTTVLGARTEQE----AAAAFIKPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEF 2229
Cdd:PRK12467 2715 VVYKqaRLPFSRLDWRDRADLEQAldalAAADRQQGFDLLSAPLLRLTLVRTGEDRHHLIYTNHHILMDGWSGSQLLGEV 2794
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2230 GELYNNRKLPALRIQYKDYAVWqegFKTGDAyKMQEAYWLKQL----EGELPVLDLPADHARPpvRSFAGDKvSFTLEPE 2305
Cdd:PRK12467 2795 LQRYFGQPPPAREGRYRDYIAW---LQAQDA-EASEAFWKEQLaaleEPTRLARALYPAPAEA--VAGHGAH-YLHLDAT 2867
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2306 VASGLHKLARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPH--KDLEPILGMFVNTLALRTRPEGGKPFVQYL 2383
Cdd:PRK12467 2868 QTRQLIEFARRHRVTLNTLVQGAWLLLLQRFTGQDTVCFGATVAGRPAqlRGAEQQLGLFINTLPVIASPRAEQTVSDWL 2947
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2384 QEVRETALEAFEHQNYPFeelvdkLELTRDMSR--NPVFDAMLVVQNndYePLHLHDLQMKPAQV------SHLVSKFDL 2455
Cdd:PRK12467 2948 QQVQAQNLALREFEHTPL------ADIQRWAGQggEALFDSILVFEN--Y-PISEALKQGAPSGLrfgavsSREQTNYPL 3018
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2456 TLQASEGDG-NIHFLfeYSTALFEKTTIERWASHLTNVLSIIGKNPKVTLNHIDILTQEERHQLLNEFNTGQANQYGVQT 2534
Cdd:PRK12467 3019 TLAVGLGDTlELEFS--YDRQHFDAAAIERLAESFDRLLQAMLNNPAARLGELPTLAAHERRQVLHAWNATAAAYPSERL 3096
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2535 ISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPID 2614
Cdd:PRK12467 3097 VHQLIEAQVARTPEAPALVFGDQQLSYAELNRRANRLAHRLIAIGVGPDVLVGVAVERSVEMIVALLAVLKAGGAYVPLD 3176
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2615 PEYPKERKRYILSDSGTKLLMTINE--ADLGVLADfeGEILTIESVEEDDKSP-LPQMSS-AHHLAYIIYTSGTTGRPKG 2690
Cdd:PRK12467 3177 PEYPRERLAYMIEDSGVKLLLTQAHllEQLPAPAG--DTALTLDRLDLNGYSEnNPSTRVmGENLAYVIYTSGSTGKPKG 3254
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2691 VMVEHKGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAkAVLLHEEEAKDILAIKHQLSRQRITHMII 2770
Cdd:PRK12467 3255 VGVRHGALANHLCWIAEAYELDANDRVLLFMSFSFDGAQERFLWTLICGG-CLVVRDNDLWDPEELWQAIHAHRISIACF 3333
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2771 VPVLYRALLDVVQPEDVKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTENSVA----TTVMRHMEKQAYVSIGQ 2846
Cdd:PRK12467 3334 PPAYLQQFAEDAGGADCASLDIYVFGGEAVPPAAFEQVKRKLKPRGLTNGYGPTEAVVTvtlwKCGGDAVCEAPYAPIGR 3413
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2847 PIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKPEA-RMYRTGDAARWMADGTLEYLGRI 2925
Cdd:PRK12467 3414 PVAGRSIYVLDGQLNPVPVGVAGELYIGGVGLARGYHQRPSLTAERFVADPFSGSGgRLYRTGDLARYRADGVIEYLGRI 3493
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2926 DDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQtELSAYVVTK--PGLSTNAVRSELQNKLPVFMHPAFIEKL 3003
Cdd:PRK12467 3494 DHQVKIRGFRIELGEIEARLLQHPSVREAVVLARDGAGGK-QLVAYVVPAdpQGDWRETLRDHLAASLPDYMVPAQLLVL 3572
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3004 DSLPLSPNGKLDRGALPKPvyNHEGERPFLPPSSKMEQILADIWKEVLGAEKIGTADSFFELGGDSIKALQVSARLHR-I 3082
Cdd:PRK12467 3573 AAMPLGPNGKVDRKALPDP--DAKGSREYVAPRSEVEQQLAAIWADVLGVEQVGVTDNFFELGGDSLLALQVLSRIRQsL 3650
|
1050 1060 1070
....*....|....*....|....*....|
gi 1678550997 3083 GKQMAVKDLFSHPTIQELAAYIRDSDTSSS 3112
Cdd:PRK12467 3651 GLKLSLRDLMSAPTIAELAGYSPLGDVPVN 3680
|
|
| A_NRPS |
cd05930 |
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain ... |
1508-1983 |
0e+00 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341253 [Multi-domain] Cd Length: 444 Bit Score: 644.58 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1508 PDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLL 1587
Cdd:cd05930 1 PDAVAVVDGDQSLTYAELDARANRLARYLRERGVGPGDLVAVLLERSLEMVVAILAVLKAGAAYVPLDPSYPAERLAYIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1588 EDSGTNILLLQsaglhvpeftgeivylnqtnsglahrlsnpnvdvlPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSL 1667
Cdd:cd05930 81 EDSGAKLVLTD-----------------------------------PDDLAYVIYTSGSTGKPKGVMVEHRGLVNLLLWM 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1668 QSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYR 1747
Cdd:cd05930 126 QEAYPLTPGDRVLQFTSFSFDVSVWEIFGALLAGATLVVLPEEVRKDPEALADLLAEEGITVLHLTPSLLRLLLQELELA 205
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1748 SVPiktnRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFDCPP-HEKLERIPIGKPVHHVRLYLLNQ 1826
Cdd:cd05930 206 ALP----SLRLVLVGGEALPPDLVRRWRELLPGARLVNLYGPTEATVDATYYRVPPdDEEDGRVPIGRPIPNTRVYVLDE 281
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1827 NQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEP 1906
Cdd:cd05930 282 NLRPVPPGVPGELYIGGAGLARGYLNRPELTAERFVPNPFGPGERMYRTGDLVRWLPDGNLEFLGRIDDQVKIRGYRIEL 361
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1907 GEIEAALRSIEGVREAAVTVRTD-SGEPELCAYV-----EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDR 1980
Cdd:cd05930 362 GEIEAALLAHPGVREAAVVAREDgDGEKRLVAYVvpdegGELDEEELRAHLAERLPDYMVPSAFVVLDALPLTPNGKVDR 441
|
...
gi 1678550997 1981 NAL 1983
Cdd:cd05930 442 KAL 444
|
|
| A_NRPS |
cd05930 |
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain ... |
2547-3019 |
0e+00 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341253 [Multi-domain] Cd Length: 444 Bit Score: 637.26 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2547 PKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYIL 2626
Cdd:cd05930 1 PDAVAVVDGDQSLTYAELDARANRLARYLRERGVGPGDLVAVLLERSLEMVVAILAVLKAGAAYVPLDPSYPAERLAYIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2627 SDSGTKLLMTineadlgvladfegeiltiesveeddksplpqmsSAHHLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRR 2706
Cdd:cd05930 81 EDSGAKLVLT----------------------------------DPDDLAYVIYTSGSTGKPKGVMVEHRGLVNLLLWMQ 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2707 NAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDVVQPED 2786
Cdd:cd05930 127 EAYPLTPGDRVLQFTSFSFDVSVWEIFGALLAGATLVVLPEEVRKDPEALADLLAEEGITVLHLTPSLLRLLLQELELAA 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2787 VKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTENSVATTVMR---HMEKQAYVSIGQPIDGTQVLILNSNHQLQ 2863
Cdd:cd05930 207 LPSLRLVLVGGEALPPDLVRRWRELLPGARLVNLYGPTEATVDATYYRvppDDEEDGRVPIGRPIPNTRVYVLDENLRPV 286
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2864 PIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIES 2943
Cdd:cd05930 287 PPGVPGELYIGGAGLARGYLNRPELTAERFVPNPFGPGERMYRTGDLVRWLPDGNLEFLGRIDDQVKIRGYRIELGEIEA 366
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1678550997 2944 VIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:cd05930 367 ALLAHPGVREAAVVAREDGDGEKRLVAYVVPDEGgeLDEEELRAHLAERLPDYMVPSAFVVLDALPLTPNGKVDRKAL 444
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
2089-3118 |
0e+00 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 623.99 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2089 PVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGdPVQRIHDEVPF-TLQT 2167
Cdd:PRK10252 9 PLVAAQPGIWMAEKLSPLPSAWSVAHYVELTGELDAPLLARAVVAGLAEADTLRMRFTEDNGE-VWQWVDPALTFpLPEI 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2168 TVLGARTEQEAAAAFIKPFDLSQA-------PLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELYNNRK--- 2237
Cdd:PRK10252 88 IDLRTQPDPHAAAQALMQADLQQDlrvdsgkPLVFHQLIQLGDNRWYWYQRYHHLLVDGFSFPAITRRIAAIYCAWLrge 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2238 ------LPALRIQYKDYAVWQEGfktgDAYKMQEAYWLKQLEGELPVLDLPAdhARPPVRSFAGDKVSFTLEPEVASGLH 2311
Cdd:PRK10252 168 ptpaspFTPFADVVEEYQRYRAS----EAWQRDAAFWAEQRRQLPPPASLSP--APLPGRSASADILRLKLEFTDGAFRQ 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2312 KLARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHKDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRETAL 2391
Cdd:PRK10252 242 LAAQASGVQRPDLALALVALWLGRLCGRMDYAAGFIFMRRLGSAALTATGPVLNVLPLRVHIAAQETLPELATRLAAQLK 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2392 EAFEHQNYPFEELVdkleltRDMSR----NPVFDAMLVVQNNDYePLHLHDLQmkpAQVSHLVSK--FDLTLQAS-EGDG 2464
Cdd:PRK10252 322 KMRRHQRYDAEQIV------RDSGRaagdEPLFGPVLNIKVFDY-QLDFPGVQ---AQTHTLATGpvNDLELALFpDEHG 391
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2465 NIHFLFEYSTALFEKTTIERWASHLTNVLSIIGKNPKVTLNHIDILTQEErHQLLNEFNtgqANQYGV--QTISQLFEQQ 2542
Cdd:PRK10252 392 GLSIEILANPQRYDEATLIAHAERLKALIAQFAADPALLCGDVDILLPGE-YAQLAQVN---ATAVEIpeTTLSALVAQQ 467
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2543 AARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERK 2622
Cdd:PRK10252 468 AAKTPDAPALADARYQFSYREMREQVVALANLLRERGVKPGDSVAVALPRSVFLTLALHAIVEAGAAWLPLDTGYPDDRL 547
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2623 RYILSDSGTKLLMTiNEADLGVLADFEG-EILTIESVEEDDKSPLPQMSSAHHLAYIIYTSGTTGRPKGVMVEHKGIANT 2701
Cdd:PRK10252 548 KMMLEDARPSLLIT-TADQLPRFADVPDlTSLCYNAPLAPQGAAPLQLSQPHHTAYIIFTSGSTGRPKGVMVGQTAIVNR 626
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2702 LQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDV 2781
Cdd:PRK10252 627 LLWMQNHYPLTADDVVLQKTPCSFDVSVWEFFWPFIAGAKLVMAEPEAHRDPLAMQQFFAEYGVTTTHFVPSMLAAFVAS 706
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2782 VQPED----VKTLRVVTLAGEAADRELIAR--SLAicpHTELANEYGPTENSV------ATTVMRHMEKQAYVSIGQPID 2849
Cdd:PRK10252 707 LTPEGarqsCASLRQVFCSGEALPADLCREwqQLT---GAPLHNLYGPTEAAVdvswypAFGEELAAVRGSSVPIGYPVW 783
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2850 GTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKPEARMYRTGDAARWMADGTLEYLGRIDDQV 2929
Cdd:PRK10252 784 NTGLRILDARMRPVPPGVAGDLYLTGIQLAQGYLGRPDLTASRFIADPFAPGERMYRTGDVARWLDDGAVEYLGRSDDQL 863
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2930 KIRGYRVETKEIESVIRCIKGVKDAAVVAHV------TASGQTELSAYVVTKPGLS--TNAVRSELQNKLPVFMHPAFIE 3001
Cdd:PRK10252 864 KIRGQRIELGEIDRAMQALPDVEQAVTHACVinqaaaTGGDARQLVGYLVSQSGLPldTSALQAQLRERLPPHMVPVVLL 943
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3002 KLDSLPLSPNGKLDRGALPKPvyNHEGERPFLPPSSKMEQILADIWKEVLGAEKIGTADSFFELGGDSIKALQVSARLHR 3081
Cdd:PRK10252 944 QLDQLPLSANGKLDRKALPLP--ELKAQVPGRAPKTGTETIIAAAFSSLLGCDVVDADADFFALGGHSLLAMKLAAQLSR 1021
|
1050 1060 1070
....*....|....*....|....*....|....*...
gi 1678550997 3082 I-GKQMAVKDLFSHPTIQELAAYIrdsDTSSSQAAVEG 3118
Cdd:PRK10252 1022 QfARQVTPGQVMVASTVAKLATLL---DAEEDESRRLG 1056
|
|
| DCL_NRPS |
cd19543 |
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the ... |
10-433 |
0e+00 |
|
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor; The DCL-type Condensation (C) domain catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. This domain is D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains in addition to the LCL- and DCL-types such as starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380465 [Multi-domain] Cd Length: 423 Bit Score: 621.53 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 10 IYPLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNVSSPQQVVLRERNVIVL 89
Cdd:cd19543 1 IYPLSPMQEGMLFHSLLDPGSGAYVEQMVITLEGPLDPDRFRAAWQAVVDRHPILRTSFVWEGLGEPLQVVLKDRKLPWR 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 90 EEDITHLNEAEQSQFIEQWKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASYVN 169
Cdd:cd19543 81 ELDLSHLSEAEQEAELEALAEEDRERGFDLARAPLMRLTLIRLGDDRYRLVWSFHHILLDGWSLPILLKELFAIYAALGE 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 170 ASPITLEPVQPYGKYIKWLMEQDKEQAVSYWDHYLSGHEQQTVLPKQKKTKGKS--RQEHVTFSFSKEESSRLSELAARE 247
Cdd:cd19543 161 GQPPSLPPVRPYRDYIAWLQRQDKEAAEAYWREYLAGFEEPTPLPKELPADADGsyEPGEVSFELSAELTARLQELARQH 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 248 EVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRPAEIEGIEHMVGLFINTMPVRVQGAK-TPFLQLIKDMQKDRLAAEA 326
Cdd:cd19543 241 GVTLNTVVQGAWALLLSRYSGRDDVVFGTTVSGRPAELPGIETMVGLFINTLPVRVRLDPdQTVLELLKDLQAQQLELRE 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 327 YSYHPLYEIQSRSAVKQGLIDHILVFENYPVQQEIQMlnkqEHASDLFQIHNFTVADETNYSFYLMVAPGEEIHIKMNYD 406
Cdd:cd19543 321 HEYVPLYEIQAWSEGKQALFDHLLVFENYPVDESLEE----EQDEDGLRITDVSAEEQTNYPLTVVAIPGEELTIKLSYD 396
|
410 420
....*....|....*....|....*..
gi 1678550997 407 AEQHDRSFVLSVKEHLLNAVSQILNNP 433
Cdd:cd19543 397 AEVFDEATIERLLGHLRRVLEQVAANP 423
|
|
| LCL_NRPS-like |
cd19531 |
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar ... |
2087-2500 |
0e+00 |
|
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar domains including the C-domain of SgcC5, a free-standing NRPS with both ester- and amide- bond forming activity; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. Streptomyces globisporus SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380454 [Multi-domain] Cd Length: 427 Bit Score: 599.34 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2087 TYPVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGdPVQRIHDEVPFTLQ 2166
Cdd:cd19531 1 PLPLSFAQQRLWFLDQLEPGSAAYNIPGALRLRGPLDVAALERALNELVARHEALRTTFVEVDGE-PVQVILPPLPLPLP 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2167 TTVLGARTE-------QEAAAAFI-KPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELYNNR-- 2236
Cdd:cd19531 80 VVDLSGLPEaereaeaQRLAREEArRPFDLARGPLLRATLLRLGEDEHVLLLTMHHIVSDGWSMGVLLRELAALYAAFla 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2237 ----KLPALRIQYKDYAVWQEGFKTGDAYKMQEAYWLKQLEGELPVLDLPADHARPPVRSFAGDKVSFTLEPEVASGLHK 2312
Cdd:cd19531 160 grpsPLPPLPIQYADYAVWQREWLQGEVLERQLAYWREQLAGAPPVLELPTDRPRPAVQSFRGARVRFTLPAELTAALRA 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2313 LARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHKDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRETALE 2392
Cdd:cd19531 240 LARREGATLFMTLLAAFQVLLHRYSGQDDIVVGTPVAGRNRAELEGLIGFFVNTLVLRTDLSGDPTFRELLARVRETALE 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2393 AFEHQNYPFEELVDKLELTRDMSRNPVFDAMLVVQNNDYEPLHLHDLQMKPAQVSHLVSKFDLTLQASEGDGNIHFLFEY 2472
Cdd:cd19531 320 AYAHQDLPFEKLVEALQPERDLSRSPLFQVMFVLQNAPAAALELPGLTVEPLEVDSGTAKFDLTLSLTETDGGLRGSLEY 399
|
410 420
....*....|....*....|....*...
gi 1678550997 2473 STALFEKTTIERWASHLTNVLSIIGKNP 2500
Cdd:cd19531 400 NTDLFDAATIERMAGHFQTLLEAIVADP 427
|
|
| A_NRPS_AB3403-like |
cd17646 |
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or ... |
1497-1983 |
0e+00 |
|
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341301 [Multi-domain] Cd Length: 488 Bit Score: 592.71 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1497 HYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDP 1576
Cdd:cd17646 1 HALVAEQAARTPDAPAVVDEGRTLTYRELDERANRLAHLLRARGVGPEDRVAVLLPRSADLVVALLAVLKAGAAYLPLDP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1577 DYPEERISFLLEDSGTNILLLQSAGLHVPEFTGEIVYLNQTNSGlAHRLSNPNVDVLPQSLAYVIYTSGSTGMPKGVEIE 1656
Cdd:cd17646 81 GYPADRLAYMLADAGPAVVLTTADLAARLPAGGDVALLGDEALA-APPATPPLVPPRPDNLAYVIYTSGSTGRPKGVMVT 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1657 HRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPSM 1736
Cdd:cd17646 160 HAGIVNRLLWMQDEYPLGPGDRVLQKTPLSFDVSVWELFWPLVAGARLVVARPGGHRDPAYLAALIREHGVTTCHFVPSM 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1737 LHAFLEHIKYRSVPiktnRLKRVFSGGEQLGTHLVSRFYELlPNVSITNSYGPTEATVEAAFFDCPPHEKLERIPIGKPV 1816
Cdd:cd17646 240 LRVFLAEPAAGSCA----SLRRVFCSGEALPPELAARFLAL-PGAELHNLYGPTEAAIDVTHWPVRGPAETPSVPIGRPV 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1817 HHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYPGERMYKTGDVARWLPDGNVEFLGRTDDQ 1896
Cdd:cd17646 315 PNTRLYVLDDALRPVPVGVPGELYLGGVQLARGYLGRPALTAERFVPDPFGPGSRMYRTGDLARWRPDGALEFLGRSDDQ 394
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1897 VKIRGYRIEPGEIEAALRSIEGVREAAVTVRTD-SGEPELCAYV------EGLQRNEVRAQLERLLPGYMVPAYMIEMEQ 1969
Cdd:cd17646 395 VKIRGFRVEPGEIEAALAAHPAVTHAVVVARAApAGAARLVGYVvpaagaAGPDTAALRAHLAERLPEYMVPAAFVVLDA 474
|
490
....*....|....
gi 1678550997 1970 WPVTPSGKLDRNAL 1983
Cdd:cd17646 475 LPLTANGKLDRAAL 488
|
|
| A_NRPS_Bac |
cd17655 |
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of ... |
1501-1986 |
0e+00 |
|
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetases 1, 2, and 3 (BA1, also known as ATP-dependent cysteine adenylase or cysteine activase, BA2, also known as ATP-dependent lysine adenylase or lysine activase, and BA3, also known as ATP-dependent isoleucine adenylase or isoleucine activase) in Bacilli. Bacitracin is a mixture of related cyclic peptides used as a polypeptide antibiotic. This family also includes gramicidin synthetase 1 involved in synthesis of the cyclic peptide antibiotic gramicidin S via activation of phenylalanine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341310 [Multi-domain] Cd Length: 490 Bit Score: 590.84 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1501 EQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPE 1580
Cdd:cd17655 4 EEQAEKTPDHTAVVFEDQTLTYRELNERANQLARTLREKGVGPDTIVGIMAERSLEMIVGILGILKAGGAYLPIDPDYPE 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1581 ERISFLLEDSGTNILLLQSAGLHVPEFTGEIVYLNQTNSGLAHRlSNPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSA 1660
Cdd:cd17655 84 ERIQYILEDSGADILLTQSHLQPPIAFIGLIDLLDEDTIYHEES-ENLEPVSKSDDLAYVIYTSGSTGKPKGVMIEHRGV 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1661 VNFLNSLQSR-YQLKHSDMIMHkTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITamhfVPSMLHA 1739
Cdd:cd17655 163 VNLVEWANKViYQGEHLRVALF-ASISFDASVTEIFASLLSGNTLYIVRKETVLDGQALTQYIRQNRIT----IIDLTPA 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1740 FLEHIKYRSVPIKTNrLKRVFSGGEQLGTHLVSRFYELL-PNVSITNSYGPTEATVEAAFFDC-PPHEKLERIPIGKPVH 1817
Cdd:cd17655 238 HLKLLDAADDSEGLS-LKHLIVGGEALSTELAKKIIELFgTNPTITNAYGPTETTVDASIYQYePETDQQVSVPIGKPLG 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1818 HVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYPGERMYKTGDVARWLPDGNVEFLGRTDDQV 1897
Cdd:cd17655 317 NTRIYILDQYGRPQPVGVAGELYIGGEGVARGYLNRPELTAEKFVDDPFVPGERMYRTGDLARWLPDGNIEFLGRIDHQV 396
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1898 KIRGYRIEPGEIEAALRSIEGVREAAVTVRTD-SGEPELCAYV---EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVT 1973
Cdd:cd17655 397 KIRGYRIELGEIEARLLQHPDIKEAVVIARKDeQGQNYLCAYIvseKELPVAQLREFLARELPDYMIPSYFIKLDEIPLT 476
|
490
....*....|...
gi 1678550997 1974 PSGKLDRNALPAP 1986
Cdd:cd17655 477 PNGKVDRKALPEP 489
|
|
| LCL_NRPS-like |
cd19531 |
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar ... |
1056-1460 |
0e+00 |
|
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar domains including the C-domain of SgcC5, a free-standing NRPS with both ester- and amide- bond forming activity; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. Streptomyces globisporus SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380454 [Multi-domain] Cd Length: 427 Bit Score: 580.47 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1056 TYPVSSAQKRIYVLQQLDEG-VAYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSgADDEPVQRIHTEVPFTLS 1134
Cdd:cd19531 1 PLPLSFAQQRLWFLDQLEPGsAAYNIPGALRLRGPLDVAALERALNELVARHEALRTTFVE-VDGEPVQVILPPLPLPLP 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1135 -----------KETTIEGFV-----RPFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYANR-- 1196
Cdd:cd19531 80 vvdlsglpeaeREAEAQRLAreearRPFDLARGPLLRATLLRLGEDEHVLLLTMHHIVSDGWSMGVLLRELAALYAAFla 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1197 ----QLKPLRIQYKDYAVWQQKFKKGDSYQKQETYWQQQFSGDLPILELPTDKRRPAERQFIGGKVTFQLDKEITARIKR 1272
Cdd:cd19531 160 grpsPLPPLPIQYADYAVWQREWLQGEVLERQLAYWREQLAGAPPVLELPTDRPRPAVQSFRGARVRFTLPAELTAALRA 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1273 LAHKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPHADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQTALE 1352
Cdd:cd19531 240 LARREGATLFMTLLAAFQVLLHRYSGQDDIVVGTPVAGRNRAELEGLIGFFVNTLVLRTDLSGDPTFRELLARVRETALE 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1353 AYEHQDYPFEELVDKLGVQREMSRNPLFDTTLVLQNMEQQKLKMNDVQLQWNDLEHPISKFDISLYVTEHDSELFCQFEY 1432
Cdd:cd19531 320 AYAHQDLPFEKLVEALQPERDLSRSPLFQVMFVLQNAPAAALELPGLTVEPLEVDSGTAKFDLTLSLTETDGGLRGSLEY 399
|
410 420
....*....|....*....|....*...
gi 1678550997 1433 STALFEKETIQRWASLFTTLVEHTAASP 1460
Cdd:cd19531 400 NTDLFDAATIERMAGHFQTLLEAIVADP 427
|
|
| A_NRPS |
cd05930 |
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain ... |
477-952 |
1.66e-179 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341253 [Multi-domain] Cd Length: 444 Bit Score: 559.45 E-value: 1.66e-179
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 477 PDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYIL 556
Cdd:cd05930 1 PDAVAVVDGDQSLTYAELDARANRLARYLRERGVGPGDLVAVLLERSLEMVVAILAVLKAGAAYVPLDPSYPAERLAYIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 557 HDCGCSHVVSQAhlpsslednyiithpedieskvdgsniksvnnaDDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEYT 636
Cdd:cd05930 81 EDSGAKLVLTDP---------------------------------DDLAYVIYTSGSTGKPKGVMVEHRGLVNLLLWMQE 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 637 HSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNIVFLPTAFIKMIFSERELANs 716
Cdd:cd05930 128 AYPLTPGDRVLQFTSFSFDVSVWEIFGALLAGATLVVLPEEVRKDPEALADLLAEEGITVLHLTPSLLRLLLQELELAA- 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 717 fPDGVKHLIAAGEQLMiSDLFQDVLRK-RGIHLHNHYGPSETHVVST-YTIHPGDPIPELPPIGKPIGCTDLYILNHQKQ 794
Cdd:cd05930 207 -LPSLRLVLVGGEALP-PDLVRRWRELlPGARLVNLYGPTEATVDATyYRVPPDDEEDGRVPIGRPIPNTRVYVLDENLR 284
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 795 LQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPDVIMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEI 874
Cdd:cd05930 285 PVPPGVPGELYIGGAGLARGYLNRPELTAERFVPNPFGPGERMYRTGDLVRWLPDGNLEFLGRIDDQVKIRGYRIELGEI 364
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 875 EVTLMNHPDISEAAILIWQDQNGEHELCAYY--CSVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:cd05930 365 EAALLAHPGVREAAVVAREDGDGEKRLVAYVvpDEGGELDEEELRAHLAERLPDYMVPSAFVVLDALPLTPNGKVDRKAL 444
|
|
| A_NRPS_Bac |
cd17655 |
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of ... |
468-956 |
8.49e-178 |
|
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetases 1, 2, and 3 (BA1, also known as ATP-dependent cysteine adenylase or cysteine activase, BA2, also known as ATP-dependent lysine adenylase or lysine activase, and BA3, also known as ATP-dependent isoleucine adenylase or isoleucine activase) in Bacilli. Bacitracin is a mixture of related cyclic peptides used as a polypeptide antibiotic. This family also includes gramicidin synthetase 1 involved in synthesis of the cyclic peptide antibiotic gramicidin S via activation of phenylalanine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341310 [Multi-domain] Cd Length: 490 Bit Score: 556.56 E-value: 8.49e-178
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 468 MFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHY 547
Cdd:cd17655 2 LFEEQAEKTPDHTAVVFEDQTLTYRELNERANQLARTLREKGVGPDTIVGIMAERSLEMIVGILGILKAGGAYLPIDPDY 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 548 PADRIRYILHDCGCSHVVSQAHLPSSLEDNYIIT--HPEDIESKvDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHR 625
Cdd:cd17655 82 PEERIQYILEDSGADILLTQSHLQPPIAFIGLIDllDEDTIYHE-ESENLEPVSKSDDLAYVIYTSGSTGKPKGVMIEHR 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 626 NMANLLKFeYTHSGIDFEAD-VLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNIVFLPTAFI 704
Cdd:cd17655 161 GVVNLVEW-ANKVIYQGEHLrVALFASISFDASVTEIFASLLSGNTLYIVRKETVLDGQALTQYIRQNRITIIDLTPAHL 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 705 KMIFSERELANSfpdGVKHLIAAGEQL------MISDLFQDvlrkrGIHLHNHYGPSETHV-VSTYTIHPGDPIPELPPI 777
Cdd:cd17655 240 KLLDAADDSEGL---SLKHLIVGGEALstelakKIIELFGT-----NPTITNAYGPTETTVdASIYQYEPETDQQVSVPI 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 778 GKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPDVIMYRTGDLARRLEDGNIEYIGR 857
Cdd:cd17655 312 GKPLGNTRIYILDQYGRPQPVGVAGELYIGGEGVARGYLNRPELTAEKFVDDPFVPGERMYRTGDLARWLPDGNIEFLGR 391
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 858 ADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCSVQKLNTIDLRSYMASELPEYMIPAKWIWVD 937
Cdd:cd17655 392 IDHQVKIRGYRIELGEIEARLLQHPDIKEAVVIARKDEQGQNYLCAYIVSEKELPVAQLREFLARELPDYMIPSYFIKLD 471
|
490
....*....|....*....
gi 1678550997 938 SIPLTPNGKVDRAALPEPD 956
Cdd:cd17655 472 EIPLTPNGKVDRKALPEPD 490
|
|
| A_NRPS_Bac |
cd17655 |
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of ... |
2537-3022 |
1.35e-177 |
|
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetases 1, 2, and 3 (BA1, also known as ATP-dependent cysteine adenylase or cysteine activase, BA2, also known as ATP-dependent lysine adenylase or lysine activase, and BA3, also known as ATP-dependent isoleucine adenylase or isoleucine activase) in Bacilli. Bacitracin is a mixture of related cyclic peptides used as a polypeptide antibiotic. This family also includes gramicidin synthetase 1 involved in synthesis of the cyclic peptide antibiotic gramicidin S via activation of phenylalanine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341310 [Multi-domain] Cd Length: 490 Bit Score: 555.79 E-value: 1.35e-177
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2537 QLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPE 2616
Cdd:cd17655 1 ELFEEQAEKTPDHTAVVFEDQTLTYRELNERANQLARTLREKGVGPDTIVGIMAERSLEMIVGILGILKAGGAYLPIDPD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2617 YPKERKRYILSDSGTKLLMTinEADLGVLADFEGEILTIE--SVEEDDKSPLPQMSSAHHLAYIIYTSGTTGRPKGVMVE 2694
Cdd:cd17655 81 YPEERIQYILEDSGADILLT--QSHLQPPIAFIGLIDLLDedTIYHEESENLEPVSKSDDLAYVIYTSGSTGKPKGVMIE 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2695 HKGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPvl 2774
Cdd:cd17655 159 HRGVVNLVEWANKVIYQGEHLRVALFASISFDASVTEIFASLLSGNTLYIVRKETVLDGQALTQYIRQNRITIIDLTP-- 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2775 yrALLDVVQPEDVKT---LRVVTLAGEAADRELIARSLAICPHT-ELANEYGPTENSVATTVMRHME---KQAYVSIGQP 2847
Cdd:cd17655 237 --AHLKLLDAADDSEglsLKHLIVGGEALSTELAKKIIELFGTNpTITNAYGPTETTVDASIYQYEPetdQQVSVPIGKP 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2848 IDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKPEARMYRTGDAARWMADGTLEYLGRIDD 2927
Cdd:cd17655 315 LGNTRIYILDQYGRPQPVGVAGELYIGGEGVARGYLNRPELTAEKFVDDPFVPGERMYRTGDLARWLPDGNIEFLGRIDH 394
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2928 QVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTNAVRSELQNKLPVFMHPAFIEKLDSLP 3007
Cdd:cd17655 395 QVKIRGYRIELGEIEARLLQHPDIKEAVVIARKDEQGQNYLCAYIVSEKELPVAQLREFLARELPDYMIPSYFIKLDEIP 474
|
490
....*....|....*
gi 1678550997 3008 LSPNGKLDRGALPKP 3022
Cdd:cd17655 475 LTPNGKVDRKALPEP 489
|
|
| E_NRPS |
cd19534 |
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
3119-3570 |
1.84e-174 |
|
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Epimerization (E) domains of nonribosomal peptide synthetases (NRPS) flip the chirality of the end amino acid of a peptide being manufactured by the NRPS. E-domains are homologous to the Condensation (C) domains. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Specialized tailoring NRPS domains such as E-domains greatly increase the range of possible peptide products created by the NRPS machinery. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the E-domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380457 [Multi-domain] Cd Length: 428 Bit Score: 544.15 E-value: 1.84e-174
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3119 DVQWSPVQKWFLSQDIKEKHHFNQSVMLHRSTSVQEDALRKTLKAITCHHDALRMVFTQNEqGKWDQYNRPLshsDDALY 3198
Cdd:cd19534 1 EVPLTPIQRWFFEQNLAGRHHFNQSVLLRVPQGLDPDALRQALRALVEHHDALRMRFRRED-GGWQQRIRGD---VEELF 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3199 GLQMIDLSApdgtdgnRPYEPLIKRHVLDIQQKMDLKNGPLLQAGLFH-TIDGDFLFLSAHHLVVDGISWRVLLEDLALG 3277
Cdd:cd19534 77 RLEVVDLSS-------LAQAAAIEALAAEAQSSLDLEEGPLLAAALFDgTDGGDRLLLVIHHLVVDGVSWRILLEDLEAA 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3278 YRQAAGGEDIKLPPKTSsFKAYAKKLSDYAESQQLMKQLKYWREAEEYQTEALPFDQIdgtrAHEGQRSTISFTLNDKET 3357
Cdd:cd19534 150 YEQALAGEPIPLPSKTS-FQTWAELLAEYAQSPALLEELAYWRELPAADYWGLPKDPE----QTYGDARTVSFTLDEEET 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3358 AALLKDANSAYNTDTQDMLLASVILALRHWTNQSAFKLSLEGHGREDVLKGIDVSRTIGWFTAIYPLLIKlnadlPDSEE 3437
Cdd:cd19534 225 EALLQEANAAYRTEINDLLLAALALAFQDWTGRAPPAIFLEGHGREEIDPGLDLSRTVGWFTSMYPVVLD-----LEASE 299
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3438 SMVHVLKTTKDTLRRVPDKGFGYGVIKYLTPPGKKDINFTGAPEISFNYLGQFESGRTaevpeEDAFSFSPLGAGG-DIS 3516
Cdd:cd19534 300 DLGDTLKRVKEQLRRIPNKGIGYGILRYLTPEGTKRLAFHPQPEISFNYLGQFDQGER-----DDALFVSAVGGGGsDIG 374
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 3517 TTWNREQSLDISAIAAEGKLTVNMTYDNARFQRKTIEQLSETCRQFLLQLIEHC 3570
Cdd:cd19534 375 PDTPRFALLDINAVVEGGQLVITVSYSRNMYHEETIQQLADSYKEALEALIEHC 428
|
|
| A_NRPS_Srf_like |
cd12117 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis ... |
2537-3019 |
2.68e-174 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis termination module Surfactin (SrfA-C); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the adenylation domain of the Bacillus subtilis termination module (Surfactin domain, SrfA-C) which recognizes a specific amino acid building block, which is then activated and transferred to the terminal thiol of the 4'-phosphopantetheine (Ppan) arm of the downstream peptidyl carrier protein (PCP) domain.
Pssm-ID: 341282 [Multi-domain] Cd Length: 483 Bit Score: 546.03 E-value: 2.68e-174
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2537 QLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPE 2616
Cdd:cd12117 1 ELFEEQAARTPDAVAVVYGDRSLTYAELNERANRLARRLRAAGVGPGDVVGVLAERSPELVVALLAVLKAGAAYVPLDPE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2617 YPKERKRYILSDSGTKLLMTiNEADLGVLADFEGEILTIESVEEDDKSPLPQMSSAHHLAYIIYTSGTTGRPKGVMVEHK 2696
Cdd:cd12117 81 LPAERLAFMLADAGAKVLLT-DRSLAGRAGGLEVAVVIDEALDAGPAGNPAVPVSPDDLAYVMYTSGSTGRPKGVAVTHR 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2697 GIAnTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLYR 2776
Cdd:cd12117 160 GVV-RLVKNTNYVTLGPDDRVLQTSPLAFDASTFEIWGALLNGARLVLAPKGTLLDPDALGALIAEEGVTVLWLTAALFN 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2777 ALLDVVqPEDVKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTENSVATT---VMRHMEKQAYVSIGQPIDGTQV 2853
Cdd:cd12117 239 QLADED-PECFAGLRELLTGGEVVSPPHVRRVLAACPGLRLVNGYGPTENTTFTTshvVTELDEVAGSIPIGRPIANTRV 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2854 LILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRG 2933
Cdd:cd12117 318 YVLDEDGRPVPPGVPGELYVGGDGLALGYLNRPALTAERFVADPFGPGERLYRTGDLARWLPDGRLEFLGRIDDQVKIRG 397
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2934 YRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGK 3013
Cdd:cd12117 398 FRIELGEIEAALRAHPGVREAVVVVREDAGGDKRLVAYVVAEGALDAAELRAFLRERLPAYMVPAAFVVLDELPLTANGK 477
|
....*.
gi 1678550997 3014 LDRGAL 3019
Cdd:cd12117 478 VDRRAL 483
|
|
| A_NRPS_VisG_like |
cd17651 |
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) ... |
469-953 |
2.29e-171 |
|
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes virginiamycin S synthetase (VisG) in Streptomyces virginiae; VisG is involved in virginiamycin S (VS) biosynthesis as the provider of an L-pheGly molecule, a highly specific substrate for the last condensation step by VisF. This family also includes linear gramicidin synthetase B (LgrB) in Brevibacillus brevis. Substrate specificity analysis using residues of the substrate-binding pockets of all 16 adenylation domains has shown good agreement of the substrate amino acids predicted with the sequence of linear gramicidin. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341306 [Multi-domain] Cd Length: 491 Bit Score: 538.08 E-value: 2.29e-171
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 469 FEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYP 548
Cdd:cd17651 1 FERQAARTPDAPALVAEGRRLTYAELDRRANRLAHRLRARGVGPGDLVALCARRSAELVVALLAILKAGAAYVPLDPAYP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 549 ADRIRYILHDCGCSHVVSQAHLPSSLEDNYIITHPEDIESKVDGSNIKSV--NNADDLLYMIYTSGTTGKPKGVQFEHRN 626
Cdd:cd17651 81 AERLAFMLADAGPVLVLTHPALAGELAVELVAVTLLDQPGAAAGADAEPDpaLDADDLAYVIYTSGSTGRPKGVVMPHRS 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 627 MANLLKFEYTHSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNIVFLPTAFIKM 706
Cdd:cd17651 161 LANLVAWQARASSLGPGARTLQFAGLGFDVSVQEIFSTLCAGATLVLPPEEVRTDPPALAAWLDEQRISRVFLPTVALRA 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 707 IFSERELANSFPDGVKHLIAAGEQLMISDLFQDVLRKR-GIHLHNHYGPSETHVVSTYTIhPGDPI--PELPPIGKPIGC 783
Cdd:cd17651 241 LAEHGRPLGVRLAALRYLLTGGEQLVLTEDLREFCAGLpGLRLHNHYGPTETHVVTALSL-PGDPAawPAPPPIGRPIDN 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 784 TDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPDVIMYRTGDLARRLEDGNIEYIGRADNQVK 863
Cdd:cd17651 320 TRVYVLDAALRPVPPGVPGELYIGGAGLARGYLNRPELTAERFVPDPFVPGARMYRTGDLARWLPDGELEFLGRADDQVK 399
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 864 IRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCSVQ--KLNTIDLRSYMASELPEYMIPAKWIWVDSIPL 941
Cdd:cd17651 400 IRGFRIELGEIEAALARHPGVREAVVLAREDRPGEKRLVAYVVGDPeaPVDAAELRAALATHLPEYMVPSAFVLLDALPL 479
|
490
....*....|..
gi 1678550997 942 TPNGKVDRAALP 953
Cdd:cd17651 480 TPNGKLDRRALP 491
|
|
| A_NRPS_Srf_like |
cd12117 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis ... |
1501-1983 |
3.77e-169 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis termination module Surfactin (SrfA-C); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the adenylation domain of the Bacillus subtilis termination module (Surfactin domain, SrfA-C) which recognizes a specific amino acid building block, which is then activated and transferred to the terminal thiol of the 4'-phosphopantetheine (Ppan) arm of the downstream peptidyl carrier protein (PCP) domain.
Pssm-ID: 341282 [Multi-domain] Cd Length: 483 Bit Score: 531.39 E-value: 3.77e-169
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1501 EQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPE 1580
Cdd:cd12117 4 EEQAARTPDAVAVVYGDRSLTYAELNERANRLARRLRAAGVGPGDVVGVLAERSPELVVALLAVLKAGAAYVPLDPELPA 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1581 ERISFLLEDSGTNILLLQSAGLHVPEFTGEIVYLNQTNSglAHRLSNPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSA 1660
Cdd:cd12117 84 ERLAFMLADAGAKVLLTDRSLAGRAGGLEVAVVIDEALD--AGPAGNPAVPVSPDDLAYVMYTSGSTGRPKGVAVTHRGV 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1661 VNFLnsLQSRY-QLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPSMLHA 1739
Cdd:cd12117 162 VRLV--KNTNYvTLGPDDRVLQTSPLAFDASTFEIWGALLNGARLVLAPKGTLLDPDALGALIAEEGVTVLWLTAALFNQ 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1740 FLEHikyrsVPIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFDCPPHEKLER-IPIGKPVHH 1818
Cdd:cd12117 240 LADE-----DPECFAGLRELLTGGEVVSPPHVRRVLAACPGLRLVNGYGPTENTTFTTSHVVTELDEVAGsIPIGRPIAN 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1819 VRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYPGERMYKTGDVARWLPDGNVEFLGRTDDQVK 1898
Cdd:cd12117 315 TRVYVLDEDGRPVPPGVPGELYVGGDGLALGYLNRPALTAERFVADPFGPGERLYRTGDLARWLPDGRLEFLGRIDDQVK 394
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1899 IRGYRIEPGEIEAALRSIEGVREAAVTVRTD-SGEPELCAYV---EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTP 1974
Cdd:cd12117 395 IRGFRIELGEIEAALRAHPGVREAVVVVREDaGGDKRLVAYVvaeGALDAAELRAFLRERLPAYMVPAAFVVLDELPLTA 474
|
....*....
gi 1678550997 1975 SGKLDRNAL 1983
Cdd:cd12117 475 NGKVDRRAL 483
|
|
| A_NRPS_Srf_like |
cd12117 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis ... |
467-952 |
5.05e-168 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis termination module Surfactin (SrfA-C); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the adenylation domain of the Bacillus subtilis termination module (Surfactin domain, SrfA-C) which recognizes a specific amino acid building block, which is then activated and transferred to the terminal thiol of the 4'-phosphopantetheine (Ppan) arm of the downstream peptidyl carrier protein (PCP) domain.
Pssm-ID: 341282 [Multi-domain] Cd Length: 483 Bit Score: 527.92 E-value: 5.05e-168
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 467 AMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPH 546
Cdd:cd12117 1 ELFEEQAARTPDAVAVVYGDRSLTYAELNERANRLARRLRAAGVGPGDVVGVLAERSPELVVALLAVLKAGAAYVPLDPE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 547 YPADRIRYILHDCGCSHVVSQAHLPSSLEDNYIITHPEDIESKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRN 626
Cdd:cd12117 81 LPAERLAFMLADAGAKVLLTDRSLAGRAGGLEVAVVIDEALDAGPAGNPAVPVSPDDLAYVMYTSGSTGRPKGVAVTHRG 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 627 MANLLKfeyTHSGIDFEAD--VLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNIVFLPTAFi 704
Cdd:cd12117 161 VVRLVK---NTNYVTLGPDdrVLQTSPLAFDASTFEIWGALLNGARLVLAPKGTLLDPDALGALIAEEGVTVLWLTAAL- 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 705 kmiFseRELANSFPD---GVKHLIAAGEQLMISdLFQDVLRKR-GIHLHNHYGPSETHVVST-YTIHPGDPIPELPPIGK 779
Cdd:cd12117 237 ---F--NQLADEDPEcfaGLRELLTGGEVVSPP-HVRRVLAACpGLRLVNGYGPTENTTFTTsHVVTELDEVAGSIPIGR 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 780 PIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPDVIMYRTGDLARRLEDGNIEYIGRAD 859
Cdd:cd12117 311 PIANTRVYVLDEDGRPVPPGVPGELYVGGDGLALGYLNRPALTAERFVADPFGPGERLYRTGDLARWLPDGRLEFLGRID 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 860 NQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCSVQKLNTIDLRSYMASELPEYMIPAKWIWVDSI 939
Cdd:cd12117 391 DQVKIRGFRIELGEIEAALRAHPGVREAVVVVREDAGGDKRLVAYVVAEGALDAAELRAFLRERLPAYMVPAAFVVLDEL 470
|
490
....*....|...
gi 1678550997 940 PLTPNGKVDRAAL 952
Cdd:cd12117 471 PLTANGKVDRRAL 483
|
|
| A_NRPS_VisG_like |
cd17651 |
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) ... |
1500-1984 |
1.14e-167 |
|
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes virginiamycin S synthetase (VisG) in Streptomyces virginiae; VisG is involved in virginiamycin S (VS) biosynthesis as the provider of an L-pheGly molecule, a highly specific substrate for the last condensation step by VisF. This family also includes linear gramicidin synthetase B (LgrB) in Brevibacillus brevis. Substrate specificity analysis using residues of the substrate-binding pockets of all 16 adenylation domains has shown good agreement of the substrate amino acids predicted with the sequence of linear gramicidin. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341306 [Multi-domain] Cd Length: 491 Bit Score: 527.30 E-value: 1.14e-167
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYP 1579
Cdd:cd17651 1 FERQAARTPDAPALVAEGRRLTYAELDRRANRLAHRLRARGVGPGDLVALCARRSAELVVALLAILKAGAAYVPLDPAYP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1580 EERISFLLEDSGTNILLLQSAglHVPEFTGEIVYLNQTNSGLAHRL--SNPNVDVLPQSLAYVIYTSGSTGMPKGVEIEH 1657
Cdd:cd17651 81 AERLAFMLADAGPVLVLTHPA--LAGELAVELVAVTLLDQPGAAAGadAEPDPALDADDLAYVIYTSGSTGRPKGVVMPH 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1658 RSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELfwWPY--AGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPS 1735
Cdd:cd17651 159 RSLANLVAWQARASSLGPGARTLQFAGLGFDVSVQEI--FSTlcAGATLVLPPEEVRTDPPALAAWLDEQRISRVFLPTV 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1736 MLHAFLEHIKYRSVPIKtnRLKRVFSGGEQLG-THLVSRFYELLPNVSITNSYGPTEATVEAAF-FDCPPHEKLERIPIG 1813
Cdd:cd17651 237 ALRALAEHGRPLGVRLA--ALRYLLTGGEQLVlTEDLREFCAGLPGLRLHNHYGPTETHVVTALsLPGDPAAWPAPPPIG 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1814 KPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYPGERMYKTGDVARWLPDGNVEFLGRT 1893
Cdd:cd17651 315 RPIDNTRVYVLDAALRPVPPGVPGELYIGGAGLARGYLNRPELTAERFVPDPFVPGARMYRTGDLARWLPDGELEFLGRA 394
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1894 DDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTD-SGEPELCAYVEGLQRN-----EVRAQLERLLPGYMVPAYMIEM 1967
Cdd:cd17651 395 DDQVKIRGFRIELGEIEAALARHPGVREAVVLAREDrPGEKRLVAYVVGDPEApvdaaELRAALATHLPEYMVPSAFVLL 474
|
490
....*....|....*..
gi 1678550997 1968 EQWPVTPSGKLDRNALP 1984
Cdd:cd17651 475 DALPLTPNGKLDRRALP 491
|
|
| AA-adenyl-dom |
TIGR01733 |
amino acid adenylation domain; This model represents a domain responsible for the specific ... |
1521-1924 |
2.70e-166 |
|
amino acid adenylation domain; This model represents a domain responsible for the specific recognition of amino acids and activation as adenylyl amino acids. The reaction catalyzed is aa + ATP -> aa-AMP + PPi. These domains are usually found as components of multi-domain non-ribosomal peptide synthetases and are usually called "A-domains" in that context. A-domains are almost invariably followed by "T-domains" (thiolation domains, pfam00550) to which the amino acid adenylate is transferred as a thiol-ester to a bound pantetheine cofactor with the release of AMP (these are also called peptide carrier proteins, or PCPs. When the A-domain does not represent the first module (corresponding to the first amino acid in the product molecule) it is usually preceded by a "C-domain" (condensation domain, pfam00668) which catalyzes the ligation of two amino acid thiol-esters from neighboring modules. This domain is a subset of the AMP-binding domain found in Pfam (pfam00501) which also hits substrate--CoA ligases and luciferases. Sequences scoring in between trusted and noise for this model may be ambiguous as to whether they activate amino acids or other molecules lacking an alpha amino group.
Pssm-ID: 273779 [Multi-domain] Cd Length: 409 Bit Score: 519.90 E-value: 2.70e-166
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1521 TYKELNEQANRIAWELIGR-GVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLLQS 1599
Cdd:TIGR01733 1 TYRELDERANRLARHLRAAgGVGPGDRVAVLLERSAELVVAILAVLKAGAAYVPLDPAYPAERLAFILEDAGARLLLTDS 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1600 AGLH-VPEFTGEIVYLNQTNSGLAHRLSN---PNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKH 1675
Cdd:TIGR01733 81 ALASrLAGLVLPVILLDPLELAALDDAPApppPDAPSGPDDLAYVIYTSGSTGRPKGVVVTHRSLVNLLAWLARRYGLDP 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1676 SDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEK-EPEVIAKAIEEQKITAMHFVPSMLHAFLEHIkyrsvPIKTN 1754
Cdd:TIGR01733 161 DDRVLQFASLSFDASVEEIFGALLAGATLVVPPEDEERdDAALLAALIAEHPVTVLNLTPSLLALLAAAL-----PPALA 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1755 RLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFDCPPHE--KLERIPIGKPVHHVRLYLLNQNQRMLP 1832
Cdd:TIGR01733 236 SLRLVILGGEALTPALVDRWRARGPGARLINLYGPTETTVWSTATLVDPDDapRESPVPIGRPLANTRLYVLDDDLRPVP 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1833 VGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYP--GERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIE 1910
Cdd:TIGR01733 316 VGVVGELYIGGPGVARGYLNRPELTAERFVPDPFAGgdGARLYRTGDLVRYLPDGNLEFLGRIDDQVKIRGYRIELGEIE 395
|
410
....*....|....
gi 1678550997 1911 AALRSIEGVREAAV 1924
Cdd:TIGR01733 396 AALLRHPGVREAVV 409
|
|
| Condensation |
pfam00668 |
Condensation domain; This domain is found in many multi-domain enzymes which synthesize ... |
2084-2519 |
6.55e-165 |
|
Condensation domain; This domain is found in many multi-domain enzymes which synthesize peptide antibiotics. This domain catalyzes a condensation reaction to form peptide bonds in non- ribosomal peptide biosynthesis. It is usually found to the carboxy side of a phosphopantetheine binding domain (pfam00550). It has been shown that mutations in the HHXXXDG motif abolish activity suggesting this is part of the active site.
Pssm-ID: 395541 [Multi-domain] Cd Length: 454 Bit Score: 517.66 E-value: 6.55e-165
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2084 KQETYPVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGDPVQRIHDEVPF 2163
Cdd:pfam00668 1 VQDEYPLSPAQKRMWFLEKLEPHSSAYNMPAVLKLTGELDPERLEKALQELINRHDALRTVFIRQENGEPVQVILEERPF 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2164 TLQTTVLG---ARTEQEAAAAFI-----KPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELY-- 2233
Cdd:pfam00668 81 ELEIIDISdlsESEEEEAIEAFIqrdlqSPFDLEKGPLFRAGLFRIAENRHHLLLSMHHIIVDGVSLGILLRDLADLYqq 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2234 --NNRKLPALRIQ-YKDYAVWQEGFKTGDAYKMQEAYWLKQLEGELPVLDLPADHARPPVRSFAGDKVSFTLEPEVASGL 2310
Cdd:pfam00668 161 llKGEPLPLPPKTpYKDYAEWLQQYLQSEDYQKDAAYWLEQLEGELPVLQLPKDYARPADRSFKGDRLSFTLDEDTEELL 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2311 HKLARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHKDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRETA 2390
Cdd:pfam00668 241 RKLAKAHGTTLNDVLLAAYGLLLSRYTGQDDIVVGTPGSGRPSPDIERMVGMFVNTLPLRIDPKGGKTFSELIKRVQEDL 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2391 LEAFEHQNYPFEELVDKLELTRDMSRNPVFDAMLVVQNNDY-----EPLHLHDLQMKPAQVSHLVSKFDLTLQASEGDGN 2465
Cdd:pfam00668 321 LSAEPHQGYPFGDLVNDLRLPRDLSRHPLFDPMFSFQNYLGqdsqeEEFQLSELDLSVSSVIEEEAKYDLSLTASERGGG 400
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 2466 IHFLFEYSTALFEKTTIERWASHLTNVLSIIGKNPKVTLNHIDILTQEERHQLL 2519
Cdd:pfam00668 401 LTIKIDYNTSLFDEETIERFAEHFKELLEQAIAHPSQPLSELDLLSDAEKQKLL 454
|
|
| AA-adenyl-dom |
TIGR01733 |
amino acid adenylation domain; This model represents a domain responsible for the specific ... |
2560-2956 |
3.74e-162 |
|
amino acid adenylation domain; This model represents a domain responsible for the specific recognition of amino acids and activation as adenylyl amino acids. The reaction catalyzed is aa + ATP -> aa-AMP + PPi. These domains are usually found as components of multi-domain non-ribosomal peptide synthetases and are usually called "A-domains" in that context. A-domains are almost invariably followed by "T-domains" (thiolation domains, pfam00550) to which the amino acid adenylate is transferred as a thiol-ester to a bound pantetheine cofactor with the release of AMP (these are also called peptide carrier proteins, or PCPs. When the A-domain does not represent the first module (corresponding to the first amino acid in the product molecule) it is usually preceded by a "C-domain" (condensation domain, pfam00668) which catalyzes the ligation of two amino acid thiol-esters from neighboring modules. This domain is a subset of the AMP-binding domain found in Pfam (pfam00501) which also hits substrate--CoA ligases and luciferases. Sequences scoring in between trusted and noise for this model may be ambiguous as to whether they activate amino acids or other molecules lacking an alpha amino group.
Pssm-ID: 273779 [Multi-domain] Cd Length: 409 Bit Score: 507.96 E-value: 3.74e-162
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2560 TYQELDEWSNGIARALRSR-GVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMTIN 2638
Cdd:TIGR01733 1 TYRELDERANRLARHLRAAgGVGPGDRVAVLLERSAELVVAILAVLKAGAAYVPLDPAYPAERLAFILEDAGARLLLTDS 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2639 EADLG----VLADFEGEILTIESVEEDDKSPLPQMSSAH-HLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNE 2713
Cdd:TIGR01733 81 ALASRlaglVLPVILLDPLELAALDDAPAPPPPDAPSGPdDLAYVIYTSGSTGRPKGVVVTHRSLVNLLAWLARRYGLDP 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2714 TDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQR-ITHMIIVPVLYRALLDvVQPEDVKTLRV 2792
Cdd:TIGR01733 161 DDRVLQFASLSFDASVEEIFGALLAGATLVVPPEDEERDDAALLAALIAEHpVTVLNLTPSLLALLAA-ALPPALASLRL 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2793 VTLAGEAADRELIARSLAICPHTELANEYGPTENSVATT---VMRHMEKQAY-VSIGQPIDGTQVLILNSNHQLQPIGVA 2868
Cdd:TIGR01733 240 VILGGEALTPALVDRWRARGPGARLINLYGPTETTVWSTatlVDPDDAPRESpVPIGRPLANTRLYVLDDDLRPVPVGVV 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2869 GELCIAGTGLARGYVNLPELTERAFTQNPF--KPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIR 2946
Cdd:TIGR01733 320 GELYIGGPGVARGYLNRPELTAERFVPDPFagGDGARLYRTGDLVRYLPDGNLEFLGRIDDQVKIRGYRIELGEIEAALL 399
|
410
....*....|
gi 1678550997 2947 CIKGVKDAAV 2956
Cdd:TIGR01733 400 RHPGVREAVV 409
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
4-1038 |
2.28e-161 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 565.95 E-value: 2.28e-161
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 4 ANSIQDIYPLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFiSQNVSSPQ-QVVLR 82
Cdd:PRK05691 3251 AAEIEDVYPLTPMQEGLLLHTLLEPGTGLYYMQDRYRINSALDPERFAQAWQAVVARHEALRASF-SWNAGETMlQVIHK 3329
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 83 ERNVIVLEEDITHLNEAEQSQFIEQWKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLH 162
Cdd:PRK05691 3330 PGRTPIDYLDWRGLPEDGQEQRLQALHKQEREAGFDLLNQPPFHLRLIRVDEARYWFMMSNHHILIDAWCRSLLMNDFFE 3409
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 163 IYASYVNASPITLEPVQPYGKYIKWLMEQDKEQAVSYWDHYLSGHEQQTVLPKQKKTkgksRQEHVTFS----------- 231
Cdd:PRK05691 3410 IYTALGEGREAQLPVPPRYRDYIGWLQRQDLAQARQWWQDNLRGFERPTPIPSDRPF----LREHAGDSggmvvgdcytr 3485
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 232 FSKEESSRLSELAAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRPAEIEGIEHMVGLFINTMPVRVQ----GAK 307
Cdd:PRK05691 3486 LDAADGARLRELAQAHQLTVNTFAQAAWALVLRRYSGDRDVLFGVTVAGRPVSMPQMQRTVGLFINSIALRVQlpaaGQR 3565
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 308 TPFLQLIKDMQKDRLAAEAYSYHPLYEIQSRSAVKQG--LIDHILVFENYPVqqEIQMLNKQEH---ASDLFQIHnftva 382
Cdd:PRK05691 3566 CSVRQWLQGLLDSNMELREYEYLPLVAIQECSELPKGqpLFDSLFVFENAPV--EVSVLDRAQSlnaSSDSGRTH----- 3638
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 383 deTNYSFYLMVAPGEEIHIKMNYDAEQHDRSFV---LSVKEHLLNAVSQILNNPnlpPEEIDITTDTEKRQLIGEiTDQT 459
Cdd:PRK05691 3639 --TNFPLTAVCYPGDDLGLHLSYDQRYFDAPTVerlLGEFKRLLLALVQGFHGD---LSELPLLGEQERDFLLDG-CNRS 3712
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 460 ----PVYETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILK 535
Cdd:PRK05691 3713 erdyPLEQSYVRLFEAQVAAHPQRIAASCLDQQWSYAELNRAANRLGHALRAAGVGVDQPVALLAERGLDLLGMIVGSFK 3792
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 536 AGGAIVPVDPHYPADRIRYILHDCG-----CSHV-VSQAHlpSSLEDNYIITHP-----EDIE-SKVDGSNIKSVNNADD 603
Cdd:PRK05691 3793 AGAGYLPLDPGLPAQRLQRIIELSRtpvlvCSAAcREQAR--ALLDELGCANRPrllvwEEVQaGEVASHNPGIYSGPDN 3870
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 604 LLYMIYTSGTTGKPKGVQFEHRNMAN--LLKFEYTHSGidfEADVL-QFATPSFDVCYQEIFSALLKGGTLHIVPEAIKR 680
Cdd:PRK05691 3871 LAYVIYTSGSTGLPKGVMVEQRGMLNnqLSKVPYLALS---EADVIaQTASQSFDISVWQFLAAPLFGARVEIVPNAIAH 3947
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 681 DVPQLFAFInkHQTNIVFL---PTAFIKMIFSERELAnsfpDGVKHLIAAGEQLMISDLFQDVLRKRGIHLHNHYGPSE- 756
Cdd:PRK05691 3948 DPQGLLAHV--QAQGITVLesvPSLIQGMLAEDRQAL----DGLRWMLPTGEAMPPELARQWLQRYPQIGLVNAYGPAEc 4021
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 757 THVVSTYTIHPGDPIPELPPIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPF-KPDV 835
Cdd:PRK05691 4022 SDDVAFFRVDLASTRGSYLPIGSPTDNNRLYLLDEALELVPLGAVGELCVAGTGVGRGYVGDPLRTALAFVPHPFgAPGE 4101
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 836 IMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHeLCAYYCSVQKLNTID 915
Cdd:PRK05691 4102 RLYRTGDLARRRSDGVLEYVGRIDHQVKIRGYRIELGEIEARLHEQAEVREAAVAVQEGVNGKH-LVGYLVPHQTVLAQG 4180
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 916 -----LRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPEPDAS-ISGNPYTAPRNLLEAKLSQLFEDVLKNGHIG 989
Cdd:PRK05691 4181 allerIKQRLRAELPDYMVPLHWLWLDRLPLNANGKLDRKALPALDIGqLQSQAYLAPRNELEQTLATIWADVLKVERVG 4260
|
1050 1060 1070 1080
....*....|....*....|....*....|....*....|....*....
gi 1678550997 990 IQDNFFDNGGHSLKATVLMSRIAKEFHVQVSLKDIFAHPTVEGLALIIR 1038
Cdd:PRK05691 4261 VHDNFFELGGHSLLATQIASRVQKALQRNVPLRAMFECSTVEELAEYIE 4309
|
|
| A_NRPS_PvdJ-like |
cd17649 |
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal ... |
1508-1984 |
2.41e-157 |
|
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes pyoverdine biosynthesis protein PvdJ involved in the synthesis of pyoverdine, which consists of a chromophore group attached to a variable peptide chain and comprises around 6-12 amino acids that are specific for each Pseudomonas species, and for which the peptide might be first synthesized before the chromophore assembly. Also included is ornibactin biosynthesis protein OrbI; ornibactin is a tetrapeptide siderophore with an l-ornithine-d-hydroxyaspartate-l-serine-l-ornithine backbone. The adenylation domain at the N-terminal of OrbI possibly initiates the ornibactin with the binding of N5-hydroxyornithine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341304 [Multi-domain] Cd Length: 450 Bit Score: 495.74 E-value: 2.41e-157
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1508 PDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLL 1587
Cdd:cd17649 1 PDAVALVFGDQSLSYAELDARANRLAHRLRALGVGPEVRVGIALERSLEMVVALLAILKAGGAYVPLDPEYPAERLRYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1588 EDSGTNILLLQSaglhvpeftgeivylnqtnsglahrlsnpnvdvlPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSL 1667
Cdd:cd17649 81 EDSGAGLLLTHH----------------------------------PRQLAYVIYTSGSTGTPKGVAVSHGPLAAHCQAT 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1668 QSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHI--K 1745
Cdd:cd17649 127 AERYGLTPGDRELQFASFNFDGAHEQLLPPLICGACVVLRPDELWASADELAEMVRELGVTVLDLPPAYLQQLAEEAdrT 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1746 YRSVPIktnRLKRVFSGGEQLGTHLVSRFyeLLPNVSITNSYGPTEATVEAAFFDCPPHEKL--ERIPIGKPVHHVRLYL 1823
Cdd:cd17649 207 GDGRPP---SLRLYIFGGEALSPELLRRW--LKAPVRLFNAYGPTEATVTPLVWKCEAGAARagASMPIGRPLGGRSAYI 281
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1824 LNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFY-PGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGY 1902
Cdd:cd17649 282 LDADLNPVPVGVTGELYIGGEGLARGYLGRPELTAERFVPDPFGaPGSRLYRTGDLARWRDDGVIEYLGRVDHQVKIRGF 361
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1903 RIEPGEIEAALRSIEGVREAAVTVRTDSGEPELCAYVEGLQ-------RNEVRAQLERLLPGYMVPAYMIEMEQWPVTPS 1975
Cdd:cd17649 362 RIELGEIEAALLEHPGVREAAVVALDGAGGKQLVAYVVLRAaaaqpelRAQLRTALRASLPDYMVPAHLVFLARLPLTPN 441
|
....*....
gi 1678550997 1976 GKLDRNALP 1984
Cdd:cd17649 442 GKLDRKALP 450
|
|
| A_NRPS_VisG_like |
cd17651 |
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) ... |
2539-3020 |
5.06e-157 |
|
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes virginiamycin S synthetase (VisG) in Streptomyces virginiae; VisG is involved in virginiamycin S (VS) biosynthesis as the provider of an L-pheGly molecule, a highly specific substrate for the last condensation step by VisF. This family also includes linear gramicidin synthetase B (LgrB) in Brevibacillus brevis. Substrate specificity analysis using residues of the substrate-binding pockets of all 16 adenylation domains has shown good agreement of the substrate amino acids predicted with the sequence of linear gramicidin. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341306 [Multi-domain] Cd Length: 491 Bit Score: 496.87 E-value: 5.06e-157
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2539 FEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYP 2618
Cdd:cd17651 1 FERQAARTPDAPALVAEGRRLTYAELDRRANRLAHRLRARGVGPGDLVALCARRSAELVVALLAILKAGAAYVPLDPAYP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2619 KERKRYILSDSGTKLLMTINEA--DLGVLADFEGEILTIESVEEDDKSPLPQMSsAHHLAYIIYTSGTTGRPKGVMVEHK 2696
Cdd:cd17651 81 AERLAFMLADAGPVLVLTHPALagELAVELVAVTLLDQPGAAAGADAEPDPALD-ADDLAYVIYTSGSTGRPKGVVMPHR 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2697 GIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLYR 2776
Cdd:cd17651 160 SLANLVAWQARASSLGPGARTLQFAGLGFDVSVQEIFSTLCAGATLVLPPEEVRTDPPALAAWLDEQRISRVFLPTVALR 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2777 ALLDVVQPEDVK--TLRVVTLAGEAA-DRELIARSLAICPHTELANEYGPTENSVAT------TVMRHMEKqayVSIGQP 2847
Cdd:cd17651 240 ALAEHGRPLGVRlaALRYLLTGGEQLvLTEDLREFCAGLPGLRLHNHYGPTETHVVTalslpgDPAAWPAP---PPIGRP 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2848 IDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKPEARMYRTGDAARWMADGTLEYLGRIDD 2927
Cdd:cd17651 317 IDNTRVYVLDAALRPVPPGVPGELYIGGAGLARGYLNRPELTAERFVPDPFVPGARMYRTGDLARWLPDGELEFLGRADD 396
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2928 QVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPG--LSTNAVRSELQNKLPVFMHPAFIEKLDS 3005
Cdd:cd17651 397 QVKIRGFRIELGEIEAALARHPGVREAVVLAREDRPGEKRLVAYVVGDPEapVDAAELRAALATHLPEYMVPSAFVLLDA 476
|
490
....*....|....*
gi 1678550997 3006 LPLSPNGKLDRGALP 3020
Cdd:cd17651 477 LPLTPNGKLDRRALP 491
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
12-1455 |
4.15e-155 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 545.15 E-value: 4.15e-155
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 12 PLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNvSSPQQVVLRERNVIVLEE 91
Cdd:PRK05691 1730 PLSYSQQRMWFLWQMEPDSPAYNVGGMARLSGVLDVDRFEAALQALILRHETLRTTFPSVD-GVPVQQVAEDSGLRMDWQ 1808
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 92 DITHLNEAEQSQFIEQWKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASYVNA- 170
Cdd:PRK05691 1809 DFSALPADARQQRLQQLADSEAHQPFDLERGPLLRACLVKAAEREHYFVLTLHHIVTEGWAMDIFARELGALYEAFLDDr 1888
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 171 -SPITLEPVQpYGKYI----KWLMEQDKEQAVSYWDHYLSGHEQQTVLP--KQKKTKGKSRQEHVTFSFSKEESSRLSEL 243
Cdd:PRK05691 1889 eSPLEPLPVQ-YLDYSvwqrQWLESGERQRQLDYWKAQLGNEHPLLELPadRPRPPVQSHRGELYRFDLSPELAARVRAF 1967
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 244 AAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGR-PAEIEGiehMVGLFINTMPVRVQ--GAKT------------ 308
Cdd:PRK05691 1968 NAQRGLTLFMTMTATLAALLYRYSGQRDLRIGAPVANRiRPESEG---LIGAFLNTQVLRCQldGQMSvselleqvrqtv 2044
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 309 ---------PFLQLIKDMQKDRLAAeaysYHPLYEIqsrsavkqglidhilvfenypvqqeiqMLNKQEHAsdlFQ---- 375
Cdd:PRK05691 2045 iegqshqdlPFDHLVEALQPPRSAA----YNPLFQV---------------------------MCNVQRWE---FQqsrq 2090
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 376 IHNFTV------ADETNYSFYLMVAP-GEEIHIKMNYDAEQHDRSFVLSVKEHLLNAVSQILNNPNLPPEEIDITTDTEK 448
Cdd:PRK05691 2091 LAGMTVeylvndARATKFDLNLEVTDlDGRLGCCLTYSRDLFDEPRIARMAEHWQNLLEALLGDPQQRLAELPLLAAAEQ 2170
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 449 RQLI----GEITDQtPVYETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSA 524
Cdd:PRK05691 2171 QQLLdslaGEAGEA-RLDQTLHGLFAAQAARTPQAPALTFAGQTLSYAELDARANRLARALRERGVGPQVRVGLALERSL 2249
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 525 AFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSQA-------HLPS-----SLEDNYIIThpedieSKVDG 592
Cdd:PRK05691 2250 EMVVGLLAILKAGGAYVPLDPEYPLERLHYMIEDSGIGLLLSDRalfealgELPAgvarwCLEDDAAAL------AAYSD 2323
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 593 SNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEYTHSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLH 672
Cdd:PRK05691 2324 APLPFLSLPQHQAYLIYTSGSTGKPKGVVVSHGEIAMHCQAVIERFGMRADDCELHFYSINFDAASERLLVPLLCGARVV 2403
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 673 IVPEAiKRDVPQLFAFINKHQTNIV-FLP---TAFIKMIFSERElanSFPdgVKHLIAAGEQLM------ISDLFQDVLr 742
Cdd:PRK05691 2404 LRAQG-QWGAEEICQLIREQQVSILgFTPsygSQLAQWLAGQGE---QLP--VRMCITGGEALTgehlqrIRQAFAPQL- 2476
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 743 krgihLHNHYGPSETHVVSTYTIHPgDPIPE---LPPIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHD 819
Cdd:PRK05691 2477 -----FFNAYGPTETVVMPLACLAP-EQLEEgaaSVPIGRVVGARVAYILDADLALVPQGATGELYVGGAGLAQGYHDRP 2550
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 820 KLTSDKFSSDPFKPDV-IMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIwQDQNGE 898
Cdd:PRK05691 2551 GLTAERFVADPFAADGgRLYRTGDLVRLRADGLVEYVGRIDHQVKIRGFRIELGEIESRLLEHPAVREAVVLA-LDTPSG 2629
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 899 HELCAYYCSVQKLNTID--------LRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPEPDASISGNPYTAPRNL 970
Cdd:PRK05691 2630 KQLAGYLVSAVAGQDDEaqaalreaLKAHLKQQLPDYMVPAHLILLDSLPLTANGKLDRRALPAPDPELNRQAYQAPRSE 2709
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 971 LEAKLSQLFEDVLKNGHIGIQDNFFDNGGHSLKATVLMSRiAKEFHVQVSLKDIFAHPTVEGLALIIREAEQnlyAAIEP 1050
Cdd:PRK05691 2710 LEQQLAQIWREVLNVERVGLGDNFFELGGDSILSIQVVSR-ARQLGIHFSPRDLFQHQTVQTLAAVATHSEA---AQAEQ 2785
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1051 AEKRDTYPVSSAQKRIYVlQQLDEGVAYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFvSGADDEpVQRIHTEVP 1130
Cdd:PRK05691 2786 GPLQGASGLTPIQHWFFD-SPVPQPQHWNQALLLEPRQALDPALLEQALQALVEHHDALRLRF-SQADGR-WQAEYRAVT 2862
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1131 F-TLSKETTIEGFV----------RPFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYanRQLK 1199
Cdd:PRK05691 2863 AqELLWQVTVADFAecaalfadaqRSLDLQQGPLLRALLVDGPQGQQRLLLAIHHLVVDGVSWRVLLEDLQALY--RQLS 2940
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1200 PLRIQ--------YKDYAVWQQKFKKGDSYQKQETYWQQQFSGdlPILELPTDKRRPAERQFIGGKVTFQLDKEITARIK 1271
Cdd:PRK05691 2941 AGAEPalpaktsaFRDWAARLQAYAGSESLREELGWWQAQLGG--PRAELPCDRPQGGNLNRHAQTVSVRLDAERTRQLL 3018
|
1370 1380 1390 1400 1410 1420 1430 1440
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1272 RLA----HKNRSTLYMTLLAlysAFLSRLSGQDDIVIGSPIAGRPHA----DLEAVLGMFVNTLALRTRPAGNKTFE--E 1341
Cdd:PRK05691 3019 QQApaayRTQVNDLLLTALA---RVLCRWSGQPSVLVQLEGHGREALfddiDLTRSVGWFTSAYPLRLTPAPGDDAArgE 3095
|
1450 1460 1470 1480 1490 1500 1510 1520
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1342 FLKEVRQTaLEAYEH--QDY-PFEELVDKLGVQReMSRNPLFDTTL-VLQNMEQQklKMNDVQLQW--------NDLEHP 1409
Cdd:PRK05691 3096 SIKAIKEQ-LRAVPHkgLGYgVLRYLADAAVREA-MAALPQAPITFnYLGQFDQS--FASDALFRPldepagpaHDPDAP 3171
|
1530 1540 1550 1560 1570
....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1410 ISKfDISLYVTEHDSELFCQFEYSTALFEKETIQRWASLF----TTLVEH 1455
Cdd:PRK05691 3172 LPN-ELSVDGQVYGGELVLRWTYSAERYDEQTIAELAEAYlaelQALIAH 3220
|
|
| A_NRPS_CmdD_like |
cd17652 |
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) ... |
1508-1984 |
6.33e-155 |
|
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes phosphinothricin tripeptide (PTT, phosphinothricylalanylalanine) synthetase, where PTT is a natural-product antibiotic and potent herbicide that is produced by Streptomyces hygroscopicus. This adenylation domain has been confirmed to directly activate beta-tyrosine, and fluorinated chondramides are produced through precursor-directed biosynthesis. Also included in this family is chondramide synthase D (also known as ATP-dependent phenylalanine adenylase or phenylalanine activase or tyrosine activase). Chondramides A-D are depsipeptide antitumor and antifungal antibiotics produced by C. crocatus, are a class of mixed peptide/polyketide depsipeptides comprised of three amino acids (alanine, N-methyltryptophan, plus the unusual amino acid beta-tyrosine or alpha-methoxy-beta-tyrosine) and a polyketide chain ([E]-7-hydroxy-2,4,6-trimethyloct-4-enoic acid).
Pssm-ID: 341307 [Multi-domain] Cd Length: 436 Bit Score: 488.30 E-value: 6.33e-155
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1508 PDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLL 1587
Cdd:cd17652 1 PDAPAVVFGDETLTYAELNARANRLARLLAARGVGPERLVALALPRSAELVVAILAVLKAGAAYLPLDPAYPAERIAYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1588 EDSGTNILLLQsaglhvpeftgeivylnqtnsglahrlsnpnvdvlPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSL 1667
Cdd:cd17652 81 ADARPALLLTT-----------------------------------PDNLAYVIYTSGSTGRPKGVVVTHRGLANLAAAQ 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1668 QSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPSMLHAflehIKYR 1747
Cdd:cd17652 126 IAAFDVGPGSRVLQFASPSFDASVWELLMALLAGATLVLAPAEELLPGEPLADLLREHRITHVTLPPAALAA----LPPD 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1748 SVPiktnRLKRVFSGGEQLGTHLVSRFyelLPNVSITNSYGPTEATVEAAFFDCPPHEklERIPIGKPVHHVRLYLLNQN 1827
Cdd:cd17652 202 DLP----DLRTLVVAGEACPAELVDRW---APGRRMINAYGPTETTVCATMAGPLPGG--GVPPIGRPVPGTRVYVLDAR 272
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1828 QRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPF-YPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEP 1906
Cdd:cd17652 273 LRPVPPGVPGELYIAGAGLARGYLNRPGLTAERFVADPFgAPGSRMYRTGDLARWRADGQLEFLGRADDQVKIRGFRIEL 352
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1907 GEIEAALRSIEGVREAAVTVRTD-SGEPELCAYV-----EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDR 1980
Cdd:cd17652 353 GEVEAALTEHPGVAEAVVVVRDDrPGDKRLVAYVvpapgAAPTAAELRAHLAERLPGYMVPAAFVVLDALPLTPNGKLDR 432
|
....
gi 1678550997 1981 NALP 1984
Cdd:cd17652 433 RALP 436
|
|
| A_NRPS_AB3403-like |
cd17646 |
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or ... |
2538-3019 |
5.08e-154 |
|
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341301 [Multi-domain] Cd Length: 488 Bit Score: 487.94 E-value: 5.08e-154
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2538 LFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEY 2617
Cdd:cd17646 3 LVAEQAARTPDAPAVVDEGRTLTYRELDERANRLAHLLRARGVGPEDRVAVLLPRSADLVVALLAVLKAGAAYLPLDPGY 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2618 PKERKRYILSDSGTKLLMTINE-----ADLGVLADFEGEILTIESVEEDDKSPLPqmssaHHLAYIIYTSGTTGRPKGVM 2692
Cdd:cd17646 83 PADRLAYMLADAGPAVVLTTADlaarlPAGGDVALLGDEALAAPPATPPLVPPRP-----DNLAYVIYTSGSTGRPKGVM 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2693 VEHKGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVP 2772
Cdd:cd17646 158 VTHAGIVNRLLWMQDEYPLGPGDRVLQKTPLSFDVSVWELFWPLVAGARLVVARPGGHRDPAYLAALIREHGVTTCHFVP 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2773 VLYRALLDVVQPEDVKTLRVVTLAGEAADRELIARSLAIcPHTELANEYGPTENSVATT--VMRHMEKQAYVSIGQPIDG 2850
Cdd:cd17646 238 SMLRVFLAEPAAGSCASLRRVFCSGEALPPELAARFLAL-PGAELHNLYGPTEAAIDVThwPVRGPAETPSVPIGRPVPN 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2851 TQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKPEARMYRTGDAARWMADGTLEYLGRIDDQVK 2930
Cdd:cd17646 317 TRLYVLDDALRPVPVGVPGELYLGGVQLARGYLGRPALTAERFVPDPFGPGSRMYRTGDLARWRPDGALEFLGRSDDQVK 396
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2931 IRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVV---TKPGLSTNAVRSELQNKLPVFMHPAFIEKLDSLP 3007
Cdd:cd17646 397 IRGFRVEPGEIEAALAAHPAVTHAVVVARAAPAGAARLVGYVVpaaGAAGPDTAALRAHLAERLPEYMVPAAFVVLDALP 476
|
490
....*....|..
gi 1678550997 3008 LSPNGKLDRGAL 3019
Cdd:cd17646 477 LTANGKLDRAAL 488
|
|
| A_NRPS_Ta1_like |
cd12116 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A ... |
2547-3019 |
5.66e-151 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A polyketide synthase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the myxovirescin (TA) antibiotic biosynthetic gene in Myxococcus xanthus; TA production plays a role in predation. It also includes the salinosporamide A polyketide synthase which is involved in the biosynthesis of salinosporamide A, a marine microbial metabolite whose chlorine atom is crucial for potent proteasome inhibition and anticancer activity.
Pssm-ID: 341281 [Multi-domain] Cd Length: 470 Bit Score: 478.32 E-value: 5.66e-151
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2547 PKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYIL 2626
Cdd:cd12116 1 PDATAVRDDDRSLSYAELDERANRLAARLRARGVGPGDRVAVYLPRSARLVAAMLAVLKAGAAYVPLDPDYPADRLRYIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2627 SDSGTKLLMTINEADLGVLADFEGEILTIESVEEDDKSPLPQMSSaHHLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRR 2706
Cdd:cd12116 81 EDAEPALVLTDDALPDRLPAGLPVLLLALAAAAAAPAAPRTPVSP-DDLAYVIYTSGSTGRPKGVVVSHRNLVNFLHSMR 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2707 NAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDvVQPED 2786
Cdd:cd12116 160 ERLGLGPGDRLLAVTTYAFDISLLELLLPLLAGARVVIAPRETQRDPEALARLIEAHSITVMQATPATWRMLLD-AGWQG 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2787 VKTLRVVTlAGEAADRELIARSLAicPHTELANEYGPTENSVATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQLQPIG 2866
Cdd:cd12116 239 RAGLTALC-GGEALPPDLAARLLS--RVGSLWNLYGPTETTIWSTAARVTAAAGPIPIGRPLANTQVYVLDAALRPVPPG 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2867 VAGELCIAGTGLARGYVNLPELTERAFTQNPFKPE-ARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVI 2945
Cdd:cd12116 316 VPGELYIGGDGVAQGYLGRPALTAERFVPDPFAGPgSRLYRTGDLVRRRADGRLEYLGRADGQVKIRGHRIELGEIEAAL 395
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 2946 RCIKGVKDAAVVAHvTASGQTELSAYVVTK--PGLSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:cd12116 396 AAHPGVAQAAVVVR-EDGGDRRLVAYVVLKagAAPDAAALRAHLRATLPAYMVPSAFVRLDALPLTANGKLDRKAL 470
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
1047-2069 |
1.91e-150 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 529.74 E-value: 1.91e-150
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1047 AIEPAEKRDTYPVSSAQKRIYVLQQLDEGVA-YNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSGADDEPVQRI 1125
Cdd:PRK05691 3248 PVPAAEIEDVYPLTPMQEGLLLHTLLEPGTGlYYMQDRYRINSALDPERFAQAWQAVVARHEALRASFSWNAGETMLQVI 3327
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1126 HT------------EVPFTlSKETTIEGFVRP-----FDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIRE 1188
Cdd:PRK05691 3328 HKpgrtpidyldwrGLPED-GQEQRLQALHKQereagFDLLNQPPFHLRLIRVDEARYWFMMSNHHILIDAWCRSLLMND 3406
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1189 FTDLYA----NRQLK-PLRIQYKDYAVWQQKFKKGDSYQkqetYWQQQFSGDLPILELPTDkrRPAERQFIG-------G 1256
Cdd:PRK05691 3407 FFEIYTalgeGREAQlPVPPRYRDYIGWLQRQDLAQARQ----WWQDNLRGFERPTPIPSD--RPFLREHAGdsggmvvG 3480
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1257 KVTFQLDKEITARIKRLAHKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRP--HADLEAVLGMFVNTLALRTR-P 1333
Cdd:PRK05691 3481 DCYTRLDAADGARLRELAQAHQLTVNTFAQAAWALVLRRYSGDRDVLFGVTVAGRPvsMPQMQRTVGLFINSIALRVQlP 3560
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1334 AGNK--TFEEFLKEVRQTALEAYEHQDYPfeeLVDkLGVQREMSR-NPLFDTTLVLQNMEQQKLKMNDVQlQWN---DLE 1407
Cdd:PRK05691 3561 AAGQrcSVRQWLQGLLDSNMELREYEYLP---LVA-IQECSELPKgQPLFDSLFVFENAPVEVSVLDRAQ-SLNassDSG 3635
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1408 HPISKFDISLYVTEHDsELFCQFEYSTALFEKETIQRWASLFTTLVEHTAASPETELDNIPILTKEEERDFIESCHLfEE 1487
Cdd:PRK05691 3636 RTHTNFPLTAVCYPGD-DLGLHLSYDQRYFDAPTVERLLGEFKRLLLALVQGFHGDLSELPLLGEQERDFLLDGCNR-SE 3713
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1488 TGYSMNQTLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKA 1567
Cdd:PRK05691 3714 RDYPLEQSYVRLFEAQVAAHPQRIAASCLDQQWSYAELNRAANRLGHALRAAGVGVDQPVALLAERGLDLLGMIVGSFKA 3793
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1568 GGAYLPIDPDYPEERISFLLEDSGTNILLLQSAGLH-----VPEFTGE-----IVYLNQTNSGLAHrlSNPNVDVLPQSL 1637
Cdd:PRK05691 3794 GAGYLPLDPGLPAQRLQRIIELSRTPVLVCSAACREqaralLDELGCAnrprlLVWEEVQAGEVAS--HNPGIYSGPDNL 3871
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1638 AYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEV 1717
Cdd:PRK05691 3872 AYVIYTSGSTGLPKGVMVEQRGMLNNQLSKVPYLALSEADVIAQTASQSFDISVWQFLAAPLFGARVEIVPNAIAHDPQG 3951
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1718 IAKAIEEQKITAMHFVPSMLHAFLEHIKyrsvpIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAA 1797
Cdd:PRK05691 3952 LLAHVQAQGITVLESVPSLIQGMLAEDR-----QALDGLRWMLPTGEAMPPELARQWLQRYPQIGLVNAYGPAECSDDVA 4026
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1798 FFdcPPHEKLER---IPIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPF-YPGERMY 1873
Cdd:PRK05691 4027 FF--RVDLASTRgsyLPIGSPTDNNRLYLLDEALELVPLGAVGELCVAGTGVGRGYVGDPLRTALAFVPHPFgAPGERLY 4104
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1874 KTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDSGEPELCAYV--------EGLQRN 1945
Cdd:PRK05691 4105 RTGDLARRRSDGVLEYVGRIDHQVKIRGYRIELGEIEARLHEQAEVREAAVAVQEGVNGKHLVGYLvphqtvlaQGALLE 4184
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1946 EVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNALPAPG-GAADAETYTAPRNVTEMKLSQLWEDVLKNGPVGIHDN 2024
Cdd:PRK05691 4185 RIKQRLRAELPDYMVPLHWLWLDRLPLNANGKLDRKALPALDiGQLQSQAYLAPRNELEQTLATIWADVLKVERVGVHDN 4264
|
1050 1060 1070 1080
....*....|....*....|....*....|....*....|....*
gi 1678550997 2025 FFDRGGHSLKATALVSRITKEFDVQVPLKDVFAHPTVEGLATVIR 2069
Cdd:PRK05691 4265 FFELGGHSLLATQIASRVQKALQRNVPLRAMFECSTVEELAEYIE 4309
|
|
| A_NRPS_Ta1_like |
cd12116 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A ... |
1508-1983 |
3.78e-150 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A polyketide synthase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the myxovirescin (TA) antibiotic biosynthetic gene in Myxococcus xanthus; TA production plays a role in predation. It also includes the salinosporamide A polyketide synthase which is involved in the biosynthesis of salinosporamide A, a marine microbial metabolite whose chlorine atom is crucial for potent proteasome inhibition and anticancer activity.
Pssm-ID: 341281 [Multi-domain] Cd Length: 470 Bit Score: 476.01 E-value: 3.78e-150
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1508 PDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLL 1587
Cdd:cd12116 1 PDATAVRDDDRSLSYAELDERANRLAARLRARGVGPGDRVAVYLPRSARLVAAMLAVLKAGAAYVPLDPDYPADRLRYIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1588 EDSGTNILLLQSAGLHVPEFTGEIVYLNQTNSGLAHrlSNPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSL 1667
Cdd:cd12116 81 EDAEPALVLTDDALPDRLPAGLPVLLLALAAAAAAP--AAPRTPVSPDDLAYVIYTSGSTGRPKGVVVSHRNLVNFLHSM 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1668 QSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEhikyr 1747
Cdd:cd12116 159 RERLGLGPGDRLLAVTTYAFDISLLELLLPLLAGARVVIAPRETQRDPEALARLIEAHSITVMQATPATWRMLLD----- 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1748 SVPIKTNRLkRVFSGGEQLGTHLVSRFyeLLPNVSITNSYGPTEATVEAAFfdCPPHEKLERIPIGKPVHHVRLYLLNQN 1827
Cdd:cd12116 234 AGWQGRAGL-TALCGGEALPPDLAARL--LSRVGSLWNLYGPTETTIWSTA--ARVTAAAGPIPIGRPLANTQVYVLDAA 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1828 QRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFY-PGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEP 1906
Cdd:cd12116 309 LRPVPPGVPGELYIGGDGVAQGYLGRPALTAERFVPDPFAgPGSRLYRTGDLVRRRADGRLEYLGRADGQVKIRGHRIEL 388
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1907 GEIEAALRSIEGVREAAVTVRTDSGEPELCAYVEG-----LQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRN 1981
Cdd:cd12116 389 GEIEAALAAHPGVAQAAVVVREDGGDRRLVAYVVLkagaaPDAAALRAHLRATLPAYMVPSAFVRLDALPLTANGKLDRK 468
|
..
gi 1678550997 1982 AL 1983
Cdd:cd12116 469 AL 470
|
|
| A_NRPS_CmdD_like |
cd17652 |
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) ... |
2547-3020 |
1.09e-149 |
|
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes phosphinothricin tripeptide (PTT, phosphinothricylalanylalanine) synthetase, where PTT is a natural-product antibiotic and potent herbicide that is produced by Streptomyces hygroscopicus. This adenylation domain has been confirmed to directly activate beta-tyrosine, and fluorinated chondramides are produced through precursor-directed biosynthesis. Also included in this family is chondramide synthase D (also known as ATP-dependent phenylalanine adenylase or phenylalanine activase or tyrosine activase). Chondramides A-D are depsipeptide antitumor and antifungal antibiotics produced by C. crocatus, are a class of mixed peptide/polyketide depsipeptides comprised of three amino acids (alanine, N-methyltryptophan, plus the unusual amino acid beta-tyrosine or alpha-methoxy-beta-tyrosine) and a polyketide chain ([E]-7-hydroxy-2,4,6-trimethyloct-4-enoic acid).
Pssm-ID: 341307 [Multi-domain] Cd Length: 436 Bit Score: 473.28 E-value: 1.09e-149
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2547 PKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYIL 2626
Cdd:cd17652 1 PDAPAVVFGDETLTYAELNARANRLARLLAARGVGPERLVALALPRSAELVVAILAVLKAGAAYLPLDPAYPAERIAYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2627 SDSGTKLLMTineadlgvladfegeiltiesveeddksplpqmsSAHHLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRR 2706
Cdd:cd17652 81 ADARPALLLT----------------------------------TPDNLAYVIYTSGSTGRPKGVVVTHRGLANLAAAQI 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2707 NAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPvlyrALLDVVQPED 2786
Cdd:cd17652 127 AAFDVGPGSRVLQFASPSFDASVWELLMALLAGATLVLAPAEELLPGEPLADLLREHRITHVTLPP----AALAALPPDD 202
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2787 VKTLRVVTLAGEAADRELIARslaICPHTELANEYGPTENSVATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQLQPIG 2866
Cdd:cd17652 203 LPDLRTLVVAGEACPAELVDR---WAPGRRMINAYGPTETTVCATMAGPLPGGGVPPIGRPVPGTRVYVLDARLRPVPPG 279
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2867 VAGELCIAGTGLARGYVNLPELTERAFTQNPF-KPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVI 2945
Cdd:cd17652 280 VPGELYIAGAGLARGYLNRPGLTAERFVADPFgAPGSRMYRTGDLARWRADGQLEFLGRADDQVKIRGFRIELGEVEAAL 359
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 2946 RCIKGVKDAAVVAHVTASGQTELSAYVVTKPG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGALP 3020
Cdd:cd17652 360 TEHPGVAEAVVVVRDDRPGDKRLVAYVVPAPGaaPTAAELRAHLAERLPGYMVPAAFVVLDALPLTPNGKLDRRALP 436
|
|
| A_NRPS_Cytc1-like |
cd17643 |
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation ... |
1508-1983 |
3.46e-147 |
|
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Streptomyces sp. cytotrienin synthetase (CytC1), a relatively promiscuous adenylation enzyme that installs the aminoacyl moieties on the phosphopantetheinyl arm of the holo carrier protein CytC2. Also included are Streptomyces sp Thr1, involved in the biosynthesis of 4-chlorothreonine, Pseudomonas aeruginosa pyoverdine synthetase D (PvdD), involved in the biosynthesis of the siderophore pyoverdine and Pseudomonas syringae syringopeptin synthetase, where syringpeptin is a necrosis-inducing phytotoxin that functions as a virulence determinant in the plant-pathogen interaction. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341298 [Multi-domain] Cd Length: 450 Bit Score: 466.78 E-value: 3.46e-147
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1508 PDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLL 1587
Cdd:cd17643 1 PEAVAVVDEDRRLTYGELDARANRLARTLRAEGVGPGDRVALALPRSAELIVALLAILKAGGAYVPIDPAYPVERIAFIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1588 EDSGTNILLLQsaglhvpeftgeivylnqtnsglahrlsnpnvdvlPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSL 1667
Cdd:cd17643 81 ADSGPSLLLTD-----------------------------------PDDLAYVIYTSGSTGRPKGVVVSHANVLALFAAT 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1668 QSRYQLKHSDMIMHKTSYSFDASIWELfWWPYA-GASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIky 1746
Cdd:cd17643 126 QRWFGFNEDDVWTLFHSYAFDFSVWEI-WGALLhGGRLVVVPYEVARSPEDFARLLRDEGVTVLNQTPSAFYQLVEAA-- 202
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1747 RSVPIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVS--ITNSYGPTEATVEAAFF-----DCPPHEkleRIPIGKPVHHV 1819
Cdd:cd17643 203 DRDGRDPLALRYVIFGGEALEAAMLRPWAGRFGLDRpqLVNMYGITETTVHVTFRpldaaDLPAAA---ASPIGRPLPGL 279
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1820 RLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFY-PGERMYKTGDVARWLPDGNVEFLGRTDDQVK 1898
Cdd:cd17643 280 RVYVLDADGRPVPPGVVGELYVSGAGVARGYLGRPELTAERFVANPFGgPGSRMYRTGDLARRLPDGELEYLGRADEQVK 359
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1899 IRGYRIEPGEIEAALRSIEGVREAAVTVRTDS-GEPELCAYV-----EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPV 1972
Cdd:cd17643 360 IRGFRIELGEIEAALATHPSVRDAAVIVREDEpGDTRLVAYVvaddgAAADIAELRALLKELLPDYMVPARYVPLDALPL 439
|
490
....*....|.
gi 1678550997 1973 TPSGKLDRNAL 1983
Cdd:cd17643 440 TVNGKLDRAAL 450
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
2078-3105 |
9.84e-147 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 517.80 E-value: 9.84e-147
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2078 AIKPAEKQETYPVSSAQKRIyVLQQLEDGGTG-YNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGDPVQR 2156
Cdd:PRK05691 3248 PVPAAEIEDVYPLTPMQEGL-LLHTLLEPGTGlYYMQDRYRINSALDPERFAQAWQAVVARHEALRASFSWNAGETMLQV 3326
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2157 IHD------------EVPFTLQTTVLGARTEQEAAAAFikpfDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNI 2224
Cdd:PRK05691 3327 IHKpgrtpidyldwrGLPEDGQEQRLQALHKQEREAGF----DLLNQPPFHLRLIRVDEARYWFMMSNHHILIDAWCRSL 3402
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2225 LIQEFGELYN------NRKLPALRiQYKDYAVWQEGFKTGDAykmqEAYWLKQLEG-ELPVLdLPADhaRPPVRSFAGDK 2297
Cdd:PRK05691 3403 LMNDFFEIYTalgegrEAQLPVPP-RYRDYIGWLQRQDLAQA----RQWWQDNLRGfERPTP-IPSD--RPFLREHAGDS 3474
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2298 VSFT-------LEPEVASGLHKLARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRP--HKDLEPILGMFVNTLA 2368
Cdd:PRK05691 3475 GGMVvgdcytrLDAADGARLRELAQAHQLTVNTFAQAAWALVLRRYSGDRDVLFGVTVAGRPvsMPQMQRTVGLFINSIA 3554
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2369 LRTR-PEGGKP--FVQYLQEVRETALEAFEHQNYPfeeLVDKLELTRDMSRNPVFDAMLVVQNNDYEPLHLHDLQMKPAQ 2445
Cdd:PRK05691 3555 LRVQlPAAGQRcsVRQWLQGLLDSNMELREYEYLP---LVAIQECSELPKGQPLFDSLFVFENAPVEVSVLDRAQSLNAS 3631
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2446 V----SHlvSKFDLTLQASEGDgNIHFLFEYSTALFEKTTIERWASHLTNVLSIIGKNPKVTLNHIDILTQEERHQLLNE 2521
Cdd:PRK05691 3632 SdsgrTH--TNFPLTAVCYPGD-DLGLHLSYDQRYFDAPTVERLLGEFKRLLLALVQGFHGDLSELPLLGEQERDFLLDG 3708
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2522 FNTGQANQYGVQTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASIL 2601
Cdd:PRK05691 3709 CNRSERDYPLEQSYVRLFEAQVAAHPQRIAASCLDQQWSYAELNRAANRLGHALRAAGVGVDQPVALLAERGLDLLGMIV 3788
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2602 GVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLM---TINEADLGVLADFEG----EILTIESVEEDD-KSPLPQM-SSA 2672
Cdd:PRK05691 3789 GSFKAGAGYLPLDPGLPAQRLQRIIELSRTPVLVcsaACREQARALLDELGCanrpRLLVWEEVQAGEvASHNPGIySGP 3868
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2673 HHLAYIIYTSGTTGRPKGVMVEHKGIANTlQWRRNAY-AFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAK 2751
Cdd:PRK05691 3869 DNLAYVIYTSGSTGLPKGVMVEQRGMLNN-QLSKVPYlALSEADVIAQTASQSFDISVWQFLAAPLFGARVEIVPNAIAH 3947
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2752 DILAIKHQLSRQRITHMIIVPVLYRALLdvVQPED-VKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTENSVAT 2830
Cdd:PRK05691 3948 DPQGLLAHVQAQGITVLESVPSLIQGML--AEDRQaLDGLRWMLPTGEAMPPELARQWLQRYPQIGLVNAYGPAECSDDV 4025
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2831 TVMR---HMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPF-KPEARMYR 2906
Cdd:PRK05691 4026 AFFRvdlASTRGSYLPIGSPTDNNRLYLLDEALELVPLGAVGELCVAGTGVGRGYVGDPLRTALAFVPHPFgAPGERLYR 4105
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2907 TGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQtELSAYVVTKPGLSTNA---- 2982
Cdd:PRK05691 4106 TGDLARRRSDGVLEYVGRIDHQVKIRGYRIELGEIEARLHEQAEVREAAVAVQEGVNGK-HLVGYLVPHQTVLAQGalle 4184
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2983 -VRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGALPKPVYNHEGERPFLPPSSKMEQILADIWKEVLGAEKIGTADS 3061
Cdd:PRK05691 4185 rIKQRLRAELPDYMVPLHWLWLDRLPLNANGKLDRKALPALDIGQLQSQAYLAPRNELEQTLATIWADVLKVERVGVHDN 4264
|
1050 1060 1070 1080
....*....|....*....|....*....|....*....|....*
gi 1678550997 3062 FFELGGDSIKALQVSARLHR-IGKQMAVKDLFSHPTIQELAAYIR 3105
Cdd:PRK05691 4265 FFELGGHSLLATQIASRVQKaLQRNVPLRAMFECSTVEELAEYIE 4309
|
|
| A_NRPS_Sfm_like |
cd12115 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene ... |
2535-3019 |
2.16e-145 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene cluster from Streptomyces lavendulae; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the saframycin A gene cluster from Streptomyces lavendulae which implicates the NRPS system for assembling the unusual tetrapeptidyl skeleton in an iterative manner. It also includes saframycin Mx1 produced by Myxococcus xanthus NRPS.
Pssm-ID: 341280 [Multi-domain] Cd Length: 447 Bit Score: 461.40 E-value: 2.16e-145
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2535 ISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPID 2614
Cdd:cd12115 1 LHDLVEAQAARTPDAIALVCGDESLTYAELNRRANRLAARLRAAGVGPESRVGVCLERTPDLVVALLAVLKAGAAYVPLD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2615 PEYPKERKRYILSDSGTKLLMTineadlgvladfegeiltiesveeddksplpqmsSAHHLAYIIYTSGTTGRPKGVMVE 2694
Cdd:cd12115 81 PAYPPERLRFILEDAQARLVLT----------------------------------DPDDLAYVIYTSGSTGRPKGVAIE 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2695 HKGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLlheeeAKDILAIKHQLSRQRITHMIIVPVL 2774
Cdd:cd12115 127 HRNAAAFLQWAAAAFSAEELAGVLASTSICFDLSVFELFGPLATGGKVVL-----ADNVLALPDLPAAAEVTLINTVPSA 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2775 YRALLDV-VQPedvKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTEN---SVATTVMRHMEKQayVSIGQPIDG 2850
Cdd:cd12115 202 AAELLRHdALP---ASVRVVNLAGEPLPRDLVQRLYARLQVERVVNLYGPSEDttySTVAPVPPGASGE--VSIGRPLAN 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2851 TQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKPEARMYRTGDAARWMADGTLEYLGRIDDQVK 2930
Cdd:cd12115 277 TQAYVLDRALQPVPLGVPGELYIGGAGVARGYLGRPGLTAERFLPDPFGPGARLYRTGDLVRWRPDGLLEFLGRADNQVK 356
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2931 IRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLS--TNAVRSELQNKLPVFMHPAFIEKLDSLPL 3008
Cdd:cd12115 357 VRGFRIELGEIEAALRSIPGVREAVVVAIGDAAGERRLVAYIVAEPGAAglVEDLRRHLGTRLPAYMVPSRFVRLDALPL 436
|
490
....*....|.
gi 1678550997 3009 SPNGKLDRGAL 3019
Cdd:cd12115 437 TPNGKIDRSAL 447
|
|
| Condensation |
pfam00668 |
Condensation domain; This domain is found in many multi-domain enzymes which synthesize ... |
1053-1477 |
1.06e-144 |
|
Condensation domain; This domain is found in many multi-domain enzymes which synthesize peptide antibiotics. This domain catalyzes a condensation reaction to form peptide bonds in non- ribosomal peptide biosynthesis. It is usually found to the carboxy side of a phosphopantetheine binding domain (pfam00550). It has been shown that mutations in the HHXXXDG motif abolish activity suggesting this is part of the active site.
Pssm-ID: 395541 [Multi-domain] Cd Length: 454 Bit Score: 459.88 E-value: 1.06e-144
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1053 KRDTYPVSSAQKRIYVLQQLDEG-VAYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSGADDEPVQRIHTEVPF 1131
Cdd:pfam00668 1 VQDEYPLSPAQKRMWFLEKLEPHsSAYNMPAVLKLTGELDPERLEKALQELINRHDALRTVFIRQENGEPVQVILEERPF 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1132 TL-----------SKETTIEGFVR-----PFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYA- 1194
Cdd:pfam00668 81 ELeiidisdlsesEEEEAIEAFIQrdlqsPFDLEKGPLFRAGLFRIAENRHHLLLSMHHIIVDGVSLGILLRDLADLYQq 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1195 ---NRQLKPLRIQ-YKDYAVWQQKFKKGDSYQKQETYWQQQFSGDLPILELPTDKRRPAERQFIGGKVTFQLDKEITARI 1270
Cdd:pfam00668 161 llkGEPLPLPPKTpYKDYAEWLQQYLQSEDYQKDAAYWLEQLEGELPVLQLPKDYARPADRSFKGDRLSFTLDEDTEELL 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1271 KRLAHKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPHADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQTA 1350
Cdd:pfam00668 241 RKLAKAHGTTLNDVLLAAYGLLLSRYTGQDDIVVGTPGSGRPSPDIERMVGMFVNTLPLRIDPKGGKTFSELIKRVQEDL 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1351 LEAYEHQDYPFEELVDKLGVQREMSRNPLFDTTLVLQNMEQQKLKMNDVQLQWNDL-----EHPISKFDISLYVTEHDSE 1425
Cdd:pfam00668 321 LSAEPHQGYPFGDLVNDLRLPRDLSRHPLFDPMFSFQNYLGQDSQEEEFQLSELDLsvssvIEEEAKYDLSLTASERGGG 400
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 1426 LFCQFEYSTALFEKETIQRWASLFTTLVEHTAASPETELDNIPILTKEEERD 1477
Cdd:pfam00668 401 LTIKIDYNTSLFDEETIERFAEHFKELLEQAIAHPSQPLSELDLLSDAEKQK 452
|
|
| A_NRPS_ApnA-like |
cd17644 |
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the ... |
1495-1984 |
1.42e-144 |
|
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Planktothrix agardhii anabaenopeptin synthetase (ApnA A1), which is capable of activating two chemically distinct amino acids (Arg and Tyr). Structural studies show that the architecture of the active site forces Arg to adopt a Tyr-like conformation, thus explaining the bispecificity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341299 [Multi-domain] Cd Length: 465 Bit Score: 459.98 E-value: 1.42e-144
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1495 TLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPI 1574
Cdd:cd17644 1 CIHQLFEEQVERTPDAVAVVFEDQQLTYEELNTKANQLAHYLQSLGVKSESLVGICVERSLEMIIGLLAILKAGGAYVPL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1575 DPDYPEERISFLLEDSGTNILLLQsaglhvpeftgeivylnqtnsglahrlsnpnvdvlPQSLAYVIYTSGSTGMPKGVE 1654
Cdd:cd17644 81 DPNYPQERLTYILEDAQISVLLTQ-----------------------------------PENLAYVIYTSGSTGKPKGVM 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1655 IEHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVP 1734
Cdd:cd17644 126 IEHQSLVNLSHGLIKEYGITSSDRVLQFASIAFDVAAEEIYVTLLSGATLVLRPEEMRSSLEDFVQYIQQWQLTVLSLPP 205
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1735 SMLHAFLEHIKYRSVPIkTNRLKRVFSGGEQLGTHLVSRFYELL-PNVSITNSYGPTEATVEAAFFDC--PPHEKLERIP 1811
Cdd:cd17644 206 AYWHLLVLELLLSTIDL-PSSLRLVIVGGEAVQPELVRQWQKNVgNFIQLINVYGPTEATIAATVCRLtqLTERNITSVP 284
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1812 IGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFY--PGERMYKTGDVARWLPDGNVEF 1889
Cdd:cd17644 285 IGRPIANTQVYILDENLQPVPVGVPGELHIGGVGLARGYLNRPELTAEKFISHPFNssESERLYKTGDLARYLPDGNIEY 364
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1890 LGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTD-SGEPELCAYV-----EGLQRNEVRAQLERLLPGYMVPAY 1963
Cdd:cd17644 365 LGRIDNQVKIRGFRIELGEIEAVLSQHNDVKTAVVIVREDqPGNKRLVAYIvphyeESPSTVELRQFLKAKLPDYMIPSA 444
|
490 500
....*....|....*....|.
gi 1678550997 1964 MIEMEQWPVTPSGKLDRNALP 1984
Cdd:cd17644 445 FVVLEELPLTPNGKIDRRALP 465
|
|
| A_NRPS_Sfm_like |
cd12115 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene ... |
1496-1983 |
1.51e-144 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene cluster from Streptomyces lavendulae; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the saframycin A gene cluster from Streptomyces lavendulae which implicates the NRPS system for assembling the unusual tetrapeptidyl skeleton in an iterative manner. It also includes saframycin Mx1 produced by Myxococcus xanthus NRPS.
Pssm-ID: 341280 [Multi-domain] Cd Length: 447 Bit Score: 459.09 E-value: 1.51e-144
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1496 LHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPID 1575
Cdd:cd12115 1 LHDLVEAQAARTPDAIALVCGDESLTYAELNRRANRLAARLRAAGVGPESRVGVCLERTPDLVVALLAVLKAGAAYVPLD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1576 PDYPEERISFLLEDSGTNILLLQsaglhvpeftgeivylnqtnsglahrlsnpnvdvlPQSLAYVIYTSGSTGMPKGVEI 1655
Cdd:cd12115 81 PAYPPERLRFILEDAQARLVLTD-----------------------------------PDDLAYVIYTSGSTGRPKGVAI 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1656 EHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLpqggEKEPEVIAKAIEEQkITAMHFVPS 1735
Cdd:cd12115 126 EHRNAAAFLQWAAAAFSAEELAGVLASTSICFDLSVFELFGPLATGGKVVLA----DNVLALPDLPAAAE-VTLINTVPS 200
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1736 MLHAFLEHikyRSVPiktNRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFDCPPHEKlERIPIGKP 1815
Cdd:cd12115 201 AAAELLRH---DALP---ASVRVVNLAGEPLPRDLVQRLYARLQVERVVNLYGPSEDTTYSTVAPVPPGAS-GEVSIGRP 273
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1816 VHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYPGERMYKTGDVARWLPDGNVEFLGRTDD 1895
Cdd:cd12115 274 LANTQAYVLDRALQPVPLGVPGELYIGGAGVARGYLGRPGLTAERFLPDPFGPGARLYRTGDLVRWRPDGLLEFLGRADN 353
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1896 QVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS-GEPELCAYV-----EGLQRNEVRAQLERLLPGYMVPAYMIEMEQ 1969
Cdd:cd12115 354 QVKVRGFRIELGEIEAALRSIPGVREAVVVAIGDAaGERRLVAYIvaepgAAGLVEDLRRHLGTRLPAYMVPSRFVRLDA 433
|
490
....*....|....
gi 1678550997 1970 WPVTPSGKLDRNAL 1983
Cdd:cd12115 434 LPLTPNGKIDRSAL 447
|
|
| A_NRPS_PpsD_like |
cd17650 |
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation ... |
1508-1983 |
4.55e-144 |
|
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetase 1 (BacA) in Bacillus licheniformis, tyrocidine synthetase in Brevibacillus brevis, plipastatin synthase (PpsD, an important antifungal protein) in Bacillus subtilis and mannopeptimycin peptide synthetase (MppB) in Streptomyces hygroscopicus. Plipastatin has strong fungitoxic activity and is involved in inhibition of phospholipase A2 and biofilm formation. Bacitracin, a mixture of related cyclic peptides, is used as a polypeptide antibiotic while function of tyrocidine is thought to be regulation of sporulation. MppB is involved in biosynthetic pathway of mannopeptimycin, a novel class of mannosylated lipoglycopeptides. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341305 [Multi-domain] Cd Length: 447 Bit Score: 457.70 E-value: 4.55e-144
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1508 PDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLL 1587
Cdd:cd17650 1 PDAIAVSDATRQLTYRELNERANQLARTLRGLGVAPGSVVGVCADRSLDAIVGLLAVLKAGGAYVPIDPDYPAERLQYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1588 EDSGTNILLLQsaglhvpeftgeivylnqtnsglahrlsnpnvdvlPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSL 1667
Cdd:cd17650 81 EDSGAKLLLTQ-----------------------------------PEDLAYVIYTSGTTGKPKGVMVEHRNVAHAAHAW 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1668 QSRYQL-KHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKY 1746
Cdd:cd17650 126 RREYELdSFPVRLLQMASFSFDVFAGDFARSLLNGGTLVICPDEVKLDPAALYDLILKSRITLMESTPALIRPVMAYVYR 205
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1747 RSVPIKTNRLKRVFSGGEQLG--THLVSRFyelLPNVSITNSYGPTEATVEAAFF--DCPPHEKLERIPIGKPVHHVRLY 1822
Cdd:cd17650 206 NGLDLSAMRLLIVGSDGCKAQdfKTLAARF---GQGMRIINSYGVTEATIDSTYYeeGRDPLGDSANVPIGRPLPNTAMY 282
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1823 LLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGY 1902
Cdd:cd17650 283 VLDERLQPQPVGVAGELYIGGAGVARGYLNRPELTAERFVENPFAPGERMYRTGDLARWRADGNVELLGRVDHQVKIRGF 362
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1903 RIEPGEIEAALRSIEGVREAAVTVRTDS-GEPELCAYV---EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKL 1978
Cdd:cd17650 363 RIELGEIESQLARHPAIDEAVVAVREDKgGEARLCAYVvaaATLNTAELRAFLAKELPSYMIPSYYVQLDALPLTPNGKV 442
|
....*
gi 1678550997 1979 DRNAL 1983
Cdd:cd17650 443 DRRAL 447
|
|
| A_NRPS_AB3403-like |
cd17646 |
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or ... |
466-952 |
5.65e-141 |
|
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341301 [Multi-domain] Cd Length: 488 Bit Score: 450.57 E-value: 5.65e-141
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 466 HAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDP 545
Cdd:cd17646 1 HALVAEQAARTPDAPAVVDEGRTLTYRELDERANRLAHLLRARGVGPEDRVAVLLPRSADLVVALLAVLKAGAAYLPLDP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 546 HYPADRIRYILHDCGCSHVVSQAHLPSSLEDNYIITHPEDIE-SKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEH 624
Cdd:cd17646 81 GYPADRLAYMLADAGPAVVLTTADLAARLPAGGDVALLGDEAlAAPPATPPLVPPRPDNLAYVIYTSGSTGRPKGVMVTH 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 625 RNMANLLKFEYTHSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNIV-FLPT-- 701
Cdd:cd17646 161 AGIVNRLLWMQDEYPLGPGDRVLQKTPLSFDVSVWELFWPLVAGARLVVARPGGHRDPAYLAALIREHGVTTChFVPSml 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 702 -AFIkmifseRELANSFPDGVKHLIAAGEQLMIsDLFQDVLRKRGIHLHNHYGPSETHV-VSTYTIHPGDPIPELPpIGK 779
Cdd:cd17646 241 rVFL------AEPAAGSCASLRRVFCSGEALPP-ELAARFLALPGAELHNLYGPTEAAIdVTHWPVRGPAETPSVP-IGR 312
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 780 PIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPDVIMYRTGDLARRLEDGNIEYIGRAD 859
Cdd:cd17646 313 PVPNTRLYVLDDALRPVPVGVPGELYLGGVQLARGYLGRPALTAERFVPDPFGPGSRMYRTGDLARWRPDGALEFLGRSD 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 860 NQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCSV---QKLNTIDLRSYMASELPEYMIPAKWIWV 936
Cdd:cd17646 393 DQVKIRGFRVEPGEIEAALAAHPAVTHAVVVARAAPAGAARLVGYVVPAagaAGPDTAALRAHLAERLPEYMVPAAFVVL 472
|
490
....*....|....*.
gi 1678550997 937 DSIPLTPNGKVDRAAL 952
Cdd:cd17646 473 DALPLTANGKLDRAAL 488
|
|
| A_NRPS_CmdD_like |
cd17652 |
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) ... |
477-953 |
6.96e-139 |
|
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes phosphinothricin tripeptide (PTT, phosphinothricylalanylalanine) synthetase, where PTT is a natural-product antibiotic and potent herbicide that is produced by Streptomyces hygroscopicus. This adenylation domain has been confirmed to directly activate beta-tyrosine, and fluorinated chondramides are produced through precursor-directed biosynthesis. Also included in this family is chondramide synthase D (also known as ATP-dependent phenylalanine adenylase or phenylalanine activase or tyrosine activase). Chondramides A-D are depsipeptide antitumor and antifungal antibiotics produced by C. crocatus, are a class of mixed peptide/polyketide depsipeptides comprised of three amino acids (alanine, N-methyltryptophan, plus the unusual amino acid beta-tyrosine or alpha-methoxy-beta-tyrosine) and a polyketide chain ([E]-7-hydroxy-2,4,6-trimethyloct-4-enoic acid).
Pssm-ID: 341307 [Multi-domain] Cd Length: 436 Bit Score: 442.08 E-value: 6.96e-139
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 477 PDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYIL 556
Cdd:cd17652 1 PDAPAVVFGDETLTYAELNARANRLARLLAARGVGPERLVALALPRSAELVVAILAVLKAGAAYLPLDPAYPAERIAYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 557 HDCGCSHVVSQAhlpsslednyiithpedieskvdgsniksvnnaDDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEYT 636
Cdd:cd17652 81 ADARPALLLTTP---------------------------------DNLAYVIYTSGSTGRPKGVVVTHRGLANLAAAQIA 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 637 HSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNIVFLPTAFIKMIfSERELans 716
Cdd:cd17652 128 AFDVGPGSRVLQFASPSFDASVWELLMALLAGATLVLAPAEELLPGEPLADLLREHRITHVTLPPAALAAL-PPDDL--- 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 717 fPDGVkHLIAAGEQLMISdlfqdvLRKR---GIHLHNHYGPSETHVVSTYtiHPGDPIPELPPIGKPIGCTDLYILNHQK 793
Cdd:cd17652 204 -PDLR-TLVVAGEACPAE------LVDRwapGRRMINAYGPTETTVCATM--AGPLPGGGVPPIGRPVPGTRVYVLDARL 273
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 794 QLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPF-KPDVIMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQ 872
Cdd:cd17652 274 RPVPPGVPGELYIAGAGLARGYLNRPGLTAERFVADPFgAPGSRMYRTGDLARWRADGQLEFLGRADDQVKIRGFRIELG 353
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 873 EIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCSVQKLNTI--DLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRA 950
Cdd:cd17652 354 EVEAALTEHPGVAEAVVVVRDDRPGDKRLVAYVVPAPGAAPTaaELRAHLAERLPGYMVPAAFVVLDALPLTPNGKLDRR 433
|
...
gi 1678550997 951 ALP 953
Cdd:cd17652 434 ALP 436
|
|
| AA-adenyl-dom |
TIGR01733 |
amino acid adenylation domain; This model represents a domain responsible for the specific ... |
490-888 |
1.67e-138 |
|
amino acid adenylation domain; This model represents a domain responsible for the specific recognition of amino acids and activation as adenylyl amino acids. The reaction catalyzed is aa + ATP -> aa-AMP + PPi. These domains are usually found as components of multi-domain non-ribosomal peptide synthetases and are usually called "A-domains" in that context. A-domains are almost invariably followed by "T-domains" (thiolation domains, pfam00550) to which the amino acid adenylate is transferred as a thiol-ester to a bound pantetheine cofactor with the release of AMP (these are also called peptide carrier proteins, or PCPs. When the A-domain does not represent the first module (corresponding to the first amino acid in the product molecule) it is usually preceded by a "C-domain" (condensation domain, pfam00668) which catalyzes the ligation of two amino acid thiol-esters from neighboring modules. This domain is a subset of the AMP-binding domain found in Pfam (pfam00501) which also hits substrate--CoA ligases and luciferases. Sequences scoring in between trusted and noise for this model may be ambiguous as to whether they activate amino acids or other molecules lacking an alpha amino group.
Pssm-ID: 273779 [Multi-domain] Cd Length: 409 Bit Score: 440.16 E-value: 1.67e-138
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 490 TYRELNKAANRLARHLR-MKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSQA 568
Cdd:TIGR01733 1 TYRELDERANRLARHLRaAGGVGPGDRVAVLLERSAELVVAILAVLKAGAAYVPLDPAYPAERLAFILEDAGARLLLTDS 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 569 HLPSSLEDNYI------ITHPEDIESKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEYTHSGIDF 642
Cdd:TIGR01733 81 ALASRLAGLVLpvilldPLELAALDDAPAPPPPDAPSGPDDLAYVIYTSGSTGRPKGVVVTHRSLVNLLAWLARRYGLDP 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 643 EADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVP-QLFAFINKHQTNIVFLPTAFIKMIfseRELANSFPDGV 721
Cdd:TIGR01733 161 DDRVLQFASLSFDASVEEIFGALLAGATLVVPPEDEERDDAaLLAALIAEHPVTVLNLTPSLLALL---AAALPPALASL 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 722 KHLIAAGEQLMISDLfqDVLRKR--GIHLHNHYGPSETHVVSTYTIHPGDPIP--ELPPIGKPIGCTDLYILNHQKQLQP 797
Cdd:TIGR01733 238 RLVILGGEALTPALV--DRWRARgpGARLINLYGPTETTVWSTATLVDPDDAPreSPVPIGRPLANTRLYVLDDDLRPVP 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 798 CGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPDV--IMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIE 875
Cdd:TIGR01733 316 VGVVGELYIGGPGVARGYLNRPELTAERFVPDPFAGGDgaRLYRTGDLVRYLPDGNLEFLGRIDDQVKIRGYRIELGEIE 395
|
410
....*....|...
gi 1678550997 876 VTLMNHPDISEAA 888
Cdd:TIGR01733 396 AALLRHPGVREAV 408
|
|
| A_NRPS_ProA |
cd17656 |
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the ... |
1507-1984 |
5.09e-138 |
|
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains gramicidin S synthase 2 (also known as ATP-dependent proline adenylase or proline activase or ProA). ProA is a multifunctional enzyme involved in synthesis of the cyclic peptide antibiotic gramicidin S and able to activate and polymerize the amino acids proline, valine, ornithine and leucine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341311 [Multi-domain] Cd Length: 479 Bit Score: 441.53 E-value: 5.09e-138
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1507 TPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFL 1586
Cdd:cd17656 1 TPDAVAVVFENQKLTYRELNERSNQLARFLREKGVKKDSIVAIMMERSAEMIVGILGILKAGGAFVPIDPEYPEERRIYI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1587 LEDSGTNILLLQSAGLHVPEFTGEIVYLNQTNsgLAHRL-SNPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLN 1665
Cdd:cd17656 81 MLDSGVRVVLTQRHLKSKLSFNKSTILLEDPS--ISQEDtSNIDYINNSDDLLYIIYTSGTTGKPKGVQLEHKNMVNLLH 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1666 SLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMhFVPSMLHAFLEHIK 1745
Cdd:cd17656 159 FEREKTNINFSDKVLQFATCSFDVCYQEIFSTLLSGGTLYIIREETKRDVEQLFDLVKRHNIEVV-FLPVAFLKFIFSER 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1746 YRSVPIKTNrLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFDCPPHEKLERIPIGKPVHHVRLYLLN 1825
Cdd:cd17656 238 EFINRFPTC-VKHIITAGEQLVITNEFKEMLHEHNVHLHNHYGPSETHVVTTYTINPEAEIPELPPIGKPISNTWIYILD 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1826 QNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIE 1905
Cdd:cd17656 317 QEQQLQPQGIVGELYISGASVARGYLNRQELTAEKFFPDPFDPNERMYRTGDLARYLPDGNIEFLGRADHQVKIRGYRIE 396
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1906 PGEIEAALRSIEGVREAAVTVRTDS-GEPELCAYVEGLQR---NEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRN 1981
Cdd:cd17656 397 LGEIEAQLLNHPGVSEAVVLDKADDkGEKYLCAYFVMEQElniSQLREYLAKQLPEYMIPSFFVPLDQLPLTPNGKVDRK 476
|
...
gi 1678550997 1982 ALP 1984
Cdd:cd17656 477 ALP 479
|
|
| A_NRPS_LgrA-like |
cd17645 |
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This ... |
1497-1984 |
1.37e-135 |
|
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes linear gramicidin synthetase (LgrA) in Brevibacillus brevis. LgrA has a formylation domain fused to the N-terminal end that formylates its substrate for linear gramicidin synthesis to proceed. This formyl group is essential for the clinically important antibacterial activity of gramicidin by enabling head-to-head gramicidin dimers to make a beta-helical pore in gram-positive bacterial membranes, allowing free passage of monovalent cations, destroying the ion gradient and killing bacteria. This family also includes bacitracin synthetase 1 (known as ATP-dependent cysteine adenylase or BA1); it activates cysteine, incorporates two D-amino acids, releases and cyclizes the mature bacitracin, an antibiotic that is a mixture of related cyclic peptides that disrupt gram positive bacteria by interfering with cell wall and peptidoglycan synthesis. Also included is surfactin synthetase which activates and polymerizes the amino acids Leu, Glu, Asp, and Val to form the antibiotic surfactin.
Pssm-ID: 341300 [Multi-domain] Cd Length: 440 Bit Score: 433.13 E-value: 1.37e-135
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1497 HYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDP 1576
Cdd:cd17645 1 HQLFEEQVERTPDHVAVVDRGQSLTYKQLNEKANQLARHLRGKGVKPDDQVGIMLDKSLDMIAAILGVLKAGGAYVPIDP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1577 DYPEERISFLLEDSGTNILLLQsaglhvpeftgeivylnqtnsglahrlsnpnvdvlPQSLAYVIYTSGSTGMPKGVEIE 1656
Cdd:cd17645 81 DYPGERIAYMLADSSAKILLTN-----------------------------------PDDLAYVIYTSGSTGLPKGVMIE 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1657 HRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITaMHFVPSM 1736
Cdd:cd17645 126 HHNLVNLCEWHRPYFGVTPADKSLVYASFSFDASAWEIFPHLTAGAALHVVPSERRLDLDALNDYFNQEGIT-ISFLPTG 204
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1737 L-HAFLEhikyrsvpIKTNRLKRVFSGGEQLgTHLVSRFYELLpnvsitNSYGPTEATVEAAFFdcPPHEKLERIPIGKP 1815
Cdd:cd17645 205 AaEQFMQ--------LDNQSLRVLLTGGDKL-KKIERKGYKLV------NNYGPTENTVVATSF--EIDKPYANIPIGKP 267
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1816 VHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYPGERMYKTGDVARWLPDGNVEFLGRTDD 1895
Cdd:cd17645 268 IDNTRVYILDEALQLQPIGVAGELCIAGEGLARGYLNRPELTAEKFIVHPFVPGERMYRTGDLAKFLPDGNIEFLGRLDQ 347
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1896 QVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS-GEPELCAYV---EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWP 1971
Cdd:cd17645 348 QVKIRGYRIEPGEIEPFLMNHPLIELAAVLAKEDAdGRKYLVAYVtapEEIPHEELREWLKNDLPDYMIPTYFVHLKALP 427
|
490
....*....|...
gi 1678550997 1972 VTPSGKLDRNALP 1984
Cdd:cd17645 428 LTANGKVDRKALP 440
|
|
| A_NRPS_Cytc1-like |
cd17643 |
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation ... |
2547-3019 |
8.20e-135 |
|
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Streptomyces sp. cytotrienin synthetase (CytC1), a relatively promiscuous adenylation enzyme that installs the aminoacyl moieties on the phosphopantetheinyl arm of the holo carrier protein CytC2. Also included are Streptomyces sp Thr1, involved in the biosynthesis of 4-chlorothreonine, Pseudomonas aeruginosa pyoverdine synthetase D (PvdD), involved in the biosynthesis of the siderophore pyoverdine and Pseudomonas syringae syringopeptin synthetase, where syringpeptin is a necrosis-inducing phytotoxin that functions as a virulence determinant in the plant-pathogen interaction. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341298 [Multi-domain] Cd Length: 450 Bit Score: 430.96 E-value: 8.20e-135
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2547 PKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYIL 2626
Cdd:cd17643 1 PEAVAVVDEDRRLTYGELDARANRLARTLRAEGVGPGDRVALALPRSAELIVALLAILKAGGAYVPIDPAYPVERIAFIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2627 SDSGTKLLMTineadlgvladfegeiltiesveeddksplpqmsSAHHLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRR 2706
Cdd:cd17643 81 ADSGPSLLLT----------------------------------DPDDLAYVIYTSGSTGRPKGVVVSHANVLALFAATQ 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2707 NAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDVVQ--P 2784
Cdd:cd17643 127 RWFGFNEDDVWTLFHSYAFDFSVWEIWGALLHGGRLVVVPYEVARSPEDFARLLRDEGVTVLNQTPSAFYQLVEAADrdG 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2785 EDVKTLRVVTLAGEAADRELIARSLA--ICPHTELANEYGPTENSVATTVMR----HMEKQAYVSIGQPIDGTQVLILNS 2858
Cdd:cd17643 207 RDPLALRYVIFGGEALEAAMLRPWAGrfGLDRPQLVNMYGITETTVHVTFRPldaaDLPAAAASPIGRPLPGLRVYVLDA 286
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2859 NHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKPE-ARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVE 2937
Cdd:cd17643 287 DGRPVPPGVVGELYVSGAGVARGYLGRPELTAERFVANPFGGPgSRMYRTGDLARRLPDGELEYLGRADEQVKIRGFRIE 366
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2938 TKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTN--AVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLD 3015
Cdd:cd17643 367 LGEIEAALATHPSVRDAAVIVREDEPGDTRLVAYVVADDGAAADiaELRALLKELLPDYMVPARYVPLDALPLTVNGKLD 446
|
....
gi 1678550997 3016 RGAL 3019
Cdd:cd17643 447 RAAL 450
|
|
| A_NRPS_LgrA-like |
cd17645 |
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This ... |
466-953 |
1.79e-134 |
|
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes linear gramicidin synthetase (LgrA) in Brevibacillus brevis. LgrA has a formylation domain fused to the N-terminal end that formylates its substrate for linear gramicidin synthesis to proceed. This formyl group is essential for the clinically important antibacterial activity of gramicidin by enabling head-to-head gramicidin dimers to make a beta-helical pore in gram-positive bacterial membranes, allowing free passage of monovalent cations, destroying the ion gradient and killing bacteria. This family also includes bacitracin synthetase 1 (known as ATP-dependent cysteine adenylase or BA1); it activates cysteine, incorporates two D-amino acids, releases and cyclizes the mature bacitracin, an antibiotic that is a mixture of related cyclic peptides that disrupt gram positive bacteria by interfering with cell wall and peptidoglycan synthesis. Also included is surfactin synthetase which activates and polymerizes the amino acids Leu, Glu, Asp, and Val to form the antibiotic surfactin.
Pssm-ID: 341300 [Multi-domain] Cd Length: 440 Bit Score: 429.67 E-value: 1.79e-134
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 466 HAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDP 545
Cdd:cd17645 1 HQLFEEQVERTPDHVAVVDRGQSLTYKQLNEKANQLARHLRGKGVKPDDQVGIMLDKSLDMIAAILGVLKAGGAYVPIDP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 546 HYPADRIRYILHDCGCSHVVSqahlpsslednyiithpedieskvdgsniksvnNADDLLYMIYTSGTTGKPKGVQFEHR 625
Cdd:cd17645 81 DYPGERIAYMLADSSAKILLT---------------------------------NPDDLAYVIYTSGSTGLPKGVMIEHH 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 626 NMANLLKFEYTHSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNIVFLPTAFIK 705
Cdd:cd17645 128 NLVNLCEWHRPYFGVTPADKSLVYASFSFDASAWEIFPHLTAGAALHVVPSERRLDLDALNDYFNQEGITISFLPTGAAE 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 706 MIFserELANSfpdGVKHLIAAGEQLmisdlfqDVLRKRGIHLHNHYGPSETHVVSTytIHPGDPIPELPPIGKPIGCTD 785
Cdd:cd17645 208 QFM---QLDNQ---SLRVLLTGGDKL-------KKIERKGYKLVNNYGPTENTVVAT--SFEIDKPYANIPIGKPIDNTR 272
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 786 LYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPDVIMYRTGDLARRLEDGNIEYIGRADNQVKIR 865
Cdd:cd17645 273 VYILDEALQLQPIGVAGELCIAGEGLARGYLNRPELTAEKFIVHPFVPGERMYRTGDLAKFLPDGNIEFLGRLDQQVKIR 352
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 866 GYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCSVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNG 945
Cdd:cd17645 353 GYRIEPGEIEPFLMNHPLIELAAVLAKEDADGRKYLVAYVTAPEEIPHEELREWLKNDLPDYMIPTYFVHLKALPLTANG 432
|
....*...
gi 1678550997 946 KVDRAALP 953
Cdd:cd17645 433 KVDRKALP 440
|
|
| A_NRPS_Ta1_like |
cd12116 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A ... |
477-952 |
1.95e-134 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A polyketide synthase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the myxovirescin (TA) antibiotic biosynthetic gene in Myxococcus xanthus; TA production plays a role in predation. It also includes the salinosporamide A polyketide synthase which is involved in the biosynthesis of salinosporamide A, a marine microbial metabolite whose chlorine atom is crucial for potent proteasome inhibition and anticancer activity.
Pssm-ID: 341281 [Multi-domain] Cd Length: 470 Bit Score: 430.94 E-value: 1.95e-134
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 477 PDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYIL 556
Cdd:cd12116 1 PDATAVRDDDRSLSYAELDERANRLAARLRARGVGPGDRVAVYLPRSARLVAAMLAVLKAGAAYVPLDPDYPADRLRYIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 557 HDCGCSHVVSQAHLPSSLEDNYIITHPEDIESKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRNMANLLkfeyt 636
Cdd:cd12116 81 EDAEPALVLTDDALPDRLPAGLPVLLLALAAAAAAPAAPRTPVSPDDLAYVIYTSGSTGRPKGVVVSHRNLVNFL----- 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 637 HS-----GIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNIVFLPTAFIKMIFSER 711
Cdd:cd12116 156 HSmrerlGLGPGDRLLAVTTYAFDISLLELLLPLLAGARVVIAPRETQRDPEALARLIEAHSITVMQATPATWRMLLDAG 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 712 ELANsfpDGVkHLIAAGEQLmISDLFQDVLRkRGIHLHNHYGPSETHVVStyTIHPGDPIPELPPIGKPIGCTDLYILNH 791
Cdd:cd12116 236 WQGR---AGL-TALCGGEAL-PPDLAARLLS-RVGSLWNLYGPTETTIWS--TAARVTAAAGPIPIGRPLANTQVYVLDA 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 792 QKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFK-PDVIMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIE 870
Cdd:cd12116 308 ALRPVPPGVPGELYIGGDGVAQGYLGRPALTAERFVPDPFAgPGSRLYRTGDLVRRRADGRLEYLGRADGQVKIRGHRIE 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 871 PQEIEVTLMNHPDISEAAILIWQDQNGEHeLCAYY--CSVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVD 948
Cdd:cd12116 388 LGEIEAALAAHPGVAQAAVVVREDGGDRR-LVAYVvlKAGAAPDAAALRAHLRATLPAYMVPSAFVRLDALPLTANGKLD 466
|
....
gi 1678550997 949 RAAL 952
Cdd:cd12116 467 RKAL 470
|
|
| A_NRPS_LgrA-like |
cd17645 |
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This ... |
2537-3020 |
7.18e-134 |
|
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes linear gramicidin synthetase (LgrA) in Brevibacillus brevis. LgrA has a formylation domain fused to the N-terminal end that formylates its substrate for linear gramicidin synthesis to proceed. This formyl group is essential for the clinically important antibacterial activity of gramicidin by enabling head-to-head gramicidin dimers to make a beta-helical pore in gram-positive bacterial membranes, allowing free passage of monovalent cations, destroying the ion gradient and killing bacteria. This family also includes bacitracin synthetase 1 (known as ATP-dependent cysteine adenylase or BA1); it activates cysteine, incorporates two D-amino acids, releases and cyclizes the mature bacitracin, an antibiotic that is a mixture of related cyclic peptides that disrupt gram positive bacteria by interfering with cell wall and peptidoglycan synthesis. Also included is surfactin synthetase which activates and polymerizes the amino acids Leu, Glu, Asp, and Val to form the antibiotic surfactin.
Pssm-ID: 341300 [Multi-domain] Cd Length: 440 Bit Score: 428.13 E-value: 7.18e-134
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2537 QLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPE 2616
Cdd:cd17645 2 QLFEEQVERTPDHVAVVDRGQSLTYKQLNEKANQLARHLRGKGVKPDDQVGIMLDKSLDMIAAILGVLKAGGAYVPIDPD 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2617 YPKERKRYILSDSGTKLLMTineadlgvladfegeiltiesveeddksplpqmsSAHHLAYIIYTSGTTGRPKGVMVEHK 2696
Cdd:cd17645 82 YPGERIAYMLADSSAKILLT----------------------------------NPDDLAYVIYTSGSTGLPKGVMIEHH 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2697 GIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAikhqLSRQRITHMIIVPVLYR 2776
Cdd:cd17645 128 NLVNLCEWHRPYFGVTPADKSLVYASFSFDASAWEIFPHLTAGAALHVVPSERRLDLDA----LNDYFNQEGITISFLPT 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2777 ALLDVVQPEDVKTLRVVTLAGEAADRelIARSlaicPHTeLANEYGPTENSVATTVMRHMEKQAYVSIGQPIDGTQVLIL 2856
Cdd:cd17645 204 GAAEQFMQLDNQSLRVLLTGGDKLKK--IERK----GYK-LVNNYGPTENTVVATSFEIDKPYANIPIGKPIDNTRVYIL 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2857 NSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRV 2936
Cdd:cd17645 277 DEALQLQPIGVAGELCIAGEGLARGYLNRPELTAEKFIVHPFVPGERMYRTGDLAKFLPDGNIEFLGRLDQQVKIRGYRI 356
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2937 ETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDR 3016
Cdd:cd17645 357 EPGEIEPFLMNHPLIELAAVLAKEDADGRKYLVAYVTAPEEIPHEELREWLKNDLPDYMIPTYFVHLKALPLTANGKVDR 436
|
....
gi 1678550997 3017 GALP 3020
Cdd:cd17645 437 KALP 440
|
|
| A_NRPS_Sfm_like |
cd12115 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene ... |
465-952 |
1.52e-133 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene cluster from Streptomyces lavendulae; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the saframycin A gene cluster from Streptomyces lavendulae which implicates the NRPS system for assembling the unusual tetrapeptidyl skeleton in an iterative manner. It also includes saframycin Mx1 produced by Myxococcus xanthus NRPS.
Pssm-ID: 341280 [Multi-domain] Cd Length: 447 Bit Score: 427.50 E-value: 1.52e-133
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 465 IHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVD 544
Cdd:cd12115 1 LHDLVEAQAARTPDAIALVCGDESLTYAELNRRANRLAARLRAAGVGPESRVGVCLERTPDLVVALLAVLKAGAAYVPLD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 545 PHYPADRIRYILHDCGCSHVVSQAhlpsslednyiithpedieskvdgsniksvnnaDDLLYMIYTSGTTGKPKGVQFEH 624
Cdd:cd12115 81 PAYPPERLRFILEDAQARLVLTDP---------------------------------DDLAYVIYTSGSTGRPKGVAIEH 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 625 RNMANLLKFEYTHSGIDFEADVLQfATP-SFDVCYQEIFSALLKGGTLHIVpeaikRDVPQLFAF-INKHQTNIVFLPTA 702
Cdd:cd12115 128 RNAAAFLQWAAAAFSAEELAGVLA-STSiCFDLSVFELFGPLATGGKVVLA-----DNVLALPDLpAAAEVTLINTVPSA 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 703 FikmifseREL--ANSFPDGVKHLIAAGEQLMiSDLFQDVLRK-RGIHLHNHYGPSETHVVSTYT-IHPGDPipELPPIG 778
Cdd:cd12115 202 A-------AELlrHDALPASVRVVNLAGEPLP-RDLVQRLYARlQVERVVNLYGPSEDTTYSTVApVPPGAS--GEVSIG 271
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 779 KPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPDVIMYRTGDLARRLEDGNIEYIGRA 858
Cdd:cd12115 272 RPLANTQAYVLDRALQPVPLGVPGELYIGGAGVARGYLGRPGLTAERFLPDPFGPGARLYRTGDLVRWRPDGLLEFLGRA 351
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 859 DNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCS--VQKLNTIDLRSYMASELPEYMIPAKWIWV 936
Cdd:cd12115 352 DNQVKVRGFRIELGEIEAALRSIPGVREAVVVAIGDAAGERRLVAYIVAepGAAGLVEDLRRHLGTRLPAYMVPSRFVRL 431
|
490
....*....|....*.
gi 1678550997 937 DSIPLTPNGKVDRAAL 952
Cdd:cd12115 432 DALPLTPNGKIDRSAL 447
|
|
| A_NRPS_ApnA-like |
cd17644 |
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the ... |
2534-3020 |
1.61e-133 |
|
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Planktothrix agardhii anabaenopeptin synthetase (ApnA A1), which is capable of activating two chemically distinct amino acids (Arg and Tyr). Structural studies show that the architecture of the active site forces Arg to adopt a Tyr-like conformation, thus explaining the bispecificity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341299 [Multi-domain] Cd Length: 465 Bit Score: 428.01 E-value: 1.61e-133
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2534 TISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPI 2613
Cdd:cd17644 1 CIHQLFEEQVERTPDAVAVVFEDQQLTYEELNTKANQLAHYLQSLGVKSESLVGICVERSLEMIIGLLAILKAGGAYVPL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2614 DPEYPKERKRYILSDSGTKLLMTineadlgvladfegeiltiesveeddksplpqmsSAHHLAYIIYTSGTTGRPKGVMV 2693
Cdd:cd17644 81 DPNYPQERLTYILEDAQISVLLT----------------------------------QPENLAYVIYTSGSTGKPKGVMI 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2694 EHKGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPV 2773
Cdd:cd17644 127 EHQSLVNLSHGLIKEYGITSSDRVLQFASIAFDVAAEEIYVTLLSGATLVLRPEEMRSSLEDFVQYIQQWQLTVLSLPPA 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2774 LYRALLDVVQPED---VKTLRVVTLAGEAADRELIAR-SLAICPHTELANEYGPTENSVATTVMR----HMEKQAYVSIG 2845
Cdd:cd17644 207 YWHLLVLELLLSTidlPSSLRLVIVGGEAVQPELVRQwQKNVGNFIQLINVYGPTEATIAATVCRltqlTERNITSVPIG 286
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2846 QPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPF--KPEARMYRTGDAARWMADGTLEYLG 2923
Cdd:cd17644 287 RPIANTQVYILDENLQPVPVGVPGELHIGGVGLARGYLNRPELTAEKFISHPFnsSESERLYKTGDLARYLPDGNIEYLG 366
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2924 RIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTK--PGLSTNAVRSELQNKLPVFMHPAFIE 3001
Cdd:cd17644 367 RIDNQVKIRGFRIELGEIEAVLSQHNDVKTAVVIVREDQPGNKRLVAYIVPHyeESPSTVELRQFLKAKLPDYMIPSAFV 446
|
490
....*....|....*....
gi 1678550997 3002 KLDSLPLSPNGKLDRGALP 3020
Cdd:cd17644 447 VLEELPLTPNGKIDRRALP 465
|
|
| A_NRPS_PvdJ-like |
cd17649 |
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal ... |
2547-3020 |
4.50e-133 |
|
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes pyoverdine biosynthesis protein PvdJ involved in the synthesis of pyoverdine, which consists of a chromophore group attached to a variable peptide chain and comprises around 6-12 amino acids that are specific for each Pseudomonas species, and for which the peptide might be first synthesized before the chromophore assembly. Also included is ornibactin biosynthesis protein OrbI; ornibactin is a tetrapeptide siderophore with an l-ornithine-d-hydroxyaspartate-l-serine-l-ornithine backbone. The adenylation domain at the N-terminal of OrbI possibly initiates the ornibactin with the binding of N5-hydroxyornithine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341304 [Multi-domain] Cd Length: 450 Bit Score: 426.01 E-value: 4.50e-133
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2547 PKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYIL 2626
Cdd:cd17649 1 PDAVALVFGDQSLSYAELDARANRLAHRLRALGVGPEVRVGIALERSLEMVVALLAILKAGGAYVPLDPEYPAERLRYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2627 SDSGTKLLMTineadlgvladfegeiltiesveeddksplpqmssaHH---LAYIIYTSGTTGRPKGVMVEHKGIANTLQ 2703
Cdd:cd17649 81 EDSGAGLLLT------------------------------------HHprqLAYVIYTSGSTGTPKGVAVSHGPLAAHCQ 124
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2704 WRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDV-- 2781
Cdd:cd17649 125 ATAERYGLTPGDRELQFASFNFDGAHEQLLPPLICGACVVLRPDELWASADELAEMVRELGVTVLDLPPAYLQQLAEEad 204
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2782 -VQPEDVKTLRVVTLAGEAADRELIARSLAIcpHTELANEYGPTENSVATTVM----RHMEKQAYVSIGQPIDGTQVLIL 2856
Cdd:cd17649 205 rTGDGRPPSLRLYIFGGEALSPELLRRWLKA--PVRLFNAYGPTEATVTPLVWkceaGAARAGASMPIGRPLGGRSAYIL 282
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2857 NSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPF-KPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYR 2935
Cdd:cd17649 283 DADLNPVPVGVTGELYIGGEGLARGYLGRPELTAERFVPDPFgAPGSRLYRTGDLARWRDDGVIEYLGRVDHQVKIRGFR 362
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2936 VETKEIESVIRCIKGVKDAAVVAhVTASGQTELSAYVVTKPGLSTNA----VRSELQNKLPVFMHPAFIEKLDSLPLSPN 3011
Cdd:cd17649 363 IELGEIEAALLEHPGVREAAVVA-LDGAGGKQLVAYVVLRAAAAQPElraqLRTALRASLPDYMVPAHLVFLARLPLTPN 441
|
....*....
gi 1678550997 3012 GKLDRGALP 3020
Cdd:cd17649 442 GKLDRKALP 450
|
|
| A_NRPS_ProA |
cd17656 |
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the ... |
2546-3020 |
1.80e-132 |
|
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains gramicidin S synthase 2 (also known as ATP-dependent proline adenylase or proline activase or ProA). ProA is a multifunctional enzyme involved in synthesis of the cyclic peptide antibiotic gramicidin S and able to activate and polymerize the amino acids proline, valine, ornithine and leucine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341311 [Multi-domain] Cd Length: 479 Bit Score: 425.73 E-value: 1.80e-132
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2546 TPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYI 2625
Cdd:cd17656 1 TPDAVAVVFENQKLTYRELNERSNQLARFLREKGVKKDSIVAIMMERSAEMIVGILGILKAGGAFVPIDPEYPEERRIYI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2626 LSDSGTKLLMTINEadLGVLADFEGEILTIE--SVEEDDKSPLPQMSSAHHLAYIIYTSGTTGRPKGVMVEHKGIANTLQ 2703
Cdd:cd17656 81 MLDSGVRVVLTQRH--LKSKLSFNKSTILLEdpSISQEDTSNIDYINNSDDLLYIIYTSGTTGKPKGVQLEHKNMVNLLH 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2704 WRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDVVQ 2783
Cdd:cd17656 159 FEREKTNINFSDKVLQFATCSFDVCYQEIFSTLLSGGTLYIIREETKRDVEQLFDLVKRHNIEVVFLPVAFLKFIFSERE 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2784 -----PEDVKTLrvvTLAGEAADRELIARSLAICPHTELANEYGPTENSVATTVMRH--MEKQAYVSIGQPIDGTQVLIL 2856
Cdd:cd17656 239 finrfPTCVKHI---ITAGEQLVITNEFKEMLHEHNVHLHNHYGPSETHVVTTYTINpeAEIPELPPIGKPISNTWIYIL 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2857 NSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRV 2936
Cdd:cd17656 316 DQEQQLQPQGIVGELYISGASVARGYLNRQELTAEKFFPDPFDPNERMYRTGDLARYLPDGNIEFLGRADHQVKIRGYRI 395
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2937 ETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDR 3016
Cdd:cd17656 396 ELGEIEAQLLNHPGVSEAVVLDKADDKGEKYLCAYFVMEQELNISQLREYLAKQLPEYMIPSFFVPLDQLPLTPNGKVDR 475
|
....
gi 1678550997 3017 GALP 3020
Cdd:cd17656 476 KALP 479
|
|
| A_NRPS_ApnA-like |
cd17644 |
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the ... |
464-953 |
2.69e-132 |
|
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Planktothrix agardhii anabaenopeptin synthetase (ApnA A1), which is capable of activating two chemically distinct amino acids (Arg and Tyr). Structural studies show that the architecture of the active site forces Arg to adopt a Tyr-like conformation, thus explaining the bispecificity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341299 [Multi-domain] Cd Length: 465 Bit Score: 424.54 E-value: 2.69e-132
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 464 TIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPV 543
Cdd:cd17644 1 CIHQLFEEQVERTPDAVAVVFEDQQLTYEELNTKANQLAHYLQSLGVKSESLVGICVERSLEMIIGLLAILKAGGAYVPL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 544 DPHYPADRIRYILHDCGCSHVVSQAHlpsslednyiithpedieskvdgsniksvnnadDLLYMIYTSGTTGKPKGVQFE 623
Cdd:cd17644 81 DPNYPQERLTYILEDAQISVLLTQPE---------------------------------NLAYVIYTSGSTGKPKGVMIE 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 624 HRNMANLLKFEYTHSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNIVFLPTAF 703
Cdd:cd17644 128 HQSLVNLSHGLIKEYGITSSDRVLQFASIAFDVAAEEIYVTLLSGATLVLRPEEMRSSLEDFVQYIQQWQLTVLSLPPAY 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 704 IKMIFSERELAN-SFPDGVKHLIAAGEQLMIS--DLFQDVLRKRgIHLHNHYGPSETHVVSTYTiHPGDPIPEL---PPI 777
Cdd:cd17644 208 WHLLVLELLLSTiDLPSSLRLVIVGGEAVQPElvRQWQKNVGNF-IQLINVYGPTEATIAATVC-RLTQLTERNitsVPI 285
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 778 GKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPF--KPDVIMYRTGDLARRLEDGNIEYI 855
Cdd:cd17644 286 GRPIANTQVYILDENLQPVPVGVPGELHIGGVGLARGYLNRPELTAEKFISHPFnsSESERLYKTGDLARYLPDGNIEYL 365
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 856 GRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYC--SVQKLNTIDLRSYMASELPEYMIPAKW 933
Cdd:cd17644 366 GRIDNQVKIRGFRIELGEIEAVLSQHNDVKTAVVIVREDQPGNKRLVAYIVphYEESPSTVELRQFLKAKLPDYMIPSAF 445
|
490 500
....*....|....*....|
gi 1678550997 934 IWVDSIPLTPNGKVDRAALP 953
Cdd:cd17644 446 VVLEELPLTPNGKIDRRALP 465
|
|
| A_NRPS_PpsD_like |
cd17650 |
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation ... |
477-952 |
2.87e-132 |
|
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetase 1 (BacA) in Bacillus licheniformis, tyrocidine synthetase in Brevibacillus brevis, plipastatin synthase (PpsD, an important antifungal protein) in Bacillus subtilis and mannopeptimycin peptide synthetase (MppB) in Streptomyces hygroscopicus. Plipastatin has strong fungitoxic activity and is involved in inhibition of phospholipase A2 and biofilm formation. Bacitracin, a mixture of related cyclic peptides, is used as a polypeptide antibiotic while function of tyrocidine is thought to be regulation of sporulation. MppB is involved in biosynthetic pathway of mannopeptimycin, a novel class of mannosylated lipoglycopeptides. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341305 [Multi-domain] Cd Length: 447 Bit Score: 423.80 E-value: 2.87e-132
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 477 PDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYIL 556
Cdd:cd17650 1 PDAIAVSDATRQLTYRELNERANQLARTLRGLGVAPGSVVGVCADRSLDAIVGLLAVLKAGGAYVPIDPDYPAERLQYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 557 HDCGCSHVVSQahlpsslednyiithpedieskvdgsniksvnnADDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEYT 636
Cdd:cd17650 81 EDSGAKLLLTQ---------------------------------PEDLAYVIYTSGTTGKPKGVMVEHRNVAHAAHAWRR 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 637 HSGID-FEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNI-VFLPTAFIK-MIFSEREL 713
Cdd:cd17650 128 EYELDsFPVRLLQMASFSFDVFAGDFARSLLNGGTLVICPDEVKLDPAALYDLILKSRITLmESTPALIRPvMAYVYRNG 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 714 ANsfPDGVKHLIAAGEQLMISDlFQDVLRKRGIHLH--NHYGPSETHVVSTYTIHPGDPIPE--LPPIGKPIGCTDLYIL 789
Cdd:cd17650 208 LD--LSAMRLLIVGSDGCKAQD-FKTLAARFGQGMRiiNSYGVTEATIDSTYYEEGRDPLGDsaNVPIGRPLPNTAMYVL 284
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 790 NHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPDVIMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRI 869
Cdd:cd17650 285 DERLQPQPVGVAGELYIGGAGVARGYLNRPELTAERFVENPFAPGERMYRTGDLARWRADGNVELLGRVDHQVKIRGFRI 364
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 870 EPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCSVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDR 949
Cdd:cd17650 365 ELGEIESQLARHPAIDEAVVAVREDKGGEARLCAYVVAAATLNTAELRAFLAKELPSYMIPSYYVQLDALPLTPNGKVDR 444
|
...
gi 1678550997 950 AAL 952
Cdd:cd17650 445 RAL 447
|
|
| A_NRPS_PpsD_like |
cd17650 |
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation ... |
2547-3019 |
8.86e-132 |
|
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetase 1 (BacA) in Bacillus licheniformis, tyrocidine synthetase in Brevibacillus brevis, plipastatin synthase (PpsD, an important antifungal protein) in Bacillus subtilis and mannopeptimycin peptide synthetase (MppB) in Streptomyces hygroscopicus. Plipastatin has strong fungitoxic activity and is involved in inhibition of phospholipase A2 and biofilm formation. Bacitracin, a mixture of related cyclic peptides, is used as a polypeptide antibiotic while function of tyrocidine is thought to be regulation of sporulation. MppB is involved in biosynthetic pathway of mannopeptimycin, a novel class of mannosylated lipoglycopeptides. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341305 [Multi-domain] Cd Length: 447 Bit Score: 422.26 E-value: 8.86e-132
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2547 PKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYIL 2626
Cdd:cd17650 1 PDAIAVSDATRQLTYRELNERANQLARTLRGLGVAPGSVVGVCADRSLDAIVGLLAVLKAGGAYVPIDPDYPAERLQYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2627 SDSGTKLLMTineadlgvladfegeiltiesvEEDDksplpqmssahhLAYIIYTSGTTGRPKGVMVEHKGIANT-LQWR 2705
Cdd:cd17650 81 EDSGAKLLLT----------------------QPED------------LAYVIYTSGTTGKPKGVMVEHRNVAHAaHAWR 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2706 RNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDVV--- 2782
Cdd:cd17650 127 REYELDSFPVRLLQMASFSFDVFAGDFARSLLNGGTLVICPDEVKLDPAALYDLILKSRITLMESTPALIRPVMAYVyrn 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2783 --QPEDVKTLRVVTLAGEAAD-RELIARSLAicpHTELANEYGPTENSVATTV----MRHMEKQAYVSIGQPIDGTQVLI 2855
Cdd:cd17650 207 glDLSAMRLLIVGSDGCKAQDfKTLAARFGQ---GMRIINSYGVTEATIDSTYyeegRDPLGDSANVPIGRPLPNTAMYV 283
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2856 LNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYR 2935
Cdd:cd17650 284 LDERLQPQPVGVAGELYIGGAGVARGYLNRPELTAERFVENPFAPGERMYRTGDLARWRADGNVELLGRVDHQVKIRGFR 363
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2936 VETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLD 3015
Cdd:cd17650 364 IELGEIESQLARHPAIDEAVVAVREDKGGEARLCAYVVAAATLNTAELRAFLAKELPSYMIPSYYVQLDALPLTPNGKVD 443
|
....
gi 1678550997 3016 RGAL 3019
Cdd:cd17650 444 RRAL 447
|
|
| A_NRPS_SidN3_like |
cd05918 |
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); ... |
2535-3019 |
1.47e-131 |
|
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family of siderophore-synthesizing NRPS includes the third adenylation domain of SidN from the endophytic fungus Neotyphodium lolii, ferrichrome siderophore synthetase, HC-toxin synthetase, and enniatin synthase. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341242 [Multi-domain] Cd Length: 481 Bit Score: 423.11 E-value: 1.47e-131
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2535 ISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPID 2614
Cdd:cd05918 1 VHDLIEERARSQPDAPAVCAWDGSLTYAELDRLSSRLAHHLRSLGVGPGVFVPLCFEKSKWAVVAMLAVLKAGGAFVPLD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2615 PEYPKERKRYILSDSGTKLLMTineadlgvladfegeiltiesveeddksplpqmSSAHHLAYIIYTSGTTGRPKGVMVE 2694
Cdd:cd05918 81 PSHPLQRLQEILQDTGAKVVLT---------------------------------SSPSDAAYVIFTSGSTGKPKGVVIE 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2695 HKGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAikHQLSRQRITHMIIVPvl 2774
Cdd:cd05918 128 HRALSTSALAHGRALGLTSESRVLQFASYTFDVSILEIFTTLAAGGCLCIPSEEDRLNDLA--GFINRLRVTWAFLTP-- 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2775 yrALLDVVQPEDVKTLRVVTLAGEAADRELIARslaICPHTELANEYGPTENSVATTVMRHMEKQAYVSIGQPIDGTQ-V 2853
Cdd:cd05918 204 --SVARLLDPEDVPSLRTLVLGGEALTQSDVDT---WADRVRLINAYGPAECTIAATVSPVVPSTDPRNIGRPLGATCwV 278
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2854 LILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNP-------FKPEARMYRTGDAARWMADGTLEYLGRID 2926
Cdd:cd05918 279 VDPDNHDRLVPIGAVGELLIEGPILARGYLNDPEKTAAAFIEDPawlkqegSGRGRRLYRTGDLVRYNPDGSLEYVGRKD 358
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2927 DQVKIRGYRVETKEIESVIR-CIKGVKD--AAVVAHVTASGQTELSAYVVTKPGLSTN-------------------AVR 2984
Cdd:cd05918 359 TQVKIRGQRVELGEIEHHLRqSLPGAKEvvVEVVKPKDGSSSPQLVAFVVLDGSSSGSgdgdslflepsdefralvaELR 438
|
490 500 510
....*....|....*....|....*....|....*
gi 1678550997 2985 SELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:cd05918 439 SKLRQRLPSYMVPSVFLPLSHLPLTASGKIDRRAL 473
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
12-1042 |
1.99e-131 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 449.49 E-value: 1.99e-131
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 12 PLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNvSSPQQVVlrERNVIVLEE 91
Cdd:PRK10252 9 PLVAAQPGIWMAEKLSPLPSAWSVAHYVELTGELDAPLLARAVVAGLAEADTLRMRFTEDN-GEVWQWV--DPALTFPLP 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 92 DITHLNEAEQSQFIEQ-WKEKDRDRGFHL-QKDVLMRIALIQTGESQYscIW--TFHHIMMDGWCLSIVLKEFLHIYASY 167
Cdd:PRK10252 86 EIIDLRTQPDPHAAAQaLMQADLQQDLRVdSGKPLVFHQLIQLGDNRW--YWyqRYHHLLVDGFSFPAITRRIAAIYCAW 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 168 VNASPITLEPVQPYG----KYIKWLMEQDKEQAVSYWdhylsgHEQQTVLPK-----QKKTKGKSRQEH---VTFSFSKE 235
Cdd:PRK10252 164 LRGEPTPASPFTPFAdvveEYQRYRASEAWQRDAAFW------AEQRRQLPPpaslsPAPLPGRSASADilrLKLEFTDG 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 236 ESSRLseLAAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGR--------PAeiegiehMVglfINTMPVRVQGAK 307
Cdd:PRK10252 238 AFRQL--AAQASGVQRPDLALALVALWLGRLCGRMDYAAGFIFMRRlgsaaltaTG-------PV---LNVLPLRVHIAA 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 308 TpflQLIKDMQKdRLAAEAYSY--HPLYEIQ------SRSAVKQ---GLIDHILVFENYPVQQEIQMlnkqehasdlfQI 376
Cdd:PRK10252 306 Q---ETLPELAT-RLAAQLKKMrrHQRYDAEqivrdsGRAAGDEplfGPVLNIKVFDYQLDFPGVQA-----------QT 370
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 377 HNFTVADETNYSFYLMVAPGEEIHIKMNYDAEQHDRSFVLSVKEHLLNAVSQILNNPNLPPEEIDITTDTEKRQLI-GEI 455
Cdd:PRK10252 371 HTLATGPVNDLELALFPDEHGGLSIEILANPQRYDEATLIAHAERLKALIAQFAADPALLCGDVDILLPGEYAQLAqVNA 450
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 456 TDQTPVYETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILK 535
Cdd:PRK10252 451 TAVEIPETTLSALVAQQAAKTPDAPALADARYQFSYREMREQVVALANLLRERGVKPGDSVAVALPRSVFLTLALHAIVE 530
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 536 AGGAIVPVDPHYPADRIRYILHDCGCSHVVSQAHLPSSLEDNYIITHPE-DIESKVDGSNIKSVNNADDLLYMIYTSGTT 614
Cdd:PRK10252 531 AGAAWLPLDTGYPDDRLKMMLEDARPSLLITTADQLPRFADVPDLTSLCyNAPLAPQGAAPLQLSQPHHTAYIIFTSGST 610
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 615 GKPKGVQFEHRNMANLLKFEYTHSGIDFEADVLQfATP-SFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQ 693
Cdd:PRK10252 611 GRPKGVMVGQTAIVNRLLWMQNHYPLTADDVVLQ-KTPcSFDVSVWEFFWPFIAGAKLVMAEPEAHRDPLAMQQFFAEYG 689
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 694 -TNIVFLPT---AFIKMIFSERelANSFPDGVKHLIAAGEQLMIS--DLFQdvlRKRGIHLHNHYGPSETHV-VSTY--- 763
Cdd:PRK10252 690 vTTTHFVPSmlaAFVASLTPEG--ARQSCASLRQVFCSGEALPADlcREWQ---QLTGAPLHNLYGPTEAAVdVSWYpaf 764
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 764 ----TIHPGDPIPelppIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPDVIMYR 839
Cdd:PRK10252 765 geelAAVRGSSVP----IGYPVWNTGLRILDARMRPVPPGVAGDLYLTGIQLAQGYLGRPDLTASRFIADPFAPGERMYR 840
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 840 TGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEA---AILIWQDQ---NGEHELCAYYCSVQ--KL 911
Cdd:PRK10252 841 TGDVARWLDDGAVEYLGRSDDQLKIRGQRIELGEIDRAMQALPDVEQAvthACVINQAAatgGDARQLVGYLVSQSglPL 920
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 912 NTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPEPDaSISGNPYTAPRNLLEAKLSQLFEDVLKNGHIGIQ 991
Cdd:PRK10252 921 DTSALQAQLRERLPPHMVPVVLLQLDQLPLSANGKLDRKALPLPE-LKAQVPGRAPKTGTETIIAAAFSSLLGCDVVDAD 999
|
1050 1060 1070 1080 1090
....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 992 DNFFDNGGHSLKATVLMSRIAKEFHVQVSLKDIFAHPTVEGLALIIREAEQ 1042
Cdd:PRK10252 1000 ADFFALGGHSLLAMKLAAQLSRQFARQVTPGQVMVASTVAKLATLLDAEED 1050
|
|
| A_NRPS_TlmIV_like |
cd12114 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including ... |
1508-1983 |
2.49e-130 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Streptoalloteichus tallysomycin biosynthesis genes; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the TLM biosynthetic gene cluster from Streptoalloteichus that consists of nine NRPS genes; the N-terminal module of TlmVI (NRPS-5) and the starter module of BlmVI (NRPS-5) are comprised of the acyl CoA ligase (AL) and acyl carrier protein (ACP)-like domains, which are thought to be involved in the biosynthesis of the beta-aminoalaninamide moiety.
Pssm-ID: 341279 [Multi-domain] Cd Length: 477 Bit Score: 419.37 E-value: 2.49e-130
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1508 PDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLL 1587
Cdd:cd12114 1 PDATAVICGDGTLTYGELAERARRVAGALKAAGVRPGDLVAVTLPKGPEQVVAVLGILAAGAAYVPVDIDQPAARREAIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1588 EDSGTNILLLQsaglHVPEFTGEIVYLNQTNSGLAHRLS--NPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLN 1665
Cdd:cd12114 81 ADAGARLVLTD----GPDAQLDVAVFDVLILDLDALAAPapPPPVDVAPDDLAYVIFTSGSTGTPKGVMISHRAALNTIL 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1666 SLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHik 1745
Cdd:cd12114 157 DINRRFAVGPDDRVLALSSLSFDLSVYDIFGALSAGATLVLPDEARRRDPAHWAELIERHGVTLWNSVPALLEMLLDV-- 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1746 YRSVPIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFDC-PPHEKLERIPIGKPVHHVRLYLL 1824
Cdd:cd12114 235 LEAAQALLPSLRLVLLSGDWIPLDLPARLRALAPDARLISLGGATEASIWSIYHPIdEVPPDWRSIPYGRPLANQRYRVL 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1825 NQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPfyPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRI 1904
Cdd:cd12114 315 DPRGRDCPDWVPGELWIGGRGVALGYLGDPELTAARFVTHP--DGERLYRTGDLGRYRPDGTLEFLGRRDGQVKVRGYRI 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1905 EPGEIEAALRSIEGVREAAVTVRTDSGEPELCAYVE------GLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKL 1978
Cdd:cd12114 393 ELGEIEAALQAHPGVARAVVVVLGDPGGKRLAAFVVpdndgtPIAPDALRAFLAQTLPAYMIPSRVIALEALPLTANGKV 472
|
....*
gi 1678550997 1979 DRNAL 1983
Cdd:cd12114 473 DRAAL 477
|
|
| A_NRPS_Cytc1-like |
cd17643 |
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation ... |
477-952 |
4.02e-129 |
|
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Streptomyces sp. cytotrienin synthetase (CytC1), a relatively promiscuous adenylation enzyme that installs the aminoacyl moieties on the phosphopantetheinyl arm of the holo carrier protein CytC2. Also included are Streptomyces sp Thr1, involved in the biosynthesis of 4-chlorothreonine, Pseudomonas aeruginosa pyoverdine synthetase D (PvdD), involved in the biosynthesis of the siderophore pyoverdine and Pseudomonas syringae syringopeptin synthetase, where syringpeptin is a necrosis-inducing phytotoxin that functions as a virulence determinant in the plant-pathogen interaction. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341298 [Multi-domain] Cd Length: 450 Bit Score: 414.78 E-value: 4.02e-129
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 477 PDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYIL 556
Cdd:cd17643 1 PEAVAVVDEDRRLTYGELDARANRLARTLRAEGVGPGDRVALALPRSAELIVALLAILKAGGAYVPIDPAYPVERIAFIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 557 HDCGcshvvsqahlPSSLednyiithpedieskvdgsniksVNNADDLLYMIYTSGTTGKPKGVQFEHRNMANLlkFEYT 636
Cdd:cd17643 81 ADSG----------PSLL-----------------------LTDPDDLAYVIYTSGSTGRPKGVVVSHANVLAL--FAAT 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 637 HSGIDFEAD--VLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDvPQLFAFINKHQTNIVF--LPTAFIKMIFSERE 712
Cdd:cd17643 126 QRWFGFNEDdvWTLFHSYAFDFSVWEIWGALLHGGRLVVVPYEVARS-PEDFARLLRDEGVTVLnqTPSAFYQLVEAADR 204
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 713 lANSFPDGVKHLIAAGEQL---MISDLFQDVLRKRGiHLHNHYGPSETHVVSTYtiHPGDPiPELP-----PIGKPIGCT 784
Cdd:cd17643 205 -DGRDPLALRYVIFGGEALeaaMLRPWAGRFGLDRP-QLVNMYGITETTVHVTF--RPLDA-ADLPaaaasPIGRPLPGL 279
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 785 DLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFK-PDVIMYRTGDLARRLEDGNIEYIGRADNQVK 863
Cdd:cd17643 280 RVYVLDADGRPVPPGVVGELYVSGAGVARGYLGRPELTAERFVANPFGgPGSRMYRTGDLARRLPDGELEYLGRADEQVK 359
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 864 IRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYC--SVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPL 941
Cdd:cd17643 360 IRGFRIELGEIEAALATHPSVRDAAVIVREDEPGDTRLVAYVVadDGAAADIAELRALLKELLPDYMVPARYVPLDALPL 439
|
490
....*....|.
gi 1678550997 942 TPNGKVDRAAL 952
Cdd:cd17643 440 TVNGKLDRAAL 450
|
|
| A_NRPS_ACVS-like |
cd17648 |
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV ... |
1508-1984 |
2.81e-128 |
|
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV synthetase (ACVS, EC 6.3.2.26; also known as N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase or delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase) is involved in medically important antibiotic biosynthesis. ACV synthetase is active in an early step in the penicillin G biosynthesis pathway which involves the formation of the tripeptide 6-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine (ACV); each of the constituent amino acids of the tripeptide ACV are activated as aminoacyl-adenylates with peptide bonds formed through the participation of amino acid thioester intermediates. ACV is then cyclized by the action of isopenicillin N synthase.
Pssm-ID: 341303 [Multi-domain] Cd Length: 453 Bit Score: 412.56 E-value: 2.81e-128
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1508 PDQAAVIFEDGVMTYKELNEQANRIAWELIGRG-VKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFL 1586
Cdd:cd17648 1 PDRVAVVYGDKRLTYRELNERANRLAHYLLSVAeIRPDDLVGLVLDKSELMIIAILAVWKAGAAYVPIDPSYPDERIQFI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1587 LEDSGTNILLlqsaglhvpeftgeivylnqTNsglahrlsnpnvdvlPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNS 1666
Cdd:cd17648 81 LEDTGARVVI--------------------TN---------------STDLAYAIYTSGTTGKPKGVLVEHGSVVNLRTS 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1667 LQSRYQLKHSD--MIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPSMLhaflEHI 1744
Cdd:cd17648 126 LSERYFGRDNGdeAVLFFSNYVFDFFVEQMTLALLNGQKLVVPPDEMRFDPDRFYAYINREKVTYLSGTPSVL----QQY 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1745 KYRSVPiktnRLKRVFSGGEQLGT----HLVSRFYELlpnvsITNSYGPTEATVEAAFFDCPPHEKLERiPIGKPVHHVR 1820
Cdd:cd17648 202 DLARLP----HLKRVDAAGEEFTApvfeKLRSRFAGL-----IINAYGPTETTVTNHKRFFPGDQRFDK-SLGRPVRNTK 271
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1821 LYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFY-PGE-------RMYKTGDVARWLPDGNVEFLGR 1892
Cdd:cd17648 272 CYVLNDAMKRVPVGAVGELYLGGDGVARGYLNRPELTAERFLPNPFQtEQErargrnaRLYKTGDLVRWLPSGELEYLGR 351
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1893 TDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVR---TDSGEPE----LCAYV---EGLQRNEVRAQLERLLPGYMVPA 1962
Cdd:cd17648 352 NDFQVKIRGQRIEPGEVEAALASYPGVRECAVVAKedaSQAQSRIqkylVGYYLpepGHVPESDLLSFLRAKLPRYMVPA 431
|
490 500
....*....|....*....|..
gi 1678550997 1963 YMIEMEQWPVTPSGKLDRNALP 1984
Cdd:cd17648 432 RLVRLEGIPVTINGKLDVRALP 453
|
|
| LCL_NRPS-like |
cd19540 |
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; ... |
2089-2493 |
1.32e-125 |
|
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380463 [Multi-domain] Cd Length: 433 Bit Score: 403.73 E-value: 1.32e-125
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2089 PVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGdPVQRIHD--EVPFTLQ 2166
Cdd:cd19540 3 PLSFAQQRLWFLNRLDGPSAAYNIPLALRLTGALDVDALRAALADVVARHESLRTVFPEDDGG-PYQVVLPaaEARPDLT 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2167 TTVLGARTEQEAAAAFI-KPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELYNNR------KLP 2239
Cdd:cd19540 82 VVDVTEDELAARLAEAArRGFDLTAELPLRARLFRLGPDEHVLVLVVHHIAADGWSMAPLARDLATAYAARragrapDWA 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2240 ALRIQYKDYAVWQ------EGFKTGDAYKmQEAYWLKQLEGeLP-VLDLPADHARPPVRSFAGDKVSFTLEPEVASGLHK 2312
Cdd:cd19540 162 PLPVQYADYALWQrellgdEDDPDSLAAR-QLAYWRETLAG-LPeELELPTDRPRPAVASYRGGTVEFTIDAELHARLAA 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2313 LARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHKDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRETALE 2392
Cdd:cd19540 240 LAREHGATLFMVLHAALAVLLSRLGAGDDIPIGTPVAGRGDEALDDLVGMFVNTLVLRTDVSGDPTFAELLARVRETDLA 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2393 AFEHQNYPFEELVDKLELTRDMSRNPVFDAMLVVQNNDYEPLHLHDLQMKPAQVSHLVSKFDLTLQASE------GDGNI 2466
Cdd:cd19540 320 AFAHQDVPFERLVEALNPPRSTARHPLFQVMLAFQNTAAATLELPGLTVEPVPVDTGVAKFDLSFTLTErrdadgAPAGL 399
|
410 420
....*....|....*....|....*..
gi 1678550997 2467 HFLFEYSTALFEKTTIERWASHLTNVL 2493
Cdd:cd19540 400 TGELEYATDLFDRSTAERLADRFVRVL 426
|
|
| LCL_NRPS-like |
cd19540 |
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; ... |
1058-1460 |
2.59e-125 |
|
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380463 [Multi-domain] Cd Length: 433 Bit Score: 402.96 E-value: 2.59e-125
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1058 PVSSAQKRIYVLQQLD-EGVAYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSgADDEPVQRIH--TEVPFTLS 1134
Cdd:cd19540 3 PLSFAQQRLWFLNRLDgPSAAYNIPLALRLTGALDVDALRAALADVVARHESLRTVFPE-DDGGPYQVVLpaAEARPDLT 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1135 KETTIEGFV---------RPFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYANR------QLK 1199
Cdd:cd19540 82 VVDVTEDELaarlaeaarRGFDLTAELPLRARLFRLGPDEHVLVLVVHHIAADGWSMAPLARDLATAYAARragrapDWA 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1200 PLRIQYKDYAVWQQKF----KKGDS-YQKQETYWQQQFSGdLP-ILELPTDKRRPAERQFIGGKVTFQLDKEITARIKRL 1273
Cdd:cd19540 162 PLPVQYADYALWQRELlgdeDDPDSlAARQLAYWRETLAG-LPeELELPTDRPRPAVASYRGGTVEFTIDAELHARLAAL 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1274 AHKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPHADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQTALEA 1353
Cdd:cd19540 241 AREHGATLFMVLHAALAVLLSRLGAGDDIPIGTPVAGRGDEALDDLVGMFVNTLVLRTDVSGDPTFAELLARVRETDLAA 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1354 YEHQDYPFEELVDKLGVQREMSRNPLFDTTLVLQNMEQQKLKMNDVQLQWNDLEHPISKFDISLYVTEHDSE------LF 1427
Cdd:cd19540 321 FAHQDVPFERLVEALNPPRSTARHPLFQVMLAFQNTAAATLELPGLTVEPVPVDTGVAKFDLSFTLTERRDAdgapagLT 400
|
410 420 430
....*....|....*....|....*....|...
gi 1678550997 1428 CQFEYSTALFEKETIQRWASLFTTLVEHTAASP 1460
Cdd:cd19540 401 GELEYATDLFDRSTAERLADRFVRVLEAVVADP 433
|
|
| A_NRPS_PvdJ-like |
cd17649 |
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal ... |
477-953 |
6.28e-124 |
|
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes pyoverdine biosynthesis protein PvdJ involved in the synthesis of pyoverdine, which consists of a chromophore group attached to a variable peptide chain and comprises around 6-12 amino acids that are specific for each Pseudomonas species, and for which the peptide might be first synthesized before the chromophore assembly. Also included is ornibactin biosynthesis protein OrbI; ornibactin is a tetrapeptide siderophore with an l-ornithine-d-hydroxyaspartate-l-serine-l-ornithine backbone. The adenylation domain at the N-terminal of OrbI possibly initiates the ornibactin with the binding of N5-hydroxyornithine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341304 [Multi-domain] Cd Length: 450 Bit Score: 399.82 E-value: 6.28e-124
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 477 PDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYIL 556
Cdd:cd17649 1 PDAVALVFGDQSLSYAELDARANRLAHRLRALGVGPEVRVGIALERSLEMVVALLAILKAGGAYVPLDPEYPAERLRYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 557 HDCGCSHVVSQahlpsslednyiitHPedieskvdgsniksvnnaDDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEYT 636
Cdd:cd17649 81 EDSGAGLLLTH--------------HP------------------RQLAYVIYTSGSTGTPKGVAVSHGPLAAHCQATAE 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 637 HSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNIVFLPTAFIKMIFSE-RELAN 715
Cdd:cd17649 129 RYGLTPGDRELQFASFNFDGAHEQLLPPLICGACVVLRPDELWASADELAEMVRELGVTVLDLPPAYLQQLAEEaDRTGD 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 716 SFPDGVKHLIAAGEQLMISDLFQdvLRKRGIHLHNHYGPSETHVVST-YTIHPGDP-IPELPPIGKPIGCTDLYILNHQK 793
Cdd:cd17649 209 GRPPSLRLYIFGGEALSPELLRR--WLKAPVRLFNAYGPTEATVTPLvWKCEAGAArAGASMPIGRPLGGRSAYILDADL 286
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 794 QLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPF-KPDVIMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQ 872
Cdd:cd17649 287 NPVPVGVTGELYIGGEGLARGYLGRPELTAERFVPDPFgAPGSRLYRTGDLARWRDDGVIEYLGRVDHQVKIRGFRIELG 366
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 873 EIEVTLMNHPDISEAAILIwQDQNGEHELCAYYCSVQKLNTID----LRSYMASELPEYMIPAKWIWVDSIPLTPNGKVD 948
Cdd:cd17649 367 EIEAALLEHPGVREAAVVA-LDGAGGKQLVAYVVLRAAAAQPElraqLRTALRASLPDYMVPAHLVFLARLPLTPNGKLD 445
|
....*
gi 1678550997 949 RAALP 953
Cdd:cd17649 446 RKALP 450
|
|
| Condensation |
pfam00668 |
Condensation domain; This domain is found in many multi-domain enzymes which synthesize ... |
7-452 |
1.79e-120 |
|
Condensation domain; This domain is found in many multi-domain enzymes which synthesize peptide antibiotics. This domain catalyzes a condensation reaction to form peptide bonds in non- ribosomal peptide biosynthesis. It is usually found to the carboxy side of a phosphopantetheine binding domain (pfam00550). It has been shown that mutations in the HHXXXDG motif abolish activity suggesting this is part of the active site.
Pssm-ID: 395541 [Multi-domain] Cd Length: 454 Bit Score: 390.16 E-value: 1.79e-120
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 7 IQDIYPLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNVSSPQQVVLRERNV 86
Cdd:pfam00668 1 VQDEYPLSPAQKRMWFLEKLEPHSSAYNMPAVLKLTGELDPERLEKALQELINRHDALRTVFIRQENGEPVQVILEERPF 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 87 IVLEEDITHLNEAEQSQFIEQWKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYAS 166
Cdd:pfam00668 81 ELEIIDISDLSESEEEEAIEAFIQRDLQSPFDLEKGPLFRAGLFRIAENRHHLLLSMHHIIVDGVSLGILLRDLADLYQQ 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 167 YVNASPITLEPVQPYGKYIKW----LMEQDKEQAVSYWDHYLSGHEQQTVLPKQKKTKGKS--RQEHVTFSFSKEESSRL 240
Cdd:pfam00668 161 LLKGEPLPLPPKTPYKDYAEWlqqyLQSEDYQKDAAYWLEQLEGELPVLQLPKDYARPADRsfKGDRLSFTLDEDTEELL 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 241 SELAAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRPAeiEGIEHMVGLFINTMPVRVQ--GAKTpFLQLIKDMQ 318
Cdd:pfam00668 241 RKLAKAHGTTLNDVLLAAYGLLLSRYTGQDDIVVGTPGSGRPS--PDIERMVGMFVNTLPLRIDpkGGKT-FSELIKRVQ 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 319 KDRLAAEAYSYHPLYEIQSRSAVKQ-----GLIDHILVFENYPVQQEIQmlnkQEHASDLFQIHNFTVA-DETNYSFYLM 392
Cdd:pfam00668 318 EDLLSAEPHQGYPFGDLVNDLRLPRdlsrhPLFDPMFSFQNYLGQDSQE----EEFQLSELDLSVSSVIeEEAKYDLSLT 393
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 393 VAP-GEEIHIKMNYDAEQHDRSFVLSVKEHLLNAVSQILNNPNLPPEEIDITTDTEKRQLI 452
Cdd:pfam00668 394 ASErGGGLTIKIDYNTSLFDEETIERFAEHFKELLEQAIAHPSQPLSELDLLSDAEKQKLL 454
|
|
| A_NRPS_SidN3_like |
cd05918 |
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); ... |
1496-1983 |
1.33e-119 |
|
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family of siderophore-synthesizing NRPS includes the third adenylation domain of SidN from the endophytic fungus Neotyphodium lolii, ferrichrome siderophore synthetase, HC-toxin synthetase, and enniatin synthase. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341242 [Multi-domain] Cd Length: 481 Bit Score: 388.44 E-value: 1.33e-119
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1496 LHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPID 1575
Cdd:cd05918 1 VHDLIEERARSQPDAPAVCAWDGSLTYAELDRLSSRLAHHLRSLGVGPGVFVPLCFEKSKWAVVAMLAVLKAGGAFVPLD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1576 PDYPEERISFLLEDSGTNILLlqsaglhvpeftgeivylnqtnsglAHRlsnpnvdvlPQSLAYVIYTSGSTGMPKGVEI 1655
Cdd:cd05918 81 PSHPLQRLQEILQDTGAKVVL-------------------------TSS---------PSDAAYVIFTSGSTGKPKGVVI 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1656 EHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPqggEKE-PEVIAKAIEEQKITAMHFVP 1734
Cdd:cd05918 127 EHRALSTSALAHGRALGLTSESRVLQFASYTFDVSILEIFTTLAAGGCLCIPS---EEDrLNDLAGFINRLRVTWAFLTP 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1735 SMLHafleHIKYRSVPiktnRLKRVFSGGEQLGTHLVSRFyelLPNVSITNSYGPTEATVEAAFFDCPPHEKLERIpiGK 1814
Cdd:cd05918 204 SVAR----LLDPEDVP----SLRTLVLGGEALTQSDVDTW---ADRVRLINAYGPAECTIAATVSPVVPSTDPRNI--GR 270
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1815 PVHhVRLYLLNQN--QRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFY-------PGERMYKTGDVARWLPDG 1885
Cdd:cd05918 271 PLG-ATCWVVDPDnhDRLVPIGAVGELLIEGPILARGYLNDPEKTAAAFIEDPAWlkqegsgRGRRLYRTGDLVRYNPDG 349
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1886 NVEFLGRTDDQVKIRGYRIEPGEIEAALRS-IEGVREAAVTV---RTDSGEPELCAYVEG-------------------- 1941
Cdd:cd05918 350 SLEYVGRKDTQVKIRGQRVELGEIEHHLRQsLPGAKEVVVEVvkpKDGSSSPQLVAFVVLdgsssgsgdgdslflepsde 429
|
490 500 510 520
....*....|....*....|....*....|....*....|....
gi 1678550997 1942 LQRN--EVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd05918 430 FRALvaELRSKLRQRLPSYMVPSVFLPLSHLPLTASGKIDRRAL 473
|
|
| A_NRPS_SidN3_like |
cd05918 |
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); ... |
465-952 |
2.23e-119 |
|
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family of siderophore-synthesizing NRPS includes the third adenylation domain of SidN from the endophytic fungus Neotyphodium lolii, ferrichrome siderophore synthetase, HC-toxin synthetase, and enniatin synthase. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341242 [Multi-domain] Cd Length: 481 Bit Score: 388.05 E-value: 2.23e-119
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 465 IHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVD 544
Cdd:cd05918 1 VHDLIEERARSQPDAPAVCAWDGSLTYAELDRLSSRLAHHLRSLGVGPGVFVPLCFEKSKWAVVAMLAVLKAGGAFVPLD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 545 PHYPADRIRYILHDCGCSHVVsqahlpsslednyiithpedieskvdgsniksVNNADDLLYMIYTSGTTGKPKGVQFEH 624
Cdd:cd05918 81 PSHPLQRLQEILQDTGAKVVL--------------------------------TSSPSDAAYVIFTSGSTGKPKGVVIEH 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 625 RNMANLLKFEYTHSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDvpQLFAFINKHQTNIVFLPTAFI 704
Cdd:cd05918 129 RALSTSALAHGRALGLTSESRVLQFASYTFDVSILEIFTTLAAGGCLCIPSEEDRLN--DLAGFINRLRVTWAFLTPSVA 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 705 KMIFSErelanSFPDgVKHLIAAGEQLMisdlfQDVLRK--RGIHLHNHYGPSETHVVSTYtihpGDPIPELPP--IGKP 780
Cdd:cd05918 207 RLLDPE-----DVPS-LRTLVLGGEALT-----QSDVDTwaDRVRLINAYGPAECTIAATV----SPVVPSTDPrnIGRP 271
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 781 IGCTdLYIL---NHQkQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDP-------FKPDVIMYRTGDLARRLEDG 850
Cdd:cd05918 272 LGAT-CWVVdpdNHD-RLVPIGAVGELLIEGPILARGYLNDPEKTAAAFIEDPawlkqegSGRGRRLYRTGDLVRYNPDG 349
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 851 NIEYIGRADNQVKIRGYRIEPQEIE--------------VTLMNHPDISEAAILI--------WQDQNGEHELCAYYCSV 908
Cdd:cd05918 350 SLEYVGRKDTQVKIRGQRVELGEIEhhlrqslpgakevvVEVVKPKDGSSSPQLVafvvldgsSSGSGDGDSLFLEPSDE 429
|
490 500 510 520
....*....|....*....|....*....|....*....|....
gi 1678550997 909 QKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:cd05918 430 FRALVAELRSKLRQRLPSYMVPSVFLPLSHLPLTASGKIDRRAL 473
|
|
| A_NRPS_GliP_like |
cd17653 |
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of ... |
2537-3019 |
5.14e-118 |
|
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of nonribosomal peptide synthases (NRPS) gliotoxin biosynthesis protein P (GliP), thioclapurine biosynthesis protein P (tcpP) and Sirodesmin biosynthesis protein P (SirP). In the filamentous fungus Aspergillus fumigatus, NRPS GliP is involved in the biosynthesis of gliotoxin, which is initiated by the condensation of serine and phenylalanine. Studies show that GliP is not required for invasive aspergillosis, suggesting that the principal targets of gliotoxin are neutrophils or other phagocytes. SirP is a phytotoxin produced by the fungus Leptosphaeria maculans, which causes blackleg disease of canola (Brassica napus). In the fungus Claviceps purpurea, NRPS tcpP catalyzes condensation of tyrosine and glycine, part of biosynthesis of an unusual class of epipolythiodioxopiperazines (ETPs) that lacks the reactive thiol group for toxicity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341308 [Multi-domain] Cd Length: 433 Bit Score: 382.04 E-value: 5.14e-118
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2537 QLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPE 2616
Cdd:cd17653 1 DAFERIAAAHPDAVAVESLGGSLTYGELDAASNALANRLLQLGVVPGDVVPLLSDRSLEMLVAILAILKAGAAYVPLDAK 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2617 YPKERKRYILSDSGTKLLMTINeadlgvladfegeiltiesveeddksplpqmsSAHHLAYIIYTSGTTGRPKGVMVEHK 2696
Cdd:cd17653 81 LPSARIQAILRTSGATLLLTTD--------------------------------SPDDLAYIIFTSGSTGIPKGVMVPHR 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2697 GIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLlhEEEAKDILAIKhqlsrQRITHMIIVPvlyr 2776
Cdd:cd17653 129 GVLNYVSQPPARLDVGPGSRVAQVLSIAFDACIGEIFSTLCNGGTLVL--ADPSDPFAHVA-----RTVDALMSTP---- 197
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2777 ALLDVVQPEDVKTLRVVTLAGEAADRELIARSLaicPHTELANEYGPTENSVATTvMRHMEKQAYVSIGQPIDGTQVLIL 2856
Cdd:cd17653 198 SILSTLSPQDFPNLKTIFLGGEAVPPSLLDRWS---PGRRLYNAYGPTECTISST-MTELLPGQPVTIGKPIPNSTCYIL 273
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2857 NSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRV 2936
Cdd:cd17653 274 DADLQPVPEGVVGEICISGVQVARGYLGNPALTASKFVPDPFWPGSRMYRTGDYGRWTEDGGLEFLGREDNQVKVRGFRI 353
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2937 ETKEIESVIRCI-KGVKDAAVVAHvtasgQTELSAYvVTKPGLSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLD 3015
Cdd:cd17653 354 NLEEIEEVVLQSqPEVTQAAAIVV-----NGRLVAF-VTPETVDVDGLRSELAKHLPSYAVPDRIIALDSFPLTANGKVD 427
|
....
gi 1678550997 3016 RGAL 3019
Cdd:cd17653 428 RKAL 431
|
|
| MenE/FadK |
COG0318 |
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid ... |
2535-3030 |
5.21e-117 |
|
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) is part of the Pathway/BioSystem: Menaquinone biosynthesis
Pssm-ID: 440087 [Multi-domain] Cd Length: 452 Bit Score: 379.92 E-value: 5.21e-117
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2535 ISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPID 2614
Cdd:COG0318 1 LADLLRRAAARHPDRPALVFGGRRLTYAELDARARRLAAALRALGVGPGDRVALLLPNSPEFVVAFLAALRAGAVVVPLN 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2615 PEYPKERKRYILSDSGTKLLMTineadlgvladfegeiltiesveeddksplpqmssahhlAYIIYTSGTTGRPKGVMVE 2694
Cdd:COG0318 81 PRLTAEELAYILEDSGARALVT---------------------------------------ALILYTSGTTGRPKGVMLT 121
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2695 HKGI-ANTLQWRRnAYAFNETDTILQLFSFSFD-GFITSMFTPLLSGAKAVLLHEEEAKDILAikhQLSRQRITHMIIVP 2772
Cdd:COG0318 122 HRNLlANAAAIAA-ALGLTPGDVVLVALPLFHVfGLTVGLLAPLLAGATLVLLPRFDPERVLE---LIERERVTVLFGVP 197
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2773 VLYRALLDVVQ--PEDVKTLRVVTLAGEAADRELIARSLAICpHTELANEYGPTENSVATTVMRHMEKQAY-VSIGQPID 2849
Cdd:COG0318 198 TMLARLLRHPEfaRYDLSSLRLVVSGGAPLPPELLERFEERF-GVRIVEGYGLTETSPVVTVNPEDPGERRpGSVGRPLP 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2850 GTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFtqnpfkpEARMYRTGDAARWMADGTLEYLGRIDDQV 2929
Cdd:COG0318 277 GVEVRIVDEDGRELPPGEVGEIVVRGPNVMKGYWNDPEATAEAF-------RDGWLRTGDLGRLDEDGYLYIVGRKKDMI 349
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2930 KIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLP 3007
Cdd:COG0318 350 ISGGENVYPAEVEEVLAAHPGVAEAAVVGVPDEKWGERVVAFVVLRPGaeLDAEELRAFLRERLARYKVPRRVEFVDELP 429
|
490 500
....*....|....*....|...
gi 1678550997 3008 LSPNGKLDRGALPKPVYNHEGER 3030
Cdd:COG0318 430 RTASGKIDRRALRERYAAGALEA 452
|
|
| A_NRPS_GliP_like |
cd17653 |
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of ... |
469-952 |
8.07e-117 |
|
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of nonribosomal peptide synthases (NRPS) gliotoxin biosynthesis protein P (GliP), thioclapurine biosynthesis protein P (tcpP) and Sirodesmin biosynthesis protein P (SirP). In the filamentous fungus Aspergillus fumigatus, NRPS GliP is involved in the biosynthesis of gliotoxin, which is initiated by the condensation of serine and phenylalanine. Studies show that GliP is not required for invasive aspergillosis, suggesting that the principal targets of gliotoxin are neutrophils or other phagocytes. SirP is a phytotoxin produced by the fungus Leptosphaeria maculans, which causes blackleg disease of canola (Brassica napus). In the fungus Claviceps purpurea, NRPS tcpP catalyzes condensation of tyrosine and glycine, part of biosynthesis of an unusual class of epipolythiodioxopiperazines (ETPs) that lacks the reactive thiol group for toxicity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341308 [Multi-domain] Cd Length: 433 Bit Score: 378.58 E-value: 8.07e-117
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 469 FEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYP 548
Cdd:cd17653 3 FERIAAAHPDAVAVESLGGSLTYGELDAASNALANRLLQLGVVPGDVVPLLSDRSLEMLVAILAILKAGAAYVPLDAKLP 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 549 ADRIRYILHDCGCSHVVSQahlpsslednyiithpedieskvdgsniksvNNADDLLYMIYTSGTTGKPKGVQFEHRNMA 628
Cdd:cd17653 83 SARIQAILRTSGATLLLTT-------------------------------DSPDDLAYIIFTSGSTGIPKGVMVPHRGVL 131
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 629 NLLKFEYTHSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLhivpeaIKRDVPQLFAFINKHQTNIVFLPTAFIKMif 708
Cdd:cd17653 132 NYVSQPPARLDVGPGSRVAQVLSIAFDACIGEIFSTLCNGGTL------VLADPSDPFAHVARTVDALMSTPSILSTL-- 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 709 sereLANSFPDgVKHLIAAGEQLMisdlfQDVLRK--RGIHLHNHYGPSETHVVSTYT-IHPGDPIPelppIGKPIGCTD 785
Cdd:cd17653 204 ----SPQDFPN-LKTIFLGGEAVP-----PSLLDRwsPGRRLYNAYGPTECTISSTMTeLLPGQPVT----IGKPIPNST 269
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 786 LYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPDVIMYRTGDLARRLEDGNIEYIGRADNQVKIR 865
Cdd:cd17653 270 CYILDADLQPVPEGVVGEICISGVQVARGYLGNPALTASKFVPDPFWPGSRMYRTGDYGRWTEDGGLEFLGREDNQVKVR 349
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 866 GYRIEPQEIEVTLM-NHPDISEAAILIWQDQngeheLCAYYcSVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPN 944
Cdd:cd17653 350 GFRINLEEIEEVVLqSQPEVTQAAAIVVNGR-----LVAFV-TPETVDVDGLRSELAKHLPSYAVPDRIIALDSFPLTAN 423
|
....*...
gi 1678550997 945 GKVDRAAL 952
Cdd:cd17653 424 GKVDRKAL 431
|
|
| A_NRPS_GliP_like |
cd17653 |
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of ... |
1499-1983 |
4.79e-115 |
|
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of nonribosomal peptide synthases (NRPS) gliotoxin biosynthesis protein P (GliP), thioclapurine biosynthesis protein P (tcpP) and Sirodesmin biosynthesis protein P (SirP). In the filamentous fungus Aspergillus fumigatus, NRPS GliP is involved in the biosynthesis of gliotoxin, which is initiated by the condensation of serine and phenylalanine. Studies show that GliP is not required for invasive aspergillosis, suggesting that the principal targets of gliotoxin are neutrophils or other phagocytes. SirP is a phytotoxin produced by the fungus Leptosphaeria maculans, which causes blackleg disease of canola (Brassica napus). In the fungus Claviceps purpurea, NRPS tcpP catalyzes condensation of tyrosine and glycine, part of biosynthesis of an unusual class of epipolythiodioxopiperazines (ETPs) that lacks the reactive thiol group for toxicity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341308 [Multi-domain] Cd Length: 433 Bit Score: 373.57 E-value: 4.79e-115
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1499 ALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDY 1578
Cdd:cd17653 2 AFERIAAAHPDAVAVESLGGSLTYGELDAASNALANRLLQLGVVPGDVVPLLSDRSLEMLVAILAILKAGAAYVPLDAKL 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1579 PEERISFLLEDSGTNILLLQSAglhvpeftgeivylnqtnsglahrlsnpnvdvlPQSLAYVIYTSGSTGMPKGVEIEHR 1658
Cdd:cd17653 82 PSARIQAILRTSGATLLLTTDS---------------------------------PDDLAYIIFTSGSTGIPKGVMVPHR 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1659 SAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLlpqggeKEPE--VIAKAieeQKITAMHFVPSm 1736
Cdd:cd17653 129 GVLNYVSQPPARLDVGPGSRVAQVLSIAFDACIGEIFSTLCNGGTLVL------ADPSdpFAHVA---RTVDALMSTPS- 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1737 lhaFLEHIKYRSVPiktnRLKRVFSGGEQLGTHLVSRFyelLPNVSITNSYGPTEATVEAAFFDCPPHEkleRIPIGKPV 1816
Cdd:cd17653 199 ---ILSTLSPQDFP----NLKTIFLGGEAVPPSLLDRW---SPGRRLYNAYGPTECTISSTMTELLPGQ---PVTIGKPI 265
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1817 HHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYPGERMYKTGDVARWLPDGNVEFLGRTDDQ 1896
Cdd:cd17653 266 PNSTCYILDADLQPVPEGVVGEICISGVQVARGYLGNPALTASKFVPDPFWPGSRMYRTGDYGRWTEDGGLEFLGREDNQ 345
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1897 VKIRGYRIEPGEIEA-ALRSIEGVREAAVTVRTDSgepeLCAYV--EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVT 1973
Cdd:cd17653 346 VKVRGFRINLEEIEEvVLQSQPEVTQAAAIVVNGR----LVAFVtpETVDVDGLRSELAKHLPSYAVPDRIIALDSFPLT 421
|
490
....*....|
gi 1678550997 1974 PSGKLDRNAL 1983
Cdd:cd17653 422 ANGKVDRKAL 431
|
|
| A_NRPS_TlmIV_like |
cd12114 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including ... |
2547-3019 |
1.23e-112 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Streptoalloteichus tallysomycin biosynthesis genes; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the TLM biosynthetic gene cluster from Streptoalloteichus that consists of nine NRPS genes; the N-terminal module of TlmVI (NRPS-5) and the starter module of BlmVI (NRPS-5) are comprised of the acyl CoA ligase (AL) and acyl carrier protein (ACP)-like domains, which are thought to be involved in the biosynthesis of the beta-aminoalaninamide moiety.
Pssm-ID: 341279 [Multi-domain] Cd Length: 477 Bit Score: 368.52 E-value: 1.23e-112
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2547 PKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYIL 2626
Cdd:cd12114 1 PDATAVICGDGTLTYGELAERARRVAGALKAAGVRPGDLVAVTLPKGPEQVVAVLGILAAGAAYVPVDIDQPAARREAIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2627 SDSGTKLLMTINEADLGVLADFegeILTIESVEEDDKS--PLPQMSSAHHLAYIIYTSGTTGRPKGVMVEHKGIANTLQW 2704
Cdd:cd12114 81 ADAGARLVLTDGPDAQLDVAVF---DVLILDLDALAAPapPPPVDVAPDDLAYVIFTSGSTGTPKGVMISHRAALNTILD 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2705 RRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDVV-- 2782
Cdd:cd12114 158 INRRFAVGPDDRVLALSSLSFDLSVYDIFGALSAGATLVLPDEARRRDPAHWAELIERHGVTLWNSVPALLEMLLDVLea 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2783 QPEDVKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTENSVATTVMR-HMEKQAYVSI--GQPIDGTQVLILNSN 2859
Cdd:cd12114 238 AQALLPSLRLVLLSGDWIPLDLPARLRALAPDARLISLGGATEASIWSIYHPiDEVPPDWRSIpyGRPLANQRYRVLDPR 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2860 HQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPfkPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETK 2939
Cdd:cd12114 318 GRDCPDWVPGELWIGGRGVALGYLGDPELTAARFVTHP--DGERLYRTGDLGRYRPDGTLEFLGRRDGQVKVRGYRIELG 395
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2940 EIESVIRCIKGVKDAAVVAhVTASGQTELSAYVVTKPGLST---NAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDR 3016
Cdd:cd12114 396 EIEAALQAHPGVARAVVVV-LGDPGGKRLAAFVVPDNDGTPiapDALRAFLAQTLPAYMIPSRVIALEALPLTANGKVDR 474
|
...
gi 1678550997 3017 GAL 3019
Cdd:cd12114 475 AAL 477
|
|
| DltA |
cd05945 |
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes ... |
2543-3019 |
1.28e-112 |
|
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes D-alanyl carrier protein ligase DltA and aliphatic beta-amino acid adenylation enzymes IdnL1 and CmiS6. DltA incorporates D-ala in techoic acids in gram-positive bacteria via a two-step process, starting with adenylation of D-alanine that transfers D-alanine to the D-alanyl carrier protein. IdnL1, a short-chain aliphatic beta-amino acid adenylation enzyme, recognizes 3-aminobutanoic acid, and is involved in the synthesis of the macrolactam antibiotic incednine. CmiS6 is a medium-chain beta-amino acid adenylation enzyme that recognizes 3-aminononanoic acid, and is involved in the synthesis of cremimycin, also a macrolactam antibiotic. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341267 [Multi-domain] Cd Length: 449 Bit Score: 367.34 E-value: 1.28e-112
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2543 AARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERK 2622
Cdd:cd05945 1 AAANPDRPAVVEGGRTLTYRELKERADALAAALASLGLDAGDPVVVYGHKSPDAIAAFLAALKAGHAYVPLDASSPAERI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2623 RYILSDSGTKLLMtineadlgvladfegeiltiesVEEDDksplpqmssahhLAYIIYTSGTTGRPKGVMVEHKGIANTL 2702
Cdd:cd05945 81 REILDAAKPALLI----------------------ADGDD------------NAYIIFTSGSTGRPKGVQISHDNLVSFT 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2703 QWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLYRALL--D 2780
Cdd:cd05945 127 NWMLSDFPLGPGDVFLNQAPFSFDLSVMDLYPALASGATLVPVPRDATADPKQLFRFLAEHGITVWVSTPSFAAMCLlsP 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2781 VVQPEDVKTLRVVTLAGEA----ADRELIARSlaicPHTELANEYGPTENSVATTVMRHMEKQAY----VSIGQPIDGTQ 2852
Cdd:cd05945 207 TFTPESLPSLRHFLFCGEVlphkTARALQQRF----PDARIYNTYGPTEATVAVTYIEVTPEVLDgydrLPIGYAKPGAK 282
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2853 VLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKpeaRMYRTGDAARWMADGTLEYLGRIDDQVKIR 2932
Cdd:cd05945 283 LVILDEDGRPVPPGEKGELVISGPSVSKGYLNNPEKTAAAFFPDEGQ---RAYRTGDLVRLEADGLLFYRGRLDFQVKLN 359
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2933 GYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLS---TNAVRSELQNKLPVFMHPAFIEKLDSLPLS 3009
Cdd:cd05945 360 GYRIELEEIEAALRQVPGVKEAVVVPKYKGEKVTELIAFVVPKPGAEaglTKAIKAELAERLPPYMIPRRFVYLDELPLN 439
|
490
....*....|
gi 1678550997 3010 PNGKLDRGAL 3019
Cdd:cd05945 440 ANGKIDRKAL 449
|
|
| AMP-binding |
pfam00501 |
AMP-binding enzyme; |
1500-1900 |
1.59e-112 |
|
AMP-binding enzyme;
Pssm-ID: 459834 [Multi-domain] Cd Length: 417 Bit Score: 365.48 E-value: 1.59e-112
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAV-IFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDY 1578
Cdd:pfam00501 1 LERQAARTPDKTALeVGEGRRLTYRELDERANRLAAGLRALGVGKGDRVAILLPNSPEWVVAFLACLKAGAVYVPLNPRL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1579 PEERISFLLEDSGTNILLLQSAGL-----------------HVPEFTGEIVYLNQ-TNSGLAHRLSNPNVDVLPQSLAYV 1640
Cdd:pfam00501 81 PAEELAYILEDSGAKVLITDDALKleellealgklevvklvLVLDRDPVLKEEPLpEEAKPADVPPPPPPPPDPDDLAYI 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1641 IYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQ----LKHSDMIMHKTSYSFDAS-IWELFWWPYAGASVYLLPQGGEKEP 1715
Cdd:pfam00501 161 IYTSGTTGKPKGVMLTHRNLVANVLSIKRVRPrgfgLGPDDRVLSTLPLFHDFGlSLGLLGPLLAGATVVLPPGFPALDP 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1716 EVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRsvPIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVsITNSYGPTEATVe 1795
Cdd:pfam00501 241 AALLELIERYKVTVLYGVPTLLNMLLEAGAPK--RALLSSLRLVLSGGAPLPPELARRFRELFGGA-LVNGYGLTETTG- 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1796 AAFFDCPPHEKLERIP-IGKPVHHVRLYLLNQN-QRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDpfypgeRMY 1873
Cdd:pfam00501 317 VVTTPLPLDEDLRSLGsVGRPLPGTEVKIVDDEtGEPVPPGEPGELCVRGPGVMKGYLNDPELTAEAFDED------GWY 390
|
410 420
....*....|....*....|....*..
gi 1678550997 1874 KTGDVARWLPDGNVEFLGRTDDQVKIR 1900
Cdd:pfam00501 391 RTGDLGRRDEDGYLEIVGRKKDQIKLG 417
|
|
| MenE/FadK |
COG0318 |
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid ... |
1496-1994 |
1.75e-112 |
|
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) is part of the Pathway/BioSystem: Menaquinone biosynthesis
Pssm-ID: 440087 [Multi-domain] Cd Length: 452 Bit Score: 366.83 E-value: 1.75e-112
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1496 LHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPID 1575
Cdd:COG0318 1 LADLLRRAAARHPDRPALVFGGRRLTYAELDARARRLAAALRALGVGPGDRVALLLPNSPEFVVAFLAALRAGAVVVPLN 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1576 PDYPEERISFLLEDSGTNILLLqsaglhvpeftgeivylnqtnsglahrlsnpnvdvlpqslAYVIYTSGSTGMPKGVEI 1655
Cdd:COG0318 81 PRLTAEELAYILEDSGARALVT----------------------------------------ALILYTSGTTGRPKGVML 120
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1656 EHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWP-YAGASVYLLPqggEKEPEVIAKAIEEQKITAMHFVP 1734
Cdd:COG0318 121 THRNLLANAAAIAAALGLTPGDVVLVALPLFHVFGLTVGLLAPlLAGATLVLLP---RFDPERVLELIERERVTVLFGVP 197
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1735 SMLHAFLEHIKYRsvPIKTNRLKRVFSGGEQLGTHLVSRFYELLpNVSITNSYGPTEATVEAAffdCPPHEKLERIP--I 1812
Cdd:COG0318 198 TMLARLLRHPEFA--RYDLSSLRLVVSGGAPLPPELLERFEERF-GVRIVEGYGLTETSPVVT---VNPEDPGERRPgsV 271
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1813 GKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFlEDPFYpgermyKTGDVARWLPDGNVEFLGR 1892
Cdd:COG0318 272 GRPLPGVEVRIVDEDGRELPPGEVGEIVVRGPNVMKGYWNDPEATAEAF-RDGWL------RTGDLGRLDEDGYLYIVGR 344
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1893 TDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTD--SGEpELCAYV-----EGLQRNEVRAQLERLLPGYMVPAYMI 1965
Cdd:COG0318 345 KKDMIISGGENVYPAEVEEVLAAHPGVAEAAVVGVPDekWGE-RVVAFVvlrpgAELDAEELRAFLRERLARYKVPRRVE 423
|
490 500
....*....|....*....|....*....
gi 1678550997 1966 EMEQWPVTPSGKLDRNALPAPGGAADAET 1994
Cdd:COG0318 424 FVDELPRTASGKIDRRALRERYAAGALEA 452
|
|
| A_NRPS_ACVS-like |
cd17648 |
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV ... |
2547-3020 |
1.03e-111 |
|
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV synthetase (ACVS, EC 6.3.2.26; also known as N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase or delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase) is involved in medically important antibiotic biosynthesis. ACV synthetase is active in an early step in the penicillin G biosynthesis pathway which involves the formation of the tripeptide 6-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine (ACV); each of the constituent amino acids of the tripeptide ACV are activated as aminoacyl-adenylates with peptide bonds formed through the participation of amino acid thioester intermediates. ACV is then cyclized by the action of isopenicillin N synthase.
Pssm-ID: 341303 [Multi-domain] Cd Length: 453 Bit Score: 364.80 E-value: 1.03e-111
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2547 PKASALVSGDKTLTYQELDEWSNGIARALRSRG-VKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYI 2625
Cdd:cd17648 1 PDRVAVVYGDKRLTYRELNERANRLAHYLLSVAeIRPDDLVGLVLDKSELMIIAILAVWKAGAAYVPIDPSYPDERIQFI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2626 LSDSGTKLLMTineadlgvladfegeiltiesveeddksplpqmsSAHHLAYIIYTSGTTGRPKGVMVEHKGIAN--TLQ 2703
Cdd:cd17648 81 LEDTGARVVIT----------------------------------NSTDLAYAIYTSGTTGKPKGVLVEHGSVVNlrTSL 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2704 WRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPvlyrallDVVQ 2783
Cdd:cd17648 127 SERYFGRDNGDEAVLFFSNYVFDFFVEQMTLALLNGQKLVVPPDEMRFDPDRFYAYINREKVTYLSGTP-------SVLQ 199
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2784 PEDVK---TLRVVTLAGE---AADRELIARSLAicphTELANEYGPTENSVATTVMRHMEKQAY-VSIGQPIDGTQVLIL 2856
Cdd:cd17648 200 QYDLArlpHLKRVDAAGEeftAPVFEKLRSRFA----GLIINAYGPTETTVTNHKRFFPGDQRFdKSLGRPVRNTKCYVL 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2857 NSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKPE--------ARMYRTGDAARWMADGTLEYLGRIDDQ 2928
Cdd:cd17648 276 NDAMKRVPVGAVGELYLGGDGVARGYLNRPELTAERFLPNPFQTEqerargrnARLYKTGDLVRWLPSGELEYLGRNDFQ 355
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2929 VKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTAS-----GQTELSAYVVTKPG-LSTNAVRSELQNKLPVFMHPAFIEK 3002
Cdd:cd17648 356 VKIRGQRIEPGEVEAALASYPGVRECAVVAKEDASqaqsrIQKYLVGYYLPEPGhVPESDLLSFLRAKLPRYMVPARLVR 435
|
490
....*....|....*...
gi 1678550997 3003 LDSLPLSPNGKLDRGALP 3020
Cdd:cd17648 436 LEGIPVTINGKLDVRALP 453
|
|
| AMP-binding |
pfam00501 |
AMP-binding enzyme; |
469-865 |
2.27e-111 |
|
AMP-binding enzyme;
Pssm-ID: 459834 [Multi-domain] Cd Length: 417 Bit Score: 362.40 E-value: 2.27e-111
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 469 FEKQAEKTPDAHAV-IDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHY 547
Cdd:pfam00501 1 LERQAARTPDKTALeVGEGRRLTYRELDERANRLAAGLRALGVGKGDRVAILLPNSPEWVVAFLACLKAGAVYVPLNPRL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 548 PADRIRYILHDCGCSHVVSQAHLP--------SSLEDNYIITH------------PEDIESKVDGSNIKSVNNADDLLYM 607
Cdd:pfam00501 81 PAEELAYILEDSGAKVLITDDALKleellealGKLEVVKLVLVldrdpvlkeeplPEEAKPADVPPPPPPPPDPDDLAYI 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 608 IYTSGTTGKPKGVQFEHRNMANLL----KFEYTHSGIDFEADVLQFATPSFDVCYQ-EIFSALLKGGTLHIVPEAIKRDV 682
Cdd:pfam00501 161 IYTSGTTGKPKGVMLTHRNLVANVlsikRVRPRGFGLGPDDRVLSTLPLFHDFGLSlGLLGPLLAGATVVLPPGFPALDP 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 683 PQLFAFINKHQTNIVFLPTAFIKMIFSERELANSFPDGVKHLIAAGEQLMiSDLFQDVLRKRGIHLHNHYGPSETHVVST 762
Cdd:pfam00501 241 AALLELIERYKVTVLYGVPTLLNMLLEAGAPKRALLSSLRLVLSGGAPLP-PELARRFRELFGGALVNGYGLTETTGVVT 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 763 YTIHPGDPIPELPPIGKPIGCTDLYILN-HQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPfkpdviMYRTG 841
Cdd:pfam00501 320 TPLPLDEDLRSLGSVGRPLPGTEVKIVDdETGEPVPPGEPGELCVRGPGVMKGYLNDPELTAEAFDEDG------WYRTG 393
|
410 420
....*....|....*....|....
gi 1678550997 842 DLARRLEDGNIEYIGRADNQVKIR 865
Cdd:pfam00501 394 DLGRRDEDGYLEIVGRKKDQIKLG 417
|
|
| LCL_NRPS |
cd19538 |
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; ... |
2089-2500 |
2.90e-111 |
|
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380461 [Multi-domain] Cd Length: 432 Bit Score: 362.74 E-value: 2.90e-111
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2089 PVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFeQDEGGDPVQRIHDEVPFTL--- 2165
Cdd:cd19538 3 PLSFAQRRLWFLHQLEGPSATYNIPLVIKLKGKLDVQALQQALYDVVERHESLRTVF-PEEDGVPYQLILEEDEATPkle 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2166 QTTVLGARTEQEAAAAFIKPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELYNNR------KLP 2239
Cdd:cd19538 82 IKEVDEEELESEINEAVRYPFDLSEEPPFRATLFELGENEHVLLLLLHHIAADGWSLAPLTRDLSKAYRARckgeapELA 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2240 ALRIQYKDYAVWQEGF---KTGDAYKM--QEAYWLKQLEGeLPV-LDLPADHARPPVRSFAGDKVSFTLEPEVASGLHKL 2313
Cdd:cd19538 162 PLPVQYADYALWQQELlgdESDPDSLIarQLAYWKKQLAG-LPDeIELPTDYPRPAESSYEGGTLTFEIDSELHQQLLQL 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2314 ARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHKDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRETALEA 2393
Cdd:cd19538 241 AKDNNVTLFMVLQAGFAALLTRLGAGTDIPIGSPVAGRNDDSLEDLVGFFVNTLVLRTDTSGNPSFRELLERVKETNLEA 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2394 FEHQNYPFEELVDKLELTRDMSRNPVFDAMLVVQNNDYEPLHLHDLQMKPAQVSHLVSKFDLTLQ-----ASEGDGNIHF 2468
Cdd:cd19538 321 YEHQDIPFERLVEALNPTRSRSRHPLFQIMLALQNTPQPSLDLPGLEAKLELRTVGSAKFDLTFElreqyNDGTPNGIEG 400
|
410 420 430
....*....|....*....|....*....|..
gi 1678550997 2469 LFEYSTALFEKTTIERWASHLTNVLSIIGKNP 2500
Cdd:cd19538 401 FIEYRTDLFDHETIEALAQRYLLLLESAVENP 432
|
|
| AMP-binding |
pfam00501 |
AMP-binding enzyme; |
2539-2932 |
6.37e-111 |
|
AMP-binding enzyme;
Pssm-ID: 459834 [Multi-domain] Cd Length: 417 Bit Score: 360.86 E-value: 6.37e-111
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2539 FEQQAARTPKASALVSGD-KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEY 2617
Cdd:pfam00501 1 LERQAARTPDKTALEVGEgRRLTYRELDERANRLAAGLRALGVGKGDRVAILLPNSPEWVVAFLACLKAGAVYVPLNPRL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2618 PKERKRYILSDSGTKLLMTINEADLGVLADFEG-------------------EILTIESVEEDDKSPLPQMSSAHHLAYI 2678
Cdd:pfam00501 81 PAEELAYILEDSGAKVLITDDALKLEELLEALGklevvklvlvldrdpvlkeEPLPEEAKPADVPPPPPPPPDPDDLAYI 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2679 IYTSGTTGRPKGVMVEHKGIANTLQW----RRNAYAFNETDTILQLFSFSFD-GFITSMFTPLLSGAKAVLLHEEEAKDI 2753
Cdd:pfam00501 161 IYTSGTTGKPKGVMLTHRNLVANVLSikrvRPRGFGLGPDDRVLSTLPLFHDfGLSLGLLGPLLAGATVVLPPGFPALDP 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2754 LAIKHQLSRQRITHMIIVPVLYRALLDV--VQPEDVKTLRVVTLAGEAADRELIARSLAICPHtELANEYGPTENS-VAT 2830
Cdd:pfam00501 241 AALLELIERYKVTVLYGVPTLLNMLLEAgaPKRALLSSLRLVLSGGAPLPPELARRFRELFGG-ALVNGYGLTETTgVVT 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2831 TVMRHMEKQAYV-SIGQPIDGTQVLILNSNH-QLQPIGVAGELCIAGTGLARGYVNLPELTERAFTqnpfkpEARMYRTG 2908
Cdd:pfam00501 320 TPLPLDEDLRSLgSVGRPLPGTEVKIVDDETgEPVPPGEPGELCVRGPGVMKGYLNDPELTAEAFD------EDGWYRTG 393
|
410 420
....*....|....*....|....
gi 1678550997 2909 DAARWMADGTLEYLGRIDDQVKIR 2932
Cdd:pfam00501 394 DLGRRDEDGYLEIVGRKKDQIKLG 417
|
|
| LCL_NRPS |
cd19538 |
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; ... |
1058-1460 |
2.28e-110 |
|
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380461 [Multi-domain] Cd Length: 432 Bit Score: 360.04 E-value: 2.28e-110
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1058 PVSSAQKRIYVLQQLdEGV--AYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSgADDEPVQRIHTE----VPF 1131
Cdd:cd19538 3 PLSFAQRRLWFLHQL-EGPsaTYNIPLVIKLKGKLDVQALQQALYDVVERHESLRTVFPE-EDGVPYQLILEEdeatPKL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1132 TLSK------ETTIEGFVR-PFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYANR------QL 1198
Cdd:cd19538 81 EIKEvdeeelESEINEAVRyPFDLSEEPPFRATLFELGENEHVLLLLLHHIAADGWSLAPLTRDLSKAYRARckgeapEL 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1199 KPLRIQYKDYAVWQQKFKKGDSYQ-----KQETYWQQQFSGdLP-ILELPTDKRRPAERQFIGGKVTFQLDKEITARIKR 1272
Cdd:cd19538 161 APLPVQYADYALWQQELLGDESDPdsliaRQLAYWKKQLAG-LPdEIELPTDYPRPAESSYEGGTLTFEIDSELHQQLLQ 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1273 LAHKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPHADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQTALE 1352
Cdd:cd19538 240 LAKDNNVTLFMVLQAGFAALLTRLGAGTDIPIGSPVAGRNDDSLEDLVGFFVNTLVLRTDTSGNPSFRELLERVKETNLE 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1353 AYEHQDYPFEELVDKLGVQREMSRNPLFDTTLVLQNMEQQKLKMNDVQLQWNDLEHPISKFDISLYVTEH-----DSELF 1427
Cdd:cd19538 320 AYEHQDIPFERLVEALNPTRSRSRHPLFQIMLALQNTPQPSLDLPGLEAKLELRTVGSAKFDLTFELREQyndgtPNGIE 399
|
410 420 430
....*....|....*....|....*....|...
gi 1678550997 1428 CQFEYSTALFEKETIQRWASLFTTLVEHTAASP 1460
Cdd:cd19538 400 GFIEYRTDLFDHETIEALAQRYLLLLESAVENP 432
|
|
| DltA |
cd05945 |
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes ... |
1504-1983 |
1.46e-108 |
|
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes D-alanyl carrier protein ligase DltA and aliphatic beta-amino acid adenylation enzymes IdnL1 and CmiS6. DltA incorporates D-ala in techoic acids in gram-positive bacteria via a two-step process, starting with adenylation of D-alanine that transfers D-alanine to the D-alanyl carrier protein. IdnL1, a short-chain aliphatic beta-amino acid adenylation enzyme, recognizes 3-aminobutanoic acid, and is involved in the synthesis of the macrolactam antibiotic incednine. CmiS6 is a medium-chain beta-amino acid adenylation enzyme that recognizes 3-aminononanoic acid, and is involved in the synthesis of cremimycin, also a macrolactam antibiotic. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341267 [Multi-domain] Cd Length: 449 Bit Score: 355.40 E-value: 1.46e-108
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1504 AEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERI 1583
Cdd:cd05945 1 AAANPDRPAVVEGGRTLTYRELKERADALAAALASLGLDAGDPVVVYGHKSPDAIAAFLAALKAGHAYVPLDASSPAERI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1584 SFLLEDSGTNILLlqsaglhvpeftgeivylnqtnsglahrlsnpnvdVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNF 1663
Cdd:cd05945 81 REILDAAKPALLI-----------------------------------ADGDDNAYIIFTSGSTGRPKGVQISHDNLVSF 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1664 LNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEH 1743
Cdd:cd05945 126 TNWMLSDFPLGPGDVFLNQAPFSFDLSVMDLYPALASGATLVPVPRDATADPKQLFRFLAEHGITVWVSTPSFAAMCLLS 205
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1744 IKYrsVPIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFDCPPH--EKLERIPIGKPVHHVRL 1821
Cdd:cd05945 206 PTF--TPESLPSLRHFLFCGEVLPHKTARALQQRFPDARIYNTYGPTEATVAVTYIEVTPEvlDGYDRLPIGYAKPGAKL 283
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1822 YLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPfypGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRG 1901
Cdd:cd05945 284 VILDEDGRPVPPGEKGELVISGPSVSKGYLNNPEKTAAAFFPDE---GQRAYRTGDLVRLEADGLLFYRGRLDFQVKLNG 360
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1902 YRIEPGEIEAALRSIEGVREAAVTVRTDS-GEPELCAYVEG------LQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTP 1974
Cdd:cd05945 361 YRIELEEIEAALRQVPGVKEAVVVPKYKGeKVTELIAFVVPkpgaeaGLTKAIKAELAERLPPYMIPRRFVYLDELPLNA 440
|
....*....
gi 1678550997 1975 SGKLDRNAL 1983
Cdd:cd05945 441 NGKIDRKAL 449
|
|
| DltA |
cd05945 |
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes ... |
473-952 |
1.83e-107 |
|
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes D-alanyl carrier protein ligase DltA and aliphatic beta-amino acid adenylation enzymes IdnL1 and CmiS6. DltA incorporates D-ala in techoic acids in gram-positive bacteria via a two-step process, starting with adenylation of D-alanine that transfers D-alanine to the D-alanyl carrier protein. IdnL1, a short-chain aliphatic beta-amino acid adenylation enzyme, recognizes 3-aminobutanoic acid, and is involved in the synthesis of the macrolactam antibiotic incednine. CmiS6 is a medium-chain beta-amino acid adenylation enzyme that recognizes 3-aminononanoic acid, and is involved in the synthesis of cremimycin, also a macrolactam antibiotic. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341267 [Multi-domain] Cd Length: 449 Bit Score: 352.32 E-value: 1.83e-107
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 473 AEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRI 552
Cdd:cd05945 1 AAANPDRPAVVEGGRTLTYRELKERADALAAALASLGLDAGDPVVVYGHKSPDAIAAFLAALKAGHAYVPLDASSPAERI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 553 RYILHDCGCSHVVsqahlpsslednyiithpedieskVDGsniksvnnaDDLLYMIYTSGTTGKPKGVQFEHRNMANLLK 632
Cdd:cd05945 81 REILDAAKPALLI------------------------ADG---------DDNAYIIFTSGSTGRPKGVQISHDNLVSFTN 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 633 FEYTHSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNIVFLPTAFIKMIFSERE 712
Cdd:cd05945 128 WMLSDFPLGPGDVFLNQAPFSFDLSVMDLYPALASGATLVPVPRDATADPKQLFRFLAEHGITVWVSTPSFAAMCLLSPT 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 713 LANSFPDGVKHLIAAGEQLMISDLfqDVLRKR--GIHLHNHYGPSETHVVSTYTIHPGDPIPELP--PIGKPIGCTDLYI 788
Cdd:cd05945 208 FTPESLPSLRHFLFCGEVLPHKTA--RALQQRfpDARIYNTYGPTEATVAVTYIEVTPEVLDGYDrlPIGYAKPGAKLVI 285
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 789 LNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYR 868
Cdd:cd05945 286 LDEDGRPVPPGEKGELVISGPSVSKGYLNNPEKTAAAFFPDEGQR---AYRTGDLVRLEADGLLFYRGRLDFQVKLNGYR 362
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 869 IEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYC---SVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNG 945
Cdd:cd05945 363 IELEEIEAALRQVPGVKEAVVVPKYKGEKVTELIAFVVpkpGAEAGLTKAIKAELAERLPPYMIPRRFVYLDELPLNANG 442
|
....*..
gi 1678550997 946 KVDRAAL 952
Cdd:cd05945 443 KIDRKAL 449
|
|
| A_NRPS_ACVS-like |
cd17648 |
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV ... |
477-953 |
1.60e-106 |
|
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV synthetase (ACVS, EC 6.3.2.26; also known as N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase or delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase) is involved in medically important antibiotic biosynthesis. ACV synthetase is active in an early step in the penicillin G biosynthesis pathway which involves the formation of the tripeptide 6-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine (ACV); each of the constituent amino acids of the tripeptide ACV are activated as aminoacyl-adenylates with peptide bonds formed through the participation of amino acid thioester intermediates. ACV is then cyclized by the action of isopenicillin N synthase.
Pssm-ID: 341303 [Multi-domain] Cd Length: 453 Bit Score: 349.78 E-value: 1.60e-106
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 477 PDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVR-QEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYI 555
Cdd:cd17648 1 PDRVAVVYGDKRLTYRELNERANRLAHYLLSVAEIRpDDLVGLVLDKSELMIIAILAVWKAGAAYVPIDPSYPDERIQFI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 556 LHDcgcshvvSQAHLpsslednyIITHPEdieskvdgsniksvnnadDLLYMIYTSGTTGKPKGVQFEHRNMANL---LK 632
Cdd:cd17648 81 LED-------TGARV--------VITNST------------------DLAYAIYTSGTTGKPKGVLVEHGSVVNLrtsLS 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 633 FEYTHSGIDFEAdVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQ-TNIVFLPTafikmIFSER 711
Cdd:cd17648 128 ERYFGRDNGDEA-VLFFSNYVFDFFVEQMTLALLNGQKLVVPPDEMRFDPDRFYAYINREKvTYLSGTPS-----VLQQY 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 712 ELANSfpDGVKHLIAAGEQLMISDLfqDVLRKR-GIHLHNHYGPSETHVVSTYTIHPGDPiPELPPIGKPIGCTDLYILN 790
Cdd:cd17648 202 DLARL--PHLKRVDAAGEEFTAPVF--EKLRSRfAGLIINAYGPTETTVTNHKRFFPGDQ-RFDKSLGRPVRNTKCYVLN 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 791 HQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPD--------VIMYRTGDLARRLEDGNIEYIGRADNQV 862
Cdd:cd17648 277 DAMKRVPVGAVGELYLGGDGVARGYLNRPELTAERFLPNPFQTEqerargrnARLYKTGDLVRWLPSGELEYLGRNDFQV 356
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 863 KIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHE-----LCAYY-CSVQKLNTIDLRSYMASELPEYMIPAKWIWV 936
Cdd:cd17648 357 KIRGQRIEPGEVEAALASYPGVRECAVVAKEDASQAQSriqkyLVGYYlPEPGHVPESDLLSFLRAKLPRYMVPARLVRL 436
|
490
....*....|....*..
gi 1678550997 937 DSIPLTPNGKVDRAALP 953
Cdd:cd17648 437 EGIPVTINGKLDVRALP 453
|
|
| MenE/FadK |
COG0318 |
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid ... |
465-954 |
2.64e-104 |
|
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) is part of the Pathway/BioSystem: Menaquinone biosynthesis
Pssm-ID: 440087 [Multi-domain] Cd Length: 452 Bit Score: 343.33 E-value: 2.64e-104
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 465 IHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVD 544
Cdd:COG0318 1 LADLLRRAAARHPDRPALVFGGRRLTYAELDARARRLAAALRALGVGPGDRVALLLPNSPEFVVAFLAALRAGAVVVPLN 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 545 PHYPADRIRYILHDCGCSHVVSqahlpsslednyiithpedieskvdgsniksvnnaddlLYMIYTSGTTGKPKGVQFEH 624
Cdd:COG0318 81 PRLTAEELAYILEDSGARALVT--------------------------------------ALILYTSGTTGRPKGVMLTH 122
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 625 RNMANLLKFEYTHSGIDfEADVLQFATPSFDV--CYQEIFSALLKGGTLHIVPeaiKRDVPQLFAFINKHQTNIVFLPTA 702
Cdd:COG0318 123 RNLLANAAAIAAALGLT-PGDVVLVALPLFHVfgLTVGLLAPLLAGATLVLLP---RFDPERVLELIERERVTVLFGVPT 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 703 FIKMIFSERELANSFPDGVKHLIAAGEQLMIsDLFQDVLRKRGIHLHNHYGPSETHVVSTYTihPGDPIPELP-PIGKPI 781
Cdd:COG0318 199 MLARLLRHPEFARYDLSSLRLVVSGGAPLPP-ELLERFEERFGVRIVEGYGLTETSPVVTVN--PEDPGERRPgSVGRPL 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 782 GCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSsDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQ 861
Cdd:COG0318 276 PGVEVRIVDEDGRELPPGEVGEIVVRGPNVMKGYWNDPEATAEAFR-DGW------LRTGDLGRLDEDGYLYIVGRKKDM 348
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 862 VKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCSV--QKLNTIDLRSYMASELPEYMIPAKWIWVDSI 939
Cdd:COG0318 349 IISGGENVYPAEVEEVLAAHPGVAEAAVVGVPDEKWGERVVAFVVLRpgAELDAEELRAFLRERLARYKVPRRVEFVDEL 428
|
490
....*....|....*
gi 1678550997 940 PLTPNGKVDRAALPE 954
Cdd:COG0318 429 PRTASGKIDRRALRE 443
|
|
| A_NRPS_TlmIV_like |
cd12114 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including ... |
477-952 |
7.49e-104 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Streptoalloteichus tallysomycin biosynthesis genes; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the TLM biosynthetic gene cluster from Streptoalloteichus that consists of nine NRPS genes; the N-terminal module of TlmVI (NRPS-5) and the starter module of BlmVI (NRPS-5) are comprised of the acyl CoA ligase (AL) and acyl carrier protein (ACP)-like domains, which are thought to be involved in the biosynthesis of the beta-aminoalaninamide moiety.
Pssm-ID: 341279 [Multi-domain] Cd Length: 477 Bit Score: 343.10 E-value: 7.49e-104
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 477 PDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYIL 556
Cdd:cd12114 1 PDATAVICGDGTLTYGELAERARRVAGALKAAGVRPGDLVAVTLPKGPEQVVAVLGILAAGAAYVPVDIDQPAARREAIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 557 HDCGCSHVVSQAHLPSSLEDNYIITHPEDIESKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEYT 636
Cdd:cd12114 81 ADAGARLVLTDGPDAQLDVAVFDVLILDLDALAAPAPPPPVDVAPDDLAYVIFTSGSTGTPKGVMISHRAALNTILDINR 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 637 HSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNI-VFLPtAFIKMIFSERELAN 715
Cdd:cd12114 161 RFAVGPDDRVLALSSLSFDLSVYDIFGALSAGATLVLPDEARRRDPAHWAELIERHGVTLwNSVP-ALLEMLLDVLEAAQ 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 716 SFPDGVKhliaageQLMIS------DLfQDVLRKR--GIHLHNHYGPSETHVVSTYtiHP-GDPIPELPPI--GKPIGCT 784
Cdd:cd12114 240 ALLPSLR-------LVLLSgdwiplDL-PARLRALapDARLISLGGATEASIWSIY--HPiDEVPPDWRSIpyGRPLANQ 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 785 DLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPfkPDVIMYRTGDLARRLEDGNIEYIGRADNQVKI 864
Cdd:cd12114 310 RYRVLDPRGRDCPDWVPGELWIGGRGVALGYLGDPELTAARFVTHP--DGERLYRTGDLGRYRPDGTLEFLGRRDGQVKV 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 865 RGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHeLCAYYCSVQKLNTI---DLRSYMASELPEYMIPAKWIWVDSIPL 941
Cdd:cd12114 388 RGYRIELGEIEAALQAHPGVARAVVVVLGDPGGKR-LAAFVVPDNDGTPIapdALRAFLAQTLPAYMIPSRVIALEALPL 466
|
490
....*....|.
gi 1678550997 942 TPNGKVDRAAL 952
Cdd:cd12114 467 TANGKVDRAAL 477
|
|
| alpha_am_amid |
TIGR03443 |
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are ... |
1228-2085 |
4.43e-102 |
|
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), product of the LYS2 gene. It is also called alpha-aminoadipate reductase. In fungi, lysine is synthesized via aminoadipate. Currently, all members of this family are fungal.
Pssm-ID: 274582 [Multi-domain] Cd Length: 1389 Bit Score: 362.85 E-value: 4.43e-102
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1228 WQQQFSgDLPILELPTDKRRPAERQFIGGKVTFQLDKEitarikRLAHKNRSTLYMTLLALYSAFLSRLSGQDDIVIG-- 1305
Cdd:TIGR03443 2 WSERLD-NPTLSVLPHDYLRPANNRLVEATYSLQLPSA------EVTAGGGSTPFIILLAAFAALVYRLTGDEDIVLGts 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1306 SPIAGRPhadleavlgmfvntLALRTRPAGNKTFEEFLKEVRQTALEAYEHQDYPFEELVDKLGVQREMSRNP-LFDTTL 1384
Cdd:TIGR03443 75 SNKSGRP--------------FVLRLNITPELSFLQLYAKVSEEEKEGASDIGVPFDELSEHIQAAKKLERTPpLFRLAF 140
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1385 VLQNMEQQKlkmndvqlqwNDLEHPISkfDISLYVTEHDSELFCQFEYSTALFEKETIQRWASLFTTLVEHTAASPETEL 1464
Cdd:TIGR03443 141 QDAPDNQQT----------TYSTGSTT--DLTVFLTPSSPELELSIYYNSLLFSSDRITIVADQLAQLLSAASSNPDEPI 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1465 DNIPILTkEEERDFIE--SCHLfEETGYsmNQTLHYALEQQAEKTPDQAAVI----FEDG-----VMTYKELNEQANRIA 1533
Cdd:TIGR03443 209 GKVSLIT-PSQKSLLPdpTKDL-DWSGF--RGAIHDIFADNAEKHPDRTCVVetpsFLDPssktrSFTYKQINEASNILA 284
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1534 WELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILL-LQSAGLHVP------- 1605
Cdd:TIGR03443 285 HYLLKTGIKRGDVVMIYAYRGVDLVVAVMGVLKAGATFSVIDPAYPPARQTIYLSVAKPRALIvIEKAGTLDQlvrdyid 364
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1606 ---EFTGEIVYLNQTNSG--LAHRLSNPNVDVLPQSLAY------VI----------YTSGSTGMPKGVEIEHRSAVNFL 1664
Cdd:TIGR03443 365 kelELRTEIPALALQDDGslVGGSLEGGETDVLAPYQALkdtptgVVvgpdsnptlsFTSGSEGIPKGVLGRHFSLAYYF 444
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1665 NSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPSM---LHAfl 1741
Cdd:TIGR03443 445 PWMAKRFGLSENDKFTMLSGIAHDPIQRDMFTPLFLGAQLLVPTADDIGTPGRLAEWMAKYGATVTHLTPAMgqlLSA-- 522
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1742 ehikYRSVPIKTnrLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFDCPPH-------EKLER-IPIG 1813
Cdd:TIGR03443 523 ----QATTPIPS--LHHAFFVGDILTKRDCLRLQTLAENVCIVNMYGTTETQRAVSYFEIPSRssdstflKNLKDvMPAG 596
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1814 KPVHHVRLYLLNQNQRMLP--VGCIGELYIAGAGVARGYLNRPALTEERFL--------------------EDPFY--PG 1869
Cdd:TIGR03443 597 KGMKNVQLLVVNRNDRTQTcgVGEVGEIYVRAGGLAEGYLGLPELNAEKFVnnwfvdpshwidldkennkpEREFWlgPR 676
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1870 ERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTD-SGEPELCAY---------- 1938
Cdd:TIGR03443 677 DRLYRTGDLGRYLPDGNVECCGRADDQVKIRGFRIELGEIDTHLSQHPLVRENVTLVRRDkDEEPTLVSYivpqdksdel 756
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1939 ----------------VEGLQR-----NEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNALP----------APG 1987
Cdd:TIGR03443 757 eefksevddeessdpvVKGLIKyrkliKDIREYLKKKLPSYAIPTVIVPLKKLPLNPNGKVDKPALPfpdtaqlaavAKN 836
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1988 GAADAETYTAprNVTEMKLSQLWEDVLKNGP--VGIHDNFFDRGGHSLKATALVSRITKEFDVQVPLKDVFAHPTVEGLA 2065
Cdd:TIGR03443 837 RSASAADEEF--TETEREIRDLWLELLPNRPatISPDDSFFDLGGHSILATRMIFELRKKLNVELPLGLIFKSPTIKGFA 914
|
970 980
....*....|....*....|....*
gi 1678550997 2066 TVIR-----EGTDSPYEAIKPAEKQ 2085
Cdd:TIGR03443 915 KEVDrlkkgEELADEGDSEIEEEET 939
|
|
| Condensation |
pfam00668 |
Condensation domain; This domain is found in many multi-domain enzymes which synthesize ... |
3116-3589 |
6.93e-96 |
|
Condensation domain; This domain is found in many multi-domain enzymes which synthesize peptide antibiotics. This domain catalyzes a condensation reaction to form peptide bonds in non- ribosomal peptide biosynthesis. It is usually found to the carboxy side of a phosphopantetheine binding domain (pfam00550). It has been shown that mutations in the HHXXXDG motif abolish activity suggesting this is part of the active site.
Pssm-ID: 395541 [Multi-domain] Cd Length: 454 Bit Score: 319.28 E-value: 6.93e-96
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3116 VEGDVQWSPVQK--WFLSQDIKEKHHFNQSVMLHRSTSVQEDALRKTLKAITCHHDALRMVFTQNEQGKWDQYNRPLSHS 3193
Cdd:pfam00668 1 VQDEYPLSPAQKrmWFLEKLEPHSSAYNMPAVLKLTGELDPERLEKALQELINRHDALRTVFIRQENGEPVQVILEERPF 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3194 DdalygLQMIDLSAPDGTDGNRPYEPLIKRhvlDIQQKMDLKNGPLLQAGLF-HTIDGDFLFLSAHHLVVDGISWRVLLE 3272
Cdd:pfam00668 81 E-----LEIIDISDLSESEEEEAIEAFIQR---DLQSPFDLEKGPLFRAGLFrIAENRHHLLLSMHHIIVDGVSLGILLR 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3273 DLALGYRQAAGGEDIKLPPKTSsFKAYAKKLSDYAESQQLMKQLKYWRE--AEEYQTEALPFDQIDgTRAHEGQRSTISF 3350
Cdd:pfam00668 153 DLADLYQQLLKGEPLPLPPKTP-YKDYAEWLQQYLQSEDYQKDAAYWLEqlEGELPVLQLPKDYAR-PADRSFKGDRLSF 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3351 TLnDKETAALLKDANSAYNTDTQDMLLASVILALRHWTNQSAFKLSLEGHGREdvlkGIDVSRTIGWFTAIYPLLIKLNA 3430
Cdd:pfam00668 231 TL-DEDTEELLRKLAKAHGTTLNDVLLAAYGLLLSRYTGQDDIVVGTPGSGRP----SPDIERMVGMFVNTLPLRIDPKG 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3431 DlpdseESMVHVLKTTKDTLRRV-PDKGFGYGVIKYLTP-PGKKDINFTGAPEISF-NYLGQFEsgrtaevpEEDAFSFS 3507
Cdd:pfam00668 306 G-----KTFSELIKRVQEDLLSAePHQGYPFGDLVNDLRlPRDLSRHPLFDPMFSFqNYLGQDS--------QEEEFQLS 372
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3508 PLGAGGDISTTWNREQSLDISAIAAEGKLTVNMTYDNARFQRKTIEQLSETCRQFLLQLIEHCQNKSETEKTISDFDDQE 3587
Cdd:pfam00668 373 ELDLSVSSVIEEEAKYDLSLTASERGGGLTIKIDYNTSLFDEETIERFAEHFKELLEQAIAHPSQPLSELDLLSDAEKQK 452
|
..
gi 1678550997 3588 LT 3589
Cdd:pfam00668 453 LL 454
|
|
| SgcC5_NRPS-like |
cd19539 |
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- ... |
1058-1460 |
1.67e-94 |
|
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- bond forming activity and similar C-domains of modular NRPSs; SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. This subfamily also includes similar C-domains of modular NRPSs such as Penicillium chrysogenum N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase PCBAB. Condensation (C) domains of NRPSs normally catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380462 [Multi-domain] Cd Length: 427 Bit Score: 314.32 E-value: 1.67e-94
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1058 PVSSAQKRIYVLQQLDEG-VAYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSGADDEPVQRI---------HT 1127
Cdd:cd19539 3 PLSFAQERLWFIDQGEDGgPAYNIPGAWRLTGPLDVEALREALRDVVARHEALRTLLVRDDGGVPRQEIlppgpapleVR 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1128 EVPFTLSK-ETTIEGFVR-----PFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYANRQ---- 1197
Cdd:cd19539 83 DLSDPDSDrERRLEELLReresrGFDLDEEPPIRAVLGRFDPDDHVLVLVAHHTAFDAWSLDVFARDLAALYAARRkgpa 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1198 --LKPLRIQYKDYAVWQQKFKKGDSYQKQETYWQQQFSGdLPILELPTDKRRPAERQFIGGKVTFQLDKEITARIKRLAH 1275
Cdd:cd19539 163 apLPELRQQYKEYAAWQREALAAPRAAELLDFWRRRLRG-AEPTALPTDRPRPAGFPYPGADLRFELDAELVAALRELAK 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1276 KNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPHADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQTALEAYE 1355
Cdd:cd19539 242 RARSSLFMVLLAAYCVLLRRYTGQTDIVVGTPVAGRNHPRFESTVGFFVNLLPLRVDVSDCATFRDLIARVRKALVDAQR 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1356 HQDYPFEELVDKLGVQREMSRNPLFDTTLVLQN---MEQQKLKMNDVQLQWndLEHPISKFDISLYVTEHDSELFCQFEY 1432
Cdd:cd19539 322 HQELPFQQLVAELPVDRDAGRHPLVQIVFQVTNapaGELELAGGLSYTEGS--DIPDGAKFDLNLTVTEEGTGLRGSLGY 399
|
410 420
....*....|....*....|....*...
gi 1678550997 1433 STALFEKETIQRWASLFTTLVEHTAASP 1460
Cdd:cd19539 400 ATSLFDEETIQGFLADYLQVLRQLLANP 427
|
|
| SgcC5_NRPS-like |
cd19539 |
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- ... |
2089-2493 |
1.38e-91 |
|
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- bond forming activity and similar C-domains of modular NRPSs; SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. This subfamily also includes similar C-domains of modular NRPSs such as Penicillium chrysogenum N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase PCBAB. Condensation (C) domains of NRPSs normally catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380462 [Multi-domain] Cd Length: 427 Bit Score: 305.84 E-value: 1.38e-91
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2089 PVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGDPVQRIHDEVPFTLQTT 2168
Cdd:cd19539 3 PLSFAQERLWFIDQGEDGGPAYNIPGAWRLTGPLDVEALREALRDVVARHEALRTLLVRDDGGVPRQEILPPGPAPLEVR 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2169 VLGARTEQEAAAAFI-------KPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELYNNRK---- 2237
Cdd:cd19539 83 DLSDPDSDRERRLEEllreresRGFDLDEEPPIRAVLGRFDPDDHVLVLVAHHTAFDAWSLDVFARDLAALYAARRkgpa 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2238 --LPALRIQYKDYAVWQEGFKTGDAYKMQEAYWLKQLEGeLPVLDLPADHARPPVRSFAGDKVSFTLEPEVASGLHKLAR 2315
Cdd:cd19539 163 apLPELRQQYKEYAAWQREALAAPRAAELLDFWRRRLRG-AEPTALPTDRPRPAGFPYPGADLRFELDAELVAALRELAK 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2316 ENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHKDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRETALEAFE 2395
Cdd:cd19539 242 RARSSLFMVLLAAYCVLLRRYTGQTDIVVGTPVAGRNHPRFESTVGFFVNLLPLRVDVSDCATFRDLIARVRKALVDAQR 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2396 HQNYPFEELVDKLELTRDMSRNPVFDAMLVVQNNDYEPLHLH-DLQMKPAQVSHLVSKFDLTLQASEGDGNIHFLFEYST 2474
Cdd:cd19539 322 HQELPFQQLVAELPVDRDAGRHPLVQIVFQVTNAPAGELELAgGLSYTEGSDIPDGAKFDLNLTVTEEGTGLRGSLGYAT 401
|
410
....*....|....*....
gi 1678550997 2475 ALFEKTTIERWASHLTNVL 2493
Cdd:cd19539 402 SLFDEETIQGFLADYLQVL 420
|
|
| DCL_NRPS-like |
cd19536 |
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal ... |
10-433 |
2.95e-91 |
|
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal fungal CT domains and Dual Epimerization/Condensation (E/C) domains; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type [D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L))], which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380459 [Multi-domain] Cd Length: 419 Bit Score: 304.37 E-value: 2.95e-91
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 10 IYPLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNVSSPQQVVLRERNVIVL 89
Cdd:cd19536 1 MYPLSSLQEGMLFHSLLNPGGSVYLHNYTYTVGRRLNLDLLLEALQVLIDRHDILRTSFIEDGLGQPVQVVHRQAQVPVT 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 90 EEDITHLNEAEQSqfIEQWKEKDRDRGFHLQKDVLMRIALI-QTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASYV 168
Cdd:cd19536 81 ELDLTPLEEQLDP--LRAYKEETKIRRFDLGRAPLVRAALVrKDERERFLLVISDHHSILDGWSLYLLVKEILAVYNQLL 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 169 NASPITLEPVQPYGKYIKWLMEQ-DKEQAVSYWDHYLSGHEQQTVLPKQKKTKGKSRQEHVTFsFSKEESSRLSELAARE 247
Cdd:cd19536 159 EYKPLSLPPAQPYRDFVAHERASiQQAASERYWREYLAGATLATLPALSEAVGGGPEQDSELL-VSVPLPVRSRSLAKRS 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 248 EVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRPAEIEGIEHMVGLFINTMPVRVQGAKTPFLQLIKDMQKDRLAAEAY 327
Cdd:cd19536 238 GIPLSTLLLAAWALVLSRHSGSDDVVFGTVVHGRSEETTGAERLLGLFLNTLPLRVTLSEETVEDLLKRAQEQELESLSH 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 328 SYHPLYEIQSRSAvKQGLIDHILVFENYPVQQEIQmLNKQEHASDLFQIHNFTVadeTNYSFYLMVAP-GEEIHIKMNYD 406
Cdd:cd19536 318 EQVPLADIQRCSE-GEPLFDSIVNFRHFDLDFGLP-EWGSDEGMRRGLLFSEFK---SNYDVNLSVLPkQDRLELKLAYN 392
|
410 420
....*....|....*....|....*..
gi 1678550997 407 AEQHDRSFVLSVKEHLLNAVSQILNNP 433
Cdd:cd19536 393 SQVLDEEQAQRLAAYYKSAIAELATAP 419
|
|
| COG4908 |
COG4908 |
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General ... |
2090-2322 |
1.97e-81 |
|
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General function prediction only];
Pssm-ID: 443936 [Multi-domain] Cd Length: 243 Bit Score: 269.22 E-value: 1.97e-81
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2090 VSSAQKRIYVLqqlEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGdPVQRIHDEVPFTLQTTV 2169
Cdd:COG4908 1 LSPAQKRFLFL---EPGSNAYNIPAVLRLEGPLDVEALERALRELVRRHPALRTRFVEEDGE-PVQRIDPDADLPLEVVD 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2170 LG--------ARTEQEAAAAFIKPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELYNNR----- 2236
Cdd:COG4908 77 LSalpepereAELEELVAEEASRPFDLARGPLLRAALIRLGEDEHVLLLTIHHIISDGWSLGILLRELAALYAALlegep 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2237 -KLPALRIQYKDYAVWQEGFKTGDAYKMQEAYWLKQLEGELPVLDLPADHARPPVRSFAGDKVSFTLEPEVASGLHKLAR 2315
Cdd:COG4908 157 pPLPELPIQYADYAAWQRAWLQSEALEKQLEYWRQQLAGAPPVLELPTDRPRPAVQTFRGATLSFTLPAELTEALKALAK 236
|
....*..
gi 1678550997 2316 ENGSTLY 2322
Cdd:COG4908 237 AHGATVN 243
|
|
| C_NRPS-like |
cd19066 |
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of ... |
2088-2500 |
2.28e-80 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long, with various activities such as antibiotic, antifungal, antitumor and immunosuppression. There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380453 [Multi-domain] Cd Length: 427 Bit Score: 273.52 E-value: 2.28e-80
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2088 YPVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQdEGGDPVQRIHDEVPFTL-- 2165
Cdd:cd19066 2 IPLSPMQRGMWFLKKLATDPSAFNVAIEMFLTGSLDLARLKQALDAVMERHDVLRTRFCE-EAGRYEQVVLDKTVRFRie 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2166 -----QTTVLGARTEQEAAAAFIKPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELYN-----N 2235
Cdd:cd19066 81 iidlrNLADPEARLLELIDQIQQTIYDLERGPLVRVALFRLADERDVLVVAIHHIIVDGGSFQILFEDISSVYDaaerqK 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2236 RKLPALRIQYKDYAVWQEGFKTGDAYKMQEAYWLKQLEGELPVLDLPADHARPPVRSFAGDKVSFTLEPEVASGLHKLAR 2315
Cdd:cd19066 161 PTLPPPVGSYADYAAWLEKQLESEAAQADLAYWTSYLHGLPPPLPLPKAKRPSQVASYEVLTLEFFLRSEETKRLREVAR 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2316 ENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHKDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRETALEAFE 2395
Cdd:cd19066 241 ESGTTPTQLLLAAFALALKRLTASIDVVIGLTFLNRPDEAVEDTIGLFLNLLPLRIDTSPDATFPELLKRTKEQSREAIE 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2396 HQNYPFEELVDKLELTRDMSRNPVFDAMLVVQNNdYEPLHLHDLQMKPAQVSHLV--SKFDLTLQASEG-DGNIHFLFEY 2472
Cdd:cd19066 321 HQRVPFIELVRHLGVVPEAPKHPLFEPVFTFKNN-QQQLGKTGGFIFTTPVYTSSegTVFDLDLEASEDpDGDLLLRLEY 399
|
410 420
....*....|....*....|....*...
gi 1678550997 2473 STALFEKTTIERWASHLTNVLSIIGKNP 2500
Cdd:cd19066 400 SRGVYDERTIDRFAERYMTALRQLIENP 427
|
|
| PRK04813 |
PRK04813 |
D-alanine--poly(phosphoribitol) ligase subunit DltA; |
469-952 |
6.29e-80 |
|
D-alanine--poly(phosphoribitol) ligase subunit DltA;
Pssm-ID: 235313 [Multi-domain] Cd Length: 503 Bit Score: 274.85 E-value: 6.29e-80
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 469 FEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYP 548
Cdd:PRK04813 8 IEEFAQTQPDFPAYDYLGEKLTYGQLKEDSDALAAFIDSLKLPDKSPIIVFGHMSPEMLATFLGAVKAGHAYIPVDVSSP 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 549 ADRIRYILHDCGCSHVVSQAHLPSSLEDNYIIThPEDIESKVDGSNIKSVNNA---DDLLYMIYTSGTTGKPKGVQFEHr 625
Cdd:PRK04813 88 AERIEMIIEVAKPSLIIATEELPLEILGIPVIT-LDELKDIFATGNPYDFDHAvkgDDNYYIIFTSGTTGKPKGVQISH- 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 626 nmANLLKFeyTHSGI-DFE-ADVLQF---ATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNI-VFL 699
Cdd:PRK04813 166 --DNLVSF--TNWMLeDFAlPEGPQFlnqAPYSFDLSVMDLYPTLASGGTLVALPKDMTANFKQLFETLPQLPINVwVST 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 700 PTaFIKMIFSEREL-ANSFPDgVKHLIAAGEQLMISDlfQDVLRKR--GIHLHNHYGPSETHV-VSTYTIHPgDPIPELP 775
Cdd:PRK04813 242 PS-FADMCLLDPSFnEEHLPN-LTHFLFCGEELPHKT--AKKLLERfpSATIYNTYGPTEATVaVTSIEITD-EMLDQYK 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 776 --PIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPdviMYRTGDLARrLEDGNIE 853
Cdd:PRK04813 317 rlPIGYAKPDSPLLIIDEEGTKLPDGEQGEIVISGPSVSKGYLNNPEKTAEAFFTFDGQP---AYHTGDAGY-LEDGLLF 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 854 YIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYcsVQKLNTID--------LRSYMASELP 925
Cdd:PRK04813 393 YQGRIDFQIKLNGYRIELEEIEQNLRQSSYVESAVVVPYNKDHKVQYLIAYV--VPKEEDFErefeltkaIKKELKERLM 470
|
490 500
....*....|....*....|....*..
gi 1678550997 926 EYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PRK04813 471 EYMIPRKFIYRDSLPLTPNGKIDRKAL 497
|
|
| D-ala-DACP-lig |
TIGR01734 |
D-alanine--poly(phosphoribitol) ligase, subunit 1; This model represents the enzyme (also ... |
465-954 |
1.64e-79 |
|
D-alanine--poly(phosphoribitol) ligase, subunit 1; This model represents the enzyme (also called D-alanine-D-alanyl carrier protein ligase) which activates D-alanine as an adenylate via the reaction D-ala + ATP -> D-ala-AMP + PPi, and further catalyzes the condensation of the amino acid adenylate with the D-alanyl carrier protein (D-ala-ACP). The D-alanine is then further transferred to teichoic acid in the biosynthesis of lipoteichoic acid (LTA) and wall teichoic acid (WTA) in gram positive bacteria, both polysacchatides. [Cell envelope, Biosynthesis and degradation of murein sacculus and peptidoglycan]
Pssm-ID: 273780 [Multi-domain] Cd Length: 502 Bit Score: 273.56 E-value: 1.64e-79
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 465 IHAMFEkQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVD 544
Cdd:TIGR01734 3 IEAIQA-FAETYPQTIAYRYQGQELTYQQLKEQSDRLAAFIQKRILPKKSPIIVYGHMEPHMLVAFLGSIKSGHAYIPVD 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 545 PHYPADRIRYILHDCGCSHVVSQAHLPSSLEDNYIITHP--EDIESKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQF 622
Cdd:TIGR01734 82 TSIPSERIEMIIEAAGPELVIHTAELSIDAVGTQIITLSalEQAETSGGPVSFDHAVKGDDNYYIIYTSGSTGNPKGVQI 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 623 EHrnmANLLKFeyTHSGI-DF----EADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNIV 697
Cdd:TIGR01734 162 SH---DNLVSF--TNWMLaDFplseGKQFLNQAPFSFDLSVMDLYPCLASGGTLHCLDKDITNNFKLLFEELPKTGLNVW 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 698 FLPTAFIKMI-----FSERELANsfpdgVKHLIAAGEQLMISDLFQDVLRKRGIHLHNHYGPSETHVVSTYTIHPGDPIP 772
Cdd:TIGR01734 237 VSTPSFVDMClldpnFNQENYPH-----LTHFLFCGEELPVKTAKALLERFPKATIYNTYGPTEATVAVTSVKITQEILD 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 773 ELP--PIG--KPIgcTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPdviMYRTGDLARrLE 848
Cdd:TIGR01734 312 QYPrlPIGfaKPD--MNLFIMDEEGEPLPEGEKGEIVIVGPSVSKGYLNNPEKTAEAFFSHEGQP---AYRTGDAGT-IT 385
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 849 DGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAIL-IWQDQNGEHELCAYycSVQKLN--------TIDLRSY 919
Cdd:TIGR01734 386 DGQLFYQGRLDFQIKLHGYRIELEDIEFNLRQSSYIESAVVVpKYNKDHKVEYLIAA--IVPETEdfekefqlTKAIKKE 463
|
490 500 510
....*....|....*....|....*....|....*
gi 1678550997 920 MASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPE 954
Cdd:TIGR01734 464 LKKSLPAYMIPRKFIYRDQLPLTANGKIDRKALAE 498
|
|
| C_PKS-NRPS_PksJ-like |
cd20484 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
1056-1460 |
4.49e-78 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs), similar to Bacillus subtilis PksJ; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily have the typical C-domain HHxxxD motif. PksJ is involved in some intermediate steps for the synthesis of the antibiotic polyketide bacillaene which is important in secondary metabolism. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380472 [Multi-domain] Cd Length: 430 Bit Score: 266.87 E-value: 4.49e-78
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1056 TYPVSSAQKRIYVLQQLDEGV-AYNMPAVLELEGALDVAKLSAVCKELISRHePLRTSFVSGADDEPVQRIHTEVPFTLS 1134
Cdd:cd20484 1 RSPLSEGQKGLWMLQKMSPEMsAYNVPLCFRFSSKLDVEKFKQACQFVLEQH-PILKSVIEEEDGVPFQKIEPSKPLSFQ 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1135 -------KETTIEGFVR-----PFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYanRQL---K 1199
Cdd:cd20484 80 eedisslKESEIIAYLRekakePFVLENGPLMRVHLFSRSEQEHFVLITIHHIIFDGSSSLTLIHSLLDAY--QALlqgK 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1200 PLRIQ-----YKDYAVWQQKFKKGDSYQKQETYWQQQFSGDLPILELPTDKRRPAERQFIGGKVTFQLDKEITARIKRLA 1274
Cdd:cd20484 158 QPTLAsspasYYDFVAWEQDMLAGAEGEEHRAYWKQQLSGTLPILELPADRPRSSAPSFEGQTYTRRLPSELSNQIKSFA 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1275 HKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPHADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQTALEAY 1354
Cdd:cd20484 238 RSQSINLSTVFLGIFKLLLHRYTGQEDIIVGMPTMGRPEERFDSLIGYFINMLPIRSRILGEETFSDFIRKLQLTVLDGL 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1355 EHQDYPFEELVDKLGVQREMSRNPLFDTTLVLQNMeQQKLKMNDVQLQWND---LE-----HPISKFDISLYVTEHDSEL 1426
Cdd:cd20484 318 DHAAYPFPAMVRDLNIPRSQANSPVFQVAFFYQNF-LQSTSLQQFLAEYQDvlsIEfvegiHQEGEYELVLEVYEQEDRF 396
|
410 420 430
....*....|....*....|....*....|....
gi 1678550997 1427 FCQFEYSTALFEKETIQRWASLFTTLVEHTAASP 1460
Cdd:cd20484 397 TLNIKYNPDLFDASTIERMMEHYVKLAEELIANP 430
|
|
| C_NRPS-like |
cd19066 |
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of ... |
1057-1460 |
4.90e-78 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long, with various activities such as antibiotic, antifungal, antitumor and immunosuppression. There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380453 [Multi-domain] Cd Length: 427 Bit Score: 266.58 E-value: 4.90e-78
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1057 YPVSSAQKRIYVLQQLDEG-VAYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSGADD------EPVQRIHTEV 1129
Cdd:cd19066 2 IPLSPMQRGMWFLKKLATDpSAFNVAIEMFLTGSLDLARLKQALDAVMERHDVLRTRFCEEAGRyeqvvlDKTVRFRIEI 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1130 pFTLSKETTIEGFV---------RPFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLY--ANRQL 1198
Cdd:cd19066 82 -IDLRNLADPEARLlelidqiqqTIYDLERGPLVRVALFRLADERDVLVVAIHHIIVDGGSFQILFEDISSVYdaAERQK 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1199 K---PLRIQYKDYAVWQQKFKKGDSYQKQETYWQQQFSGDLPILELPTDKRRPAERQFIGGKVTFQLDKEITARIKRLAH 1275
Cdd:cd19066 161 PtlpPPVGSYADYAAWLEKQLESEAAQADLAYWTSYLHGLPPPLPLPKAKRPSQVASYEVLTLEFFLRSEETKRLREVAR 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1276 KNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPHADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQTALEAYE 1355
Cdd:cd19066 241 ESGTTPTQLLLAAFALALKRLTASIDVVIGLTFLNRPDEAVEDTIGLFLNLLPLRIDTSPDATFPELLKRTKEQSREAIE 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1356 HQDYPFEELVDKLGVQREMSRNPLFDTTLVLQNMEQQKLKMNDVQLQWNDLEHPI-SKFDISLYVTEH-DSELFCQFEYS 1433
Cdd:cd19066 321 HQRVPFIELVRHLGVVPEAPKHPLFEPVFTFKNNQQQLGKTGGFIFTTPVYTSSEgTVFDLDLEASEDpDGDLLLRLEYS 400
|
410 420
....*....|....*....|....*..
gi 1678550997 1434 TALFEKETIQRWASLFTTLVEHTAASP 1460
Cdd:cd19066 401 RGVYDERTIDRFAERYMTALRQLIENP 427
|
|
| PRK04813 |
PRK04813 |
D-alanine--poly(phosphoribitol) ligase subunit DltA; |
1499-1983 |
1.22e-76 |
|
D-alanine--poly(phosphoribitol) ligase subunit DltA;
Pssm-ID: 235313 [Multi-domain] Cd Length: 503 Bit Score: 265.22 E-value: 1.22e-76
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1499 ALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDY 1578
Cdd:PRK04813 7 TIEEFAQTQPDFPAYDYLGEKLTYGQLKEDSDALAAFIDSLKLPDKSPIIVFGHMSPEMLATFLGAVKAGHAYIPVDVSS 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1579 PEERISFLLEDSGTNILL----LQSAGLHVPEFTGEIVylnqTNSGLAHRLSNPNVDVLPQSLAYVIYTSGSTGMPKGVE 1654
Cdd:PRK04813 87 PAERIEMIIEVAKPSLIIateeLPLEILGIPVITLDEL----KDIFATGNPYDFDHAVKGDDNYYIIFTSGTTGKPKGVQ 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1655 IEHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIweLFWWP--YAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHF 1732
Cdd:PRK04813 163 ISHDNLVSFTNWMLEDFALPEGPQFLNQAPYSFDLSV--MDLYPtlASGGTLVALPKDMTANFKQLFETLPQLPINVWVS 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1733 VPS------MLHAFLEHikyrsvpiKTNRLKRVFSGGEQLgTH-----LVSRFyellPNVSITNSYGPTEATV------- 1794
Cdd:PRK04813 241 TPSfadmclLDPSFNEE--------HLPNLTHFLFCGEEL-PHktakkLLERF----PSATIYNTYGPTEATVavtsiei 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1795 --EAAffdcpphEKLERIPIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEdpfYPGERM 1872
Cdd:PRK04813 308 tdEML-------DQYKRLPIGYAKPDSPLLIIDEEGTKLPDGEQGEIVISGPSVSKGYLNNPEKTAEAFFT---FDGQPA 377
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1873 YKTGDVARwLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREA-AVTVRTDSGEPELCAYV---EGLQRNE-- 1946
Cdd:PRK04813 378 YHTGDAGY-LEDGLLFYQGRIDFQIKLNGYRIELEEIEQNLRQSSYVESAvVVPYNKDHKVQYLIAYVvpkEEDFEREfe 456
|
490 500 510 520
....*....|....*....|....*....|....*....|.
gi 1678550997 1947 ----VRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK04813 457 ltkaIKKELKERLMEYMIPRKFIYRDSLPLTPNGKIDRKAL 497
|
|
| D-ala-DACP-lig |
TIGR01734 |
D-alanine--poly(phosphoribitol) ligase, subunit 1; This model represents the enzyme (also ... |
1499-1983 |
1.64e-76 |
|
D-alanine--poly(phosphoribitol) ligase, subunit 1; This model represents the enzyme (also called D-alanine-D-alanyl carrier protein ligase) which activates D-alanine as an adenylate via the reaction D-ala + ATP -> D-ala-AMP + PPi, and further catalyzes the condensation of the amino acid adenylate with the D-alanyl carrier protein (D-ala-ACP). The D-alanine is then further transferred to teichoic acid in the biosynthesis of lipoteichoic acid (LTA) and wall teichoic acid (WTA) in gram positive bacteria, both polysacchatides. [Cell envelope, Biosynthesis and degradation of murein sacculus and peptidoglycan]
Pssm-ID: 273780 [Multi-domain] Cd Length: 502 Bit Score: 264.70 E-value: 1.64e-76
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1499 ALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDY 1578
Cdd:TIGR01734 5 AIQAFAETYPQTIAYRYQGQELTYQQLKEQSDRLAAFIQKRILPKKSPIIVYGHMEPHMLVAFLGSIKSGHAYIPVDTSI 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1579 PEERISFLLEDSGTNiLLLQSAGLHVPEFTGEIVYLNQT----NSGLAHRLSNPnvdVLPQSLAYVIYTSGSTGMPKGVE 1654
Cdd:TIGR01734 85 PSERIEMIIEAAGPE-LVIHTAELSIDAVGTQIITLSALeqaeTSGGPVSFDHA---VKGDDNYYIIYTSGSTGNPKGVQ 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1655 IEHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVP 1734
Cdd:TIGR01734 161 ISHDNLVSFTNWMLADFPLSEGKQFLNQAPFSFDLSVMDLYPCLASGGTLHCLDKDITNNFKLLFEELPKTGLNVWVSTP 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1735 SMLHAFL--EHIKYRSVPiktnRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEA-------AFFDcpphe 1805
Cdd:TIGR01734 241 SFVDMCLldPNFNQENYP----HLTHFLFCGEELPVKTAKALLERFPKATIYNTYGPTEATVAVtsvkitqEILD----- 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1806 KLERIPIG--KPvhHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLedpFYPGERMYKTGDVARwLP 1883
Cdd:TIGR01734 312 QYPRLPIGfaKP--DMNLFIMDEEGEPLPEGEKGEIVIVGPSVSKGYLNNPEKTAEAFF---SHEGQPAYRTGDAGT-IT 385
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1884 DGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDSGEP--ELCAYV---------EGLQRNEVRAQLE 1952
Cdd:TIGR01734 386 DGQLFYQGRLDFQIKLHGYRIELEDIEFNLRQSSYIESAVVVPKYNKDHKveYLIAAIvpetedfekEFQLTKAIKKELK 465
|
490 500 510
....*....|....*....|....*....|.
gi 1678550997 1953 RLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:TIGR01734 466 KSLPAYMIPRKFIYRDQLPLTANGKIDRKAL 496
|
|
| PRK04813 |
PRK04813 |
D-alanine--poly(phosphoribitol) ligase subunit DltA; |
2539-3023 |
5.60e-76 |
|
D-alanine--poly(phosphoribitol) ligase subunit DltA;
Pssm-ID: 235313 [Multi-domain] Cd Length: 503 Bit Score: 263.29 E-value: 5.60e-76
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2539 FEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYP 2618
Cdd:PRK04813 8 IEEFAQTQPDFPAYDYLGEKLTYGQLKEDSDALAAFIDSLKLPDKSPIIVFGHMSPEMLATFLGAVKAGHAYIPVDVSSP 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2619 KERKRYILSDSGTKLLMTINEADLGVLadfEGEILTIESVEED---DKSPLPQMS-SAHHLAYIIYTSGTTGRPKGVMVE 2694
Cdd:PRK04813 88 AERIEMIIEVAKPSLIIATEELPLEIL---GIPVITLDELKDIfatGNPYDFDHAvKGDDNYYIIFTSGTTGKPKGVQIS 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2695 HKGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVL 2774
Cdd:PRK04813 165 HDNLVSFTNWMLEDFALPEGPQFLNQAPYSFDLSVMDLYPTLASGGTLVALPKDMTANFKQLFETLPQLPINVWVSTPSF 244
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2775 YR-ALLDvvqP----EDVKTLRVVTLAGEA----ADRELIARSlaicPHTELANEYGPTENSVATT---VMRHM-EKQAY 2841
Cdd:PRK04813 245 ADmCLLD---PsfneEHLPNLTHFLFCGEElphkTAKKLLERF----PSATIYNTYGPTEATVAVTsieITDEMlDQYKR 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2842 VSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQnpFKPEaRMYRTGDAARwMADGTLEY 2921
Cdd:PRK04813 318 LPIGYAKPDSPLLIIDEEGTKLPDGEQGEIVISGPSVSKGYLNNPEKTAEAFFT--FDGQ-PAYHTGDAGY-LEDGLLFY 393
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2922 LGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGL------STNAVRSELQNKLPVFM 2995
Cdd:PRK04813 394 QGRIDFQIKLNGYRIELEEIEQNLRQSSYVESAVVVPYNKDHKVQYLIAYVVPKEEDferefeLTKAIKKELKERLMEYM 473
|
490 500
....*....|....*....|....*...
gi 1678550997 2996 HPAFIEKLDSLPLSPNGKLDRGALPKPV 3023
Cdd:PRK04813 474 IPRKFIYRDSLPLTPNGKIDRKALIEEV 501
|
|
| C_PKS-NRPS |
cd19532 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
1056-1460 |
8.10e-76 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHxxxD motif, a few such as Monascus pilosus lovastatin nonaketide synthase MokA have a non-canonical HRxxxD motif in the C-domain and are unable to catalyze amide-bond formation. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380455 [Multi-domain] Cd Length: 421 Bit Score: 260.08 E-value: 8.10e-76
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1056 TYPVSSAQKRIYVLQQ-LDEGVAYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSF-VSGADDEPVQRIHTEVPFTL 1133
Cdd:cd19532 1 TEPMSFGQSRFWFLQQyLEDPTTFNVTFSYRLTGPLDVARLERAVRAVGQRHEALRTCFfTDPEDGEPMQGVLASSPLRL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1134 ------SKETTIEGF----VRPFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYANRQLKPLRI 1203
Cdd:cd19532 81 ehvqisDEAEVEEEFerlkNHVYDLESGETMRIVLLSLSPTEHYLIFGYHHIAMDGVSFQIFLRDLERAYNGQPLLPPPL 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1204 QYKDYAVWQQKFKKGDSYQKQETYWQQQFSGD---LPILELPTDKRRPAERQFIGGKVTFQLDKEITARIKRLAHKNRST 1280
Cdd:cd19532 161 QYLDFAARQRQDYESGALDEDLAYWKSEFSTLpepLPLLPFAKVKSRPPLTRYDTHTAERRLDAALAARIKEASRKLRVT 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1281 ---LYmtlLALYSAFLSRLSGQDDIVIGspI--AGRPHADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQTALEAYE 1355
Cdd:cd19532 241 pfhFY---LAALQVLLARLLDVDDICIG--IadANRTDEDFMETIGFFLNLLPLRFRRDPSQTFADVLKETRDKAYAALA 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1356 HQDYPFEELVDKLGVQREMSRNPLFDTTL--VLQNMEQQKL---KMNDVqlQWNDLEHPiskFDISLYVTEHDS-----E 1425
Cdd:cd19532 316 HSRVPFDVLLDELGVPRSATHSPLFQVFInyRQGVAESRPFgdcELEGE--EFEDARTP---YDLSLDIIDNPDgdcllT 390
|
410 420 430
....*....|....*....|....*....|....*
gi 1678550997 1426 LFCQfeysTALFEKETIQRWASLFTTLVEHTAASP 1460
Cdd:cd19532 391 LKVQ----SSLYSEEDAELLLDSYVNLLEAFARDP 421
|
|
| AFD_class_I |
cd04433 |
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as ... |
1637-1979 |
1.26e-75 |
|
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as the ANL (acyl-CoA synthetases, the NRPS adenylation domains, and the Luciferase enzymes) superfamily. It includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases.The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341228 [Multi-domain] Cd Length: 336 Bit Score: 256.06 E-value: 1.26e-75
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1637 LAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGgekEPE 1716
Cdd:cd04433 2 PALILYTSGTTGKPKGVVLSHRNLLAAAAALAASGGLTEGDVFLSTLPLFHIGGLFGLLGALLAGGTVVLLPKF---DPE 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1717 VIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIktNRLKRVFSGGEQLGTHLVSRFYELlPNVSITNSYGPTEATVEA 1796
Cdd:cd04433 79 AALELIEREKVTILLGVPTLLARLLKAPESAGYDL--SSLRALVSGGAPLPPELLERFEEA-PGIKLVNGYGLTETGGTV 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1797 AFfdCPPHEKLERIP-IGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFledpfypGERMYKT 1875
Cdd:cd04433 156 AT--GPPDDDARKPGsVGRPVPGVEVRIVDPDGGELPPGEIGELVVRGPSVMKGYWNNPEATAAVD-------EDGWYRT 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1876 GDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GEpELCAYVE-----GLQRNEVR 1948
Cdd:cd04433 227 GDLGRLDEDGYLYIVGRLKDMIKSGGENVYPAEVEAVLLGHPGVAEAAVVGVPDPewGE-RVVAVVVlrpgaDLDAEELR 305
|
330 340 350
....*....|....*....|....*....|.
gi 1678550997 1949 AQLERLLPGYMVPAYMIEMEQWPVTPSGKLD 1979
Cdd:cd04433 306 AHVRERLAPYKVPRRVVFVDALPRTASGKID 336
|
|
| AFD_class_I |
cd04433 |
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as ... |
2674-3015 |
2.13e-75 |
|
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as the ANL (acyl-CoA synthetases, the NRPS adenylation domains, and the Luciferase enzymes) superfamily. It includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases.The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341228 [Multi-domain] Cd Length: 336 Bit Score: 255.67 E-value: 2.13e-75
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2674 HLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDI 2753
Cdd:cd04433 1 DPALILYTSGTTGKPKGVVLSHRNLLAAAAALAASGGLTEGDVFLSTLPLFHIGGLFGLLGALLAGGTVVLLPKFDPEAA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2754 LAIkhqLSRQRITHMIIVPVLYRALLDV--VQPEDVKTLRVVTLAGEAADRELIARSLAIcPHTELANEYGPTENSVATT 2831
Cdd:cd04433 81 LEL---IEREKVTILLGVPTLLARLLKApeSAGYDLSSLRALVSGGAPLPPELLERFEEA-PGIKLVNGYGLTETGGTVA 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2832 VMR-HMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFtqnpfkpEARMYRTGDA 2910
Cdd:cd04433 157 TGPpDDDARKPGSVGRPVPGVEVRIVDPDGGELPPGEIGELVVRGPSVMKGYWNNPEATAAVD-------EDGWYRTGDL 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2911 ARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPG--LSTNAVRSELQ 2988
Cdd:cd04433 230 GRLDEDGYLYIVGRLKDMIKSGGENVYPAEVEAVLLGHPGVAEAAVVGVPDPEWGERVVAVVVLRPGadLDAEELRAHVR 309
|
330 340
....*....|....*....|....*..
gi 1678550997 2989 NKLPVFMHPAFIEKLDSLPLSPNGKLD 3015
Cdd:cd04433 310 ERLAPYKVPRRVVFVDALPRTASGKID 336
|
|
| C_PKS-NRPS |
cd20483 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
1058-1455 |
2.74e-74 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHXXXD motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380471 [Multi-domain] Cd Length: 430 Bit Score: 255.65 E-value: 2.74e-74
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1058 PVSSAQKRIYVLQQ-LDEGVAYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSGaDDEPVQRIHTEVPFTLSK- 1135
Cdd:cd20483 3 PMSTFQRRLWFLHNfLEDKTFLNLLLVCHIKGKPDVNLLQKALSELVRRHEVLRTAYFEG-DDFGEQQVLDDPSFHLIVi 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1136 --------ETTIEGFVR-----PFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLY---ANRQ-- 1197
Cdd:cd20483 82 dlseaadpEAALDQLVRnlrrqELDIEEGEVIRGWLVKLPDEEFALVLASHHIAWDRGSSKSIFEQFTALYdalRAGRdl 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1198 --LKPLRIQYKDYAVWQQKFKKGDSYQKQETYWQQQFSG--DLPILeLPTDKR-RPAERQFIGGKVTFQLDKEITARIKR 1272
Cdd:cd20483 162 atVPPPPVQYIDFTLWHNALLQSPLVQPLLDFWKEKLEGipDASKL-LPFAKAeRPPVKDYERSTVEATLDKELLARMKR 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1273 LAHKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPHADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQTALE 1352
Cdd:cd20483 241 ICAQHAVTPFMFLLAAFRAFLYRYTEDEDLTIGMVDGDRPHPDFDDLVGFFVNMLPIRCRMDCDMSFDDLLESTKTTCLE 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1353 AYEHQDYPFEELVDKLGVQREMSRNPLFDTTLVLQ------NMEQQKLKMNDVqlqwnDLEHPISKFDISLYVTEH-DSE 1425
Cdd:cd20483 321 AYEHSAVPFDYIVDALDVPRSTSHFPIGQIAVNYQvhgkfpEYDTGDFKFTDY-----DHYDIPTACDIALEAEEDpDGG 395
|
410 420 430
....*....|....*....|....*....|
gi 1678550997 1426 LFCQFEYSTALFEKETIQRWASLFTTLVEH 1455
Cdd:cd20483 396 LDLRLEFSTTLYDSADMERFLDNFVTFLTS 425
|
|
| ligase_PEP_1 |
TIGR03098 |
acyl-CoA ligase (AMP-forming), exosortase A-associated; This group of proteins contains an ... |
2534-3021 |
5.00e-74 |
|
acyl-CoA ligase (AMP-forming), exosortase A-associated; This group of proteins contains an AMP-binding domain (pfam00501) associated with acyl CoA-ligases. These proteins are generally found in genomes containing the exosortase/PEP-CTERM protein expoert system, specifically the type 1 variant of this system described by the Genome Property GenProp0652. When found in this context they are invariably present next to a decarboxylase enzyme. A number of sequences from Burkholderia species also hit this model, but the genomic context is obviously different. The hypothesis of a constant substrate for this family is only strong where the exosortase context is present.
Pssm-ID: 211788 [Multi-domain] Cd Length: 517 Bit Score: 258.17 E-value: 5.00e-74
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2534 TISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPI 2613
Cdd:TIGR03098 1 LLHHLLEDAAARLPDATALVHHDRTLTYAALSERVLALASGLRGLGLARGERVAIYLDKRLETVTAMFGAALAGGVFVPI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2614 DPEYPKERKRYILSDSGTKLLMT------INEADLGVLADFEGEILTIESVEEDDKSPLPQMSS------------AH-- 2673
Cdd:TIGR03098 81 NPLLKAEQVAHILADCNVRLLVTsserldLLHPALPGCHDLRTLIIVGDPAHASEGHPGEEPASwpkllalgdadpPHpv 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2674 ---HLAYIIYTSGTTGRPKGVMVEHK----GIANTLQWRRNayafNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLH 2746
Cdd:TIGR03098 161 idsDMAAILYTSGSTGRPKGVVLSHRnlvaGAQSVATYLEN----RPDDRLLAVLPLSFDYGFNQLTTAFYVGATVVLHD 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2747 EEEAKDILAIkhqLSRQRITHMIIVPVLYRAL--LDvVQPEDVKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPT 2824
Cdd:TIGR03098 237 YLLPRDVLKA---LEKHGITGLAAVPPLWAQLaqLD-WPESAAPSLRYLTNSGGAMPRATLSRLRSFLPNARLFLMYGLT 312
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2825 ENSVATT-----VMRHMEkqayvSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNP-F 2898
Cdd:TIGR03098 313 EAFRSTYlppeeVDRRPD-----SIGKAIPNAEVLVLREDGSECAPGEEGELVHRGALVAMGYWNDPEKTAERFRPLPpF 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2899 KPEARMYRT----GDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAV--VAHVTaSGQTelSAYV 2972
Cdd:TIGR03098 388 PGELHLPELavwsGDTVRRDEEGFLYFVGRRDEMIKTSGYRVSPTEVEEVAYATGLVAEAVAfgVPDPT-LGQA--IVLV 464
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 2973 VTKPG---LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGALPK 3021
Cdd:TIGR03098 465 VTPPGgeeLDRAALLAECRARLPNYMVPALIHVRQALPRNANGKIDRKALAK 516
|
|
| COG4908 |
COG4908 |
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General ... |
1059-1282 |
5.27e-74 |
|
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General function prediction only];
Pssm-ID: 443936 [Multi-domain] Cd Length: 243 Bit Score: 247.64 E-value: 5.27e-74
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1059 VSSAQKRIYVLQQldEGVAYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSgADDEPVQRIHTEVPFTLS---- 1134
Cdd:COG4908 1 LSPAQKRFLFLEP--GSNAYNIPAVLRLEGPLDVEALERALRELVRRHPALRTRFVE-EDGEPVQRIDPDADLPLEvvdl 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1135 -------KETTIEGFV-----RPFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYANR------ 1196
Cdd:COG4908 78 salpepeREAELEELVaeeasRPFDLARGPLLRAALIRLGEDEHVLLLTIHHIISDGWSLGILLRELAALYAALlegepp 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1197 QLKPLRIQYKDYAVWQQKFKKGDSYQKQETYWQQQFSGDLPILELPTDKRRPAERQFIGGKVTFQLDKEITARIKRLAHK 1276
Cdd:COG4908 158 PLPELPIQYADYAAWQRAWLQSEALEKQLEYWRQQLAGAPPVLELPTDRPRPAVQTFRGATLSFTLPAELTEALKALAKA 237
|
....*.
gi 1678550997 1277 NRSTLY 1282
Cdd:COG4908 238 HGATVN 243
|
|
| DCL_NRPS |
cd19543 |
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the ... |
2088-2500 |
6.50e-74 |
|
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor; The DCL-type Condensation (C) domain catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. This domain is D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains in addition to the LCL- and DCL-types such as starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380465 [Multi-domain] Cd Length: 423 Bit Score: 254.44 E-value: 6.50e-74
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2088 YPVSSAQKRIYvLQQLEDGGTG-YNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGDPVQRIHDEVPFTLQ 2166
Cdd:cd19543 2 YPLSPMQEGML-FHSLLDPGSGaYVEQMVITLEGPLDPDRFRAAWQAVVDRHPILRTSFVWEGLGEPLQVVLKDRKLPWR 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2167 TTVLGARTEQEAAAAF--------IKPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELYN---- 2234
Cdd:cd19543 81 ELDLSHLSEAEQEAELealaeedrERGFDLARAPLMRLTLIRLGDDRYRLVWSFHHILLDGWSLPILLKELFAIYAalge 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2235 --NRKLPALRiQYKDYAVWQEGFKTGDAykmqEAYWLKQLEG--ELPVldLPADHARPPVRSFAGDKVSFTLEPEVASGL 2310
Cdd:cd19543 161 gqPPSLPPVR-PYRDYIAWLQRQDKEAA----EAYWREYLAGfeEPTP--LPKELPADADGSYEPGEVSFELSAELTARL 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2311 HKLARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPH--KDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRE 2388
Cdd:cd19543 234 QELARQHGVTLNTVVQGAWALLLSRYSGRDDVVFGTTVSGRPAelPGIETMVGLFINTLPVRVRLDPDQTVLELLKDLQA 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2389 TALEAFEHQNYPFEELvdkleLTRDMSRNPVFDAMLVVQN----------NDYEPLHLHDLQMkpAQVSHlvskFDLTLQ 2458
Cdd:cd19543 314 QQLELREHEYVPLYEI-----QAWSEGKQALFDHLLVFENypvdesleeeQDEDGLRITDVSA--EEQTN----YPLTVV 382
|
410 420 430 440
....*....|....*....|....*....|....*....|..
gi 1678550997 2459 ASEGDGnIHFLFEYSTALFEKTTIERWASHLTNVLSIIGKNP 2500
Cdd:cd19543 383 AIPGEE-LTIKLSYDAEVFDEATIERLLGHLRRVLEQVAANP 423
|
|
| FC-FACS_FadD_like |
cd05936 |
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This ... |
2535-3019 |
6.76e-74 |
|
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This subfamily of the AMP-forming adenylation family contains Escherichia coli FadD and similar prokaryotic fatty acid CoA synthetases. FadD was characterized as a long-chain fatty acid CoA synthetase. The gene fadD is regulated by the fatty acid regulatory protein FadR. Fatty acid CoA synthetase catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341259 [Multi-domain] Cd Length: 468 Bit Score: 255.95 E-value: 6.76e-74
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2535 ISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPID 2614
Cdd:cd05936 1 LADLLEEAARRFPDKTALIFMGRKLTYRELDALAEAFAAGLQNLGVQPGDRVALMLPNCPQFPIAYFGALKAGAVVVPLN 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2615 PEYPKERKRYILSDSGTKLLMTInEADLGVLADFEGEILTIESVEEDdksplpqmssahhLAYIIYTSGTTGRPKGVMVE 2694
Cdd:cd05936 81 PLYTPRELEHILNDSGAKALIVA-VSFTDLLAAGAPLGERVALTPED-------------VAVLQYTSGTTGVPKGAMLT 146
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2695 HKGI-ANTLQWRRNAYAFNETD----TILQLF-SFsfdGFITSMFTPLLSGAKAVLLHEEEAKDILaikHQLSRQRITHM 2768
Cdd:cd05936 147 HRNLvANALQIKAWLEDLLEGDdvvlAALPLFhVF---GLTVALLLPLALGATIVLIPRFRPIGVL---KEIRKHRVTIF 220
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2769 IIVPVLYRALLDV--VQPEDVKTLRVVTLAGEAADRELIARSLAI--CPhteLANEYGPTENSVATTVMRHMEKQAYVSI 2844
Cdd:cd05936 221 PGVPTMYIALLNApeFKKRDFSSLRLCISGGAPLPVEVAERFEELtgVP---IVEGYGLTETSPVVAVNPLDGPRKPGSI 297
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2845 GQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmyRTGDAARWMADGTLEYLGR 2924
Cdd:cd05936 298 GIPLPGTEVKIVDDDGEELPPGEVGELWVRGPQVMKGYWNRPEETAEAFVDGWL-------RTGDIGYMDEDGYFFIVDR 370
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2925 IDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPG--LSTNAVRSELQNKLPVFMHPAFIEK 3002
Cdd:cd05936 371 KKDMIIVGGFNVYPREVEEVLYEHPAVAEAAVVGVPDPYSGEAVKAFVVLKEGasLTEEEIIAFCREQLAGYKVPRQVEF 450
|
490
....*....|....*..
gi 1678550997 3003 LDSLPLSPNGKLDRGAL 3019
Cdd:cd05936 451 RDELPKSAVGKILRREL 467
|
|
| alpha_am_amid |
TIGR03443 |
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are ... |
2268-3119 |
2.07e-73 |
|
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), product of the LYS2 gene. It is also called alpha-aminoadipate reductase. In fungi, lysine is synthesized via aminoadipate. Currently, all members of this family are fungal.
Pssm-ID: 274582 [Multi-domain] Cd Length: 1389 Bit Score: 273.09 E-value: 2.07e-73
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2268 WLKQLEGeLPVLDLPADHARPPVRSFAGDKVSFTLEPEVAsglhklARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSp 2347
Cdd:TIGR03443 2 WSERLDN-PTLSVLPHDYLRPANNRLVEATYSLQLPSAEV------TAGGGSTPFIILLAAFAALVYRLTGDEDIVLGT- 73
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2348 iagRPHKDLEPilgmfvntLALRTRPEGGKPFVQYLQEVRETALEAFEHQNYPFEELVDKLELTRDMSRNPVFDAMLVVq 2427
Cdd:TIGR03443 74 ---SSNKSGRP--------FVLRLNITPELSFLQLYAKVSEEEKEGASDIGVPFDELSEHIQAAKKLERTPPLFRLAFQ- 141
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2428 nndyeplHLHDLQMKPAQVSHLVskfDLTLQASEGDGNIHFLFEYSTALFEKTTIERWASHLTNVLSIIGKNPKVTLNHI 2507
Cdd:TIGR03443 142 -------DAPDNQQTTYSTGSTT---DLTVFLTPSSPELELSIYYNSLLFSSDRITIVADQLAQLLSAASSNPDEPIGKV 211
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2508 DILTQEERHQLLNEfnTGQANQYG-VQTISQLFEQQAAR---------TPKASALVSGDKTLTYQELDEWSNGIARALRS 2577
Cdd:TIGR03443 212 SLITPSQKSLLPDP--TKDLDWSGfRGAIHDIFADNAEKhpdrtcvveTPSFLDPSSKTRSFTYKQINEASNILAHYLLK 289
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2578 RGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMTINEAdlGVLADF-------EG 2650
Cdd:TIGR03443 290 TGIKRGDVVMIYAYRGVDLVVAVMGVLKAGATFSVIDPAYPPARQTIYLSVAKPRALIVIEKA--GTLDQLvrdyidkEL 367
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2651 EILT-IESVE-EDDKS----PLPQMSS---AHHLAY----------------IIYTSGTTGRPKGVMVEHKGIANTLQWR 2705
Cdd:TIGR03443 368 ELRTeIPALAlQDDGSlvggSLEGGETdvlAPYQALkdtptgvvvgpdsnptLSFTSGSEGIPKGVLGRHFSLAYYFPWM 447
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2706 RNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKavlLHEEEAKDI-----LAIKHQLSRQRITHMI----------- 2769
Cdd:TIGR03443 448 AKRFGLSENDKFTMLSGIAHDPIQRDMFTPLFLGAQ---LLVPTADDIgtpgrLAEWMAKYGATVTHLTpamgqllsaqa 524
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2770 --IVPVLYRALL--DVVQPEDVktLRVVTLAgeaadreliarslaicPHTELANEYGPTENSVAT---TVMRHMEKQAYV 2842
Cdd:TIGR03443 525 ttPIPSLHHAFFvgDILTKRDC--LRLQTLA----------------ENVCIVNMYGTTETQRAVsyfEIPSRSSDSTFL 586
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2843 S-------IGQPIDGTQVLILNSNHQLQPIGVA--GELCIAGTGLARGYVNLPELTERAFTQNPF--------------- 2898
Cdd:TIGR03443 587 KnlkdvmpAGKGMKNVQLLVVNRNDRTQTCGVGevGEIYVRAGGLAEGYLGLPELNAEKFVNNWFvdpshwidldkennk 666
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2899 -------KPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEI-----------ESV--IRCIKGVKDAAVVA 2958
Cdd:TIGR03443 667 perefwlGPRDRLYRTGDLGRYLPDGNVECCGRADDQVKIRGFRIELGEIdthlsqhplvrENVtlVRRDKDEEPTLVSY 746
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2959 HVTASGQTELSAYVVTKPGLSTNA---------------VRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGALPKP- 3022
Cdd:TIGR03443 747 IVPQDKSDELEEFKSEVDDEESSDpvvkglikyrklikdIREYLKKKLPSYAIPTVIVPLKKLPLNPNGKVDKPALPFPd 826
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3023 ------VYNHEGERPFLPPSSKMEQILADIWKEVL--GAEKIGTADSFFELGGDSIKALQVsarLHRIGKQMAVK----D 3090
Cdd:TIGR03443 827 taqlaaVAKNRSASAADEEFTETEREIRDLWLELLpnRPATISPDDSFFDLGGHSILATRM---IFELRKKLNVElplgL 903
|
970 980
....*....|....*....|....*....
gi 1678550997 3091 LFSHPTIQELAAYIrDSDTSSSQAAVEGD 3119
Cdd:TIGR03443 904 IFKSPTIKGFAKEV-DRLKKGEELADEGD 931
|
|
| C_PKS-NRPS |
cd19532 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
2087-2431 |
7.09e-73 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHxxxD motif, a few such as Monascus pilosus lovastatin nonaketide synthase MokA have a non-canonical HRxxxD motif in the C-domain and are unable to catalyze amide-bond formation. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380455 [Multi-domain] Cd Length: 421 Bit Score: 251.22 E-value: 7.09e-73
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2087 TYPVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEG-GDPVQRIHDEVPFTL 2165
Cdd:cd19532 1 TEPMSFGQSRFWFLQQYLEDPTTFNVTFSYRLTGPLDVARLERAVRAVGQRHEALRTCFFTDPEdGEPMQGVLASSPLRL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2166 QTtvLGARTEQEAAAAFIK----PFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELYNNRKLPAL 2241
Cdd:cd19532 81 EH--VQISDEAEVEEEFERlknhVYDLESGETMRIVLLSLSPTEHYLIFGYHHIAMDGVSFQIFLRDLERAYNGQPLLPP 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2242 RIQYKDYAVWQ-EGFKTGdayKMQE--AYWLKQLEGE---LPVLDLPADHARPPVRSFAGDKVSFTLEPEVASGLHKLAR 2315
Cdd:cd19532 159 PLQYLDFAARQrQDYESG---ALDEdlAYWKSEFSTLpepLPLLPFAKVKSRPPLTRYDTHTAERRLDAALAARIKEASR 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2316 ENGSTLYMVLLAAYTAFLSRLSGQEDIIVGspI--AGRPHKDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRETALEA 2393
Cdd:cd19532 236 KLRVTPFHFYLAALQVLLARLLDVDDICIG--IadANRTDEDFMETIGFFLNLLPLRFRRDPSQTFADVLKETRDKAYAA 313
|
330 340 350
....*....|....*....|....*....|....*...
gi 1678550997 2394 FEHQNYPFEELVDKLELTRDMSRNPVFDAMLvvqnnDY 2431
Cdd:cd19532 314 LAHSRVPFDVLLDELGVPRSATHSPLFQVFI-----NY 346
|
|
| C_PKS-NRPS_PksJ-like |
cd20484 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
2087-2500 |
5.20e-72 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs), similar to Bacillus subtilis PksJ; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily have the typical C-domain HHxxxD motif. PksJ is involved in some intermediate steps for the synthesis of the antibiotic polyketide bacillaene which is important in secondary metabolism. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380472 [Multi-domain] Cd Length: 430 Bit Score: 249.16 E-value: 5.20e-72
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2087 TYPVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGdPVQRIHDEVPFTLQ 2166
Cdd:cd20484 1 RSPLSEGQKGLWMLQKMSPEMSAYNVPLCFRFSSKLDVEKFKQACQFVLEQHPILKSVIEEEDGV-PFQKIEPSKPLSFQ 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2167 TTVLGARTEQEAAAaFI-----KPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELY-------N 2234
Cdd:cd20484 80 EEDISSLKESEIIA-YLrekakEPFVLENGPLMRVHLFSRSEQEHFVLITIHHIIFDGSSSLTLIHSLLDAYqallqgkQ 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2235 NRKLPALRIqYKDYAVWQEGFKTGDAYKMQEAYWLKQLEGELPVLDLPADHARPPVRSFAGDKVSFTLEPEVASGLHKLA 2314
Cdd:cd20484 159 PTLASSPAS-YYDFVAWEQDMLAGAEGEEHRAYWKQQLSGTLPILELPADRPRSSAPSFEGQTYTRRLPSELSNQIKSFA 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2315 RENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHKDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRETALEAF 2394
Cdd:cd20484 238 RSQSINLSTVFLGIFKLLLHRYTGQEDIIVGMPTMGRPEERFDSLIGYFINMLPIRSRILGEETFSDFIRKLQLTVLDGL 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2395 EHQNYPFEELVDKLELTRDMSRNPVFDAMLVVQNNdYEPLHLHDLQMKPAQVSH--LVSK------FDLTLQASEGDGNI 2466
Cdd:cd20484 318 DHAAYPFPAMVRDLNIPRSQANSPVFQVAFFYQNF-LQSTSLQQFLAEYQDVLSieFVEGihqegeYELVLEVYEQEDRF 396
|
410 420 430
....*....|....*....|....*....|....
gi 1678550997 2467 HFLFEYSTALFEKTTIERWASHLTNVLSIIGKNP 2500
Cdd:cd20484 397 TLNIKYNPDLFDASTIERMMEHYVKLAEELIANP 430
|
|
| C_PKS-NRPS |
cd20483 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
2089-2486 |
1.16e-69 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHXXXD motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380471 [Multi-domain] Cd Length: 430 Bit Score: 242.55 E-value: 1.16e-69
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2089 PVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDeGGDPVQRIHDEVPFTLqtT 2168
Cdd:cd20483 3 PMSTFQRRLWFLHNFLEDKTFLNLLLVCHIKGKPDVNLLQKALSELVRRHEVLRTAYFEG-DDFGEQQVLDDPSFHL--I 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2169 VLGARTEQEAAAAF--------IKPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELYNNRK--- 2237
Cdd:cd20483 80 VIDLSEAADPEAALdqlvrnlrRQELDIEEGEVIRGWLVKLPDEEFALVLASHHIAWDRGSSKSIFEQFTALYDALRagr 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2238 ----LPALRIQYKDYAVWQEGFKTGDAYKMQEAYWLKQLEGELPVLD-LP-ADHARPPVRSFAGDKVSFTLEPEVASGLH 2311
Cdd:cd20483 160 dlatVPPPPVQYIDFTLWHNALLQSPLVQPLLDFWKEKLEGIPDASKlLPfAKAERPPVKDYERSTVEATLDKELLARMK 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2312 KLARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHKDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRETAL 2391
Cdd:cd20483 240 RICAQHAVTPFMFLLAAFRAFLYRYTEDEDLTIGMVDGDRPHPDFDDLVGFFVNMLPIRCRMDCDMSFDDLLESTKTTCL 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2392 EAFEHQNYPFEELVDKLELTRDMSRNPVFD---------AMLVVQNNDYEPLHLHDLQMKPAqvshlvskFDLTLQASE- 2461
Cdd:cd20483 320 EAYEHSAVPFDYIVDALDVPRSTSHFPIGQiavnyqvhgKFPEYDTGDFKFTDYDHYDIPTA--------CDIALEAEEd 391
|
410 420
....*....|....*....|....*
gi 1678550997 2462 GDGNIHFLFEYSTALFEKTTIERWA 2486
Cdd:cd20483 392 PDGGLDLRLEFSTTLYDSADMERFL 416
|
|
| alpha_am_amid |
TIGR03443 |
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are ... |
236-1117 |
1.57e-69 |
|
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), product of the LYS2 gene. It is also called alpha-aminoadipate reductase. In fungi, lysine is synthesized via aminoadipate. Currently, all members of this family are fungal.
Pssm-ID: 274582 [Multi-domain] Cd Length: 1389 Bit Score: 260.38 E-value: 1.57e-69
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 236 ESSRLSElAAREEVTLSTIFH---TIWGILLQKYNNNDDAVFGSvisgrPAEIEGIEHMVGLFINtmpvrvqgAKTPFLQ 312
Cdd:TIGR03443 31 YSLQLPS-AEVTAGGGSTPFIillAAFAALVYRLTGDEDIVLGT-----SSNKSGRPFVLRLNIT--------PELSFLQ 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 313 LIKDMQKDRLAAEAYSYHPLYEIQSRSAVKQGLidhilvfENYPVQQEIQMLNKQEhasdlFQIHNFTVADETNYSFYLM 392
Cdd:TIGR03443 97 LYAKVSEEEKEGASDIGVPFDELSEHIQAAKKL-------ERTPPLFRLAFQDAPD-----NQQTTYSTGSTTDLTVFLT 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 393 VAPGE-EIHIKMNYDAEQHDRsfVLSVKEHLLNAVSQILNNPNLPPEEIDITTDTEKRQLigeiTDQTPVYE------TI 465
Cdd:TIGR03443 165 PSSPElELSIYYNSLLFSSDR--ITIVADQLAQLLSAASSNPDEPIGKVSLITPSQKSLL----PDPTKDLDwsgfrgAI 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 466 HAMFEKQAEKTPDAHAVIDQACSL---------TYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKA 536
Cdd:TIGR03443 239 HDIFADNAEKHPDRTCVVETPSFLdpssktrsfTYKQINEASNILAHYLLKTGIKRGDVVMIYAYRGVDLVVAVMGVLKA 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 537 GGAIVPVDPHYPADRIRYILhdcGCSH-----VVSQAHLPSSLEDNYI------ITHPEDIESKVDGSNI--KSVNNADD 603
Cdd:TIGR03443 319 GATFSVIDPAYPPARQTIYL---SVAKpraliVIEKAGTLDQLVRDYIdkelelRTEIPALALQDDGSLVggSLEGGETD 395
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 604 LL---------------------YMIYTSGTTGKPKGVQFEHRNMA----------NLLKFE-YTH-SGIdfEADVLQfa 650
Cdd:TIGR03443 396 VLapyqalkdtptgvvvgpdsnpTLSFTSGSEGIPKGVLGRHFSLAyyfpwmakrfGLSENDkFTMlSGI--AHDPIQ-- 471
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 651 tpsfdvcyQEIFSALLKGGTLHiVPEAIKRDVP-QLFAFINKHQTNIVFLPTAfikmifserelansfpdgVKHLIAAGE 729
Cdd:TIGR03443 472 --------RDMFTPLFLGAQLL-VPTADDIGTPgRLAEWMAKYGATVTHLTPA------------------MGQLLSAQA 524
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 730 QLMISDLFQ-----DVLRKR----------GIHLHNHYGPSETH-VVSTYTIHP--GDP-----IPELPPIGKPIGCTDL 786
Cdd:TIGR03443 525 TTPIPSLHHaffvgDILTKRdclrlqtlaeNVCIVNMYGTTETQrAVSYFEIPSrsSDStflknLKDVMPAGKGMKNVQL 604
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 787 YILNHQKQLQPCGVP--GELYISGASVARGYVNHDKLTSDKFSSDPFKPDVI----------------------MYRTGD 842
Cdd:TIGR03443 605 LVVNRNDRTQTCGVGevGEIYVRAGGLAEGYLGLPELNAEKFVNNWFVDPSHwidldkennkperefwlgprdrLYRTGD 684
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 843 LARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYcsVQKLNTI-------- 914
Cdd:TIGR03443 685 LGRYLPDGNVECCGRADDQVKIRGFRIELGEIDTHLSQHPLVRENVTLVRRDKDEEPTLVSYI--VPQDKSDeleefkse 762
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 915 ----------------------DLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPEPD------ASISGNPYTA 966
Cdd:TIGR03443 763 vddeessdpvvkglikyrklikDIREYLKKKLPSYAIPTVIVPLKKLPLNPNGKVDKPALPFPDtaqlaaVAKNRSASAA 842
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 967 PRNL--LEAKLSQLFEDVLKN--GHIGIQDNFFDNGGHSLKATVLMSRIAKEFHVQVSLKDIFAHPTVEGLAliiREAEQ 1042
Cdd:TIGR03443 843 DEEFteTEREIRDLWLELLPNrpATISPDDSFFDLGGHSILATRMIFELRKKLNVELPLGLIFKSPTIKGFA---KEVDR 919
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1043 nLYAAIEPAEKRDTYPVSSAQkriyvlqqldegvaynmpaVLELEGALDVAKLSA-VCKELISRHEPL----RTSFVSGA 1117
Cdd:TIGR03443 920 -LKKGEELADEGDSEIEEEET-------------------VLELDYAKDAKTLVDsLPKSYPSRKELDastpITVFLTGA 979
|
|
| ligase_PEP_1 |
TIGR03098 |
acyl-CoA ligase (AMP-forming), exosortase A-associated; This group of proteins contains an ... |
1495-1985 |
2.00e-69 |
|
acyl-CoA ligase (AMP-forming), exosortase A-associated; This group of proteins contains an AMP-binding domain (pfam00501) associated with acyl CoA-ligases. These proteins are generally found in genomes containing the exosortase/PEP-CTERM protein expoert system, specifically the type 1 variant of this system described by the Genome Property GenProp0652. When found in this context they are invariably present next to a decarboxylase enzyme. A number of sequences from Burkholderia species also hit this model, but the genomic context is obviously different. The hypothesis of a constant substrate for this family is only strong where the exosortase context is present.
Pssm-ID: 211788 [Multi-domain] Cd Length: 517 Bit Score: 244.69 E-value: 2.00e-69
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1495 TLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPI 1574
Cdd:TIGR03098 1 LLHHLLEDAAARLPDATALVHHDRTLTYAALSERVLALASGLRGLGLARGERVAIYLDKRLETVTAMFGAALAGGVFVPI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1575 DPDYPEERISFLLEDSGTNILLLQSAGL-----------------HVPEFTGEIVYLNQTNSGLAHRL-----SNPNVDV 1632
Cdd:TIGR03098 81 NPLLKAEQVAHILADCNVRLLVTSSERLdllhpalpgchdlrtliIVGDPAHASEGHPGEEPASWPKLlalgdADPPHPV 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1633 LPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASV----YLLP 1708
Cdd:TIGR03098 161 IDSDMAAILYTSGSTGRPKGVVLSHRNLVAGAQSVATYLENRPDDRLLAVLPLSFDYGFNQLTTAFYVGATVvlhdYLLP 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1709 QggekepEVIaKAIEEQKITAMHFVPSmLHAFLEHIKYRsvPIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYG 1788
Cdd:TIGR03098 241 R------DVL-KALEKHGITGLAAVPP-LWAQLAQLDWP--ESAAPSLRYLTNSGGAMPRATLSRLRSFLPNARLFLMYG 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1789 PTEAtVEAAFFdcPPhEKLERIP--IGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPF 1866
Cdd:TIGR03098 311 LTEA-FRSTYL--PP-EEVDRRPdsIGKAIPNAEVLVLREDGSECAPGEEGELVHRGALVAMGYWNDPEKTAERFRPLPP 386
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1867 YPG-----ERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAA--------------VTVR 1927
Cdd:TIGR03098 387 FPGelhlpELAVWSGDTVRRDEEGFLYFVGRRDEMIKTSGYRVSPTEVEEVAYATGLVAEAVafgvpdptlgqaivLVVT 466
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*...
gi 1678550997 1928 TDSGEPelcayvegLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNALPA 1985
Cdd:TIGR03098 467 PPGGEE--------LDRAALLAECRARLPNYMVPALIHVRQALPRNANGKIDRKALAK 516
|
|
| D-ala-DACP-lig |
TIGR01734 |
D-alanine--poly(phosphoribitol) ligase, subunit 1; This model represents the enzyme (also ... |
2535-3019 |
4.88e-68 |
|
D-alanine--poly(phosphoribitol) ligase, subunit 1; This model represents the enzyme (also called D-alanine-D-alanyl carrier protein ligase) which activates D-alanine as an adenylate via the reaction D-ala + ATP -> D-ala-AMP + PPi, and further catalyzes the condensation of the amino acid adenylate with the D-alanyl carrier protein (D-ala-ACP). The D-alanine is then further transferred to teichoic acid in the biosynthesis of lipoteichoic acid (LTA) and wall teichoic acid (WTA) in gram positive bacteria, both polysacchatides. [Cell envelope, Biosynthesis and degradation of murein sacculus and peptidoglycan]
Pssm-ID: 273780 [Multi-domain] Cd Length: 502 Bit Score: 240.05 E-value: 4.88e-68
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2535 ISQLFEQqAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPID 2614
Cdd:TIGR01734 3 IEAIQAF-AETYPQTIAYRYQGQELTYQQLKEQSDRLAAFIQKRILPKKSPIIVYGHMEPHMLVAFLGSIKSGHAYIPVD 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2615 PEYPKERKRYILSDSGTKLLMTINEADLGVLadfEGEILTIESVE--EDDKSPLPQMS--SAHHLAYIIYTSGTTGRPKG 2690
Cdd:TIGR01734 82 TSIPSERIEMIIEAAGPELVIHTAELSIDAV---GTQIITLSALEqaETSGGPVSFDHavKGDDNYYIIYTSGSTGNPKG 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2691 VMVEHKGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMII 2770
Cdd:TIGR01734 159 VQISHDNLVSFTNWMLADFPLSEGKQFLNQAPFSFDLSVMDLYPCLASGGTLHCLDKDITNNFKLLFEELPKTGLNVWVS 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2771 VPVLYR-ALLD-VVQPEDVKTLRVVTLAGE----AADRELIARslaiCPHTELANEYGPTENSVATT---VMRHMEKQ-A 2840
Cdd:TIGR01734 239 TPSFVDmCLLDpNFNQENYPHLTHFLFCGEelpvKTAKALLER----FPKATIYNTYGPTEATVAVTsvkITQEILDQyP 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2841 YVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFtqnpFKPEA-RMYRTGDAARwMADGTL 2919
Cdd:TIGR01734 315 RLPIGFAKPDMNLFIMDEEGEPLPEGEKGEIVIVGPSVSKGYLNNPEKTAEAF----FSHEGqPAYRTGDAGT-ITDGQL 389
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2920 EYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTE-LSAYVVTKPG------LSTNAVRSELQNKLP 2992
Cdd:TIGR01734 390 FYQGRLDFQIKLHGYRIELEDIEFNLRQSSYIESAVVVPKYNKDHKVEyLIAAIVPETEdfekefQLTKAIKKELKKSLP 469
|
490 500
....*....|....*....|....*..
gi 1678550997 2993 VFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:TIGR01734 470 AYMIPRKFIYRDQLPLTANGKIDRKAL 496
|
|
| DCL_NRPS |
cd19543 |
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the ... |
1057-1460 |
9.88e-67 |
|
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor; The DCL-type Condensation (C) domain catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. This domain is D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains in addition to the LCL- and DCL-types such as starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380465 [Multi-domain] Cd Length: 423 Bit Score: 233.63 E-value: 9.88e-67
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1057 YPVSSAQKRIYVLQQLDEGV-AYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSGADDEPVQRIHTEVPFTL-- 1133
Cdd:cd19543 2 YPLSPMQEGMLFHSLLDPGSgAYVEQMVITLEGPLDPDRFRAAWQAVVDRHPILRTSFVWEGLGEPLQVVLKDRKLPWre 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1134 ---------SKETTIEGFV-----RPFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYA----- 1194
Cdd:cd19543 82 ldlshlseaEQEAELEALAeedreRGFDLARAPLMRLTLIRLGDDRYRLVWSFHHILLDGWSLPILLKELFAIYAalgeg 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1195 -NRQLKPLRiQYKDYAVWQQKFKKGDSyqkqETYWQQQFSG--DLPilELPTDKRRPAERQFIGGKVTFQLDKEITARIK 1271
Cdd:cd19543 162 qPPSLPPVR-PYRDYIAWLQRQDKEAA----EAYWREYLAGfeEPT--PLPKELPADADGSYEPGEVSFELSAELTARLQ 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1272 RLAHKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPhADL---EAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQ 1348
Cdd:cd19543 235 ELARQHGVTLNTVVQGAWALLLSRYSGRDDVVFGTTVSGRP-AELpgiETMVGLFINTLPVRVRLDPDQTVLELLKDLQA 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1349 TALEAYEHQDYPfeeLVDklgVQR-EMSRNPLFDTTLVLQN----------MEQQKLKMNDVQLQwndlEHpiSKFDISL 1417
Cdd:cd19543 314 QQLELREHEYVP---LYE---IQAwSEGKQALFDHLLVFENypvdesleeeQDEDGLRITDVSAE----EQ--TNYPLTV 381
|
410 420 430 440
....*....|....*....|....*....|....*....|...
gi 1678550997 1418 YVTEhDSELFCQFEYSTALFEKETIQRWASLFTTLVEHTAASP 1460
Cdd:cd19543 382 VAIP-GEELTIKLSYDAEVFDEATIERLLGHLRRVLEQVAANP 423
|
|
| A_NRPS_alphaAR |
cd17647 |
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as ... |
1521-1986 |
3.60e-66 |
|
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as alpha-aminoadipate reductase (EC 1.2.1.95) or alpha-AR or L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), which catalyzes the activation of alpha-aminoadipate by ATP-dependent adenylation and the reduction of activated alpha-aminoadipate by NADPH. The activated alpha-aminoadipate is bound to the phosphopantheinyl group of the enzyme itself before it is reduced to (S)-2-amino-6-oxohexanoate.
Pssm-ID: 341302 [Multi-domain] Cd Length: 520 Bit Score: 235.49 E-value: 3.60e-66
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1521 TYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERisflledsgtnilllQSA 1600
Cdd:cd17647 22 TYRDINEASNIVAHYLIKTGIKRGDVVMIYSYRGVDLMVAVMGVLKAGATFSVIDPAYPPAR---------------QNI 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1601 GLHVPEFTGEIVylnqtnsglahrLSNPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIM 1680
Cdd:cd17647 87 YLGVAKPRGLIV------------IRAAGVVVGPDSNPTLSFTSGSEGIPKGVLGRHFSLAYYFPWMAKRFNLSENDKFT 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1681 HKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHikyRSVPIKTnrLKRVF 1760
Cdd:cd17647 155 MLSGIAHDPIQRDMFTPLFLGAQLLVPTQDDIGTPGRLAEWMAKYGATVTHLTPAMGQLLTAQ---ATTPFPK--LHHAF 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1761 SGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFDCP-----PH--EKLER-IPIGKPVHHVRLYLLNQNQR--M 1830
Cdd:cd17647 230 FVGDILTKRDCLRLQTLAENVRIVNMYGTTETQRAVSYFEVPsrssdPTflKNLKDvMPAGRGMLNVQLLVVNRNDRtqI 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1831 LPVGCIGELYIAGAGVARGYLNRPALTEERFLED--------------------PFY--PGERMYKTGDVARWLPDGNVE 1888
Cdd:cd17647 310 CGIGEVGEIYVRAGGLAEGYRGLPELNKEKFVNNwfvepdhwnyldkdnnepwrQFWlgPRDRLYRTGDLGRYLPNGDCE 389
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1889 FLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTD-SGEPELCAY---------------------------VE 1940
Cdd:cd17647 390 CCGRADDQVKIRGFRIELGEIDTHISQHPLVRENITLVRRDkDEEPTLVSYivprfdkpddesfaqedvpkevstdpiVK 469
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 1941 GLQR-----NEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNALPAP 1986
Cdd:cd17647 470 GLIGyrkliKDIREFLKKRLASYAIPSLIVVLDKLPLNPNGKVDKPKLQFP 520
|
|
| FACL_FadD13-like |
cd17631 |
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, ... |
2539-3016 |
1.40e-64 |
|
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, including Mycobacterium tuberculosis acid-induced operon MymA encoding the fatty acyl-CoA synthetase FadD13 which is essential for virulence and intracellular growth of the pathogen. The fatty acyl-CoA synthetase activates lipids before entering into the metabolic pathways and is also involved in transmembrane lipid transport. However, unlike soluble fatty acyl-CoA synthetases, but like the mammalian integral-membrane very-long-chain acyl-CoA synthetases, FadD13 accepts lipid substrates up to the maximum length of C26, and this is facilitated by an extensive hydrophobic tunnel from the active site to a positively charged patch. Also included is feruloyl-CoA synthetase (Fcs) in Rhodococcus strains where it is involved in biotechnological vanillin production from eugenol and ferulic acid via a non-beta-oxidative pathway.
Pssm-ID: 341286 [Multi-domain] Cd Length: 435 Bit Score: 227.88 E-value: 1.40e-64
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2539 FEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYP 2618
Cdd:cd17631 1 LRRRARRHPDRTALVFGGRSLTYAELDERVNRLAHALRALGVAKGDRVAVLSKNSPEFLELLFAAARLGAVFVPLNFRLT 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2619 KERKRYILSDSGTKLLMtineadlgvladfegeiltiesveeDDksplpqmssahhLAYIIYTSGTTGRPKGVMVEHKGI 2698
Cdd:cd17631 81 PPEVAYILADSGAKVLF-------------------------DD------------LALLMYTSGTTGRPKGAMLTHRNL 123
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2699 -ANTLQWRrNAYAFNETDTILQLFSFsFDGFITSMFTP--LLSGAKAVLLHEEEAKDILAikhQLSRQRITHMIIVPVLY 2775
Cdd:cd17631 124 lWNAVNAL-AALDLGPDDVLLVVAPL-FHIGGLGVFTLptLLRGGTVVILRKFDPETVLD---LIERHRVTSFFLVPTMI 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2776 RALLDVVQPE--DVKTLRVVTLAGEAADRELIARSLAIcpHTELANEYGPTENSVATTVMR---HMEKQAyvSIGQPIDG 2850
Cdd:cd17631 199 QALLQHPRFAttDLSSLRAVIYGGAPMPERLLRALQAR--GVKFVQGYGMTETSPGVTFLSpedHRRKLG--SAGRPVFF 274
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2851 TQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmyRTGDAARWMADGTLEYLGRIDDQVK 2930
Cdd:cd17631 275 VEVRIVDPDGREVPPGEVGEIVVRGPHVMAGYWNRPEATAAAFRDGWF-------HTGDLGRLDEDGYLYIVDRKKDMII 347
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2931 IRGYRVETKEIESVIRCIKGVKDAAVVA--------HVTasgqtelsAYVVTKPG--LSTNAVRSELQNKLPVFMHPAFI 3000
Cdd:cd17631 348 SGGENVYPAEVEDVLYEHPAVAEVAVIGvpdekwgeAVV--------AVVVPRPGaeLDEDELIAHCRERLARYKIPKSV 419
|
490
....*....|....*.
gi 1678550997 3001 EKLDSLPLSPNGKLDR 3016
Cdd:cd17631 420 EFVDALPRNATGKILK 435
|
|
| AFD_class_I |
cd04433 |
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as ... |
603-948 |
1.14e-63 |
|
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as the ANL (acyl-CoA synthetases, the NRPS adenylation domains, and the Luciferase enzymes) superfamily. It includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases.The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341228 [Multi-domain] Cd Length: 336 Bit Score: 221.78 E-value: 1.14e-63
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 603 DLLYMIYTSGTTGKPKGVQFEHRNMANLLKFeYTHSGIDFEADVLQFATPSFDVCYQ-EIFSALLKGGTLHIVPeaiKRD 681
Cdd:cd04433 1 DPALILYTSGTTGKPKGVVLSHRNLLAAAAA-LAASGGLTEGDVFLSTLPLFHIGGLfGLLGALLAGGTVVLLP---KFD 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 682 VPQLFAFINKHQTNIVFLPTAFIKMIFSERELANSFPDGVKHLIAAGEQlMISDLFQDVLRKRGIHLHNHYGPSETHVVS 761
Cdd:cd04433 77 PEAALELIEREKVTILLGVPTLLARLLKAPESAGYDLSSLRALVSGGAP-LPPELLERFEEAPGIKLVNGYGLTETGGTV 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 762 TyTIHPGDPIPELPPIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTsdkfssDPFKPDvIMYRTG 841
Cdd:cd04433 156 A-TGPPDDDARKPGSVGRPVPGVEVRIVDPDGGELPPGEIGELVVRGPSVMKGYWNNPEAT------AAVDED-GWYRTG 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 842 DLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAY--YCSVQKLNTIDLRSY 919
Cdd:cd04433 228 DLGRLDEDGYLYIVGRLKDMIKSGGENVYPAEVEAVLLGHPGVAEAAVVGVPDPEWGERVVAVvvLRPGADLDAEELRAH 307
|
330 340
....*....|....*....|....*....
gi 1678550997 920 MASELPEYMIPAKWIWVDSIPLTPNGKVD 948
Cdd:cd04433 308 VRERLAPYKVPRRVVFVDALPRTASGKID 336
|
|
| Acs |
COG0365 |
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism]; |
2557-3019 |
1.86e-63 |
|
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism];
Pssm-ID: 440134 [Multi-domain] Cd Length: 565 Bit Score: 228.84 E-value: 1.86e-63
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2557 KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMT 2636
Cdd:COG0365 38 RTLTYAELRREVNRFANALRALGVKKGDRVAIYLPNIPEAVIAMLACARIGAVHSPVFPGFGAEALADRIEDAEAKVLIT 117
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2637 ----------------INEA--------------DLGVLADFEGEILTIESVEEDDKSPLPQMSSAHHLAYIIYTSGTTG 2686
Cdd:COG0365 118 adgglrggkvidlkekVDEAleelpslehvivvgRTGADVPMEGDLDWDELLAAASAEFEPEPTDADDPLFILYTSGTTG 197
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2687 RPKGVMVEHKGIANTLQWR-RNAYAFNETDTIlqlFSFSfD-GFIT----SMFTPLLSGAkAVLLHEE-----EAKDILA 2755
Cdd:COG0365 198 KPKGVVHTHGGYLVHAATTaKYVLDLKPGDVF---WCTA-DiGWATghsyIVYGPLLNGA-TVVLYEGrpdfpDPGRLWE 272
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2756 IkhqLSRQRITHMIIVPVLYRALL----DVVQPEDVKTLRVVTLAGEAADRELIARSLAI--CPhteLANEYGPTE---- 2825
Cdd:COG0365 273 L---IEKYGVTVFFTAPTAIRALMkagdEPLKKYDLSSLRLLGSAGEPLNPEVWEWWYEAvgVP---IVDGWGQTEtggi 346
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2826 --NSVATTVMRhmekqaYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAG--TGLARGYVNLPELTERAFtqnpFKPE 2901
Cdd:COG0365 347 fiSNLPGLPVK------PGSMGKPVPGYDVAVVDEDGNPVPPGEEGELVIKGpwPGMFRGYWNDPERYRETY----FGRF 416
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2902 ARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLS-T 2980
Cdd:COG0365 417 PGWYRTGDGARRDEDGYFWILGRSDDVINVSGHRIGTAEIESALVSHPAVAEAAVVGVPDEIRGQVVKAFVVLKPGVEpS 496
|
490 500 510 520
....*....|....*....|....*....|....*....|...
gi 1678550997 2981 NAVRSELQN----KLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:COG0365 497 DELAKELQAhvreELGPYAYPREIEFVDELPKTRSGKIMRRLL 539
|
|
| FC-FACS_FadD_like |
cd05936 |
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This ... |
1500-1983 |
5.29e-63 |
|
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This subfamily of the AMP-forming adenylation family contains Escherichia coli FadD and similar prokaryotic fatty acid CoA synthetases. FadD was characterized as a long-chain fatty acid CoA synthetase. The gene fadD is regulated by the fatty acid regulatory protein FadR. Fatty acid CoA synthetase catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341259 [Multi-domain] Cd Length: 468 Bit Score: 224.36 E-value: 5.29e-63
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYP 1579
Cdd:cd05936 5 LEEAARRFPDKTALIFMGRKLTYRELDALAEAFAAGLQNLGVQPGDRVALMLPNCPQFPIAYFGALKAGAVVVPLNPLYT 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1580 EERISFLLEDSGTNILLLQSAGLHV---PEFTGEIVYLNqtnsglahrlsnpnvdvlPQSLAYVIYTSGSTGMPKGVEIE 1656
Cdd:cd05936 85 PRELEHILNDSGAKALIVAVSFTDLlaaGAPLGERVALT------------------PEDVAVLQYTSGTTGVPKGAMLT 146
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1657 HRsavNFL-NSLQSRYQLKHS----DMIM------HktSYSFDASiweLFWWPYAGASVYLLPQggeKEPEVIAKAIEEQ 1725
Cdd:cd05936 147 HR---NLVaNALQIKAWLEDLlegdDVVLaalplfH--VFGLTVA---LLLPLALGATIVLIPR---FRPIGVLKEIRKH 215
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1726 KITAMHFVPSMLHAFLEHIKYRSVPIKTnrLKRVFSGGEQLGTHLVSRFYELLpNVSITNSYGPTEATVEAAFfdCPPHE 1805
Cdd:cd05936 216 RVTIFPGVPTMYIALLNAPEFKKRDFSS--LRLCISGGAPLPVEVAERFEELT-GVPIVEGYGLTETSPVVAV--NPLDG 290
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1806 klERIP--IGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFypgermyKTGDVARWLP 1883
Cdd:cd05936 291 --PRKPgsIGIPLPGTEVKIVDDDGEELPPGEVGELWVRGPQVMKGYWNRPEETAEAFVDGWL-------RTGDIGYMDE 361
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1884 DGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVT--VRTDSGEpELCAYV-----EGLQRNEVRAQLERLLP 1956
Cdd:cd05936 362 DGYFFIVDRKKDMIIVGGFNVYPREVEEVLYEHPAVAEAAVVgvPDPYSGE-AVKAFVvlkegASLTEEEIIAFCREQLA 440
|
490 500
....*....|....*....|....*..
gi 1678550997 1957 GYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd05936 441 GYKVPRQVEFRDELPKSAVGKILRREL 467
|
|
| starter-C_NRPS |
cd19533 |
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases ... |
2087-2500 |
6.28e-63 |
|
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. While standard C-domains catalyze peptide bond formation between two amino acids, an initial, ('starter') C-domain may instead acylate an amino acid with a fatty acid. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380456 [Multi-domain] Cd Length: 419 Bit Score: 222.63 E-value: 6.28e-63
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2087 TYPVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGdPVQRIHDEVPFTLQ 2166
Cdd:cd19533 1 RLPLTSAQRGVWFAEQLDPEGSIYNLAEYLEITGPVDLAVLERALRQVIAEAETLRLRFTEEEGE-PYQWIDPYTPVPIR 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2167 -TTVLGARTEQEAA-----AAFIKPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELYNNRK--- 2237
Cdd:cd19533 80 hIDLSGDPDPEGAAqqwmqEDLRKPLPLDNDPLFRHALFTLGDNRHFWYQRVHHIVMDGFSFALFGQRVAEIYTALLkgr 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2238 -------LPALRIQYKDYAvwqegFKTGDAYKMQEAYWLKQLEGELPVLDLpADhaRPPVRSFAGDKVSFTLEPEVASGL 2310
Cdd:cd19533 160 pappapfGSFLDLVEEEQA-----YRQSERFERDRAFWTEQFEDLPEPVSL-AR--RAPGRSLAFLRRTAELPPELTRTL 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2311 HKLARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHKDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRETA 2390
Cdd:cd19533 232 LEAAEAHGASWPSFFIALVAAYLHRLTGANDVVLGVPVMGRLGAAARQTPGMVANTLPLRLTVDPQQTFAELVAQVSREL 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2391 LEAFEHQNYPFEELVDKLELTRDmsRNPVFDAMLVVQNNDYePLHLHDLQMKPAQVSHLVSKfDLTLQASE--GDGNIHF 2468
Cdd:cd19533 312 RSLLRHQRYRYEDLRRDLGLTGE--LHPLFGPTVNYMPFDY-GLDFGGVVGLTHNLSSGPTN-DLSIFVYDrdDESGLRI 387
|
410 420 430
....*....|....*....|....*....|..
gi 1678550997 2469 LFEYSTALFEKTTIERWASHLTNVLSIIGKNP 2500
Cdd:cd19533 388 DFDANPALYSGEDLARHQERLLRLLEEAAADP 419
|
|
| PRK06187 |
PRK06187 |
long-chain-fatty-acid--CoA ligase; Validated |
1490-1983 |
3.57e-61 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235730 [Multi-domain] Cd Length: 521 Bit Score: 220.83 E-value: 3.57e-61
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1490 YSMNQTLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGG 1569
Cdd:PRK06187 2 QDYPLTIGRILRHGARKHPDKEAVYFDGRRTTYAELDERVNRLANALRALGVKKGDRVAVFDWNSHEYLEAYFAVPKIGA 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1570 AYLPIDPDYPEERISFLLEDSGTNILLLQSAglHVPEFTG---------EIVYLNQT----NSGLAHRLSN--------- 1627
Cdd:PRK06187 82 VLHPINIRLKPEEIAYILNDAEDRVVLVDSE--FVPLLAAilpqlptvrTVIVEGDGpaapLAPEVGEYEEllaaasdtf 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1628 PNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAvnFLNSLQSRYQLK--HSDMIMHKTSYsFDASIWelfWWPY----AG 1701
Cdd:PRK06187 160 DFPDIDENDAAAMLYTSGTTGHPKGVVLSHRNL--FLHSLAVCAWLKlsRDDVYLVIVPM-FHVHAW---GLPYlalmAG 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1702 AS-VYLlpqgGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIkyRSVPIKTNRLKRVFSGGEQLGTHLVSRFYELLpN 1780
Cdd:PRK06187 234 AKqVIP----RRFDPENLLDLIETERVTFFFAVPTIWQMLLKAP--RAYFVDFSSLRLVIYGGAALPPALLREFKEKF-G 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1781 VSITNSYGPTEA--TVEAAFfdcPPHEKLERIPI----GKPVHHVRLYLLNQNQRMLPV--GCIGELYIAGAGVARGYLN 1852
Cdd:PRK06187 307 IDLVQGYGMTETspVVSVLP---PEDQLPGQWTKrrsaGRPLPGVEARIVDDDGDELPPdgGEVGEIIVRGPWLMQGYWN 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1853 RPALTEERFLEDpfypgerMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTvrtdsGE 1932
Cdd:PRK06187 384 RPEATAETIDGG-------WLHTGDVGYIDEDGYLYITDRIKDVIISGGENIYPRELEDALYGHPAVAEVAVI-----GV 451
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 1933 P------ELCAYV-----EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK06187 452 PdekwgeRPVAVVvlkpgATLDAKELRAFLRGRLAKFKLPKRIAFVDELPRTSVGKILKRVL 513
|
|
| FC-FACS_FadD_like |
cd05936 |
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This ... |
467-952 |
1.45e-60 |
|
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This subfamily of the AMP-forming adenylation family contains Escherichia coli FadD and similar prokaryotic fatty acid CoA synthetases. FadD was characterized as a long-chain fatty acid CoA synthetase. The gene fadD is regulated by the fatty acid regulatory protein FadR. Fatty acid CoA synthetase catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341259 [Multi-domain] Cd Length: 468 Bit Score: 217.43 E-value: 1.45e-60
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 467 AMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPH 546
Cdd:cd05936 3 DLLEEAARRFPDKTALIFMGRKLTYRELDALAEAFAAGLQNLGVQPGDRVALMLPNCPQFPIAYFGALKAGAVVVPLNPL 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 547 YPADRIRYILHDCGCSHVVSQAHLPSSLEDnyiithPEDIESKVdgsniksVNNADDLLYMIYTSGTTGKPKGVQFEHRN 626
Cdd:cd05936 83 YTPRELEHILNDSGAKALIVAVSFTDLLAA------GAPLGERV-------ALTPEDVAVLQYTSGTTGVPKGAMLTHRN 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 627 M-ANLLKFEYTHSGIDFEADVLQFATP-----SFDVCYqeiFSALLKGGTLHIVPEAikrDVPQLFAFINKHQ-TNIVFL 699
Cdd:cd05936 150 LvANALQIKAWLEDLLEGDDVVLAALPlfhvfGLTVAL---LLPLALGATIVLIPRF---RPIGVLKEIRKHRvTIFPGV 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 700 PTAFIKMI-FSERELANsfPDGVKHLIAAGEQLMIsDLFQDVLRKRGIHLHNHYGPSETHVVSTYT-----IHPGDpipe 773
Cdd:cd05936 224 PTMYIALLnAPEFKKRD--FSSLRLCISGGAPLPV-EVAERFEELTGVPIVEGYGLTETSPVVAVNpldgpRKPGS---- 296
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 774 lppIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimyRTGDLARRLEDGNIE 853
Cdd:cd05936 297 ---IGIPLPGTEVKIVDDDGEELPPGEVGELWVRGPQVMKGYWNRPEETAEAFVDGWL-------RTGDIGYMDEDGYFF 366
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 854 YIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYycsV-----QKLNTIDLRSYMASELPEYM 928
Cdd:cd05936 367 IVDRKKDMIIVGGFNVYPREVEEVLYEHPAVAEAAVVGVPDPYSGEAVKAF---VvlkegASLTEEEIIAFCREQLAGYK 443
|
490 500
....*....|....*....|....
gi 1678550997 929 IPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:cd05936 444 VPRQVEFRDELPKSAVGKILRREL 467
|
|
| FACL_FadD13-like |
cd17631 |
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, ... |
1500-1980 |
1.14e-59 |
|
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, including Mycobacterium tuberculosis acid-induced operon MymA encoding the fatty acyl-CoA synthetase FadD13 which is essential for virulence and intracellular growth of the pathogen. The fatty acyl-CoA synthetase activates lipids before entering into the metabolic pathways and is also involved in transmembrane lipid transport. However, unlike soluble fatty acyl-CoA synthetases, but like the mammalian integral-membrane very-long-chain acyl-CoA synthetases, FadD13 accepts lipid substrates up to the maximum length of C26, and this is facilitated by an extensive hydrophobic tunnel from the active site to a positively charged patch. Also included is feruloyl-CoA synthetase (Fcs) in Rhodococcus strains where it is involved in biotechnological vanillin production from eugenol and ferulic acid via a non-beta-oxidative pathway.
Pssm-ID: 341286 [Multi-domain] Cd Length: 435 Bit Score: 213.63 E-value: 1.14e-59
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYP 1579
Cdd:cd17631 1 LRRRARRHPDRTALVFGGRSLTYAELDERVNRLAHALRALGVAKGDRVAVLSKNSPEFLELLFAAARLGAVFVPLNFRLT 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1580 EERISFLLEDSGTNILLlqsaglhvpeftgeivylnqtnsglahrlsnpnvdvlpQSLAYVIYTSGSTGMPKGVEIEHRs 1659
Cdd:cd17631 81 PPEVAYILADSGAKVLF--------------------------------------DDLALLMYTSGTTGRPKGAMLTHR- 121
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1660 avNFLNSLQSryQLKHSDMIMHKTSYS----FDASIWELFWWP--YAGASVYLLPqggEKEPEVIAKAIEEQKITAMHFV 1733
Cdd:cd17631 122 --NLLWNAVN--ALAALDLGPDDVLLVvaplFHIGGLGVFTLPtlLRGGTVVILR---KFDPETVLDLIERHRVTSFFLV 194
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1734 PSMLHAFLEHIKYRSVpiKTNRLKRVFSGGEQLGTHLVSRFYELlpNVSITNSYGPTEATVEAAFFdcPPHEKLERI-PI 1812
Cdd:cd17631 195 PTMIQALLQHPRFATT--DLSSLRAVIYGGAPMPERLLRALQAR--GVKFVQGYGMTETSPGVTFL--SPEDHRRKLgSA 268
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1813 GKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFypgermyKTGDVARWLPDGNVEFLGR 1892
Cdd:cd17631 269 GRPVFFVEVRIVDPDGREVPPGEVGEIVVRGPHVMAGYWNRPEATAAAFRDGWF-------HTGDLGRLDEDGYLYIVDR 341
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1893 TDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GEpELCAYV---EG--LQRNEVRAQLERLLPGYMVPAYMI 1965
Cdd:cd17631 342 KKDMIISGGENVYPAEVEDVLYEHPAVAEVAVIGVPDEkwGE-AVVAVVvprPGaeLDEDELIAHCRERLARYKIPKSVE 420
|
490
....*....|....*
gi 1678550997 1966 EMEQWPVTPSGKLDR 1980
Cdd:cd17631 421 FVDALPRNATGKILK 435
|
|
| starter-C_NRPS |
cd19533 |
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases ... |
1056-1460 |
4.56e-58 |
|
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. While standard C-domains catalyze peptide bond formation between two amino acids, an initial, ('starter') C-domain may instead acylate an amino acid with a fatty acid. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380456 [Multi-domain] Cd Length: 419 Bit Score: 208.38 E-value: 4.56e-58
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1056 TYPVSSAQKRIYVLQQLD-EGVAYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSgADDEPVQRIHTEVPF--- 1131
Cdd:cd19533 1 RLPLTSAQRGVWFAEQLDpEGSIYNLAEYLEITGPVDLAVLERALRQVIAEAETLRLRFTE-EEGEPYQWIDPYTPVpir 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1132 --TLSKETTIEGFVR---------PFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLY----ANR 1196
Cdd:cd19533 80 hiDLSGDPDPEGAAQqwmqedlrkPLPLDNDPLFRHALFTLGDNRHFWYQRVHHIVMDGFSFALFGQRVAEIYtallKGR 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1197 QLKP------LRIQYKDyavwqQKFKKGDSYQKQETYWQQQFsGDLPilELPTDKRRPAERQFIGGKVTFQLDKEITARI 1270
Cdd:cd19533 160 PAPPapfgsfLDLVEEE-----QAYRQSERFERDRAFWTEQF-EDLP--EPVSLARRAPGRSLAFLRRTAELPPELTRTL 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1271 KRLAHKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPHADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQTA 1350
Cdd:cd19533 232 LEAAEAHGASWPSFFIALVAAYLHRLTGANDVVLGVPVMGRLGAAARQTPGMVANTLPLRLTVDPQQTFAELVAQVSREL 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1351 LEAYEHQDYPFEELVDKLGvqREMSRNPLFDTTLVLQNMEQQkLKMNDVQLQWNDLEHPISKfDISLYVTEHD--SELFC 1428
Cdd:cd19533 312 RSLLRHQRYRYEDLRRDLG--LTGELHPLFGPTVNYMPFDYG-LDFGGVVGLTHNLSSGPTN-DLSIFVYDRDdeSGLRI 387
|
410 420 430
....*....|....*....|....*....|..
gi 1678550997 1429 QFEYSTALFEKETIQRWASLFTTLVEHTAASP 1460
Cdd:cd19533 388 DFDANPALYSGEDLARHQERLLRLLEEAAADP 419
|
|
| X-Domain_NRPS |
cd19546 |
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to ... |
1055-1460 |
5.85e-58 |
|
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to the non-ribosomal peptide synthetase (NRPS); The X-domain is a catalytically inactive member of the Condensation (C) domain family of non-ribosomal peptide synthetase (NRPS). It has been shown to recruit oxygenases to the NRPS to perform side-chain crosslinking in the production of glycopeptide antibiotics. C-domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as this X-domain, the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, and dual E/C (epimerization and condensation) domains. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity; members of this X-domain subfamily lack the second H of this motif.
Pssm-ID: 380468 [Multi-domain] Cd Length: 440 Bit Score: 208.87 E-value: 5.85e-58
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1055 DTYPVSSAQKRIYVLQQLDEGV-AYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSGADDePVQRIH------T 1127
Cdd:cd19546 3 DEVPATAGQLRTWLLARLDEETrGRHLSVALRLRGRLDRDALEAALGDVAARHEILRTTFPGDGGD-VHQRILdadaarP 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1128 EVPFTLSKETTIEGFV-----RPFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYANR------ 1196
Cdd:cd19546 82 ELPVVPATEEELPALLadraaHLFDLTRETPWRCTLFALSDTEHVLLLVVHRIAADDESLDVLVRDLAAAYGARregrap 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1197 QLKPLRIQYKDYAVWQQKFKKGDSYQK-----QETYWQQQFSGDLPILELPTDKRRPAERQFIGGKVTFQLDKEITARIK 1271
Cdd:cd19546 162 ERAPLPLQFADYALWERELLAGEDDRDsligdQIAYWRDALAGAPDELELPTDRPRPVLPSRRAGAVPLRLDAEVHARLM 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1272 RLAHKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRP-HADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQTA 1350
Cdd:cd19546 242 EAAESAGATMFTVVQAALAMLLTRLGAGTDVTVGTVLPRDDeEGDLEGMVGPFARPLALRTDLSGDPTFRELLGRVREAV 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1351 LEAYEHQDYPFEELVDKLGVQREMSRNPLFDTTLVLQNMEQQK--------LKMNDVqlqwnDLEHPISKFDISLYVTEH 1422
Cdd:cd19546 322 REARRHQDVPFERLAELLALPPSADRHPVFQVALDVRDDDNDPwdapelpgLRTSPV-----PLGTEAMELDLSLALTER 396
|
410 420 430 440
....*....|....*....|....*....|....*....|....
gi 1678550997 1423 DSE------LFCQFEYSTALFEKETIQRWASLFTTLVEHTAASP 1460
Cdd:cd19546 397 RNDdgdpdgLDGSLRYAADLFDRATAAALARRLVRVLEQVAADP 440
|
|
| FACL_DitJ_like |
cd05934 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
2560-3020 |
2.20e-57 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Members of this family include DitJ from Pseudomonas and similar proteins.
Pssm-ID: 341257 [Multi-domain] Cd Length: 422 Bit Score: 206.37 E-value: 2.20e-57
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2560 TYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLlmtine 2639
Cdd:cd05934 5 TYAELLRESARIAAALAALGIRPGDRVALMLDNCPEFLFAWFALAKLGAVLVPINTALRGDELAYIIDHSGAQL------ 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2640 adlgVLADfegeiltiesveeddksplpqmssahhLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTIL- 2718
Cdd:cd05934 79 ----VVVD---------------------------PASILYTSGTTGPPKGVVITHANLTFAGYYSARRFGLGEDDVYLt 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2719 QLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAikhQLSRQRITHMIIVPVLYRALLdvVQPEDVK----TLRVVT 2794
Cdd:cd05934 128 VLPLFHINAQAVSVLAALSVGATLVLLPRFSASRFWS---DVRRYGATVTNYLGAMLSYLL--AQPPSPDdrahRLRAAY 202
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2795 LAGEAAD--RELIARSlaicpHTELANEYGPTENSVATTVMRHmEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELC 2872
Cdd:cd05934 203 GAPNPPElhEEFEERF-----GVRLLEGYGMTETIVGVIGPRD-EPRRPGSIGRPAPGYEVRIVDDDGQELPAGEPGELV 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2873 I---AGTGLARGYVNLPELTERAFtqnpfkpEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIK 2949
Cdd:cd05934 277 IrglRGWGFFKGYYNMPEATAEAM-------RNGWFHTGDLGYRDADGFFYFVDRKKDMIRRRGENISSAEVERAILRHP 349
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 2950 GVKDAAVVAHVTASGQTELSAYVVTKPG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGALP 3020
Cdd:cd05934 350 AVREAAVVAVPDEVGEDEVKAVVVLRPGetLDPEELFAFCEGQLAYFKVPRYIRFVDDLPKTPTEKVAKAQLR 422
|
|
| X-Domain_NRPS |
cd19546 |
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to ... |
2089-2500 |
2.39e-57 |
|
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to the non-ribosomal peptide synthetase (NRPS); The X-domain is a catalytically inactive member of the Condensation (C) domain family of non-ribosomal peptide synthetase (NRPS). It has been shown to recruit oxygenases to the NRPS to perform side-chain crosslinking in the production of glycopeptide antibiotics. C-domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as this X-domain, the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, and dual E/C (epimerization and condensation) domains. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity; members of this X-domain subfamily lack the second H of this motif.
Pssm-ID: 380468 [Multi-domain] Cd Length: 440 Bit Score: 206.95 E-value: 2.39e-57
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2089 PVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDeGGDPVQRIHDEVPFTLQTT 2168
Cdd:cd19546 6 PATAGQLRTWLLARLDEETRGRHLSVALRLRGRLDRDALEAALGDVAARHEILRTTFPGD-GGDVHQRILDADAARPELP 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2169 VLGArTEQEA----AAAFIKPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELYNNR---KLP-- 2239
Cdd:cd19546 85 VVPA-TEEELpallADRAAHLFDLTRETPWRCTLFALSDTEHVLLLVVHRIAADDESLDVLVRDLAAAYGARregRAPer 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2240 -ALRIQYKDYAVWQEGFKTG--DAYKM---QEAYWLKQLEGELPVLDLPADHARPPVRSFAGDKVSFTLEPEVASGLHKL 2313
Cdd:cd19546 164 aPLPLQFADYALWERELLAGedDRDSLigdQIAYWRDALAGAPDELELPTDRPRPVLPSRRAGAVPLRLDAEVHARLMEA 243
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2314 ARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHK-DLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRETALE 2392
Cdd:cd19546 244 AESAGATMFTVVQAALAMLLTRLGAGTDVTVGTVLPRDDEEgDLEGMVGPFARPLALRTDLSGDPTFRELLGRVREAVRE 323
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2393 AFEHQNYPFEELVDKLELTRDMSRNPVFDAMLVVQNND---YEPLHLHDLQMKPAQVSHLVSKFDLTLQASEG------- 2462
Cdd:cd19546 324 ARRHQDVPFERLAELLALPPSADRHPVFQVALDVRDDDndpWDAPELPGLRTSPVPLGTEAMELDLSLALTERrnddgdp 403
|
410 420 430 440
....*....|....*....|....*....|....*....|.
gi 1678550997 2463 ---DGNIHflfeYSTALFEKTTIERWASHLTNVLSIIGKNP 2500
Cdd:cd19546 404 dglDGSLR----YAADLFDRATAAALARRLVRVLEQVAADP 440
|
|
| CT_NRPS-like |
cd19542 |
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike ... |
10-432 |
1.06e-56 |
|
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike bacterial NRPS, which typically have specialized terminal thioesterase (TE) domains to cyclize peptide products, many fungal NRPSs employ a terminal condensation-like (CT) domain to produce macrocyclic peptidyl products (e.g. cyclosporine and echinocandin). Domains in this subfamily (which includes both terminal and non-terminal domains) typically have a non-canonical conserved [SN]HxxxDx(14)Y motif at their active site compared to the standard Condensation (C) domain active site motif (HHxxxD). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380464 [Multi-domain] Cd Length: 401 Bit Score: 203.69 E-value: 1.06e-56
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 10 IYPLSYMQEGMLFHSLlqKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNVSSP-QQVVLRErnviv 88
Cdd:cd19542 1 IYPCTPMQEGMLLSQL--RSPGLYFNHFVFDLDSSVDVERLRNAWRQLVQRHDILRTVFVESSAEGTfLQVVLKS----- 73
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 89 LEEDITHLNEAEQSQFIEQWKEKDRDRGFhlqKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLhiyASYV 168
Cdd:cd19542 74 LDPPIEEVETDEDSLDALTRDLLDDPTLF---GQPPHRLTLLETSSGEVYLVLRISHALYDGVSLPIILRDLA---AAYN 147
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 169 NASPitlEPVQPYGKYIKWLMEQDKEQAVSYWDHYLSGHEQqTVLPKQKKTKGKSRQEHVTFSFSKEessrLSELAAREE 248
Cdd:cd19542 148 GQLL---PPAPPFSDYISYLQSQSQEESLQYWRKYLQGASP-CAFPSLSPKRPAERSLSSTRRSLAK----LEAFCASLG 219
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 249 VTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRPAEIEGIEHMVGLFINTMPVRVQ-GAKTPFLQLIKDMQKDRLAAEAY 327
Cdd:cd19542 220 VTLASLFQAAWALVLARYTGSRDVVFGYVVSGRDLPVPGIDDIVGPCINTLPVRVKlDPDWTVLDLLRQLQQQYLRSLPH 299
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 328 SYHPLYEIQ--SRSAVKQGLIDHILVFENYPVQQEiqmlnkqehaSDLFQIHNFTVADETNYSFYLM----VAPGEEIHI 401
Cdd:cd19542 300 QHLSLREIQraLGLWPSGTLFNTLVSYQNFEASPE----------SELSGSSVFELSAAEDPTEYPVavevEPSGDSLKV 369
|
410 420 430
....*....|....*....|....*....|...
gi 1678550997 402 KMNYDaeqhdrSFVLSVK--EHLLNAVSQILNN 432
Cdd:cd19542 370 SLAYS------TSVLSEEqaEELLEQFDDILEA 396
|
|
| PRK07656 |
PRK07656 |
long-chain-fatty-acid--CoA ligase; Validated |
2532-3019 |
2.09e-56 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236072 [Multi-domain] Cd Length: 513 Bit Score: 206.29 E-value: 2.09e-56
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2532 VQTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYV 2611
Cdd:PRK07656 4 WMTLPELLARAARRFGDKEAYVFGDQRLTYAELNARVRRAAAALAALGIGKGDRVAIWAPNSPHWVIAALGALKAGAVVV 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2612 PIDPEYPKERKRYILSDSGTKLLMTINEAdLGVLADFEGEILTIESV----EEDDKSPLPQMSS-----AHH-------- 2674
Cdd:PRK07656 84 PLNTRYTADEAAYILARGDAKALFVLGLF-LGVDYSATTRLPALEHVviceTEEDDPHTEKMKTftdflAAGdpaerape 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2675 -----LAYIIYTSGTTGRPKGVMVEHKgiaNTLqwrRNAYAF------NETDTILQL--FSFSFdGFITSMFTPLLSGAK 2741
Cdd:PRK07656 163 vdpddVADILFTSGTTGRPKGAMLTHR---QLL---SNAADWaeylglTEGDRYLAAnpFFHVF-GYKAGVNAPLMRGAT 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2742 AVLLHEEEAKDILAIkhqLSRQRITHMIIVPVLYRALLDVVQ--PEDVKTLRVVTLAGEAADRELIARSLAICPHTELAN 2819
Cdd:PRK07656 236 ILPLPVFDPDEVFRL---IETERITVLPGPPTMYNSLLQHPDrsAEDLSSLRLAVTGAASMPVALLERFESELGVDIVLT 312
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2820 EYGPTENSVATTVMRHMEKQAYV--SIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAftqnp 2897
Cdd:PRK07656 313 GYGLSEASGVTTFNRLDDDRKTVagTIGTAIAGVENKIVNELGEEVPVGEVGELLVRGPNVMKGYYDDPEATAAA----- 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2898 FKPEARMYrTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAhV--TASGQTeLSAYVVTK 2975
Cdd:PRK07656 388 IDADGWLH-TGDLGRLDEEGYLYIVDRKKDMFIVGGFNVYPAEVEEVLYEHPAVAEAAVIG-VpdERLGEV-GKAYVVLK 464
|
490 500 510 520
....*....|....*....|....*....|....*....|....*.
gi 1678550997 2976 PG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK07656 465 PGaeLTEEELIAYCREHLAKYKVPRSIEFLDELPKNATGKVLKRAL 510
|
|
| PRK06187 |
PRK06187 |
long-chain-fatty-acid--CoA ligase; Validated |
2529-3019 |
2.52e-56 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235730 [Multi-domain] Cd Length: 521 Bit Score: 206.58 E-value: 2.52e-56
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2529 QYGVQTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGG 2608
Cdd:PRK06187 2 QDYPLTIGRILRHGARKHPDKEAVYFDGRRTTYAELDERVNRLANALRALGVKKGDRVAVFDWNSHEYLEAYFAVPKIGA 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2609 CYVPIDPEYPKERKRYILSDSGTKLLMtINEADLGVLADFEGEILTIESV---EEDDKSPLPQMSSAHH----------- 2674
Cdd:PRK06187 82 VLHPINIRLKPEEIAYILNDAEDRVVL-VDSEFVPLLAAILPQLPTVRTViveGDGPAAPLAPEVGEYEellaaasdtfd 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2675 --------LAYIIYTSGTTGRPKGVMVEHKGI-ANTLQ---WRRnayaFNETDTILQlfsfsfdgfITSMF--------- 2733
Cdd:PRK06187 161 fpdidendAAAMLYTSGTTGHPKGVVLSHRNLfLHSLAvcaWLK----LSRDDVYLV---------IVPMFhvhawglpy 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2734 TPLLSGAKAVLLHEEEAKDILaikHQLSRQRITHMIIVPVLYRALLD--VVQPEDVKTLRVVTLAGEAADRELIARSLAI 2811
Cdd:PRK06187 228 LALMAGAKQVIPRRFDPENLL---DLIETERVTFFFAVPTIWQMLLKapRAYFVDFSSLRLVIYGGAALPPALLREFKEK 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2812 CpHTELANEYGPTENSVATTVMR---HMEKQAYV--SIGQPIDGTQVLILNSNHQLQP--IGVAGELCIAGTGLARGYVN 2884
Cdd:PRK06187 305 F-GIDLVQGYGMTETSPVVSVLPpedQLPGQWTKrrSAGRPLPGVEARIVDDDGDELPpdGGEVGEIIVRGPWLMQGYWN 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2885 LPELTERAFtqnpfkpEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAhV--TA 2962
Cdd:PRK06187 384 RPEATAETI-------DGGWLHTGDVGYIDEDGYLYITDRIKDVIISGGENIYPRELEDALYGHPAVAEVAVIG-VpdEK 455
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 2963 SGQTELsAYVVTKPG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK06187 456 WGERPV-AVVVLKPGatLDAKELRAFLRGRLAKFKLPKRIAFVDELPRTSVGKILKRVL 513
|
|
| C_NRPS-like |
cd19066 |
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of ... |
11-433 |
3.10e-56 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long, with various activities such as antibiotic, antifungal, antitumor and immunosuppression. There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380453 [Multi-domain] Cd Length: 427 Bit Score: 203.41 E-value: 3.10e-56
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 11 YPLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFIsQNVSSPQQVVLRERNVIVLE 90
Cdd:cd19066 2 IPLSPMQRGMWFLKKLATDPSAFNVAIEMFLTGSLDLARLKQALDAVMERHDVLRTRFC-EEAGRYEQVVLDKTVRFRIE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 91 E-DITHLNEAEQSqfIEQWKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASYVN 169
Cdd:cd19066 81 IiDLRNLADPEAR--LLELIDQIQQTIYDLERGPLVRVALFRLADERDVLVVAIHHIIVDGGSFQILFEDISSVYDAAER 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 170 ASPITLEPVQPYGKYIKWLMEQDKEQA----VSYWDHYLSGHEQQTVLPKQKKTKGKSRQE--HVTFSFSKEESSRLSEL 243
Cdd:cd19066 159 QKPTLPPPVGSYADYAAWLEKQLESEAaqadLAYWTSYLHGLPPPLPLPKAKRPSQVASYEvlTLEFFLRSEETKRLREV 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 244 AAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRPAeiEGIEHMVGLFINTMPVRVQGAKTP-FLQLIKDMQKDRL 322
Cdd:cd19066 239 ARESGTTPTQLLLAAFALALKRLTASIDVVIGLTFLNRPD--EAVEDTIGLFLNLLPLRIDTSPDAtFPELLKRTKEQSR 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 323 AAEAYSYHPLYEIQSRSAVKQG-----LIDHILVFENYPvqqeiQMLNKQEHASDLFQIHnfTVADETNYSFYLMVAPGE 397
Cdd:cd19066 317 EAIEHQRVPFIELVRHLGVVPEapkhpLFEPVFTFKNNQ-----QQLGKTGGFIFTTPVY--TSSEGTVFDLDLEASEDP 389
|
410 420 430
....*....|....*....|....*....|....*...
gi 1678550997 398 --EIHIKMNYDAEQHDRSFVLSVKEHLLNAVSQILNNP 433
Cdd:cd19066 390 dgDLLLRLEYSRGVYDERTIDRFAERYMTALRQLIENP 427
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
2533-3402 |
4.50e-56 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 218.50 E-value: 4.50e-56
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2533 QTISQLFEQQAARTPKASALV------SGDKTLTYQELDEWSNGIARALRSRGVKPDTPVgIMMHRSFSMIASILGVWKA 2606
Cdd:PRK05691 9 LTLVQALQRRAAQTPDRLALRfladdpGEGVVLSYRDLDLRARTIAAALQARASFGDRAV-LLFPSGPDYVAAFFGCLYA 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2607 GGCYVPIDP-----EYPKERKRYILSDSGTKLLMTIneadlgvlADFEGEILTIESVEEDDKSPL--------------- 2666
Cdd:PRK05691 88 GVIAVPAYPpesarRHHQERLLSIIADAEPRLLLTV--------ADLRDSLLQMEELAAANAPELlcvdtldpalaeawq 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2667 -PQMSsAHHLAYIIYTSGTTGRPKGVMVEHKG-IANTLQWRRN-AYAFNETDTILQLFSFSFD-GFITSMFTPLLSGAKA 2742
Cdd:PRK05691 160 ePALQ-PDDIAFLQYTSGSTALPKGVQVSHGNlVANEQLIRHGfGIDLNPDDVIVSWLPLYHDmGLIGGLLQPIFSGVPC 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2743 VLLH-----EEEAKDILAIKH-------------QLSRQRITHmiivpvlyrallDVVQPEDVKTLRVVTLAGEAADR-- 2802
Cdd:PRK05691 239 VLMSpayflERPLRWLEAISEyggtisggpdfayRLCSERVSE------------SALERLDLSRWRVAYSGSEPIRQds 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2803 -ELIARSLAIC---PHTELANeYGPTENSVATTVMR--------HMEKQAY-------------VSIGQPIDGTQVLILN 2857
Cdd:PRK05691 307 lERFAEKFAACgfdPDSFFAS-YGLAEATLFVSGGRrgqgipalELDAEALarnraepgtgsvlMSCGRSQPGHAVLIVD 385
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2858 SNH-QLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNpfkpEARMY-RTGDAArWMADGTLEYLGRIDDQVKIRGYR 2935
Cdd:PRK05691 386 PQSlEVLGDNRVGEIWASGPSIAHGYWRNPEASAKTFVEH----DGRTWlRTGDLG-FLRDGELFVTGRLKDMLIVRGHN 460
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2936 VETKEIESVI-RCIKGVKDAAVVAH-VTASGQ------TELSAYV--VTKPGLSTNAVR---SELQNKLP---VFMHPAf 2999
Cdd:PRK05691 461 LYPQDIEKTVeREVEVVRKGRVAAFaVNHQGEegigiaAEISRSVqkILPPQALIKSIRqavAEACQEAPsvvLLLNPG- 539
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3000 iekldSLPLSPNGKLDRGALPK-------------PVYNHEGERPFLPPSSKMEQILADIWKEVLGAEKIGTADSFFELG 3066
Cdd:PRK05691 540 -----ALPKTSSGKLQRSACRLrladgsldsyalfPALQAVEAAQTAASGDELQARIAAIWCEQLKVEQVAADDHFFLLG 614
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3067 GDSIKALQVSARLH-RIGKQMAVKDLFSHPTIQELAAYIRD--SDTSSSQAAV-----EGDVQWSPVQK--WFLSQDIKE 3136
Cdd:PRK05691 615 GNSIAATQVVARLRdELGIDLNLRQLFEAPTLAAFSAAVARqlAGGGAAQAAIarlprGQALPQSLAQNrlWLLWQLDPQ 694
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3137 KHHFNQSVMLHRSTSVQEDALRKTLKAITCHHDALRMVFTQnEQGKwdQYNRPLSHSDdalYGLQMIDLSAPDGTDgnRP 3216
Cdd:PRK05691 695 SAAYNIPGGLHLRGELDEAALRASFQRLVERHESLRTRFYE-RDGV--ALQRIDAQGE---FALQRIDLSDLPEAE--RE 766
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3217 YEPLIKRHVlDIQQKMDLKNGPLLQAGLFHTIDGDF-LFLSAHHLVVDGISWRVLLEDLALGYRQAAGGEDIKLPPKTSS 3295
Cdd:PRK05691 767 ARAAQIREE-EARQPFDLEKGPLLRVTLVRLDDEEHqLLVTLHHIVADGWSLNILLDEFSRLYAAACQGQTAELAPLPLG 845
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3296 FKAYAKKLSDYAESQQLMKQLKYWRE--AEEYQTEALPFDQidgTRAHEGQRSTISFTLN-DKETAALLKDANSAYNTDT 3372
Cdd:PRK05691 846 YADYGAWQRQWLAQGEAARQLAYWKAqlGDEQPVLELATDH---PRSARQAHSAARYSLRvDASLSEALRGLAQAHQATL 922
|
970 980 990
....*....|....*....|....*....|
gi 1678550997 3373 QDMLLASVILALRHWTNQSAFKLSLEGHGR 3402
Cdd:PRK05691 923 FMVLLAAFQALLHRYSGQGDIRIGVPNANR 952
|
|
| BCL_like |
cd05919 |
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate ... |
2550-3019 |
9.36e-56 |
|
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate CoA ligase (BCL) and related ligases that catalyze the acylation of benzoate derivatives, 2-aminobenzoate and 4-hydroxybenzoate. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Xenobiotic aromatic compounds are also a major class of man-made pollutants. Some bacteria use benzoate as the sole source of carbon and energy through benzoate degradation. Benzoate degradation starts with its activation to benzoyl-CoA by benzoate CoA ligase. The reaction catalyzed by benzoate CoA ligase proceeds via a two-step process; the first ATP-dependent step forms an acyl-AMP intermediate, and the second step forms the acyl-CoA ester with release of the AMP.
Pssm-ID: 341243 [Multi-domain] Cd Length: 436 Bit Score: 202.31 E-value: 9.36e-56
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2550 SALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDS 2629
Cdd:cd05919 2 TAFYAADRSVTYGQLHDGANRLGSALRNLGVSSGDRVLLLMLDSPELVQLFLGCLARGAIAVVINPLLHPDDYAYIARDC 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2630 GTKLLMTineadlgvladfegeiltiesvEEDDksplpqmssahhLAYIIYTSGTTGRPKGVMVEHKGIANTLQ-WRRNA 2708
Cdd:cd05919 82 EARLVVT----------------------SADD------------IAYLLYSSGTTGPPKGVMHAHRDPLLFADaMAREA 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2709 YAFNETDTIL---QLFsFSFdGFITSMFTPLLSGAKAVLlhEEEAKDILAIKHQLSRQRITHMIIVPVLYRALLD--VVQ 2783
Cdd:cd05919 128 LGLTPGDRVFssaKMF-FGY-GLGNSLWFPLAVGASAVL--NPGWPTAERVLATLARFRPTVLYGVPTFYANLLDscAGS 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2784 PEDVKTLRVVTLAGEAADRELIARSLAicpHT--ELANEYGPTENsVATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQ 2861
Cdd:cd05919 204 PDALRSLRLCVSAGEALPRGLGERWME---HFggPILDGIGATEV-GHIFLSNRPGAWRLGSTGRPVPGYEIRLVDEEGH 279
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2862 LQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNpfkpearMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEI 2941
Cdd:cd05919 280 TIPPGEEGDLLVRGPSAAVGYWNNPEKSRATFNGG-------WYRTGDKFCRDADGWYTHAGRADDMLKVGGQWVSPVEV 352
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2942 ESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTNAVRSE-----LQNKLPVFMHPAFIEKLDSLPLSPNGKLDR 3016
Cdd:cd05919 353 ESLIIQHPAVAEAAVVAVPESTGLSRLTAFVVLKSPAAPQESLARdihrhLLERLSAHKVPRRIAFVDELPRTATGKLQR 432
|
...
gi 1678550997 3017 GAL 3019
Cdd:cd05919 433 FKL 435
|
|
| beta-lac_NRPS |
cd19547 |
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis ... |
10-415 |
1.40e-55 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis NocB which exhibits an unusual cyclization to form beta-lactam rings in pro-nocardicin G synthesis; Nocardia uniformis NRPS NocB acts centrally in the biosynthesis of the nocardicin monocyclic beta-lactam antibiotics. Along with another NRPS NocA, it mediates an unusual cyclization to form beta-lactam rings in the synthesis of the beta-lactam-containing pentapeptide pro-nocardicin G. This small subfamily is related to DCL-type Condensation (C) domains, which catalyze condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; domains belonging to this subfamily have an HHHxxxD motif at the active site.
Pssm-ID: 380469 [Multi-domain] Cd Length: 422 Bit Score: 201.39 E-value: 1.40e-55
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 10 IYPLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNVSSPQQVVLRERNVIVL 89
Cdd:cd19547 1 VYPLAPMQEGMLFRGLFWPDSDAYFNQNVLELVGGTDEDVLREAWRRVADRYEILRTGFTWRDRAEPLQYVRDDLAPPWA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 90 EEDITHLNEAEQSQFIEQWKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASYVN 169
Cdd:cd19547 81 LLDWSGEDPDRRAELLERLLADDRAAGLSLADCPLYRLTLVRLGGGRHYLLWSHHHILLDGWCLSLIWGDVFRVYEELAH 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 170 ASPITLEPVQPYGKYIKWLMEQ--DKEQAVSYWDHYLSgheqqTVLPKQKKTKGKSRQ---EHVTFSFSKEESSRLSELA 244
Cdd:cd19547 161 GREPQLSPCRPYRDYVRWIRARtaQSEESERFWREYLR-----DLTPSPFSTAPADREgefDTVVHEFPEQLTRLVNEAA 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 245 AREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRPAEIEGIEHMVGLFINTMPVRVQ-GAKTPFLQLIKDMQKDRLA 323
Cdd:cd19547 236 RGYGVTTNAISQAAWSMLLALQTGARDVVHGLTIAGRPPELEGSEHMVGIFINTIPLRIRlDPDQTVTGLLETIHRDLAT 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 324 AEAYSYHPLYEIQSRSAVKQ----GLIDHILVFENYPVQQeiqmLNKQEHASDLFQIHnftVADETNYSFYLMVAPGEEI 399
Cdd:cd19547 316 TAAHGHVPLAQIKSWASGERlsggRVFDNLVAFENYPEDN----LPGDDLSIQIIDLH---AQEKTEYPIGLIVLPLQKL 388
|
410
....*....|....*.
gi 1678550997 400 HIKMNYDAEQHDRSFV 415
Cdd:cd19547 389 AFHFNYDTTHFTRAQV 404
|
|
| FACL_FadD13-like |
cd17631 |
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, ... |
469-949 |
3.37e-55 |
|
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, including Mycobacterium tuberculosis acid-induced operon MymA encoding the fatty acyl-CoA synthetase FadD13 which is essential for virulence and intracellular growth of the pathogen. The fatty acyl-CoA synthetase activates lipids before entering into the metabolic pathways and is also involved in transmembrane lipid transport. However, unlike soluble fatty acyl-CoA synthetases, but like the mammalian integral-membrane very-long-chain acyl-CoA synthetases, FadD13 accepts lipid substrates up to the maximum length of C26, and this is facilitated by an extensive hydrophobic tunnel from the active site to a positively charged patch. Also included is feruloyl-CoA synthetase (Fcs) in Rhodococcus strains where it is involved in biotechnological vanillin production from eugenol and ferulic acid via a non-beta-oxidative pathway.
Pssm-ID: 341286 [Multi-domain] Cd Length: 435 Bit Score: 200.53 E-value: 3.37e-55
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 469 FEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYP 548
Cdd:cd17631 1 LRRRARRHPDRTALVFGGRSLTYAELDERVNRLAHALRALGVAKGDRVAVLSKNSPEFLELLFAAARLGAVFVPLNFRLT 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 549 ADRIRYILHDCGcSHVVsqahlpsslednyiithpedieskvdgsniksvnnADDLLYMIYTSGTTGKPKGVQFEHRNMA 628
Cdd:cd17631 81 PPEVAYILADSG-AKVL-----------------------------------FDDLALLMYTSGTTGRPKGAMLTHRNLL 124
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 629 nllkFEYTHSGIDFEA---DVLQFATPSFDV----CYqeIFSALLKGGTLHIVPeaiKRDVPQLFAFINKHQTNIVFL-P 700
Cdd:cd17631 125 ----WNAVNALAALDLgpdDVLLVVAPLFHIgglgVF--TLPTLLRGGTVVILR---KFDPETVLDLIERHRVTSFFLvP 195
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 701 TAFIKMI----FSERELANsfpdgVKHLIAAGEQlMISDLFQdVLRKRGIHLHNHYGPSETHVVSTyTIHPGDPIPELPP 776
Cdd:cd17631 196 TMIQALLqhprFATTDLSS-----LRAVIYGGAP-MPERLLR-ALQARGVKFVQGYGMTETSPGVT-FLSPEDHRRKLGS 267
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 777 IGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimyRTGDLARRLEDGNIEYIG 856
Cdd:cd17631 268 AGRPVFFVEVRIVDPDGREVPPGEVGEIVVRGPHVMAGYWNRPEATAAAFRDGWF-------HTGDLGRLDEDGYLYIVD 340
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 857 RADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQN-GEhELCAyYCSVQKLNTID---LRSYMASELPEYMIPAK 932
Cdd:cd17631 341 RKKDMIISGGENVYPAEVEDVLYEHPAVAEVAVIGVPDEKwGE-AVVA-VVVPRPGAELDedeLIAHCRERLARYKIPKS 418
|
490
....*....|....*..
gi 1678550997 933 WIWVDSIPLTPNGKVDR 949
Cdd:cd17631 419 VEFVDALPRNATGKILK 435
|
|
| Firefly_Luc_like |
cd05911 |
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family ... |
1519-1924 |
3.67e-55 |
|
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family contains insect firefly luciferases that share significant sequence similarity to plant 4-coumarate:coenzyme A ligases, despite their functional diversity. Luciferase catalyzes the production of light in the presence of MgATP, molecular oxygen, and luciferin. In the first step, luciferin is activated by acylation of its carboxylate group with ATP, resulting in an enzyme-bound luciferyl adenylate. In the second step, luciferyl adenylate reacts with molecular oxygen, producing an enzyme-bound excited state product (Luc=O*) and releasing AMP. This excited-state product then decays to the ground state (Luc=O), emitting a quantum of visible light.
Pssm-ID: 341237 [Multi-domain] Cd Length: 486 Bit Score: 202.06 E-value: 3.67e-55
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1519 VMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLLQ 1598
Cdd:cd05911 10 ELTYAQLRTLSRRLAAGLRKLGLKKGDVVGIISPNSTYYPPVFLGCLFAGGIFSAANPIYTADELAHQLKISKPKVIFTD 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1599 SAGLHV-------PEFTGEIVYLNQTNSGLAHR---LSNPNVD----------VLPQSLAYVIYTSGSTGMPKGVEIEHR 1658
Cdd:cd05911 90 PDGLEKvkeaakeLGPKDKIIVLDDKPDGVLSIedlLSPTLGEededlppplkDGKDDTAAILYSSGTTGLPKGVCLSHR 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1659 SAVNflNSLQSRYQLKHSDmIMHKTSYSFD-----ASIWELFWWPYAGASVYLLPQGgekEPEVIAKAIEEQKITAMHFV 1733
Cdd:cd05911 170 NLIA--NLSQVQTFLYGND-GSNDVILGFLplyhiYGLFTTLASLLNGATVIIMPKF---DSELFLDLIEKYKITFLYLV 243
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1734 PSMLHAFLEHIKYRSvpIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAffdCPPHEKLERIPIG 1813
Cdd:cd05911 244 PPIAAALAKSPLLDK--YDLSSLRVILSGGAPLSKELQELLAKRFPNATIKQGYGMTETGGILT---VNPDGDDKPGSVG 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1814 KPVHHVRLYLLN-QNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYpgermyKTGDVARWLPDGNVEFLGR 1892
Cdd:cd05911 319 RLLPNVEAKIVDdDGKDSLGPNEPGEICVRGPQVMKGYYNNPEATKETFDEDGWL------HTGDIGYFDEDGYLYIVDR 392
|
410 420 430
....*....|....*....|....*....|..
gi 1678550997 1893 TDDQVKIRGYRIEPGEIEAALRSIEGVREAAV 1924
Cdd:cd05911 393 KKELIKYKGFQVAPAELEAVLLEHPGVADAAV 424
|
|
| Firefly_Luc_like |
cd05911 |
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family ... |
2551-3014 |
5.78e-55 |
|
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family contains insect firefly luciferases that share significant sequence similarity to plant 4-coumarate:coenzyme A ligases, despite their functional diversity. Luciferase catalyzes the production of light in the presence of MgATP, molecular oxygen, and luciferin. In the first step, luciferin is activated by acylation of its carboxylate group with ATP, resulting in an enzyme-bound luciferyl adenylate. In the second step, luciferyl adenylate reacts with molecular oxygen, producing an enzyme-bound excited state product (Luc=O*) and releasing AMP. This excited-state product then decays to the ground state (Luc=O), emitting a quantum of visible light.
Pssm-ID: 341237 [Multi-domain] Cd Length: 486 Bit Score: 201.29 E-value: 5.78e-55
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2551 ALVSGD--KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSD 2628
Cdd:cd05911 1 AQIDADtgKELTYAQLRTLSRRLAAGLRKLGLKKGDVVGIISPNSTYYPPVFLGCLFAGGIFSAANPIYTADELAHQLKI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2629 SGTKLL-----------------------MTINEADLGVLadFEGEILTIESVEEDDKSPLPQMSSAHHLAYIIYTSGTT 2685
Cdd:cd05911 81 SKPKVIftdpdglekvkeaakelgpkdkiIVLDDKPDGVL--SIEDLLSPTLGEEDEDLPPPLKDGKDDTAAILYSSGTT 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2686 GRPKGVMVEHKG-IANTLQWRRNAYAFNETDTILQLFSfSFD---GFITSMFTPLLsGAKAVLLHEEEAKDILAIkhqLS 2761
Cdd:cd05911 159 GLPKGVCLSHRNlIANLSQVQTFLYGNDGSNDVILGFL-PLYhiyGLFTTLASLLN-GATVIIMPKFDSELFLDL---IE 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2762 RQRITHMIIVPVLYRALLD--VVQPEDVKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTENSVATTVMRHMEKQ 2839
Cdd:cd05911 234 KYKITFLYLVPPIAAALAKspLLDKYDLSSLRVILSGGAPLSKELQELLAKRFPNATIKQGYGMTETGGILTVNPDGDDK 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2840 aYVSIGQPIDGTQVLILNSN-HQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMADGT 2918
Cdd:cd05911 314 -PGSVGRLLPNVEAKIVDDDgKDSLGPNEPGEICVRGPQVMKGYYNNPEATKETFDEDGW------LHTGDIGYFDEDGY 386
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2919 LEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAhVTASGQTEL-SAYVVTKPG--LSTNAVRSELQNKLP--- 2992
Cdd:cd05911 387 LYIVDRKKELIKYKGFQVAPAELEAVLLEHPGVADAAVIG-IPDEVSGELpRAYVVRKPGekLTEKEVKDYVAKKVAsyk 465
|
490 500
....*....|....*....|....*..
gi 1678550997 2993 -----VFmhpaFIeklDSLPLSPNGKL 3014
Cdd:cd05911 466 qlrggVV----FV---DEIPKSASGKI 485
|
|
| BCL_4HBCL |
cd05959 |
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate ... |
2551-3019 |
9.78e-55 |
|
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate CoA ligase and 4-hydroxybenzoate-coenzyme A ligase catalyze the first activating step for benzoate and 4-hydroxybenzoate catabolic pathways, respectively. Although these two enzymes share very high sequence homology, they have their own substrate preference. The reaction proceeds via a two-step process; the first ATP-dependent step forms the substrate-AMP intermediate, while the second step forms the acyl-CoA ester, releasing the AMP. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Some bacteria can use benzoic acid or benzenoid compounds as the sole source of carbon and energy through degradation. Benzoate CoA ligase and 4-hydroxybenzoate-Coenzyme A ligase are key enzymes of this process.
Pssm-ID: 341269 [Multi-domain] Cd Length: 508 Bit Score: 201.44 E-value: 9.78e-55
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2551 ALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSG 2630
Cdd:cd05959 22 AFIDDAGSLTYAELEAEARRVAGALRALGVKREERVLLIMLDTVDFPTAFLGAIRAGIVPVPVNTLLTPDDYAYYLEDSR 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2631 TK-------LLMTINEADLGVLADFEGEILTiESVEEDDKSPL-------------PQMSSAHHLAYIIYTSGTTGRPKG 2690
Cdd:cd05959 102 ARvvvvsgeLAPVLAAALTKSEHTLVVLIVS-GGAGPEAGALLlaelvaaeaeqlkPAATHADDPAFWLYSSGSTGRPKG 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2691 VMVEHKGIANTLQ-WRRNAYAFNETDTIL---QLFsFSFdGFITSMFTPLLSGAKAVLLHEEEAKDilAIKHQLSRQRIT 2766
Cdd:cd05959 181 VVHLHADIYWTAElYARNVLGIREDDVCFsaaKLF-FAY-GLGNSLTFPLSVGATTVLMPERPTPA--AVFKRIRRYRPT 256
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2767 HMIIVPVLYRALL--DVVQPEDVKTLRVVTLAGEAADRELIARSLAICPHTELaneygpteNSVATTVMRHM------EK 2838
Cdd:cd05959 257 VFFGVPTLYAAMLaaPNLPSRDLSSLRLCVSAGEALPAEVGERWKARFGLDIL--------DGIGSTEMLHIflsnrpGR 328
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2839 QAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFtqnpfkpEARMYRTGDAARWMADGT 2918
Cdd:cd05959 329 VRYGTTGKPVPGYEVELRDEDGGDVADGEPGELYVRGPSSATMYWNNRDKTRDTF-------QGEWTRTGDKYVRDDDGF 401
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2919 LEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTNAV-RSELQ----NKLPV 2993
Cdd:cd05959 402 YTYAGRADDMLKVSGIWVSPFEVESALVQHPAVLEAAVVGVEDEDGLTKPKAFVVLRPGYEDSEAlEEELKefvkDRLAP 481
|
490 500
....*....|....*....|....*.
gi 1678550997 2994 FMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:cd05959 482 YKYPRWIVFVDELPKTATGKIQRFKL 507
|
|
| Acs |
COG0365 |
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism]; |
1497-1983 |
1.42e-54 |
|
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism];
Pssm-ID: 440134 [Multi-domain] Cd Length: 565 Bit Score: 202.65 E-value: 1.42e-54
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1497 HYALEQQAEKTPDQAAVIFED-----GVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAY 1571
Cdd:COG0365 12 YNCLDRHAEGRGDKVALIWEGedgeeRTLTYAELRREVNRFANALRALGVKKGDRVAIYLPNIPEAVIAMLACARIGAVH 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1572 LPIDPDYPEERISFLLEDSGTNILLLQSAGLhvpeFTGEIVYLNQTNSGLAHRLSNP-NVDVLPQSL------------- 1637
Cdd:COG0365 92 SPVFPGFGAEALADRIEDAEAKVLITADGGL----RGGKVIDLKEKVDEALEELPSLeHVIVVGRTGadvpmegdldwde 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1638 -------------------AYVIYTSGSTGMPKGVEIEHRS-AVNFLNSLQSRYQLKHSDmimhktsysfdasiweLFWW 1697
Cdd:COG0365 168 llaaasaefepeptdaddpLFILYTSGTTGKPKGVVHTHGGyLVHAATTAKYVLDLKPGD----------------VFWC 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1698 P-----------------YAGASVYLLPQGGE-KEPEVIAKAIEEQKITAMHFVPSMLHAFlehIKYRSVPIKT---NRL 1756
Cdd:COG0365 232 TadigwatghsyivygplLNGATVVLYEGRPDfPDPGRLWELIEKYGVTVFFTAPTAIRAL---MKAGDEPLKKydlSSL 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1757 KRVFSGGEQLGTHLVSRFYELLpNVSITNSYGPTEATveAAFFDCPPHEKLERIPIGKPV--HHVRLylLNQNQRMLPVG 1834
Cdd:COG0365 309 RLLGSAGEPLNPEVWEWWYEAV-GVPIVDGWGQTETG--GIFISNLPGLPVKPGSMGKPVpgYDVAV--VDEDGNPVPPG 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1835 CIGELYIAGA--GVARGYLNRPALTEERFLEDpfYPGerMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAA 1912
Cdd:COG0365 384 EEGELVIKGPwpGMFRGYWNDPERYRETYFGR--FPG--WYRTGDGARRDEDGYFWILGRSDDVINVSGHRIGTAEIESA 459
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1913 LRSIEGVREAAVTVRTDS--GEpELCAYV---EGLQ-----RNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNA 1982
Cdd:COG0365 460 LVSHPAVAEAAVVGVPDEirGQ-VVKAFVvlkPGVEpsdelAKELQAHVREELGPYAYPREIEFVDELPKTRSGKIMRRL 538
|
.
gi 1678550997 1983 L 1983
Cdd:COG0365 539 L 539
|
|
| FACL_like_6 |
cd05922 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
2568-3019 |
1.20e-53 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341246 [Multi-domain] Cd Length: 457 Bit Score: 196.89 E-value: 1.20e-53
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2568 SNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGC----YVPIDPEYPKERKRYILSDSGTKL------LMTI 2637
Cdd:cd05922 3 VSAAASALLEAGGVRGERVVLILPNRFTYIELSFAVAYAGGRlglvFVPLNPTLKESVLRYLVADAGGRIvladagAADR 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2638 NEADLGVLADfEGEILTIESVEeDDKSPLPQMSSAHH-LAYIIYTSGTTGRPKGVMVEHKGIantlqwRRNAYAFNE--- 2713
Cdd:cd05922 83 LRDALPASPD-PGTVLDADGIR-AARASAPAHEVSHEdLALLLYTSGSTGSPKLVRLSHQNL------LANARSIAEylg 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2714 ---TDTILQLFSFSFDGFITSMFTPLLSGAKAVLlHEEEAKDILAIKhQLSRQRITHMIIVPVLYrALLDVV--QPEDVK 2788
Cdd:cd05922 155 itaDDRALTVLPLSYDYGLSVLNTHLLRGATLVL-TNDGVLDDAFWE-DLREHGATGLAGVPSTY-AMLTRLgfDPAKLP 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2789 TLRVVTLAGEAADRELIARSLAICPHTELANEYGPTENSVATTVM-RHMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGV 2867
Cdd:cd05922 232 SLRYLTQAGGRLPQETIARLRELLPGAQVYVMYGQTEATRRMTYLpPERILEKPGSIGLAIPGGEFEILDDDGTPTPPGE 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2868 AGELCIAGTGLARGYVNLPelterAFTQNPFKPEARMYrTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRC 2947
Cdd:cd05922 312 PGEIVHRGPNVMKGYWNDP-----PYRRKEGRGGGVLH-TGDLARRDEDGFLFIVGRRDRMIKLFGNRISPTEIEAAARS 385
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 2948 IKGVKDAAVVAHVTASGQtELSAYVVTKPGLSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:cd05922 386 IGLIIEAAAVGLPDPLGE-KLALFVTAPDKIDPKDVLRSLAERLPPYKVPATVRVVDELPLTASGKVDYAAL 456
|
|
| MCS |
cd05941 |
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step ... |
2551-3019 |
1.32e-53 |
|
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step reaction consisting of the adenylation of malonate with ATP, followed by malonyl transfer from malonyl-AMP to CoA. Malonic acid and its derivatives are the building blocks of polyketides and malonyl-CoA serves as the substrate of polyketide synthases. Malonyl-CoA synthetase has broad substrate tolerance and can activate a variety of malonyl acid derivatives. MCS may play an important role in biosynthesis of polyketides, the important secondary metabolites with therapeutic and agrochemical utility.
Pssm-ID: 341264 [Multi-domain] Cd Length: 442 Bit Score: 195.97 E-value: 1.32e-53
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2551 ALVSGDKTLTYQELDEWSNGIARAL-RSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDS 2629
Cdd:cd05941 4 AIVDDGDSITYADLVARAARLANRLlALGKDLRGDRVAFLAPPSAEYVVAQLAIWRAGGVAVPLNPSYPLAELEYVITDS 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2630 GTKLLMtineadlgvladfegeiltiesveeddksplpqmssahHLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAY 2709
Cdd:cd05941 84 EPSLVL--------------------------------------DPALILYTSGTTGRPKGVVLTHANLAANVRALVDAW 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2710 AFNETDTILQ-LFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQlsrQRITHMIIVPVLYRALLDVVQpEDVK 2788
Cdd:cd05941 126 RWTEDDVLLHvLPLHHVHGLVNALLCPLFAGASVEFLPKFDPKEVAISRLM---PSITVFMGVPTIYTRLLQYYE-AHFT 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2789 TLRVVTLAGEAADRELIARSLAICPHT--ELAN--------EYGPTENSVATTVMRHMEKQAYvSIGQPIDGTQVLIL-N 2857
Cdd:cd05941 202 DPQFARAAAAERLRLMVSGSAALPVPTleEWEAitghtlleRYGMTEIGMALSNPLDGERRPG-TVGMPLPGVQARIVdE 280
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2858 SNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMADGTLEYLGRI-DDQVKIRGYRV 2936
Cdd:cd05941 281 ETGEPLPRGEVGEIQVRGPSVFKEYWNKPEATKEEFTDDGW------FKTGDLGVVDEDGYYWILGRSsVDIIKSGGYKV 354
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2937 ETKEIESVIRCIKGVKDAAVV--AHVTAsGQtELSAYVVTKPG---LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPN 3011
Cdd:cd05941 355 SALEIERVLLAHPGVSECAVIgvPDPDW-GE-RVVAVVVLRAGaaaLSLEELKEWAKQRLAPYKRPRRLILVDELPRNAM 432
|
....*...
gi 1678550997 3012 GKLDRGAL 3019
Cdd:cd05941 433 GKVNKKEL 440
|
|
| FUM14_C_NRPS-like |
cd19545 |
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond ... |
10-433 |
2.54e-53 |
|
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond forming Fusarium verticillioides FUM14 protein; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) typically catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. However, some C-domains have ester-bond forming activity. This subfamily includes Fusarium verticillioides FUM14 (also known as NRPS8), a bi-domain protein with an ester-bond forming NRPS C-domain, which catalyzes linkages between an aminoacyl/peptidyl-PCP donor and a hydroxyl-containing acceptor. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. FUM14 has an altered active site motif DHTHCD instead of the typical HHxxxD motif seen in other subfamily members. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380467 [Multi-domain] Cd Length: 395 Bit Score: 193.67 E-value: 2.54e-53
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 10 IYPLSYMQEGMLFHSLlqKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNVSSPQQVVLRErnvivl 89
Cdd:cd19545 1 IYPCTPLQEGLMALTA--RQPGAYVGQRVFELPPDIDLARLQAAWEQVVQANPILRTRIVQSDSGGLLQVVVKE------ 72
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 90 eEDITHlneaEQSQFIEQWKEKDRDRGFHLQKDvLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASYvn 169
Cdd:cd19545 73 -SPISW----TESTSLDEYLEEDRAAPMGLGGP-LVRLALVEDPDTERYFVWTIHHALYDGWSLPLILRQVLAAYQGE-- 144
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 170 aspiTLEPVQPYGKYIKWLMEQDKEQAVSYWDHYLSGhEQQTVLP-----KQKKTKGKSRQEHVTFSFSkeessrlsela 244
Cdd:cd19545 145 ----PVPQPPPFSRFVKYLRQLDDEAAAEFWRSYLAG-LDPAVFPplpssRYQPRPDATLEHSISLPSS----------- 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 245 AREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRPAEIEGIEHMVGLFINTMPVRVQ-GAKTPFLQLIKDMQKDRLA 323
Cdd:cd19545 209 ASSGVTLATVLRAAWALVLSRYTGSDDVVFGVTLSGRNAPVPGIEQIVGPTIATVPLRVRiDPEQSVEDFLQTVQKDLLD 288
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 324 AEAYSYHPLYEIQSRS--AVKQGLIDHILVFEnYPVQQEiqmlnkqEHASDLFQIHNFTVADETNYSFYLMV---APGEE 398
Cdd:cd19545 289 MIPFEHTGLQNIRRLGpdARAACNFQTLLVVQ-PALPSS-------TSESLELGIEEESEDLEDFSSYGLTLecqLSGSG 360
|
410 420 430
....*....|....*....|....*....|....*
gi 1678550997 399 IHIKMNYDAEQHDRSFVLSVKEHLLNAVSQILNNP 433
Cdd:cd19545 361 LRVRARYDSSVISEEQVERLLDQFEHVLQQLASAP 395
|
|
| ligase_PEP_1 |
TIGR03098 |
acyl-CoA ligase (AMP-forming), exosortase A-associated; This group of proteins contains an ... |
464-952 |
5.85e-53 |
|
acyl-CoA ligase (AMP-forming), exosortase A-associated; This group of proteins contains an AMP-binding domain (pfam00501) associated with acyl CoA-ligases. These proteins are generally found in genomes containing the exosortase/PEP-CTERM protein expoert system, specifically the type 1 variant of this system described by the Genome Property GenProp0652. When found in this context they are invariably present next to a decarboxylase enzyme. A number of sequences from Burkholderia species also hit this model, but the genomic context is obviously different. The hypothesis of a constant substrate for this family is only strong where the exosortase context is present.
Pssm-ID: 211788 [Multi-domain] Cd Length: 517 Bit Score: 196.54 E-value: 5.85e-53
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 464 TIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPV 543
Cdd:TIGR03098 1 LLHHLLEDAAARLPDATALVHHDRTLTYAALSERVLALASGLRGLGLARGERVAIYLDKRLETVTAMFGAALAGGVFVPI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 544 DPHYPADRIRYILHDCGCSHVVSQAHLPSSLEDN----------YIITHPEDIESKVDGSNIKSVNNA------------ 601
Cdd:TIGR03098 81 NPLLKAEQVAHILADCNVRLLVTSSERLDLLHPAlpgchdlrtlIIVGDPAHASEGHPGEEPASWPKLlalgdadpphpv 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 602 --DDLLYMIYTSGTTGKPKGVQFEHRNM-------ANLLKFEythsgidfEADVLQFATP-SFDVCYQEIFSALLKGGTL 671
Cdd:TIGR03098 161 idSDMAAILYTSGSTGRPKGVVLSHRNLvagaqsvATYLENR--------PDDRLLAVLPlSFDYGFNQLTTAFYVGATV 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 672 HIVPEAIKRDVPQLfafINKHQ-TNIVFLPTAFIKMifSERELANSFPDGVKHLIAAGEQL---MISDLFQDVLRKRgih 747
Cdd:TIGR03098 233 VLHDYLLPRDVLKA---LEKHGiTGLAAVPPLWAQL--AQLDWPESAAPSLRYLTNSGGAMpraTLSRLRSFLPNAR--- 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 748 LHNHYGPSEThVVSTYtihpgdpipeLPP---------IGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNH 818
Cdd:TIGR03098 305 LFLMYGLTEA-FRSTY----------LPPeevdrrpdsIGKAIPNAEVLVLREDGSECAPGEEGELVHRGALVAMGYWND 373
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 819 DKLTSDKFSSDPFKPDV-----IMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQ 893
Cdd:TIGR03098 374 PEKTAERFRPLPPFPGElhlpeLAVWSGDTVRRDEEGFLYFVGRRDEMIKTSGYRVSPTEVEEVAYATGLVAEAVAFGVP 453
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 894 DQNGEHELCAYYCSVQK--LNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:TIGR03098 454 DPTLGQAIVLVVTPPGGeeLDRAALLAECRARLPNYMVPALIHVRQALPRNANGKIDRKAL 514
|
|
| Acs |
COG0365 |
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism]; |
466-952 |
1.01e-52 |
|
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism];
Pssm-ID: 440134 [Multi-domain] Cd Length: 565 Bit Score: 196.87 E-value: 1.01e-52
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 466 HAMFEKQAEKTPDAHAVI-----DQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAI 540
Cdd:COG0365 12 YNCLDRHAEGRGDKVALIwegedGEERTLTYAELRREVNRFANALRALGVKKGDRVAIYLPNIPEAVIAMLACARIGAVH 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 541 VPVDPHYPADRIRYILHDCGCSHVVS--------------------QAHLPSsLEdNYIITHPEDIESKVDGSN-----I 595
Cdd:COG0365 92 SPVFPGFGAEALADRIEDAEAKVLITadgglrggkvidlkekvdeaLEELPS-LE-HVIVVGRTGADVPMEGDLdwdelL 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 596 KSVN--------NADDLLYMIYTSGTTGKPKGVQFEHRNManLLKFEYTHSGI-DFEAD--VLQFATPSF-----DVCYq 659
Cdd:COG0365 170 AAASaefepeptDADDPLFILYTSGTTGKPKGVVHTHGGY--LVHAATTAKYVlDLKPGdvFWCTADIGWatghsYIVY- 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 660 eifSALLKGGTLHIVPEAIKRDVPQ-LFAFINKHQTNIVFL-PTAFIKMIFSERELANSFP-DGVKHLIAAGEQLMiSDL 736
Cdd:COG0365 247 ---GPLLNGATVVLYEGRPDFPDPGrLWELIEKYGVTVFFTaPTAIRALMKAGDEPLKKYDlSSLRLLGSAGEPLN-PEV 322
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 737 FQDVLRKRGIHLHNHYGPSET--HVVStytihpgdPIPELPP----IGKPI-GCtDLYILNHQKQLQPCGVPGELYISGA 809
Cdd:COG0365 323 WEWWYEAVGVPIVDGWGQTETggIFIS--------NLPGLPVkpgsMGKPVpGY-DVAVVDEDGNPVPPGEEGELVIKGP 393
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 810 --SVARGYVNHDKLTSDKFSSDPfkPDVimYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEA 887
Cdd:COG0365 394 wpGMFRGYWNDPERYRETYFGRF--PGW--YRTGDGARRDEDGYFWILGRSDDVINVSGHRIGTAEIESALVSHPAVAEA 469
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 888 AILIWQDQNGEHELCAYycsVqKLN---------TIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:COG0365 470 AVVGVPDEIRGQVVKAF---V-VLKpgvepsdelAKELQAHVREELGPYAYPREIEFVDELPKTRSGKIMRRLL 539
|
|
| CHC_CoA_lg |
cd05903 |
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); ... |
2558-3014 |
7.03e-52 |
|
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); Cyclohexanecarboxylate-CoA ligase activates the aliphatic ring compound, cyclohexanecarboxylate, for degradation. It catalyzes the synthesis of cyclohexanecarboxylate-CoA thioesters in a two-step reaction involving the formation of cyclohexanecarboxylate-AMP anhydride, followed by the nucleophilic substitution of AMP by CoA.
Pssm-ID: 341229 [Multi-domain] Cd Length: 437 Bit Score: 191.05 E-value: 7.03e-52
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2558 TLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMTI 2637
Cdd:cd05903 1 RLTYSELDTRADRLAAGLAALGVGPGDVVAFQLPNWWEFAVLYLACLRIGAVTNPILPFFREHELAFILRRAKAKVFVVP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2638 NEadlgvladFEGeiltiesveeddKSPLPQMSSahhLAYIIYTSGTTGRPKGVMVEHKGI-ANTLQWRRNaYAFNETDT 2716
Cdd:cd05903 81 ER--------FRQ------------FDPAAMPDA---VALLLFTSGTTGEPKGVMHSHNTLsASIRQYAER-LGLGPGDV 136
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2717 ILQLFSFS-FDGFITSMFTPLLSGAKAVLLHEEEAKDILAIkhqLSRQRITHMIIVPVLYRALLDVV--QPEDVKTLRVV 2793
Cdd:cd05903 137 FLVASPMAhQTGFVYGFTLPLLLGAPVVLQDIWDPDKALAL---MREHGVTFMMGATPFLTDLLNAVeeAGEPLSRLRTF 213
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2794 TLAGEAADRELIARsLAICPHTELANEYGPTENSVATTVMR-HMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELC 2872
Cdd:cd05903 214 VCGGATVPRSLARR-AAELLGAKVCSAYGSTECPGAVTSITpAPEDRRLYTDGRPLPGVEIKVVDDTGATLAPGVEGELL 292
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2873 IAGTGLARGYVNLPELTERAFTQNpfkpearMYRTGDAARWMADGTLEYLGRIDDqVKIR-GYRVETKEIESVIRCIKGV 2951
Cdd:cd05903 293 SRGPSVFLGYLDRPDLTADAAPEG-------WFRTGDLARLDEDGYLRITGRSKD-IIIRgGENIPVLEVEDLLLGHPGV 364
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 2952 KDAAVVAHVTASGQTELSAYVVTKPG--LSTNAVRSELQNK-LPVFMHPAFIEKLDSLPLSPNGKL 3014
Cdd:cd05903 365 IEAAVVALPDERLGERACAVVVTKSGalLTFDELVAYLDRQgVAKQYWPERLVHVDDLPRTPSGKV 430
|
|
| PRK07656 |
PRK07656 |
long-chain-fatty-acid--CoA ligase; Validated |
1491-1983 |
6.22e-51 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236072 [Multi-domain] Cd Length: 513 Bit Score: 190.50 E-value: 6.22e-51
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1491 SMNQTLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGA 1570
Cdd:PRK07656 2 NEWMTLPELLARAARRFGDKEAYVFGDQRLTYAELNARVRRAAAALAALGIGKGDRVAIWAPNSPHWVIAALGALKAGAV 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1571 YLPIDPDYPEERISFLLEDSGTNILL--------LQSAGLHVPEFtgEIVYLNQTNSGLAHR---------LSNPNVD-- 1631
Cdd:PRK07656 82 VVPLNTRYTADEAAYILARGDAKALFvlglflgvDYSATTRLPAL--EHVVICETEEDDPHTekmktftdfLAAGDPAer 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1632 ---VLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIM------HKTSY--SFDASIwelfwwpYA 1700
Cdd:PRK07656 160 apeVDPDDVADILFTSGTTGRPKGAMLTHRQLLSNAADWAEYLGLTEGDRYLaanpffHVFGYkaGVNAPL-------MR 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1701 GASVYLLPQggeKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTNRLkrVFSGGEQLGTHLVSRFYELLPN 1780
Cdd:PRK07656 233 GATILPLPV---FDPDEVFRLIETERITVLPGPPTMYNSLLQHPDRSAEDLSSLRL--AVTGAASMPVALLERFESELGV 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1781 VSITNSYGPTEATVEAAFfdCPPHEKLERIP--IGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTE 1858
Cdd:PRK07656 308 DIVLTGYGLSEASGVTTF--NRLDDDRKTVAgtIGTAIAGVENKIVNELGEEVPVGEVGELLVRGPNVMKGYYDDPEATA 385
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1859 ERFLEDPFypgerMYkTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTvrtdsGEPE---- 1934
Cdd:PRK07656 386 AAIDADGW-----LH-TGDLGRLDEEGYLYIVDRKKDMFIVGGFNVYPAEVEEVLYEHPAVAEAAVI-----GVPDerlg 454
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 1935 --LCAYV-----EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK07656 455 evGKAYVvlkpgAELTEEELIAYCREHLAKYKVPRSIEFLDELPKNATGKVLKRAL 510
|
|
| A_NRPS_acs4 |
cd17654 |
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal ... |
2556-3019 |
7.00e-51 |
|
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains acyl-CoA synthethase family member 4, also known as 2-aminoadipic 6-semialdehyde dehydrogenase or aminoadipate-semialdehyde dehydrogenase, most of which are uncharacterized. Acyl-CoA synthetase catalyzes the initial reaction in fatty acid metabolism, by forming a thioester with CoA. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341309 [Multi-domain] Cd Length: 449 Bit Score: 188.45 E-value: 7.00e-51
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2556 DKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLM 2635
Cdd:cd17654 14 DTTVSYADLAEKISNLSNFLRKKFQTEERAIGLRCDRGTESPVAILAILFLGAAYAPIDPASPEQRSLTVMKKCHVSYLL 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2636 TiNEADlgvlaDFEGEILTIESVEEDdksplpqMSSAHHLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAyaFNET- 2714
Cdd:cd17654 94 Q-NKEL-----DNAPLSFTPEHRHFN-------IRTDECLAYVIHTSGTTGTPKIVAVPHKCILPNIQHFRSL--FNITs 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2715 DTILQLFSF-SFDGFITSMFTPLLSGAkaVLLHEEEAKDILAIKHQ---LSRQRITHMIIVPVLYRALLDVVQPEDV--- 2787
Cdd:cd17654 159 EDILFLTSPlTFDPSVVEIFLSLSSGA--TLLIVPTSVKVLPSKLAdilFKRHRITVLQATPTLFRRFGSQSIKSTVlsa 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2788 -KTLRVVTLAGEAADRELIARSLA-ICPHTELANEYGPTENSVATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQLQpi 2865
Cdd:cd17654 237 tSSLRVLALGGEPFPSLVILSSWRgKGNRTRIFNIYGITEVSCWALAYKVPEEDSPVQLGSPLLGTVIEVRDQNGSEG-- 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2866 gvAGELCIAGtgLARGYVNLPELTeraftqnpfKPEARMYRTGDAARwMADGTLEYLGRIDDQVKIRGYRVETKEIESVI 2945
Cdd:cd17654 315 --TGQVFLGG--LNRVCILDDEVT---------VPKGTMRATGDFVT-VKDGELFFLGRKDSQIKRRGKRINLDLIQQVI 380
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 2946 RCIKGVkdaaVVAHVTASGQTELSAYVVTKPglSTNAVRSELQ-NKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:cd17654 381 ESCLGV----ESCAVTLSDQQRLIAFIVGES--SSSRIHKELQlTLLSSHAIPDTFVQIDKLPLTSHGKVDKSEL 449
|
|
| FACL_like_6 |
cd05922 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
1533-1983 |
9.66e-51 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341246 [Multi-domain] Cd Length: 457 Bit Score: 188.42 E-value: 9.66e-51
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1533 AWELIGrGVKPETTVAIIGKRSPEMLLgIYGILKAGGA----YLPIDPDYPEERISFLLEDSGTNILLLQSAGlhVPEFT 1608
Cdd:cd05922 9 ALLEAG-GVRGERVVLILPNRFTYIEL-SFAVAYAGGRlglvFVPLNPTLKESVLRYLVADAGGRIVLADAGA--ADRLR 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1609 -GEIVYLNQTNS----GLAHRLSN-PNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIMHK 1682
Cdd:cd05922 85 dALPASPDPGTVldadGIRAARASaPAHEVSHEDLALLLYTSGSTGSPKLVRLSHQNLLANARSIAEYLGITADDRALTV 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1683 TSYSFDASIWELFWWPYAGASVYLLPQGgeKEPEVIAKAIEEQKITAMHFVPSmLHAFLEHIKYRsvPIKTNRLKRVFSG 1762
Cdd:cd05922 165 LPLSYDYGLSVLNTHLLRGATLVLTNDG--VLDDAFWEDLREHGATGLAGVPS-TYAMLTRLGFD--PAKLPSLRYLTQA 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1763 GEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFdcPPHEKLERI-PIGKPVHHVRLYLLNQNQRMLPVGCIGELYI 1841
Cdd:cd05922 240 GGRLPQETIARLRELLPGAQVYVMYGQTEATRRMTYL--PPERILEKPgSIGLAIPGGEFEILDDDGTPTPPGEPGEIVH 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1842 AGAGVARGYLNRPAlteerFLEDPFYPGERMYkTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVRE 1921
Cdd:cd05922 318 RGPNVMKGYWNDPP-----YRRKEGRGGGVLH-TGDLARRDEDGFLFIVGRRDRMIKLFGNRISPTEIEAAARSIGLIIE 391
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 1922 AAVTVRTDSGEPELCAYVEGLQRNEVRAQLERL---LPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd05922 392 AAAVGLPDPLGEKLALFVTAPDKIDPKDVLRSLaerLPPYKVPATVRVVDELPLTASGKVDYAAL 456
|
|
| LCL_NRPS-like |
cd19531 |
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar ... |
11-328 |
2.17e-50 |
|
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar domains including the C-domain of SgcC5, a free-standing NRPS with both ester- and amide- bond forming activity; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. Streptomyces globisporus SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380454 [Multi-domain] Cd Length: 427 Bit Score: 186.41 E-value: 2.17e-50
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 11 YPLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNvSSPQQVVLRERNVIVLE 90
Cdd:cd19531 2 LPLSFAQQRLWFLDQLEPGSAAYNIPGALRLRGPLDVAALERALNELVARHEALRTTFVEVD-GEPVQVILPPLPLPLPV 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 91 EDITHLNEAEQSQFIEQWKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASYVNA 170
Cdd:cd19531 81 VDLSGLPEAEREAEAQRLAREEARRPFDLARGPLLRATLLRLGEDEHVLLLTMHHIVSDGWSMGVLLRELAALYAAFLAG 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 171 SPITLE--PVQpYGKYIKW---LMEQDK-EQAVSYWDHYLSGHeqQTVL--------PKQKKTKGKSrqehVTFSFSKEE 236
Cdd:cd19531 161 RPSPLPplPIQ-YADYAVWqreWLQGEVlERQLAYWREQLAGA--PPVLelptdrprPAVQSFRGAR----VRFTLPAEL 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 237 SSRLSELAAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRP-AEIEGiehMVGLFINTMPVRVQ--GAKTpFLQL 313
Cdd:cd19531 234 TAALRALARREGATLFMTLLAAFQVLLHRYSGQDDIVVGTPVAGRNrAELEG---LIGFFVNTLVLRTDlsGDPT-FREL 309
|
330
....*....|....*
gi 1678550997 314 IKDMQKDrlAAEAYS 328
Cdd:cd19531 310 LARVRET--ALEAYA 322
|
|
| BCL_4HBCL |
cd05959 |
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate ... |
462-952 |
2.21e-50 |
|
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate CoA ligase and 4-hydroxybenzoate-coenzyme A ligase catalyze the first activating step for benzoate and 4-hydroxybenzoate catabolic pathways, respectively. Although these two enzymes share very high sequence homology, they have their own substrate preference. The reaction proceeds via a two-step process; the first ATP-dependent step forms the substrate-AMP intermediate, while the second step forms the acyl-CoA ester, releasing the AMP. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Some bacteria can use benzoic acid or benzenoid compounds as the sole source of carbon and energy through degradation. Benzoate CoA ligase and 4-hydroxybenzoate-Coenzyme A ligase are key enzymes of this process.
Pssm-ID: 341269 [Multi-domain] Cd Length: 508 Bit Score: 188.73 E-value: 2.21e-50
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 462 YETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIV 541
Cdd:cd05959 3 YNAATLVDLNLNEGRGDKTAFIDDAGSLTYAELEAEARRVAGALRALGVKREERVLLIMLDTVDFPTAFLGAIRAGIVPV 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 542 PVDPHYPADRIRYILHDCGCS-HVVSQAHLP---SSLEDNY------IITHPEDIESKVD----------GSNIKSVNNA 601
Cdd:cd05959 83 PVNTLLTPDDYAYYLEDSRARvVVVSGELAPvlaAALTKSEhtlvvlIVSGGAGPEAGALllaelvaaeaEQLKPAATHA 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 602 DDLLYMIYTSGTTGKPKGVQFEHRNMA--------NLLKFEythsgidfEADVLqFATPSFDVCY---QEIFSALLKGGT 670
Cdd:cd05959 163 DDPAFWLYSSGSTGRPKGVVHLHADIYwtaelyarNVLGIR--------EDDVC-FSAAKLFFAYglgNSLTFPLSVGAT 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 671 LHIVPEaikRDVPQL-FAFINKHQTNIVF-LPTAFIKMIFSERELANSFpDGVKHLIAAGEQLMiSDLFQDVLRKRGIHL 748
Cdd:cd05959 234 TVLMPE---RPTPAAvFKRIRRYRPTVFFgVPTLYAAMLAAPNLPSRDL-SSLRLCVSAGEALP-AEVGERWKARFGLDI 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 749 HNHYGPSET-HVVSTYT---IHPGDPipelppiGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSD 824
Cdd:cd05959 309 LDGIGSTEMlHIFLSNRpgrVRYGTT-------GKPVPGYEVELRDEDGGDVADGEPGELYVRGPSSATMYWNNRDKTRD 381
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 825 KFSSDpfkpdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAY 904
Cdd:cd05959 382 TFQGE-------WTRTGDKYVRDDDGFYTYAGRADDMLKVSGIWVSPFEVESALVQHPAVLEAAVVGVEDEDGLTKPKAF 454
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 905 Y-----CSVQKLNTIDLRSYMASELPEYMIPaKWI-WVDSIPLTPNGKVDRAAL 952
Cdd:cd05959 455 VvlrpgYEDSEALEEELKEFVKDRLAPYKYP-RWIvFVDELPKTATGKIQRFKL 507
|
|
| COG4908 |
COG4908 |
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General ... |
13-251 |
1.61e-49 |
|
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General function prediction only];
Pssm-ID: 443936 [Multi-domain] Cd Length: 243 Bit Score: 177.54 E-value: 1.61e-49
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 13 LSYMQEGMLFhslLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNvSSPQQVVLRERNVIVLEED 92
Cdd:COG4908 1 LSPAQKRFLF---LEPGSNAYNIPAVLRLEGPLDVEALERALRELVRRHPALRTRFVEED-GEPVQRIDPDADLPLEVVD 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 93 ITHLNEAEQSQFIEQWKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASYVNASP 172
Cdd:COG4908 77 LSALPEPEREAELEELVAEEASRPFDLARGPLLRAALIRLGEDEHVLLLTIHHIISDGWSLGILLRELAALYAALLEGEP 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 173 ITLEPVQ-PYGKYIKWLMEQ----DKEQAVSYWDHYLSGHEQQTVLPKQKK--TKGKSRQEHVTFSFSKEESSRLSELAA 245
Cdd:COG4908 157 PPLPELPiQYADYAAWQRAWlqseALEKQLEYWRQQLAGAPPVLELPTDRPrpAVQTFRGATLSFTLPAELTEALKALAK 236
|
....*.
gi 1678550997 246 REEVTL 251
Cdd:COG4908 237 AHGATV 242
|
|
| C_NRPS-like |
cd19066 |
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of ... |
3123-3570 |
2.28e-49 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long, with various activities such as antibiotic, antifungal, antitumor and immunosuppression. There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380453 [Multi-domain] Cd Length: 427 Bit Score: 183.38 E-value: 2.28e-49
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3123 SPVQK--WFLSQDIKEKHHFNQSVMLHRSTSVQEDALRKTLKAITCHHDALRMVFTQnEQGKWDQYNRPLSHSDDalygL 3200
Cdd:cd19066 5 SPMQRgmWFLKKLATDPSAFNVAIEMFLTGSLDLARLKQALDAVMERHDVLRTRFCE-EAGRYEQVVLDKTVRFR----I 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3201 QMIDLSapDGTDGNRPYEPLIKRhvlDIQQKMDLKNGPLLQAGLFHT-IDGDFLFLSAHHLVVDGISWRVLLEDLALGYR 3279
Cdd:cd19066 80 EIIDLR--NLADPEARLLELIDQ---IQQTIYDLERGPLVRVALFRLaDERDVLVVAIHHIIVDGGSFQILFEDISSVYD 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3280 QAAGGEDIkLPPKTSSFKAYAKKLSDYAESQQLMKQLKYWREAEEYQTEALPF--DQIDGTRAHEGQRsTISFTLNDKET 3357
Cdd:cd19066 155 AAERQKPT-LPPPVGSYADYAAWLEKQLESEAAQADLAYWTSYLHGLPPPLPLpkAKRPSQVASYEVL-TLEFFLRSEET 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3358 AAlLKDANSAYNTDTQDMLLASVILALRHWTNQSAFKLSLEGHGREDVlkgiDVSRTIGWFTAIYPLLIKLNADlpdseE 3437
Cdd:cd19066 233 KR-LREVARESGTTPTQLLLAAFALALKRLTASIDVVIGLTFLNRPDE----AVEDTIGLFLNLLPLRIDTSPD-----A 302
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3438 SMVHVLKTTKDTLRRVPDKGFGYGVIKYLTPPGKKDINFTGAPEISFNYLGQFESGRTAEVPEEDafsfsplgaGGDIST 3517
Cdd:cd19066 303 TFPELLKRTKEQSREAIEHQRVPFIELVRHLGVVPEAPKHPLFEPVFTFKNNQQQLGKTGGFIFT---------TPVYTS 373
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 3518 TWNREQSLDISAIA-AEGKLTVNMTYDNARFQRKTIEQLSETCRQFLLQLIEHC 3570
Cdd:cd19066 374 SEGTVFDLDLEASEdPDGDLLLRLEYSRGVYDERTIDRFAERYMTALRQLIENP 427
|
|
| DCL_NRPS-like |
cd19536 |
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal ... |
2088-2489 |
7.66e-49 |
|
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal fungal CT domains and Dual Epimerization/Condensation (E/C) domains; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type [D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L))], which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380459 [Multi-domain] Cd Length: 419 Bit Score: 181.49 E-value: 7.66e-49
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2088 YPVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGDPVQRIH--------- 2158
Cdd:cd19536 2 YPLSSLQEGMLFHSLLNPGGSVYLHNYTYTVGRRLNLDLLLEALQVLIDRHDILRTSFIEDGLGQPVQVVHrqaqvpvte 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2159 -DEVPFTLQTTVLGARTEQEaaaaFIKPFDLSQAPLFRAQIVKVSDERHLLLV-DMHHIISDGVSVNILIQEFGELYN-- 2234
Cdd:cd19536 82 lDLTPLEEQLDPLRAYKEET----KIRRFDLGRAPLVRAALVRKDERERFLLViSDHHSILDGWSLYLLVKEILAVYNql 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2235 ---NRKLPALRIQYKDYAVWQEGFKTGDAYkmqEAYWLKQLEGelpvLDLPADHARPPVRSFAGDKVSFTLEPEVASGL- 2310
Cdd:cd19536 158 leyKPLSLPPAQPYRDFVAHERASIQQAAS---ERYWREYLAG----ATLATLPALSEAVGGGPEQDSELLVSVPLPVRs 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2311 HKLARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPH--KDLEPILGMFVNTLALRTRPEGGkPFVQYLQEVRE 2388
Cdd:cd19536 231 RSLAKRSGIPLSTLLLAAWALVLSRHSGSDDVVFGTVVHGRSEetTGAERLLGLFLNTLPLRVTLSEE-TVEDLLKRAQE 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2389 TALEAFEHQNYPFEelvdklELTRDMSRNPVFDAMLVVQNNDY---------EPLHLHDLQMkpaqvSHLVSKFDLTLQA 2459
Cdd:cd19536 310 QELESLSHEQVPLA------DIQRCSEGEPLFDSIVNFRHFDLdfglpewgsDEGMRRGLLF-----SEFKSNYDVNLSV 378
|
410 420 430
....*....|....*....|....*....|
gi 1678550997 2460 SEGDGNIHFLFEYSTALFEKTTIERWASHL 2489
Cdd:cd19536 379 LPKQDRLELKLAYNSQVLDEEQAQRLAAYY 408
|
|
| A_NRPS_acs4 |
cd17654 |
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal ... |
1508-1983 |
2.82e-48 |
|
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains acyl-CoA synthethase family member 4, also known as 2-aminoadipic 6-semialdehyde dehydrogenase or aminoadipate-semialdehyde dehydrogenase, most of which are uncharacterized. Acyl-CoA synthetase catalyzes the initial reaction in fatty acid metabolism, by forming a thioester with CoA. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341309 [Multi-domain] Cd Length: 449 Bit Score: 180.75 E-value: 2.82e-48
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1508 PDQAAVIFE----DGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERI 1583
Cdd:cd17654 1 PDRPALIIDqttsDTTVSYADLAEKISNLSNFLRKKFQTEERAIGLRCDRGTESPVAILAILFLGAAYAPIDPASPEQRS 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1584 SFLLEDSGTNILLLQSAGLHVPE-FTGEIVYLNQTnsglahrlsnpnvdvLPQSLAYVIYTSGSTGMPKGVEIEHRSAVN 1662
Cdd:cd17654 81 LTVMKKCHVSYLLQNKELDNAPLsFTPEHRHFNIR---------------TDECLAYVIHTSGTTGTPKIVAVPHKCILP 145
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1663 FLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAI-EEQKITAMHFVPSMLHAFL 1741
Cdd:cd17654 146 NIQHFRSLFNITSEDILFLTSPLTFDPSVVEIFLSLSSGATLLIVPTSVKVLPSKLADILfKRHRITVLQATPTLFRRFG 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1742 EHIKYRSVPIKTNRLKRVFSGGEQL--GTHLVSRFYElLPNVSITNSYGPTEATVEAAFFDCPphEKLERIPIGKPVHHV 1819
Cdd:cd17654 226 SQSIKSTVLSATSSLRVLALGGEPFpsLVILSSWRGK-GNRTRIFNIYGITEVSCWALAYKVP--EEDSPVQLGSPLLGT 302
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1820 RLYLLNQNQRMLPvgciGELY---IAGAGVARGYLNRPALTeerfledpfypgerMYKTGDVARwLPDGNVEFLGRTDDQ 1896
Cdd:cd17654 303 VIEVRDQNGSEGT----GQVFlggLNRVCILDDEVTVPKGT--------------MRATGDFVT-VKDGELFFLGRKDSQ 363
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1897 VKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDsgEPELCAYVEGLQRNEVRAQLER-LLPGYMVPAYMIEMEQWPVTPS 1975
Cdd:cd17654 364 IKRRGKRINLDLIQQVIESCLGVESCAVTLSDQ--QRLIAFIVGESSSSRIHKELQLtLLSSHAIPDTFVQIDKLPLTSH 441
|
....*...
gi 1678550997 1976 GKLDRNAL 1983
Cdd:cd17654 442 GKVDKSEL 449
|
|
| A_NRPS_alphaAR |
cd17647 |
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as ... |
2557-3022 |
4.01e-48 |
|
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as alpha-aminoadipate reductase (EC 1.2.1.95) or alpha-AR or L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), which catalyzes the activation of alpha-aminoadipate by ATP-dependent adenylation and the reduction of activated alpha-aminoadipate by NADPH. The activated alpha-aminoadipate is bound to the phosphopantheinyl group of the enzyme itself before it is reduced to (S)-2-amino-6-oxohexanoate.
Pssm-ID: 341302 [Multi-domain] Cd Length: 520 Bit Score: 182.33 E-value: 4.01e-48
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2557 KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMT 2636
Cdd:cd17647 19 RSFTYRDINEASNIVAHYLIKTGIKRGDVVMIYSYRGVDLMVAVMGVLKAGATFSVIDPAYPPARQNIYLGVAKPRGLIV 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2637 INEADLGVLADfegeiltiesveeddksPLPQMSsahhlayiiYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDT 2716
Cdd:cd17647 99 IRAAGVVVGPD-----------------SNPTLS---------FTSGSEGIPKGVLGRHFSLAYYFPWMAKRFNLSENDK 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2717 ILQLFSFSFDGFITSMFTPLLSGAKavlLHEEEAKDI-----LAIKHQLSRQRITHMII-------------VPVLYRAL 2778
Cdd:cd17647 153 FTMLSGIAHDPIQRDMFTPLFLGAQ---LLVPTQDDIgtpgrLAEWMAKYGATVTHLTPamgqlltaqattpFPKLHHAF 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2779 L--DVVQPEDVktLRVVTLAgeaadreliarslaicPHTELANEYGPTENSVATT---VMRHMEKQAY-------VSIGQ 2846
Cdd:cd17647 230 FvgDILTKRDC--LRLQTLA----------------ENVRIVNMYGTTETQRAVSyfeVPSRSSDPTFlknlkdvMPAGR 291
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2847 PIDGTQVLILNSN--HQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPF----------------------KPEA 2902
Cdd:cd17647 292 GMLNVQLLVVNRNdrTQICGIGEVGEIYVRAGGLAEGYRGLPELNKEKFVNNWFvepdhwnyldkdnnepwrqfwlGPRD 371
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2903 RMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKP------ 2976
Cdd:cd17647 372 RLYRTGDLGRYLPNGDCECCGRADDQVKIRGFRIELGEIDTHISQHPLVRENITLVRRDKDEEPTLVSYIVPRFdkpdde 451
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 2977 ------------------GLS-----TNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGALPKP 3022
Cdd:cd17647 452 sfaqedvpkevstdpivkGLIgyrklIKDIREFLKKRLASYAIPSLIVVLDKLPLNPNGKVDKPKLQFP 520
|
|
| NRPS-para261 |
TIGR01720 |
non-ribosomal peptide synthase domain TIGR01720; This domain appears to be located immediately ... |
3441-3596 |
5.67e-48 |
|
non-ribosomal peptide synthase domain TIGR01720; This domain appears to be located immediately downstream from a condensation domain (pfam00668), and is followed primarily by the end of the molecule or another condensation domain (in a few cases it is followed by pfam00501, an AMP-binding module). The converse is not true, pfam00668 domains are not always followed by this domain. This implicates this domain in possible post-condensation modification events. This model is 171 amino acids long and contains three very highly conserved regions. At the N-terminus is a nearly invariant lysine (position 11) followed by xxxRxxPxxGxGYG in which the proline and the first glycine are invariant. This is followed approximately 22 residues later by the motif FNYLG. Near the C-terminus of the domain is the sequence TxSD where the serine and aspartate are nearly invariant.
Pssm-ID: 273774 [Multi-domain] Cd Length: 153 Bit Score: 169.38 E-value: 5.67e-48
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3441 HVLKTTKDTLRRVPDKGFGYGVIKYLTPPGKKdINFTGAPEISFNYLGQFESGRtaevpEEDAFSFSPLGAGGDISTTWN 3520
Cdd:TIGR01720 4 RLIKAVKEQLRRIPNKGVGYGVLRYLTEPEEK-LAASPQPEISFNYLGQFDADS-----NDELFQPSSYSPGEAISPESP 77
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 3521 REQSLDISAIAAEGKLTVNMTYDNARFQRKTIEQLSETCRQFLLQLIEHCQNKSETEKTISDFDDQELTEDALQEI 3596
Cdd:TIGR01720 78 RPYALEINAMIEDGELTLTWSYPTQLFSEDTIEQLADRFKEALEALIAHCAGKEGGGLTPSDFSLKDLTQDELDEL 153
|
|
| A_NRPS_alphaAR |
cd17647 |
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as ... |
488-955 |
8.09e-48 |
|
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as alpha-aminoadipate reductase (EC 1.2.1.95) or alpha-AR or L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), which catalyzes the activation of alpha-aminoadipate by ATP-dependent adenylation and the reduction of activated alpha-aminoadipate by NADPH. The activated alpha-aminoadipate is bound to the phosphopantheinyl group of the enzyme itself before it is reduced to (S)-2-amino-6-oxohexanoate.
Pssm-ID: 341302 [Multi-domain] Cd Length: 520 Bit Score: 181.56 E-value: 8.09e-48
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 488 SLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHdcgcshvVSQ 567
Cdd:cd17647 20 SFTYRDINEASNIVAHYLIKTGIKRGDVVMIYSYRGVDLMVAVMGVLKAGATFSVIDPAYPPARQNIYLG-------VAK 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 568 AHLPSSLEDNYIITHPEDIESkvdgsniksvnnaddllyMIYTSGTTGKPKGVQFEHRNMANLLKFEYTHSGIDFEADVL 647
Cdd:cd17647 93 PRGLIVIRAAGVVVGPDSNPT------------------LSFTSGSEGIPKGVLGRHFSLAYYFPWMAKRFNLSENDKFT 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 648 QFATPSFDVCYQEIFSALLKGGTLhIVPEAIKRDVP-QLFAFINKHQTNIVFLPTAFIKMIFSERelANSFPdGVKHLIA 726
Cdd:cd17647 155 MLSGIAHDPIQRDMFTPLFLGAQL-LVPTQDDIGTPgRLAEWMAKYGATVTHLTPAMGQLLTAQA--TTPFP-KLHHAFF 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 727 AGEQLMISDLFQDVLRKRGIHLHNHYGPSETH------VVSTYTIHPG--DPIPELPPIGKPIGCTDLYILNHQKQLQPC 798
Cdd:cd17647 231 VGDILTKRDCLRLQTLAENVRIVNMYGTTETQravsyfEVPSRSSDPTflKNLKDVMPAGRGMLNVQLLVVNRNDRTQIC 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 799 GVP--GELYISGASVARGYVNHDKLTSDKF-----------------SSDP-----FKPDVIMYRTGDLARRLEDGNIEY 854
Cdd:cd17647 311 GIGevGEIYVRAGGLAEGYRGLPELNKEKFvnnwfvepdhwnyldkdNNEPwrqfwLGPRDRLYRTGDLGRYLPNGDCEC 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 855 IGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYY---------------------------CS 907
Cdd:cd17647 391 CGRADDQVKIRGFRIELGEIDTHISQHPLVRENITLVRRDKDEEPTLVSYIvprfdkpddesfaqedvpkevstdpivKG 470
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|
gi 1678550997 908 VQKLNTI--DLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPEP 955
Cdd:cd17647 471 LIGYRKLikDIREFLKKRLASYAIPSLIVVLDKLPLNPNGKVDKPKLQFP 520
|
|
| CT_NRPS-like |
cd19542 |
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike ... |
2088-2500 |
1.25e-47 |
|
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike bacterial NRPS, which typically have specialized terminal thioesterase (TE) domains to cyclize peptide products, many fungal NRPSs employ a terminal condensation-like (CT) domain to produce macrocyclic peptidyl products (e.g. cyclosporine and echinocandin). Domains in this subfamily (which includes both terminal and non-terminal domains) typically have a non-canonical conserved [SN]HxxxDx(14)Y motif at their active site compared to the standard Condensation (C) domain active site motif (HHxxxD). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380464 [Multi-domain] Cd Length: 401 Bit Score: 177.50 E-value: 1.25e-47
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2088 YPVSSAQKRIyVLQQLEDGGTGYNmPAVLELEGKLNPERMDRAFQELIKRHESLRTSF-EQDEGGDPVQRIHDEVPFTLQ 2166
Cdd:cd19542 2 YPCTPMQEGM-LLSQLRSPGLYFN-HFVFDLDSSVDVERLRNAWRQLVQRHDILRTVFvESSAEGTFLQVVLKSLDPPIE 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2167 TTvlgaRTEQEAAAAFIKPFD----LSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELYNNRKLPAlR 2242
Cdd:cd19542 80 EV----ETDEDSLDALTRDLLddptLFGQPPHRLTLLETSSGEVYLVLRISHALYDGVSLPIILRDLAAAYNGQLLPP-A 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2243 IQYKDYAVWQEGFKTGDAYkmqeAYWLKQLEGELPVLDLPADHARPPVRSfaGDKVSFTLEPevasgLHKLARENGSTLY 2322
Cdd:cd19542 155 PPFSDYISYLQSQSQEESL----QYWRKYLQGASPCAFPSLSPKRPAERS--LSSTRRSLAK-----LEAFCASLGVTLA 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2323 MVLLAAYTAFLSRLSGQEDIIVGSPIAGR--PHKDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRETALEAFEHQNYP 2400
Cdd:cd19542 224 SLFQAAWALVLARYTGSRDVVFGYVVSGRdlPVPGIDDIVGPCINTLPVRVKLDPDWTVLDLLRQLQQQYLRSLPHQHLS 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2401 FEELVDKLELTRdmsRNPVFDAMLVVQNNDYEPLHLHDLQMKPAQVS-HLVSKFDLTLQASEGDGNIHFLFEYSTALFEK 2479
Cdd:cd19542 304 LREIQRALGLWP---SGTLFNTLVSYQNFEASPESELSGSSVFELSAaEDPTEYPVAVEVEPSGDSLKVSLAYSTSVLSE 380
|
410 420
....*....|....*....|.
gi 1678550997 2480 TTIERWASHLTNVLSIIGKNP 2500
Cdd:cd19542 381 EQAEELLEQFDDILEALLANP 401
|
|
| CT_NRPS-like |
cd19542 |
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike ... |
1057-1460 |
2.19e-47 |
|
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike bacterial NRPS, which typically have specialized terminal thioesterase (TE) domains to cyclize peptide products, many fungal NRPSs employ a terminal condensation-like (CT) domain to produce macrocyclic peptidyl products (e.g. cyclosporine and echinocandin). Domains in this subfamily (which includes both terminal and non-terminal domains) typically have a non-canonical conserved [SN]HxxxDx(14)Y motif at their active site compared to the standard Condensation (C) domain active site motif (HHxxxD). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380464 [Multi-domain] Cd Length: 401 Bit Score: 176.73 E-value: 2.19e-47
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1057 YPVSSAQKRIyVLQQLDEGVAYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSGADDEP-VQ----RIHTEVPF 1131
Cdd:cd19542 2 YPCTPMQEGM-LLSQLRSPGLYFNHFVFDLDSSVDVERLRNAWRQLVQRHDILRTVFVESSAEGTfLQvvlkSLDPPIEE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1132 TLSKETTIEGFVRPFD----LSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYANRQLKPlRIQYKD 1207
Cdd:cd19542 81 VETDEDSLDALTRDLLddptLFGQPPHRLTLLETSSGEVYLVLRISHALYDGVSLPIILRDLAAAYNGQLLPP-APPFSD 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1208 YAVWQQkfkkGDSYQKQETYWQQQFSGDLPIlELPTdkrrpaerQFIGGKVTFQLDKEITARIKrlAHKNRSTLYMTLLA 1287
Cdd:cd19542 160 YISYLQ----SQSQEESLQYWRKYLQGASPC-AFPS--------LSPKRPAERSLSSTRRSLAK--LEAFCASLGVTLAS 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1288 LYSA----FLSRLSGQDDIVIGSPIAGR--PHADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQTALEAYEHQDYPF 1361
Cdd:cd19542 225 LFQAawalVLARYTGSRDVVFGYVVSGRdlPVPGIDDIVGPCINTLPVRVKLDPDWTVLDLLRQLQQQYLRSLPHQHLSL 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1362 EELVDKLGVqreMSRNPLFDTTLVLQNME-QQKLKMNDVQLQWNDLEHPISKFDISLYVTEHDSELFCQFEYSTALFEKE 1440
Cdd:cd19542 305 REIQRALGL---WPSGTLFNTLVSYQNFEaSPESELSGSSVFELSAAEDPTEYPVAVEVEPSGDSLKVSLAYSTSVLSEE 381
|
410 420
....*....|....*....|
gi 1678550997 1441 TIQRWASLFTTLVEHTAASP 1460
Cdd:cd19542 382 QAEELLEQFDDILEALLANP 401
|
|
| PRK06188 |
PRK06188 |
acyl-CoA synthetase; Validated |
2534-3019 |
4.36e-47 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235731 [Multi-domain] Cd Length: 524 Bit Score: 179.41 E-value: 4.36e-47
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2534 TISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIM-MHRS---FSMIASILgvwkAGGC 2609
Cdd:PRK06188 13 TYGHLLVSALKRYPDRPALVLGDTRLTYGQLADRISRYIQAFEALGLGTGDAVALLsLNRPevlMAIGAAQL----AGLR 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2610 YVPIDPEYPKERKRYILSDSGTKLLMTIN----EADLGVLADFEG--EILTIESVEED----------DKSPLPQMSSAH 2673
Cdd:PRK06188 89 RTALHPLGSLDDHAYVLEDAGISTLIVDPapfvERALALLARVPSlkHVLTLGPVPDGvdllaaaakfGPAPLVAAALPP 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2674 HLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQLFSFSFDGfiTSMFTP-LLSGAKAVLLHEEEAKD 2752
Cdd:PRK06188 169 DIAGLAYTGGTTGKPKGVMGTHRSIATMAQIQLAEWEWPADPRFLMCTPLSHAG--GAFFLPtLLRGGTVIVLAKFDPAE 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2753 ILAIkhqLSRQRITHMIIVPVLYRALLDVVQPE--DVKTLRVVTLAGEAAD----RELIARSLAIcphteLANEYGPTEN 2826
Cdd:PRK06188 247 VLRA---IEEQRITATFLVPTMIYALLDHPDLRtrDLSSLETVYYGASPMSpvrlAEAIERFGPI-----FAQYYGQTEA 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2827 SVATTVMR---HMEKQAYV--SIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNpfkpe 2901
Cdd:PRK06188 319 PMVITYLRkrdHDPDDPKRltSCGRPTPGLRVALLDEDGREVAQGEVGEICVRGPLVMDGYWNRPEETAEAFRDG----- 393
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2902 arMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAhVTASGQTE-LSAYVVTKPGLST 2980
Cdd:PRK06188 394 --WLHTGDVAREDEDGFYYIVDRKKDMIVTGGFNVFPREVEDVLAEHPAVAQVAVIG-VPDEKWGEaVTAVVVLRPGAAV 470
|
490 500 510 520
....*....|....*....|....*....|....*....|....
gi 1678550997 2981 NAvrSELQN-----KLPVFMhPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK06188 471 DA--AELQAhvkerKGSVHA-PKQVDFVDSLPLTALGKPDKKAL 511
|
|
| MCS |
cd05941 |
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step ... |
1509-1983 |
4.55e-47 |
|
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step reaction consisting of the adenylation of malonate with ATP, followed by malonyl transfer from malonyl-AMP to CoA. Malonic acid and its derivatives are the building blocks of polyketides and malonyl-CoA serves as the substrate of polyketide synthases. Malonyl-CoA synthetase has broad substrate tolerance and can activate a variety of malonyl acid derivatives. MCS may play an important role in biosynthesis of polyketides, the important secondary metabolites with therapeutic and agrochemical utility.
Pssm-ID: 341264 [Multi-domain] Cd Length: 442 Bit Score: 177.10 E-value: 4.55e-47
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1509 DQAAVIFEDGVMTYKELNEQANRIAWELIGRG-VKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLL 1587
Cdd:cd05941 1 DRIAIVDDGDSITYADLVARAARLANRLLALGkDLRGDRVAFLAPPSAEYVVAQLAIWRAGGVAVPLNPSYPLAELEYVI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1588 EDSGTNILLlqsaglhvpeftgeivylnqtnsglahrlsnpnvdvlpqSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSL 1667
Cdd:cd05941 81 TDSEPSLVL---------------------------------------DPALILYTSGTTGRPKGVVLTHANLAANVRAL 121
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1668 QSRYQLKHSDMIMH-----KTSYSFDASIWELFwwpyAGASVYLLPqggEKEPEVIAKAIEEQKITAMHFVPSML----- 1737
Cdd:cd05941 122 VDAWRWTEDDVLLHvlplhHVHGLVNALLCPLF----AGASVEFLP---KFDPKEVAISRLMPSITVFMGVPTIYtrllq 194
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1738 ---HAFLEHIKYRSVPIKTNRLkrVFSGGEQLGTHLVSRFYELLPNVsITNSYGPTEATVEAAffdCPPHEklERIP--I 1812
Cdd:cd05941 195 yyeAHFTDPQFARAAAAERLRL--MVSGSAALPVPTLEEWEAITGHT-LLERYGMTEIGMALS---NPLDG--ERRPgtV 266
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1813 GKPVHHVRLYLLNQN-QRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFypgermYKTGDVARWLPDGNVEFLG 1891
Cdd:cd05941 267 GMPLPGVQARIVDEEtGEPLPRGEVGEIQVRGPSVFKEYWNKPEATKEEFTDDGW------FKTGDLGVVDEDGYYWILG 340
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1892 RT-DDQVKIRGYRIEPGEIEAALRSIEGVREAAVTvrtdsGEPE------LCAYV------EGLQRNEVRAQLERLLPGY 1958
Cdd:cd05941 341 RSsVDIIKSGGYKVSALEIERVLLAHPGVSECAVI-----GVPDpdwgerVVAVVvlragaAALSLEELKEWAKQRLAPY 415
|
490 500
....*....|....*....|....*
gi 1678550997 1959 MVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd05941 416 KRPRRLILVDELPRNAMGKVNKKEL 440
|
|
| PRK06187 |
PRK06187 |
long-chain-fatty-acid--CoA ligase; Validated |
460-955 |
4.94e-47 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235730 [Multi-domain] Cd Length: 521 Bit Score: 178.84 E-value: 4.94e-47
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 460 PVYETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGA 539
Cdd:PRK06187 3 DYPLTIGRILRHGARKHPDKEAVYFDGRRTTYAELDERVNRLANALRALGVKKGDRVAVFDWNSHEYLEAYFAVPKIGAV 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 540 IVPVDPHYPADRIRYILHDCGCSHV-VSQAHLP--SSLEDN------YIITHPEDIESKV-------DGSNIKSVN---- 599
Cdd:PRK06187 83 LHPINIRLKPEEIAYILNDAEDRVVlVDSEFVPllAAILPQlptvrtVIVEGDGPAAPLApevgeyeELLAAASDTfdfp 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 600 --NADDLLYMIYTSGTTGKPKGVQFEHRNManLLKFEYTHSGIDF-EADVLQFATPSFDV-----CYQeifsALLKGGTL 671
Cdd:PRK06187 163 diDENDAAAMLYTSGTTGHPKGVVLSHRNL--FLHSLAVCAWLKLsRDDVYLVIVPMFHVhawglPYL----ALMAGAKQ 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 672 hIVPEAIkrDVPQLFAFINKHQTNIVFL-PTAFiKMIFseRELANSFPD--GVKHLIAAG----EQLMisdlfQDVLRKR 744
Cdd:PRK06187 237 -VIPRRF--DPENLLDLIETERVTFFFAvPTIW-QMLL--KAPRAYFVDfsSLRLVIYGGaalpPALL-----REFKEKF 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 745 GIHLHNHYGPSETHVVSTYTiHPGDPIPELPPI----GKPIGCTDLYILNHQKQLQPC--GVPGELYISGASVARGYVNH 818
Cdd:PRK06187 306 GIDLVQGYGMTETSPVVSVL-PPEDQLPGQWTKrrsaGRPLPGVEARIVDDDGDELPPdgGEVGEIIVRGPWLMQGYWNR 384
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 819 DKLTSDKFSSDpfkpdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQN-G 897
Cdd:PRK06187 385 PEATAETIDGG-------WLHTGDVGYIDEDGYLYITDRIKDVIISGGENIYPRELEDALYGHPAVAEVAVIGVPDEKwG 457
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 898 EhELCAYYcsVQK----LNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPEP 955
Cdd:PRK06187 458 E-RPVAVV--VLKpgatLDAKELRAFLRGRLAKFKLPKRIAFVDELPRTSVGKILKRVLREQ 516
|
|
| COG4908 |
COG4908 |
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General ... |
3123-3370 |
1.29e-46 |
|
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General function prediction only];
Pssm-ID: 443936 [Multi-domain] Cd Length: 243 Bit Score: 169.06 E-value: 1.29e-46
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3123 SPVQKWFLSQDiKEKHHFNQSVMLHRSTSVQEDALRKTLKAITCHHDALRMVFTQnEQGKWDQYNRPlshsdDALYGLQM 3202
Cdd:COG4908 2 SPAQKRFLFLE-PGSNAYNIPAVLRLEGPLDVEALERALRELVRRHPALRTRFVE-EDGEPVQRIDP-----DADLPLEV 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3203 IDLSAPDGTDGNRPYEPLIKRhvlDIQQKMDLKNGPLLQAGLFHT-IDGDFLFLSAHHLVVDGISWRVLLEDLALGYRQA 3281
Cdd:COG4908 75 VDLSALPEPEREAELEELVAE---EASRPFDLARGPLLRAALIRLgEDEHVLLLTIHHIISDGWSLGILLRELAALYAAL 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3282 AGGEDIKLPPKTSSFKAYAKKLSDYAESQQLMKQLKYWREAEEYQTEA--LPFDQIDG-TRAHEGqrSTISFTLNDKETA 3358
Cdd:COG4908 152 LEGEPPPLPELPIQYADYAAWQRAWLQSEALEKQLEYWRQQLAGAPPVleLPTDRPRPaVQTFRG--ATLSFTLPAELTE 229
|
250
....*....|..
gi 1678550997 3359 ALLKDAnSAYNT 3370
Cdd:COG4908 230 ALKALA-KAHGA 240
|
|
| A_NRPS_acs4 |
cd17654 |
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal ... |
477-952 |
1.56e-46 |
|
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains acyl-CoA synthethase family member 4, also known as 2-aminoadipic 6-semialdehyde dehydrogenase or aminoadipate-semialdehyde dehydrogenase, most of which are uncharacterized. Acyl-CoA synthetase catalyzes the initial reaction in fatty acid metabolism, by forming a thioester with CoA. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341309 [Multi-domain] Cd Length: 449 Bit Score: 175.74 E-value: 1.56e-46
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 477 PDAHAVIDQAC----SLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRI 552
Cdd:cd17654 1 PDRPALIIDQTtsdtTVSYADLAEKISNLSNFLRKKFQTEERAIGLRCDRGTESPVAILAILFLGAAYAPIDPASPEQRS 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 553 RYILHDCGCSHVVSQAHLPSSLEdnYIITHPEDIESKVDGSniksvnnaddLLYMIYTSGTTGKPKGVQFEHRNMANLLk 632
Cdd:cd17654 81 LTVMKKCHVSYLLQNKELDNAPL--SFTPEHRHFNIRTDEC----------LAYVIHTSGTTGTPKIVAVPHKCILPNI- 147
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 633 feyTHSGIDFE---ADVLQFATP-SFDVCYQEIFSALLKGGTLHIVPEAIKRdVPQLFAFI--NKHQTNIVFLPTAFIKM 706
Cdd:cd17654 148 ---QHFRSLFNitsEDILFLTSPlTFDPSVVEIFLSLSSGATLLIVPTSVKV-LPSKLADIlfKRHRITVLQATPTLFRR 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 707 IFSE--RELANSFPDGVKHLIAAGEQLmISDLFQDVLRKRG--IHLHNHYGPSETHVVSTYTIHPGDPIPElpPIGKPIG 782
Cdd:cd17654 224 FGSQsiKSTVLSATSSLRVLALGGEPF-PSLVILSSWRGKGnrTRIFNIYGITEVSCWALAYKVPEEDSPV--QLGSPLL 300
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 783 CTDLYIlnhqKQLQPCGVPGELYISGasVARGYVNHDKLTsdkfssdpfKPDVIMYRTGDLARRlEDGNIEYIGRADNQV 862
Cdd:cd17654 301 GTVIEV----RDQNGSEGTGQVFLGG--LNRVCILDDEVT---------VPKGTMRATGDFVTV-KDGELFFLGRKDSQI 364
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 863 KIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNgeheLCAYYCSVQKLNTIDLRSYMaSELPEYMIPAKWIWVDSIPLT 942
Cdd:cd17654 365 KRRGKRINLDLIQQVIESCLGVESCAVTLSDQQR----LIAFIVGESSSSRIHKELQL-TLLSSHAIPDTFVQIDKLPLT 439
|
490
....*....|
gi 1678550997 943 PNGKVDRAAL 952
Cdd:cd17654 440 SHGKVDKSEL 449
|
|
| PRK07656 |
PRK07656 |
long-chain-fatty-acid--CoA ligase; Validated |
459-954 |
2.91e-46 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236072 [Multi-domain] Cd Length: 513 Bit Score: 176.63 E-value: 2.91e-46
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 459 TPVYETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGG 538
Cdd:PRK07656 1 DNEWMTLPELLARAARRFGDKEAYVFGDQRLTYAELNARVRRAAAALAALGIGKGDRVAIWAPNSPHWVIAALGALKAGA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 539 AIVPVDPHYPADRIRYILHDCGCSHVVSQAHL----------PSSLEDNYIITHPEDIESKVDGSNIKSVN--------- 599
Cdd:PRK07656 81 VVVPLNTRYTADEAAYILARGDAKALFVLGLFlgvdysattrLPALEHVVICETEEDDPHTEKMKTFTDFLaagdpaera 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 600 ---NADDLLYMIYTSGTTGKPKGVQFEHRNM-------ANLLKFEythsgidfEADVLQFATPSFDV-CYQE-IFSALLK 667
Cdd:PRK07656 161 pevDPDDVADILFTSGTTGRPKGAMLTHRQLlsnaadwAEYLGLT--------EGDRYLAANPFFHVfGYKAgVNAPLMR 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 668 GGTLHIVPeaiKRDVPQLFAFINKHQTNiVF--LPTAFIKMIfserelanSFPDGVKH------LIAAGEQLMISDLFQD 739
Cdd:PRK07656 233 GATILPLP---VFDPDEVFRLIETERIT-VLpgPPTMYNSLL--------QHPDRSAEdlsslrLAVTGAASMPVALLER 300
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 740 VLRKRGI-HLHNHYGPSETHVVSTYTiHPGDPIPELP-PIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVN 817
Cdd:PRK07656 301 FESELGVdIVLTGYGLSEASGVTTFN-RLDDDRKTVAgTIGTAIAGVENKIVNELGEEVPVGEVGELLVRGPNVMKGYYD 379
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 818 hdkltsdkfssDP------FKPDVIMYrTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILI 891
Cdd:PRK07656 380 -----------DPeataaaIDADGWLH-TGDLGRLDEEGYLYIVDRKKDMFIVGGFNVYPAEVEEVLYEHPAVAEAAVIG 447
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 892 WQDQN-GEhELCAYYC--SVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPE 954
Cdd:PRK07656 448 VPDERlGE-VGKAYVVlkPGAELTEEELIAYCREHLAKYKVPRSIEFLDELPKNATGKVLKRALRE 512
|
|
| FACL_fum10p_like |
cd05926 |
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL ... |
2547-3019 |
3.14e-46 |
|
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Fum10p is a fatty acid CoA ligase involved in the synthesis of fumonisin, a polyketide mycotoxin, in Gibberella moniliformis.
Pssm-ID: 341249 [Multi-domain] Cd Length: 493 Bit Score: 175.96 E-value: 3.14e-46
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2547 PKASALVS--GDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRY 2624
Cdd:cd05926 1 PDAPALVVpgSTPALTYADLAELVDDLARQLAALGIKKGDRVAIALPNGLEFVVAFLAAARAGAVVAPLNPAYKKAEFEF 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2625 ILSDSGTKLLMTINEADLGVL-ADFEGEILTIESVEED-------DKSPLPQMSSAHH------------LAYIIYTSGT 2684
Cdd:cd05926 81 YLADLGSKLVLTPKGELGPASrAASKLGLAILELALDVgvlirapSAESLSNLLADKKnaksegvplpddLALILHTSGT 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2685 TGRPKGVMVEHKGIANTLQWRRNAYAFNETD-TILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILaikhQLSRQ 2763
Cdd:cd05926 161 TGRPKGVPLTHRNLAASATNITNTYKLTPDDrTLVVMPLFHVHGLVASLLSTLAAGGSVVLPPRFSASTFW----PDVRD 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2764 -RITHMIIVPVLYRALLDVVQPEDVK---TLRVVTLAGEAADrELIARSLAICPHTELANEYGPTENS--VATTVMRHmE 2837
Cdd:cd05926 237 yNATWYTAVPTIHQILLNRPEPNPESpppKLRFIRSCSASLP-PAVLEALEATFGAPVLEAYGMTEAAhqMTSNPLPP-G 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2838 KQAYVSIGQPiDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMADG 2917
Cdd:cd05926 315 PRKPGSVGKP-VGVEVRILDEDGEILPPGVVGEICLRGPNVTRGYLNNPEANAEAAFKDGW------FRTGDLGYLDADG 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2918 TLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVA--HVTAsGQtELSAYVVTKPG--LSTNAVRSELQNKLPV 2993
Cdd:cd05926 388 YLFLTGRIKELINRGGEKISPLEVDGVLLSHPAVLEAVAFGvpDEKY-GE-EVAAAVVLREGasVTEEELRAFCRKHLAA 465
|
490 500
....*....|....*....|....*.
gi 1678550997 2994 FMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:cd05926 466 FKVPKKVYFVDELPKTATGKIQRRKV 491
|
|
| FACL_like_6 |
cd05922 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
497-952 |
3.85e-46 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341246 [Multi-domain] Cd Length: 457 Bit Score: 174.55 E-value: 3.85e-46
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 497 AANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAI----VPVDPHYPADRIRYILHDCGCSHVVSQAHLPS 572
Cdd:cd05922 2 GVSAAASALLEAGGVRGERVVLILPNRFTYIELSFAVAYAGGRLglvfVPLNPTLKESVLRYLVADAGGRIVLADAGAAD 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 573 SLEDNYIITHPEDIESKVD-----GSNIKSVNNA-DDLLYMIYTSGTTGKPKGVQFEHRNM---ANLLKfEYThsGIDfE 643
Cdd:cd05922 82 RLRDALPASPDPGTVLDADgiraaRASAPAHEVShEDLALLLYTSGSTGSPKLVRLSHQNLlanARSIA-EYL--GIT-A 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 644 ADVLQFATP-SFDVCYQEIFSALLKGGTLHI-----VPEAIKRDvpqlfafINKHQ-TNIVFLPTAF---IKMIFSEREL 713
Cdd:cd05922 158 DDRALTVLPlSYDYGLSVLNTHLLRGATLVLtndgvLDDAFWED-------LREHGaTGLAGVPSTYamlTRLGFDPAKL 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 714 ANsfpdgVKHLIAAGEQLmiSDLFQDVLRK--RGIHLHNHYGPSETHVVSTYTihPGDPIPELP-PIGKPIGCTDLYILN 790
Cdd:cd05922 231 PS-----LRYLTQAGGRL--PQETIARLREllPGAQVYVMYGQTEATRRMTYL--PPERILEKPgSIGLAIPGGEFEILD 301
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 791 HQKQLQPCGVPGELYISGASVARGYVNhdkltSDKFSSDPFKPDVIMYrTGDLARRLEDGNIEYIGRADNQVKIRGYRIE 870
Cdd:cd05922 302 DDGTPTPPGEPGEIVHRGPNVMKGYWN-----DPPYRRKEGRGGGVLH-TGDLARRDEDGFLFIVGRRDRMIKLFGNRIS 375
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 871 PQEIEVTLMNHPDISEAAILIWQDQNGEhELCAYYCSVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRA 950
Cdd:cd05922 376 PTEIEAAARSIGLIIEAAAVGLPDPLGE-KLALFVTAPDKIDPKDVLRSLAERLPPYKVPATVRVVDELPLTASGKVDYA 454
|
..
gi 1678550997 951 AL 952
Cdd:cd05922 455 AL 456
|
|
| FACL_DitJ_like |
cd05934 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
490-953 |
7.38e-46 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Members of this family include DitJ from Pseudomonas and similar proteins.
Pssm-ID: 341257 [Multi-domain] Cd Length: 422 Bit Score: 172.86 E-value: 7.38e-46
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 490 TYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSqah 569
Cdd:cd05934 5 TYAELLRESARIAAALAALGIRPGDRVALMLDNCPEFLFAWFALAKLGAVLVPINTALRGDELAYIIDHSGAQLVVV--- 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 570 lpsslednyiithpedieskvdgsniksvnnadDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEYTHSGIDfEADVLQF 649
Cdd:cd05934 82 ---------------------------------DPASILYTSGTTGPPKGVVITHANLTFAGYYSARRFGLG-EDDVYLT 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 650 ATPSFD---VCYQeIFSALLKGGTLHIVPeaiKRDVPQLFAFINKHQTNIVFLPTAFIKMIFSERELansfPDGVKHLI- 725
Cdd:cd05934 128 VLPLFHinaQAVS-VLAALSVGATLVLLP---RFSASRFWSDVRRYGATVTNYLGAMLSYLLAQPPS----PDDRAHRLr 199
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 726 AAGEQLMISDLFQDVLRKRGIHLHNHYGPSETHVVstyTIHPGDPIPELPPIGKPIGCTDLYILNHQKQLQPCGVPGELY 805
Cdd:cd05934 200 AAYGAPNPPELHEEFEERFGVRLLEGYGMTETIVG---VIGPRDEPRRPGSIGRPAPGYEVRIVDDDGQELPAGEPGELV 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 806 ISGA---SVARGYVNHDKLTSDKFSSDpfkpdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHP 882
Cdd:cd05934 277 IRGLrgwGFFKGYYNMPEATAEAMRNG-------WFHTGDLGYRDADGFFYFVDRKKDMIRRRGENISSAEVERAILRHP 349
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 883 DISEAAILIWQDQNGEHELCAYYCSV--QKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALP 953
Cdd:cd05934 350 AVREAAVVAVPDEVGEDEVKAVVVLRpgETLDPEELFAFCEGQLAYFKVPRYIRFVDDLPKTPTEKVAKAQLR 422
|
|
| C_NRPS-like |
cd19537 |
Condensation family domain with an atypical active site motif; Condensation (C) domains of ... |
1071-1448 |
1.09e-45 |
|
Condensation family domain with an atypical active site motif; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily typically have a non-canonical conserved SHXXXDX(14)Y motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380460 [Multi-domain] Cd Length: 395 Bit Score: 171.60 E-value: 1.09e-45
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1071 QLDEGV-AYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSGaDDEPVQRIHTEVP-------FTLSKEttiegF 1142
Cdd:cd19537 16 QLSTGTsSFNVSFACRLSGDVDRDRLASAWNTVLARHRILRSRYVPR-DGGLRRSYSSSPPrvqrvdtLDVWKE-----I 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1143 VRPFDLSQAPLFRaglIEVSNEkHVLLVdMHHIISDGVSVQLLIREFTDLYANRQLKPLRIQYKDYAVWQQkfkkgDSYQ 1222
Cdd:cd19537 90 NRPFDLEREDPIR---VFISPD-TLLVV-MSHIICDLTTLQLLLREVSAAYNGKLLPPVRREYLDSTAWSR-----PASP 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1223 KQETYWQQQFSGdLPILELPtdkRRPAERQFIGGKVTFQLDKEITARIKRLAHKNRSTLYMTLLALYSAFLSRLSGQDDI 1302
Cdd:cd19537 160 EDLDFWSEYLSG-LPLLNLP---RRTSSKSYRGTSRVFQLPGSLYRSLLQFSTSSGITLHQLALAAVALALQDLSDRTDI 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1303 VIGSPIAGRPHADLEAVLGMFVNTLALRTR--PAGNKTFEEFLKEVRQTALEAYEHQdYPFEELVDKLGVQREMSRNPLF 1380
Cdd:cd19537 236 VLGAPYLNRTSEEDMETVGLFLEPLPIRIRfpSSSDASAADFLRAVRRSSQAALAHA-IPWHQLLEHLGLPPDSPNHPLF 314
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 1381 DT--TLVLQNMEQQKLKMNDVQLQwndlehPI----SKFDISLYVTE-HDSELFCQFEYSTALFEKETIQRWASL 1448
Cdd:cd19537 315 DVmvTFHDDRGVSLALPIPGVEPL------YTwaegAKFPLMFEFTAlSDDSLLLRLEYDTDCFSEEEIDRIESL 383
|
|
| MACS_like |
cd05972 |
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of ... |
489-952 |
1.70e-45 |
|
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes.
Pssm-ID: 341276 [Multi-domain] Cd Length: 428 Bit Score: 172.14 E-value: 1.70e-45
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 489 LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSqa 568
Cdd:cd05972 1 WSFRELKRESAKAANVLAKLGLRKGDRVAVLLPRVPELWAVILAVIKLGAVYVPLTTLLGPKDIEYRLEAAGAKAIVT-- 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 569 hlpsslednyiithpedieskvdgsniksvnNADDLLYMIYTSGTTGKPKGVQFEHRNMANLLKfeYTHSGIDFEADVLQ 648
Cdd:cd05972 79 -------------------------------DAEDPALIYFTSGTTGLPKGVLHTHSYPLGHIP--TAAYWLGLRPDDIH 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 649 FAT--PSFDVC-YQEIFSALLKGGTLhIVPEAIKRDVPQLFAFINKHQTNIVFLPTAFIKMIFSERELANSFPdGVKHLI 725
Cdd:cd05972 126 WNIadPGWAKGaWSSFFGPWLLGATV-FVYEGPRFDAERILELLERYGVTSFCGPPTAYRMLIKQDLSSYKFS-HLRLVV 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 726 AAGEQLM--ISDLFQDVLrkrGIHLHNHYGPSETHVV----STYTIHPGDpipelppIGKPIGCTDLYILNHQKQLQPCG 799
Cdd:cd05972 204 SAGEPLNpeVIEWWRAAT---GLPIRDGYGQTETGLTvgnfPDMPVKPGS-------MGRPTPGYDVAIIDDDGRELPPG 273
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 800 VPGELYI--SGASVARGYVNHDKLTSDKFSSDpfkpdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVT 877
Cdd:cd05972 274 EEGDIAIklPPPGLFLGYVGDPEKTEASIRGD-------YYLTGDRAYRDEDGYFWFVGRADDIIKSSGYRIGPFEVESA 346
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 878 LMNHPDISEAAI------LIWQDQNGEHELCAYYCSVQKLnTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAA 951
Cdd:cd05972 347 LLEHPAVAEAAVvgspdpVRGEVVKAFVVLTSGYEPSEEL-AEELQGHVKKVLAPYKYPREIEFVEELPKTISGKIRRVE 425
|
.
gi 1678550997 952 L 952
Cdd:cd05972 426 L 426
|
|
| MCS |
cd05941 |
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step ... |
478-952 |
2.82e-45 |
|
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step reaction consisting of the adenylation of malonate with ATP, followed by malonyl transfer from malonyl-AMP to CoA. Malonic acid and its derivatives are the building blocks of polyketides and malonyl-CoA serves as the substrate of polyketide synthases. Malonyl-CoA synthetase has broad substrate tolerance and can activate a variety of malonyl acid derivatives. MCS may play an important role in biosynthesis of polyketides, the important secondary metabolites with therapeutic and agrochemical utility.
Pssm-ID: 341264 [Multi-domain] Cd Length: 442 Bit Score: 171.70 E-value: 2.82e-45
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 478 DAHAVIDQACSLTYRELNKAANRLARHLRMKGVV-RQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYIL 556
Cdd:cd05941 1 DRIAIVDDGDSITYADLVARAARLANRLLALGKDlRGDRVAFLAPPSAEYVVAQLAIWRAGGVAVPLNPSYPLAELEYVI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 557 HDCGCSHVVsqahlpsslednyiithpedieskvdgsniksvnnadDLLYMIYTSGTTGKPKGVQFEHRNMANLLK---- 632
Cdd:cd05941 81 TDSEPSLVL-------------------------------------DPALILYTSGTTGRPKGVVLTHANLAANVRalvd 123
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 633 -FEYThsgidfEADVLQFATPSFDV--CYQEIFSALLKGGTLHIVPeaiKRDVPQlfAFINKHQTNIVFL---PTAFIKM 706
Cdd:cd05941 124 aWRWT------EDDVLLHVLPLHHVhgLVNALLCPLFAGASVEFLP---KFDPKE--VAISRLMPSITVFmgvPTIYTRL 192
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 707 IfSERELANSFPDGVKHLIAAGEQLMIS-------DLFQDVLRKRGIHLHNHYGPSETHVVSTYTIHpGDPIPElpPIGK 779
Cdd:cd05941 193 L-QYYEAHFTDPQFARAAAAERLRLMVSgsaalpvPTLEEWEAITGHTLLERYGMTEIGMALSNPLD-GERRPG--TVGM 268
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 780 PIGCTDLYIL-NHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGR- 857
Cdd:cd05941 269 PLPGVQARIVdEETGEPLPRGEVGEIQVRGPSVFKEYWNKPEATKEEFTDDGW------FKTGDLGVVDEDGYYWILGRs 342
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 858 ADNQVKIRGYRIEPQEIEVTLMNHPDISEAAIL-----IWqdqnGEhELCAYYC---SVQKLNTIDLRSYMASELPEYMI 929
Cdd:cd05941 343 SVDIIKSGGYKVSALEIERVLLAHPGVSECAVIgvpdpDW----GE-RVVAVVVlraGAAALSLEELKEWAKQRLAPYKR 417
|
490 500
....*....|....*....|...
gi 1678550997 930 PAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:cd05941 418 PRRLILVDELPRNAMGKVNKKEL 440
|
|
| DCL_NRPS-like |
cd19536 |
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal ... |
1057-1460 |
2.91e-45 |
|
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal fungal CT domains and Dual Epimerization/Condensation (E/C) domains; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type [D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L))], which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380459 [Multi-domain] Cd Length: 419 Bit Score: 171.09 E-value: 2.91e-45
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1057 YPVSSAQKRIYVLQQLD-EGVAYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSGADDEPVQRIHTEVPFTLSK 1135
Cdd:cd19536 2 YPLSSLQEGMLFHSLLNpGGSVYLHNYTYTVGRRLNLDLLLEALQVLIDRHDILRTSFIEDGLGQPVQVVHRQAQVPVTE 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1136 ETTIEG--------------FVRPFDLSQAPLFRAGLIEVSNEKHVLLV-DMHHIISDGVSVQLLIREFTDLYANR---- 1196
Cdd:cd19536 82 LDLTPLeeqldplraykeetKIRRFDLGRAPLVRAALVRKDERERFLLViSDHHSILDGWSLYLLVKEILAVYNQLleyk 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1197 --QLKPlRIQYKDYAVWQQKfkkgdSYQKQET--YWQQQFSG-DLPILELPTDKRRPAERQfigGKVTFqLDKEITARIK 1271
Cdd:cd19536 162 plSLPP-AQPYRDFVAHERA-----SIQQAASerYWREYLAGaTLATLPALSEAVGGGPEQ---DSELL-VSVPLPVRSR 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1272 RLAHKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPH--ADLEAVLGMFVNTLALRTRPAGNkTFEEFLKEVRQT 1349
Cdd:cd19536 232 SLAKRSGIPLSTLLLAAWALVLSRHSGSDDVVFGTVVHGRSEetTGAERLLGLFLNTLPLRVTLSEE-TVEDLLKRAQEQ 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1350 ALEAYEHQDYPFEELvdklgvQREMSRNPLFDTTLVLQNMEQqklkmnDVQLQWNDLEHPI----------SKFDISLYV 1419
Cdd:cd19536 311 ELESLSHEQVPLADI------QRCSEGEPLFDSIVNFRHFDL------DFGLPEWGSDEGMrrgllfsefkSNYDVNLSV 378
|
410 420 430 440
....*....|....*....|....*....|....*....|.
gi 1678550997 1420 TEHDSELFCQFEYSTALFEKETIQRWASLFTTLVEHTAASP 1460
Cdd:cd19536 379 LPKQDRLELKLAYNSQVLDEEQAQRLAAYYKSAIAELATAP 419
|
|
| BCL_4HBCL |
cd05959 |
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate ... |
1499-1983 |
5.19e-45 |
|
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate CoA ligase and 4-hydroxybenzoate-coenzyme A ligase catalyze the first activating step for benzoate and 4-hydroxybenzoate catabolic pathways, respectively. Although these two enzymes share very high sequence homology, they have their own substrate preference. The reaction proceeds via a two-step process; the first ATP-dependent step forms the substrate-AMP intermediate, while the second step forms the acyl-CoA ester, releasing the AMP. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Some bacteria can use benzoic acid or benzenoid compounds as the sole source of carbon and energy through degradation. Benzoate CoA ligase and 4-hydroxybenzoate-Coenzyme A ligase are key enzymes of this process.
Pssm-ID: 341269 [Multi-domain] Cd Length: 508 Bit Score: 172.55 E-value: 5.19e-45
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1499 ALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDY 1578
Cdd:cd05959 9 VDLNLNEGRGDKTAFIDDAGSLTYAELEAEARRVAGALRALGVKREERVLLIMLDTVDFPTAFLGAIRAGIVPVPVNTLL 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1579 PEERISFLLEDSGTNILLLQSA-------GLHVPEFTGEIVYLNQTNSGLAHRL-----------SNPNVDVLPQSLAYV 1640
Cdd:cd05959 89 TPDDYAYYLEDSRARVVVVSGElapvlaaALTKSEHTLVVLIVSGGAGPEAGALllaelvaaeaeQLKPAATHADDPAFW 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1641 IYTSGSTGMPKGVEIEHRS----AVNFL-NSLQSRyqlkHSDMIMHKT----SYSFDASIWELFWwpyAGASVYLLPqgG 1711
Cdd:cd05959 169 LYSSGSTGRPKGVVHLHADiywtAELYArNVLGIR----EDDVCFSAAklffAYGLGNSLTFPLS---VGATTVLMP--E 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1712 EKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHikyrSVPIKTN--RLKRVFSGGEQLGTHLVSRFYELLpNVSITNSYGP 1789
Cdd:cd05959 240 RPTPAAVFKRIRRYRPTVFFGVPTLYAAMLAA----PNLPSRDlsSLRLCVSAGEALPAEVGERWKARF-GLDILDGIGS 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1790 TEATveAAFFDCPPHEKlERIPIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLedpfypG 1869
Cdd:cd05959 315 TEML--HIFLSNRPGRV-RYGTTGKPVPGYEVELRDEDGGDVADGEPGELYVRGPSSATMYWNNRDKTRDTFQ------G 385
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1870 ErMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVT-VRTDSGEPELCAYV--------E 1940
Cdd:cd05959 386 E-WTRTGDKYVRDDDGFYTYAGRADDMLKVSGIWVSPFEVESALVQHPAVLEAAVVgVEDEDGLTKPKAFVvlrpgyedS 464
|
490 500 510 520
....*....|....*....|....*....|....*....|...
gi 1678550997 1941 GLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd05959 465 EALEEELKEFVKDRLAPYKYPRWIVFVDELPKTATGKIQRFKL 507
|
|
| C_NRPS-like |
cd19537 |
Condensation family domain with an atypical active site motif; Condensation (C) domains of ... |
2102-2499 |
9.60e-45 |
|
Condensation family domain with an atypical active site motif; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily typically have a non-canonical conserved SHXXXDX(14)Y motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380460 [Multi-domain] Cd Length: 395 Bit Score: 168.90 E-value: 9.60e-45
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2102 QLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGdPVQRIHDEVPFTLQTTVLGARTEqeaaaa 2181
Cdd:cd19537 16 QLSTGTSSFNVSFACRLSGDVDRDRLASAWNTVLARHRILRSRYVPRDGG-LRRSYSSSPPRVQRVDTLDVWKE------ 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2182 FIKPFDLSQAPLFRaqiVKVSDeRHLLLVdMHHIISDGVSVNILIQEFGELYNNRKLPALRIQYKDYAVWQegfKTGDAY 2261
Cdd:cd19537 89 INRPFDLEREDPIR---VFISP-DTLLVV-MSHIICDLTTLQLLLREVSAAYNGKLLPPVRREYLDSTAWS---RPASPE 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2262 KMQeaYWLKQLEGeLPVLDLPAdhaRPPVRSFAGDKVSFTLEPEVASGLHKLARENGSTLYMVLLAAYTAFLSRLSGQED 2341
Cdd:cd19537 161 DLD--FWSEYLSG-LPLLNLPR---RTSSKSYRGTSRVFQLPGSLYRSLLQFSTSSGITLHQLALAAVALALQDLSDRTD 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2342 IIVGSPIAGRPHKDLEPILGMFVNTLALRTR--PEGGKPFVQYLQEVRETALEAFEHQnYPFEELVDKLELTRDMSRNPV 2419
Cdd:cd19537 235 IVLGAPYLNRTSEEDMETVGLFLEPLPIRIRfpSSSDASAADFLRAVRRSSQAALAHA-IPWHQLLEHLGLPPDSPNHPL 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2420 FDAMlvVQNNDYEPLHLHdLQMKPAQVSHLV---SKFDLTLQASE-GDGNIHFLFEYSTALFEKTTIERWASHLTNVLSI 2495
Cdd:cd19537 314 FDVM--VTFHDDRGVSLA-LPIPGVEPLYTWaegAKFPLMFEFTAlSDDSLLLRLEYDTDCFSEEEIDRIESLILAALEL 390
|
....
gi 1678550997 2496 IGKN 2499
Cdd:cd19537 391 LVEG 394
|
|
| MACS_like_3 |
cd05971 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
490-952 |
1.46e-44 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341275 [Multi-domain] Cd Length: 439 Bit Score: 169.54 E-value: 1.46e-44
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 490 TYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSqah 569
Cdd:cd05971 8 TFKELKTASNRFANVLKEIGLEKGDRVGVFLSQGPECAIAHIAILRSGAIAVPLFALFGPEALEYRLSNSGASALVT--- 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 570 lpsslednyiithpedieskvDGSniksvnnaDDLLYMIYTSGTTGKPKGVQFEHRN-MANLLKFEYTHSGIDFEADVlq 648
Cdd:cd05971 85 ---------------------DGS--------DDPALIIYTSGTTGPPKGALHAHRVlLGHLPGVQFPFNLFPRDGDL-- 133
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 649 FATPS--------FDVcyqeIFSALLKGGTLhIVPEAIKRDVPQLFAFINKHQTNIVFLPTAFIKMIFSERELANSFPDG 720
Cdd:cd05971 134 YWTPAdwawigglLDV----LLPSLYFGVPV-LAHRMTKFDPKAALDLMSRYGVTTAFLPPTALKMMRQQGEQLKHAQVK 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 721 VKHLIAAGEQLMiSDLFQDVLRKRGIHLHNHYGPSETHVVST-----YTIHPGDpipelppIGKPIGCTDLYILNHQKQL 795
Cdd:cd05971 209 LRAIATGGESLG-EELLGWAREQFGVEVNEFYGQTECNLVIGncsalFPIKPGS-------MGKPIPGHRVAIVDDNGTP 280
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 796 QPCGVPGELYIS-GASVAR-GYVNHDKLTSDKFSSDPFkpdvimyRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQE 873
Cdd:cd05971 281 LPPGEVGEIAVElPDPVAFlGYWNNPSATEKKMAGDWL-------LTGDLGRKDSDGYFWYVGRDDDVITSSGYRIGPAE 353
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 874 IEVTLMNHPDISEAAILIWQDQNGEHELCAYYC---SVQKLNTI--DLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVD 948
Cdd:cd05971 354 IEECLLKHPAVLMAAVVGIPDPIRGEIVKAFVVlnpGETPSDALarEIQELVKTRLAAHEYPREIEFVNELPRTATGKIR 433
|
....
gi 1678550997 949 RAAL 952
Cdd:cd05971 434 RREL 437
|
|
| MACS_like |
cd05972 |
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of ... |
2559-3019 |
1.55e-44 |
|
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes.
Pssm-ID: 341276 [Multi-domain] Cd Length: 428 Bit Score: 169.05 E-value: 1.55e-44
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2559 LTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMTin 2638
Cdd:cd05972 1 WSFRELKRESAKAANVLAKLGLRKGDRVAVLLPRVPELWAVILAVIKLGAVYVPLTTLLGPKDIEYRLEAAGAKAIVT-- 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2639 eadlgvladfegeiltiesvEEDDksplpqmssahhLAYIIYTSGTTGRPKGVMVEHK-------GIANTLQWRRNAYAF 2711
Cdd:cd05972 79 --------------------DAED------------PALIYFTSGTTGLPKGVLHTHSyplghipTAAYWLGLRPDDIHW 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2712 NETDTILQLFSFSfdgfitSMFTPLLSGAkAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDVVQPE-DVKTL 2790
Cdd:cd05972 127 NIADPGWAKGAWS------SFFGPWLLGA-TVFVYEGPRFDAERILELLERYGVTSFCGPPTAYRMLIKQDLSSyKFSHL 199
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2791 RVVTLAGEAADRELIARSLAiCPHTELANEYGPTENSVATTVMRHME-KQAyvSIGQPIDGTQVLILNSNHQLQPIGVAG 2869
Cdd:cd05972 200 RLVVSAGEPLNPEVIEWWRA-ATGLPIRDGYGQTETGLTVGNFPDMPvKPG--SMGRPTPGYDVAIIDDDGRELPPGEEG 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2870 ELCI--AGTGLARGYVNLPELTERAFTQNpfkpearMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRC 2947
Cdd:cd05972 277 DIAIklPPPGLFLGYVGDPEKTEASIRGD-------YYLTGDRAYRDEDGYFWFVGRADDIIKSSGYRIGPFEVESALLE 349
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1678550997 2948 IKGVKDAAVVAHV-TASGQTeLSAYVVTKPG-LSTNAVRSELQNK----LPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:cd05972 350 HPAVAEAAVVGSPdPVRGEV-VKAFVVLTSGyEPSEELAEELQGHvkkvLAPYKYPREIEFVEELPKTISGKIRRVEL 426
|
|
| Firefly_Luc_like |
cd05911 |
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family ... |
488-947 |
2.35e-44 |
|
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family contains insect firefly luciferases that share significant sequence similarity to plant 4-coumarate:coenzyme A ligases, despite their functional diversity. Luciferase catalyzes the production of light in the presence of MgATP, molecular oxygen, and luciferin. In the first step, luciferin is activated by acylation of its carboxylate group with ATP, resulting in an enzyme-bound luciferyl adenylate. In the second step, luciferyl adenylate reacts with molecular oxygen, producing an enzyme-bound excited state product (Luc=O*) and releasing AMP. This excited-state product then decays to the ground state (Luc=O), emitting a quantum of visible light.
Pssm-ID: 341237 [Multi-domain] Cd Length: 486 Bit Score: 170.09 E-value: 2.35e-44
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 488 SLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSQ 567
Cdd:cd05911 10 ELTYAQLRTLSRRLAAGLRKLGLKKGDVVGIISPNSTYYPPVFLGCLFAGGIFSAANPIYTADELAHQLKISKPKVIFTD 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 568 AH--------------------LPSSLEDnyiITHPEDIESKVDGSNIKSV-----NNADDLLYMIYTSGTTGKPKGVQF 622
Cdd:cd05911 90 PDglekvkeaakelgpkdkiivLDDKPDG---VLSIEDLLSPTLGEEDEDLppplkDGKDDTAAILYSSGTTGLPKGVCL 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 623 EHRNMANLLKFEYTHSGIDFEADVLQFATPSFDVCY--QEIFSALLKGGTLHIVPeaiKRDVPQLFAFINKHQTNIVFL- 699
Cdd:cd05911 167 SHRNLIANLSQVQTFLYGNDGSNDVILGFLPLYHIYglFTTLASLLNGATVIIMP---KFDSELFLDLIEKYKITFLYLv 243
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 700 PTAFIKMIFSERELANSFPDgVKHLIAAGEQLmiSDLFQDVLRKRGI--HLHNHYGPSETHVVSTYTIhPGDPIPElpPI 777
Cdd:cd05911 244 PPIAAALAKSPLLDKYDLSS-LRVILSGGAPL--SKELQELLAKRFPnaTIKQGYGMTETGGILTVNP-DGDDKPG--SV 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 778 GKPIGCTDLYILNHQ-KQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIG 856
Cdd:cd05911 318 GRLLPNVEAKIVDDDgKDSLGPNEPGEICVRGPQVMKGYYNNPEATKETFDEDGW------LHTGDIGYFDEDGYLYIVD 391
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 857 RADNQVKIRGYRIEPQEIEVTLMNHPDISEAA-ILIWQDQNGEhelcAYYCSV-----QKLNTIDLRSYMASELPEYmip 930
Cdd:cd05911 392 RKKELIKYKGFQVAPAELEAVLLEHPGVADAAvIGIPDEVSGE----LPRAYVvrkpgEKLTEKEVKDYVAKKVASY--- 464
|
490 500
....*....|....*....|..
gi 1678550997 931 aKW-----IWVDSIPLTPNGKV 947
Cdd:cd05911 465 -KQlrggvVFVDEIPKSASGKI 485
|
|
| MACS_like_3 |
cd05971 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
2557-3019 |
1.61e-43 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341275 [Multi-domain] Cd Length: 439 Bit Score: 166.45 E-value: 1.61e-43
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2557 KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMT 2636
Cdd:cd05971 5 EKVTFKELKTASNRFANVLKEIGLEKGDRVGVFLSQGPECAIAHIAILRSGAIAVPLFALFGPEALEYRLSNSGASALVT 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2637 ineadlgvlaDfegeiltiesvEEDDksplpqmssahhLAYIIYTSGTTGRPKGVMVEHK---GIANTLQ-----WRRNA 2708
Cdd:cd05971 85 ----------D-----------GSDD------------PALIIYTSGTTGPPKGALHAHRvllGHLPGVQfpfnlFPRDG 131
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2709 YAFNETDtilqlfSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPV---LYRALLDVVQPE 2785
Cdd:cd05971 132 DLYWTPA------DWAWIGGLLDVLLPSLYFGVPVLAHRMTKFDPKAALDLMSRYGVTTAFLPPTalkMMRQQGEQLKHA 205
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2786 DVKtLRVVTLAGEAADRELIA---RSLAIcphtELANEYGPTENSVATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQL 2862
Cdd:cd05971 206 QVK-LRAIATGGESLGEELLGwarEQFGV----EVNEFYGQTECNLVIGNCSALFPIKPGSMGKPIPGHRVAIVDDNGTP 280
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2863 QPIGVAGELCI----AGTGLarGYVNLPELTERaftqnpfKPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVET 2938
Cdd:cd05971 281 LPPGEVGEIAVelpdPVAFL--GYWNNPSATEK-------KMAGDWLLTGDLGRKDSDGYFWYVGRDDDVITSSGYRIGP 351
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2939 KEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTN-AVRSELQN----KLPVFMHPAFIEKLDSLPLSPNGK 3013
Cdd:cd05971 352 AEIEECLLKHPAVLMAAVVGIPDPIRGEIVKAFVVLNPGETPSdALAREIQElvktRLAAHEYPREIEFVNELPRTATGK 431
|
....*.
gi 1678550997 3014 LDRGAL 3019
Cdd:cd05971 432 IRRREL 437
|
|
| PRK06839 |
PRK06839 |
o-succinylbenzoate--CoA ligase; |
1494-1983 |
5.23e-43 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 168698 [Multi-domain] Cd Length: 496 Bit Score: 166.57 E-value: 5.23e-43
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1494 QTLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGR-GVKPETTVAIIGKRSPEMLLGIYGILKAGGAYL 1572
Cdd:PRK06839 2 QGIAYWIEKRAYLHPDRIAIITEEEEMTYKQLHEYVSKVAAYLIYElNVKKGERIAILSQNSLEYIVLLFAIAKVECIAV 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1573 PIDPDYPEERISFLLEDSGTNILLLQsaglhvPEFTGEIVYLnQTNSGLAH--RLSNP---------NVDVLPQSLAYVI 1641
Cdd:PRK06839 82 PLNIRLTENELIFQLKDSGTTVLFVE------KTFQNMALSM-QKVSYVQRviSITSLkeiedrkidNFVEKNESASFII 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1642 -YTSGSTGMPKGVEIehrSAVN-FLNSLQSRYQLkhsDMIMHKTSYS----FDASIWELFWWP--YAGASVyLLPqgGEK 1713
Cdd:PRK06839 155 cYTSGTTGKPKGAVL---TQENmFWNALNNTFAI---DLTMHDRSIVllplFHIGGIGLFAFPtlFAGGVI-IVP--RKF 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1714 EPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTNRLkrVFSGGEQLGTHLVSRFYEllPNVSITNSYGPTEaT 1793
Cdd:PRK06839 226 EPTKALSMIEKHKVTVVMGVPTIHQALINCSKFETTNLQSVRW--FYNGGAPCPEELMREFID--RGFLFGQGFGMTE-T 300
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1794 VEAAFFdcPPHEKLERIP--IGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYpger 1871
Cdd:PRK06839 301 SPTVFM--LSEEDARRKVgsIGKPVLFCDYELIDENKNKVEVGEVGELLIRGPNVMKEYWNRPDATEETIQDGWLC---- 374
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1872 mykTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GEPELCAYV----EGLQRN 1945
Cdd:PRK06839 375 ---TGDLARVDEDGFVYIVGRKKEMIISGGENIYPLEVEQVINKLSDVYEVAVVGRQHVkwGEIPIAFIVkkssSVLIEK 451
|
490 500 510
....*....|....*....|....*....|....*...
gi 1678550997 1946 EVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK06839 452 DVIEHCRLFLAKYKIPKEIVFLKELPKNATGKIQKAQL 489
|
|
| FACL_DitJ_like |
cd05934 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
1521-1984 |
7.98e-43 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Members of this family include DitJ from Pseudomonas and similar proteins.
Pssm-ID: 341257 [Multi-domain] Cd Length: 422 Bit Score: 164.00 E-value: 7.98e-43
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1521 TYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLlqsa 1600
Cdd:cd05934 5 TYAELLRESARIAAALAALGIRPGDRVALMLDNCPEFLFAWFALAKLGAVLVPINTALRGDELAYIIDHSGAQLVV---- 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1601 glhvpeftgeivylnqtnsglahrlsnpnVDvlpqsLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMI- 1679
Cdd:cd05934 81 -----------------------------VD-----PASILYTSGTTGPPKGVVITHANLTFAGYYSARRFGLGEDDVYl 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1680 -------MHKTSYSFDASIWelfwwpyAGASVYLLPQggeKEPEVIAKAIEEQKITAMHFVPSMLHAFLEhiKYRSVPIK 1752
Cdd:cd05934 127 tvlplfhINAQAVSVLAALS-------VGATLVLLPR---FSASRFWSDVRRYGATVTNYLGAMLSYLLA--QPPSPDDR 194
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1753 TNRLKRVFSGG--EQLGTHLVSRFyellpNVSITNSYGPTEATVEAAffdCPPHEKLERIPIGKPVHHVRLYLLNQNQRM 1830
Cdd:cd05934 195 AHRLRAAYGAPnpPELHEEFEERF-----GVRLLEGYGMTETIVGVI---GPRDEPRRPGSIGRPAPGYEVRIVDDDGQE 266
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1831 LPVGCIGELYIAGA---GVARGYLNRPALTEERFledpfypGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPG 1907
Cdd:cd05934 267 LPAGEPGELVIRGLrgwGFFKGYYNMPEATAEAM-------RNGWFHTGDLGYRDADGFFYFVDRKKDMIRRRGENISSA 339
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1908 EIEAALRSIEGVREAAV-TVRTDSGEPELCAYV-----EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRN 1981
Cdd:cd05934 340 EVERAILRHPAVREAAVvAVPDEVGEDEVKAVVvlrpgETLDPEELFAFCEGQLAYFKVPRYIRFVDDLPKTPTEKVAKA 419
|
...
gi 1678550997 1982 ALP 1984
Cdd:cd05934 420 QLR 422
|
|
| ttLC_FACS_AEE21_like |
cd12118 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This ... |
1500-1983 |
9.09e-43 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This family includes fatty acyl-CoA synthetases that can activate medium to long-chain fatty acids. These enzymes catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family has been shown to catalyze the long-chain fatty acid, myristoyl acid. Also included in this family are acyl activating enzymes from Arabidopsis, which contains a large number of proteins from this family with up to 63 different genes, many of which are uncharacterized.
Pssm-ID: 341283 [Multi-domain] Cd Length: 486 Bit Score: 165.55 E-value: 9.09e-43
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYP 1579
Cdd:cd12118 10 LERAAAVYPDRTSIVYGDRRYTWRQTYDRCRRLASALAALGISRGDTVAVLAPNTPAMYELHFGVPMAGAVLNALNTRLD 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1580 EERISFLLEDSGTNILLLQSaglhvpEFTGEIVylnqTNSGlahrlsNPNVDVLP-----QSLAyVIYTSGSTGMPKGVE 1654
Cdd:cd12118 90 AEEIAFILRHSEAKVLFVDR------EFEYEDL----LAEG------DPDFEWIPpadewDPIA-LNYTSGTTGRPKGVV 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1655 IEHRSAvnFLNSLQS--RYQLKHSDMIMHkTSYSFDASIWELFWWPYA-GASVYLLPQggeKEPEVIAKAIEEQKITAMH 1731
Cdd:cd12118 153 YHHRGA--YLNALANilEWEMKQHPVYLW-TLPMFHCNGWCFPWTVAAvGGTNVCLRK---VDAKAIYDLIEKHKVTHFC 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1732 FVPSMLHAFLEHIKYRSVPIktNRLKRVFSGGEQLGTHLVSRFYELlpNVSITNSYGPTEATVEAAFfdCPPHEKLERIP 1811
Cdd:cd12118 227 GAPTVLNMLANAPPSDARPL--PHRVHVMTAGAPPPAAVLAKMEEL--GFDVTHVYGLTETYGPATV--CAWKPEWDELP 300
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1812 IG-----KPVHHVRLYLLNQ-----NQRMLPV----GCIGELYIAGAGVARGYLNRPALTEERFLEDPFYpgermykTGD 1877
Cdd:cd12118 301 TEerarlKARQGVRYVGLEEvdvldPETMKPVprdgKTIGEIVFRGNIVMKGYLKNPEATAEAFRGGWFH-------SGD 373
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1878 VARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GEpELCAYVE-----GLQRNEVRAQ 1950
Cdd:cd12118 374 LAVIHPDGYIEIKDRSKDIIISGGENISSVEVEGVLYKHPAVLEAAVVARPDEkwGE-VPCAFVElkegaKVTEEEIIAF 452
|
490 500 510
....*....|....*....|....*....|...
gi 1678550997 1951 LERLLPGYMVPAYMIEMEqWPVTPSGKLDRNAL 1983
Cdd:cd12118 453 CREHLAGFMVPKTVVFGE-LPKTSTGKIQKFVL 484
|
|
| menE |
TIGR01923 |
O-succinylbenzoate-CoA ligase; This model represents an enzyme, O-succinylbenzoate-CoA ligase, ... |
2560-3019 |
1.91e-42 |
|
O-succinylbenzoate-CoA ligase; This model represents an enzyme, O-succinylbenzoate-CoA ligase, which is involved in the fourth step of the menaquinone biosynthesis pathway. O-succinylbenzoate-CoA ligase, together with menB - naphtoate synthase, take 2-succinylbenzoate and convert it into 1,4-di-hydroxy-2- naphtoate. [Biosynthesis of cofactors, prosthetic groups, and carriers, Menaquinone and ubiquinone]
Pssm-ID: 162605 [Multi-domain] Cd Length: 436 Bit Score: 163.39 E-value: 1.91e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2560 TYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMTine 2639
Cdd:TIGR01923 1 TWQDLDCEAAHLAKALKAQGIRSGSRVALVGQNSIEMVLLLHACLLLGAEIAMLNTRLTENERTNQLEDLDVQLLLT--- 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2640 ADLgvladFEGEILTIESVEEDDKSPLPQMS-----SAHHLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNET 2714
Cdd:TIGR01923 78 DSL-----LEEKDFQADSLDRIEAAGRYETSlsasfNMDQIATLMFTSGTTGKPKAVPHTFRNHYASAVGSKENLGFTED 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2715 DT---ILQLFSFSFDGFItsmFTPLLSGAkAVLLHEEEAkdilAIKHQLSRQRITHMIIVPVLYRALLDVVQPEDvkTLR 2791
Cdd:TIGR01923 153 DNwllSLPLYHISGLSIL---FRWLIEGA-TLRIVDKFN----QLLEMIANERVTHISLVPTQLNRLLDEGGHNE--NLR 222
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2792 VVTLAGEAADRELIARslAICPHTELANEYGPTENSVATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQLQpigvaGEL 2871
Cdd:TIGR01923 223 KILLGGSAIPAPLIEE--AQQYGLPIYLSYGMTETCSQVTTATPEMLHARPDVGRPLAGREIKIKVDNKEGH-----GEI 295
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2872 CIAGTGLARGYVNLPELTERAFTQNPFKpearmyrTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGV 2951
Cdd:TIGR01923 296 MVKGANLMKGYLYQGELTPAFEQQGWFN-------TGDIGELDGEGFLYVLGRRDDLIISGGENIYPEEIETVLYQHPGI 368
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 2952 KDAAVVAHVTAS-GQTELsAYVVTKPGLSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:TIGR01923 369 QEAVVVPKPDAEwGQVPV-AYIVSESDISQAKLIAYLTEKLAKYKVPIAFEKLDELPYNASGKILRNQL 436
|
|
| BCL_like |
cd05919 |
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate ... |
481-952 |
2.02e-42 |
|
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate CoA ligase (BCL) and related ligases that catalyze the acylation of benzoate derivatives, 2-aminobenzoate and 4-hydroxybenzoate. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Xenobiotic aromatic compounds are also a major class of man-made pollutants. Some bacteria use benzoate as the sole source of carbon and energy through benzoate degradation. Benzoate degradation starts with its activation to benzoyl-CoA by benzoate CoA ligase. The reaction catalyzed by benzoate CoA ligase proceeds via a two-step process; the first ATP-dependent step forms an acyl-AMP intermediate, and the second step forms the acyl-CoA ester with release of the AMP.
Pssm-ID: 341243 [Multi-domain] Cd Length: 436 Bit Score: 163.40 E-value: 2.02e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 481 AVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCG 560
Cdd:cd05919 3 AFYAADRSVTYGQLHDGANRLGSALRNLGVSSGDRVLLLMLDSPELVQLFLGCLARGAIAVVINPLLHPDDYAYIARDCE 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 561 CSHVVSqahlpsslednyiithpedieskvdgsniksvnNADDLLYMIYTSGTTGKPKGVQFEHRN---MANLLKFEYTh 637
Cdd:cd05919 83 ARLVVT---------------------------------SADDIAYLLYSSGTTGPPKGVMHAHRDpllFADAMAREAL- 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 638 sGIDfEADVLqFATPSFDVCY---QEIFSALLKGGTLHIVPEAikRDVPQLFAFINKHQTNIVF-LPTAFIKMIFSEREL 713
Cdd:cd05919 129 -GLT-PGDRV-FSSAKMFFGYglgNSLWFPLAVGASAVLNPGW--PTAERVLATLARFRPTVLYgVPTFYANLLDSCAGS 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 714 ANSFPDgVKHLIAAGEQLMiSDLFQDVLRKRGIHLHNHYGPSET-HV-VSTytiHPGDpiPELPPIGKPIGCTDLYILNH 791
Cdd:cd05919 204 PDALRS-LRLCVSAGEALP-RGLGERWMEHFGGPILDGIGATEVgHIfLSN---RPGA--WRLGSTGRPVPGYEIRLVDE 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 792 QKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDpfkpdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEP 871
Cdd:cd05919 277 EGHTIPPGEEGDLLVRGPSAAVGYWNNPEKSRATFNGG-------WYRTGDKFCRDADGWYTHAGRADDMLKVGGQWVSP 349
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 872 QEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYC-----SVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGK 946
Cdd:cd05919 350 VEVESLIIQHPAVAEAAVVAVPESTGLSRLTAFVVlkspaAPQESLARDIHRHLLERLSAHKVPRRIAFVDELPRTATGK 429
|
....*.
gi 1678550997 947 VDRAAL 952
Cdd:cd05919 430 LQRFKL 435
|
|
| ttLC_FACS_AlkK_like |
cd12119 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes ... |
1521-1983 |
4.04e-42 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes fatty acyl-CoA synthetases that can activate medium-chain to long-chain fatty acids. They catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family catalyzes the long-chain fatty acid, myristoyl acid, while another member in this family, the AlkK protein identified from Pseudomonas oleovorans, targets medium chain fatty acids. This family also includes uncharacterized FACS proteins.
Pssm-ID: 341284 [Multi-domain] Cd Length: 518 Bit Score: 164.34 E-value: 4.04e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1521 TYKELNEQANRIAWELIGRGVKPETTVAIIG---KRSPEMLLGIYGIlkagGAYL-PIDPDYPEERISFLLEDSGTNILL 1596
Cdd:cd12119 27 TYAEVAERARRLANALRRLGVKPGDRVATLAwntHRHLELYYAVPGM----GAVLhTINPRLFPEQIAYIINHAEDRVVF 102
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1597 LQSAGL--------------HVPEFTGEIVYLNQTNSGLAH--RL--SNPNVDVLPQS---LAYVI-YTSGSTGMPKGVE 1654
Cdd:cd12119 103 VDRDFLplleaiaprlptveHVVVMTDDAAMPEPAGVGVLAyeELlaAESPEYDWPDFdenTAAAIcYTSGTTGNPKGVV 182
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1655 IEHRSavNFLNSLQSRYQ----LKHSDMIMHKTSYsFDASIWELfwwPYAGASV---YLLPqGGEKEPEVIAKAIEEQKI 1727
Cdd:cd12119 183 YSHRS--LVLHAMAALLTdglgLSESDVVLPVVPM-FHVNAWGL---PYAAAMVgakLVLP-GPYLDPASLAELIEREGV 255
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1728 TAMHFVPSMLHAFLEHIKYRSVPIKTnrLKRVFSGGEQLGTHLVSRFYELLpnVSITNSYGPTE-------ATVEAAFFD 1800
Cdd:cd12119 256 TFAAGVPTVWQGLLDHLEANGRDLSS--LRRVVIGGSAVPRSLIEAFEERG--VRVIHAWGMTEtsplgtvARPPSEHSN 331
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1801 CPPHEKLE-RIPIGKPVHHVRLYLLNQNQRMLPV--GCIGELYIAGAGVARGYLNRPALTEErFLEDPFYpgermyKTGD 1877
Cdd:cd12119 332 LSEDEQLAlRAKQGRPVPGVELRIVDDDGRELPWdgKAVGELQVRGPWVTKSYYKNDEESEA-LTEDGWL------RTGD 404
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1878 VARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GE-PELCAYV---EGLQRNEVRAQL 1951
Cdd:cd12119 405 VATIDEDGYLTITDRSKDVIKSGGEWISSVELENAIMAHPAVAEAAVIGVPHPkwGErPLAVVVLkegATVTAEELLEFL 484
|
490 500 510
....*....|....*....|....*....|..
gi 1678550997 1952 ERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd12119 485 ADKVAKWWLPDDVVFVDEIPKTSTGKIDKKAL 516
|
|
| menE |
TIGR01923 |
O-succinylbenzoate-CoA ligase; This model represents an enzyme, O-succinylbenzoate-CoA ligase, ... |
1521-1983 |
7.22e-42 |
|
O-succinylbenzoate-CoA ligase; This model represents an enzyme, O-succinylbenzoate-CoA ligase, which is involved in the fourth step of the menaquinone biosynthesis pathway. O-succinylbenzoate-CoA ligase, together with menB - naphtoate synthase, take 2-succinylbenzoate and convert it into 1,4-di-hydroxy-2- naphtoate. [Biosynthesis of cofactors, prosthetic groups, and carriers, Menaquinone and ubiquinone]
Pssm-ID: 162605 [Multi-domain] Cd Length: 436 Bit Score: 161.46 E-value: 7.22e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1521 TYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNiLLLQSA 1600
Cdd:TIGR01923 1 TWQDLDCEAAHLAKALKAQGIRSGSRVALVGQNSIEMVLLLHACLLLGAEIAMLNTRLTENERTNQLEDLDVQ-LLLTDS 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1601 GLHVPEFTgeIVYLNQTnSGLAHRLSNPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHR----SAVNFLNSL----QSRYQ 1672
Cdd:TIGR01923 80 LLEEKDFQ--ADSLDRI-EAAGRYETSLSASFNMDQIATLMFTSGTTGKPKAVPHTFRnhyaSAVGSKENLgfteDDNWL 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1673 LkhSDMIMHKTSYSFdasiweLFWWPYAGASVYLlPQGGEKepevIAKAIEEQKITAMHFVPSMLHAFLEhikyrsvpiK 1752
Cdd:TIGR01923 157 L--SLPLYHISGLSI------LFRWLIEGATLRI-VDKFNQ----LLEMIANERVTHISLVPTQLNRLLD---------E 214
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1753 TN---RLKRVFSGGEQLGTHLVSRFYELlpNVSITNSYGPTEA--TVEAAffdcPPHEKLERIPIGKPVHHVRLYLLNQN 1827
Cdd:TIGR01923 215 GGhneNLRKILLGGSAIPAPLIEEAQQY--GLPIYLSYGMTETcsQVTTA----TPEMLHARPDVGRPLAGREIKIKVDN 288
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1828 QRMlpvgcIGELYIAGAGVARGYLNRPALTEERFLEDPFypgermyKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPG 1907
Cdd:TIGR01923 289 KEG-----HGEIMVKGANLMKGYLYQGELTPAFEQQGWF-------NTGDIGELDGEGFLYVLGRRDDLIISGGENIYPE 356
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1908 EIEAALRSIEGVREAAVTVRTDS--GE-PElcAYVEGlqRNEV-RAQLERLLPG----YMVPAYMIEMEQWPVTPSGKLD 1979
Cdd:TIGR01923 357 EIETVLYQHPGIQEAVVVPKPDAewGQvPV--AYIVS--ESDIsQAKLIAYLTEklakYKVPIAFEKLDELPYNASGKIL 432
|
....
gi 1678550997 1980 RNAL 1983
Cdd:TIGR01923 433 RNQL 436
|
|
| 4CL |
cd05904 |
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the ... |
2538-3016 |
1.02e-41 |
|
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the phenylpropanoid metabolic pathway for monolignol and flavonoid biosynthesis. It catalyzes the synthesis of hydroxycinnamate-CoA thioesters in a two-step reaction, involving the formation of hydroxycinnamate-AMP anhydride and the nucleophilic substitution of AMP by CoA. The phenylpropanoid pathway is one of the most important secondary metabolism pathways in plants and hydroxycinnamate-CoA thioesters are the precursors of lignin and other important phenylpropanoids.
Pssm-ID: 341230 [Multi-domain] Cd Length: 505 Bit Score: 162.79 E-value: 1.02e-41
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2538 LFEQQAARTPkasALV--SGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDP 2615
Cdd:cd05904 13 LFASAHPSRP---ALIdaATGRALTYAELERRVRRLAAGLAKRGGRKGDVVLLLSPNSIEFPVAFLAVLSLGAVVTTANP 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2616 EY-PKERKRYIlSDSGTKLLMTINE-----ADLGVL------ADFEGEILTIESVEEDDKSPLPQMSSAHHLAYIIYTSG 2683
Cdd:cd05904 90 LStPAEIAKQV-KDSGAKLAFTTAElaeklASLALPvvlldsAEFDSLSFSDLLFEADEAEPPVVVIKQDDVAALLYSSG 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2684 TTGRPKGVMVEHKG-IANTLQ--WRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIkhqL 2760
Cdd:cd05904 169 TTGRSKGVMLTHRNlIAMVAQfvAGEGSNSDSEDVFLCVLPMFHIYGLSSFALGLLRLGATVVVMPRFDLEELLAA---I 245
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2761 SRQRITHMIIVPVLYRALL--DVVQPEDVKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTENS--VATTVMRHM 2836
Cdd:cd05904 246 ERYKVTHLPVVPPIVLALVksPIVDKYDLSSLRQIMSGAAPLGKELIEAFRAKFPNVDLGQGYGMTESTgvVAMCFAPEK 325
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2837 EKQAYVSIGQPIDGTQVLILNSNH-QLQPIGVAGELCIAGTGLARGYVNLPELTERAFTqnpfkpEARMYRTGDAARWMA 2915
Cdd:cd05904 326 DRAKYGSVGRLVPNVEAKIVDPETgESLPPNQTGELWIRGPSIMKGYLNNPEATAATID------KEGWLHTGDLCYIDE 399
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2916 DGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVV-AHVTASGQTELsAYVVTKPGLSTNAvrSELQNklpvf 2994
Cdd:cd05904 400 DGYLFIVDRLKELIKYKGFQVAPAELEALLLSHPEILDAAVIpYPDEEAGEVPM-AFVVRKPGSSLTE--DEIMD----- 471
|
490 500 510
....*....|....*....|....*....|....*
gi 1678550997 2995 mhpaFIEK-------------LDSLPLSPNGKLDR 3016
Cdd:cd05904 472 ----FVAKqvapykkvrkvafVDAIPKSPSGKILR 502
|
|
| E-C_NRPS |
cd19544 |
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); ... |
10-341 |
1.16e-41 |
|
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); Dual function Epimerization/Condensation (E/C) domains have both an epimerization and a DCL condensation activity. Dual E/C domains first epimerize the substrate amino acid to produce a D-configuration, then catalyze the condensation between the D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. They are D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. These Dual E/C domains contain an extended His-motif (HHx(N)GD) near the N-terminus of the domain in addition to the standard Condensation (C) domain active site motif (HHxxxD). C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains, these include the DCL-type, LCL-type, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C domains, and the X-domain.
Pssm-ID: 380466 [Multi-domain] Cd Length: 413 Bit Score: 160.30 E-value: 1.16e-41
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 10 IYPLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNVSSPQQVVLRERNVIVl 89
Cdd:cd19544 1 IYPLAPLQEGILFHHLLAEEGDPYLLRSLLAFDSRARLDAFLAALQQVIDRHDILRTAILWEGLSEPVQVVWRQAELPV- 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 90 eediTHLNEAEQSQFIEQWKEKDRDRGFHLqkDV----LMRIALIQTGESQ-YSCIWTFHHIMMDGWCLSIVLKEFlhiy 164
Cdd:cd19544 80 ----EELTLDPGDDALAQLRARFDPRRYRL--DLrqapLLRAHVAEDPANGrWLLLLLFHHLISDHTSLELLLEEI---- 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 165 ASYVNASPITLEPVQPYGKYI-KWLMEQDKEQAVSYWDHYLSGHEQQT----VLPKQkkTKGKSRQEHvTFSFSKEESSR 239
Cdd:cd19544 150 QAILAGRAAALPPPVPYRNFVaQARLGASQAEHEAFFREMLGDVDEPTapfgLLDVQ--GDGSDITEA-RLALDAELAQR 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 240 LSELAAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRPAEIEGIEHMVGLFINTMPVRVQGAKTPFLQLIKDMQk 319
Cdd:cd19544 227 LRAQARRLGVSPASLFHLAWALVLARCSGRDDVVFGTVLSGRMQGGAGADRALGMFINTLPLRVRLGGRSVREAVRQTH- 305
|
330 340
....*....|....*....|...
gi 1678550997 320 DRLAA-EAYSYHPLYEIQSRSAV 341
Cdd:cd19544 306 ARLAElLRHEHASLALAQRCSGV 328
|
|
| MACS_like_2 |
cd05973 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
2559-3021 |
2.50e-41 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341277 [Multi-domain] Cd Length: 437 Bit Score: 159.99 E-value: 2.50e-41
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2559 LTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMTiN 2638
Cdd:cd05973 1 LTFGELRALSARFANALQELGVGPGDVVAGLLPRTPELVVTILGIWRLGAVYQPLFTAFGPKAIEHRLRTSGARLVVT-D 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2639 EADLGVLadfegeiltiesveedDKSPLPQMSsahhlayiiyTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTIL 2718
Cdd:cd05973 80 AANRHKL----------------DSDPFVMMF----------TSGTTGLPKGVPVPLRALAAFGAYLRDAVDLRPEDSFW 133
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2719 QLFSFSFD-GFITSMFTPLLSGAKAVLLH----EEEAKDIlaikhqLSRQRITHMIIVPVLYRALL--DVVQPEDVK-TL 2790
Cdd:cd05973 134 NAADPGWAyGLYYAITGPLALGHPTILLEggfsVESTWRV------IERLGVTNLAGSPTAYRLLMaaGAEVPARPKgRL 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2791 RVVTLAGEAADRELIaRSLAICPHTELANEYGPTENSVATTVMRHMEKQAYV-SIGQPIDGTQVLILNSNHQLQPIGVAG 2869
Cdd:cd05973 208 RRVSSAGEPLTPEVI-RWFDAALGVPIHDHYGQTELGMVLANHHALEHPVHAgSAGRAMPGWRVAVLDDDGDELGPGEPG 286
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2870 ELCIagtglarGYVNLPELTERAFTQNPFK-PEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCI 2948
Cdd:cd05973 287 RLAI-------DIANSPLMWFRGYQLPDTPaIDGGYYLTGDTVEFDPDGSFSFIGRADDVITMSGYRIGPFDVESALIEH 359
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 2949 KGVKDAAVVAhVTASGQTE-LSAYVVTKPGL-STNAVRSELQ----NKLPVFMHPAFIEKLDSLPLSPNGKLDRGALPK 3021
Cdd:cd05973 360 PAVAEAAVIG-VPDPERTEvVKAFVVLRGGHeGTPALADELQlhvkKRLSAHAYPRTIHFVDELPKTPSGKIQRFLLRR 437
|
|
| FACL_fum10p_like |
cd05926 |
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL ... |
477-954 |
3.61e-41 |
|
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Fum10p is a fatty acid CoA ligase involved in the synthesis of fumonisin, a polyketide mycotoxin, in Gibberella moniliformis.
Pssm-ID: 341249 [Multi-domain] Cd Length: 493 Bit Score: 160.94 E-value: 3.61e-41
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 477 PDAHAVI--DQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRY 554
Cdd:cd05926 1 PDAPALVvpGSTPALTYADLAELVDDLARQLAALGIKKGDRVAIALPNGLEFVVAFLAAARAGAVVAPLNPAYKKAEFEF 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 555 ILHDCGCSHVVSQ----------------AHLPSSLEDNYIITHPEDIE---SKVDGSNIKSVNNA--DDLLYMIYTSGT 613
Cdd:cd05926 81 YLADLGSKLVLTPkgelgpasraasklglAILELALDVGVLIRAPSAESlsnLLADKKNAKSEGVPlpDDLALILHTSGT 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 614 TGKPKGVQFEHRNMANLLK-----FEYThsgidfEADVLQFATPSFDVCYQ--EIFSALLKGGTLhIVPEaikRDVPQLF 686
Cdd:cd05926 161 TGRPKGVPLTHRNLAASATnitntYKLT------PDDRTLVVMPLFHVHGLvaSLLSTLAAGGSV-VLPP---RFSASTF 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 687 --AFINKHQTNIVFLPTafIKMIFSERELANsfPDGVKHL---IAAGEQLMISDLFQDVLRKRGIHLHNHYGPSET-HVV 760
Cdd:cd05926 231 wpDVRDYNATWYTAVPT--IHQILLNRPEPN--PESPPPKlrfIRSCSASLPPAVLEALEATFGAPVLEAYGMTEAaHQM 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 761 STytihpgDPIPELPP----IGKPIGcTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvi 836
Cdd:cd05926 307 TS------NPLPPGPRkpgsVGKPVG-VEVRILDEDGEILPPGVVGEICLRGPNVTRGYLNNPEANAEAAFKDGW----- 374
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 837 mYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAIL-IWQDQNGEHELCAYYCSVQKLNTI- 914
Cdd:cd05926 375 -FRTGDLGYLDADGYLFLTGRIKELINRGGEKISPLEVDGVLLSHPAVLEAVAFgVPDEKYGEEVAAAVVLREGASVTEe 453
|
490 500 510 520
....*....|....*....|....*....|....*....|
gi 1678550997 915 DLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPE 954
Cdd:cd05926 454 ELRAFCRKHLAAFKVPKKVYFVDELPKTATGKIQRRKVAE 493
|
|
| FACL_fum10p_like |
cd05926 |
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL ... |
1508-1983 |
4.20e-41 |
|
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Fum10p is a fatty acid CoA ligase involved in the synthesis of fumonisin, a polyketide mycotoxin, in Gibberella moniliformis.
Pssm-ID: 341249 [Multi-domain] Cd Length: 493 Bit Score: 160.94 E-value: 4.20e-41
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1508 PDQAAVIFEDGVM--TYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISF 1585
Cdd:cd05926 1 PDAPALVVPGSTPalTYADLAELVDDLARQLAALGIKKGDRVAIALPNGLEFVVAFLAAARAGAVVAPLNPAYKKAEFEF 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1586 LLEDSGTNILLLQSAGLH-----VPEFTGEIVYL-----NQTNSGLAHRLSNPNVD---------VLPQSLAYVIYTSGS 1646
Cdd:cd05926 81 YLADLGSKLVLTPKGELGpasraASKLGLAILELaldvgVLIRAPSAESLSNLLADkknaksegvPLPDDLALILHTSGT 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1647 TGMPKGVEIEHRsavNFLNS---LQSRYQLKHSD---MIM-----HKTSYSFDASIwelfwwpYAGASVyLLPqggekeP 1715
Cdd:cd05926 161 TGRPKGVPLTHR---NLAASatnITNTYKLTPDDrtlVVMplfhvHGLVASLLSTL-------AAGGSV-VLP------P 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1716 EVIAKA----IEEQKITAMHFVPSMLHAFL--EHIKYRSVPIKtnrLKRVFSGGEQLGTHLVSRFYELLpNVSITNSYGP 1789
Cdd:cd05926 224 RFSASTfwpdVRDYNATWYTAVPTIHQILLnrPEPNPESPPPK---LRFIRSCSASLPPAVLEALEATF-GAPVLEAYGM 299
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1790 TEATVEAAffdCPPHEKLERIP--IGKPVHhVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFy 1867
Cdd:cd05926 300 TEAAHQMT---SNPLPPGPRKPgsVGKPVG-VEVRILDEDGEILPPGVVGEICLRGPNVTRGYLNNPEANAEAAFKDGW- 374
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1868 pgermYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GEpELCAYV---EG- 1941
Cdd:cd05926 375 -----FRTGDLGYLDADGYLFLTGRIKELINRGGEKISPLEVDGVLLSHPAVLEAVAFGVPDEkyGE-EVAAAVvlrEGa 448
|
490 500 510 520
....*....|....*....|....*....|....*....|...
gi 1678550997 1942 -LQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd05926 449 sVTEEELRAFCRKHLAAFKVPKKVYFVDELPKTATGKIQRRKV 491
|
|
| MACS_like_3 |
cd05971 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
1521-1983 |
6.33e-41 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341275 [Multi-domain] Cd Length: 439 Bit Score: 158.75 E-value: 6.33e-41
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1521 TYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILllqsa 1600
Cdd:cd05971 8 TFKELKTASNRFANVLKEIGLEKGDRVGVFLSQGPECAIAHIAILRSGAIAVPLFALFGPEALEYRLSNSGASAL----- 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1601 glhvpeftgeivylnqtnsglahrlsnpnVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIM 1680
Cdd:cd05971 83 -----------------------------VTDGSDDPALIIYTSGTTGPPKGALHAHRVLLGHLPGVQFPFNLFPRDGDL 133
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1681 HKTSYSFdASIWELF-----WWpYAGasVYLLPQGGEK-EPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIktN 1754
Cdd:cd05971 134 YWTPADW-AWIGGLLdvllpSL-YFG--VPVLAHRMTKfDPKAALDLMSRYGVTTAFLPPTALKMMRQQGEQLKHAQ--V 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1755 RLKRVFSGGEQLGTHLVSRFYELLpNVSITNSYGPTEATV----EAAFFDCPPHEkleripIGKPVHHVRLYLLNQNQRM 1830
Cdd:cd05971 208 KLRAIATGGESLGEELLGWAREQF-GVEVNEFYGQTECNLvignCSALFPIKPGS------MGKPIPGHRVAIVDDNGTP 280
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1831 LPVGCIGELYI--AGAGVARGYLNRPALTEERFLEDPFypgermyKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGE 1908
Cdd:cd05971 281 LPPGEVGEIAVelPDPVAFLGYWNNPSATEKKMAGDWL-------LTGDLGRKDSDGYFWYVGRDDDVITSSGYRIGPAE 353
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1909 IEAALRSIEGVREAAVTVRTD--SGEpELCAYV---------EGLQRnEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGK 1977
Cdd:cd05971 354 IEECLLKHPAVLMAAVVGIPDpiRGE-IVKAFVvlnpgetpsDALAR-EIQELVKTRLAAHEYPREIEFVNELPRTATGK 431
|
....*.
gi 1678550997 1978 LDRNAL 1983
Cdd:cd05971 432 IRRREL 437
|
|
| PRK03640 |
PRK03640 |
o-succinylbenzoate--CoA ligase; |
1500-1983 |
7.35e-41 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 235146 [Multi-domain] Cd Length: 483 Bit Score: 159.74 E-value: 7.35e-41
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYP 1579
Cdd:PRK03640 8 LKQRAFLTPDRTAIEFEEKKVTFMELHEAVVSVAGKLAALGVKKGDRVALLMKNGMEMILVIHALQQLGAVAVLLNTRLS 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1580 EERISFLLEDSGTnILLLQSAGLHVPEFTGEIVYLNQTNSGlahrlsnPNVDVLPQS------LAYVIYTSGSTGMPKGV 1653
Cdd:PRK03640 88 REELLWQLDDAEV-KCLITDDDFEAKLIPGISVKFAELMNG-------PKEEAEIQEefdldeVATIMYTSGTTGKPKGV 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1654 EIEHR----SAV-NFLNslqsrYQLKHSDM------IMHKTSYS--FDASIWelfwwpyaGASVYLLPQGGEKEpevIAK 1720
Cdd:PRK03640 160 IQTYGnhwwSAVgSALN-----LGLTEDDCwlaavpIFHISGLSilMRSVIY--------GMRVVLVEKFDAEK---INK 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1721 AIEEQKITAMHFVPSMLHAFLEHIKYRSVPiktNRLKRVFSGG--------EQLGTHlvsrfyellpNVSITNSYGPTEA 1792
Cdd:PRK03640 224 LLQTGGVTIISVVSTMLQRLLERLGEGTYP---SSFRCMLLGGgpapkpllEQCKEK----------GIPVYQSYGMTET 290
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1793 TVEAAFFdcPPHEKLERI-PIGKPVHHVRLYLLNQNQRMLPvGCIGELYIAGAGVARGYLNRPALTEERFLEDPFypger 1871
Cdd:PRK03640 291 ASQIVTL--SPEDALTKLgSAGKPLFPCELKIEKDGVVVPP-FEEGEIVVKGPNVTKGYLNREDATRETFQDGWF----- 362
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1872 myKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTvrtdsGEPEL------CAYV---EGL 1942
Cdd:PRK03640 363 --KTGDIGYLDEEGFLYVLDRRSDLIISGGENIYPAEIEEVLLSHPGVAEAGVV-----GVPDDkwgqvpVAFVvksGEV 435
|
490 500 510 520
....*....|....*....|....*....|....*....|.
gi 1678550997 1943 QRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK03640 436 TEEELRHFCEEKLAKYKVPKRFYFVEELPRNASGKLLRHEL 476
|
|
| LC_FACS_like |
cd05935 |
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain ... |
2559-3019 |
1.34e-40 |
|
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain fatty acyl-CoA synthetases, which catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters.
Pssm-ID: 341258 [Multi-domain] Cd Length: 430 Bit Score: 157.64 E-value: 1.34e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2559 LTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMTIN 2638
Cdd:cd05935 2 LTYLELLEVVKKLASFLSNKGVRKGDRVGICLQNSPQYVIAYFAIWRANAVVVPINPMLKERELEYILNDSGAKVAVVGS 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2639 EADlgvladfegeiltiesveeddksplpqmssahHLAYIIYTSGTTGRPKGVMVEHKGI-ANTLQWRRnAYAFNETDTI 2717
Cdd:cd05935 82 ELD--------------------------------DLALIPYTSGTTGLPKGCMHTHFSAaANALQSAV-WTGLTPSDVI 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2718 LQ-LFSFSFDGFITSMFTPLLSGAKAVLL---HEEEAKDIlaikhqLSRQRITHMIIVPVLYRALLDVV--QPEDVKTLR 2791
Cdd:cd05935 129 LAcLPLFHVTGFVGSLNTAVYVGGTYVLMarwDRETALEL------IEKYKVTFWTNIPTMLVDLLATPefKTRDLSSLK 202
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2792 VVTlAGEAADRELIARSLAICPHTELANEYGPTEnSVATTVMRHMEKQAYVSIGQPIDGTQVLILN-SNHQLQPIGVAGE 2870
Cdd:cd05935 203 VLT-GGGAPMPPAVAEKLLKLTGLRFVEGYGLTE-TMSQTHTNPPLRPKLQCLGIP*FGVDARVIDiETGRELPPNEVGE 280
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2871 LCIAGTGLARGYVNLPELTERAFTQNPFKpeaRMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKG 2950
Cdd:cd05935 281 IVVRGPQIFKGYWNRPEETEESFIEIKGR---RFFRTGDLGYMDEEGYFFFVDRVKRMINVSGFKVWPAEVEAKLYKHPA 357
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 2951 VKDAAVVAHVTASGQTELSAYVVTKPGLSTNAVRSEL----QNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:cd05935 358 I*EVCVISVPDERVGEEVKAFIVLRPEYRGKVTEEDIiewaREQMAAYKYPREVEFVDELPRSASGKILWRLL 430
|
|
| FAA1 |
COG1022 |
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; |
1486-1924 |
3.08e-40 |
|
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism];
Pssm-ID: 440645 [Multi-domain] Cd Length: 603 Bit Score: 160.27 E-value: 3.08e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1486 EETGYSMNQTLHYALEQQAEKTPDQAAVIF-EDGV---MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGI 1561
Cdd:COG1022 3 EFSDVPPADTLPDLLRRRAARFPDRVALREkEDGIwqsLTWAEFAERVRALAAGLLALGVKPGDRVAILSDNRPEWVIAD 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1562 YGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLLQSAGL---------HVPEFTgEIVYLNQTNSGLAHRL------- 1625
Cdd:COG1022 83 LAILAAGAVTVPIYPTSSAEEVAYILNDSGAKVLFVEDQEQldkllevrdELPSLR-HIVVLDPRGLRDDPRLlsldell 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1626 ------SNPN------VDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIMhktSY-----SFd 1688
Cdd:COG1022 162 algrevADPAelearrAAVKPDDLATIIYTSGTTGRPKGVMLTHRNLLSNARALLERLPLGPGDRTL---SFlplahVF- 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1689 ASIWELFWWpYAGASVYLLPqggekEPEVIAKAIEEQKITAMHFVP---------------------------------- 1734
Cdd:COG1022 238 ERTVSYYAL-AAGATVAFAE-----SPDTLAEDLREVKPTFMLAVPrvwekvyagiqakaeeagglkrklfrwalavgrr 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1735 ---------------SMLHAFLEHIKYRsvPIKT---NRLKRVFSGGEQLGTHLVsRFYELLpNVSITNSYGPTEATVeA 1796
Cdd:COG1022 312 yararlagkspslllRLKHALADKLVFS--KLREalgGRLRFAVSGGAALGPELA-RFFRAL-GIPVLEGYGLTETSP-V 386
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1797 AFFDCPPHEKLERipIGKPVHHVRLYLLNQnqrmlpvgciGELYIAGAGVARGYLNRPALTEERFLEDPFypgermYKTG 1876
Cdd:COG1022 387 ITVNRPGDNRIGT--VGPPLPGVEVKIAED----------GEILVRGPNVMKGYYKNPEATAEAFDADGW------LHTG 448
|
490 500 510 520
....*....|....*....|....*....|....*....|....*....
gi 1678550997 1877 DVARWLPDGNVEFLGRTDDQVKIR-GYRIEPGEIEAALRSIEGVREAAV 1924
Cdd:COG1022 449 DIGELDEDGFLRITGRKKDLIVTSgGKNVAPQPIENALKASPLIEQAVV 497
|
|
| PRK07788 |
PRK07788 |
acyl-CoA synthetase; Validated |
2529-3021 |
1.57e-39 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236097 [Multi-domain] Cd Length: 549 Bit Score: 157.40 E-value: 1.57e-39
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2529 QYGvqTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMM--HRSFsmIASILGVWKA 2606
Cdd:PRK07788 47 RYG--PFAGLVAHAARRAPDRAALIDERGTLTYAELDEQSNALARGLLALGVRAGDGVAVLArnHRGF--VLALYAAGKV 122
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2607 GGCYVPIDPEYPKERKRYILSDSGTKLLMtINEADLGVLADFE---GEILTI------------------ESVEEDDKSP 2665
Cdd:PRK07788 123 GARIILLNTGFSGPQLAEVAAREGVKALV-YDDEFTDLLSALPpdlGRLRAWggnpdddepsgstdetldDLIAGSSTAP 201
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2666 LPQMSSAHHLayIIYTSGTTGRPKGVMVEH-------KGIANTLQWRRNayafnetDTILQ---LF-SFSFDGFITSMFT 2734
Cdd:PRK07788 202 LPKPPKPGGI--VILTSGTTGTPKGAPRPEpsplaplAGLLSRVPFRAG-------ETTLLpapMFhATGWAHLTLAMAL 272
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2735 pllsGAKAVLLHEEEAKDILAikhQLSRQRITHMIIVPVLYRALLD----VVQPEDVKTLRVVTLAGEAADRELIARSL- 2809
Cdd:PRK07788 273 ----GSTVVLRRRFDPEATLE---DIAKHKATALVVVPVMLSRILDlgpeVLAKYDTSSLKIIFVSGSALSPELATRALe 345
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2810 AICPhtELANEYGPTENSVATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNlpelt 2889
Cdd:PRK07788 346 AFGP--VLYNLYGSTEVAFATIATPEDLAEAPGTVGRPPKGVTVKILDENGNEVPRGVVGRIFVGNGFPFEGYTD----- 418
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2890 eraftqNPFKPEAR-MYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAhV--TASGQt 2966
Cdd:PRK07788 419 ------GRDKQIIDgLLSSGDVGYFDEDGLLFVDGRDDDMIVSGGENVFPAEVEDLLAGHPDVVEAAVIG-VddEEFGQ- 490
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 2967 ELSAYVVTKPG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGALPK 3021
Cdd:PRK07788 491 RLRAFVVKAPGaaLDEDAIKDYVRDNLARYKVPRDVVFLDELPRNPTGKVLKRELRE 547
|
|
| PRK07798 |
PRK07798 |
acyl-CoA synthetase; Validated |
2534-3015 |
3.43e-39 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236100 [Multi-domain] Cd Length: 533 Bit Score: 155.81 E-value: 3.43e-39
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2534 TISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPI 2613
Cdd:PRK07798 4 NIADLFEAVADAVPDRVALVCGDRRLTYAELEERANRLAHYLIAQGLGPGDHVGIYARNRIEYVEAMLGAFKARAVPVNV 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2614 DPEYPKERKRYILSDSGTKLLmtINEADLG-----VLADFEGEILTIEsVEEDDKSPLP-----------QMSSAHHLA- 2676
Cdd:PRK07798 84 NYRYVEDELRYLLDDSDAVAL--VYEREFAprvaeVLPRLPKLRTLVV-VEDGSGNDLLpgavdyedalaAGSPERDFGe 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2677 ------YIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSM---------------FTP 2735
Cdd:PRK07798 161 rspddlYLLYTGGTTGMPKGVMWRQEDIFRVLLGGRDFATGEPIEDEEELAKRAAAGPGMRRfpapplmhgagqwaaFAA 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2736 LLSGAKAVLLHEEE--AKDILAIKHqlsRQRITHMIIV-PVLYRALLDVVQPE---DVKTLRVVTLAGEAADRELIARSL 2809
Cdd:PRK07798 241 LFSGQTVVLLPDVRfdADEVWRTIE---REKVNVITIVgDAMARPLLDALEARgpyDLSSLFAIASGGALFSPSVKEALL 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2810 AICPHTELANEYGPTEnsvATTVMRHMEKQAYVSIGQP---IDGTQVLILNSNHQLQP-IGVAGElcIAGTG-LARGYVN 2884
Cdd:PRK07798 318 ELLPNVVLTDSIGSSE---TGFGGSGTVAKGAVHTGGPrftIGPRTVVLDEDGNPVEPgSGEIGW--IARRGhIPLGYYK 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2885 LPELTERAFtqnpfkPEARMYR---TGDAARWMADGTLEYLGRidDQVKIR--GYRVETKEIESVIRCIKGVKDAAVVAh 2959
Cdd:PRK07798 393 DPEKTAETF------PTIDGVRyaiPGDRARVEADGTITLLGR--GSVCINtgGEKVFPEEVEEALKAHPDVADALVVG- 463
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 2960 vTAS---GQtELSAYVVTKPG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLD 3015
Cdd:PRK07798 464 -VPDerwGQ-EVVAVVQLREGarPDLAELRAHCRSSLAGYKVPRAIWFVDEVQRSPAGKAD 522
|
|
| LC_FACS_like |
cd05935 |
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain ... |
1520-1983 |
4.10e-39 |
|
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain fatty acyl-CoA synthetases, which catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters.
Pssm-ID: 341258 [Multi-domain] Cd Length: 430 Bit Score: 153.40 E-value: 4.10e-39
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1520 MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLLQS 1599
Cdd:cd05935 2 LTYLELLEVVKKLASFLSNKGVRKGDRVGICLQNSPQYVIAYFAIWRANAVVVPINPMLKERELEYILNDSGAKVAVVGS 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1600 AglhvpeftgeivylnqtnsglahrlsnpnvdvlPQSLAYVIYTSGSTGMPKGVEIEHRSAVnfLNSLQSR--YQLKHSD 1677
Cdd:cd05935 82 E---------------------------------LDDLALIPYTSGTTGLPKGCMHTHFSAA--ANALQSAvwTGLTPSD 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1678 MIM------HKTSY--SFDASIwelfwwpYAGASVYLLpqgGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSV 1749
Cdd:cd05935 127 VILaclplfHVTGFvgSLNTAV-------YVGGTYVLM---ARWDRETALELIEKYKVTFWTNIPTMLVDLLATPEFKTR 196
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1750 PIKTnrLKRVFSGGEQLGTHLVSRFYELLpNVSITNSYGPTEAtveaaffdCP-----PHEKLERIPIGKPVHHVRLYLL 1824
Cdd:cd05935 197 DLSS--LKVLTGGGAPMPPAVAEKLLKLT-GLRFVEGYGLTET--------MSqthtnPPLRPKLQCLGIP*FGVDARVI 265
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1825 N-QNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPfypGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYR 1903
Cdd:cd05935 266 DiETGRELPPNEVGEIVVRGPQIFKGYWNRPEETEESFIEIK---GRRFFRTGDLGYMDEEGYFFFVDRVKRMINVSGFK 342
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1904 IEPGEIEAALRSIEGVREAAVTVRTD--SGEpELCAYVegLQRNEVRAQL---------ERLLPGYMVPAYMIEMEQWPV 1972
Cdd:cd05935 343 VWPAEVEAKLYKHPAI*EVCVISVPDerVGE-EVKAFI--VLRPEYRGKVteediiewaREQMAAYKYPREVEFVDELPR 419
|
490
....*....|.
gi 1678550997 1973 TPSGKLDRNAL 1983
Cdd:cd05935 420 SASGKILWRLL 430
|
|
| MACS_like |
cd05972 |
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of ... |
1521-1983 |
5.20e-39 |
|
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes.
Pssm-ID: 341276 [Multi-domain] Cd Length: 428 Bit Score: 152.88 E-value: 5.20e-39
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1521 TYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLLQSa 1600
Cdd:cd05972 2 SFRELKRESAKAANVLAKLGLRKGDRVAVLLPRVPELWAVILAVIKLGAVYVPLTTLLGPKDIEYRLEAAGAKAIVTDA- 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1601 glhvpeftgeivylnqtnsglahrlsnpnvdvlpQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIm 1680
Cdd:cd05972 81 ----------------------------------EDPALIYFTSGTTGLPKGVLHTHSYPLGHIPTAAYWLGLRPDDIH- 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1681 hktsYSFDASIWELFWWpYAGASVYLLP------QGGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPiktN 1754
Cdd:cd05972 126 ----WNIADPGWAKGAW-SSFFGPWLLGatvfvyEGPRFDAERILELLERYGVTSFCGPPTAYRMLIKQDLSSYKF---S 197
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1755 RLKRVFSGGEQLGTHLVSRFYELLpNVSITNSYGPTEATVEAAFFDC-PPHekleriP--IGKPVHHVRLYLLNQNQRML 1831
Cdd:cd05972 198 HLRLVVSAGEPLNPEVIEWWRAAT-GLPIRDGYGQTETGLTVGNFPDmPVK------PgsMGRPTPGYDVAIIDDDGREL 270
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1832 PVGCIGELYI--AGAGVARGYLNRPALTEERFLEDpfypgerMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEI 1909
Cdd:cd05972 271 PPGEEGDIAIklPPPGLFLGYVGDPEKTEASIRGD-------YYLTGDRAYRDEDGYFWFVGRADDIIKSSGYRIGPFEV 343
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1910 EAALRSIEGVREAAVTVRTD--------------SGEPELCAYVEGLQrNEVRAQLERllpgYMVPaYMIEM-EQWPVTP 1974
Cdd:cd05972 344 ESALLEHPAVAEAAVVGSPDpvrgevvkafvvltSGYEPSEELAEELQ-GHVKKVLAP----YKYP-REIEFvEELPKTI 417
|
....*....
gi 1678550997 1975 SGKLDRNAL 1983
Cdd:cd05972 418 SGKIRRVEL 426
|
|
| CBAL |
cd05923 |
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) ... |
1494-1983 |
7.25e-39 |
|
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) to 4-chlorobenzoyl-coenzyme A (4-CB-CoA) by the two-step adenylation and thioester-forming reactions. 4-Chlorobenzoate (4-CBA) is an environmental pollutant derived from microbial breakdown of aromatic pollutants, such as polychlorinated biphenyls (PCBs), DDT, and certain herbicides. The 4-CBA degrading pathway converts 4-CBA to the metabolite 4-hydroxybezoate (4-HBA), allowing some soil-dwelling microbes to utilize 4-CBA as an alternate carbon source. This pathway consists of three chemical steps catalyzed by 4-CBA-CoA ligase, 4-CBA-CoA dehalogenase, and 4HBA-CoA thioesterase in sequential reactions.
Pssm-ID: 341247 [Multi-domain] Cd Length: 493 Bit Score: 154.20 E-value: 7.25e-39
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1494 QTLHYALEQQAEKTPDQAAVIFEDG--VMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAY 1571
Cdd:cd05923 1 QTVFEMLRRAASRAPDACAIADPARglRLTYSELRARIEAVAARLHARGLRPGQRVAVVLPNSVEAVIALLALHRLGAVP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1572 LPIDPDYPEERISFLLEDSGTNILLLQSAGLHVPEF---TGEIVYLNQ-TNSGLAHRLSNPNVD--VLPQSLAYVIYTSG 1645
Cdd:cd05923 81 ALINPRLKAAELAELIERGEMTAAVIAVDAQVMDAIfqsGVRVLALSDlVGLGEPESAGPLIEDppREPEQPAFVFYTSG 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1646 STGMPKGVEIEHRSAVNFLNSLQSRYQLKHSD-------MIMHKTSYSFdasiwELFWWPYAGASVYLLPQggEKEPEVI 1718
Cdd:cd05923 161 TTGLPKGAVIPQRAAESRVLFMSTQAGLRHGRhnvvlglMPLYHVIGFF-----AVLVAALALDGTYVVVE--EFDPADA 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1719 AKAIEEQKITAMHFVPSMLHAFLEHIKYrsVPIKTNRLKRVFSGGEQLGTHLVSRFYELLPNvSITNSYGPTEATveAAF 1798
Cdd:cd05923 234 LKLIEQERVTSLFATPTHLDALAAAAEF--AGLKLSSLRHVTFAGATMPDAVLERVNQHLPG-EKVNIYGTTEAM--NSL 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1799 FDCPPHEKLEripiGKP--VHHVRLY-LLNQNQRMLPVGCIGELYIAGAGVA--RGYLNRPALTEERFLEdpfypgeRMY 1873
Cdd:cd05923 309 YMRDARTGTE----MRPgfFSEVRIVrIGGSPDEALANGEEGELIVAAAADAafTGYLNQPEATAKKLQD-------GWY 377
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1874 KTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GEPELCAYVeglqRNEVRAQL 1951
Cdd:cd05923 378 RTGDVGYVDPSGDVRILGRVDDMIISGGENIHPSEIERVLSRHPGVTEVVVIGVADErwGQSVTACVV----PREGTLSA 453
|
490 500 510 520
....*....|....*....|....*....|....*....|
gi 1678550997 1952 ERL--------LPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd05923 454 DELdqfcraseLADFKRPRRYFFLDELPKNAMNKVLRRQL 493
|
|
| PRK08316 |
PRK08316 |
acyl-CoA synthetase; Validated |
2533-3014 |
8.48e-39 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181381 [Multi-domain] Cd Length: 523 Bit Score: 154.71 E-value: 8.48e-39
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2533 QTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVP 2612
Cdd:PRK08316 11 QTIGDILRRSARRYPDKTALVFGDRSWTYAELDAAVNRVAAALLDLGLKKGDRVAALGHNSDAYALLWLACARAGAVHVP 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2613 IDPEYPKERKRYILSDSGTKLLMTinEADLGVLADFEGEILTIESVEEDDKSPLPQMSSAHH------------------ 2674
Cdd:PRK08316 91 VNFMLTGEELAYILDHSGARAFLV--DPALAPTAEAALALLPVDTLILSLVLGGREAPGGWLdfadwaeagsvaepdvel 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2675 ----LAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQ---LF-SFSFDGFitsMFTPLLSGAKAVLLH 2746
Cdd:PRK08316 169 adddLAQILYTSGTESLPKGAMLTHRALIAEYVSCIVAGDMSADDIPLHalpLYhCAQLDVF---LGPYLYVGATNVILD 245
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2747 EEEAKDILAIkhqLSRQRITHMIIVPVLYRALL--DVVQPEDVKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPT 2824
Cdd:PRK08316 246 APDPELILRT---IEAERITSFFAPPTVWISLLrhPDFDTRDLSSLRKGYYGASIMPVEVLKELRERLPGLRFYNCYGQT 322
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2825 ENSVATTVMR---HMEKQAyvSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpe 2901
Cdd:PRK08316 323 EIAPLATVLGpeeHLRRPG--SAGRPVLNVETRVVDDDGNDVAPGEVGEIVHRSPQLMLGYWDDPEKTAEAFRGGWF--- 397
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2902 armyRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVA--H------VTasgqtelsAYVV 2973
Cdd:PRK08316 398 ----HSGDLGVMDEEGYITVVDRKKDMIKTGGENVASREVEEALYTHPAVAEVAVIGlpDpkwieaVT--------AVVV 465
|
490 500 510 520
....*....|....*....|....*....|....*....|...
gi 1678550997 2974 TKPG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKL 3014
Cdd:PRK08316 466 PKAGatVTEDELIAHCRARLAGFKVPKRVIFVDELPRNPSGKI 508
|
|
| menE |
TIGR01923 |
O-succinylbenzoate-CoA ligase; This model represents an enzyme, O-succinylbenzoate-CoA ligase, ... |
490-952 |
1.38e-38 |
|
O-succinylbenzoate-CoA ligase; This model represents an enzyme, O-succinylbenzoate-CoA ligase, which is involved in the fourth step of the menaquinone biosynthesis pathway. O-succinylbenzoate-CoA ligase, together with menB - naphtoate synthase, take 2-succinylbenzoate and convert it into 1,4-di-hydroxy-2- naphtoate. [Biosynthesis of cofactors, prosthetic groups, and carriers, Menaquinone and ubiquinone]
Pssm-ID: 162605 [Multi-domain] Cd Length: 436 Bit Score: 151.83 E-value: 1.38e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 490 TYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSQAH 569
Cdd:TIGR01923 1 TWQDLDCEAAHLAKALKAQGIRSGSRVALVGQNSIEMVLLLHACLLLGAEIAMLNTRLTENERTNQLEDLDVQLLLTDSL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 570 LpsSLEDNYIITHPEDIESKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRN-----MANLLKFEYThsgidfEA 644
Cdd:TIGR01923 81 L--EEKDFQADSLDRIEAAGRYETSLSASFNMDQIATLMFTSGTTGKPKAVPHTFRNhyasaVGSKENLGFT------ED 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 645 DVLQFATPSFDVCYQEI-FSALLKGGTLHIV-PEAikrdvpQLFAFINKHQ-TNIVFLPTAFIKMIfseRELanSFPDGV 721
Cdd:TIGR01923 153 DNWLLSLPLYHISGLSIlFRWLIEGATLRIVdKFN------QLLEMIANERvTHISLVPTQLNRLL---DEG--GHNENL 221
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 722 KHLIAAGEQLMISdLFQDVlRKRGIHLHNHYGPSEThvVSTYTIHPGDPIPELPPIGKPIGCTDLYILNHQKQLQpcgvp 801
Cdd:TIGR01923 222 RKILLGGSAIPAP-LIEEA-QQYGLPIYLSYGMTET--CSQVTTATPEMLHARPDVGRPLAGREIKIKVDNKEGH----- 292
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 802 GELYISGASVARGYVNHDKLTSDKFSSDPFKpdvimyrTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNH 881
Cdd:TIGR01923 293 GEIMVKGANLMKGYLYQGELTPAFEQQGWFN-------TGDIGELDGEGFLYVLGRRDDLIISGGENIYPEEIETVLYQH 365
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 882 PDISEAAILIWQDQNGEHELCAYYCSVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:TIGR01923 366 PGIQEAVVVPKPDAEWGQVPVAYIVSESDISQAKLIAYLTEKLAKYKVPIAFEKLDELPYNASGKILRNQL 436
|
|
| MACS_like_4 |
cd05969 |
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most ... |
1521-1985 |
1.40e-38 |
|
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most similar to acetyl-CoA synthetase. Acetyl-CoA synthetase (ACS) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is only present in bacteria.
Pssm-ID: 341273 [Multi-domain] Cd Length: 442 Bit Score: 151.89 E-value: 1.40e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1521 TYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLlqsa 1600
Cdd:cd05969 2 TFAQLKVLSARFANVLKSLGVGKGDRVFVLSPRSPELYFSMLGIGKIGAVICPLFSAFGPEAIRDRLENSEAKVLI---- 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1601 glhvpeftgeivylnqTNSGLAHRLSnpnvdvlPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIM 1680
Cdd:cd05969 78 ----------------TTEELYERTD-------PEDPTLLHYTSGTTGTPKGVLHVHDAMIFYYFTGKYVLDLHPDDIYW 134
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1681 HKTSYSFDASIWELFWWPYA-GASVYLlpQGGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTNRLKRV 1759
Cdd:cd05969 135 CTADPGWVTGTVYGIWAPWLnGVTNVV--YEGRFDAESWYGIIERVKVTVWYTAPTAIRMLMKEGDELARKYDLSSLRFI 212
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1760 FSGGEQLGTHLVSRFYELLpNVSITNSYGPTE-ATVEAAFFDCPPhekLERIPIGKPVHHVRLYLLNQNQRMLPVGCIGE 1838
Cdd:cd05969 213 HSVGEPLNPEAIRWGMEVF-GVPIHDTWWQTEtGSIMIANYPCMP---IKPGSMGKPLPGVKAAVVDENGNELPPGTKGI 288
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1839 LYIAGA--GVARGYLNRPALTEERFLEDpfypgerMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSI 1916
Cdd:cd05969 289 LALKPGwpSMFRGIWNDEERYKNSFIDG-------WYLTGDLAYRDEDGYFWFVGRADDIIKTSGHRVGPFEVESALMEH 361
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1678550997 1917 EGVREAAVTVRTDSGEPELC-AYV---EGLQ-----RNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNALPA 1985
Cdd:cd05969 362 PAVAEAGVIGKPDPLRGEIIkAFIslkEGFEpsdelKEEIINFVRQKLGAHVAPREIEFVDNLPKTRSGKIMRRVLKA 439
|
|
| PRK07788 |
PRK07788 |
acyl-CoA synthetase; Validated |
1501-1985 |
2.06e-38 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236097 [Multi-domain] Cd Length: 549 Bit Score: 153.93 E-value: 2.06e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1501 EQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPE 1580
Cdd:PRK07788 56 AHAARRAPDRAALIDERGTLTYAELDEQSNALARGLLALGVRAGDGVAVLARNHRGFVLALYAAGKVGARIILLNTGFSG 135
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1581 ERISFLLEDSGTNILLlqsaglHVPEFTGEIVYLNQTNSGL--------AHRLSNPNVDVLPQSLA-------------- 1638
Cdd:PRK07788 136 PQLAEVAAREGVKALV------YDDEFTDLLSALPPDLGRLrawggnpdDDEPSGSTDETLDDLIAgsstaplpkppkpg 209
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1639 -YVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIM------HKTSYSFDASIWELfwwpyaGASVYLLpqgg 1711
Cdd:PRK07788 210 gIVILTSGTTGTPKGAPRPEPSPLAPLAGLLSRVPFRAGETTLlpapmfHATGWAHLTLAMAL------GSTVVLR---- 279
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1712 EK-EPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVsITNSYGPT 1790
Cdd:PRK07788 280 RRfDPEATLEDIAKHKATALVVVPVMLSRILDLGPEVLAKYDTSSLKIIFVSGSALSPELATRALEAFGPV-LYNLYGST 358
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1791 EATVeAAFFDcpPHEkLERIP--IGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLN-RPALTEERFLEdpfy 1867
Cdd:PRK07788 359 EVAF-ATIAT--PED-LAEAPgtVGRPPKGVTVKILDENGNEVPRGVVGRIFVGNGFPFEGYTDgRDKQIIDGLLS---- 430
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1868 pgermykTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVT-VRTDSGEPELCAYV---EGLQ 1943
Cdd:PRK07788 431 -------SGDVGYFDEDGLLFVDGRDDDMIVSGGENVFPAEVEDLLAGHPDVVEAAVIgVDDEEFGQRLRAFVvkaPGAA 503
|
490 500 510 520
....*....|....*....|....*....|....*....|....*...
gi 1678550997 1944 RNE------VRAQLERllpgYMVPAYMIEMEQWPVTPSGKLDRNALPA 1985
Cdd:PRK07788 504 LDEdaikdyVRDNLAR----YKVPRDVVFLDELPRNPTGKVLKRELRE 547
|
|
| PRK06155 |
PRK06155 |
crotonobetaine/carnitine-CoA ligase; Provisional |
460-954 |
2.68e-38 |
|
crotonobetaine/carnitine-CoA ligase; Provisional
Pssm-ID: 235719 [Multi-domain] Cd Length: 542 Bit Score: 153.38 E-value: 2.68e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 460 PVYETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGA 539
Cdd:PRK06155 18 PSERTLPAMLARQAERYPDRPLLVFGGTRWTYAEAARAAAAAAHALAAAGVKRGDRVALMCGNRIEFLDVFLGCAWLGAI 97
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 540 IVPVDPHYPADRIRYILHDCGCSHVVSQAHLPSSLEdnYIITHPEDIES--KVDGSNIKSVNNA---------------- 601
Cdd:PRK06155 98 AVPINTALRGPQLEHILRNSGARLLVVEAALLAALE--AADPGDLPLPAvwLLDAPASVSVPAGwstaplppldapapaa 175
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 602 ----DDLLYMIYTSGTTGKPKGVQFEH-------RNMANLLKFEythsgidfEADVLQFATPSFDVCYQEIF-SALLKGG 669
Cdd:PRK06155 176 avqpGDTAAILYTSGTTGPSKGVCCPHaqfywwgRNSAEDLEIG--------ADDVLYTTLPLFHTNALNAFfQALLAGA 247
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 670 TLHIVPeaiKRDVPQLFAFINKHQTNIVFLPTAFIKMIFSERELANSFPDGVKHLIAAGeqlmISDLFQDVLRKR-GIHL 748
Cdd:PRK06155 248 TYVLEP---RFSASGFWPAVRRHGATVTYLLGAMVSILLSQPARESDRAHRVRVALGPG----VPAALHAAFRERfGVDL 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 749 HNHYGPSETHVVStytihpGDPIPELPP--IGKPIGCTDLYILNHQKQLQPCGVPGELYISGA---SVARGYVNHDKLTS 823
Cdd:PRK06155 321 LDGYGSTETNFVI------AVTHGSQRPgsMGRLAPGFEARVVDEHDQELPDGEPGELLLRADepfAFATGYFGMPEKTV 394
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 824 DKFSSdpfkpdvIMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCA 903
Cdd:PRK06155 395 EAWRN-------LWFHTGDRVVRDADGWFRFVDRIKDAIRRRGENISSFEVEQVLLSHPAVAAAAVFPVPSELGEDEVMA 467
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 904 yycSV-----QKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPE 954
Cdd:PRK06155 468 ---AVvlrdgTALEPVALVRHCEPRLAYFAVPRYVEFVAALPKTENGKVQKFVLRE 520
|
|
| CBAL |
cd05923 |
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) ... |
2533-3019 |
2.74e-38 |
|
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) to 4-chlorobenzoyl-coenzyme A (4-CB-CoA) by the two-step adenylation and thioester-forming reactions. 4-Chlorobenzoate (4-CBA) is an environmental pollutant derived from microbial breakdown of aromatic pollutants, such as polychlorinated biphenyls (PCBs), DDT, and certain herbicides. The 4-CBA degrading pathway converts 4-CBA to the metabolite 4-hydroxybezoate (4-HBA), allowing some soil-dwelling microbes to utilize 4-CBA as an alternate carbon source. This pathway consists of three chemical steps catalyzed by 4-CBA-CoA ligase, 4-CBA-CoA dehalogenase, and 4HBA-CoA thioesterase in sequential reactions.
Pssm-ID: 341247 [Multi-domain] Cd Length: 493 Bit Score: 152.28 E-value: 2.74e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2533 QTISQLFEQQAARTPKASALV--SGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCY 2610
Cdd:cd05923 1 QTVFEMLRRAASRAPDACAIAdpARGLRLTYSELRARIEAVAARLHARGLRPGQRVAVVLPNSVEAVIALLALHRLGAVP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2611 VPIDPEY-PKERKRYILSDSGTKLLMTINEADLGVLADFEGEILTIE------SVEEDDKSPLPQMSSAHHLAYIIYTSG 2683
Cdd:cd05923 81 ALINPRLkAAELAELIERGEMTAAVIAVDAQVMDAIFQSGVRVLALSdlvglgEPESAGPLIEDPPREPEQPAFVFYTSG 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2684 TTGRPKGVMVEHKGIANTLQW--RRNAYAFNETDTILQLFS-FSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIkhqL 2760
Cdd:cd05923 161 TTGLPKGAVIPQRAAESRVLFmsTQAGLRHGRHNVVLGLMPlYHVIGFFAVLVAALALDGTYVVVEEFDPADALKL---I 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2761 SRQRITHMIIVPVLYRALLDVVQ--PEDVKTLRVVTLAGEAADRELIARsLAICPHTELANEYGPTEnSVATTVMRHMEK 2838
Cdd:cd05923 238 EQERVTSLFATPTHLDALAAAAEfaGLKLSSLRHVTFAGATMPDAVLER-VNQHLPGEKVNIYGTTE-AMNSLYMRDART 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2839 QAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLA--RGYVNLPELTERaftqnpfKPEARMYRTGDAARWMAD 2916
Cdd:cd05923 316 GTEMRPGFFSEVRIVRIGGSPDEALANGEEGELIVAAAADAafTGYLNQPEATAK-------KLQDGWYRTGDVGYVDPS 388
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2917 GTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPG-LSTNAVR-----SELQNk 2990
Cdd:cd05923 389 GDVRILGRVDDMIISGGENIHPSEIERVLSRHPGVTEVVVIGVADERWGQSVTACVVPREGtLSADELDqfcraSELAD- 467
|
490 500
....*....|....*....|....*....
gi 1678550997 2991 lpvFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:cd05923 468 ---FKRPRRYFFLDELPKNAMNKVLRRQL 493
|
|
| EntE |
COG1021 |
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase ... |
463-952 |
5.43e-38 |
|
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440644 [Multi-domain] Cd Length: 533 Bit Score: 152.22 E-value: 5.43e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 463 ETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGgaIVP 542
Cdd:COG1021 25 ETLGDLLRRRAERHPDRIAVVDGERRLSYAELDRRADRLAAGLLALGLRPGDRVVVQLPNVAEFVIVFFALFRAG--AIP 102
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 543 VDPhYPADRIRYILHDCGCS----HVVSQAHLP--------------SSLEDNYIITHPEDIES-----KVDGSNIKSVN 599
Cdd:COG1021 103 VFA-LPAHRRAEISHFAEQSeavaYIIPDRHRGfdyralarelqaevPSLRHVLVVGDAGEFTSldallAAPADLSEPRP 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 600 NADDLLYMIYTSGTTGKPKGVQFEHRnmanllkfEYTHS--------GIDfEADVLQFATP---SFDVCYQEIFSALLKG 668
Cdd:COG1021 182 DPDDVAFFQLSGGTTGLPKLIPRTHD--------DYLYSvrasaeicGLD-ADTVYLAALPaahNFPLSSPGVLGVLYAG 252
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 669 GT--LHIVPEAikrdvPQLFAFINKHQTNIVFL-PTAFIKMI-FSERELANsfPDGVKHLIAAGEQLmisdlfQDVLRKR 744
Cdd:COG1021 253 GTvvLAPDPSP-----DTAFPLIERERVTVTALvPPLALLWLdAAERSRYD--LSSLRVLQVGGAKL------SPELARR 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 745 -----GIHLHNHYGPSETHVvsTYTiHPGDPiPELppI----GKPIgCTD--LYILNHQKQLQPCGVPGELYISGASVAR 813
Cdd:COG1021 320 vrpalGCTLQQVFGMAEGLV--NYT-RLDDP-EEV--IlttqGRPI-SPDdeVRIVDEDGNPVPPGEVGELLTRGPYTIR 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 814 GYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQVkIR-GYRIEPQEIEVTLMNHPDISEAAILIW 892
Cdd:COG1021 393 GYYRAPEHNARAFTPDGF------YRTGDLVRRTPDGYLVVEGRAKDQI-NRgGEKIAAEEVENLLLAHPAVHDAAVVAM 465
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 893 QDQN-GEhELCAYY-CSVQKLNTIDLRSYMAS-ELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:COG1021 466 PDEYlGE-RSCAFVvPRGEPLTLAELRRFLRErGLAAFKLPDRLEFVDALPLTAVGKIDKKAL 527
|
|
| LCL_NRPS |
cd19538 |
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; ... |
12-356 |
6.31e-38 |
|
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380461 [Multi-domain] Cd Length: 432 Bit Score: 149.72 E-value: 6.31e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 12 PLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNvSSPQQVVLRERNV-IVLE 90
Cdd:cd19538 3 PLSFAQRRLWFLHQLEGPSATYNIPLVIKLKGKLDVQALQQALYDVVERHESLRTVFPEED-GVPYQLILEEDEAtPKLE 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 91 edITHLNEAEQSQFIEQWKEkdrdRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASYVNA 170
Cdd:cd19538 82 --IKEVDEEELESEINEAVR----YPFDLSEEPPFRATLFELGENEHVLLLLLHHIAADGWSLAPLTRDLSKAYRARCKG 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 171 SPITLE--PVQpYGKYIKW---LMEQDKEQA------VSYWDHYLSGHEQQTVL------PKQKKTKGksrqEHVTFSFS 233
Cdd:cd19538 156 EAPELAplPVQ-YADYALWqqeLLGDESDPDsliarqLAYWKKQLAGLPDEIELptdyprPAESSYEG----GTLTFEID 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 234 KEESSRLSELAAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRpaEIEGIEHMVGLFINTMPVRVQGAKTP-FLQ 312
Cdd:cd19538 231 SELHQQLLQLAKDNNVTLFMVLQAGFAALLTRLGAGTDIPIGSPVAGR--NDDSLEDLVGFFVNTLVLRTDTSGNPsFRE 308
|
330 340 350 360
....*....|....*....|....*....|....*....|....*....
gi 1678550997 313 LIKDMQKDRLAAEAYSYHPLYEI-----QSRSAVKQGLIDHILVFENYP 356
Cdd:cd19538 309 LLERVKETNLEAYEHQDIPFERLvealnPTRSRSRHPLFQIMLALQNTP 357
|
|
| BCL_like |
cd05919 |
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate ... |
1510-1983 |
1.02e-37 |
|
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate CoA ligase (BCL) and related ligases that catalyze the acylation of benzoate derivatives, 2-aminobenzoate and 4-hydroxybenzoate. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Xenobiotic aromatic compounds are also a major class of man-made pollutants. Some bacteria use benzoate as the sole source of carbon and energy through benzoate degradation. Benzoate degradation starts with its activation to benzoyl-CoA by benzoate CoA ligase. The reaction catalyzed by benzoate CoA ligase proceeds via a two-step process; the first ATP-dependent step forms an acyl-AMP intermediate, and the second step forms the acyl-CoA ester with release of the AMP.
Pssm-ID: 341243 [Multi-domain] Cd Length: 436 Bit Score: 149.53 E-value: 1.02e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1510 QAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLED 1589
Cdd:cd05919 1 KTAFYAADRSVTYGQLHDGANRLGSALRNLGVSSGDRVLLLMLDSPELVQLFLGCLARGAIAVVINPLLHPDDYAYIARD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1590 SGTNILLLQSAglhvpeftgeivylnqtnsglahrlsnpnvdvlpqSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQS 1669
Cdd:cd05919 81 CEARLVVTSAD-----------------------------------DIAYLLYSSGTTGPPKGVMHAHRDPLLFADAMAR 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1670 RY-QLKHSDMIMHKTSYSFDASIWELFWWP-YAGASVYLLPqgGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYR 1747
Cdd:cd05919 126 EAlGLTPGDRVFSSAKMFFGYGLGNSLWFPlAVGASAVLNP--GWPTAERVLATLARFRPTVLYGVPTFYANLLDSCAGS 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1748 SVPIKTNRLkrVFSGGEQLGTHLVSRFYELLpNVSITNSYGPTEAtveAAFFDCPPHEKLERIPIGKPVHHVRLYLLNQN 1827
Cdd:cd05919 204 PDALRSLRL--CVSAGEALPRGLGERWMEHF-GGPILDGIGATEV---GHIFLSNRPGAWRLGSTGRPVPGYEIRLVDEE 277
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1828 QRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDpfypgerMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPG 1907
Cdd:cd05919 278 GHTIPPGEEGDLLVRGPSAAVGYWNNPEKSRATFNGG-------WYRTGDKFCRDADGWYTHAGRADDMLKVGGQWVSPV 350
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1908 EIEAALRSIEGVREAAVT-VRTDSGEPELCAYV---------EGLQRNEVRAQLERlLPGYMVPAYMIEMEQWPVTPSGK 1977
Cdd:cd05919 351 EVESLIIQHPAVAEAAVVaVPESTGLSRLTAFVvlkspaapqESLARDIHRHLLER-LSAHKVPRRIAFVDELPRTATGK 429
|
....*.
gi 1678550997 1978 LDRNAL 1983
Cdd:cd05919 430 LQRFKL 435
|
|
| PRK06145 |
PRK06145 |
acyl-CoA synthetase; Validated |
2543-3014 |
2.00e-37 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 102207 [Multi-domain] Cd Length: 497 Bit Score: 150.04 E-value: 2.00e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2543 AARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERK 2622
Cdd:PRK06145 12 ARRTPDRAALVYRDQEISYAEFHQRILQAAGMLHARGIGQGDVVALLMKNSAAFLELAFAASYLGAVFLPINYRLAADEV 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2623 RYILSDSGTKLLMTINEADlgVLADFEGEILTIESVEEDDKSPL--------PQMSSA-HHLAYIIYTSGTTGRPKGVMV 2693
Cdd:PRK06145 92 AYILGDAGAKLLLVDEEFD--AIVALETPKIVIDAAAQADSRRLaqggleipPQAAVApTDLVRLMYTSGTTDRPKGVMH 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2694 EHkgiaNTLQWRRN----AYAFNETDTIL------QLFSFSFDGFITsmftpLLSGAKAVLLHEEEAKDILAikhQLSRQ 2763
Cdd:PRK06145 170 SY----GNLHWKSIdhviALGLTASERLLvvgplyHVGAFDLPGIAV-----LWVGGTLRIHREFDPEAVLA---AIERH 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2764 RITHMIIVPVLYRALLDVVQPE--DVKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTENSVATTVM---RHMEK 2838
Cdd:PRK06145 238 RLTCAWMAPVMLSRVLTVPDRDrfDLDSLAWCIGGGEKTPESRIRDFTRVFTRARYIDAYGLTETCSGDTLMeagREIEK 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2839 QAyvSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmyRTGDAARWMADGT 2918
Cdd:PRK06145 318 IG--STGRALAHVEIRIADGAGRWLPPNMKGEICMRGPKVTKGYWKDPEKTAEAFYGDWF-------RSGDVGYLDEEGF 388
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2919 LEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPG--LSTNAVRSELQNKLPVFMH 2996
Cdd:PRK06145 389 LYLTDRKKDMIISGGENIASSEVERVIYELPEVAEAAVIGVHDDRWGERITAVVVLNPGatLTLEALDRHCRQRLASFKV 468
|
490
....*....|....*...
gi 1678550997 2997 PAFIEKLDSLPLSPNGKL 3014
Cdd:PRK06145 469 PRQLKVRDELPRNPSGKV 486
|
|
| EntE |
COG1021 |
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase ... |
2533-3019 |
2.03e-37 |
|
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440644 [Multi-domain] Cd Length: 533 Bit Score: 150.68 E-value: 2.03e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2533 QTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGcyVP 2612
Cdd:COG1021 25 ETLGDLLRRRAERHPDRIAVVDGERRLSYAELDRRADRLAAGLLALGLRPGDRVVVQLPNVAEFVIVFFALFRAGA--IP 102
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2613 IDPeYPKERK---RYILSDSGTKLLMTINEADL--------GVLADFE-----------GEILTIESVEEDDKSPLPQMS 2670
Cdd:COG1021 103 VFA-LPAHRRaeiSHFAEQSEAVAYIIPDRHRGfdyralarELQAEVPslrhvlvvgdaGEFTSLDALLAAPADLSEPRP 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2671 SAHHLAYIIYTSGTTGRPKGvmvehkgIANT-----LQWRRNAYA--FNETDTILQL------FSFSFDGFitsmFTPLL 2737
Cdd:COG1021 182 DPDDVAFFQLSGGTTGLPKL-------IPRThddylYSVRASAEIcgLDADTVYLAAlpaahnFPLSSPGV----LGVLY 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2738 SGAKAVLLHEEEAKDILAIkhqLSRQRITHMIIVPVLYRALLDVVQ--PEDVKTLRVV-----TLAGEAADR---ELIAR 2807
Cdd:COG1021 251 AGGTVVLAPDPSPDTAFPL---IERERVTVTALVPPLALLWLDAAErsRYDLSSLRVLqvggaKLSPELARRvrpALGCT 327
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2808 slaicphteLANEYGPTENSVATTVMRHMEKQAYVSIGQPI-DGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLP 2886
Cdd:COG1021 328 ---------LQQVFGMAEGLVNYTRLDDPEEVILTTQGRPIsPDDEVRIVDEDGNPVPPGEVGELLTRGPYTIRGYYRAP 398
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2887 ELTERAFTQNPFkpearmYRTGDAARWMADGTLEYLGRIDDQVkIR-GYRVETKEIESVIRCIKGVKDAAVVAHVTAS-G 2964
Cdd:COG1021 399 EHNARAFTPDGF------YRTGDLVRRTPDGYLVVEGRAKDQI-NRgGEKIAAEEVENLLLAHPAVHDAAVVAMPDEYlG 471
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*...
gi 1678550997 2965 qtELS-AYVVTK-PGLSTNAVRSELQNK-LPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:COG1021 472 --ERScAFVVPRgEPLTLAELRRFLRERgLAAFKLPDRLEFVDALPLTAVGKIDKKAL 527
|
|
| PRK07059 |
PRK07059 |
Long-chain-fatty-acid--CoA ligase; Validated |
2527-3019 |
2.59e-37 |
|
Long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235923 [Multi-domain] Cd Length: 557 Bit Score: 150.94 E-value: 2.59e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2527 ANQYgvQTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKA 2606
Cdd:PRK07059 19 ASQY--PSLADLLEESFRQYADRPAFICMGKAITYGELDELSRALAAWLQSRGLAKGARVAIMMPNVLQYPVAIAAVLRA 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2607 GGCYVPIDPEY-PKERKrYILSDSGTKLLMTINE-------------------ADLGVLADFEGEI--LTIESVeeddKS 2664
Cdd:PRK07059 97 GYVVVNVNPLYtPRELE-HQLKDSGAEAIVVLENfattvqqvlaktavkhvvvASMGDLLGFKGHIvnFVVRRV----KK 171
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2665 PLPQMSSAHH------------------------LAYIIYTSGTTGRPKGVMVEHKGI-ANTLQ---WRRNAYA----FN 2712
Cdd:PRK07059 172 MVPAWSLPGHvrfndalaegarqtfkpvklgpddVAFLQYTGGTTGVSKGATLLHRNIvANVLQmeaWLQPAFEkkprPD 251
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2713 ETDTILQL-----FSFSFDGFITsmftpLLSGAKAVLLheEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDvvQPE-- 2785
Cdd:PRK07059 252 QLNFVCALplyhiFALTVCGLLG-----MRTGGRNILI--PNPRDIPGFIKELKKYQVHIFPAVNTLYNALLN--NPDfd 322
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2786 --DVKTLRVVTLAGEAADRELIARSLAI--CPHTElanEYGPTENSVATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQ 2861
Cdd:PRK07059 323 klDFSKLIVANGGGMAVQRPVAERWLEMtgCPITE---GYGLSETSPVATCNPVDATEFSGTIGLPLPSTEVSIRDDDGN 399
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2862 LQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEI 2941
Cdd:PRK07059 400 DLPLGEPGEICIRGPQVMAGYWNRPDETAKVMTADGF------FRTGDVGVMDERGYTKIVDRKKDMILVSGFNVYPNEI 473
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2942 ESVIRCIKGVKDAAVVA-HVTASGQTeLSAYVVTK-PGLSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK07059 474 EEVVASHPGVLEVAAVGvPDEHSGEA-VKLFVVKKdPALTEEDVKAFCKERLTNYKRPKFVEFRTELPKTNVGKILRREL 552
|
|
| FAA1 |
COG1022 |
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; |
2531-2962 |
7.50e-37 |
|
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism];
Pssm-ID: 440645 [Multi-domain] Cd Length: 603 Bit Score: 150.25 E-value: 7.50e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2531 GVQTISQLFEQQAARTPKASAL---VSGD-KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKA 2606
Cdd:COG1022 9 PADTLPDLLRRRAARFPDRVALrekEDGIwQSLTWAEFAERVRALAAGLLALGVKPGDRVAILSDNRPEWVIADLAILAA 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2607 GGCYVPIDPEYPKERKRYILSDSGTKLLMTINEADLGVLADFEGE------ILTIESVEEDDKSPLPQMS---------- 2670
Cdd:COG1022 89 GAVTVPIYPTSSAEEVAYILNDSGAKVLFVEDQEQLDKLLEVRDElpslrhIVVLDPRGLRDDPRLLSLDellalgreva 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2671 ------------SAHHLAYIIYTSGTTGRPKGVMVEHKGI-ANTLQWRRnAYAFNETDTILqlfSF-----SFDGFITSM 2732
Cdd:COG1022 169 dpaelearraavKPDDLATIIYTSGTTGRPKGVMLTHRNLlSNARALLE-RLPLGPGDRTL---SFlplahVFERTVSYY 244
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2733 FtpLLSGAKAVLlheeeAKDILAIKHQLSRQRITHMIIVPVLYRALLDVVQ------PEDVKTL-----RVVTLAGEA-- 2799
Cdd:COG1022 245 A--LAAGATVAF-----AESPDTLAEDLREVKPTFMLAVPRVWEKVYAGIQakaeeaGGLKRKLfrwalAVGRRYARArl 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2800 ---------------ADReLIARSL----------AIC------PHT------------ELaneYGPTENSVATTVMRhM 2836
Cdd:COG1022 318 agkspslllrlkhalADK-LVFSKLrealggrlrfAVSggaalgPELarffralgipvlEG---YGLTETSPVITVNR-P 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2837 EKQAYVSIGQPIDGTQVlilnsnhqlqPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMAD 2916
Cdd:COG1022 393 GDNRIGTVGPPLPGVEV----------KIAEDGEILVRGPNVMKGYYKNPEATAEAFDADGW------LHTGDIGELDED 456
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 2917 GTLEYLGRIDDQVKIR-GYRVETKEIESVIRCIKGVKDAAVVAH----VTA 2962
Cdd:COG1022 457 GFLRITGRKKDLIVTSgGKNVAPQPIENALKASPLIEQAVVVGDgrpfLAA 507
|
|
| 23DHB-AMP_lg |
cd05920 |
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2, ... |
473-952 |
1.26e-36 |
|
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2,3-dihydroxybenzoate (DHB) by ligation of AMP from ATP with the release of pyrophosphate. However, it can also catalyze the ATP-PPi exchange for 2,3-DHB analogs, such as salicyclic acid (o-hydrobenzoate), as well as 2,4-DHB and 2,5-DHB, but with less efficiency. Proteins in this family are the stand-alone adenylation components of non-ribosomal peptide synthases (NRPSs) involved in the biosynthesis of siderophores, which are low molecular weight iron-chelating compounds synthesized by many bacteria to aid in the acquisition of this vital trace elements. In Escherichia coli, the 2,3-dihydroxybenzoate-AMP ligase is called EntE, the adenylation component of the enterobactin NRPS system.
Pssm-ID: 341244 [Multi-domain] Cd Length: 482 Bit Score: 147.09 E-value: 1.26e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 473 AEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGgaIVPVDPhYPADRI 552
Cdd:cd05920 25 AARHPDRIAVVDGDRRLTYRELDRRADRLAAGLRGLGIRPGDRVVVQLPNVAEFVVLFFALLRLG--AVPVLA-LPSHRR 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 553 RYILHDCGCSHVVSqahlpsslednYIIthpEDIESKVDGSN--IKSVNNADDLLYMIYTSGTTGKPKGVQFEHRNMANL 630
Cdd:cd05920 102 SELSAFCAHAEAVA-----------YIV---PDRHAGFDHRAlaRELAESIPEVALFLLSGGTTGTPKLIPRTHNDYAYN 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 631 LKFEYTHSGIDfEADVLQFATP---SFDVCYQEIFSALLKGGTLHIVPEAIKRDVpqlFAFINKHQTNIVFLPTAFIKMI 707
Cdd:cd05920 168 VRASAEVCGLD-QDTVYLAVLPaahNFPLACPGVLGTLLAGGRVVLAPDPSPDAA---FPLIEREGVTVTALVPALVSLW 243
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 708 FSERElANSFPDGVKHLIAAGEQLMISDLFQDVLRKRGIHLHNHYGPSETHVvsTYTiHPGDPiPELppI----GKPIGC 783
Cdd:cd05920 244 LDAAA-SRRADLSSLRLLQVGGARLSPALARRVPPVLGCTLQQVFGMAEGLL--NYT-RLDDP-DEV--IihtqGRPMSP 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 784 TD-LYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQV 862
Cdd:cd05920 317 DDeIRVVDEEGNPVPPGEEGELLTRGPYTIRGYYRAPEHNARAFTPDGF------YRTGDLVRRTPDGYLVVEGRIKDQI 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 863 KIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQN-GEhELCAY-YCSVQKLNTIDLRSYM-ASELPEYMIPAKWIWVDSI 939
Cdd:cd05920 391 NRGGEKIAAEEVENLLLRHPAVHDAAVVAMPDELlGE-RSCAFvVLRDPPPSAAQLRRFLrERGLAAYKLPDRIEFVDSL 469
|
490
....*....|...
gi 1678550997 940 PLTPNGKVDRAAL 952
Cdd:cd05920 470 PLTAVGKIDKKAL 482
|
|
| PRK06155 |
PRK06155 |
crotonobetaine/carnitine-CoA ligase; Provisional |
2533-3019 |
3.10e-36 |
|
crotonobetaine/carnitine-CoA ligase; Provisional
Pssm-ID: 235719 [Multi-domain] Cd Length: 542 Bit Score: 147.21 E-value: 3.10e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2533 QTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVP 2612
Cdd:PRK06155 21 RTLPAMLARQAERYPDRPLLVFGGTRWTYAEAARAAAAAAHALAAAGVKRGDRVALMCGNRIEFLDVFLGCAWLGAIAVP 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2613 IDPEYPKERKRYILSDSGTKLLMT-------INEADLGVLAdfEGEILTIESVEED------DKSPLPQMSSA------- 2672
Cdd:PRK06155 101 INTALRGPQLEHILRNSGARLLVVeaallaaLEAADPGDLP--LPAVWLLDAPASVsvpagwSTAPLPPLDAPapaaavq 178
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2673 -HHLAYIIYTSGTTGRPKGVMVEHkgiANTLQWRRN---AYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEE 2748
Cdd:PRK06155 179 pGDTAAILYTSGTTGPSKGVCCPH---AQFYWWGRNsaeDLEIGADDVLYTTLPLFHTNALNAFFQALLAGATYVLEPRF 255
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2749 EAKDILA--IKHQLSrqrITHMI--IVPVLyralldVVQP----EDVKTLRVVTLAGEAAD--RELIARSlaicpHTELA 2818
Cdd:PRK06155 256 SASGFWPavRRHGAT---VTYLLgaMVSIL------LSQParesDRAHRVRVALGPGVPAAlhAAFRERF-----GVDLL 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2819 NEYGPTENSVATTVMRHMEKQAYvsIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGT---GLARGYVNLPELTERAFtQ 2895
Cdd:PRK06155 322 DGYGSTETNFVIAVTHGSQRPGS--MGRLAPGFEARVVDEHDQELPDGEPGELLLRADepfAFATGYFGMPEKTVEAW-R 398
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2896 NPFkpearmYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTK 2975
Cdd:PRK06155 399 NLW------FHTGDRVVRDADGWFRFVDRIKDAIRRRGENISSFEVEQVLLSHPAVAAAAVFPVPSELGEDEVMAAVVLR 472
|
490 500 510 520
....*....|....*....|....*....|....*....|....*.
gi 1678550997 2976 PGLSTN--AVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK06155 473 DGTALEpvALVRHCEPRLAYFAVPRYVEFVAALPKTENGKVQKFVL 518
|
|
| Cyc_NRPS |
cd19535 |
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
2114-2399 |
3.69e-36 |
|
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Cyc (heterocyclization) domains catalyze two separate reactions in the creation of heterocyclized peptide products in nonribosomal peptide synthesis: amide bond formation followed by intramolecular cyclodehydration between a Cys, Ser, or Thr side chain and a carbonyl carbon on the peptide backbone to form a thiazoline, oxazoline, or methyloxazoline ring. Cyc-domains are homologous to standard NRPS Condensation (C) domains. C-domains typically have a conserved HHxxxD motif at the active site; Cyc-domains have an alternative, conserved DxxxxD active site motif, mutation of the aspartate residues in this motif can abolish or diminish condensation activity. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and Cyc-domains. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380458 [Multi-domain] Cd Length: 423 Bit Score: 144.55 E-value: 3.69e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2114 AVLELEGK-LNPERMDRAFQELIKRHESLRTSFeqDEGGDpvQRIHDEVP-FTLQTTVLGARTEQEAAAAFIK------- 2184
Cdd:cd19535 28 AYLEFDGEdLDPDRLERAWNKLIARHPMLRAVF--LDDGT--QQILPEVPwYGITVHDLRGLSEEEAEAALEElrerlsh 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2185 -PFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELYNNRK--LPALRIQYKDYAVWQEGFKtGDAY 2261
Cdd:cd19535 104 rVLDVERGPLFDIRLSLLPEGRTRLHLSIDLLVADALSLQILLRELAALYEDPGepLPPLELSFRDYLLAEQALR-ETAY 182
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2262 KMQEAYWLKQLEG-----ELPVLDLPADHARPPVRSFagdkvSFTLEPEVASGLHKLARENGSTLYMVLLAAYTAFLSRL 2336
Cdd:cd19535 183 ERARAYWQERLPTlppapQLPLAKDPEEIKEPRFTRR-----EHRLSAEQWQRLKERARQHGVTPSMVLLTAYAEVLARW 257
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 2337 SGQEDIIVGSPIAGRP--HKDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRETALEAFEHQNY 2399
Cdd:cd19535 258 SGQPRFLLNLTLFNRLplHPDVNDVVGDFTSLLLLEVDGSEGQSFLERARRLQQQLWEDLDHSSY 322
|
|
| ABCL |
cd05958 |
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate ... |
2549-3019 |
4.14e-36 |
|
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate aerobic degradation pathway by activating 2-aminobenzoate to 2-aminobenzoyl-CoA. The reaction is carried out via a two-step process; the first step is ATP-dependent and forms a 2-aminobenzoyl-AMP intermediate, and the second step forms the 2-aminobenzoyl-CoA ester and releases the AMP. 2-Aminobenzoyl-CoA is further converted to 2-amino-5-oxo-cyclohex-1-ene-1-carbonyl-CoA catalyzed by 2-aminobenzoyl-CoA monooxygenase/reductase. ABCL has been purified from cells aerobically grown with 2-aminobenzoate as sole carbon, energy, and nitrogen source, and has been characterized as a monomer.
Pssm-ID: 341268 [Multi-domain] Cd Length: 439 Bit Score: 144.54 E-value: 4.14e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2549 ASALVSGDKTLTYQELDEWSNGIARALRSRGV-KPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILS 2627
Cdd:cd05958 1 RTCLRSPEREWTYRDLLALANRIANVLVGELGiVPGNRVLLRGSNSPELVACWFGIQKAGAIAVATMPLLRPKELAYILD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2628 DSgtkllmtinEADLGVLADfegeiltiesveeddksplpQMSSAHHLAYIIYTSGTTGRPKGVMVEHKGIANTLQ-WRR 2706
Cdd:cd05958 81 KA---------RITVALCAH--------------------ALTASDDICILAFTSGTTGAPKATMHFHRDPLASADrYAV 131
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2707 NAYAFNETDTILQL----FSFSFDGFitsMFTPLLSGAKAVLLHEEEAKDILAIkhqLSRQRITHMIIVPVLYRALL--- 2779
Cdd:cd05958 132 NVLRLREDDRFVGSpplaFTFGLGGV---LLFPFGVGASGVLLEEATPDLLLSA---IARYKPTVLFTAPTAYRAMLahp 205
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2780 DVVQPeDVKTLRVVTLAGEAADRELIARSLAICpHTELANEYGPTEnsvattvMRHM-----EKQAYV-SIGQPIDGTQV 2853
Cdd:cd05958 206 DAAGP-DLSSLRKCVSAGEALPAALHRAWKEAT-GIPIIDGIGSTE-------MFHIfisarPGDARPgATGKPVPGYEA 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2854 LILNSNHQLQPIGVAGELCIAGtglARGYVNLPELTERAFTQNPFKPearmyrTGDAARWMADGTLEYLGRIDDQVKIRG 2933
Cdd:cd05958 277 KVVDDEGNPVPDGTIGRLAVRG---PTGCRYLADKRQRTYVQGGWNI------TGDTYSRDPDGYFRHQGRSDDMIVSGG 347
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2934 YRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTN-AVRSELQN----KLPVFMHPAFIEKLDSLPL 3008
Cdd:cd05958 348 YNIAPPEVEDVLLQHPAVAECAVVGHPDESRGVVVKAFVVLRPGVIPGpVLARELQDhakaHIAPYKYPRAIEFVTELPR 427
|
490
....*....|.
gi 1678550997 3009 SPNGKLDRGAL 3019
Cdd:cd05958 428 TATGKLQRFAL 438
|
|
| MACS_like_4 |
cd05969 |
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most ... |
2559-3019 |
4.30e-36 |
|
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most similar to acetyl-CoA synthetase. Acetyl-CoA synthetase (ACS) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is only present in bacteria.
Pssm-ID: 341273 [Multi-domain] Cd Length: 442 Bit Score: 144.57 E-value: 4.30e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2559 LTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMTIN 2638
Cdd:cd05969 1 YTFAQLKVLSARFANVLKSLGVGKGDRVFVLSPRSPELYFSMLGIGKIGAVICPLFSAFGPEAIRDRLENSEAKVLITTE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2639 EadlgvLADfegeiltiesvEEDDKSPlpqmssahhlAYIIYTSGTTGRPKGVMVEHKgiANTLQWRRNAYAFNETDTil 2718
Cdd:cd05969 81 E-----LYE-----------RTDPEDP----------TLLHYTSGTTGTPKGVLHVHD--AMIFYYFTGKYVLDLHPD-- 130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2719 QLFSFSFD-GFIT----SMFTPLLSGAKAVLlhEEEAKDILAIKHQLSRQRITHMIIVPVLYRALL----DVVQPEDVKT 2789
Cdd:cd05969 131 DIYWCTADpGWVTgtvyGIWAPWLNGVTNVV--YEGRFDAESWYGIIERVKVTVWYTAPTAIRMLMkegdELARKYDLSS 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2790 LRVVTLAGEAADRELIARSLAICpHTELANEYGPTENSVATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAG 2869
Cdd:cd05969 209 LRFIHSVGEPLNPEAIRWGMEVF-GVPIHDTWWQTETGSIMIANYPCMPIKPGSMGKPLPGVKAAVVDENGNELPPGTKG 287
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2870 ELCI-AG-TGLARGYVNLPELTERAFTQNpfkpearMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRC 2947
Cdd:cd05969 288 ILALkPGwPSMFRGIWNDEERYKNSFIDG-------WYLTGDLAYRDEDGYFWFVGRADDIIKTSGHRVGPFEVESALME 360
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 2948 IKGVKDAAVVAHVTASGQTELSAYVVTKPGLS-TNAVRSELQN----KLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:cd05969 361 HPAVAEAGVIGKPDPLRGEIIKAFISLKEGFEpSDELKEEIINfvrqKLGAHVAPREIEFVDNLPKTRSGKIMRRVL 437
|
|
| PRK06188 |
PRK06188 |
acyl-CoA synthetase; Validated |
1508-1986 |
5.74e-36 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235731 [Multi-domain] Cd Length: 524 Bit Score: 145.90 E-value: 5.74e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1508 PDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLL 1587
Cdd:PRK06188 26 PDRPALVLGDTRLTYGQLADRISRYIQAFEALGLGTGDAVALLSLNRPEVLMAIGAAQLAGLRRTALHPLGSLDDHAYVL 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1588 EDSGTNILLL--------------QSAGL-HVpeFT-GEIVYLNQTNSGLAHRLSNPNVDV-LPQSLAYVIYTSGSTGMP 1650
Cdd:PRK06188 106 EDAGISTLIVdpapfveralallaRVPSLkHV--LTlGPVPDGVDLLAAAAKFGPAPLVAAaLPPDIAGLAYTGGTTGKP 183
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1651 KGVEIEHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASiweLFWWP--YAGASVYLLPQggeKEPEVIAKAIEEQKIT 1728
Cdd:PRK06188 184 KGVMGTHRSIATMAQIQLAEWEWPADPRFLMCTPLSHAGG---AFFLPtlLRGGTVIVLAK---FDPAEVLRAIEEQRIT 257
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1729 AMHFVPSMLHAFLEH-------------IKYRSVPIKTNRLKRvfsGGEQLGTHLVsrfyellpnvsitNSYGPTEATVE 1795
Cdd:PRK06188 258 ATFLVPTMIYALLDHpdlrtrdlssletVYYGASPMSPVRLAE---AIERFGPIFA-------------QYYGQTEAPMV 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1796 AAFFD----CPPHEKLeRIPIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYpger 1871
Cdd:PRK06188 322 ITYLRkrdhDPDDPKR-LTSCGRPTPGLRVALLDEDGREVAQGEVGEICVRGPLVMDGYWNRPEETAEAFRDGWLH---- 396
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1872 mykTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GEpELCAYV---EGLQRN- 1945
Cdd:PRK06188 397 ---TGDVAREDEDGFYYIVDRKKDMIVTGGFNVFPREVEDVLAEHPAVAQVAVIGVPDEkwGE-AVTAVVvlrPGAAVDa 472
|
490 500 510 520
....*....|....*....|....*....|....*....|..
gi 1678550997 1946 -EVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNALPAP 1986
Cdd:PRK06188 473 aELQAHVKERKGSVHAPKQVDFVDSLPLTALGKPDKKALRAR 514
|
|
| LC_FACS_like |
cd05935 |
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain ... |
488-952 |
5.94e-36 |
|
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain fatty acyl-CoA synthetases, which catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters.
Pssm-ID: 341258 [Multi-domain] Cd Length: 430 Bit Score: 144.16 E-value: 5.94e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 488 SLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSQ 567
Cdd:cd05935 1 SLTYLELLEVVKKLASFLSNKGVRKGDRVGICLQNSPQYVIAYFAIWRANAVVVPINPMLKERELEYILNDSGAKVAVVG 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 568 AHLpsslednyiithpedieskvdgsniksvnnaDDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEYTHSGIDFEaDVL 647
Cdd:cd05935 81 SEL-------------------------------DDLALIPYTSGTTGLPKGCMHTHFSAAANALQSAVWTGLTPS-DVI 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 648 QFATPSFDVC--YQEIFSALLKGGTLHIVPEAIKRDVPQLF-AFINKHQTNIvflPTAFIKMI----FSERELANsfpdg 720
Cdd:cd05935 129 LACLPLFHVTgfVGSLNTAVYVGGTYVLMARWDRETALELIeKYKVTFWTNI---PTMLVDLLatpeFKTRDLSS----- 200
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 721 vKHLIAAGEQLMISDLFQDVLRKRGIHLHNHYGPSEThVVSTYTIHPGDpiPELPPIGKPIGCTDLYILNHQ--KQLQPc 798
Cdd:cd05935 201 -LKVLTGGGAPMPPAVAEKLLKLTGLRFVEGYGLTET-MSQTHTNPPLR--PKLQCLGIP*FGVDARVIDIEtgRELPP- 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 799 GVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTL 878
Cdd:cd05935 276 NEVGEIVVRGPQIFKGYWNRPEETEESFIEIKGRR---FFRTGDLGYMDEEGYFFFVDRVKRMINVSGFKVWPAEVEAKL 352
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1678550997 879 MNHPDISEAAILIWQDQNGEHELCAYYC----SVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:cd05935 353 YKHPAI*EVCVISVPDERVGEEVKAFIVlrpeYRGKVTEEDIIEWAREQMAAYKYPREVEFVDELPRSASGKILWRLL 430
|
|
| PRK07798 |
PRK07798 |
acyl-CoA synthetase; Validated |
1500-1979 |
8.93e-36 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236100 [Multi-domain] Cd Length: 533 Bit Score: 145.80 E-value: 8.93e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYP 1579
Cdd:PRK07798 9 FEAVADAVPDRVALVCGDRRLTYAELEERANRLAHYLIAQGLGPGDHVGIYARNRIEYVEAMLGAFKARAVPVNVNYRYV 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1580 EERISFLLEDSGTNILLLQSaglhvpEFTGEIVYLNQTNSGLAHRL-----------------------SNPNVDVLPQS 1636
Cdd:PRK07798 89 EDELRYLLDDSDAVALVYER------EFAPRVAEVLPRLPKLRTLVvvedgsgndllpgavdyedalaaGSPERDFGERS 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1637 L--AYVIYTSGSTGMPKGV----EIEHRSA---VNFLNSLQSRYQLKHSDMI--------------MHKTSYSfdASIWE 1693
Cdd:PRK07798 163 PddLYLLYTGGTTGMPKGVmwrqEDIFRVLlggRDFATGEPIEDEEELAKRAaagpgmrrfpapplMHGAGQW--AAFAA 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1694 LFwwpyAGASVYLLPqGGEKEPEVIAKAIEEQKITAMHFV------PsMLHAFLEHIKYRsvpikTNRLKRVFSGGEQLG 1767
Cdd:PRK07798 241 LF----SGQTVVLLP-DVRFDADEVWRTIEREKVNVITIVgdamarP-LLDALEARGPYD-----LSSLFAIASGGALFS 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1768 THLVSRFYELLPNVSITNSYGPTEA----TVEAAffDCPPHEKLERIPIGKPVHhvrlyLLNQNQRMLPVGCIGELYIAG 1843
Cdd:PRK07798 310 PSVKEALLELLPNVVLTDSIGSSETgfggSGTVA--KGAVHTGGPRFTIGPRTV-----VLDEDGNPVEPGSGEIGWIAR 382
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1844 AG-VARGYLNRPALTEERFLEdpfYPGERMYKTGDVARWLPDGNVEFLGRtdDQVKIR--GYRIEPGEIEAALRSIEGVR 1920
Cdd:PRK07798 383 RGhIPLGYYKDPEKTAETFPT---IDGVRYAIPGDRARVEADGTITLLGR--GSVCINtgGEKVFPEEVEEALKAHPDVA 457
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 1921 EAAVTVRTDS--GEpELCAYVE-----GLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLD 1979
Cdd:PRK07798 458 DALVVGVPDErwGQ-EVVAVVQlregaRPDLAELRAHCRSSLAGYKVPRAIWFVDEVQRSPAGKAD 522
|
|
| A_NRPS_TubE_like |
cd05906 |
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) ... |
1494-1983 |
9.11e-36 |
|
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) synthesizing toxins and antitumor agents; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino)-acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family includes NRPSs that synthesize toxins and antitumor agents; for example, TubE for Tubulysine, CrpA for cryptophycin, TdiA for terrequinone A, KtzG for kutzneride, and Vlm1/Vlm2 for Valinomycin. Nonribosomal peptide synthetases are large multifunctional enzymes which synthesize many therapeutically useful peptides. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341232 [Multi-domain] Cd Length: 540 Bit Score: 145.89 E-value: 9.11e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1494 QTLHYALEQQAEKTPDQAAV-IFEDG---VMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGG 1569
Cdd:cd05906 10 RTLLELLLRAAERGPTKGITyIDADGseeFQSYQDLLEDARRLAAGLRQLGLRPGDSVILQFDDNEDFIPAFWACVLAGF 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1570 --AYLPIDPDYPE--------ERISFLLEDSgtniLLLQSAGLhVPEF---TGEIVYLNQTNSGLAHRLSNPNVDVLPQS 1636
Cdd:cd05906 90 vpAPLTVPPTYDEpnarlrklRHIWQLLGSP----VVLTDAEL-VAEFaglETLSGLPGIRVLSIEELLDTAADHDLPQS 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1637 ----LAYVIYTSGSTGMPKGVEIEHRsavNFLNSLQSRYQLKHSDmimhktsySFDASiweLFWWP--YAGASVYL---- 1706
Cdd:cd05906 165 rpddLALLMLTSGSTGFPKAVPLTHR---NILARSAGKIQHNGLT--------PQDVF---LNWVPldHVGGLVELhlra 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1707 LPQGGE----KEPEVIAKA------IEEQKIT---AMHFVPSMLHAFLEHIKYRSVPIktNRLKRVFSGGEQLGTHLVSR 1773
Cdd:cd05906 231 VYLGCQqvhvPTEEILADPlrwldlIDRYRVTitwAPNFAFALLNDLLEEIEDGTWDL--SSLRYLVNAGEAVVAKTIRR 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1774 FYELL------PNVsITNSYGPTEaTVEAAFFD----CPPH-EKLERIPIGKPVHHVRLYLLNQNQRMLPVGCIGELYIA 1842
Cdd:cd05906 309 LLRLLepyglpPDA-IRPAFGMTE-TCSGVIYSrsfpTYDHsQALEFVSLGRPIPGVSMRIVDDEGQLLPEGEVGRLQVR 386
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1843 GAGVARGYLNRPALTEERFLEDPFypgermYKTGDVArWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVRE- 1921
Cdd:cd05906 387 GPVVTKGYYNNPEANAEAFTEDGW------FRTGDLG-FLDNGNLTITGRTKDTIIVNGVNYYSHEIEAAVEEVPGVEPs 459
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 1922 --AAVTVRTDSGEPELCA--YVEGLQRNEVRAQLER-----------LLPGYMVPaymIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd05906 460 ftAAFAVRDPGAETEELAifFVPEYDLQDALSETLRairsvvsrevgVSPAYLIP---LPKEEIPKTSLGKIQRSKL 533
|
|
| OSB_CoA_lg |
cd05912 |
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA ... |
2558-3019 |
1.03e-35 |
|
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA synthetase, or MenE); O-succinylbenzoic acid-CoA synthase catalyzes the coenzyme A (CoA)- and ATP-dependent conversion of o-succinylbenzoic acid to o-succinylbenzoyl-CoA. The reaction is the fourth step of the biosynthesis pathway of menaquinone (vitamin K2). In certain bacteria, menaquinone is used during fumarate reduction in anaerobic respiration. In cyanobacteria, the product of the menaquinone pathway is phylloquinone (2-methyl-3-phytyl-1,4-naphthoquinone), a molecule used exclusively as an electron transfer cofactor in Photosystem 1. In green sulfur bacteria and heliobacteria, menaquinones are used as loosely bound secondary electron acceptors in the photosynthetic reaction center.
Pssm-ID: 341238 [Multi-domain] Cd Length: 411 Bit Score: 142.87 E-value: 1.03e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2558 TLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDpeypkerkryilsdsgTKLlmTI 2637
Cdd:cd05912 1 SYTFAELFEEVSRLAEHLAALGVRKGDRVALLSKNSIEMILLIHALWLLGAEAVLLN----------------TRL--TP 62
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2638 NEadlgvLADfegEILTIESVEEDdksplpqmssahhLAYIIYTSGTTGRPKGVmvehkgiantLQWRRNAYA------- 2710
Cdd:cd05912 63 NE-----LAF---QLKDSDVKLDD-------------IATIMYTSGTTGKPKGV----------QQTFGNHWWsaigsal 111
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2711 ---FNETD---TILQLFSFSfdGfITSMFTPLLSGAKAVLLHEEEAKDILaikHQLSRQRITHMIIVPVLYRALLDVVQP 2784
Cdd:cd05912 112 nlgLTEDDnwlCALPLFHIS--G-LSILMRSVIYGMTVYLVDKFDAEQVL---HLINSGKVTIISVVPTMLQRLLEILGE 185
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2785 EDVKTLRVVTLAGEAADRELiarsLAICPHTELA--NEYGPTENS---VATTVMRHMEKQAyvSIGQPIDGTQVLIlnsN 2859
Cdd:cd05912 186 GYPNNLRCILLGGGPAPKPL----LEQCKEKGIPvyQSYGMTETCsqiVTLSPEDALNKIG--SAGKPLFPVELKI---E 256
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2860 HQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKpearmyrTGDAARWMADGTLEYLGRIDDQVKIRGYRVETK 2939
Cdd:cd05912 257 DDGQPPYEVGEILLKGPNVTKGYLNRPDATEESFENGWFK-------TGDIGYLDEEGFLYVLDRRSDLIISGGENIYPA 329
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2940 EIESVIRCIKGVKDAAVVAHVTAS-GQTELsAYVVTKPGLSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGA 3018
Cdd:cd05912 330 EIEEVLLSHPAIKEAGVVGIPDDKwGQVPV-AFVVSERPISEEELIAYCSEKLAKYKVPKKIYFVDELPRTASGKLLRHE 408
|
.
gi 1678550997 3019 L 3019
Cdd:cd05912 409 L 409
|
|
| ACS-like |
cd17634 |
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the ... |
2550-3014 |
1.34e-35 |
|
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases. The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341289 [Multi-domain] Cd Length: 587 Bit Score: 146.18 E-value: 1.34e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2550 SALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDS 2629
Cdd:cd17634 76 GDDTSQSRTISYRELHREVCRFAGTLLDLGVKKGDRVAIYMPMIPEAAVAMLACARIGAVHSVIFGGFAPEAVAGRIIDS 155
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2630 GTKLLMTINEA-------DLGVLADfEGEILTIESVEE-------------------------DDKSP--LPQMSSAHHL 2675
Cdd:cd17634 156 SSRLLITADGGvragrsvPLKKNVD-DALNPNVTSVEHvivlkrtgsdidwqegrdlwwrdliAKASPehQPEAMNAEDP 234
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2676 AYIIYTSGTTGRPKGVMVEHKGIANTLQWR-RNAYAFNETDTIlqlFSFSFDGFITS----MFTPLLSGAKAVLLH-EEE 2749
Cdd:cd17634 235 LFILYTSGTTGKPKGVLHTTGGYLVYAATTmKYVFDYGPGDIY---WCTADVGWVTGhsylLYGPLACGATTLLYEgVPN 311
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2750 AKDILAIKHQLSRQRITHMIIVPVLYRALL----DVVQPEDVKTLRVVTLAGEAADRELIARSLAI-----CPhteLANE 2820
Cdd:cd17634 312 WPTPARMWQVVDKHGVNILYTAPTAIRALMaagdDAIEGTDRSSLRILGSVGEPINPEAYEWYWKKigkekCP---VVDT 388
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2821 YGPTENSVA-TTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGT--GLARGYVNLPElterAFTQNP 2897
Cdd:cd17634 389 WWQTETGGFmITPLPGAIELKAGSATRPVFGVQPAVVDNEGHPQPGGTEGNLVITDPwpGQTRTLFGDHE----RFEQTY 464
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2898 FKPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPG 2977
Cdd:cd17634 465 FSTFKGMYFSGDGARRDEDGYYWITGRSDDVINVAGHRLGTAEIESVLVAHPKVAEAAVVGIPHAIKGQAPYAYVVLNHG 544
|
490 500 510 520
....*....|....*....|....*....|....*....|..
gi 1678550997 2978 LS-----TNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKL 3014
Cdd:cd17634 545 VEpspelYAELRNWVRKEIGPLATPDVVHWVDSLPKTRSGKI 586
|
|
| OSB_CoA_lg |
cd05912 |
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA ... |
1521-1983 |
1.58e-35 |
|
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA synthetase, or MenE); O-succinylbenzoic acid-CoA synthase catalyzes the coenzyme A (CoA)- and ATP-dependent conversion of o-succinylbenzoic acid to o-succinylbenzoyl-CoA. The reaction is the fourth step of the biosynthesis pathway of menaquinone (vitamin K2). In certain bacteria, menaquinone is used during fumarate reduction in anaerobic respiration. In cyanobacteria, the product of the menaquinone pathway is phylloquinone (2-methyl-3-phytyl-1,4-naphthoquinone), a molecule used exclusively as an electron transfer cofactor in Photosystem 1. In green sulfur bacteria and heliobacteria, menaquinones are used as loosely bound secondary electron acceptors in the photosynthetic reaction center.
Pssm-ID: 341238 [Multi-domain] Cd Length: 411 Bit Score: 142.10 E-value: 1.58e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1521 TYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSgtnilllqsa 1600
Cdd:cd05912 3 TFAELFEEVSRLAEHLAALGVRKGDRVALLSKNSIEMILLIHALWLLGAEAVLLNTRLTPNELAFQLKDS---------- 72
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1601 glhvpeftgeivylnqtnsglahrlsnpnvDVLPQSLAYVIYTSGSTGMPKGVEIEHR----SAVNFLNSLQsryqLKHS 1676
Cdd:cd05912 73 ------------------------------DVKLDDIATIMYTSGTTGKPKGVQQTFGnhwwSAIGSALNLG----LTED 118
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1677 DM------IMHKTSYSFdasiweLFWWPYAGASVYLLPQggeKEPEVIAKAIEEQKITAMHFVPSMLHAFLEhIKYRSVP 1750
Cdd:cd05912 119 DNwlcalpLFHISGLSI------LMRSVIYGMTVYLVDK---FDAEQVLHLINSGKVTIISVVPTMLQRLLE-ILGEGYP 188
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1751 iktNRLKRVFSGGEQLGTHLVSRFYELlpNVSITNSYGPTEATVEAAFFdcPPHEKLERI-PIGKPVHHVRLYLLNQNQr 1829
Cdd:cd05912 189 ---NNLRCILLGGGPAPKPLLEQCKEK--GIPVYQSYGMTETCSQIVTL--SPEDALNKIgSAGKPLFPVELKIEDDGQ- 260
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1830 mlPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFypgermyKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEI 1909
Cdd:cd05912 261 --PPYEVGEILLKGPNVTKGYLNRPDATEESFENGWF-------KTGDIGYLDEEGFLYVLDRRSDLIISGGENIYPAEI 331
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1910 EAALRSIEGVREAAVTVRTDS--GE-PelCAYV---EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd05912 332 EEVLLSHPAIKEAGVVGIPDDkwGQvP--VAFVvseRPISEEELIAYCSEKLAKYKVPKKIYFVDELPRTASGKLLRHEL 409
|
|
| FAAL |
cd05931 |
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and ... |
2541-2958 |
1.73e-35 |
|
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and is homologous to fatty acyl-coenzyme A (CoA) ligases (FACLs). However, FAALs produce only the acyl adenylate and are unable to perform the thioester-forming reaction, while FACLs perform a two-step catalytic reaction; AMP ligation followed by CoA ligation using ATP and CoA as cofactors. FAALs have insertion motifs between the N-terminal and C-terminal subdomains that distinguish them from the FACLs. This insertion motif precludes the binding of CoA, thus preventing CoA ligation. It has been suggested that the acyl adenylates serve as substrates for multifunctional polyketide synthases to permit synthesis of complex lipids such as phthiocerol dimycocerosate, sulfolipids, mycolic acids, and mycobactin.
Pssm-ID: 341254 [Multi-domain] Cd Length: 547 Bit Score: 145.07 E-value: 1.73e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2541 QQAARTPKASALV------SGDKTLTYQELDEWSNGIARALRSRGvKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPI- 2613
Cdd:cd05931 1 RRAAARPDRPAYTflddegGREETLTYAELDRRARAIAARLQAVG-KPGDRVLLLAPPGLDFVAAFLGCLYAGAIAVPLp 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2614 DPEYPKERKRY--ILSDSGTKLLMTINEADLGVLADFEG-------EILTIESVEEDDKSPLPQMSSAHH-LAYIIYTSG 2683
Cdd:cd05931 80 PPTPGRHAERLaaILADAGPRVVLTTAAALAAVRAFAASrpaagtpRLLVVDLLPDTSAADWPPPSPDPDdIAYLQYTSG 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2684 TTGRPKGVMVEHKGI-ANTLQWRRnAYAFNETDTI---LQLFSfsfD-GFITSMFTPLLSGAKAVLLHEEE--AKDILAI 2756
Cdd:cd05931 160 STGTPKGVVVTHRNLlANVRQIRR-AYGLDPGDVVvswLPLYH---DmGLIGGLLTPLYSGGPSVLMSPAAflRRPLRWL 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2757 KHqLSRQRITHMIIVPVLYRALLDVVQPE-----DVKTLRVVTLAGEAADRELIARSL-----------AICPHtelane 2820
Cdd:cd05931 236 RL-ISRYRATISAAPNFAYDLCVRRVRDEdleglDLSSWRVALNGAEPVRPATLRRFAeafapfgfrpeAFRPS------ 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2821 YGPTENSVATT--------VMRHMEKQAY-----------------VSIGQPIDGTQVLILNSN-HQLQPIGVAGELCIA 2874
Cdd:cd05931 309 YGLAEATLFVSggppgtgpVVLRVDRDALagravavaaddpaarelVSCGRPLPDQEVRIVDPEtGRELPDGEVGEIWVR 388
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2875 GTGLARGYVNLPELTERAFTQNPFKPEARMYRTGDAARwMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDA 2954
Cdd:cd05931 389 GPSVASGYWGRPEATAETFGALAATDEGGWLRTGDLGF-LHDGELYITGRLKDLIIVRGRNHYPQDIEATAEEAHPALRP 467
|
....
gi 1678550997 2955 AVVA 2958
Cdd:cd05931 468 GCVA 471
|
|
| CHC_CoA_lg |
cd05903 |
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); ... |
1519-1978 |
3.24e-35 |
|
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); Cyclohexanecarboxylate-CoA ligase activates the aliphatic ring compound, cyclohexanecarboxylate, for degradation. It catalyzes the synthesis of cyclohexanecarboxylate-CoA thioesters in a two-step reaction involving the formation of cyclohexanecarboxylate-AMP anhydride, followed by the nucleophilic substitution of AMP by CoA.
Pssm-ID: 341229 [Multi-domain] Cd Length: 437 Bit Score: 142.13 E-value: 3.24e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1519 VMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLlq 1598
Cdd:cd05903 1 RLTYSELDTRADRLAAGLAALGVGPGDVVAFQLPNWWEFAVLYLACLRIGAVTNPILPFFREHELAFILRRAKAKVFV-- 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1599 saglhVPEFTGEIVYLNQtnsglahrlsnpnvdvlPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDM 1678
Cdd:cd05903 79 -----VPERFRQFDPAAM-----------------PDAVALLLFTSGTTGEPKGVMHSHNTLSASIRQYAERLGLGPGDV 136
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1679 IM------HKTSYSFDASIWELfwwpyAGASVYLLPQGgekEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIK 1752
Cdd:cd05903 137 FLvaspmaHQTGFVYGFTLPLL-----LGAPVVLQDIW---DPDKALALMREHGVTFMMGATPFLTDLLNAVEEAGEPLS 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1753 tnRLKRVFSGGEQLGTHLVSRFYELLPNVsITNSYGPTEatVEAAFFDCPPHEKLERIPI-GKPVHHVRLYLLNQNQRML 1831
Cdd:cd05903 209 --RLRTFVCGGATVPRSLARRAAELLGAK-VCSAYGSTE--CPGAVTSITPAPEDRRLYTdGRPLPGVEIKVVDDTGATL 283
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1832 PVGCIGELYIAGAGVARGYLNRPALTEErfledpFYPgERMYKTGDVARWLPDGNVEFLGRTDDqVKIR-GYRIEPGEIE 1910
Cdd:cd05903 284 APGVEGELLSRGPSVFLGYLDRPDLTAD------AAP-EGWFRTGDLARLDEDGYLRITGRSKD-IIIRgGENIPVLEVE 355
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 1911 AALRSIEGVREAAVTVRTDS--GEpELCAYV---EG--LQRNEVRAQLERL-LPGYMVPAYMIEMEQWPVTPSGKL 1978
Cdd:cd05903 356 DLLLGHPGVIEAAVVALPDErlGE-RACAVVvtkSGalLTFDELVAYLDRQgVAKQYWPERLVHVDDLPRTPSGKV 430
|
|
| VL_LC_FACS_like |
cd05907 |
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA ... |
2557-2958 |
4.40e-35 |
|
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA synthetases; This family includes long-chain fatty acid (C12-C20) CoA synthetases and Bubblegum-like very long-chain (>C20) fatty acid CoA synthetases. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Drosophila melanogaster mutant bubblegum (BGM) have elevated levels of very-long-chain fatty acids (VLCFA) caused by a defective gene later named bubblegum. The human homolog (hsBG) of bubblegum has been characterized as a very long chain fatty acid CoA synthetase that functions specifically in the brain; hsBG may play a central role in brain VLCFA metabolism and myelinogenesis. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341233 [Multi-domain] Cd Length: 452 Bit Score: 141.96 E-value: 4.40e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2557 KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMT 2636
Cdd:cd05907 4 QPITWAEFAEEVRALAKGLIALGVEPGDRVAILSRNRPEWTIADLAILAIGAVPVPIYPTSSAEQIAYILNDSEAKALFV 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2637 INEADLgvladfegeiltiesveeddksplpqmssahhlAYIIYTSGTTGRPKGVMVEHKGIAntlqwrRNAYAFNETDT 2716
Cdd:cd05907 84 EDPDDL---------------------------------ATIIYTSGTTGRPKGVMLSHRNIL------SNALALAERLP 124
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2717 ILQ---LFSF-----SFdGFITSMFTPLLSGakAVLLHEEEAKDILAikhQLSRQRITHMIIVPVLYRALLDVVQPEDVK 2788
Cdd:cd05907 125 ATEgdrHLSFlplahVF-ERRAGLYVPLLAG--ARIYFASSAETLLD---DLSEVRPTVFLAVPRVWEKVYAAIKVKAVP 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2789 T-------------LRVVTLAGEAADRELIARSLAI-CPHTELaneYGPTENSVATTVMrHMEKQAYVSIGQPIDGTQVl 2854
Cdd:cd05907 199 GlkrklfdlavggrLRFAASGGAPLPAELLHFFRALgIPVYEG---YGLTETSAVVTLN-PPGDNRIGTVGKPLPGVEV- 273
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2855 ilnsnhqlqPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMADGTLEYLGRIDD-QVKIRG 2933
Cdd:cd05907 274 ---------RIADDGEILVRGPNVMLGYYKNPEATAEALDADGW------LHTGDLGEIDEDGFLHITGRKKDlIITSGG 338
|
410 420
....*....|....*....|....*
gi 1678550997 2934 YRVETKEIESVIRCIKGVKDAAVVA 2958
Cdd:cd05907 339 KNISPEPIENALKASPLISQAVVIG 363
|
|
| VL_LC_FACS_like |
cd05907 |
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA ... |
488-952 |
5.66e-35 |
|
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA synthetases; This family includes long-chain fatty acid (C12-C20) CoA synthetases and Bubblegum-like very long-chain (>C20) fatty acid CoA synthetases. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Drosophila melanogaster mutant bubblegum (BGM) have elevated levels of very-long-chain fatty acids (VLCFA) caused by a defective gene later named bubblegum. The human homolog (hsBG) of bubblegum has been characterized as a very long chain fatty acid CoA synthetase that functions specifically in the brain; hsBG may play a central role in brain VLCFA metabolism and myelinogenesis. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341233 [Multi-domain] Cd Length: 452 Bit Score: 141.58 E-value: 5.66e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 488 SLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVsq 567
Cdd:cd05907 5 PITWAEFAEEVRALAKGLIALGVEPGDRVAILSRNRPEWTIADLAILAIGAVPVPIYPTSSAEQIAYILNDSEAKALF-- 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 568 ahlpsslednyiithpedieskvdgsniksVNNADDLLYMIYTSGTTGKPKGVQFEHRNMA----NLLKFeythsgIDFE 643
Cdd:cd05907 83 ------------------------------VEDPDDLATIIYTSGTTGRPKGVMLSHRNILsnalALAER------LPAT 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 644 AD-----VLQFATpsfdvCYQEI---FSALLKGGTLHIVP------EAIKRDVPQLFA----FINKHQTNIVF-LPTAFI 704
Cdd:cd05907 127 EGdrhlsFLPLAH-----VFERRaglYVPLLAGARIYFASsaetllDDLSEVRPTVFLavprVWEKVYAAIKVkAVPGLK 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 705 KMIFSERELANsfpdgVKHLIAAGeqlmiSDLFQDVL---RKRGIHLHNHYGPSETHVVSTYTiHPGDPIPELppIGKPI 781
Cdd:cd05907 202 RKLFDLAVGGR-----LRFAASGG-----APLPAELLhffRALGIPVYEGYGLTETSAVVTLN-PPGDNRIGT--VGKPL 268
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 782 GCTDLYIlnhqkqlqpcGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADN- 860
Cdd:cd05907 269 PGVEVRI----------ADDGEILVRGPNVMLGYYKNPEATAEALDADGW------LHTGDLGEIDEDGFLHITGRKKDl 332
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 861 QVKIRGYRIEPQEIEVTLMNHPDISEAAI----------LI---------WQDQNGEH-----ELCAYYCSVQklntiDL 916
Cdd:cd05907 333 IITSGGKNISPEPIENALKASPLISQAVVigdgrpflvaLIvpdpealeaWAEEHGIAytdvaELAANPAVRA-----EI 407
|
490 500 510 520
....*....|....*....|....*....|....*....|....*
gi 1678550997 917 RSYMAS---ELPEYMIPAKWI-----W-VDSIPLTPNGKVDRAAL 952
Cdd:cd05907 408 EAAVEAanaRLSRYEQIKKFLllpepFtIENGELTPTLKLKRPVI 452
|
|
| 23DHB-AMP_lg |
cd05920 |
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2, ... |
1485-1983 |
6.34e-35 |
|
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2,3-dihydroxybenzoate (DHB) by ligation of AMP from ATP with the release of pyrophosphate. However, it can also catalyze the ATP-PPi exchange for 2,3-DHB analogs, such as salicyclic acid (o-hydrobenzoate), as well as 2,4-DHB and 2,5-DHB, but with less efficiency. Proteins in this family are the stand-alone adenylation components of non-ribosomal peptide synthases (NRPSs) involved in the biosynthesis of siderophores, which are low molecular weight iron-chelating compounds synthesized by many bacteria to aid in the acquisition of this vital trace elements. In Escherichia coli, the 2,3-dihydroxybenzoate-AMP ligase is called EntE, the adenylation component of the enterobactin NRPS system.
Pssm-ID: 341244 [Multi-domain] Cd Length: 482 Bit Score: 142.08 E-value: 6.34e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1485 FEETGYSMNQTLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGI 1564
Cdd:cd05920 6 YRAAGYWQDEPLGDLLARSAARHPDRIAVVDGDRRLTYRELDRRADRLAAGLRGLGIRPGDRVVVQLPNVAEFVVLFFAL 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1565 LKAGGAYLPIDPDYPEERISFLLEDSgtnilllQSAGLHVPEFTGEIVYLNqtnsgLAHRLSNPNVDVlpqslAYVIYTS 1644
Cdd:cd05920 86 LRLGAVPVLALPSHRRSELSAFCAHA-------EAVAYIVPDRHAGFDHRA-----LARELAESIPEV-----ALFLLSG 148
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1645 GSTGMPKGVEIEHRSAVnflnslqsrYQLKHSDMIMHktsysFDASIWELFWWP----------------YAGASVYLLP 1708
Cdd:cd05920 149 GTTGTPKLIPRTHNDYA---------YNVRASAEVCG-----LDQDTVYLAVLPaahnfplacpgvlgtlLAGGRVVLAP 214
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1709 QGgekEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTNRLKRVfsGGEQLGTHLVSRFYELLpNVSITNSYG 1788
Cdd:cd05920 215 DP---SPDAAFPLIEREGVTVTALVPALVSLWLDAAASRRADLSSLRLLQV--GGARLSPALARRVPPVL-GCTLQQVFG 288
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1789 PTEATVEAAFFDcPPHEKLERIPiGKPVH-HVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFY 1867
Cdd:cd05920 289 MAEGLLNYTRLD-DPDEVIIHTQ-GRPMSpDDEIRVVDEEGNPVPPGEEGELLTRGPYTIRGYYRAPEHNARAFTPDGFY 366
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1868 pgermyKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GEpELCAYV----EG 1941
Cdd:cd05920 367 ------RTGDLVRRTPDGYLVVEGRIKDQINRGGEKIAAEEVENLLLRHPAVHDAAVVAMPDEllGE-RSCAFVvlrdPP 439
|
490 500 510 520
....*....|....*....|....*....|....*....|...
gi 1678550997 1942 LQRNEVRAQL-ERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd05920 440 PSAAQLRRFLrERGLAAYKLPDRIEFVDSLPLTAVGKIDKKAL 482
|
|
| PRK03640 |
PRK03640 |
o-succinylbenzoate--CoA ligase; |
2541-3016 |
6.41e-35 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 235146 [Multi-domain] Cd Length: 483 Bit Score: 142.02 E-value: 6.41e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2541 QQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKE 2620
Cdd:PRK03640 10 QRAFLTPDRTAIEFEEKKVTFMELHEAVVSVAGKLAALGVKKGDRVALLMKNGMEMILVIHALQQLGAVAVLLNTRLSRE 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2621 RKRYILSDSGTKLLMTineADLGVLADFEGEILTIESVEEDDKSPlPQMSSAHHL---AYIIYTSGTTGRPKGVMVEHKg 2697
Cdd:PRK03640 90 ELLWQLDDAEVKCLIT---DDDFEAKLIPGISVKFAELMNGPKEE-AEIQEEFDLdevATIMYTSGTTGKPKGVIQTYG- 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2698 iaNTLqWRRNAYAFN----ETDTIL---QLFSFSfdGFiTSMFTPLLSGAKAVLLHEEEAKDILAIkhqLSRQRITHMII 2770
Cdd:PRK03640 165 --NHW-WSAVGSALNlgltEDDCWLaavPIFHIS--GL-SILMRSVIYGMRVVLVEKFDAEKINKL---LQTGGVTIISV 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2771 VPVLYRALLDVVQPEDV-KTLRVVTLAGEAADRELiarsLAICPHTELA--NEYGPTENS---VATTVMRHMEKQAyvSI 2844
Cdd:PRK03640 236 VSTMLQRLLERLGEGTYpSSFRCMLLGGGPAPKPL----LEQCKEKGIPvyQSYGMTETAsqiVTLSPEDALTKLG--SA 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2845 GQPIDGTQVLILNSNHQLQPiGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKpearmyrTGDAARWMADGTLEYLGR 2924
Cdd:PRK03640 310 GKPLFPCELKIEKDGVVVPP-FEEGEIVVKGPNVTKGYLNREDATRETFQDGWFK-------TGDIGYLDEEGFLYVLDR 381
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2925 IDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVahvtasGQTELS------AYVVTKPGLSTNAVRSELQNKLPVFMHPA 2998
Cdd:PRK03640 382 RSDLIISGGENIYPAEIEEVLLSHPGVAEAGVV------GVPDDKwgqvpvAFVVKSGEVTEEELRHFCEEKLAKYKVPK 455
|
490
....*....|....*...
gi 1678550997 2999 FIEKLDSLPLSPNGKLDR 3016
Cdd:PRK03640 456 RFYFVEELPRNASGKLLR 473
|
|
| CBAL |
cd05923 |
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) ... |
463-952 |
7.12e-35 |
|
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) to 4-chlorobenzoyl-coenzyme A (4-CB-CoA) by the two-step adenylation and thioester-forming reactions. 4-Chlorobenzoate (4-CBA) is an environmental pollutant derived from microbial breakdown of aromatic pollutants, such as polychlorinated biphenyls (PCBs), DDT, and certain herbicides. The 4-CBA degrading pathway converts 4-CBA to the metabolite 4-hydroxybezoate (4-HBA), allowing some soil-dwelling microbes to utilize 4-CBA as an alternate carbon source. This pathway consists of three chemical steps catalyzed by 4-CBA-CoA ligase, 4-CBA-CoA dehalogenase, and 4HBA-CoA thioesterase in sequential reactions.
Pssm-ID: 341247 [Multi-domain] Cd Length: 493 Bit Score: 142.26 E-value: 7.12e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 463 ETIHAMFEKQAEKTPDAHAVIDQACS--LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAI 540
Cdd:cd05923 1 QTVFEMLRRAASRAPDACAIADPARGlrLTYSELRARIEAVAARLHARGLRPGQRVAVVLPNSVEAVIALLALHRLGAVP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 541 VPVDPHYPADRIRY-ILHDCGCSHVVSQAHLP------SSLEDNYIITHPEDIESKVDGSNIKS-VNNADDLLYMIYTSG 612
Cdd:cd05923 81 ALINPRLKAAELAElIERGEMTAAVIAVDAQVmdaifqSGVRVLALSDLVGLGEPESAGPLIEDpPREPEQPAFVFYTSG 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 613 TTGKPKGVQFEHRNMANLLKFEYTHSGIDFEA-DVLQFATPSFDVC-YQEIFSALLKGGTLHIVPEAIKRdvPQLFAFIN 690
Cdd:cd05923 161 TTGLPKGAVIPQRAAESRVLFMSTQAGLRHGRhNVVLGLMPLYHVIgFFAVLVAALALDGTYVVVEEFDP--ADALKLIE 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 691 KHQ-TNIVFLPTAFIKMIFSErELANSFPDGVKHLIAAGeqlmiSDLFQDVLRKRGIHLH----NHYGPSEThVVSTYti 765
Cdd:cd05923 239 QERvTSLFATPTHLDALAAAA-EFAGLKLSSLRHVTFAG-----ATMPDAVLERVNQHLPgekvNIYGTTEA-MNSLY-- 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 766 hpgDPIPELPPIGKPigctDLY-------ILNHQKQLQPCGVPGELYISGASVA--RGYVNHDKLTSDKFSSDpfkpdvi 836
Cdd:cd05923 310 ---MRDARTGTEMRP----GFFsevrivrIGGSPDEALANGEEGELIVAAAADAafTGYLNQPEATAKKLQDG------- 375
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 837 MYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAyyCSVQKLNTI-- 914
Cdd:cd05923 376 WYRTGDVGYVDPSGDVRILGRVDDMIISGGENIHPSEIERVLSRHPGVTEVVVIGVADERWGQSVTA--CVVPREGTLsa 453
|
490 500 510 520
....*....|....*....|....*....|....*....|
gi 1678550997 915 -DLRSY-MASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:cd05923 454 dELDQFcRASELADFKRPRRYFFLDELPKNAMNKVLRRQL 493
|
|
| VL_LC_FACS_like |
cd05907 |
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA ... |
1520-1983 |
7.84e-35 |
|
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA synthetases; This family includes long-chain fatty acid (C12-C20) CoA synthetases and Bubblegum-like very long-chain (>C20) fatty acid CoA synthetases. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Drosophila melanogaster mutant bubblegum (BGM) have elevated levels of very-long-chain fatty acids (VLCFA) caused by a defective gene later named bubblegum. The human homolog (hsBG) of bubblegum has been characterized as a very long chain fatty acid CoA synthetase that functions specifically in the brain; hsBG may play a central role in brain VLCFA metabolism and myelinogenesis. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341233 [Multi-domain] Cd Length: 452 Bit Score: 141.19 E-value: 7.84e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1520 MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILllqs 1599
Cdd:cd05907 6 ITWAEFAEEVRALAKGLIALGVEPGDRVAILSRNRPEWTIADLAILAIGAVPVPIYPTSSAEQIAYILNDSEAKAL---- 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1600 aglhvpeFTGEivylnqtnsglahrlsnpnvdvlPQSLAYVIYTSGSTGMPKGVEIEHRsavNFLNSLQSRYQLKHSDMI 1679
Cdd:cd05907 82 -------FVED-----------------------PDDLATIIYTSGTTGRPKGVMLSHR---NILSNALALAERLPATEG 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1680 MHKTSY-----SFDASIWELFWWpYAGASVYLLPqggekEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVP---- 1750
Cdd:cd05907 129 DRHLSFlplahVFERRAGLYVPL-LAGARIYFAS-----SAETLLDDLSEVRPTVFLAVPRVWEKVYAAIKVKAVPglkr 202
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1751 -----IKTNRLKRVFSGGEQLGTHLVSRFYELlpNVSITNSYGPTE--ATVEAAFFDCPPHEKleripIGKPVH--HVRl 1821
Cdd:cd05907 203 klfdlAVGGRLRFAASGGAPLPAELLHFFRAL--GIPVYEGYGLTEtsAVVTLNPPGDNRIGT-----VGKPLPgvEVR- 274
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1822 yllnqnqrmlpVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFypgermYKTGDVARWLPDGNVEFLGRTDD-QVKIR 1900
Cdd:cd05907 275 -----------IADDGEILVRGPNVMLGYYKNPEATAEALDADGW------LHTGDLGEIDEDGFLHITGRKKDlIITSG 337
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1901 GYRIEPGEIEAALRSIEGVREAAV------------TVRTDSGE-------PELCAYVEGLQRNEVRAQLER-------L 1954
Cdd:cd05907 338 GKNISPEPIENALKASPLISQAVVigdgrpflvaliVPDPEALEawaeehgIAYTDVAELAANPAVRAEIEAaveaanaR 417
|
490 500 510
....*....|....*....|....*....|....*
gi 1678550997 1955 LPGY-MVPAYMIEMEQWPV-----TPSGKLDRNAL 1983
Cdd:cd05907 418 LSRYeQIKKFLLLPEPFTIengelTPTLKLKRPVI 452
|
|
| PRK07638 |
PRK07638 |
acyl-CoA synthetase; Validated |
1504-1983 |
7.99e-35 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236071 [Multi-domain] Cd Length: 487 Bit Score: 141.84 E-value: 7.99e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1504 AEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETtVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERI 1583
Cdd:PRK07638 11 ASLQPNKIAIKENDRVLTYKDWFESVCKVANWLNEKESKNKT-IAILLENRIEFLQLFAGAAMAGWTCVPLDIKWKQDEL 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1584 SFLLEDSGTNILLLQSAGLH-VPEFTGEIVYLNQTNSGLAHRLSNP-NVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAV 1661
Cdd:PRK07638 90 KERLAISNADMIVTERYKLNdLPDEEGRVIEIDEWKRMIEKYLPTYaPIENVQNAPFYMGFTSGSTGKPKAFLRAQQSWL 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1662 NFLNSLQSRYQLKHSDMI------MHktSYSFDASIWELfwwpYAGASVYLLPQggeKEPEVIAKAIEEQKITAMHFVPS 1735
Cdd:PRK07638 170 HSFDCNVHDFHMKREDSVliagtlVH--SLFLYGAISTL----YVGQTVHLMRK---FIPNQVLDKLETENISVMYTVPT 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1736 MLHAFLEHIKYRSVPIKtnrlkrVFSGGEQLGTHLVSRFYELLPNVSITNSYGpteaTVEAAFFDCPPHEKLERIP--IG 1813
Cdd:PRK07638 241 MLESLYKENRVIENKMK------IISSGAKWEAEAKEKIKNIFPYAKLYEFYG----ASELSFVTALVDEESERRPnsVG 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1814 KPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEErfledpfyPGERMYKT-GDVARWLPDGNVEFLGR 1892
Cdd:PRK07638 311 RPFHNVQVRICNEAGEEVQKGEIGTVYVKSPQFFMGYIIGGVLARE--------LNADGWMTvRDVGYEDEEGFIYIVGR 382
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1893 TDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GE-PElcAYVEGLQ-RNEVRAQLERLLPGYMVPAYMIEME 1968
Cdd:PRK07638 383 EKNMILFGGINIFPEEIESVLHEHPAVDEIVVIGVPDSywGEkPV--AIIKGSAtKQQLKSFCLQRLSSFKIPKEWHFVD 460
|
490
....*....|....*
gi 1678550997 1969 QWPVTPSGKLDRNAL 1983
Cdd:PRK07638 461 EIPYTNSGKIARMEA 475
|
|
| PRK06839 |
PRK06839 |
o-succinylbenzoate--CoA ligase; |
470-954 |
8.55e-35 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 168698 [Multi-domain] Cd Length: 496 Bit Score: 141.92 E-value: 8.55e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 470 EKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMK-GVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYP 548
Cdd:PRK06839 9 EKRAYLHPDRIAIITEEEEMTYKQLHEYVSKVAAYLIYElNVKKGERIAILSQNSLEYIVLLFAIAKVECIAVPLNIRLT 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 549 ADRIRYILHDCGCSHVVSQ---AHLPSSLEDNYIITHPEDIESKVDGSNIKSVN----NADDLLYMIYTSGTTGKPKGVQ 621
Cdd:PRK06839 89 ENELIFQLKDSGTTVLFVEktfQNMALSMQKVSYVQRVISITSLKEIEDRKIDNfvekNESASFIICYTSGTTGKPKGAV 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 622 FEHRNM-----ANLLKFEYTHSgidfeaDVLQFATPSFDVCYQEIFS--ALLKGGTLhIVPEaiKRDVPQLFAFINKHQT 694
Cdd:PRK06839 169 LTQENMfwnalNNTFAIDLTMH------DRSIVLLPLFHIGGIGLFAfpTLFAGGVI-IVPR--KFEPTKALSMIEKHKV 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 695 NIVF-LPTAFIKMIFSERELANSFpDGVKHLIAAG----EQLMISdlFQDvlrkRGIHLHNHYGPSEThVVSTYTIHPGD 769
Cdd:PRK06839 240 TVVMgVPTIHQALINCSKFETTNL-QSVRWFYNGGapcpEELMRE--FID----RGFLFGQGFGMTET-SPTVFMLSEED 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 770 PIPELPPIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimyRTGDLARRLED 849
Cdd:PRK06839 312 ARRKVGSIGKPVLFCDYELIDENKNKVEVGEVGELLIRGPNVMKEYWNRPDATEETIQDGWL-------CTGDLARVDED 384
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 850 GNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQN-GEHELCAYYC-SVQKLNTIDLRSYMASELPEY 927
Cdd:PRK06839 385 GFVYIVGRKKEMIISGGENIYPLEVEQVINKLSDVYEVAVVGRQHVKwGEIPIAFIVKkSSSVLIEKDVIEHCRLFLAKY 464
|
490 500
....*....|....*....|....*..
gi 1678550997 928 MIPAKWIWVDSIPLTPNGKVDRAALPE 954
Cdd:PRK06839 465 KIPKEIVFLKELPKNATGKIQKAQLVN 491
|
|
| PRK06087 |
PRK06087 |
medium-chain fatty-acid--CoA ligase; |
440-952 |
9.80e-35 |
|
medium-chain fatty-acid--CoA ligase;
Pssm-ID: 180393 [Multi-domain] Cd Length: 547 Bit Score: 142.96 E-value: 9.80e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 440 IDITTDTEKRQL---IGEITDqtpvyETIHAMFEKQAEKTPDAHAVID-QACSLTYRELNKAANRLARHLRMKGVVRQEP 515
Cdd:PRK06087 2 VTLTFNEQRRAAyrqQGYWGD-----ASLADYWQQTARAMPDKIAVVDnHGASYTYSALDHAASRLANWLLAKGIEPGDR 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 516 VAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCG-----CSHVVSQ-----------AHLPS----SLE 575
Cdd:PRK06087 77 VAFQLPGWCEFTIIYLACLKVGAVSVPLLPSWREAELVWVLNKCQakmffAPTLFKQtrpvdlilplqNQLPQlqqiVGV 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 576 DNYIITHPEDIESKV--DGSNIK-SVN-NADDLLYMIYTSGTTGKPKGVQFEHRNM-----ANLLKFEYTHSGIDFEADV 646
Cdd:PRK06087 157 DKLAPATSSLSLSQIiaDYEPLTtAITtHGDELAAVLFTSGTEGLPKGVMLTHNNIlaserAYCARLNLTWQDVFMMPAP 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 647 LQFATPSFdvcyQEIFSALLKGGTlhIVPEAIKRDVpQLFAFINKHQTNIVFLPTAFIKMIFSERELANSFPDGVKHLIA 726
Cdd:PRK06087 237 LGHATGFL----HGVTAPFLIGAR--SVLLDIFTPD-ACLALLEQQRCTCMLGATPFIYDLLNLLEKQPADLSALRFFLC 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 727 AGEQLMiSDLFQDVLRkRGIHLHNHYGPSET--HVVstytIHPGDPIPELPPI-GKPIGCTDLYILNHQKQLQPCGVPGE 803
Cdd:PRK06087 310 GGTTIP-KKVARECQQ-RGIKLLSVYGSTESspHAV----VNLDDPLSRFMHTdGYAAAGVEIKVVDEARKTLPPGCEGE 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 804 LYISGASVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRaDNQVKIRG-YRIEPQEIEVTLMNHP 882
Cdd:PRK06087 384 EASRGPNVFMGYLDEPELTARALDEEGW------YYSGDLCRMDEAGYIKITGR-KKDIIVRGgENISSREVEDILLQHP 456
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 883 DISEAAILIWQDQNGEHELCAYYC---SVQKLNTIDLRSYMASE-LPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PRK06087 457 KIHDACVVAMPDERLGERSCAYVVlkaPHHSLTLEEVVAFFSRKrVAKYKYPEHIVVIDKLPRTASGKIQKFLL 530
|
|
| PRK06178 |
PRK06178 |
acyl-CoA synthetase; Validated |
2543-3019 |
1.74e-34 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235724 [Multi-domain] Cd Length: 567 Bit Score: 142.49 E-value: 1.74e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2543 AARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERK 2622
Cdd:PRK06178 43 ARERPQRPAIIFYGHVITYAELDELSDRFAALLRQRGVGAGDRVAVFLPNCPQFHIVFFGILKLGAVHVPVSPLFREHEL 122
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2623 RYILSDSGTKLLMTINE---------ADLGV-------LADFEGEILTIE-------------------SVEEDDKSPLP 2667
Cdd:PRK06178 123 SYELNDAGAEVLLALDQlapvveqvrAETSLrhvivtsLADVLPAEPTLPlpdslraprlaaagaidllPALRACTAPVP 202
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2668 QMSSA-HHLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQLF--SFSFDGFITSMFTPLLSGAKAVL 2744
Cdd:PRK06178 203 LPPPAlDALAALNYTGGTTGMPKGCEHTQRDMVYTAAAAYAVAVVGGEDSVFLSFlpEFWIAGENFGLLFPLFSGATLVL 282
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2745 LHEEEAKDILAIKHqlsRQRITHMIIVPVLYRALLDvvQPE----DVKTLRVVTLAG--EAADRELIARSLAICPHTELA 2818
Cdd:PRK06178 283 LARWDAVAFMAAVE---RYRVTRTVMLVDNAVELMD--HPRfaeyDLSSLRQVRVVSfvKKLNPDYRQRWRALTGSVLAE 357
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2819 NEYGPTENSVATTVMRHMEKQAY------VSIGQPIDGTQVLILN-SNHQLQPIGVAGELCIAGTGLARGYVNLPELTER 2891
Cdd:PRK06178 358 AAWGMTETHTCDTFTAGFQDDDFdllsqpVFVGLPVPGTEFKICDfETGELLPLGAEGEIVVRTPSLLKGYWNKPEATAE 437
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2892 AFTQNpfkpearMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTA-SGQTELsA 2970
Cdd:PRK06178 438 ALRDG-------WLHTGDIGKIDEQGFLHYLGRRKEMLKVNGMSVFPSEVEALLGQHPAVLGSAVVGRPDPdKGQVPV-A 509
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 2971 YVVTKPG--LSTNAVRSELQNKLPVFMHPAfIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK06178 510 FVQLKPGadLTAAALQAWCRENMAVYKVPE-IRIVDALPMTATGKVRKQDL 559
|
|
| PRK06145 |
PRK06145 |
acyl-CoA synthetase; Validated |
1504-1983 |
3.66e-34 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 102207 [Multi-domain] Cd Length: 497 Bit Score: 140.02 E-value: 3.66e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1504 AEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERI 1583
Cdd:PRK06145 12 ARRTPDRAALVYRDQEISYAEFHQRILQAAGMLHARGIGQGDVVALLMKNSAAFLELAFAASYLGAVFLPINYRLAADEV 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1584 SFLLEDSGTNILLLQSAGLHVPEFTGEIVYLNQTNSGLAHRLSNPNVDVLPQS------LAYVIYTSGSTGMPKGVeieH 1657
Cdd:PRK06145 92 AYILGDAGAKLLLVDEEFDAIVALETPKIVIDAAAQADSRRLAQGGLEIPPQAavaptdLVRLMYTSGTTDRPKGV---M 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1658 RSAVNFlnslqsryqlkHSDMIMHKTSYSFDASIWELFWWP--YAGA----SVYLLPQGG------EKEPEVIAKAIEEQ 1725
Cdd:PRK06145 169 HSYGNL-----------HWKSIDHVIALGLTASERLLVVGPlyHVGAfdlpGIAVLWVGGtlrihrEFDPEAVLAAIERH 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1726 KITAMHFVPSMLHAFLehikyrSVPIK----TNRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFDc 1801
Cdd:PRK06145 238 RLTCAWMAPVMLSRVL------TVPDRdrfdLDSLAWCIGGGEKTPESRIRDFTRVFTRARYIDAYGLTETCSGDTLME- 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1802 pPHEKLERI-PIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFypgermyKTGDVAR 1880
Cdd:PRK06145 311 -AGREIEKIgSTGRALAHVEIRIADGAGRWLPPNMKGEICMRGPKVTKGYWKDPEKTAEAFYGDWF-------RSGDVGY 382
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1881 WLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVT-VRTDSGEPELCAYV---EG--LQRNEVRAQLERL 1954
Cdd:PRK06145 383 LDEEGFLYLTDRKKDMIISGGENIASSEVERVIYELPEVAEAAVIgVHDDRWGERITAVVvlnPGatLTLEALDRHCRQR 462
|
490 500
....*....|....*....|....*....
gi 1678550997 1955 LPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK06145 463 LASFKVPRQLKVRDELPRNPSGKVLKRVL 491
|
|
| PRK07798 |
PRK07798 |
acyl-CoA synthetase; Validated |
464-948 |
5.68e-34 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236100 [Multi-domain] Cd Length: 533 Bit Score: 140.02 E-value: 5.68e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 464 TIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPV 543
Cdd:PRK07798 4 NIADLFEAVADAVPDRVALVCGDRRLTYAELEERANRLAHYLIAQGLGPGDHVGIYARNRIEYVEAMLGAFKARAVPVNV 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 544 DPHYPADRIRYILHDCGCSHVVSQAH--------LPS--------SLEDNYIITHP------EDIESKVDGSNIKSVNNA 601
Cdd:PRK07798 84 NYRYVEDELRYLLDDSDAVALVYEREfaprvaevLPRlpklrtlvVVEDGSGNDLLpgavdyEDALAAGSPERDFGERSP 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 602 DDlLYMIYTSGTTGKPKGVQFEHRNM-------ANLLKFEYTHSGIDFEADVLQ-FATPSFDVC-------YQEIFSALL 666
Cdd:PRK07798 164 DD-LYLLYTGGTTGMPKGVMWRQEDIfrvllggRDFATGEPIEDEEELAKRAAAgPGMRRFPAPplmhgagQWAAFAALF 242
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 667 KGGTLhIVPEAIKRDVPQLFAFINKHQTNIVFLP-TAFIK-MIfseRELANSFPDGVKHL--IAAGEQLM---ISDLFQD 739
Cdd:PRK07798 243 SGQTV-VLLPDVRFDADEVWRTIEREKVNVITIVgDAMARpLL---DALEARGPYDLSSLfaIASGGALFspsVKEALLE 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 740 VLrkRGIHLHNHYGPSET-----HVVSTYTIHPGDPIPELPPIGKPIGcTDLYIlnhqkqLQP-CGVPGELYISGAsVAR 813
Cdd:PRK07798 319 LL--PNVVLTDSIGSSETgfggsGTVAKGAVHTGGPRFTIGPRTVVLD-EDGNP------VEPgSGEIGWIARRGH-IPL 388
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 814 GYVNHDKLTSDKFssdpfkPDVIMYR---TGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAIL 890
Cdd:PRK07798 389 GYYKDPEKTAETF------PTIDGVRyaiPGDRARVEADGTITLLGRGSVCINTGGEKVFPEEVEEALKAHPDVADALVV 462
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 891 IWQDQNGEHELCAyycsVQKLNT------IDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVD 948
Cdd:PRK07798 463 GVPDERWGQEVVA----VVQLREgarpdlAELRAHCRSSLAGYKVPRAIWFVDEVQRSPAGKAD 522
|
|
| PRK08314 |
PRK08314 |
long-chain-fatty-acid--CoA ligase; Validated |
1495-1924 |
6.01e-34 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236235 [Multi-domain] Cd Length: 546 Bit Score: 140.48 E-value: 6.01e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1495 TLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGR-GVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLP 1573
Cdd:PRK08314 11 SLFHNLEVSARRYPDKTAIVFYGRAISYRELLEEAERLAGYLQQEcGVRKGDRVLLYMQNSPQFVIAYYAILRANAVVVP 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1574 IDPDYPEERISFLLEDSGTNIL------------LLQSAGLH------------------VPEF-----------TGEIV 1612
Cdd:PRK08314 91 VNPMNREEELAHYVTDSGARVAivgselapkvapAVGNLRLRhvivaqysdylpaepeiaVPAWlraepplqalaPGGVV 170
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1613 YLNQTnsgLAHRLSNPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSaVNFLNSLQSRYQLKHSDMIM-------HKTS- 1684
Cdd:PRK08314 171 AWKEA---LAAGLAPPPHTAGPDDLAVLPYTSGTTGVPKGCMHTHRT-VMANAVGSVLWSNSTPESVVlavlplfHVTGm 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1685 -YSFDASIwelfwwpYAGASVYLLPQGgekEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTnrLKRVFSGG 1763
Cdd:PRK08314 247 vHSMNAPI-------YAGATVVLMPRW---DREAAARLIERYRVTHWTNIPTMVVDFLASPGLAERDLSS--LRYIGGGG 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1764 EQLGTHLVSRFYELLpNVSITNSYGPTEaTVEAAFFDCPPHEKLEriPIGKPVHHVRLYLLN-QNQRMLPVGCIGELYIA 1842
Cdd:PRK08314 315 AAMPEAVAERLKELT-GLDYVEGYGLTE-TMAQTHSNPPDRPKLQ--CLGIPTFGVDARVIDpETLEELPPGEVGEIVVH 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1843 GAGVARGYLNRPALTEERFLEdpfYPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREA 1922
Cdd:PRK08314 391 GPQVFKGYWNRPEATAEAFIE---IDGKRFFRTGDLGRMDEEGYFFITDRLKRMINASGFKVWPAEVENLLYKHPAIQEA 467
|
..
gi 1678550997 1923 AV 1924
Cdd:PRK08314 468 CV 469
|
|
| A_NRPS_TubE_like |
cd05906 |
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) ... |
473-952 |
7.36e-34 |
|
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) synthesizing toxins and antitumor agents; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino)-acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family includes NRPSs that synthesize toxins and antitumor agents; for example, TubE for Tubulysine, CrpA for cryptophycin, TdiA for terrequinone A, KtzG for kutzneride, and Vlm1/Vlm2 for Valinomycin. Nonribosomal peptide synthetases are large multifunctional enzymes which synthesize many therapeutically useful peptides. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341232 [Multi-domain] Cd Length: 540 Bit Score: 140.11 E-value: 7.36e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 473 AEKTPDAHAV-IDQACS---LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGG--AIVPVDPH 546
Cdd:cd05906 20 AERGPTKGITyIDADGSeefQSYQDLLEDARRLAAGLRQLGLRPGDSVILQFDDNEDFIPAFWACVLAGFvpAPLTVPPT 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 547 YPADR--------IRYILHDCGCshVVSQAHLPSSLEDNYIITHPED----IESKVDGSNIKSVNNA--DDLLYMIYTSG 612
Cdd:cd05906 100 YDEPNarlrklrhIWQLLGSPVV--LTDAELVAEFAGLETLSGLPGIrvlsIEELLDTAADHDLPQSrpDDLALLMLTSG 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 613 TTGKPKGVQFEHRNMANLLKFEYTHSGIdFEADVlQFATPSFD----VCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAF 688
Cdd:cd05906 178 STGFPKAVPLTHRNILARSAGKIQHNGL-TPQDV-FLNWVPLDhvggLVELHLRAVYLGCQQVHVPTEEILADPLRWLDL 255
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 689 INKHQTNIVFLPTAFIKMIfseRELANSFPDG------VKHLIAAGEQLMIS--DLFQDVLRKRGIH---LHNHYGPSET 757
Cdd:cd05906 256 IDRYRVTITWAPNFAFALL---NDLLEEIEDGtwdlssLRYLVNAGEAVVAKtiRRLLRLLEPYGLPpdaIRPAFGMTET 332
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 758 HVVSTYTIHPG-DPIPELPP---IGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkp 833
Cdd:cd05906 333 CSGVIYSRSFPtYDHSQALEfvsLGRPIPGVSMRIVDDEGQLLPEGEVGRLQVRGPVVTKGYYNNPEANAEAFTEDGW-- 410
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 834 dvimYRTGDLArRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDI---SEAAILIWQDQNGEHELCAYYCSVQK 910
Cdd:cd05906 411 ----FRTGDLG-FLDNGNLTITGRTKDTIIVNGVNYYSHEIEAAVEEVPGVepsFTAAFAVRDPGAETEELAIFFVPEYD 485
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 911 LNtiDLRSYMASEL-----------PEYMIPakwIWVDSIPLTPNGKVDRAAL 952
Cdd:cd05906 486 LQ--DALSETLRAIrsvvsrevgvsPAYLIP---LPKEEIPKTSLGKIQRSKL 533
|
|
| PRK07786 |
PRK07786 |
long-chain-fatty-acid--CoA ligase; Validated |
2524-3019 |
1.05e-33 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 169098 [Multi-domain] Cd Length: 542 Bit Score: 139.53 E-value: 1.05e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2524 TGQANQYGVQTISQLFEQQAAR----TPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIAS 2599
Cdd:PRK07786 4 LTLAQEQPYLARRQNWVNQLARhalmQPDAPALRFLGNTTTWRELDDRVAALAGALSRRGVGFGDRVLILMLNRTEFVES 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2600 ILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMTinEADLGVLA------------------DFEGEILTIES-VEE 2660
Cdd:PRK07786 84 VLAANMLGAIAVPVNFRLTPPEIAFLVSDCGAHVVVT--EAALAPVAtavrdivpllstvvvaggSSDDSVLGYEDlLAE 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2661 DDKSPLPQMSSAHHLAYIIYTSGTTGRPKGVMVEHKGI-ANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSG 2739
Cdd:PRK07786 162 AGPAHAPVDIPNDSPALIMYTSGTTGRPKGAVLTHANLtGQAMTCLRTNGADINSDVGFVGVPLFHIAGIGSMLPGLLLG 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2740 AKAVlLHEEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDV--VQPEDVKtLRVVTLAGEAADRELIARSLAICPHTEL 2817
Cdd:PRK07786 242 APTV-IYPLGAFDPGQLLDVLEAEKVTGIFLVPAQWQAVCAEqqARPRDLA-LRVLSWGAAPASDTLLRQMAATFPEAQI 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2818 ANEYGPTENSVATTVMRHMEKQAYV-SIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFtqn 2896
Cdd:PRK07786 320 LAAFGQTEMSPVTCMLLGEDAIRKLgSVGKVIPTVAARVVDENMNDVPVGEVGEIVYRAPTLMSGYWNNPEATAEAF--- 396
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2897 pfkpEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTAS-GQTELSAYVVTK 2975
Cdd:PRK07786 397 ----AGGWFHSGDLVRQDEEGYVWVVDRKKDMIISGGENIYCAEVENVLASHPDIVEVAVIGRADEKwGEVPVAVAAVRN 472
|
490 500 510 520
....*....|....*....|....*....|....*....|....*.
gi 1678550997 2976 PG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK07786 473 DDaaLTLEDLAEFLTDRLARYKHPKALEIVDALPRNPAGKVLKTEL 518
|
|
| FAAL |
cd05931 |
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and ... |
1502-1982 |
1.77e-33 |
|
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and is homologous to fatty acyl-coenzyme A (CoA) ligases (FACLs). However, FAALs produce only the acyl adenylate and are unable to perform the thioester-forming reaction, while FACLs perform a two-step catalytic reaction; AMP ligation followed by CoA ligation using ATP and CoA as cofactors. FAALs have insertion motifs between the N-terminal and C-terminal subdomains that distinguish them from the FACLs. This insertion motif precludes the binding of CoA, thus preventing CoA ligation. It has been suggested that the acyl adenylates serve as substrates for multifunctional polyketide synthases to permit synthesis of complex lipids such as phthiocerol dimycocerosate, sulfolipids, mycolic acids, and mycobactin.
Pssm-ID: 341254 [Multi-domain] Cd Length: 547 Bit Score: 138.91 E-value: 1.77e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1502 QQAEKTPDQAAVIF------EDGVMTYKELNEQANRIAWELIGRGvKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPID 1575
Cdd:cd05931 1 RRAAARPDRPAYTFlddeggREETLTYAELDRRARAIAARLQAVG-KPGDRVLLLAPPGLDFVAAFLGCLYAGAIAVPLP 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1576 PDYPE---ERISFLLEDSGTNILLLQSAGL-HVPEF--------TGEIVYLNQTNSGLAHRLSNPNVDvlPQSLAYVIYT 1643
Cdd:cd05931 80 PPTPGrhaERLAAILADAGPRVVLTTAAALaAVRAFaasrpaagTPRLLVVDLLPDTSAADWPPPSPD--PDDIAYLQYT 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1644 SGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMImhktsysfdasiweLFWWP---------------YAGASVYLL- 1707
Cdd:cd05931 158 SGSTGTPKGVVVTHRNLLANVRQIRRAYGLDPGDVV--------------VSWLPlyhdmgligglltplYSGGPSVLMs 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1708 PQGGEKEPEVIAKAIEEQKITAMhFVPSMlhAFlEHIKYRSVPIKT-----NRLKRVFSGGEQLGTHLVSRFYEL----- 1777
Cdd:cd05931 224 PAAFLRRPLRWLRLISRYRATIS-AAPNF--AY-DLCVRRVRDEDLegldlSSWRVALNGAEPVRPATLRRFAEAfapfg 299
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1778 LPNVSITNSYGPTEATV-----------------------EAAFFDCPPHEKLERIPIGKPVHHVRLYLLN-QNQRMLPV 1833
Cdd:cd05931 300 FRPEAFRPSYGLAEATLfvsggppgtgpvvlrvdrdalagRAVAVAADDPAARELVSCGRPLPDQEVRIVDpETGRELPD 379
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1834 GCIGELYIAGAGVARGYLNRPALTEERFLEDPFYPGERMYKTGDVARwLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAAL 1913
Cdd:cd05931 380 GEVGEIWVRGPSVASGYWGRPEATAETFGALAATDEGGWLRTGDLGF-LHDGELYITGRLKDLIIVRGRNHYPQDIEATA 458
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1914 RSIEGV----REAAVTVRTDSGEP-----ELCAYVEGLQ----RNEVRAQLER---------LLpgymVPAYMIemeqwP 1971
Cdd:cd05931 459 EEAHPAlrpgCVAAFSVPDDGEERlvvvaEVERGADPADlaaiAAAIRAAVARehgvapadvVL----VRPGSI-----P 529
|
570
....*....|.
gi 1678550997 1972 VTPSGKLDRNA 1982
Cdd:cd05931 530 RTSSGKIQRRA 540
|
|
| EntE |
COG1021 |
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase ... |
1485-1983 |
1.99e-33 |
|
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440644 [Multi-domain] Cd Length: 533 Bit Score: 138.35 E-value: 1.99e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1485 FEETGYSMNQTLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGI 1564
Cdd:COG1021 16 YREAGYWRGETLGDLLRRRAERHPDRIAVVDGERRLSYAELDRRADRLAAGLLALGLRPGDRVVVQLPNVAEFVIVFFAL 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1565 LKAGGayLPIDPdYPEER---ISFLLEdsgtnilLLQSAGLHVPEFTGEIVY------LNQTNSGLAHRL---------- 1625
Cdd:COG1021 96 FRAGA--IPVFA-LPAHRraeISHFAE-------QSEAVAYIIPDRHRGFDYralareLQAEVPSLRHVLvvgdagefts 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1626 -----------SNPNVDvlPQSLAYVIYTSGSTGMPKGVEIEHRSAVnflnslqsrYQLKHSDMIMHKTSYS-------- 1686
Cdd:COG1021 166 ldallaapadlSEPRPD--PDDVAFFQLSGGTTGLPKLIPRTHDDYL---------YSVRASAEICGLDADTvylaalpa 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1687 ---FDASIWELFWWPYAGASVYLLPQGgekEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTnrLKRVFSGG 1763
Cdd:COG1021 235 ahnFPLSSPGVLGVLYAGGTVVLAPDP---SPDTAFPLIERERVTVTALVPPLALLWLDAAERSRYDLSS--LRVLQVGG 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1764 EQLGTHLVSRFYELLPnVSITNSYGPTEATVEAAFFDCPPheklERI--PIGKPVHH---VRLylLNQNQRMLPVGCIGE 1838
Cdd:COG1021 310 AKLSPELARRVRPALG-CTLQQVFGMAEGLVNYTRLDDPE----EVIltTQGRPISPddeVRI--VDEDGNPVPPGEVGE 382
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1839 LYIAGAGVARGYLNRPALTEERFLEDPFYpgermyKTGDVARWLPDGNVEFLGRTDDQVkIR-GYRIEPGEIEAALRSIE 1917
Cdd:COG1021 383 LLTRGPYTIRGYYRAPEHNARAFTPDGFY------RTGDLVRRTPDGYLVVEGRAKDQI-NRgGEKIAAEEVENLLLAHP 455
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 1918 GVREAAVTVRTDS--GEpELCAYV----EGLQRNEVRAQL-ERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:COG1021 456 AVHDAAVVAMPDEylGE-RSCAFVvprgEPLTLAELRRFLrERGLAAFKLPDRLEFVDALPLTAVGKIDKKAL 527
|
|
| PRK07514 |
PRK07514 |
malonyl-CoA synthase; Validated |
2538-3013 |
4.82e-33 |
|
malonyl-CoA synthase; Validated
Pssm-ID: 181011 [Multi-domain] Cd Length: 504 Bit Score: 136.93 E-value: 4.82e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2538 LFEQQAARTPKASAL---VSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPID 2614
Cdd:PRK07514 5 LFDALRAAFADRDAPfieTPDGLRYTYGDLDAASARLANLLVALGVKPGDRVAVQVEKSPEALALYLATLRAGAVFLPLN 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2615 PEYPKERKRYILSDSGTKLLMT--INEADLGVLADFEGEIlTIESVEEDDKSPLPQ----MSSAHH--------LAYIIY 2680
Cdd:PRK07514 85 TAYTLAELDYFIGDAEPALVVCdpANFAWLSKIAAAAGAP-HVETLDADGTGSLLEaaaaAPDDFEtvprgaddLAAILY 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2681 TSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQ-LFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIkhq 2759
Cdd:PRK07514 164 TSGTTGRSKGAMLSHGNLLSNALTLVDYWRFTPDDVLIHaLPIFHTHGLFVATNVALLAGASMIFLPKFDPDAVLAL--- 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2760 lsRQRITHMIIVPVLYRALLD--VVQPEDVKTLRVVTlAGEA---AD--RELIARSlaicPHTELaNEYGPTENSVATTV 2832
Cdd:PRK07514 241 --MPRATVMMGVPTFYTRLLQepRLTREAAAHMRLFI-SGSApllAEthREFQERT----GHAIL-ERYGMTETNMNTSN 312
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2833 MRHMEKQAyVSIGQPIDGTQVLILN--SNHQLqPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDA 2910
Cdd:PRK07514 313 PYDGERRA-GTVGFPLPGVSLRVTDpeTGAEL-PPGEIGMIEVKGPNVFKGYWRMPEKTAEEFRADGF------FITGDL 384
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2911 ARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAV--VAH------VTasgqtelsAYVVTKPG--LST 2980
Cdd:PRK07514 385 GKIDERGYVHIVGRGKDLIISGGYNVYPKEVEGEIDELPGVVESAVigVPHpdfgegVT--------AVVVPKPGaaLDE 456
|
490 500 510
....*....|....*....|....*....|...
gi 1678550997 2981 NAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGK 3013
Cdd:PRK07514 457 AAILAALKGRLARFKQPKRVFFVDELPRNTMGK 489
|
|
| ttLC_FACS_AlkK_like |
cd12119 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes ... |
2560-3019 |
4.86e-33 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes fatty acyl-CoA synthetases that can activate medium-chain to long-chain fatty acids. They catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family catalyzes the long-chain fatty acid, myristoyl acid, while another member in this family, the AlkK protein identified from Pseudomonas oleovorans, targets medium chain fatty acids. This family also includes uncharacterized FACS proteins.
Pssm-ID: 341284 [Multi-domain] Cd Length: 518 Bit Score: 136.99 E-value: 4.86e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2560 TYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMtINE 2639
Cdd:cd12119 27 TYAEVAERARRLANALRRLGVKPGDRVATLAWNTHRHLELYYAVPGMGAVLHTINPRLFPEQIAYIINHAEDRVVF-VDR 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2640 ADLGVLADFEGEILTIESV---EEDDKSPLPQMSSAHHL---------------------AYIIYTSGTTGRPKGVMVEH 2695
Cdd:cd12119 106 DFLPLLEAIAPRLPTVEHVvvmTDDAAMPEPAGVGVLAYeellaaespeydwpdfdentaAAICYTSGTTGNPKGVVYSH 185
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2696 K-------GIANTlqwrrNAYAFNETDTILQlfsfsfdgfITSMF------TP---LLSGAKAVL----LHeeeAKDILA 2755
Cdd:cd12119 186 RslvlhamAALLT-----DGLGLSESDVVLP---------VVPMFhvnawgLPyaaAMVGAKLVLpgpyLD---PASLAE 248
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2756 IkhqLSRQRITHMIIVPVLYRALLDVV--QPEDVKTLRVVTLAGEAADRELIARSLAIcpHTELANEYGPTENSVATTVM 2833
Cdd:cd12119 249 L---IEREGVTFAAGVPTVWQGLLDHLeaNGRDLSSLRRVVIGGSAVPRSLIEAFEER--GVRVIHAWGMTETSPLGTVA 323
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2834 R---------HMEKQAY-VSIGQPIDGTQVLILNSNHQLQPI-GVA-GELCIAGTGLARGYVNLPELTErAFTQNPFkpe 2901
Cdd:cd12119 324 RppsehsnlsEDEQLALrAKQGRPVPGVELRIVDDDGRELPWdGKAvGELQVRGPWVTKSYYKNDEESE-ALTEDGW--- 399
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2902 armYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTN 2981
Cdd:cd12119 400 ---LRTGDVATIDEDGYLTITDRSKDVIKSGGEWISSVELENAIMAHPAVAEAAVIGVPHPKWGERPLAVVVLKEGATVT 476
|
490 500 510 520
....*....|....*....|....*....|....*....|
gi 1678550997 2982 A--VRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:cd12119 477 AeeLLEFLADKVAKWWLPDDVVFVDEIPKTSTGKIDKKAL 516
|
|
| LC_FACS_like |
cd17640 |
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA ... |
489-895 |
5.20e-33 |
|
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA synthetases, including an Arabidopsis gene At4g14070 that plays a role in activation and elongation of exogenous fatty acids. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341295 [Multi-domain] Cd Length: 468 Bit Score: 135.95 E-value: 5.20e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 489 LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSQa 568
Cdd:cd17640 6 ITYKDLYQEILDFAAGLRSLGVKAGEKVALFADNSPRWLIADQGIMALGAVDVVRGSDSSVEELLYILNHSESVALVVE- 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 569 hlpsslednyiithpedieskvdgsniksvNNADDLLYMIYTSGTTGKPKGVQFEHRN----MANLLKFEYTHSGidfea 644
Cdd:cd17640 85 ------------------------------NDSDDLATIIYTSGTTGNPKGVMLTHANllhqIRSLSDIVPPQPG----- 129
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 645 DVLQFATPSFDVcYQEIFS--ALLKGGTLHIV-PEAIKRD-----------VPQLF-AFINKHQTNIVflptafiKMIFS 709
Cdd:cd17640 130 DRFLSILPIWHS-YERSAEyfIFACGCSQAYTsIRTLKDDlkrvkphyivsVPRLWeSLYSGIQKQVS-------KSSPI 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 710 ERELANSFPDG--VKHLIAAGEQLMIS-DLFQDVLrkrGIHLHNHYGPSETHVVSTYTIHPGdpiPELPPIGKPIGCTDL 786
Cdd:cd17640 202 KQFLFLFFLSGgiFKFGISGGGALPPHvDTFFEAI---GIEVLNGYGLTETSPVVSARRLKC---NVRGSVGRPLPGTEI 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 787 YILNHQ-KQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRA-DNQVKI 864
Cdd:cd17640 276 KIVDPEgNVVLPPGEKGIVWVRGPQVMKGYYKNPEATSKVLDSDGW------FNTGDLGWLTCGGELVLTGRAkDTIVLS 349
|
410 420 430
....*....|....*....|....*....|.
gi 1678550997 865 RGYRIEPQEIEVTLMNHPDIsEAAILIWQDQ 895
Cdd:cd17640 350 NGENVEPQPIEEALMRSPFI-EQIMVVGQDQ 379
|
|
| OSB_MenE-like |
cd17630 |
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) ... |
2675-3019 |
5.99e-33 |
|
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) synthetase (also known as O-succinylbenzoic acid CoA ligase) that belongs to the ANL superfamily and catalyzes the ligation of CoA to o-succinylbenzoate (OSB). It includes MenE in the bacterial menaquinone biosynthesis pathway which is a promising target for the development of novel antibacterial agents. MenE catalyzes CoA ligation via an acyl-adenylate intermediate; tight-binding inhibitors of MenE based on stable acyl-sulfonyladenosine analogs of this intermediate provide a pathway toward the development of optimized MenE inhibitors.
Pssm-ID: 341285 [Multi-domain] Cd Length: 325 Bit Score: 132.45 E-value: 5.99e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2675 LAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDT-ILQLFSFSFDGFITsMFTPLLSGAKAVLLheeEAKDI 2753
Cdd:cd17630 2 LATVILTSGSTGTPKAVVHTAANLLASAAGLHSRLGFGGGDSwLLSLPLYHVGGLAI-LVRSLLAGAELVLL---ERNQA 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2754 LAIKHQlsRQRITHMIIVPV-LYRALLDVVQPEDVKTLRVVTLAGEAADRELIARslAICPHTELANEYGPTENS--VAT 2830
Cdd:cd17630 78 LAEDLA--PPGVTHVSLVPTqLQRLLDSGQGPAALKSLRAVLLGGAPIPPELLER--AADRGIPLYTTYGMTETAsqVAT 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2831 TVMRHMEKQayvSIGQPIDGTQVLILNsnhqlqpigvAGELCIAGTGLARGYVNLPElteraftQNPFkPEARMYRTGDA 2910
Cdd:cd17630 154 KRPDGFGRG---GVGVLLPGRELRIVE----------DGEIWVGGASLAMGYLRGQL-------VPEF-NEDGWFTTKDL 212
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2911 ARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTAS-GQTeLSAYVVTKPGLSTNAVRSELQN 2989
Cdd:cd17630 213 GELHADGRLTVLGRADNMIISGGENIQPEEIEAALAAHPAVRDAFVVGVPDEElGQR-PVAVIVGRGPADPAELRAWLKD 291
|
330 340 350
....*....|....*....|....*....|
gi 1678550997 2990 KLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:cd17630 292 KLARFKLPKRIYPVPELPRTGGGKVDRRAL 321
|
|
| PRK08316 |
PRK08316 |
acyl-CoA synthetase; Validated |
1494-1978 |
9.46e-33 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181381 [Multi-domain] Cd Length: 523 Bit Score: 136.22 E-value: 9.46e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1494 QTLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLP 1573
Cdd:PRK08316 11 QTIGDILRRSARRYPDKTALVFGDRSWTYAELDAAVNRVAAALLDLGLKKGDRVAALGHNSDAYALLWLACARAGAVHVP 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1574 IDPDYPEERISFLLEDSGTNILLLQSA---------GLHVPEFTGEIVYLNQTNSG--------LAHRLSNPNVDVLPQS 1636
Cdd:PRK08316 91 VNFMLTGEELAYILDHSGARAFLVDPAlaptaeaalALLPVDTLILSLVLGGREAPggwldfadWAEAGSVAEPDVELAD 170
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1637 --LAYVIYTSGSTGMPKGVEIEHRSAV----------------NFLNSLqsryQLKHSDMiMHktsysfdasiweLFWWP 1698
Cdd:PRK08316 171 ddLAQILYTSGTESLPKGAMLTHRALIaeyvscivagdmsaddIPLHAL----PLYHCAQ-LD------------VFLGP 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1699 --YAGASVYLLPQggeKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTnrLKRVFSGGEQLGTHLVSRFYE 1776
Cdd:PRK08316 234 ylYVGATNVILDA---PDPELILRTIEAERITSFFAPPTVWISLLRHPDFDTRDLSS--LRKGYYGASIMPVEVLKELRE 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1777 LLPNVSITNSYGPTE----ATVeaaffdCPPHEKLERI-PIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYL 1851
Cdd:PRK08316 309 RLPGLRFYNCYGQTEiaplATV------LGPEEHLRRPgSAGRPVLNVETRVVDDDGNDVAPGEVGEIVHRSPQLMLGYW 382
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1852 NRPALTEERFLEDPFYpgermykTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAV------- 1924
Cdd:PRK08316 383 DDPEKTAEAFRGGWFH-------SGDLGVMDEEGYITVVDRKKDMIKTGGENVASREVEEALYTHPAVAEVAViglpdpk 455
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 1925 -------TVRTDSG----EPELCAYveglqrneVRAQlerlLPGYMVPAYMIEMEQWPVTPSGKL 1978
Cdd:PRK08316 456 wieavtaVVVPKAGatvtEDELIAH--------CRAR----LAGFKVPKRVIFVDELPRNPSGKI 508
|
|
| PRK13383 |
PRK13383 |
acyl-CoA synthetase; Provisional |
2517-3020 |
1.13e-32 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139531 [Multi-domain] Cd Length: 516 Bit Score: 135.89 E-value: 1.13e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2517 QLLNEFNTGQANQYGVQTISqlfeqqAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSM 2596
Cdd:PRK13383 25 RLLREASRGGTNPYTLLAVT------AARWPGRTAIIDDDGALSYRELQRATESLARRLTRDGVAPGRAVGVMCRNGRGF 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2597 IASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMTINE-ADLGVLADFEGEILTIESVEEDDKSPLPQMSSAHHL 2675
Cdd:PRK13383 99 VTAVFAVGLLGADVVPISTEFRSDALAAALRAHHISTVVADNEfAERIAGADDAVAVIDPATAGAEESGGRPAVAAPGRI 178
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2676 ayIIYTSGTTGRPKGVMVEHK-----GIANTLQWRRNAyafnETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEE-E 2749
Cdd:PRK13383 179 --VLLTSGTTGKPKGVPRAPQlrsavGVWVTILDRTRL----RTGSRISVAMPMFHGLGLGMLMLTIALGGTVLTHRHfD 252
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2750 AKDILAikhQLSRQRITHMIIVPVLYRALLDVvqPEDVKT------LRVVTLAGEAADRELIARSLAICPHTeLANEYGP 2823
Cdd:PRK13383 253 AEAALA---QASLHRADAFTAVPVVLARILEL--PPRVRArnplpqLRVVMSSGDRLDPTLGQRFMDTYGDI-LYNGYGS 326
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2824 TENSVATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHqlQPIG--VAGELCIAGtglargyvnlpELTERAFTQNPFKPE 2901
Cdd:PRK13383 327 TEVGIGALATPADLRDAPETVGKPVAGCPVRILDRNN--RPVGprVTGRIFVGG-----------ELAGTRYTDGGGKAV 393
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2902 AR-MYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPG--L 2978
Cdd:PRK13383 394 VDgMTSTGDMGYLDNAGRLFIVGREDDMIISGGENVYPRAVENALAAHPAVADNAVIGVPDERFGHRLAAFVVLHPGsgV 473
|
490 500 510 520
....*....|....*....|....*....|....*....|..
gi 1678550997 2979 STNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGALP 3020
Cdd:PRK13383 474 DAAQLRDYLKDRVSRFEQPRDINIVSSIPRNPTGKVLRKELP 515
|
|
| Cyc_NRPS |
cd19535 |
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
1082-1376 |
1.15e-32 |
|
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Cyc (heterocyclization) domains catalyze two separate reactions in the creation of heterocyclized peptide products in nonribosomal peptide synthesis: amide bond formation followed by intramolecular cyclodehydration between a Cys, Ser, or Thr side chain and a carbonyl carbon on the peptide backbone to form a thiazoline, oxazoline, or methyloxazoline ring. Cyc-domains are homologous to standard NRPS Condensation (C) domains. C-domains typically have a conserved HHxxxD motif at the active site; Cyc-domains have an alternative, conserved DxxxxD active site motif, mutation of the aspartate residues in this motif can abolish or diminish condensation activity. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and Cyc-domains. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380458 [Multi-domain] Cd Length: 423 Bit Score: 134.15 E-value: 1.15e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1082 AVLELEGA-LDVAKLSAVCKELISRHEPLRTSFvsgaDDEPVQRIHTEVPF---------TLSKETTIEGFV-------- 1143
Cdd:cd19535 28 AYLEFDGEdLDPDRLERAWNKLIARHPMLRAVF----LDDGTQQILPEVPWygitvhdlrGLSEEEAEAALEelrerlsh 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1144 RPFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYANR--QLKPLRIQYKDYAVWQQKFKKgDSY 1221
Cdd:cd19535 104 RVLDVERGPLFDIRLSLLPEGRTRLHLSIDLLVADALSLQILLRELAALYEDPgePLPPLELSFRDYLLAEQALRE-TAY 182
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1222 QKQETYWQQQFSgDLPI-LELPTdKRRPAERQfiggKVTF-----QLDKEITARIKRLAHKNRSTLYMTLLALYSAFLSR 1295
Cdd:cd19535 183 ERARAYWQERLP-TLPPaPQLPL-AKDPEEIK----EPRFtrrehRLSAEQWQRLKERARQHGVTPSMVLLTAYAEVLAR 256
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1296 LSGQDDIVIGSPIAGRP--HADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQTALEAYEHQDYPfeelvdklG--VQ 1371
Cdd:cd19535 257 WSGQPRFLLNLTLFNRLplHPDVNDVVGDFTSLLLLEVDGSEGQSFLERARRLQQQLWEDLDHSSYS--------GvvVV 328
|
....*
gi 1678550997 1372 REMSR 1376
Cdd:cd19535 329 RRLLR 333
|
|
| PRK12406 |
PRK12406 |
long-chain-fatty-acid--CoA ligase; Provisional |
2549-3028 |
1.59e-32 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 183506 [Multi-domain] Cd Length: 509 Bit Score: 135.60 E-value: 1.59e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2549 ASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSD 2628
Cdd:PRK12406 2 YATIISGDRRRSFDELAQRAARAAGGLAALGVRPGDCVALLMRNDFAFFEAAYAAMRLGAYAVPVNWHFKPEEIAYILED 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2629 SGTKLLmtINEADLgvLADFEG---------------EILTIESVEEDDKSP----------LPQMSSAHHL-----AYI 2678
Cdd:PRK12406 82 SGARVL--IAHADL--LHGLASalpagvtvlsvptppEIAAAYRISPALLTPpagaidwegwLAQQEPYDGPpvpqpQSM 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2679 IYTSGTTGRPKGV-----MVEHKgiANTLQWRRNAYAFNETDTIL---QLFSFSFDGFitSMFTPLLsGAKAVLLHEEEA 2750
Cdd:PRK12406 158 IYTSGTTGHPKGVrraapTPEQA--AAAEQMRALIYGLKPGIRALltgPLYHSAPNAY--GLRAGRL-GGVLVLQPRFDP 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2751 KDILAIkhqLSRQRITHMIIVPVLYRALLDVvqPE------DVKTLRVVTLAGeaadreliarslAICP-HTELA----- 2818
Cdd:PRK12406 233 EELLQL---IERHRITHMHMVPTMFIRLLKL--PEevrakyDVSSLRHVIHAA------------APCPaDVKRAmieww 295
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2819 ----NE-YGPTENSVATTvmrHMEKQAYV---SIGQPIDGTQVLILNSNHQLQPIGVAGELciagtglargYVNLPELTE 2890
Cdd:PRK12406 296 gpviYEyYGSTESGAVTF---ATSEDALShpgTVGKAAPGAELRFVDEDGRPLPQGEIGEI----------YSRIAGNPD 362
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2891 raFTQNPfKPEAR-------MYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTAS 2963
Cdd:PRK12406 363 --FTYHN-KPEKRaeidrggFITSGDVGYLDADGYLFLCDRKRDMVISGGVNIYPAEIEAVLHAVPGVHDCAVFGIPDAE 439
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 2964 GQTELSAYVVTKPG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGALPKPVYNHEG 3028
Cdd:PRK12406 440 FGEALMAVVEPQPGatLDEADIRAQLKARLAGYKVPKHIEIMAELPREDSGKIFKRRLRDPYWANAG 506
|
|
| PRK08751 |
PRK08751 |
long-chain fatty acid--CoA ligase; |
2533-3019 |
1.80e-32 |
|
long-chain fatty acid--CoA ligase;
Pssm-ID: 181546 [Multi-domain] Cd Length: 560 Bit Score: 136.16 E-value: 1.80e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2533 QTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSR-GVKPDTPVGIMMHRSFSMIASILGVWKAGGCYV 2611
Cdd:PRK08751 25 RTVAEVFATSVAKFADRPAYHSFGKTITYREADQLVEQFAAYLLGElQLKKGDRVALMMPNCLQYPIATFGVLRAGLTVV 104
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2612 PIDPEYPKERKRYILSDSGTKLLMTINE---------AD----------LGVLADF----------------------EG 2650
Cdd:PRK08751 105 NVNPLYTPRELKHQLIDSGASVLVVIDNfgttvqqviADtpvkqvittgLGDMLGFpkaalvnfvvkyvkklvpeyriNG 184
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2651 EILTIESVEEDDKSPLPQMSSAHH-LAYIIYTSGTTGRPKGVMVEHKG-IANTLQ---WRRNAYAFNETDTIL------- 2718
Cdd:PRK08751 185 AIRFREALALGRKHSMPTLQIEPDdIAFLQYTGGTTGVAKGAMLTHRNlVANMQQahqWLAGTGKLEEGCEVVitalply 264
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2719 QLFSFSFDGFITSMFtpllSGAKAVLlheEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDV--VQPEDVKTLRVvTLA 2796
Cdd:PRK08751 265 HIFALTANGLVFMKI----GGCNHLI---SNPRDMPGFVKELKKTRFTAFTGVNTLFNGLLNTpgFDQIDFSSLKM-TLG 336
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2797 GEAADRELIARSLAICPHTELANEYGPTENSVATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGT 2876
Cdd:PRK08751 337 GGMAVQRSVAERWKQVTGLTLVEAYGLTETSPAACINPLTLKEYNGSIGLPIPSTDACIKDDAGTVLAIGEIGELCIKGP 416
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2877 GLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAV 2956
Cdd:PRK08751 417 QVMKGYWKRPEETAKVMDADGW------LHTGDIARMDEQGFVYIVDRKKDMILVSGFNVYPNEIEDVIAMMPGVLEVAA 490
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 2957 VAhVTASGQTELSAYVVTK--PGLSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK08751 491 VG-VPDEKSGEIVKVVIVKkdPALTAEDVKAHARANLTGYKQPRIIEFRKELPKTNVGKILRREL 554
|
|
| PRK07638 |
PRK07638 |
acyl-CoA synthetase; Validated |
464-952 |
1.92e-32 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236071 [Multi-domain] Cd Length: 487 Bit Score: 134.91 E-value: 1.92e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 464 TIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVvRQEPVAIMMERSAAFITGVLGILKAGGAIVPV 543
Cdd:PRK07638 2 GITKEYKKHASLQPNKIAIKENDRVLTYKDWFESVCKVANWLNEKES-KNKTIAILLENRIEFLQLFAGAAMAGWTCVPL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 544 DPHYPADRIRYILHDCGCSHVVSQAHLPSSL--EDNYIITHPE---DIESKVD-GSNIKSVNNADdlLYMIYTSGTTGKP 617
Cdd:PRK07638 81 DIKWKQDELKERLAISNADMIVTERYKLNDLpdEEGRVIEIDEwkrMIEKYLPtYAPIENVQNAP--FYMGFTSGSTGKP 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 618 KGVQFEHRNmanllkfeYTHSgidFEADVLQFATPSFD------------VCYQEIfSALLKGGTLHIVPEAIKRDVPQl 685
Cdd:PRK07638 159 KAFLRAQQS--------WLHS---FDCNVHDFHMKREDsvliagtlvhslFLYGAI-STLYVGQTVHLMRKFIPNQVLD- 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 686 faFINKHQTNIVF-LPT---AFIKmifserelANSFPDGVKHLIAAGEQLMISDLFQDVLRKRGIHLHNHYGPSETHVVS 761
Cdd:PRK07638 226 --KLETENISVMYtVPTmleSLYK--------ENRVIENKMKIISSGAKWEAEAKEKIKNIFPYAKLYEFYGASELSFVT 295
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 762 TytIHPGDPipELPP--IGKPIGCTDLYILNH-QKQLQPcGVPGELYISGASVARGYVNHdkltsdkfSSDPFKPDVIMY 838
Cdd:PRK07638 296 A--LVDEES--ERRPnsVGRPFHNVQVRICNEaGEEVQK-GEIGTVYVKSPQFFMGYIIG--------GVLARELNADGW 362
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 839 RT-GDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYcsVQKLNTIDLR 917
Cdd:PRK07638 363 MTvRDVGYEDEEGFIYIVGREKNMILFGGINIFPEEIESVLHEHPAVDEIVVIGVPDSYWGEKPVAII--KGSATKQQLK 440
|
490 500 510
....*....|....*....|....*....|....*
gi 1678550997 918 SYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PRK07638 441 SFCLQRLSSFKIPKEWHFVDEIPYTNSGKIARMEA 475
|
|
| PRK12406 |
PRK12406 |
long-chain-fatty-acid--CoA ligase; Provisional |
1511-1986 |
1.98e-32 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 183506 [Multi-domain] Cd Length: 509 Bit Score: 135.21 E-value: 1.98e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1511 AAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDS 1590
Cdd:PRK12406 3 ATIISGDRRRSFDELAQRAARAAGGLAALGVRPGDCVALLMRNDFAFFEAAYAAMRLGAYAVPVNWHFKPEEIAYILEDS 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1591 GTNIL-----LLQSAGLHVPEftGEIVYLNQT------NSGL--AHRLSNPN-VDV---LPQSLAY----------VIYT 1643
Cdd:PRK12406 83 GARVLiahadLLHGLASALPA--GVTVLSVPTppeiaaAYRIspALLTPPAGaIDWegwLAQQEPYdgppvpqpqsMIYT 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1644 SGSTGMPKGVEIEHRSAVNFLNSLQSR---YQLKHSDMIM------HKTSYSFDASIWELfwwpyaGASVYLLPQggeKE 1714
Cdd:PRK12406 161 SGTTGHPKGVRRAAPTPEQAAAAEQMRaliYGLKPGIRALltgplyHSAPNAYGLRAGRL------GGVLVLQPR---FD 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1715 PEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVsITNSYGPTEATV 1794
Cdd:PRK12406 232 PEELLQLIERHRITHMHMVPTMFIRLLKLPEEVRAKYDVSSLRHVIHAAAPCPADVKRAMIEWWGPV-IYEYYGSTESGA 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1795 eAAFfdCPPHEKLERiP--IGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVAR-GYLNRPaltEERFLEDPfypgER 1871
Cdd:PRK12406 311 -VTF--ATSEDALSH-PgtVGKAAPGAELRFVDEDGRPLPQGEIGEIYSRIAGNPDfTYHNKP---EKRAEIDR----GG 379
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1872 MYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GEpELCAYVE-----GLQR 1944
Cdd:PRK12406 380 FITSGDVGYLDADGYLFLCDRKRDMVISGGVNIYPAEIEAVLHAVPGVHDCAVFGIPDAefGE-ALMAVVEpqpgaTLDE 458
|
490 500 510 520
....*....|....*....|....*....|....*....|..
gi 1678550997 1945 NEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNALPAP 1986
Cdd:PRK12406 459 ADIRAQLKARLAGYKVPKHIEIMAELPREDSGKIFKRRLRDP 500
|
|
| caiC |
PRK08008 |
putative crotonobetaine/carnitine-CoA ligase; Validated |
2531-3019 |
2.10e-32 |
|
putative crotonobetaine/carnitine-CoA ligase; Validated
Pssm-ID: 181195 [Multi-domain] Cd Length: 517 Bit Score: 135.20 E-value: 2.10e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2531 GVQTISQLFEQQAARTPKASALV----SGD-KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWK 2605
Cdd:PRK08008 5 GGQHLRQMWDDLADVYGHKTALIfessGGVvRRYSYLELNEEINRTANLFYSLGIRKGDKVALHLDNCPEFIFCWFGLAK 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2606 AGGCYVPIDPEYPKERKRYILSDSGTKLLMT---------------------------INEADLGVLaDFEgEILTIESV 2658
Cdd:PRK08008 85 IGAIMVPINARLLREESAWILQNSQASLLVTsaqfypmyrqiqqedatplrhicltrvALPADDGVS-SFT-QLKAQQPA 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2659 EEDDKSPLpqmsSAHHLAYIIYTSGTTGRPKGVMVEHkgiANTL------QWRrnaYAFNETDTILQLF-SFSFDGFITS 2731
Cdd:PRK08008 163 TLCYAPPL----STDDTAEILFTSGTTSRPKGVVITH---YNLRfagyysAWQ---CALRDDDVYLTVMpAFHIDCQCTA 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2732 MFTPLLSGAKAVLLHEEEAKdilAIKHQLSRQR--ITHMIivPVLYRALLdvVQP----EDVKTLRVVTLAGEAADREli 2805
Cdd:PRK08008 233 AMAAFSAGATFVLLEKYSAR---AFWGQVCKYRatITECI--PMMIRTLM--VQPpsanDRQHCLREVMFYLNLSDQE-- 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2806 arSLAICPH--TELANEYGPTENSVATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCI---AGTGLAR 2880
Cdd:PRK08008 304 --KDAFEERfgVRLLTSYGMTETIVGIIGDRPGDKRRWPSIGRPGFCYEAEIRDDHNRPLPAGEIGEICIkgvPGKTIFK 381
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2881 GYVNLPELTERAFTqnpfkPEARMYrTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAhV 2960
Cdd:PRK08008 382 EYYLDPKATAKVLE-----ADGWLH-TGDTGYVDEEGFFYFVDRRCNMIKRGGENVSCVELENIIATHPKIQDIVVVG-I 454
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 2961 TASGQTE-LSAYVVTKPG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK08008 455 KDSIRDEaIKAFVVLNEGetLSEEEFFAFCEQNMAKFKVPSYLEIRKDLPRNCSGKIIKKNL 516
|
|
| FACL_like_2 |
cd05917 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
2678-3016 |
2.12e-32 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341241 [Multi-domain] Cd Length: 349 Bit Score: 131.25 E-value: 2.12e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2678 IIYTSGTTGRPKGVMVEHKGIANtlqwrrNAY------AFNETDTI-LQLFSFSFDGFITSMFTPLLSGAKAVLLheEEA 2750
Cdd:cd05917 7 IQFTSGTTGSPKGATLTHHNIVN------NGYfigerlGLTEQDRLcIPVPLFHCFGSVLGVLACLTHGATMVFP--SPS 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2751 KDILAIKHQLSRQRITHMIIVPVLYRALLDvvQPE----DVKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTEN 2826
Cdd:cd05917 79 FDPLAVLEAIEKEKCTALHGVPTMFIAELE--HPDfdkfDLSSLRTGIMAGAPCPPELMKRVIEVMNMKDVTIAYGMTET 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2827 SVATTVMR---HMEKQaYVSIGQPIDGTQVLILNS-NHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNpfkpea 2902
Cdd:cd05917 157 SPVSTQTRtddSIEKR-VNTVGRIMPHTEAKIVDPeGGIVPPVGVPGELCIRGYSVMKGYWNDPEKTAEAIDGD------ 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2903 RMYRTGDAARWMADGTLEYLGRIDDQVkIRG-YRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTN 2981
Cdd:cd05917 230 GWLHTGDLAVMDEDGYCRIVGRIKDMI-IRGgENIYPREIEEFLHTHPKVSDVQVVGVPDERYGEEVCAWIRLKEGAELT 308
|
330 340 350
....*....|....*....|....*....|....*..
gi 1678550997 2982 A--VRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDR 3016
Cdd:cd05917 309 EedIKAYCKGKIAHYKVPRYVFFVDEFPLTVSGKIQK 345
|
|
| MACS_like_4 |
cd05969 |
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most ... |
489-952 |
2.23e-32 |
|
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most similar to acetyl-CoA synthetase. Acetyl-CoA synthetase (ACS) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is only present in bacteria.
Pssm-ID: 341273 [Multi-domain] Cd Length: 442 Bit Score: 133.78 E-value: 2.23e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 489 LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDcgcshvvSQA 568
Cdd:cd05969 1 YTFAQLKVLSARFANVLKSLGVGKGDRVFVLSPRSPELYFSMLGIGKIGAVICPLFSAFGPEAIRDRLEN-------SEA 73
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 569 HLpsslednyIITHPEDIESKvdgsniksvnNADDLLYMIYTSGTTGKPKGVQFEHRNMAnllkFEY--THSGIDFEADV 646
Cdd:cd05969 74 KV--------LITTEELYERT----------DPEDPTLLHYTSGTTGTPKGVLHVHDAMI----FYYftGKYVLDLHPDD 131
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 647 LQFAT--PSF--DVCYQeIFSALLKGGTLHIVPEaiKRDVPQLFAFINKHQTNIVFL-PTAFIKMIFSERELANSFP-DG 720
Cdd:cd05969 132 IYWCTadPGWvtGTVYG-IWAPWLNGVTNVVYEG--RFDAESWYGIIERVKVTVWYTaPTAIRMLMKEGDELARKYDlSS 208
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 721 VKHLIAAGEQLMisdlfQDVLR----KRGIHLHNHYGPSEThvvSTYTI--HPGDPIpELPPIGKPIGCTDLYILNHQKQ 794
Cdd:cd05969 209 LRFIHSVGEPLN-----PEAIRwgmeVFGVPIHDTWWQTET---GSIMIanYPCMPI-KPGSMGKPLPGVKAAVVDENGN 279
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 795 LQPCGVPGELYISGA--SVARGYVNHDKLTSDKFSSDpfkpdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQ 872
Cdd:cd05969 280 ELPPGTKGILALKPGwpSMFRGIWNDEERYKNSFIDG-------WYLTGDLAYRDEDGYFWFVGRADDIIKTSGHRVGPF 352
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 873 EIEVTLMNHPDISEAAILIWQDQNGEHELCAY------YCSVQKLNTiDLRSYMASELPEYMIPAKWIWVDSIPLTPNGK 946
Cdd:cd05969 353 EVESALMEHPAVAEAGVIGKPDPLRGEIIKAFislkegFEPSDELKE-EIINFVRQKLGAHVAPREIEFVDNLPKTRSGK 431
|
....*.
gi 1678550997 947 VDRAAL 952
Cdd:cd05969 432 IMRRVL 437
|
|
| PRK06178 |
PRK06178 |
acyl-CoA synthetase; Validated |
1504-1983 |
2.91e-32 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235724 [Multi-domain] Cd Length: 567 Bit Score: 135.55 E-value: 2.91e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1504 AEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERI 1583
Cdd:PRK06178 43 ARERPQRPAIIFYGHVITYAELDELSDRFAALLRQRGVGAGDRVAVFLPNCPQFHIVFFGILKLGAVHVPVSPLFREHEL 122
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1584 SFLLEDSGTNILLLQSAGLHVPEFTgeivyLNQTnsGLAHRLSNPNVDVLP----------------------------- 1634
Cdd:PRK06178 123 SYELNDAGAEVLLALDQLAPVVEQV-----RAET--SLRHVIVTSLADVLPaeptlplpdslraprlaaagaidllpalr 195
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1635 -------------QSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIMhktsysfdASIWELFW----- 1696
Cdd:PRK06178 196 actapvplpppalDALAALNYTGGTTGMPKGCEHTQRDMVYTAAAAYAVAVVGGEDSVF--------LSFLPEFWiagen 267
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1697 ----WP-YAGASVYLLPQGgekEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTNRLKRVFSGGEQLGTHLV 1771
Cdd:PRK06178 268 fgllFPlFSGATLVLLARW---DAVAFMAAVERYRVTRTVMLVDNAVELMDHPRFAEYDLSSLRQVRVVSFVKKLNPDYR 344
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1772 SRFYELLPNVSITNSYGPTEA----TVEAAF----FDcpphekLERIPI--GKPVHHVRLYLLN-QNQRMLPVGCIGELY 1840
Cdd:PRK06178 345 QRWRALTGSVLAEAAWGMTEThtcdTFTAGFqdddFD------LLSQPVfvGLPVPGTEFKICDfETGELLPLGAEGEIV 418
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1841 IAGAGVARGYLNRPALTEERFLEDpfypgerMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVR 1920
Cdd:PRK06178 419 VRTPSLLKGYWNKPEATAEALRDG-------WLHTGDIGKIDEQGFLHYLGRRKEMLKVNGMSVFPSEVEALLGQHPAVL 491
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 1921 EAAVTVRTDSGEPEL-CAYVE-----GLQRNEVRAQLERLLPGYMVPAYMIeMEQWPVTPSGKLDRNAL 1983
Cdd:PRK06178 492 GSAVVGRPDPDKGQVpVAFVQlkpgaDLTAAALQAWCRENMAVYKVPEIRI-VDALPMTATGKVRKQDL 559
|
|
| FAA1 |
COG1022 |
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; |
456-890 |
3.02e-32 |
|
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism];
Pssm-ID: 440645 [Multi-domain] Cd Length: 603 Bit Score: 136.00 E-value: 3.02e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 456 TDQTPVYETIHAMFEKQAEKTPDAHAVI----DQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVL 531
Cdd:COG1022 4 FSDVPPADTLPDLLRRRAARFPDRVALRekedGIWQSLTWAEFAERVRALAAGLLALGVKPGDRVAILSDNRPEWVIADL 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 532 GILKAGGAIVPVDPHYPADRIRYILHDCGCSHVV------------SQAHLPS-----------SLEDNYIIT------- 581
Cdd:COG1022 84 AILAAGAVTVPIYPTSSAEEVAYILNDSGAKVLFvedqeqldklleVRDELPSlrhivvldprgLRDDPRLLSldellal 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 582 -----HPEDIESKVDGSniksvnNADDLLYMIYTSGTTGKPKGVQFEHRNMA----NLLKFEythsGIDFEADVLQFATP 652
Cdd:COG1022 164 grevaDPAELEARRAAV------KPDDLATIIYTSGTTGRPKGVMLTHRNLLsnarALLERL----PLGPGDRTLSFLPL 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 653 S--FDVCYQeiFSALLKGGTLHIV--PEAIKRD-----------VPQLF-AFINKHQTNIVFLPtAFIKMIF-------- 708
Cdd:COG1022 234 AhvFERTVS--YYALAAGATVAFAesPDTLAEDlrevkptfmlaVPRVWeKVYAGIQAKAEEAG-GLKRKLFrwalavgr 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 709 --SERELAN---SFPDGVKHLIAagEQLMISDLfQDVL--RKR--------------------GIHLHNHYGPSETHVVS 761
Cdd:COG1022 311 ryARARLAGkspSLLLRLKHALA--DKLVFSKL-REALggRLRfavsggaalgpelarffralGIPVLEGYGLTETSPVI 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 762 TYTiHPGDPIPElpPIGKPIGCTDLYIlnhqkqlqpcGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimYRTG 841
Cdd:COG1022 388 TVN-RPGDNRIG--TVGPPLPGVEVKI----------AEDGEILVRGPNVMKGYYKNPEATAEAFDADGW------LHTG 448
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|
gi 1678550997 842 DLARRLEDGNIEYIGRADNQVKIR-GYRIEPQEIEVTLMNHPDISEAAIL 890
Cdd:COG1022 449 DIGELDEDGFLRITGRKKDLIVTSgGKNVAPQPIENALKASPLIEQAVVV 498
|
|
| PRK12583 |
PRK12583 |
acyl-CoA synthetase; Provisional |
2533-3016 |
3.17e-32 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237145 [Multi-domain] Cd Length: 558 Bit Score: 135.29 E-value: 3.17e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2533 QTISQLFEQQAARTPKASALVSG--DKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCY 2610
Cdd:PRK12583 18 QTIGDAFDATVARFPDREALVVRhqALRYTWRQLADAVDRLARGLLALGVQPGDRVGIWAPNCAEWLLTQFATARIGAIL 97
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2611 VPIDPEYPKERKRYILSDSGTKLLMTIN-----------EADLGVLADFEGEILTIESVEE------DDKSPLPQMSSAH 2673
Cdd:PRK12583 98 VNINPAYRASELEYALGQSGVRWVICADafktsdyhamlQELLPGLAEGQPGALACERLPElrgvvsLAPAPPPGFLAWH 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2674 HLAY------------------------IIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQLFSFsFDGFI 2729
Cdd:PRK12583 178 ELQArgetvsrealaerqasldrddpinIQYTSGTTGFPKGATLSHHNILNNGYFVAESLGLTEHDRLCVPVPL-YHCFG 256
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2730 TSMFTPLLSGAKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDvvQPE----DVKTLRVVTLAGEAADRELI 2805
Cdd:PRK12583 257 MVLANLGCMTVGACLVYPNEAFDPLATLQAVEEERCTALYGVPTMFIAELD--HPQrgnfDLSSLRTGIMAGAPCPIEVM 334
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2806 ARSLAICPHTELANEYGPTENS---VATTVMRHMEKQAyVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGY 2882
Cdd:PRK12583 335 RRVMDEMHMAEVQIAYGMTETSpvsLQTTAADDLERRV-ETVGRTQPHLEVKVVDPDGATVPRGEIGELCTRGYSVMKGY 413
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2883 VNLPELTERAFTQNPFkpearMYrTGDAARWMADGTLEYLGRIDDQVkIR-GYRVETKEIESVIRCIKGVKDAAVVAHVT 2961
Cdd:PRK12583 414 WNNPEATAESIDEDGW-----MH-TGDLATMDEQGYVRIVGRSKDMI-IRgGENIYPREIEEFLFTHPAVADVQVFGVPD 486
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 2962 ASGQTELSAYVVTKPG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDR 3016
Cdd:PRK12583 487 EKYGEEIVAWVRLHPGhaASEEELREFCKARIAHFKVPRYFRFVDEFPMTVTGKVQK 543
|
|
| FUM14_C_NRPS-like |
cd19545 |
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond ... |
1077-1460 |
4.09e-32 |
|
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond forming Fusarium verticillioides FUM14 protein; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) typically catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. However, some C-domains have ester-bond forming activity. This subfamily includes Fusarium verticillioides FUM14 (also known as NRPS8), a bi-domain protein with an ester-bond forming NRPS C-domain, which catalyzes linkages between an aminoacyl/peptidyl-PCP donor and a hydroxyl-containing acceptor. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. FUM14 has an altered active site motif DHTHCD instead of the typical HHxxxD motif seen in other subfamily members. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380467 [Multi-domain] Cd Length: 395 Bit Score: 131.65 E-value: 4.09e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1077 AYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSGADDEPVQRIHTEVPFTLSKETTIEGFV-----RPFDLSQa 1151
Cdd:cd19545 21 AYVGQRVFELPPDIDLARLQAAWEQVVQANPILRTRIVQSDSGGLLQVVVKESPISWTESTSLDEYLeedraAPMGLGG- 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1152 PLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYANRQLKPlRIQYKDYavwQQKFKKGDSYQKQEtYWQQQ 1231
Cdd:cd19545 100 PLVRLALVEDPDTERYFVWTIHHALYDGWSLPLILRQVLAAYQGEPVPQ-PPPFSRF---VKYLRQLDDEAAAE-FWRSY 174
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1232 FSGDLPIL--ELPTDKRRPaerqfiggkvtfQLDKEITARIKRLAHKNRS-TLYMTLLALYSAFLSRLSGQDDIVIGSPI 1308
Cdd:cd19545 175 LAGLDPAVfpPLPSSRYQP------------RPDATLEHSISLPSSASSGvTLATVLRAAWALVLSRYTGSDDVVFGVTL 242
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1309 AGR--PHADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQTALEA--YEHqdypfeelvdkLGVQ--REMSRN----P 1378
Cdd:cd19545 243 SGRnaPVPGIEQIVGPTIATVPLRVRIDPEQSVEDFLQTVQKDLLDMipFEH-----------TGLQniRRLGPDaraaC 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1379 LFDTTLVLQNMEQQklkmNDVQLQWNDLEHPISKFD------ISLYVTEHDSELFCQFEYSTALFEKETIQRWASLFTTL 1452
Cdd:cd19545 312 NFQTLLVVQPALPS----STSESLELGIEEESEDLEdfssygLTLECQLSGSGLRVRARYDSSVISEEQVERLLDQFEHV 387
|
....*...
gi 1678550997 1453 VEHTAASP 1460
Cdd:cd19545 388 LQQLASAP 395
|
|
| 23DHB-AMP_lg |
cd05920 |
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2, ... |
2533-3019 |
4.15e-32 |
|
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2,3-dihydroxybenzoate (DHB) by ligation of AMP from ATP with the release of pyrophosphate. However, it can also catalyze the ATP-PPi exchange for 2,3-DHB analogs, such as salicyclic acid (o-hydrobenzoate), as well as 2,4-DHB and 2,5-DHB, but with less efficiency. Proteins in this family are the stand-alone adenylation components of non-ribosomal peptide synthases (NRPSs) involved in the biosynthesis of siderophores, which are low molecular weight iron-chelating compounds synthesized by many bacteria to aid in the acquisition of this vital trace elements. In Escherichia coli, the 2,3-dihydroxybenzoate-AMP ligase is called EntE, the adenylation component of the enterobactin NRPS system.
Pssm-ID: 341244 [Multi-domain] Cd Length: 482 Bit Score: 133.61 E-value: 4.15e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2533 QTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVP 2612
Cdd:cd05920 15 EPLGDLLARSAARHPDRIAVVDGDRRLTYRELDRRADRLAAGLRGLGIRPGDRVVVQLPNVAEFVVLFFALLRLGAVPVL 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2613 IDPEYPKERKRYILSDSGTKLLmtineADLGVLADFEGEILTIESVEEddkspLPQmssahhLAYIIYTSGTTGRPKGVM 2692
Cdd:cd05920 95 ALPSHRRSELSAFCAHAEAVAY-----IVPDRHAGFDHRALARELAES-----IPE------VALFLLSGGTTGTPKLIP 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2693 VEHKGIANTLqwRRNAYA--FNETDTILQLFSFSFdGFITS---MFTPLLSGAKAVLLHEEEAKDILAIkhqLSRQRITH 2767
Cdd:cd05920 159 RTHNDYAYNV--RASAEVcgLDQDTVYLAVLPAAH-NFPLAcpgVLGTLLAGGRVVLAPDPSPDAAFPL---IEREGVTV 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2768 MIIVPVLYRALLDVV--QPEDVKTLRVVTLAGEAADRELIARSLAI--CphtELANEYGPTENSVATTVMRHMEKQAYVS 2843
Cdd:cd05920 233 TALVPALVSLWLDAAasRRADLSSLRLLQVGGARLSPALARRVPPVlgC---TLQQVFGMAEGLLNYTRLDDPDEVIIHT 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2844 IGQPID-GTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMADGTLEYL 2922
Cdd:cd05920 310 QGRPMSpDDEIRVVDEEGNPVPPGEEGELLTRGPYTIRGYYRAPEHNARAFTPDGF------YRTGDLVRRTPDGYLVVE 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2923 GRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHV-TASGQTELSAYVVTKPGLSTNAVRSELQNK-LPVFMHPAFI 3000
Cdd:cd05920 384 GRIKDQINRGGEKIAAEEVENLLLRHPAVHDAAVVAMPdELLGERSCAFVVLRDPPPSAAQLRRFLRERgLAAYKLPDRI 463
|
490
....*....|....*....
gi 1678550997 3001 EKLDSLPLSPNGKLDRGAL 3019
Cdd:cd05920 464 EFVDSLPLTAVGKIDKKAL 482
|
|
| SgcC5_NRPS-like |
cd19539 |
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- ... |
12-433 |
4.40e-32 |
|
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- bond forming activity and similar C-domains of modular NRPSs; SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. This subfamily also includes similar C-domains of modular NRPSs such as Penicillium chrysogenum N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase PCBAB. Condensation (C) domains of NRPSs normally catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380462 [Multi-domain] Cd Length: 427 Bit Score: 132.50 E-value: 4.40e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 12 PLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNVSSPQQVVL--RERNVIVL 89
Cdd:cd19539 3 PLSFAQERLWFIDQGEDGGPAYNIPGAWRLTGPLDVEALREALRDVVARHEALRTLLVRDDGGVPRQEILppGPAPLEVR 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 90 EEDIThlnEAEQSQFIEQWKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASYVN 169
Cdd:cd19539 83 DLSDP---DSDRERRLEELLRERESRGFDLDEEPPIRAVLGRFDPDDHVLVLVAHHTAFDAWSLDVFARDLAALYAARRK 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 170 ASPITL-EPVQPYGKYIKWLMEQDKEQAVS----YWDHYLSGHEQQTVLPKQKKTKGKSRQEHVT-FSFSKEESSRLSEL 243
Cdd:cd19539 160 GPAAPLpELRQQYKEYAAWQREALAAPRAAelldFWRRRLRGAEPTALPTDRPRPAGFPYPGADLrFELDAELVAALREL 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 244 AAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRPAeiEGIEHMVGLFINTMPVRVQ-GAKTPFLQLIKDMQKDRL 322
Cdd:cd19539 240 AKRARSSLFMVLLAAYCVLLRRYTGQTDIVVGTPVAGRNH--PRFESTVGFFVNLLPLRVDvSDCATFRDLIARVRKALV 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 323 AAEAYSYHPLYEI-----QSRSAVKQGLIDHILVFENYP-VQQEIQMLNKQEHASDlfqihnftVADETNYSFYLMVAP- 395
Cdd:cd19539 318 DAQRHQELPFQQLvaelpVDRDAGRHPLVQIVFQVTNAPaGELELAGGLSYTEGSD--------IPDGAKFDLNLTVTEe 389
|
410 420 430
....*....|....*....|....*....|....*...
gi 1678550997 396 GEEIHIKMNYDAEQHDRSFVLSVKEHLLNAVSQILNNP 433
Cdd:cd19539 390 GTGLRGSLGYATSLFDEETIQGFLADYLQVLRQLLANP 427
|
|
| CHC_CoA_lg |
cd05903 |
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); ... |
488-947 |
4.68e-32 |
|
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); Cyclohexanecarboxylate-CoA ligase activates the aliphatic ring compound, cyclohexanecarboxylate, for degradation. It catalyzes the synthesis of cyclohexanecarboxylate-CoA thioesters in a two-step reaction involving the formation of cyclohexanecarboxylate-AMP anhydride, followed by the nucleophilic substitution of AMP by CoA.
Pssm-ID: 341229 [Multi-domain] Cd Length: 437 Bit Score: 132.50 E-value: 4.68e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 488 SLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVsq 567
Cdd:cd05903 1 RLTYSELDTRADRLAAGLAALGVGPGDVVAFQLPNWWEFAVLYLACLRIGAVTNPILPFFREHELAFILRRAKAKVFV-- 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 568 ahLPSSLEDNYIITHPedieskvdgsniksvnnaDDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEYTHSGIDfEADVL 647
Cdd:cd05903 79 --VPERFRQFDPAAMP------------------DAVALLLFTSGTTGEPKGVMHSHNTLSASIRQYAERLGLG-PGDVF 137
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 648 QFATPsfdVCYQE-----IFSALLKGGTLHIVPEAIKRDVPQLfafINKHQTNIVFLPTAFIKMIFSERELANSFPDGVK 722
Cdd:cd05903 138 LVASP---MAHQTgfvygFTLPLLLGAPVVLQDIWDPDKALAL---MREHGVTFMMGATPFLTDLLNAVEEAGEPLSRLR 211
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 723 HLIAAG--------EQLmisdlfQDVLrkrGIHLHNHYGPSET-HVVSTytIHPGDPIPELPPIGKPIGCTDLYILNHQK 793
Cdd:cd05903 212 TFVCGGatvprslaRRA------AELL---GAKVCSAYGSTECpGAVTS--ITPAPEDRRLYTDGRPLPGVEIKVVDDTG 280
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 794 QLQPCGVPGELYISGASVARGYVNHDKLTSDKFssdpfkpDVIMYRTGDLARRLEDGNIEYIGRADNqVKIR-GYRIEPQ 872
Cdd:cd05903 281 ATLAPGVEGELLSRGPSVFLGYLDRPDLTADAA-------PEGWFRTGDLARLDEDGYLRITGRSKD-IIIRgGENIPVL 352
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 873 EIEVTLMNHPDISEAAILIWQDQNGEHELCAYYcsVQK----LNTIDLRSYM-ASELPEYMIPAKWIWVDSIPLTPNGKV 947
Cdd:cd05903 353 EVEDLLLGHPGVIEAAVVALPDERLGERACAVV--VTKsgalLTFDELVAYLdRQGVAKQYWPERLVHVDDLPRTPSGKV 430
|
|
| MACS_AAE_MA_like |
cd05970 |
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation ... |
2543-3019 |
7.66e-32 |
|
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This family of MACS enzymes is found in archaea and bacteria. It is represented by the acyl-adenylating enzyme from Methanosarcina acetivorans (AAE_MA). AAE_MA is most active with propionate, butyrate, and the branched analogs: 2-methyl-propionate, butyrate, and pentanoate. The specific activity is weaker for smaller or larger acids.
Pssm-ID: 341274 [Multi-domain] Cd Length: 537 Bit Score: 133.77 E-value: 7.66e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2543 AARTPKASALVSGD-----KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEY 2617
Cdd:cd05970 27 AKEYPDKLALVWCDdageeRIFTFAELADYSDKTANFFKAMGIGKGDTVMLTLKRRYEFWYSLLALHKLGAIAIPATHQL 106
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2618 PKERKRYILSDSGTKLLMTINEADlgVLADFEGEILTIESVEE-------------------DDKSPL------PQMSSA 2672
Cdd:cd05970 107 TAKDIVYRIESADIKMIVAIAEDN--IPEEIEKAAPECPSKPKlvwvgdpvpegwidfrkliKNASPDferptaNSYPCG 184
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2673 HHLAYIIYTSGTTGRPKgvMVEHKG------IANTLQW---RRNAYAFNETDTilqlfsfsfdGFITSMFTPL----LSG 2739
Cdd:cd05970 185 EDILLVYFSSGTTGMPK--MVEHDFtyplghIVTAKYWqnvREGGLHLTVADT----------GWGKAVWGKIygqwIAG 252
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2740 AkAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLYRALL-DVVQPEDVKTLRVVTLAGEAADRELIARSLAicpHT--E 2816
Cdd:cd05970 253 A-AVFVYDYDKFDPKALLEKLSKYGVTTFCAPPTIYRFLIrEDLSRYDLSSLRYCTTAGEALNPEVFNTFKE---KTgiK 328
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2817 LANEYGPTENSVATTVMRHMEKQAYvSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGT-----GLARGYVNLPELTER 2891
Cdd:cd05970 329 LMEGFGQTETTLTIATFPWMEPKPG-SMGKPAPGYEIDLIDREGRSCEAGEEGEIVIRTSkgkpvGLFGGYYKDAEKTAE 407
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2892 AFTQNpfkpearMYRTGDAArWM-ADGTLEYLGRIDDQVKIRGYRVETKEIES-------VIRC-IKGVKDAavvahvtA 2962
Cdd:cd05970 408 VWHDG-------YYHTGDAA-WMdEDGYLWFVGRTDDLIKSSGYRIGPFEVESaliqhpaVLECaVTGVPDP-------I 472
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 2963 SGQTELSAYVVTKPGLSTNAVRSELQNKL----PVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:cd05970 473 RGQVVKATIVLAKGYEPSEELKKELQDHVkkvtAPYKYPRIVEFVDELPKTISGKIRRVEI 533
|
|
| 4CL |
cd05904 |
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the ... |
1493-1925 |
8.03e-32 |
|
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the phenylpropanoid metabolic pathway for monolignol and flavonoid biosynthesis. It catalyzes the synthesis of hydroxycinnamate-CoA thioesters in a two-step reaction, involving the formation of hydroxycinnamate-AMP anhydride and the nucleophilic substitution of AMP by CoA. The phenylpropanoid pathway is one of the most important secondary metabolism pathways in plants and hydroxycinnamate-CoA thioesters are the precursors of lignin and other important phenylpropanoids.
Pssm-ID: 341230 [Multi-domain] Cd Length: 505 Bit Score: 133.13 E-value: 8.03e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1493 NQTLHYALEQQAEKTPDQAAVIfeDGV----MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAG 1568
Cdd:cd05904 4 DLPLDSVSFLFASAHPSRPALI--DAAtgraLTYAELERRVRRLAAGLAKRGGRKGDVVLLLSPNSIEFPVAFLAVLSLG 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1569 GAYLPIDPDYPEERISFLLEDSGTNILLLQSAGLH-VPEFTGEIVYLNQTNSGLAHRLSN---------PNVDVLPQSLA 1638
Cdd:cd05904 82 AVVTTANPLSTPAEIAKQVKDSGAKLAFTTAELAEkLASLALPVVLLDSAEFDSLSFSDLlfeadeaepPVVVIKQDDVA 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1639 YVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRY--QLKHSDMIM------HktSYSFDASIWELFwwpYAGASVYLLPQg 1710
Cdd:cd05904 162 ALLYSSGTTGRSKGVMLTHRNLIAMVAQFVAGEgsNSDSEDVFLcvlpmfH--IYGLSSFALGLL---RLGATVVVMPR- 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1711 geKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTnrLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPT 1790
Cdd:cd05904 236 --FDLEELLAAIERYKVTHLPVVPPIVLALVKSPIVDKYDLSS--LRQIMSGAAPLGKELIEAFRAKFPNVDLGQGYGMT 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1791 EATVEAAFfdCPPHEKlERIPIGK-----PVHHVRLYLLNQNQrMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDP 1865
Cdd:cd05904 312 ESTGVVAM--CFAPEK-DRAKYGSvgrlvPNVEAKIVDPETGE-SLPPNQTGELWIRGPSIMKGYLNNPEATAATIDKEG 387
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1866 FYpgermyKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVT 1925
Cdd:cd05904 388 WL------HTGDLCYIDEDGYLFIVDRLKELIKYKGFQVAPAELEALLLSHPEILDAAVI 441
|
|
| FACL_like_2 |
cd05917 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
1642-1983 |
1.27e-31 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341241 [Multi-domain] Cd Length: 349 Bit Score: 128.93 E-value: 1.27e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1642 YTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMI------MHktsySFDASIWELFWWPYAGASVYllPQGGEKeP 1715
Cdd:cd05917 9 FTSGTTGSPKGATLTHHNIVNNGYFIGERLGLTEQDRLcipvplFH----CFGSVLGVLACLTHGATMVF--PSPSFD-P 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1716 EVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTnrLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEAT-- 1793
Cdd:cd05917 82 LAVLEAIEKEKCTALHGVPTMFIAELEHPDFDKFDLSS--LRTGIMAGAPCPPELMKRVIEVMNMKDVTIAYGMTETSpv 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1794 VEAAFFDCPPHEKLEriPIGKPVHHVRLYLLNQNQR-MLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDpfypgeRM 1872
Cdd:cd05917 160 STQTRTDDSIEKRVN--TVGRIMPHTEAKIVDPEGGiVPPVGVPGELCIRGYSVMKGYWNDPEKTAEAIDGD------GW 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1873 YKTGDVARWLPDGNVEFLGRTDDQVkIRG-YRIEPGEIEAALRSIEGVREAAVTVRTDS--GEpELCAYV---EG--LQR 1944
Cdd:cd05917 232 LHTGDLAVMDEDGYCRIVGRIKDMI-IRGgENIYPREIEEFLHTHPKVSDVQVVGVPDEryGE-EVCAWIrlkEGaeLTE 309
|
330 340 350
....*....|....*....|....*....|....*....
gi 1678550997 1945 NEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd05917 310 EDIKAYCKGKIAHYKVPRYVFFVDEFPLTVSGKIQKFKL 348
|
|
| PRK06087 |
PRK06087 |
medium-chain fatty-acid--CoA ligase; |
1484-1983 |
1.32e-31 |
|
medium-chain fatty-acid--CoA ligase;
Pssm-ID: 180393 [Multi-domain] Cd Length: 547 Bit Score: 133.33 E-value: 1.32e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1484 LFEETGYSMNQTLHYALEQQAEKTPDQAAVIFEDGV-MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIY 1562
Cdd:PRK06087 13 AYRQQGYWGDASLADYWQQTARAMPDKIAVVDNHGAsYTYSALDHAASRLANWLLAKGIEPGDRVAFQLPGWCEFTIIYL 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1563 GILKAGGAYLPIDPDYPEERISFLLEDSGTNILL---LQSAGLHVPEFT---------GEIVYLNQ----TNS-GLAHRL 1625
Cdd:PRK06087 93 ACLKVGAVSVPLLPSWREAELVWVLNKCQAKMFFaptLFKQTRPVDLILplqnqlpqlQQIVGVDKlapaTSSlSLSQII 172
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1626 SN-------PNVDvlPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIM------HKTSYsFDASIW 1692
Cdd:PRK06087 173 ADyeplttaITTH--GDELAAVLFTSGTEGLPKGVMLTHNNILASERAYCARLNLTWQDVFMmpaplgHATGF-LHGVTA 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1693 ELFwwpyAGASVYLLPQggeKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIkyRSVPIKTNRLKRVFSGGEQLGTHLVS 1772
Cdd:PRK06087 250 PFL----IGARSVLLDI---FTPDACLALLEQQRCTCMLGATPFIYDLLNLL--EKQPADLSALRFFLCGGTTIPKKVAR 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1773 RFYEllPNVSITNSYGPTEATVEAAffdCPPHEKLERI--PIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGY 1850
Cdd:PRK06087 321 ECQQ--RGIKLLSVYGSTESSPHAV---VNLDDPLSRFmhTDGYAAAGVEIKVVDEARKTLPPGCEGEEASRGPNVFMGY 395
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1851 LNRPALTeERFLEDpfypgERMYKTGDVARWLPDGNVEFLGRTDDqVKIR-GYRIEPGEIEAALRSIEGVREAAVTVRTD 1929
Cdd:PRK06087 396 LDEPELT-ARALDE-----EGWYYSGDLCRMDEAGYIKITGRKKD-IIVRgGENISSREVEDILLQHPKIHDACVVAMPD 468
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 1930 S--GEpELCAYVEgLQRNEVRAQLERLL--------PGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK06087 469 ErlGE-RSCAYVV-LKAPHHSLTLEEVVaffsrkrvAKYKYPEHIVVIDKLPRTASGKIQKFLL 530
|
|
| benz_CoA_lig |
TIGR02262 |
benzoate-CoA ligase family; Characterized members of this protein family include benzoate-CoA ... |
1504-1980 |
2.91e-31 |
|
benzoate-CoA ligase family; Characterized members of this protein family include benzoate-CoA ligase, 4-hydroxybenzoate-CoA ligase, 2-aminobenzoate-CoA ligase, etc. Members are related to fatty acid and acetate CoA ligases.
Pssm-ID: 274059 [Multi-domain] Cd Length: 505 Bit Score: 131.50 E-value: 2.91e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1504 AEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERI 1583
Cdd:TIGR02262 15 VEGRGGKTAFIDDISSLSYGELEAQVRRLAAALRRLGVKREERVLLLMLDGVDFPIAFLGAIRAGIVPVALNTLLTADDY 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1584 SFLLEDSGTNILLLQSAGLHV-PEFTGEIVYLNQTNsgLAHRLSNPNVDVL----------------PQSLAYVIYTSGS 1646
Cdd:TIGR02262 95 AYMLEDSRARVVFVSGALLPViKAALGKSPHLEHRV--VVGRPEAGEVQLAellateseqfkpaatqADDPAFWLYSSGS 172
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1647 TGMPKGVEIEHRSA-VNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYA-GASVYLLPQggEKEPEVIAKAIEE 1724
Cdd:TIGR02262 173 TGMPKGVVHTHSNPyWTAELYARNTLGIREDDVCFSAAKLFFAYGLGNALTFPMSvGATTVLMGE--RPTPDAVFDRLRR 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1725 QKITAMHFVPSMLHAFLEHIKYRSVpiKTNRLKRVFSGGE----QLGTHLVSRFyellpNVSITNSYGPTEatVEAAFFD 1800
Cdd:TIGR02262 251 HQPTIFYGVPTLYAAMLADPNLPSE--DQVRLRLCTSAGEalpaEVGQRWQARF-----GVDIVDGIGSTE--MLHIFLS 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1801 CPPHEkLERIPIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLedpfypGErMYKTGDVAR 1880
Cdd:TIGR02262 322 NLPGD-VRYGTSGKPVPGYRLRLVGDGGQDVADGEPGELLISGPSSATMYWNNRAKSRDTFQ------GE-WTRSGDKYV 393
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1881 WLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS-GEPELCAYV-----EGLQRNEVRAQLERL 1954
Cdd:TIGR02262 394 RNDDGSYTYAGRTDDMLKVSGIYVSPFEIESALIQHPAVLEAAVVGVADEdGLIKPKAFVvlrpgQTALETELKEHVKDR 473
|
490 500
....*....|....*....|....*.
gi 1678550997 1955 LPGYMVPAYMIEMEQWPVTPSGKLDR 1980
Cdd:TIGR02262 474 LAPYKYPRWIVFVDDLPKTATGKIQR 499
|
|
| OSB_CoA_lg |
cd05912 |
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA ... |
488-952 |
2.97e-31 |
|
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA synthetase, or MenE); O-succinylbenzoic acid-CoA synthase catalyzes the coenzyme A (CoA)- and ATP-dependent conversion of o-succinylbenzoic acid to o-succinylbenzoyl-CoA. The reaction is the fourth step of the biosynthesis pathway of menaquinone (vitamin K2). In certain bacteria, menaquinone is used during fumarate reduction in anaerobic respiration. In cyanobacteria, the product of the menaquinone pathway is phylloquinone (2-methyl-3-phytyl-1,4-naphthoquinone), a molecule used exclusively as an electron transfer cofactor in Photosystem 1. In green sulfur bacteria and heliobacteria, menaquinones are used as loosely bound secondary electron acceptors in the photosynthetic reaction center.
Pssm-ID: 341238 [Multi-domain] Cd Length: 411 Bit Score: 129.39 E-value: 2.97e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 488 SLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILhdcgcshvvsq 567
Cdd:cd05912 1 SYTFAELFEEVSRLAEHLAALGVRKGDRVALLSKNSIEMILLIHALWLLGAEAVLLNTRLTPNELAFQL----------- 69
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 568 ahlpsslednyiithpEDIESKVDgsniksvnnadDLLYMIYTSGTTGKPKGVQFEHRN--------MANLlkfeythsG 639
Cdd:cd05912 70 ----------------KDSDVKLD-----------DIATIMYTSGTTGKPKGVQQTFGNhwwsaigsALNL--------G 114
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 640 IDfEADVLQFATPSFDVCYQEI-FSALLKGGTLHIVPeaiKRDVPQLFAFINKHQTNIVFL-PTAFIKMIfseRELANSF 717
Cdd:cd05912 115 LT-EDDNWLCALPLFHISGLSIlMRSVIYGMTVYLVD---KFDAEQVLHLINSGKVTIISVvPTMLQRLL---EILGEGY 187
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 718 PDGVKHLIAAGEQLMISDLFQdvLRKRGIHLHNHYGPSET--HVVstyTIHPGDPIPELPPIGKPIGCTDLYIlnhQKQL 795
Cdd:cd05912 188 PNNLRCILLGGGPAPKPLLEQ--CKEKGIPVYQSYGMTETcsQIV---TLSPEDALNKIGSAGKPLFPVELKI---EDDG 259
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 796 QPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKpdvimyrTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIE 875
Cdd:cd05912 260 QPPYEVGEILLKGPNVTKGYLNRPDATEESFENGWFK-------TGDIGYLDEEGFLYVLDRRSDLIISGGENIYPAEIE 332
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 876 VTLMNHPDISEAAILIWQDQNGEHELCAYYCSVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:cd05912 333 EVLLSHPAIKEAGVVGIPDDKWGQVPVAFVVSERPISEEELIAYCSEKLAKYKVPKKIYFVDELPRTASGKLLRHEL 409
|
|
| PRK06164 |
PRK06164 |
acyl-CoA synthetase; Validated |
2534-3012 |
3.78e-31 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235722 [Multi-domain] Cd Length: 540 Bit Score: 131.79 E-value: 3.78e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2534 TISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPI 2613
Cdd:PRK06164 11 TLASLLDAHARARPDAVALIDEDRPLSRAELRALVDRLAAWLAAQGVRRGDRVAVWLPNCIEWVVLFLACARLGATVIAV 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2614 DPEYPKERKRYILSDSGTKLLMT------------INEADLGVLADFEGeILTIESVEEDDKSPLP--------QMSSAH 2673
Cdd:PRK06164 91 NTRYRSHEVAHILGRGRARWLVVwpgfkgidfaaiLAAVPPDALPPLRA-IAVVDDAADATPAPAPgarvqlfaLPDPAP 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2674 H------------LAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQLFSFS--FdGFITsmftpLLSG 2739
Cdd:PRK06164 170 PaaageraadpdaGALLFTTSGTTSGPKLVLHRQATLLRHARAIARAYGYDPGAVLLAALPFCgvF-GFST-----LLGA 243
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2740 -AKAVLLHEEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDVV-QPEDVKTLRVVTLAGEA-ADRELIARSLAicPHTE 2816
Cdd:PRK06164 244 lAGGAPLVCEPVFDAARTARALRRHRVTHTFGNDEMLRRILDTAgERADFPSARLFGFASFApALGELAALARA--RGVP 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2817 LANEYGPTE-------NSVATTV-MRH------MEKQAYVSIGQPIDGTqvlilnsnhqLQPIGVAGELCIAGTGLARGY 2882
Cdd:PRK06164 322 LTGLYGSSEvqalvalQPATDPVsVRIegggrpASPEARVRARDPQDGA----------LLPDGESGEIEIRAPSLMRGY 391
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2883 VNLPELTERAFTQNPFkpearmYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAhVTA 2962
Cdd:PRK06164 392 LDNPDATARALTDDGY------FRTGDLGYTRGDGQFVYQTRMGDSLRLGGFLVNPAEIEHALEALPGVAAAQVVG-ATR 464
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 2963 SGQTELSAYVVTKPGLSTNA--VRSELQNKLPVFMHPAFIEKLDSLP--LSPNG 3012
Cdd:PRK06164 465 DGKTVPVAFVIPTDGASPDEagLMAACREALAGFKVPARVQVVEAFPvtESANG 518
|
|
| MACS_like_2 |
cd05973 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
489-952 |
3.84e-31 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341277 [Multi-domain] Cd Length: 437 Bit Score: 129.95 E-value: 3.84e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 489 LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSQA 568
Cdd:cd05973 1 LTFGELRALSARFANALQELGVGPGDVVAGLLPRTPELVVTILGIWRLGAVYQPLFTAFGPKAIEHRLRTSGARLVVTDA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 569 hlpsslednyiithpeDIESKVDgsniksvnnaDDLLYMIYTSGTTGKPKGVQFEHRNmanLLKFE-YTHSGIDFEAD-- 645
Cdd:cd05973 81 ----------------ANRHKLD----------SDPFVMMFTSGTTGLPKGVPVPLRA---LAAFGaYLRDAVDLRPEds 131
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 646 VLQFATPSFDV-CYQEIFSALLKGgTLHIVPEAiKRDVPQLFAFINKHQ-TNIVFLPTAFIKMIFSERELANSFPDGVKH 723
Cdd:cd05973 132 FWNAADPGWAYgLYYAITGPLALG-HPTILLEG-GFSVESTWRVIERLGvTNLAGSPTAYRLLMAAGAEVPARPKGRLRR 209
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 724 LIAAGEQLM--ISDLFQDVLrkrGIHLHNHYGPSETHVVSTYTIHPGDPIPElPPIGKPIGCTDLYILNHQKQLQPCGVP 801
Cdd:cd05973 210 VSSAGEPLTpeVIRWFDAAL---GVPIHDHYGQTELGMVLANHHALEHPVHA-GSAGRAMPGWRVAVLDDDGDELGPGEP 285
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 802 GELYISGASVA----RGYVNHDklTSDkfssdpfkPDVIMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVT 877
Cdd:cd05973 286 GRLAIDIANSPlmwfRGYQLPD--TPA--------IDGGYYLTGDTVEFDPDGSFSFIGRADDVITMSGYRIGPFDVESA 355
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 878 LMNHPDISEAAILIWQD-QNGEH-----ELCAYYCSVQKLNTiDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAA 951
Cdd:cd05973 356 LIEHPAVAEAAVIGVPDpERTEVvkafvVLRGGHEGTPALAD-ELQLHVKKRLSAHAYPRTIHFVDELPKTPSGKIQRFL 434
|
.
gi 1678550997 952 L 952
Cdd:cd05973 435 L 435
|
|
| LC_FACS_like |
cd17640 |
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA ... |
1521-1913 |
3.85e-31 |
|
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA synthetases, including an Arabidopsis gene At4g14070 that plays a role in activation and elongation of exogenous fatty acids. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341295 [Multi-domain] Cd Length: 468 Bit Score: 130.56 E-value: 3.85e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1521 TYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLLQSA 1600
Cdd:cd17640 7 TYKDLYQEILDFAAGLRSLGVKAGEKVALFADNSPRWLIADQGIMALGAVDVVRGSDSSVEELLYILNHSESVALVVEND 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1601 glhvpeftgeivylnqtnsglahrlsnpnvdvlPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIM 1680
Cdd:cd17640 87 ---------------------------------SDDLATIIYTSGTTGNPKGVMLTHANLLHQIRSLSDIVPPQPGDRFL 133
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1681 hktsysfdaSIWELfWWPYAGASVY-LLPQGGEK---EPEVIAKAIEEQKITAMHFVPSMLHAFLEHI---KYRSVPIKT 1753
Cdd:cd17640 134 ---------SILPI-WHSYERSAEYfIFACGCSQaytSIRTLKDDLKRVKPHYIVSVPRLWESLYSGIqkqVSKSSPIKQ 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1754 ---------NRLKRVFSGGEQLGTHlVSRFYELLpNVSITNSYGPTEATVEAAffdCPPHEKLERIPIGKPVHHVRLYLL 1824
Cdd:cd17640 204 flflfflsgGIFKFGISGGGALPPH-VDTFFEAI-GIEVLNGYGLTETSPVVS---ARRLKCNVRGSVGRPLPGTEIKIV 278
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1825 NQNQR-MLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYpgermyKTGDVARWLPDGNVEFLGRTDDQVKIR-GY 1902
Cdd:cd17640 279 DPEGNvVLPPGEKGIVWVRGPQVMKGYYKNPEATSKVLDSDGWF------NTGDLGWLTCGGELVLTGRAKDTIVLSnGE 352
|
410
....*....|.
gi 1678550997 1903 RIEPGEIEAAL 1913
Cdd:cd17640 353 NVEPQPIEEAL 363
|
|
| PRK06164 |
PRK06164 |
acyl-CoA synthetase; Validated |
1491-1983 |
5.68e-31 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235722 [Multi-domain] Cd Length: 540 Bit Score: 131.40 E-value: 5.68e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1491 SMNQTLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGA 1570
Cdd:PRK06164 7 PRADTLASLLDAHARARPDAVALIDEDRPLSRAELRALVDRLAAWLAAQGVRRGDRVAVWLPNCIEWVVLFLACARLGAT 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1571 YLPIDPDYPEERISFLLEDSGTNILLLQSA--GLHVPEFTGEIVY-----------LNQTNSGLAHRLSNPNVDVLPQ-- 1635
Cdd:PRK06164 87 VIAVNTRYRSHEVAHILGRGRARWLVVWPGfkGIDFAAILAAVPPdalpplraiavVDDAADATPAPAPGARVQLFALpd 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1636 ---------------SLAYVIYTSGSTGMPKGVEieHRSAVnflnslqsryQLKHSDMIMHKTSYSFDASIweLFWWPY- 1699
Cdd:PRK06164 167 pappaaageraadpdAGALLFTTSGTTSGPKLVL--HRQAT----------LLRHARAIARAYGYDPGAVL--LAALPFc 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1700 -------------AGASVYLLPQggeKEPEVIAKAIEEQKITamhfvpsmlHAFLEHIKYRSVpIKTNRLKRVFSGGEQL 1766
Cdd:PRK06164 233 gvfgfstllgalaGGAPLVCEPV---FDAARTARALRRHRVT---------HTFGNDEMLRRI-LDTAGERADFPSARLF 299
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1767 G-THLVSRFYELLP-----NVSITNSYGPTEATVEAAFFDCPPHEKLERIPIGKPVH---HVRLyLLNQNQRMLPVGCIG 1837
Cdd:PRK06164 300 GfASFAPALGELAAlararGVPLTGLYGSSEVQALVALQPATDPVSVRIEGGGRPASpeaRVRA-RDPQDGALLPDGESG 378
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1838 ELYIAGAGVARGYLNRPALTEERFLEDPFYpgermyKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIE 1917
Cdd:PRK06164 379 EIEIRAPSLMRGYLDNPDATARALTDDGYF------RTGDLGYTRGDGQFVYQTRMGDSLRLGGFLVNPAEIEHALEALP 452
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 1918 GVREAAVTVRTDSGEPELCAYV-----EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSG---KLDRNAL 1983
Cdd:PRK06164 453 GVAAAQVVGATRDGKTVPVAFViptdgASPDEAGLMAACREALAGFKVPARVQVVEAFPVTESAngaKIQKHRL 526
|
|
| C_PKS-NRPS_PksJ-like |
cd20484 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
11-433 |
6.08e-31 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs), similar to Bacillus subtilis PksJ; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily have the typical C-domain HHxxxD motif. PksJ is involved in some intermediate steps for the synthesis of the antibiotic polyketide bacillaene which is important in secondary metabolism. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380472 [Multi-domain] Cd Length: 430 Bit Score: 128.97 E-value: 6.08e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 11 YPLSYMQEGMLfhsLLQK---DSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNvSSPQQVVLRERNVI 87
Cdd:cd20484 2 SPLSEGQKGLW---MLQKmspEMSAYNVPLCFRFSSKLDVEKFKQACQFVLEQHPILKSVIEEED-GVPFQKIEPSKPLS 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 88 VLEEDITHLNEAEQSQFIeqwKEKDRDrGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASY 167
Cdd:cd20484 78 FQEEDISSLKESEIIAYL---REKAKE-PFVLENGPLMRVHLFSRSEQEHFVLITIHHIIFDGSSSLTLIHSLLDAYQAL 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 168 VNASPITLEPVQP-YGKYIKW----LMEQDKEQAVSYWDHYLSGHEQQTVLPKQK-KTKGKSRQEHV-TFSFSKEESSRL 240
Cdd:cd20484 154 LQGKQPTLASSPAsYYDFVAWeqdmLAGAEGEEHRAYWKQQLSGTLPILELPADRpRSSAPSFEGQTyTRRLPSELSNQI 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 241 SELAAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRPAeiEGIEHMVGLFINTMPVRVQ-GAKTPFLQLIKDMQ- 318
Cdd:cd20484 234 KSFARSQSINLSTVFLGIFKLLLHRYTGQEDIIVGMPTMGRPE--ERFDSLIGYFINMLPIRSRiLGEETFSDFIRKLQl 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 319 --KDRLAAEAYSYHPLYE------IQSRSAVKQglidhiLVFENYPVQQEIQMLNKQEHASDLFQIhNFT--VADETNYS 388
Cdd:cd20484 312 tvLDGLDHAAYPFPAMVRdlniprSQANSPVFQ------VAFFYQNFLQSTSLQQFLAEYQDVLSI-EFVegIHQEGEYE 384
|
410 420 430 440
....*....|....*....|....*....|....*....|....*...
gi 1678550997 389 FYLMVAPGEE---IHIKmnYDAEQHDRSFVLSVKEHLLNAVSQILNNP 433
Cdd:cd20484 385 LVLEVYEQEDrftLNIK--YNPDLFDASTIERMMEHYVKLAEELIANP 430
|
|
| PRK09088 |
PRK09088 |
acyl-CoA synthetase; Validated |
472-954 |
6.56e-31 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181644 [Multi-domain] Cd Length: 488 Bit Score: 130.31 E-value: 6.56e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 472 QAEKTPDAHAVIDQACSL--TYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPA 549
Cdd:PRK09088 4 HARLQPQRLAAVDLALGRrwTYAELDALVGRLAAVLRRRGCVDGERLAVLARNSVWLVALHFACARVGAIYVPLNWRLSA 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 550 DRIRYILHDCGCSHVVSQAHLPSSLEDnyiithPEDIE---SKVDGSNIKSVNNAD-DLLYMI-YTSGTTGKPKGVQFEH 624
Cdd:PRK09088 84 SELDALLQDAEPRLLLGDDAVAAGRTD------VEDLAafiASADALEPADTPSIPpERVSLIlFTSGTSGQPKGVMLSE 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 625 RNManllkfeyTHSGIDF-------EADVLQFATPSFDVC--YQEIFSALLKGGTLHIVP-----EAIKR---------- 680
Cdd:PRK09088 158 RNL--------QQTAHNFgvlgrvdAHSSFLCDAPMFHIIglITSVRPVLAVGGSILVSNgfepkRTLGRlgdpalgith 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 681 --DVPQLFAFINKHQTnivFLPTAFikmifseRELANSFPDGVKHliaAGEQLM--ISDlfqdvlrkrGIHLHNHYGPSE 756
Cdd:PRK09088 230 yfCVPQMAQAFRAQPG---FDAAAL-------RHLTALFTGGAPH---AAEDILgwLDD---------GIPMVDGFGMSE 287
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 757 THVVSTYTIHPGDPIPELPPIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvi 836
Cdd:PRK09088 288 AGTVFGMSVDCDVIRAKAGAAGIPTPTVQTRVVDDQGNDCPAGVPGELLLRGPNLSPGYWRRPQATARAFTGDGW----- 362
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 837 mYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQN-GEHELCAYYCSVQ-KLNTI 914
Cdd:PRK09088 363 -FRTGDIARRDADGFFWVVDRKKDMFISGGENVYPAEIEAVLADHPGIRECAVVGMADAQwGEVGYLAIVPADGaPLDLE 441
|
490 500 510 520
....*....|....*....|....*....|....*....|
gi 1678550997 915 DLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPE 954
Cdd:PRK09088 442 RIRSHLSTRLAKYKVPKHLRLVDALPRTASGKLQKARLRD 481
|
|
| PRK07787 |
PRK07787 |
acyl-CoA synthetase; Validated |
1496-1933 |
1.01e-30 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236096 [Multi-domain] Cd Length: 471 Bit Score: 129.34 E-value: 1.01e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1496 LHYALEQQAEKTPDqaAVIFEDGVMTYKELNEQANRIAWELIGRGvkpetTVAIIGKRSPEMLLGIYGILKAGGAYLPID 1575
Cdd:PRK07787 4 LNPAAVAAAADIAD--AVRIGGRVLSRSDLAGAATAVAERVAGAR-----RVAVLATPTLATVLAVVGALIAGVPVVPVP 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1576 PDYPEERISFLLEDSGTNILL----LQSAGL-HVPeftgeiVYLNQTNsglAHRLSNPNvdvlPQSLAYVIYTSGSTGMP 1650
Cdd:PRK07787 77 PDSGVAERRHILADSGAQAWLgpapDDPAGLpHVP------VRLHARS---WHRYPEPD----PDAPALIVYTSGTTGPP 143
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1651 KGVEIEHRSAVNFLNSLQSRYQLKHSDMIMHKTSysfdasiweLFwwpyagaSVYLLPQG--------------GEKEPE 1716
Cdd:PRK07787 144 KGVVLSRRAIAADLDALAEAWQWTADDVLVHGLP---------LF-------HVHGLVLGvlgplrignrfvhtGRPTPE 207
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1717 VIAKAIEEQkiTAMHF-VPSMLH---AFLEHIKyrsvPIKTNRLkrVFSGGEQLGTHLVSRFYELlPNVSITNSYGPTEA 1792
Cdd:PRK07787 208 AYAQALSEG--GTLYFgVPTVWSriaADPEAAR----ALRGARL--LVSGSAALPVPVFDRLAAL-TGHRPVERYGMTET 278
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1793 --TVeAAFFDCppheklERIP--IGKPVHHVRLYLLNQNQRMLPVG--CIGELYIAGAGVARGYLNRPALTEERFLEDPF 1866
Cdd:PRK07787 279 liTL-STRADG------ERRPgwVGLPLAGVETRLVDEDGGPVPHDgeTVGELQVRGPTLFDGYLNRPDATAAAFTADGW 351
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1678550997 1867 YpgermyKTGDVARWLPDGNVEFLGR-TDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTvrtdsGEP 1933
Cdd:PRK07787 352 F------RTGDVAVVDPDGMHRIVGReSTDLIKSGGYRIGAGEIETALLGHPGVREAAVV-----GVP 408
|
|
| beta-lac_NRPS |
cd19547 |
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis ... |
1066-1460 |
1.40e-30 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis NocB which exhibits an unusual cyclization to form beta-lactam rings in pro-nocardicin G synthesis; Nocardia uniformis NRPS NocB acts centrally in the biosynthesis of the nocardicin monocyclic beta-lactam antibiotics. Along with another NRPS NocA, it mediates an unusual cyclization to form beta-lactam rings in the synthesis of the beta-lactam-containing pentapeptide pro-nocardicin G. This small subfamily is related to DCL-type Condensation (C) domains, which catalyze condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; domains belonging to this subfamily have an HHHxxxD motif at the active site.
Pssm-ID: 380469 [Multi-domain] Cd Length: 422 Bit Score: 127.81 E-value: 1.40e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1066 IYVLQQLDEGV-----------AYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSGADDEPVQRIHTEV--PFT 1132
Cdd:cd19547 1 VYPLAPMQEGMlfrglfwpdsdAYFNQNVLELVGGTDEDVLREAWRRVADRYEILRTGFTWRDRAEPLQYVRDDLapPWA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1133 L------SKETTIEGFVR--------PFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLL----IREFTDLYA 1194
Cdd:cd19547 81 LldwsgeDPDRRAELLERlladdraaGLSLADCPLYRLTLVRLGGGRHYLLWSHHHILLDGWCLSLIwgdvFRVYEELAH 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1195 NR--QLKPLRiQYKDYAVW-QQKFKKGDsyqKQETYWqQQFSGDLPilelPTD-KRRPAERQFIGGKVTFQLDKEITARI 1270
Cdd:cd19547 161 GRepQLSPCR-PYRDYVRWiRARTAQSE---ESERFW-REYLRDLT----PSPfSTAPADREGEFDTVVHEFPEQLTRLV 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1271 KRLAHKNRSTLYMTLLALYSAFLSRLSGQDDIVIGSPIAGRPH--ADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQ 1348
Cdd:cd19547 232 NEAARGYGVTTNAISQAAWSMLLALQTGARDVVHGLTIAGRPPelEGSEHMVGIFINTIPLRIRLDPDQTVTGLLETIHR 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1349 TALEAYEHQDYPFEELVDKLGVQReMSRNPLFDTTLVLQNMEQQKLKMNDVQLQWNDL------EHPISKFDISLyvteh 1422
Cdd:cd19547 312 DLATTAAHGHVPLAQIKSWASGER-LSGGRVFDNLVAFENYPEDNLPGDDLSIQIIDLhaqektEYPIGLIVLPL----- 385
|
410 420 430
....*....|....*....|....*....|....*...
gi 1678550997 1423 dSELFCQFEYSTALFEKETIQRWASLFTTLVEHTAASP 1460
Cdd:cd19547 386 -QKLAFHFNYDTTHFTRAQVDRFIEVFRLLTEQLCRRP 422
|
|
| PRK12583 |
PRK12583 |
acyl-CoA synthetase; Provisional |
1494-1980 |
1.47e-30 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237145 [Multi-domain] Cd Length: 558 Bit Score: 130.28 E-value: 1.47e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1494 QTLHYALEQQAEKTPDQAAVIF-EDGV-MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAY 1571
Cdd:PRK12583 18 QTIGDAFDATVARFPDREALVVrHQALrYTWRQLADAVDRLARGLLALGVQPGDRVGIWAPNCAEWLLTQFATARIGAIL 97
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1572 LPIDPDYPEERISFLLEDSGTNILLLQSA---------------GLH-----------VPEFTGEIVYLNQTNSGLA--H 1623
Cdd:PRK12583 98 VNINPAYRASELEYALGQSGVRWVICADAfktsdyhamlqellpGLAegqpgalacerLPELRGVVSLAPAPPPGFLawH 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1624 RLSNPNVDVLPQSLAY------------VIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIMHKTS--YSFDA 1689
Cdd:PRK12583 178 ELQARGETVSREALAErqasldrddpinIQYTSGTTGFPKGATLSHHNILNNGYFVAESLGLTEHDRLCVPVPlyHCFGM 257
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1690 SIWELFWWPYAGASVYllPQGgEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTnrLKRVFSGGEQLGTH 1769
Cdd:PRK12583 258 VLANLGCMTVGACLVY--PNE-AFDPLATLQAVEEERCTALYGVPTMFIAELDHPQRGNFDLSS--LRTGIMAGAPCPIE 332
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1770 LVSRFYELLPNVSITNSYGPTEATveAAFFDCPPHEKLER--IPIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVA 1847
Cdd:PRK12583 333 VMRRVMDEMHMAEVQIAYGMTETS--PVSLQTTAADDLERrvETVGRTQPHLEVKVVDPDGATVPRGEIGELCTRGYSVM 410
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1848 RGYLNRPALTEERFLEDPFypgerMYkTGDVARWLPDGNVEFLGRTDDQVkIR-GYRIEPGEIEAALRSIEGVREAAVTV 1926
Cdd:PRK12583 411 KGYWNNPEATAESIDEDGW-----MH-TGDLATMDEQGYVRIVGRSKDMI-IRgGENIYPREIEEFLFTHPAVADVQVFG 483
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 1927 RTDS--GEpELCAYV-----EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDR 1980
Cdd:PRK12583 484 VPDEkyGE-EIVAWVrlhpgHAASEEELREFCKARIAHFKVPRYFRFVDEFPMTVTGKVQK 543
|
|
| PRK06087 |
PRK06087 |
medium-chain fatty-acid--CoA ligase; |
2530-3021 |
1.80e-30 |
|
medium-chain fatty-acid--CoA ligase;
Pssm-ID: 180393 [Multi-domain] Cd Length: 547 Bit Score: 129.87 E-value: 1.80e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2530 YGVQTISQLFEQQAARTPKASALVSGDKT-LTYQELDEWSNGIARALRSRGVKPDTPVGIMMHR--SFSMIAsiLGVWKA 2606
Cdd:PRK06087 20 WGDASLADYWQQTARAMPDKIAVVDNHGAsYTYSALDHAASRLANWLLAKGIEPGDRVAFQLPGwcEFTIIY--LACLKV 97
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2607 GGCYVPIDPEYPKERKRYILSDSGTKLLMT------INEADL-------------GVLADFEGEILTIESVEE--DDKSP 2665
Cdd:PRK06087 98 GAVSVPLLPSWREAELVWVLNKCQAKMFFAptlfkqTRPVDLilplqnqlpqlqqIVGVDKLAPATSSLSLSQiiADYEP 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2666 L--PQMSSAHHLAYIIYTSGTTGRPKGVMVEHkgiaNTLQWRRNAYA----FNETDTILQLFSFSF-DGFITSMFTPLLS 2738
Cdd:PRK06087 178 LttAITTHGDELAAVLFTSGTEGLPKGVMLTH----NNILASERAYCarlnLTWQDVFMMPAPLGHaTGFLHGVTAPFLI 253
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2739 GAKAVLLHEEEAKDILAIkhqLSRQRITHMI-IVPVLYRALLDV-VQPEDVKTLRVVTLAGEAADRELIARSLAicPHTE 2816
Cdd:PRK06087 254 GARSVLLDIFTPDACLAL---LEQQRCTCMLgATPFIYDLLNLLeKQPADLSALRFFLCGGTTIPKKVARECQQ--RGIK 328
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2817 LANEYGPTENSVATTVM--RHMEKQAYVSiGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFT 2894
Cdd:PRK06087 329 LLSVYGSTESSPHAVVNldDPLSRFMHTD-GYAAAGVEIKVVDEARKTLPPGCEGEEASRGPNVFMGYLDEPELTARALD 407
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2895 QNPFkpearmYRTGDAARWMADGTLEYLGRIDDqVKIR-GYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVV 2973
Cdd:PRK06087 408 EEGW------YYSGDLCRMDEAGYIKITGRKKD-IIVRgGENISSREVEDILLQHPKIHDACVVAMPDERLGERSCAYVV 480
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 2974 TKPGLSTNAVRSEL----QNKLPVFMHPAFIEKLDSLPLSPNGKLDRGALPK 3021
Cdd:PRK06087 481 LKAPHHSLTLEEVVaffsRKRVAKYKYPEHIVVIDKLPRTASGKIQKFLLRK 532
|
|
| PRK05677 |
PRK05677 |
long-chain-fatty-acid--CoA ligase; Validated |
2528-3019 |
2.16e-30 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 168170 [Multi-domain] Cd Length: 562 Bit Score: 129.88 E-value: 2.16e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2528 NQYgvQTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSR-GVKPDTPVGIMMHRSFSMIASILGVWKA 2606
Cdd:PRK05677 21 DEY--PNIQAVLKQSCQRFADKPAFSNLGKTLTYGELYKLSGAFAAWLQQHtDLKPGDRIAVQLPNVLQYPVAVFGAMRA 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2607 GGCYVPIDPEYPKERKRYILSDSGTKLLMTI-NEADL--------GV-------LADFEGEI--LTIESVEEDDKSPLPQ 2668
Cdd:PRK05677 99 GLIVVNTNPLYTAREMEHQFNDSGAKALVCLaNMAHLaekvlpktGVkhvivteVADMLPPLkrLLINAVVKHVKKMVPA 178
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2669 MS------------------------SAHHLAYIIYTSGTTGRPKGVMVEHKG-IANTLQWRR-NAYAFNETDTIL---- 2718
Cdd:PRK05677 179 YHlpqavkfndalakgagqpvteanpQADDVAVLQYTGGTTGVAKGAMLTHRNlVANMLQCRAlMGSNLNEGCEILiapl 258
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2719 ---QLFSFSFDgfitSMFTpLLSGAKAVLLheEEAKDILAIKHQLSRQRITHMIIVPVLYRALldvVQPEDVKTLRV--- 2792
Cdd:PRK05677 259 plyHIYAFTFH----CMAM-MLIGNHNILI--SNPRDLPAMVKELGKWKFSGFVGLNTLFVAL---CNNEAFRKLDFsal 328
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2793 -VTLAGEAADRELIA---RSLAICPHTElanEYGPTENSVATTVmRHMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVA 2868
Cdd:PRK05677 329 kLTLSGGMALQLATAerwKEVTGCAICE---GYGMTETSPVVSV-NPSQAIQVGTIGIPVPSTLCKVIDDDGNELPLGEV 404
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2869 GELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCI 2948
Cdd:PRK05677 405 GELCVKGPQVMKGYWQRPEATDEILDSDGW------LKTGDIALIQEDGYMRIVDRKKDMILVSGFNVYPNELEDVLAAL 478
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 2949 KGVKD-AAVVAHVTASGQTeLSAYVVTKPG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK05677 479 PGVLQcAAIGVPDEKSGEA-IKVFVVVKPGetLTKEQVMEHMRANLTGYKVPKAVEFRDELPTTNVGKILRREL 551
|
|
| PRK03640 |
PRK03640 |
o-succinylbenzoate--CoA ligase; |
471-949 |
2.69e-30 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 235146 [Multi-domain] Cd Length: 483 Bit Score: 128.16 E-value: 2.69e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 471 KQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPAD 550
Cdd:PRK03640 10 QRAFLTPDRTAIEFEEKKVTFMELHEAVVSVAGKLAALGVKKGDRVALLMKNGMEMILVIHALQQLGAVAVLLNTRLSRE 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 551 RIRYILHDCGCSHVVSQAHLPSSLEDNYIITHPEDIESKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRN---- 626
Cdd:PRK03640 90 ELLWQLDDAEVKCLITDDDFEAKLIPGISVKFAELMNGPKEEAEIQEEFDLDEVATIMYTSGTTGKPKGVIQTYGNhwws 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 627 -MANLLKFEYThsgidfEADVLQFATPSFDVcyqEIFSALLK----GGTLHIVPeaiKRDVPQLFAFINKHQTNIVFLPT 701
Cdd:PRK03640 170 aVGSALNLGLT------EDDCWLAAVPIFHI---SGLSILMRsviyGMRVVLVE---KFDAEKINKLLQTGGVTIISVVS 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 702 AFIKMIFSERELANsFPDGVKHLIAAGEQLMISDLfqDVLRKRGIHLHNHYGPSET--HVVstyTIHPGDPIPELPPIGK 779
Cdd:PRK03640 238 TMLQRLLERLGEGT-YPSSFRCMLLGGGPAPKPLL--EQCKEKGIPVYQSYGMTETasQIV---TLSPEDALTKLGSAGK 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 780 PIGCTDLYILNHQKQLQPcGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKpdvimyrTGDLARRLEDGNIEYIGRAD 859
Cdd:PRK03640 312 PLFPCELKIEKDGVVVPP-FEEGEIVVKGPNVTKGYLNREDATRETFQDGWFK-------TGDIGYLDEEGFLYVLDRRS 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 860 NQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCSVQKLNTIDLRSYMASELPEYMIPAKWIWVDSI 939
Cdd:PRK03640 384 DLIISGGENIYPAEIEEVLLSHPGVAEAGVVGVPDDKWGQVPVAFVVKSGEVTEEELRHFCEEKLAKYKVPKRFYFVEEL 463
|
490
....*....|
gi 1678550997 940 PLTPNGKVDR 949
Cdd:PRK03640 464 PRNASGKLLR 473
|
|
| AAS_C |
cd05909 |
C-terminal domain of the acyl-acyl carrier protein synthetase (also called ... |
2558-3015 |
3.91e-30 |
|
C-terminal domain of the acyl-acyl carrier protein synthetase (also called 2-acylglycerophosphoethanolamine acyltransferase, Aas); Acyl-acyl carrier protein synthase (Aas) is a membrane protein responsible for a minor pathway of incorporating exogenous fatty acids into membrane phospholipids. Its in vitro activity is characterized by the ligation of free fatty acids between 8 and 18 carbons in length to the acyl carrier protein sulfydryl group (ACP-SH) in the presence of ATP and Mg2+. However, its in vivo function is as a 2-acylglycerophosphoethanolamine (2-acyl-GPE) acyltransferase. The reaction occurs in two steps: the acyl chain is first esterified to acyl carrier protein (ACP) via a thioester bond, followed by a second step where the acyl chain is transferred to a 2-acyllysophospholipid, thus completing the transacylation reaction. This model represents the C-terminal domain of the enzyme, which belongs to the class I adenylate-forming enzyme family, including acyl-CoA synthetases.
Pssm-ID: 341235 [Multi-domain] Cd Length: 490 Bit Score: 127.83 E-value: 3.91e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2558 TLTYQELDEWSNGIARALRsRGVKPDTPVGIMMHRSFSMIASILGVWKAGgcYVPIDPEYP--KERKRYILSDSGTKLLM 2635
Cdd:cd05909 7 SLTYRKLLTGAIALARKLA-KMTKEGENVGVMLPPSAGGALANFALALSG--KVPVMLNYTagLRELRACIKLAGIKTVL 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2636 T----INEADL--GVLADFEGEILTIESVEED----DK---------SPLPQMS-------SAHHLAYIIYTSGTTGRPK 2689
Cdd:cd05909 84 TskqfIEKLKLhhLFDVEYDARIVYLEDLRAKiskaDKckaflagkfPPKWLLRifgvapvQPDDPAVILFTSGSEGLPK 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2690 GVMVEHKGIANTLQWRRNAYAFNETDTILQLFSF--SFdGFITSMFTPLLSGAKAVLL-HEEEAKDILAIKHQlsrQRIT 2766
Cdd:cd05909 164 GVVLSHKNLLANVEQITAIFDPNPEDVVFGALPFfhSF-GLTGCLWLPLLSGIKVVFHpNPLDYKKIPELIYD---KKAT 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2767 HMIIVPVLYRALLDVVQPEDVKTLRVVTLAGEA---ADRELIARSLAICPhtelaNE-YGPTENS-VATTVMRHMEKQAY 2841
Cdd:cd05909 240 ILLGTPTFLRGYARAAHPEDFSSLRLVVAGAEKlkdTLRQEFQEKFGIRI-----LEgYGTTECSpVISVNTPQSPNKEG 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2842 vSIGQPIDGTQVLILN-SNHQLQPIGVAGELCIAGTGLARGYVNLPELTEraftqnpFKPEARMYRTGDAARWMADGTLE 2920
Cdd:cd05909 315 -TVGRPLPGMEVKIVSvETHEEVPIGEGGLLLVRGPNVMLGYLNEPELTS-------FAFGDGWYDTGDIGKIDGEGFLT 386
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2921 YLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTNAVRSELQN-KLPVFMHPAF 2999
Cdd:cd05909 387 ITGRLSRFAKIAGEMVSLEAIEDILSEILPEDNEVAVVSVPDGRKGEKIVLLTTTTDTDPSSLNDILKNaGISNLAKPSY 466
|
490
....*....|....*.
gi 1678550997 3000 IEKLDSLPLSPNGKLD 3015
Cdd:cd05909 467 IHQVEEIPLLGTGKPD 482
|
|
| caiC |
PRK08008 |
putative crotonobetaine/carnitine-CoA ligase; Validated |
463-952 |
4.13e-30 |
|
putative crotonobetaine/carnitine-CoA ligase; Validated
Pssm-ID: 181195 [Multi-domain] Cd Length: 517 Bit Score: 128.26 E-value: 4.13e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 463 ETIHAMFEKQAEKTPDAHAVIDQAC-----SLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAG 537
Cdd:PRK08008 7 QHLRQMWDDLADVYGHKTALIFESSggvvrRYSYLELNEEINRTANLFYSLGIRKGDKVALHLDNCPEFIFCWFGLAKIG 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 538 GAIVPVDPHYPADRIRYILHDCGCSHVVSQAHL-----------PSSLEDNYII-THPEDIESKVDGSNIKSVN------ 599
Cdd:PRK08008 87 AIMVPINARLLREESAWILQNSQASLLVTSAQFypmyrqiqqedATPLRHICLTrVALPADDGVSSFTQLKAQQpatlcy 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 600 ----NADDLLYMIYTSGTTGKPKGVQFEHRNmanlLKFE--YTHSGIDFEA-DVLQFATPSFDVCYQ--EIFSALLKGGT 670
Cdd:PRK08008 167 applSTDDTAEILFTSGTTSRPKGVVITHYN----LRFAgyYSAWQCALRDdDVYLTVMPAFHIDCQctAAMAAFSAGAT 242
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 671 LHIVPEAIKRdvpqlfAF---INKHQTNIvflpTAFIKMIFSERELANSFPDGVKHLIaagEQLM----ISDLFQDVLRK 743
Cdd:PRK08008 243 FVLLEKYSAR------AFwgqVCKYRATI----TECIPMMIRTLMVQPPSANDRQHCL---REVMfylnLSDQEKDAFEE 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 744 R-GIHLHNHYGPSEThVVSTYTIHPGDPiPELPPIGKPIGCTDLYILNHQKQLQPCGVPGELYISGA---SVARGYVNHD 819
Cdd:PRK08008 310 RfGVRLLTSYGMTET-IVGIIGDRPGDK-RRWPSIGRPGFCYEAEIRDDHNRPLPAGEIGEICIKGVpgkTIFKEYYLDP 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 820 KLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEH 899
Cdd:PRK08008 388 KATAKVLEADGW------LHTGDTGYVDEEGFFYFVDRRCNMIKRGGENVSCVELENIIATHPKIQDIVVVGIKDSIRDE 461
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 900 ELCAYYCSVQ--KLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PRK08008 462 AIKAFVVLNEgeTLSEEEFFAFCEQNMAKFKVPSYLEIRKDLPRNCSGKIIKKNL 516
|
|
| PRK12583 |
PRK12583 |
acyl-CoA synthetase; Provisional |
463-954 |
8.31e-30 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237145 [Multi-domain] Cd Length: 558 Bit Score: 127.97 E-value: 8.31e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 463 ETIHAMFEKQAEKTPDAHAVI--DQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAI 540
Cdd:PRK12583 18 QTIGDAFDATVARFPDREALVvrHQALRYTWRQLADAVDRLARGLLALGVQPGDRVGIWAPNCAEWLLTQFATARIGAIL 97
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 541 VPVDPHYPADRIRYILHDCGCS-------------HVVSQAHLPSSLEDNYIITHPE----------------------- 584
Cdd:PRK12583 98 VNINPAYRASELEYALGQSGVRwvicadafktsdyHAMLQELLPGLAEGQPGALACErlpelrgvvslapapppgflawh 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 585 DIESKVDGSNIKSVN------NADDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEYTHSGIDfEADVLQFATPSFDvCY 658
Cdd:PRK12583 178 ELQARGETVSREALAerqaslDRDDPINIQYTSGTTGFPKGATLSHHNILNNGYFVAESLGLT-EHDRLCVPVPLYH-CF 255
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 659 QEIFSALL---KGGTLHIVPEAIKRDVpQLFAFINKHQTNIVFLPTAFIKMI----FSERELAnSFPDGvkhlIAAGEQL 731
Cdd:PRK12583 256 GMVLANLGcmtVGACLVYPNEAFDPLA-TLQAVEEERCTALYGVPTMFIAELdhpqRGNFDLS-SLRTG----IMAGAPC 329
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 732 MIsdlfqDVLRKRGIHLHNH-----YGPSETHVVSTYTIhPGDPIP-ELPPIGKPIGCTDLYILNHQKQLQPCGVPGELY 805
Cdd:PRK12583 330 PI-----EVMRRVMDEMHMAevqiaYGMTETSPVSLQTT-AADDLErRVETVGRTQPHLEVKVVDPDGATVPRGEIGELC 403
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 806 ISGASVARGYVNHDKLTSDKFSSDPFkpdviMYrTGDLARRLEDGNIEYIGRADNQVkIR-GYRIEPQEIEVTLMNHPDI 884
Cdd:PRK12583 404 TRGYSVMKGYWNNPEATAESIDEDGW-----MH-TGDLATMDEQGYVRIVGRSKDMI-IRgGENIYPREIEEFLFTHPAV 476
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 885 SEAAILIWQDQNGEHELCAYYC--SVQKLNTIDLRSYMASELPEYMIPaKWIW-VDSIPLTPNGKVDRAALPE 954
Cdd:PRK12583 477 ADVQVFGVPDEKYGEEIVAWVRlhPGHAASEEELREFCKARIAHFKVP-RYFRfVDEFPMTVTGKVQKFRMRE 548
|
|
| PRK08316 |
PRK08316 |
acyl-CoA synthetase; Validated |
464-947 |
8.88e-30 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181381 [Multi-domain] Cd Length: 523 Bit Score: 127.36 E-value: 8.88e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 464 TIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPV 543
Cdd:PRK08316 12 TIGDILRRSARRYPDKTALVFGDRSWTYAELDAAVNRVAAALLDLGLKKGDRVAALGHNSDAYALLWLACARAGAVHVPV 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 544 DPHYPADRIRYILHDCGCSHVVSQAHLPSSLEDNYIITHPEDIE-------SKVDGSNIKSVN--------------NAD 602
Cdd:PRK08316 92 NFMLTGEELAYILDHSGARAFLVDPALAPTAEAALALLPVDTLIlslvlggREAPGGWLDFADwaeagsvaepdvelADD 171
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 603 DLLYMIYTSGTTGKPKGVQFEHRNmanlLKFEYTHSGIDFE---ADVLQFATPSFDvCYQ-EIF--SALLKGGTLHIVPE 676
Cdd:PRK08316 172 DLAQILYTSGTESLPKGAMLTHRA----LIAEYVSCIVAGDmsaDDIPLHALPLYH-CAQlDVFlgPYLYVGATNVILDA 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 677 AikrDVPQLFAFINKHQTNIVFL-PTAFIKMI----FSERELANsfpdgvkhLIAA--GEQLMISDLFQDvLRKR--GIH 747
Cdd:PRK08316 247 P---DPELILRTIEAERITSFFApPTVWISLLrhpdFDTRDLSS--------LRKGyyGASIMPVEVLKE-LRERlpGLR 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 748 LHNHYGPSETHVVSTyTIHPGDPIPELPPIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFS 827
Cdd:PRK08316 315 FYNCYGQTEIAPLAT-VLGPEEHLRRPGSAGRPVLNVETRVVDDDGNDVAPGEVGEIVHRSPQLMLGYWDDPEKTAEAFR 393
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 828 SDPFkpdvimyRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAyyCS 907
Cdd:PRK08316 394 GGWF-------HSGDLGVMDEEGYITVVDRKKDMIKTGGENVASREVEEALYTHPAVAEVAVIGLPDPKWIEAVTA--VV 464
|
490 500 510 520
....*....|....*....|....*....|....*....|....
gi 1678550997 908 VQK----LNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKV 947
Cdd:PRK08316 465 VPKagatVTEDELIAHCRARLAGFKVPKRVIFVDELPRNPSGKI 508
|
|
| PRK09088 |
PRK09088 |
acyl-CoA synthetase; Validated |
2542-3019 |
9.36e-30 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181644 [Multi-domain] Cd Length: 488 Bit Score: 126.85 E-value: 9.36e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2542 QAARTPKASA---LVSGDKtLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYP 2618
Cdd:PRK09088 4 HARLQPQRLAavdLALGRR-WTYAELDALVGRLAAVLRRRGCVDGERLAVLARNSVWLVALHFACARVGAIYVPLNWRLS 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2619 KERKRYILSDSGTKLLMtineADLGVLA------DFEGEILTIESVEEDDKSPLPqmssAHHLAYIIYTSGTTGRPKGVM 2692
Cdd:PRK09088 83 ASELDALLQDAEPRLLL----GDDAVAAgrtdveDLAAFIASADALEPADTPSIP----PERVSLILFTSGTSGQPKGVM 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2693 VEHKGIANTlqwrrnAYAFNETDTILQLFSFSFD-------GFITSMFTPLLSGAKAVLLHEEEAKDILAikhQLSRQR- 2764
Cdd:PRK09088 155 LSERNLQQT------AHNFGVLGRVDAHSSFLCDapmfhiiGLITSVRPVLAVGGSILVSNGFEPKRTLG---RLGDPAl 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2765 -ITHMIIVPVLYRALLDvvQPE-DVKTLRVVT--LAGEA--ADRELIARSLAICPhteLANEYGPTEnsvATTVMrHMEK 2838
Cdd:PRK09088 226 gITHYFCVPQMAQAFRA--QPGfDAAALRHLTalFTGGAphAAEDILGWLDDGIP---MVDGFGMSE---AGTVF-GMSV 296
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2839 QAYV------SIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTqnpfkpEARMYRTGDAAR 2912
Cdd:PRK09088 297 DCDVirakagAAGIPTPTVQTRVVDDQGNDCPAGVPGELLLRGPNLSPGYWRRPQATARAFT------GDGWFRTGDIAR 370
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2913 WMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTNA--VRSELQNK 2990
Cdd:PRK09088 371 RDADGFFWVVDRKKDMFISGGENVYPAEIEAVLADHPGIRECAVVGMADAQWGEVGYLAIVPADGAPLDLerIRSHLSTR 450
|
490 500
....*....|....*....|....*....
gi 1678550997 2991 LPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK09088 451 LAKYKVPKHLRLVDALPRTASGKLQKARL 479
|
|
| PRK07529 |
PRK07529 |
AMP-binding domain protein; Validated |
1485-1983 |
9.43e-30 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236043 [Multi-domain] Cd Length: 632 Bit Score: 128.53 E-value: 9.43e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1485 FEETGYS---MNQTLHYALEQQAEKTPDQAAVIF--------EDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKR 1553
Cdd:PRK07529 13 IEAVPLAardLPASTYELLSRAAARHPDAPALSFlldadpldRPETWTYAELLADVTRTANLLHSLGVGPGDVVAFLLPN 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1554 SPEMLLGIYGILKAGGAYlPIDPDYPEERISFLLEDSGTNIL---------------------------LLQSAGL-HVP 1605
Cdd:PRK07529 93 LPETHFALWGGEAAGIAN-PINPLLEPEQIAELLRAAGAKVLvtlgpfpgtdiwqkvaevlaalpelrtVVEVDLArYLP 171
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1606 EFTGEIVYLNQTNSGL-------------AHRLSNPNVdVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQ 1672
Cdd:PRK07529 172 GPKRLAVPLIRRKAHArildfdaelarqpGDRLFSGRP-IGPDDVAAYFHTGGTTGMPKLAQHTHGNEVANAWLGALLLG 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1673 LKHSDMIMHKTS-YSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIA---KAIEEQKITAMHFVPSMLHAFLEhikyrs 1748
Cdd:PRK07529 251 LGPGDTVFCGLPlFHVNALLVTGLAPLARGAHVVLATPQGYRGPGVIAnfwKIVERYRINFLSGVPTVYAALLQ------ 324
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1749 VPIK---TNRLKRVFSGGEQLGTHLVSRFYELLpNVSITNSYGPTEATVEAAffdCPPHEKLERI-PIGKPV--HHVRLY 1822
Cdd:PRK07529 325 VPVDghdISSLRYALCGAAPLPVEVFRRFEAAT-GVRIVEGYGLTEATCVSS---VNPPDGERRIgSVGLRLpyQRVRVV 400
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1823 LLNQN---QRMLPVGCIGELYIAGAGVARGYL----NRPALTEERFLedpfypgermyKTGDVARWLPDGNVEFLGRTDD 1895
Cdd:PRK07529 401 ILDDAgryLRDCAVDEVGVLCIAGPNVFSGYLeaahNKGLWLEDGWL-----------NTGDLGRIDADGYFWLTGRAKD 469
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1896 QVkIR-GYRIEPGEIEAALRSIEGVREAAVTVRTDSGEPEL-CAYVE---GLQRNE------VRAQL-ERLlpgyMVPAY 1963
Cdd:PRK07529 470 LI-IRgGHNIDPAAIEEALLRHPAVALAAAVGRPDAHAGELpVAYVQlkpGASATEaellafARDHIaERA----AVPKH 544
|
570 580
....*....|....*....|
gi 1678550997 1964 MIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK07529 545 VRILDALPKTAVGKIFKPAL 564
|
|
| PRK09088 |
PRK09088 |
acyl-CoA synthetase; Validated |
1503-1983 |
1.03e-29 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181644 [Multi-domain] Cd Length: 488 Bit Score: 126.46 E-value: 1.03e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1503 QAEKTPDQ-AAVIFEDGV-MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPE 1580
Cdd:PRK09088 4 HARLQPQRlAAVDLALGRrWTYAELDALVGRLAAVLRRRGCVDGERLAVLARNSVWLVALHFACARVGAIYVPLNWRLSA 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1581 ERISFLLEDSGTNILL----LQSAGLHVPEFTGEIVYLNQtnSGLAHRLSNPnvdvlPQSLAYVIYTSGSTGMPKGVEIE 1656
Cdd:PRK09088 84 SELDALLQDAEPRLLLgddaVAAGRTDVEDLAAFIASADA--LEPADTPSIP-----PERVSLILFTSGTSGQPKGVMLS 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1657 HR----SAVNFlnSLQSRyqlkhsdmIMHKTSYSFDASIWELFwwpyaGASVYLLP---QGGEK------EPEVIAKAIE 1723
Cdd:PRK09088 157 ERnlqqTAHNF--GVLGR--------VDAHSSFLCDAPMFHII-----GLITSVRPvlaVGGSIlvsngfEPKRTLGRLG 221
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1724 EQKITAMHF--VPSMLHAFLEHIKYRsvPIKTNRLKRVFSGGeqlGTHLVSRFYELLPN-VSITNSYGPTEA-TVEAAFF 1799
Cdd:PRK09088 222 DPALGITHYfcVPQMAQAFRAQPGFD--AAALRHLTALFTGG---APHAAEDILGWLDDgIPMVDGFGMSEAgTVFGMSV 296
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1800 DCppheklERI-----PIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYpgermyK 1874
Cdd:PRK09088 297 DC------DVIrakagAAGIPTPTVQTRVVDDQGNDCPAGVPGELLLRGPNLSPGYWRRPQATARAFTGDGWF------R 364
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1875 TGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GEPELCAYV--EG--LQRNEVR 1948
Cdd:PRK09088 365 TGDIARRDADGFFWVVDRKKDMFISGGENVYPAEIEAVLADHPGIRECAVVGMADAqwGEVGYLAIVpaDGapLDLERIR 444
|
490 500 510
....*....|....*....|....*....|....*
gi 1678550997 1949 AQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK09088 445 SHLSTRLAKYKVPKHLRLVDALPRTASGKLQKARL 479
|
|
| PRK06188 |
PRK06188 |
acyl-CoA synthetase; Validated |
477-952 |
1.30e-29 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235731 [Multi-domain] Cd Length: 524 Bit Score: 126.64 E-value: 1.30e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 477 PDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIM-MERSAAFITGVLGILkAGGAIVPVDPHYPADRIRYI 555
Cdd:PRK06188 26 PDRPALVLGDTRLTYGQLADRISRYIQAFEALGLGTGDAVALLsLNRPEVLMAIGAAQL-AGLRRTALHPLGSLDDHAYV 104
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 556 LHDCGCSHVVS------------QAHLPSSLEdnyIITH-----PEDIESKVDGSNIKSVNNAD---DLLYMIYTSGTTG 615
Cdd:PRK06188 105 LEDAGISTLIVdpapfveralalLARVPSLKH---VLTLgpvpdGVDLLAAAAKFGPAPLVAAAlppDIAGLAYTGGTTG 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 616 KPKGVQFEHRNMANLLKFEYTHSGIDFEADVLqFATPSFDVCYQEIFSALLKGGTLHIVPeaiKRDVPQLFAFINKHQTN 695
Cdd:PRK06188 182 KPKGVMGTHRSIATMAQIQLAEWEWPADPRFL-MCTPLSHAGGAFFLPTLLRGGTVIVLA---KFDPAEVLRAIEEQRIT 257
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 696 IVFL-PTafikMIFSERELansfPDGVKH------LIAAGEQLMISDLFQDVLRKRGIHLHNHYGPSETHVVSTYTI--- 765
Cdd:PRK06188 258 ATFLvPT----MIYALLDH----PDLRTRdlssleTVYYGASPMSPVRLAEAIERFGPIFAQYYGQTEAPMVITYLRkrd 329
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 766 HPGDPIPELPPIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDpfkpdviMYRTGDLAR 845
Cdd:PRK06188 330 HDPDDPKRLTSCGRPTPGLRVALLDEDGREVAQGEVGEICVRGPLVMDGYWNRPEETAEAFRDG-------WLHTGDVAR 402
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 846 RLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAIL-IWQDQNGEH-ELCAYYCSVQKLNTIDLRSYMASE 923
Cdd:PRK06188 403 EDEDGFYYIVDRKKDMIVTGGFNVFPREVEDVLAEHPAVAQVAVIgVPDEKWGEAvTAVVVLRPGAAVDAAELQAHVKER 482
|
490 500
....*....|....*....|....*....
gi 1678550997 924 LPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PRK06188 483 KGSVHAPKQVDFVDSLPLTALGKPDKKAL 511
|
|
| LC_FACL_like |
cd05914 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are ... |
2555-3016 |
1.42e-29 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are bacterial long-chain fatty acid CoA synthetase, most of which are as yet uncharacterized. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341240 [Multi-domain] Cd Length: 463 Bit Score: 125.63 E-value: 1.42e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2555 GDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLL 2634
Cdd:cd05914 4 GGEPLTYKDLADNIAKFALLLKINGVGTGDRVALMGENRPEWGIAFFAIWTYGAIAVPILAEFTADEVHHILNHSEAKAI 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2635 MTINEADLgvladfegeiltiesveeddksplpqmssahhlAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNET 2714
Cdd:cd05914 84 FVSDEDDV---------------------------------ALINYTSGTTGNSKGVMLTYRNIVSNVDGVKEVVLLGKG 130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2715 DTILQLFSFSFD-GFITSMFTPLLSGAKAVLLHEEEAKDILAikhqLSRQRITHMIIVPVLY----RALLDVVQPED--- 2786
Cdd:cd05914 131 DKILSILPLHHIyPLTFTLLLPLLNGAHVVFLDKIPSAKIIA----LAFAQVTPTLGVPVPLviekIFKMDIIPKLTlkk 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2787 --------VKTLRVVTLAGEAAD-------RELIARSLAICPHTE---------LANEYGPTENS--VATTVmrhMEKQA 2840
Cdd:cd05914 207 fkfklakkINNRKIRKLAFKKVHeafggniKEFVIGGAKINPDVEeflrtigfpYTIGYGMTETApiISYSP---PNRIR 283
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2841 YVSIGQPIDGTQVLILNSNhqlqPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMADGTLE 2920
Cdd:cd05914 284 LGSAGKVIDGVEVRIDSPD----PATGEGEIIVRGPNVMKGYYKNPEATAEAFDKDGW------FHTGDLGKIDAEGYLY 353
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2921 YLGRIDDQ-VKIRGYRVETKEIESVIRCIKGV---------KDAAVVAHVTASGQTELSAYVVTKPGLSTNAVRSELQNK 2990
Cdd:cd05914 354 IRGRKKEMiVLSSGKNIYPEEIEAKINNMPFVleslvvvqeKKLVALAYIDPDFLDVKALKQRNIIDAIKWEVRDKVNQK 433
|
490 500
....*....|....*....|....*..
gi 1678550997 2991 LPVFMHPA-FIEKLDSLPLSPNGKLDR 3016
Cdd:cd05914 434 VPNYKKISkVKIVKEEFEKTPKGKIKR 460
|
|
| AFD_YhfT-like |
cd17633 |
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, ... |
1636-1980 |
1.71e-29 |
|
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, as well as long-chain fatty acid-CoA ligase VraA, all of which are as yet to be characterized. These proteins belong to the adenylate-forming enzymes which catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain
Pssm-ID: 341288 [Multi-domain] Cd Length: 320 Bit Score: 122.13 E-value: 1.71e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1636 SLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLlpQGGEKEP 1715
Cdd:cd17633 1 NPFYIGFTSGTTGLPKAYYRSERSWIESFVCNEDLFNISGEDAILAPGPLSHSLFLYGAISALYLGGTFIG--QRKFNPK 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1716 EVIAKaIEEQKITAMHFVPSMLHAFLEHikyrSVPIktNRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVE 1795
Cdd:cd17633 79 SWIRK-INQYNATVIYLVPTMLQALART----LEPE--SKIKSIFSSGQKLFESTKKKLKNIFPKANLIEFYGTSELSFI 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1796 AAFFD---CPPHEkleripIGKPVHHVRLYLLNQNQrmlpvGCIGELYIAGAGVARGYLNRPALTEERFledpfypgerm 1872
Cdd:cd17633 152 TYNFNqesRPPNS------VGRPFPNVEIEIRNADG-----GEIGKIFVKSEMVFSGYVRGGFSNPDGW----------- 209
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1873 YKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDSGEPELCAYV---EGLQRNEVRA 1949
Cdd:cd17633 210 MSVGDIGYVDEEGYLYLVGRESDMIIIGGINIFPTEIESVLKAIPGIEEAIVVGIPDARFGEIAVALysgDKLTYKQLKR 289
|
330 340 350
....*....|....*....|....*....|.
gi 1678550997 1950 QLERLLPGYMVPAYMIEMEQWPVTPSGKLDR 1980
Cdd:cd17633 290 FLKQKLSRYEIPKKIIFVDSLPYTSSGKIAR 320
|
|
| FACL_like_2 |
cd05917 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
602-949 |
1.86e-29 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341241 [Multi-domain] Cd Length: 349 Bit Score: 122.77 E-value: 1.86e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 602 DDLLYMIYTSGTTGKPKGVQFEHRNMAN-------LLKFEythsgidfEADVLQFATPSFDV--CYQEIFSALLKGGTlh 672
Cdd:cd05917 2 DDVINIQFTSGTTGSPKGATLTHHNIVNngyfigeRLGLT--------EQDRLCIPVPLFHCfgSVLGVLACLTHGAT-- 71
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 673 IVPEAIKRDVPQLFAFINKHQTNIVF-LPTAFIKMIFSERELANSFpDGVKHLIAAG----EQLMisdlfQDVLRKRGI- 746
Cdd:cd05917 72 MVFPSPSFDPLAVLEAIEKEKCTALHgVPTMFIAELEHPDFDKFDL-SSLRTGIMAGapcpPELM-----KRVIEVMNMk 145
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 747 HLHNHYGPSETHVVSTYTIhPGDPIPE-LPPIGKPIGCTDLYILNHQ-KQLQPCGVPGELYISGASVARGYVNHDKLTSD 824
Cdd:cd05917 146 DVTIAYGMTETSPVSTQTR-TDDSIEKrVNTVGRIMPHTEAKIVDPEgGIVPPVGVPGELCIRGYSVMKGYWNDPEKTAE 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 825 KFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQVkIRG-YRIEPQEIEVTLMNHPDISEAAIL-IWQDQNGEhELC 902
Cdd:cd05917 225 AIDGDGW------LHTGDLAVMDEDGYCRIVGRIKDMI-IRGgENIYPREIEEFLHTHPKVSDVQVVgVPDERYGE-EVC 296
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 903 AYycsVQ-----KLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDR 949
Cdd:cd05917 297 AW---IRlkegaELTEEDIKAYCKGKIAHYKVPRYVFFVDEFPLTVSGKIQK 345
|
|
| AACS_like |
cd05968 |
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This ... |
2557-3016 |
2.15e-29 |
|
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This uncharacterized acyl-CoA synthetase family (EC 6.2.1.16, or acetoacetate#CoA ligase or acetoacetate:CoA ligase (AMP-forming)) is highly homologous to acetoacetyl-CoA synthetase. However, the proteins in this family exist in only bacteria and archaea. AACS is a cytosolic ligase that specifically activates acetoacetate to its coenzyme A ester by a two-step reaction. Acetoacetate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is the first step of the mevalonate pathway of isoprenoid biosynthesis via isopentenyl diphosphate. Isoprenoids are a large class of compounds found in all living organisms.
Pssm-ID: 341272 [Multi-domain] Cd Length: 610 Bit Score: 127.22 E-value: 2.15e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2557 KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMT 2636
Cdd:cd05968 90 RTLTYGELLYEVKRLANGLRALGVGKGDRVGIYLPMIPEIVPAFLAVARIGGIVVPIFSGFGKEAAATRLQDAEAKALIT 169
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2637 ----------IN---EADLGVLADFEGEILTIE---------------SVEEDDKSPLPQMSSAHHL--AYIIYTSGTTG 2686
Cdd:cd05968 170 adgftrrgreVNlkeEADKACAQCPTVEKVVVVrhlgndftpakgrdlSYDEEKETAGDGAERTESEdpLMIIYTSGTTG 249
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2687 RPKGVMVEHKGIAntLQWRRNAY-AFN--ETDTilqLFSFSFDGFITS---MFTPLLSGAKAVLLheEEAKDILA---IK 2757
Cdd:cd05968 250 KPKGTVHVHAGFP--LKAAQDMYfQFDlkPGDL---LTWFTDLGWMMGpwlIFGGLILGATMVLY--DGAPDHPKadrLW 322
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2758 HQLSRQRITHMIIVPVLYRALL----DVVQPEDVKTLRVVTLAGEAADRE---------LIARslaiCPhteLANEYGPT 2824
Cdd:cd05968 323 RMVEDHEITHLGLSPTLIRALKprgdAPVNAHDLSSLRVLGSTGEPWNPEpwnwlfetvGKGR----NP---IINYSGGT 395
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2825 ENSVATTVMRHMEKQAYVSIGQPIDGTQVLILNSnhQLQPI-GVAGELCIAG--TGLARGYvnlpelteraftqnpFKPE 2901
Cdd:cd05968 396 EISGGILGNVLIKPIKPSSFNGPVPGMKADVLDE--SGKPArPEVGELVLLApwPGMTRGF---------------WRDE 458
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2902 ARMYRT-----------GDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSA 2970
Cdd:cd05968 459 DRYLETywsrfdnvwvhGDFAYYDEEGYFYILGRSDDTINVAGKRVGPAEIESVLNAHPAVLESAAIGVPHPVKGEAIVC 538
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 2971 YVVTKPGLS-TNAVRSEL----QNKLPVFMHPAFIEKLDSLPLSPNGKLDR 3016
Cdd:cd05968 539 FVVLKPGVTpTEALAEELmervADELGKPLSPERILFVKDLPKTRNAKVMR 589
|
|
| ABCL |
cd05958 |
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate ... |
481-952 |
2.61e-29 |
|
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate aerobic degradation pathway by activating 2-aminobenzoate to 2-aminobenzoyl-CoA. The reaction is carried out via a two-step process; the first step is ATP-dependent and forms a 2-aminobenzoyl-AMP intermediate, and the second step forms the 2-aminobenzoyl-CoA ester and releases the AMP. 2-Aminobenzoyl-CoA is further converted to 2-amino-5-oxo-cyclohex-1-ene-1-carbonyl-CoA catalyzed by 2-aminobenzoyl-CoA monooxygenase/reductase. ABCL has been purified from cells aerobically grown with 2-aminobenzoate as sole carbon, energy, and nitrogen source, and has been characterized as a monomer.
Pssm-ID: 341268 [Multi-domain] Cd Length: 439 Bit Score: 124.51 E-value: 2.61e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 481 AVIDQACSLTYRELNKAANRLARHLRMKGVVRQ-EPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDC 559
Cdd:cd05958 3 CLRSPEREWTYRDLLALANRIANVLVGELGIVPgNRVLLRGSNSPELVACWFGIQKAGAIAVATMPLLRPKELAYILDKA 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 560 GCSHVVsqahlpsslednyiITHpedieskvdgsnikSVNNADDLLYMIYTSGTTGKPKGVQFEHRNManLLKFE-YTHS 638
Cdd:cd05958 83 RITVAL--------------CAH--------------ALTASDDICILAFTSGTTGAPKATMHFHRDP--LASADrYAVN 132
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 639 GIDFEADVLQFATPsfdvcyqEIFSALLKGGTL---HIVPEAI----KRDVPQLFAFINKHQTNIVF-LPTAFIKMI--- 707
Cdd:cd05958 133 VLRLREDDRFVGSP-------PLAFTFGLGGVLlfpFGVGASGvlleEATPDLLLSAIARYKPTVLFtAPTAYRAMLahp 205
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 708 -FSERELAnsfpdGVKHLIAAGEQL--MISDLFQDVLrkrGIHLHNHYGPSET-HVVSTYTihPGDPIPElpPIGKPIGC 783
Cdd:cd05958 206 dAAGPDLS-----SLRKCVSAGEALpaALHRAWKEAT---GIPIIDGIGSTEMfHIFISAR--PGDARPG--ATGKPVPG 273
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 784 TDLYILNHQKQLQPCGVPGELYISGASVARGyvNHDKLTSDKFSSDpfkpdviMYRTGDLARRLEDGNIEYIGRADNQVK 863
Cdd:cd05958 274 YEAKVVDDEGNPVPDGTIGRLAVRGPTGCRY--LADKRQRTYVQGG-------WNITGDTYSRDPDGYFRHQGRSDDMIV 344
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 864 IRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYcsVQKLNTI-------DLRSYMASELPEYMIPAKWIWV 936
Cdd:cd05958 345 SGGYNIAPPEVEDVLLQHPAVAECAVVGHPDESRGVVVKAFV--VLRPGVIpgpvlarELQDHAKAHIAPYKYPRAIEFV 422
|
490
....*....|....*.
gi 1678550997 937 DSIPLTPNGKVDRAAL 952
Cdd:cd05958 423 TELPRTATGKLQRFAL 438
|
|
| PRK13295 |
PRK13295 |
cyclohexanecarboxylate-CoA ligase; Reviewed |
2533-3019 |
2.76e-29 |
|
cyclohexanecarboxylate-CoA ligase; Reviewed
Pssm-ID: 171961 [Multi-domain] Cd Length: 547 Bit Score: 126.32 E-value: 2.76e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2533 QTISQLFEQQAARTPKASALVS------GDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKA 2606
Cdd:PRK13295 24 RTINDDLDACVASCPDKTAVTAvrlgtgAPRRFTYRELAALVDRVAVGLARLGVGRGDVVSCQLPNWWEFTVLYLACSRI 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2607 GGCYVPIDPEYPKERKRYILSDSGTKLLMTINE-----------------ADLG--VLADFEG----EILTIESVEEDDK 2663
Cdd:PRK13295 104 GAVLNPLMPIFRERELSFMLKHAESKVLVVPKTfrgfdhaamarrlrpelPALRhvVVVGGDGadsfEALLITPAWEQEP 183
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2664 SpLPQMSSAHH-----LAYIIYTSGTTGRPKGVMveHKgiANTLQWRRNAYA----FNETDTILQLFSFSF-DGFITSMF 2733
Cdd:PRK13295 184 D-APAILARLRpgpddVTQLIYTSGTTGEPKGVM--HT--ANTLMANIVPYAerlgLGADDVILMASPMAHqTGFMYGLM 258
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2734 TPLLSGAKAVLLHEEEAKDILAIkhqLSRQRITH-MIIVPVLYRaLLDVVQ--PEDVKTLRVVTLAGEAADRELIARSLA 2810
Cdd:PRK13295 259 MPVMLGATAVLQDIWDPARAAEL---IRTEGVTFtMASTPFLTD-LTRAVKesGRPVSSLRTFLCAGAPIPGALVERARA 334
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2811 ICpHTELANEYGPTEN-SVATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELT 2889
Cdd:PRK13295 335 AL-GAKIVSAWGMTENgAVTLTKLDDPDERASTTDGCPLPGVEVRVVDADGAPLPAGQIGRLQVRGCSNFGGYLKRPQLN 413
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2890 ERAFTQnpfkpearMYRTGDAARWMADGTLEYLGRIDDqVKIRG-YRVETKEIESVIRCIKGVKDAAVVAHVTASGQTEL 2968
Cdd:PRK13295 414 GTDADG--------WFDTGDLARIDADGYIRISGRSKD-VIIRGgENIPVVEIEALLYRHPAIAQVAIVAYPDERLGERA 484
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 2969 SAYVVTKPGLS---TNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK13295 485 CAFVVPRPGQSldfEEMVEFLKAQKVAKQYIPERLVVRDALPRTPSGKIQKFRL 538
|
|
| PRK05605 |
PRK05605 |
long-chain-fatty-acid--CoA ligase; Validated |
1495-1980 |
3.22e-29 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235531 [Multi-domain] Cd Length: 573 Bit Score: 126.27 E-value: 3.22e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1495 TLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPI 1574
Cdd:PRK05605 33 TLVDLYDNAVARFGDRPALDFFGATTTYAELGKQVRRAAAGLRALGVRPGDRVAIVLPNCPQHIVAFYAVLRLGAVVVEH 112
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1575 DPDYPEERISFLLEDSGTNIL--------------------------------LLQSAGLHVP---------EFTGEI-- 1611
Cdd:PRK05605 113 NPLYTAHELEHPFEDHGARVAivwdkvaptverlrrttpletivsvnmiaampLLQRLALRLPipalrkaraALTGPApg 192
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1612 -----VYLNQTNSGLAHRLSNPNVDvlPQSLAYVIYTSGSTGMPKGVEIEHRSAvnFLNSLQSRY---QLKHSDMIMHKT 1683
Cdd:PRK05605 193 tvpweTLVDAAIGGDGSDVSHPRPT--PDDVALILYTSGTTGKPKGAQLTHRNL--FANAAQGKAwvpGLGDGPERVLAA 268
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1684 SYSFDA---SIWELFWwPYAGASVYLLPQggeKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTNRlkRVF 1760
Cdd:PRK05605 269 LPMFHAyglTLCLTLA-VSIGGELVLLPA---PDIDLILDAMKKHPPTWLPGVPPLYEKIAEAAEERGVDLSGVR--NAF 342
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1761 SGGEQLGTHLVSRfYELLPNVSITNSYGPTEATVEAAFFDCPPHEKLERIPIGKPVHHVRLYLLNQNQRMLPVGCIGELY 1840
Cdd:PRK05605 343 SGAMALPVSTVEL-WEKLTGGLLVEGYGLTETSPIIVGNPMSDDRRPGYVGVPFPDTEVRIVDPEDPDETMPDGEEGELL 421
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1841 IAGAGVARGYLNRPALTEERFLEDpfypgerMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVR 1920
Cdd:PRK05605 422 VRGPQVFKGYWNRPEETAKSFLDG-------WFRTGDVVVMEEDGFIRIVDRIKELIITGGFNVYPAEVEEVLREHPGVE 494
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 1921 EAAVT--VRTDSGEPELCAYV--EG--LQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDR 1980
Cdd:PRK05605 495 DAAVVglPREDGSEEVVAAVVlePGaaLDPEGLRAYCREHLTRYKVPRRFYHVDELPRDQLGKVRR 560
|
|
| MACS_like_2 |
cd05973 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
1520-1983 |
3.94e-29 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341277 [Multi-domain] Cd Length: 437 Bit Score: 123.78 E-value: 3.94e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1520 MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLLQS 1599
Cdd:cd05973 1 LTFGELRALSARFANALQELGVGPGDVVAGLLPRTPELVVTILGIWRLGAVYQPLFTAFGPKAIEHRLRTSGARLVVTDA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1600 AGLHVpeftgeivylnqtnsglahrlsnpnvdvLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMI 1679
Cdd:cd05973 81 ANRHK----------------------------LDSDPFVMMFTSGTTGLPKGVPVPLRALAAFGAYLRDAVDLRPEDSF 132
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1680 MHKTSYSFDASIWELFWWPYAGASVYLLPQGGeKEPEVIAKAIEEQKITAMHFVPSMlhaflehikYR-------SVPIK 1752
Cdd:cd05973 133 WNAADPGWAYGLYYAITGPLALGHPTILLEGG-FSVESTWRVIERLGVTNLAGSPTA---------YRllmaagaEVPAR 202
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1753 -TNRLKRVFSGGEQLGTHLVSRFYELLpNVSITNSYGPTEATVEAAFFDCPPHEkLERIPIGKPVHHVRLYLLNQNQRML 1831
Cdd:cd05973 203 pKGRLRRVSSAGEPLTPEVIRWFDAAL-GVPIHDHYGQTELGMVLANHHALEHP-VHAGSAGRAMPGWRVAVLDDDGDEL 280
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1832 PVGCIGELYIAGAGVA----RGYLNrpalteerfLEDPFYPGeRMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPG 1907
Cdd:cd05973 281 GPGEPGRLAIDIANSPlmwfRGYQL---------PDTPAIDG-GYYLTGDTVEFDPDGSFSFIGRADDVITMSGYRIGPF 350
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1908 EIEAALRSIEGVREAAVTVRTDSGEPELC-AYV---EGLQRN-EVRAQLERL----LPGYMVPAYMIEMEQWPVTPSGKL 1978
Cdd:cd05973 351 DVESALIEHPAVAEAAVIGVPDPERTEVVkAFVvlrGGHEGTpALADELQLHvkkrLSAHAYPRTIHFVDELPKTPSGKI 430
|
....*
gi 1678550997 1979 DRNAL 1983
Cdd:cd05973 431 QRFLL 435
|
|
| PRK08314 |
PRK08314 |
long-chain-fatty-acid--CoA ligase; Validated |
458-947 |
6.39e-29 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236235 [Multi-domain] Cd Length: 546 Bit Score: 125.07 E-value: 6.39e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 458 QTPVYETIhamfEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMK-GVVRQEPVAIMMERSAAFITGVLGILKA 536
Cdd:PRK08314 9 ETSLFHNL----EVSARRYPDKTAIVFYGRAISYRELLEEAERLAGYLQQEcGVRKGDRVLLYMQNSPQFVIAYYAILRA 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 537 GGAIVPVDPHYPADRIRYILHDCGCS----------------------HVVSqAHLPSSLEDNYIITHPEDIESKVDGSN 594
Cdd:PRK08314 85 NAVVVPVNPMNREEELAHYVTDSGARvaivgselapkvapavgnlrlrHVIV-AQYSDYLPAEPEIAVPAWLRAEPPLQA 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 595 IKSVN-------------------NADDLLYMIYTSGTTGKPKGVQFEHRN-MANLLKFeYTHSGIDFEADVLQFAtPSF 654
Cdd:PRK08314 164 LAPGGvvawkealaaglappphtaGPDDLAVLPYTSGTTGVPKGCMHTHRTvMANAVGS-VLWSNSTPESVVLAVL-PLF 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 655 DVCYQE--IFSALLKGGTLHIVPEAIKRDVPQLfafINKHQ----TNIvflPTAFIKMI----FSERELAN--------- 715
Cdd:PRK08314 242 HVTGMVhsMNAPIYAGATVVLMPRWDREAAARL---IERYRvthwTNI---PTMVVDFLaspgLAERDLSSlryigggga 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 716 SFPDGVkhliaaGEQLMisDLFqdvlrkrGIHLHNHYGPSEThvVSTYTIHPGDPiPELPPIGKPIGCTDLYILNHQ--K 793
Cdd:PRK08314 316 AMPEAV------AERLK--ELT-------GLDYVEGYGLTET--MAQTHSNPPDR-PKLQCLGIPTFGVDARVIDPEtlE 377
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 794 QLqPCGVPGELYISGASVARGYVNHDKLTSDKF---SSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIE 870
Cdd:PRK08314 378 EL-PPGEVGEIVVHGPQVFKGYWNRPEATAEAFieiDGKRF------FRTGDLGRMDEEGYFFITDRLKRMINASGFKVW 450
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 871 PQEIEVTLMNHPDISEAAILIWQDQ-NGEhELCAYYC-------SVQKLNTID-LRSYMASelpeYMIPAKWIWVDSIPL 941
Cdd:PRK08314 451 PAEVENLLYKHPAIQEACVIATPDPrRGE-TVKAVVVlrpeargKTTEEEIIAwAREHMAA----YKYPRIVEFVDSLPK 525
|
....*.
gi 1678550997 942 TPNGKV 947
Cdd:PRK08314 526 SGSGKI 531
|
|
| ttLC_FACS_AEE21_like |
cd12118 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This ... |
2540-3013 |
8.74e-29 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This family includes fatty acyl-CoA synthetases that can activate medium to long-chain fatty acids. These enzymes catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family has been shown to catalyze the long-chain fatty acid, myristoyl acid. Also included in this family are acyl activating enzymes from Arabidopsis, which contains a large number of proteins from this family with up to 63 different genes, many of which are uncharacterized.
Pssm-ID: 341283 [Multi-domain] Cd Length: 486 Bit Score: 123.56 E-value: 8.74e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2540 EQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPK 2619
Cdd:cd12118 11 ERAAAVYPDRTSIVYGDRRYTWRQTYDRCRRLASALAALGISRGDTVAVLAPNTPAMYELHFGVPMAGAVLNALNTRLDA 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2620 ERKRYILSDSGTKLLMTINEadlgvladFEGEILtiesVEEDDKSPLPQMSSAHHLAYII-YTSGTTGRPKGVMVEHKG- 2697
Cdd:cd12118 91 EEIAFILRHSEAKVLFVDRE--------FEYEDL----LAEGDPDFEWIPPADEWDPIALnYTSGTTGRPKGVVYHHRGa 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2698 ----IANTLQWR---RNAYAfnetdTILQLFSFSFDGFITSMFTpllSGAKAVLLHEEEAKDILAIkhqLSRQRITHMII 2770
Cdd:cd12118 159 ylnaLANILEWEmkqHPVYL-----WTLPMFHCNGWCFPWTVAA---VGGTNVCLRKVDAKAIYDL---IEKHKVTHFCG 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2771 VPVLYRALLDvVQPEDVKTL--RV-VTLAGEAADRELIAR--SLAICP-HTelaneYGPTENSVATTVMR--------HM 2836
Cdd:cd12118 228 APTVLNMLAN-APPSDARPLphRVhVMTAGAPPPAAVLAKmeELGFDVtHV-----YGLTETYGPATVCAwkpewdelPT 301
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2837 EKQAYVSIGQPI-----DGTQVLilnSNHQLQPI---GV-AGELCIAGTGLARGYVNLPELTERAFtqnpfkpEARMYRT 2907
Cdd:cd12118 302 EERARLKARQGVryvglEEVDVL---DPETMKPVprdGKtIGEIVFRGNIVMKGYLKNPEATAEAF-------RGGWFHS 371
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2908 GDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTNAvrSEL 2987
Cdd:cd12118 372 GDLAVIHPDGYIEIKDRSKDIIISGGENISSVEVEGVLYKHPAVLEAAVVARPDEKWGEVPCAFVELKEGAKVTE--EEI 449
|
490 500 510
....*....|....*....|....*....|
gi 1678550997 2988 Q----NKLPVFMHPAFIEKLDsLPLSPNGK 3013
Cdd:cd12118 450 IafcrEHLAGFMVPKTVVFGE-LPKTSTGK 478
|
|
| PRK06839 |
PRK06839 |
o-succinylbenzoate--CoA ligase; |
2532-3019 |
9.04e-29 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 168698 [Multi-domain] Cd Length: 496 Bit Score: 123.82 E-value: 9.04e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2532 VQTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSR-GVKPDTPVGIMMHRSFSMIASILGVWKAGGCY 2610
Cdd:PRK06839 1 MQGIAYWIEKRAYLHPDRIAIITEEEEMTYKQLHEYVSKVAAYLIYElNVKKGERIAILSQNSLEYIVLLFAIAKVECIA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2611 VPIDPEYPKERKRYILSDSGTKLLMTINE-----ADLGVLADFEGEILTIESVEEDDKSPLPQMSSAHHLAYII-YTSGT 2684
Cdd:PRK06839 81 VPLNIRLTENELIFQLKDSGTTVLFVEKTfqnmaLSMQKVSYVQRVISITSLKEIEDRKIDNFVEKNESASFIIcYTSGT 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2685 TGRPKG-VMVEHKGIANTLQwrrNAYAFNETD-----TILQLFSFSFDGFITsmFTPLLSGAKAVLLHEEEAKDILAIkh 2758
Cdd:PRK06839 161 TGKPKGaVLTQENMFWNALN---NTFAIDLTMhdrsiVLLPLFHIGGIGLFA--FPTLFAGGVIIVPRKFEPTKALSM-- 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2759 qLSRQRITHMIIVPVLYRALLDVVQPE--DVKTLRVVTLAGEAADRELI----ARSLaicphtELANEYGPTENSvaTTV 2832
Cdd:PRK06839 234 -IEKHKVTVVMGVPTIHQALINCSKFEttNLQSVRWFYNGGAPCPEELMrefiDRGF------LFGQGFGMTETS--PTV 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2833 MRHMEKQAYV---SIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmyRTGD 2909
Cdd:PRK06839 305 FMLSEEDARRkvgSIGKPVLFCDYELIDENKNKVEVGEVGELLIRGPNVMKEYWNRPDATEETIQDGWL-------CTGD 377
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2910 AARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPG--LSTNAVRSEL 2987
Cdd:PRK06839 378 LARVDEDGFVYIVGRKKEMIISGGENIYPLEVEQVINKLSDVYEVAVVGRQHVKWGEIPIAFIVKKSSsvLIEKDVIEHC 457
|
490 500 510
....*....|....*....|....*....|..
gi 1678550997 2988 QNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK06839 458 RLFLAKYKIPKEIVFLKELPKNATGKIQKAQL 489
|
|
| FACL_like_5 |
cd05924 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
1639-1979 |
1.52e-28 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341248 [Multi-domain] Cd Length: 364 Bit Score: 120.56 E-value: 1.52e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1639 YVIYTSGSTGMPKGV-------------------------EIEHRSAVNflNSLQSRYQLKHsdmIMHKTSysfdasIWE 1693
Cdd:cd05924 7 YILYTGGTTGMPKGVmwrqedifrmlmggadfgtgeftpsEDAHKAAAA--AAGTVMFPAPP---LMHGTG------SWT 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1694 LFWWPYAGASVyLLPqGGEKEPEVIAKAIEEQKITAMHFV-PSMLHAFLEHIK-YRSVPIKTnrLKRVFSGGEQLGTHLV 1771
Cdd:cd05924 76 AFGGLLGGQTV-VLP-DDRFDPEEVWRTIEKHKVTSMTIVgDAMARPLIDALRdAGPYDLSS--LFAISSGGALLSPEVK 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1772 SRFYELLPNVSITNSYGPTEA-TVEAAFFDCPPHEKLERIPIGKpvhhvRLYLLNQNQRMLPVGCIGELYIAGAG-VARG 1849
Cdd:cd05924 152 QGLLELVPNITLVDAFGSSETgFTGSGHSAGSGPETGPFTRANP-----DTVVLDDDGRVVPPGSGGVGWIARRGhIPLG 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1850 YLNRPALTEERFLEdpfYPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTD 1929
Cdd:cd05924 227 YYGDEAKTAETFPE---VDGVRYAVPGDRATVEADGTVTLLGRGSVCINTGGEKVFPEEVEEALKSHPAVYDVLVVGRPD 303
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 1930 S--GEpELCAYVE-----GLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLD 1979
Cdd:cd05924 304 ErwGQ-EVVAVVQlregaGVDLEELREHCRTRIARYKLPKQVVFVDEIERSPAGKAD 359
|
|
| PRK08314 |
PRK08314 |
long-chain-fatty-acid--CoA ligase; Validated |
2540-3014 |
1.56e-28 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236235 [Multi-domain] Cd Length: 546 Bit Score: 123.92 E-value: 1.56e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2540 EQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSR-GVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYP 2618
Cdd:PRK08314 17 EVSARRYPDKTAIVFYGRAISYRELLEEAERLAGYLQQEcGVRKGDRVLLYMQNSPQFVIAYYAILRANAVVVPVNPMNR 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2619 KERKRYILSDSGTKLLMTINE---------ADLG----VLADF--------------------------EGEILTIESVE 2659
Cdd:PRK08314 97 EEELAHYVTDSGARVAIVGSElapkvapavGNLRlrhvIVAQYsdylpaepeiavpawlraepplqalaPGGVVAWKEAL 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2660 EDDKSPLPQMSSAHHLAYIIYTSGTTGRPKGVMVEHKGI-ANTL---QWrRNAYAFNETDTILQLFSFSfdGFITSMFTP 2735
Cdd:PRK08314 177 AAGLAPPPHTAGPDDLAVLPYTSGTTGVPKGCMHTHRTVmANAVgsvLW-SNSTPESVVLAVLPLFHVT--GMVHSMNAP 253
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2736 LLSGAKAVLL---HEEEAKDIlaikhqLSRQRITHMIIVPVLyraLLDV-----VQPEDVKTLRVVTlAGEAADRELIAR 2807
Cdd:PRK08314 254 IYAGATVVLMprwDREAAARL------IERYRVTHWTNIPTM---VVDFlaspgLAERDLSSLRYIG-GGGAAMPEAVAE 323
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2808 SLaicphTELAN----E-YGPTEnSVATTVMRHMEKQAYVSIGQPIDGTQVLILN-SNHQLQPIGVAGELCIAGTGLARG 2881
Cdd:PRK08314 324 RL-----KELTGldyvEgYGLTE-TMAQTHSNPPDRPKLQCLGIPTFGVDARVIDpETLEELPPGEVGEIVVHGPQVFKG 397
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2882 YVNLPELTERAFTQNPFKpeaRMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESV------IR--CIKGVKD 2953
Cdd:PRK08314 398 YWNRPEATAEAFIEIDGK---RFFRTGDLGRMDEEGYFFITDRLKRMINASGFKVWPAEVENLlykhpaIQeaCVIATPD 474
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 2954 AAVvahvtasGQTeLSAYVVTKPGLSTNAVRSELQN----KLPVFMHPAFIEKLDSLPLSPNGKL 3014
Cdd:PRK08314 475 PRR-------GET-VKAVVVLRPEARGKTTEEEIIAwareHMAAYKYPRIVEFVDSLPKSGSGKI 531
|
|
| PRK06710 |
PRK06710 |
long-chain-fatty-acid--CoA ligase; Validated |
2530-3019 |
1.84e-28 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 180666 [Multi-domain] Cd Length: 563 Bit Score: 123.99 E-value: 1.84e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2530 YGVQTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGC 2609
Cdd:PRK06710 21 YDIQPLHKYVEQMASRYPEKKALHFLGKDITFSVFHDKVKRFANYLQKLGVEKGDRVAIMLPNCPQAVIGYYGTLLAGGI 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2610 YVPIDPEYPKERKRYILSDSGTKLLM----------------TINEADLGVLADF------------------------E 2649
Cdd:PRK06710 101 VVQTNPLYTERELEYQLHDSGAKVILcldlvfprvtnvqsatKIEHVIVTRIADFlpfpknllypfvqkkqsnlvvkvsE 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2650 GEILTI-ESVEEDDKSPLPQMSSAHH-LAYIIYTSGTTGRPKGVMVEHKG-IANTL---QWRRNAYAFNETDTILQLFsF 2723
Cdd:PRK06710 181 SETIHLwNSVEKEVNTGVEVPCDPENdLALLQYTGGTTGFPKGVMLTHKNlVSNTLmgvQWLYNCKEGEEVVLGVLPF-F 259
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2724 SFDGFITSMFTPLLSGAKAVLLHEEEAKDIL-AIKhqlsRQRITHMIIVPVLYRALLD--VVQPEDVKTLRVVtLAGEAA 2800
Cdd:PRK06710 260 HVYGMTAVMNLSIMQGYKMVLIPKFDMKMVFeAIK----KHKVTLFPGAPTIYIALLNspLLKEYDISSIRAC-ISGSAP 334
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2801 DRELIARSLAICPHTELANEYGPTENSVATTVMRHMEKQAYVSIGQPIDGTQVLI--LNSNHQLQPiGVAGELCIAGTGL 2878
Cdd:PRK06710 335 LPVEVQEKFETVTGGKLVEGYGLTESSPVTHSNFLWEKRVPGSIGVPWPDTEAMImsLETGEALPP-GEIGEIVVKGPQI 413
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2879 ARGYVNLPELTErAFTQNPFkpearmYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVA 2958
Cdd:PRK06710 414 MKGYWNKPEETA-AVLQDGW------LHTGDVGYMDEDGFFYVKDRKKDMIVASGFNVYPREVEEVLYEHEKVQEVVTIG 486
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 2959 HVTASGQTELSAYVVTKPG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK06710 487 VPDPYRGETVKAFVVLKEGteCSEEELNQFARKYLAAYKVPKVYEFRDELPKTTVGKILRRVL 549
|
|
| ABCL |
cd05958 |
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate ... |
1520-1983 |
1.99e-28 |
|
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate aerobic degradation pathway by activating 2-aminobenzoate to 2-aminobenzoyl-CoA. The reaction is carried out via a two-step process; the first step is ATP-dependent and forms a 2-aminobenzoyl-AMP intermediate, and the second step forms the 2-aminobenzoyl-CoA ester and releases the AMP. 2-Aminobenzoyl-CoA is further converted to 2-amino-5-oxo-cyclohex-1-ene-1-carbonyl-CoA catalyzed by 2-aminobenzoyl-CoA monooxygenase/reductase. ABCL has been purified from cells aerobically grown with 2-aminobenzoate as sole carbon, energy, and nitrogen source, and has been characterized as a monomer.
Pssm-ID: 341268 [Multi-domain] Cd Length: 439 Bit Score: 121.82 E-value: 1.99e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1520 MTYKELNEQANRIAWELIGRGV-KPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPdypeerisflledsgtnilLLQ 1598
Cdd:cd05958 11 WTYRDLLALANRIANVLVGELGiVPGNRVLLRGSNSPELVACWFGIQKAGAIAVATMP-------------------LLR 71
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1599 SaglhvPEFTGEIVYLNQTNSGLAHRLSNPNvDVlpqslAYVIYTSGSTGMPKGVEIEHRS--------AVNFLnslqsr 1670
Cdd:cd05958 72 P-----KELAYILDKARITVALCAHALTASD-DI-----CILAFTSGTTGAPKATMHFHRDplasadryAVNVL------ 134
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1671 yQLKHSDMIMH--KTSYSFDASIWELFWWpYAGASVYLLPQggeKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRS 1748
Cdd:cd05958 135 -RLREDDRFVGspPLAFTFGLGGVLLFPF-GVGASGVLLEE---ATPDLLLSAIARYKPTVLFTAPTAYRAMLAHPDAAG 209
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1749 VPIKTnrLKRVFSGGEQLGTHLVSRFYELLpNVSITNSYGPTEAT---VEAAFFDCPPHEkleripIGKPVHHVRLYLLN 1825
Cdd:cd05958 210 PDLSS--LRKCVSAGEALPAALHRAWKEAT-GIPIIDGIGSTEMFhifISARPGDARPGA------TGKPVPGYEAKVVD 280
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1826 QNQRMLPVGCIGELYIAGAGVARGylnrpaLTEERflEDPFYPGERMYkTGDVARWLPDGNVEFLGRTDDQVKIRGYRIE 1905
Cdd:cd05958 281 DEGNPVPDGTIGRLAVRGPTGCRY------LADKR--QRTYVQGGWNI-TGDTYSRDPDGYFRHQGRSDDMIVSGGYNIA 351
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1906 PGEIEAALRSIEGVREAAVT-VRTDSGEPELCAYV---------EGLQRnEVRAQLERLLPGYMVPAYMIEMEQWPVTPS 1975
Cdd:cd05958 352 PPEVEDVLLQHPAVAECAVVgHPDESRGVVVKAFVvlrpgvipgPVLAR-ELQDHAKAHIAPYKYPRAIEFVTELPRTAT 430
|
....*...
gi 1678550997 1976 GKLDRNAL 1983
Cdd:cd05958 431 GKLQRFAL 438
|
|
| E-C_NRPS |
cd19544 |
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); ... |
2088-2396 |
5.44e-28 |
|
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); Dual function Epimerization/Condensation (E/C) domains have both an epimerization and a DCL condensation activity. Dual E/C domains first epimerize the substrate amino acid to produce a D-configuration, then catalyze the condensation between the D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. They are D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. These Dual E/C domains contain an extended His-motif (HHx(N)GD) near the N-terminus of the domain in addition to the standard Condensation (C) domain active site motif (HHxxxD). C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains, these include the DCL-type, LCL-type, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C domains, and the X-domain.
Pssm-ID: 380466 [Multi-domain] Cd Length: 413 Bit Score: 119.85 E-value: 5.44e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2088 YPVSSAQKRIYVLQQLEDGGTGYNMPAVLELEgklNPERMDR---AFQELIKRHESLRTSF-----EQdeggdPVQRIHD 2159
Cdd:cd19544 2 YPLAPLQEGILFHHLLAEEGDPYLLRSLLAFD---SRARLDAflaALQQVIDRHDILRTAIlweglSE-----PVQVVWR 73
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2160 EVPFTLQTTVL-GARTEQEAAAAFIKP----FDLSQAPLFRAQIVKVSD-ERHLLLVDMHHIISDGVSVNILIQEFGELY 2233
Cdd:cd19544 74 QAELPVEELTLdPGDDALAQLRARFDPrryrLDLRQAPLLRAHVAEDPAnGRWLLLLLFHHLISDHTSLELLLEEIQAIL 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2234 NNR--KLPALrIQYKDY-AVWQEGFKTGDAykmqEAYWLKQL----EGELP--VLDLPADHARPpvrsfagDKVSFTLEP 2304
Cdd:cd19544 154 AGRaaALPPP-VPYRNFvAQARLGASQAEH----EAFFREMLgdvdEPTAPfgLLDVQGDGSDI-------TEARLALDA 221
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2305 EVASGLHKLARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPH--KDLEPILGMFVNTLALRTRPeGGKPFVQY 2382
Cdd:cd19544 222 ELAQRLRAQARRLGVSPASLFHLAWALVLARCSGRDDVVFGTVLSGRMQggAGADRALGMFINTLPLRVRL-GGRSVREA 300
|
330
....*....|....*.
gi 1678550997 2383 LQEVRE--TALEAFEH 2396
Cdd:cd19544 301 VRQTHArlAELLRHEH 316
|
|
| PRK06710 |
PRK06710 |
long-chain-fatty-acid--CoA ligase; Validated |
1494-1983 |
9.04e-28 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 180666 [Multi-domain] Cd Length: 563 Bit Score: 121.68 E-value: 9.04e-28
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1494 QTLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLP 1573
Cdd:PRK06710 24 QPLHKYVEQMASRYPEKKALHFLGKDITFSVFHDKVKRFANYLQKLGVEKGDRVAIMLPNCPQAVIGYYGTLLAGGIVVQ 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1574 IDPDYPEERISFLLEDSGTNILL-----------LQSAGL--HVP--------EFTGEIVY--LNQTNSGLAHRLS---- 1626
Cdd:PRK06710 104 TNPLYTERELEYQLHDSGAKVILcldlvfprvtnVQSATKieHVIvtriadflPFPKNLLYpfVQKKQSNLVVKVSeset 183
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1627 -----------NPNVDVL--PQS-LAYVIYTSGSTGMPKGVEIEHRSAV-NFLNSLQSRYQLKHSDMI---------MHK 1682
Cdd:PRK06710 184 ihlwnsvekevNTGVEVPcdPENdLALLQYTGGTTGFPKGVMLTHKNLVsNTLMGVQWLYNCKEGEEVvlgvlpffhVYG 263
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1683 TSYSFDASIWElfwwpyaGASVYLLPQGGEKepeVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTnrLKRVFSG 1762
Cdd:PRK06710 264 MTAVMNLSIMQ-------GYKMVLIPKFDMK---MVFEAIKKHKVTLFPGAPTIYIALLNSPLLKEYDISS--IRACISG 331
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1763 GEQLGTHLVSRFyELLPNVSITNSYGPTEAT--VEAAFFdcppHEKleRIP--IGKPVHHVRLYLLN-QNQRMLPVGCIG 1837
Cdd:PRK06710 332 SAPLPVEVQEKF-ETVTGGKLVEGYGLTESSpvTHSNFL----WEK--RVPgsIGVPWPDTEAMIMSlETGEALPPGEIG 404
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1838 ELYIAGAGVARGYLNRPALTEErFLEDPFypgermYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIE 1917
Cdd:PRK06710 405 EIVVKGPQIMKGYWNKPEETAA-VLQDGW------LHTGDVGYMDEDGFFYVKDRKKDMIVASGFNVYPREVEEVLYEHE 477
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 1918 GVREAAVTVRTDSGEPELCAYVEGLQRNEVRAQLE------RLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK06710 478 KVQEVVTIGVPDPYRGETVKAFVVLKEGTECSEEElnqfarKYLAAYKVPKVYEFRDELPKTTVGKILRRVL 549
|
|
| 4CL |
cd05904 |
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the ... |
473-949 |
1.20e-27 |
|
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the phenylpropanoid metabolic pathway for monolignol and flavonoid biosynthesis. It catalyzes the synthesis of hydroxycinnamate-CoA thioesters in a two-step reaction, involving the formation of hydroxycinnamate-AMP anhydride and the nucleophilic substitution of AMP by CoA. The phenylpropanoid pathway is one of the most important secondary metabolism pathways in plants and hydroxycinnamate-CoA thioesters are the precursors of lignin and other important phenylpropanoids.
Pssm-ID: 341230 [Multi-domain] Cd Length: 505 Bit Score: 120.42 E-value: 1.20e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 473 AEKTPDAHAVIDQA--CSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPAD 550
Cdd:cd05904 15 ASAHPSRPALIDAAtgRALTYAELERRVRRLAAGLAKRGGRKGDVVLLLSPNSIEFPVAFLAVLSLGAVVTTANPLSTPA 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 551 RIRYILHDCGCSHVVSQA---------HLPSSLEDNYII--THPEDIESKVDGSNIKSVN-NADDLLYMIYTSGTTGKPK 618
Cdd:cd05904 95 EIAKQVKDSGAKLAFTTAelaeklaslALPVVLLDSAEFdsLSFSDLLFEADEAEPPVVViKQDDVAALLYSSGTTGRSK 174
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 619 GVQFEHRNM-ANLLKFE-YTHSGIDFEaDVLQFATPSFDVcY--QEIFSALLK-GGTLHIVPeaiKRDVPQLFAFINKHQ 693
Cdd:cd05904 175 GVMLTHRNLiAMVAQFVaGEGSNSDSE-DVFLCVLPMFHI-YglSSFALGLLRlGATVVVMP---RFDLEELLAAIERYK 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 694 -TNIVFLPTAFIKMifserelansfpdgVKHLIAAGEQL----MIS--------DLFQDVLRK-RGIHLHNHYGPSETHV 759
Cdd:cd05904 250 vTHLPVVPPIVLAL--------------VKSPIVDKYDLsslrQIMsgaaplgkELIEAFRAKfPNVDLGQGYGMTESTG 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 760 VSTYTIHPGDPIPELPPIGKPIGCTDLYILNHQK-QLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimY 838
Cdd:cd05904 316 VVAMCFAPEKDRAKYGSVGRLVPNVEAKIVDPETgESLPPNQTGELWIRGPSIMKGYLNNPEATAATIDKEGW------L 389
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 839 RTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYcsVQK----LNTI 914
Cdd:cd05904 390 HTGDLCYIDEDGYLFIVDRLKELIKYKGFQVAPAELEALLLSHPEILDAAVIPYPDEEAGEVPMAFV--VRKpgssLTED 467
|
490 500 510
....*....|....*....|....*....|....*
gi 1678550997 915 DLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDR 949
Cdd:cd05904 468 EIMDFVAKQVAPYKKVRKVAFVDAIPKSPSGKILR 502
|
|
| PRK07470 |
PRK07470 |
acyl-CoA synthetase; Validated |
2532-3020 |
1.32e-27 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 180988 [Multi-domain] Cd Length: 528 Bit Score: 120.53 E-value: 1.32e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2532 VQTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYV 2611
Cdd:PRK07470 6 VMNLAHFLRQAARRFPDRIALVWGDRSWTWREIDARVDALAAALAARGVRKGDRILVHSRNCNQMFESMFAAFRLGAVWV 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2612 PIDPEYPKERKRYILSDSGTKLLM-----------------------TINEADLG-----VLADFEGEILTIESVEEDDk 2663
Cdd:PRK07470 86 PTNFRQTPDEVAYLAEASGARAMIchadfpehaaavraaspdlthvvAIGGARAGldyeaLVARHLGARVANAAVDHDD- 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2664 sPLpqmssahhlaYIIYTSGTTGRPKGVMVEHKGIANTLQwrrNAYA-----FNETDTILQLFSFSfDGFITSMFTPLLS 2738
Cdd:PRK07470 165 -PC----------WFFFTSGTTGRPKAAVLTHGQMAFVIT---NHLAdlmpgTTEQDASLVVAPLS-HGAGIHQLCQVAR 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2739 GAKAVLLHEEEAkDILAIKHQLSRQRITHMIIVPVLYRALLD--VVQPEDVKTLRVVTLAGEAADRELIARSLAICPHTe 2816
Cdd:PRK07470 230 GAATVLLPSERF-DPAEVWALVERHRVTNLFTVPTILKMLVEhpAVDRYDHSSLRYVIYAGAPMYRADQKRALAKLGKV- 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2817 LANEYGPTENSVATTV----MRHMEKQAYVSIGQ---PIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELT 2889
Cdd:PRK07470 308 LVQYFGLGEVTGNITVlppaLHDAEDGPDARIGTcgfERTGMEVQIQDDEGRELPPGETGEICVIGPAVFAGYYNNPEAN 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2890 ERAFTQNPFkpearmyRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAhVTASGQTELS 2969
Cdd:PRK07470 388 AKAFRDGWF-------RTGDLGHLDARGFLYITGRASDMYISGGSNVYPREIEEKLLTHPAVSEVAVLG-VPDPVWGEVG 459
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 2970 -AYVVTKPG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGK----------LDRGALP 3020
Cdd:PRK07470 460 vAVCVARDGapVDEAELLAWLDGKVARYKLPKRFFFWDALPKSGYGKitkkmvreelEERGLLD 523
|
|
| PRK05605 |
PRK05605 |
long-chain-fatty-acid--CoA ligase; Validated |
2530-3016 |
1.33e-27 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235531 [Multi-domain] Cd Length: 573 Bit Score: 121.26 E-value: 1.33e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2530 YGVQTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGC 2609
Cdd:PRK05605 29 YGDTTLVDLYDNAVARFGDRPALDFFGATTTYAELGKQVRRAAAGLRALGVRPGDRVAIVLPNCPQHIVAFYAVLRLGAV 108
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2610 YVPIDPEYPKERKRYILSDSGTKLLMTINE-ADL--GVLADFEGEilTIESVEEDDKSPLPQ------------------ 2668
Cdd:PRK05605 109 VVEHNPLYTAHELEHPFEDHGARVAIVWDKvAPTveRLRRTTPLE--TIVSVNMIAAMPLLQrlalrlpipalrkaraal 186
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2669 -------------MSSA---------------HHLAYIIYTSGTTGRPKGVMVEHKGI-ANTLQ---W-------RRNAY 2709
Cdd:PRK05605 187 tgpapgtvpwetlVDAAiggdgsdvshprptpDDVALILYTSGTTGKPKGAQLTHRNLfANAAQgkaWvpglgdgPERVL 266
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2710 AfnetdtILQLFSfSFDGFITSMFTPLLsGAKAVLLHEEEAKDILAIkhqLSRQRITHMIIVPVLYRALLDVVQPEDVkt 2789
Cdd:PRK05605 267 A------ALPMFH-AYGLTLCLTLAVSI-GGELVLLPAPDIDLILDA---MKKHPPTWLPGVPPLYEKIAEAAEERGV-- 333
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2790 lrvvTLAGEaadRELIARSLAICPHT----------ELANEYGPTENS--VATTVMRHMEKQAYVSIgqPIDGTQVLILN 2857
Cdd:PRK05605 334 ----DLSGV---RNAFSGAMALPVSTvelwekltggLLVEGYGLTETSpiIVGNPMSDDRRPGYVGV--PFPDTEVRIVD 404
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2858 SNH--QLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNpfkpearMYRTGDAARWMADGTLEYLGRIDDQVKIRGYR 2935
Cdd:PRK05605 405 PEDpdETMPDGEEGELLVRGPQVFKGYWNRPEETAKSFLDG-------WFRTGDVVVMEEDGFIRIVDRIKELIITGGFN 477
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2936 VETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGK 3013
Cdd:PRK05605 478 VYPAEVEEVLREHPGVEDAAVVGLPREDGSEEVVAAVVLEPGaaLDPEGLRAYCREHLTRYKVPRRFYHVDELPRDQLGK 557
|
...
gi 1678550997 3014 LDR 3016
Cdd:PRK05605 558 VRR 560
|
|
| PRK12492 |
PRK12492 |
long-chain-fatty-acid--CoA ligase; Provisional |
2533-3019 |
1.39e-27 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 171539 [Multi-domain] Cd Length: 562 Bit Score: 121.08 E-value: 1.39e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2533 QTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSR-GVKPDTPVGIMMHRSFSMIASILGVWKAGGCYV 2611
Cdd:PRK12492 24 KSVVEVFERSCKKFADRPAFSNLGVTLSYAELERHSAAFAAYLQQHtDLVPGDRIAVQMPNVLQYPIAVFGALRAGLIVV 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2612 PIDPEYPKERKRYILSDSGTKLLMTINEadLG-----VLADFEGEILtIESVEEDDKSPL------------PQMSSAHH 2674
Cdd:PRK12492 104 NTNPLYTAREMRHQFKDSGARALVYLNM--FGklvqeVLPDTGIEYL-IEAKMGDLLPAAkgwlvntvvdkvKKMVPAYH 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2675 L----------------------------AYIIYTSGTTGRPKGVMVEHKG-IANTLQWRRNAYAFNETD---------- 2715
Cdd:PRK12492 181 LpqavpfkqalrqgrglslkpvpvglddiAVLQYTGGTTGLAKGAMLTHGNlVANMLQVRACLSQLGPDGqplmkegqev 260
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2716 TILQLFSFSFDGFITSMFTPLLSGAKAVLLheEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDvvQPE----DVKTLR 2791
Cdd:PRK12492 261 MIAPLPLYHIYAFTANCMCMMVSGNHNVLI--TNPRDIPGFIKELGKWRFSALLGLNTLFVALMD--HPGfkdlDFSALK 336
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2792 VVTLAGEAADRELIAR--SLAICPHTElanEYGPTENSVATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAG 2869
Cdd:PRK12492 337 LTNSGGTALVKATAERweQLTGCTIVE---GYGLTETSPVASTNPYGELARLGTVGIPVPGTALKVIDDDGNELPLGERG 413
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2870 ELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIK 2949
Cdd:PRK12492 414 ELCIKGPQVMKGYWQQPEATAEALDAEGW------FKTGDIAVIDPDGFVRIVDRKKDLIIVSGFNVYPNEIEDVVMAHP 487
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 2950 GVKDAAVVAHVTASGQTELSAYVVTK-PGLSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK12492 488 KVANCAAIGVPDERSGEAVKLFVVARdPGLSVEELKAYCKENFTGYKVPKHIVLRDSLPMTPVGKILRREL 558
|
|
| LC_FACL_like |
cd05914 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are ... |
1513-1980 |
1.56e-27 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are bacterial long-chain fatty acid CoA synthetase, most of which are as yet uncharacterized. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341240 [Multi-domain] Cd Length: 463 Bit Score: 119.47 E-value: 1.56e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1513 VIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGT 1592
Cdd:cd05914 1 LYYGGEPLTYKDLADNIAKFALLLKINGVGTGDRVALMGENRPEWGIAFFAIWTYGAIAVPILAEFTADEVHHILNHSEA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1593 NILllqsaglhvpeFTGEivylnqtnsglahrlsnpnvdvlPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQ 1672
Cdd:cd05914 81 KAI-----------FVSD-----------------------EDDVALINYTSGTTGNSKGVMLTYRNIVSNVDGVKEVVL 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1673 LKHSDMIMHKTSYSfdaSIWEL---FWWP-YAGASVYLLpqggEKEPEVIAKAIEEQKITAMHFVPSMLHafLEHI---- 1744
Cdd:cd05914 127 LGKGDKILSILPLH---HIYPLtftLLLPlLNGAHVVFL----DKIPSAKIIALAFAQVTPTLGVPVPLV--IEKIfkmd 197
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1745 ----------KYR-SVPIKTN----------------RLKRVFSGGEQLGTHLVSRFYELlpNVSITNSYGPTEaTVEAA 1797
Cdd:cd05914 198 iipkltlkkfKFKlAKKINNRkirklafkkvheafggNIKEFVIGGAKINPDVEEFLRTI--GFPYTIGYGMTE-TAPII 274
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1798 FFDCPPHEKLERipIGKPVHHVRLYLLNQNqrmlPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFypgermYKTGD 1877
Cdd:cd05914 275 SYSPPNRIRLGS--AGKVIDGVEVRIDSPD----PATGEGEIIVRGPNVMKGYYKNPEATAEAFDKDGW------FHTGD 342
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1878 VARWLPDGNVEFLGRTDDQ-VKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDSG------EPELCAYVEGLQRN----- 1945
Cdd:cd05914 343 LGKIDAEGYLYIRGRKKEMiVLSSGKNIYPEEIEAKINNMPFVLESLVVVQEKKLvalayiDPDFLDVKALKQRNiidai 422
|
490 500 510
....*....|....*....|....*....|....*...
gi 1678550997 1946 --EVRAQLERLLPGY-MVPAYMIEMEQWPVTPSGKLDR 1980
Cdd:cd05914 423 kwEVRDKVNQKVPNYkKISKVKIVKEEFEKTPKGKIKR 460
|
|
| PRK08276 |
PRK08276 |
long-chain-fatty-acid--CoA ligase; Validated |
488-946 |
2.18e-27 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236215 [Multi-domain] Cd Length: 502 Bit Score: 119.62 E-value: 2.18e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 488 SLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSQ 567
Cdd:PRK08276 11 VVTYGELEARSNRLAHGLRALGLREGDVVAILLENNPEFFEVYWAARRSGLYYTPINWHLTAAEIAYIVDDSGAKVLIVS 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 568 A-----------HLPSSLEDNYIITHP----EDIESKVDG---SNIKSVNNADDllyMIYTSGTTGKPKGV--QFEHRN- 626
Cdd:PRK08276 91 AaladtaaelaaELPAGVPLLLVVAGPvpgfRSYEEALAAqpdTPIADETAGAD---MLYSSGTTGRPKGIkrPLPGLDp 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 627 ----MANLLKFEYTHSGID----------FEADVLQFATpsfdvcyqeifSALLKGGTLHIVPeaiKRDVPQLFAFINKH 692
Cdd:PRK08276 168 deapGMMLALLGFGMYGGPdsvylspaplYHTAPLRFGM-----------SALALGGTVVVME---KFDAEEALALIERY 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 693 Q-TNIVFLPTAFIKMIFSERELANSFpD--GVKHLIAAG-------EQLMIsDLFQDVlrkrgihLHNHYGPSETHVVST 762
Cdd:PRK08276 234 RvTHSQLVPTMFVRMLKLPEEVRARY-DvsSLRVAIHAAapcpvevKRAMI-DWWGPI-------IHEYYASSEGGGVTV 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 763 YT-----IHPGDpipelppIGKPIGCTdLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSsdpfkpDVIM 837
Cdd:PRK08276 305 ITsedwlAHPGS-------VGKAVLGE-VRILDEDGNELPPGEIGTVYFEMDGYPFEYHNDPEKTAAARN------PHGW 370
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 838 YRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAIL-IWQDQNGEhELCAYycsVQKLNTIDL 916
Cdd:PRK08276 371 VTVGDVGYLDEDGYLYLTDRKSDMIISGGVNIYPQEIENLLVTHPKVADVAVFgVPDEEMGE-RVKAV---VQPADGADA 446
|
490 500 510
....*....|....*....|....*....|....*...
gi 1678550997 917 RSYMASELPE--------YMIPAKWIWVDSIPLTPNGK 946
Cdd:PRK08276 447 GDALAAELIAwlrgrlahYKCPRSIDFEDELPRTPTGK 484
|
|
| FadD3 |
cd17638 |
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ... |
2678-3014 |
2.52e-27 |
|
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ligases, including FadD3 which is an acyl-CoA synthetase that initiates catabolism of cholesterol rings C and D in actinobacteria. The cholesterol catabolic pathway occurs in most mycolic acid-containing actinobacteria, such as Rhodococcus jostii RHA1, and is critical for Mycobacterium tuberculosis (Mtb) during infection. FadD3 catalyzes the ATP-dependent CoA thioesterification of 3a-alpha-H-4alpha(3'-propanoate)-7a-beta-methylhexahydro-1,5-indanedione (HIP) to yield HIP-CoA. Hydroxylated analogs of HIP, 5alpha-OH HIP and 1beta-OH HIP, can also be used.
Pssm-ID: 341293 [Multi-domain] Cd Length: 330 Bit Score: 116.06 E-value: 2.52e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2678 IIYTSGTTGRPKGVMVEHK-GIANTLQWRRNAyAFNETDT--ILQLFSFSFdGFITSMFTPLLSGAKAVllhEEEAKDIL 2754
Cdd:cd17638 5 IMFTSGTTGRSKGVMCAHRqTLRAAAAWADCA-DLTEDDRylIINPFFHTF-GYKAGIVACLLTGATVV---PVAVFDVD 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2755 AIKHQLSRQRITHMIIVPVLYRALLDVVQPE--DVKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTENSVAtTV 2832
Cdd:cd17638 80 AILEAIERERITVLPGPPTLFQSLLDHPGRKkfDLSSLRAAVTGAATVPVELVRRMRSELGFETVLTAYGLTEAGVA-TM 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2833 MRHMEKQAYVS--IGQPIDGTQVlilnsnhqlqPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDA 2910
Cdd:cd17638 159 CRPGDDAETVAttCGRACPGFEV----------RIADDGEVLVRGYNVMQGYLDDPEATAEAIDADGW------LHTGDV 222
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2911 ARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAhVTASGQTELS-AYVVTKPG--LSTNAVRSEL 2987
Cdd:cd17638 223 GELDERGYLRITDRLKDMYIVGGFNVYPAEVEGALAEHPGVAQVAVIG-VPDERMGEVGkAFVVARPGvtLTEEDVIAWC 301
|
330 340
....*....|....*....|....*..
gi 1678550997 2988 QNKLPVFMHPAFIEKLDSLPLSPNGKL 3014
Cdd:cd17638 302 RERLANYKVPRFVRFLDELPRNASGKV 328
|
|
| PRK13382 |
PRK13382 |
bile acid CoA ligase; |
2534-3022 |
3.18e-27 |
|
bile acid CoA ligase;
Pssm-ID: 172019 [Multi-domain] Cd Length: 537 Bit Score: 119.86 E-value: 3.18e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2534 TISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMM--HRSFsmIASILGVWKAGGCYV 2611
Cdd:PRK13382 44 GPTSGFAIAAQRCPDRPGLIDELGTLTWRELDERSDALAAALQALPIGEPRVVGIMCrnHRGF--VEALLAANRIGADIL 121
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2612 PIDPEYPKERKRYILSDSGTKLLMTINEADLGVLADFEGEILTIESV---EEDDKSPLPQMSSAH----------HLAYI 2678
Cdd:PRK13382 122 LLNTSFAGPALAEVVTREGVDTVIYDEEFSATVDRALADCPQATRIVawtDEDHDLTVEVLIAAHagqrpeptgrKGRVI 201
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2679 IYTSGTTGRPKGVMVEHKGIANTLQ-------WRrnayafNETDTILQLFSFSFDGFITSMFTPLLSgAKAVLLHEEEAK 2751
Cdd:PRK13382 202 LLTSGTTGTPKGARRSGPGGIGTLKaildrtpWR------AEEPTVIVAPMFHAWGFSQLVLAASLA-CTIVTRRRFDPE 274
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2752 DILAIkhqLSRQRITHMIIVPVLYRALLDVVQ----PEDVKTLRVVTLAGEAAdRELIARSLAICPHTELANEYGPTENS 2827
Cdd:PRK13382 275 ATLDL---IDRHRATGLAVVPVMFDRIMDLPAevrnRYSGRSLRFAAASGSRM-RPDVVIAFMDQFGDVIYNNYNATEAG 350
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2828 VATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNlpeLTERAFTQNpfkpearMYRT 2907
Cdd:PRK13382 351 MIATATPADLRAAPDTAGRPAEGTEIRILDQDFREVPTGEVGTIFVRNDTQFDGYTS---GSTKDFHDG-------FMAS 420
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2908 GDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAhVTAS--GQtELSAYVVTKPGLST--NAV 2983
Cdd:PRK13382 421 GDVGYLDENGRLFVVGRDDEMIVSGGENVYPIEVEKTLATHPDVAEAAVIG-VDDEqyGQ-RLAAFVVLKPGASAtpETL 498
|
490 500 510
....*....|....*....|....*....|....*....
gi 1678550997 2984 RSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGALPKP 3022
Cdd:PRK13382 499 KQHVRDNLANYKVPRDIVVLDELPRGATGKILRRELQAR 537
|
|
| PLN02574 |
PLN02574 |
4-coumarate--CoA ligase-like |
2535-3019 |
4.28e-27 |
|
4-coumarate--CoA ligase-like
Pssm-ID: 215312 [Multi-domain] Cd Length: 560 Bit Score: 119.56 E-value: 4.28e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2535 ISQLFEQQAarTPKASALV--SGDKTLTYQELDEWSNGIARALRSR-GVKPDTPVGIMMHRSFSMIASILGVWKAGGCYV 2611
Cdd:PLN02574 43 VSFIFSHHN--HNGDTALIdsSTGFSISYSELQPLVKSMAAGLYHVmGVRQGDVVLLLLPNSVYFPVIFLAVLSLGGIVT 120
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2612 PIDPEYPKERKRYILSDSGTKLLMTINE-----ADLGVLAdfegeILTIESVEEDDKSP---------------LPQ-MS 2670
Cdd:PLN02574 121 TMNPSSSLGEIKKRVVDCSVGLAFTSPEnveklSPLGVPV-----IGVPENYDFDSKRIefpkfyelikedfdfVPKpVI 195
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2671 SAHHLAYIIYTSGTTGRPKGVMVEHKGIANTLQ----WRRNAYAFNETDTILQLFSFSFDGFITSMF-TPLLS-GAKAVL 2744
Cdd:PLN02574 196 KQDDVAAIMYSSGTTGASKGVVLTHRNLIAMVElfvrFEASQYEYPGSDNVYLAALPMFHIYGLSLFvVGLLSlGSTIVV 275
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2745 LHEEEAKDILAIKHqlsRQRITHMIIVPVLYRALLDVVQP---EDVKTLRVVTLAGEAADRELIARSLAICPHTELANEY 2821
Cdd:PLN02574 276 MRRFDASDMVKVID---RFKVTHFPVVPPILMALTKKAKGvcgEVLKSLKQVSCGAAPLSGKFIQDFVQTLPHVDFIQGY 352
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2822 GPTENSVATTVMRHMEK-QAYVSIGQPIDGTQVLILN-SNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFk 2899
Cdd:PLN02574 353 GMTESTAVGTRGFNTEKlSKYSSVGLLAPNMQAKVVDwSTGCLLPPGNCGELWIQGPGVMKGYLNNPKATQSTIDKDGW- 431
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2900 pearmYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPG-- 2977
Cdd:PLN02574 432 -----LRTGDIAYFDEDGYLYIVDRLKEIIKYKGFQIAPADLEAVLISHPEIIDAAVTAVPDKECGEIPVAFVVRRQGst 506
|
490 500 510 520
....*....|....*....|....*....|....*....|..
gi 1678550997 2978 LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PLN02574 507 LSQEAVINYVAKQVAPYKKVRKVVFVQSIPKSPAGKILRREL 548
|
|
| AFD_YhfT-like |
cd17633 |
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, ... |
603-949 |
4.71e-27 |
|
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, as well as long-chain fatty acid-CoA ligase VraA, all of which are as yet to be characterized. These proteins belong to the adenylate-forming enzymes which catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain
Pssm-ID: 341288 [Multi-domain] Cd Length: 320 Bit Score: 114.81 E-value: 4.71e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 603 DLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEYTHSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHI----VPEAI 678
Cdd:cd17633 1 NPFYIGFTSGTTGLPKAYYRSERSWIESFVCNEDLFNISGEDAILAPGPLSHSLFLYGAISALYLGGTFIGqrkfNPKSW 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 679 KRDVPQLFAfinkhqTNIVFLPTafikMIfseRELANS-FPDGVKHLIAAGEQLMISDLFQDVlrKRG---IHLHNHYGP 754
Cdd:cd17633 81 IRKINQYNA------TVIYLVPT----ML---QALARTlEPESKIKSIFSSGQKLFESTKKKL--KNIfpkANLIEFYGT 145
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 755 SETHVVsTYTIhPGDPIPELPpIGKPIGCTDLYILNHQKqlqpcGVPGELYISGASVARGYVNHDKLTSDKFSSdpfkpd 834
Cdd:cd17633 146 SELSFI-TYNF-NQESRPPNS-VGRPFPNVEIEIRNADG-----GEIGKIFVKSEMVFSGYVRGGFSNPDGWMS------ 211
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 835 vimyrTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYcSVQKLNTI 914
Cdd:cd17633 212 -----VGDIGYVDEEGYLYLVGRESDMIIIGGINIFPTEIESVLKAIPGIEEAIVVGIPDARFGEIAVALY-SGDKLTYK 285
|
330 340 350
....*....|....*....|....*....|....*
gi 1678550997 915 DLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDR 949
Cdd:cd17633 286 QLKRFLKQKLSRYEIPKKIIFVDSLPYTSSGKIAR 320
|
|
| PRK13382 |
PRK13382 |
bile acid CoA ligase; |
464-955 |
5.21e-27 |
|
bile acid CoA ligase;
Pssm-ID: 172019 [Multi-domain] Cd Length: 537 Bit Score: 119.09 E-value: 5.21e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 464 TIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPV 543
Cdd:PRK13382 44 GPTSGFAIAAQRCPDRPGLIDELGTLTWRELDERSDALAAALQALPIGEPRVVGIMCRNHRGFVEALLAANRIGADILLL 123
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 544 DPHYPADRIRYILHDCGCSHVVsqahlpssLEDNYIITHPEDIESKVDGSNIKSVNNADDLL------------------ 605
Cdd:PRK13382 124 NTSFAGPALAEVVTREGVDTVI--------YDEEFSATVDRALADCPQATRIVAWTDEDHDLtvevliaahagqrpeptg 195
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 606 ----YMIYTSGTTGKPKGVQfeHRNMANLLKFEYTHSGIDFEAD-VLQFATPSFdvcYQEIFSALLKGGTLH--IV---- 674
Cdd:PRK13382 196 rkgrVILLTSGTTGTPKGAR--RSGPGGIGTLKAILDRTPWRAEePTVIVAPMF---HAWGFSQLVLAASLActIVtrrr 270
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 675 --PEAIkrdvpqlFAFINKHQ-TNIVFLPTAFIKMIFSERELANSFPDGVKHLIAAGEQLMISDLFQDVLRKRGIHLHNH 751
Cdd:PRK13382 271 fdPEAT-------LDLIDRHRaTGLAVVPVMFDRIMDLPAEVRNRYSGRSLRFAAASGSRMRPDVVIAFMDQFGDVIYNN 343
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 752 YGPSETHVVSTYTihPGDPIPELPPIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVN-HDKLTSDKFSSdp 830
Cdd:PRK13382 344 YNATEAGMIATAT--PADLRAAPDTAGRPAEGTEIRILDQDFREVPTGEVGTIFVRNDTQFDGYTSgSTKDFHDGFMA-- 419
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 831 fkpdvimyrTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCSVQK 910
Cdd:PRK13382 420 ---------SGDVGYLDENGRLFVVGRDDEMIVSGGENVYPIEVEKTLATHPDVAEAAVIGVDDEQYGQRLAAFVVLKPG 490
|
490 500 510 520
....*....|....*....|....*....|....*....|....*..
gi 1678550997 911 LNTI--DLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPEP 955
Cdd:PRK13382 491 ASATpeTLKQHVRDNLANYKVPRDIVVLDELPRGATGKILRRELQAR 537
|
|
| PRK06178 |
PRK06178 |
acyl-CoA synthetase; Validated |
452-952 |
5.97e-27 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235724 [Multi-domain] Cd Length: 567 Bit Score: 119.38 E-value: 5.97e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 452 IGEItdqtPVYETIHAMfekqAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVL 531
Cdd:PRK06178 30 HGER----PLTEYLRAW----ARERPQRPAIIFYGHVITYAELDELSDRFAALLRQRGVGAGDRVAVFLPNCPQFHIVFF 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 532 GILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSQ---------------------------------AHLPSSLEDNY 578
Cdd:PRK06178 102 GILKLGAVHVPVSPLFREHELSYELNDAGAEVLLALdqlapvveqvraetslrhvivtsladvlpaeptLPLPDSLRAPR 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 579 II-THPEDIESKVDGSNIKSVNNA---DDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEYTHSGIDFEADVLQFATPSF 654
Cdd:PRK06178 182 LAaAGAIDLLPALRACTAPVPLPPpalDALAALNYTGGTTGMPKGCEHTQRDMVYTAAAAYAVAVVGGEDSVFLSFLPEF 261
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 655 -----DVCyqeIFSALLKGGTLHIvpeaIKRDVPQLF-AFINKHQTNIVFLPT-AFIKMI----FSEREL-------ANS 716
Cdd:PRK06178 262 wiageNFG---LLFPLFSGATLVL----LARWDAVAFmAAVERYRVTRTVMLVdNAVELMdhprFAEYDLsslrqvrVVS 334
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 717 FpdgVKHLIAAgeqlmisdlfqdvLRKRGIHLHNH------YGPSETHVVSTYT--IHPGDPIPELPPI--GKPIGCTDL 786
Cdd:PRK06178 335 F---VKKLNPD-------------YRQRWRALTGSvlaeaaWGMTETHTCDTFTagFQDDDFDLLSQPVfvGLPVPGTEF 398
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 787 YILNHQK-QLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDpfkpdviMYRTGDLARRLEDGNIEYIGRADNQVKIR 865
Cdd:PRK06178 399 KICDFETgELLPLGAEGEIVVRTPSLLKGYWNKPEATAEALRDG-------WLHTGDIGKIDEQGFLHYLGRRKEMLKVN 471
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 866 GYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYycsVQ-----KLNTIDLRSYMASELPEYMIPAKWIwVDSIP 940
Cdd:PRK06178 472 GMSVFPSEVEALLGQHPAVLGSAVVGRPDPDKGQVPVAF---VQlkpgaDLTAAALQAWCRENMAVYKVPEIRI-VDALP 547
|
570
....*....|..
gi 1678550997 941 LTPNGKVDRAAL 952
Cdd:PRK06178 548 MTATGKVRKQDL 559
|
|
| PRK07470 |
PRK07470 |
acyl-CoA synthetase; Validated |
473-954 |
6.12e-27 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 180988 [Multi-domain] Cd Length: 528 Bit Score: 118.61 E-value: 6.12e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 473 AEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRI 552
Cdd:PRK07470 17 ARRFPDRIALVWGDRSWTWREIDARVDALAAALAARGVRKGDRILVHSRNCNQMFESMFAAFRLGAVWVPTNFRQTPDEV 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 553 RYILHDCGCSHVVSQA----HLPSSLEDNYIITH---------PEDIESKVDGSNIKSVNNA----DDLLYMIYTSGTTG 615
Cdd:PRK07470 97 AYLAEASGARAMICHAdfpeHAAAVRAASPDLTHvvaiggaraGLDYEALVARHLGARVANAavdhDDPCWFFFTSGTTG 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 616 KPKGVQFEHRNMA----NLLkfeythsgidfeADVLQfATPSFDVCYqeIFSALLKGGTLH-----------IVPEAIKR 680
Cdd:PRK07470 177 RPKAAVLTHGQMAfvitNHL------------ADLMP-GTTEQDASL--VVAPLSHGAGIHqlcqvargaatVLLPSERF 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 681 DVPQLFAFINKHQ-TNIVFLPTaFIKMIFSERELANSFPDGVKHLIAAGEQLMISDLfQDVLRKRGIHLHNHYGPSEthV 759
Cdd:PRK07470 242 DPAEVWALVERHRvTNLFTVPT-ILKMLVEHPAVDRYDHSSLRYVIYAGAPMYRADQ-KRALAKLGKVLVQYFGLGE--V 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 760 VSTYTI-----HPGDPIPE--LPPIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFk 832
Cdd:PRK07470 318 TGNITVlppalHDAEDGPDarIGTCGFERTGMEVQIQDDEGRELPPGETGEICVIGPAVFAGYYNNPEANAKAFRDGWF- 396
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 833 pdvimyRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAIL-----IWqdqnGEHELCAYYCS 907
Cdd:PRK07470 397 ------RTGDLGHLDARGFLYITGRASDMYISGGSNVYPREIEEKLLTHPAVSEVAVLgvpdpVW----GEVGVAVCVAR 466
|
490 500 510 520
....*....|....*....|....*....|....*....|....*...
gi 1678550997 908 V-QKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPE 954
Cdd:PRK07470 467 DgAPVDEAELLAWLDGKVARYKLPKRFFFWDALPKSGYGKITKKMVRE 514
|
|
| C_PKS-NRPS |
cd20483 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
12-330 |
7.17e-27 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHXXXD motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380471 [Multi-domain] Cd Length: 430 Bit Score: 116.98 E-value: 7.17e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 12 PLSYMQEGMLF-HSLLQkDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNVSSPQQVV-LRERNVIVL 89
Cdd:cd20483 3 PMSTFQRRLWFlHNFLE-DKTFLNLLLVCHIKGKPDVNLLQKALSELVRRHEVLRTAYFEGDDFGEQQVLdDPSFHLIVI 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 90 EEDITHLNEAEQSQFIEQWKEKDrdrgFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASYVN 169
Cdd:cd20483 82 DLSEAADPEAALDQLVRNLRRQE----LDIEEGEVIRGWLVKLPDEEFALVLASHHIAWDRGSSKSIFEQFTALYDALRA 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 170 ASP-ITLEPVqPYGkYI-------KWLMEQDKEQAVSYWDHYLSGHEQQ-TVLPKQKKTKGKSRQEH---VTFSFSKEES 237
Cdd:cd20483 158 GRDlATVPPP-PVQ-YIdftlwhnALLQSPLVQPLLDFWKEKLEGIPDAsKLLPFAKAERPPVKDYErstVEATLDKELL 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 238 SRLSELAAREEVtlsTIFHTI---WGILLQKYNNNDDAVFGSVISGRP-AEiegIEHMVGLFINTMPVRVQGA-KTPFLQ 312
Cdd:cd20483 236 ARMKRICAQHAV---TPFMFLlaaFRAFLYRYTEDEDLTIGMVDGDRPhPD---FDDLVGFFVNMLPIRCRMDcDMSFDD 309
|
330
....*....|....*...
gi 1678550997 313 LIKDMQKdrLAAEAYSYH 330
Cdd:cd20483 310 LLESTKT--TCLEAYEHS 325
|
|
| ACS-like |
cd17634 |
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the ... |
1489-1978 |
8.69e-27 |
|
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases. The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341289 [Multi-domain] Cd Length: 587 Bit Score: 118.83 E-value: 8.69e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1489 GYSMNqTLHYALEQQAEKTPDQAAVIFEdGVM-------TYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGI 1561
Cdd:cd17634 49 DATLN-LAANALDRHLRENGDRTAIIYE-GDDtsqsrtiSYRELHREVCRFAGTLLDLGVKKGDRVAIYMPMIPEAAVAM 126
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1562 YGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLLQSAGLHvpefTGEIV-YLNQTNSGLAHRLSNP-NVDVL------ 1633
Cdd:cd17634 127 LACARIGAVHSVIFGGFAPEAVAGRIIDSSSRLLITADGGVR----AGRSVpLKKNVDDALNPNVTSVeHVIVLkrtgsd 202
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1634 ----------------------------PQSLAYVIYTSGSTGMPKGVEIEHRSavnflnslqsrYQLKHS-DMimhktS 1684
Cdd:cd17634 203 idwqegrdlwwrdliakaspehqpeamnAEDPLFILYTSGTTGKPKGVLHTTGG-----------YLVYAAtTM-----K 266
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1685 YSFDASIWELFWW----------PY-------AGASVYLL---PQGgeKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHI 1744
Cdd:cd17634 267 YVFDYGPGDIYWCtadvgwvtghSYllygplaCGATTLLYegvPNW--PTPARMWQVVDKHGVNILYTAPTAIRALMAAG 344
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1745 KYRSVPIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVS--ITNSYGPTEAtveaAFFDCPPHEKLERIPIG---KPVHHV 1819
Cdd:cd17634 345 DDAIEGTDRSSLRILGSVGEPINPEAYEWYWKKIGKEKcpVVDTWWQTET----GGFMITPLPGAIELKAGsatRPVFGV 420
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1820 RLYLLNQNQRMLPVGCIGELYIAGA--GVARGYLNRPalteERFLEDPFYPGERMYKTGDVARWLPDGNVEFLGRTDDQV 1897
Cdd:cd17634 421 QPAVVDNEGHPQPGGTEGNLVITDPwpGQTRTLFGDH----ERFEQTYFSTFKGMYFSGDGARRDEDGYYWITGRSDDVI 496
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1898 KIRGYRIEPGEIEAALRSIEGVREAAVT-VRTDSGEPELCAYV---------EGLqRNEVRAQLERLLPGYMVPAYMIEM 1967
Cdd:cd17634 497 NVAGHRLGTAEIESVLVAHPKVAEAAVVgIPHAIKGQAPYAYVvlnhgvepsPEL-YAELRNWVRKEIGPLATPDVVHWV 575
|
570
....*....|.
gi 1678550997 1968 EQWPVTPSGKL 1978
Cdd:cd17634 576 DSLPKTRSGKI 586
|
|
| OSB_MenE-like |
cd17630 |
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) ... |
1636-1983 |
9.07e-27 |
|
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) synthetase (also known as O-succinylbenzoic acid CoA ligase) that belongs to the ANL superfamily and catalyzes the ligation of CoA to o-succinylbenzoate (OSB). It includes MenE in the bacterial menaquinone biosynthesis pathway which is a promising target for the development of novel antibacterial agents. MenE catalyzes CoA ligation via an acyl-adenylate intermediate; tight-binding inhibitors of MenE based on stable acyl-sulfonyladenosine analogs of this intermediate provide a pathway toward the development of optimized MenE inhibitors.
Pssm-ID: 341285 [Multi-domain] Cd Length: 325 Bit Score: 114.35 E-value: 9.07e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1636 SLAYVIYTSGSTGMPKGVeiehrsavnflnsLQSRYQLKHSDMIMHKtSYSFDASI-W-------------ELFWWPYAG 1701
Cdd:cd17630 1 RLATVILTSGSTGTPKAV-------------VHTAANLLASAAGLHS-RLGFGGGDsWllslplyhvgglaILVRSLLAG 66
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1702 ASVYLLpqggEKEPEViAKAIEEQKITAMHFVPSMLHAFLEhikYRSVPIKTNRLKRVFSGGEQLGTHLVSRFYELlpNV 1781
Cdd:cd17630 67 AELVLL----ERNQAL-AEDLAPPGVTHVSLVPTQLQRLLD---SGQGPAALKSLRAVLLGGAPIPPELLERAADR--GI 136
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1782 SITNSYGPTEATVEAAFFDCPPHEKLEripIGKPVHHVRLYLLNQnqrmlpvgciGELYIAGAGVARGYLNRPalTEERF 1861
Cdd:cd17630 137 PLYTTYGMTETASQVATKRPDGFGRGG---VGVLLPGRELRIVED----------GEIWVGGASLAMGYLRGQ--LVPEF 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1862 LEDPFYPgermykTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GEpELCAYV 1939
Cdd:cd17630 202 NEDGWFT------TKDLGELHADGRLTVLGRADNMIISGGENIQPEEIEAALAAHPAVRDAFVVGVPDEelGQ-RPVAVI 274
|
330 340 350 360
....*....|....*....|....*....|....*....|....*..
gi 1678550997 1940 EGLQRN---EVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd17630 275 VGRGPAdpaELRAWLKDKLARFKLPKRIYPVPELPRTGGGKVDRRAL 321
|
|
| ttLC_FACS_AlkK_like |
cd12119 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes ... |
490-952 |
9.15e-27 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes fatty acyl-CoA synthetases that can activate medium-chain to long-chain fatty acids. They catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family catalyzes the long-chain fatty acid, myristoyl acid, while another member in this family, the AlkK protein identified from Pseudomonas oleovorans, targets medium chain fatty acids. This family also includes uncharacterized FACS proteins.
Pssm-ID: 341284 [Multi-domain] Cd Length: 518 Bit Score: 118.12 E-value: 9.15e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 490 TYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHV----- 564
Cdd:cd12119 27 TYAEVAERARRLANALRRLGVKPGDRVATLAWNTHRHLELYYAVPGMGAVLHTINPRLFPEQIAYIINHAEDRVVfvdrd 106
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 565 ---VSQAHLPSSLEDNYIITHPEDIESKVDGsnIKSVNNADDLL------------------YMIYTSGTTGKPKGVQFE 623
Cdd:cd12119 107 flpLLEAIAPRLPTVEHVVVMTDDAAMPEPA--GVGVLAYEELLaaespeydwpdfdentaaAICYTSGTTGNPKGVVYS 184
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 624 HRN-----MANLLKfeythSGIDFEA-DVLQFATPSFDVCYQEI-FSALLKGGTLhIVPEaiKRDVPQ-LFAFINKHQ-T 694
Cdd:cd12119 185 HRSlvlhaMAALLT-----DGLGLSEsDVVLPVVPMFHVNAWGLpYAAAMVGAKL-VLPG--PYLDPAsLAELIEREGvT 256
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 695 NIVFLPTaFIKMIFSERELANS-FPDGVKHLI---AAGEQLMISdlfqdvLRKRGIHLHNHYGPSETHVVSTyTIHPGDP 770
Cdd:cd12119 257 FAAGVPT-VWQGLLDHLEANGRdLSSLRRVVIggsAVPRSLIEA------FEERGVRVIHAWGMTETSPLGT-VARPPSE 328
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 771 IPELPP---------IGKPIGCTDLYILNHQKQLQPC-GVP-GELYISGASVARGYVNHDKlTSDKFSSDPFkpdvimYR 839
Cdd:cd12119 329 HSNLSEdeqlalrakQGRPVPGVELRIVDDDGRELPWdGKAvGELQVRGPWVTKSYYKNDE-ESEALTEDGW------LR 401
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 840 TGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQN-GEHELCayyCSV----QKLNTI 914
Cdd:cd12119 402 TGDVATIDEDGYLTITDRSKDVIKSGGEWISSVELENAIMAHPAVAEAAVIGVPHPKwGERPLA---VVVlkegATVTAE 478
|
490 500 510
....*....|....*....|....*....|....*...
gi 1678550997 915 DLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:cd12119 479 ELLEFLADKVAKWWLPDDVVFVDEIPKTSTGKIDKKAL 516
|
|
| E-C_NRPS |
cd19544 |
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); ... |
1073-1356 |
9.43e-27 |
|
Dual Epimerization/Condensation (E/C) domains of nonribosomal peptide synthetases (NRPSs); Dual function Epimerization/Condensation (E/C) domains have both an epimerization and a DCL condensation activity. Dual E/C domains first epimerize the substrate amino acid to produce a D-configuration, then catalyze the condensation between the D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. They are D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. These Dual E/C domains contain an extended His-motif (HHx(N)GD) near the N-terminus of the domain in addition to the standard Condensation (C) domain active site motif (HHxxxD). C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains, these include the DCL-type, LCL-type, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C domains, and the X-domain.
Pssm-ID: 380466 [Multi-domain] Cd Length: 413 Bit Score: 116.00 E-value: 9.43e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1073 DEGVAYNMPAVLEL--EGALD--VAKLSAVckelISRHEPLRTSFVSGADDEPVQRIHTEVP-----FTLSKETTIEGFV 1143
Cdd:cd19544 19 EEGDPYLLRSLLAFdsRARLDafLAALQQV----IDRHDILRTAILWEGLSEPVQVVWRQAElpveeLTLDPGDDALAQL 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1144 R--------PFDLSQAPLFRAGLIE-VSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYANR--QLKPLrIQYKDYaVWQ 1212
Cdd:cd19544 95 RarfdprryRLDLRQAPLLRAHVAEdPANGRWLLLLLFHHLISDHTSLELLLEEIQAILAGRaaALPPP-VPYRNF-VAQ 172
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1213 QkfKKGDSYQKQETYWQQQFsGD-----LP--ILELPTDKRRPAErqfiggkVTFQLDKEITARIKRLAhknrSTLYMTL 1285
Cdd:cd19544 173 A--RLGASQAEHEAFFREML-GDvdeptAPfgLLDVQGDGSDITE-------ARLALDAELAQRLRAQA----RRLGVSP 238
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 1286 LALY-SAF---LSRLSGQDDIVIGSPIAGRPHADLEA--VLGMFVNTLALRTRpAGNKTFEEFLKEVRQ--TALEAYEH 1356
Cdd:cd19544 239 ASLFhLAWalvLARCSGRDDVVFGTVLSGRMQGGAGAdrALGMFINTLPLRVR-LGGRSVREAVRQTHArlAELLRHEH 316
|
|
| PRK13391 |
PRK13391 |
acyl-CoA synthetase; Provisional |
468-946 |
9.51e-27 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 184022 [Multi-domain] Cd Length: 511 Bit Score: 117.87 E-value: 9.51e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 468 MF-EKQAEKTPDAHAVIDQAC--SLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVD 544
Cdd:PRK13391 1 MYpGIHAQTTPDKPAVIMASTgeVVTYRELDERSNRLAHLFRSLGLKRGDHVAIFMENNLRYLEVCWAAERSGLYYTCVN 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 545 PHYPADRIRYILHDCGCSHVV-SQAHL---PSSLEDNYIITHPEDIESKVDGSNIKSVNNA----------DDLL--YMI 608
Cdd:PRK13391 81 SHLTPAEAAYIVDDSGARALItSAAKLdvaRALLKQCPGVRHRLVLDGDGELEGFVGYAEAvaglpatpiaDESLgtDML 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 609 YTSGTTGKPKGV--QFEHRNMANLLK-FEYTHSGIDFEADV-------LQFATPSFDVcyqeiFSALLKGGTlHIVPEAI 678
Cdd:PRK13391 161 YSSGTTGRPKGIkrPLPEQPPDTPLPlTAFLQRLWGFRSDMvylspapLYHSAPQRAV-----MLVIRLGGT-VIVMEHF 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 679 krDVPQLFAFINKHQ-TNIVFLPTAFIKMIFSERELANSFP----DGVKHLIAAGEQlmisDLFQDVLRKRGIHLHNHYG 753
Cdd:PRK13391 235 --DAEQYLALIEEYGvTHTQLVPTMFSRMLKLPEEVRDKYDlsslEVAIHAAAPCPP----QVKEQMIDWWGPIIHEYYA 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 754 PSE---THVVST--YTIHPGDpipelppIGKPIgCTDLYILNHQKQLQPCGVPGELYISGASVARgYVNHDKLTSDKFSS 828
Cdd:PRK13391 309 ATEglgFTACDSeeWLAHPGT-------VGRAM-FGDLHILDDDGAELPPGEPGTIWFEGGRPFE-YLNDPAKTAEARHP 379
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 829 DPfkpdvIMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAIL-IWQDQNGEhELCAYycs 907
Cdd:PRK13391 380 DG-----TWSTVGDIGYVDEDGYLYLTDRAAFMIISGGVNIYPQEAENLLITHPKVADAAVFgVPNEDLGE-EVKAV--- 450
|
490 500 510 520
....*....|....*....|....*....|....*....|....*..
gi 1678550997 908 VQKLNTID--------LRSYMASELPEYMIPAKWIWVDSIPLTPNGK 946
Cdd:PRK13391 451 VQPVDGVDpgpalaaeLIAFCRQRLSRQKCPRSIDFEDELPRLPTGK 497
|
|
| PRK07787 |
PRK07787 |
acyl-CoA synthetase; Validated |
2549-3023 |
1.14e-26 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236096 [Multi-domain] Cd Length: 471 Bit Score: 117.01 E-value: 1.14e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2549 ASALVSGDKTLTYQELdewsNGIARALRSRgVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEY-PKERkRYILS 2627
Cdd:PRK07787 16 ADAVRIGGRVLSRSDL----AGAATAVAER-VAGARRVAVLATPTLATVLAVVGALIAGVPVVPVPPDSgVAER-RHILA 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2628 DSGTKLLmtineadLGVLADfEGEILTIESVEEDDKS----PLPQMSSAhhlAYIIYTSGTTGRPKGVMVEHKGIANTLQ 2703
Cdd:PRK07787 90 DSGAQAW-------LGPAPD-DPAGLPHVPVRLHARSwhryPEPDPDAP---ALIVYTSGTTGPPKGVVLSRRAIAADLD 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2704 WRRNAYAFNETDTILQ-LFSFSFDGFITSMFTPLLSGAKAVLLheeeAKDILAIKHQLSRQRITHMIIVPVLYRALLDvv 2782
Cdd:PRK07787 159 ALAEAWQWTADDVLVHgLPLFHVHGLVLGVLGPLRIGNRFVHT----GRPTPEAYAQALSEGGTLYFGVPTVWSRIAA-- 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2783 QPEDVKTLRVVTL--AGEAA----DRELIArslAICPHtELANEYGPTENSVATTVMRHMEKQAYvSIGQPIDGTQVLIL 2856
Cdd:PRK07787 233 DPEAARALRGARLlvSGSAAlpvpVFDRLA---ALTGH-RPVERYGMTETLITLSTRADGERRPG-WVGLPLAGVETRLV 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2857 NSNHQLQPIGVA--GELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMADGTLEYLGRID-DQVKIRG 2933
Cdd:PRK07787 308 DEDGGPVPHDGEtvGELQVRGPTLFDGYLNRPDATAAAFTADGW------FRTGDVAVVDPDGMHRIVGREStDLIKSGG 381
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2934 YRVETKEIESVIRCIKGVKDAAVVAHVTAS-GQtELSAYVVTKPGLSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNG 3012
Cdd:PRK07787 382 YRIGAGEIETALLGHPGVREAAVVGVPDDDlGQ-RIVAYVVGADDVAADELIDFVAQQLSVHKRPREVRFVDALPRNAMG 460
|
490
....*....|.
gi 1678550997 3013 KLDRGALPKPV 3023
Cdd:PRK07787 461 KVLKKQLLSEG 471
|
|
| FUM14_C_NRPS-like |
cd19545 |
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond ... |
2091-2500 |
1.25e-26 |
|
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond forming Fusarium verticillioides FUM14 protein; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) typically catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. However, some C-domains have ester-bond forming activity. This subfamily includes Fusarium verticillioides FUM14 (also known as NRPS8), a bi-domain protein with an ester-bond forming NRPS C-domain, which catalyzes linkages between an aminoacyl/peptidyl-PCP donor and a hydroxyl-containing acceptor. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. FUM14 has an altered active site motif DHTHCD instead of the typical HHxxxD motif seen in other subfamily members. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380467 [Multi-domain] Cd Length: 395 Bit Score: 115.47 E-value: 1.25e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2091 SSAQKRIYVLQQledggtgynmpaVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGDPVQRIHDEVPFTLQTtvl 2170
Cdd:cd19545 15 TARQPGAYVGQR------------VFELPPDIDLARLQAAWEQVVQANPILRTRIVQSDSGGLLQVVVKESPISWTE--- 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2171 gARTEQEA-AAAFIKPFDLSQaPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELYNNRKLPAlRIQYKDYA 2249
Cdd:cd19545 80 -STSLDEYlEEDRAAPMGLGG-PLVRLALVEDPDTERYFVWTIHHALYDGWSLPLILRQVLAAYQGEPVPQ-PPPFSRFV 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2250 vwqeGF-KTGDAYKMQEaYWLKQLEGELPVLDLPADHARPPVRSFAGDKVSFTLePEVASGLHKLArengstlyMVLLAA 2328
Cdd:cd19545 157 ----KYlRQLDDEAAAE-FWRSYLAGLDPAVFPPLPSSRYQPRPDATLEHSISL-PSSASSGVTLA--------TVLRAA 222
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2329 YTAFLSRLSGQEDIIVGSPIAGR--PHKDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRETALEA--FEH---QNypf 2401
Cdd:cd19545 223 WALVLSRYTGSDDVVFGVTLSGRnaPVPGIEQIVGPTIATVPLRVRIDPEQSVEDFLQTVQKDLLDMipFEHtglQN--- 299
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2402 eelvdKLELTRDMSRNPVFDAMLVVQNNDYEPLHLHDLQMKPAQVSHLVSKFD--LTLQASEGDGNIHFLFEYSTALFEK 2479
Cdd:cd19545 300 -----IRRLGPDARAACNFQTLLVVQPALPSSTSESLELGIEEESEDLEDFSSygLTLECQLSGSGLRVRARYDSSVISE 374
|
410 420
....*....|....*....|.
gi 1678550997 2480 TTIERWASHLTNVLSIIGKNP 2500
Cdd:cd19545 375 EQVERLLDQFEHVLQQLASAP 395
|
|
| EntF2 |
COG3319 |
Thioesterase domain of type I polyketide synthase or non-ribosomal peptide synthetase ... |
1499-2075 |
1.39e-26 |
|
Thioesterase domain of type I polyketide synthase or non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442548 [Multi-domain] Cd Length: 855 Bit Score: 119.81 E-value: 1.39e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1499 ALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDY 1578
Cdd:COG3319 6 AAAAAAAAAAAAAAAAAAAAALAAAAAAAAAAALLLLAAALLVALAALALAALALAALLAVALLAAALALAALAALAALA 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1579 PEERISFLLEDSGTNILLLQSAGLHVPEFTGEIVYLNQTNSGLAHRLSNPNVDVLPQSL---AYVIYTSGSTGMPKGVEI 1655
Cdd:COG3319 86 LALAAAAAALLLAALALLLALLAALALALLALLLAALLLALAALAAAAAAAALAAAAAAaaaLAAAAGLGGGGGGAGVLV 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1656 EHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHFVPS 1735
Cdd:COG3319 166 LVLAALLALLLAALLALALALAALLLLALAAALALALLLLLALLLLLLLLLALLLLLLLALLAAAALLALLLALLLLLLA 245
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1736 MLHAFLEHIKYRSVPiktnRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAAFFDCPPHEKLERIPIGKP 1815
Cdd:COG3319 246 ALLLLLALALLLLLA----LLLLLGLLALLLALLLLLALLLLAAAAALAAGGTATTAAVTTTAAAAAPGVAGALGPIGGG 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1816 VHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPF--YPGERMYKTGDVARWLPDGNVEFLGRT 1893
Cdd:COG3319 322 PGLLVLLVLLVLLLPLLLGVGGGGGGGGGGGGAGGLAGRGLRAAAALRDPAgaGARGRLRRGGDRGRRLGGGLLLGLGRL 401
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1894 DDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDSGEPELCAYVEGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPV- 1972
Cdd:COG3319 402 RLQRLRRGLREELEEAEAALAEAAAVAAAVAAAAAAAAAAAALAAAVVAAAALAAAALLLLLLLLLLPPPLPPALLLLLl 481
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1973 ---TPSGKLDRNALPAPGGAADAETYTAPRNVTEMKLSQLWEDVLKNGPVGIHDNFFDRGGHSLKATALVSRITKEFDVQ 2049
Cdd:COG3319 482 lllLLLLAALLLAAAAPAAAAAAAAAPAPAAALELALALLLLLLLGLGLVGDDDDFFGGGGGSLLALLLLLLLLALLLRL 561
|
570 580
....*....|....*....|....*.
gi 1678550997 2050 VPLKDVFAHPTVEGLATVIREGTDSP 2075
Cdd:COG3319 562 LLLLALLLAPTLAALAAALAAAAAAA 587
|
|
| PRK05852 |
PRK05852 |
fatty acid--CoA ligase family protein; |
2535-3019 |
1.49e-26 |
|
fatty acid--CoA ligase family protein;
Pssm-ID: 235625 [Multi-domain] Cd Length: 534 Bit Score: 117.68 E-value: 1.49e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2535 ISQLFEQQAARTPKASALVSGDK--TLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVP 2612
Cdd:PRK05852 18 IADLVEVAATRLPEAPALVVTADriAISYRDLARLVDDLAGQLTRSGLLPGDRVALRMGSNAEFVVALLAASRADLVVVP 97
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2613 IDPEYPKERKRYILSDSGTKLLMTINEA--------------DLGVLADFEGEILTIESVEEDDKSPLPQMSSAHHL--- 2675
Cdd:PRK05852 98 LDPALPIAEQRVRSQAAGARVVLIDADGphdraepttrwwplTVNVGGDSGPSGGTLSVHLDAATEPTPATSTPEGLrpd 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2676 -AYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETD-TILQLFSFSFDGFITSMFTPLLSGAkAVLLHEEEAKDI 2753
Cdd:PRK05852 178 dAMIMFTGGTTGLPKMVPWTHANIASSVRAIITGYRLSPRDaTVAVMPLYHGHGLIAALLATLASGG-AVLLPARGRFSA 256
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2754 LAIKHQLSRQRITHMIIVPVLYRALLDVVQPEDVKTLRvvtlageAADRELIARSLAICPHTELANE----------YGP 2823
Cdd:PRK05852 257 HTFWDDIKAVGATWYTAVPTIHQILLERAATEPSGRKP-------AALRFIRSCSAPLTAETAQALQtefaapvvcaFGM 329
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2824 TE--NSVATTVMR---HMEKQAyVSIG--QPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQN 2896
Cdd:PRK05852 330 TEatHQVTTTQIEgigQTENPV-VSTGlvGRSTGAQIRIVGSDGLPLPAGAVGEVWLRGTTVVRGYLGDPTITAANFTDG 408
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2897 PFkpearmyRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVtkP 2976
Cdd:PRK05852 409 WL-------RTGDLGSLSAAGDLSIRGRIKELINRGGEKISPERVEGVLASHPNVMEAAVFGVPDQLYGEAVAAVIV--P 479
|
490 500 510 520
....*....|....*....|....*....|....*....|....*..
gi 1678550997 2977 GLSTNAVRSEL----QNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK05852 480 RESAPPTAEELvqfcRERLAAFEIPASFQEASGLPHTAKGSLDRRAV 526
|
|
| PRK09274 |
PRK09274 |
peptide synthase; Provisional |
1500-1956 |
1.90e-26 |
|
peptide synthase; Provisional
Pssm-ID: 236443 [Multi-domain] Cd Length: 552 Bit Score: 117.31 E-value: 1.90e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFEDGV----------MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGG 1569
Cdd:PRK09274 12 LPRAAQERPDQLAVAVPGGRgadgklaydeLSFAELDARSDAIAHGLNAAGIGRGMRAVLMVTPSLEFFALTFALFKAGA 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1570 AYLPIDP--DY-----------PEERI--------SFLLEDSGTNILLLQSAGlhVPEFTGEIVyLNQTNSGLAHrLSNP 1628
Cdd:PRK09274 92 VPVLVDPgmGIknlkqclaeaqPDAFIgipkahlaRRLFGWGKPSVRRLVTVG--GRLLWGGTT-LATLLRDGAA-APFP 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1629 NVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDmimhktsysFDASIWELF--WWPYAG-ASVy 1705
Cdd:PRK09274 168 MADLAPDDMAAILFTSGSTGTPKGVVYTHGMFEAQIEALREDYGIEPGE---------IDLPTFPLFalFGPALGmTSV- 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1706 lLP-----QGGEKEPEVIAKAIEEQKITAMhFV-PSMLHAFLEHIKYRsvPIKTNRLKRVFSGGEQLGTHLVSRFYELLP 1779
Cdd:PRK09274 238 -IPdmdptRPATVDPAKLFAAIERYGVTNL-FGsPALLERLGRYGEAN--GIKLPSLRRVISAGAPVPIAVIERFRAMLP 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1780 N-VSITNSYGPTEA----TVE--AAFFDCPPH-EKLERIPIGKPVHHVRLYLLN---------QNQRMLPVGCIGELYIA 1842
Cdd:PRK09274 314 PdAEILTPYGATEAlpisSIEsrEILFATRAAtDNGAGICVGRPVDGVEVRIIAisdapipewDDALRLATGEIGEIVVA 393
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1843 GAGVARGYLNRPALTEERFLEDPfyPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGV-RE 1921
Cdd:PRK09274 394 GPMVTRSYYNRPEATRLAKIPDG--QGDVWHRMGDLGYLDAQGRLWFCGRKAHRVETAGGTLYTIPCERIFNTHPGVkRS 471
|
490 500 510
....*....|....*....|....*....|....*..
gi 1678550997 1922 AAVTVRTD-SGEPELCayVEGLQRNEV-RAQLERLLP 1956
Cdd:PRK09274 472 ALVGVGVPgAQRPVLC--VELEPGVACsKSALYQELR 506
|
|
| PRK07059 |
PRK07059 |
Long-chain-fatty-acid--CoA ligase; Validated |
462-952 |
3.03e-26 |
|
Long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235923 [Multi-domain] Cd Length: 557 Bit Score: 117.04 E-value: 3.03e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 462 YETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIV 541
Cdd:PRK07059 22 YPSLADLLEESFRQYADRPAFICMGKAITYGELDELSRALAAWLQSRGLAKGARVAIMMPNVLQYPVAIAAVLRAGYVVV 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 542 PVDPHYPADRIRYILHDCGC---------SHVVSQA-------H-LPSSLED---------NYIITH-----PE------ 584
Cdd:PRK07059 102 NVNPLYTPRELEHQLKDSGAeaivvlenfATTVQQVlaktavkHvVVASMGDllgfkghivNFVVRRvkkmvPAwslpgh 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 585 ----DIESKVDGSNIKSVNNA-DDLLYMIYTSGTTGKPKGVQFEHRNM-ANLLKFE-YTHSGIDFEADVLQF----ATP- 652
Cdd:PRK07059 182 vrfnDALAEGARQTFKPVKLGpDDVAFLQYTGGTTGVSKGATLLHRNIvANVLQMEaWLQPAFEKKPRPDQLnfvcALPl 261
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 653 ----SFDVCYqeiFSALLKGGTLHIVPEAikRDVPQLFAFINKHQTNIvfLPT------------AFIKMIFSERELANS 716
Cdd:PRK07059 262 yhifALTVCG---LLGMRTGGRNILIPNP--RDIPGFIKELKKYQVHI--FPAvntlynallnnpDFDKLDFSKLIVANG 334
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 717 FPDGVKHLIAagEQLmisdlfqdvLRKRGIHLHNHYGPSETHVVSTytIHPGDPIPELPPIGKPIGCTDLYILNHQKQLQ 796
Cdd:PRK07059 335 GGMAVQRPVA--ERW---------LEMTGCPITEGYGLSETSPVAT--CNPVDATEFSGTIGLPLPSTEVSIRDDDGNDL 401
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 797 PCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEV 876
Cdd:PRK07059 402 PLGEPGEICIRGPQVMAGYWNRPDETAKVMTADGF------FRTGDVGVMDERGYTKIVDRKKDMILVSGFNVYPNEIEE 475
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 877 TLMNHPDISEAAILIWQDQNGEHELCAYYcsVQK---LNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PRK07059 476 VVASHPGVLEVAAVGVPDEHSGEAVKLFV--VKKdpaLTEEDVKAFCKERLTNYKRPKFVEFRTELPKTNVGKILRREL 552
|
|
| PRK07638 |
PRK07638 |
acyl-CoA synthetase; Validated |
2534-3028 |
3.87e-26 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236071 [Multi-domain] Cd Length: 487 Bit Score: 115.65 E-value: 3.87e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2534 TISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTpVGIMMHRSFSMIASILGVWKAGGCYVPI 2613
Cdd:PRK07638 2 GITKEYKKHASLQPNKIAIKENDRVLTYKDWFESVCKVANWLNEKESKNKT-IAILLENRIEFLQLFAGAAMAGWTCVPL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2614 DPEYPKERKRYILSDSGTKLLMTiNEADLGVLADFEGEILTI----ESVEEDDKSPLPQMSSAHHLAYIIYTSGTTGRPK 2689
Cdd:PRK07638 81 DIKWKQDELKERLAISNADMIVT-ERYKLNDLPDEEGRVIEIdewkRMIEKYLPTYAPIENVQNAPFYMGFTSGSTGKPK 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2690 GVMVEHKGIANTLQWRRNAYAFNETDTIL---QLFSfsfdgfitSMFtplLSGAKAVL-----LHEEEAKDILAIKHQLS 2761
Cdd:PRK07638 160 AFLRAQQSWLHSFDCNVHDFHMKREDSVLiagTLVH--------SLF---LYGAISTLyvgqtVHLMRKFIPNQVLDKLE 228
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2762 RQRITHMIIVPVLYRALLDVVQ-PEDvktlrVVTLAGEAADRELIA--RSLAICPHTELANEYGPTENSVATTVMRHMEK 2838
Cdd:PRK07638 229 TENISVMYTVPTMLESLYKENRvIEN-----KMKIISSGAKWEAEAkeKIKNIFPYAKLYEFYGASELSFVTALVDEESE 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2839 QAYVSIGQPIDGTQVLILNSnhqlqpigvAGELCIAG-TGlaRGYVNLPELteraFTQnpFKPEARMYRTGDAARWMA-- 2915
Cdd:PRK07638 304 RRPNSVGRPFHNVQVRICNE---------AGEEVQKGeIG--TVYVKSPQF----FMG--YIIGGVLARELNADGWMTvr 366
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2916 -------DGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAhVTASGQTELSAYVVtKPGLSTNAVRSELQ 2988
Cdd:PRK07638 367 dvgyedeEGFIYIVGREKNMILFGGINIFPEEIESVLHEHPAVDEIVVIG-VPDSYWGEKPVAII-KGSATKQQLKSFCL 444
|
490 500 510 520
....*....|....*....|....*....|....*....|
gi 1678550997 2989 NKLPVFMHPAFIEKLDSLPLSPNGKLDRGALPKPVYNHEG 3028
Cdd:PRK07638 445 QRLSSFKIPKEWHFVDEIPYTNSGKIARMEAKSWIENQEK 484
|
|
| OSB_MenE-like |
cd17630 |
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) ... |
603-952 |
4.17e-26 |
|
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) synthetase (also known as O-succinylbenzoic acid CoA ligase) that belongs to the ANL superfamily and catalyzes the ligation of CoA to o-succinylbenzoate (OSB). It includes MenE in the bacterial menaquinone biosynthesis pathway which is a promising target for the development of novel antibacterial agents. MenE catalyzes CoA ligation via an acyl-adenylate intermediate; tight-binding inhibitors of MenE based on stable acyl-sulfonyladenosine analogs of this intermediate provide a pathway toward the development of optimized MenE inhibitors.
Pssm-ID: 341285 [Multi-domain] Cd Length: 325 Bit Score: 112.42 E-value: 4.17e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 603 DLLYMIYTSGTTGKPKGVQFEHRNManLLKFEYTHSGIDFEA-DVLQFATPSFDVC-YQEIFSALLKGGTLHIvpeaikR 680
Cdd:cd17630 1 RLATVILTSGSTGTPKAVVHTAANL--LASAAGLHSRLGFGGgDSWLLSLPLYHVGgLAILVRSLLAGAELVL------L 72
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 681 DVPQLFAfINKHQTNIVFL---PTAFIKMIfsERELANSFPDGVKHLIAAGEQLMISDLfqDVLRKRGIHLHNHYGPSET 757
Cdd:cd17630 73 ERNQALA-EDLAPPGVTHVslvPTQLQRLL--DSGQGPAALKSLRAVLLGGAPIPPELL--ERAADRGIPLYTTYGMTET 147
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 758 hvVSTYTIHPGDpIPELPPIGKPIGCTDLYILNhqkqlqpcgvPGELYISGASVARGYVNHDklTSDKFSSDPFkpdvim 837
Cdd:cd17630 148 --ASQVATKRPD-GFGRGGVGVLLPGRELRIVE----------DGEIWVGGASLAMGYLRGQ--LVPEFNEDGW------ 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 838 YRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCSVQKLNTIDLR 917
Cdd:cd17630 207 FTTKDLGELHADGRLTVLGRADNMIISGGENIQPEEIEAALAAHPAVRDAFVVGVPDEELGQRPVAVIVGRGPADPAELR 286
|
330 340 350
....*....|....*....|....*....|....*
gi 1678550997 918 SYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:cd17630 287 AWLKDKLARFKLPKRIYPVPELPRTGGGKVDRRAL 321
|
|
| PRK06710 |
PRK06710 |
long-chain-fatty-acid--CoA ligase; Validated |
463-956 |
5.25e-26 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 180666 [Multi-domain] Cd Length: 563 Bit Score: 116.29 E-value: 5.25e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 463 ETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVP 542
Cdd:PRK06710 24 QPLHKYVEQMASRYPEKKALHFLGKDITFSVFHDKVKRFANYLQKLGVEKGDRVAIMLPNCPQAVIGYYGTLLAGGIVVQ 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 543 VDPHYPADRIRYILHDCGC----------------------SHVV---------------------SQAHLPSSLEDNYI 579
Cdd:PRK06710 104 TNPLYTERELEYQLHDSGAkvilcldlvfprvtnvqsatkiEHVIvtriadflpfpknllypfvqkKQSNLVVKVSESET 183
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 580 ITHPEDIESKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRNMAN--LLKFEYTHSGIDFEADVLQfATPSFDVC 657
Cdd:PRK06710 184 IHLWNSVEKEVNTGVEVPCDPENDLALLQYTGGTTGFPKGVMLTHKNLVSntLMGVQWLYNCKEGEEVVLG-VLPFFHVY 262
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 658 YQEIFS--ALLKGGTLHIVPeaiKRDVPQLFAFINKHQTNIV-FLPTAFIKMIFSerELANSFPDGVKHLIAAGEQLMIS 734
Cdd:PRK06710 263 GMTAVMnlSIMQGYKMVLIP---KFDMKMVFEAIKKHKVTLFpGAPTIYIALLNS--PLLKEYDISSIRACISGSAPLPV 337
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 735 DLFQDVLRKRGIHLHNHYGPSETHVVSTYTIHPGDPIPElpPIGKPIGCTDLYILNHQK-QLQPCGVPGELYISGASVAR 813
Cdd:PRK06710 338 EVQEKFETVTGGKLVEGYGLTESSPVTHSNFLWEKRVPG--SIGVPWPDTEAMIMSLETgEALPPGEIGEIVVKGPQIMK 415
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 814 GYVNHDKLTSDKFSSDpfkpdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQ 893
Cdd:PRK06710 416 GYWNKPEETAAVLQDG-------WLHTGDVGYMDEDGFFYVKDRKKDMIVASGFNVYPREVEEVLYEHEKVQEVVTIGVP 488
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 894 DQNGEHELCAYY-------CSVQKLNTIdLRSYMASelpeYMIPAKWIWVDSIPLTPNGKVDRAALPEPD 956
Cdd:PRK06710 489 DPYRGETVKAFVvlkegteCSEEELNQF-ARKYLAA----YKVPKVYEFRDELPKTTVGKILRRVLIEEE 553
|
|
| PRK07786 |
PRK07786 |
long-chain-fatty-acid--CoA ligase; Validated |
470-967 |
6.34e-26 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 169098 [Multi-domain] Cd Length: 542 Bit Score: 115.64 E-value: 6.34e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 470 EKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPA 549
Cdd:PRK07786 24 ARHALMQPDAPALRFLGNTTTWRELDDRVAALAGALSRRGVGFGDRVLILMLNRTEFVESVLAANMLGAIAVPVNFRLTP 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 550 DRIRYILHDCGCSHVVSQAHLPSslednyIITHPEDIESKVD------GSNIKSVNNADDLL------------------ 605
Cdd:PRK07786 104 PEIAFLVSDCGAHVVVTEAALAP------VATAVRDIVPLLStvvvagGSSDDSVLGYEDLLaeagpahapvdipndspa 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 606 YMIYTSGTTGKPKGVQFEHRNM-ANLLKFEYThSGIDFEADVLQFATPSFDVC-YQEIFSALLKGGTLHIVPEAiKRDVP 683
Cdd:PRK07786 178 LIMYTSGTTGRPKGAVLTHANLtGQAMTCLRT-NGADINSDVGFVGVPLFHIAgIGSMLPGLLLGAPTVIYPLG-AFDPG 255
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 684 QLFAFINKHQTNIVFLPTAFIKMIFSE-------------------------RELANSFPDGvkHLIAAGEQLMISD--- 735
Cdd:PRK07786 256 QLLDVLEAEKVTGIFLVPAQWQAVCAEqqarprdlalrvlswgaapasdtllRQMAATFPEA--QILAAFGQTEMSPvtc 333
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 736 --LFQDVLRKRGihlhnhygpsethvvstytihpgdpipelpPIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVAR 813
Cdd:PRK07786 334 mlLGEDAIRKLG------------------------------SVGKVIPTVAARVVDENMNDVPVGEVGEIVYRAPTLMS 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 814 GYVNHDKLTSDKFSSDPFkpdvimyRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQ 893
Cdd:PRK07786 384 GYWNNPEATAEAFAGGWF-------HSGDLVRQDEEGYVWVVDRKKDMIISGGENIYCAEVENVLASHPDIVEVAVIGRA 456
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 894 DQN-GEH--ELCAYYCSVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPE----PDASISGNPYTA 966
Cdd:PRK07786 457 DEKwGEVpvAVAAVRNDDAALTLEDLAEFLTDRLARYKHPKALEIVDALPRNPAGKVLKTELRErygaCVNVERRSASAG 536
|
.
gi 1678550997 967 P 967
Cdd:PRK07786 537 F 537
|
|
| PRK07788 |
PRK07788 |
acyl-CoA synthetase; Validated |
462-956 |
7.72e-26 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236097 [Multi-domain] Cd Length: 549 Bit Score: 115.41 E-value: 7.72e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 462 YETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIV 541
Cdd:PRK07788 48 YGPFAGLVAHAARRAPDRAALIDERGTLTYAELDEQSNALARGLLALGVRAGDGVAVLARNHRGFVLALYAAGKVGARII 127
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 542 PVDPHYPA---------DRIRYILHDCGCSHVVSQahLPSSLED-NYIITHPEDIESKVDGsniksVNNADDLL------ 605
Cdd:PRK07788 128 LLNTGFSGpqlaevaarEGVKALVYDDEFTDLLSA--LPPDLGRlRAWGGNPDDDEPSGST-----DETLDDLIagssta 200
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 606 ----------YMIYTSGTTGKPKGVQFEHRN----MANLLkfeythSGIDFEAD-VLQFATPSFD----VCYQEIFsALl 666
Cdd:PRK07788 201 plpkppkpggIVILTSGTTGTPKGAPRPEPSplapLAGLL------SRVPFRAGeTTLLPAPMFHatgwAHLTLAM-AL- 272
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 667 kGGTL----HIVPEAIKRDvpqlfafINKHQ-TNIVFLPTaFIKMIFSERELANSFPD--GVKHLIAAGEQLMiSDLFQD 739
Cdd:PRK07788 273 -GSTVvlrrRFDPEATLED-------IAKHKaTALVVVPV-MLSRILDLGPEVLAKYDtsSLKIIFVSGSALS-PELATR 342
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 740 VLRKRGIHLHNHYGPSEthvVSTYTI-HPGDpIPELPPI-GK-PIGCTdLYILNHQKQLQPCGVPGELYISGASVARGYV 816
Cdd:PRK07788 343 ALEAFGPVLYNLYGSTE---VAFATIaTPED-LAEAPGTvGRpPKGVT-VKILDENGNEVPRGVVGRIFVGNGFPFEGYT 417
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 817 N-HDKLTSDKFSSdpfkpdvimyrTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQ 895
Cdd:PRK07788 418 DgRDKQIIDGLLS-----------SGDVGYFDEDGLLFVDGRDDDMIVSGGENVFPAEVEDLLAGHPDVVEAAVIGVDDE 486
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 896 NGEHELCAYYcsVQK----LNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPEPD 956
Cdd:PRK07788 487 EFGQRLRAFV--VKApgaaLDEDAIKDYVRDNLARYKVPRDVVFLDELPRNPTGKVLKRELREMD 549
|
|
| PrpE |
cd05967 |
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or ... |
2550-3046 |
8.17e-26 |
|
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or propionate#CoA ligase (PrpE) catalyzes the first step of the 2-methylcitric acid cycle for propionate catabolism. It activates propionate to propionyl-CoA in a two-step reaction, which proceeds through a propionyl-AMP intermediate and requires ATP and Mg2+. In Salmonella enterica, the PrpE protein is required for growth of Salmonella enterica on propionate and can substitute for the acetyl-CoA synthetase (Acs) enzyme during growth on acetate. PrpE can also activate acetate, 3HP, and butyrate to their corresponding CoA-thioesters, although with less efficiency.
Pssm-ID: 341271 [Multi-domain] Cd Length: 617 Bit Score: 116.26 E-value: 8.17e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2550 SALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMM----HRSFSMIAS---------ILGVWKAGGCYVPIDPE 2616
Cdd:cd05967 74 SPVTGTERTYTYAELLDEVSRLAGVLRKLGVVKGDRVIIYMpmipEAAIAMLACarigaihsvVFGGFAAKELASRIDDA 153
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2617 YPK---------ERKRYI---------LSDSGTK---------LLMTINEADLGVLADFEGEILTIESVEeddksPLPqm 2669
Cdd:cd05967 154 KPKlivtascgiEPGKVVpykplldkaLELSGHKphhvlvlnrPQVPADLTKPGRDLDWSELLAKAEPVD-----CVP-- 226
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2670 SSAHHLAYIIYTSGTTGRPKGVMVEHKGIANTLQWR-RNAYAFNETDTilqLFSFSFDGFIT----SMFTPLLSGAKAVL 2744
Cdd:cd05967 227 VAATDPLYILYTSGTTGKPKGVVRDNGGHAVALNWSmRNIYGIKPGDV---WWAASDVGWVVghsyIVYGPLLHGATTVL 303
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2745 LheeEAK-----DILAIKHQLSRQRITHMIIVPVLYRAL------LDVVQPEDVKTLRVVTLAGEAAD---RELIARSLa 2810
Cdd:cd05967 304 Y---EGKpvgtpDPGAFWRVIEKYQVNALFTAPTAIRAIrkedpdGKYIKKYDLSSLRTLFLAGERLDpptLEWAENTL- 379
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2811 icpHTELANEYGPTEN--SVATTVM--RHMEKQAYvSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGT---GLARGYV 2883
Cdd:cd05967 380 ---GVPVIDHWWQTETgwPITANPVglEPLPIKAG-SPGKPVPGYQVQVLDEDGEPVGPNELGNIVIKLPlppGCLLTLW 455
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2884 NLPELTERAFTQNpFKPearMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTA- 2962
Cdd:cd05967 456 KNDERFKKLYLSK-FPG---YYDTGDAGYKDEDGYLFIMGRTDDVINVAGHRLSTGEMEESVLSHPAVAECAVVGVRDEl 531
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2963 SGQTELsAYVVTKPGLSTNAvrSELQNKL---------PV--FMHPAFIEKldsLPLSPNGKLDRGALPKPVynhEGERP 3031
Cdd:cd05967 532 KGQVPL-GLVVLKEGVKITA--EELEKELvalvreqigPVaaFRLVIFVKR---LPKTRSGKILRRTLRKIA---DGEDY 602
|
570
....*....|....*
gi 1678550997 3032 FLPPSSKMEQILADI 3046
Cdd:cd05967 603 TIPSTIEDPSVLDEI 617
|
|
| ACLS-CaiC |
cd17637 |
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ... |
2678-3016 |
8.97e-26 |
|
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized, but may be similar to Carnitine-CoA ligase (CaiC) which catalyzes the transfer of CoA to carnitine. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341292 [Multi-domain] Cd Length: 333 Bit Score: 111.59 E-value: 8.97e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2678 IIYTSGTTGRPKGVMVEHKG-IANTLQWRrNAYAFNETDT---ILQLFSFSfdGFITSmFTPLLSGAKAVLLH----EEE 2749
Cdd:cd17637 5 IIHTAAVAGRPRGAVLSHGNlIAANLQLI-HAMGLTEADVylnMLPLFHIA--GLNLA-LATFHAGGANVVMEkfdpAEA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2750 AKDILAikhqlsrQRITHMIIVPVLYRALLDVVQ--PEDVKTLRVVTlaGEAADrELIARSLAICPHTELANeYGPTENS 2827
Cdd:cd17637 81 LELIEE-------EKVTLMGSFPPILSNLLDAAEksGVDLSSLRHVL--GLDAP-ETIQRFEETTGATFWSL-YGQTETS 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2828 VATTVMRHMEKQAyvSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFtQNPFkpearmYRT 2907
Cdd:cd17637 150 GLVTLSPYRERPG--SAGRPGPLVRVRIVDDNDRPVPAGETGEIVVRGPLVFQGYWNLPELTAYTF-RNGW------HHT 220
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2908 GDAARWMADGTLEYLGRI--DDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAhVTASGQTE-LSAYVVTKPG--LSTNA 2982
Cdd:cd17637 221 GDLGRFDEDGYLWYAGRKpeKELIKPGGENVYPAEVEKVILEHPAIAEVCVIG-VPDPKWGEgIKAVCVLKPGatLTADE 299
|
330 340 350
....*....|....*....|....*....|....
gi 1678550997 2983 VRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDR 3016
Cdd:cd17637 300 LIEFVGSRIARYKKPRYVVFVEALPKTADGSIDR 333
|
|
| MACS_AAE_MA_like |
cd05970 |
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation ... |
462-956 |
9.49e-26 |
|
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This family of MACS enzymes is found in archaea and bacteria. It is represented by the acyl-adenylating enzyme from Methanosarcina acetivorans (AAE_MA). AAE_MA is most active with propionate, butyrate, and the branched analogs: 2-methyl-propionate, butyrate, and pentanoate. The specific activity is weaker for smaller or larger acids.
Pssm-ID: 341274 [Multi-domain] Cd Length: 537 Bit Score: 115.29 E-value: 9.49e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 462 YETIHAMfekqAEKTPDAHAVI---DQACS--LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKA 536
Cdd:cd05970 20 YDVVDAM----AKEYPDKLALVwcdDAGEEriFTFAELADYSDKTANFFKAMGIGKGDTVMLTLKRRYEFWYSLLALHKL 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 537 GGAIVPVDPHYPADRIRYILHDCGCSHVVS------QAHLPSSLEDNYIIT-----HPEDIESKVDGSniKSVNNA---- 601
Cdd:cd05970 96 GAIAIPATHQLTAKDIVYRIESADIKMIVAiaedniPEEIEKAAPECPSKPklvwvGDPVPEGWIDFR--KLIKNAspdf 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 602 -----------DDLLYMIYTSGTTGKPKGVqfEHRN---MANLLKFEYTHsgiDFEADVLQFA---TPSFDVCYQEIFSA 664
Cdd:cd05970 174 erptansypcgEDILLVYFSSGTTGMPKMV--EHDFtypLGHIVTAKYWQ---NVREGGLHLTvadTGWGKAVWGKIYGQ 248
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 665 LLKGGTLhIVPEAIKRDVPQLFAFINKHQ-TNIVFLPTAF---IKMIFSERELAnsfpdGVKHLIAAGEQLMiSDLFQDV 740
Cdd:cd05970 249 WIAGAAV-FVYDYDKFDPKALLEKLSKYGvTTFCAPPTIYrflIREDLSRYDLS-----SLRYCTTAGEALN-PEVFNTF 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 741 LRKRGIHLHNHYGPSEThVVSTYTIHPGDPIPElpPIGKPIGCTDLYILNHQKQLQPCGVPGELYI---SGASVA--RGY 815
Cdd:cd05970 322 KEKTGIKLMEGFGQTET-TLTIATFPWMEPKPG--SMGKPAPGYEIDLIDREGRSCEAGEEGEIVIrtsKGKPVGlfGGY 398
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 816 VNHDKLTSDKFSSDpfkpdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQ 895
Cdd:cd05970 399 YKDAEKTAEVWHDG-------YYHTGDAAWMDEDGYLWFVGRTDDLIKSSGYRIGPFEVESALIQHPAVLECAVTGVPDP 471
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 896 -NGEhelcayycsVQKLNTIDLRSYMASELPE-------------YMIPAKWIWVDSIPLTPNGKVDRAALPEPD 956
Cdd:cd05970 472 iRGQ---------VVKATIVLAKGYEPSEELKkelqdhvkkvtapYKYPRIVEFVDELPKTISGKIRRVEIRERD 537
|
|
| PRK13295 |
PRK13295 |
cyclohexanecarboxylate-CoA ligase; Reviewed |
1489-1983 |
9.76e-26 |
|
cyclohexanecarboxylate-CoA ligase; Reviewed
Pssm-ID: 171961 [Multi-domain] Cd Length: 547 Bit Score: 115.15 E-value: 9.76e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1489 GYSMNQTLHYALEQQAEKTPDQAAVI-FEDGV-----MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIY 1562
Cdd:PRK13295 19 GHWHDRTINDDLDACVASCPDKTAVTaVRLGTgaprrFTYRELAALVDRVAVGLARLGVGRGDVVSCQLPNWWEFTVLYL 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1563 GILKAGGAYLPIDPDYPEERISFLLEDSGTNILLLQS-----------AGLH--VPEFTGEIVYLNQTNSGLAHRLSNPN 1629
Cdd:PRK13295 99 ACSRIGAVLNPLMPIFRERELSFMLKHAESKVLVVPKtfrgfdhaamaRRLRpeLPALRHVVVVGGDGADSFEALLITPA 178
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1630 VD-------VL------PQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIM------HKTSYSFDAS 1690
Cdd:PRK13295 179 WEqepdapaILarlrpgPDDVTQLIYTSGTTGEPKGVMHTANTLMANIVPYAERLGLGADDVILmaspmaHQTGFMYGLM 258
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1691 IwelfwwP-YAGASVYLLPQGgekEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTnrLKRVFSGGEQLGTH 1769
Cdd:PRK13295 259 M------PvMLGATAVLQDIW---DPARAAELIRTEGVTFTMASTPFLTDLTRAVKESGRPVSS--LRTFLCAGAPIPGA 327
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1770 LVSRFYELLpNVSITNSYGPTE-ATVEAAFFDCPPheklERIPI--GKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGV 1846
Cdd:PRK13295 328 LVERARAAL-GAKIVSAWGMTEnGAVTLTKLDDPD----ERASTtdGCPLPGVEVRVVDADGAPLPAGQIGRLQVRGCSN 402
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1847 ARGYLNRPALTEERFledpfypgERMYKTGDVARWLPDGNVEFLGRTDDqVKIRG-YRIEPGEIEAALRSIEGVREAAVT 1925
Cdd:PRK13295 403 FGGYLKRPQLNGTDA--------DGWFDTGDLARIDADGYIRISGRSKD-VIIRGgENIPVVEIEALLYRHPAIAQVAIV 473
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 1926 VRTDS--GEpELCAYV-----EGLQRNEVRAQLE--RLLPGYMvPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK13295 474 AYPDErlGE-RACAFVvprpgQSLDFEEMVEFLKaqKVAKQYI-PERLVVRDALPRTPSGKIQKFRL 538
|
|
| LC_FACS_like |
cd17640 |
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA ... |
2557-2945 |
1.04e-25 |
|
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA synthetases, including an Arabidopsis gene At4g14070 that plays a role in activation and elongation of exogenous fatty acids. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341295 [Multi-domain] Cd Length: 468 Bit Score: 113.99 E-value: 1.04e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2557 KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSgtkllmt 2636
Cdd:cd17640 4 KRITYKDLYQEILDFAAGLRSLGVKAGEKVALFADNSPRWLIADQGIMALGAVDVVRGSDSSVEELLYILNHS------- 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2637 ineadlgvladfEGEILTIESVEEDdksplpqmssahhLAYIIYTSGTTGRPKGVMVEHkgiANTLQWRRNAYAFNETD- 2715
Cdd:cd17640 77 ------------ESVALVVENDSDD-------------LATIIYTSGTTGNPKGVMLTH---ANLLHQIRSLSDIVPPQp 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2716 -----TILQL---FSFSFDGFItsmftpLLSGAkavllhEEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDVVQPEdv 2787
Cdd:cd17640 129 gdrflSILPIwhsYERSAEYFI------FACGC------SQAYTSIRTLKDDLKRVKPHYIVSVPRLWESLYSGIQKQ-- 194
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2788 ktlrvvtLAGEAADRELIARSL--------------AICPHT---------ELANEYGPTENSVATTVMRHMEKQAYvSI 2844
Cdd:cd17640 195 -------VSKSSPIKQFLFLFFlsggifkfgisgggALPPHVdtffeaigiEVLNGYGLTETSPVVSARRLKCNVRG-SV 266
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2845 GQPIDGTQVLI--LNSNHQLQPiGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMADGTLEYL 2922
Cdd:cd17640 267 GRPLPGTEIKIvdPEGNVVLPP-GEKGIVWVRGPQVMKGYYKNPEATSKVLDSDGW------FNTGDLGWLTCGGELVLT 339
|
410 420
....*....|....*....|....
gi 1678550997 2923 GRIDDQVKIR-GYRVETKEIESVI 2945
Cdd:cd17640 340 GRAKDTIVLSnGENVEPQPIEEAL 363
|
|
| LC_FACL_like |
cd05914 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are ... |
489-949 |
1.28e-25 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are bacterial long-chain fatty acid CoA synthetase, most of which are as yet uncharacterized. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341240 [Multi-domain] Cd Length: 463 Bit Score: 113.69 E-value: 1.28e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 489 LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCgcshvvsqa 568
Cdd:cd05914 8 LTYKDLADNIAKFALLLKINGVGTGDRVALMGENRPEWGIAFFAIWTYGAIAVPILAEFTADEVHHILNHS--------- 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 569 hlpsslEDNYIIthpedieskvdgsniksVNNADDLLYMIYTSGTTGKPKGVQFEHRNMAnllkfeythSGIDF------ 642
Cdd:cd05914 79 ------EAKAIF-----------------VSDEDDVALINYTSGTTGNSKGVMLTYRNIV---------SNVDGvkevvl 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 643 --EADVLQFATP---SFDVCYQEIFsALLKGGTLH----------------------IVP-------EAIKRDVPQLFAF 688
Cdd:cd05914 127 lgKGDKILSILPlhhIYPLTFTLLL-PLLNGAHVVfldkipsakiialafaqvtptlGVPvplviekIFKMDIIPKLTLK 205
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 689 INKHQTNIVFLPTAFIKMIFseRELANSFPDGVKHLIAAGEQlMISDLFQDvLRKRGIHLHNHYGPSETHVVSTYTIhPG 768
Cdd:cd05914 206 KFKFKLAKKINNRKIRKLAF--KKVHEAFGGNIKEFVIGGAK-INPDVEEF-LRTIGFPYTIGYGMTETAPIISYSP-PN 280
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 769 DPIpeLPPIGKPIGCTDLYIlnhqKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLE 848
Cdd:cd05914 281 RIR--LGSAGKVIDGVEVRI----DSPDPATGEGEIIVRGPNVMKGYYKNPEATAEAFDKDGW------FHTGDLGKIDA 348
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 849 DGNIEYIGRADNQ-VKIRGYRIEPQEIEVTLMNHPDISEAAILIwQDQNGEHELCAYYCSVQKL-----NTID-----LR 917
Cdd:cd05914 349 EGYLYIRGRKKEMiVLSSGKNIYPEEIEAKINNMPFVLESLVVV-QEKKLVALAYIDPDFLDVKalkqrNIIDaikweVR 427
|
490 500 510
....*....|....*....|....*....|...
gi 1678550997 918 SYMASELPEYMIPAKWIWV-DSIPLTPNGKVDR 949
Cdd:cd05914 428 DKVNQKVPNYKKISKVKIVkEEFEKTPKGKIKR 460
|
|
| PRK08315 |
PRK08315 |
AMP-binding domain protein; Validated |
2533-3013 |
1.92e-25 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236236 [Multi-domain] Cd Length: 559 Bit Score: 114.52 E-value: 1.92e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2533 QTISQLFEQQAARTPKASALVSGDKTL--TYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCY 2610
Cdd:PRK08315 16 QTIGQLLDRTAARYPDREALVYRDQGLrwTYREFNEEVDALAKGLLALGIEKGDRVGIWAPNVPEWVLTQFATAKIGAIL 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2611 VPIDPEYPKERKRYILSDSGTKLLMTIN---EAD-LGVLADFEGEILTIESVE---------------EDDKSP------ 2665
Cdd:PRK08315 96 VTINPAYRLSELEYALNQSGCKALIAADgfkDSDyVAMLYELAPELATCEPGQlqsarlpelrrviflGDEKHPgmlnfd 175
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2666 ----LPQMSSAHHLAY------------IIYTSGTTGRPKGVMVEHKGIANtlqwrrNAY------AFNETDTI---LQL 2720
Cdd:PRK08315 176 ellaLGRAVDDAELAArqatldpddpinIQYTSGTTGFPKGATLTHRNILN------NGYfigeamKLTEEDRLcipVPL 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2721 FS-FsfdGFITSMFTPLLSGAKAVLLHEeeAKDILAIKHQLSRQRITHMIIVPVLYRALLDvvQPE----DVKTLRVVTL 2795
Cdd:PRK08315 250 YHcF---GMVLGNLACVTHGATMVYPGE--GFDPLATLAAVEEERCTALYGVPTMFIAELD--HPDfarfDLSSLRTGIM 322
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2796 AGeaadreliarslAICP-----------H-TELANEYGPTENS---------------VAT--TVMRHMEkqayVSIGQ 2846
Cdd:PRK08315 323 AG------------SPCPievmkrvidkmHmSEVTIAYGMTETSpvstqtrtddplekrVTTvgRALPHLE----VKIVD 386
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2847 PIDGTQVlilnsnhqlqPIGVAGELCIAGTGLARGYVNLPELTERAFtqnpfkpearmyrtgDAARWM---------ADG 2917
Cdd:PRK08315 387 PETGETV----------PRGEQGELCTRGYSVMKGYWNDPEKTAEAI---------------DADGWMhtgdlavmdEEG 441
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2918 TLEYLGRIDDQVkIRG----YrveTKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPG--LSTNAVRSELQNKL 2991
Cdd:PRK08315 442 YVNIVGRIKDMI-IRGgeniY---PREIEEFLYTHPKIQDVQVVGVPDEKYGEEVCAWIILRPGatLTEEDVRDFCRGKI 517
|
570 580
....*....|....*....|..
gi 1678550997 2992 PVFMHPAFIEKLDSLPLSPNGK 3013
Cdd:PRK08315 518 AHYKIPRYIRFVDEFPMTVTGK 539
|
|
| FACL_like_1 |
cd05910 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
1520-1983 |
1.93e-25 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341236 [Multi-domain] Cd Length: 457 Bit Score: 112.94 E-value: 1.93e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1520 MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGtnilllqs 1599
Cdd:cd05910 3 LSFRELDERSDRIAQGLTAYGIRRGMRAVLMVPPGPDFFALTFALFKAGAVPVLIDPGMGRKNLKQCLQEAE-------- 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1600 aglhvPE-FTGEivylnqtnsglahrlsnPNVDvlpqSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDM 1678
Cdd:cd05910 75 -----PDaFIGI-----------------PKAD----EPAAILFTSGSTGTPKGVVYRHGTFAAQIDALRQLYGIRPGEV 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1679 imhktsysfDASIWELF--WWPYAG-ASV-----YLLPqgGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVP 1750
Cdd:cd05910 129 ---------DLATFPLFalFGPALGlTSVipdmdPTRP--ARADPQKLVGAIRQYGVSIVFGSPALLERVARYCAQHGIT 197
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1751 IKTnrLKRVFSGGEQLGTHLVSRFYELL-PNVSITNSYGPTEATVEAAFFD-------CPPHEKLERIPIGKPVHHVRLY 1822
Cdd:cd05910 198 LPS--LRRVLSAGAPVPIALAARLRKMLsDEAEILTPYGATEALPVSSIGSrellattTAATSGGAGTCVGRPIPGVRVR 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1823 LLN---------QNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDpfyPGERM-YKTGDVARWLPDGNVEFLGR 1892
Cdd:cd05910 276 IIEiddepiaewDDTLELPRGEIGEITVTGPTVTPTYVNRPVATALAKIDD---NSEGFwHRMGDLGYLDDEGRLWFCGR 352
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1893 TDDQVKIRGYRIEPGEIEAALRSIEGVREAA-VTVRTDSG-------EPELCAYVEGLQ-RNEVRAQLERLLPGYMVPAY 1963
Cdd:cd05910 353 KAHRVITTGGTLYTEPVERVFNTHPGVRRSAlVGVGKPGCqlpvlcvEPLPGTITPRARlEQELRALAKDYPHTQRIGRF 432
|
490 500
....*....|....*....|..
gi 1678550997 1964 MIEmEQWPVTP--SGKLDRNAL 1983
Cdd:cd05910 433 LIH-PSFPVDIrhNAKIFREKL 453
|
|
| A_NRPS_MycA_like |
cd05908 |
The adenylation domain of nonribosomal peptide synthetases (NRPS) similar to mycosubtilin ... |
2547-2975 |
1.98e-25 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS) similar to mycosubtilin synthase subunit A (MycA); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as (amino)-acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family includes NRPS similar to mycosubtilin synthase subunit A (MycA). Mycosubtilin, which is characterized by a beta-amino fatty acid moiety linked to the circular heptapeptide Asn-Tyr-Asn-Gln-Pro-Ser-Asn, belongs to the iturin family of lipopeptide antibiotics. The mycosubtilin synthase subunit A (MycA) combines functional domains derived from peptide synthetases, amino transferases, and fatty acid synthases. Nonribosomal peptide synthetases are large multifunction enzymes that synthesize many therapeutically useful peptides. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341234 [Multi-domain] Cd Length: 499 Bit Score: 113.74 E-value: 1.98e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2547 PKASALVSGDKT---LTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGgcYVPIdPEYPKERKR 2623
Cdd:cd05908 1 PEGIIFILGDKKekfVSYRHLREEALGYLGALQELGIKPGQEVVFQITHNNKFLYLFWACLLGG--MIAV-PVSIGSNEE 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2624 YILsdsgtKLLMTINEADLGVLadfegeiLTIESVEEDDKSplpqmssahHLAYIIYTSGTTGRPKGVMVEHKGIANTLQ 2703
Cdd:cd05908 78 HKL-----KLNKVWNTLKNPYL-------ITEEEVLCELAD---------ELAFIQFSSGSTGDPKGVMLTHENLVHNMF 136
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2704 WRRNAYAFNETDTILQLFSFSFD-GFITSMFTPLLSGAKAVLLHEEE--AKDILAIKhQLSRQRITHMIIVPVLYRALLD 2780
Cdd:cd05908 137 AILNSTEWKTKDRILSWMPLTHDmGLIAFHLAPLIAGMNQYLMPTRLfiRRPILWLK-KASEHKATIVSSPNFGYKYFLK 215
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2781 VVQPE-----DVKTLRVVTLAGEAADRELIARSLAIC-PH----TELANEYGPTENSVATTV-------------MRHM- 2836
Cdd:cd05908 216 TLKPEkandwDLSSIRMILNGAEPIDYELCHEFLDHMsKYglkrNAILPVYGLAEASVGASLpkaqspfktitlgRRHVt 295
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2837 -----------EKQAY--VSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpear 2903
Cdd:cd05908 296 hgepepevdkkDSECLtfVEVGKPIDETDIRICDEDNKILPDGYIGHIQIRGKNVTPGYYNNPEATAKVFTDDGW----- 370
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 2904 mYRTGDAArWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVA---HVTASGQTELSAYVVTK 2975
Cdd:cd05908 371 -LKTGDLG-FIRNGRLVITGREKDIIFVNGQNVYPHDIERIAEELEGVELGRVVAcgvNNSNTRNEEIFCFIEHR 443
|
|
| PRK06145 |
PRK06145 |
acyl-CoA synthetase; Validated |
473-947 |
2.28e-25 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 102207 [Multi-domain] Cd Length: 497 Bit Score: 113.44 E-value: 2.28e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 473 AEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRI 552
Cdd:PRK06145 12 ARRTPDRAALVYRDQEISYAEFHQRILQAAGMLHARGIGQGDVVALLMKNSAAFLELAFAASYLGAVFLPINYRLAADEV 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 553 RYILHDCGCSHVVSQAHL--PSSLEDNYIIThpeDIESKVDGSNI---------KSVNNADDLLYMIYTSGTTGKPKGVQ 621
Cdd:PRK06145 92 AYILGDAGAKLLLVDEEFdaIVALETPKIVI---DAAAQADSRRLaqggleippQAAVAPTDLVRLMYTSGTTDRPKGVM 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 622 FEHRNMAnLLKFEYTHS-GIDFEaDVLQFATPSFDV--CYQEIFSALLKGGTLHIV----PEAIkrdvpqlFAFINKHQT 694
Cdd:PRK06145 169 HSYGNLH-WKSIDHVIAlGLTAS-ERLLVVGPLYHVgaFDLPGIAVLWVGGTLRIHrefdPEAV-------LAAIERHRL 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 695 NIVFLPTAFIKMIFSERELANSFPDGVKHLIAAGE---QLMISDLFQDVLRKRGIhlhNHYGPSETHVVSTYtIHPGDPI 771
Cdd:PRK06145 240 TCAWMAPVMLSRVLTVPDRDRFDLDSLAWCIGGGEktpESRIRDFTRVFTRARYI---DAYGLTETCSGDTL-MEAGREI 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 772 PELPPIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimyRTGDLARRLEDGN 851
Cdd:PRK06145 316 EKIGSTGRALAHVEIRIADGAGRWLPPNMKGEICMRGPKVTKGYWKDPEKTAEAFYGDWF-------RSGDVGYLDEEGF 388
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 852 IEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYC--SVQKLNTIDLRSYMASELPEYMI 929
Cdd:PRK06145 389 LYLTDRKKDMIISGGENIASSEVERVIYELPEVAEAAVIGVHDDRWGERITAVVVlnPGATLTLEALDRHCRQRLASFKV 468
|
490
....*....|....*...
gi 1678550997 930 PAKWIWVDSIPLTPNGKV 947
Cdd:PRK06145 469 PRQLKVRDELPRNPSGKV 486
|
|
| MACS_AAE_MA_like |
cd05970 |
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation ... |
1500-1925 |
2.38e-25 |
|
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This family of MACS enzymes is found in archaea and bacteria. It is represented by the acyl-adenylating enzyme from Methanosarcina acetivorans (AAE_MA). AAE_MA is most active with propionate, butyrate, and the branched analogs: 2-methyl-propionate, butyrate, and pentanoate. The specific activity is weaker for smaller or larger acids.
Pssm-ID: 341274 [Multi-domain] Cd Length: 537 Bit Score: 113.74 E-value: 2.38e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIF-----EDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLP- 1573
Cdd:cd05970 23 VDAMAKEYPDKLALVWcddagEERIFTFAELADYSDKTANFFKAMGIGKGDTVMLTLKRRYEFWYSLLALHKLGAIAIPa 102
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1574 -----------------------IDPDYPEERISFLLEDSGTNILLLQSAGlhvPEFTGEIVYlNQTNSGLAHRLSNPNV 1630
Cdd:cd05970 103 thqltakdivyriesadikmivaIAEDNIPEEIEKAAPECPSKPKLVWVGD---PVPEGWIDF-RKLIKNASPDFERPTA 178
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1631 DVLP--QSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFW--WpYAGASVYL 1706
Cdd:cd05970 179 NSYPcgEDILLVYFSSGTTGMPKMVEHDFTYPLGHIVTAKYWQNVREGGLHLTVADTGWGKAVWGKIYgqW-IAGAAVFV 257
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1707 LPQGgEKEPEVIAKAIEEQKITAMhFVPSMLHAFLEHIKYRSVPIKTnrLKRVFSGGEQLGTHLVSRFYELlPNVSITNS 1786
Cdd:cd05970 258 YDYD-KFDPKALLEKLSKYGVTTF-CAPPTIYRFLIREDLSRYDLSS--LRYCTTAGEALNPEVFNTFKEK-TGIKLMEG 332
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1787 YGPTEATVEAAFFDCpphekLERIP--IGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGA-----GVARGYLNRPALTEE 1859
Cdd:cd05970 333 FGQTETTLTIATFPW-----MEPKPgsMGKPAPGYEIDLIDREGRSCEAGEEGEIVIRTSkgkpvGLFGGYYKDAEKTAE 407
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 1860 RFLEDpfypgerMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVT 1925
Cdd:cd05970 408 VWHDG-------YYHTGDAAWMDEDGYLWFVGRTDDLIKSSGYRIGPFEVESALIQHPAVLECAVT 466
|
|
| ACS-like |
cd17634 |
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the ... |
464-947 |
2.41e-25 |
|
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases. The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341289 [Multi-domain] Cd Length: 587 Bit Score: 114.21 E-value: 2.41e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 464 TIHAMFEKQAEKTPDAHAVI------DQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAG 537
Cdd:cd17634 54 LAANALDRHLRENGDRTAIIyegddtSQSRTISYRELHREVCRFAGTLLDLGVKKGDRVAIYMPMIPEAAVAMLACARIG 133
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 538 GAIVPVDPHYPADRIRYILHDCGCSHVVS-------------QAHLPSSLEDNyiITHPEDI------ESKVDGSNIKSV 598
Cdd:cd17634 134 AVHSVIFGGFAPEAVAGRIIDSSSRLLITadggvragrsvplKKNVDDALNPN--VTSVEHVivlkrtGSDIDWQEGRDL 211
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 599 N-----------------NADDLLYMIYTSGTTGKPKGVQfeHRNMANLLKFEYTHSGI-DFEA-DVLQFATpsfDVCYQ 659
Cdd:cd17634 212 WwrdliakaspehqpeamNAEDPLFILYTSGTTGKPKGVL--HTTGGYLVYAATTMKYVfDYGPgDIYWCTA---DVGWV 286
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 660 EIFSALLKGGTLHIVPEAIKRDVP------QLFAFINKHQTNIVFL-PTAFikmifseRELANSFPDGV--------KHL 724
Cdd:cd17634 287 TGHSYLLYGPLACGATTLLYEGVPnwptpaRMWQVVDKHGVNILYTaPTAI-------RALMAAGDDAIegtdrsslRIL 359
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 725 IAAGEQLMIS--DLFQDVLRKRGIHLHNHYGPSEThvvsTYTIHPGDPIPELPPIG---KPIGCTDLYILNHQKQLQPCG 799
Cdd:cd17634 360 GSVGEPINPEayEWYWKKIGKEKCPVVDTWWQTET----GGFMITPLPGAIELKAGsatRPVFGVQPAVVDNEGHPQPGG 435
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 800 VPGELYISGA--SVARGYV-NHDKLTSDKFSSdpFKPdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEV 876
Cdd:cd17634 436 TEGNLVITDPwpGQTRTLFgDHERFEQTYFST--FKG---MYFSGDGARRDEDGYYWITGRSDDVINVAGHRLGTAEIES 510
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 877 TLMNHPDISEAAIL-IWQDQNGEhelcAYYCSVQ-KLNTID-------LRSYMASELPEYMIPAKWIWVDSIPLTPNGKV 947
Cdd:cd17634 511 VLVAHPKVAEAAVVgIPHAIKGQ----APYAYVVlNHGVEPspelyaeLRNWVRKEIGPLATPDVVHWVDSLPKTRSGKI 586
|
|
| PRK05677 |
PRK05677 |
long-chain-fatty-acid--CoA ligase; Validated |
462-952 |
2.95e-25 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 168170 [Multi-domain] Cd Length: 562 Bit Score: 113.70 E-value: 2.95e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 462 YETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQ-EPVAIMMERSAAFITGVLGILKAGGAI 540
Cdd:PRK05677 23 YPNIQAVLKQSCQRFADKPAFSNLGKTLTYGELYKLSGAFAAWLQQHTDLKPgDRIAVQLPNVLQYPVAVFGAMRAGLIV 102
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 541 VPVDPHYPADRIRYILHDCGCSHVVSQAHLPSSLED---------------------------NYIITH----------P 583
Cdd:PRK05677 103 VNTNPLYTAREMEHQFNDSGAKALVCLANMAHLAEKvlpktgvkhvivtevadmlpplkrlliNAVVKHvkkmvpayhlP 182
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 584 E-----DIESKVDGSNIKSVN-NADDLLYMIYTSGTTGKPKGVQFEHRNM-ANLLKFEYTHSGIDFEA-DVLQFATPSFD 655
Cdd:PRK05677 183 QavkfnDALAKGAGQPVTEANpQADDVAVLQYTGGTTGVAKGAMLTHRNLvANMLQCRALMGSNLNEGcEILIAPLPLYH 262
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 656 VcYQEIF---SALLKGGTLHIVPEAikRDVPQLFAFINKHQ-TNIVFLPTAFIKMIFSE--RELANSfpdGVKHLIAAGE 729
Cdd:PRK05677 263 I-YAFTFhcmAMMLIGNHNILISNP--RDLPAMVKELGKWKfSGFVGLNTLFVALCNNEafRKLDFS---ALKLTLSGGM 336
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 730 --QLMISDLFQDVlrkRGIHLHNHYGPSETHVVSTytIHPGDPIpELPPIGKPIGCTDLYILNHQKQLQPCGVPGELYIS 807
Cdd:PRK05677 337 alQLATAERWKEV---TGCAICEGYGMTETSPVVS--VNPSQAI-QVGTIGIPVPSTLCKVIDDDGNELPLGEVGELCVK 410
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 808 GASVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISE- 886
Cdd:PRK05677 411 GPQVMKGYWQRPEATDEILDSDGW------LKTGDIALIQEDGYMRIVDRKKDMILVSGFNVYPNELEDVLAALPGVLQc 484
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 887 AAILIWQDQNGEH-ELCAYYCSVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PRK05677 485 AAIGVPDEKSGEAiKVFVVVKPGETLTKEQVMEHMRANLTGYKVPKAVEFRDELPTTNVGKILRREL 551
|
|
| FADD10 |
cd17635 |
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain ... |
1640-1980 |
4.12e-25 |
|
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain fatty acid CoA ligases, including FadD10 which is involved in the synthesis of a virulence-related lipopeptide. FadD10 is a fatty acyl-AMP ligase (FAAL) that transfers fatty acids to an acyl carrier protein. Structures of FadD10 in apo- and complexed form with dodecanoyl-AMP, show a novel open conformation, facilitated by its unique inter-domain and intermolecular interactions, which is critical for the enzyme to carry out the acyl transfer onto the acyl carrier protein (Rv0100) rather than coenzyme A.
Pssm-ID: 341290 [Multi-domain] Cd Length: 340 Bit Score: 109.66 E-value: 4.12e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1640 VIYTSGSTGMPKGVEIEHRSAVNFLNSLQSrYQLKHSD-----MIMHkTSYSFdASIWELFWWPYAGASVYllpqGGE-K 1713
Cdd:cd17635 6 VIFTSGTTGEPKAVLLANKTFFAVPDILQK-EGLNWVVgdvtyLPLP-ATHIG-GLWWILTCLIHGGLCVT----GGEnT 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1714 EPEVIAKAIEEQKITAMHFVPSMLHAFLehIKYRSVPIKTNRLKRVFSGGEQLgTHLVSRFYELLPNVSITNSYGPTEAT 1793
Cdd:cd17635 79 TYKSLFKILTTNAVTTTCLVPTLLSKLV--SELKSANATVPSLRLIGYGGSRA-IAADVRFIEATGLTNTAQVYGLSETG 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1794 veAAFFdCPPHEKLERI-PIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYpgerm 1872
Cdd:cd17635 156 --TALC-LPTDDDSIEInAVGRPYPGVDVYLAATDGIAGPSASFGTIWIKSPANMLGYWNNPERTAEVLIDGWVN----- 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1873 ykTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDSGEPELC-AYV---EGLQRNEVR 1948
Cdd:cd17635 228 --TGDLGERREDGFLFITGRSSESINCGGVKIAPDEVERIAEGVSGVQECACYEISDEEFGELVgLAVvasAELDENAIR 305
|
330 340 350
....*....|....*....|....*....|....*
gi 1678550997 1949 AQLERL---LPGYMVPAYMIEMEQWPVTPSGKLDR 1980
Cdd:cd17635 306 ALKHTIrreLEPYARPSTIVIVTDIPRTQSGKVKR 340
|
|
| Ac_CoA_lig_AcsA |
TIGR02188 |
acetate--CoA ligase; This model describes acetate-CoA ligase (EC 6.2.1.1), also called ... |
470-949 |
4.71e-25 |
|
acetate--CoA ligase; This model describes acetate-CoA ligase (EC 6.2.1.1), also called acetyl-CoA synthetase and acetyl-activating enzyme. It catalyzes the reaction ATP + acetate + CoA = AMP + diphosphate + acetyl-CoA and belongs to the family of AMP-binding enzymes described by pfam00501.
Pssm-ID: 274022 [Multi-domain] Cd Length: 626 Bit Score: 113.88 E-value: 4.71e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 470 EKQAEKTPDAHAVI------DQACSLTYRELNKAANRLARHLRMKGVVRQEPVAI---MMERSAAFITGVLGIlkagGAI 540
Cdd:TIGR02188 64 DRHLEARPDKVAIIwegdepGEVRKITYRELHREVCRFANVLKSLGVKKGDRVAIympMIPEAAIAMLACARI----GAI 139
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 541 VPV-----DPHYPADRIryilHDCGCSHVVSQ--------------------AHLPSSLEDNYIITHP-EDIESKVDGSN 594
Cdd:TIGR02188 140 HSVvfggfSAEALADRI----NDAGAKLVITAdeglrggkviplkaivdealEKCPVSVEHVLVVRRTgNPVVPWVEGRD 215
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 595 ------IKSVN--------NADDLLYMIYTSGTTGKPKGVQfeHRNMANLLKFEYTHSGIdFE----------ADVLQFA 650
Cdd:TIGR02188 216 vwwhdlMAKASaycepepmDSEDPLFILYTSGSTGKPKGVL--HTTGGYLLYAAMTMKYV-FDikdgdifwctADVGWIT 292
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 651 TPSFdVCYqeifSALLKGGTLHI---VPeaikrDVPQ---LFAFINKHQTNIVFL-PTAfIKMIfseRELANSFPDgvKH 723
Cdd:TIGR02188 293 GHSY-IVY----GPLANGATTVMfegVP-----TYPDpgrFWEIIEKHKVTIFYTaPTA-IRAL---MRLGDEWVK--KH 356
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 724 liaageqlmisDLfqDVLRKRG-----IH------LHNHYGPSETHVVSTY--TIHPG---DPIPELPPIgKPIGCT--- 784
Cdd:TIGR02188 357 -----------DL--SSLRLLGsvgepINpeawmwYYKVVGKERCPIVDTWwqTETGGimiTPLPGATPT-KPGSATlpf 422
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 785 ---DLYIL-NHQKQLQPCGVPGELYISGA--SVARG-YVNHDKLTSDKFSsdPFKPdviMYRTGDLARRLEDGNIEYIGR 857
Cdd:TIGR02188 423 fgiEPAVVdEEGNPVEGPGEGGYLVIKQPwpGMLRTiYGDHERFVDTYFS--PFPG---YYFTGDGARRDKDGYIWITGR 497
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 858 ADNQVKIRGYRIEPQEIEVTLMNHPDISEAAIL-IWQDQNGEhELCAYYCSVQKLNTID-----LRSYMASELPEYMIPA 931
Cdd:TIGR02188 498 VDDVINVSGHRLGTAEIESALVSHPAVAEAAVVgIPDDIKGQ-AIYAFVTLKDGYEPDDelrkeLRKHVRKEIGPIAKPD 576
|
570
....*....|....*...
gi 1678550997 932 KWIWVDSIPLTPNGKVDR 949
Cdd:TIGR02188 577 KIRFVPGLPKTRSGKIMR 594
|
|
| PRK06155 |
PRK06155 |
crotonobetaine/carnitine-CoA ligase; Provisional |
1494-1999 |
7.83e-25 |
|
crotonobetaine/carnitine-CoA ligase; Provisional
Pssm-ID: 235719 [Multi-domain] Cd Length: 542 Bit Score: 112.16 E-value: 7.83e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1494 QTLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLP 1573
Cdd:PRK06155 21 RTLPAMLARQAERYPDRPLLVFGGTRWTYAEAARAAAAAAHALAAAGVKRGDRVALMCGNRIEFLDVFLGCAWLGAIAVP 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1574 IDPDYPEERISFLLEDSGTNILLLQSAGLHV-------PEFTGEIVYLNQTNSGLAHR-----------LSNPNVDVLPQ 1635
Cdd:PRK06155 101 INTALRGPQLEHILRNSGARLLVVEAALLAAleaadpgDLPLPAVWLLDAPASVSVPAgwstaplppldAPAPAAAVQPG 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1636 SLAYVIYTSGSTGMPKGVEIEH-------RSAVNFL-----------------NSLQSRYQLKHSDMIMHKTSySFDASi 1691
Cdd:PRK06155 181 DTAAILYTSGTTGPSKGVCCPHaqfywwgRNSAEDLeigaddvlyttlplfhtNALNAFFQALLAGATYVLEP-RFSAS- 258
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1692 weLFWwpyagasvyllpqggekepeviaKAIEEQKITAMHFVPSMLHAFLEhiKYRSVPIKTNRLKRVFSGG--EQLGTH 1769
Cdd:PRK06155 259 --GFW-----------------------PAVRRHGATVTYLLGAMVSILLS--QPARESDRAHRVRVALGPGvpAALHAA 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1770 LVSRFyellpNVSITNSYGPTEATveAAFFDCPPHEK---LERIpigKPVHHVRLylLNQNQRMLPVGCIGELYIAGA-- 1844
Cdd:PRK06155 312 FRERF-----GVDLLDGYGSTETN--FVIAVTHGSQRpgsMGRL---APGFEARV--VDEHDQELPDGEPGELLLRADep 379
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1845 -GVARGYLNRPALTEERFLEDPFYPGERmyktgdVARwLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAA 1923
Cdd:PRK06155 380 fAFATGYFGMPEKTVEAWRNLWFHTGDR------VVR-DADGWFRFVDRIKDAIRRRGENISSFEVEQVLLSHPAVAAAA 452
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1924 V-TVRTDSGEPELCAYV---EGLQRN--EVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNALPAPGGAAD-----A 1992
Cdd:PRK06155 453 VfPVPSELGEDEVMAAVvlrDGTALEpvALVRHCEPRLAYFAVPRYVEFVAALPKTENGKVQKFVLREQGVTADtwdreA 532
|
....*..
gi 1678550997 1993 ETYTAPR 1999
Cdd:PRK06155 533 AGVQLPR 539
|
|
| PRK04319 |
PRK04319 |
acetyl-CoA synthetase; Provisional |
488-889 |
9.49e-25 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 235279 [Multi-domain] Cd Length: 570 Bit Score: 112.30 E-value: 9.49e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 488 SLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVS- 566
Cdd:PRK04319 73 KYTYKELKELSNKFANVLKELGVEKGDRVFIFMPRIPELYFALLGALKNGAIVGPLFEAFMEEAVRDRLEDSEAKVLITt 152
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 567 --------QAHLPS-----------SLEDNYIiTHPEDIESKVDGSNIKSVNnADDLLYMIYTSGTTGKPKGVQFEHRNM 627
Cdd:PRK04319 153 pallerkpADDLPSlkhvllvgedvEEGPGTL-DFNALMEQASDEFDIEWTD-REDGAILHYTSGSTGKPKGVLHVHNAM 230
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 628 anllkfeYTH--SG---IDFEADvlqfatpsfDV--CYQE----------IFSALLKGGTLhIVPEAiKRDVPQLFAFIN 690
Cdd:PRK04319 231 -------LQHyqTGkyvLDLHED---------DVywCTADpgwvtgtsygIFAPWLNGATN-VIDGG-RFSPERWYRILE 292
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 691 KHQTNIVF-LPTAFIKMIFSERELANSFP-DGVKHLIAAGEQLMISDLF--QDVLRKRgihLHNHYGPSET--HVVSTYT 764
Cdd:PRK04319 293 DYKVTVWYtAPTAIRMLMGAGDDLVKKYDlSSLRHILSVGEPLNPEVVRwgMKVFGLP---IHDNWWMTETggIMIANYP 369
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 765 ---IHPGDpipelppIGKPIGCTDLYILNHQKQLQPCGVPGELYISGA--SVARGYVNHDKLTSDKFSSDpfkpdviMYR 839
Cdd:PRK04319 370 amdIKPGS-------MGKPLPGIEAAIVDDQGNELPPNRMGNLAIKKGwpSMMRGIWNNPEKYESYFAGD-------WYV 435
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|
gi 1678550997 840 TGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAI 889
Cdd:PRK04319 436 SGDSAYMDEDGYFWFQGRVDDVIKTSGERVGPFEVESKLMEHPAVAEAGV 485
|
|
| PRK13383 |
PRK13383 |
acyl-CoA synthetase; Provisional |
473-953 |
1.31e-24 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139531 [Multi-domain] Cd Length: 516 Bit Score: 111.24 E-value: 1.31e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 473 AEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRI 552
Cdd:PRK13383 45 AARWPGRTAIIDDDGALSYRELQRATESLARRLTRDGVAPGRAVGVMCRNGRGFVTAVFAVGLLGADVVPISTEFRSDAL 124
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 553 RYILHDCGCSHVVSQ---AHLPSSLEDNYIITHPEDIESKVDGSNIKSVNNADDLLYmiyTSGTTGKPKGVQFEHRnman 629
Cdd:PRK13383 125 AAALRAHHISTVVADnefAERIAGADDAVAVIDPATAGAEESGGRPAVAAPGRIVLL---TSGTTGKPKGVPRAPQ---- 197
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 630 llkfeyTHSGIDFEADVLQ-----------FATPSFD-VCYQEIFSALLKGGTL----HIVPEAIkrdvpqlFAFINKHQ 693
Cdd:PRK13383 198 ------LRSAVGVWVTILDrtrlrtgsrisVAMPMFHgLGLGMLMLTIALGGTVlthrHFDAEAA-------LAQASLHR 264
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 694 TN-IVFLPTAFIKMI-FSERELA-NSFPDgVKHLIAAGEQLMISdLFQDVLRKRGIHLHNHYGPSETHVVSTYTihPGDP 770
Cdd:PRK13383 265 ADaFTAVPVVLARILeLPPRVRArNPLPQ-LRVVMSSGDRLDPT-LGQRFMDTYGDILYNGYGSTEVGIGALAT--PADL 340
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 771 IPELPPIGKPIGCTDLYILNHQKQlqPCG--VPGELYISGasvargyvnhdKLTSDKFSSDPFKPDVI-MYRTGDLARRL 847
Cdd:PRK13383 341 RDAPETVGKPVAGCPVRILDRNNR--PVGprVTGRIFVGG-----------ELAGTRYTDGGGKAVVDgMTSTGDMGYLD 407
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 848 EDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYY-----CSVqklNTIDLRSYMAS 922
Cdd:PRK13383 408 NAGRLFIVGREDDMIISGGENVYPRAVENALAAHPAVADNAVIGVPDERFGHRLAAFVvlhpgSGV---DAAQLRDYLKD 484
|
490 500 510
....*....|....*....|....*....|.
gi 1678550997 923 ELPEYMIPAKWIWVDSIPLTPNGKVDRAALP 953
Cdd:PRK13383 485 RVSRFEQPRDINIVSSIPRNPTGKVLRKELP 515
|
|
| FAAL |
cd05931 |
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and ... |
473-883 |
1.34e-24 |
|
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and is homologous to fatty acyl-coenzyme A (CoA) ligases (FACLs). However, FAALs produce only the acyl adenylate and are unable to perform the thioester-forming reaction, while FACLs perform a two-step catalytic reaction; AMP ligation followed by CoA ligation using ATP and CoA as cofactors. FAALs have insertion motifs between the N-terminal and C-terminal subdomains that distinguish them from the FACLs. This insertion motif precludes the binding of CoA, thus preventing CoA ligation. It has been suggested that the acyl adenylates serve as substrates for multifunctional polyketide synthases to permit synthesis of complex lipids such as phthiocerol dimycocerosate, sulfolipids, mycolic acids, and mycobactin.
Pssm-ID: 341254 [Multi-domain] Cd Length: 547 Bit Score: 111.56 E-value: 1.34e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 473 AEKTPDAHAV--IDQAC----SLTYRELNKAANRLARHLRMKGVVRqEPVAIMMERSAAFITGVLGILKAGGAIVPV-DP 545
Cdd:cd05931 3 AAARPDRPAYtfLDDEGgreeTLTYAELDRRARAIAARLQAVGKPG-DRVLLLAPPGLDFVAAFLGCLYAGAIAVPLpPP 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 546 HYP--ADRIRYILHDCGCSHVVSQA----------HLPSSLEDNYIITHPEDIESKVDGSNIKSVNnADDLLYMIYTSGT 613
Cdd:cd05931 82 TPGrhAERLAAILADAGPRVVLTTAaalaavrafaASRPAAGTPRLLVVDLLPDTSAADWPPPSPD-PDDIAYLQYTSGS 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 614 TGKPKGVQFEHRN-MANLLkfEYTHSGIDFEADVLQFATPsfdvCYQE------IFSALLKGGTLHIV-PEA-IKRdvP- 683
Cdd:cd05931 161 TGTPKGVVVTHRNlLANVR--QIRRAYGLDPGDVVVSWLP----LYHDmgliggLLTPLYSGGPSVLMsPAAfLRR--Pl 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 684 ---QLfafINKHQTNIVFLPT-AF---IKMIfSERELANSfpD--GVKHLIAAGEQLMISDL--FQDVLRKRGIH---LH 749
Cdd:cd05931 233 rwlRL---ISRYRATISAAPNfAYdlcVRRV-RDEDLEGL--DlsSWRVALNGAEPVRPATLrrFAEAFAPFGFRpeaFR 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 750 NHYGPSETHV-VST------YTIH----------------PGDPIPELPPIGKPIGCTDLYILN-HQKQLQPCGVPGELY 805
Cdd:cd05931 307 PSYGLAEATLfVSGgppgtgPVVLrvdrdalagravavaaDDPAARELVSCGRPLPDQEVRIVDpETGRELPDGEVGEIW 386
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 806 ISGASVARGYVNHDKLTSDKFSSDPFKPDVIMYRTGDLArRLEDGNIeYI-GRADNQVKIRGYRIEPQEIEVTLMNHPD 883
Cdd:cd05931 387 VRGPSVASGYWGRPEATAETFGALAATDEGGWLRTGDLG-FLHDGEL-YItGRLKDLIIVRGRNHYPQDIEATAEEAHP 463
|
|
| AFD_YhfT-like |
cd17633 |
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, ... |
2674-3016 |
1.54e-24 |
|
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, as well as long-chain fatty acid-CoA ligase VraA, all of which are as yet to be characterized. These proteins belong to the adenylate-forming enzymes which catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain
Pssm-ID: 341288 [Multi-domain] Cd Length: 320 Bit Score: 107.49 E-value: 1.54e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2674 HLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDI 2753
Cdd:cd17633 1 NPFYIGFTSGTTGLPKAYYRSERSWIESFVCNEDLFNISGEDAILAPGPLSHSLFLYGAISALYLGGTFIGQRKFNPKSW 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2754 LAIkhqLSRQRITHMIIVPVLYRALLDVVQPEDvkTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTENSVATTVM 2833
Cdd:cd17633 81 IRK---INQYNATVIYLVPTMLQALARTLEPES--KIKSIFSSGQKLFESTKKKLKNIFPKANLIEFYGTSELSFITYNF 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2834 RHMEKQAYvSIGQPIDGTQVLILNSNHqlqpiGVAGELCIAGTGLARGYVNLPELteraftqNPFKPearmYRTGDAARW 2913
Cdd:cd17633 156 NQESRPPN-SVGRPFPNVEIEIRNADG-----GEIGKIFVKSEMVFSGYVRGGFS-------NPDGW----MSVGDIGYV 218
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2914 MADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAhVTASGQTELSAYVVTKPGLSTNAVRSELQNKLPV 2993
Cdd:cd17633 219 DEEGYLYLVGRESDMIIIGGINIFPTEIESVLKAIPGIEEAIVVG-IPDARFGEIAVALYSGDKLTYKQLKRFLKQKLSR 297
|
330 340
....*....|....*....|...
gi 1678550997 2994 FMHPAFIEKLDSLPLSPNGKLDR 3016
Cdd:cd17633 298 YEIPKKIIFVDSLPYTSSGKIAR 320
|
|
| PRK05852 |
PRK05852 |
fatty acid--CoA ligase family protein; |
468-954 |
1.67e-24 |
|
fatty acid--CoA ligase family protein;
Pssm-ID: 235625 [Multi-domain] Cd Length: 534 Bit Score: 111.13 E-value: 1.67e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 468 MFEKQAEKTPDAHAVI--DQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDP 545
Cdd:PRK05852 21 LVEVAATRLPEAPALVvtADRIAISYRDLARLVDDLAGQLTRSGLLPGDRVALRMGSNAEFVVALLAASRADLVVVPLDP 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 546 HYPA----DR-----IRYILHDC------------------------GCSHVVSQAHLPSSLEDNYIITHPEDIeskvdg 592
Cdd:PRK05852 101 ALPIaeqrVRsqaagARVVLIDAdgphdraepttrwwpltvnvggdsGPSGGTLSVHLDAATEPTPATSTPEGL------ 174
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 593 sniksvnNADDLLYMiYTSGTTGKPKGVQFEHRNMANLLKFEYTHSGI-DFEADVLQFATPSFDVCYQEIFSALLKGGTL 671
Cdd:PRK05852 175 -------RPDDAMIM-FTGGTTGLPKMVPWTHANIASSVRAIITGYRLsPRDATVAVMPLYHGHGLIAALLATLASGGAV 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 672 hIVPEAIKRDVPQLFAFINK-HQTNIVFLPTafIKMIFSERELANSFPDGVKHL--IAAGEQLMISDLFQDVLRKRGIHL 748
Cdd:PRK05852 247 -LLPARGRFSAHTFWDDIKAvGATWYTAVPT--IHQILLERAATEPSGRKPAALrfIRSCSAPLTAETAQALQTEFAAPV 323
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 749 HNHYGPSE-THVVSTYTI----HPGDPIPELPPIGKPIGcTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTS 823
Cdd:PRK05852 324 VCAFGMTEaTHQVTTTQIegigQTENPVVSTGLVGRSTG-AQIRIVGSDGLPLPAGAVGEVWLRGTTVVRGYLGDPTITA 402
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 824 DKFSSDPFkpdvimyRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCA 903
Cdd:PRK05852 403 ANFTDGWL-------RTGDLGSLSAAGDLSIRGRIKELINRGGEKISPERVEGVLASHPNVMEAAVFGVPDQLYGEAVAA 475
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 904 YYC--SVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPE 954
Cdd:PRK05852 476 VIVprESAPPTAEELVQFCRERLAAFEIPASFQEASGLPHTAKGSLDRRAVAE 528
|
|
| entE |
PRK10946 |
(2,3-dihydroxybenzoyl)adenylate synthase; |
468-952 |
2.13e-24 |
|
(2,3-dihydroxybenzoyl)adenylate synthase;
Pssm-ID: 236803 [Multi-domain] Cd Length: 536 Bit Score: 110.85 E-value: 2.13e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 468 MFEKQAEktPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGgaIVPVDPHY 547
Cdd:PRK10946 30 ILTRHAA--SDAIAVICGERQFSYRELNQASDNLACSLRRQGIKPGDTALVQLGNVAEFYITFFALLKLG--VAPVNALF 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 548 ---------------PA--------------DRIRYILHDCGCSHVVSQAHLPSSLEDNYIITHPEdieskvdGSNIKSV 598
Cdd:PRK10946 106 shqrselnayasqiePAlliadrqhalfsddDFLNTLVAEHSSLRVVLLLNDDGEHSLDDAINHPA-------EDFTATP 178
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 599 NNADDLLYMIYTSGTTGKPKGVQFEHRnmanllkfEYTHSgIDFEADVLQF--------ATPS---FDVCYQEIFSALLK 667
Cdd:PRK10946 179 SPADEVAFFQLSGGSTGTPKLIPRTHN--------DYYYS-VRRSVEICGFtpqtrylcALPAahnYPMSSPGALGVFLA 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 668 GGTLHIV--PEAIkrdvpQLFAFINKHQTNIVFL-PTAFIKMIfserelansfpdgvKHLIAAGEQLMISDL-------- 736
Cdd:PRK10946 250 GGTVVLApdPSAT-----LCFPLIEKHQVNVTALvPPAVSLWL--------------QAIAEGGSRAQLASLkllqvgga 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 737 -FQDVLRKR-----GIHLHNHYGPSETHVvsTYTIHPGDPIPELPPIGKPIGCTD-LYILNHQKQLQPCGVPGELYISGA 809
Cdd:PRK10946 311 rLSETLARRipaelGCQLQQVFGMAEGLV--NYTRLDDSDERIFTTQGRPMSPDDeVWVADADGNPLPQGEVGRLMTRGP 388
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 810 SVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAI 889
Cdd:PRK10946 389 YTFRGYYKSPQHNASAFDANGF------YCSGDLVSIDPDGYITVVGREKDQINRGGEKIAAEEIENLLLRHPAVIHAAL 462
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 890 LIWQD-QNGEHElCAYYCSVQKLNTIDLRSYMASE-LPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PRK10946 463 VSMEDeLMGEKS-CAFLVVKEPLKAVQLRRFLREQgIAEFKLPDRVECVDSLPLTAVGKVDKKQL 526
|
|
| PRK07514 |
PRK07514 |
malonyl-CoA synthase; Validated |
1492-1983 |
2.79e-24 |
|
malonyl-CoA synthase; Validated
Pssm-ID: 181011 [Multi-domain] Cd Length: 504 Bit Score: 109.97 E-value: 2.79e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1492 MNQTLhYALEQQAEKTPDQAAVIFEDG-VMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLgIY-GILKAGG 1569
Cdd:PRK07514 1 MNNNL-FDALRAAFADRDAPFIETPDGlRYTYGDLDAASARLANLLVALGVKPGDRVAVQVEKSPEALA-LYlATLRAGA 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1570 AYLPIDPDYPEERISFLLEDSGTNILLLQSA------GLHVPEFTGEIVYLNQTNSG------LAHRLSNPNVDVLPQSL 1637
Cdd:PRK07514 79 VFLPLNTAYTLAELDYFIGDAEPALVVCDPAnfawlsKIAAAAGAPHVETLDADGTGslleaaAAAPDDFETVPRGADDL 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1638 AYVIYTSGSTGMPKGVEIEHRsavNFL-NS--LQSRYQLKHSDMIMH-----KTSYSFDASIWELFwwpyAGASVYLLPQ 1709
Cdd:PRK07514 159 AAILYTSGTTGRSKGAMLSHG---NLLsNAltLVDYWRFTPDDVLIHalpifHTHGLFVATNVALL----AGASMIFLPK 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1710 ggeKEPEVIAKAIEEQkiTAMHFVPSMLHAFLEHIKYRSVPIKTNRLkrvF-SGGEQL--GTHlvSRFYELLPNvSITNS 1786
Cdd:PRK07514 232 ---FDPDAVLALMPRA--TVMMGVPTFYTRLLQEPRLTREAAAHMRL---FiSGSAPLlaETH--REFQERTGH-AILER 300
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1787 YGPTEATVEAAffdcPPHEKlERIP--IGKPVHHVRLYLLN-QNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLE 1863
Cdd:PRK07514 301 YGMTETNMNTS----NPYDG-ERRAgtVGFPLPGVSLRVTDpETGAELPPGEIGMIEVKGPNVFKGYWRMPEKTAEEFRA 375
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1864 DPFYpgermyKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAV--TVRTDSGE-------PE 1934
Cdd:PRK07514 376 DGFF------ITGDLGKIDERGYVHIVGRGKDLIISGGYNVYPKEVEGEIDELPGVVESAVigVPHPDFGEgvtavvvPK 449
|
490 500 510 520
....*....|....*....|....*....|....*....|....*....
gi 1678550997 1935 LCAYVEGlqrNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK07514 450 PGAALDE---AAILAALKGRLARFKQPKRVFFVDELPRNTMGKVQKNLL 495
|
|
| PRK09274 |
PRK09274 |
peptide synthase; Provisional |
2535-2987 |
3.03e-24 |
|
peptide synthase; Provisional
Pssm-ID: 236443 [Multi-domain] Cd Length: 552 Bit Score: 110.76 E-value: 3.03e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2535 ISQLFEQQAARTPKASALVSGD----------KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVW 2604
Cdd:PRK09274 8 IARHLPRAAQERPDQLAVAVPGgrgadgklayDELSFAELDARSDAIAHGLNAAGIGRGMRAVLMVTPSLEFFALTFALF 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2605 KAGGCYVPIDPEYPKERKRYILSDSGTKLLMTINEADLG--------------VLAD----FEGEIL-TIESVEEDDKSP 2665
Cdd:PRK09274 88 KAGAVPVLVDPGMGIKNLKQCLAEAQPDAFIGIPKAHLArrlfgwgkpsvrrlVTVGgrllWGGTTLaTLLRDGAAAPFP 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2666 LPQMSsAHHLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAF--NETD-TILQLFSFsfdgfitsmFTPLLsGAKA 2742
Cdd:PRK09274 168 MADLA-PDDMAAILFTSGSTGTPKGVVYTHGMFEAQIEALREDYGIepGEIDlPTFPLFAL---------FGPAL-GMTS 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2743 VLLHEEEAKDILA----IKHQLSRQRITHMIIVPVLYRALLDVVQPEDVK--TLRVVTLAGEAADRELIARSLAICPH-T 2815
Cdd:PRK09274 237 VIPDMDPTRPATVdpakLFAAIERYGVTNLFGSPALLERLGRYGEANGIKlpSLRRVISAGAPVPIAVIERFRAMLPPdA 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2816 ELANEYGPTEN-SVATTVMR--------HMEKQAYVSIGQPIDGTQVLILN---------SNHQLQPIGVAGELCIAGTG 2877
Cdd:PRK09274 317 EILTPYGATEAlPISSIESReilfatraATDNGAGICVGRPVDGVEVRIIAisdapipewDDALRLATGEIGEIVVAGPM 396
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2878 LARGYVNLPELTERAftqnpfK-PEARM---YRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKD 2953
Cdd:PRK09274 397 VTRSYYNRPEATRLA------KiPDGQGdvwHRMGDLGYLDAQGRLWFCGRKAHRVETAGGTLYTIPCERIFNTHPGVKR 470
|
490 500 510
....*....|....*....|....*....|....*....
gi 1678550997 2954 AAVVAHVTASGQT-----ELSAYVVTkpglSTNAVRSEL 2987
Cdd:PRK09274 471 SALVGVGVPGAQRpvlcvELEPGVAC----SKSALYQEL 505
|
|
| FadD3 |
cd17638 |
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ... |
1640-1978 |
3.33e-24 |
|
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ligases, including FadD3 which is an acyl-CoA synthetase that initiates catabolism of cholesterol rings C and D in actinobacteria. The cholesterol catabolic pathway occurs in most mycolic acid-containing actinobacteria, such as Rhodococcus jostii RHA1, and is critical for Mycobacterium tuberculosis (Mtb) during infection. FadD3 catalyzes the ATP-dependent CoA thioesterification of 3a-alpha-H-4alpha(3'-propanoate)-7a-beta-methylhexahydro-1,5-indanedione (HIP) to yield HIP-CoA. Hydroxylated analogs of HIP, 5alpha-OH HIP and 1beta-OH HIP, can also be used.
Pssm-ID: 341293 [Multi-domain] Cd Length: 330 Bit Score: 106.82 E-value: 3.33e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1640 VIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSD--MIMHKTSYSFDasiwelfwwpYAGASVYLLPQGGEKEPEV 1717
Cdd:cd17638 5 IMFTSGTTGRSKGVMCAHRQTLRAAAAWADCADLTEDDryLIINPFFHTFG----------YKAGIVACLLTGATVVPVA 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1718 ------IAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTnrLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTE 1791
Cdd:cd17638 75 vfdvdaILEAIERERITVLPGPPTLFQSLLDHPGRKKFDLSS--LRAAVTGAATVPVELVRRMRSELGFETVLTAYGLTE 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1792 ATVEAAffdCPPHEKLERIP--IGKPVHHVRLYLLNQnqrmlpvgciGELYIAGAGVARGYLNRPALTEERFLEDPFYpg 1869
Cdd:cd17638 153 AGVATM---CRPGDDAETVAttCGRACPGFEVRIADD----------GEVLVRGYNVMQGYLDDPEATAEAIDADGWL-- 217
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1870 ermyKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDSGEPEL-CAYV-----EGLQ 1943
Cdd:cd17638 218 ----HTGDVGELDERGYLRITDRLKDMYIVGGFNVYPAEVEGALAEHPGVAQVAVIGVPDERMGEVgKAFVvarpgVTLT 293
|
330 340 350
....*....|....*....|....*....|....*
gi 1678550997 1944 RNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKL 1978
Cdd:cd17638 294 EEDVIAWCRERLANYKVPRFVRFLDELPRNASGKV 328
|
|
| PRK08162 |
PRK08162 |
acyl-CoA synthetase; Validated |
1500-1983 |
4.11e-24 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236169 [Multi-domain] Cd Length: 545 Bit Score: 110.04 E-value: 4.11e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYP 1579
Cdd:PRK08162 24 LERAAEVYPDRPAVIHGDRRRTWAETYARCRRLASALARRGIGRGDTVAVLLPNIPAMVEAHFGVPMAGAVLNTLNTRLD 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1580 EERISFLLEDSGTNIL-------------LLQSAGLHVP------------EFTGEIVYLNQTNSGlahrlsNPNVD-VL 1633
Cdd:PRK08162 104 AASIAFMLRHGEAKVLivdtefaevareaLALLPGPKPLvidvddpeypggRFIGALDYEAFLASG------DPDFAwTL 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1634 PQ------SLAYviyTSGSTGMPKGVEIEHRSAvnFLNSLQSryqLKHSDMIMHKTsYsfdasIWEL---------FWWP 1698
Cdd:PRK08162 178 PAdewdaiALNY---TSGTTGNPKGVVYHHRGA--YLNALSN---ILAWGMPKHPV-Y-----LWTLpmfhcngwcFPWT 243
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1699 Y---AGASVYLlpqggEK-EPEVIAKAIEEQKITamHF-----VPSML-HAFLEHIKYRSVPIKTNRL-----KRVFSGG 1763
Cdd:PRK08162 244 VaarAGTNVCL-----RKvDPKLIFDLIREHGVT--HYcgapiVLSALiNAPAEWRAGIDHPVHAMVAgaappAAVIAKM 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1764 EQLG---THLvsrfYELlpnvsiTNSYGPteATVeaaffdCPPHEKLERIPIGKPVHH-----VRLYLLNQ-----NQRM 1830
Cdd:PRK08162 317 EEIGfdlTHV----YGL------TETYGP--ATV------CAWQPEWDALPLDERAQLkarqgVRYPLQEGvtvldPDTM 378
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1831 LPVG----CIGELYIAGAGVARGYLNRPALTEERFLEDPFYpgermykTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEP 1906
Cdd:PRK08162 379 QPVPadgeTIGEIMFRGNIVMKGYLKNPKATEEAFAGGWFH-------TGDLAVLHPDGYIKIKDRSKDIIISGGENISS 451
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1907 GEIEAALRSIEGVREAAVTVRTDS--GE-PelCAYVE---GLQ--RNEVRAQLERLLPGYMVPAyMIEMEQWPVTPSGKL 1978
Cdd:PRK08162 452 IEVEDVLYRHPAVLVAAVVAKPDPkwGEvP--CAFVElkdGASatEEEIIAHCREHLAGFKVPK-AVVFGELPKTSTGKI 528
|
....*
gi 1678550997 1979 DRNAL 1983
Cdd:PRK08162 529 QKFVL 533
|
|
| PRK07787 |
PRK07787 |
acyl-CoA synthetase; Validated |
488-952 |
4.62e-24 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236096 [Multi-domain] Cd Length: 471 Bit Score: 108.92 E-value: 4.62e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 488 SLTYRELNKAANRLARhlRMKGVVRqepVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSQ 567
Cdd:PRK07787 25 VLSRSDLAGAATAVAE--RVAGARR---VAVLATPTLATVLAVVGALIAGVPVVPVPPDSGVAERRHILADSGAQAWLGP 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 568 AhlPSSLEDnyiITHpEDIESKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRNMAnllkfeythSGIDFEA--- 644
Cdd:PRK07787 100 A--PDDPAG---LPH-VPVRLHARSWHRYPEPDPDAPALIVYTSGTTGPPKGVVLSRRAIA---------ADLDALAeaw 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 645 -----DVLQFATPSFDV--CYQEIFSALLKGGTL-HIVpeaikRDVPQLFAFINKHQTNIVF-LPTAFIKmIFSERELAN 715
Cdd:PRK07787 165 qwtadDVLVHGLPLFHVhgLVLGVLGPLRIGNRFvHTG-----RPTPEAYAQALSEGGTLYFgVPTVWSR-IAADPEAAR 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 716 SFpdgvkhliaAGEQLMISD-------LFQDVLRKRGIHLHNHYGPSEThVVSTYTIHPGDPIPELppIGKPIGCTDLYI 788
Cdd:PRK07787 239 AL---------RGARLLVSGsaalpvpVFDRLAALTGHRPVERYGMTET-LITLSTRADGERRPGW--VGLPLAGVETRL 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 789 LNHQKQLQPCGVP--GELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGR-ADNQVKIR 865
Cdd:PRK07787 307 VDEDGGPVPHDGEtvGELQVRGPTLFDGYLNRPDATAAAFTADGW------FRTGDVAVVDPDGMHRIVGReSTDLIKSG 380
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 866 GYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCSVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNG 945
Cdd:PRK07787 381 GYRIGAGEIETALLGHPGVREAAVVGVPDDDLGQRIVAYVVGADDVAADELIDFVAQQLSVHKRPREVRFVDALPRNAMG 460
|
....*..
gi 1678550997 946 KVDRAAL 952
Cdd:PRK07787 461 KVLKKQL 467
|
|
| PRK06164 |
PRK06164 |
acyl-CoA synthetase; Validated |
456-954 |
6.55e-24 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235722 [Multi-domain] Cd Length: 540 Bit Score: 109.45 E-value: 6.55e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 456 TDQTPVYETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILK 535
Cdd:PRK06164 3 HDAAPRADTLASLLDAHARARPDAVALIDEDRPLSRAELRALVDRLAAWLAAQGVRRGDRVAVWLPNCIEWVVLFLACAR 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 536 AGGAIVPVDPHYPADRIRYILHDCGCSHVVSQAH-----LPSSLEDnyiITHPEDIESK----VDGSN------------ 594
Cdd:PRK06164 83 LGATVIAVNTRYRSHEVAHILGRGRARWLVVWPGfkgidFAAILAA---VPPDALPPLRaiavVDDAAdatpapapgarv 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 595 --------------IKSVNNADDLLYMIYTSGTTGKPKGVQfeHRNmANLLKfeytHSGIDFEA------DVLQFATPsf 654
Cdd:PRK06164 160 qlfalpdpappaaaGERAADPDAGALLFTTSGTTSGPKLVL--HRQ-ATLLR----HARAIARAygydpgAVLLAALP-- 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 655 dVC----YQEIFSALLKGGTLHIVPEAikrDVPQLFAFINKHQTNIVFLPTAFIKMIFSERELANSFPdGVKHLIAAGEQ 730
Cdd:PRK06164 231 -FCgvfgFSTLLGALAGGAPLVCEPVF---DAARTARALRRHRVTHTFGNDEMLRRILDTAGERADFP-SARLFGFASFA 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 731 LMISDLFQDVlRKRGIHLHNHYGPSEthVVSTYTIHPGDPiPELPPI---GKPI-GCTDLYILNHQK-QLQPCGVPGELY 805
Cdd:PRK06164 306 PALGELAALA-RARGVPLTGLYGSSE--VQALVALQPATD-PVSVRIeggGRPAsPEARVRARDPQDgALLPDGESGEIE 381
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 806 ISGASVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDIS 885
Cdd:PRK06164 382 IRAPSLMRGYLDNPDATARALTDDGY------FRTGDLGYTRGDGQFVYQTRMGDSLRLGGFLVNPAEIEHALEALPGVA 455
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 886 EAAIlIWQDQNGEHELCAYYC--SVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLT--PNG-KVDRAALPE 954
Cdd:PRK06164 456 AAQV-VGATRDGKTVPVAFVIptDGASPDEAGLMAACREALAGFKVPARVQVVEAFPVTesANGaKIQKHRLRE 528
|
|
| FACL_like_4 |
cd05944 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
1634-1983 |
6.58e-24 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341266 [Multi-domain] Cd Length: 359 Bit Score: 106.41 E-value: 6.58e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1634 PQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIMHKTS-YSFDASIWELFWWPYAGASVYLLPQGGE 1712
Cdd:cd05944 1 SDDVAAYFHTGGTTGTPKLAQHTHSNEVYNAWMLALNSLFDPDDVLLCGLPlFHVNGSVVTLLTPLASGAHVVLAGPAGY 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1713 KEPEVIA---KAIEEQKITAMHFVPSMLHAFLEhikyrsVPIKTN--RLKRVFSGGEQLGTHLVSRFyELLPNVSITNSY 1787
Cdd:cd05944 81 RNPGLFDnfwKLVERYRITSLSTVPTVYAALLQ------VPVNADisSLRFAMSGAAPLPVELRARF-EDATGLPVVEGY 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1788 GPTEATVEAAffdCPPHEKLERI-PIGKPVHH--VRLYLLNQNQRML---PVGCIGELYIAGAGVARGYL----NRPALT 1857
Cdd:cd05944 154 GLTEATCLVA---VNPPDGPKRPgSVGLRLPYarVRIKVLDGVGRLLrdcAPDEVGEICVAGPGVFGGYLytegNKNAFV 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1858 EERFLedpfypgermyKTGDVARWLPDGNVEFLGRTDDQVkIRG-YRIEPGEIEAALRSIEGVREAAVTVRTDSGEPEL- 1935
Cdd:cd05944 231 ADGWL-----------NTGDLGRLDADGYLFITGRAKDLI-IRGgHNIDPALIEEALLRHPAVAFAGAVGQPDAHAGELp 298
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 1936 CAYVEGLQRNEVR-AQL-----ERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd05944 299 VAYVQLKPGAVVEeEELlawarDHVPERAAVPKHIEVLEELPVTAVGKVFKPAL 352
|
|
| FACL_like_1 |
cd05910 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
2558-3019 |
8.89e-24 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341236 [Multi-domain] Cd Length: 457 Bit Score: 107.93 E-value: 8.89e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2558 TLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTkllmti 2637
Cdd:cd05910 2 RLSFRELDERSDRIAQGLTAYGIRRGMRAVLMVPPGPDFFALTFALFKAGAVPVLIDPGMGRKNLKQCLQEAEP------ 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2638 nEADLGVladfegeiltiesveeddksPLpqmssAHHLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTI 2717
Cdd:cd05910 76 -DAFIGI--------------------PK-----ADEPAAILFTSGSTGTPKGVVYRHGTFAAQIDALRQLYGIRPGEVD 129
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2718 LQLFSfsfdgfITSMFTPLLSGAKAV--LLHEEEAKDILAIKHQLSRQ-RITHMIIVPVLYRALLDVVQPEDVK--TLRV 2792
Cdd:cd05910 130 LATFP------LFALFGPALGLTSVIpdMDPTRPARADPQKLVGAIRQyGVSIVFGSPALLERVARYCAQHGITlpSLRR 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2793 VTLAGEAADRELIAR-SLAICPHTELANEYGPTE---------NSVATTVMRHMEKQAYVSIGQPIDGTQVLILNSN--- 2859
Cdd:cd05910 204 VLSAGAPVPIALAARlRKMLSDEAEILTPYGATEalpvssigsRELLATTTAATSGGAGTCVGRPIPGVRVRIIEIDdep 283
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2860 -------HQLqPIGVAGELCIAGTGLARGYVNLPELTerAFTQNPFKPEARMYRTGDAARWMADGTLEYLGRIDDQVKIR 2932
Cdd:cd05910 284 iaewddtLEL-PRGEIGEITVTGPTVTPTYVNRPVAT--ALAKIDDNSEGFWHRMGDLGYLDDEGRLWFCGRKAHRVITT 360
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2933 GYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELsayVVTKPGLSTNAVRSELQNKL--------------PVFMHPA 2998
Cdd:cd05910 361 GGTLYTEPVERVFNTHPGVRRSALVGVGKPGCQLPV---LCVEPLPGTITPRARLEQELralakdyphtqrigRFLIHPS 437
|
490 500
....*....|....*....|...
gi 1678550997 2999 FiekldslPLSP--NGKLDRGAL 3019
Cdd:cd05910 438 F-------PVDIrhNAKIFREKL 453
|
|
| Ac_CoA_lig_AcsA |
TIGR02188 |
acetate--CoA ligase; This model describes acetate-CoA ligase (EC 6.2.1.1), also called ... |
2557-3016 |
1.14e-23 |
|
acetate--CoA ligase; This model describes acetate-CoA ligase (EC 6.2.1.1), also called acetyl-CoA synthetase and acetyl-activating enzyme. It catalyzes the reaction ATP + acetate + CoA = AMP + diphosphate + acetyl-CoA and belongs to the family of AMP-binding enzymes described by pfam00501.
Pssm-ID: 274022 [Multi-domain] Cd Length: 626 Bit Score: 109.26 E-value: 1.14e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2557 KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPI----DPEYPKERkryiLSDSGTK 2632
Cdd:TIGR02188 87 RKITYRELHREVCRFANVLKSLGVKKGDRVAIYMPMIPEAAIAMLACARIGAIHSVVfggfSAEALADR----INDAGAK 162
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2633 LLMTINEA-------DLGVLAD--FEGEILTIESV--------------------------EEDDKSPLPQMSSAHHLaY 2677
Cdd:TIGR02188 163 LVITADEGlrggkviPLKAIVDeaLEKCPVSVEHVlvvrrtgnpvvpwvegrdvwwhdlmaKASAYCEPEPMDSEDPL-F 241
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2678 IIYTSGTTGRPKGVMveHK------GIANTLQWrrnayAFNETDTilQLFSFSFD-GFITS----MFTPLLSGAkAVLLH 2746
Cdd:TIGR02188 242 ILYTSGSTGKPKGVL--HTtggyllYAAMTMKY-----VFDIKDG--DIFWCTADvGWITGhsyiVYGPLANGA-TTVMF 311
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2747 E-----EEAKDILAIkhqLSRQRITHMIIVPVLYRALL----DVVQPEDVKTLRVVTLAGEAADRE-------LIARSLa 2810
Cdd:TIGR02188 312 EgvptyPDPGRFWEI---IEKHKVTIFYTAPTAIRALMrlgdEWVKKHDLSSLRLLGSVGEPINPEawmwyykVVGKER- 387
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2811 iCPhteLANEYGPTEN-SVATTVMRHMEKQAYVSIGQPIDGTQVLILNSN-HQLQPIGVAGELCIAGT--GLARGYVNLP 2886
Cdd:TIGR02188 388 -CP---IVDTWWQTETgGIMITPLPGATPTKPGSATLPFFGIEPAVVDEEgNPVEGPGEGGYLVIKQPwpGMLRTIYGDH 463
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2887 ElterAFTQNPFKPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVA-HVTASGQ 2965
Cdd:TIGR02188 464 E----RFVDTYFSPFPGYYFTGDGARRDKDGYIWITGRVDDVINVSGHRLGTAEIESALVSHPAVAEAAVVGiPDDIKGQ 539
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 2966 tELSAYVVTKPGLSTNA-----VRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDR 3016
Cdd:TIGR02188 540 -AIYAFVTLKDGYEPDDelrkeLRKHVRKEIGPIAKPDKIRFVPGLPKTRSGKIMR 594
|
|
| PRK05852 |
PRK05852 |
fatty acid--CoA ligase family protein; |
1500-1983 |
1.33e-23 |
|
fatty acid--CoA ligase family protein;
Pssm-ID: 235625 [Multi-domain] Cd Length: 534 Bit Score: 108.44 E-value: 1.33e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFEDG--VMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPD 1577
Cdd:PRK05852 22 VEVAATRLPEAPALVVTADriAISYRDLARLVDDLAGQLTRSGLLPGDRVALRMGSNAEFVVALLAASRADLVVVPLDPA 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1578 YPEERISFLLEDSGTNILLLQSAGLH------VPEFTGEIVYLNQTNSGLA----HR--LSNPNVDV-LPQSL----AYV 1640
Cdd:PRK05852 102 LPIAEQRVRSQAAGARVVLIDADGPHdraeptTRWWPLTVNVGGDSGPSGGtlsvHLdaATEPTPATsTPEGLrpddAMI 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1641 IYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVIAK 1720
Cdd:PRK05852 182 MFTGGTTGLPKMVPWTHANIASSVRAIITGYRLSPRDATVAVMPLYHGHGLIAALLATLASGGAVLLPARGRFSAHTFWD 261
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1721 AIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTNRLKRVFSGGEQL----GTHLVSRFyeLLPNVSitnSYGPTEATVEA 1796
Cdd:PRK05852 262 DIKAVGATWYTAVPTIHQILLERAATEPSGRKPAALRFIRSCSAPLtaetAQALQTEF--AAPVVC---AFGMTEATHQV 336
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1797 A-----FFDCPPHEKLERIPIGKPVHhVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFypger 1871
Cdd:PRK05852 337 TttqieGIGQTENPVVSTGLVGRSTG-AQIRIVGSDGLPLPAGAVGEVWLRGTTVVRGYLGDPTITAANFTDGWL----- 410
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1872 myKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GEPELCAYVE----GLQRN 1945
Cdd:PRK05852 411 --RTGDLGSLSAAGDLSIRGRIKELINRGGEKISPERVEGVLASHPNVMEAAVFGVPDQlyGEAVAAVIVPresaPPTAE 488
|
490 500 510
....*....|....*....|....*....|....*...
gi 1678550997 1946 EVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK05852 489 ELVQFCRERLAAFEIPASFQEASGLPHTAKGSLDRRAV 526
|
|
| PRK12492 |
PRK12492 |
long-chain-fatty-acid--CoA ligase; Provisional |
462-955 |
1.47e-23 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 171539 [Multi-domain] Cd Length: 562 Bit Score: 108.76 E-value: 1.47e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 462 YETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMK-GVVRQEPVAIMMERSAAFITGVLGILKAGGAI 540
Cdd:PRK12492 23 YKSVVEVFERSCKKFADRPAFSNLGVTLSYAELERHSAAFAAYLQQHtDLVPGDRIAVQMPNVLQYPIAVFGALRAGLIV 102
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 541 VPVDPHYPADRIRYILHDCGCSHVV--------SQAHLPSSLEDNYIITHPED---------IESKVD------------ 591
Cdd:PRK12492 103 VNTNPLYTAREMRHQFKDSGARALVylnmfgklVQEVLPDTGIEYLIEAKMGDllpaakgwlVNTVVDkvkkmvpayhlp 182
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 592 -------------GSNIKSVN-NADDLLYMIYTSGTTGKPKGVQFEHRNM-ANLLKF--------EYTHSGIDFEADVLQ 648
Cdd:PRK12492 183 qavpfkqalrqgrGLSLKPVPvGLDDIAVLQYTGGTTGLAKGAMLTHGNLvANMLQVraclsqlgPDGQPLMKEGQEVMI 262
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 649 FATPSFDVcYQeiFSA-----LLKGGtlHIVPEAIKRDVPQLFAFINKHQ-TNIVFLPTAFIKMI---------FSEREL 713
Cdd:PRK12492 263 APLPLYHI-YA--FTAncmcmMVSGN--HNVLITNPRDIPGFIKELGKWRfSALLGLNTLFVALMdhpgfkdldFSALKL 337
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 714 ANSfpdGVKHLIAAgeqlmISDLFQDVlrkRGIHLHNHYGPSETH-VVSTytiHPGDPIPELPPIGKPIGCTDLYILNHQ 792
Cdd:PRK12492 338 TNS---GGTALVKA-----TAERWEQL---TGCTIVEGYGLTETSpVAST---NPYGELARLGTVGIPVPGTALKVIDDD 403
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 793 KQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQ 872
Cdd:PRK12492 404 GNELPLGERGELCIKGPQVMKGYWQQPEATAEALDAEGW------FKTGDIAVIDPDGFVRIVDRKKDLIIVSGFNVYPN 477
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 873 EIEVTLMNHPDISE-AAILIWQDQNGEHELCAYYCSVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAA 951
Cdd:PRK12492 478 EIEDVVMAHPKVANcAAIGVPDERSGEAVKLFVVARDPGLSVEELKAYCKENFTGYKVPKHIVLRDSLPMTPVGKILRRE 557
|
....
gi 1678550997 952 LPEP 955
Cdd:PRK12492 558 LRDI 561
|
|
| PRK07529 |
PRK07529 |
AMP-binding domain protein; Validated |
2524-3019 |
1.52e-23 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236043 [Multi-domain] Cd Length: 632 Bit Score: 108.89 E-value: 1.52e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2524 TGQANQYGVQTISQLFEQQAARTPKASALV----SGDK----TLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFS 2595
Cdd:PRK07529 16 VPLAARDLPASTYELLSRAAARHPDAPALSflldADPLdrpeTWTYAELLADVTRTANLLHSLGVGPGDVVAFLLPNLPE 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2596 MIASILGVwKAGGCYVPIDPEYPKERKRYILSDSGTKLLMT-------------------------INEADLG------- 2643
Cdd:PRK07529 96 THFALWGG-EAAGIANPINPLLEPEQIAELLRAAGAKVLVTlgpfpgtdiwqkvaevlaalpelrtVVEVDLArylpgpk 174
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2644 -------------VLADFEGEIltieSVEEDDKSPLPQMSSAHHLAYIIYTSGTTGRPKGVMVEHKG-IANTlqWRRNAY 2709
Cdd:PRK07529 175 rlavplirrkahaRILDFDAEL----ARQPGDRLFSGRPIGPDDVAAYFHTGGTTGMPKLAQHTHGNeVANA--WLGALL 248
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2710 AF-NETDTIL-QLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAIKH--QL-SRQRITHMIIVPVLYRALLDV-VQ 2783
Cdd:PRK07529 249 LGlGPGDTVFcGLPLFHVNALLVTGLAPLARGAHVVLATPQGYRGPGVIANfwKIvERYRINFLSGVPTVYAALLQVpVD 328
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2784 PEDVKTLRVVtLAGEAA-DRELIARSLAicpHT--ELANEYGPTENSVATTVmrhmekqAYV-------SIGQPIDGTQV 2853
Cdd:PRK07529 329 GHDISSLRYA-LCGAAPlPVEVFRRFEA---ATgvRIVEGYGLTEATCVSSV-------NPPdgerrigSVGLRLPYQRV 397
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2854 LILNSN---HQLQPIGVA--GELCIAGTGLARGYVNlPELTERAFTqnpfkpEARMYRTGDAARWMADGTLEYLGRIDDQ 2928
Cdd:PRK07529 398 RVVILDdagRYLRDCAVDevGVLCIAGPNVFSGYLE-AAHNKGLWL------EDGWLNTGDLGRIDADGYFWLTGRAKDL 470
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2929 VkIR-GYRVETKEIESVIRCIKGVKDAAVV----AHvtaSGqtELS-AYVVTKPGLSTNAvrSELQNKLPVFMH-----P 2997
Cdd:PRK07529 471 I-IRgGHNIDPAAIEEALLRHPAVALAAAVgrpdAH---AG--ELPvAYVQLKPGASATE--AELLAFARDHIAeraavP 542
|
570 580
....*....|....*....|..
gi 1678550997 2998 AFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK07529 543 KHVRILDALPKTAVGKIFKPAL 564
|
|
| PRK13391 |
PRK13391 |
acyl-CoA synthetase; Provisional |
2540-3014 |
1.78e-23 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 184022 [Multi-domain] Cd Length: 511 Bit Score: 107.85 E-value: 1.78e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2540 EQQAARTPKASALV--SGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEY 2617
Cdd:PRK13391 4 GIHAQTTPDKPAVImaSTGEVVTYRELDERSNRLAHLFRSLGLKRGDHVAIFMENNLRYLEVCWAAERSGLYYTCVNSHL 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2618 PKERKRYILSDSGTKLLMT------INEADLG--------VLADFEGEILTIESVEEDDKS----PLPQMSSAHHLayiI 2679
Cdd:PRK13391 84 TPAEAAYIVDDSGARALITsaakldVARALLKqcpgvrhrLVLDGDGELEGFVGYAEAVAGlpatPIADESLGTDM---L 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2680 YTSGTTGRPKGVM--------VEHKGIANTLQwrrNAYAFNETDTILQ---LF---SFSFDGFITSMftpllsGAKAVLL 2745
Cdd:PRK13391 161 YSSGTTGRPKGIKrplpeqppDTPLPLTAFLQ---RLWGFRSDMVYLSpapLYhsaPQRAVMLVIRL------GGTVIVM 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2746 HEEEAKDILAIkhqLSRQRITHMIIVPVLYRALL----DVVQPEDVKTLRVVTLAGeaadreliarslAICP---HTELA 2818
Cdd:PRK13391 232 EHFDAEQYLAL---IEEYGVTHTQLVPTMFSRMLklpeEVRDKYDLSSLEVAIHAA------------APCPpqvKEQMI 296
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2819 NEYGP--------TENSVATTVMRHMEKQAYVSIGQPIDGTqVLILNSNHQLQPIGVAGELCIAGtGLARGYVNLPELTE 2890
Cdd:PRK13391 297 DWWGPiiheyyaaTEGLGFTACDSEEWLAHPGTVGRAMFGD-LHILDDDGAELPPGEPGTIWFEG-GRPFEYLNDPAKTA 374
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2891 RAFTqnpfkPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSA 2970
Cdd:PRK13391 375 EARH-----PDGTWSTVGDIGYVDEDGYLYLTDRAAFMIISGGVNIYPQEAENLLITHPKVADAAVFGVPNEDLGEEVKA 449
|
490 500 510 520
....*....|....*....|....*....|....*....|....*....
gi 1678550997 2971 YVVTKPGL-STNAVRSEL----QNKLPVFMHPAFIEKLDSLPLSPNGKL 3014
Cdd:PRK13391 450 VVQPVDGVdPGPALAAELiafcRQRLSRQKCPRSIDFEDELPRLPTGKL 498
|
|
| PRK13295 |
PRK13295 |
cyclohexanecarboxylate-CoA ligase; Reviewed |
463-954 |
1.83e-23 |
|
cyclohexanecarboxylate-CoA ligase; Reviewed
Pssm-ID: 171961 [Multi-domain] Cd Length: 547 Bit Score: 108.22 E-value: 1.83e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 463 ETIHAMFEKQAEKTPDAHAVID------QACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKA 536
Cdd:PRK13295 24 RTINDDLDACVASCPDKTAVTAvrlgtgAPRRFTYRELAALVDRVAVGLARLGVGRGDVVSCQLPNWWEFTVLYLACSRI 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 537 GGAIVPVDPHYPADRIRYILHDCGCSHVVS----------------QAHLPS-------------SLEDNYIITHPEDiE 587
Cdd:PRK13295 104 GAVLNPLMPIFRERELSFMLKHAESKVLVVpktfrgfdhaamarrlRPELPAlrhvvvvggdgadSFEALLITPAWEQ-E 182
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 588 SKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRN-MANLLKF-EYTHSGIDfeaDVLQFATPsfdVCYQEIFsal 665
Cdd:PRK13295 183 PDAPAILARLRPGPDDVTQLIYTSGTTGEPKGVMHTANTlMANIVPYaERLGLGAD---DVILMASP---MAHQTGF--- 253
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 666 LKGGTLHIV--PEAIKRDV--PQLFA-FINKHQTNIVFLPTAFI-KMIFSERELANSFPDgVKHLIAAGEQLMiSDLFQD 739
Cdd:PRK13295 254 MYGLMMPVMlgATAVLQDIwdPARAAeLIRTEGVTFTMASTPFLtDLTRAVKESGRPVSS-LRTFLCAGAPIP-GALVER 331
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 740 VLRKRGIHLHNHYGPSETHVVSTytIHPGDPiPELPPI--GKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVN 817
Cdd:PRK13295 332 ARAALGAKIVSAWGMTENGAVTL--TKLDDP-DERASTtdGCPLPGVEVRVVDADGAPLPAGQIGRLQVRGCSNFGGYLK 408
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 818 HDKLTSDKFSSdpfkpdviMYRTGDLARRLEDGNIEYIGRADNqVKIRG-YRIEPQEIEVTLMNHPDISEAAILIWQDQN 896
Cdd:PRK13295 409 RPQLNGTDADG--------WFDTGDLARIDADGYIRISGRSKD-VIIRGgENIPVVEIEALLYRHPAIAQVAIVAYPDER 479
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 897 GEHELCAyyCSVQKL-NTIDLRSyMASELPE------YmIPAKWIWVDSIPLTPNGKVDRAALPE 954
Cdd:PRK13295 480 LGERACA--FVVPRPgQSLDFEE-MVEFLKAqkvakqY-IPERLVVRDALPRTPSGKIQKFRLRE 540
|
|
| PRK08633 |
PRK08633 |
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated |
2663-3019 |
1.98e-23 |
|
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated
Pssm-ID: 236315 [Multi-domain] Cd Length: 1146 Bit Score: 110.01 E-value: 1.98e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2663 KSPLPQMSSAHHLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQLFSF--SFdGFITSMFTPLLSGA 2740
Cdd:PRK08633 772 KRLYGPTFKPDDTATIIFSSGSEGEPKGVMLSHHNILSNIEQISDVFNLRNDDVILSSLPFfhSF-GLTVTLWLPLLEGI 850
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2741 KAVllHEEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDV--VQPEDVKTLRVVtLAGEAADRELIARSLAICPHTELA 2818
Cdd:PRK08633 851 KVV--YHPDPTDALGIAKLVAKHRATILLGTPTFLRLYLRNkkLHPLMFASLRLV-VAGAEKLKPEVADAFEEKFGIRIL 927
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2819 NEYGPTENS-VATTVMR-HMEKQAYV-------SIGQPIDGTQVLILN-SNHQLQPIGVAGELCIAGTGLARGYVNLPEL 2888
Cdd:PRK08633 928 EGYGATETSpVASVNLPdVLAADFKRqtgskegSVGMPLPGVAVRIVDpETFEELPPGEDGLILIGGPQVMKGYLGDPEK 1007
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2889 TERAFTQNPFKpeaRMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIrcIKGVKDAAVVAHVTA---SGQ 2965
Cdd:PRK08633 1008 TAEVIKDIDGI---GWYVTGDKGHLDEDGFLTITDRYSRFAKIGGEMVPLGAVEEEL--AKALGGEEVVFAVTAvpdEKK 1082
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 2966 TELSAYVVTKPGLSTNAVRSEL-QNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK08633 1083 GEKLVVLHTCGAEDVEELKRAIkESGLPNLWKPSRYFKVEALPLLGSGKLDLKGL 1137
|
|
| PRK07529 |
PRK07529 |
AMP-binding domain protein; Validated |
463-952 |
2.41e-23 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236043 [Multi-domain] Cd Length: 632 Bit Score: 108.50 E-value: 2.41e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 463 ETIHAMFEKQAEKTPDAHAVI--------DQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGIL 534
Cdd:PRK07529 25 ASTYELLSRAAARHPDAPALSflldadplDRPETWTYAELLADVTRTANLLHSLGVGPGDVVAFLLPNLPETHFALWGGE 104
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 535 KAGgaIV-PVDPHYPADRIRYILHDCGCSHVVS----------------QAHLP------------------SSLEDNYI 579
Cdd:PRK07529 105 AAG--IAnPINPLLEPEQIAELLRAAGAKVLVTlgpfpgtdiwqkvaevLAALPelrtvvevdlarylpgpkRLAVPLIR 182
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 580 ITHPEDI------------ESKVDGSNIksvnNADDLLYMIYTSGTTGKPKGVQFEHRNM------ANLLkfeythSGID 641
Cdd:PRK07529 183 RKAHARIldfdaelarqpgDRLFSGRPI----GPDDVAAYFHTGGTTGMPKLAQHTHGNEvanawlGALL------LGLG 252
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 642 fEADVLQFATPSFDV--CYQEIFSALLKGGTLHIVPEAIKRDvPQLFA----FINKHQTN-IVFLPTAFikmifseRELA 714
Cdd:PRK07529 253 -PGDTVFCGLPLFHVnaLLVTGLAPLARGAHVVLATPQGYRG-PGVIAnfwkIVERYRINfLSGVPTVY-------AALL 323
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 715 NSFPDG--VKHLIAA--GEQLMISDLFQDVLRKRGIHLHNHYGPSETHVVSTytIHPGDPIPELPPIGKPIGCTDLYIL- 789
Cdd:PRK07529 324 QVPVDGhdISSLRYAlcGAAPLPVEVFRRFEAATGVRIVEGYGLTEATCVSS--VNPPDGERRIGSVGLRLPYQRVRVVi 401
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 790 --NHQKQLQPCGV--PGELYISGASVARGYV----NHDKLTSDKFssdpfkpdvimYRTGDLARRLEDGNIEYIGRADNQ 861
Cdd:PRK07529 402 ldDAGRYLRDCAVdeVGVLCIAGPNVFSGYLeaahNKGLWLEDGW-----------LNTGDLGRIDADGYFWLTGRAKDL 470
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 862 VkIR-GYRIEPQEIEVTLMNHPDISEAAILiwqDQNGEH--EL-CAYycsVQ-----KLNTIDLRSYMASELPEYMIPAK 932
Cdd:PRK07529 471 I-IRgGHNIDPAAIEEALLRHPAVALAAAV---GRPDAHagELpVAY---VQlkpgaSATEAELLAFARDHIAERAAVPK 543
|
570 580
....*....|....*....|.
gi 1678550997 933 WIW-VDSIPLTPNGKVDRAAL 952
Cdd:PRK07529 544 HVRiLDALPKTAVGKIFKPAL 564
|
|
| C_PKS-NRPS |
cd19532 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
12-328 |
3.56e-23 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHxxxD motif, a few such as Monascus pilosus lovastatin nonaketide synthase MokA have a non-canonical HRxxxD motif in the C-domain and are unable to catalyze amide-bond formation. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380455 [Multi-domain] Cd Length: 421 Bit Score: 105.62 E-value: 3.56e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 12 PLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNVSS-PQQVVLrERNVIVLE 90
Cdd:cd19532 3 PMSFGQSRFWFLQQYLEDPTTFNVTFSYRLTGPLDVARLERAVRAVGQRHEALRTCFFTDPEDGePMQGVL-ASSPLRLE 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 91 -EDITHLNEAEQsQFieqwkEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASyvn 169
Cdd:cd19532 82 hVQISDEAEVEE-EF-----ERLKNHVYDLESGETMRIVLLSLSPTEHYLIFGYHHIAMDGVSFQIFLRDLERAYNG--- 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 170 aSPITLEPVQpygkYIKWLMEQDKEQA-------VSYWDHYLSGHEQqtVLP-------KQKKTKGKSRQEHVTFSFSKE 235
Cdd:cd19532 153 -QPLLPPPLQ----YLDFAARQRQDYEsgaldedLAYWKSEFSTLPE--PLPllpfakvKSRPPLTRYDTHTAERRLDAA 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 236 ESSRLSELAAREEVtlsTIFH---TIWGILLQKYNNNDDAVFGSVISGRPAeiEGIEHMVGLFINTMPVRVQ-GAKTPFL 311
Cdd:cd19532 226 LAARIKEASRKLRV---TPFHfylAALQVLLARLLDVDDICIGIADANRTD--EDFMETIGFFLNLLPLRFRrDPSQTFA 300
|
330
....*....|....*..
gi 1678550997 312 QLIKDMQKDRLAAEAYS 328
Cdd:cd19532 301 DVLKETRDKAYAALAHS 317
|
|
| Firefly_Luc |
cd17642 |
insect luciferase, similar to plant 4-coumarate: CoA ligases; This family contains insect ... |
478-954 |
3.85e-23 |
|
insect luciferase, similar to plant 4-coumarate: CoA ligases; This family contains insect firefly luciferases that share significant sequence similarity to plant 4-coumarate:coenzyme A ligases, despite their functional diversity. Luciferase catalyzes the production of light in the presence of MgATP, molecular oxygen, and luciferin. In the first step, luciferin is activated by acylation of its carboxylate group with ATP, resulting in an enzyme-bound luciferyl adenylate. In the second step, luciferyl adenylate reacts with molecular oxygen, producing an enzyme-bound excited state product (Luc=O*) and releasing AMP. This excited-state product then decays to the ground state (Luc=O), emitting a quantum of visible light.
Pssm-ID: 341297 [Multi-domain] Cd Length: 532 Bit Score: 106.84 E-value: 3.85e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 478 DAHAVIDqacsLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYpadRIRYILH 557
Cdd:cd17642 38 DAHTGVN----YSYAEYLEMSVRLAEALKKYGLKQNDRIAVCSENSLQFFLPVIAGLFIGVGVAPTNDIY---NERELDH 110
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 558 DCGCSH--------------VVSQAHLP--------SSLED-------NYIITHPEDIESKVDGSNIKSVNNADDLLYMI 608
Cdd:cd17642 111 SLNISKptivfcskkglqkvLNVQKKLKiiktiiilDSKEDykgyqclYTFITQNLPPGFNEYDFKPPSFDRDEQVALIM 190
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 609 YTSGTTGKPKGVQFEHRNManLLKFEYT---------------------HSGIDFEAdVLQFATPSFDVCYQEIFSALLK 667
Cdd:cd17642 191 NSSGSTGLPKGVQLTHKNI--VARFSHArdpifgnqiipdtailtvipfHHGFGMFT-TLGYLICGFRVVLMYKFEEELF 267
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 668 GGTL--HIVPEAIKrdVPQLFAFINKHQtnivflptafikmIFSERELANSfpdgvkHLIAAGEQLMISDLFQDVLRKRG 745
Cdd:cd17642 268 LRSLqdYKVQSALL--VPTLFAFFAKST-------------LVDKYDLSNL------HEIASGGAPLSKEVGEAVAKRFK 326
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 746 IH-LHNHYGPSEThvVSTYTIHP-GDPIPELPPIGKPIGCTDLYILNHQKQLQPcGVPGELYISGASVARGYVNHDKLTS 823
Cdd:cd17642 327 LPgIRQGYGLTET--TSAILITPeGDDKPGAVGKVVPFFYAKVVDLDTGKTLGP-NERGELCVKGPMIMKGYVNNPEATK 403
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 824 DKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGeHELCA 903
Cdd:cd17642 404 ALIDKDGW------LHSGDIAYYDEDGHFFIVDRLKSLIKYKGYQVPPAELESILLQHPKIFDAGVAGIPDEDA-GELPA 476
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 904 YYCSVQ---KLNTIDLRSYMASELPeymiPAKW-----IWVDSIPLTPNGKVDRAALPE 954
Cdd:cd17642 477 AVVVLEagkTMTEKEVMDYVASQVS----TAKRlrggvKFVDEVPKGLTGKIDRRKIRE 531
|
|
| PLN02574 |
PLN02574 |
4-coumarate--CoA ligase-like |
460-952 |
3.88e-23 |
|
4-coumarate--CoA ligase-like
Pssm-ID: 215312 [Multi-domain] Cd Length: 560 Bit Score: 107.24 E-value: 3.88e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 460 PVYETIHAMFEKQAEktPDAHAVIDQAC--SLTYRELNKAANRLARHLRMKGVVRQ-EPVAIMMERSAAFITGVLGILKA 536
Cdd:PLN02574 38 PNLDAVSFIFSHHNH--NGDTALIDSSTgfSISYSELQPLVKSMAAGLYHVMGVRQgDVVLLLLPNSVYFPVIFLAVLSL 115
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 537 GGAIVPVDPHYPADRIRYILHDCGCSHV--------------VSQAHLPSSLEDNYIITHPEDIESKVDGSN---IKSVN 599
Cdd:PLN02574 116 GGIVTTMNPSSSLGEIKKRVVDCSVGLAftspenveklsplgVPVIGVPENYDFDSKRIEFPKFYELIKEDFdfvPKPVI 195
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 600 NADDLLYMIYTSGTTGKPKGVQFEHRN----MANLLKFE---YTHSGIDfeaDVLQFATPSFDVCYQEIF-SALLKGGTL 671
Cdd:PLN02574 196 KQDDVAAIMYSSGTTGASKGVVLTHRNliamVELFVRFEasqYEYPGSD---NVYLAALPMFHIYGLSLFvVGLLSLGST 272
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 672 HIVpeaIKR-DVPQLFAFINKHQ-TNIVFLPTAFIKMIFSEREL-ANSFpdGVKHLIAAGEQLMISDLFQDVLRK-RGIH 747
Cdd:PLN02574 273 IVV---MRRfDASDMVKVIDRFKvTHFPVVPPILMALTKKAKGVcGEVL--KSLKQVSCGAAPLSGKFIQDFVQTlPHVD 347
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 748 LHNHYGPSETHVVSTYTIHPgDPIPELPPIGkpigctdLYILNHQKQ--------LQPCGVPGELYISGASVARGYVNHD 819
Cdd:PLN02574 348 FIQGYGMTESTAVGTRGFNT-EKLSKYSSVG-------LLAPNMQAKvvdwstgcLLPPGNCGELWIQGPGVMKGYLNNP 419
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 820 KLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEH 899
Cdd:PLN02574 420 KATQSTIDKDGW------LRTGDIAYFDEDGYLYIVDRLKEIIKYKGFQIAPADLEAVLISHPEIIDAAVTAVPDKECGE 493
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 900 ELCAYYCSVQK--LNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PLN02574 494 IPVAFVVRRQGstLSQEAVINYVAKQVAPYKKVRKVVFVQSIPKSPAGKILRREL 548
|
|
| AcpA |
COG3433 |
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites ... |
1802-2070 |
4.19e-23 |
|
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442659 [Multi-domain] Cd Length: 295 Bit Score: 102.52 E-value: 4.19e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1802 PPHEKLERIPIGKPVHHVRLYLLNQ-NQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYPGERMYKTGDVAR 1880
Cdd:COG3433 10 PPTPDEPPPVIPPAIVQARALLLIVdLQGYFGGFGGEGGLLGAGLLLRIRLLAAAARAPFIPVPYPAQPGRQADDLRLLL 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1881 WLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDSGEP--ELCAYVEGLQRNEVRAQLERLLPGY 1958
Cdd:COG3433 90 RRGLGPGGGLERLVQQVVIRAERGEEEELLLVLRAAAVVRVAVLAALRGAGVGllLIVGAVAALDGLAAAAALAALDKVP 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1959 --MVPAYMIEMEQWPVTPSGKLDRNALPAPGGAADAETYTAPRNVTEM-----KLSQLWEDVLKNGP--VGIHDNFFDRG 2029
Cdd:COG3433 170 pdVVAASAVVALDALLLLALKVVARAAPALAAAEALLAAASPAPALETalteeELRADVAELLGVDPeeIDPDDNLFDLG 249
|
250 260 270 280
....*....|....*....|....*....|....*....|.
gi 1678550997 2030 GHSLKATALVSRItKEFDVQVPLKDVFAHPTVEGLATVIRE 2070
Cdd:COG3433 250 LDSIRLMQLVERW-RKAGLDVSFADLAEHPTLAAWWALLAA 289
|
|
| PLN02479 |
PLN02479 |
acetate-CoA ligase |
1500-1985 |
6.35e-23 |
|
acetate-CoA ligase
Pssm-ID: 178097 [Multi-domain] Cd Length: 567 Bit Score: 106.47 E-value: 6.35e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYP 1579
Cdd:PLN02479 26 LERAAVVHPTRKSVVHGSVRYTWAQTYQRCRRLASALAKRSIGPGSTVAVIAPNIPAMYEAHFGVPMAGAVVNCVNIRLN 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1580 EERISFLLEDSGTNILLLQSAGLHVPEFTGEIVYLNQTNS-----------------GLAHRLS-------------NPN 1629
Cdd:PLN02479 106 APTIAFLLEHSKSEVVMVDQEFFTLAEEALKILAEKKKSSfkppllivigdptcdpkSLQYALGkgaieyekfletgDPE 185
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1630 VDVLP-----QSLAyVIYTSGSTGMPKGVEIEHRSAvnFLNSLQsryqlkhsdmimhktsysfDASIWEL------FW-- 1696
Cdd:PLN02479 186 FAWKPpadewQSIA-LGYTSGTTASPKGVVLHHRGA--YLMALS-------------------NALIWGMnegavyLWtl 243
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1697 -------WPY-------AGASVYLLpqggEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVpIKTNRLKRVFSG 1762
Cdd:PLN02479 244 pmfhcngWCFtwtlaalCGTNICLR----QVTAKAIYSAIANYGVTHFCAAPVVLNTIVNAPKSETI-LPLPRVVHVMTA 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1763 GEQLGTHLVSRFYELLPNVS----ITNSYGPTEATVEAAFFDCPPHEKLERIPIGKPVHHVRLYLLN--QNQRMLPV--- 1833
Cdd:PLN02479 319 GAAPPPSVLFAMSEKGFRVThtygLSETYGPSTVCAWKPEWDSLPPEEQARLNARQGVRYIGLEGLDvvDTKTMKPVpad 398
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1834 -GCIGELYIAGAGVARGYLNRPALTEERFLEDPFYpgermykTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAA 1912
Cdd:PLN02479 399 gKTMGEIVMRGNMVMKGYLKNPKANEEAFANGWFH-------SGDLGVKHPDGYIEIKDRSKDIIISGGENISSLEVENV 471
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1913 LRSIEGVREAAVTVRTDS--GEPElCAYV---EGLQRNEVRAQLERL-------LPGYMVPAYMIeMEQWPVTPSGKLDR 1980
Cdd:PLN02479 472 VYTHPAVLEASVVARPDErwGESP-CAFVtlkPGVDKSDEAALAEDImkfcrerLPAYWVPKSVV-FGPLPKTATGKIQK 549
|
....*
gi 1678550997 1981 NALPA 1985
Cdd:PLN02479 550 HVLRA 554
|
|
| PRK08974 |
PRK08974 |
long-chain-fatty-acid--CoA ligase FadD; |
434-952 |
9.02e-23 |
|
long-chain-fatty-acid--CoA ligase FadD;
Pssm-ID: 236359 [Multi-domain] Cd Length: 560 Bit Score: 105.91 E-value: 9.02e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 434 NLP---PEEIDittdtekrqligeiTDQtpvYETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMK-G 509
Cdd:PRK08974 8 RYPadvPAEIN--------------PDR---YQSLVDMFEQAVARYADQPAFINMGEVMTFRKLEERSRAFAAYLQNGlG 70
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 510 VVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSQAHLPSSLE--------DNYIIT 581
Cdd:PRK08974 71 LKKGDRVALMMPNLLQYPIALFGILRAGMIVVNVNPLYTPRELEHQLNDSGAKAIVIVSNFAHTLEkvvfktpvKHVILT 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 582 HPEDIESKVDGS-----------------------------------NIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRN 626
Cdd:PRK08974 151 RMGDQLSTAKGTlvnfvvkyikrlvpkyhlpdaisfrsalhkgrrmqYVKPELVPEDLAFLQYTGGTTGVAKGAMLTHRN 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 627 M-ANLLKFEYTHSG-IDFEADVLQFATPSFdvcyqEIFS----ALL---KGGT-LHIV-PeaikRDVPQLFAFINKHQ-T 694
Cdd:PRK08974 231 MlANLEQAKAAYGPlLHPGKELVVTALPLY-----HIFAltvnCLLfieLGGQnLLITnP----RDIPGFVKELKKYPfT 301
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 695 NIVFLPTAFIKMIFSE--RELANSfpdGVKHLIAAGE--QLMISDLFQDVlrkRGIHLHNHYGPSE-THVVSTYTI---- 765
Cdd:PRK08974 302 AITGVNTLFNALLNNEefQELDFS---SLKLSVGGGMavQQAVAERWVKL---TGQYLLEGYGLTEcSPLVSVNPYdldy 375
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 766 HPGDpipelppIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDkfssdpfkpdVIM---YRTGD 842
Cdd:PRK08974 376 YSGS-------IGLPVPSTEIKLVDDDGNEVPPGEPGELWVKGPQVMLGYWQRPEATDE----------VIKdgwLATGD 438
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 843 LARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISE-AAILIWQDQNGEhelCAYYCSVQK---LNTIDLRS 918
Cdd:PRK08974 439 IAVMDEEGFLRIVDRKKDMILVSGFNVYPNEIEDVVMLHPKVLEvAAVGVPSEVSGE---AVKIFVVKKdpsLTEEELIT 515
|
570 580 590
....*....|....*....|....*....|....
gi 1678550997 919 YMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PRK08974 516 HCRRHLTGYKVPKLVEFRDELPKSNVGKILRREL 549
|
|
| FADD10 |
cd17635 |
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain ... |
603-949 |
9.81e-23 |
|
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain fatty acid CoA ligases, including FadD10 which is involved in the synthesis of a virulence-related lipopeptide. FadD10 is a fatty acyl-AMP ligase (FAAL) that transfers fatty acids to an acyl carrier protein. Structures of FadD10 in apo- and complexed form with dodecanoyl-AMP, show a novel open conformation, facilitated by its unique inter-domain and intermolecular interactions, which is critical for the enzyme to carry out the acyl transfer onto the acyl carrier protein (Rv0100) rather than coenzyme A.
Pssm-ID: 341290 [Multi-domain] Cd Length: 340 Bit Score: 102.72 E-value: 9.81e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 603 DLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEYTHSGIDFEADVLQFATP-SFDVCYQEIFSALLKGGTLhivpeAIKRD 681
Cdd:cd17635 2 DPLAVIFTSGTTGEPKAVLLANKTFFAVPDILQKEGLNWVVGDVTYLPLPaTHIGGLWWILTCLIHGGLC-----VTGGE 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 682 VPQLFAFINKHQTN----IVFLPTAFIKMIFSERELANSFPDgvKHLIAAGEQLMISDLFQDVLRKRGIHLHNHYGPSET 757
Cdd:cd17635 77 NTTYKSLFKILTTNavttTCLVPTLLSKLVSELKSANATVPS--LRLIGYGGSRAIAADVRFIEATGLTNTAQVYGLSET 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 758 HVVSTytIHPGDPIPELPPIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKpdvim 837
Cdd:cd17635 155 GTALC--LPTDDDSIEINAVGRPYPGVDVYLAATDGIAGPSASFGTIWIKSPANMLGYWNNPERTAEVLIDGWVN----- 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 838 yrTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQN-GEHELCAYYCSVQKLNTI-- 914
Cdd:cd17635 228 --TGDLGERREDGFLFITGRSSESINCGGVKIAPDEVERIAEGVSGVQECACYEISDEEfGELVGLAVVASAELDENAir 305
|
330 340 350
....*....|....*....|....*....|....*
gi 1678550997 915 DLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDR 949
Cdd:cd17635 306 ALKHTIRRELEPYARPSTIVIVTDIPRTQSGKVKR 340
|
|
| PRK13382 |
PRK13382 |
bile acid CoA ligase; |
1504-1986 |
1.13e-22 |
|
bile acid CoA ligase;
Pssm-ID: 172019 [Multi-domain] Cd Length: 537 Bit Score: 105.61 E-value: 1.13e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1504 AEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERI 1583
Cdd:PRK13382 53 AQRCPDRPGLIDELGTLTWRELDERSDALAAALQALPIGEPRVVGIMCRNHRGFVEALLAANRIGADILLLNTSFAGPAL 132
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1584 SFLLEDSGTNIL--------LLQSAGLHVPEFTGEIVYLNQTNSGLAHRLSNPNVDVLPQSLA----YVIYTSGSTGMPK 1651
Cdd:PRK13382 133 AEVVTREGVDTViydeefsaTVDRALADCPQATRIVAWTDEDHDLTVEVLIAAHAGQRPEPTGrkgrVILLTSGTTGTPK 212
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1652 GVEIEHRSAVNFLNSLQSRYQLKHsdmimHKTSY----SFDAsiWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQKI 1727
Cdd:PRK13382 213 GARRSGPGGIGTLKAILDRTPWRA-----EEPTVivapMFHA--WGFSQLVLAASLACTIVTRRRFDPEATLDLIDRHRA 285
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1728 TAMHFVPSMLHAFLEHIKYRSVPIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVsITNSYGPTEATVEAAffdCPPhEKL 1807
Cdd:PRK13382 286 TGLAVVPVMFDRIMDLPAEVRNRYSGRSLRFAAASGSRMRPDVVIAFMDQFGDV-IYNNYNATEAGMIAT---ATP-ADL 360
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1808 ERIP--IGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYlnRPALTEErfledpFYPGerMYKTGDVARWLPDG 1885
Cdd:PRK13382 361 RAAPdtAGRPAEGTEIRILDQDFREVPTGEVGTIFVRNDTQFDGY--TSGSTKD------FHDG--FMASGDVGYLDENG 430
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1886 NVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVT-VRTDSGEPELCAYV---EGLQ------RNEVRAQLERll 1955
Cdd:PRK13382 431 RLFVVGRDDEMIVSGGENVYPIEVEKTLATHPDVAEAAVIgVDDEQYGQRLAAFVvlkPGASatpetlKQHVRDNLAN-- 508
|
490 500 510
....*....|....*....|....*....|.
gi 1678550997 1956 pgYMVPAYMIEMEQWPVTPSGKLDRNALPAP 1986
Cdd:PRK13382 509 --YKVPRDIVVLDELPRGATGKILRRELQAR 537
|
|
| AAS_C |
cd05909 |
C-terminal domain of the acyl-acyl carrier protein synthetase (also called ... |
488-948 |
2.08e-22 |
|
C-terminal domain of the acyl-acyl carrier protein synthetase (also called 2-acylglycerophosphoethanolamine acyltransferase, Aas); Acyl-acyl carrier protein synthase (Aas) is a membrane protein responsible for a minor pathway of incorporating exogenous fatty acids into membrane phospholipids. Its in vitro activity is characterized by the ligation of free fatty acids between 8 and 18 carbons in length to the acyl carrier protein sulfydryl group (ACP-SH) in the presence of ATP and Mg2+. However, its in vivo function is as a 2-acylglycerophosphoethanolamine (2-acyl-GPE) acyltransferase. The reaction occurs in two steps: the acyl chain is first esterified to acyl carrier protein (ACP) via a thioester bond, followed by a second step where the acyl chain is transferred to a 2-acyllysophospholipid, thus completing the transacylation reaction. This model represents the C-terminal domain of the enzyme, which belongs to the class I adenylate-forming enzyme family, including acyl-CoA synthetases.
Pssm-ID: 341235 [Multi-domain] Cd Length: 490 Bit Score: 104.34 E-value: 2.08e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 488 SLTYRELNKAANRLARHLRmKGVVRQEPVAIMMERSAAFITGVLGILKAGGaiVPVDPHYPA--DRIRYILHDCGCSHVV 565
Cdd:cd05909 7 SLTYRKLLTGAIALARKLA-KMTKEGENVGVMLPPSAGGALANFALALSGK--VPVMLNYTAglRELRACIKLAGIKTVL 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 566 -SQA--------HLPSSLEDNYIItHPEDIESKVDGSN-----------------IKSVNN--ADDLLYMIYTSGTTGKP 617
Cdd:cd05909 84 tSKQfieklklhHLFDVEYDARIV-YLEDLRAKISKADkckaflagkfppkwllrIFGVAPvqPDDPAVILFTSGSEGLP 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 618 KGVQFEHRN-MANLlkfEYTHSGIDF-EADVLQFATPSF-----DVCyqeIFSALLKGGTLHIVPEAIkrDVPQLFAFIN 690
Cdd:cd05909 163 KGVVLSHKNlLANV---EQITAIFDPnPEDVVFGALPFFhsfglTGC---LWLPLLSGIKVVFHPNPL--DYKKIPELIY 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 691 KHQTNIVFLPTAFIkMIFSERELANSFPdGVKHLIAAGEQLMiSDLFQDVLRKRGIHLHNHYGPSETHVVSTYTIHPGDP 770
Cdd:cd05909 235 DKKATILLGTPTFL-RGYARAAHPEDFS-SLRLVVAGAEKLK-DTLRQEFQEKFGIRILEGYGTTECSPVISVNTPQSPN 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 771 IPElpPIGKPIGCTDLYILNHQ-KQLQPCGVPGELYISGASVARGYVNHDKLTSdkfssdpFKPDVIMYRTGDLARRLED 849
Cdd:cd05909 312 KEG--TVGRPLPGMEVKIVSVEtHEEVPIGEGGLLLVRGPNVMLGYLNEPELTS-------FAFGDGWYDTGDIGKIDGE 382
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 850 GNIEYIGRADNQVKIRGYRIEPQEIEVTLMNH-PDISEAAILIWQD-QNGEHELCAYYCSVqkLNTIDLRSYM-ASELPE 926
Cdd:cd05909 383 GFLTITGRLSRFAKIAGEMVSLEAIEDILSEIlPEDNEVAVVSVPDgRKGEKIVLLTTTTD--TDPSSLNDILkNAGISN 460
|
490 500
....*....|....*....|..
gi 1678550997 927 YMIPAKWIWVDSIPLTPNGKVD 948
Cdd:cd05909 461 LAKPSYIHQVEEIPLLGTGKPD 482
|
|
| beta-lac_NRPS |
cd19547 |
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis ... |
2088-2484 |
2.32e-22 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis NocB which exhibits an unusual cyclization to form beta-lactam rings in pro-nocardicin G synthesis; Nocardia uniformis NRPS NocB acts centrally in the biosynthesis of the nocardicin monocyclic beta-lactam antibiotics. Along with another NRPS NocA, it mediates an unusual cyclization to form beta-lactam rings in the synthesis of the beta-lactam-containing pentapeptide pro-nocardicin G. This small subfamily is related to DCL-type Condensation (C) domains, which catalyze condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; domains belonging to this subfamily have an HHHxxxD motif at the active site.
Pssm-ID: 380469 [Multi-domain] Cd Length: 422 Bit Score: 103.16 E-value: 2.32e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2088 YPVSSAQKRIYVLQQLEDGGTGYNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGDPVQRIHDEV--PFTL 2165
Cdd:cd19547 2 YPLAPMQEGMLFRGLFWPDSDAYFNQNVLELVGGTDEDVLREAWRRVADRYEILRTGFTWRDRAEPLQYVRDDLapPWAL 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2166 ----------QTTVLGARTEQEAAAAFikpfDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNIL----IQEFGE 2231
Cdd:cd19547 82 ldwsgedpdrRAELLERLLADDRAAGL----SLADCPLYRLTLVRLGGGRHYLLWSHHHILLDGWCLSLIwgdvFRVYEE 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2232 LYNNR--KLPALRiQYKDYAVWQEGfKTGDAYKmQEAYWLKQLEgEL---PVLDLPADharppvRSFAGDKVSFTLEPEV 2306
Cdd:cd19547 158 LAHGRepQLSPCR-PYRDYVRWIRA-RTAQSEE-SERFWREYLR-DLtpsPFSTAPAD------REGEFDTVVHEFPEQL 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2307 ASGLHKLARENGSTLYMVLLAAYTAFLSRLSGQEDIIVGSPIAGRPHK--DLEPILGMFVNTLALRTRPEGGKPFVQYLQ 2384
Cdd:cd19547 228 TRLVNEAARGYGVTTNAISQAAWSMLLALQTGARDVVHGLTIAGRPPEleGSEHMVGIFINTIPLRIRLDPDQTVTGLLE 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2385 EV-RETALEAfEHQNYPFEELVDKLELTRdMSRNPVFDAMLVVQNNDYEPLHLHDLQMK------PAQVSHLVSKFDLTL 2457
Cdd:cd19547 308 TIhRDLATTA-AHGHVPLAQIKSWASGER-LSGGRVFDNLVAFENYPEDNLPGDDLSIQiidlhaQEKTEYPIGLIVLPL 385
|
410 420
....*....|....*....|....*..
gi 1678550997 2458 QasegdgNIHFLFEYSTALFEKTTIER 2484
Cdd:cd19547 386 Q------KLAFHFNYDTTHFTRAQVDR 406
|
|
| AcpA |
COG3433 |
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites ... |
2844-3105 |
2.49e-22 |
|
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442659 [Multi-domain] Cd Length: 295 Bit Score: 100.59 E-value: 2.49e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2844 IGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPF-KPEARMYRTGDAARWMADGTLEYL 2922
Cdd:COG3433 20 IPPAIVQARALLLIVDLQGYFGGFGGEGGLLGAGLLLRIRLLAAAARAPFIPVPYpAQPGRQADDLRLLLRRGLGPGGGL 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2923 GRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTNAVRSELQNKLPVFMHPAFIEK 3002
Cdd:COG3433 100 ERLVQQVVIRAERGEEEELLLVLRAAAVVRVAVLAALRGAGVGLLLIVGAVAALDGLAAAAALAALDKVPPDVVAASAVV 179
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3003 LDSLPLSPNGKLDRGALPKPVYN-----HEGERPFLPPSSKMEQILADiWKEVLG--AEKIGTADSFFELGGDSIKALQV 3075
Cdd:COG3433 180 ALDALLLLALKVVARAAPALAAAeallaAASPAPALETALTEEELRAD-VAELLGvdPEEIDPDDNLFDLGLDSIRLMQL 258
|
250 260 270
....*....|....*....|....*....|
gi 1678550997 3076 SARLHRIGKQMAVKDLFSHPTIQELAAYIR 3105
Cdd:COG3433 259 VERWRKAGLDVSFADLAEHPTLAAWWALLA 288
|
|
| PRK12492 |
PRK12492 |
long-chain-fatty-acid--CoA ligase; Provisional |
1520-1983 |
3.98e-22 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 171539 [Multi-domain] Cd Length: 562 Bit Score: 104.13 E-value: 3.98e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1520 MTYKELNEQ-ANRIAWELIGRGVKPETTVAIigkRSPEML---LGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNIL 1595
Cdd:PRK12492 50 LSYAELERHsAAFAAYLQQHTDLVPGDRIAV---QMPNVLqypIAVFGALRAGLIVVNTNPLYTAREMRHQFKDSGARAL 126
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1596 L-LQSAGLHVPEFTG--EIVYLNQTNSG-----LAHRLSNPNVDV---------LPQSLAY------------------- 1639
Cdd:PRK12492 127 VyLNMFGKLVQEVLPdtGIEYLIEAKMGdllpaAKGWLVNTVVDKvkkmvpayhLPQAVPFkqalrqgrglslkpvpvgl 206
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1640 -----VIYTSGSTGMPKGVEIEHRSAVnfLNSLQSRYQLKHSD-------------MIMHKTSYSFDASIWELFWWPYAG 1701
Cdd:PRK12492 207 ddiavLQYTGGTTGLAKGAMLTHGNLV--ANMLQVRACLSQLGpdgqplmkegqevMIAPLPLYHIYAFTANCMCMMVSG 284
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1702 ASVYLLpqggeKEPEVIAKAIEE---QKITAMHFVPSMLHAFLEHIKYRSVPIktNRLKRVFSGGEQLGTHLVSRfYELL 1778
Cdd:PRK12492 285 NHNVLI-----TNPRDIPGFIKElgkWRFSALLGLNTLFVALMDHPGFKDLDF--SALKLTNSGGTALVKATAER-WEQL 356
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1779 PNVSITNSYGPTEATVEAAffdCPPHEKLERI-PIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALT 1857
Cdd:PRK12492 357 TGCTIVEGYGLTETSPVAS---TNPYGELARLgTVGIPVPGTALKVIDDDGNELPLGERGELCIKGPQVMKGYWQQPEAT 433
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1858 EERFledpfyPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTD--SGEPE- 1934
Cdd:PRK12492 434 AEAL------DAEGWFKTGDIAVIDPDGFVRIVDRKKDLIIVSGFNVYPNEIEDVVMAHPKVANCAAIGVPDerSGEAVk 507
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 1935 --LCAYVEGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK12492 508 lfVVARDPGLSVEELKAYCKENFTGYKVPKHIVLRDSLPMTPVGKILRREL 558
|
|
| PRK07786 |
PRK07786 |
long-chain-fatty-acid--CoA ligase; Validated |
1500-1998 |
4.28e-22 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 169098 [Multi-domain] Cd Length: 542 Bit Score: 103.70 E-value: 4.28e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYP 1579
Cdd:PRK07786 23 LARHALMQPDAPALRFLGNTTTWRELDDRVAALAGALSRRGVGFGDRVLILMLNRTEFVESVLAANMLGAIAVPVNFRLT 102
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1580 EERISFLLEDSGTNILLLQS--AGLH------VPEFTGEIV-----------YLNQTNS-GLAHrlsnPNVDVLPQSLAY 1639
Cdd:PRK07786 103 PPEIAFLVSDCGAHVVVTEAalAPVAtavrdiVPLLSTVVVaggssddsvlgYEDLLAEaGPAH----APVDIPNDSPAL 178
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1640 VIYTSGSTGMPKGVEIEHRS----AVNFLNSlqSRYQLKHSdmIMHKTSYSFD-ASIWELFWWPYAGASVYLLPQGGeKE 1714
Cdd:PRK07786 179 IMYTSGTTGRPKGAVLTHANltgqAMTCLRT--NGADINSD--VGFVGVPLFHiAGIGSMLPGLLLGAPTVIYPLGA-FD 253
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1715 PEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTnrlkRVFSGGEQLGTH-LVSRFYELLPNVSITNSYGPTEAT 1793
Cdd:PRK07786 254 PGQLLDVLEAEKVTGIFLVPAQWQAVCAEQQARPRDLAL----RVLSWGAAPASDtLLRQMAATFPEAQILAAFGQTEMS 329
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1794 VEAAFFDcpPHEKLERI-PIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYpgerm 1872
Cdd:PRK07786 330 PVTCMLL--GEDAIRKLgSVGKVIPTVAARVVDENMNDVPVGEVGEIVYRAPTLMSGYWNNPEATAEAFAGGWFH----- 402
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1873 ykTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDSGEPELCAYVEGLQRNEVRAQLE 1952
Cdd:PRK07786 403 --SGDLVRQDEEGYVWVVDRKKDMIISGGENIYCAEVENVLASHPDIVEVAVIGRADEKWGEVPVAVAAVRNDDAALTLE 480
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 1953 RL-------LPGYMVPAYMIEMEQWPVTPSGKLD----RNALPAPGGAADAETYTAP 1998
Cdd:PRK07786 481 DLaefltdrLARYKHPKALEIVDALPRNPAGKVLktelRERYGACVNVERRSASAGF 537
|
|
| PRK05677 |
PRK05677 |
long-chain-fatty-acid--CoA ligase; Validated |
1620-1983 |
4.57e-22 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 168170 [Multi-domain] Cd Length: 562 Bit Score: 103.69 E-value: 4.57e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1620 GLAHRLSNPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNflNSLQSRyQLKHSDM------------IMHKTSYSF 1687
Cdd:PRK05677 192 AKGAGQPVTEANPQADDVAVLQYTGGTTGVAKGAMLTHRNLVA--NMLQCR-ALMGSNLnegceiliaplpLYHIYAFTF 268
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1688 DASIWELfwwpyAGASVYLLPQggEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIktNRLKRVFSGGEQLg 1767
Cdd:PRK05677 269 HCMAMML-----IGNHNILISN--PRDLPAMVKELGKWKFSGFVGLNTLFVALCNNEAFRKLDF--SALKLTLSGGMAL- 338
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1768 THLVSRFYELLPNVSITNSYGPTEATVEAAFfdcPPHEKLERIPIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVA 1847
Cdd:PRK05677 339 QLATAERWKEVTGCAICEGYGMTETSPVVSV---NPSQAIQVGTIGIPVPSTLCKVIDDDGNELPLGEVGELCVKGPQVM 415
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1848 RGYLNRPALTEERFLEDPFYpgermyKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVRE-AAVTV 1926
Cdd:PRK05677 416 KGYWQRPEATDEILDSDGWL------KTGDIALIQEDGYMRIVDRKKDMILVSGFNVYPNELEDVLAALPGVLQcAAIGV 489
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 1927 RTD-SGEpELCAYV-----EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK05677 490 PDEkSGE-AIKVFVvvkpgETLTKEQVMEHMRANLTGYKVPKAVEFRDELPTTNVGKILRREL 551
|
|
| FADD10 |
cd17635 |
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain ... |
2678-3016 |
4.65e-22 |
|
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain fatty acid CoA ligases, including FadD10 which is involved in the synthesis of a virulence-related lipopeptide. FadD10 is a fatty acyl-AMP ligase (FAAL) that transfers fatty acids to an acyl carrier protein. Structures of FadD10 in apo- and complexed form with dodecanoyl-AMP, show a novel open conformation, facilitated by its unique inter-domain and intermolecular interactions, which is critical for the enzyme to carry out the acyl transfer onto the acyl carrier protein (Rv0100) rather than coenzyme A.
Pssm-ID: 341290 [Multi-domain] Cd Length: 340 Bit Score: 100.80 E-value: 4.65e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2678 IIYTSGTTGRPKGVMVEHKG-IANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLL-SGAKAVLLHEEEAKDILA 2755
Cdd:cd17635 6 VIFTSGTTGEPKAVLLANKTfFAVPDILQKEGLNWVVGDVTYLPLPATHIGGLWWILTCLIhGGLCVTGGENTTYKSLFK 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2756 IkhqLSRQRITHMIIVPVLYRALLDVVQP--EDVKTLRVVTLAGEAADRELIARSLAIcPHTELANEYGPTENSVATTVM 2833
Cdd:cd17635 86 I---LTTNAVTTTCLVPTLLSKLVSELKSanATVPSLRLIGYGGSRAIAADVRFIEAT-GLTNTAQVYGLSETGTALCLP 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2834 RHMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFKpearmyrTGDAARW 2913
Cdd:cd17635 162 TDDDSIEINAVGRPYPGVDVYLAATDGIAGPSASFGTIWIKSPANMLGYWNNPERTAEVLIDGWVN-------TGDLGER 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2914 MADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTNAVRS---ELQNK 2990
Cdd:cd17635 235 REDGFLFITGRSSESINCGGVKIAPDEVERIAEGVSGVQECACYEISDEEFGELVGLAVVASAELDENAIRAlkhTIRRE 314
|
330 340
....*....|....*....|....*.
gi 1678550997 2991 LPVFMHPAFIEKLDSLPLSPNGKLDR 3016
Cdd:cd17635 315 LEPYARPSTIVIVTDIPRTQSGKVKR 340
|
|
| PRK12406 |
PRK12406 |
long-chain-fatty-acid--CoA ligase; Provisional |
479-955 |
5.15e-22 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 183506 [Multi-domain] Cd Length: 509 Bit Score: 103.24 E-value: 5.15e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 479 AHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHD 558
Cdd:PRK12406 2 YATIISGDRRRSFDELAQRAARAAGGLAALGVRPGDCVALLMRNDFAFFEAAYAAMRLGAYAVPVNWHFKPEEIAYILED 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 559 CGCSHVVSQA--------HLPSSLEDNYIITHPEDIES-KVDGSNIKSVNNADDL--------LY----------MIYTS 611
Cdd:PRK12406 82 SGARVLIAHAdllhglasALPAGVTVLSVPTPPEIAAAyRISPALLTPPAGAIDWegwlaqqePYdgppvpqpqsMIYTS 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 612 GTTGKPKGVQfehRNMANLlkfEYTHSGIDFEADVLQFATPSFDVC----YQE------IFSALLkGGTLHIVPeaiKRD 681
Cdd:PRK12406 162 GTTGHPKGVR---RAAPTP---EQAAAAEQMRALIYGLKPGIRALLtgplYHSapnaygLRAGRL-GGVLVLQP---RFD 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 682 VPQLFAFINKHQ-TNIVFLPTAFIKMIfserelanSFPDGVK---------HLIAAG-------EQLMIsDLFQDVlrkr 744
Cdd:PRK12406 232 PEELLQLIERHRiTHMHMVPTMFIRLL--------KLPEEVRakydvsslrHVIHAAapcpadvKRAMI-EWWGPV---- 298
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 745 gihLHNHYGPSETHVVSTYTI-----HPGDpipelppIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVAR-GYVNH 818
Cdd:PRK12406 299 ---IYEYYGSTESGAVTFATSedalsHPGT-------VGKAAPGAELRFVDEDGRPLPQGEIGEIYSRIAGNPDfTYHNK 368
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 819 D----KLTSDKFSSdpfkpdvimyrTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQD 894
Cdd:PRK12406 369 PekraEIDRGGFIT-----------SGDVGYLDADGYLFLCDRKRDMVISGGVNIYPAEIEAVLHAVPGVHDCAVFGIPD 437
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 895 QNGEHELCAYycsVQ-----KLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPEP 955
Cdd:PRK12406 438 AEFGEALMAV---VEpqpgaTLDEADIRAQLKARLAGYKVPKHIEIMAELPREDSGKIFKRRLRDP 500
|
|
| FACL_like_4 |
cd05944 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
2675-3019 |
7.04e-22 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341266 [Multi-domain] Cd Length: 359 Bit Score: 100.63 E-value: 7.04e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2675 LAYIIYTSGTTGRPKGVMVEHKG-IANTLQWRRNAyAFNETDTIL-QLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKD 2752
Cdd:cd05944 4 VAAYFHTGGTTGTPKLAQHTHSNeVYNAWMLALNS-LFDPDDVLLcGLPLFHVNGSVVTLLTPLASGAHVVLAGPAGYRN 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2753 ILAIKH---QLSRQRITHMIIVPVLYRALLDVVQPEDVKTLRVVTLAGEAADRELIARslaICPHTELA--NEYGPTENS 2827
Cdd:cd05944 83 PGLFDNfwkLVERYRITSLSTVPTVYAALLQVPVNADISSLRFAMSGAAPLPVELRAR---FEDATGLPvvEGYGLTEAT 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2828 VATTVMRHMEKQAYVSIGQPIDGTQVLILNSN---HQLQPIGV--AGELCIAGTGLARGYVNlPELTERAFTQNpfkpea 2902
Cdd:cd05944 160 CLVAVNPPDGPKRPGSVGLRLPYARVRIKVLDgvgRLLRDCAPdeVGEICVAGPGVFGGYLY-TEGNKNAFVAD------ 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2903 RMYRTGDAARWMADGTLEYLGRIDDQVkIR-GYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLS-- 2979
Cdd:cd05944 233 GWLNTGDLGRLDADGYLFITGRAKDLI-IRgGHNIDPALIEEALLRHPAVAFAGAVGQPDAHAGELPVAYVQLKPGAVve 311
|
330 340 350 360
....*....|....*....|....*....|....*....|....
gi 1678550997 2980 ----TNAVRSELQNKLPVfmhPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:cd05944 312 eeelLAWARDHVPERAAV---PKHIEVLEELPVTAVGKVFKPAL 352
|
|
| PRK08974 |
PRK08974 |
long-chain-fatty-acid--CoA ligase FadD; |
2527-3019 |
8.62e-22 |
|
long-chain-fatty-acid--CoA ligase FadD;
Pssm-ID: 236359 [Multi-domain] Cd Length: 560 Bit Score: 102.82 E-value: 8.62e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2527 ANQYgvQTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSR-GVKPDTPVGIMMHRSFSMIASILGVWK 2605
Cdd:PRK08974 19 PDRY--QSLVDMFEQAVARYADQPAFINMGEVMTFRKLEERSRAFAAYLQNGlGLKKGDRVALMMPNLLQYPIALFGILR 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2606 AGGCYVPIDPEY-PKERKrYILSDSGTKLLMtineadlgVLADFEGeilTIESVEEDD---------------------- 2662
Cdd:PRK08974 97 AGMIVVNVNPLYtPRELE-HQLNDSGAKAIV--------IVSNFAH---TLEKVVFKTpvkhviltrmgdqlstakgtlv 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2663 ------------KSPLPQ---MSSAHH----------------LAYIIYTSGTTGRPKGVMVEHKG-IANTLQWRRNAYA 2710
Cdd:PRK08974 165 nfvvkyikrlvpKYHLPDaisFRSALHkgrrmqyvkpelvpedLAFLQYTGGTTGVAKGAMLTHRNmLANLEQAKAAYGP 244
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2711 FNETD-----TILQL---FSFSFDGFitsMFTPLlsGAKAVLLheEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDvv 2782
Cdd:PRK08974 245 LLHPGkelvvTALPLyhiFALTVNCL---LFIEL--GGQNLLI--TNPRDIPGFVKELKKYPFTAITGVNTLFNALLN-- 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2783 QPE----DVKTLRVVTLAGEAADRELIARSLAICpHTELANEYGPTENSVATTVMRHMEKQAYVSIGQPIDGTQVLILNS 2858
Cdd:PRK08974 316 NEEfqelDFSSLKLSVGGGMAVQQAVAERWVKLT-GQYLLEGYGLTECSPLVSVNPYDLDYYSGSIGLPVPSTEIKLVDD 394
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2859 NHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNpfkpearMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVET 2938
Cdd:PRK08974 395 DGNEVPPGEPGELWVKGPQVMLGYWQRPEATDEVIKDG-------WLATGDIAVMDEEGFLRIVDRKKDMILVSGFNVYP 467
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2939 KEIESVIRCIKGVKDAAV--VAHvTASGQTeLSAYVVTK-PGLSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLD 3015
Cdd:PRK08974 468 NEIEDVVMLHPKVLEVAAvgVPS-EVSGEA-VKIFVVKKdPSLTEEELITHCRRHLTGYKVPKLVEFRDELPKSNVGKIL 545
|
....
gi 1678550997 3016 RGAL 3019
Cdd:PRK08974 546 RREL 549
|
|
| ttLC_FACS_AEE21_like |
cd12118 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This ... |
470-947 |
8.69e-22 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This family includes fatty acyl-CoA synthetases that can activate medium to long-chain fatty acids. These enzymes catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family has been shown to catalyze the long-chain fatty acid, myristoyl acid. Also included in this family are acyl activating enzymes from Arabidopsis, which contains a large number of proteins from this family with up to 63 different genes, many of which are uncharacterized.
Pssm-ID: 341283 [Multi-domain] Cd Length: 486 Bit Score: 102.38 E-value: 8.69e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 470 EKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPA 549
Cdd:cd12118 11 ERAAAVYPDRTSIVYGDRRYTWRQTYDRCRRLASALAALGISRGDTVAVLAPNTPAMYELHFGVPMAGAVLNALNTRLDA 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 550 DRIRYILHDCGCSHVvsqahlpsslednyIITHPEDIESKVDGSN----IKSVNNADDLLYMIYTSGTTGKPKGVQFEHR 625
Cdd:cd12118 91 EEIAFILRHSEAKVL--------------FVDREFEYEDLLAEGDpdfeWIPPADEWDPIALNYTSGTTGRPKGVVYHHR 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 626 N-----MANLLKFEYTHSGidfeadVLQFATPSFDV---CYQEIFSALlkGGTlHIVPEAIkrDVPQLFAFINKHQ-TNI 696
Cdd:cd12118 157 GaylnaLANILEWEMKQHP------VYLWTLPMFHCngwCFPWTVAAV--GGT-NVCLRKV--DAKAIYDLIEKHKvTHF 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 697 VFLPTAFIKMIFSERELANSFPDGVK----------HLIAAGEQLmisdlfqdvlrkrGIHLHNHYGPSET---HVVSTY 763
Cdd:cd12118 226 CGAPTVLNMLANAPPSDARPLPHRVHvmtagapppaAVLAKMEEL-------------GFDVTHVYGLTETygpATVCAW 292
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 764 TihpgDPIPELPP---------IGKP-IGCTDLYILNHQKQlQPcgVP------GELYISGASVARGYVNHDKLTSDKFS 827
Cdd:cd12118 293 K----PEWDELPTeerarlkarQGVRyVGLEEVDVLDPETM-KP--VPrdgktiGEIVFRGNIVMKGYLKNPEATAEAFR 365
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 828 SDpfkpdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQN-GEhELCAYyc 906
Cdd:cd12118 366 GG-------WFHSGDLAVIHPDGYIEIKDRSKDIIISGGENISSVEVEGVLYKHPAVLEAAVVARPDEKwGE-VPCAF-- 435
|
490 500 510 520
....*....|....*....|....*....|....*....|....*.
gi 1678550997 907 sV-----QKLNTIDLRSYMASELPEYMIPaKWIWVDSIPLTPNGKV 947
Cdd:cd12118 436 -VelkegAKVTEEEIIAFCREHLAGFMVP-KTVVFGELPKTSTGKI 479
|
|
| FACL_like_5 |
cd05924 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
2677-3015 |
1.09e-21 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341248 [Multi-domain] Cd Length: 364 Bit Score: 100.15 E-value: 1.09e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2677 YIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTP-------------LLSGAKAV 2743
Cdd:cd05924 7 YILYTGGTTGMPKGVMWRQEDIFRMLMGGADFGTGEFTPSEDAHKAAAAAAGTVMFPAPplmhgtgswtafgGLLGGQTV 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2744 LLHEEE--AKDILAIKHqlsRQRITHMIIV-PVLYRALLDVVQ---PEDVKTLRVVTLAGEAADRELIARSLAICPHTEL 2817
Cdd:cd05924 87 VLPDDRfdPEEVWRTIE---KHKVTSMTIVgDAMARPLIDALRdagPYDLSSLFAISSGGALLSPEVKQGLLELVPNITL 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2818 ANEYGPTENSvatTVMRHMEKQAYVSIG--QPIDGTQVLILNSNHQLQPiGVAGELCIAGTGL-ARGYVNLPELTERAFt 2894
Cdd:cd05924 164 VDAFGSSETG---FTGSGHSAGSGPETGpfTRANPDTVVLDDDGRVVPP-GSGGVGWIARRGHiPLGYYGDEAKTAETF- 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2895 qnPFKPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVT 2974
Cdd:cd05924 239 --PEVDGVRYAVPGDRATVEADGTVTLLGRGSVCINTGGEKVFPEEVEEALKSHPAVYDVLVVGRPDERWGQEVVAVVQL 316
|
330 340 350 360
....*....|....*....|....*....|....*....|...
gi 1678550997 2975 KPG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLD 3015
Cdd:cd05924 317 REGagVDLEELREHCRTRIARYKLPKQVVFVDEIERSPAGKAD 359
|
|
| PRK08315 |
PRK08315 |
AMP-binding domain protein; Validated |
1493-1977 |
1.20e-21 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236236 [Multi-domain] Cd Length: 559 Bit Score: 102.58 E-value: 1.20e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1493 NQTLHYALEQQAEKTPDQAAVIFED-GV-MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGA 1570
Cdd:PRK08315 15 EQTIGQLLDRTAARYPDREALVYRDqGLrWTYREFNEEVDALAKGLLALGIEKGDRVGIWAPNVPEWVLTQFATAKIGAI 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1571 YLPIDPDYPEERISFLLEDSGTNILL----------------------------LQSAGLhvPEFTgEIVYLNQTNSG-- 1620
Cdd:PRK08315 95 LVTINPAYRLSELEYALNQSGCKALIaadgfkdsdyvamlyelapelatcepgqLQSARL--PELR-RVIFLGDEKHPgm 171
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1621 --------LAHRLSNPNVDVLPQSLAY--VI---YTSGSTGMPKGVEIEHRsavNFLN---SLQSRYQLKHSD------- 1677
Cdd:PRK08315 172 lnfdellaLGRAVDDAELAARQATLDPddPIniqYTSGTTGFPKGATLTHR---NILNngyFIGEAMKLTEEDrlcipvp 248
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1678 ------MIM-------HktsysfdasiwelfwwpyaGAS-VYLLPqggEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEH 1743
Cdd:PRK08315 249 lyhcfgMVLgnlacvtH-------------------GATmVYPGE---GFDPLATLAAVEEERCTALYGVPTMFIAELDH 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1744 IKYRS---------------VPIKTnrLKRVfsggeqlgthlVSRFYelLPNVSItnSYGPTEAT-VeaaFFDCPPHEKL 1807
Cdd:PRK08315 307 PDFARfdlsslrtgimagspCPIEV--MKRV-----------IDKMH--MSEVTI--AYGMTETSpV---STQTRTDDPL 366
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1808 ER--IPIGKPVHHVRLYLLN-QNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFypgerMYkTGDVARWLPD 1884
Cdd:PRK08315 367 EKrvTTVGRALPHLEVKIVDpETGETVPRGEQGELCTRGYSVMKGYWNDPEKTAEAIDADGW-----MH-TGDLAVMDEE 440
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1885 GNVEFLGRTDDQVkIR-GYRIEPGEIEAALRSIEGVREAAVTVRTDS--GEpELCAYV---EG--LQRNEVRA----QLE 1952
Cdd:PRK08315 441 GYVNIVGRIKDMI-IRgGENIYPREIEEFLYTHPKIQDVQVVGVPDEkyGE-EVCAWIilrPGatLTEEDVRDfcrgKIA 518
|
570 580
....*....|....*....|....*
gi 1678550997 1953 RllpgYMVPAYMIEMEQWPVTPSGK 1977
Cdd:PRK08315 519 H----YKIPRYIRFVDEFPMTVTGK 539
|
|
| LC-FACS_euk |
cd05927 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are ... |
2559-2930 |
1.37e-21 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are eukaryotic fatty acid CoA synthetases that activate fatty acids with chain lengths of 12 to 20. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells.
Pssm-ID: 341250 [Multi-domain] Cd Length: 545 Bit Score: 102.29 E-value: 1.37e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2559 LTYQELDEWSNGIARALRSRGVK--PDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMt 2636
Cdd:cd05927 6 ISYKEVAERADNIGSALRSLGGKpaPASFVGIYSINRPEWIISELACYAYSLVTVPLYDTLGPEAIEYILNHAEISIVF- 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2637 ineADLGVladfegEILTIESVEE---DDKSPLPQmSSAHHLAYIIYTSGTTGRPKGVMVEHKGIANTL-----QWRRnA 2708
Cdd:cd05927 85 ---CDAGV------KVYSLEEFEKlgkKNKVPPPP-PKPEDLATICYTSGTTGNPKGVMLTHGNIVSNVagvfkILEI-L 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2709 YAFNETDTilqLFSF-----SFDGFITSMFtpLLSGAK---------------AVL--------------LHE-----EE 2749
Cdd:cd05927 154 NKINPTDV---YISYlplahIFERVVEALF--LYHGAKigfysgdirlllddiKALkptvfpgvprvlnrIYDkifnkVQ 228
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2750 AKDIL-------AIKHQLSRQRITHMIIVPVLYRALLDVVQPEDVKTLRVVTLAGEAADRELI--ARSLAICPHTElanE 2820
Cdd:cd05927 229 AKGPLkrklfnfALNYKLAELRSGVVRASPFWDKLVFNKIKQALGGNVRLMLTGSAPLSPEVLefLRVALGCPVLE---G 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2821 YGPTENSVATTVMRHMEKqAYVSIGQPIDGTQV-LI----LNSNHQLQPigVAGELCIAGTGLARGYVNLPELTERAFTQ 2895
Cdd:cd05927 306 YGQTECTAGATLTLPGDT-SVGHVGGPLPCAEVkLVdvpeMNYDAKDPN--PRGEVCIRGPNVFSGYYKDPEKTAEALDE 382
|
410 420 430
....*....|....*....|....*....|....*
gi 1678550997 2896 NPFkpearmYRTGDAARWMADGTLeylgRIDDQVK 2930
Cdd:cd05927 383 DGW------LHTGDIGEWLPNGTL----KIIDRKK 407
|
|
| MACS_like_1 |
cd05974 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
489-890 |
1.55e-21 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341278 [Multi-domain] Cd Length: 432 Bit Score: 100.72 E-value: 1.55e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 489 LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRyilhdcgcSHVVSQA 568
Cdd:cd05974 1 VSFAEMSARSSRVANFLRSIGVGRGDRILLMLGNVVELWEAMLAAMKLGAVVIPATTLLTPDDLR--------DRVDRGG 72
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 569 HLPSSLEDNyiiTHpedieskvdgsniksvnnADDLLYMIYTSGTTGKPKGVQFEHRNM-ANLLKFEYtHSGIDfEADV- 646
Cdd:cd05974 73 AVYAAVDEN---TH------------------ADDPMLLYFTSGTTSKPKLVEHTHRSYpVGHLSTMY-WIGLK-PGDVh 129
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 647 LQFATPSF-DVCYQEIFSALLKGGTLHIVPEAiKRDVPQLFAFINKHQTNIVFLPTAFIKMIFSErELAnSFPDGVKHLI 725
Cdd:cd05974 130 WNISSPGWaKHAWSCFFAPWNAGATVFLFNYA-RFDAKRVLAALVRYGVTTLCAPPTVWRMLIQQ-DLA-SFDVKLREVV 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 726 AAGEQLMiSDLFQDVLRKRGIHLHNHYGPSETHVVSTYTihPGDPIpELPPIGKPIGCTDLYILNhqkqlqPCGVP---G 802
Cdd:cd05974 207 GAGEPLN-PEVIEQVRRAWGLTIRDGYGQTETTALVGNS--PGQPV-KAGSMGRPLPGYRVALLD------PDGAPateG 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 803 ELYIS-----GASVARGYVNHDKLTSDKFSSDpfkpdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVT 877
Cdd:cd05974 277 EVALDlgdtrPVGLMKGYAGDPDKTAHAMRGG-------YYRTGDIAMRDEDGYLTYVGRADDVFKSSDYRISPFELESV 349
|
410
....*....|...
gi 1678550997 878 LMNHPDISEAAIL 890
Cdd:cd05974 350 LIEHPAVAEAAVV 362
|
|
| A_NRPS_TubE_like |
cd05906 |
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) ... |
2533-3021 |
2.36e-21 |
|
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) synthesizing toxins and antitumor agents; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino)-acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family includes NRPSs that synthesize toxins and antitumor agents; for example, TubE for Tubulysine, CrpA for cryptophycin, TdiA for terrequinone A, KtzG for kutzneride, and Vlm1/Vlm2 for Valinomycin. Nonribosomal peptide synthetases are large multifunctional enzymes which synthesize many therapeutically useful peptides. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341232 [Multi-domain] Cd Length: 540 Bit Score: 101.59 E-value: 2.36e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2533 QTISQLFEQQAARTPKA----SALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGG 2608
Cdd:cd05906 10 RTLLELLLRAAERGPTKgityIDADGSEEFQSYQDLLEDARRLAAGLRQLGLRPGDSVILQFDDNEDFIPAFWACVLAGF 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2609 --CYVPIDPEYPKERKR--------------YILSDSGTKLLMTINEADLGVLADfegEILTIESVEEDDKSPLPQMSSA 2672
Cdd:cd05906 90 vpAPLTVPPTYDEPNARlrklrhiwqllgspVVLTDAELVAEFAGLETLSGLPGI---RVLSIEELLDTAADHDLPQSRP 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2673 HHLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQLFSFSFDGFITSM-FTPLLSGAKAVLLHEEEak 2751
Cdd:cd05906 167 DDLALLMLTSGSTGFPKAVPLTHRNILARSAGKIQHNGLTPQDVFLNWVPLDHVGGLVELhLRAVYLGCQQVHVPTEE-- 244
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2752 dILAIKHQ----LSRQRITHMIIVPVLYRALLDVV-----QPEDVKTLRVVTLAGEAADRELIARSLAI-----CPHTEL 2817
Cdd:cd05906 245 -ILADPLRwldlIDRYRVTITWAPNFAFALLNDLLeeiedGTWDLSSLRYLVNAGEAVVAKTIRRLLRLlepygLPPDAI 323
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2818 ANEYGPTENSVATTVMRHMEKQA------YVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTER 2891
Cdd:cd05906 324 RPAFGMTETCSGVIYSRSFPTYDhsqaleFVSLGRPIPGVSMRIVDDEGQLLPEGEVGRLQVRGPVVTKGYYNNPEANAE 403
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2892 AFTqnpfkpEARMYRTGDAArWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKD--AAVVAHVTASGQTE-- 2967
Cdd:cd05906 404 AFT------EDGWFRTGDLG-FLDNGNLTITGRTKDTIIVNGVNYYSHEIEAAVEEVPGVEPsfTAAFAVRDPGAETEel 476
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 2968 ----LSAYVVTKPGLSTN-AVRSELQNKLPVfmHPAFIEKL--DSLPLSPNGKLDRGALPK 3021
Cdd:cd05906 477 aiffVPEYDLQDALSETLrAIRSVVSREVGV--SPAYLIPLpkEEIPKTSLGKIQRSKLKA 535
|
|
| PLN02574 |
PLN02574 |
4-coumarate--CoA ligase-like |
1635-1983 |
2.40e-21 |
|
4-coumarate--CoA ligase-like
Pssm-ID: 215312 [Multi-domain] Cd Length: 560 Bit Score: 101.46 E-value: 2.40e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1635 QSLAYVIYTSGSTGMPKGVEIEHRsavNFLNSLQ-------SRYQLKHSDMIMHKTSYSFDASIWELFWWPYA--GASVY 1705
Cdd:PLN02574 198 DDVAAIMYSSGTTGASKGVVLTHR---NLIAMVElfvrfeaSQYEYPGSDNVYLAALPMFHIYGLSLFVVGLLslGSTIV 274
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1706 LLPQGGEKEpevIAKAIEEQKITAMHFVPSMLHAFLEHIK-YRSVPIKTnrLKRVFSGGEQLGTHLVSRFYELLPNVSIT 1784
Cdd:PLN02574 275 VMRRFDASD---MVKVIDRFKVTHFPVVPPILMALTKKAKgVCGEVLKS--LKQVSCGAAPLSGKFIQDFVQTLPHVDFI 349
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1785 NSYGPTEAT-VEAAFFDCPPHEKLERIPIGKPVHHVRLYLLNQNQrMLPVGCIGELYIAGAGVARGYLNRPALTEERFLE 1863
Cdd:PLN02574 350 QGYGMTESTaVGTRGFNTEKLSKYSSVGLLAPNMQAKVVDWSTGC-LLPPGNCGELWIQGPGVMKGYLNNPKATQSTIDK 428
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1864 DPFYpgermyKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDSGEPEL-CAYV--- 1939
Cdd:PLN02574 429 DGWL------RTGDIAYFDEDGYLYIVDRLKEIIKYKGFQIAPADLEAVLISHPEIIDAAVTAVPDKECGEIpVAFVvrr 502
|
330 340 350 360
....*....|....*....|....*....|....*....|....*.
gi 1678550997 1940 --EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PLN02574 503 qgSTLSQEAVINYVAKQVAPYKKVRKVVFVQSIPKSPAGKILRREL 548
|
|
| Firefly_Luc |
cd17642 |
insect luciferase, similar to plant 4-coumarate: CoA ligases; This family contains insect ... |
2675-3019 |
3.42e-21 |
|
insect luciferase, similar to plant 4-coumarate: CoA ligases; This family contains insect firefly luciferases that share significant sequence similarity to plant 4-coumarate:coenzyme A ligases, despite their functional diversity. Luciferase catalyzes the production of light in the presence of MgATP, molecular oxygen, and luciferin. In the first step, luciferin is activated by acylation of its carboxylate group with ATP, resulting in an enzyme-bound luciferyl adenylate. In the second step, luciferyl adenylate reacts with molecular oxygen, producing an enzyme-bound excited state product (Luc=O*) and releasing AMP. This excited-state product then decays to the ground state (Luc=O), emitting a quantum of visible light.
Pssm-ID: 341297 [Multi-domain] Cd Length: 532 Bit Score: 101.06 E-value: 3.42e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2675 LAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRN---AYAFNETDTILQLFSFsFDGFitSMFTPL---LSGAKAVLLHEE 2748
Cdd:cd17642 186 VALIMNSSGSTGLPKGVQLTHKNIVARFSHARDpifGNQIIPDTAILTVIPF-HHGF--GMFTTLgylICGFRVVLMYKF 262
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2749 EAKDILAikhQLSRQRITHMIIVPVLYRALL--DVVQPEDVKTLRVVTLAGEAADREL---IARSLAIcphTELANEYGP 2823
Cdd:cd17642 263 EEELFLR---SLQDYKVQSALLVPTLFAFFAksTLVDKYDLSNLHEIASGGAPLSKEVgeaVAKRFKL---PGIRQGYGL 336
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2824 TENSVATTVMRHME-KQAYVSIGQPIDGTQVLILNSNHQLQPiGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpea 2902
Cdd:cd17642 337 TETTSAILITPEGDdKPGAVGKVVPFFYAKVVDLDTGKTLGP-NERGELCVKGPMIMKGYVNNPEATKALIDKDGW---- 411
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2903 rmYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAvVAHVTASGQTEL-SAYVVTKPGLSTN 2981
Cdd:cd17642 412 --LHSGDIAYYDEDGHFFIVDRLKSLIKYKGYQVPPAELESILLQHPKIFDAG-VAGIPDEDAGELpAAVVVLEAGKTMT 488
|
330 340 350 360
....*....|....*....|....*....|....*....|...
gi 1678550997 2982 avRSELQNKLPVFMHPAF-----IEKLDSLPLSPNGKLDRGAL 3019
Cdd:cd17642 489 --EKEVMDYVASQVSTAKrlrggVKFVDEVPKGLTGKIDRRKI 529
|
|
| PRK04319 |
PRK04319 |
acetyl-CoA synthetase; Provisional |
2556-3016 |
3.83e-21 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 235279 [Multi-domain] Cd Length: 570 Bit Score: 101.13 E-value: 3.83e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2556 DKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPI----DPEYPKERkryiLSDSGT 2631
Cdd:PRK04319 71 KEKYTYKELKELSNKFANVLKELGVEKGDRVFIFMPRIPELYFALLGALKNGAIVGPLfeafMEEAVRDR----LEDSEA 146
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2632 KLLMTINEADLGVLAD----FEGEILTIESVEEDDKS-PLPQ-MSSAHH-----------LAYIIYTSGTTGRPKGVMVE 2694
Cdd:PRK04319 147 KVLITTPALLERKPADdlpsLKHVLLVGEDVEEGPGTlDFNAlMEQASDefdiewtdredGAILHYTSGSTGKPKGVLHV 226
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2695 HKgiANTLQWRRNAYA--FNETDtilqLFSFSFD-GFITSM----FTPLLSGAKAVLLHEE-EAKDILAIkhqLSRQRIT 2766
Cdd:PRK04319 227 HN--AMLQHYQTGKYVldLHEDD----VYWCTADpGWVTGTsygiFAPWLNGATNVIDGGRfSPERWYRI---LEDYKVT 297
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2767 HMIIVPVLYRALL----DVVQPEDVKTLRVVTLAGEAADRELI---ARSLAICPH-----TE-----LANEYGptensva 2829
Cdd:PRK04319 298 VWYTAPTAIRMLMgagdDLVKKYDLSSLRHILSVGEPLNPEVVrwgMKVFGLPIHdnwwmTEtggimIANYPA------- 370
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2830 ttvmrhME-KQAyvSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAgTG---LARGYVNLPELTERAFTQNpfkpearMY 2905
Cdd:PRK04319 371 ------MDiKPG--SMGKPLPGIEAAIVDDQGNELPPNRMGNLAIK-KGwpsMMRGIWNNPEKYESYFAGD-------WY 434
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2906 RTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAH---VTasGQTeLSAYVVTKPGL-STN 2981
Cdd:PRK04319 435 VSGDSAYMDEDGYFWFQGRVDDVIKTSGERVGPFEVESKLMEHPAVAEAGVIGKpdpVR--GEI-IKAFVALRPGYePSE 511
|
490 500 510
....*....|....*....|....*....|....*....
gi 1678550997 2982 AVRSELQN----KLPVFMHPAFIEKLDSLPLSPNGKLDR 3016
Cdd:PRK04319 512 ELKEEIRGfvkkGLGAHAAPREIEFKDKLPKTRSGKIMR 550
|
|
| Firefly_Luc |
cd17642 |
insect luciferase, similar to plant 4-coumarate: CoA ligases; This family contains insect ... |
1496-1983 |
4.04e-21 |
|
insect luciferase, similar to plant 4-coumarate: CoA ligases; This family contains insect firefly luciferases that share significant sequence similarity to plant 4-coumarate:coenzyme A ligases, despite their functional diversity. Luciferase catalyzes the production of light in the presence of MgATP, molecular oxygen, and luciferin. In the first step, luciferin is activated by acylation of its carboxylate group with ATP, resulting in an enzyme-bound luciferyl adenylate. In the second step, luciferyl adenylate reacts with molecular oxygen, producing an enzyme-bound excited state product (Luc=O*) and releasing AMP. This excited-state product then decays to the ground state (Luc=O), emitting a quantum of visible light.
Pssm-ID: 341297 [Multi-domain] Cd Length: 532 Bit Score: 100.68 E-value: 4.04e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1496 LHYALEQQAeKTPDqaAVIFEDGV----MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAY 1571
Cdd:cd17642 20 LHKAMKRYA-SVPG--TIAFTDAHtgvnYSYAEYLEMSVRLAEALKKYGLKQNDRIAVCSENSLQFFLPVIAGLFIGVGV 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1572 LPIDPDYPEERISFLLEDSGTNILLLQSAGLH--------VPeFTGEIVYLN--------QTNSGLAHRLSNPNVDVLP- 1634
Cdd:cd17642 97 APTNDIYNERELDHSLNISKPTIVFCSKKGLQkvlnvqkkLK-IIKTIIILDskedykgyQCLYTFITQNLPPGFNEYDf 175
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1635 --------QSLAYVIYTSGSTGMPKGVEIEHRsavNFLNSLQSRYQLKHSDMIMHKTS--------YSFdaSIWELFWWP 1698
Cdd:cd17642 176 kppsfdrdEQVALIMNSSGSTGLPKGVQLTHK---NIVARFSHARDPIFGNQIIPDTAiltvipfhHGF--GMFTTLGYL 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1699 YAGASVYLLPQggeKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHI---KYrsvpiKTNRLKRVFSGGEQL----GTHLV 1771
Cdd:cd17642 251 ICGFRVVLMYK---FEEELFLRSLQDYKVQSALLVPTLFAFFAKSTlvdKY-----DLSNLHEIASGGAPLskevGEAVA 322
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1772 SRFYelLPnvSITNSYGPTEATVEAAFF---DCPPHEkleripIGK--PVHHVRLY------LLNQNQRmlpvgciGELY 1840
Cdd:cd17642 323 KRFK--LP--GIRQGYGLTETTSAILITpegDDKPGA------VGKvvPFFYAKVVdldtgkTLGPNER-------GELC 385
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1841 IAGAGVARGYLNRPALTEERFLEDPFYpgermyKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVR 1920
Cdd:cd17642 386 VKGPMIMKGYVNNPEATKALIDKDGWL------HSGDIAYYDEDGHFFIVDRLKSLIKYKGYQVPPAELESILLQHPKIF 459
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 1921 EAAVTVRTDSGEPELCAYV----EGLQRNE------VRAQL---ERLLPGymvpayMIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd17642 460 DAGVAGIPDEDAGELPAAVvvleAGKTMTEkevmdyVASQVstaKRLRGG------VKFVDEVPKGLTGKIDRRKI 529
|
|
| SgcC5_NRPS-like |
cd19539 |
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- ... |
3151-3566 |
5.44e-21 |
|
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- bond forming activity and similar C-domains of modular NRPSs; SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. This subfamily also includes similar C-domains of modular NRPSs such as Penicillium chrysogenum N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase PCBAB. Condensation (C) domains of NRPSs normally catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380462 [Multi-domain] Cd Length: 427 Bit Score: 98.99 E-value: 5.44e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3151 SVQEDALRKTLKAITCHHDALRMVFTQNEQGKWDQYNRPLSHSDDALyglqmIDLSAPDGtdgnrPYEPLIKRHVLDIQQ 3230
Cdd:cd19539 35 PLDVEALREALRDVVARHEALRTLLVRDDGGVPRQEILPPGPAPLEV-----RDLSDPDS-----DRERRLEELLRERES 104
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3231 K-MDLKNGPLLQAGLF-HTIDGDFLFLSAHHLVVDGISWRVLLEDLALGYRQAAGGEDIKLPPKTSSFKAYAKKLSDYAE 3308
Cdd:cd19539 105 RgFDLDEEPPIRAVLGrFDPDDHVLVLVAHHTAFDAWSLDVFARDLAALYAARRKGPAAPLPELRQQYKEYAAWQREALA 184
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3309 SQQLMKQLKYWREA-EEYQTEALPFDQidgTRAHEGQRST--ISFTLNDKETAALLKDANSAYNTDTQdMLLASVILALR 3385
Cdd:cd19539 185 APRAAELLDFWRRRlRGAEPTALPTDR---PRPAGFPYPGadLRFELDAELVAALRELAKRARSSLFM-VLLAAYCVLLR 260
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3386 HWTNQSafklsleghgreDVLKGIDVS--------RTIGWFTAIYPLLIKLNaDLPDSEESMVHVLKTTKDTLR--RVPd 3455
Cdd:cd19539 261 RYTGQT------------DIVVGTPVAgrnhprfeSTVGFFVNLLPLRVDVS-DCATFRDLIARVRKALVDAQRhqELP- 326
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3456 kgfgygvIKYLTPPGKKDINFTGAP--EISFnylgQFESGRTAEVPEEDAFSFSPlgaGGDISTTwnreQSLDISAIAAE 3533
Cdd:cd19539 327 -------FQQLVAELPVDRDAGRHPlvQIVF----QVTNAPAGELELAGGLSYTE---GSDIPDG----AKFDLNLTVTE 388
|
410 420 430
....*....|....*....|....*....|....*
gi 1678550997 3534 --GKLTVNMTYDNARFQRKTIEQLSETCRQFLLQL 3566
Cdd:cd19539 389 egTGLRGSLGYATSLFDEETIQGFLADYLQVLRQL 423
|
|
| PRK05605 |
PRK05605 |
long-chain-fatty-acid--CoA ligase; Validated |
463-949 |
5.87e-21 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235531 [Multi-domain] Cd Length: 573 Bit Score: 100.46 E-value: 5.87e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 463 ETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVP 542
Cdd:PRK05605 32 TTLVDLYDNAVARFGDRPALDFFGATTTYAELGKQVRRAAAGLRALGVRPGDRVAIVLPNCPQHIVAFYAVLRLGAVVVE 111
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 543 VDPHYPADRIRYILHDCGC----------------------SHVVS---------------QAHLPSSLEDNYIITHP-- 583
Cdd:PRK05605 112 HNPLYTAHELEHPFEDHGArvaivwdkvaptverlrrttplETIVSvnmiaampllqrlalRLPIPALRKARAALTGPap 191
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 584 --EDIESKVDGSNIKSVN-------NADDLLYMIYTSGTTGKPKGVQFEHRN-MANLLKFEYTHSGIDFEADVLQFATPS 653
Cdd:PRK05605 192 gtVPWETLVDAAIGGDGSdvshprpTPDDVALILYTSGTTGKPKGAQLTHRNlFANAAQGKAWVPGLGDGPERVLAALPM 271
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 654 FDV-----CyqeIFSALLKGGTLHIVPeaiKRDVPQLFAFINKHQTNIV-FLPTAFIKMIFSERE-------LANSFpDG 720
Cdd:PRK05605 272 FHAygltlC---LTLAVSIGGELVLLP---APDIDLILDAMKKHPPTWLpGVPPLYEKIAEAAEErgvdlsgVRNAF-SG 344
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 721 VKHLIAAgeqlmISDLFQDVlrkRGIHLHNHYGPSETHVVSTytihpGDPI-PELPP--IGKPIGCTDLYILNHQK--QL 795
Cdd:PRK05605 345 AMALPVS-----TVELWEKL---TGGLLVEGYGLTETSPIIV-----GNPMsDDRRPgyVGVPFPDTEVRIVDPEDpdET 411
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 796 QPCGVPGELYISGASVARGYVNHDKLTSDKFSSDpfkpdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIE 875
Cdd:PRK05605 412 MPDGEEGELLVRGPQVFKGYWNRPEETAKSFLDG-------WFRTGDVVVMEEDGFIRIVDRIKELIITGGFNVYPAEVE 484
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 876 VTLMNHPDISEAAILIWQDQNGEHELCAyyCSVqkLN---TID---LRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDR 949
Cdd:PRK05605 485 EVLREHPGVEDAAVVGLPREDGSEEVVA--AVV--LEpgaALDpegLRAYCREHLTRYKVPRRFYHVDELPRDQLGKVRR 560
|
|
| PRK12582 |
PRK12582 |
acyl-CoA synthetase; Provisional |
1495-1892 |
6.82e-21 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237144 [Multi-domain] Cd Length: 624 Bit Score: 100.51 E-value: 6.82e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1495 TLHYALEQQAEKTPDQAAVIFEDGV------MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAG 1568
Cdd:PRK12582 50 SIPHLLAKWAAEAPDRPWLAQREPGhgqwrkVTYGEAKRAVDALAQALLDLGLDPGRPVMILSGNSIEHALMTLAAMQAG 129
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1569 GAYLPIDPDYP-----EERISFLLEDSGTNILLLQSA-----GLHVPEFTG-EIVYLNQTNSG-----LAHRLSNPNVD- 1631
Cdd:PRK12582 130 VPAAPVSPAYSlmshdHAKLKHLFDLVKPRVVFAQSGapfarALAALDLLDvTVVHVTGPGEGiasiaFADLAATPPTAa 209
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1632 -------VLPQSLAYVIYTSGSTGMPKGVEIEHRS-AVNFLNSLQSRYQL---KHSD----MIMHKTS---YSFDASIWE 1693
Cdd:PRK12582 210 vaaaiaaITPDTVAKYLFTSGSTGMPKAVINTQRMmCANIAMQEQLRPREpdpPPPVsldwMPWNHTMggnANFNGLLWG 289
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1694 lfwwpyaGASVYLlpQGGEKEPEVIAKAIE---EQKITAMHFVPSMLHAFLEHIKYRSVPIKT--NRLKRVFSGGEQLGT 1768
Cdd:PRK12582 290 -------GGTLYI--DDGKPLPGMFEETIRnlrEISPTVYGNVPAGYAMLAEAMEKDDALRRSffKNLRLMAYGGATLSD 360
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1769 HLVSRFYELL-----PNVSITNSYGPTeatvEAAFFDCPPHEKLERIP-IGKPVHHVRLyllnqnqRMLPVGCIGELYIA 1842
Cdd:PRK12582 361 DLYERMQALAvrttgHRIPFYTGYGAT----ETAPTTTGTHWDTERVGlIGLPLPGVEL-------KLAPVGDKYEVRVK 429
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 1843 GAGVARGYLNRPALTEERFLEDPFypgermYKTGDVARWL-PDGNVE---FLGR 1892
Cdd:PRK12582 430 GPNVTPGYHKDPELTAAAFDEEGF------YRLGDAARFVdPDDPEKgliFDGR 477
|
|
| caiC |
PRK08008 |
putative crotonobetaine/carnitine-CoA ligase; Validated |
1493-1983 |
7.21e-21 |
|
putative crotonobetaine/carnitine-CoA ligase; Validated
Pssm-ID: 181195 [Multi-domain] Cd Length: 517 Bit Score: 99.76 E-value: 7.21e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1493 NQTLHYALEQQAEKTPDQAAVIFED--GVM---TYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKA 1567
Cdd:PRK08008 6 GQHLRQMWDDLADVYGHKTALIFESsgGVVrrySYLELNEEINRTANLFYSLGIRKGDKVALHLDNCPEFIFCWFGLAKI 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1568 GGAYLPIDPDYPEERISFLLEDSGTNILLLQSAGL----------------------HVPEFTGEIVY---LNQTNSGLA 1622
Cdd:PRK08008 86 GAIMVPINARLLREESAWILQNSQASLLVTSAQFYpmyrqiqqedatplrhicltrvALPADDGVSSFtqlKAQQPATLC 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1623 HR--LSNPNVdvlpqslAYVIYTSGSTGMPKGVEIEHrsaVNFLNS-LQSRYQ--LKHSDMIMH-KTSYSFDASIWELFW 1696
Cdd:PRK08008 166 YAppLSTDDT-------AEILFTSGTTSRPKGVVITH---YNLRFAgYYSAWQcaLRDDDVYLTvMPAFHIDCQCTAAMA 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1697 WPYAGASVYLLpqggEK-EPEVIAKAIEEQKITAMHFVPSMLHAFLehIKYRSVPIKTNRLKRVF-----SGGEQLGthL 1770
Cdd:PRK08008 236 AFSAGATFVLL----EKySARAFWGQVCKYRATITECIPMMIRTLM--VQPPSANDRQHCLREVMfylnlSDQEKDA--F 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1771 VSRFyellpNVSITNSYGPTEaTVEAAFFDCPPHEKleRIP-IGKPVHHVRLYLLNQNQRMLPVGCIGELYI---AGAGV 1846
Cdd:PRK08008 308 EERF-----GVRLLTSYGMTE-TIVGIIGDRPGDKR--RWPsIGRPGFCYEAEIRDDHNRPLPAGEIGEICIkgvPGKTI 379
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1847 ARGYLNRPALTEERFLEDPFypgermYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTV 1926
Cdd:PRK08008 380 FKEYYLDPKATAKVLEADGW------LHTGDTGYVDEEGFFYFVDRRCNMIKRGGENVSCVELENIIATHPKIQDIVVVG 453
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 1927 RTDSGEPE-LCAYV-----EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK08008 454 IKDSIRDEaIKAFVvlnegETLSEEEFFAFCEQNMAKFKVPSYLEIRKDLPRNCSGKIIKKNL 516
|
|
| PRK08315 |
PRK08315 |
AMP-binding domain protein; Validated |
463-947 |
1.45e-20 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236236 [Multi-domain] Cd Length: 559 Bit Score: 99.11 E-value: 1.45e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 463 ETIHAMFEKQAEKTPDAHAVI--DQACSLTYRELNKAANRLARHLRMKGVVRQEPVAI----------MMERSAafitgv 530
Cdd:PRK08315 16 QTIGQLLDRTAARYPDREALVyrDQGLRWTYREFNEEVDALAKGLLALGIEKGDRVGIwapnvpewvlTQFATA------ 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 531 lgilKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSQAHLPSSledNYIIT-----------HPEDIESK---------- 589
Cdd:PRK08315 90 ----KIGAILVTINPAYRLSELEYALNQSGCKALIAADGFKDS---DYVAMlyelapelatcEPGQLQSArlpelrrvif 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 590 ----------------VDGSN--------IKSVNNADDLLYMIYTSGTTGKPKGVQFEHRNMAN-------LLKFEyths 638
Cdd:PRK08315 163 lgdekhpgmlnfdellALGRAvddaelaaRQATLDPDDPINIQYTSGTTGFPKGATLTHRNILNngyfigeAMKLT---- 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 639 gidfEADVLQFATPSFDvCyqeiF-------SALLKGGTLHIVPEAIkrDVPQLFAFINKHQTNIVF-LPTAFIKMI--- 707
Cdd:PRK08315 239 ----EEDRLCIPVPLYH-C----FgmvlgnlACVTHGATMVYPGEGF--DPLATLAAVEEERCTALYgVPTMFIAELdhp 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 708 -FSERELAnSFPDGvkhlIAAG----EQLMisdlfQDVLRKrgIHLHN---HYGPSETHVVSTYTiHPGDPI-------- 771
Cdd:PRK08315 308 dFARFDLS-SLRTG----IMAGspcpIEVM-----KRVIDK--MHMSEvtiAYGMTETSPVSTQT-RTDDPLekrvttvg 374
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 772 ---PEL------PPIGKPIgctdlyilnhqkqlqPCGVPGELYISGASVARGYVNhdkltsdkfssDPFKP-DVI----- 836
Cdd:PRK08315 375 ralPHLevkivdPETGETV---------------PRGEQGELCTRGYSVMKGYWN-----------DPEKTaEAIdadgw 428
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 837 MyRTGDLARRLEDGNIEYIGRADNQVkIR-GYRIEPQEIEVTLMNHPDISEAAILIWQDQN-GEhELCAYycsV-----Q 909
Cdd:PRK08315 429 M-HTGDLAVMDEEGYVNIVGRIKDMI-IRgGENIYPREIEEFLYTHPKIQDVQVVGVPDEKyGE-EVCAW---IilrpgA 502
|
570 580 590
....*....|....*....|....*....|....*....
gi 1678550997 910 KLNTIDLRSYMASELPEYMIPaKWIW-VDSIPLTPNGKV 947
Cdd:PRK08315 503 TLTEEDVRDFCRGKIAHYKIP-RYIRfVDEFPMTVTGKI 540
|
|
| PLN02330 |
PLN02330 |
4-coumarate--CoA ligase-like 1 |
470-960 |
1.85e-20 |
|
4-coumarate--CoA ligase-like 1
Pssm-ID: 215189 [Multi-domain] Cd Length: 546 Bit Score: 98.51 E-value: 1.85e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 470 EKQAEKTPDAHAVIDQAcsLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPA 549
Cdd:PLN02330 39 ELYADKVAFVEAVTGKA--VTYGEVVRDTRRFAKALRSLGLRKGQVVVVVLPNVAEYGIVALGIMAAGGVFSGANPTALE 116
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 550 DRIRYILHDCGCSHVVSQA---HLPSSLEDNYIITHPEDIESKVDGSNIksVNNAD--------------DLLYMIYTSG 612
Cdd:PLN02330 117 SEIKKQAEAAGAKLIVTNDtnyGKVKGLGLPVIVLGEEKIEGAVNWKEL--LEAADragdtsdneeilqtDLCALPFSSG 194
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 613 TTGKPKGVQFEHRNM-ANLLKfeyTHSGIDFEAdVLQFAT----PSFDV------CyqeiFSALLKGGTLHIVPEAIKRD 681
Cdd:PLN02330 195 TTGISKGVMLTHRNLvANLCS---SLFSVGPEM-IGQVVTlgliPFFHIygitgiC----CATLRNKGKVVVMSRFELRT 266
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 682 VpqLFAFINKHQTNIVFLPTAFIKM----IFSERELANSfpdGVKHLIAAGEQLMiSDLFQDVLRK-RGIHLHNHYGPSE 756
Cdd:PLN02330 267 F--LNALITQEVSFAPIVPPIILNLvknpIVEEFDLSKL---KLQAIMTAAAPLA-PELLTAFEAKfPGVQVQEAYGLTE 340
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 757 tHvvSTYTIHPGDP-----IPELPPIGKPIGCTDLYILNHQKQLQ-PCGVPGELYISGASVARGYVNHDKLTSDKFSSDP 830
Cdd:PLN02330 341 -H--SCITLTHGDPekghgIAKKNSVGFILPNLEVKFIDPDTGRSlPKNTPGELCVRSQCVMQGYYNNKEETDRTIDEDG 417
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 831 FkpdvimYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQN-GE-HELCAYYCSV 908
Cdd:PLN02330 418 W------LHTGDIGYIDDDGDIFIVDRIKELIKYKGFQVAPAELEAILLTHPSVEDAAVVPLPDEEaGEiPAACVVINPK 491
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 909 QKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPEPDASIS 960
Cdd:PLN02330 492 AKESEEDILNFVAANVAHYKKVRVVQFVDSIPKSLSGKIMRRLLKEKMLSIN 543
|
|
| E_NRPS |
cd19534 |
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
2110-2496 |
1.85e-20 |
|
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Epimerization (E) domains of nonribosomal peptide synthetases (NRPS) flip the chirality of the end amino acid of a peptide being manufactured by the NRPS. E-domains are homologous to the Condensation (C) domains. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Specialized tailoring NRPS domains such as E-domains greatly increase the range of possible peptide products created by the NRPS machinery. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the E-domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380457 [Multi-domain] Cd Length: 428 Bit Score: 97.32 E-value: 1.85e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2110 YNMPAVLELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGdPVQRIHDEV--PFTLQTTVLGARTEQEAAAAFI---- 2183
Cdd:cd19534 22 FNQSVLLRVPQGLDPDALRQALRALVEHHDALRMRFRREDGG-WQQRIRGDVeeLFRLEVVDLSSLAQAAAIEALAaeaq 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2184 KPFDLSQAPLFRAQIVKVSDERHLLLVDMHHIISDGVSVNILIQEFGELYNN---RKLPAL--RIQYKDYAVWQEGFKTG 2258
Cdd:cd19534 101 SSLDLEEGPLLAAALFDGTDGGDRLLLVIHHLVVDGVSWRILLEDLEAAYEQalaGEPIPLpsKTSFQTWAELLAEYAQS 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2259 DAYKMQEAYWLKQLEGELPvlDLPADHarpPVRSFAGDKVSFTLEPE-VASGLHKLARENGSTLYMVLLAAYTAFLSRLS 2337
Cdd:cd19534 181 PALLEELAYWRELPAADYW--GLPKDP---EQTYGDARTVSFTLDEEeTEALLQEANAAYRTEINDLLLAALALAFQDWT 255
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2338 GQEDIIVGSPIAGR----PHKDLEPILGMFVNTLALRTRPEGGKPFVQYLQEVRE----------------------TAL 2391
Cdd:cd19534 256 GRAPPAIFLEGHGReeidPGLDLSRTVGWFTSMYPVVLDLEASEDLGDTLKRVKEqlrripnkgigygilryltpegTKR 335
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2392 EAFEHQ-----NYpfeelvdkLELTRDMSRNPVFDAMLVVQnndyePLHLHDLQMKpaqvshLVSKFDLTLQASegDGNI 2466
Cdd:cd19534 336 LAFHPQpeisfNY--------LGQFDQGERDDALFVSAVGG-----GGSDIGPDTP------RFALLDINAVVE--GGQL 394
|
410 420 430
....*....|....*....|....*....|
gi 1678550997 2467 HFLFEYSTALFEKTTIERWASHLTNVLSII 2496
Cdd:cd19534 395 VITVSYSRNMYHEETIQQLADSYKEALEAL 424
|
|
| FATP_FACS |
cd05940 |
Fatty acid transport proteins (FATP) play dual roles as fatty acid transporters and its ... |
2556-3006 |
2.16e-20 |
|
Fatty acid transport proteins (FATP) play dual roles as fatty acid transporters and its activation enzymes; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. At least five copies of FATPs are identified in mammalian cells. This family also includes prokaryotic FATPs. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341263 [Multi-domain] Cd Length: 449 Bit Score: 97.42 E-value: 2.16e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2556 DKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDpeypkerkryilsdsgTKLlm 2635
Cdd:cd05940 1 DEALTYAELDAMANRYARWLKSLGLKPGDVVALFMENRPEYVLLWLGLVKIGAVAALIN----------------YNL-- 62
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2636 tineadlgvladfEGEILTiESVeeddksplpQMSSAHHL----AYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAF 2711
Cdd:cd05940 63 -------------RGESLA-HCL---------NVSSAKHLvvdaALYIYTSGTTGLPKAAIISHRRAWRGGAFFAGSGGA 119
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2712 NETDTI---LQLFSFSfdGFITSMFTPLLSGAKAVLLHEEEAKDIL--AIKHQlsrqrITHMIIVPVLYRALLDVVQPED 2786
Cdd:cd05940 120 LPSDVLytcLPLYHST--ALIVGWSACLASGATLVIRKKFSASNFWddIRKYQ-----ATIFQYIGELCRYLLNQPPKPT 192
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2787 VK--TLRVVTLAGEAAD--RELIARsLAICPHTELaneYGPTENSVAT--------TVMRHMEKQAYVS----------I 2844
Cdd:cd05940 193 ERkhKVRMIFGNGLRPDiwEEFKER-FGVPRIAEF---YAATEGNSGFinffgkpgAIGRNPSLLRKVAplalvkydleS 268
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2845 GQPIDGTQVLILNSnhqlqPIGVAGELCIAGTGLAR--GYVNlPELTERAFTQNPFKPEARMYRTGDAARWMADGTLEYL 2922
Cdd:cd05940 269 GEPIRDAEGRCIKV-----PRGEPGLLISRINPLEPfdGYTD-PAATEKKILRDVFKKGDAWFNTGDLMRLDGEGFWYFV 342
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2923 GRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAV--VAHVTASGQTELSAyVVTKPGLSTN--AVRSELQNKLPVFMHPA 2998
Cdd:cd05940 343 DRLGDTFRWKGENVSTTEVAAVLGAFPGVEEANVygVQVPGTDGRAGMAA-IVLQPNEEFDlsALAAHLEKNLPGYARPL 421
|
....*...
gi 1678550997 2999 FIEKLDSL 3006
Cdd:cd05940 422 FLRLQPEM 429
|
|
| FATP_FACS |
cd05940 |
Fatty acid transport proteins (FATP) play dual roles as fatty acid transporters and its ... |
1517-1961 |
2.45e-20 |
|
Fatty acid transport proteins (FATP) play dual roles as fatty acid transporters and its activation enzymes; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. At least five copies of FATPs are identified in mammalian cells. This family also includes prokaryotic FATPs. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341263 [Multi-domain] Cd Length: 449 Bit Score: 97.42 E-value: 2.45e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1517 DGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAylpidpdypeerisflledsgtnill 1596
Cdd:cd05940 1 DEALTYAELDAMANRYARWLKSLGLKPGDVVALFMENRPEYVLLWLGLVKIGAV-------------------------- 54
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1597 lqsaglhvpefTGEIVYlNQTNSGLAHRLSNPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHS 1676
Cdd:cd05940 55 -----------AALINY-NLRGESLAHCLNVSSAKHLVVDAALYIYTSGTTGLPKAAIISHRRAWRGGAFFAGSGGALPS 122
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1677 DMIM------HKTS--YSFDASIwelfwwpYAGASVyllpqggekepeVIAKaieeqKITAMHFVPsmlhaflEHIKYRS 1748
Cdd:cd05940 123 DVLYtclplyHSTAliVGWSACL-------ASGATL------------VIRK-----KFSASNFWD-------DIRKYQA 171
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1749 VPI-------------------KTNRLKRVFSGGeqLGTHLVSRFYELLPNVSITNSYGPTEATVE---------AAFFD 1800
Cdd:cd05940 172 TIFqyigelcryllnqppkpteRKHKVRMIFGNG--LRPDIWEEFKERFGVPRIAEFYAATEGNSGfinffgkpgAIGRN 249
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1801 CPPHEKLERIPIGKPVHHVRLYLLNQNQRMLPVG------CIGElyIAGAGVARGYLNrPALTEERFLEDPFYPGERMYK 1874
Cdd:cd05940 250 PSLLRKVAPLALVKYDLESGEPIRDAEGRCIKVPrgepglLISR--INPLEPFDGYTD-PAATEKKILRDVFKKGDAWFN 326
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1875 TGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREA---AVTVRTDSGEPELCAYV----EGLQRNEV 1947
Cdd:cd05940 327 TGDLMRLDGEGFWYFVDRLGDTFRWKGENVSTTEVAAVLGAFPGVEEAnvyGVQVPGTDGRAGMAAIVlqpnEEFDLSAL 406
|
490
....*....|....
gi 1678550997 1948 RAQLERLLPGYMVP 1961
Cdd:cd05940 407 AAHLEKNLPGYARP 420
|
|
| PLN02246 |
PLN02246 |
4-coumarate--CoA ligase |
2541-3016 |
2.56e-20 |
|
4-coumarate--CoA ligase
Pssm-ID: 215137 [Multi-domain] Cd Length: 537 Bit Score: 98.13 E-value: 2.56e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2541 QQAARTPKASALVSGD--KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEY- 2617
Cdd:PLN02246 31 ERLSEFSDRPCLIDGAtgRVYTYADVELLSRRVAAGLHKLGIRQGDVVMLLLPNCPEFVLAFLGASRRGAVTTTANPFYt 110
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2618 PKERKRYILSdSGTKLLMTiNEADLGVLADFEGE----ILTIESVEE----------DDKSPLPQMS-SAHHLAYIIYTS 2682
Cdd:PLN02246 111 PAEIAKQAKA-SGAKLIIT-QSCYVDKLKGLAEDdgvtVVTIDDPPEgclhfseltqADENELPEVEiSPDDVVALPYSS 188
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2683 GTTGRPKGVMVEHKGIANTLQWR-----RNAYaFNETDTI---LQLFS-FSFDgfiTSMFTPLLSGAKAVLLHEEEakdI 2753
Cdd:PLN02246 189 GTTGLPKGVMLTHKGLVTSVAQQvdgenPNLY-FHSDDVIlcvLPMFHiYSLN---SVLLCGLRVGAAILIMPKFE---I 261
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2754 LAIKHQLSRQRITHMIIVP--VLYRALLDVVQPEDVKTLRVVtLAGEAA-DRELIARSLAICPHTELANEYGPTEN---- 2826
Cdd:PLN02246 262 GALLELIQRHKVTIAPFVPpiVLAIAKSPVVEKYDLSSIRMV-LSGAAPlGKELEDAFRAKLPNAVLGQGYGMTEAgpvl 340
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2827 --SVA-------------TTVMRHMEkqayVSIGQPIDGTQVlilnsnhqlqPIGVAGELCIAGTGLARGYVNLPELTER 2891
Cdd:PLN02246 341 amCLAfakepfpvksgscGTVVRNAE----LKIVDPETGASL----------PRNQPGEICIRGPQIMKGYLNDPEATAN 406
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2892 AFTQNPFkpearmYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHV-TASGQTELsA 2970
Cdd:PLN02246 407 TIDKDGW------LHTGDIGYIDDDDELFIVDRLKELIKYKGFQVAPAELEALLISHPSIADAAVVPMKdEVAGEVPV-A 479
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 2971 YVVTKPG--LSTNAVRsELQNKLPVF---MHPAFIekLDSLPLSPNGKLDR 3016
Cdd:PLN02246 480 FVVRSNGseITEDEIK-QFVAKQVVFykrIHKVFF--VDSIPKAPSGKILR 527
|
|
| MACS_like_1 |
cd05974 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
2559-2977 |
2.70e-20 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341278 [Multi-domain] Cd Length: 432 Bit Score: 96.87 E-value: 2.70e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2559 LTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPidpeypkerkryilsdsGTKLLmtiN 2638
Cdd:cd05974 1 VSFAEMSARSSRVANFLRSIGVGRGDRILLMLGNVVELWEAMLAAMKLGAVVIP-----------------ATTLL---T 60
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2639 EADLGVLADFEGEilTIESVEEDDKSPLPQMssahhlayIIYTSGTTGRPKGVMVEHK----GIANTLQW---RRNAYAF 2711
Cdd:cd05974 61 PDDLRDRVDRGGA--VYAAVDENTHADDPML--------LYFTSGTTSKPKLVEHTHRsypvGHLSTMYWiglKPGDVHW 130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2712 NETDTILQLFSFSfdgfitSMFTPLLSGAKAVLLHEE--EAKDILAikhQLSRQRITHMIIVPVLYRALLDvvqpEDVKT 2789
Cdd:cd05974 131 NISSPGWAKHAWS------CFFAPWNAGATVFLFNYArfDAKRVLA---ALVRYGVTTLCAPPTVWRMLIQ----QDLAS 197
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2790 LRV----VTLAGEAADRELIARSLAICPHTeLANEYGPTENsvaTTVMRHMEKQAYV--SIGQPIDGTQVLILNsnhqlq 2863
Cdd:cd05974 198 FDVklreVVGAGEPLNPEVIEQVRRAWGLT-IRDGYGQTET---TALVGNSPGQPVKagSMGRPLPGYRVALLD------ 267
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2864 PIGVA---GELCIA-----GTGLARGYVNLPELTERAFtqnpfkpEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYR 2935
Cdd:cd05974 268 PDGAPateGEVALDlgdtrPVGLMKGYAGDPDKTAHAM-------RGGYYRTGDIAMRDEDGYLTYVGRADDVFKSSDYR 340
|
410 420 430 440
....*....|....*....|....*....|....*....|..
gi 1678550997 2936 VETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPG 2977
Cdd:cd05974 341 ISPFELESVLIEHPAVAEAAVVPSPDPVRLSVPKAFIVLRAG 382
|
|
| PRK06060 |
PRK06060 |
p-hydroxybenzoic acid--AMP ligase FadD22; |
1493-1985 |
2.79e-20 |
|
p-hydroxybenzoic acid--AMP ligase FadD22;
Pssm-ID: 180374 [Multi-domain] Cd Length: 705 Bit Score: 98.95 E-value: 2.79e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1493 NQTLHYALEQQAEKT--PDQAAVIFEDgVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGA 1570
Cdd:PRK06060 3 NGNLAGLLAEQASEAgwYDRPAFYAAD-VVTHGQIHDGAARLGEVLRNRGLSSGDRVLLCLPDSPDLVQLLLACLARGVM 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1571 YLPIDPDYPEERISFLLEDsgTNILLLQSAGLHVPEFTGEIVYLNQTNSGLAHRLSNPNVDVLP-QSLAYVIYTSGSTGM 1649
Cdd:PRK06060 82 AFLANPELHRDDHALAARN--TEPALVVTSDALRDRFQPSRVAEAAELMSEAARVAPGGYEPMGgDALAYATYTSGTTGP 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1650 PKGVEIEHRSAVNFLNSL-QSRYQLKHSDMIMHKTSYSFDASIWELFWWPYA---GASVYLLPQGGEKEPEVIAKaieeq 1725
Cdd:PRK06060 160 PKAAIHRHADPLTFVDAMcRKALRLTPEDTGLCSARMYFAYGLGNSVWFPLAtggSAVINSAPVTPEAAAILSAR----- 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1726 kitamhFVPSMLHA---FLEHIKYRSVPIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEAT---VEAAFF 1799
Cdd:PRK06060 235 ------FGPSVLYGvpnFFARVIDSCSPDSFRSLRCVVSAGEALELGLAERLMEFFGGIPILDGIGSTEVGqtfVSNRVD 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1800 DCPPHEkleripIGK--PVHHVRLylLNQNQRMLPVGCIGELYIAGAGVARGYLNRPalteerfleDPFYPGERMYKTGD 1877
Cdd:PRK06060 309 EWRLGT------LGRvlPPYEIRV--VAPDGTTAGPGVEGDLWVRGPAIAKGYWNRP---------DSPVANEGWLDTRD 371
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1878 VARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVT-VRTDSGEPELCAYV-----EGLQRNEVRAQL 1951
Cdd:PRK06060 372 RVCIDSDGWVTYRCRADDTEVIGGVNVDPREVERLIIEDEAVAEAAVVaVRESTGASTLQAFLvatsgATIDGSVMRDLH 451
|
490 500 510
....*....|....*....|....*....|....*..
gi 1678550997 1952 ERL---LPGYMVPAYMIEMEQWPVTPSGKLDRNALPA 1985
Cdd:PRK06060 452 RGLlnrLSAFKVPHRFAVVDRLPRTPNGKLVRGALRK 488
|
|
| PLN03102 |
PLN03102 |
acyl-activating enzyme; Provisional |
1500-1983 |
2.89e-20 |
|
acyl-activating enzyme; Provisional
Pssm-ID: 215576 [Multi-domain] Cd Length: 579 Bit Score: 98.17 E-value: 2.89e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYP 1579
Cdd:PLN03102 20 LKRASECYPNRTSIIYGKTRFTWPQTYDRCCRLAASLISLNITKNDVVSVLAPNTPAMYEMHFAVPMAGAVLNPINTRLD 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1580 EERISFLLEDSGTNILLL-----------------QSAGLHVPeftgeIVYLNQTNSglAHRLSNPNVDV---------L 1633
Cdd:PLN03102 100 ATSIAAILRHAKPKILFVdrsfeplarevlhllssEDSNLNLP-----VIFIHEIDF--PKRPSSEELDYecliqrgepT 172
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1634 PQSLAYVI------------YTSGSTGMPKGVEIEHRSAvnFLNSLQS--RYQLKHSDMIMHkTSYSFDASIWELFWWPY 1699
Cdd:PLN03102 173 PSLVARMFriqdehdpislnYTSGTTADPKGVVISHRGA--YLSTLSAiiGWEMGTCPVYLW-TLPMFHCNGWTFTWGTA 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1700 A--GASVYLLPQGGekePEvIAKAIEEQKITAMHFVPSMLHAFLE----HIKYRSVPIKtnrlkrVFSGGEQLGTHLVSR 1773
Cdd:PLN03102 250 ArgGTSVCMRHVTA---PE-IYKNIEMHNVTHMCCVPTVFNILLKgnslDLSPRSGPVH------VLTGGSPPPAALVKK 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1774 FYELlpNVSITNSYGPTEATVEAAFFD-------CPPHEKLErIPIGKPVHHVRLYLLN----QNQRMLPVG--CIGELY 1840
Cdd:PLN03102 320 VQRL--GFQVMHAYGLTEATGPVLFCEwqdewnrLPENQQME-LKARQGVSILGLADVDvknkETQESVPRDgkTMGEIV 396
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1841 IAGAGVARGYLNRPALTEERFLEDpfypgerMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVR 1920
Cdd:PLN03102 397 IKGSSIMKGYLKNPKATSEAFKHG-------WLNTGDVGVIHPDGHVEIKDRSKDIIISGGENISSVEVENVLYKYPKVL 469
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1921 EAAVT--------------VRTDSGEPELCAYVEGLQRNEvRAQLERL---LPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PLN03102 470 ETAVVamphptwgetpcafVVLEKGETTKEDRVDKLVTRE-RDLIEYCrenLPHFMCPRKVVFLQELPKNGNGKILKPKL 548
|
|
| PLN02246 |
PLN02246 |
4-coumarate--CoA ligase |
454-952 |
2.90e-20 |
|
4-coumarate--CoA ligase
Pssm-ID: 215137 [Multi-domain] Cd Length: 537 Bit Score: 98.13 E-value: 2.90e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 454 EITDQTPVYETIhamFEKQAEkTPDAHAVIDQAC--SLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVL 531
Cdd:PLN02246 18 YIPNHLPLHDYC---FERLSE-FSDRPCLIDGATgrVYTYADVELLSRRVAAGLHKLGIRQGDVVMLLLPNCPEFVLAFL 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 532 GILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSQA----HLPSSLEDN--YIITHPEDIE--------SKVDGSNIKS 597
Cdd:PLN02246 94 GASRRGAVTTTANPFYTPAEIAKQAKASGAKLIITQScyvdKLKGLAEDDgvTVVTIDDPPEgclhfselTQADENELPE 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 598 VN-NADDLLYMIYTSGTTGKPKGVQFEHRNM----ANLLKFE----YTHSGidfeaDVLQFATPSFDV-CYQEI-FSALL 666
Cdd:PLN02246 174 VEiSPDDVVALPYSSGTTGLPKGVMLTHKGLvtsvAQQVDGEnpnlYFHSD-----DVILCVLPMFHIySLNSVlLCGLR 248
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 667 KGGTLHIVPeaiKRDVPQLFAFINKHQTNIV-FLPTAFIkmifserELANSfPDGVKH------LIAAGEQLMISDLfQD 739
Cdd:PLN02246 249 VGAAILIMP---KFEIGALLELIQRHKVTIApFVPPIVL-------AIAKS-PVVEKYdlssirMVLSGAAPLGKEL-ED 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 740 VLRKR--GIHLHNHYGPSETH-VVSTYTIHPGDPIPElppigKPIGC------TDLYILNHQKQLQ-PCGVPGELYISGA 809
Cdd:PLN02246 317 AFRAKlpNAVLGQGYGMTEAGpVLAMCLAFAKEPFPV-----KSGSCgtvvrnAELKIVDPETGASlPRNQPGEICIRGP 391
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 810 SVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAI 889
Cdd:PLN02246 392 QIMKGYLNDPEATANTIDKDGW------LHTGDIGYIDDDDELFIVDRLKELIKYKGFQVAPAELEALLISHPSIADAAV 465
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 890 LIWQDQNGEHELCAYYCSVQ--KLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PLN02246 466 VPMKDEVAGEVPVAFVVRSNgsEITEDEIKQFVAKQVVFYKRIHKVFFVDSIPKAPSGKILRKDL 530
|
|
| starter-C_NRPS |
cd19533 |
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases ... |
11-433 |
3.14e-20 |
|
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. While standard C-domains catalyze peptide bond formation between two amino acids, an initial, ('starter') C-domain may instead acylate an amino acid with a fatty acid. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380456 [Multi-domain] Cd Length: 419 Bit Score: 96.67 E-value: 3.14e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 11 YPLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFISQNvSSPQQVVLRERnvivlE 90
Cdd:cd19533 2 LPLTSAQRGVWFAEQLDPEGSIYNLAEYLEITGPVDLAVLERALRQVIAEAETLRLRFTEEE-GEPYQWIDPYT-----P 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 91 EDITHLN---EAEQSQFIEQWKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYASY 167
Cdd:cd19533 76 VPIRHIDlsgDPDPEGAAQQWMQEDLRKPLPLDNDPLFRHALFTLGDNRHFWYQRVHHIVMDGFSFALFGQRVAEIYTAL 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 168 VNASPItlePVQPYGKYIKWLMEQDK-------EQAVSYW-DHYlsGHEQQTVLPKQKKTKGKSRQEHVTFSFSKEESSR 239
Cdd:cd19533 156 LKGRPA---PPAPFGSFLDLVEEEQAyrqserfERDRAFWtEQF--EDLPEPVSLARRAPGRSLAFLRRTAELPPELTRT 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 240 LSELAAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGR--PAEIegieHMVGLFINTMPVRVQGA-KTPFLQLIKD 316
Cdd:cd19533 231 LLEAAEAHGASWPSFFIALVAAYLHRLTGANDVVLGVPVMGRlgAAAR----QTPGMVANTLPLRLTVDpQQTFAELVAQ 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 317 MQKDRLAAEAYSYHPLYEIQ---SRSAVKQGLIDHILVFENYPVQQEIqmlnkqehASDLFQIHNFTVADETNYSFYLM- 392
Cdd:cd19533 307 VSRELRSLLRHQRYRYEDLRrdlGLTGELHPLFGPTVNYMPFDYGLDF--------GGVVGLTHNLSSGPTNDLSIFVYd 378
|
410 420 430 440
....*....|....*....|....*....|....*....|.
gi 1678550997 393 VAPGEEIHIKMNYDAEQHDRSFVLSVKEHLLNAVSQILNNP 433
Cdd:cd19533 379 RDDESGLRIDFDANPALYSGEDLARHQERLLRLLEEAAADP 419
|
|
| PRK06060 |
PRK06060 |
p-hydroxybenzoic acid--AMP ligase FadD22; |
2559-3024 |
3.83e-20 |
|
p-hydroxybenzoic acid--AMP ligase FadD22;
Pssm-ID: 180374 [Multi-domain] Cd Length: 705 Bit Score: 98.57 E-value: 3.83e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2559 LTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMTIn 2638
Cdd:PRK06060 31 VTHGQIHDGAARLGEVLRNRGLSSGDRVLLCLPDSPDLVQLLLACLARGVMAFLANPELHRDDHALAARNTEPALVVTS- 109
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2639 eadlGVLAD-FE-------GEILTIES-VEEDDKSPLpqmsSAHHLAYIIYTSGTTGRPKGVMVEHKGIANTLQWR-RNA 2708
Cdd:PRK06060 110 ----DALRDrFQpsrvaeaAELMSEAArVAPGGYEPM----GGDALAYATYTSGTTGPPKAAIHRHADPLTFVDAMcRKA 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2709 YAFNETDTILQLFSFSFD-GFITSMFTPLLSGAKAVLLHEEEAKDILAIKHqlSRQRITHMIIVPVLYRALLDVVQPEDV 2787
Cdd:PRK06060 182 LRLTPEDTGLCSARMYFAyGLGNSVWFPLATGGSAVINSAPVTPEAAAILS--ARFGPSVLYGVPNFFARVIDSCSPDSF 259
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2788 KTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTENSvATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGV 2867
Cdd:PRK06060 260 RSLRCVVSAGEALELGLAERLMEFFGGIPILDGIGSTEVG-QTFVSNRVDEWRLGTLGRVLPPYEIRVVAPDGTTAGPGV 338
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2868 AGELCIAGTGLARGYVNLPElteraftqnPFKPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRC 2947
Cdd:PRK06060 339 EGDLWVRGPAIAKGYWNRPD---------SPVANEGWLDTRDRVCIDSDGWVTYRCRADDTEVIGGVNVDPREVERLIIE 409
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2948 IKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTNA-----VRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL--- 3019
Cdd:PRK06060 410 DEAVAEAAVVAVRESTGASTLQAFLVATSGATIDGsvmrdLHRGLLNRLSAFKVPHRFAVVDRLPRTPNGKLVRGALrkq 489
|
....*..
gi 1678550997 3020 --PKPVY 3024
Cdd:PRK06060 490 spTKPIW 496
|
|
| PRK08751 |
PRK08751 |
long-chain fatty acid--CoA ligase; |
462-952 |
3.91e-20 |
|
long-chain fatty acid--CoA ligase;
Pssm-ID: 181546 [Multi-domain] Cd Length: 560 Bit Score: 97.64 E-value: 3.91e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 462 YETIHAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHL----RMKgvvRQEPVAIMMERSAAFITGVLGILKAG 537
Cdd:PRK08751 24 FRTVAEVFATSVAKFADRPAYHSFGKTITYREADQLVEQFAAYLlgelQLK---KGDRVALMMPNCLQYPIATFGVLRAG 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 538 GAIVPVDPHYPADRIRYILHDCGCSHVVSQAHLPSSLED---------------------------NYIITHPEDI--ES 588
Cdd:PRK08751 101 LTVVNVNPLYTPRELKHQLIDSGASVLVVIDNFGTTVQQviadtpvkqvittglgdmlgfpkaalvNFVVKYVKKLvpEY 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 589 KVDGS-------------NIKSVNNA-DDLLYMIYTSGTTGKPKGVQFEHRNM-ANLLKFEY---THSGIDFEADVLQFA 650
Cdd:PRK08751 181 RINGAirfrealalgrkhSMPTLQIEpDDIAFLQYTGGTTGVAKGAMLTHRNLvANMQQAHQwlaGTGKLEEGCEVVITA 260
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 651 TPSFdvcyqEIFS------ALLK-GGTLHIVPEAikRDVPQLFAFINKHQ-TNIVFLPTAFIKMI----FSERELANsfp 718
Cdd:PRK08751 261 LPLY-----HIFAltanglVFMKiGGCNHLISNP--RDMPGFVKELKKTRfTAFTGVNTLFNGLLntpgFDQIDFSS--- 330
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 719 dgVKHLIAAGE--QLMISDLFQDVlrkRGIHLHNHYGPSETHVVSTytIHPGDPIPELPPIGKPIGCTDLYILNHQKQLQ 796
Cdd:PRK08751 331 --LKMTLGGGMavQRSVAERWKQV---TGLTLVEAYGLTETSPAAC--INPLTLKEYNGSIGLPIPSTDACIKDDAGTVL 403
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 797 PCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEV 876
Cdd:PRK08751 404 AIGEIGELCIKGPQVMKGYWKRPEETAKVMDADGW------LHTGDIARMDEQGFVYIVDRKKDMILVSGFNVYPNEIED 477
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 877 TLMNHPDISE-AAILIWQDQNGEHELCAYYCSVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PRK08751 478 VIAMMPGVLEvAAVGVPDEKSGEIVKVVIVKKDPALTAEDVKAHARANLTGYKQPRIIEFRKELPKTNVGKILRREL 554
|
|
| PRK08276 |
PRK08276 |
long-chain-fatty-acid--CoA ligase; Validated |
2549-3030 |
4.17e-20 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236215 [Multi-domain] Cd Length: 502 Bit Score: 97.28 E-value: 4.17e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2549 ASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSD 2628
Cdd:PRK08276 2 AVIMAPSGEVVTYGELEARSNRLAHGLRALGLREGDVVAILLENNPEFFEVYWAARRSGLYYTPINWHLTAAEIAYIVDD 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2629 SGTKLLMT-------------INEADLGVLADFEGEILTIESVEE--DDKS--PLPQMSSAHHLAyiiYTSGTTGRPKGV 2691
Cdd:PRK08276 82 SGAKVLIVsaaladtaaelaaELPAGVPLLLVVAGPVPGFRSYEEalAAQPdtPIADETAGADML---YSSGTTGRPKGI 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2692 MVEhkgiantLQWRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGA-------------KAVLLHEEEAKDILAikh 2758
Cdd:PRK08276 159 KRP-------LPGLDPDEAPGMMLALLGFGMYGGPDSVYLSPAPLYHTAplrfgmsalalggTVVVMEKFDAEEALA--- 228
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2759 QLSRQRITHMIIVPVLYRALL----DVVQPEDVKTLRVVTLAGeaadreliarslAICP-HTELA---------NE-YGP 2823
Cdd:PRK08276 229 LIERYRVTHSQLVPTMFVRMLklpeEVRARYDVSSLRVAIHAA------------APCPvEVKRAmidwwgpiiHEyYAS 296
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2824 TENSVATTV-----MRHMEkqayvSIGQPIDGtQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAftQNPf 2898
Cdd:PRK08276 297 SEGGGVTVItsedwLAHPG-----SVGKAVLG-EVRILDEDGNELPPGEIGTVYFEMDGYPFEYHNDPEKTAAA--RNP- 367
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2899 kpeARMYRTGDAARWMADGTLeYL-GRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPG 2977
Cdd:PRK08276 368 ---HGWVTVGDVGYLDEDGYL-YLtDRKSDMIISGGVNIYPQEIENLLVTHPKVADVAVFGVPDEEMGERVKAVVQPADG 443
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*...
gi 1678550997 2978 -LSTNAVRSEL----QNKLPVFMHPAFIEKLDSLPLSPNGKLDRGALPKPVYNHEGER 3030
Cdd:PRK08276 444 aDAGDALAAELiawlRGRLAHYKCPRSIDFEDELPRTPTGKLYKRRLRDRYWEGRQRA 501
|
|
| PRK07059 |
PRK07059 |
Long-chain-fatty-acid--CoA ligase; Validated |
1500-1983 |
4.21e-20 |
|
Long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235923 [Multi-domain] Cd Length: 557 Bit Score: 97.78 E-value: 4.21e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIgkrSPEML---LGIYGILKAGGAYLPIDP 1576
Cdd:PRK07059 29 LEESFRQYADRPAFICMGKAITYGELDELSRALAAWLQSRGLAKGARVAIM---MPNVLqypVAIAAVLRAGYVVVNVNP 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1577 DYPEERISFLLEDSGTN--ILL------LQSAGLHVP-------------EFTGEIVYL-----------------NQTN 1618
Cdd:PRK07059 106 LYTPRELEHQLKDSGAEaiVVLenfattVQQVLAKTAvkhvvvasmgdllGFKGHIVNFvvrrvkkmvpawslpghVRFN 185
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1619 SGLAH--RLSNPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAV-NFLNS---LQSRYQLK-HSDMIMHKTS---YSFD 1688
Cdd:PRK07059 186 DALAEgaRQTFKPVKLGPDDVAFLQYTGGTTGVSKGATLLHRNIVaNVLQMeawLQPAFEKKpRPDQLNFVCAlplYHIF 265
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1689 ASIWELFWWPYAGASVYLLPQggekePEVIAKAIEEQKITAMHFVP---SMLHAFLEHIKYRSVPIKtnRLKRVFSGGEQ 1765
Cdd:PRK07059 266 ALTVCGLLGMRTGGRNILIPN-----PRDIPGFIKELKKYQVHIFPavnTLYNALLNNPDFDKLDFS--KLIVANGGGMA 338
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1766 LGTHLVSRFYELLpNVSITNSYGPTEATVEAAffdCPPHEKLERI-PIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGA 1844
Cdd:PRK07059 339 VQRPVAERWLEMT-GCPITEGYGLSETSPVAT---CNPVDATEFSgTIGLPLPSTEVSIRDDDGNDLPLGEPGEICIRGP 414
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1845 GVARGYLNRPALTEERFLEDPFypgermYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAV 1924
Cdd:PRK07059 415 QVMAGYWNRPDETAKVMTADGF------FRTGDVGVMDERGYTKIVDRKKDMILVSGFNVYPNEIEEVVASHPGVLEVAA 488
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 1925 TVRTD--SGEpELCAYV----EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK07059 489 VGVPDehSGE-AVKLFVvkkdPALTEEDVKAFCKERLTNYKRPKFVEFRTELPKTNVGKILRREL 552
|
|
| AAS_C |
cd05909 |
C-terminal domain of the acyl-acyl carrier protein synthetase (also called ... |
1630-1979 |
4.31e-20 |
|
C-terminal domain of the acyl-acyl carrier protein synthetase (also called 2-acylglycerophosphoethanolamine acyltransferase, Aas); Acyl-acyl carrier protein synthase (Aas) is a membrane protein responsible for a minor pathway of incorporating exogenous fatty acids into membrane phospholipids. Its in vitro activity is characterized by the ligation of free fatty acids between 8 and 18 carbons in length to the acyl carrier protein sulfydryl group (ACP-SH) in the presence of ATP and Mg2+. However, its in vivo function is as a 2-acylglycerophosphoethanolamine (2-acyl-GPE) acyltransferase. The reaction occurs in two steps: the acyl chain is first esterified to acyl carrier protein (ACP) via a thioester bond, followed by a second step where the acyl chain is transferred to a 2-acyllysophospholipid, thus completing the transacylation reaction. This model represents the C-terminal domain of the enzyme, which belongs to the class I adenylate-forming enzyme family, including acyl-CoA synthetases.
Pssm-ID: 341235 [Multi-domain] Cd Length: 490 Bit Score: 97.02 E-value: 4.31e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1630 VDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIM------HktSYSFDASIWELFwwpYAGAS 1703
Cdd:cd05909 142 APVQPDDPAVILFTSGSEGLPKGVVLSHKNLLANVEQITAIFDPNPEDVVFgalpffH--SFGLTGCLWLPL---LSGIK 216
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1704 VYLLPQggEKEPEVIAKAIEEQKITAMHFVPSmlhaFLEHIKYRSVPIKTNRLKRVFSGGEQLGTHLVSRFYELLpNVSI 1783
Cdd:cd05909 217 VVFHPN--PLDYKKIPELIYDKKATILLGTPT----FLRGYARAAHPEDFSSLRLVVAGAEKLKDTLRQEFQEKF-GIRI 289
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1784 TNSYGPTEAtveaaffdCPPheklerIPIGKPVHH-----VRLYLLNQNQRMLPV--------GCIGELYIAGAGVARGY 1850
Cdd:cd05909 290 LEGYGTTEC--------SPV------ISVNTPQSPnkegtVGRPLPGMEVKIVSVetheevpiGEGGLLLVRGPNVMLGY 355
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1851 LNRPALTEerfledpFYPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGV-REAAVTVRTD 1929
Cdd:cd05909 356 LNEPELTS-------FAFGDGWYDTGDIGKIDGEGFLTITGRLSRFAKIAGEMVSLEAIEDILSEILPEdNEVAVVSVPD 428
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 1930 S--GEPE-LCAYVEGLQRNEVRAQL-ERLLPGYMVPAYMIEMEQWPVTPSGKLD 1979
Cdd:cd05909 429 GrkGEKIvLLTTTTDTDPSSLNDILkNAGISNLAKPSYIHQVEEIPLLGTGKPD 482
|
|
| PrpE |
cd05967 |
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or ... |
1495-1998 |
5.42e-20 |
|
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or propionate#CoA ligase (PrpE) catalyzes the first step of the 2-methylcitric acid cycle for propionate catabolism. It activates propionate to propionyl-CoA in a two-step reaction, which proceeds through a propionyl-AMP intermediate and requires ATP and Mg2+. In Salmonella enterica, the PrpE protein is required for growth of Salmonella enterica on propionate and can substitute for the acetyl-CoA synthetase (Acs) enzyme during growth on acetate. PrpE can also activate acetate, 3HP, and butyrate to their corresponding CoA-thioesters, although with less efficiency.
Pssm-ID: 341271 [Multi-domain] Cd Length: 617 Bit Score: 97.77 E-value: 5.42e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1495 TLHYALEQQAEK-TPDQAAVIFEDGV------MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKA 1567
Cdd:cd05967 51 TCYNALDRHVEAgRGDQIALIYDSPVtgtertYTYAELLDEVSRLAGVLRKLGVVKGDRVIIYMPMIPEAAIAMLACARI 130
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1568 GGAYLPIDPDYPEERISFLLEDSGTNILLLQSAGLhvpEFTGEIVY-------LNQTNSGLAH-----------RLSNPN 1629
Cdd:cd05967 131 GAIHSVVFGGFAAKELASRIDDAKPKLIVTASCGI---EPGKVVPYkplldkaLELSGHKPHHvlvlnrpqvpaDLTKPG 207
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1630 VDVLPQSL-----------------AYVIYTSGSTGMPKGVEIE---HRSAVNFlnSLQSRYQLKHSDMimhktsysfda 1689
Cdd:cd05967 208 RDLDWSELlakaepvdcvpvaatdpLYILYTSGTTGKPKGVVRDnggHAVALNW--SMRNIYGIKPGDV----------- 274
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1690 siwelfWWpyaGAS-----------VY---------LLPQG---GEKEPEVIAKAIEEQKITAMHFVPSMLHA---FLEH 1743
Cdd:cd05967 275 ------WW---AASdvgwvvghsyiVYgpllhgattVLYEGkpvGTPDPGAFWRVIEKYQVNALFTAPTAIRAirkEDPD 345
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1744 IKY-RSVPIktNRLKRVFSGGEqlgtHLVSRFYELLPN---VSITNSYGPTEATVEAAffdCPPhEKLERIPI-----GK 1814
Cdd:cd05967 346 GKYiKKYDL--SSLRTLFLAGE----RLDPPTLEWAENtlgVPVIDHWWQTETGWPIT---ANP-VGLEPLPIkagspGK 415
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1815 PVHHVRLYLLNQNQRMLPVGCIGELYIAGAgVARGYLNRPALTEERFLEDPF--YPGerMYKTGDVARWLPDGNVEFLGR 1892
Cdd:cd05967 416 PVPGYQVQVLDEDGEPVGPNELGNIVIKLP-LPPGCLLTLWKNDERFKKLYLskFPG--YYDTGDAGYKDEDGYLFIMGR 492
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1893 TDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GEPELCAYV--------EGLQRNEVRAQLERLLPGYMVPA 1962
Cdd:cd05967 493 TDDVINVAGHRLSTGEMEESVLSHPAVAECAVVGVRDElkGQVPLGLVVlkegvkitAEELEKELVALVREQIGPVAAFR 572
|
570 580 590
....*....|....*....|....*....|....*.
gi 1678550997 1963 YMIEMEQWPVTPSGKLDRNALPApggAADAETYTAP 1998
Cdd:cd05967 573 LVIFVKRLPKTRSGKILRRTLRK---IADGEDYTIP 605
|
|
| PRK05857 |
PRK05857 |
fatty acid--CoA ligase; |
1502-1996 |
6.89e-20 |
|
fatty acid--CoA ligase;
Pssm-ID: 180293 [Multi-domain] Cd Length: 540 Bit Score: 97.00 E-value: 6.89e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1502 QQAEKTPDQAAVIFEDGV--MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYP 1579
Cdd:PRK05857 22 EQARQQPEAIALRRCDGTsaLRYRELVAEVGGLAADLRAQSVSRGSRVLVISDNGPETYLSVLACAKLGAIAVMADGNLP 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1580 EERISFLLEDSGTNILLLQSAG----LHVPEFTGEIVYLN-QTNSGLAHRLSNPNVDVLPQSLAY-------VIYTSGST 1647
Cdd:PRK05857 102 IAAIERFCQITDPAAALVAPGSkmasSAVPEALHSIPVIAvDIAAVTRESEHSLDAASLAGNADQgsedplaMIFTSGTT 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1648 GMPKGVEIEHRSAVNFLNSLQSRyQLKHSDMIMHKTSYS-FDASIWELFWWPYAGASVYLLPQGGEKEPEVIAKAIEEQK 1726
Cdd:PRK05857 182 GEPKAVLLANRTFFAVPDILQKE-GLNWVTWVVGETTYSpLPATHIGGLWWILTCLMHGGLCVTGGENTTSLLEILTTNA 260
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1727 ITAMHFVPSMLHAFLEHIKYRSVPIKTNRLKrVFSGGEQLGTHLvsRFYELlPNVSITNSYGPTEATVEAAffdCPPHE- 1805
Cdd:PRK05857 261 VATTCLVPTLLSKLVSELKSANATVPSLRLV-GYGGSRAIAADV--RFIEA-TGVRTAQVYGLSETGCTAL---CLPTDd 333
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1806 ----KLERIPIGKPVHHVRLYLLNQN------QRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDpfypgerMYKT 1875
Cdd:PRK05857 334 gsivKIEAGAVGRPYPGVDVYLAATDgigptaPGAGPSASFGTLWIKSPANMLGYWNNPERTAEVLIDG-------WVNT 406
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1876 GDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDsgePELCAYVeGLQ------------ 1943
Cdd:PRK05857 407 GDLLERREDGFFYIKGRSSEMIICGGVNIAPDEVDRIAEGVSGVREAACYEIPD---EEFGALV-GLAvvasaeldesaa 482
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 1944 ---RNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNALPAPGGAADAETYT 1996
Cdd:PRK05857 483 ralKHTIAARFRRESEPMARPSTIVIVTDIPRTQSGKVMRASLAAAATADKARVVV 538
|
|
| PRK08276 |
PRK08276 |
long-chain-fatty-acid--CoA ligase; Validated |
1511-1978 |
7.49e-20 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236215 [Multi-domain] Cd Length: 502 Bit Score: 96.51 E-value: 7.49e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1511 AAVIFEDG-VMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLED 1589
Cdd:PRK08276 2 AVIMAPSGeVVTYGELEARSNRLAHGLRALGLREGDVVAILLENNPEFFEVYWAARRSGLYYTPINWHLTAAEIAYIVDD 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1590 SGTNIL------------LLQSAGLHVPEFT---GEIVYLNQTNSGLAHRLSNPNVDVLPQSLayVIYTSGSTGMPKGVe 1654
Cdd:PRK08276 82 SGAKVLivsaaladtaaeLAAELPAGVPLLLvvaGPVPGFRSYEEALAAQPDTPIADETAGAD--MLYSSGTTGRPKGI- 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1655 iehrsavnflnslqsRYQLKHSDMIMhktsySFDASIWELFWWPYAGA-SVYLLP----------------QGGEK---- 1713
Cdd:PRK08276 159 ---------------KRPLPGLDPDE-----APGMMLALLGFGMYGGPdSVYLSPaplyhtaplrfgmsalALGGTvvvm 218
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1714 ---EPEVIAKAIEEQKITAMHFVPSMLHAFL---EHIKYR----SvpiktnrLKRVFSGGEQLGTHLVSRFYELLPNVsI 1783
Cdd:PRK08276 219 ekfDAEEALALIERYRVTHSQLVPTMFVRMLklpEEVRARydvsS-------LRVAIHAAAPCPVEVKRAMIDWWGPI-I 290
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1784 TNSYGPTEA---TVeaaffdCPPHEKLERiP--IGKPVHHVrLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTE 1858
Cdd:PRK08276 291 HEYYASSEGggvTV------ITSEDWLAH-PgsVGKAVLGE-VRILDEDGNELPPGEIGTVYFEMDGYPFEYHNDPEKTA 362
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1859 ERfledpfYPGERMYKTGDVArWL-PDGnveFLGRTD---DQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GE 1932
Cdd:PRK08276 363 AA------RNPHGWVTVGDVG-YLdEDG---YLYLTDrksDMIISGGVNIYPQEIENLLVTHPKVADVAVFGVPDEemGE 432
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 1933 pELCAYVEGLQ--------RNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKL 1978
Cdd:PRK08276 433 -RVKAVVQPADgadagdalAAELIAWLRGRLAHYKCPRSIDFEDELPRTPTGKL 485
|
|
| AACS_like |
cd05968 |
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This ... |
465-963 |
8.08e-20 |
|
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This uncharacterized acyl-CoA synthetase family (EC 6.2.1.16, or acetoacetate#CoA ligase or acetoacetate:CoA ligase (AMP-forming)) is highly homologous to acetoacetyl-CoA synthetase. However, the proteins in this family exist in only bacteria and archaea. AACS is a cytosolic ligase that specifically activates acetoacetate to its coenzyme A ester by a two-step reaction. Acetoacetate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is the first step of the mevalonate pathway of isoprenoid biosynthesis via isopentenyl diphosphate. Isoprenoids are a large class of compounds found in all living organisms.
Pssm-ID: 341272 [Multi-domain] Cd Length: 610 Bit Score: 97.18 E-value: 8.08e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 465 IHAMFEKQAEKTPDAHAVI-----DQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGA 539
Cdd:cd05968 63 VEQLLDKWLADTRTRPALRwegedGTSRTLTYGELLYEVKRLANGLRALGVGKGDRVGIYLPMIPEIVPAFLAVARIGGI 142
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 540 IVPVDPHYPADRIRYILHDCG--------------------------CSH--------VVSQAHLPSSLEDNYIITHPED 585
Cdd:cd05968 143 VVPIFSGFGKEAAATRLQDAEakalitadgftrrgrevnlkeeadkaCAQcptvekvvVVRHLGNDFTPAKGRDLSYDEE 222
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 586 IESKVDGSnikSVNNADDLLYMIYTSGTTGKPKGVQfeHRNMANLLK--FEYTHsGIDF-EADVLQFATpsfDVCYQE-- 660
Cdd:cd05968 223 KETAGDGA---ERTESEDPLMIIYTSGTTGKPKGTV--HVHAGFPLKaaQDMYF-QFDLkPGDLLTWFT---DLGWMMgp 293
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 661 --IFSALLKGGTLHIVPEAIKRDVP-QLFAFINKHQTNIVFLPTAFIK--MIFSERELANSFPDGVKHLIAAGEQLMISD 735
Cdd:cd05968 294 wlIFGGLILGATMVLYDGAPDHPKAdRLWRMVEDHEITHLGLSPTLIRalKPRGDAPVNAHDLSSLRVLGSTGEPWNPEP 373
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 736 ---LFQDVLRKRgIHLHNHYGPSEthvVSTyTIHPGDPIPELPPIG--KPIGCTDLYILNHQKQLQPCGVpGELYISGA- 809
Cdd:cd05968 374 wnwLFETVGKGR-NPIINYSGGTE---ISG-GILGNVLIKPIKPSSfnGPVPGMKADVLDESGKPARPEV-GELVLLAPw 447
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 810 -SVARGYVNHDKLTSDKFSSDpfKPDVIMYrtGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISE-A 887
Cdd:cd05968 448 pGMTRGFWRDEDRYLETYWSR--FDNVWVH--GDFAYYDEEGYFYILGRSDDTINVAGKRVGPAEIESVLNAHPAVLEsA 523
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 888 AILIWQDQNGEHELCAyycSVQKLNTI-------DLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDR-----AALPEP 955
Cdd:cd05968 524 AIGVPHPVKGEAIVCF---VVLKPGVTptealaeELMERVADELGKPLSPERILFVKDLPKTRNAKVMRrviraAYLGKE 600
|
570
....*....|
gi 1678550997 956 DASISG--NP 963
Cdd:cd05968 601 LGDLSSleNP 610
|
|
| AACS_like |
cd05968 |
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This ... |
1489-1985 |
8.15e-20 |
|
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This uncharacterized acyl-CoA synthetase family (EC 6.2.1.16, or acetoacetate#CoA ligase or acetoacetate:CoA ligase (AMP-forming)) is highly homologous to acetoacetyl-CoA synthetase. However, the proteins in this family exist in only bacteria and archaea. AACS is a cytosolic ligase that specifically activates acetoacetate to its coenzyme A ester by a two-step reaction. Acetoacetate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is the first step of the mevalonate pathway of isoprenoid biosynthesis via isopentenyl diphosphate. Isoprenoids are a large class of compounds found in all living organisms.
Pssm-ID: 341272 [Multi-domain] Cd Length: 610 Bit Score: 97.18 E-value: 8.15e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1489 GYSMNqTLHYALEQQAEKTPDQAAVIF--EDG---VMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYG 1563
Cdd:cd05968 57 GGRMN-IVEQLLDKWLADTRTRPALRWegEDGtsrTLTYGELLYEVKRLANGLRALGVGKGDRVGIYLPMIPEIVPAFLA 135
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1564 ILKAGGAYLPIDPDYPEERISFLLEDSGTNILL-----------------LQSAGLHVPEFTGEIVYLNQTNSGLAHR-- 1624
Cdd:cd05968 136 VARIGGIVVPIFSGFGKEAAATRLQDAEAKALItadgftrrgrevnlkeeADKACAQCPTVEKVVVVRHLGNDFTPAKgr 215
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1625 -LSNPNVDVLPQSLA---------YVIYTSGSTGMPKGVEieHRSAVNFLNSLQSRY---QLKHSDMIMHKTSYSFDASI 1691
Cdd:cd05968 216 dLSYDEEKETAGDGAertesedplMIIYTSGTTGKPKGTV--HVHAGFPLKAAQDMYfqfDLKPGDLLTWFTDLGWMMGP 293
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1692 WELFWWPYAGASVYLLpQG--GEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHikyRSVPIKTNRLK--RVF-SGGEQL 1766
Cdd:cd05968 294 WLIFGGLILGATMVLY-DGapDHPKADRLWRMVEDHEITHLGLSPTLIRALKPR---GDAPVNAHDLSslRVLgSTGEPW 369
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1767 GTHLVSRFYE--LLPNVSITNSYGPTEatVEAAFFDCPPHEKLERIPIGKPVHHVRLYLLNQNQRMLPvGCIGELYIAGA 1844
Cdd:cd05968 370 NPEPWNWLFEtvGKGRNPIINYSGGTE--ISGGILGNVLIKPIKPSSFNGPVPGMKADVLDESGKPAR-PEVGELVLLAP 446
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1845 --GVARGYLNrpalTEERFLEDPFYPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVRE- 1921
Cdd:cd05968 447 wpGMTRGFWR----DEDRYLETYWSRFDNVWVHGDFAYYDEEGYFYILGRSDDTINVAGKRVGPAEIESVLNAHPAVLEs 522
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 1922 AAVTVRTD-SGEPELCAYV--------EGLqRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNALPA 1985
Cdd:cd05968 523 AAIGVPHPvKGEAIVCFVVlkpgvtptEAL-AEELMERVADELGKPLSPERILFVKDLPKTRNAKVMRRVIRA 594
|
|
| PRK08279 |
PRK08279 |
long-chain-acyl-CoA synthetase; Validated |
2533-3000 |
1.02e-19 |
|
long-chain-acyl-CoA synthetase; Validated
Pssm-ID: 236217 [Multi-domain] Cd Length: 600 Bit Score: 96.87 E-value: 1.02e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2533 QTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGC--- 2609
Cdd:PRK08279 37 RSLGDVFEEAAARHPDRPALLFEDQSISYAELNARANRYAHWAAARGVGKGDVVALLMENRPEYLAAWLGLAKLGAVval 116
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2610 --------------------YVPIDPEYpkeRKRYILSDSGTKLLMTINEADLGVLADFEGEI-LTIESVEEDDKSP-LP 2667
Cdd:PRK08279 117 lntqqrgavlahslnlvdakHLIVGEEL---VEAFEEARADLARPPRLWVAGGDTLDDPEGYEdLAAAAAGAPTTNPaSR 193
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2668 QMSSAHHLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTI---LQLFSFSfdGFITSMFTPLLSGAKavl 2744
Cdd:PRK08279 194 SGVTAKDTAFYIYTSGTTGLPKAAVMSHMRWLKAMGGFGGLLRLTPDDVLyccLPLYHNT--GGTVAWSSVLAAGAT--- 268
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2745 lheeeakdiLAIKHQLS---------RQRITHMIIVPVLYRALLDvvQPEDVK----TLRVVTLAG-------EAADREL 2804
Cdd:PRK08279 269 ---------LALRRKFSasrfwddvrRYRATAFQYIGELCRYLLN--QPPKPTdrdhRLRLMIGNGlrpdiwdEFQQRFG 337
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2805 IARslaICphtELaneYGPTE------------NSVATTVMRHMEKQAYVSI----GQPIDGTQVLilnsnhqLQPIGvA 2868
Cdd:PRK08279 338 IPR---IL---EF---YAASEgnvgfinvfnfdGTVGRVPLWLAHPYAIVKYdvdtGEPVRDADGR-------CIKVK-P 400
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2869 GE--LCIAG-TGLAR--GYVNlPELTERAFTQNPFKPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIES 2943
Cdd:PRK08279 401 GEvgLLIGRiTDRGPfdGYTD-PEASEKKILRDVFKKGDAWFNTGDLMRDDGFGHAQFVDRLGDTFRWKGENVATTEVEN 479
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2944 VIRCIKGVKDAAV--VAHVTASGQTELSAYVVTK-PGLSTNAVRSELQNKLPVFMHPAFI 3000
Cdd:PRK08279 480 ALSGFPGVEEAVVygVEVPGTDGRAGMAAIVLADgAEFDLAALAAHLYERLPAYAVPLFV 539
|
|
| PLN02330 |
PLN02330 |
4-coumarate--CoA ligase-like 1 |
2557-3019 |
1.81e-19 |
|
4-coumarate--CoA ligase-like 1
Pssm-ID: 215189 [Multi-domain] Cd Length: 546 Bit Score: 95.43 E-value: 1.81e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2557 KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMT 2636
Cdd:PLN02330 54 KAVTYGEVVRDTRRFAKALRSLGLRKGQVVVVVLPNVAEYGIVALGIMAAGGVFSGANPTALESEIKKQAEAAGAKLIVT 133
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2637 --------------------------INEADLGVLADFEGEILTIESVEEDDKSPLPqmssahhlayiiYTSGTTGRPKG 2690
Cdd:PLN02330 134 ndtnygkvkglglpvivlgeekiegaVNWKELLEAADRAGDTSDNEEILQTDLCALP------------FSSGTTGISKG 201
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2691 VMVEHKG-IANTLQ--WRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKDILaikHQLSRQRITH 2767
Cdd:PLN02330 202 VMLTHRNlVANLCSslFSVGPEMIGQVVTLGLIPFFHIYGITGICCATLRNKGKVVVMSRFELRTFL---NALITQEVSF 278
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2768 MIIVPVLYRALLD--VVQPEDVKTLRVVTLAGEAAD--RELIARSLAICPHTELANEYGPTENSVATTVMRHMEKQAYV- 2842
Cdd:PLN02330 279 APIVPPIILNLVKnpIVEEFDLSKLKLQAIMTAAAPlaPELLTAFEAKFPGVQVQEAYGLTEHSCITLTHGDPEKGHGIa 358
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2843 ---SIGQPIDGTQVLILN-SNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMADGT 2918
Cdd:PLN02330 359 kknSVGFILPNLEVKFIDpDTGRSLPKNTPGELCVRSQCVMQGYYNNKEETDRTIDEDGW------LHTGDIGYIDDDGD 432
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2919 LEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPglstNAVRSE------LQNKLP 2992
Cdd:PLN02330 433 IFIVDRIKELIKYKGFQVAPAELEAILLTHPSVEDAAVVPLPDEEAGEIPAACVVINP----KAKESEedilnfVAANVA 508
|
490 500
....*....|....*....|....*..
gi 1678550997 2993 VFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PLN02330 509 HYKKVRVVQFVDSIPKSLSGKIMRRLL 535
|
|
| PRK13391 |
PRK13391 |
acyl-CoA synthetase; Provisional |
1501-1983 |
2.21e-19 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 184022 [Multi-domain] Cd Length: 511 Bit Score: 95.14 E-value: 2.21e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1501 EQQAEKTPDQAAVIF--EDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDY 1578
Cdd:PRK13391 4 GIHAQTTPDKPAVIMasTGEVVTYRELDERSNRLAHLFRSLGLKRGDHVAIFMENNLRYLEVCWAAERSGLYYTCVNSHL 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1579 PEERISFLLEDSGTNILLLQSAGL--------HVPEFTGEIVYLNQTNS----GLAHRLSNPNVDVLP-QSL-AYVIYTS 1644
Cdd:PRK13391 84 TPAEAAYIVDDSGARALITSAAKLdvarallkQCPGVRHRLVLDGDGELegfvGYAEAVAGLPATPIAdESLgTDMLYSS 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1645 GSTGMPKGV-----EIEHRSAVNFLNSLQSRYQLKhSDMIM-------HKTSYSFDASIWELfwwpyaGASVYLLpqggE 1712
Cdd:PRK13391 164 GTTGRPKGIkrplpEQPPDTPLPLTAFLQRLWGFR-SDMVYlspaplyHSAPQRAVMLVIRL------GGTVIVM----E 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1713 K-EPEVIAKAIEEQKITAMHFVPSMLHAFL---EHIKYRsvpIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVsITNSYG 1788
Cdd:PRK13391 233 HfDAEQYLALIEEYGVTHTQLVPTMFSRMLklpEEVRDK---YDLSSLEVAIHAAAPCPPQVKEQMIDWWGPI-IHEYYA 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1789 PTEAtveAAFFDCPPHEKLE-RIPIGKPVHHVrLYLLNQNQRMLPVGCIGELYIAGaGVARGYLNRPALTEERFLEDPfy 1867
Cdd:PRK13391 309 ATEG---LGFTACDSEEWLAhPGTVGRAMFGD-LHILDDDGAELPPGEPGTIWFEG-GRPFEYLNDPAKTAEARHPDG-- 381
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1868 pgeRMYKTGDVARWLPDGnveFLGRTDDQVKI---RGYRIEPGEIEAALRSIEGVREAAV--TVRTDSGEpELCAYV--- 1939
Cdd:PRK13391 382 ---TWSTVGDIGYVDEDG---YLYLTDRAAFMiisGGVNIYPQEAENLLITHPKVADAAVfgVPNEDLGE-EVKAVVqpv 454
|
490 500 510 520
....*....|....*....|....*....|....*....|....*....
gi 1678550997 1940 EGLQRN-----EVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK13391 455 DGVDPGpalaaELIAFCRQRLSRQKCPRSIDFEDELPRLPTGKLYKRLL 503
|
|
| FACL_like_4 |
cd05944 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
602-952 |
3.47e-19 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341266 [Multi-domain] Cd Length: 359 Bit Score: 92.54 E-value: 3.47e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 602 DDLLYMIYTSGTTGKPKGVQFEHRN-------MANLLKFEythsgidfEADVLQFATPSFDV--CYQEIFSALLKGGTLH 672
Cdd:cd05944 2 DDVAAYFHTGGTTGTPKLAQHTHSNevynawmLALNSLFD--------PDDVLLCGLPLFHVngSVVTLLTPLASGAHVV 73
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 673 IVPEAIKRD---VPQLFAFINKHQ-TNIVFLPTAFIKMIfserelanSFPDGVK----HLIAAGEQLMISDLFQDVLRKR 744
Cdd:cd05944 74 LAGPAGYRNpglFDNFWKLVERYRiTSLSTVPTVYAALL--------QVPVNADisslRFAMSGAAPLPVELRARFEDAT 145
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 745 GIHLHNHYGPSETHVVSTYTiHPGDPIpELPPIGKPIGCTDLYILNHQ---KQLQPCGVP--GELYISGASVARGYVNhD 819
Cdd:cd05944 146 GLPVVEGYGLTEATCLVAVN-PPDGPK-RPGSVGLRLPYARVRIKVLDgvgRLLRDCAPDevGEICVAGPGVFGGYLY-T 222
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 820 KLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQVkIR-GYRIEPQEIEVTLMNHPDISEAAILIWQDQNGE 898
Cdd:cd05944 223 EGNKNAFVADGW------LNTGDLGRLDADGYLFITGRAKDLI-IRgGHNIDPALIEEALLRHPAVAFAGAVGQPDAHAG 295
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 899 HELCAYYCSVQ--KLNTIDLRSYMASELPEYMIPAKWIWV-DSIPLTPNGKVDRAAL 952
Cdd:cd05944 296 ELPVAYVQLKPgaVVEEEELLAWARDHVPERAAVPKHIEVlEELPVTAVGKVFKPAL 352
|
|
| PRK08751 |
PRK08751 |
long-chain fatty acid--CoA ligase; |
1519-1983 |
3.58e-19 |
|
long-chain fatty acid--CoA ligase;
Pssm-ID: 181546 [Multi-domain] Cd Length: 560 Bit Score: 94.56 E-value: 3.58e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1519 VMTYKELNEQANRIAWELIGR-GVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLL 1597
Cdd:PRK08751 50 TITYREADQLVEQFAAYLLGElQLKKGDRVALMMPNCLQYPIATFGVLRAGLTVVNVNPLYTPRELKHQLIDSGASVLVV 129
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1598 Q--------------------SAGLH---------------------VPEFT--GEIVYLNQTNSGLAHRLsnPNVDVLP 1634
Cdd:PRK08751 130 IdnfgttvqqviadtpvkqviTTGLGdmlgfpkaalvnfvvkyvkklVPEYRinGAIRFREALALGRKHSM--PTLQIEP 207
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1635 QSLAYVIYTSGSTGMPKGVEIEHRSAVnfLNSLQSRYQLKHSDMIMHKTSYSFDA-SIWELFwwPYAGASVYLLPQGG-- 1711
Cdd:PRK08751 208 DDIAFLQYTGGTTGVAKGAMLTHRNLV--ANMQQAHQWLAGTGKLEEGCEVVITAlPLYHIF--ALTANGLVFMKIGGcn 283
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1712 -----EKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTnrLKRVFSGGEQLGTHLVSRfYELLPNVSITNS 1786
Cdd:PRK08751 284 hlisnPRDMPGFVKELKKTRFTAFTGVNTLFNGLLNTPGFDQIDFSS--LKMTLGGGMAVQRSVAER-WKQVTGLTLVEA 360
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1787 YGPTEATVEAAF--FDCPPHEKleriPIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLED 1864
Cdd:PRK08751 361 YGLTETSPAACInpLTLKEYNG----SIGLPIPSTDACIKDDAGTVLAIGEIGELCIKGPQVMKGYWKRPEETAKVMDAD 436
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1865 PFYpgermyKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVRE-AAVTVRTD-SGEPELCAYVE-- 1940
Cdd:PRK08751 437 GWL------HTGDIARMDEQGFVYIVDRKKDMILVSGFNVYPNEIEDVIAMMPGVLEvAAVGVPDEkSGEIVKVVIVKkd 510
|
490 500 510 520
....*....|....*....|....*....|....*....|....
gi 1678550997 1941 -GLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK08751 511 pALTAEDVKAHARANLTGYKQPRIIEFRKELPKTNVGKILRREL 554
|
|
| PRK08279 |
PRK08279 |
long-chain-acyl-CoA synthetase; Validated |
1499-1961 |
3.61e-19 |
|
long-chain-acyl-CoA synthetase; Validated
Pssm-ID: 236217 [Multi-domain] Cd Length: 600 Bit Score: 94.94 E-value: 3.61e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1499 ALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGA-------- 1570
Cdd:PRK08279 42 VFEEAAARHPDRPALLFEDQSISYAELNARANRYAHWAAARGVGKGDVVALLMENRPEYLAAWLGLAKLGAVvallntqq 121
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1571 ---------------YLPIDPDYPE--ERISFLLEDSGTnILLLQSAGLHVPEFTGEivyLNQTNSGLAHRlsNPNV--D 1631
Cdd:PRK08279 122 rgavlahslnlvdakHLIVGEELVEafEEARADLARPPR-LWVAGGDTLDDPEGYED---LAAAAAGAPTT--NPASrsG 195
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1632 VLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIM------HKTSY------------------SF 1687
Cdd:PRK08279 196 VTAKDTAFYIYTSGTTGLPKAAVMSHMRWLKAMGGFGGLLRLTPDDVLYcclplyHNTGGtvawssvlaagatlalrrKF 275
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1688 DASiweLFWwpyagasvyllpqggekePEVIAkaieeQKITAMHFVPSMLHAFLEHikyrsvPIKT----NRLKRVFSGG 1763
Cdd:PRK08279 276 SAS---RFW------------------DDVRR-----YRATAFQYIGELCRYLLNQ------PPKPtdrdHRLRLMIGNG 323
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1764 ----------EQLGthlVSRFYELlpnvsitnsYGPTEATVeaAFFD----------CPPHEKleripigKPVHHVRL-- 1821
Cdd:PRK08279 324 lrpdiwdefqQRFG---IPRILEF---------YAASEGNV--GFINvfnfdgtvgrVPLWLA-------HPYAIVKYdv 382
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1822 ----YLLNQNQRMLPVG------CIGElyIAGAGVARGYlNRPALTEERFLEDPFYPGERMYKTGDVARWLPDGNVEFLG 1891
Cdd:PRK08279 383 dtgePVRDADGRCIKVKpgevglLIGR--ITDRGPFDGY-TDPEASEKKILRDVFKKGDAWFNTGDLMRDDGFGHAQFVD 459
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1892 RTDDQVKIRGYRIEPGEIEAALRSIEGVREAAV---------------TVRTDSGepelcayvEGLQRNEVRAQLERLLP 1956
Cdd:PRK08279 460 RLGDTFRWKGENVATTEVENALSGFPGVEEAVVygvevpgtdgragmaAIVLADG--------AEFDLAALAAHLYERLP 531
|
....*
gi 1678550997 1957 GYMVP 1961
Cdd:PRK08279 532 AYAVP 536
|
|
| PRK13390 |
PRK13390 |
acyl-CoA synthetase; Provisional |
472-952 |
3.75e-19 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139538 [Multi-domain] Cd Length: 501 Bit Score: 94.31 E-value: 3.75e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 472 QAEKTPDAHAVI--DQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPA 549
Cdd:PRK13390 6 HAQIAPDRPAVIvaETGEQVSYRQLDDDSAALARVLYDAGLRTGDVVALLSDNSPEALVVLWAALRSGLYITAINHHLTA 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 550 DRIRYILHDCGCSHVVSQAHLpssleDNYIITHPEDIESKVD-GSNIKSVNNADDLL--------------YMIYTSGTT 614
Cdd:PRK13390 86 PEADYIVGDSGARVLVASAAL-----DGLAAKVGADLPLRLSfGGEIDGFGSFEAALagagprlteqpcgaVMLYSSGTT 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 615 GKPKGVQ--FEHRN----------MANLLkFEYTHSGIDFEADVLQFATPsfdVCYQEIFSALlkGGTLHIvpeAIKRDV 682
Cdd:PRK13390 161 GFPKGIQpdLPGRDvdapgdpivaIARAF-YDISESDIYYSSAPIYHAAP---LRWCSMVHAL--GGTVVL---AKRFDA 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 683 PQLFAFINKHQTNIV-FLPTAFIKMIFSERELANSFP-DGVKHLIAAGEQLMIsDLFQDVLRKRGIHLHNHYGPSETHVV 760
Cdd:PRK13390 232 QATLGHVERYRITVTqMVPTMFVRLLKLDADVRTRYDvSSLRAVIHAAAPCPV-DVKHAMIDWLGPIVYEYYSSTEAHGM 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 761 StyTIHPGDPIPELPPIGKPIgCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNH-DKLTSDKFSSDPFKPDVimyr 839
Cdd:PRK13390 311 T--FIDSPDWLAHPGSVGRSV-LGDLHICDDDGNELPAGRIGTVYFERDRLPFRYLNDpEKTAAAQHPAHPFWTTV---- 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 840 tGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCSVQKLNTID---- 915
Cdd:PRK13390 384 -GDLGSVDEDGYLYLADRKSFMIISGGVNIYPQETENALTMHPAVHDVAVIGVPDPEMGEQVKAVIQLVEGIRGSDelar 462
|
490 500 510
....*....|....*....|....*....|....*...
gi 1678550997 916 -LRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PRK13390 463 eLIDYTRSRIAHYKAPRSVEFVDELPRTPTGKLVKGLL 500
|
|
| FACL_like_5 |
cd05924 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
601-948 |
3.76e-19 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341248 [Multi-domain] Cd Length: 364 Bit Score: 92.45 E-value: 3.76e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 601 ADDLlYMIYTSGTTGKPKGVQFEHRNM-------ANLLKFEYTHSGIDFEADVLQFATPSFDVC-------YQEIFSALL 666
Cdd:cd05924 3 ADDL-YILYTGGTTGMPKGVMWRQEDIfrmlmggADFGTGEFTPSEDAHKAAAAAAGTVMFPAPplmhgtgSWTAFGGLL 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 667 KGGTLhIVPEaIKRDVPQLFAFINKHQTN-IVFLPTAFIKMIFSERELANSFPDGVKHLIAAGEQLMISDLFQDVLR-KR 744
Cdd:cd05924 82 GGQTV-VLPD-DRFDPEEVWRTIEKHKVTsMTIVGDAMARPLIDALRDAGPYDLSSLFAISSGGALLSPEVKQGLLElVP 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 745 GIHLHNHYGPSETHvvSTYTIHPGDPIPELPPIGKPIGCTDLyILNHQKQLQP-CGVPGELYISGaSVARGYVNHDKLTS 823
Cdd:cd05924 160 NITLVDAFGSSETG--FTGSGHSAGSGPETGPFTRANPDTVV-LDDDGRVVPPgSGGVGWIARRG-HIPLGYYGDEAKTA 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 824 DKFssdPFKPDVIMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCA 903
Cdd:cd05924 236 ETF---PEVDGVRYAVPGDRATVEADGTVTLLGRGSVCINTGGEKVFPEEVEEALKSHPAVYDVLVVGRPDERWGQEVVA 312
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 904 yycsVQKLNTI------DLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVD 948
Cdd:cd05924 313 ----VVQLREGagvdleELREHCRTRIARYKLPKQVVFVDEIERSPAGKAD 359
|
|
| EntF2 |
COG3319 |
Thioesterase domain of type I polyketide synthase or non-ribosomal peptide synthetase ... |
466-1041 |
6.67e-19 |
|
Thioesterase domain of type I polyketide synthase or non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442548 [Multi-domain] Cd Length: 855 Bit Score: 94.77 E-value: 6.67e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 466 HAMFEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDP 545
Cdd:COG3319 4 AAAAAAAAAAAAAAAAAAAAAAALAAAAAAAAAAALLLLAAALLVALAALALAALALAALLAVALLAAALALAALAALAA 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 546 HYPADRIRYILHDCGCSHVVSQ----AHLPSSLEDNYIITHPEDIESKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQ 621
Cdd:COG3319 84 LALALAAAAAALLLAALALLLAllaaLALALLALLLAALLLALAALAAAAAAAALAAAAAAAAALAAAAGLGGGGGGAGV 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 622 FEHRNMANLLKFEYTHSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAIKRDVPQLFAFINKHQTNIVFLPT 701
Cdd:COG3319 164 LVLVLAALLALLLAALLALALALAALLLLALAAALALALLLLLALLLLLLLLLALLLLLLLALLAAAALLALLLALLLLL 243
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 702 AFIkmIFSERELANSFPDGVKHLIAAGEQLMISDLFQDVLRKRGIHLHNHYGPSETHVVSTYT---IHPGDPIPELPPIG 778
Cdd:COG3319 244 LAA--LLLLLALALLLLLALLLLLGLLALLLALLLLLALLLLAAAAALAAGGTATTAAVTTTAaaaAPGVAGALGPIGGG 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 779 KPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFKPDVIMYRTGDLARRLEDGNIEYIGRA 858
Cdd:COG3319 322 PGLLVLLVLLVLLLPLLLGVGGGGGGGGGGGGAGGLAGRGLRAAAALRDPAGAGARGRLRRGGDRGRRLGGGLLLGLGRL 401
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 859 DNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCSVQKLNTIDLRSYMASELPEYMIPAKWIWVDS 938
Cdd:COG3319 402 RLQRLRRGLREELEEAEAALAEAAAVAAAVAAAAAAAAAAAALAAAVVAAAALAAAALLLLLLLLLLPPPLPPALLLLLL 481
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 939 IPLTPNGKVDRAALPEPDASISGNPYTAPRNLLEAKLSQLFEDVLKNGHIGIQDNFFDNGGHSLKATVLMSRIAKEFHVQ 1018
Cdd:COG3319 482 LLLLLLLAALLLAAAAPAAAAAAAAAPAPAAALELALALLLLLLLGLGLVGDDDDFFGGGGGSLLALLLLLLLLALLLRL 561
|
570 580
....*....|....*....|...
gi 1678550997 1019 VSLKDIFAHPTVEGLALIIREAE 1041
Cdd:COG3319 562 LLLLALLLAPTLAALAAALAAAA 584
|
|
| PRK09029 |
PRK09029 |
O-succinylbenzoic acid--CoA ligase; Provisional |
1504-1924 |
6.93e-19 |
|
O-succinylbenzoic acid--CoA ligase; Provisional
Pssm-ID: 236363 [Multi-domain] Cd Length: 458 Bit Score: 93.01 E-value: 6.93e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1504 AEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERI 1583
Cdd:PRK09029 13 AQVRPQAIALRLNDEVLTWQQLCARIDQLAAGFAQQGVVEGSGVALRGKNSPETLLAYLALLQCGARVLPLNPQLPQPLL 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1584 SFLLEDSGTNILLLqsaglhvpeFTGEIVYLNQTNSGLAHRLSNPNVDVLPQSLAYVIYTSGSTGMPKGVeiEHrSAVNF 1663
Cdd:PRK09029 93 EELLPSLTLDFALV---------LEGENTFSALTSLHLQLVEGAHAVAWQPQRLATMTLTSGSTGLPKAA--VH-TAQAH 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1664 LNSLQSRYQLkhsdmiMHktsysFDAS-IW----ELF--------W-WPYAGASVYLlpqgGEKEPevIAKAIeeQKITA 1729
Cdd:PRK09029 161 LASAEGVLSL------MP-----FTAQdSWllslPLFhvsgqgivWrWLYAGATLVV----RDKQP--LEQAL--AGCTH 221
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1730 MHFVPSMLHAFLEhikYRSVPIktnRLKRVFSGGEQLGTHLVSRFYELlpnvSITN--SYGPTEA--TVEAaffdcpphE 1805
Cdd:PRK09029 222 ASLVPTQLWRLLD---NRSEPL---SLKAVLLGGAAIPVELTEQAEQQ----GIRCwcGYGLTEMasTVCA--------K 283
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1806 KLERIP-IGKPVHHVRLYLLNqnqrmlpvgciGELYIAGAGVARGYLNRPALTeerfledPFYPGERMYKTGDVARWLpD 1884
Cdd:PRK09029 284 RADGLAgVGSPLPGREVKLVD-----------GEIWLRGASLALGYWRQGQLV-------PLVNDEGWFATRDRGEWQ-N 344
|
410 420 430 440
....*....|....*....|....*....|....*....|
gi 1678550997 1885 GNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAV 1924
Cdd:PRK09029 345 GELTILGRLDNLFFSGGEGIQPEEIERVINQHPLVQQVFV 384
|
|
| PLN02860 |
PLN02860 |
o-succinylbenzoate-CoA ligase |
2535-2957 |
7.30e-19 |
|
o-succinylbenzoate-CoA ligase
Pssm-ID: 215464 [Multi-domain] Cd Length: 563 Bit Score: 93.71 E-value: 7.30e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2535 ISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPID 2614
Cdd:PLN02860 9 ICQCLTRLATLRGNAVVTISGNRRRTGHEFVDGVLSLAAGLLRLGLRNGDVVAIAALNSDLYLEWLLAVACAGGIVAPLN 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2615 PEYP-KERKRYILS--------DSGTK---LLMTIN-----------EADLGVLADFEGEILTIESVEEDD-KSPLPQMS 2670
Cdd:PLN02860 89 YRWSfEEAKSAMLLvrpvmlvtDETCSswyEELQNDrlpslmwqvflESPSSSVFIFLNSFLTTEMLKQRAlGTTELDYA 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2671 SA-HHLAYIIYTSGTTGRPKGVMVEHKG-IANTLQwRRNAYAFNETDTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEE 2748
Cdd:PLN02860 169 WApDDAVLICFTSGTTGRPKGVTISHSAlIVQSLA-KIAIVGYGEDDVYLHTAPLCHIGGLSSALAMLMVGACHVLLPKF 247
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2749 EAKDIL-AIKHqlsrQRITHMIIVPVLYRALLDVVQPEDV----KTLRVVTLAGEAADRELIARSLAICPHTELANEYGP 2823
Cdd:PLN02860 248 DAKAALqAIKQ----HNVTSMITVPAMMADLISLTRKSMTwkvfPSVRKILNGGGSLSSRLLPDAKKLFPNAKLFSAYGM 323
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2824 TENSVATTVMR-HMEKQAyvSIGQPIDGTQVLILNSNHQLQPIGVAG-----ELCIA-------GTGLARGyvnlPELTE 2890
Cdd:PLN02860 324 TEACSSLTFMTlHDPTLE--SPKQTLQTVNQTKSSSVHQPQGVCVGKpaphvELKIGldessrvGRILTRG----PHVML 397
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 2891 RAFTQNPFKPEARM----YRTGDAArWMAD-GTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVV 2957
Cdd:PLN02860 398 GYWGQNSETASVLSndgwLDTGDIG-WIDKaGNLWLIGRSNDRIKTGGENVYPEEVEAVLSQHPGVASVVVV 468
|
|
| E_NRPS |
cd19534 |
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
1058-1456 |
1.04e-18 |
|
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Epimerization (E) domains of nonribosomal peptide synthetases (NRPS) flip the chirality of the end amino acid of a peptide being manufactured by the NRPS. E-domains are homologous to the Condensation (C) domains. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Specialized tailoring NRPS domains such as E-domains greatly increase the range of possible peptide products created by the NRPS machinery. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the E-domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380457 [Multi-domain] Cd Length: 428 Bit Score: 91.93 E-value: 1.04e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1058 PVSSAQKRiYVLQQLDEGVAYNMPAVLELEGALDVAKLSAVCKELISRHEPLRTSFVSgADDEPVQRIH--TEVPFTL-- 1133
Cdd:cd19534 3 PLTPIQRW-FFEQNLAGRHHFNQSVLLRVPQGLDPDALRQALRALVEHHDALRMRFRR-EDGGWQQRIRgdVEELFRLev 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1134 ------SKETTIEGFV----RPFDLSQAPLFRAGLIEVSNEKHVLLVDMHHIISDGVSVQLLIREFTDLYANRQL----- 1198
Cdd:cd19534 81 vdlsslAQAAAIEALAaeaqSSLDLEEGPLLAAALFDGTDGGDRLLLVIHHLVVDGVSWRILLEDLEAAYEQALAgepip 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1199 KPLRIQYKDYAVWQQKFKKGDSYQKQETYWQQQFSGDLPilELPTDkrrPAERQFIGGKVTFQLDKEITARIkrLAHKNR 1278
Cdd:cd19534 161 LPSKTSFQTWAELLAEYAQSPALLEELAYWRELPAADYW--GLPKD---PEQTYGDARTVSFTLDEEETEAL--LQEANA 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1279 StlYMT-----LL-ALYSAFlSRLSGQDDIVIGSPIAGR----PHADLEAVLGMFVNTLALRTRPAGNKTFEEFLKEVRQ 1348
Cdd:cd19534 234 A--YRTeindlLLaALALAF-QDWTGRAPPAIFLEGHGReeidPGLDLSRTVGWFTSMYPVVLDLEASEDLGDTLKRVKE 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1349 TA---------------LEAYEHQDYPF----EELVDKLGVQREMSRNPLFDTTLVLQNMEQQKLKMndvqlqwnDLEHP 1409
Cdd:cd19534 311 QLrripnkgigygilryLTPEGTKRLAFhpqpEISFNYLGQFDQGERDDALFVSAVGGGGSDIGPDT--------PRFAL 382
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 1410 iskFDISLYVteHDSELFCQFEYSTALFEKETIQRWASLF----TTLVEHT 1456
Cdd:cd19534 383 ---LDINAVV--EGGQLVITVSYSRNMYHEETIQQLADSYkealEALIEHC 428
|
|
| LC_FACS_euk1 |
cd17639 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The ... |
2554-2963 |
1.07e-18 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The members of this family are eukaryotic fatty acid CoA synthetases (EC 6.2.1.3) that activate fatty acids with chain lengths of 12 to 20 and includes fungal proteins. They act on a wide range of long-chain saturated and unsaturated fatty acids, but the enzymes from different tissues show some variation in specificity. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. In Schizosaccharomyces pombe, lcf1 gene encodes a new fatty acyl-CoA synthetase that preferentially recognizes myristic acid as a substrate.
Pssm-ID: 341294 [Multi-domain] Cd Length: 507 Bit Score: 92.66 E-value: 1.07e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2554 SGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGgcyVPIDPEYPKerkryiLSDSGtkL 2633
Cdd:cd17639 1 GEYKYMSYAEVWERVLNFGRGLVELGLKPGDKVAIFAETRAEWLITALGCWSQN---IPIVTVYAT------LGEDA--L 69
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2634 LMTINEADLGVLadfegeiltIESVEEDDksplpqmssahhLAYIIYTSGTTGRPKGVMVEHKGIANTL--QWRRNAYAF 2711
Cdd:cd17639 70 IHSLNETECSAI---------FTDGKPDD------------LACIMYTSGSTGNPKGVMLTHGNLVAGIagLGDRVPELL 128
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2712 NETDTIL------QLFSFSFD----------GFIT----------------SMFTP-LLSGAKAVLlhEEEAKDILA--- 2755
Cdd:cd17639 129 GPDDRYLaylplaHIFELAAEnvclyrggtiGYGSprtltdkskrgckgdlTEFKPtLMVGVPAIW--DTIRKGVLAkln 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2756 ----IKHQL------SRQ-RITHMIIVPVLYRALLdvvqpedvKTLRVVT-------LAGEAA----DRELIarSLAICP 2813
Cdd:cd17639 207 pmggLKRTLfwtayqSKLkALKEGPGTPLLDELVF--------KKVRAALggrlrymLSGGAPlsadTQEFL--NIVLCP 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2814 hteLANEYGPTENSVATTVMRHMEkQAYVSIGQPIDGTQVLILN------SNHQLQPigvAGELCIAGTGLARGYVNLPE 2887
Cdd:cd17639 277 ---VIQGYGLTETCAGGTVQDPGD-LETGRVGPPLPCCEIKLVDweeggySTDKPPP---RGEILIRGPNVFKGYYKNPE 349
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 2888 LTERAFTqnpfkpEARMYRTGDAARWMADGTLEYLGRIDDQVKIR-GYRVETKEIESVIRCIKGVKDAAVVAHVTAS 2963
Cdd:cd17639 350 KTKEAFD------GDGWFHTGDIGEFHPDGTLKIIDRKKDLVKLQnGEYIALEKLESIYRSNPLVNNICVYADPDKS 420
|
|
| LCL_NRPS-like |
cd19531 |
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar ... |
3123-3362 |
1.27e-18 |
|
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar domains including the C-domain of SgcC5, a free-standing NRPS with both ester- and amide- bond forming activity; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. Streptomyces globisporus SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380454 [Multi-domain] Cd Length: 427 Bit Score: 91.65 E-value: 1.27e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3123 SPVQK--WFLSQDIKEKHHFNQSVMLHRSTSVQEDALRKTLKAITCHHDALRMVFTQNEQgkwdqynRPLSH-SDDALYG 3199
Cdd:cd19531 5 SFAQQrlWFLDQLEPGSAAYNIPGALRLRGPLDVAALERALNELVARHEALRTTFVEVDG-------EPVQViLPPLPLP 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3200 LQMIDLSAPDGTDGnrpyEPLIKRHVLD-IQQKMDLKNGPLLQAGLFHTIDGDF-LFLSAHHLVVDGISWRVLLEDLALG 3277
Cdd:cd19531 78 LPVVDLSGLPEAER----EAEAQRLAREeARRPFDLARGPLLRATLLRLGEDEHvLLLTMHHIVSDGWSMGVLLRELAAL 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3278 YRQAAGGEDIKLPPktssfkayakkLS----DYAESQQ-------LMKQLKYWRE--AEEYQTEALPFDqidgtRAHEGQ 3344
Cdd:cd19531 154 YAAFLAGRPSPLPP-----------LPiqyaDYAVWQRewlqgevLERQLAYWREqlAGAPPVLELPTD-----RPRPAV 217
|
250 260
....*....|....*....|..
gi 1678550997 3345 RS----TISFTLnDKETAALLK 3362
Cdd:cd19531 218 QSfrgaRVRFTL-PAELTAALR 238
|
|
| LC_FACS_euk1 |
cd17639 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The ... |
1520-1939 |
1.38e-18 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The members of this family are eukaryotic fatty acid CoA synthetases (EC 6.2.1.3) that activate fatty acids with chain lengths of 12 to 20 and includes fungal proteins. They act on a wide range of long-chain saturated and unsaturated fatty acids, but the enzymes from different tissues show some variation in specificity. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. In Schizosaccharomyces pombe, lcf1 gene encodes a new fatty acyl-CoA synthetase that preferentially recognizes myristic acid as a substrate.
Pssm-ID: 341294 [Multi-domain] Cd Length: 507 Bit Score: 92.28 E-value: 1.38e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1520 MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGgaylpidpdypeerisflledsgtnilllqs 1599
Cdd:cd17639 6 MSYAEVWERVLNFGRGLVELGLKPGDKVAIFAETRAEWLITALGCWSQN------------------------------- 54
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1600 aglhvpeFTGEIVYLNQTNSGLAHRLSNPNVDVL-----PQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSR-YQL 1673
Cdd:cd17639 55 -------IPIVTVYATLGEDALIHSLNETECSAIftdgkPDDLACIMYTSGSTGNPKGVMLTHGNLVAGIAGLGDRvPEL 127
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1674 KHSD--MImhktSYSFDASIWE-------LFWWPYAG-ASVYLL-------PQGGEKE---------PEV---IAKAIEE 1724
Cdd:cd17639 128 LGPDdrYL----AYLPLAHIFElaaenvcLYRGGTIGyGSPRTLtdkskrgCKGDLTEfkptlmvgvPAIwdtIRKGVLA 203
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1725 qKITAMHFVPSML--HAFLEHIKYRSVPIKT----------------NRLKRVFSGGEQLG--THlvsRFYELL--Pnvs 1782
Cdd:cd17639 204 -KLNPMGGLKRTLfwTAYQSKLKALKEGPGTplldelvfkkvraalgGRLRYMLSGGAPLSadTQ---EFLNIVlcP--- 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1783 ITNSYGPTEaTVEAAFFDCPPHEKLERIpiGKPVHHVRLYLLN-----------QNQrmlpvgciGELYIAGAGVARGYL 1851
Cdd:cd17639 277 VIQGYGLTE-TCAGGTVQDPGDLETGRV--GPPLPCCEIKLVDweeggystdkpPPR--------GEILIRGPNVFKGYY 345
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1852 NRPALTEERFLEDpfypgeRMYKTGDVARWLPDGNVEFLGRTDDQVKIR-GYRIEPGEIEAALRSIEGVreAAVTVRTDS 1930
Cdd:cd17639 346 KNPEKTKEAFDGD------GWFHTGDIGEFHPDGTLKIIDRKKDLVKLQnGEYIALEKLESIYRSNPLV--NNICVYADP 417
|
....*....
gi 1678550997 1931 GEPELCAYV 1939
Cdd:cd17639 418 DKSYPVAIV 426
|
|
| MACS_euk |
cd05928 |
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step ... |
1497-1983 |
1.43e-18 |
|
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes. MACS enzymes are localized to mitochondria. Two murine MACS family proteins are found in liver and kidney. In rodents, a MACS member is detected particularly in the olfactory epithelium and is called O-MACS. O-MACS demonstrates substrate preference for the fatty acid lengths of C6-C12.
Pssm-ID: 341251 [Multi-domain] Cd Length: 530 Bit Score: 92.53 E-value: 1.43e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1497 HYALEQQAEKTPDQAAVIFEDG----VM-TYKELNEQANRIAWELIGR-GVKPETTVAIIGKRSPEMLLGIYGILKAGGA 1570
Cdd:cd05928 14 QWADKEKAGKRPPNPALWWVNGkgdeVKwSFRELGSLSRKAANVLSGAcGLQRGDRVAVILPRVPEWWLVNVACIRTGLV 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1571 YLPIDPDYPEERISFLLEDSGTNILL--------LQSAGLHVPEFTGEIVYLNQTNSG------LAHRLSNPNVDVLPQS 1636
Cdd:cd05928 94 FIPGTIQLTAKDILYRLQASKAKCIVtsdelapeVDSVASECPSLKTKLLVSEKSRDGwlnfkeLLNEASTEHHCVETGS 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1637 L-AYVIY-TSGSTGMPKGVEIEHRSAVNFLnSLQSRY--QLKHSDmIMHKTSYS--FDASIWELFW-WPyAGASVY--LL 1707
Cdd:cd05928 174 QePMAIYfTSGTTGSPKMAEHSHSSLGLGL-KVNGRYwlDLTASD-IMWNTSDTgwIKSAWSSLFEpWI-QGACVFvhHL 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1708 PQggeKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRsvpIKTNRLKRVFSGGEQLGTHLVSRFYELlPNVSITNSY 1787
Cdd:cd05928 251 PR---FDPLVILKTLSSYPITTFCGAPTVYRMLVQQDLSS---YKFPSLQHCVTGGEPLNPEVLEKWKAQ-TGLDIYEGY 323
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1788 GPTEATVEAAFFDcppHEKLERIPIGKPVHHVRLYLLNQNQRMLPVGCIGELYI-----AGAGVARGYLNRPALTEERFL 1862
Cdd:cd05928 324 GQTETGLICANFK---GMKIKPGSMGKASPPYDVQIIDDNGNVLPPGTEGDIGIrvkpiRPFGLFSGYVDNPEKTAATIR 400
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1863 EDpfypgerMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDSGEPELC-AYV-- 1939
Cdd:cd05928 401 GD-------FYLTGDRGIMDEDGYFWFMGRADDVINSSGYRIGPFEVESALIEHPAVVESAVVSSPDPIRGEVVkAFVvl 473
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 1940 ---------EGLQRnEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd05928 474 apqflshdpEQLTK-ELQQHVKSVTAPYKYPRKVEFVQELPKTVTGKIQRNEL 525
|
|
| PRK13390 |
PRK13390 |
acyl-CoA synthetase; Provisional |
2544-3019 |
2.03e-18 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139538 [Multi-domain] Cd Length: 501 Bit Score: 91.99 E-value: 2.03e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2544 ART-PKASALVSGD--KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKE 2620
Cdd:PRK13390 7 AQIaPDRPAVIVAEtgEQVSYRQLDDDSAALARVLYDAGLRTGDVVALLSDNSPEALVVLWAALRSGLYITAINHHLTAP 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2621 RKRYILSDSGTKLLMTINEADlGVLAD----------FEGEILTIESVEEDDKSPLPQMSSAHHLAYIIYTSGTTGRPKG 2690
Cdd:PRK13390 87 EADYIVGDSGARVLVASAALD-GLAAKvgadlplrlsFGGEIDGFGSFEAALAGAGPRLTEQPCGAVMLYSSGTTGFPKG 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2691 VM-------VEHKGiANTLQWRRNAYAFNETDT------ILQLFSFSFDGFITSMftpllsGAKAVLLHEEEAKDILAik 2757
Cdd:PRK13390 166 IQpdlpgrdVDAPG-DPIVAIARAFYDISESDIyyssapIYHAAPLRWCSMVHAL------GGTVVLAKRFDAQATLG-- 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2758 hQLSRQRITHMIIVPVLYRALL----DVVQPEDVKTLRVVTLAgeAADRELIARSLAICPHTELANEYGPTENSVATTVM 2833
Cdd:PRK13390 237 -HVERYRITVTQMVPTMFVRLLkldaDVRTRYDVSSLRAVIHA--AAPCPVDVKHAMIDWLGPIVYEYYSSTEAHGMTFI 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2834 RHMEKQAYV-SIGQPIDGTQVLILNSNHQLqPIGVAGELCIAGTGLARGYVNLPELTERAftQNPFKPearMYRT-GDAA 2911
Cdd:PRK13390 314 DSPDWLAHPgSVGRSVLGDLHICDDDGNEL-PAGRIGTVYFERDRLPFRYLNDPEKTAAA--QHPAHP---FWTTvGDLG 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2912 RWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLS-TNAVRSEL--- 2987
Cdd:PRK13390 388 SVDEDGYLYLADRKSFMIISGGVNIYPQETENALTMHPAVHDVAVIGVPDPEMGEQVKAVIQLVEGIRgSDELARELidy 467
|
490 500 510
....*....|....*....|....*....|...
gi 1678550997 2988 -QNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK13390 468 tRSRIAHYKAPRSVEFVDELPRTPTGKLVKGLL 500
|
|
| PRK13383 |
PRK13383 |
acyl-CoA synthetase; Provisional |
1496-1985 |
2.19e-18 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139531 [Multi-domain] Cd Length: 516 Bit Score: 91.98 E-value: 2.19e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1496 LHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPID 1575
Cdd:PRK13383 37 PYTLLAVTAARWPGRTAIIDDDGALSYRELQRATESLARRLTRDGVAPGRAVGVMCRNGRGFVTAVFAVGLLGADVVPIS 116
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1576 PDYPEERISFLLEDSGTNILLLQSAGLHVPEFTGE-IVYLNQTNSGLAHRLSNPNVdvlPQSLAYVIYTSGSTGMPKGV- 1653
Cdd:PRK13383 117 TEFRSDALAAALRAHHISTVVADNEFAERIAGADDaVAVIDPATAGAEESGGRPAV---AAPGRIVLLTSGTTGKPKGVp 193
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1654 -EIEHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVyLLPQGGEKEPEVIAKAIeeQKITAMHF 1732
Cdd:PRK13383 194 rAPQLRSAVGVWVTILDRTRLRTGSRISVAMPMFHGLGLGMLMLTIALGGTV-LTHRHFDAEAALAQASL--HRADAFTA 270
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1733 VPSMLHAFLE---HIKYRSvPIKtnRLKRVFSGGEQLGTHLVSRFYELLPNVsITNSYGPTEATVEAAffdCPPHEkLER 1809
Cdd:PRK13383 271 VPVVLARILElppRVRARN-PLP--QLRVVMSSGDRLDPTLGQRFMDTYGDI-LYNGYGSTEVGIGAL---ATPAD-LRD 342
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1810 IP--IGKPVHHVRLYLLNQNQRmlPVG--CIGELYIAGAGVARGYLNRPAlteeRFLEDPfypgerMYKTGDVARWLPDG 1885
Cdd:PRK13383 343 APetVGKPVAGCPVRILDRNNR--PVGprVTGRIFVGGELAGTRYTDGGG----KAVVDG------MTSTGDMGYLDNAG 410
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1886 NVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVT-VRTDSGEPELCAYV-----EGLQRNEVRAQLERLLPGYM 1959
Cdd:PRK13383 411 RLFIVGREDDMIISGGENVYPRAVENALAAHPAVADNAVIgVPDERFGHRLAAFVvlhpgSGVDAAQLRDYLKDRVSRFE 490
|
490 500
....*....|....*....|....*.
gi 1678550997 1960 VPAYMIEMEQWPVTPSGKLDRNALPA 1985
Cdd:PRK13383 491 QPRDINIVSSIPRNPTGKVLRKELPG 516
|
|
| ACS |
cd05966 |
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); ... |
2556-3016 |
2.26e-18 |
|
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); Acetyl-CoA synthetase (ACS, EC 6.2.1.1, acetate#CoA ligase or acetate:CoA ligase (AMP-forming)) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is widely present in all living organisms. The activity of this enzyme is crucial for maintaining the required levels of acetyl-CoA, a key intermediate in many important biosynthetic and catabolic processes. Acetyl-CoA is used in the biosynthesis of glucose, fatty acids, and cholesterol. It can also be used in the production of energy in the citric acid cycle. Eukaryotes typically have two isoforms of acetyl-CoA synthetase, a cytosolic form involved in biosynthetic processes and a mitochondrial form primarily involved in energy generation.
Pssm-ID: 341270 [Multi-domain] Cd Length: 608 Bit Score: 92.24 E-value: 2.26e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2556 DKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPI----DPEYPKERkryiLSDSGT 2631
Cdd:cd05966 82 SRTITYRELLREVCRFANVLKSLGVKKGDRVAIYMPMIPELVIAMLACARIGAVHSVVfagfSAESLADR----INDAQC 157
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2632 KLLMTINEA-------DLGVLADfegEIL----TIESV-------------------------EEDDKSPLPQMSSAHHL 2675
Cdd:cd05966 158 KLVITADGGyrggkviPLKEIVD---EALekcpSVEKVlvvkrtggevpmtegrdlwwhdlmaKQSPECEPEWMDSEDPL 234
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2676 aYIIYTSGTTGRPKGVMVEHKG----IANTLQWrrnayAFNETDTilQLFSFSFD-GFIT----SMFTPLLSGAKAVLLh 2746
Cdd:cd05966 235 -FILYTSGSTGKPKGVVHTTGGyllyAATTFKY-----VFDYHPD--DIYWCTADiGWITghsyIVYGPLANGATTVMF- 305
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2747 eEEAK---------DILAiKHqlsrqRITHMIIVPVLYRALL----DVVQPEDVKTLRVVTLAGEAAD-------RELIA 2806
Cdd:cd05966 306 -EGTPtypdpgrywDIVE-KH-----KVTIFYTAPTAIRALMkfgdEWVKKHDLSSLRVLGSVGEPINpeawmwyYEVIG 378
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2807 RSLaiCP------HTE-----LANEYG--PTENSVATTvmrhmekqayvsigqPIDGTQVLILNSNHQLQPIGVAGELCI 2873
Cdd:cd05966 379 KER--CPivdtwwQTEtggimITPLPGatPLKPGSATR---------------PFFGIEPAILDEEGNEVEGEVEGYLVI 441
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2874 AGT--GLARGYVNLPELTERAFtqnpFKPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGV 2951
Cdd:cd05966 442 KRPwpGMARTIYGDHERYEDTY----FSKFPGYYFTGDGARRDEDGYYWITGRVDDVINVSGHRLGTAEVESALVAHPAV 517
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 2952 KDAAVVAH---VTasGQTeLSAYVVTKPGLSTN-AVRSEL----QNKLPVFMHPAFIEKLDSLPLSPNGKLDR 3016
Cdd:cd05966 518 AEAAVVGRphdIK--GEA-IYAFVTLKDGEEPSdELRKELrkhvRKEIGPIATPDKIQFVPGLPKTRSGKIMR 587
|
|
| PLN02246 |
PLN02246 |
4-coumarate--CoA ligase |
1496-1932 |
3.20e-18 |
|
4-coumarate--CoA ligase
Pssm-ID: 215137 [Multi-domain] Cd Length: 537 Bit Score: 91.58 E-value: 3.20e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1496 LH-YALEQQAEkTPDQAAVIfeDG----VMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGA 1570
Cdd:PLN02246 25 LHdYCFERLSE-FSDRPCLI--DGatgrVYTYADVELLSRRVAAGLHKLGIRQGDVVMLLLPNCPEFVLAFLGASRRGAV 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1571 YLPIDPDYPEERISFLLEDSGTNILLLQSAGL-HVPEFTGE----IVYLNQTNSGLAH--RLSN------PNVDVLPQSL 1637
Cdd:PLN02246 102 TTTANPFYTPAEIAKQAKASGAKLIITQSCYVdKLKGLAEDdgvtVVTIDDPPEGCLHfsELTQadenelPEVEISPDDV 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1638 AYVIYTSGSTGMPKGVEIEHRSAVNflnslqSRYQ----------LKHSDMIM------HktSYSFDaSIweLFWWPYAG 1701
Cdd:PLN02246 182 VALPYSSGTTGLPKGVMLTHKGLVT------SVAQqvdgenpnlyFHSDDVILcvlpmfH--IYSLN-SV--LLCGLRVG 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1702 ASVYLLPQggeKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHikyrsvPIKTNR----LKRVFSGGEQLGTHLVSRFYEL 1777
Cdd:PLN02246 251 AAILIMPK---FEIGALLELIQRHKVTIAPFVPPIVLAIAKS------PVVEKYdlssIRMVLSGAAPLGKELEDAFRAK 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1778 LPNVSITNSYGPTEA-TVEAAffdCPPHEKlERIPI-----GKPVHHVRLYLLNQNQRM-LPVGCIGELYIAGAGVARGY 1850
Cdd:PLN02246 322 LPNAVLGQGYGMTEAgPVLAM---CLAFAK-EPFPVksgscGTVVRNAELKIVDPETGAsLPRNQPGEICIRGPQIMKGY 397
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1851 LNRPALTEErfledpfypgermykTGDVARWLPDGNVEFLGRTD-----DQV----KIRGYRIEPGEIEAALRSIEGVRE 1921
Cdd:PLN02246 398 LNDPEATAN---------------TIDKDGWLHTGDIGYIDDDDelfivDRLkeliKYKGFQVAPAELEALLISHPSIAD 462
|
490
....*....|...
gi 1678550997 1922 AAVTVRTD--SGE 1932
Cdd:PLN02246 463 AAVVPMKDevAGE 475
|
|
| BACL_like |
cd05929 |
Bacterial Bile acid CoA ligases and similar proteins; Bile acid-Coenzyme A ligase catalyzes ... |
2543-3019 |
9.44e-18 |
|
Bacterial Bile acid CoA ligases and similar proteins; Bile acid-Coenzyme A ligase catalyzes the formation of bile acid-CoA conjugates in a two-step reaction: the formation of a bile acid-AMP molecule as an intermediate, followed by the formation of a bile acid-CoA. This ligase requires a bile acid with a free carboxyl group, ATP, Mg2+, and CoA for synthesis of the final bile acid-CoA conjugate. The bile acid-CoA ligation is believed to be the initial step in the bile acid 7alpha-dehydroxylation pathway in the intestinal bacterium Eubacterium sp.
Pssm-ID: 341252 [Multi-domain] Cd Length: 473 Bit Score: 89.74 E-value: 9.44e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2543 AARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERK 2622
Cdd:cd05929 2 EARDLDRAQVFHQRRLLLLDVYSIALNRNARAAAAEGVWIADGVYIYLINSILTVFAAAAAWKCGACPAYKSSRAPRAEA 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2623 R---YILSDSGTKLLMTINEAdLGVLADFEgeiltiESVEEDDKSPLPQMSSAHhlaYIIYTSGTTGRPKGVMVEHKGIA 2699
Cdd:cd05929 82 CaiiEIKAAALVCGLFTGGGA-LDGLEDYE------AAEGGSPETPIEDEAAGW---KMLYSGGTTGRPKGIKRGLPGGP 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2700 NTLQWRRNAyafnetdtiLQLFSFSFD-------------GFITSMfTPLLSGAKAVLLHEEEAKDILAIkhqLSRQRIT 2766
Cdd:cd05929 152 PDNDTLMAA---------ALGFGPGADsvylspaplyhaaPFRWSM-TALFMGGTLVLMEKFDPEEFLRL---IERYRVT 218
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2767 HMIIVPVLYRALL----DVVQPEDVKTLRVVTLAGEAADRELIARSLAICPhtELANE-YGPTEnSVATTVMRHMEKQAY 2841
Cdd:cd05929 219 FAQFVPTMFVRLLklpeAVRNAYDLSSLKRVIHAAAPCPPWVKEQWIDWGG--PIIWEyYGGTE-GQGLTIINGEEWLTH 295
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2842 V-SIGQPIDGtQVLILNSNHQLQPIGVAGELCIAGtGLARGYVNLPELTERAFtqnpfkpEARMYRT-GDAARWMADGTL 2919
Cdd:cd05929 296 PgSVGRAVLG-KVHILDEDGNEVPPGEIGEVYFAN-GPGFEYTNDPEKTAAAR-------NEGGWSTlGDVGYLDEDGYL 366
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2920 EYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVV-AHVTASGQtELSAYVVTKPGLSTNAVRSE-----LQNKLPV 2993
Cdd:cd05929 367 YLTDRRSDMIISGGVNIYPQEIENALIAHPKVLDAAVVgVPDEELGQ-RVHAVVQPAPGADAGTALAEeliafLRDRLSR 445
|
490 500
....*....|....*....|....*.
gi 1678550997 2994 FMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:cd05929 446 YKCPRSIEFVAELPRDDTGKLYRRLL 471
|
|
| MACS_like_1 |
cd05974 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
1520-1924 |
1.16e-17 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341278 [Multi-domain] Cd Length: 432 Bit Score: 88.78 E-value: 1.16e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1520 MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLP----IDPDYPEERIsflleDSGTNIL 1595
Cdd:cd05974 1 VSFAEMSARSSRVANFLRSIGVGRGDRILLMLGNVVELWEAMLAAMKLGAVVIPattlLTPDDLRDRV-----DRGGAVY 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1596 LLQSAGLHVpeftgeivylnqtnsglahrlSNPnvdvlpqSLAYviYTSGSTGMPKGVEIEHRS-AVNFLNSLqsrY--Q 1672
Cdd:cd05974 76 AAVDENTHA---------------------DDP-------MLLY--FTSGTTSKPKLVEHTHRSyPVGHLSTM---YwiG 122
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1673 LKHSDMIMHKTSYSFDASIWELFWWPY-AGASVYLLPQGgEKEPEVIAKAIEEQKITAMHFVPSMLHAFL-EHIKYRSVP 1750
Cdd:cd05974 123 LKPGDVHWNISSPGWAKHAWSCFFAPWnAGATVFLFNYA-RFDAKRVLAALVRYGVTTLCAPPTVWRMLIqQDLASFDVK 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1751 iktnrLKRVFSGGEQLGTHLVSRFYELLpNVSITNSYGPTEATVEAAffdCPPHEKLERIPIGKPVHHVRLYLLNQNQRM 1830
Cdd:cd05974 202 -----LREVVGAGEPLNPEVIEQVRRAW-GLTIRDGYGQTETTALVG---NSPGQPVKAGSMGRPLPGYRVALLDPDGAP 272
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1831 LPVGCIGELYIAG--AGVARGYLNRPALTEERfLEDPFYPgermykTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGE 1908
Cdd:cd05974 273 ATEGEVALDLGDTrpVGLMKGYAGDPDKTAHA-MRGGYYR------TGDIAMRDEDGYLTYVGRADDVFKSSDYRISPFE 345
|
410
....*....|....*.
gi 1678550997 1909 IEAALRSIEGVREAAV 1924
Cdd:cd05974 346 LESVLIEHPAVAEAAV 361
|
|
| ACS |
cd05966 |
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); ... |
470-949 |
1.25e-17 |
|
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); Acetyl-CoA synthetase (ACS, EC 6.2.1.1, acetate#CoA ligase or acetate:CoA ligase (AMP-forming)) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is widely present in all living organisms. The activity of this enzyme is crucial for maintaining the required levels of acetyl-CoA, a key intermediate in many important biosynthetic and catabolic processes. Acetyl-CoA is used in the biosynthesis of glucose, fatty acids, and cholesterol. It can also be used in the production of energy in the citric acid cycle. Eukaryotes typically have two isoforms of acetyl-CoA synthetase, a cytosolic form involved in biosynthetic processes and a mitochondrial form primarily involved in energy generation.
Pssm-ID: 341270 [Multi-domain] Cd Length: 608 Bit Score: 89.93 E-value: 1.25e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 470 EKQAEKTPDAHAVI------DQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGgAIVPV 543
Cdd:cd05966 60 DRHLKERGDKVAIIwegdepDQSRTITYRELLREVCRFANVLKSLGVKKGDRVAIYMPMIPELVIAMLACARIG-AVHSV 138
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 544 -----DPHYPADRIryilHDCGCS--------------------------------HVVSQAHLPSSLEDNYIITHP-ED 585
Cdd:cd05966 139 vfagfSAESLADRI----NDAQCKlvitadggyrggkviplkeivdealekcpsveKVLVVKRTGGEVPMTEGRDLWwHD 214
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 586 IESKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQfeHRNMANLLKFEYTHSGI-DFEADvlqfatpsfDV--CYQEI- 661
Cdd:cd05966 215 LMAKQSPECEPEWMDSEDPLFILYTSGSTGKPKGVV--HTTGGYLLYAATTFKYVfDYHPD---------DIywCTADIg 283
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 662 ---------FSALLKGGTLHI---VPeaikrDVPQ---LFAFINKHQTNIVFL-PTAfIKMifserelansfpdgvkhLI 725
Cdd:cd05966 284 witghsyivYGPLANGATTVMfegTP-----TYPDpgrYWDIVEKHKVTIFYTaPTA-IRA-----------------LM 340
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 726 AAGEQ-LMISDLFQdvLRKRG-----IH------LHNHYGPSETHVVSTY----------TihpgdPIPELPPIgKPIGC 783
Cdd:cd05966 341 KFGDEwVKKHDLSS--LRVLGsvgepINpeawmwYYEVIGKERCPIVDTWwqtetggimiT-----PLPGATPL-KPGSA 412
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 784 T------DLYILNHQKQLQPCGVPGELYISGA--SVARG-YVNHDKLTSDKFSsdPFKPdviMYRTGDLARRLEDGNIEY 854
Cdd:cd05966 413 TrpffgiEPAILDEEGNEVEGEVEGYLVIKRPwpGMARTiYGDHERYEDTYFS--KFPG---YYFTGDGARRDEDGYYWI 487
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 855 IGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAIL-IWQDQNGEhelcAYYCSV---------QKLNTiDLRSYMASEL 924
Cdd:cd05966 488 TGRVDDVINVSGHRLGTAEVESALVAHPAVAEAAVVgRPHDIKGE----AIYAFVtlkdgeepsDELRK-ELRKHVRKEI 562
|
570 580
....*....|....*....|....*
gi 1678550997 925 PEYMIPAKWIWVDSIPLTPNGKVDR 949
Cdd:cd05966 563 GPIATPDKIQFVPGLPKTRSGKIMR 587
|
|
| BACL_like |
cd05929 |
Bacterial Bile acid CoA ligases and similar proteins; Bile acid-Coenzyme A ligase catalyzes ... |
473-952 |
1.41e-17 |
|
Bacterial Bile acid CoA ligases and similar proteins; Bile acid-Coenzyme A ligase catalyzes the formation of bile acid-CoA conjugates in a two-step reaction: the formation of a bile acid-AMP molecule as an intermediate, followed by the formation of a bile acid-CoA. This ligase requires a bile acid with a free carboxyl group, ATP, Mg2+, and CoA for synthesis of the final bile acid-CoA conjugate. The bile acid-CoA ligation is believed to be the initial step in the bile acid 7alpha-dehydroxylation pathway in the intestinal bacterium Eubacterium sp.
Pssm-ID: 341252 [Multi-domain] Cd Length: 473 Bit Score: 88.97 E-value: 1.41e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 473 AEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRI 552
Cdd:cd05929 2 EARDLDRAQVFHQRRLLLLDVYSIALNRNARAAAAEGVWIADGVYIYLINSILTVFAAAAAWKCGACPAYKSSRAPRAEA 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 553 RYILHDCGCSHVVSQAHLPSSLEdnyiitHPEDIESKVDGSN---IKSVNNADDllyMIYTSGTTGKPKGVQ--FEHRNM 627
Cdd:cd05929 82 CAIIEIKAAALVCGLFTGGGALD------GLEDYEAAEGGSPetpIEDEAAGWK---MLYSGGTTGRPKGIKrgLPGGPP 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 628 ANLLKFEYThSGIDFEADVLQF-------ATPsFDVCyqeiFSALLKGGTLHIVPeaiKRDVPQLFAFINKHQ-TNIVFL 699
Cdd:cd05929 153 DNDTLMAAA-LGFGPGADSVYLspaplyhAAP-FRWS----MTALFMGGTLVLME---KFDPEEFLRLIERYRvTFAQFV 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 700 PTAFIKMIFSERELANSFP-DGVKHLIAAG-------EQLMIsDLFQDVLrkrgihlHNHYGPSE----THVVST-YTIH 766
Cdd:cd05929 224 PTMFVRLLKLPEAVRNAYDlSSLKRVIHAAapcppwvKEQWI-DWGGPII-------WEYYGGTEgqglTIINGEeWLTH 295
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 767 PGDpipelppIGKPIGcTDLYILNHQKQLQPCGVPGELYISGASvARGYVNHDKLTSDKFSSDPFkpdvimyRT-GDLAR 845
Cdd:cd05929 296 PGS-------VGRAVL-GKVHILDEDGNEVPPGEIGEVYFANGP-GFEYTNDPEKTAAARNEGGW-------STlGDVGY 359
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 846 RLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAIL-IWQDQNGEHELCAyycsVQKLNTIDLRSYMASEL 924
Cdd:cd05929 360 LDEDGYLYLTDRRSDMIISGGVNIYPQEIENALIAHPKVLDAAVVgVPDEELGQRVHAV----VQPAPGADAGTALAEEL 435
|
490 500 510
....*....|....*....|....*....|....*.
gi 1678550997 925 PE--------YMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:cd05929 436 IAflrdrlsrYKCPRSIEFVAELPRDDTGKLYRRLL 471
|
|
| PRK08308 |
PRK08308 |
acyl-CoA synthetase; Validated |
517-953 |
1.45e-17 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236231 [Multi-domain] Cd Length: 414 Bit Score: 88.17 E-value: 1.45e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 517 AIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSQahlpsslEDNYIITHpedieskvdgsnIK 596
Cdd:PRK08308 36 AVCLKDPFDIITLVFFLKEKGASVLPIHPDTPKEAAIRMAKRAGCHGLLYG-------ESDFTKLE------------AV 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 597 SVNNADDLLYMiYTSGTTGKPKGVqfehrnmanllkfEYTHSGIDFEAD--VLQFATPSFDV----C-----YQEI---F 662
Cdd:PRK08308 97 NYLAEEPSLLQ-YSSGTTGEPKLI-------------RRSWTEIDREIEayNEALNCEQDETpivaCpvthsYGLIcgvL 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 663 SALLKGGTLHIV----PE---AIKRDVPQlfafinkhqtNIVFLPTAFIKMIfserelaNSFPDGVK--HLIAAGEQLMI 733
Cdd:PRK08308 163 AALTRGSKPVIItnknPKfalNILRNTPQ----------HILYAVPLMLHIL-------GRLLPGTFqfHAVMTSGTPLP 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 734 SDLFQDvLRKRGIHLHNHYGPSETHVVStytIHPgdPIPELPPIGKPigctdlyiLNHqkqlqpcgvpgelyisgASVAR 813
Cdd:PRK08308 226 EAWFYK-LRERTTYMMQQYGCSEAGCVS---ICP--DMKSHLDLGNP--------LPH-----------------VSVSA 274
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 814 GyvnhdkltsdkfsSDPFKPDVIMYR-------TGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISE 886
Cdd:PRK08308 275 G-------------SDENAPEEIVVKmgdkeifTKDLGYKSERGTLHFMGRMDDVINVSGLNVYPIEVEDVMLRLPGVQE 341
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 887 AAILIWQDQNGEHELCAYYCSVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALP 953
Cdd:PRK08308 342 AVVYRGKDPVAGERVKAKVISHEEIDPVQLREWCIQHLAPYQVPHEIESVTEIPKNANGKVSRKLLE 408
|
|
| PRK07470 |
PRK07470 |
acyl-CoA synthetase; Validated |
1492-1978 |
1.91e-17 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 180988 [Multi-domain] Cd Length: 528 Bit Score: 88.94 E-value: 1.91e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1492 MNqtLHYALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAY 1571
Cdd:PRK07470 7 MN--LAHFLRQAARRFPDRIALVWGDRSWTWREIDARVDALAAALAARGVRKGDRILVHSRNCNQMFESMFAAFRLGAVW 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1572 LPIDPDYPEERISFLLEDSGTNILLLQSA-GLHV-------PEFTGEIV---------YLNQTNSGLAHRLSNPNVDvlP 1634
Cdd:PRK07470 85 VPTNFRQTPDEVAYLAEASGARAMICHADfPEHAaavraasPDLTHVVAiggaragldYEALVARHLGARVANAAVD--H 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1635 QSLAYVIYTSGSTGMPKGVEIEHRS----AVNFLNSLQSryQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVyLLPqg 1710
Cdd:PRK07470 163 DDPCWFFFTSGTTGRPKAAVLTHGQmafvITNHLADLMP--GTTEQDASLVVAPLSHGAGIHQLCQVARGAATV-LLP-- 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1711 GEK-EPEVIAKAIEEQKITAMHFVPSML-------------HAFLEHIKYRSVPIKTNRLKRVFsggEQLGTHLVSRFye 1776
Cdd:PRK07470 238 SERfDPAEVWALVERHRVTNLFTVPTILkmlvehpavdrydHSSLRYVIYAGAPMYRADQKRAL---AKLGKVLVQYF-- 312
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1777 llpnvsitnsyGPTEATVEAAFFdcPPHEKLE------RI-PIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARG 1849
Cdd:PRK07470 313 -----------GLGEVTGNITVL--PPALHDAedgpdaRIgTCGFERTGMEVQIQDDEGRELPPGETGEICVIGPAVFAG 379
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1850 YLNRPALTEERFLEDPFypgermyKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTD 1929
Cdd:PRK07470 380 YYNNPEANAKAFRDGWF-------RTGDLGHLDARGFLYITGRASDMYISGGSNVYPREIEEKLLTHPAVSEVAVLGVPD 452
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 1930 S--GEP--ELCAYVEGLQRN--EVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKL 1978
Cdd:PRK07470 453 PvwGEVgvAVCVARDGAPVDeaELLAWLDGKVARYKLPKRFFFWDALPKSGYGKI 507
|
|
| entE |
PRK10946 |
(2,3-dihydroxybenzoyl)adenylate synthase; |
1483-1983 |
2.06e-17 |
|
(2,3-dihydroxybenzoyl)adenylate synthase;
Pssm-ID: 236803 [Multi-domain] Cd Length: 536 Bit Score: 88.89 E-value: 2.06e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1483 HLFEETGYSMNQTLHYALEQQAEktPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIY 1562
Cdd:PRK10946 14 RRYREKGYWQDLPLTDILTRHAA--SDAIAVICGERQFSYRELNQASDNLACSLRRQGIKPGDTALVQLGNVAEFYITFF 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1563 GILKAGGAylPIDPDYPEERI--------------------SFLLEDSGTNILLLQSAGLHVPEFTGEivylnQTNSGLA 1622
Cdd:PRK10946 92 ALLKLGVA--PVNALFSHQRSelnayasqiepalliadrqhALFSDDDFLNTLVAEHSSLRVVLLLND-----DGEHSLD 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1623 HRLSNPNVDVLPQS-----LAYVIYTSGSTGMPK---------------GVEI-EHRSAVNFLNSLQSryqlkhsdmiMH 1681
Cdd:PRK10946 165 DAINHPAEDFTATPspadeVAFFQLSGGSTGTPKliprthndyyysvrrSVEIcGFTPQTRYLCALPA----------AH 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1682 KTSYSFDASIWELfwwpYAGASVYLLPqggEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIK---YRSvPIKTNRLKR 1758
Cdd:PRK10946 235 NYPMSSPGALGVF----LAGGTVVLAP---DPSATLCFPLIEKHQVNVTALVPPAVSLWLQAIAeggSRA-QLASLKLLQ 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1759 VfsGGEQLGTHLVSRFYELLpNVSITNSYGPTEATVEAAFFDCPPheklERI------PIgKPVHHVRLylLNQNQRMLP 1832
Cdd:PRK10946 307 V--GGARLSETLARRIPAEL-GCQLQQVFGMAEGLVNYTRLDDSD----ERIfttqgrPM-SPDDEVWV--ADADGNPLP 376
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1833 VGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYpgermyKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAA 1912
Cdd:PRK10946 377 QGEVGRLMTRGPYTFRGYYKSPQHNASAFDANGFY------CSGDLVSIDPDGYITVVGREKDQINRGGEKIAAEEIENL 450
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 1913 LRSIEGVREAAVTVRTDS--GEPElCAYVegLQRNEVRA-QLERLLPG-----YMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK10946 451 LLRHPAVIHAALVSMEDElmGEKS-CAFL--VVKEPLKAvQLRRFLREqgiaeFKLPDRVECVDSLPLTAVGKVDKKQL 526
|
|
| PLN02860 |
PLN02860 |
o-succinylbenzoate-CoA ligase |
1499-1981 |
3.51e-17 |
|
o-succinylbenzoate-CoA ligase
Pssm-ID: 215464 [Multi-domain] Cd Length: 563 Bit Score: 88.32 E-value: 3.51e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1499 ALEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDY 1578
Cdd:PLN02860 12 CLTRLATLRGNAVVTISGNRRRTGHEFVDGVLSLAAGLLRLGLRNGDVVAIAALNSDLYLEWLLAVACAGGIVAPLNYRW 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1579 PEERISFLLEDSGTNILLLQSAGLHVPE--FTGEI------VYLNQTNSGLAHRLSN----------------PNVDVLP 1634
Cdd:PLN02860 92 SFEEAKSAMLLVRPVMLVTDETCSSWYEelQNDRLpslmwqVFLESPSSSVFIFLNSflttemlkqralgtteLDYAWAP 171
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1635 QSLAYVIYTSGSTGMPKGVEIEHRSAVnflnsLQSRYQLK-----HSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQ 1709
Cdd:PLN02860 172 DDAVLICFTSGTTGRPKGVTISHSALI-----VQSLAKIAivgygEDDVYLHTAPLCHIGGLSSALAMLMVGACHVLLPK 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1710 ggeKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGP 1789
Cdd:PLN02860 247 ---FDAKAALQAIKQHNVTSMITVPAMMADLISLTRKSMTWKVFPSVRKILNGGGSLSSRLLPDAKKLFPNAKLFSAYGM 323
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1790 TEATVEAAFFdcPPHEKLERIPIGKPVHHVRLYLLNQNQrmlPVG-CIG------ELYIAGAGVAR--GYLNRPALTEER 1860
Cdd:PLN02860 324 TEACSSLTFM--TLHDPTLESPKQTLQTVNQTKSSSVHQ---PQGvCVGkpaphvELKIGLDESSRvgRILTRGPHVMLG 398
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1861 FL-EDPFYPGERM----YKTGDVArWLPD-GNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDSGEPE 1934
Cdd:PLN02860 399 YWgQNSETASVLSndgwLDTGDIG-WIDKaGNLWLIGRSNDRIKTGGENVYPEEVEAVLSQHPGVASVVVVGVPDSRLTE 477
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 1935 LCAYV----EGLQRNEVRAQLERL-----------------LPGYMVP-AYMIEMEQWPVTPSGKLDRN 1981
Cdd:PLN02860 478 MVVACvrlrDGWIWSDNEKENAKKnltlssetlrhhcreknLSRFKIPkLFVQWRKPFPLTTTGKIRRD 546
|
|
| LCL_NRPS-like |
cd19540 |
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; ... |
12-304 |
3.57e-17 |
|
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380463 [Multi-domain] Cd Length: 433 Bit Score: 87.48 E-value: 3.57e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 12 PLSYMQEGMLFHSLLQKDSQAYVEQASFTIEGKVNPQFFQNSINALVERHDIFRTIFIS------QNVSSPQQVVLRERN 85
Cdd:cd19540 3 PLSFAQQRLWFLNRLDGPSAAYNIPLALRLTGALDVDALRAALADVVARHESLRTVFPEddggpyQVVLPAAEARPDLTV 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 86 VIVLEEDITHLNEAEQSqfieqwkekdrdRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDGWCLSIVLKEFLHIYA 165
Cdd:cd19540 83 VDVTEDELAARLAEAAR------------RGFDLTAELPLRARLFRLGPDEHVLVLVVHHIAADGWSMAPLARDLATAYA 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 166 SYVNASPITLEP--VQpYGKYIKW---LM--EQDKEQAVS----YWDHYLSGHEQQTVLP--KQKKTKGKSRQEHVTFSF 232
Cdd:cd19540 151 ARRAGRAPDWAPlpVQ-YADYALWqreLLgdEDDPDSLAArqlaYWRETLAGLPEELELPtdRPRPAVASYRGGTVEFTI 229
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 233 SKEESSRLSELAAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRPAeiEGIEHMVGLFINTMPVRVQ 304
Cdd:cd19540 230 DAELHARLAALAREHGATLFMVLHAALAVLLSRLGAGDDIPIGTPVAGRGD--EALDDLVGMFVNTLVLRTD 299
|
|
| PRK08279 |
PRK08279 |
long-chain-acyl-CoA synthetase; Validated |
469-625 |
4.14e-17 |
|
long-chain-acyl-CoA synthetase; Validated
Pssm-ID: 236217 [Multi-domain] Cd Length: 600 Bit Score: 88.39 E-value: 4.14e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 469 FEKQAEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGG---------- 538
Cdd:PRK08279 43 FEEAAARHPDRPALLFEDQSISYAELNARANRYAHWAAARGVGKGDVVALLMENRPEYLAAWLGLAKLGAvvallntqqr 122
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 539 ------AIVPVDPhypadriRYILHDCGCSHVVSQA------HLPSSLEDNYIITHPEDIESKVDGSNIKSVNN------ 600
Cdd:PRK08279 123 gavlahSLNLVDA-------KHLIVGEELVEAFEEAradlarPPRLWVAGGDTLDDPEGYEDLAAAAAGAPTTNpasrsg 195
|
170 180
....*....|....*....|....*..
gi 1678550997 601 --ADDLLYMIYTSGTTGKPKGVQFEHR 625
Cdd:PRK08279 196 vtAKDTAFYIYTSGTTGLPKAAVMSHM 222
|
|
| AcpA |
COG3433 |
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites ... |
761-1043 |
5.06e-17 |
|
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442659 [Multi-domain] Cd Length: 295 Bit Score: 84.80 E-value: 5.06e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 761 STYTIHPGDPIPELPPIGKPIGCTDLYILNHQKQLQPcgVPGELYISGASVARGYVNHDKLTsDKFSSDPFKPDVI---- 836
Cdd:COG3433 2 AIATPPPAPPTPDEPPPVIPPAIVQARALLLIVDLQG--YFGGFGGEGGLLGAGLLLRIRLL-AAAARAPFIPVPYpaqp 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 837 --MYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHP-DISEAAILIWQDQNGEHELCAYYCsVQKLNT 913
Cdd:COG3433 79 grQADDLRLLLRRGLGPGGGLERLVQQVVIRAERGEEEELLLVLRAAAvVRVAVLAALRGAGVGLLLIVGAVA-ALDGLA 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 914 IDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPEPDASISGNPYTAPRN-----LLEAKLSQLFEDVLKNG-- 986
Cdd:COG3433 158 AAAALAALDKVPPDVVAASAVVALDALLLLALKVVARAAPALAAAEALLAAASPAPaletaLTEEELRADVAELLGVDpe 237
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 987 HIGIQDNFFDNGGHSLKATVLMSRiAKEFHVQVSLKDIFAHPTVEGLALIIREAEQN 1043
Cdd:COG3433 238 EIDPDDNLFDLGLDSIRLMQLVER-WRKAGLDVSFADLAEHPTLAAWWALLAAAQAA 293
|
|
| LC_FACS_bac |
cd05932 |
Bacterial long-chain fatty acid CoA synthetase (LC-FACS), including Marinobacter ... |
489-902 |
6.04e-17 |
|
Bacterial long-chain fatty acid CoA synthetase (LC-FACS), including Marinobacter hydrocarbonoclasticus isoprenoid Coenzyme A synthetase; The members of this family are bacterial long-chain fatty acid CoA synthetase. Marinobacter hydrocarbonoclasticus isoprenoid Coenzyme A synthetase in this family is involved in the synthesis of isoprenoid wax ester storage compounds when grown on phytol as the sole carbon source. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341255 [Multi-domain] Cd Length: 508 Bit Score: 87.14 E-value: 6.04e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 489 LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVV--- 565
Cdd:cd05932 7 FTWGEVADKARRLAAALRALGLEPGSKIALISKNCAEWFITDLAIWMAGHISVPLYPTLNPDTIRYVLEHSESKALFvgk 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 566 -----SQAH-LPSSLEDNYIITHP--------EDIESKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRNMANLL 631
Cdd:cd05932 87 lddwkAMAPgVPEGLISISLPPPSaancqyqwDDLIAQHPPLEERPTRFPEQLATLIYTSGTTGQPKGVMLTFGSFAWAA 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 632 KFEYTHSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAI-------KRDVPQLFAFI----NKHQTNI---- 696
Cdd:cd05932 167 QAGIEHIGTEENDRMLSYLPLAHVTERVFVEGGSLYGGVLVAFAESLdtfvedvQRARPTLFFSVprlwTKFQQGVqdki 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 697 ------VFLPTAFIKMIFSERELANSFPDGVKhlIAAGEQLMISDLFQDVLRKRGIHLHNHYGPSETHVVSTYTiHPGDp 770
Cdd:cd05932 247 pqqklnLLLKIPVVNSLVKRKVLKGLGLDQCR--LAGCGSAPVPPALLEWYRSLGLNILEAYGMTENFAYSHLN-YPGR- 322
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 771 iPELPPIGKPIGCTDLYIlnhqkqlqpcGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDG 850
Cdd:cd05932 323 -DKIGTVGNAGPGVEVRI----------SEDGEILVRSPALMMGYYKDPEATAEAFTADGF------LRTGDKGELDADG 385
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 851 NIEYIGRADNQVKI-RGYRIEPQEIEVTLMNHPDIsEAAILIWQDQNGEHELC 902
Cdd:cd05932 386 NLTITGRVKDIFKTsKGKYVAPAPIENKLAEHDRV-EMVCVIGSGLPAPLALV 437
|
|
| LC_FACS_bac |
cd05932 |
Bacterial long-chain fatty acid CoA synthetase (LC-FACS), including Marinobacter ... |
2559-2991 |
7.86e-17 |
|
Bacterial long-chain fatty acid CoA synthetase (LC-FACS), including Marinobacter hydrocarbonoclasticus isoprenoid Coenzyme A synthetase; The members of this family are bacterial long-chain fatty acid CoA synthetase. Marinobacter hydrocarbonoclasticus isoprenoid Coenzyme A synthetase in this family is involved in the synthesis of isoprenoid wax ester storage compounds when grown on phytol as the sole carbon source. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341255 [Multi-domain] Cd Length: 508 Bit Score: 87.14 E-value: 7.86e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2559 LTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMtin 2638
Cdd:cd05932 7 FTWGEVADKARRLAAALRALGLEPGSKIALISKNCAEWFITDLAIWMAGHISVPLYPTLNPDTIRYVLEHSESKALF--- 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2639 eadLGVLADFE-------GEILTIESveeddkSPLPQMSS---------------------AHHLAYIIYTSGTTGRPKG 2690
Cdd:cd05932 84 ---VGKLDDWKamapgvpEGLISISL------PPPSAANCqyqwddliaqhppleerptrfPEQLATLIYTSGTTGQPKG 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2691 VMVEHKGIANTLQWRRNAYAFNETDtilQLFSFSFDGFITS-MFTPLLSGAKAVLLHEEEAKDILAikHQLSRQRITHMI 2769
Cdd:cd05932 155 VMLTFGSFAWAAQAGIEHIGTEEND---RMLSYLPLAHVTErVFVEGGSLYGGVLVAFAESLDTFV--EDVQRARPTLFF 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2770 IVPVLY----RALLDVVQPEDVKTLRVVTLAGEAADRELIA-------------------------RSLAIcphtELANE 2820
Cdd:cd05932 230 SVPRLWtkfqQGVQDKIPQQKLNLLLKIPVVNSLVKRKVLKglgldqcrlagcgsapvppallewyRSLGL----NILEA 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2821 YGPTENSVATTVMRHMEKQAYvSIGQPIDGTQVlilnsnhqlqPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkp 2900
Cdd:cd05932 306 YGMTENFAYSHLNYPGRDKIG-TVGNAGPGVEV----------RISEDGEILVRSPALMMGYYKDPEATAEAFTADGF-- 372
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2901 earmYRTGDAARWMADGTLEYLGRIDDQVKI-RGYRVETKEIESvirciKGVKDAAVVAH-VTASGQTELSAYVVTKPG- 2977
Cdd:cd05932 373 ----LRTGDKGELDADGNLTITGRVKDIFKTsKGKYVAPAPIEN-----KLAEHDRVEMVcVIGSGLPAPLALVVLSEEa 443
|
490
....*....|....*.
gi 1678550997 2978 --LSTNAVRSELQNKL 2991
Cdd:cd05932 444 rlRADAFARAELEASL 459
|
|
| MACS_euk |
cd05928 |
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step ... |
2678-3021 |
8.66e-17 |
|
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes. MACS enzymes are localized to mitochondria. Two murine MACS family proteins are found in liver and kidney. In rodents, a MACS member is detected particularly in the olfactory epithelium and is called O-MACS. O-MACS demonstrates substrate preference for the fatty acid lengths of C6-C12.
Pssm-ID: 341251 [Multi-domain] Cd Length: 530 Bit Score: 87.14 E-value: 8.66e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2678 IIYTSGTTGRPKgvMVEHK----GIANTLQWRRnAYAFNETDTIlqlFSFSFDGFI----TSMFTPLLSGAkAVLLHEEE 2749
Cdd:cd05928 179 IYFTSGTTGSPK--MAEHShsslGLGLKVNGRY-WLDLTASDIM---WNTSDTGWIksawSSLFEPWIQGA-CVFVHHLP 251
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2750 AKDILAIKHQLSRQRITHMIIVPVLYRALLDvvqpEDVKTLRVVTL-----AGEAADRELIARSLAicpHT--ELANEYG 2822
Cdd:cd05928 252 RFDPLVILKTLSSYPITTFCGAPTVYRMLVQ----QDLSSYKFPSLqhcvtGGEPLNPEVLEKWKA---QTglDIYEGYG 324
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2823 PTENSVATTVMRHMEKQAYvSIGQPIDGTQVLILNSNHQLQPIGVAGELCI-----AGTGLARGYVNLPELTERAFTQNp 2897
Cdd:cd05928 325 QTETGLICANFKGMKIKPG-SMGKASPPYDVQIIDDNGNVLPPGTEGDIGIrvkpiRPFGLFSGYVDNPEKTAATIRGD- 402
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2898 fkpearMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPG 2977
Cdd:cd05928 403 ------FYLTGDRGIMDEDGYFWFMGRADDVINSSGYRIGPFEVESALIEHPAVVESAVVSSPDPIRGEVVKAFVVLAPQ 476
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 2978 LSTN---AVRSELQ----NKLPVFMHPAFIEKLDSLPLSPNGKLDRGALPK 3021
Cdd:cd05928 477 FLSHdpeQLTKELQqhvkSVTAPYKYPRKVEFVQELPKTVTGKIQRNELRD 527
|
|
| PRK08633 |
PRK08633 |
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated |
1624-1983 |
1.18e-16 |
|
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated
Pssm-ID: 236315 [Multi-domain] Cd Length: 1146 Bit Score: 87.67 E-value: 1.18e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1624 RLSNPNVDvlPQSLAYVIYTSGSTGMPKGVEIEHRsavNFL-NSLQSR--YQLKHSDMIM------HktSYSFDASiwel 1694
Cdd:PRK08633 773 RLYGPTFK--PDDTATIIFSSGSEGEPKGVMLSHH---NILsNIEQISdvFNLRNDDVILsslpffH--SFGLTVT---- 841
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1695 FWWPYA-GASVYLLPqggekEP---EVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRsvPIKTNRLKRVFSGGEQLGTHL 1770
Cdd:PRK08633 842 LWLPLLeGIKVVYHP-----DPtdaLGIAKLVAKHRATILLGTPTFLRLYLRNKKLH--PLMFASLRLVVAGAEKLKPEV 914
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1771 VSRFyELLPNVSITNSYGPTEaTVEAAFFDCPPHEKLERIP--------IGKPVHHVRLYLLN-QNQRMLPVGCIGELYI 1841
Cdd:PRK08633 915 ADAF-EEKFGIRILEGYGATE-TSPVASVNLPDVLAADFKRqtgskegsVGMPLPGVAVRIVDpETFEELPPGEDGLILI 992
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1842 AGAGVARGYLNRPALTEERFLEdpfYPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSI--EGV 1919
Cdd:PRK08633 993 GGPQVMKGYLGDPEKTAEVIKD---IDGIGWYVTGDKGHLDEDGFLTITDRYSRFAKIGGEMVPLGAVEEELAKAlgGEE 1069
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1678550997 1920 REAAVTVRTDS--GEPELCAYVEGLQRNE--VRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK08633 1070 VVFAVTAVPDEkkGEKLVVLHTCGAEDVEelKRAIKESGLPNLWKPSRYFKVEALPLLGSGKLDLKGL 1137
|
|
| DCL_NRPS |
cd19543 |
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the ... |
3123-3569 |
1.23e-16 |
|
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor; The DCL-type Condensation (C) domain catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. This domain is D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains in addition to the LCL- and DCL-types such as starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380465 [Multi-domain] Cd Length: 423 Bit Score: 85.72 E-value: 1.23e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3123 SPVQKWFLSQDIKEKH---HFNQSVM-LHRStsVQEDALRKTLKAITCHHDALRMVFTQNEQGKWDQY---NRPLShsdd 3195
Cdd:cd19543 5 SPMQEGMLFHSLLDPGsgaYVEQMVItLEGP--LDPDRFRAAWQAVVDRHPILRTSFVWEGLGEPLQVvlkDRKLP---- 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3196 alygLQMIDLSAPDGTDGNRPYEPLIKRhvlDIQQKMDLKNGPLLQAGLFHTIDGDF-LFLSAHHLVVDGISWRVLLEDL 3274
Cdd:cd19543 79 ----WRELDLSHLSEAEQEAELEALAEE---DRERGFDLARAPLMRLTLIRLGDDRYrLVWSFHHILLDGWSLPILLKEL 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3275 ALGYRQAAGGEDIKLPPkTSSFKAYAKKLS--DYAESQQlmkqlkYWRE--AEEYQTEALPFDQIDGTrAHEGQRSTISF 3350
Cdd:cd19543 152 FAIYAALGEGQPPSLPP-VRPYRDYIAWLQrqDKEAAEA------YWREylAGFEEPTPLPKELPADA-DGSYEPGEVSF 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3351 TLNDKETAALLKDANSAYNTdtqdmlLASVIlalrhwtnQSAFKLSLEGH-GREDVLKGIDVS----------RTIGWFT 3419
Cdd:cd19543 224 ELSAELTARLQELARQHGVT------LNTVV--------QGAWALLLSRYsGRDDVVFGTTVSgrpaelpgieTMVGLFI 289
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3420 AIYPLLIKLNADlpdseesmvhvlKTTKDTLRRVpdkgfgygvikyltppgKKDINFTgapeISFNYLGQFESGRTAEV- 3498
Cdd:cd19543 290 NTLPVRVRLDPD------------QTVLELLKDL-----------------QAQQLEL----REHEYVPLYEIQAWSEGk 336
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3499 -------------PEEDAFSFSPLGAGGDISTTWNREQS-LDISAIAAEGK-LTVNMTYDNARFQRKTIEQLSETCRQFL 3563
Cdd:cd19543 337 qalfdhllvfenyPVDESLEEEQDEDGLRITDVSAEEQTnYPLTVVAIPGEeLTIKLSYDAEVFDEATIERLLGHLRRVL 416
|
....*.
gi 1678550997 3564 LQLIEH 3569
Cdd:cd19543 417 EQVAAN 422
|
|
| hsFATP4_like |
cd05939 |
Fatty acid transport proteins (FATP), including FATP4 and FATP1, and similar proteins; Fatty ... |
2556-3025 |
1.31e-16 |
|
Fatty acid transport proteins (FATP), including FATP4 and FATP1, and similar proteins; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. At least five copies of FATPs are identified in mammalian cells. This family includes FATP4, FATP1, and homologous proteins. Each FATP has unique patterns of tissue distribution. FATP4 is mainly expressed in the brain, testis, colon and kidney. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341262 [Multi-domain] Cd Length: 474 Bit Score: 85.94 E-value: 1.31e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2556 DKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLM 2635
Cdd:cd05939 1 DRHWTFRELNEYSNKVANFFQAQGYRSGDVVALFMENRLEFVALWLGLAKIGVETALINSNLRLESLLHCITVSKAKALI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2636 TINEADLgvLADFEGEILTIESVEEDDKsplpqmssahhLAYiIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETD 2715
Cdd:cd05939 81 FNLLDPL--LTQSSTEPPSQDDVNFRDK-----------LFY-IYTSGTTGLPKAAVIVHSRYYRIAAGAYYAFGMRPED 146
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2716 TI---LQLFSFSfdGFITSMFTPLLSGAKAVLLHEEEAKDILA--IKHQLS-RQRITHMIivpvlyRALLDVVQPEDVKT 2789
Cdd:cd05939 147 VVydcLPLYHSA--GGIMGVGQALLHGSTVVIRKKFSASNFWDdcVKYNCTiVQYIGEIC------RYLLAQPPSEEEQK 218
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2790 LRVVTLAG---------EAADRELIARslaicphteLANEYGPTE-NSVATTVMRHMEKQAYVSIG----QPI------D 2849
Cdd:cd05939 219 HNVRLAVGnglrpqiweQFVRRFGIPQ---------IGEFYGATEgNSSLVNIDNHVGACGFNSRIlpsvYPIrlikvdE 289
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2850 GTQVLILNSNHQLQPI--GVAGELC---IAGTGLAR--GYVNLPElTERAFTQNPFKPEARMYRTGDAARWMADGTLEYL 2922
Cdd:cd05939 290 DTGELIRDSDGLCIPCqpGEPGLLVgkiIQNDPLRRfdGYVNEGA-TNKKIARDVFKKGDSAFLSGDVLVMDELGYLYFK 368
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2923 GRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAV----VAHVtaSGQTELSAYVVTKPGLSTNAVRSELQNKLPVFMHPA 2998
Cdd:cd05939 369 DRTGDTFRWKGENVSTTEVEGILSNVLGLEDVVVygveVPGV--EGRAGMAAIVDPERKVDLDRFSAVLAKSLPPYARPQ 446
|
490 500
....*....|....*....|....*..
gi 1678550997 2999 FIEKLDSLPLSPNGKLDRGALPKPVYN 3025
Cdd:cd05939 447 FIRLLPEVDKTGTFKLQKTDLQKEGYD 473
|
|
| PRK04319 |
PRK04319 |
acetyl-CoA synthetase; Provisional |
1497-1985 |
1.85e-16 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 235279 [Multi-domain] Cd Length: 570 Bit Score: 86.10 E-value: 1.85e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1497 HYALEQQAEKT-PDQAAVIFEDGV----MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAY 1571
Cdd:PRK04319 46 YEAIDRHADGGrKDKVALRYLDASrkekYTYKELKELSNKFANVLKELGVEKGDRVFIFMPRIPELYFALLGALKNGAIV 125
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1572 LPIDPDYPEERISFLLEDSGTNILLLQSAGL------------HV------PEFTGEIVYLNQTNSGLAHRLSNPNVDvl 1633
Cdd:PRK04319 126 GPLFEAFMEEAVRDRLEDSEAKVLITTPALLerkpaddlpslkHVllvgedVEEGPGTLDFNALMEQASDEFDIEWTD-- 203
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1634 PQSLAYVIYTSGSTGMPKGVEieHrsaVnflnslqsryqlkHSDMIMHKTS--YSFDASIWELFW------W-------- 1697
Cdd:PRK04319 204 REDGAILHYTSGSTGKPKGVL--H---V-------------HNAMLQHYQTgkYVLDLHEDDVYWctadpgWvtgtsygi 265
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1698 --PY-AGASvyLLPQGGEKEPEVIAKAIEEQKITAMHFVPS---ML-HAFLEHIKYRSVPiktnRLKRVFSGGEQLGTHL 1770
Cdd:PRK04319 266 faPWlNGAT--NVIDGGRFSPERWYRILEDYKVTVWYTAPTairMLmGAGDDLVKKYDLS----SLRHILSVGEPLNPEV 339
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1771 VSRFYELLpNVSITNSYGPTE--ATVEAAF--FDCPPHEkleripIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAgAG- 1845
Cdd:PRK04319 340 VRWGMKVF-GLPIHDNWWMTEtgGIMIANYpaMDIKPGS------MGKPLPGIEAAIVDDQGNELPPNRMGNLAIK-KGw 411
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1846 --VARGYLNRPALTEERFLEDpfypgerMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAA 1923
Cdd:PRK04319 412 psMMRGIWNNPEKYESYFAGD-------WYVSGDSAYMDEDGYFWFQGRVDDVIKTSGERVGPFEVESKLMEHPAVAEAG 484
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 1924 VTVRTDSGEPELC-AYV---EGLQ-----RNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNALPA 1985
Cdd:PRK04319 485 VIGKPDPVRGEIIkAFValrPGYEpseelKEEIRGFVKKGLGAHAAPREIEFKDKLPKTRSGKIMRRVLKA 555
|
|
| PrpE |
cd05967 |
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or ... |
600-967 |
2.07e-16 |
|
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or propionate#CoA ligase (PrpE) catalyzes the first step of the 2-methylcitric acid cycle for propionate catabolism. It activates propionate to propionyl-CoA in a two-step reaction, which proceeds through a propionyl-AMP intermediate and requires ATP and Mg2+. In Salmonella enterica, the PrpE protein is required for growth of Salmonella enterica on propionate and can substitute for the acetyl-CoA synthetase (Acs) enzyme during growth on acetate. PrpE can also activate acetate, 3HP, and butyrate to their corresponding CoA-thioesters, although with less efficiency.
Pssm-ID: 341271 [Multi-domain] Cd Length: 617 Bit Score: 86.22 E-value: 2.07e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 600 NADDLLYMIYTSGTTGKPKGVQFE--------HRNMANLlkfeY-THSGIDFEA--DVLQFATPSFdVCYqeifSALLKG 668
Cdd:cd05967 228 AATDPLYILYTSGTTGKPKGVVRDngghavalNWSMRNI----YgIKPGDVWWAasDVGWVVGHSY-IVY----GPLLHG 298
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 669 GTlHIVPEAIKRDVP---QLFAFINKHQTNIVF-LPTAFikmifseRELANSFPDG----------VKHLIAAGEQLMiS 734
Cdd:cd05967 299 AT-TVLYEGKPVGTPdpgAFWRVIEKYQVNALFtAPTAI-------RAIRKEDPDGkyikkydlssLRTLFLAGERLD-P 369
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 735 DLFQDVLRKRGIHLHNHYGPSETH--VVSTYTIHPGDPIPELPPiGKPIGCTDLYILNHQKQLQPCGVPGELYISG---- 808
Cdd:cd05967 370 PTLEWAENTLGVPVIDHWWQTETGwpITANPVGLEPLPIKAGSP-GKPVPGYQVQVLDEDGEPVGPNELGNIVIKLplpp 448
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 809 ASVARGYVNHDKLTSDKFSSDPfkpdvIMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAA 888
Cdd:cd05967 449 GCLLTLWKNDERFKKLYLSKFP-----GYYDTGDAGYKDEDGYLFIMGRTDDVINVAGHRLSTGEMEESVLSHPAVAECA 523
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 889 ILIWQDQ-NGEHELCayYCSVQKLNTID-------LRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALpepDASIS 960
Cdd:cd05967 524 VVGVRDElKGQVPLG--LVVLKEGVKITaeelekeLVALVREQIGPVAAFRLVIFVKRLPKTRSGKILRRTL---RKIAD 598
|
....*..
gi 1678550997 961 GNPYTAP 967
Cdd:cd05967 599 GEDYTIP 605
|
|
| FadD3 |
cd17638 |
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ... |
607-947 |
2.52e-16 |
|
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ligases, including FadD3 which is an acyl-CoA synthetase that initiates catabolism of cholesterol rings C and D in actinobacteria. The cholesterol catabolic pathway occurs in most mycolic acid-containing actinobacteria, such as Rhodococcus jostii RHA1, and is critical for Mycobacterium tuberculosis (Mtb) during infection. FadD3 catalyzes the ATP-dependent CoA thioesterification of 3a-alpha-H-4alpha(3'-propanoate)-7a-beta-methylhexahydro-1,5-indanedione (HIP) to yield HIP-CoA. Hydroxylated analogs of HIP, 5alpha-OH HIP and 1beta-OH HIP, can also be used.
Pssm-ID: 341293 [Multi-domain] Cd Length: 330 Bit Score: 83.32 E-value: 2.52e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 607 MIYTSGTTGKPKGVQFEHRNMANLLKfEYTHSGIDFEADVLQFATPSF-DVCYQE-IFSALLKGGTlhIVPEAIkRDVPQ 684
Cdd:cd17638 5 IMFTSGTTGRSKGVMCAHRQTLRAAA-AWADCADLTEDDRYLIINPFFhTFGYKAgIVACLLTGAT--VVPVAV-FDVDA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 685 LFAFINKHQtnIVFLP---TAFIKMI---------FSERELANSfpdGVKHLIAAGEQLMISDL-FQDVLrkrgihlhNH 751
Cdd:cd17638 81 ILEAIERER--ITVLPgppTLFQSLLdhpgrkkfdLSSLRAAVT---GAATVPVELVRRMRSELgFETVL--------TA 147
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 752 YGPSETHVVSTytIHPGDPIPELP-PIGKPIGCTDLYilnhqkqlqpCGVPGELYISGASVARGYVNHDKLTSDKFSSDP 830
Cdd:cd17638 148 YGLTEAGVATM--CRPGDDAETVAtTCGRACPGFEVR----------IADDGEVLVRGYNVMQGYLDDPEATAEAIDADG 215
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 831 FkpdvimYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCSV-- 908
Cdd:cd17638 216 W------LHTGDVGELDERGYLRITDRLKDMYIVGGFNVYPAEVEGALAEHPGVAQVAVIGVPDERMGEVGKAFVVARpg 289
|
330 340 350
....*....|....*....|....*....|....*....
gi 1678550997 909 QKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKV 947
Cdd:cd17638 290 VTLTEEDVIAWCRERLANYKVPRFVRFLDELPRNASGKV 328
|
|
| FACL_like_1 |
cd05910 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
489-889 |
3.52e-16 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341236 [Multi-domain] Cd Length: 457 Bit Score: 84.43 E-value: 3.52e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 489 LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHypadriryilhdcgcshvVSQA 568
Cdd:cd05910 3 LSFRELDERSDRIAQGLTAYGIRRGMRAVLMVPPGPDFFALTFALFKAGAVPVLIDPG------------------MGRK 64
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 569 HLPSSLEDnyiithpedieskVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRNMA---NLLK--FEYTHSGIDFe 643
Cdd:cd05910 65 NLKQCLQE-------------AEPDAFIGIPKADEPAAILFTSGSTGTPKGVVYRHGTFAaqiDALRqlYGIRPGEVDL- 130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 644 ADVLQFAtpsfdvcyqeIFSALLkgGTLHIVPE-----AIKRDVPQLFAFINKHQTNIVFLPTAFIKMIfSERELANSFP 718
Cdd:cd05910 131 ATFPLFA----------LFGPAL--GLTSVIPDmdptrPARADPQKLVGAIRQYGVSIVFGSPALLERV-ARYCAQHGIT 197
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 719 -DGVKHLIAAGEQLMISDLfqDVLRK---RGIHLHNHYGPSE--------THVVSTYTIHP---------GDPIPelPPI 777
Cdd:cd05910 198 lPSLRRVLSAGAPVPIALA--ARLRKmlsDEAEILTPYGATEalpvssigSRELLATTTAAtsggagtcvGRPIP--GVR 273
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 778 GKPIGCTDLYILNHQKQLQ-PCGVPGELYISGASVARGYVNHDKLTSDKFSSDPfkPDVIMYRTGDLARRLEDGNIEYIG 856
Cdd:cd05910 274 VRIIEIDDEPIAEWDDTLElPRGEIGEITVTGPTVTPTYVNRPVATALAKIDDN--SEGFWHRMGDLGYLDDEGRLWFCG 351
|
410 420 430
....*....|....*....|....*....|...
gi 1678550997 857 RADNQVKIRGYRIEPQEIEVTLMNHPDISEAAI 889
Cdd:cd05910 352 RKAHRVITTGGTLYTEPVERVFNTHPGVRRSAL 384
|
|
| PtmA |
cd17636 |
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, ... |
2678-3015 |
3.86e-16 |
|
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341291 [Multi-domain] Cd Length: 331 Bit Score: 82.73 E-value: 3.86e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2678 IIYTSGTTGRPKGVMVEHKGI---ANTLQWRRNAyafNETDTILQ---LFSFsfdGFITSMFTPLLSGAKAVLLHEEEAK 2751
Cdd:cd17636 5 AIYTAAFSGRPNGALLSHQALlaqALVLAVLQAI---DEGTVFLNsgpLFHI---GTLMFTLATFHAGGTNVFVRRVDAE 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2752 DILAIkhqLSRQRITHMIIVPVLYRALLDVVQ--PEDVKTLRVVTLAGE-----AADRELIARSLAicphtelanEYGPT 2824
Cdd:cd17636 79 EVLEL---IEAERCTHAFLLPPTIDQIVELNAdgLYDLSSLRSSPAAPEwndmaTVDTSPWGRKPG---------GYGQT 146
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2825 ENSvATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTqnpfkpeARM 2904
Cdd:cd17636 147 EVM-GLATFAALGGGAIGGAGRPSPLVQVRILDEDGREVPDGEVGEIVARGPTVMAGYWNRPEVNARRTR-------GGW 218
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2905 YRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLStnAVR 2984
Cdd:cd17636 219 HHTNDLGRREPDGSLSFVGPKTRMIKSGAENIYPAEVERCLRQHPAVADAAVIGVPDPRWAQSVKAIVVLKPGAS--VTE 296
|
330 340 350
....*....|....*....|....*....|....*
gi 1678550997 2985 SEL----QNKLPVFMHPAFIEKLDSLPLSPNGKLD 3015
Cdd:cd17636 297 AELiehcRARIASYKKPKSVEFADALPRTAGGADD 331
|
|
| PLN02330 |
PLN02330 |
4-coumarate--CoA ligase-like 1 |
1502-1936 |
5.33e-16 |
|
4-coumarate--CoA ligase-like 1
Pssm-ID: 215189 [Multi-domain] Cd Length: 546 Bit Score: 84.65 E-value: 5.33e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1502 QQAEKTPDQAAviFEDGV----MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPD 1577
Cdd:PLN02330 36 QDAELYADKVA--FVEAVtgkaVTYGEVVRDTRRFAKALRSLGLRKGQVVVVVLPNVAEYGIVALGIMAAGGVFSGANPT 113
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1578 YPEERISFLLEDSGTNILLLQSA------GLHVPEFT-GEIVYLNQTN----SGLAHRLSNPNV--DVLPQSLAYVIYTS 1644
Cdd:PLN02330 114 ALESEIKKQAEAAGAKLIVTNDTnygkvkGLGLPVIVlGEEKIEGAVNwkelLEAADRAGDTSDneEILQTDLCALPFSS 193
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1645 GSTGMPKGVEIEHRSAV-NFLNSLQSryqlKHSDMIMHKTSYSFdasIWELFWWPYAGASVYLLPQGGEK------EPEV 1717
Cdd:PLN02330 194 GTTGISKGVMLTHRNLVaNLCSSLFS----VGPEMIGQVVTLGL---IPFFHIYGITGICCATLRNKGKVvvmsrfELRT 266
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1718 IAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVSITNSYGPTEATVEAA 1797
Cdd:PLN02330 267 FLNALITQEVSFAPIVPPIILNLVKNPIVEEFDLSKLKLQAIMTAAAPLAPELLTAFEAKFPGVQVQEAYGLTEHSCITL 346
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1798 FFDCPP--HEKLERIPIGKPVHHVRLYLLN-QNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYpgermyK 1874
Cdd:PLN02330 347 THGDPEkgHGIAKKNSVGFILPNLEVKFIDpDTGRSLPKNTPGELCVRSQCVMQGYYNNKEETDRTIDEDGWL------H 420
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 1875 TGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTD--SGE-PELC 1936
Cdd:PLN02330 421 TGDIGYIDDDGDIFIVDRIKELIKYKGFQVAPAELEAILLTHPSVEDAAVVPLPDeeAGEiPAAC 485
|
|
| PRK07514 |
PRK07514 |
malonyl-CoA synthase; Validated |
489-954 |
6.07e-16 |
|
malonyl-CoA synthase; Validated
Pssm-ID: 181011 [Multi-domain] Cd Length: 504 Bit Score: 84.16 E-value: 6.07e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 489 LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVV--- 565
Cdd:PRK07514 29 YTYGDLDAASARLANLLVALGVKPGDRVAVQVEKSPEALALYLATLRAGAVFLPLNTAYTLAELDYFIGDAEPALVVcdp 108
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 566 SQAHLPSSLEDNYIITHPEDIESKVDGSNIKS-----------VNNADDLLYMIYTSGTTGKPKGVQFEHRNMA-NLLKF 633
Cdd:PRK07514 109 ANFAWLSKIAAAAGAPHVETLDADGTGSLLEAaaaapddfetvPRGADDLAAILYTSGTTGRSKGAMLSHGNLLsNALTL 188
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 634 -EYTHSGIDfeaDVLQFATPSFDVcyQEIFSA----LLKGGTLHIVPeaiKRDVPQLFAfinkhqtnivFLPTAFIKM-- 706
Cdd:PRK07514 189 vDYWRFTPD---DVLIHALPIFHT--HGLFVAtnvaLLAGASMIFLP---KFDPDAVLA----------LMPRATVMMgv 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 707 -IFSERELANsfpDGVKHLIAAGEQLMIS-------DLFQDVLRKRGIHLHNHYGPSEThVVSTYTIHPGDPIPElpPIG 778
Cdd:PRK07514 251 pTFYTRLLQE---PRLTREAAAHMRLFISgsapllaETHREFQERTGHAILERYGMTET-NMNTSNPYDGERRAG--TVG 324
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 779 KPIGCTDLYILNHQ--KQLqPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIG 856
Cdd:PRK07514 325 FPLPGVSLRVTDPEtgAEL-PPGEIGMIEVKGPNVFKGYWRMPEKTAEEFRADGF------FITGDLGKIDERGYVHIVG 397
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 857 RADNQVKIRGYRIEPQEIEVTL-------------MNHPDISEAAILIWQDQNGehelcayycsvQKLNTIDLRSYMASE 923
Cdd:PRK07514 398 RGKDLIISGGYNVYPKEVEGEIdelpgvvesavigVPHPDFGEGVTAVVVPKPG-----------AALDEAAILAALKGR 466
|
490 500 510
....*....|....*....|....*....|.
gi 1678550997 924 LPEYMIPAKWIWVDSIPLTPNGKVDRAALPE 954
Cdd:PRK07514 467 LARFKQPKRVFFVDELPRNTMGKVQKNLLRE 497
|
|
| MACS_euk |
cd05928 |
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step ... |
490-952 |
6.60e-16 |
|
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes. MACS enzymes are localized to mitochondria. Two murine MACS family proteins are found in liver and kidney. In rodents, a MACS member is detected particularly in the olfactory epithelium and is called O-MACS. O-MACS demonstrates substrate preference for the fatty acid lengths of C6-C12.
Pssm-ID: 341251 [Multi-domain] Cd Length: 530 Bit Score: 84.05 E-value: 6.60e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 490 TYRELNKAANRLARHLRMK-GVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSQA 568
Cdd:cd05928 43 SFRELGSLSRKAANVLSGAcGLQRGDRVAVILPRVPEWWLVNVACIRTGLVFIPGTIQLTAKDILYRLQASKAKCIVTSD 122
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 569 HLPSSLEDnyIITHPEDIESKV-------DG-SNIKS-VNNAD-----------DLLYMIYTSGTTGKPKgvqfehrnMA 628
Cdd:cd05928 123 ELAPEVDS--VASECPSLKTKLlvseksrDGwLNFKElLNEAStehhcvetgsqEPMAIYFTSGTTGSPK--------MA 192
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 629 nllkfEYTHS--GIDFEADVLQFA--TPSfDVCYQ------------EIFSALLKGGTL--HIVPeaiKRDVPQLFAFIN 690
Cdd:cd05928 193 -----EHSHSslGLGLKVNGRYWLdlTAS-DIMWNtsdtgwiksawsSLFEPWIQGACVfvHHLP---RFDPLVILKTLS 263
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 691 KHQ-TNIVFLPTAFiKMIFSERELANSFPdGVKHLIAAGEQLMiSDLFQDVLRKRGIHLHNHYGPSETHVV----STYTI 765
Cdd:cd05928 264 SYPiTTFCGAPTVY-RMLVQQDLSSYKFP-SLQHCVTGGEPLN-PEVLEKWKAQTGLDIYEGYGQTETGLIcanfKGMKI 340
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 766 HPGDpipelppIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVA-----RGYVNHDKLTSDKFSSDpfkpdviMYRT 840
Cdd:cd05928 341 KPGS-------MGKASPPYDVQIIDDNGNVLPPGTEGDIGIRVKPIRpfglfSGYVDNPEKTAATIRGD-------FYLT 406
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 841 GDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQ-NGEH-----ELCAYYCS--VQKLn 912
Cdd:cd05928 407 GDRGIMDEDGYFWFMGRADDVINSSGYRIGPFEVESALIEHPAVVESAVVSSPDPiRGEVvkafvVLAPQFLShdPEQL- 485
|
490 500 510 520
....*....|....*....|....*....|....*....|
gi 1678550997 913 TIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:cd05928 486 TKELQQHVKSVTAPYKYPRKVEFVQELPKTVTGKIQRNEL 525
|
|
| LC-FACS_euk |
cd05927 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are ... |
1520-1885 |
9.14e-16 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are eukaryotic fatty acid CoA synthetases that activate fatty acids with chain lengths of 12 to 20. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells.
Pssm-ID: 341250 [Multi-domain] Cd Length: 545 Bit Score: 83.80 E-value: 9.14e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1520 MTYKELNEQANRIAWELIGRGVK--PETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLL 1597
Cdd:cd05927 6 ISYKEVAERADNIGSALRSLGGKpaPASFVGIYSINRPEWIISELACYAYSLVTVPLYDTLGPEAIEYILNHAEISIVFC 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1598 QsAGLHVPEFTgEIVYLNQTNSGlahrlsnPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVN----FLNSLQSRYQL 1673
Cdd:cd05927 86 D-AGVKVYSLE-EFEKLGKKNKV-------PPPPPKPEDLATICYTSGTTGNPKGVMLTHGNIVSnvagVFKILEILNKI 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1674 KHSDMIMhktSY-----SFDASIWELFWwpYAGASVYLLpQGgekEPEVIAKAIEEQKITAMHFVP-------------- 1734
Cdd:cd05927 157 NPTDVYI---SYlplahIFERVVEALFL--YHGAKIGFY-SG---DIRLLLDDIKALKPTVFPGVPrvlnriydkifnkv 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1735 ---SMLHAFLEHIKYRSvpiKTNRLKR------------VF---------------SGGEQLGTHlVSRFYELLPNVSIT 1784
Cdd:cd05927 228 qakGPLKRKLFNFALNY---KLAELRSgvvraspfwdklVFnkikqalggnvrlmlTGSAPLSPE-VLEFLRVALGCPVL 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1785 NSYGPTEaTVEAAFFDCPPheklERIP--IGKPV--HHVRL-------YL-LNQNQRmlpvgciGELYIAGAGVARGYLN 1852
Cdd:cd05927 304 EGYGQTE-CTAGATLTLPG----DTSVghVGGPLpcAEVKLvdvpemnYDaKDPNPR-------GEVCIRGPNVFSGYYK 371
|
410 420 430
....*....|....*....|....*....|...
gi 1678550997 1853 RPALTEERFLEDPFypgermYKTGDVARWLPDG 1885
Cdd:cd05927 372 DPEKTAEALDEDGW------LHTGDIGEWLPNG 398
|
|
| PRK12582 |
PRK12582 |
acyl-CoA synthetase; Provisional |
2534-2912 |
1.39e-15 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237144 [Multi-domain] Cd Length: 624 Bit Score: 83.56 E-value: 1.39e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2534 TISQLFEQQAARTPKASALVSGD------KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAG 2607
Cdd:PRK12582 50 SIPHLLAKWAAEAPDRPWLAQREpghgqwRKVTYGEAKRAVDALAQALLDLGLDPGRPVMILSGNSIEHALMTLAAMQAG 129
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2608 GCYVPIDPEYP--------------KERKRYILSDSG---TKLLMTINEAD---LGVLADFEGeiltIESVEEDD---KS 2664
Cdd:PRK12582 130 VPAAPVSPAYSlmshdhaklkhlfdLVKPRVVFAQSGapfARALAALDLLDvtvVHVTGPGEG----IASIAFADlaaTP 205
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2665 PLPQMSSAHH------LAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQL-----FSFSFDGFITsmF 2733
Cdd:PRK12582 206 PTAAVAAAIAaitpdtVAKYLFTSGSTGMPKAVINTQRMMCANIAMQEQLRPREPDPPPPVSldwmpWNHTMGGNAN--F 283
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2734 TPLLSGAKAvlLHEEEAKDILAIKHQLSR--QRI--THMIIVPVLYRALLDVVQPEDV------KTLRVVTLAGEAADRE 2803
Cdd:PRK12582 284 NGLLWGGGT--LYIDDGKPLPGMFEETIRnlREIspTVYGNVPAGYAMLAEAMEKDDAlrrsffKNLRLMAYGGATLSDD 361
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2804 LIAR--SLAICPHTE---LANEYGPTENSvATTVMRHMEKQAYVSIGQPIDGTQVlilnsnhQLQPIGVAGELCIAGTGL 2878
Cdd:PRK12582 362 LYERmqALAVRTTGHripFYTGYGATETA-PTTTGTHWDTERVGLIGLPLPGVEL-------KLAPVGDKYEVRVKGPNV 433
|
410 420 430
....*....|....*....|....*....|....
gi 1678550997 2879 ARGYVNLPELTERAFTQNPFkpearmYRTGDAAR 2912
Cdd:PRK12582 434 TPGYHKDPELTAAAFDEEGF------YRLGDAAR 461
|
|
| PRK08974 |
PRK08974 |
long-chain-fatty-acid--CoA ligase FadD; |
1500-1983 |
1.50e-15 |
|
long-chain-fatty-acid--CoA ligase FadD;
Pssm-ID: 236359 [Multi-domain] Cd Length: 560 Bit Score: 83.18 E-value: 1.50e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELI-GRGVKPETTVAIIgkrSPEML---LGIYGILKAGGAYLPID 1575
Cdd:PRK08974 29 FEQAVARYADQPAFINMGEVMTFRKLEERSRAFAAYLQnGLGLKKGDRVALM---MPNLLqypIALFGILRAGMIVVNVN 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1576 PDYPEERISFLLEDSGTNILLLQSAGLHVPEftgEIVYLNQTNS----GLAHRLSNP-----NVDV-----------LPQ 1635
Cdd:PRK08974 106 PLYTPRELEHQLNDSGAKAIVIVSNFAHTLE---KVVFKTPVKHviltRMGDQLSTAkgtlvNFVVkyikrlvpkyhLPD 182
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1636 S------------------------LAYVIYTSGSTGMPKGVEIEHRSAVNflNSLQSRYqlKHSDMIMHKTSYSFDA-S 1690
Cdd:PRK08974 183 AisfrsalhkgrrmqyvkpelvpedLAFLQYTGGTTGVAKGAMLTHRNMLA--NLEQAKA--AYGPLLHPGKELVVTAlP 258
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1691 IWELFwwpyaGASV---YLLPQGGEK----EPEVIAKAIEEQK---ITAMHFVPSMLHAFLEHIKYRSVPIKTNRLKrvf 1760
Cdd:PRK08974 259 LYHIF-----ALTVnclLFIELGGQNllitNPRDIPGFVKELKkypFTAITGVNTLFNALLNNEEFQELDFSSLKLS--- 330
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1761 SGGEQLGTHLVSRFYELLPNVSITNSYGPTEAT--VEAAFFDCPPHEKleriPIGKPVHHVRLYLLNQNQRMLPVGCIGE 1838
Cdd:PRK08974 331 VGGGMAVQQAVAERWVKLTGQYLLEGYGLTECSplVSVNPYDLDYYSG----SIGLPVPSTEIKLVDDDGNEVPPGEPGE 406
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1839 LYIAGAGVARGYLNRPALTEErFLEDPFypgermYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEG 1918
Cdd:PRK08974 407 LWVKGPQVMLGYWQRPEATDE-VIKDGW------LATGDIAVMDEEGFLRIVDRKKDMILVSGFNVYPNEIEDVVMLHPK 479
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 1919 VRE-AAVTVRTD-SGEpELCAYV----EGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK08974 480 VLEvAAVGVPSEvSGE-AVKIFVvkkdPSLTEEELITHCRRHLTGYKVPKLVEFRDELPKSNVGKILRREL 549
|
|
| FATP_FACS |
cd05940 |
Fatty acid transport proteins (FATP) play dual roles as fatty acid transporters and its ... |
489-887 |
1.74e-15 |
|
Fatty acid transport proteins (FATP) play dual roles as fatty acid transporters and its activation enzymes; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. At least five copies of FATPs are identified in mammalian cells. This family also includes prokaryotic FATPs. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341263 [Multi-domain] Cd Length: 449 Bit Score: 82.40 E-value: 1.74e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 489 LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVsqa 568
Cdd:cd05940 4 LTYAELDAMANRYARWLKSLGLKPGDVVALFMENRPEYVLLWLGLVKIGAVAALINYNLRGESLAHCLNVSSAKHLV--- 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 569 hlpsslednyiithpedieskvdgsniksvnnADDLLYmIYTSGTTGKPKGVQFEHRNMANLLKFEYtHSGIDFEADVLQ 648
Cdd:cd05940 81 --------------------------------VDAALY-IYTSGTTGLPKAAIISHRRAWRGGAFFA-GSGGALPSDVLY 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 649 FATPSFD-----VCyqeIFSALLKGGTLHIvpeAIKRDVPQLFAFINKHQTNIVflptAFIKMIFseRELANS--FPDGV 721
Cdd:cd05940 127 TCLPLYHstaliVG---WSACLASGATLVI---RKKFSASNFWDDIRKYQATIF----QYIGELC--RYLLNQppKPTER 194
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 722 KHLI--AAGEQLM--ISDLFQDvlRKRGIHLHNHYGPSEThvVSTYTIHPGDP-----IPELPPIGKPIGC------TDL 786
Cdd:cd05940 195 KHKVrmIFGNGLRpdIWEEFKE--RFGVPRIAEFYAATEG--NSGFINFFGKPgaigrNPSLLRKVAPLALvkydleSGE 270
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 787 YILNHQKQLQPCGV--PGEL--YISGASVARGYVNHDKlTSDKFSSDPFKPDVIMYRTGDLARRLEDGNIEYIGRADNQV 862
Cdd:cd05940 271 PIRDAEGRCIKVPRgePGLLisRINPLEPFDGYTDPAA-TEKKILRDVFKKGDAWFNTGDLMRLDGEGFWYFVDRLGDTF 349
|
410 420
....*....|....*....|....*
gi 1678550997 863 KIRGYRIEPQEIEVTLMNHPDISEA 887
Cdd:cd05940 350 RWKGENVSTTEVAAVLGAFPGVEEA 374
|
|
| A_NRPS_MycA_like |
cd05908 |
The adenylation domain of nonribosomal peptide synthetases (NRPS) similar to mycosubtilin ... |
1514-1980 |
2.64e-15 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS) similar to mycosubtilin synthase subunit A (MycA); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as (amino)-acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family includes NRPS similar to mycosubtilin synthase subunit A (MycA). Mycosubtilin, which is characterized by a beta-amino fatty acid moiety linked to the circular heptapeptide Asn-Tyr-Asn-Gln-Pro-Ser-Asn, belongs to the iturin family of lipopeptide antibiotics. The mycosubtilin synthase subunit A (MycA) combines functional domains derived from peptide synthetases, amino transferases, and fatty acid synthases. Nonribosomal peptide synthetases are large multifunction enzymes that synthesize many therapeutically useful peptides. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341234 [Multi-domain] Cd Length: 499 Bit Score: 82.15 E-value: 2.64e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1514 IFEDGV---MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEds 1590
Cdd:cd05908 7 ILGDKKekfVSYRHLREEALGYLGALQELGIKPGQEVVFQITHNNKFLYLFWACLLGGMIAVPVSIGSNEEHKLKLNK-- 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1591 gtnilllqsaglhvpeftgeivylnqtnsgLAHRLSNPNV-------DVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNF 1663
Cdd:cd05908 85 ------------------------------VWNTLKNPYLiteeevlCELADELAFIQFSSGSTGDPKGVMLTHENLVHN 134
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1664 LNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWP-YAGASVYLLPQGGE-KEPEVIAKAIEEQKITAM---HFVPSMLH 1738
Cdd:cd05908 135 MFAILNSTEWKTKDRILSWMPLTHDMGLIAFHLAPlIAGMNQYLMPTRLFiRRPILWLKKASEHKATIVsspNFGYKYFL 214
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1739 AFLEHIKYRSVPIKTNRLkrVFSGGEQLGTHLVSRF------YELLPNvSITNSYGPTEATVEAAFFDCPPHEKL----- 1807
Cdd:cd05908 215 KTLKPEKANDWDLSSIRM--ILNGAEPIDYELCHEFldhmskYGLKRN-AILPVYGLAEASVGASLPKAQSPFKTitlgr 291
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1808 ------ERIP--------------IGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFy 1867
Cdd:cd05908 292 rhvthgEPEPevdkkdsecltfveVGKPIDETDIRICDEDNKILPDGYIGHIQIRGKNVTPGYYNNPEATAKVFTDDGW- 370
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1868 pgermYKTGDVArWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGV---REAAVTV-RTDSGEPELCAYVEGlq 1943
Cdd:cd05908 371 -----LKTGDLG-FIRNGRLVITGREKDIIFVNGQNVYPHDIERIAEELEGVelgRVVACGVnNSNTRNEEIFCFIEH-- 442
|
490 500 510 520
....*....|....*....|....*....|....*....|....*....
gi 1678550997 1944 rnevRAQLERLLP-GYMVPAYMIEMEQW-----------PVTPSGKLDR 1980
Cdd:cd05908 443 ----RKSEDDFYPlGKKIKKHLNKRGGWqinevlpirriPKTTSGKVKR 487
|
|
| starter-C_NRPS |
cd19533 |
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases ... |
3123-3569 |
3.37e-15 |
|
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. While standard C-domains catalyze peptide bond formation between two amino acids, an initial, ('starter') C-domain may instead acylate an amino acid with a fatty acid. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380456 [Multi-domain] Cd Length: 419 Bit Score: 81.26 E-value: 3.37e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3123 SPVQK--WFLSQDIKEKHHFNQSVMLHRSTSVQEDALRKTLKAITCHHDALRMVFTQNEQGKWDQYNrplshsDDALYGL 3200
Cdd:cd19533 5 TSAQRgvWFAEQLDPEGSIYNLAEYLEITGPVDLAVLERALRQVIAEAETLRLRFTEEEGEPYQWID------PYTPVPI 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3201 QMIDLSA---PDGTdgnrpYEPLIKRhvlDIQQKMDLKNGPLLQAGLFHtIDGD--FLFLSAHHLVVDGISWRVLLEDLA 3275
Cdd:cd19533 79 RHIDLSGdpdPEGA-----AQQWMQE---DLRKPLPLDNDPLFRHALFT-LGDNrhFWYQRVHHIVMDGFSFALFGQRVA 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3276 LGYRQAAGGEDIKLPPKTsSFKAYAKKLSDYAESQQLMKQLKYWREAEEYQTEALPFDQIDGTRAHEGQRSTISFTLNDK 3355
Cdd:cd19533 150 EIYTALLKGRPAPPAPFG-SFLDLVEEEQAYRQSERFERDRAFWTEQFEDLPEPVSLARRAPGRSLAFLRRTAELPPELT 228
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3356 ETaalLKDANSAYNTDTQDMLLASVILALRHWTnqsafklsleghGREDVLKGIDVSR--------TIGWFTAIYPLLIK 3427
Cdd:cd19533 229 RT---LLEAAEAHGASWPSFFIALVAAYLHRLT------------GANDVVLGVPVMGrlgaaarqTPGMVANTLPLRLT 293
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3428 LNADLPDSEesMV-HVLKTTKDTLR----RVPDKGFGYGVIKYLTPPGKKDIN---FTGAPEISFNYlgqfesGRTAevp 3499
Cdd:cd19533 294 VDPQQTFAE--LVaQVSRELRSLLRhqryRYEDLRRDLGLTGELHPLFGPTVNympFDYGLDFGGVV------GLTH--- 362
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3500 eedafsfsplgaggDISTTWNREQSLDISAIAAEGKLTVNMTYDNARFQRKTIEQLSETCRQFLLQLIEH 3569
Cdd:cd19533 363 --------------NLSSGPTNDLSIFVYDRDDESGLRIDFDANPALYSGEDLARHQERLLRLLEEAAAD 418
|
|
| CT_NRPS-like |
cd19542 |
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike ... |
3123-3569 |
4.28e-15 |
|
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike bacterial NRPS, which typically have specialized terminal thioesterase (TE) domains to cyclize peptide products, many fungal NRPSs employ a terminal condensation-like (CT) domain to produce macrocyclic peptidyl products (e.g. cyclosporine and echinocandin). Domains in this subfamily (which includes both terminal and non-terminal domains) typically have a non-canonical conserved [SN]HxxxDx(14)Y motif at their active site compared to the standard Condensation (C) domain active site motif (HHxxxD). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380464 [Multi-domain] Cd Length: 401 Bit Score: 80.43 E-value: 4.28e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3123 SPVQKWFLSQDIKEKHHFNQSVMLHRSTSVQEDALRKTLKAITCHHDALRMVFTQNE-QGKWDQ--YNRP------LSHS 3193
Cdd:cd19542 5 TPMQEGMLLSQLRSPGLYFNHFVFDLDSSVDVERLRNAWRQLVQRHDILRTVFVESSaEGTFLQvvLKSLdppieeVETD 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3194 DDALyglqmidlsapdgtdgnrpyepliKRHVLDIQQKMDLKNGPLLQAGLFHTIDGD-FLFLSAHHLVVDGISWRVLLE 3272
Cdd:cd19542 85 EDSL------------------------DALTRDLLDDPTLFGQPPHRLTLLETSSGEvYLVLRISHALYDGVSLPIILR 140
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3273 DLALGYRQaaggediKLPPKTSSFKAYAkklsDYAESQQLMKQLKYWREA-EEYQTEALPFdqidgTRAHEGQRSTISFT 3351
Cdd:cd19542 141 DLAAAYNG-------QLLPPAPPFSDYI----SYLQSQSQEESLQYWRKYlQGASPCAFPS-----LSPKRPAERSLSST 204
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3352 LNDKETaalLKDANSAYNTDTQDMLLASVILALRHWTNQSAFKLSLEGHGREDVLKGIDvsRTIGWFTAIYPLLIKLNAD 3431
Cdd:cd19542 205 RRSLAK---LEAFCASLGVTLASLFQAAWALVLARYTGSRDVVFGYVVSGRDLPVPGID--DIVGPCINTLPVRVKLDPD 279
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3432 LPDSE----------ESMVHV---LKTTKDTLRRVPDKG-FGYGVIkYLtppgkkdiNFTGAPEISFNYLGQFEsGRTAE 3497
Cdd:cd19542 280 WTVLDllrqlqqqylRSLPHQhlsLREIQRALGLWPSGTlFNTLVS-YQ--------NFEASPESELSGSSVFE-LSAAE 349
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 3498 VPEEDAFSfsplgaggdisttwnreqsldISAIAAEGKLTVNMTYDNARFQRKTIEQLSETCRQFLLQLIEH 3569
Cdd:cd19542 350 DPTEYPVA---------------------VEVEPSGDSLKVSLAYSTSVLSEEQAEELLEQFDDILEALLAN 400
|
|
| PRK06060 |
PRK06060 |
p-hydroxybenzoic acid--AMP ligase FadD22; |
489-952 |
7.01e-15 |
|
p-hydroxybenzoic acid--AMP ligase FadD22;
Pssm-ID: 180374 [Multi-domain] Cd Length: 705 Bit Score: 81.62 E-value: 7.01e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 489 LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSQA 568
Cdd:PRK06060 31 VTHGQIHDGAARLGEVLRNRGLSSGDRVLLCLPDSPDLVQLLLACLARGVMAFLANPELHRDDHALAARNTEPALVVTSD 110
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 569 HLPSSLEDNYIItHPEDIES---KVDGSNIKSVNnADDLLYMIYTSGTTGKPKGVQFEHRNMANLLK------FEYTHSG 639
Cdd:PRK06060 111 ALRDRFQPSRVA-EAAELMSeaaRVAPGGYEPMG-GDALAYATYTSGTTGPPKAAIHRHADPLTFVDamcrkaLRLTPED 188
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 640 IDFEADVLQFAtpsfdvcY---QEIFSALLKGGTLHIVPEAIKRDVPQLFAfiNKHQTNIVF-LPTAFIKMIFSERelAN 715
Cdd:PRK06060 189 TGLCSARMYFA-------YglgNSVWFPLATGGSAVINSAPVTPEAAAILS--ARFGPSVLYgVPNFFARVIDSCS--PD 257
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 716 SFpDGVKHLIAAGEQLMISDLFQDVLRKRGIHLHNHYGPSE---THVVSTY-TIHPGDPIPELPP----IGKPIGCTdly 787
Cdd:PRK06060 258 SF-RSLRCVVSAGEALELGLAERLMEFFGGIPILDGIGSTEvgqTFVSNRVdEWRLGTLGRVLPPyeirVVAPDGTT--- 333
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 788 ilnhqkqlQPCGVPGELYISGASVARGYVNHdkltsdkfsSDPFKPDVIMYRTGDLARRLEDGNIEYIGRADNQVKIRGY 867
Cdd:PRK06060 334 --------AGPGVEGDLWVRGPAIAKGYWNR---------PDSPVANEGWLDTRDRVCIDSDGWVTYRCRADDTEVIGGV 396
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 868 RIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYC---------SVQKlntiDLRSYMASELPEYMIPAKWIWVDS 938
Cdd:PRK06060 397 NVDPREVERLIIEDEAVAEAAVVAVRESTGASTLQAFLVatsgatidgSVMR----DLHRGLLNRLSAFKVPHRFAVVDR 472
|
490
....*....|....
gi 1678550997 939 IPLTPNGKVDRAAL 952
Cdd:PRK06060 473 LPRTPNGKLVRGAL 486
|
|
| ACS |
cd05966 |
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); ... |
1499-1980 |
9.24e-15 |
|
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); Acetyl-CoA synthetase (ACS, EC 6.2.1.1, acetate#CoA ligase or acetate:CoA ligase (AMP-forming)) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is widely present in all living organisms. The activity of this enzyme is crucial for maintaining the required levels of acetyl-CoA, a key intermediate in many important biosynthetic and catabolic processes. Acetyl-CoA is used in the biosynthesis of glucose, fatty acids, and cholesterol. It can also be used in the production of energy in the citric acid cycle. Eukaryotes typically have two isoforms of acetyl-CoA synthetase, a cytosolic form involved in biosynthetic processes and a mitochondrial form primarily involved in energy generation.
Pssm-ID: 341270 [Multi-domain] Cd Length: 608 Bit Score: 80.68 E-value: 9.24e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1499 ALEQQAEKTPDQAAVIFE--DGVM----TYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPE----ML----LG-IYG 1563
Cdd:cd05966 58 CLDRHLKERGDKVAIIWEgdEPDQsrtiTYRELLREVCRFANVLKSLGVKKGDRVAIYMPMIPElviaMLacarIGaVHS 137
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1564 ILKAGGAylpidPDYPEERIsfllEDSGTNILLLQSAGLHvpefTGEIVYLNQT------------NSGLAHRLSNPNV- 1630
Cdd:cd05966 138 VVFAGFS-----AESLADRI----NDAQCKLVITADGGYR----GGKVIPLKEIvdealekcpsveKVLVVKRTGGEVPm 204
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1631 ---------DVLPQSLAY-------------VIYTSGSTGMPKGVEieHRSAVNFLnslqsryqlkHSDMIMHktsYSFD 1688
Cdd:cd05966 205 tegrdlwwhDLMAKQSPEcepewmdsedplfILYTSGSTGKPKGVV--HTTGGYLL----------YAATTFK---YVFD 269
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1689 ASIWELFW------W----------P---------YAGASVYllPQggekePEVIAKAIEEQKITAMHFVPSMLHAFleh 1743
Cdd:cd05966 270 YHPDDIYWctadigWitghsyivygPlangattvmFEGTPTY--PD-----PGRYWDIVEKHKVTIFYTAPTAIRAL--- 339
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1744 IKY-RSVPIKTNR--LKRVFSGGEQLGTHLVSRFYELLPN--VSITNSYGPTE------ATVEAAffdcppheklerIPI 1812
Cdd:cd05966 340 MKFgDEWVKKHDLssLRVLGSVGEPINPEAWMWYYEVIGKerCPIVDTWWQTEtggimiTPLPGA------------TPL 407
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1813 -----GKPVHHVRLYLLNQNQRMLPVGCIGELYIAGA--GVARGYLNRPalteERFLEDPF--YPGerMYKTGDVARWLP 1883
Cdd:cd05966 408 kpgsaTRPFFGIEPAILDEEGNEVEGEVEGYLVIKRPwpGMARTIYGDH----ERYEDTYFskFPG--YYFTGDGARRDE 481
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1884 DGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTD--SGEpELCAYV---EGLQ-----RNEVRAQLER 1953
Cdd:cd05966 482 DGYYWITGRVDDVINVSGHRLGTAEVESALVAHPAVAEAAVVGRPHdiKGE-AIYAFVtlkDGEEpsdelRKELRKHVRK 560
|
570 580
....*....|....*....|....*..
gi 1678550997 1954 LLPGYMVPAYMIEMEQWPVTPSGKLDR 1980
Cdd:cd05966 561 EIGPIATPDKIQFVPGLPKTRSGKIMR 587
|
|
| PRK09274 |
PRK09274 |
peptide synthase; Provisional |
473-888 |
1.26e-14 |
|
peptide synthase; Provisional
Pssm-ID: 236443 [Multi-domain] Cd Length: 552 Bit Score: 80.33 E-value: 1.26e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 473 AEKTPDAHAVIDQA----------CSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGgaIVP 542
Cdd:PRK09274 16 AQERPDQLAVAVPGgrgadgklayDELSFAELDARSDAIAHGLNAAGIGRGMRAVLMVTPSLEFFALTFALFKAG--AVP 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 543 V--DPHYPADRIRYILhdcgcSHV-------VSQAHLPSSL--------------EDNYII--THPEDIESKVDGSNIKS 597
Cdd:PRK09274 94 VlvDPGMGIKNLKQCL-----AEAqpdafigIPKAHLARRLfgwgkpsvrrlvtvGGRLLWggTTLATLLRDGAAAPFPM 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 598 VN-NADDLLYMIYTSGTTGKPKGVQFEHRN---MANLLKFEY--THSGIDFeadvlqfAT-PSFDVcyqeiFSALLKGGT 670
Cdd:PRK09274 169 ADlAPDDMAAILFTSGSTGTPKGVVYTHGMfeaQIEALREDYgiEPGEIDL-------PTfPLFAL-----FGPALGMTS 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 671 lhIVPEA-----IKRDVPQLFAFINKHQTNIVFLPTAFIKMIFSE-RELANSFPdGVKHLIAAGEQLMISDL--FQDVLR 742
Cdd:PRK09274 237 --VIPDMdptrpATVDPAKLFAAIERYGVTNLFGSPALLERLGRYgEANGIKLP-SLRRVISAGAPVPIAVIerFRAMLP 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 743 KrGIHLHNHYGPSETHVVST------------YTiHPGDPIPelppIGKPIGCTDLYILN---------HQKQLQPCGVP 801
Cdd:PRK09274 314 P-DAEILTPYGATEALPISSiesreilfatraAT-DNGAGIC----VGRPVDGVEVRIIAisdapipewDDALRLATGEI 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 802 GELYISGASVARGYVNHDKLTSDKFSSDPfKPDViMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNH 881
Cdd:PRK09274 388 GEIVVAGPMVTRSYYNRPEATRLAKIPDG-QGDV-WHRMGDLGYLDAQGRLWFCGRKAHRVETAGGTLYTIPCERIFNTH 465
|
....*..
gi 1678550997 882 PDISEAA 888
Cdd:PRK09274 466 PGVKRSA 472
|
|
| PRK12476 |
PRK12476 |
putative fatty-acid--CoA ligase; Provisional |
1520-1982 |
1.40e-14 |
|
putative fatty-acid--CoA ligase; Provisional
Pssm-ID: 171527 [Multi-domain] Cd Length: 612 Bit Score: 80.17 E-value: 1.40e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1520 MTYKELNEQANRIAWELiGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPI-DPDYP--EERISFLLEDSGTNILL 1596
Cdd:PRK12476 69 LTWTQLGVRLRAVGARL-QQVAGPGDRVAILAPQGIDYVAGFFAAIKAGTIAVPLfAPELPghAERLDTALRDAEPTVVL 147
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1597 LQSAGLH-VPEFTGE--------IVYLNQTNSGLAHRLSNPNVDVlpQSLAYVIYTSGSTGMPKGVEIEHRSAVNflNSL 1667
Cdd:PRK12476 148 TTTAAAEaVEGFLRNlprlrrprVIAIDAIPDSAGESFVPVELDT--DDVSHLQYTSGSTRPPVGVEITHRAVGT--NLV 223
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1668 QSRYQLKHSDMIMHKTSysfdasiwelfWWP---------------YAGASVYLLPQGGEKEPEVIAKAIEEQKITAMHF 1732
Cdd:PRK12476 224 QMILSIDLLDRNTHGVS-----------WLPlyhdmglsmigfpavYGGHSTLMSPTAFVRRPQRWIKALSEGSRTGRVV 292
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1733 VPSMLHAFlEHIKYRSVPIKTNRLK----RVFSGGEQLGTHLVSRFYEL-----LPNVSITNSYGPTEATV--------- 1794
Cdd:PRK12476 293 TAAPNFAY-EWAAQRGLPAEGDDIDlsnvVLIIGSEPVSIDAVTTFNKAfapygLPRTAFKPSYGIAEATLfvatiapda 371
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1795 --EAAFFDcppHEKLE-----RIPIGKP--VHHVRLYLLNQNQRM----------LPVGCIGELYIAGAGVARGYLNRPA 1855
Cdd:PRK12476 372 epSVVYLD---REQLGagravRVAADAPnaVAHVSCGQVARSQWAvivdpdtgaeLPDGEVGEIWLHGDNIGRGYWGRPE 448
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1856 LTEERF---LEDPFYPGERMYKTGDVARWLP--------DGNVEFLGRTDDQVKIRGYRIEPGEIEA-ALRSIEGVREAA 1923
Cdd:PRK12476 449 ETERTFgakLQSRLAEGSHADGAADDGTWLRtgdlgvylDGELYITGRIADLIVIDGRNHYPQDIEAtVAEASPMVRRGY 528
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 1924 VTVRTDSGE--PELCAYVE---GLQRNE-------VRAQLERL--LPGY---MVPAYMIemeqwPVTPSGKLDRNA 1982
Cdd:PRK12476 529 VTAFTVPAEdnERLVIVAEraaGTSRADpapaidaIRAAVSRRhgLAVAdvrLVPAGAI-----PRTTSGKLARRA 599
|
|
| BACL_like |
cd05929 |
Bacterial Bile acid CoA ligases and similar proteins; Bile acid-Coenzyme A ligase catalyzes ... |
1639-1983 |
1.57e-14 |
|
Bacterial Bile acid CoA ligases and similar proteins; Bile acid-Coenzyme A ligase catalyzes the formation of bile acid-CoA conjugates in a two-step reaction: the formation of a bile acid-AMP molecule as an intermediate, followed by the formation of a bile acid-CoA. This ligase requires a bile acid with a free carboxyl group, ATP, Mg2+, and CoA for synthesis of the final bile acid-CoA conjugate. The bile acid-CoA ligation is believed to be the initial step in the bile acid 7alpha-dehydroxylation pathway in the intestinal bacterium Eubacterium sp.
Pssm-ID: 341252 [Multi-domain] Cd Length: 473 Bit Score: 79.34 E-value: 1.57e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1639 YVIYTSGSTGMPKGVEIEHrSAVNFlnslqsryqlkHSDMIMhktsysfdasIWELFWWPYAGaSVYLLP---------- 1708
Cdd:cd05929 129 KMLYSGGTTGRPKGIKRGL-PGGPP-----------DNDTLM----------AAALGFGPGAD-SVYLSPaplyhaapfr 185
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1709 -------QGG-----EK-EPEVIAKAIEEQKITAMHFVPSMLHAFLEhiKYRSVPIKTN--RLKRVFSGGEQLGTHLVSR 1773
Cdd:cd05929 186 wsmtalfMGGtlvlmEKfDPEEFLRLIERYRVTFAQFVPTMFVRLLK--LPEAVRNAYDlsSLKRVIHAAAPCPPWVKEQ 263
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1774 FYELLPNVsITNSYGPTEATveaAFFDCPPHEKLE-RIPIGKPVHHvRLYLLNQNQRMLPVGCIGELYIAGAGvARGYLN 1852
Cdd:cd05929 264 WIDWGGPI-IWEYYGGTEGQ---GLTIINGEEWLThPGSVGRAVLG-KVHILDEDGNEVPPGEIGEVYFANGP-GFEYTN 337
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1853 RPALTEERFLEDPFypgermYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAV--TVRTDS 1930
Cdd:cd05929 338 DPEKTAAARNEGGW------STLGDVGYLDEDGYLYLTDRRSDMIISGGVNIYPQEIENALIAHPKVLDAAVvgVPDEEL 411
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1931 GE-------PELCAYVEGLQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd05929 412 GQrvhavvqPAPGADAGTALAEELIAFLRDRLSRYKCPRSIEFVAELPRDDTGKLYRRLL 471
|
|
| ACLS-CaiC |
cd17637 |
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ... |
1640-1980 |
1.84e-14 |
|
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized, but may be similar to Carnitine-CoA ligase (CaiC) which catalyzes the transfer of CoA to carnitine. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341292 [Multi-domain] Cd Length: 333 Bit Score: 77.70 E-value: 1.84e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1640 VIYTSGSTGMPKGVEIEHRsavnflNSLQSRYQLKHSdmiMHKTSYSFDASIWELFWWPYAGASVYLLPQGG-----EK- 1713
Cdd:cd17637 5 IIHTAAVAGRPRGAVLSHG------NLIAANLQLIHA---MGLTEADVYLNMLPLFHIAGLNLALATFHAGGanvvmEKf 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1714 EPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTnrLKRVFsgG-------EQLGTHLVSRFYELlpnvsitns 1786
Cdd:cd17637 76 DPAEALELIEEEKVTLMGSFPPILSNLLDAAEKSGVDLSS--LRHVL--GldapetiQRFEETTGATFWSL--------- 142
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1787 YGPTEATVEAAFfdCPPHEKleriP--IGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLED 1864
Cdd:cd17637 143 YGQTETSGLVTL--SPYRER----PgsAGRPGPLVRVRIVDDNDRPVPAGETGEIVVRGPLVFQGYWNLPELTAYTFRNG 216
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1865 pfypgerMYKTGDVARWLPDGNVEFLGRT--DDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GE--PELCAY 1938
Cdd:cd17637 217 -------WHHTGDLGRFDEDGYLWYAGRKpeKELIKPGGENVYPAEVEKVILEHPAIAEVCVIGVPDPkwGEgiKAVCVL 289
|
330 340 350 360
....*....|....*....|....*....|....*....|....
gi 1678550997 1939 VEG--LQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDR 1980
Cdd:cd17637 290 KPGatLTADELIEFVGSRIARYKKPRYVVFVEALPKTADGSIDR 333
|
|
| C_PKS-NRPS |
cd19532 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
3128-3364 |
1.86e-14 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHxxxD motif, a few such as Monascus pilosus lovastatin nonaketide synthase MokA have a non-canonical HRxxxD motif in the C-domain and are unable to catalyze amide-bond formation. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380455 [Multi-domain] Cd Length: 421 Bit Score: 78.65 E-value: 1.86e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3128 WFLSQDIKEKHHFNQSVMLHRSTSVQEDALRKTLKAITCHHDALRMVFTQNE------QGKWDQ-----YNRPLSHSDDA 3196
Cdd:cd19532 12 WFLQQYLEDPTTFNVTFSYRLTGPLDVARLERAVRAVGQRHEALRTCFFTDPedgepmQGVLASsplrlEHVQISDEAEV 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3197 LYGLQmidlsapdgtdgnrpyepLIKRHVLDiqqkmdLKNGPLLQAGLFHTIDGD-FLFLSAHHLVVDGISWRVLLEDLA 3275
Cdd:cd19532 92 EEEFE------------------RLKNHVYD------LESGETMRIVLLSLSPTEhYLIFGYHHIAMDGVSFQIFLRDLE 147
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3276 LGYRQAaggediKLPPKTSSFKAYAKKLSDYAESQQLMKQLKYWReaEEYQTEA-----LPFdqidgtrAHEGQRS---- 3346
Cdd:cd19532 148 RAYNGQ------PLLPPPLQYLDFAARQRQDYESGALDEDLAYWK--SEFSTLPeplplLPF-------AKVKSRPpltr 212
|
250 260
....*....|....*....|..
gi 1678550997 3347 ----TISFTLnDKETAALLKDA 3364
Cdd:cd19532 213 ydthTAERRL-DAALAARIKEA 233
|
|
| PRK07824 |
PRK07824 |
o-succinylbenzoate--CoA ligase; |
2676-3019 |
2.19e-14 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 236108 [Multi-domain] Cd Length: 358 Bit Score: 77.78 E-value: 2.19e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2676 AYIIYTSGTTGRPKGVMVE-----------HKGIANTLQWrrnayafnetdtILQLFSFSFDGfITSMFTPLLSGAKAVL 2744
Cdd:PRK07824 38 ALVVATSGTTGTPKGAMLTaaaltasadatHDRLGGPGQW------------LLALPAHHIAG-LQVLVRSVIAGSEPVE 104
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2745 LHEEEAKDILAIK---HQLSRQRiTHMIIVPV-LYRALLDVVQPEDVKTLRVVTLAGEAADRELI--ARSLAIcphtELA 2818
Cdd:PRK07824 105 LDVSAGFDPTALPravAELGGGR-RYTSLVPMqLAKALDDPAATAALAELDAVLVGGGPAPAPVLdaAAAAGI----NVV 179
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2819 NEYGPTENSVATtvmrhmekqayVSIGQPIDGTQVLILNsnhqlqpigvaGELCIAGTGLARGYVNLPElteraftqNPF 2898
Cdd:PRK07824 180 RTYGMSETSGGC-----------VYDGVPLDGVRVRVED-----------GRIALGGPTLAKGYRNPVD--------PDP 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2899 KPEARMYRTGDAARwMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTAS-GQTELSAYVVT-KP 2976
Cdd:PRK07824 230 FAEPGWFRTDDLGA-LDDGVLTVLGRADDAISTGGLTVLPQVVEAALATHPAVADCAVFGLPDDRlGQRVVAAVVGDgGP 308
|
330 340 350 360
....*....|....*....|....*....|....*....|...
gi 1678550997 2977 GLSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK07824 309 APTLEALRAHVARTLDRTAAPRELHVVDELPRRGIGKVDRRAL 351
|
|
| AFD_CAR-like |
cd17632 |
adenylation domain of carboxylic acid reductase (CAR); This family contains the adenylation ... |
488-945 |
2.55e-14 |
|
adenylation domain of carboxylic acid reductase (CAR); This family contains the adenylation domain of carboxylic acid reductase enzymes (CARs), and performs an equivalent function to that of the ANL superfamily of adenylating enzymes. It takes a carboxylic acid substrate and ATP, and produces an AMP-acyl phosphoester intermediate, releasing pyrophosphate. Kinetic analysis using various substrates shows that this enzyme has a broad but similar substrate specificity, preferring electron-rich acids. This suggests that attack by the carboxylate on the alpha-phosphate of adenosine triphosphate (ATP) is the step that determines the substrate specificity and reaction kinetics. CAR is an important enzyme for use as a biocatalyst providing regiospecific route to aldehydes from their respective carboxylic acids.
Pssm-ID: 341287 [Multi-domain] Cd Length: 588 Bit Score: 79.42 E-value: 2.55e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 488 SLTYRELNKAANRLARHLRMKGVVRQEP-VAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHV-V 565
Cdd:cd17632 67 TITYAELWERVGAVAAAHDPEQPVRPGDfVAVLGFTSPDYATVDLALTRLGAVSVPLQAGASAAQLAPILAETEPRLLaV 146
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 566 SQAHLPSSLE--------------DNY--IITHPEDIESKVD------------------------GSNIKSVNNADDLL 605
Cdd:cd17632 147 SAEHLDLAVEavleggtpprlvvfDHRpeVDAHRAALESARErlaavgipvttltliavrgrdlppAPLFRPEPDDDPLA 226
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 606 YMIYTSGTTGKPKGVQFEHRNMANL-LKFEYTHSGIDFEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEAikrDVPQ 684
Cdd:cd17632 227 LLIYTSGSTGTPKGAMYTERLVATFwLKVSSIQDIRPPASITLNFMPMSHIAGRISLYGTLARGGTAYFAAAS---DMST 303
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 685 LFAFINKHQTNIVFLPTAFIKMIFSE--RELANSFPDGVKHLIAAGEqlMISDLFQDVLRKR------------------ 744
Cdd:cd17632 304 LFDDLALVRPTELFLVPRVCDMLFQRyqAELDRRSVAGADAETLAER--VKAELRERVLGGRllaavcgsaplsaemkaf 381
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 745 -----GIHLHNHYGPSETHVVSTytihpgDPIPELPPI--GKPIGCTDL-YILN---HQKqlqpcgvpGELYISGASVAR 813
Cdd:cd17632 382 mesllDLDLHDGYGSTEAGAVIL------DGVIVRPPVldYKLVDVPELgYFRTdrpHPR--------GELLVKTDTLFP 447
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 814 GYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQVKI-RGYRIEPQEIEVTLMNHPDI-------- 884
Cdd:cd17632 448 GYYKRPEVTAEVFDEDGF------YRTGDVMAELGPDRLVYVDRRNNVLKLsQGEFVTVARLEAVFAASPLVrqifvygn 521
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 885 SEAAILIW--------QDQNGEHEL-CAYYCSVQklntidlRSYMASELPEYMIPAKWIwVDSIPLTP-NG 945
Cdd:cd17632 522 SERAYLLAvvvptqdaLAGEDTARLrAALAESLQ-------RIAREAGLQSYEIPRDFL-IETEPFTIaNG 584
|
|
| PRK09192 |
PRK09192 |
fatty acyl-AMP ligase; |
1519-1980 |
2.68e-14 |
|
fatty acyl-AMP ligase;
Pssm-ID: 236403 [Multi-domain] Cd Length: 579 Bit Score: 79.28 E-value: 2.68e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1519 VMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGG--AYLPIdpdyPE---------ERISFLL 1587
Cdd:PRK09192 49 ALPYQTLRARAEAGARRLLALGLKPGDRVALIAETDGDFVEAFFACQYAGLvpVPLPL----PMgfggresyiAQLRGML 124
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1588 EDSGTNILLlqsAGLHVPEFTGEIVYLNQTNSGLAHRLSN--PNVDV-LPQ----SLAYVIYTSGSTGMPKGVEIEHRSA 1660
Cdd:PRK09192 125 ASAQPAAII---TPDELLPWVNEATHGNPLLHVLSHAWFKalPEADVaLPRptpdDIAYLQYSSGSTRFPRGVIITHRAL 201
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1661 VNFLNSLqSRY--QLKHSDMIMHKTSYSFDASIWELFWWPYA-GASVYLLPQGG-EKEPEVIAKAIEEQKITaMHFVP-- 1734
Cdd:PRK09192 202 MANLRAI-SHDglKVRPGDRCVSWLPFYHDMGLVGFLLTPVAtQLSVDYLPTRDfARRPLQWLDLISRNRGT-ISYSPpf 279
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1735 ----------SMLHAFLEHIKYRSVPIktnrlkrvfsGGEQLGTHLVSRFYELLPNV-----SITNSYGPTEATVEAAFf 1799
Cdd:PRK09192 280 gyelcarrvnSKDLAELDLSCWRVAGI----------GADMIRPDVLHQFAEAFAPAgfddkAFMPSYGLAEATLAVSF- 348
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1800 dcPPH-----------EKLERIPI-----------------GKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYL 1851
Cdd:PRK09192 349 --SPLgsgivveevdrDRLEYQGKavapgaetrrvrtfvncGKALPGHEIEIRNEAGMPLPERVVGHICVRGPSLMSGYF 426
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1852 NRP----ALTEERFLEdpfypgermykTGDVArWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVR--EAAVT 1925
Cdd:PRK09192 427 RDEesqdVLAADGWLD-----------TGDLG-YLLDGYLYITGRAKDLIIINGRNIWPQDIEWIAEQEPELRsgDAAAF 494
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1678550997 1926 VRTDSGEPELCAYVEG-LQRNEVRAQLERLLPGY------------MVPAYMIemeqwPVTPSGKLDR 1980
Cdd:PRK09192 495 SIAQENGEKIVLLVQCrISDEERRGQLIHALAALvrsefgveaaveLVPPHSL-----PRTSSGKLSR 557
|
|
| PRK07769 |
PRK07769 |
long-chain-fatty-acid--CoA ligase; Validated |
1493-1928 |
2.86e-14 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 181109 [Multi-domain] Cd Length: 631 Bit Score: 79.39 E-value: 2.86e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1493 NQTLHYALEQQAEKTPDQAAVIFEDgvmTYKELNEQANRIAWELIG---RGV--------KPETTVAIIGKRSPEMLLGI 1561
Cdd:PRK07769 20 NTNLVRHVERWAKVRGDKLAYRFLD---FSTERDGVARDLTWSQFGarnRAVgarlqqvtKPGDRVAILAPQNLDYLIAF 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1562 YGILKAGGAYLPI-DPDYP--EERISFLLED-SGTNILLLQSAGLHVPEF--------TGEIVYLNQTNSGLAHRLSNPN 1629
Cdd:PRK07769 97 FGALYAGRIAVPLfDPAEPghVGRLHAVLDDcTPSAILTTTDSAEGVRKFfrarpakeRPRVIAVDAVPDEVGATWVPPE 176
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1630 VDVlpQSLAYVIYTSGSTGMPKGVEIEHRSAVNflNSLQsryqlkhsdMImhkTSYSFDASIWELFWWPY---AGASVYL 1706
Cdd:PRK07769 177 ANE--DTIAYLQYTSGSTRIPAGVQITHLNLPT--NVLQ---------VI---DALEGQEGDRGVSWLPFfhdMGLITVL 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1707 LPQGGEKEPEVIAKAIEEQK----ITAMHFVPSMLH---------AFlEHIKYRSVP------IKTNRLKRVFSGGEQLG 1767
Cdd:PRK07769 241 LPALLGHYITFMSPAAFVRRpgrwIRELARKPGGTGgtfsaapnfAF-EHAAARGLPkdgeppLDLSNVKGLLNGSEPVS 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1768 THLVSRFYEL-----LPNVSITNSYGPTEATVeaaFFDCPPHEKLERipigkpVHHVRLYLLNqNQRM------------ 1830
Cdd:PRK07769 320 PASMRKFNEAfapygLPPTAIKPSYGMAEATL---FVSTTPMDEEPT------VIYVDRDELN-AGRFvevpadapnava 389
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1831 -----------------------LPVGCIGELYIAGAGVARGYLNRPALTEERF---LEDPFYP--------GERMYKTG 1876
Cdd:PRK07769 390 qvsagkvgvsewavivdpetaseLPDGQIGEIWLHGNNIGTGYWGKPEETAATFqniLKSRLSEshaegapdDALWVRTG 469
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 1877 DVARWLpDGNVEFLGRTDDQVKIRGYRIEPGEIEAAlrsiegVREAAVTVRT 1928
Cdd:PRK07769 470 DYGVYF-DGELYITGRVKDLVIIDGRNHYPQDLEYT------AQEATKALRT 514
|
|
| PRK13390 |
PRK13390 |
acyl-CoA synthetase; Provisional |
1503-1983 |
2.91e-14 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139538 [Multi-domain] Cd Length: 501 Bit Score: 78.90 E-value: 2.91e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1503 QAEKTPDQAAVIF-EDG-VMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPE 1580
Cdd:PRK13390 6 HAQIAPDRPAVIVaETGeQVSYRQLDDDSAALARVLYDAGLRTGDVVALLSDNSPEALVVLWAALRSGLYITAINHHLTA 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1581 ERISFLLEDSGTNIL--------LLQSAGLHVP---EFTGEIVYLNQTNSGLAHrlSNPNVDVLPQSlAYVIYTSGSTGM 1649
Cdd:PRK13390 86 PEADYIVGDSGARVLvasaaldgLAAKVGADLPlrlSFGGEIDGFGSFEAALAG--AGPRLTEQPCG-AVMLYSSGTTGF 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1650 PKGVEIEhrsavnflnsLQSRYQLKHSDMIMHKTSYSFDASIWELFwwpYAGASVY----------LLPQGGEKepeVIA 1719
Cdd:PRK13390 163 PKGIQPD----------LPGRDVDAPGDPIVAIARAFYDISESDIY---YSSAPIYhaaplrwcsmVHALGGTV---VLA 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1720 KA---------IEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTNRLKRVFSGGEQLGTHLVSRFYELLPNVsITNSYGPT 1790
Cdd:PRK13390 227 KRfdaqatlghVERYRITVTQMVPTMFVRLLKLDADVRTRYDVSSLRAVIHAAAPCPVDVKHAMIDWLGPI-VYEYYSST 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1791 EATvEAAFFDCP---PHEKleriPIGKPVHHVrLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERflEDPFY 1867
Cdd:PRK13390 306 EAH-GMTFIDSPdwlAHPG----SVGRSVLGD-LHICDDDGNELPAGRIGTVYFERDRLPFRYLNDPEKTAAA--QHPAH 377
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1868 PgerMYKT-GDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDsgePEL-------CAYV 1939
Cdd:PRK13390 378 P---FWTTvGDLGSVDEDGYLYLADRKSFMIISGGVNIYPQETENALTMHPAVHDVAVIGVPD---PEMgeqvkavIQLV 451
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 1940 EGLQRNEvraQLERLL--------PGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK13390 452 EGIRGSD---ELARELidytrsriAHYKAPRSVEFVDELPRTPTGKLVKGLL 500
|
|
| PRK05857 |
PRK05857 |
fatty acid--CoA ligase; |
471-952 |
3.40e-14 |
|
fatty acid--CoA ligase;
Pssm-ID: 180293 [Multi-domain] Cd Length: 540 Bit Score: 78.90 E-value: 3.40e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 471 KQAEKTPDAHAV--IDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYP 548
Cdd:PRK05857 22 EQARQQPEAIALrrCDGTSALRYRELVAEVGGLAADLRAQSVSRGSRVLVISDNGPETYLSVLACAKLGAIAVMADGNLP 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 549 ADRI-RY--------ILHDCGCShvVSQAHLPSSLEDNYIITHPEDIESKVDGSNIKSV-------NNADDLLYMIYTSG 612
Cdd:PRK05857 102 IAAIeRFcqitdpaaALVAPGSK--MASSAVPEALHSIPVIAVDIAAVTRESEHSLDAAslagnadQGSEDPLAMIFTSG 179
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 613 TTGKPKGVQFEHRN---MANLLKFEYThSGIDFEADVLQF----ATPSFDVCYqeIFSALLKGGTLHIVPEaikrDVPQL 685
Cdd:PRK05857 180 TTGEPKAVLLANRTffaVPDILQKEGL-NWVTWVVGETTYsplpATHIGGLWW--ILTCLMHGGLCVTGGE----NTTSL 252
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 686 FAFINKHQTNIVFL-PTAFIKMIfSERELANSFPDGVKHLIAAGEQLMISDLfqDVLRKRGIHLHNHYGPSETHVVSTYT 764
Cdd:PRK05857 253 LEILTTNAVATTCLvPTLLSKLV-SELKSANATVPSLRLVGYGGSRAIAADV--RFIEATGVRTAQVYGLSETGCTALCL 329
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 765 IHPGDPIP--ELPPIGKPIGCTDLYIL--NHQKQLQPCGVP----GELYISGASVARGYVNHDKLTSDKFSSDpfkpdvi 836
Cdd:PRK05857 330 PTDDGSIVkiEAGAVGRPYPGVDVYLAatDGIGPTAPGAGPsasfGTLWIKSPANMLGYWNNPERTAEVLIDG------- 402
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 837 MYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCSVQKLN---T 913
Cdd:PRK05857 403 WVNTGDLLERREDGFFYIKGRSSEMIICGGVNIAPDEVDRIAEGVSGVREAACYEIPDEEFGALVGLAVVASAELDesaA 482
|
490 500 510 520
....*....|....*....|....*....|....*....|...
gi 1678550997 914 IDLRSYMAS----ELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PRK05857 483 RALKHTIAArfrrESEPMARPSTIVIVTDIPRTQSGKVMRASL 525
|
|
| PRK06334 |
PRK06334 |
long chain fatty acid--[acyl-carrier-protein] ligase; Validated |
2676-3019 |
3.74e-14 |
|
long chain fatty acid--[acyl-carrier-protein] ligase; Validated
Pssm-ID: 180533 [Multi-domain] Cd Length: 539 Bit Score: 78.70 E-value: 3.74e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2676 AYIIYTSGTTGRPKGVMVEHkgiANTLQWRRNAYAF---NETDTILQ-LFSFSFDGFITSMFTPLLSGAKAVLLHEE-EA 2750
Cdd:PRK06334 186 AVILFTSGTEKLPKGVPLTH---ANLLANQRACLKFfspKEDDVMMSfLPPFHAYGFNSCTLFPLLSGVPVVFAYNPlYP 262
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2751 KDILAIkhqLSRQRITHMIIVPVLYRALLDVV--QPEDVKTLRVVTLAGEAADRELIARSLAICPHTELANEYGPTENSV 2828
Cdd:PRK06334 263 KKIVEM---IDEAKVTFLGSTPVFFDYILKTAkkQESCLPSLRFVVIGGDAFKDSLYQEALKTFPHIQLRQGYGTTECSP 339
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2829 ATTVMRHMEKQAYVSIGQPIDGTQVLILN-SNHQLQPIGVAGELCIAGTGLARGYvnLPELTERAFTQnpfKPEARMYRT 2907
Cdd:PRK06334 340 VITINTVNSPKHESCVGMPIRGMDVLIVSeETKVPVSSGETGLVLTRGTSLFSGY--LGEDFGQGFVE---LGGETWYVT 414
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2908 GDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAA-----VVAHVtaSGQTELSAYVVTKPgLSTNA 2982
Cdd:PRK06334 415 GDLGYVDRHGELFLKGRLSRFVKIGAEMVSLEALESILMEGFGQNAADhagplVVCGL--PGEKVRLCLFTTFP-TSISE 491
|
330 340 350
....*....|....*....|....*....|....*...
gi 1678550997 2983 VRSELQN-KLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK06334 492 VNDILKNsKTSSILKISYHHQVESIPMLGTGKPDYCSL 529
|
|
| FATP_chFAT1_like |
cd05937 |
Uncharacterized subfamily of bifunctional fatty acid transporter/very-long-chain acyl-CoA ... |
1515-1964 |
3.91e-14 |
|
Uncharacterized subfamily of bifunctional fatty acid transporter/very-long-chain acyl-CoA synthetase in fungi; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis. Members of this family are fungal FATPs, including FAT1 from Cochliobolus heterostrophus.
Pssm-ID: 341260 [Multi-domain] Cd Length: 468 Bit Score: 78.24 E-value: 3.91e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1515 FEDGVMTYKELNEQANRIA-WELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAylpidpdypeerisflledsgtn 1593
Cdd:cd05937 1 FEGKTWTYSETYDLVLRYAhWLHDDLGVQAGDFVAIDLTNSPEFVFLWLGLWSIGAA----------------------- 57
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1594 illlqsaglhvPEFtgeIVYlNQTNSGLAH--RLSNPN-VDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSR 1670
Cdd:cd05937 58 -----------PAF---INY-NLSGDPLIHclKLSGSRfVIVDPDDPAILIYTSGTTGLPKAAAISWRRTLVTSNLLSHD 122
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1671 YQLKHSDM------IMHKTSYSFdasiwelfwwpyagASVYLLPQGGekepeVIAKAieeQKITAMHFVPSMLHAFLEHI 1744
Cdd:cd05937 123 LNLKNGDRtytcmpLYHGTAAFL--------------GACNCLMSGG-----TLALS---RKFSASQFWKDVRDSGATII 180
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1745 KY--------RSVPI----KTNRLKRVFSGGeqLGTHLVSRFYELLpNVS-ITNSYGPTEATveAAFFdcppheKLERIP 1811
Cdd:cd05937 181 QYvgelcrylLSTPPspydRDHKVRVAWGNG--LRPDIWERFRERF-NVPeIGEFYAATEGV--FALT------NHNVGD 249
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1812 --IGKPVHH---VRLYLLNQ--------NQRM------------LPVGCIGELYIA----GAGVARGYLNRPALTEERFL 1862
Cdd:cd05937 250 fgAGAIGHHgliRRWKFENQvvlvkmdpETDDpirdpktgfcvrAPVGEPGEMLGRvpfkNREAFQGYLHNEDATESKLV 329
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1863 EDPFYPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREA---AVTVRTDSGEPElCAYV 1939
Cdd:cd05937 330 RDVFRKGDIYFRTGDLLRQDADGRWYFLDRLGDTFRWKSENVSTTEVADVLGAHPDIAEAnvyGVKVPGHDGRAG-CAAI 408
|
490 500 510
....*....|....*....|....*....|....
gi 1678550997 1940 EGLQRNEVR--------AQLERL-LPGYMVPAYM 1964
Cdd:cd05937 409 TLEESSAVPteftksllASLARKnLPSYAVPLFL 442
|
|
| AcpP |
COG0236 |
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the ... |
1997-2070 |
4.92e-14 |
|
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the Pathway/BioSystem: Fatty acid biosynthesis
Pssm-ID: 440006 [Multi-domain] Cd Length: 80 Bit Score: 69.88 E-value: 4.92e-14
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 1997 APRNVTEMKLSQLWEDVLKNGP--VGIHDNFF-DRGGHSLKATALVSRITKEFDVQVPLKDVFAHPTVEGLATVIRE 2070
Cdd:COG0236 1 MPREELEERLAEIIAEVLGVDPeeITPDDSFFeDLGLDSLDAVELIAALEEEFGIELPDTELFEYPTVADLADYLEE 77
|
|
| PRK13388 |
PRK13388 |
acyl-CoA synthetase; Provisional |
463-952 |
5.58e-14 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237374 [Multi-domain] Cd Length: 540 Bit Score: 78.14 E-value: 5.58e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 463 ETIHAMFEKQAEKtpDAHAVIDQACSLTYRE-LNKAANR--LARHLRMKGvvRQEPVAIMMERSAAFITGVLGILKAGGA 539
Cdd:PRK13388 3 DTIAQLLRDRAGD--DTIAVRYGDRTWTWREvLAEAAARaaALIALADPD--RPLHVGVLLGNTPEMLFWLAAAALGGYV 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 540 IVPVDP-HYPADRIRYILH-DCGCShVVSQAHLP--SSLE---DNYIIT----HPEDIESKVDGSNIKSVNnADDLLYMI 608
Cdd:PRK13388 79 LVGLNTtRRGAALAADIRRaDCQLL-VTDAEHRPllDGLDlpgVRVLDVdtpaYAELVAAAGALTPHREVD-AMDPFMLI 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 609 YTSGTTGKPKGVQFEHRNMANL---LKFEYTHSgidfEADVLQFATPSF--DVCYQEIFSALLKGGTLHIVPE------- 676
Cdd:PRK13388 157 FTSGTTGAPKAVRCSHGRLAFAgraLTERFGLT----RDDVCYVSMPLFhsNAVMAGWAPAVASGAAVALPAKfsasgfl 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 677 -AIKRDVPQLFAFINKhqtnivflPTAFIkMIFSERelansfPDGVKH--LIAAGEQLMISDLfQDVLRKRGIHLHNHYG 753
Cdd:PRK13388 233 dDVRRYGATYFNYVGK--------PLAYI-LATPER------PDDADNplRVAFGNEASPRDI-AEFSRRFGCQVEDGYG 296
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 754 PSETHVVSTytihpgdPIPELPP--IGKPIgcTDLYILNHQKqLQPCGVP---------------GELY-ISGASVARGY 815
Cdd:PRK13388 297 SSEGAVIVV-------REPGTPPgsIGRGA--PGVAIYNPET-LTECAVArfdahgallnadeaiGELVnTAGAGFFEGY 366
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 816 VNHDKLTSDKFSSDpfkpdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQ 895
Cdd:PRK13388 367 YNNPEATAERMRHG-------MYWSGDLAYRDADGWIYFAGRTADWMRVDGENLSAAPIERILLRHPAINRVAVYAVPDE 439
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1678550997 896 -NGEHELCAyycsvqkLNTIDLRSYMASELPEYM-----IPAKW----IWV-DSIPLTPNGKVDRAAL 952
Cdd:PRK13388 440 rVGDQVMAA-------LVLRDGATFDPDAFAAFLaaqpdLGTKAwpryVRIaADLPSTATNKVLKREL 500
|
|
| PRK06018 |
PRK06018 |
putative acyl-CoA synthetase; Provisional |
1521-1924 |
5.67e-14 |
|
putative acyl-CoA synthetase; Provisional
Pssm-ID: 235673 [Multi-domain] Cd Length: 542 Bit Score: 77.87 E-value: 5.67e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1521 TYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNIL----- 1595
Cdd:PRK06018 41 TYAQIHDRALKVSQALDRDGIKLGDRVATIAWNTWRHLEAWYGIMGIGAICHTVNPRLFPEQIAWIINHAEDRVVitdlt 120
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1596 ---LLQSAGLHVPEFTGEIVYlnqtnSGLAHRLSNpnvdVLPQSLAY-----------------------VIYTSGSTGM 1649
Cdd:PRK06018 121 fvpILEKIADKLPSVERYVVL-----TDAAHMPQT----TLKNAVAYeewiaeadgdfawktfdentaagMCYTSGTTGD 191
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1650 PKGVEIEHRSavNFLNSLQSRYQ----LKHSDMIMHKTSYsFDASIWEL-FWWPYAGASVyLLPqGGEKEPEVIAKAIEE 1724
Cdd:PRK06018 192 PKGVLYSHRS--NVLHALMANNGdalgTSAADTMLPVVPL-FHANSWGIaFSAPSMGTKL-VMP-GAKLDGASVYELLDT 266
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1725 QKITAMHFVPSMLHAFLEHIkyRSVPIKTNRLKRVFSGGEQLGTHLVSRFYELlpNVSITNSYGPTE-------ATVEAA 1797
Cdd:PRK06018 267 EKVTFTAGVPTVWLMLLQYM--EKEGLKLPHLKMVVCGGSAMPRSMIKAFEDM--GVEVRHAWGMTEmsplgtlAALKPP 342
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1798 FFDCPPHEKLE-RIPIGKPVHHVRLYLLNQNQRMLPVG--CIGELYIAGAGVARGYLNrpalTEERFLEDpfypgERMYK 1874
Cdd:PRK06018 343 FSKLPGDARLDvLQKQGYPPFGVEMKITDDAGKELPWDgkTFGRLKVRGPAVAAAYYR----VDGEILDD-----DGFFD 413
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1875 TGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAV 1924
Cdd:PRK06018 414 TGDVATIDAYGYMRITDRSKDVIKSGGEWISSIDLENLAVGHPKVAEAAV 463
|
|
| PRK07768 |
PRK07768 |
long-chain-fatty-acid--CoA ligase; Validated |
1521-1980 |
6.76e-14 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236091 [Multi-domain] Cd Length: 545 Bit Score: 77.73 E-value: 6.76e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1521 TYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLLQSA 1600
Cdd:PRK07768 31 TWGEVHERARRIAGGLAAAGVGPGDAVAVLAGAPVEIAPTAQGLWMRGASLTMLHQPTPRTDLAVWAEDTLRVIGMIGAK 110
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1601 GLHVPEFTGEIVYLNQTNSGLAHRLSN-------PNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQL 1673
Cdd:PRK07768 111 AVVVGEPFLAAAPVLEEKGIRVLTVADllaadpiDPVETGEDDLALMQLTSGSTGSPKAVQITHGNLYANAEAMFVAAEF 190
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1674 KHSDMIMhktsysfdasiweLFWWP---------------YAGAS-VYLLPQGGEKEPEVIAKAIEEQKIT---AMHFVP 1734
Cdd:PRK07768 191 DVETDVM-------------VSWLPlfhdmgmvgfltvpmYFGAElVKVTPMDFLRDPLLWAELISKYRGTmtaAPNFAY 257
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1735 SMLHAFLEH-IKYRSVPIKTnrLKRVFSGGEQLGTHLVSRFYEL-----LPNVSITNSYGPTEATVEAAFFDC------- 1801
Cdd:PRK07768 258 ALLARRLRRqAKPGAFDLSS--LRFALNGAEPIDPADVEDLLDAgarfgLRPEAILPAYGMAEATLAVSFSPCgaglvvd 335
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1802 --------------PPHEKLER--IPIGKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLnrpalTEERFLE-- 1863
Cdd:PRK07768 336 evdadllaalrravPATKGNTRrlATLGPPLPGLEVRVVDEDGQVLPPRGVGVIELRGESVTPGYL-----TMDGFIPaq 410
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1864 DPfypgERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREA-AVTVRTDSG----------- 1931
Cdd:PRK07768 411 DA----DGWLDTGDLGYLTEEGEVVVCGRVKDVIIMAGRNIYPTDIERAAARVEGVRPGnAVAVRLDAGhsregfavave 486
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1932 -----EPELCAYVEGLQRNEVRAQLE------RLLPGYMVPAymiemeqwpvTPSGKLDR 1980
Cdd:PRK07768 487 snafeDPAEVRRIRHQVAHEVVAEVGvrprnvVVLGPGSIPK----------TPSGKLRR 536
|
|
| PRK06018 |
PRK06018 |
putative acyl-CoA synthetase; Provisional |
2560-3019 |
6.92e-14 |
|
putative acyl-CoA synthetase; Provisional
Pssm-ID: 235673 [Multi-domain] Cd Length: 542 Bit Score: 77.87 E-value: 6.92e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2560 TYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMTine 2639
Cdd:PRK06018 41 TYAQIHDRALKVSQALDRDGIKLGDRVATIAWNTWRHLEAWYGIMGIGAICHTVNPRLFPEQIAWIINHAEDRVVIT--- 117
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2640 aDLGVLADFEGEILTIESVEE----DDKSPLPQMSSAHHLAY-----------------------IIYTSGTTGRPKGVM 2692
Cdd:PRK06018 118 -DLTFVPILEKIADKLPSVERyvvlTDAAHMPQTTLKNAVAYeewiaeadgdfawktfdentaagMCYTSGTTGDPKGVL 196
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2693 VEHKgiANTLQW----RRNAYAFNETDTILQLFS-FSFDGFITSMFTPlLSGAKAVLlheEEAK-DILAIKHQLSRQRIT 2766
Cdd:PRK06018 197 YSHR--SNVLHAlmanNGDALGTSAADTMLPVVPlFHANSWGIAFSAP-SMGTKLVM---PGAKlDGASVYELLDTEKVT 270
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2767 HMIIVPVLYRALLDVVQPEDVK--TLRVVTLAGEAADRELIARSLAIcpHTELANEYGPTENSVATTV------------ 2832
Cdd:PRK06018 271 FTAGVPTVWLMLLQYMEKEGLKlpHLKMVVCGGSAMPRSMIKAFEDM--GVEVRHAWGMTEMSPLGTLaalkppfsklpg 348
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2833 ---MRHMEKQAYvsigqPIDGTQVLILNSNHQLQPI-GVA-GELCIAGTGLARGYVNLPE--LTERAFtqnpfkpearmY 2905
Cdd:PRK06018 349 darLDVLQKQGY-----PPFGVEMKITDDAGKELPWdGKTfGRLKVRGPAVAAAYYRVDGeiLDDDGF-----------F 412
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2906 RTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVV-AHVTASGQTELsAYVVTKPGlsTNAVR 2984
Cdd:PRK06018 413 DTGDVATIDAYGYMRITDRSKDVIKSGGEWISSIDLENLAVGHPKVAEAAVIgVYHPKWDERPL-LIVQLKPG--ETATR 489
|
490 500 510
....*....|....*....|....*....|....*....
gi 1678550997 2985 SE----LQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK06018 490 EEilkyMDGKIAKWWMPDDVAFVDAIPHTATGKILKTAL 528
|
|
| PtmA |
cd17636 |
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, ... |
1640-1924 |
1.11e-13 |
|
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341291 [Multi-domain] Cd Length: 331 Bit Score: 75.42 E-value: 1.11e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1640 VIYTSGSTGMPKGVEIEHRS----AVN------------FLNSLQsryqLKHSDMIMHkTSYSFDAsiwelfwwpyAGAS 1703
Cdd:cd17636 5 AIYTAAFSGRPNGALLSHQAllaqALVlavlqaidegtvFLNSGP----LFHIGTLMF-TLATFHA----------GGTN 69
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1704 VYLlPQggeKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTNRLKRVFSGGEQLGTHLVSRFYELLPnvsi 1783
Cdd:cd17636 70 VFV-RR---VDAEEVLELIEAERCTHAFLLPPTIDQIVELNADGLYDLSSLRSSPAAPEWNDMATVDTSPWGRKPG---- 141
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1784 tnSYGPTEATVEAAFfdcpPHEKLERIPI-GKPVHHVRLYLLNQNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFl 1862
Cdd:cd17636 142 --GYGQTEVMGLATF----AALGGGAIGGaGRPSPLVQVRILDEDGREVPDGEVGEIVARGPTVMAGYWNRPEVNARRT- 214
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 1863 edpfypGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAV 1924
Cdd:cd17636 215 ------RGGWHHTNDLGRREPDGSLSFVGPKTRMIKSGAENIYPAEVERCLRQHPAVADAAV 270
|
|
| ACLS-CaiC |
cd17637 |
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ... |
603-949 |
1.37e-13 |
|
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized, but may be similar to Carnitine-CoA ligase (CaiC) which catalyzes the transfer of CoA to carnitine. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341292 [Multi-domain] Cd Length: 333 Bit Score: 75.00 E-value: 1.37e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 603 DLLYMIYTSGTTGKPKGVQFEHRNM-ANLLKFEYTHsGIDfEADVLQFATPSFDVCYQEIFSALLKGGTLHIVPEaiKRD 681
Cdd:cd17637 1 DPFVIIHTAAVAGRPRGAVLSHGNLiAANLQLIHAM-GLT-EADVYLNMLPLFHIAGLNLALATFHAGGANVVME--KFD 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 682 VPQLFAFINKHQTNIV--FLPTAFikMIFSERELANSFPDGVKHLiaAGeqLMISDLFQDVLRKRGIHLHNHYGPSETHV 759
Cdd:cd17637 77 PAEALELIEEEKVTLMgsFPPILS--NLLDAAEKSGVDLSSLRHV--LG--LDAPETIQRFEETTGATFWSLYGQTETSG 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 760 VSTYTihpgdPIPELP-PIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDpfkpdviMY 838
Cdd:cd17637 151 LVTLS-----PYRERPgSAGRPGPLVRVRIVDDNDRPVPAGETGEIVVRGPLVFQGYWNLPELTAYTFRNG-------WH 218
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 839 RTGDLARRLEDGNIEYIGRADNQ--VKIRGYRIEPQEIEVTLMNHPDISEAAILIWQD-QNGE--HELCAYYCSvQKLNT 913
Cdd:cd17637 219 HTGDLGRFDEDGYLWYAGRKPEKelIKPGGENVYPAEVEKVILEHPAIAEVCVIGVPDpKWGEgiKAVCVLKPG-ATLTA 297
|
330 340 350
....*....|....*....|....*....|....*.
gi 1678550997 914 IDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDR 949
Cdd:cd17637 298 DELIEFVGSRIARYKKPRYVVFVEALPKTADGSIDR 333
|
|
| AcpP |
COG0236 |
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the ... |
3035-3106 |
1.47e-13 |
|
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the Pathway/BioSystem: Fatty acid biosynthesis
Pssm-ID: 440006 [Multi-domain] Cd Length: 80 Bit Score: 68.34 E-value: 1.47e-13
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 3035 PSSKMEQILADIWKEVLG--AEKIGTADSFF-ELGGDSIKALQVSARLH-RIGKQMAVKDLFSHPTIQELAAYIRD 3106
Cdd:COG0236 2 PREELEERLAEIIAEVLGvdPEEITPDDSFFeDLGLDSLDAVELIAALEeEFGIELPDTELFEYPTVADLADYLEE 77
|
|
| PRK08308 |
PRK08308 |
acyl-CoA synthetase; Validated |
2594-3016 |
1.53e-13 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236231 [Multi-domain] Cd Length: 414 Bit Score: 75.84 E-value: 1.53e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2594 FSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMTineadlgvladFEGEILTIESVEEDDKSP-LPQmssa 2672
Cdd:PRK08308 43 FDIITLVFFLKEKGASVLPIHPDTPKEAAIRMAKRAGCHGLLY-----------GESDFTKLEAVNYLAEEPsLLQ---- 107
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2673 hhlayiiYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDT--ILQLFSFSFdGFITSMFTPLLSGAKAVLLHEEEA 2750
Cdd:PRK08308 108 -------YSSGTTGEPKLIRRSWTEIDREIEAYNEALNCEQDETpiVACPVTHSY-GLICGVLAALTRGSKPVIITNKNP 179
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2751 KDILAIkhqlSRQRITHMII-VPVLYRALLDVVqPEDVKTLRVVT---LAGEAADRELIARSlaicphTELANEYGPTEn 2826
Cdd:PRK08308 180 KFALNI----LRNTPQHILYaVPLMLHILGRLL-PGTFQFHAVMTsgtPLPEAWFYKLRERT------TYMMQQYGCSE- 247
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2827 svATTVMRHMEKQAYVSIGQPIdgtqvlilnSNHQLQpigvagelciAGTGlargyvnlpelterafTQNP----FKPEA 2902
Cdd:PRK08308 248 --AGCVSICPDMKSHLDLGNPL---------PHVSVS----------AGSD----------------ENAPeeivVKMGD 290
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2903 RMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTKPGLSTNA 2982
Cdd:PRK08308 291 KEIFTKDLGYKSERGTLHFMGRMDDVINVSGLNVYPIEVEDVMLRLPGVQEAVVYRGKDPVAGERVKAKVISHEEIDPVQ 370
|
410 420 430
....*....|....*....|....*....|....
gi 1678550997 2983 VRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDR 3016
Cdd:PRK08308 371 LREWCIQHLAPYQVPHEIESVTEIPKNANGKVSR 404
|
|
| PRK07824 |
PRK07824 |
o-succinylbenzoate--CoA ligase; |
602-952 |
1.56e-13 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 236108 [Multi-domain] Cd Length: 358 Bit Score: 75.08 E-value: 1.56e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 602 DDLLYMIYTSGTTGKPKGVQFehrNMANLL-KFEYTHSGIDFEADVLqFATPSFDVC-YQEIFSALLKGgtlhIVPEAIk 679
Cdd:PRK07824 35 DDVALVVATSGTTGTPKGAML---TAAALTaSADATHDRLGGPGQWL-LALPAHHIAgLQVLVRSVIAG----SEPVEL- 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 680 rDVPQLFafinkhqtNIVFLPTAFIKMIFSER-------ELANSFPDgvkhlIAAGEQLMISD--------LFQDVLRKR 744
Cdd:PRK07824 106 -DVSAGF--------DPTALPRAVAELGGGRRytslvpmQLAKALDD-----PAATAALAELDavlvgggpAPAPVLDAA 171
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 745 ---GIHLHNHYGPSETHVVSTYTihpgdpipelppiGKPIGCTDLYILNhqkqlqpcgvpGELYISGASVARGYVNHDkl 821
Cdd:PRK07824 172 aaaGINVVRTYGMSETSGGCVYD-------------GVPLDGVRVRVED-----------GRIALGGPTLAKGYRNPV-- 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 822 tsdkfSSDPFKpDVIMYRTGDLARrLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQN-GEHE 900
Cdd:PRK07824 226 -----DPDPFA-EPGWFRTDDLGA-LDDGVLTVLGRADDAISTGGLTVLPQVVEAALATHPAVADCAVFGLPDDRlGQRV 298
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 901 LCAYYCSVQKLNTID-LRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PRK07824 299 VAAVVGDGGPAPTLEaLRAHVARTLDRTAAPRELHVVDELPRRGIGKVDRRAL 351
|
|
| PLN02479 |
PLN02479 |
acetate-CoA ligase |
2526-3019 |
3.16e-13 |
|
acetate-CoA ligase
Pssm-ID: 178097 [Multi-domain] Cd Length: 567 Bit Score: 75.65 E-value: 3.16e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2526 QANqYGVQTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWK 2605
Cdd:PLN02479 14 AAN-YTALTPLWFLERAAVVHPTRKSVVHGSVRYTWAQTYQRCRRLASALAKRSIGPGSTVAVIAPNIPAMYEAHFGVPM 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2606 AGGCYVPIDPEYPKERKRYILSDSGTKLLM------TINEADLGVLAD-----FEGEILTIESVEEDDKSPLPQMSSAHH 2674
Cdd:PLN02479 93 AGAVVNCVNIRLNAPTIAFLLEHSKSEVVMvdqeffTLAEEALKILAEkkkssFKPPLLIVIGDPTCDPKSLQYALGKGA 172
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2675 LAY------------------------IIYTSGTTGRPKGVMVEHKG-----IANTLQWRRNAYAFnetdTILQLFSFSF 2725
Cdd:PLN02479 173 IEYekfletgdpefawkppadewqsiaLGYTSGTTASPKGVVLHHRGaylmaLSNALIWGMNEGAV----YLWTLPMFHC 248
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2726 DGFITSMFTPLLSGaKAVLLHEEEAKdilAIKHQLSRQRITHMIIVPVLYRALLDVVQPEDVKTL-RVVTL--AGEAADR 2802
Cdd:PLN02479 249 NGWCFTWTLAALCG-TNICLRQVTAK---AIYSAIANYGVTHFCAAPVVLNTIVNAPKSETILPLpRVVHVmtAGAAPPP 324
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2803 ELIArSLAI----CPHTE-LANEYGPT---------ENSVATTVMRHMEKQAYVSIGqpIDGTQVLILNSNHQLQPIG-V 2867
Cdd:PLN02479 325 SVLF-AMSEkgfrVTHTYgLSETYGPStvcawkpewDSLPPEEQARLNARQGVRYIG--LEGLDVVDTKTMKPVPADGkT 401
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2868 AGELCIAGTGLARGYVNLPELTERAFtqnpfkpEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRC 2947
Cdd:PLN02479 402 MGEIVMRGNMVMKGYLKNPKANEEAF-------ANGWFHSGDLGVKHPDGYIEIKDRSKDIIISGGENISSLEVENVVYT 474
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 2948 IKGVKDAAVVAHVTASGQTELSAYVVTKPGLST---NAVRSEL----QNKLPVFMHPAFIeKLDSLPLSPNGKLDRGAL 3019
Cdd:PLN02479 475 HPAVLEASVVARPDERWGESPCAFVTLKPGVDKsdeAALAEDImkfcRERLPAYWVPKSV-VFGPLPKTATGKIQKHVL 552
|
|
| PLN03102 |
PLN03102 |
acyl-activating enzyme; Provisional |
514-952 |
4.86e-13 |
|
acyl-activating enzyme; Provisional
Pssm-ID: 215576 [Multi-domain] Cd Length: 579 Bit Score: 75.06 E-value: 4.86e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 514 EPVAIMMERS-AAFITGVLGILkaggaivPVDPHYPADRIRYIlhdcgcsHVVSQAHLPSSLEDNY--IITHPEDIESKV 590
Cdd:PLN03102 111 KPKILFVDRSfEPLAREVLHLL-------SSEDSNLNLPVIFI-------HEIDFPKRPSSEELDYecLIQRGEPTPSLV 176
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 591 dgSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRN-----MANLLKFEYthsGIdfeADVLQFATPSFDvC--YQEIFS 663
Cdd:PLN03102 177 --ARMFRIQDEHDPISLNYTSGTTADPKGVVISHRGaylstLSAIIGWEM---GT---CPVYLWTLPMFH-CngWTFTWG 247
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 664 ALLKGGTlhivpEAIKRDV--PQLFAFINKHQ-TNIVFLPTAFiKMIFSERELANSFPDGVKHLIAAGEQlMISDLFQDV 740
Cdd:PLN03102 248 TAARGGT-----SVCMRHVtaPEIYKNIEMHNvTHMCCVPTVF-NILLKGNSLDLSPRSGPVHVLTGGSP-PPAALVKKV 320
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 741 lRKRGIHLHNHYGPSETH--VVSTYTIHPGDPIPELPPIG-------KPIGCTDLYILNHQKQLQpcgVP------GELY 805
Cdd:PLN03102 321 -QRLGFQVMHAYGLTEATgpVLFCEWQDEWNRLPENQQMElkarqgvSILGLADVDVKNKETQES---VPrdgktmGEIV 396
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 806 ISGASVARGYVNHDKLTSDKFSSDpfkpdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDIS 885
Cdd:PLN03102 397 IKGSSIMKGYLKNPKATSEAFKHG-------WLNTGDVGVIHPDGHVEIKDRSKDIIISGGENISSVEVENVLYKYPKVL 469
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 886 EAAIL-----IWQD--------QNGEHELCAYYCSVQKlNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PLN03102 470 ETAVVamphpTWGEtpcafvvlEKGETTKEDRVDKLVT-RERDLIEYCRENLPHFMCPRKVVFLQELPKNGNGKILKPKL 548
|
|
| PRK08180 |
PRK08180 |
feruloyl-CoA synthase; Reviewed |
1500-1892 |
5.85e-13 |
|
feruloyl-CoA synthase; Reviewed
Pssm-ID: 236175 [Multi-domain] Cd Length: 614 Bit Score: 74.92 E-value: 5.85e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFEDG-----VMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPI 1574
Cdd:PRK08180 45 LVHWAQEAPDRVFLAERGAdggwrRLTYAEALERVRAIAQALLDRGLSAERPLMILSGNSIEHALLALAAMYAGVPYAPV 124
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1575 DPDYpeeriSFLLEDSG---TNILLLQSAGLHV--------------PEFTGEIVYLNQTNSGLAHRLS-------NPNV 1630
Cdd:PRK08180 125 SPAY-----SLVSQDFGklrHVLELLTPGLVFAddgaafaralaavvPADVEVVAVRGAVPGRAATPFAallatppTAAV 199
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1631 D-----VLPQSLAYVIYTSGSTGMPKGVEIEHRS-AVNFLNSLQSRYQLKHSDMIMhktsysfdasiweLFWWP------ 1698
Cdd:PRK08180 200 DaahaaVGPDTIAKFLFTSGSTGLPKAVINTHRMlCANQQMLAQTFPFLAEEPPVL-------------VDWLPwnhtfg 266
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1699 ---------YAGASVYLlpQGGEKEPEVIAKAIEEQK--ITAMHF-VPS---MLHAFLEhikyRSVPIKTN---RLKRVF 1760
Cdd:PRK08180 267 gnhnlgivlYNGGTLYI--DDGKPTPGGFDETLRNLReiSPTVYFnVPKgweMLVPALE----RDAALRRRffsRLKLLF 340
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1761 SGGEQLGTHLVSRFYELLPN-----VSITNSYGPTEATVEAAFFdcppHEKLERI-PIGKPVHHVRLyllnqnqRMLPVG 1834
Cdd:PRK08180 341 YAGAALSQDVWDRLDRVAEAtcgerIRMMTGLGMTETAPSATFT----TGPLSRAgNIGLPAPGCEV-------KLVPVG 409
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 1835 CIGELYIAGAGVARGYLNRPALTEERFLEDPFypgermYKTGDVARWL----PDGNVEFLGR 1892
Cdd:PRK08180 410 GKLEVRVKGPNVTPGYWRAPELTAEAFDEEGY------YRSGDAVRFVdpadPERGLMFDGR 465
|
|
| PRK09029 |
PRK09029 |
O-succinylbenzoic acid--CoA ligase; Provisional |
473-890 |
7.66e-13 |
|
O-succinylbenzoic acid--CoA ligase; Provisional
Pssm-ID: 236363 [Multi-domain] Cd Length: 458 Bit Score: 74.14 E-value: 7.66e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 473 AEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRI 552
Cdd:PRK09029 13 AQVRPQAIALRLNDEVLTWQQLCARIDQLAAGFAQQGVVEGSGVALRGKNSPETLLAYLALLQCGARVLPLNPQLPQPLL 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 553 RYILHDCGCSHVVSQAHLPSSLEDNYIITHPEDIESKVDGSniksvnnADDLLYMIYTSGTTGKPKGVQFEHRN-MAN-- 629
Cdd:PRK09029 93 EELLPSLTLDFALVLEGENTFSALTSLHLQLVEGAHAVAWQ-------PQRLATMTLTSGSTGLPKAAVHTAQAhLASae 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 630 -LLkfeythSGIDFEA-DVLQFATPSFDVCYQEIF-SALLKGGTLHIvpeaikRDVPQLFAFINKhQTNIVFLPTAFikm 706
Cdd:PRK09029 166 gVL------SLMPFTAqDSWLLSLPLFHVSGQGIVwRWLYAGATLVV------RDKQPLEQALAG-CTHASLVPTQL--- 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 707 ifsERELANS-FPDGVKHLIAAGEqlMISDLFQDVLRKRGIHLHNHYGPSEthVVSTYTIHPGDpipELPPIGKPIGctd 785
Cdd:PRK09029 230 ---WRLLDNRsEPLSLKAVLLGGA--AIPVELTEQAEQQGIRCWCGYGLTE--MASTVCAKRAD---GLAGVGSPLP--- 296
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 786 lyilNHQKQLqpcgVPGELYISGASVARGYVNHDKLTsdkfssdPFKPDVIMYRTGDLArRLEDGNIEYIGRADNQVKIR 865
Cdd:PRK09029 297 ----GREVKL----VDGEIWLRGASLALGYWRQGQLV-------PLVNDEGWFATRDRG-EWQNGELTILGRLDNLFFSG 360
|
410 420
....*....|....*....|....*
gi 1678550997 866 GYRIEPQEIEVTLMNHPDISEAAIL 890
Cdd:PRK09029 361 GEGIQPEEIERVINQHPLVQQVFVV 385
|
|
| C_NRPS-like |
cd19537 |
Condensation family domain with an atypical active site motif; Condensation (C) domains of ... |
12-304 |
9.13e-13 |
|
Condensation family domain with an atypical active site motif; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily typically have a non-canonical conserved SHXXXDX(14)Y motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380460 [Multi-domain] Cd Length: 395 Bit Score: 73.37 E-value: 9.13e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 12 PLSYMQEGMLFHSLLQKDSQA----YVeqasFTIEGKVNPQFFQNSINALVERHDIFRTIFI--------SQNVSSPQQV 79
Cdd:cd19537 3 ALSPIEREWWHKYQLSTGTSSfnvsFA----CRLSGDVDRDRLASAWNTVLARHRILRSRYVprdgglrrSYSSSPPRVQ 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 80 VLRERNVivleedithlneaeqsqfieqWKEKDRDrgFHLQKDVLMRIALiqtgeSQYSCIWTFHHIMMDGWCLSIVLKE 159
Cdd:cd19537 79 RVDTLDV---------------------WKEINRP--FDLEREDPIRVFI-----SPDTLLVVMSHIICDLTTLQLLLRE 130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 160 FLHIYASyvnaspITLEPVQPygKYIKWLMEQDK--EQAVSYWDHYLSGHeQQTVLPKQKKTK---GKSRqehvTFSFSK 234
Cdd:cd19537 131 VSAAYNG------KLLPPVRR--EYLDSTAWSRPasPEDLDFWSEYLSGL-PLLNLPRRTSSKsyrGTSR----VFQLPG 197
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 235 EESSRLSELAAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISGRPAEIEgiEHMVGLFINTMPVRVQ 304
Cdd:cd19537 198 SLYRSLLQFSTSSGITLHQLALAAVALALQDLSDRTDIVLGAPYLNRTSEED--METVGLFLEPLPIRIR 265
|
|
| PaaK |
COG1541 |
Phenylacetate-coenzyme A ligase PaaK, adenylate-forming domain family [Coenzyme transport and ... |
1643-1955 |
9.63e-13 |
|
Phenylacetate-coenzyme A ligase PaaK, adenylate-forming domain family [Coenzyme transport and metabolism];
Pssm-ID: 441150 [Multi-domain] Cd Length: 423 Bit Score: 73.26 E-value: 9.63e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1643 TSGSTGMPKGV-----EIEhRSAVNFLNSLQSrYQLKHSDMIMHKTSYS-------FDASIWELfwwpyaGASVylLPQG 1710
Cdd:COG1541 91 SSGTTGKPTVVgytrkDLD-RWAELFARSLRA-AGVRPGDRVQNAFGYGlftgglgLHYGAERL------GATV--IPAG 160
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1711 GEKePEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTNRLKRVFSGGEQLGTHLVSRFYELLpNVSITNSYGPT 1790
Cdd:COG1541 161 GGN-TERQLRLMQDFGPTVLVGTPSYLLYLAEVAEEEGIDPRDLSLKKGIFGGEPWSEEMRKEIEERW-GIKAYDIYGLT 238
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1791 EATVEAAFfDCPPHEKL-----ERIP-I-----GKPVhhvrlyllnqnqrmlPVGCIGELYIAGagvargylnrpaLTEE 1859
Cdd:COG1541 239 EVGPGVAY-ECEAQDGLhiwedHFLVeIidpetGEPV---------------PEGEEGELVVTT------------LTKE 290
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1860 -----RfledpfypgermYKTGDVARWLPD-----------GNVefLGRTDDQVKIRGYRIEPGEIEAALRSIEGVR-EA 1922
Cdd:COG1541 291 ampliR------------YRTGDLTRLLPEpcpcgrthpriGRI--LGRADDMLIIRGVNVFPSQIEEVLLRIPEVGpEY 356
|
330 340 350
....*....|....*....|....*....|....*.
gi 1678550997 1923 AVTVRTDSGEPELCAYVE---GLQRNEVRAQLERLL 1955
Cdd:COG1541 357 QIVVDREGGLDELTVRVElapGASLEALAEAIAAAL 392
|
|
| PRK05850 |
PRK05850 |
acyl-CoA synthetase; Validated |
1500-1940 |
1.34e-12 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235624 [Multi-domain] Cd Length: 578 Bit Score: 73.82 E-value: 1.34e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFED------GV---MTYKELNEQANRIAWELIGRGVkPETTVAIIGKRSPEMLLGIYGILKAGGA 1570
Cdd:PRK05850 7 LRERASLQPDDAAFTFIDyeqdpaGVaetLTWSQLYRRTLNVAEELRRHGS-TGDRAVILAPQGLEYIVAFLGALQAGLI 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1571 YLPIDPDYP---EERISFLLEDSGTNILLLQSAglhvpeFTGEIV-YLNQTNSGLAHRL---------SNPNVDVLPQSL 1637
Cdd:PRK05850 86 AVPLSVPQGgahDERVSAVLRDTSPSVVLTTSA------VVDDVTeYVAPQPGQSAPPVievdlldldSPRGSDARPRDL 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1638 ---AYVIYTSGSTGMPKGVEIEHRSA-VNFLNSLQSRYQLKHSDMIMHKTSYSfdasiwelfWWP--------------- 1698
Cdd:PRK05850 160 pstAYLQYTSGSTRTPAGVMVSHRNViANFEQLMSDYFGDTGGVPPPDTTVVS---------WLPfyhdmglvlgvcapi 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1699 YAGASVYLL-PQGGEKEPE--VIAKAIEEQKITAmhfVPSMlhAF----------------LEHIKyrsvpiktnrlkRV 1759
Cdd:PRK05850 231 LGGCPAVLTsPVAFLQRPArwMQLLASNPHAFSA---APNF--AFelavrktsdddmagldLGGVL------------GI 293
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1760 FSGGEQLGTHLVSRF------YELLPNVsITNSYGPTEATV-----------EAAFFDcppHEKL-----ERIPIGKPVH 1817
Cdd:PRK05850 294 ISGSERVHPATLKRFadrfapFNLRETA-IRPSYGLAEATVyvatrepgqppESVRFD---YEKLsaghaKRCETGGGTP 369
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1818 HVRlYLLNQNQ----------RMLPVGCIGELYIAGAGVARGYLNRPALTEERF---LEDPF--YPGERMYKTGDVArWL 1882
Cdd:PRK05850 370 LVS-YGSPRSPtvrivdpdtcIECPAGTVGEIWVHGDNVAAGYWQKPEETERTFgatLVDPSpgTPEGPWLRTGDLG-FI 447
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*...
gi 1678550997 1883 PDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDSGEpELCAYVE 1940
Cdd:PRK05850 448 SEGELFIVGRIKDLLIVDGRNHYPDDIEATIQEITGGRVAAISVPDDGTE-KLVAIIE 504
|
|
| PRK07008 |
PRK07008 |
long-chain-fatty-acid--CoA ligase; Validated |
1521-1983 |
1.67e-12 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235908 [Multi-domain] Cd Length: 539 Bit Score: 73.20 E-value: 1.67e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1521 TYKELNEQANRIAWELIGRGVKPETTVAII---GKRSPEMLLGIYGIlkagGAYL-PIDPDYPEERISFLLEDSGTNILL 1596
Cdd:PRK07008 41 TYRDCERRAKQLAQALAALGVEPGDRVGTLawnGYRHLEAYYGVSGS----GAVChTINPRLFPEQIAYIVNHAEDRYVL 116
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1597 LQSAGL-----------------------HVPEFTGEIVYLNQTNSGLAHRLSNPNVDvlPQSLAYVIYTSGSTGMPKGV 1653
Cdd:PRK07008 117 FDLTFLplvdalapqcpnvkgwvamtdaaHLPAGSTPLLCYETLVGAQDGDYDWPRFD--ENQASSLCYTSGTTGNPKGA 194
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1654 EIEHRSAV--NFLNSLQSRYQLKHSDMIMHKTSYsFDASIWELfwwPYAGASV---YLLPqGGEKEPEVIAKAIEEQKIT 1728
Cdd:PRK07008 195 LYSHRSTVlhAYGAALPDAMGLSARDAVLPVVPM-FHVNAWGL---PYSAPLTgakLVLP-GPDLDGKSLYELIEAERVT 269
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1729 AMHFVPSMLHAFLEHIKYRSVPIKTnrLKRVFSGGEQLGTHLVSRFYELLpNVSITNSYGPTE-------ATVEAAFFDC 1801
Cdd:PRK07008 270 FSAGVPTVWLGLLNHMREAGLRFST--LRRTVIGGSACPPAMIRTFEDEY-GVEVIHAWGMTEmsplgtlCKLKWKHSQL 346
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1802 PPHEKLE-RIPIGKPVHHVRLYLLNQNQRMLPVG--CIGELYIAGAGVARGYLNRpaltEERFLEDPFYPgermykTGDV 1878
Cdd:PRK07008 347 PLDEQRKlLEKQGRVIYGVDMKIVGDDGRELPWDgkAFGDLQVRGPWVIDRYFRG----DASPLVDGWFP------TGDV 416
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1879 ARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAA---------------VTVRTDSGEpelcayvegLQ 1943
Cdd:PRK07008 417 ATIDADGFMQITDRSKDVIKSGGEWISSIDIENVAVAHPAVAEAAciacahpkwderpllVVVKRPGAE---------VT 487
|
490 500 510 520
....*....|....*....|....*....|....*....|
gi 1678550997 1944 RNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK07008 488 REELLAFYEGKVAKWWIPDDVVFVDAIPHTATGKLQKLKL 527
|
|
| A_NRPS_MycA_like |
cd05908 |
The adenylation domain of nonribosomal peptide synthetases (NRPS) similar to mycosubtilin ... |
600-954 |
1.70e-12 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS) similar to mycosubtilin synthase subunit A (MycA); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as (amino)-acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family includes NRPS similar to mycosubtilin synthase subunit A (MycA). Mycosubtilin, which is characterized by a beta-amino fatty acid moiety linked to the circular heptapeptide Asn-Tyr-Asn-Gln-Pro-Ser-Asn, belongs to the iturin family of lipopeptide antibiotics. The mycosubtilin synthase subunit A (MycA) combines functional domains derived from peptide synthetases, amino transferases, and fatty acid synthases. Nonribosomal peptide synthetases are large multifunction enzymes that synthesize many therapeutically useful peptides. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341234 [Multi-domain] Cd Length: 499 Bit Score: 73.29 E-value: 1.70e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 600 NADDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEYTHSGIDFEADVLQFATPSFDV----CYqeiFSALLKGGTLHIVP 675
Cdd:cd05908 104 LADELAFIQFSSGSTGDPKGVMLTHENLVHNMFAILNSTEWKTKDRILSWMPLTHDMgliaFH---LAPLIAGMNQYLMP 180
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 676 EA--IKRdvPQLFAF-INKHQTNIVFLPTAFIKMIFS--ERELANSFPDGVKHLIAAGEQLMISDL---FQDVLRKRGIH 747
Cdd:cd05908 181 TRlfIRR--PILWLKkASEHKATIVSSPNFGYKYFLKtlKPEKANDWDLSSIRMILNGAEPIDYELcheFLDHMSKYGLK 258
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 748 ---LHNHYGPSETHV----------VSTYTIH-----PGDPIPE----------LPPIGKPIGCTDLYILNHQKQLQPCG 799
Cdd:cd05908 259 rnaILPVYGLAEASVgaslpkaqspFKTITLGrrhvtHGEPEPEvdkkdsecltFVEVGKPIDETDIRICDEDNKILPDG 338
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 800 VPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLArRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLM 879
Cdd:cd05908 339 YIGHIQIRGKNVTPGYYNNPEATAKVFTDDGW------LKTGDLG-FIRNGRLVITGREKDIIFVNGQNVYPHDIERIAE 411
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 880 NHPDISE---AAILIWQDQNGEHELCAYYCSVQKLNT-IDLRSYMASELPEYmipAKW-----IWVDSIPLTPNGKVDRA 950
Cdd:cd05908 412 ELEGVELgrvVACGVNNSNTRNEEIFCFIEHRKSEDDfYPLGKKIKKHLNKR---GGWqinevLPIRRIPKTTSGKVKRY 488
|
....
gi 1678550997 951 ALPE 954
Cdd:cd05908 489 ELAQ 492
|
|
| PRK08633 |
PRK08633 |
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated |
458-948 |
2.51e-12 |
|
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated
Pssm-ID: 236315 [Multi-domain] Cd Length: 1146 Bit Score: 73.42 E-value: 2.51e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 458 QTPVYETIHAMFEKQAEKTPDAHAVIDQ-ACSLTYRELNKAANRLARHLRmKGVVRQEPVAIMMERSAAFITGVLGILKA 536
Cdd:PRK08633 610 RKEALPPLAEAWIDTAKRNWSRLAVADStGGELSYGKALTGALALARLLK-RELKDEENVGILLPPSVAGALANLALLLA 688
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 537 GgaIVPVDPHYPA--DRIRYILHDCGCSHVV-SQAHL---------PSSLEDNYIItHPEDIE---SKVDG--------- 592
Cdd:PRK08633 689 G--KVPVNLNYTAseAALKSAIEQAQIKTVItSRKFLeklknkgfdLELPENVKVI-YLEDLKakiSKVDKltallaarl 765
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 593 --------SNIKSVNNaDDLLYMIYTSGTTGKPKGVQFEHRN-MANllkfeythsgIDFEADVLQFAtpSFDVcyqeIFS 663
Cdd:PRK08633 766 lparllkrLYGPTFKP-DDTATIIFSSGSEGEPKGVMLSHHNiLSN----------IEQISDVFNLR--NDDV----ILS 828
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 664 AL-------LKGGTLHIVPEAIK-------RDVPQLFAFINKHQTNIVF-LPT---AFIKMIFSERELANSFpdgvkHLI 725
Cdd:PRK08633 829 SLpffhsfgLTVTLWLPLLEGIKvvyhpdpTDALGIAKLVAKHRATILLgTPTflrLYLRNKKLHPLMFASL-----RLV 903
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 726 AAG-EQLM--ISDLFQDvlrKRGIHLHNHYGPSETHVVST----------YTIHPGDpipELPPIGKPIGCTDLYILnHQ 792
Cdd:PRK08633 904 VAGaEKLKpeVADAFEE---KFGIRILEGYGATETSPVASvnlpdvlaadFKRQTGS---KEGSVGMPLPGVAVRIV-DP 976
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 793 KQLQPC--GVPGELYISGASVARGYVNHDKLTSdkfssdpfkpDVIM-------YRTGDLARRLEDGNIEYIGRADNQVK 863
Cdd:PRK08633 977 ETFEELppGEDGLILIGGPQVMKGYLGDPEKTA----------EVIKdidgigwYVTGDKGHLDEDGFLTITDRYSRFAK 1046
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 864 IRG-------------YRIEPQEIEVTLMNHPDiseaailiwqDQNGEHELCAYYCSVQKLNTIdLRSYMASELPEYMIP 930
Cdd:PRK08633 1047 IGGemvplgaveeelaKALGGEEVVFAVTAVPD----------EKKGEKLVVLHTCGAEDVEEL-KRAIKESGLPNLWKP 1115
|
570
....*....|....*...
gi 1678550997 931 AKWIWVDSIPLTPNGKVD 948
Cdd:PRK08633 1116 SRYFKVEALPLLGSGKLD 1133
|
|
| PRK05620 |
PRK05620 |
long-chain fatty-acid--CoA ligase; |
1632-1994 |
2.93e-12 |
|
long-chain fatty-acid--CoA ligase;
Pssm-ID: 180167 [Multi-domain] Cd Length: 576 Bit Score: 72.51 E-value: 2.93e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1632 VLPQSLAYVI-YTSGSTGMPKGVEIEHRSAvnFLNSLQSRyqLKHSDMIMHKTSYSFDASIWELFWW--PYAG--ASVYL 1706
Cdd:PRK05620 177 ELDETTAAAIcYSTGTTGAPKGVVYSHRSL--YLQSLSLR--TTDSLAVTHGESFLCCVPIYHVLSWgvPLAAfmSGTPL 252
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1707 LPQGGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHikYRSVPIKTNRLKRVFSGGEQLGTHLVsRFYELLPNVSITNS 1786
Cdd:PRK05620 253 VFPGPDLSAPTLAKIIATAMPRVAHGVPTLWIQLMVH--YLKNPPERMSLQEIYVGGSAVPPILI-KAWEERYGVDVVHV 329
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1787 YGPTEATveaaffdcpPHEKLERIPIGKPVHHVRLYLLNQ-------NQRMLPVGCI--------GELYIAGAGVARGYL 1851
Cdd:PRK05620 330 WGMTETS---------PVGTVARPPSGVSGEARWAYRVSQgrfpaslEYRIVNDGQVmestdrneGEIQVRGNWVTASYY 400
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1852 NRPALTE----------------ERFLEDPFypgermYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRS 1915
Cdd:PRK05620 401 HSPTEEGggaastfrgedvedanDRFTADGW------LRTGDVGSVTRDGFLTIHDRARDVIRSGGEWIYSAQLENYIMA 474
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1916 IEGVREAAVTVRTDS--GEPELCAYV--EGLQRN-----EVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRN----- 1981
Cdd:PRK05620 475 APEVVECAVIGYPDDkwGERPLAVTVlaPGIEPTretaeRLRDQLRDRLPNWMLPEYWTFVDEIDKTSVGKFDKKdlrqh 554
|
410 420
....*....|....*....|..
gi 1678550997 1982 ---------ALPAPGGAADAET 1994
Cdd:PRK05620 555 ladgdfeiiKLKGPGESGESDS 576
|
|
| entE |
PRK10946 |
(2,3-dihydroxybenzoyl)adenylate synthase; |
2845-3019 |
3.30e-12 |
|
(2,3-dihydroxybenzoyl)adenylate synthase;
Pssm-ID: 236803 [Multi-domain] Cd Length: 536 Bit Score: 72.33 E-value: 3.30e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2845 GQPI-DGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMADGTLEYLG 2923
Cdd:PRK10946 356 GRPMsPDDEVWVADADGNPLPQGEVGRLMTRGPYTFRGYYKSPQHNASAFDANGF------YCSGDLVSIDPDGYITVVG 429
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2924 RIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAhVTASGQTELS-AYVVTKPGLSTNAVRSELQN------KLpvfmh 2996
Cdd:PRK10946 430 REKDQINRGGEKIAAEEIENLLLRHPAVIHAALVS-MEDELMGEKScAFLVVKEPLKAVQLRRFLREqgiaefKL----- 503
|
170 180
....*....|....*....|...
gi 1678550997 2997 PAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK10946 504 PDRVECVDSLPLTAVGKVDKKQL 526
|
|
| PRK06018 |
PRK06018 |
putative acyl-CoA synthetase; Provisional |
490-954 |
4.99e-12 |
|
putative acyl-CoA synthetase; Provisional
Pssm-ID: 235673 [Multi-domain] Cd Length: 542 Bit Score: 71.71 E-value: 4.99e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 490 TYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVS--- 566
Cdd:PRK06018 41 TYAQIHDRALKVSQALDRDGIKLGDRVATIAWNTWRHLEAWYGIMGIGAICHTVNPRLFPEQIAWIINHAEDRVVITdlt 120
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 567 -----------------------QAHLPSSLEDNYIIThpEDIESKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFE 623
Cdd:PRK06018 121 fvpilekiadklpsveryvvltdAAHMPQTTLKNAVAY--EEWIAEADGDFAWKTFDENTAAGMCYTSGTTGDPKGVLYS 198
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 624 HRnmANLLkfeytHSGIDFEADVLqfATPSFDVCYQEI-----------FSALLKGGTLhIVPEAiKRDVPQLFAFINKH 692
Cdd:PRK06018 199 HR--SNVL-----HALMANNGDAL--GTSAADTMLPVVplfhanswgiaFSAPSMGTKL-VMPGA-KLDGASVYELLDTE 267
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 693 Q-TNIVFLPTAFIKMIFSERELANSFPDGVKHLI--AAGEQLMISdLFQDVlrkrGIHLHNHYGPSETHVVSTYTIHPGd 769
Cdd:PRK06018 268 KvTFTAGVPTVWLMLLQYMEKEGLKLPHLKMVVCggSAMPRSMIK-AFEDM----GVEVRHAWGMTEMSPLGTLAALKP- 341
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 770 PIPELPPIGKPigctdlyilnHQKQLQ---PCGV------------------PGELYISGASVARGYVnhdKLTSDKFSS 828
Cdd:PRK06018 342 PFSKLPGDARL----------DVLQKQgypPFGVemkitddagkelpwdgktFGRLKVRGPAVAAAYY---RVDGEILDD 408
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 829 DPFkpdvimYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAI-------------LIWQDQ 895
Cdd:PRK06018 409 DGF------FDTGDVATIDAYGYMRITDRSKDVIKSGGEWISSIDLENLAVGHPKVAEAAVigvyhpkwderplLIVQLK 482
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 896 NGEhelcayycSVQKLNTIDlrsYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPE 954
Cdd:PRK06018 483 PGE--------TATREEILK---YMDGKIAKWWMPDDVAFVDAIPHTATGKILKTALRE 530
|
|
| PLN02479 |
PLN02479 |
acetate-CoA ligase |
609-952 |
6.46e-12 |
|
acetate-CoA ligase
Pssm-ID: 178097 [Multi-domain] Cd Length: 567 Bit Score: 71.41 E-value: 6.46e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 609 YTSGTTGKPKGVQFEHRN-----MANLLKFEYThsgidfEADVLQFATPSFDV---CYQEIFSALLkgGT----LHIVPE 676
Cdd:PLN02479 202 YTSGTTASPKGVVLHHRGaylmaLSNALIWGMN------EGAVYLWTLPMFHCngwCFTWTLAALC--GTniclRQVTAK 273
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 677 AIKRdvpqlfAFINKHQTNIVFLPTAFIKMIFSER-ELANSFPDGVkHLIAAGEQLMISDLFQdvLRKRGIHLHNHYGPS 755
Cdd:PLN02479 274 AIYS------AIANYGVTHFCAAPVVLNTIVNAPKsETILPLPRVV-HVMTAGAAPPPSVLFA--MSEKGFRVTHTYGLS 344
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 756 ETHVVSTYTIHPgdpiPE---LPPIGKP----------IGCTDLYILNhQKQLQPcgVP------GELYISGASVARGYV 816
Cdd:PLN02479 345 ETYGPSTVCAWK----PEwdsLPPEEQArlnarqgvryIGLEGLDVVD-TKTMKP--VPadgktmGEIVMRGNMVMKGYL 417
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 817 NHDKLTSDKFSSDpfkpdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQN 896
Cdd:PLN02479 418 KNPKANEEAFANG-------WFHSGDLGVKHPDGYIEIKDRSKDIIISGGENISSLEVENVVYTHPAVLEASVVARPDER 490
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 897 GEHELCAYYC-------SVQKLNTIDLRSYMASELPEYMIPaKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PLN02479 491 WGESPCAFVTlkpgvdkSDEAALAEDIMKFCRERLPAYWVP-KSVVFGPLPKTATGKIQKHVL 552
|
|
| C_PKS-NRPS |
cd20483 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
3128-3449 |
6.65e-12 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHXXXD motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380471 [Multi-domain] Cd Length: 430 Bit Score: 70.75 E-value: 6.65e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3128 WFLSQDIKEKHHFNQSVMLHRSTSVQEDALRKTLKAITCHHDALRMVFTQN----EQgkwdqynRPLshsDDALYGLQMI 3203
Cdd:cd20483 12 WFLHNFLEDKTFLNLLLVCHIKGKPDVNLLQKALSELVRRHEVLRTAYFEGddfgEQ-------QVL---DDPSFHLIVI 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3204 DLS-APDgtdgnrpYEPLIKRHVLDIQQK-MDLKNGPLLQAGLFHTIDGDF-LFLSAHHLVVDGISWRVLLEDLALGYRQ 3280
Cdd:cd20483 82 DLSeAAD-------PEAALDQLVRNLRRQeLDIEEGEVIRGWLVKLPDEEFaLVLASHHIAWDRGSSKSIFEQFTALYDA 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3281 -AAGGEDIKLPPKTSSFKAYAKKLSDYAESQQLMKQLKYWREAEEYQTEA---LPFDQIDGTRAHEGQRSTISFTLnDKE 3356
Cdd:cd20483 155 lRAGRDLATVPPPPVQYIDFTLWHNALLQSPLVQPLLDFWKEKLEGIPDAsklLPFAKAERPPVKDYERSTVEATL-DKE 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3357 TAALLKDANSAYNTdTQDMLLASVILALRH-WTnqsafklsleghGREDVLKGI--------DVSRTIGWFTAIYPLLIK 3427
Cdd:cd20483 234 LLARMKRICAQHAV-TPFMFLLAAFRAFLYrYT------------EDEDLTIGMvdgdrphpDFDDLVGFFVNMLPIRCR 300
|
330 340
....*....|....*....|..
gi 1678550997 3428 LnadlpDSEESMVHVLKTTKDT 3449
Cdd:cd20483 301 M-----DCDMSFDDLLESTKTT 317
|
|
| PRK07768 |
PRK07768 |
long-chain-fatty-acid--CoA ligase; Validated |
2543-3018 |
7.82e-12 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236091 [Multi-domain] Cd Length: 545 Bit Score: 71.18 E-value: 7.82e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2543 AARTPKAsaLVSGD----KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYP 2618
Cdd:PRK07768 12 ARTSPRG--MVTGEpdapVRHTWGEVHERARRIAGGLAAAGVGPGDAVAVLAGAPVEIAPTAQGLWMRGASLTMLHQPTP 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2619 KERKRYILSDSGTKLLMTinEADLGVLAD-FE----------GEILTI-ESVEEDDKSPLPQMSSAhhLAYIIYTSGTTG 2686
Cdd:PRK07768 90 RTDLAVWAEDTLRVIGMI--GAKAVVVGEpFLaaapvleekgIRVLTVaDLLAADPIDPVETGEDD--LALMQLTSGSTG 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2687 RPKGVMVEHKGIANTLQWRRNAYAFN-ETDTILQLFSFSFD----GFITsmfTPLLSGAKAVLLHEEE-AKDILAIKHQL 2760
Cdd:PRK07768 166 SPKAVQITHGNLYANAEAMFVAAEFDvETDVMVSWLPLFHDmgmvGFLT---VPMYFGAELVKVTPMDfLRDPLLWAELI 242
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2761 SRQRIThMIIVP-----VLYRALLDVVQPE--DVKTLRVVTLAGEAADRELIARSLAI-----CPHTELANEYGPTENSV 2828
Cdd:PRK07768 243 SKYRGT-MTAAPnfayaLLARRLRRQAKPGafDLSSLRFALNGAEPIDPADVEDLLDAgarfgLRPEAILPAYGMAEATL 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2829 ATTVMR-------------------------HMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGTGLARGYV 2883
Cdd:PRK07768 322 AVSFSPcgaglvvdevdadllaalrravpatKGNTRRLATLGPPLPGLEVRVVDEDGQVLPPRGVGVIELRGESVTPGYL 401
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2884 nlpelterafTQNPFKPearmyrTGDAARWMADGTLEYL---------GRIDDQVKIRGYRVETKEIESVIRCIKGVKDA 2954
Cdd:PRK07768 402 ----------TMDGFIP------AQDADGWLDTGDLGYLteegevvvcGRVKDVIIMAGRNIYPTDIERAAARVEGVRPG 465
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 2955 AVVA-HVTASGQTELSAYVVTKPGLS------------TNAVRSElqnklpVFMHPAFIEKLD--SLPLSPNGKLDRGA 3018
Cdd:PRK07768 466 NAVAvRLDAGHSREGFAVAVESNAFEdpaevrrirhqvAHEVVAE------VGVRPRNVVVLGpgSIPKTPSGKLRRAN 538
|
|
| LC_FACS_euk1 |
cd17639 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The ... |
489-863 |
9.12e-12 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The members of this family are eukaryotic fatty acid CoA synthetases (EC 6.2.1.3) that activate fatty acids with chain lengths of 12 to 20 and includes fungal proteins. They act on a wide range of long-chain saturated and unsaturated fatty acids, but the enzymes from different tissues show some variation in specificity. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. In Schizosaccharomyces pombe, lcf1 gene encodes a new fatty acyl-CoA synthetase that preferentially recognizes myristic acid as a substrate.
Pssm-ID: 341294 [Multi-domain] Cd Length: 507 Bit Score: 70.71 E-value: 9.12e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 489 LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHvvsqa 568
Cdd:cd17639 6 MSYAEVWERVLNFGRGLVELGLKPGDKVAIFAETRAEWLITALGCWSQNIPIVTVYATLGEDALIHSLNETECSA----- 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 569 hlpsslednyIIThpedieskvdgsniksVNNADDLLYMIYTSGTTGKPKGVQFEHRNMAnllkfeythSGI-DFEADVL 647
Cdd:cd17639 81 ----------IFT----------------DGKPDDLACIMYTSGSTGNPKGVMLTHGNLV---------AGIaGLGDRVP 125
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 648 QFATPS------------FDVCYQEIFsaLLKGG--------TLHivpEAIKRD---------------VPQLFAFINKH 692
Cdd:cd17639 126 ELLGPDdrylaylplahiFELAAENVC--LYRGGtigygsprTLT---DKSKRGckgdltefkptlmvgVPAIWDTIRKG 200
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 693 QTNIVFLPTAFIKMIFS---ERELANsfpdgVKHL-------------------------------IAAGEQLMISDLFQ 738
Cdd:cd17639 201 VLAKLNPMGGLKRTLFWtayQSKLKA-----LKEGpgtplldelvfkkvraalggrlrymlsggapLSADTQEFLNIVLC 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 739 DVLrkrgihlhNHYGPSETHVVSTYTiHPGDPIPELppIGKPIGCTDLYILN-----HQKQLQPCgvPGELYISGASVAR 813
Cdd:cd17639 276 PVI--------QGYGLTETCAGGTVQ-DPGDLETGR--VGPPLPCCEIKLVDweeggYSTDKPPP--RGEILIRGPNVFK 342
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|
gi 1678550997 814 GYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQVK 863
Cdd:cd17639 343 GYYKNPEKTKEAFDGDGW------FHTGDIGEFHPDGTLKIIDRKKDLVK 386
|
|
| AcpP |
COG0236 |
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the ... |
966-1040 |
1.23e-11 |
|
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the Pathway/BioSystem: Fatty acid biosynthesis
Pssm-ID: 440006 [Multi-domain] Cd Length: 80 Bit Score: 62.95 E-value: 1.23e-11
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1678550997 966 APRNLLEAKLSQLFEDVLK--NGHIGIQDNFFDN-GGHSLKATVLMSRIAKEFHVQVSLKDIFAHPTVEGLALIIREA 1040
Cdd:COG0236 1 MPREELEERLAEIIAEVLGvdPEEITPDDSFFEDlGLDSLDAVELIAALEEEFGIELPDTELFEYPTVADLADYLEEK 78
|
|
| PRK07445 |
PRK07445 |
O-succinylbenzoic acid--CoA ligase; Reviewed |
2771-3021 |
1.25e-11 |
|
O-succinylbenzoic acid--CoA ligase; Reviewed
Pssm-ID: 236019 [Multi-domain] Cd Length: 452 Bit Score: 70.02 E-value: 1.25e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2771 VPVLYRALLDVVqPEDVKTLRVVTLAGEAADRELI--ARSLAICphteLANEYGPTENS--VATtvmrhMEKQAYV---- 2842
Cdd:PRK07445 214 VPTQLQRLLQLR-PQWLAQFRTILLGGAPAWPSLLeqARQLQLR----LAPTYGMTETAsqIAT-----LKPDDFLagnn 283
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2843 SIGQPIDGTQVLILNSNhqlqpigvAGELCIAGTGLARGYVnlPelteraftqnPFKPEARMYRTGDAARWMADGTLEYL 2922
Cdd:PRK07445 284 SSGQVLPHAQITIPANQ--------TGNITIQAQSLALGYY--P----------QILDSQGIFETDDLGYLDAQGYLHIL 343
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2923 GRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTAS-GQTELSAYVVTKPGLSTNAVRSELQNKLPVFMHPAFIE 3001
Cdd:PRK07445 344 GRNSQKIITGGENVYPAEVEAAILATGLVQDVCVLGLPDPHwGEVVTAIYVPKDPSISLEELKTAIKDQLSPFKQPKHWI 423
|
250 260
....*....|....*....|
gi 1678550997 3002 KLDSLPLSPNGKLDRGALPK 3021
Cdd:PRK07445 424 PVPQLPRNPQGKINRQQLQQ 443
|
|
| PLN02654 |
PLN02654 |
acetate-CoA ligase |
2677-3021 |
1.38e-11 |
|
acetate-CoA ligase
Pssm-ID: 215353 [Multi-domain] Cd Length: 666 Bit Score: 70.70 E-value: 1.38e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2677 YIIYTSGTTGRPKGVMVEHKG----IANTLQwrrnaYAFNETDTilQLFSFSFD-GFITS----MFTPLLSGAkAVLLHE 2747
Cdd:PLN02654 279 FLLYTSGSTGKPKGVLHTTGGymvyTATTFK-----YAFDYKPT--DVYWCTADcGWITGhsyvTYGPMLNGA-TVLVFE 350
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2748 EEAK--------DILaikhqlSRQRITHMIIVPVLYRALL----DVVQPEDVKTLRVVTLAGE----AADR---ELIARS 2808
Cdd:PLN02654 351 GAPNypdsgrcwDIV------DKYKVTIFYTAPTLVRSLMrdgdEYVTRHSRKSLRVLGSVGEpinpSAWRwffNVVGDS 424
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2809 LaiCPhteLANEYGPTENS-VATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGELCIAGT--GLARGYVNL 2885
Cdd:PLN02654 425 R--CP---ISDTWWQTETGgFMITPLPGAWPQKPGSATFPFFGVQPVIVDEKGKEIEGECSGYLCVKKSwpGAFRTLYGD 499
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2886 PELTERAFtqnpFKPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVA---HVTA 2962
Cdd:PLN02654 500 HERYETTY----FKPFAGYYFSGDGCSRDKDGYYWLTGRVDDVINVSGHRIGTAEVESALVSHPQCAEAAVVGiehEVKG 575
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 2963 SGqteLSAYVVTKPGLS-TNAVRSEL----QNKLPVFMHPAFIEKLDSLPLSPNGKLDRGALPK 3021
Cdd:PLN02654 576 QG---IYAFVTLVEGVPySEELRKSLiltvRNQIGAFAAPDKIHWAPGLPKTRSGKIMRRILRK 636
|
|
| LC_FACS_bac |
cd05932 |
Bacterial long-chain fatty acid CoA synthetase (LC-FACS), including Marinobacter ... |
1521-1983 |
1.47e-11 |
|
Bacterial long-chain fatty acid CoA synthetase (LC-FACS), including Marinobacter hydrocarbonoclasticus isoprenoid Coenzyme A synthetase; The members of this family are bacterial long-chain fatty acid CoA synthetase. Marinobacter hydrocarbonoclasticus isoprenoid Coenzyme A synthetase in this family is involved in the synthesis of isoprenoid wax ester storage compounds when grown on phytol as the sole carbon source. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341255 [Multi-domain] Cd Length: 508 Bit Score: 70.19 E-value: 1.47e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1521 TYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLL--- 1597
Cdd:cd05932 8 TWGEVADKARRLAAALRALGLEPGSKIALISKNCAEWFITDLAIWMAGHISVPLYPTLNPDTIRYVLEHSESKALFVgkl 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1598 -----QSAGlhVPEftGEIVYLNQTNSGL-AHR-------LSNPNVDVL---PQSLAYVIYTSGSTGMPKGVEIEHRSAV 1661
Cdd:cd05932 88 ddwkaMAPG--VPE--GLISISLPPPSAAnCQYqwddliaQHPPLEERPtrfPEQLATLIYTSGTTGQPKGVMLTFGSFA 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1662 NFLNSLQSRYQLKHSDMIMhktSYSFDASIWELFW----WPYAGASVYLlpqggekePEVIAKAIEEQKI---TAMHFVP 1734
Cdd:cd05932 164 WAAQAGIEHIGTEENDRML---SYLPLAHVTERVFveggSLYGGVLVAF--------AESLDTFVEDVQRarpTLFFSVP 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1735 SMLHAFLEHIKYRSVPIKTNRL-----------KRVF------------SGGEQLGTHLVSRFYELlpNVSITNSYGPTE 1791
Cdd:cd05932 233 RLWTKFQQGVQDKIPQQKLNLLlkipvvnslvkRKVLkglgldqcrlagCGSAPVPPALLEWYRSL--GLNILEAYGMTE 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1792 ATVEAAFfdCPPHEKLERIpIGKPVHHVRLYLLNQnqrmlpvgciGELYIAGAGVARGYLNRPALTEERFLEDPFYpger 1871
Cdd:cd05932 311 NFAYSHL--NYPGRDKIGT-VGNAGPGVEVRISED----------GEILVRSPALMMGYYKDPEATAEAFTADGFL---- 373
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1872 myKTGDVARWLPDGNVEFLGRTDDQVKI-RGYRIEPGEIEAALRSIEGVrEAAVTVRTDSGEP-ELCAYVEGLQ------ 1943
Cdd:cd05932 374 --RTGDKGELDADGNLTITGRVKDIFKTsKGKYVAPAPIENKLAEHDRV-EMVCVIGSGLPAPlALVVLSEEARlradaf 450
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 1944 -RNEVRAQLERLL--------PGYMVPAYMIEMEQWPV-----TPSGKLDRNAL 1983
Cdd:cd05932 451 aRAELEASLRAHLarvnstldSHEQLAGIVVVKDPWSIdngilTPTLKIKRNVL 504
|
|
| PRK00174 |
PRK00174 |
acetyl-CoA synthetase; Provisional |
2556-2989 |
1.59e-11 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 234677 [Multi-domain] Cd Length: 637 Bit Score: 70.55 E-value: 1.59e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2556 DKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMhrsfSMI--ASI--LGVWKAG--------GcyvpIDPEYPKERkr 2623
Cdd:PRK00174 96 SRKITYRELHREVCRFANALKSLGVKKGDRVAIYM----PMIpeAAVamLACARIGavhsvvfgG----FSAEALADR-- 165
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2624 yiLSDSGTKLLMTineADLGV---------------LADFEgeilTIESV-------------------------EEDDK 2663
Cdd:PRK00174 166 --IIDAGAKLVIT---ADEGVrggkpiplkanvdeaLANCP----SVEKVivvrrtggdvdwvegrdlwwhelvaGASDE 236
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2664 SPlPQMSSAHHLAYIIYTSGTTGRPKGVMveHK------GIANTLQWrrnAYAFNETDTilqlFSFSFD-GFIT----SM 2732
Cdd:PRK00174 237 CE-PEPMDAEDPLFILYTSGSTGKPKGVL--HTtggylvYAAMTMKY---VFDYKDGDV----YWCTADvGWVTghsyIV 306
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2733 FTPLLSGAKaVLLHE------EEAK--DILAiKHQlsrqrithmiiVPVLY------RALL----DVVQPEDVKTLRVVT 2794
Cdd:PRK00174 307 YGPLANGAT-TLMFEgvpnypDPGRfwEVID-KHK-----------VTIFYtaptaiRALMkegdEHPKKYDLSSLRLLG 373
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2795 LAGEAAD-------RELIARSLaiCP------HTELaneyG-----PTENSVATtvmrhmeKQAyvSIGQPIDGTQVLIL 2856
Cdd:PRK00174 374 SVGEPINpeawewyYKVVGGER--CPivdtwwQTET----GgimitPLPGATPL-------KPG--SATRPLPGIQPAVV 438
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2857 NSNHQLQPIGVAGELCIAGT--GLARGYVNLPElteRaFTQNPFKPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGY 2934
Cdd:PRK00174 439 DEEGNPLEGGEGGNLVIKDPwpGMMRTIYGDHE---R-FVKTYFSTFKGMYFTGDGARRDEDGYYWITGRVDDVLNVSGH 514
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*...
gi 1678550997 2935 RVETKEIESVIRCIKGVKDAAVV--AHVTaSGQtELSAYVVTKPGLSTN-AVRSELQN 2989
Cdd:PRK00174 515 RLGTAEIESALVAHPKVAEAAVVgrPDDI-KGQ-GIYAFVTLKGGEEPSdELRKELRN 570
|
|
| PLN02860 |
PLN02860 |
o-succinylbenzoate-CoA ligase |
602-949 |
1.84e-11 |
|
o-succinylbenzoate-CoA ligase
Pssm-ID: 215464 [Multi-domain] Cd Length: 563 Bit Score: 70.21 E-value: 1.84e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 602 DDLLYMIYTSGTTGKPKGVQFEHRNMA--NLLKFEYTHSGidfEADVLQFATPsfdVCYQEIFS---ALLKGGTLHI-VP 675
Cdd:PLN02860 172 DDAVLICFTSGTTGRPKGVTISHSALIvqSLAKIAIVGYG---EDDVYLHTAP---LCHIGGLSsalAMLMVGACHVlLP 245
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 676 eaiKRDVPQLFAFINKHQ-TNIVFLPTAFIKMIFSERELAN--SFPdGVKHLIAAGEQLMiSDLFQDVL----RKRgihL 748
Cdd:PLN02860 246 ---KFDAKAALQAIKQHNvTSMITVPAMMADLISLTRKSMTwkVFP-SVRKILNGGGSLS-SRLLPDAKklfpNAK---L 317
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 749 HNHYGPSETHVVSTY-TIHpgDPIPELPPIGKPIGCTDLYILNHQKQLQPCGVP----------------GELYISGASV 811
Cdd:PLN02860 318 FSAYGMTEACSSLTFmTLH--DPTLESPKQTLQTVNQTKSSSVHQPQGVCVGKPaphvelkigldessrvGRILTRGPHV 395
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 812 ARGYVNHDKLTSDKFSSDpfkpdvIMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAIL- 890
Cdd:PLN02860 396 MLGYWGQNSETASVLSND------GWLDTGDIGWIDKAGNLWLIGRSNDRIKTGGENVYPEEVEAVLSQHPGVASVVVVg 469
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 891 --------------------IWQDQNGEHelcayYCSVQKLNTIDLRSYMASE-LPEYMIPAKWI-WVDSIPLTPNGKVD 948
Cdd:PLN02860 470 vpdsrltemvvacvrlrdgwIWSDNEKEN-----AKKNLTLSSETLRHHCREKnLSRFKIPKLFVqWRKPFPLTTTGKIR 544
|
.
gi 1678550997 949 R 949
Cdd:PLN02860 545 R 545
|
|
| PRK13388 |
PRK13388 |
acyl-CoA synthetase; Provisional |
1492-1996 |
2.13e-11 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237374 [Multi-domain] Cd Length: 540 Bit Score: 69.67 E-value: 2.13e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1492 MNQTLHYALEQQAEKtpDQAAVIFEDGVMTYKELNEQANRIAWELIG--RGVKPeTTVAIIGKRSPEMLLGIYGILKAG- 1568
Cdd:PRK13388 1 MRDTIAQLLRDRAGD--DTIAVRYGDRTWTWREVLAEAAARAAALIAlaDPDRP-LHVGVLLGNTPEMLFWLAAAALGGy 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1569 ----------GAYLPIDPDYPEERIsfLLEDSGTNILLlqsAGLHVPEFTGEIV----YLNQTNsglAHRLSNPNVDVLP 1634
Cdd:PRK13388 78 vlvglnttrrGAALAADIRRADCQL--LVTDAEHRPLL---DGLDLPGVRVLDVdtpaYAELVA---AAGALTPHREVDA 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1635 QSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSD-----MIMhktsysFDASIWELFWWPY--AGASVYLL 1707
Cdd:PRK13388 150 MDPFMLIFTSGTTGAPKAVRCSHGRLAFAGRALTERFGLTRDDvcyvsMPL------FHSNAVMAGWAPAvaSGAAVALP 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1708 PqggekepeviakaieeqKITAMHFVPSMLHAFLEHIKYRSVPI------------KTNRLKRVF--SGGEQLGTHLVSR 1773
Cdd:PRK13388 224 A-----------------KFSASGFLDDVRRYGATYFNYVGKPLayilatperpddADNPLRVAFgnEASPRDIAEFSRR 286
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1774 FyellpNVSITNSYGPTE-ATVEAAFFDCPPHEkleripIGKPVHHVRLY-----------LLNQNQRML-PVGCIGELY 1840
Cdd:PRK13388 287 F-----GCQVEDGYGSSEgAVIVVREPGTPPGS------IGRGAPGVAIYnpetltecavaRFDAHGALLnADEAIGELV 355
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1841 -IAGAGVARGYLNRPALTEERFledpfypgeR--MYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIE 1917
Cdd:PRK13388 356 nTAGAGFFEGYYNNPEATAERM---------RhgMYWSGDLAYRDADGWIYFAGRTADWMRVDGENLSAAPIERILLRHP 426
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1918 GVREAAVTVRTD--SGEPELCAYV----EGLQRNEVRAQL--ERLLPGYMVPAYMIEMEQWPVTPSGKLDRNALPAPGGA 1989
Cdd:PRK13388 427 AINRVAVYAVPDerVGDQVMAALVlrdgATFDPDAFAAFLaaQPDLGTKAWPRYVRIAADLPSTATNKVLKRELIAQGWA 506
|
....*..
gi 1678550997 1990 ADAETYT 1996
Cdd:PRK13388 507 TGDPVTL 513
|
|
| PLN03102 |
PLN03102 |
acyl-activating enzyme; Provisional |
2647-3019 |
2.23e-11 |
|
acyl-activating enzyme; Provisional
Pssm-ID: 215576 [Multi-domain] Cd Length: 579 Bit Score: 69.66 E-value: 2.23e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2647 DFEGEILTIEsveeddksPLPQMSSA-------HHLAYIIYTSGTTGRPKGVMVEHKG-----IANTLQWRRNAYAFnet 2714
Cdd:PLN03102 161 DYECLIQRGE--------PTPSLVARmfriqdeHDPISLNYTSGTTADPKGVVISHRGaylstLSAIIGWEMGTCPV--- 229
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2715 dTILQLFSFSFDGFITSMFTPLLSGAKAVLLHEEEAKdilaIKHQLSRQRITHMIIVPVLYRALLD---VVQPEDVKTLR 2791
Cdd:PLN03102 230 -YLWTLPMFHCNGWTFTWGTAARGGTSVCMRHVTAPE----IYKNIEMHNVTHMCCVPTVFNILLKgnsLDLSPRSGPVH 304
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2792 VVTlAGEAADRELIARSLAICPHteLANEYGPTEnsvATTVMRHMEKQayvSIGQPIDGTQVLILNSNHQLQPIGVA--- 2868
Cdd:PLN03102 305 VLT-GGSPPPAALVKKVQRLGFQ--VMHAYGLTE---ATGPVLFCEWQ---DEWNRLPENQQMELKARQGVSILGLAdvd 375
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2869 -----------------GELCIAGTGLARGYVNLPELTERAFTQNpfkpearMYRTGDAARWMADGTLEYLGRIDDQVKI 2931
Cdd:PLN03102 376 vknketqesvprdgktmGEIVIKGSSIMKGYLKNPKATSEAFKHG-------WLNTGDVGVIHPDGHVEIKDRSKDIIIS 448
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2932 RGYRVETKEIESVIRCIKGVKDAAVVA--HVTAsGQTElSAYVVTKPGLSTNAVRSEL------------QNKLPVFMHP 2997
Cdd:PLN03102 449 GGENISSVEVENVLYKYPKVLETAVVAmpHPTW-GETP-CAFVVLEKGETTKEDRVDKlvtrerdlieycRENLPHFMCP 526
|
410 420
....*....|....*....|..
gi 1678550997 2998 AFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PLN03102 527 RKVVFLQELPKNGNGKILKPKL 548
|
|
| PTZ00237 |
PTZ00237 |
acetyl-CoA synthetase; Provisional |
2655-2945 |
3.32e-11 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 240325 [Multi-domain] Cd Length: 647 Bit Score: 69.39 E-value: 3.32e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2655 IESVEEDDKSP----LPQMSSahHLAYIIYTSGTTGRPKGVmVEHKGiANTLQWRRNAYAFNETDTILQLFSFSFDGFIT 2730
Cdd:PTZ00237 234 IKKIKENNQSPfyeyVPVESS--HPLYILYTSGTTGNSKAV-VRSNG-PHLVGLKYYWRSIIEKDIPTVVFSHSSIGWVS 309
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2731 --SMFTPLLSGAKAVLLHEeeaKDILAIKHQ-------LSRQRITHMIIVPVLYRALLDvVQPE--------DVKTLRVV 2793
Cdd:PTZ00237 310 fhGFLYGSLSLGNTFVMFE---GGIIKNKHIeddlwntIEKHKVTHTLTLPKTIRYLIK-TDPEatiirskyDLSNLKEI 385
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2794 TLAGEAADR---ELIARSLAICPhtelANEYGPTENSVATTVMRHMEKQAYVSIGQPIDGTQVLILNSNHQLQPIGVAGE 2870
Cdd:PTZ00237 386 WCGGEVIEEsipEYIENKLKIKS----SRGYGQTEIGITYLYCYGHINIPYNATGVPSIFIKPSILSEDGKELNVNEIGE 461
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1678550997 2871 LCIA---GTGLARGYVNLPELTERAFTQNPfkpeaRMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVI 2945
Cdd:PTZ00237 462 VAFKlpmPPSFATTFYKNDEKFKQLFSKFP-----GYYNSGDLGFKDENGYYTIVSRSDDQIKISGNKVQLNTIETSI 534
|
|
| beta-lac_NRPS |
cd19547 |
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis ... |
3139-3566 |
3.69e-11 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis NocB which exhibits an unusual cyclization to form beta-lactam rings in pro-nocardicin G synthesis; Nocardia uniformis NRPS NocB acts centrally in the biosynthesis of the nocardicin monocyclic beta-lactam antibiotics. Along with another NRPS NocA, it mediates an unusual cyclization to form beta-lactam rings in the synthesis of the beta-lactam-containing pentapeptide pro-nocardicin G. This small subfamily is related to DCL-type Condensation (C) domains, which catalyze condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; domains belonging to this subfamily have an HHHxxxD motif at the active site.
Pssm-ID: 380469 [Multi-domain] Cd Length: 422 Bit Score: 68.49 E-value: 3.69e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3139 HFNQSVmLHRSTSVQEDALRKTLKAITCHHDALRMVFTQNEQGKWDQYNRplshsDDALYGLQMIDLSapdGTDGNRPYE 3218
Cdd:cd19547 24 YFNQNV-LELVGGTDEDVLREAWRRVADRYEILRTGFTWRDRAEPLQYVR-----DDLAPPWALLDWS---GEDPDRRAE 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3219 PLIKRHVLDIQQKMDLKNGPLLQAGLFHTIDG-DFLFLSAHHLVVDGISWRVLLEDLALGYRQAAGGEDIKLPPkTSSFK 3297
Cdd:cd19547 95 LLERLLADDRAAGLSLADCPLYRLTLVRLGGGrHYLLWSHHHILLDGWCLSLIWGDVFRVYEELAHGREPQLSP-CRPYR 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3298 AYAKKLSdyAESQQLMKQLKYWREAEEYQTEAlPFDQIDGTRahEGQRSTISFTLNDKETaALLKDANSAYNTDTQDMLL 3377
Cdd:cd19547 174 DYVRWIR--ARTAQSEESERFWREYLRDLTPS-PFSTAPADR--EGEFDTVVHEFPEQLT-RLVNEAARGYGVTTNAISQ 247
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3378 A--SVILALRHWTNQSAFKLSLEghGREDVLKGIDVsrTIGWFTAIYPLLIKLnadlpDSEESMVHVLKTTKDTLRRVPD 3455
Cdd:cd19547 248 AawSMLLALQTGARDVVHGLTIA--GRPPELEGSEH--MVGIFINTIPLRIRL-----DPDQTVTGLLETIHRDLATTAA 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3456 KGFgygvikyltPPGKKDINFTGAPEIS----FNYLGQFESGRTAEVPEEDaFSFSPLgaggDISTTWNREQSLDISAIA 3531
Cdd:cd19547 319 HGH---------VPLAQIKSWASGERLSggrvFDNLVAFENYPEDNLPGDD-LSIQII----DLHAQEKTEYPIGLIVLP 384
|
410 420 430
....*....|....*....|....*....|....*
gi 1678550997 3532 AEgKLTVNMTYDNARFQRKTIEQLSETCRQFLLQL 3566
Cdd:cd19547 385 LQ-KLAFHFNYDTTHFTRAQVDRFIEVFRLLTEQL 418
|
|
| PP-binding |
pfam00550 |
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached ... |
2005-2062 |
3.91e-11 |
|
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached through a serine. This prosthetic group acts as a a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups. This domain forms a four helix bundle. This family includes members not included in Prosite. The inclusion of these members is supported by sequence analysis and functional evidence. The related domain of Swiss:P19828 has the attachment serine replaced by an alanine.
Pssm-ID: 425746 [Multi-domain] Cd Length: 62 Bit Score: 60.65 E-value: 3.91e-11
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2005 KLSQLWEDVLK--NGPVGIHDNFFDRGGHSLKATALVSRITKEFDVQVPLKDVFAHPTVE 2062
Cdd:pfam00550 2 RLRELLAEVLGvpAEEIDPDTDLFDLGLDSLLAVELIARLEEEFGVEIPPSDLFEHPTLA 61
|
|
| PRK00174 |
PRK00174 |
acetyl-CoA synthetase; Provisional |
489-949 |
4.17e-11 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 234677 [Multi-domain] Cd Length: 637 Bit Score: 69.01 E-value: 4.17e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 489 LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSaafITGVLGILKAG--GAIVPV-----DPHYPADRIRyilhDCGC 561
Cdd:PRK00174 99 ITYRELHREVCRFANALKSLGVKKGDRVAIYMPMI---PEAAVAMLACAriGAVHSVvfggfSAEALADRII----DAGA 171
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 562 SHVVS-----QAHLPSSLEDNY--IITHPEDIES----KVDGSNIKSVN----------------------NADDLLYMI 608
Cdd:PRK00174 172 KLVITadegvRGGKPIPLKANVdeALANCPSVEKvivvRRTGGDVDWVEgrdlwwhelvagasdecepepmDAEDPLFIL 251
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 609 YTSGTTGKPKGVQfeHRNMANLLKFEYTHSGIdfeadvlqfatpsFDVCYQEIF--SA---------------LLKGGTL 671
Cdd:PRK00174 252 YTSGSTGKPKGVL--HTTGGYLVYAAMTMKYV-------------FDYKDGDVYwcTAdvgwvtghsyivygpLANGATT 316
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 672 HI---VPeaikrDVPQ---LFAFINKHQTNIVFL-PTAfIKMifserelansfpdgvkhLIAAGEQLMI-SDLfqDVLRK 743
Cdd:PRK00174 317 LMfegVP-----NYPDpgrFWEVIDKHKVTIFYTaPTA-IRA-----------------LMKEGDEHPKkYDL--SSLRL 371
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 744 RG-----IH------LHNHYGPSETHVVSTY--T------IhpgDPIPELPPIgKPIGCT------DLYILNHQKQLQPC 798
Cdd:PRK00174 372 LGsvgepINpeawewYYKVVGGERCPIVDTWwqTetggimI---TPLPGATPL-KPGSATrplpgiQPAVVDEEGNPLEG 447
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 799 GVPGELYI--SGASVARG-YVNHDKLTSDKFSsdPFKPdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIE 875
Cdd:PRK00174 448 GEGGNLVIkdPWPGMMRTiYGDHERFVKTYFS--TFKG---MYFTGDGARRDEDGYYWITGRVDDVLNVSGHRLGTAEIE 522
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 876 VTLMNHPDISEAAIL-IWQDQNGEhELCAY------YCSVQKLNTiDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVD 948
Cdd:PRK00174 523 SALVAHPKVAEAAVVgRPDDIKGQ-GIYAFvtlkggEEPSDELRK-ELRNWVRKEIGPIAKPDVIQFAPGLPKTRSGKIM 600
|
.
gi 1678550997 949 R 949
Cdd:PRK00174 601 R 601
|
|
| FCS |
cd05921 |
Feruloyl-CoA synthetase (FCS); Feruloyl-CoA synthetase is an essential enzyme in the feruloyl ... |
1500-1880 |
4.35e-11 |
|
Feruloyl-CoA synthetase (FCS); Feruloyl-CoA synthetase is an essential enzyme in the feruloyl acid degradation pathway and enables some proteobacteria to grow on media containing feruloyl acid as the sole carbon source. It catalyzes the transfer of CoA to the carboxyl group of ferulic acid, which then forms feruloyl-CoA in the presence of ATP and Mg2. The resulting feruloyl-CoA is further degraded to vanillin and acetyl-CoA. Feruloyl-CoA synthetase (FCS) is a subfamily of the adenylate-forming enzymes superfamily.
Pssm-ID: 341245 [Multi-domain] Cd Length: 561 Bit Score: 69.00 E-value: 4.35e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFEDG-----VMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPI 1574
Cdd:cd05921 1 LAHWARQAPDRTWLAEREGnggwrRVTYAEALRQVRAIAQGLLDLGLSAERPLLILSGNSIEHALMALAAMYAGVPAAPV 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1575 DPDYP-----EERISFLLEDSGTNILLLQSA-----GLHVPEFTGE--IVYLNQ-------TNSGLAHRLSNPNVD---- 1631
Cdd:cd05921 81 SPAYSlmsqdLAKLKHLFELLKPGLVFAQDAapfarALAAIFPLGTplVVSRNAvagrgaiSFAELAATPPTAAVDaafa 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1632 -VLPQSLAYVIYTSGSTGMPKGVEIEHRS-AVNFLNSLQSRYQLKHSDMIMhktsysfdasiweLFWWP----------- 1698
Cdd:cd05921 161 aVGPDTVAKFLFTSGSTGLPKAVINTQRMlCANQAMLEQTYPFFGEEPPVL-------------VDWLPwnhtfggnhnf 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1699 ----YAGASVYLlpQGGEKEPEVIAKAI---EEQKITAMHFVP---SMLHAFLEH---IKYRSVpiktNRLKRVFSGGEQ 1765
Cdd:cd05921 228 nlvlYNGGTLYI--DDGKPMPGGFEETLrnlREISPTVYFNVPagwEMLVAALEKdeaLRRRFF----KRLKLMFYAGAG 301
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1766 LGTHLVSRFYELL-----PNVSITNSYGPTEATveAAFFDCppHEKLERIP-IGKPVHHVRLyllnqnqRMLPVGCIGEL 1839
Cdd:cd05921 302 LSQDVWDRLQALAvatvgERIPMMAGLGATETA--PTATFT--HWPTERSGlIGLPAPGTEL-------KLVPSGGKYEV 370
|
410 420 430 440
....*....|....*....|....*....|....*....|.
gi 1678550997 1840 YIAGAGVARGYLNRPALTEERFLEDPFypgermYKTGDVAR 1880
Cdd:cd05921 371 RVKGPNVTPGYWRQPELTAQAFDEEGF------YCLGDAAK 405
|
|
| prpE |
PRK10524 |
propionyl-CoA synthetase; Provisional |
2674-3019 |
4.35e-11 |
|
propionyl-CoA synthetase; Provisional
Pssm-ID: 182517 [Multi-domain] Cd Length: 629 Bit Score: 68.82 E-value: 4.35e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2674 HLAYIIYTSGTTGRPKGVMVEHKGIANTLQwrrnayafNETDTIlqlfsfsFDG------FITS-----------MFTPL 2736
Cdd:PRK10524 234 EPSYILYTSGTTGKPKGVQRDTGGYAVALA--------TSMDTI-------FGGkagetfFCASdigwvvghsyiVYAPL 298
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2737 LSGAKAVLLheeEAKDIL---AIKHQLSRQ-RITHMIIVPVLYRAL----LDVVQPEDVKTLRVVTLAGEAADR---ELI 2805
Cdd:PRK10524 299 LAGMATIMY---EGLPTRpdaGIWWRIVEKyKVNRMFSAPTAIRVLkkqdPALLRKHDLSSLRALFLAGEPLDEptaSWI 375
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2806 ARSLAIcPhteLANEYGPTENS-VATTVMRHMEKQA--YVSIGQPIDGTQVLILNSNhqlqpigvAGELCIAGTglaRGY 2882
Cdd:PRK10524 376 SEALGV-P---VIDNYWQTETGwPILAIARGVEDRPtrLGSPGVPMYGYNVKLLNEV--------TGEPCGPNE---KGV 440
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2883 VN----LPE--LT------ERaFTQNPFKPEARM-YRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIK 2949
Cdd:PRK10524 441 LViegpLPPgcMQtvwgddDR-FVKTYWSLFGRQvYSTFDWGIRDADGYYFILGRTDDVINVAGHRLGTREIEESISSHP 519
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2950 GVKDAAVVAHVTA-SGQTELsAYVVTKPG--LSTNAVRSELQ--------NKLPVFMHPAFIEKLDSLPLSPNGKLDRGA 3018
Cdd:PRK10524 520 AVAEVAVVGVKDAlKGQVAV-AFVVPKDSdsLADREARLALEkeimalvdSQLGAVARPARVWFVSALPKTRSGKLLRRA 598
|
.
gi 1678550997 3019 L 3019
Cdd:PRK10524 599 I 599
|
|
| PRK07867 |
PRK07867 |
acyl-CoA synthetase; Validated |
1491-1924 |
4.90e-11 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236120 [Multi-domain] Cd Length: 529 Bit Score: 68.55 E-value: 4.90e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1491 SMNQTLHYALEQQAEKtpDQAAVIFEDGVMTYKE-LNEQANRIAW--ELIGRGVKPEttVAIIGKRSPEMLL-----GIY 1562
Cdd:PRK07867 2 SSAPTVAELLLPLAED--DDRGLYFEDSFTSWREhIRGSAARAAAlrARLDPTRPPH--VGVLLDNTPEFSLllgaaALS 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1563 GILKAG------GAYLPIDPDYPEERisFLLEDSGtNILLLQSAGLHVPEFTGEIVYLNQTNSGLAHRLSNPnVDVLPQS 1636
Cdd:PRK07867 78 GIVPVGlnptrrGAALARDIAHADCQ--LVLTESA-HAELLDGLDPGVRVINVDSPAWADELAAHRDAEPPF-RVADPDD 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1637 LAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLK------------HSDMIMHKtsysfdasiwelfWWP--YAGA 1702
Cdd:PRK07867 154 LFMLIFTSGTSGDPKAVRCTHRKVASAGVMLAQRFGLGpddvcyvsmplfHSNAVMAG-------------WAValAAGA 220
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1703 SVYLlpqggekepeviakaieEQKITAMHFVPSMLHAFLEHIKYRSVPI------------KTNRLKRVFsgGEQLGTHL 1770
Cdd:PRK07867 221 SIAL-----------------RRKFSASGFLPDVRRYGATYANYVGKPLsyvlatperpddADNPLRIVY--GNEGAPGD 281
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1771 VSRFYELLpNVSITNSYGPTEATVE-AAFFDCPPHEkleripIGKPVHHVRLY-----------LLNQNQRMLPVGCIGE 1838
Cdd:PRK07867 282 IARFARRF-GCVVVDGFGSTEGGVAiTRTPDTPPGA------LGPLPPGVAIVdpdtgtecppaEDADGRLLNADEAIGE 354
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1839 LY-IAGAGVARGYLNRPALTEERFLEDpfypgerMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIE 1917
Cdd:PRK07867 355 LVnTAGPGGFEGYYNDPEADAERMRGG-------VYWSGDLAYRDADGYAYFAGRLGDWMRVDGENLGTAPIERILLRYP 427
|
....*..
gi 1678550997 1918 GVREAAV 1924
Cdd:PRK07867 428 DATEVAV 434
|
|
| Cyc_NRPS |
cd19535 |
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
30-319 |
4.94e-11 |
|
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Cyc (heterocyclization) domains catalyze two separate reactions in the creation of heterocyclized peptide products in nonribosomal peptide synthesis: amide bond formation followed by intramolecular cyclodehydration between a Cys, Ser, or Thr side chain and a carbonyl carbon on the peptide backbone to form a thiazoline, oxazoline, or methyloxazoline ring. Cyc-domains are homologous to standard NRPS Condensation (C) domains. C-domains typically have a conserved HHxxxD motif at the active site; Cyc-domains have an alternative, conserved DxxxxD active site motif, mutation of the aspartate residues in this motif can abolish or diminish condensation activity. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and Cyc-domains. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380458 [Multi-domain] Cd Length: 423 Bit Score: 67.90 E-value: 4.94e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 30 SQAYVEqasftIEGK-VNPQFFQNSINALVERHDIFRTIFISQNvsspQQVVLRERNVIVLE-EDITHLNEAEQSQFIEQ 107
Cdd:cd19535 26 CHAYLE-----FDGEdLDPDRLERAWNKLIARHPMLRAVFLDDG----TQQILPEVPWYGITvHDLRGLSEEEAEAALEE 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 108 WKEK------DRDRG--FHLQkdvlmrIALIQTGEsqysciwTFHHI-----MMDGWCLSIVLKEFLHIYASyvnaSPIT 174
Cdd:cd19535 97 LRERlshrvlDVERGplFDIR------LSLLPEGR-------TRLHLsidllVADALSLQILLRELAALYED----PGEP 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 175 LEPVQP-YGKYIKW---LMEQDKEQAVSYWDHYLSgheqqtVLP--------KQKKTKGKSRQEHVTFSFSKEESSRLSE 242
Cdd:cd19535 160 LPPLELsFRDYLLAeqaLRETAYERARAYWQERLP------TLPpapqlplaKDPEEIKEPRFTRREHRLSAEQWQRLKE 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 243 LAAREEVTLSTIFHTIWGILLQKYNNNDD-----AVFgsvisGRPAEIEGIEHMVGLFINTMPVRVQG-AKTPFLQLIKD 316
Cdd:cd19535 234 RARQHGVTPSMVLLTAYAEVLARWSGQPRfllnlTLF-----NRLPLHPDVNDVVGDFTSLLLLEVDGsEGQSFLERARR 308
|
...
gi 1678550997 317 MQK 319
Cdd:cd19535 309 LQQ 311
|
|
| DCL_NRPS-like |
cd19536 |
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal ... |
3123-3452 |
6.41e-11 |
|
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal fungal CT domains and Dual Epimerization/Condensation (E/C) domains; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type [D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L))], which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380459 [Multi-domain] Cd Length: 419 Bit Score: 67.86 E-value: 6.41e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3123 SPVQKWFLsqdikeKHHFNQ---SVMLHRST-----SVQEDALRKTLKAITCHHDALRMVFTqneqgkWDQYNRP----L 3190
Cdd:cd19536 5 SSLQEGML------FHSLLNpggSVYLHNYTytvgrRLNLDLLLEALQVLIDRHDILRTSFI------EDGLGQPvqvvH 72
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3191 SHSDdalyglqmIDLSAPDGTDGNRPYEPLIKRHVLDIQQKMDLKNGPLLQAGLFH-TIDGDFLF-LSAHHLVVDGISWR 3268
Cdd:cd19536 73 RQAQ--------VPVTELDLTPLEEQLDPLRAYKEETKIRRFDLGRAPLVRAALVRkDERERFLLvISDHHSILDGWSLY 144
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3269 VLLEDLALGYRQAAGGEDIKLPPkTSSFKAYAKKLSDYAESQQLmkqLKYWREAeeyqtealpFDQIDGTRAHEGQRSTI 3348
Cdd:cd19536 145 LLVKEILAVYNQLLEYKPLSLPP-AQPYRDFVAHERASIQQAAS---ERYWREY---------LAGATLATLPALSEAVG 211
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3349 SFTLNDKETA-ALLKDANSAYNTDTQDMLLASVILA-----LRHWTNQSAFKLSLEGHGREDVLKGIDvsRTIGWFTAIY 3422
Cdd:cd19536 212 GGPEQDSELLvSVPLPVRSRSLAKRSGIPLSTLLLAawalvLSRHSGSDDVVFGTVVHGRSEETTGAE--RLLGLFLNTL 289
|
330 340 350
....*....|....*....|....*....|
gi 1678550997 3423 PLLIKLnadlpdSEESMVHVLKTTKDTLRR 3452
Cdd:cd19536 290 PLRVTL------SEETVEDLLKRAQEQELE 313
|
|
| PaaK |
cd05913 |
Phenylacetate-CoA ligase (also known as PaaK); PaaK catalyzes the first step in the aromatic ... |
1643-1919 |
7.42e-11 |
|
Phenylacetate-CoA ligase (also known as PaaK); PaaK catalyzes the first step in the aromatic degradation pathway, by converting phenylacetic acid (PA) into phenylacetyl-CoA (PA-CoA). Phenylacetate-CoA ligase has been found in proteobacteria as well as gram positive prokaryotes. The enzyme is specifically induced after aerobic growth in a chemically defined medium containing PA or phenylalanine (Phe) as the sole carbon source. PaaKs are members of the adenylate-forming enzyme (AFE) family. However, sequence comparison reveals divergent features of PaaK with respect to the superfamily, including a novel N-terminal sequence.
Pssm-ID: 341239 [Multi-domain] Cd Length: 425 Bit Score: 67.65 E-value: 7.42e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1643 TSGSTGMPKGVEIEHRSAVNFLNsLQSRY----QLKHSDMIMHKTSYS-------FDASIWELfwwpyaGASVylLPQG- 1710
Cdd:cd05913 86 SSGTTGKPTVVGYTKNDLDVWAE-LVARCldaaGVTPGDRVQNAYGYGlftgglgFHYGAERL------GALV--IPAGg 156
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1711 GEKEPEViaKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTNRLKRVFSGGEQLGTHLVSRFyELLPNVSITNSYGPT 1790
Cdd:cd05913 157 GNTERQL--QLIKDFGPTVLCCTPSYALYLAEEAEEEGIDPRELSLKVGIFGAEPWTEEMRKRI-ERRLGIKAYDIYGLT 233
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1791 EATVEAAFFDCP---------PHEKLERI-P-IGKPVhhvrlyllnqnqrmlPVGCIGELYIAGagvargyLNRPALtee 1859
Cdd:cd05913 234 EIIGPGVAFECEekdglhiweDHFIPEIIdPeTGEPV---------------PPGEVGELVFTT-------LTKEAM--- 288
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 1860 rfledpfyPGERmYKTGDVARWLPDGNVE---------FLGRTDDQVKIRGYRIEPGEIEAALRSIEGV 1919
Cdd:cd05913 289 --------PLIR-YRTRDITRLLPGPCPCgrthrridrITGRSDDMLIIRGVNVFPSQIEDVLLKIPGL 348
|
|
| LC_FACS_bac1 |
cd17641 |
bacterial long-chain fatty acid CoA synthetase; The members of this family are bacterial ... |
490-890 |
7.95e-11 |
|
bacterial long-chain fatty acid CoA synthetase; The members of this family are bacterial long-chain fatty acid CoA synthetase, most of which are as yet uncharacterized. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341296 [Multi-domain] Cd Length: 569 Bit Score: 67.83 E-value: 7.95e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 490 TYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVS--- 566
Cdd:cd17641 13 TWADYADRVRAFALGLLALGVGRGDVVAILGDNRPEWVWAELAAQAIGALSLGIYQDSMAEEVAYLLNYTGARVVIAede 92
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 567 ---------QAHLPS---------------------SLED------NYIITHPEDIESKVDGSNiksvnnADDLLYMIYT 610
Cdd:cd17641 93 eqvdklleiADRIPSvryviycdprgmrkyddprliSFEDvvalgrALDRRDPGLYEREVAAGK------GEDVAVLCTT 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 611 SGTTGKPKGVQFEHRNM----ANLLKFEYTHSGIDFEAdVLQFATpsfdvCYQEIFS---ALLKGGTLHIV--PEAIKRD 681
Cdd:cd17641 167 SGTTGKPKLAMLSHGNFlghcAAYLAADPLGPGDEYVS-VLPLPW-----IGEQMYSvgqALVCGFIVNFPeePETMMED 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 682 VPQLfafinkhQTNIVFLP-------TAFI--KMIFSERELANSFPDGVKHLIAAGEQLM-----------ISDLFQDV- 740
Cdd:cd17641 241 LREI-------GPTFVLLPprvwegiAADVraRMMDATPFKRFMFELGMKLGLRALDRGKrgrpvslwlrlASWLADALl 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 741 ---LRKR---------------------------GIHLHNHYGPSETHVVstYTIHPGDPIPElPPIGKPIGCTDLYILN 790
Cdd:cd17641 314 frpLRDRlgfsrlrsaatggaalgpdtfrffhaiGVPLKQLYGQTELAGA--YTVHRDGDVDP-DTVGVPFPGTEVRIDE 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 791 HqkqlqpcgvpGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRA-DNQVKIRGYRI 869
Cdd:cd17641 391 V----------GEILVRSPGVFVGYYKNPEATAEDFDEDGW------LHTGDAGYFKENGHLVVIDRAkDVGTTSDGTRF 454
|
490 500
....*....|....*....|.
gi 1678550997 870 EPQEIEVTLMNHPDISEAAIL 890
Cdd:cd17641 455 SPQFIENKLKFSPYIAEAVVL 475
|
|
| PP-binding |
pfam00550 |
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached ... |
3041-3099 |
8.15e-11 |
|
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached through a serine. This prosthetic group acts as a a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups. This domain forms a four helix bundle. This family includes members not included in Prosite. The inclusion of these members is supported by sequence analysis and functional evidence. The related domain of Swiss:P19828 has the attachment serine replaced by an alanine.
Pssm-ID: 425746 [Multi-domain] Cd Length: 62 Bit Score: 59.88 E-value: 8.15e-11
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 3041 QILADIWKEVLG--AEKIGTADSFFELGGDSIKALQVSARLHR-IGKQMAVKDLFSHPTIQE 3099
Cdd:pfam00550 1 ERLRELLAEVLGvpAEEIDPDTDLFDLGLDSLLAVELIARLEEeFGVEIPPSDLFEHPTLAE 62
|
|
| PRK09029 |
PRK09029 |
O-succinylbenzoic acid--CoA ligase; Provisional |
2543-2997 |
1.17e-10 |
|
O-succinylbenzoic acid--CoA ligase; Provisional
Pssm-ID: 236363 [Multi-domain] Cd Length: 458 Bit Score: 67.20 E-value: 1.17e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2543 AARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPkERK 2622
Cdd:PRK09029 13 AQVRPQAIALRLNDEVLTWQQLCARIDQLAAGFAQQGVVEGSGVALRGKNSPETLLAYLALLQCGARVLPLNPQLP-QPL 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2623 RyilsdsgTKLLMTINeADLGVLADFEGEILTIESVEEDDKSPLPQMS-SAHHLAYIIYTSGTTGRPKGVMVEHKG-IAN 2700
Cdd:PRK09029 92 L-------EELLPSLT-LDFALVLEGENTFSALTSLHLQLVEGAHAVAwQPQRLATMTLTSGSTGLPKAAVHTAQAhLAS 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2701 T---LQWrrnaYAFNETDT---ILQLFSFSFDGFItsmFTPLLSGAKAVLLHEEEAKDILaikhqlsrQRITHMIIVPV- 2773
Cdd:PRK09029 164 AegvLSL----MPFTAQDSwllSLPLFHVSGQGIV---WRWLYAGATLVVRDKQPLEQAL--------AGCTHASLVPTq 228
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2774 LYRaLLDvvQPEDVKTLRVVTLAGEAADRELI--ARSLAICphTELAneYGPTEnsVATTVmrhMEKQAYVS--IGQPID 2849
Cdd:PRK09029 229 LWR-LLD--NRSEPLSLKAVLLGGAAIPVELTeqAEQQGIR--CWCG--YGLTE--MASTV---CAKRADGLagVGSPLP 296
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2850 GTQVLIlnsnhqlqpigVAGELCIAGTGLARGYVNLPELTeraftqnPFKPEARMYRTGDAARWmADGTLEYLGRIDDQV 2929
Cdd:PRK09029 297 GREVKL-----------VDGEIWLRGASLALGYWRQGQLV-------PLVNDEGWFATRDRGEW-QNGELTILGRLDNLF 357
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 2930 KIRGYRVETKEIESVIRCIKGVKDAAVVAHVTAS-GQTELsAYVVTKPGLSTNAVRSELQNKLPVFMHP 2997
Cdd:PRK09029 358 FSGGEGIQPEEIERVINQHPLVQQVFVVPVADAEfGQRPV-AVVESDSEAAVVNLAEWLQDKLARFQQP 425
|
|
| FATP_chFAT1_like |
cd05937 |
Uncharacterized subfamily of bifunctional fatty acid transporter/very-long-chain acyl-CoA ... |
2555-3019 |
1.20e-10 |
|
Uncharacterized subfamily of bifunctional fatty acid transporter/very-long-chain acyl-CoA synthetase in fungi; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis. Members of this family are fungal FATPs, including FAT1 from Cochliobolus heterostrophus.
Pssm-ID: 341260 [Multi-domain] Cd Length: 468 Bit Score: 67.07 E-value: 1.20e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2555 GDKTLTYQELDEWSNGIARALRS-RGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDpeypkerkrYILSdsGTKL 2633
Cdd:cd05937 2 EGKTWTYSETYDLVLRYAHWLHDdLGVQAGDFVAIDLTNSPEFVFLWLGLWSIGAAPAFIN---------YNLS--GDPL 70
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2634 LMTINeadlgvladfegeILTIESVEEDDKSPlpqmssahhlAYIIYTSGTTGRPKGVMVehkgiantlQWRRN------ 2707
Cdd:cd05937 71 IHCLK-------------LSGSRFVIVDPDDP----------AILIYTSGTTGLPKAAAI---------SWRRTlvtsnl 118
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2708 -AYAFNETDTiLQLFS----FSFDGFITSMFTPLLSGAKAVLLHEEEAKDILAikhQLSRQRITHMIIVPVLYRALLDV- 2781
Cdd:cd05937 119 lSHDLNLKNG-DRTYTcmplYHGTAAFLGACNCLMSGGTLALSRKFSASQFWK---DVRDSGATIIQYVGELCRYLLSTp 194
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2782 VQPEDVK-TLRVVTLAGEAAD-----RELIARSlaicphtELANEYGPTENSVATT----------VMRHmekqaYVSIG 2845
Cdd:cd05937 195 PSPYDRDhKVRVAWGNGLRPDiwerfRERFNVP-------EIGEFYAATEGVFALTnhnvgdfgagAIGH-----HGLIR 262
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2846 QPIDGTQVLILNSNHQLQ--------------PIGVAGELCIAGT----GLARGYVNLPELTERAFTQNPFKPEARMYRT 2907
Cdd:cd05937 263 RWKFENQVVLVKMDPETDdpirdpktgfcvraPVGEPGEMLGRVPfknrEAFQGYLHNEDATESKLVRDVFRKGDIYFRT 342
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2908 GDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAhVTASGQ--------TELSAYVVTKPGLS 2979
Cdd:cd05937 343 GDLLRQDADGRWYFLDRLGDTFRWKSENVSTTEVADVLGAHPDIAEANVYG-VKVPGHdgragcaaITLEESSAVPTEFT 421
|
490 500 510 520
....*....|....*....|....*....|....*....|
gi 1678550997 2980 TNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:cd05937 422 KSLLASLARKNLPSYAVPLFLRLTEEVATTDNHKQQKGVL 461
|
|
| PtmA |
cd17636 |
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, ... |
605-948 |
1.49e-10 |
|
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341291 [Multi-domain] Cd Length: 331 Bit Score: 65.79 E-value: 1.49e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 605 LYMIYTSGTTGKPKGVQFEHR-------NMANLLK----FEYTHSGIDFEADVLQFATPSFdvcyqeifsalLKGGTLHI 673
Cdd:cd17636 3 VLAIYTAAFSGRPNGALLSHQallaqalVLAVLQAidegTVFLNSGPLFHIGTLMFTLATF-----------HAGGTNVF 71
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 674 VPEAIKRDVPQLfafINKHQTNIVFLPTAFIKMIfseREL------------ANSFPDGVKHLIAAGEQLMISDLFQdvl 741
Cdd:cd17636 72 VRRVDAEEVLEL---IEAERCTHAFLLPPTIDQI---VELnadglydlsslrSSPAAPEWNDMATVDTSPWGRKPGG--- 142
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 742 rkrgihlhnhYGPSEthvVSTYTIHPGDPIPELPPIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYVNHDKL 821
Cdd:cd17636 143 ----------YGQTE---VMGLATFAALGGGAIGGAGRPSPLVQVRILDEDGREVPDGEVGEIVARGPTVMAGYWNRPEV 209
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 822 TSDKFSSDpfkpdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAIL-----IWqDQN 896
Cdd:cd17636 210 NARRTRGG-------WHHTNDLGRREPDGSLSFVGPKTRMIKSGAENIYPAEVERCLRQHPAVADAAVIgvpdpRW-AQS 281
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 897 -------------GEHELCAyYCsvqklntidlRSYMASelpeYMIPAKWIWVDSIPLTPNGKVD 948
Cdd:cd17636 282 vkaivvlkpgasvTEAELIE-HC----------RARIAS----YKKPKSVEFADALPRTAGGADD 331
|
|
| Cyc_NRPS |
cd19535 |
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
3155-3435 |
1.64e-10 |
|
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Cyc (heterocyclization) domains catalyze two separate reactions in the creation of heterocyclized peptide products in nonribosomal peptide synthesis: amide bond formation followed by intramolecular cyclodehydration between a Cys, Ser, or Thr side chain and a carbonyl carbon on the peptide backbone to form a thiazoline, oxazoline, or methyloxazoline ring. Cyc-domains are homologous to standard NRPS Condensation (C) domains. C-domains typically have a conserved HHxxxD motif at the active site; Cyc-domains have an alternative, conserved DxxxxD active site motif, mutation of the aspartate residues in this motif can abolish or diminish condensation activity. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and Cyc-domains. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380458 [Multi-domain] Cd Length: 423 Bit Score: 66.36 E-value: 1.64e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3155 DALRKTLKAITCHHDALRMVFTQneqgkwDQYNRPLSHSddALYGLQMIDLSAPDGTDgnrpyeplIKRHVLDI-----Q 3229
Cdd:cd19535 40 DRLERAWNKLIARHPMLRAVFLD------DGTQQILPEV--PWYGITVHDLRGLSEEE--------AEAALEELrerlsH 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3230 QKMDLKNGPL--LQAGLFHTiDGDFLFLSAHHLVVDGISWRVLLEDLALGYRQAaggeDIKLPPKTSSFKAY-----AKK 3302
Cdd:cd19535 104 RVLDVERGPLfdIRLSLLPE-GRTRLHLSIDLLVADALSLQILLRELAALYEDP----GEPLPPLELSFRDYllaeqALR 178
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3303 LSDYAESQQlmkqlkYWREaeeyQTEALPF----------DQIDGTRAHegQRstiSFTLnDKETAALLKDANSAYNTdT 3372
Cdd:cd19535 179 ETAYERARA------YWQE----RLPTLPPapqlplakdpEEIKEPRFT--RR---EHRL-SAEQWQRLKERARQHGV-T 241
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 3373 QDMLLASV---ILALrhWTNQSAFKLSLEGHGREDVLKGIDvsRTIGWFTAIypLLIKLNADLPDS 3435
Cdd:cd19535 242 PSMVLLTAyaeVLAR--WSGQPRFLLNLTLFNRLPLHPDVN--DVVGDFTSL--LLLEVDGSEGQS 301
|
|
| PRK08308 |
PRK08308 |
acyl-CoA synthetase; Validated |
1564-1990 |
1.80e-10 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236231 [Multi-domain] Cd Length: 414 Bit Score: 66.21 E-value: 1.80e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1564 ILKAGGAYLPIDPDYPEERISFLLEDSGTNILLLQSaglhvPEFTGEIVylnqtNSGLAHrlsnpnvdvlPQSLayVIYT 1643
Cdd:PRK08308 52 LKEKGASVLPIHPDTPKEAAIRMAKRAGCHGLLYGE-----SDFTKLEA-----VNYLAE----------EPSL--LQYS 109
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1644 SGSTGMPKGVEiehRSAVNFLNSLQSRYQLKHSDMIM---------HktSYSFdasIWELFWWPYAGASVYLLpqgGEKE 1714
Cdd:PRK08308 110 SGTTGEPKLIR---RSWTEIDREIEAYNEALNCEQDEtpivacpvtH--SYGL---ICGVLAALTRGSKPVII---TNKN 178
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1715 PEVIAKAIEEQKITAMHFVPSMLHAflehikyrsvpiktnrLKRVFSGGEQL------GTHLVSRFYELLPNVS--ITNS 1786
Cdd:PRK08308 179 PKFALNILRNTPQHILYAVPLMLHI----------------LGRLLPGTFQFhavmtsGTPLPEAWFYKLRERTtyMMQQ 242
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1787 YGPTEATVEAAFFDCPPHEKLeripiGKPVHHVRLyllnqnqrmlpvgcigelyiaGAGVARgylNRPaltEERFLEDpf 1866
Cdd:PRK08308 243 YGCSEAGCVSICPDMKSHLDL-----GNPLPHVSV---------------------SAGSDE---NAP---EEIVVKM-- 288
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1867 ypGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GEpELCAYV---EG 1941
Cdd:PRK08308 289 --GDKEIFTKDLGYKSERGTLHFMGRMDDVINVSGLNVYPIEVEDVMLRLPGVQEAVVYRGKDPvaGE-RVKAKVishEE 365
|
410 420 430 440
....*....|....*....|....*....|....*....|....*....
gi 1678550997 1942 LQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNALPAPGGAA 1990
Cdd:PRK08308 366 IDPVQLREWCIQHLAPYQVPHEIESVTEIPKNANGKVSRKLLELGEVTA 414
|
|
| LC-FACS_euk |
cd05927 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are ... |
489-875 |
2.77e-10 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are eukaryotic fatty acid CoA synthetases that activate fatty acids with chain lengths of 12 to 20. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells.
Pssm-ID: 341250 [Multi-domain] Cd Length: 545 Bit Score: 66.08 E-value: 2.77e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 489 LTYRELNKAANRLARHLRMKGVVRQEP--VAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVS 566
Cdd:cd05927 6 ISYKEVAERADNIGSALRSLGGKPAPAsfVGIYSINRPEWIISELACYAYSLVTVPLYDTLGPEAIEYILNHAEISIVFC 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 567 QAHLPsslednyIITHpEDIEsKVDGSNIKSVN--NADDLLYMIYTSGTTGKPKGVQFEHRNMANLLkfeythSGIDFEA 644
Cdd:cd05927 86 DAGVK-------VYSL-EEFE-KLGKKNKVPPPppKPEDLATICYTSGTTGNPKGVMLTHGNIVSNV------AGVFKIL 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 645 DVLQFATPSF-DVCY---QEIFSALLKGGTLHI-------------VPEAIKR-------DVPQLFAFI-NKHQTNIVFL 699
Cdd:cd05927 151 EILNKINPTDvYISYlplAHIFERVVEALFLYHgakigfysgdirlLLDDIKAlkptvfpGVPRVLNRIyDKIFNKVQAK 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 700 PTaFIKMIFS------ERELAN--SFPDG---------VKHLIAAGEQLMISD---LFQDVLRK-R---GIHLHNHYGPS 755
Cdd:cd05927 231 GP-LKRKLFNfalnykLAELRSgvVRASPfwdklvfnkIKQALGGNVRLMLTGsapLSPEVLEFlRvalGCPVLEGYGQT 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 756 ETHVVSTYTiHPGDPIPElpPIGKPIGC-----TDLYILN-HQKQLQPcgvPGELYISGASVARGYVNHDKLTSDKFSSD 829
Cdd:cd05927 310 ECTAGATLT-LPGDTSVG--HVGGPLPCaevklVDVPEMNyDAKDPNP---RGEVCIRGPNVFSGYYKDPEKTAEALDED 383
|
410 420 430 440
....*....|....*....|....*....|....*....|....*..
gi 1678550997 830 PFkpdvimYRTGDLARRLEDGNIEYIGRADNQVKI-RGYRIEPQEIE 875
Cdd:cd05927 384 GW------LHTGDIGEWLPNGTLKIIDRKKNIFKLsQGEYVAPEKIE 424
|
|
| ttLC_FACS_like |
cd05915 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes ... |
1509-1983 |
5.41e-10 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes fatty acyl-CoA synthetases that can activate medium-chain to long-chain fatty acids. They catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family has been shown to catalyze the long-chain fatty acid, myristoyl acid, while another member in this family, the AlkK protein identified in Pseudomonas oleovorans, targets medium chain fatty acids. This family also includes an uncharacterized subgroup of FACS.
Pssm-ID: 213283 [Multi-domain] Cd Length: 509 Bit Score: 65.14 E-value: 5.41e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1509 DQAAVIFE-----DGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERI 1583
Cdd:cd05915 9 GRKEVVSRlhtgeVHRTTYAEVYQRARRLMGGLRALGVGVGDRVATLGFNHFRHLEAYFAVPGMGAVLHTANPRLSPKEI 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1584 SFLLEDSGTNILLLQSAGLHVPEFTGEI---VYLNQTNSGLAHRLS------NPNVDVL-------PQSLAYviyTSGST 1647
Cdd:cd05915 89 AYILNHAEDKVLLFDPNLLPLVEAIRGElktVQHFVVMDEKAPEGYlayeeaLGEEADPvrvperaACGMAY---TTGTT 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1648 GMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIMHK-TSYSFDASIWELFWWPYAGASVYLLPQGGEKEpEVIAKAIEEQK 1726
Cdd:cd05915 166 GLPKGVVYSHRALVLHSLAASLVDGTALSEKDVVLpVVPMFHVNAWCLPYAATLVGAKQVLPGPRLDP-ASLVELFDGEG 244
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1727 ITAMHFVPSMLHAFL---EHIKyRSVPIKTnrlkRVFSGG----------EQLGTHLVSRFYellpnvSITNSYGPTEAT 1793
Cdd:cd05915 245 VTFTAGVPTVWLALAdylESTG-HRLKTLR----RLVVGGsaaprsliarFERMGVEVRQGY------GLTETSPVVVQN 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1794 VEAAFFDCPPHEKLERIPIGKPVHHVR--LYLLNQNQRMLPVG--CIGELYIAGAGVARGYLNRPALTEERFLEDPFYpg 1869
Cdd:cd05915 314 FVKSHLESLSEEEKLTLKAKTGLPIPLvrLRVADEEGRPVPKDgkALGEVQLKGPWITGGYYGNEEATRSALTPDGFF-- 391
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1870 ermyKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GEpELCAYVEgLQRNEV 1947
Cdd:cd05915 392 ----RTGDIAVWDEEGYVEIKDRLKDLIKSGGEWISSVDLENALMGHPKVKEAAVVAIPHPkwQE-RPLAVVV-PRGEKP 465
|
490 500 510 520
....*....|....*....|....*....|....*....|..
gi 1678550997 1948 RAQ------LERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd05915 466 TPEelnehlLKAGFAKWQLPDAYVFAEEIPRTSAGKFLKRAL 507
|
|
| PP-binding |
pfam00550 |
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached ... |
973-1031 |
5.65e-10 |
|
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached through a serine. This prosthetic group acts as a a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups. This domain forms a four helix bundle. This family includes members not included in Prosite. The inclusion of these members is supported by sequence analysis and functional evidence. The related domain of Swiss:P19828 has the attachment serine replaced by an alanine.
Pssm-ID: 425746 [Multi-domain] Cd Length: 62 Bit Score: 57.57 E-value: 5.65e-10
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 973 AKLSQLFEDVLK--NGHIGIQDNFFDNGGHSLKATVLMSRIAKEFHVQVSLKDIFAHPTVE 1031
Cdd:pfam00550 1 ERLRELLAEVLGvpAEEIDPDTDLFDLGLDSLLAVELIARLEEEFGVEIPPSDLFEHPTLA 61
|
|
| PRK05851 |
PRK05851 |
long-chain-fatty acid--ACP ligase MbtM; |
2786-3016 |
6.25e-10 |
|
long-chain-fatty acid--ACP ligase MbtM;
Pssm-ID: 180289 [Multi-domain] Cd Length: 525 Bit Score: 64.79 E-value: 6.25e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2786 DVKTLRVVTLAGEAADRELIARSL-AICPH----TELANEYGPTENSVATTVMRHME--------------KQAYVSIGQ 2846
Cdd:PRK05851 270 DLGALRVALNGGEPVDCDGFERFAtAMAPFgfdaGAAAPSYGLAESTCAVTVPVPGIglrvdevttddgsgARRHAVLGN 349
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2847 PIDGTQVLILNSNHqlqPIGVA----GELCIAGTGLARGYVNlpelteraftQNPFKPEArMYRTGDAArWMADGTLEYL 2922
Cdd:PRK05851 350 PIPGMEVRISPGDG---AAGVAgreiGEIEIRGASMMSGYLG----------QAPIDPDD-WFPTGDLG-YLVDGGLVVC 414
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2923 GRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQtelsayvvTKPGLSTNA---------VRSELQNKLP- 2992
Cdd:PRK05851 415 GRAKELITVAGRNIFPTEIERVAAQVRGVREGAVVAVGTGEGS--------ARPGLVIAAefrgpdeagARSEVVQRVAs 486
|
250 260 270
....*....|....*....|....*....|...
gi 1678550997 2993 ---------VFMHPAfiekldSLPLSPNGKLDR 3016
Cdd:PRK05851 487 ecgvvpsdvVFVAPG------SLPRTSSGKLRR 513
|
|
| PRK08162 |
PRK08162 |
acyl-CoA synthetase; Validated |
2540-2982 |
8.66e-10 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236169 [Multi-domain] Cd Length: 545 Bit Score: 64.58 E-value: 8.66e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2540 EQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPK 2619
Cdd:PRK08162 25 ERAAEVYPDRPAVIHGDRRRTWAETYARCRRLASALARRGIGRGDTVAVLLPNIPAMVEAHFGVPMAGAVLNTLNTRLDA 104
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2620 ERKRYILSDSGTKLLMTINE-ADLGVLADFEGEILTIESVEEDDKsPLPQMSSAHHLAY--------------------- 2677
Cdd:PRK08162 105 ASIAFMLRHGEAKVLIVDTEfAEVAREALALLPGPKPLVIDVDDP-EYPGGRFIGALDYeaflasgdpdfawtlpadewd 183
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2678 ---IIYTSGTTGRPKGVMVEHKG-----IANTLQW---RRNAYAFnetdtILQLF-----SFSfdgfitsmFTPLLSGAK 2741
Cdd:PRK08162 184 aiaLNYTSGTTGNPKGVVYHHRGaylnaLSNILAWgmpKHPVYLW-----TLPMFhcngwCFP--------WTVAARAGT 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2742 AVLLHEEEAKDIL-AIKhqlsRQRITHMIIVPVLYRALLDVvqPEDVK---TLRVVTL-AGEAADRELIARSLAIcpHTE 2816
Cdd:PRK08162 251 NVCLRKVDPKLIFdLIR----EHGVTHYCGAPIVLSALINA--PAEWRagiDHPVHAMvAGAAPPAAVIAKMEEI--GFD 322
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2817 LANEYGPTEN-SVATTVMRH-------MEKQAYVSIGQPI-----DGTQVLilnSNHQLQPI----GVAGELCIAGTGLA 2879
Cdd:PRK08162 323 LTHVYGLTETyGPATVCAWQpewdalpLDERAQLKARQGVryplqEGVTVL---DPDTMQPVpadgETIGEIMFRGNIVM 399
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2880 RGYVNLPELTERAFtqnpfkpEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAH 2959
Cdd:PRK08162 400 KGYLKNPKATEEAF-------AGGWFHTGDLAVLHPDGYIKIKDRSKDIIISGGENISSIEVEDVLYRHPAVLVAAVVAK 472
|
490 500
....*....|....*....|...
gi 1678550997 2960 VTASGQTELSAYVVTKPGLSTNA 2982
Cdd:PRK08162 473 PDPKWGEVPCAFVELKDGASATE 495
|
|
| PRK07824 |
PRK07824 |
o-succinylbenzoate--CoA ligase; |
1837-1983 |
1.52e-09 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 236108 [Multi-domain] Cd Length: 358 Bit Score: 62.76 E-value: 1.52e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1837 GELYIAGAGVARGYLNRPalteerflEDPFYPGERMYKTGDVARwLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSI 1916
Cdd:PRK07824 208 GRIALGGPTLAKGYRNPV--------DPDPFAEPGWFRTDDLGA-LDDGVLTVLGRADDAISTGGLTVLPQVVEAALATH 278
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 1917 EGVREAAVTVRTDS--GEPELCAYVEGLQRNEV----RAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:PRK07824 279 PAVADCAVFGLPDDrlGQRVVAAVVGDGGPAPTlealRAHVARTLDRTAAPRELHVVDELPRRGIGKVDRRAL 351
|
|
| PRK07008 |
PRK07008 |
long-chain-fatty-acid--CoA ligase; Validated |
2534-3014 |
1.58e-09 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235908 [Multi-domain] Cd Length: 539 Bit Score: 63.57 E-value: 1.58e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2534 TISQLFEQqAAR----TPKASALVSGD-KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGG 2608
Cdd:PRK07008 11 LISSLIAH-AARhagdTEIVSRRVEGDiHRYTYRDCERRAKQLAQALAALGVEPGDRVGTLAWNGYRHLEAYYGVSGSGA 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2609 CYVPIDPEYPKERKRYILSDSGTKLLMTineaDLGVLADFEGEILTIESVEE----DDKSPLPQMS----------SAHH 2674
Cdd:PRK07008 90 VCHTINPRLFPEQIAYIVNHAEDRYVLF----DLTFLPLVDALAPQCPNVKGwvamTDAAHLPAGStpllcyetlvGAQD 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2675 LAY------------IIYTSGTTGRPKGVMVEHKgiANTLqwrrNAYA--------FNETDTILQlfsfsfdgfITSMF- 2733
Cdd:PRK07008 166 GDYdwprfdenqassLCYTSGTTGNPKGALYSHR--STVL----HAYGaalpdamgLSARDAVLP---------VVPMFh 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2734 --------TPLLSGAKAVLlhEEEAKDILAIKHQLSRQRITHMIIVPVLYRALLDVVQPEDVK--TLRVVTLAGEAADRE 2803
Cdd:PRK07008 231 vnawglpySAPLTGAKLVL--PGPDLDGKSLYELIEAERVTFSAGVPTVWLGLLNHMREAGLRfsTLRRTVIGGSACPPA 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2804 LIaRSLAICPHTELANEYGPTENSVATTV---------------MRHMEKQayvsiGQPIDGTQVLILNSNHQLQPI-GV 2867
Cdd:PRK07008 309 MI-RTFEDEYGVEVIHAWGMTEMSPLGTLcklkwkhsqlpldeqRKLLEKQ-----GRVIYGVDMKIVGDDGRELPWdGK 382
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2868 A-GELCIAGTGLARGYvnlpelteraftqnpFKPEA-----RMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEI 2941
Cdd:PRK07008 383 AfGDLQVRGPWVIDRY---------------FRGDAsplvdGWFPTGDVATIDADGFMQITDRSKDVIKSGGEWISSIDI 447
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1678550997 2942 ESVIRCIKGVKDAAVVAhVTASGQTELSAYVVT-KPGlsTNAVRSEL----QNKLPVFMHPAFIEKLDSLPLSPNGKL 3014
Cdd:PRK07008 448 ENVAVAHPAVAEAACIA-CAHPKWDERPLLVVVkRPG--AEVTREELlafyEGKVAKWWIPDDVVFVDAIPHTATGKL 522
|
|
| PLN02387 |
PLN02387 |
long-chain-fatty-acid-CoA ligase family protein |
1633-1913 |
1.93e-09 |
|
long-chain-fatty-acid-CoA ligase family protein
Pssm-ID: 215217 [Multi-domain] Cd Length: 696 Bit Score: 63.60 E-value: 1.93e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1633 LPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRY-QLKHSDMIMhktSYSFDASIWELfwwpyaGASVYLLPQG- 1710
Cdd:PLN02387 248 SPNDIAVIMYTSGSTGLPKGVMMTHGNIVATVAGVMTVVpKLGKNDVYL---AYLPLAHILEL------AAESVMAAVGa 318
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1711 --GEKEPEV-------IAKA----IEEQKITAMHFVPS------------------------------------------ 1735
Cdd:PLN02387 319 aiGYGSPLTltdtsnkIKKGtkgdASALKPTLMTAVPAildrvrdgvrkkvdakgglakklfdiaykrrlaaiegswfga 398
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1736 -----MLHAFLEHIKYRSVpiKTNRLKRVFSGGEQLGTHlVSRFYELLPNVSITNSYGPTEATVEAAF--FDCPpheKLE 1808
Cdd:PLN02387 399 wglekLLWDALVFKKIRAV--LGGRIRFMLSGGAPLSGD-TQRFINICLGAPIGQGYGLTETCAGATFseWDDT---SVG 472
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1809 RIpiGKPVHHVRLYLLNQNQ-------RMLPVGcigELYIAGAGVARGYLNRPALTEERFLEDPfyPGERMYKTGDVARW 1881
Cdd:PLN02387 473 RV--GPPLPCCYVKLVSWEEggylisdKPMPRG---EIVIGGPSVTLGYFKNQEKTDEVYKVDE--RGMRWFYTGDIGQF 545
|
330 340 350
....*....|....*....|....*....|...
gi 1678550997 1882 LPDGNVEFLGRTDDQVKIR-GYRIEPGEIEAAL 1913
Cdd:PLN02387 546 HPDGCLEIIDRKKDIVKLQhGEYVSLGKVEAAL 578
|
|
| PTZ00237 |
PTZ00237 |
acetyl-CoA synthetase; Provisional |
605-949 |
1.99e-09 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 240325 [Multi-domain] Cd Length: 647 Bit Score: 63.61 E-value: 1.99e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 605 LYMIYTSGTTGKPKGVQfeHRNMANLLKFEYTHSGIDFEADVLQFATP------SFdvcYQEIFSALLKGGTL------H 672
Cdd:PTZ00237 257 LYILYTSGTTGNSKAVV--RSNGPHLVGLKYYWRSIIEKDIPTVVFSHssigwvSF---HGFLYGSLSLGNTFvmfeggI 331
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 673 IVPEAIKRDvpqLFAFINKHQTNIVF-LPTAF---IKM------IFSERELANsfpdgVKHLIAAGEQL--MISDLFQDV 740
Cdd:PTZ00237 332 IKNKHIEDD---LWNTIEKHKVTHTLtLPKTIrylIKTdpeatiIRSKYDLSN-----LKEIWCGGEVIeeSIPEYIENK 403
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 741 LRKRGIHLhnhYGPSETHVVSTYTIHP--------GDPIPELPPI-----GKPIGCTDLYILNHQKQLQPcgvpgelyis 807
Cdd:PTZ00237 404 LKIKSSRG---YGQTEIGITYLYCYGHinipynatGVPSIFIKPSilsedGKELNVNEIGEVAFKLPMPP---------- 470
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 808 gaSVARGYVNHDKLTSDKFSSDPFkpdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEA 887
Cdd:PTZ00237 471 --SFATTFYKNDEKFKQLFSKFPG-----YYNSGDLGFKDENGYYTIVSRSDDQIKISGNKVQLNTIETSILKHPLVLEC 543
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 888 AILIWQDQNGEHELCAYYC-----SVQKLNTIDLRS----YMASELPEYMIPAKWIWVDSIPLTPNGKVDR 949
Cdd:PTZ00237 544 CSIGIYDPDCYNVPIGLLVlkqdqSNQSIDLNKLKNeinnIITQDIESLAVLRKIIIVNQLPKTKTGKIPR 614
|
|
| PTZ00342 |
PTZ00342 |
acyl-CoA synthetase; Provisional |
588-870 |
2.70e-09 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 240370 [Multi-domain] Cd Length: 746 Bit Score: 63.20 E-value: 2.70e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 588 SKVDGSNIKSVNNADDLLYMI-YTSGTTGKPKGVQFEHRNMANLLKFEYTHSgidfeadVLQFATPSFDVCYQEI----- 661
Cdd:PTZ00342 289 TKNKTTNYKIQNEDPDFITSIvYTSGTSGKPKGVMLSNKNLYNTVVPLCKHS-------IFKKYNPKTHLSYLPIshiye 361
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 662 ----FSALLKGGTLHIVPEAIK---RD-----------VPQLFafiNKHQTNIV-------FLPTAFIKMIFSERELAN- 715
Cdd:PTZ00342 362 rviaYLSFMLGGTINIWSKDINyfsKDiynskgnilagVPKVF---NRIYTNIMteinnlpPLKRFLVKKILSLRKSNNn 438
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 716 ----SFPDGVKHL--------------IAAGEQLMISDLFQDVLRKRGIHLHNHYGPSEThvvsTYTI---HPGDPIPEl 774
Cdd:PTZ00342 439 ggfsKFLEGITHIsskikdkvnpnlevILNGGGKLSPKIAEELSVLLNVNYYQGYGLTET----TGPIfvqHADDNNTE- 513
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 775 pPIGKPIGCTDLYILNHQKQLQPCGVP--GELYISGASVARGYVNHDKLTSDKFSSDPFkpdvimYRTGDLARRLEDGNI 852
Cdd:PTZ00342 514 -SIGGPISPNTKYKVRTWETYKATDTLpkGELLIKSDSIFSGYFLEKEQTKNAFTEDGY------FKTGDIVQINKNGSL 586
|
330
....*....|....*....
gi 1678550997 853 EYIGRADNQVKI-RGYRIE 870
Cdd:PTZ00342 587 TFLDRSKGLVKLsQGEYIE 605
|
|
| hsFATP2a_ACSVL_like |
cd05938 |
Fatty acid transport proteins (FATP) including hsFATP2, hsFATP5, and hsFATP6, and similar ... |
488-625 |
3.17e-09 |
|
Fatty acid transport proteins (FATP) including hsFATP2, hsFATP5, and hsFATP6, and similar proteins; Fatty acid transport proteins (FATP) of this family transport long-chain or very-long-chain fatty acids across the plasma membrane. At least five copies of FATPs are identified in mammalian cells. This family includes hsFATP2, hsFATP5, and hsFATP6, and similar proteins. Each FATP has unique patterns of tissue distribution. These FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. The hsFATP proteins exist in two splice variants; the b variant, lacking exon 3, has no acyl-CoA synthetase activity. FATPs are key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341261 [Multi-domain] Cd Length: 537 Bit Score: 62.69 E-value: 3.17e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 488 SLTYRELNKAANRLARHLRMKGVVRQ-EPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYpadRIRYILHDCGCSH--- 563
Cdd:cd05938 5 TYTYRDVDRRSNQAARALLAHAGLRPgDTVALLLGNEPAFLWIWLGLAKLGCPVAFLNTNI---RSKSLLHCFRCCGakv 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 564 -VVS-------QAHLPSSLEDNYII------THPEDIES---KVDGSNIKSV--------NNADDLLYmIYTSGTTGKPK 618
Cdd:cd05938 82 lVVApelqeavEEVLPALRADGVSVwylshtSNTEGVISlldKVDAASDEPVpaslrahvTIKSPALY-IYTSGTTGLPK 160
|
....*..
gi 1678550997 619 GVQFEHR 625
Cdd:cd05938 161 AARISHL 167
|
|
| PRK07867 |
PRK07867 |
acyl-CoA synthetase; Validated |
601-889 |
3.30e-09 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236120 [Multi-domain] Cd Length: 529 Bit Score: 62.78 E-value: 3.30e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 601 ADDLLYMIYTSGTTGKPKGVQFEHRNMAnllkfeythsgidFEADVL--QFATPSFDVCY--QEIFS----------ALL 666
Cdd:PRK07867 151 PDDLFMLIFTSGTSGDPKAVRCTHRKVA-------------SAGVMLaqRFGLGPDDVCYvsMPLFHsnavmagwavALA 217
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 667 KGGTLhivpeAIKR--DVPQLFAFINKHQT---NIVFLPTAFIkMIFSERelansfPDGVKH--LIAAGEQLMISDLfQD 739
Cdd:PRK07867 218 AGASI-----ALRRkfSASGFLPDVRRYGAtyaNYVGKPLSYV-LATPER------PDDADNplRIVYGNEGAPGDI-AR 284
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 740 VLRKRGIHLHNHYGPSETHVVSTYTihpgdpiPELPP--IGKPIGctDLYILNHQKqLQPCGVP--------------GE 803
Cdd:PRK07867 285 FARRFGCVVVDGFGSTEGGVAITRT-------PDTPPgaLGPLPP--GVAIVDPDT-GTECPPAedadgrllnadeaiGE 354
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 804 LY-ISGASVARGYVNHDKLTSDKFSSDpfkpdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHP 882
Cdd:PRK07867 355 LVnTAGPGGFEGYYNDPEADAERMRGG-------VYWSGDLAYRDADGYAYFAGRLGDWMRVDGENLGTAPIERILLRYP 427
|
....*..
gi 1678550997 883 DISEAAI 889
Cdd:PRK07867 428 DATEVAV 434
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
3152-3393 |
3.78e-09 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 63.14 E-value: 3.78e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3152 VQEDALRKTLKAITCHHDALRMVFTQNEQGKWDQYNRPLshsddALYGLQMIDLS-APDGTDGNRPyepLIKRhvlDIQQ 3230
Cdd:PRK10252 42 LDAPLLARAVVAGLAEADTLRMRFTEDNGEVWQWVDPAL-----TFPLPEIIDLRtQPDPHAAAQA---LMQA---DLQQ 110
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3231 KMDLKNG-PLLQAGLFHTIDGDFL-FLSAHHLVVDGISWRVLLEDLALGYRQAAGGEdiklPPKTSSFKAYAKKLSDYA- 3307
Cdd:PRK10252 111 DLRVDSGkPLVFHQLIQLGDNRWYwYQRYHHLLVDGFSFPAITRRIAAIYCAWLRGE----PTPASPFTPFADVVEEYQr 186
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3308 --ESQQLMKQLKYWREaeeyQTEALP-FDQIDGTRAhEGQRSTISFtLNDK---ETAALLKDANSAYNTDTQDMLLASVI 3381
Cdd:PRK10252 187 yrASEAWQRDAAFWAE----QRRQLPpPASLSPAPL-PGRSASADI-LRLKlefTDGAFRQLAAQASGVQRPDLALALVA 260
|
250
....*....|..
gi 1678550997 3382 LALRHWTNQSAF 3393
Cdd:PRK10252 261 LWLGRLCGRMDY 272
|
|
| PRK05850 |
PRK05850 |
acyl-CoA synthetase; Validated |
2557-2956 |
3.83e-09 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235624 [Multi-domain] Cd Length: 578 Bit Score: 62.65 E-value: 3.83e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2557 KTLTYQELDEWSNGIARALRSRGVKPDTPVgIMMHRSFSMIASILGVWKAGGCYVPIDPEYP---KERKRYILSDSGTKL 2633
Cdd:PRK05850 34 ETLTWSQLYRRTLNVAEELRRHGSTGDRAV-ILAPQGLEYIVAFLGALQAGLIAVPLSVPQGgahDERVSAVLRDTSPSV 112
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2634 LMTINeADLGVLADFEGE--------ILTIESVEEDdkSPLPQMSSAHHL---AYIIYTSGTTGRPKGVMVEHKG-IANT 2701
Cdd:PRK05850 113 VLTTS-AVVDDVTEYVAPqpgqsappVIEVDLLDLD--SPRGSDARPRDLpstAYLQYTSGSTRTPAGVMVSHRNvIANF 189
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2702 LQWRRNAYAFNET-----DTILQLFSFSFD-GFITSMFTPLLSGAKAVLLH-----EEEAKDI--LAIKHQ--------- 2759
Cdd:PRK05850 190 EQLMSDYFGDTGGvpppdTTVVSWLPFYHDmGLVLGVCAPILGGCPAVLTSpvaflQRPARWMqlLASNPHafsaapnfa 269
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2760 --LSRQRITH--MiivpvlyrALLDV------------VQPEDVK-------------------------TLRVVT-LAG 2797
Cdd:PRK05850 270 feLAVRKTSDddM--------AGLDLggvlgiisgserVHPATLKrfadrfapfnlretairpsyglaeaTVYVATrEPG 341
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2798 EAAD-RELIARSLAicphtelANEYGPTENSVATtvmrhmekqAYVSIGQPiDGTQVLILNSNHQLQ-PIGVAGELCIAG 2875
Cdd:PRK05850 342 QPPEsVRFDYEKLS-------AGHAKRCETGGGT---------PLVSYGSP-RSPTVRIVDPDTCIEcPAGTVGEIWVHG 404
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2876 TGLARGYVNLPELTERAF-----TQNPFKPEARMYRTGDAArWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKG 2950
Cdd:PRK05850 405 DNVAAGYWQKPEETERTFgatlvDPSPGTPEGPWLRTGDLG-FISEGELFIVGRIKDLLIVDGRNHYPDDIEATIQEITG 483
|
....*.
gi 1678550997 2951 VKDAAV 2956
Cdd:PRK05850 484 GRVAAI 489
|
|
| PRK05850 |
PRK05850 |
acyl-CoA synthetase; Validated |
464-630 |
3.96e-09 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235624 [Multi-domain] Cd Length: 578 Bit Score: 62.65 E-value: 3.96e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 464 TIHAMFEKQAEKTPD--AHAVID-------QACSLTYRELNKAANRLARHLRMKGVVRqEPVAIMMERSAAFITGVLGIL 534
Cdd:PRK05850 2 SVPSLLRERASLQPDdaAFTFIDyeqdpagVAETLTWSQLYRRTLNVAEELRRHGSTG-DRAVILAPQGLEYIVAFLGAL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 535 KAGGAIVPVD-PHYPA--DRIRYILHDCGCSHVVSQahlpSSLEDN---YIITHPEDIESKV-----------DGSNIKS 597
Cdd:PRK05850 81 QAGLIAVPLSvPQGGAhdERVSAVLRDTSPSVVLTT----SAVVDDvteYVAPQPGQSAPPVievdlldldspRGSDARP 156
|
170 180 190
....*....|....*....|....*....|....
gi 1678550997 598 VNnADDLLYMIYTSGTTGKPKGVQFEHRN-MANL 630
Cdd:PRK05850 157 RD-LPSTAYLQYTSGSTRTPAGVMVSHRNvIANF 189
|
|
| PKS_PP |
smart00823 |
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the ... |
3033-3106 |
4.00e-09 |
|
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the prosthetic group of acyl carrier proteins (ACP) in some multienzyme complexes where it serves as a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups.
Pssm-ID: 214834 [Multi-domain] Cd Length: 86 Bit Score: 56.10 E-value: 4.00e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3033 LPPSSKMEQILADI---WKEVLG---AEKIGTADSFFELGGDSIKALQVSARLHR-IGKQMAVKDLFSHPTIQELAAYIR 3105
Cdd:smart00823 4 LPPAERRRLLLDLVreqVAAVLGhaaAEAIDPDRPFRDLGLDSLMAVELRNRLEAaTGLRLPATLVFDHPTPAALAEHLA 83
|
.
gi 1678550997 3106 D 3106
Cdd:smart00823 84 A 84
|
|
| PRK05851 |
PRK05851 |
long-chain-fatty acid--ACP ligase MbtM; |
1836-1980 |
4.07e-09 |
|
long-chain-fatty acid--ACP ligase MbtM;
Pssm-ID: 180289 [Multi-domain] Cd Length: 525 Bit Score: 62.48 E-value: 4.07e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1836 IGELYIAGAGVARGYLNrpalteerflEDPFYPGErMYKTGDVArWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRS 1915
Cdd:PRK05851 372 IGEIEIRGASMMSGYLG----------QAPIDPDD-WFPTGDLG-YLVDGGLVVCGRAKELITVAGRNIFPTEIERVAAQ 439
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 1916 IEGVREAAV-TVRTDSG--EPELCAYVE--GLQRNEVRAQL-ERLLP--GyMVPAYMIEME--QWPVTPSGKLDR 1980
Cdd:PRK05851 440 VRGVREGAVvAVGTGEGsaRPGLVIAAEfrGPDEAGARSEVvQRVASecG-VVPSDVVFVApgSLPRTSSGKLRR 513
|
|
| hsFATP4_like |
cd05939 |
Fatty acid transport proteins (FATP), including FATP4 and FATP1, and similar proteins; Fatty ... |
489-930 |
4.35e-09 |
|
Fatty acid transport proteins (FATP), including FATP4 and FATP1, and similar proteins; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. At least five copies of FATPs are identified in mammalian cells. This family includes FATP4, FATP1, and homologous proteins. Each FATP has unique patterns of tissue distribution. FATP4 is mainly expressed in the brain, testis, colon and kidney. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341262 [Multi-domain] Cd Length: 474 Bit Score: 62.06 E-value: 4.35e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 489 LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSQa 568
Cdd:cd05939 4 WTFRELNEYSNKVANFFQAQGYRSGDVVALFMENRLEFVALWLGLAKIGVETALINSNLRLESLLHCITVSKAKALIFN- 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 569 HLPSSLEDNYiiTHPEDIESKvdgsniksvnNADDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEYTHSGIDfEADVLQ 648
Cdd:cd05939 83 LLDPLLTQSS--TEPPSQDDV----------NFRDKLFYIYTSGTTGLPKAAVIVHSRYYRIAAGAYYAFGMR-PEDVVY 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 649 FATPSFD-----VCyqeIFSALLKGGTLHIVPeaiKRDVPQLFAFINKHQTNIVflptAFIKMIFSERELANSFPDGVKH 723
Cdd:cd05939 150 DCLPLYHsaggiMG---VGQALLHGSTVVIRK---KFSASNFWDDCVKYNCTIV----QYIGEICRYLLAQPPSEEEQKH 219
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 724 LI--AAGEQLMISdLFQDVLRKRGI-HLHNHYGPSE---------THV-----VSTY--TIHPGDPIPELPPIGKPIGCT 784
Cdd:cd05939 220 NVrlAVGNGLRPQ-IWEQFVRRFGIpQIGEFYGATEgnsslvnidNHVgacgfNSRIlpSVYPIRLIKVDEDTGELIRDS 298
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 785 DlyilnhqKQLQPCGvPGElyiSGASVAR-----------GYVNhDKLTSDKFSSDPFKPDVIMYRTGDLARRLEDGNIE 853
Cdd:cd05939 299 D-------GLCIPCQ-PGE---PGLLVGKiiqndplrrfdGYVN-EGATNKKIARDVFKKGDSAFLSGDVLVMDELGYLY 366
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 854 YIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQ--DQNGEHELCAYYCSVQKLNTIDLRSYMASELPEYMIP 930
Cdd:cd05939 367 FKDRTGDTFRWKGENVSTTEVEGILSNVLGLEDVVVYGVEvpGVEGRAGMAAIVDPERKVDLDRFSAVLAKSLPPYARP 445
|
|
| PRK09192 |
PRK09192 |
fatty acyl-AMP ligase; |
489-898 |
6.62e-09 |
|
fatty acyl-AMP ligase;
Pssm-ID: 236403 [Multi-domain] Cd Length: 579 Bit Score: 61.94 E-value: 6.62e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 489 LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGgaIVPVDPHYPA---------DRIRYILHDC 559
Cdd:PRK09192 50 LPYQTLRARAEAGARRLLALGLKPGDRVALIAETDGDFVEAFFACQYAG--LVPVPLPLPMgfggresyiAQLRGMLASA 127
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 560 GCSHVVSQAHL-------PSSLEDNYIIThPEDIESKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRN-MANLL 631
Cdd:PRK09192 128 QPAAIITPDELlpwvneaTHGNPLLHVLS-HAWFKALPEADVALPRPTPDDIAYLQYSSGSTRFPRGVIITHRAlMANLR 206
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 632 KfeYTHSGIDFEA------------------------------DVL---QFA-------------------TPSF--DVC 657
Cdd:PRK09192 207 A--ISHDGLKVRPgdrcvswlpfyhdmglvgflltpvatqlsvDYLptrDFArrplqwldlisrnrgtisySPPFgyELC 284
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 658 YQEIFSALLKGGTLH------IVPEAIKRDVPQLFA--FINKHqtnivFLPTAFIKMI-FSERELANSFPDgvkhlIAAG 728
Cdd:PRK09192 285 ARRVNSKDLAELDLScwrvagIGADMIRPDVLHQFAeaFAPAG-----FDDKAFMPSYgLAEATLAVSFSP-----LGSG 354
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 729 EQLMISDLfqDVLRKRGIHLHNhygPSETHVVSTYTIhpgdpipelppIGKPIGCTDLYILNHQKQLQPCGVPGELYISG 808
Cdd:PRK09192 355 IVVEEVDR--DRLEYQGKAVAP---GAETRRVRTFVN-----------CGKALPGHEIEIRNEAGMPLPERVVGHICVRG 418
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 809 ASVARGYVNhDKLTSDKFSSDPFkpdvimYRTGDLARrLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDI--SE 886
Cdd:PRK09192 419 PSLMSGYFR-DEESQDVLAADGW------LDTGDLGY-LLDGYLYITGRAKDLIIINGRNIWPQDIEWIAEQEPELrsGD 490
|
490
....*....|..
gi 1678550997 887 AAILIWQDQNGE 898
Cdd:PRK09192 491 AAAFSIAQENGE 502
|
|
| PRK00174 |
PRK00174 |
acetyl-CoA synthetase; Provisional |
1859-1939 |
7.19e-09 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 234677 [Multi-domain] Cd Length: 637 Bit Score: 61.70 E-value: 7.19e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1859 ERFLEDPF--YPGerMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GEpE 1934
Cdd:PRK00174 471 ERFVKTYFstFKG--MYFTGDGARRDEDGYYWITGRVDDVLNVSGHRLGTAEIESALVAHPKVAEAAVVGRPDDikGQ-G 547
|
....*
gi 1678550997 1935 LCAYV 1939
Cdd:PRK00174 548 IYAFV 552
|
|
| LC_FACS_bac1 |
cd17641 |
bacterial long-chain fatty acid CoA synthetase; The members of this family are bacterial ... |
2557-2972 |
9.04e-09 |
|
bacterial long-chain fatty acid CoA synthetase; The members of this family are bacterial long-chain fatty acid CoA synthetase, most of which are as yet uncharacterized. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341296 [Multi-domain] Cd Length: 569 Bit Score: 61.28 E-value: 9.04e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2557 KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMT 2636
Cdd:cd17641 10 QEFTWADYADRVRAFALGLLALGVGRGDVVAILGDNRPEWVWAELAAQAIGALSLGIYQDSMAEEVAYLLNYTGARVVIA 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2637 INEADLGVLADFEGEILTIESVEEDDKSPL-----PQMSS---------AHH------------------LAYIIYTSGT 2684
Cdd:cd17641 90 EDEEQVDKLLEIADRIPSVRYVIYCDPRGMrkyddPRLISfedvvalgrALDrrdpglyerevaagkgedVAVLCTTSGT 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2685 TGRPKGVMVEHKGIANTLQWRRNAYAFNETDTILQLFSFSFDG-FITSMFTPLLSGAKAVLLHEEEA--KDILAI----- 2756
Cdd:cd17641 170 TGKPKLAMLSHGNFLGHCAAYLAADPLGPGDEYVSVLPLPWIGeQMYSVGQALVCGFIVNFPEEPETmmEDLREIgptfv 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2757 -------KHQLSRQRITHMIIVPV---LYRALLDVVQP--EDVKTLRVVTLAGEAAD---RELIARSL------------ 2809
Cdd:cd17641 250 llpprvwEGIAADVRARMMDATPFkrfMFELGMKLGLRalDRGKRGRPVSLWLRLASwlaDALLFRPLrdrlgfsrlrsa 329
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2810 -----AICPHT---------ELANEYGPTENSVATTVmrHMEKQA-YVSIGQPIDGTQVLILNsnhqlqpigvAGELCIA 2874
Cdd:cd17641 330 atggaALGPDTfrffhaigvPLKQLYGQTELAGAYTV--HRDGDVdPDTVGVPFPGTEVRIDE----------VGEILVR 397
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2875 GTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMADGTLEYLGRIDDQVKI-RGYRVETKEIESVIRCIKGVKD 2953
Cdd:cd17641 398 SPGVFVGYYKNPEATAEDFDEDGW------LHTGDAGYFKENGHLVVIDRAKDVGTTsDGTRFSPQFIENKLKFSPYIAE 471
|
490
....*....|....*....
gi 1678550997 2954 AAVVAHvtasGQTELSAYV 2972
Cdd:cd17641 472 AVVLGA----GRPYLTAFI 486
|
|
| PRK08043 |
PRK08043 |
bifunctional acyl-ACP--phospholipid O-acyltransferase/long-chain-fatty-acid--ACP ligase; |
1603-1979 |
1.08e-08 |
|
bifunctional acyl-ACP--phospholipid O-acyltransferase/long-chain-fatty-acid--ACP ligase;
Pssm-ID: 181207 [Multi-domain] Cd Length: 718 Bit Score: 61.26 E-value: 1.08e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1603 HVPEFTGEI--VYLNQTNSG---------LAHRLSnPNVDVLPQS---LAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQ 1668
Cdd:PRK08043 320 HLPEQLTQVrwVYLEDLKDDvttadklwiFAHLLM-PRLAQVKQQpedAALILFTSGSEGHPKGVVHSHKSLLANVEQIK 398
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1669 SRYQLKHSDMIMHKTS--YSFDASIwELFWWPYAGASVYLLPQggekeP---EVIAKAIEEQKITAMhFVPSmlhAFLEH 1743
Cdd:PRK08043 399 TIADFTPNDRFMSALPlfHSFGLTV-GLFTPLLTGAEVFLYPS-----PlhyRIVPELVYDRNCTVL-FGTS---TFLGN 468
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1744 IKYRSVPIKTNRLKRVFSGGEQLGTHlVSRFYELLPNVSITNSYGPTEatveaaffdCPPHEKLErIPIGKPVHHVRLYL 1823
Cdd:PRK08043 469 YARFANPYDFARLRYVVAGAEKLQES-TKQLWQDKFGLRILEGYGVTE---------CAPVVSIN-VPMAAKPGTVGRIL 537
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1824 LNQNQRMLPVGCI---GELYIAGAGVARGYL--NRPALTEERFLEDPfyPGER---MYKTGDVARWLPDGNVEFLGRTDD 1895
Cdd:PRK08043 538 PGMDARLLSVPGIeqgGRLQLKGPNIMNGYLrvEKPGVLEVPTAENA--RGEMergWYDTGDIVRFDEQGFVQIQGRAKR 615
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1896 QVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDSGEPElcAYV-----EGLQRNEVRAQLERL-LPGYMVPAYMIEMEQ 1969
Cdd:PRK08043 616 FAKIAGEMVSLEMVEQLALGVSPDKQHATAIKSDASKGE--ALVlfttdSELTREKLQQYAREHgVPELAVPRDIRYLKQ 693
|
410
....*....|
gi 1678550997 1970 WPVTPSGKLD 1979
Cdd:PRK08043 694 LPLLGSGKPD 703
|
|
| X-Domain_NRPS |
cd19546 |
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to ... |
60-314 |
1.77e-08 |
|
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to the non-ribosomal peptide synthetase (NRPS); The X-domain is a catalytically inactive member of the Condensation (C) domain family of non-ribosomal peptide synthetase (NRPS). It has been shown to recruit oxygenases to the NRPS to perform side-chain crosslinking in the production of glycopeptide antibiotics. C-domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as this X-domain, the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, and dual E/C (epimerization and condensation) domains. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity; members of this X-domain subfamily lack the second H of this motif.
Pssm-ID: 380468 [Multi-domain] Cd Length: 440 Bit Score: 60.19 E-value: 1.77e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 60 RHDIFRTIFISQNVSSPQQVVLRERNVIVLEedITHLNEAEQSQFIEQwkekDRDRGFHLQKDVLMRIALIQTGESQYSC 139
Cdd:cd19546 54 RHEILRTTFPGDGGDVHQRILDADAARPELP--VVPATEEELPALLAD----RAAHLFDLTRETPWRCTLFALSDTEHVL 127
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 140 IWTFHHIMMDGWCLSIVLKEFLHIYASYVNA-----SPITLEpvqpYGKYIKW---LM--EQDKE----QAVSYWDHYLS 205
Cdd:cd19546 128 LLVVHRIAADDESLDVLVRDLAAAYGARREGraperAPLPLQ----FADYALWereLLagEDDRDsligDQIAYWRDALA 203
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 206 GHEQQTVLPKQKKTKGKS--RQEHVTFSFSKEESSRLSELAAREEVTLSTIFHTIWGILLQKYNNNDDAVFGSVISgRPA 283
Cdd:cd19546 204 GAPDELELPTDRPRPVLPsrRAGAVPLRLDAEVHARLMEAAESAGATMFTVVQAALAMLLTRLGAGTDVTVGTVLP-RDD 282
|
250 260 270
....*....|....*....|....*....|..
gi 1678550997 284 EIEGIEHMVGLFINTMPVRVQGAKTP-FLQLI 314
Cdd:cd19546 283 EEGDLEGMVGPFARPLALRTDLSGDPtFRELL 314
|
|
| PRK07445 |
PRK07445 |
O-succinylbenzoic acid--CoA ligase; Reviewed |
1813-1984 |
1.91e-08 |
|
O-succinylbenzoic acid--CoA ligase; Reviewed
Pssm-ID: 236019 [Multi-domain] Cd Length: 452 Bit Score: 60.01 E-value: 1.91e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1813 GKPVHHVRLYLLNQNqrmlpvgcIGELYIAGAGVARGYLnrPALTEERfledpfypgeRMYKTGDVARWLPDGNVEFLGR 1892
Cdd:PRK07445 286 GQVLPHAQITIPANQ--------TGNITIQAQSLALGYY--PQILDSQ----------GIFETDDLGYLDAQGYLHILGR 345
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1893 TDDQVKIRGYRIEPGEIEAALRSIEGVREAAVTVRTDS--GEPELCAYV---EGLQRNEVRAQLERLLPGYMVPAYMIEM 1967
Cdd:PRK07445 346 NSQKIITGGENVYPAEVEAAILATGLVQDVCVLGLPDPhwGEVVTAIYVpkdPSISLEELKTAIKDQLSPFKQPKHWIPV 425
|
170
....*....|....*..
gi 1678550997 1968 EQWPVTPSGKLDRNALP 1984
Cdd:PRK07445 426 PQLPRNPQGKINRQQLQ 442
|
|
| E_NRPS |
cd19534 |
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
12-324 |
1.98e-08 |
|
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Epimerization (E) domains of nonribosomal peptide synthetases (NRPS) flip the chirality of the end amino acid of a peptide being manufactured by the NRPS. E-domains are homologous to the Condensation (C) domains. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Specialized tailoring NRPS domains such as E-domains greatly increase the range of possible peptide products created by the NRPS machinery. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the E-domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380457 [Multi-domain] Cd Length: 428 Bit Score: 59.96 E-value: 1.98e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 12 PLSYMQEgMLFHslLQKDSQAYVEQA-SFTIEGKVNPQFFQNSINALVERHDIFRTIFiSQNVSSPQQVVLR-ERNVIVL 89
Cdd:cd19534 3 PLTPIQR-WFFE--QNLAGRHHFNQSvLLRVPQGLDPDALRQALRALVEHHDALRMRF-RREDGGWQQRIRGdVEELFRL 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 90 E-EDITHLNEAEQsqfIEQwKEKDRDRGFHLQKDVLMRIALIQTGESQYSCIWTFHHIMMDG--WclSIVLKEFLHIYAS 166
Cdd:cd19534 79 EvVDLSSLAQAAA---IEA-LAAEAQSSLDLEEGPLLAAALFDGTDGGDRLLLVIHHLVVDGvsW--RILLEDLEAAYEQ 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 167 YVNASPITLEPVQPYGKYIKWLMEQDKEQAVS----YWDHYLSGHEQQtvLPK-QKKTKGKSRQehVTFSFSKEESSRL- 240
Cdd:cd19534 153 ALAGEPIPLPSKTSFQTWAELLAEYAQSPALLeelaYWRELPAADYWG--LPKdPEQTYGDART--VSFTLDEEETEALl 228
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 241 SELAAReevtLST----IFHTIWGILLQKYNNNDDavfgSVIS----GRPAEIEGIEHM--VGLFiNTM-PVRVQ-GAKT 308
Cdd:cd19534 229 QEANAA----YRTeindLLLAALALAFQDWTGRAP----PAIFleghGREEIDPGLDLSrtVGWF-TSMyPVVLDlEASE 299
|
330
....*....|....*.
gi 1678550997 309 PFLQLIKDMqKDRLAA 324
Cdd:cd19534 300 DLGDTLKRV-KEQLRR 314
|
|
| prpE |
PRK10524 |
propionyl-CoA synthetase; Provisional |
1497-1985 |
2.59e-08 |
|
propionyl-CoA synthetase; Provisional
Pssm-ID: 182517 [Multi-domain] Cd Length: 629 Bit Score: 59.96 E-value: 2.59e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1497 HYALEQQAEKTPDQAAVIF------EDGVMTYKELNEQANRIAWELIGRGVKPETTVAI----IGKRSPEML----LG-- 1560
Cdd:PRK10524 56 HNAVDRHLAKRPEQLALIAvstetdEERTYTFRQLHDEVNRMAAMLRSLGVQRGDRVLIympmIAEAAFAMLacarIGai 135
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1561 ---IYGILKAGGAYLPIDPDYPEERISfllEDSGT---NIL----LLQSAgLHVPEFTGEIVYLnqTNSGLAHRLSNPNV 1630
Cdd:PRK10524 136 hsvVFGGFASHSLAARIDDAKPVLIVS---ADAGSrggKVVpykpLLDEA-IALAQHKPRHVLL--VDRGLAPMARVAGR 209
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1631 DVLPQSL-------------------AYVIYTSGSTGMPKGVEiehRS----AVNFLNSLQsryqlkhsdmimhktsYSF 1687
Cdd:PRK10524 210 DVDYATLraqhlgarvpvewlesnepSYILYTSGTTGKPKGVQ---RDtggyAVALATSMD----------------TIF 270
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1688 DASIWELFW------W----PY-------AGAS--VY----LLPQGGekepeVIAKAIEEQKITAMHFVPSMLH------ 1738
Cdd:PRK10524 271 GGKAGETFFcasdigWvvghSYivyapllAGMAtiMYeglpTRPDAG-----IWWRIVEKYKVNRMFSAPTAIRvlkkqd 345
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1739 -AFLEhiKYrsvpiKTNRLKRVFSGGEQLGTHLVSRFYELLpNVSITNSYGPTEaTVEAAFFDCPpheKLERIPI----- 1812
Cdd:PRK10524 346 pALLR--KH-----DLSSLRALFLAGEPLDEPTASWISEAL-GVPVIDNYWQTE-TGWPILAIAR---GVEDRPTrlgsp 413
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1813 GKPVHHVRLYLLNQ--------NQR-------MLPVGCIGELYiagagvarGylnrpalTEERFLEDPFYP-GERMYKTG 1876
Cdd:PRK10524 414 GVPMYGYNVKLLNEvtgepcgpNEKgvlviegPLPPGCMQTVW--------G-------DDDRFVKTYWSLfGRQVYSTF 478
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1877 DVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAV----------------TVRTDSG--EPELCAY 1938
Cdd:PRK10524 479 DWGIRDADGYYFILGRTDDVINVAGHRLGTREIEESISSHPAVAEVAVvgvkdalkgqvavafvVPKDSDSlaDREARLA 558
|
570 580 590 600
....*....|....*....|....*....|....*....|....*..
gi 1678550997 1939 VEGlqrnEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNALPA 1985
Cdd:PRK10524 559 LEK----EIMALVDSQLGAVARPARVWFVSALPKTRSGKLLRRAIQA 601
|
|
| PRK13388 |
PRK13388 |
acyl-CoA synthetase; Provisional |
2534-3019 |
3.13e-08 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237374 [Multi-domain] Cd Length: 540 Bit Score: 59.66 E-value: 3.13e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2534 TISQLFEQQAarTPKASALVSGDKTLTYQELDEWSNGIARALRSRGvKPDTP--VGIMMHRSFSMIASILGVWKAGGCYV 2611
Cdd:PRK13388 4 TIAQLLRDRA--GDDTIAVRYGDRTWTWREVLAEAAARAAALIALA-DPDRPlhVGVLLGNTPEMLFWLAAAALGGYVLV 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2612 PIDPeypKERKRYILSD---SGTKLLMTiNEADLGVLA--DFEG-EILTIESVEEDDKSPLPQMSSAH------HLAYII 2679
Cdd:PRK13388 81 GLNT---TRRGAALAADirrADCQLLVT-DAEHRPLLDglDLPGvRVLDVDTPAYAELVAAAGALTPHrevdamDPFMLI 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2680 YTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDT---ILQLFSfsfDGFITSMFTPLL-SGAKAVLLHEEEAKDILA 2755
Cdd:PRK13388 157 FTSGTTGAPKAVRCSHGRLAFAGRALTERFGLTRDDVcyvSMPLFH---SNAVMAGWAPAVaSGAAVALPAKFSASGFLD 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2756 ikhQLSRQRITHMIIV--PVLYrALLDVVQPEDVKTLRVVTLAGEAA--DRELIARSLAIcphtELANEYGPTENSVATT 2831
Cdd:PRK13388 234 ---DVRRYGATYFNYVgkPLAY-ILATPERPDDADNPLRVAFGNEASprDIAEFSRRFGC----QVEDGYGSSEGAVIVV 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2832 VMRHMEKQayvSIGQPIDGtqVLILNSnHQLQPIGVA---------------GELC-IAGTGLARGYVNLPELT-ERAft 2894
Cdd:PRK13388 306 REPGTPPG---SIGRGAPG--VAIYNP-ETLTECAVArfdahgallnadeaiGELVnTAGAGFFEGYYNNPEATaERM-- 377
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2895 qnpfkpeaR--MYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAV-------------VAH 2959
Cdd:PRK13388 378 --------RhgMYWSGDLAYRDADGWIYFAGRTADWMRVDGENLSAAPIERILLRHPAINRVAVyavpdervgdqvmAAL 449
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 2960 VTASGQT----ELSAYVVTKPGLSTNAVrselqnklpvfmhPAFIEKLDSLPLSPNGKLDRGAL 3019
Cdd:PRK13388 450 VLRDGATfdpdAFAAFLAAQPDLGTKAW-------------PRYVRIAADLPSTATNKVLKREL 500
|
|
| PLN02614 |
PLN02614 |
long-chain acyl-CoA synthetase |
1634-1919 |
3.20e-08 |
|
long-chain acyl-CoA synthetase
Pssm-ID: 166255 [Multi-domain] Cd Length: 666 Bit Score: 59.65 E-value: 3.20e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1634 PQSLAYVIYTSGSTGMPKGVEIEHRSAV-------NFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELF--------WWp 1698
Cdd:PLN02614 222 KSDICTIMYTSGTTGDPKGVMISNESIVtliagviRLLKSANAALTVKDVYLSYLPLAHIFDRVIEECFiqhgaaigFW- 300
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1699 yAGASVYLLPQGGEKEPEV---IAKAIE------EQKITAMHFVPSMLhaFLEHIKYRSVPIKT---------------- 1753
Cdd:PLN02614 301 -RGDVKLLIEDLGELKPTIfcaVPRVLDrvysglQKKLSDGGFLKKFV--FDSAFSYKFGNMKKgqshveasplcdklvf 377
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1754 NRLKR--------VFSGGEQLGTHLVSrFYELLPNVSITNSYGPTEATveAAFFDCPPHEKLERIPIGKPVHHVRLYLLN 1825
Cdd:PLN02614 378 NKVKQglggnvriILSGAAPLASHVES-FLRVVACCHVLQGYGLTESC--AGTFVSLPDELDMLGTVGPPVPNVDIRLES 454
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1826 ---QNQRMLPVGCIGELYIAGAGVARGYLNRPALTEERFLEDPFYpgermykTGDVARWLPDGNVEFLGRtddqvKIRGY 1902
Cdd:PLN02614 455 vpeMEYDALASTPRGEICIRGKTLFSGYYKREDLTKEVLIDGWLH-------TGDVGEWQPNGSMKIIDR-----KKNIF 522
|
330
....*....|....*..
gi 1678550997 1903 RIEPGEIeAALRSIEGV 1919
Cdd:PLN02614 523 KLSQGEY-VAVENIENI 538
|
|
| PRK07768 |
PRK07768 |
long-chain-fatty-acid--CoA ligase; Validated |
490-875 |
3.33e-08 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236091 [Multi-domain] Cd Length: 545 Bit Score: 59.62 E-value: 3.33e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 490 TYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIV----P---VD-PHYPAD---RIRYIlhd 558
Cdd:PRK07768 31 TWGEVHERARRIAGGLAAAGVGPGDAVAVLAGAPVEIAPTAQGLWMRGASLTmlhqPtprTDlAVWAEDtlrVIGMI--- 107
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 559 cGCSHVVSQA---HLPSSLEDNYIITHPedIESKVDGSNIKSVN-NADDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFE 634
Cdd:PRK07768 108 -GAKAVVVGEpflAAAPVLEEKGIRVLT--VADLLAADPIDPVEtGEDDLALMQLTSGSTGSPKAVQITHGNLYANAEAM 184
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 635 YTHSGIDFEADVLQFATPSFD-------VCYQEIFSAllkgGTLHIVPEAIKRDvPQLFA-FINKHQTNIVFLPtAFIKM 706
Cdd:PRK07768 185 FVAAEFDVETDVMVSWLPLFHdmgmvgfLTVPMYFGA----ELVKVTPMDFLRD-PLLWAeLISKYRGTMTAAP-NFAYA 258
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 707 IFSEReLANSFPDG------VKHLIAAGEQLMISDL--FQDVLRKRGIH---LHNHYGPSETHVVSTY----------TI 765
Cdd:PRK07768 259 LLARR-LRRQAKPGafdlssLRFALNGAEPIDPADVedLLDAGARFGLRpeaILPAYGMAEATLAVSFspcgaglvvdEV 337
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 766 HP-------------GDPIPELPPIGKPIGCTDLYILNHQKQLQPCGVPGELYISGASVARGYvnhdkLTSDKF--SSDP 830
Cdd:PRK07768 338 DAdllaalrravpatKGNTRRLATLGPPLPGLEVRVVDEDGQVLPPRGVGVIELRGESVTPGY-----LTMDGFipAQDA 412
|
410 420 430 440
....*....|....*....|....*....|....*....|....*
gi 1678550997 831 FKpdviMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIE 875
Cdd:PRK07768 413 DG----WLDTGDLGYLTEEGEVVVCGRVKDVIIMAGRNIYPTDIE 453
|
|
| prpE |
PRK10524 |
propionyl-CoA synthetase; Provisional |
606-895 |
4.65e-08 |
|
propionyl-CoA synthetase; Provisional
Pssm-ID: 182517 [Multi-domain] Cd Length: 629 Bit Score: 59.19 E-value: 4.65e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 606 YMIYTSGTTGKPKGVQfehRN-------MANLLKFEYthsgiDFEADVLQFATPSFD--VCYQEIFSALLKGGTLHIVPE 676
Cdd:PRK10524 237 YILYTSGTTGKPKGVQ---RDtggyavaLATSMDTIF-----GGKAGETFFCASDIGwvVGHSYIVYAPLLAGMATIMYE 308
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 677 A--IKRDVPQLFAFINKHQTNIVF-LPTAfIKMI--FSERELANSFPDGVKHLIAAGEQL--MISDLFQDVLRKRGIhlh 749
Cdd:PRK10524 309 GlpTRPDAGIWWRIVEKYKVNRMFsAPTA-IRVLkkQDPALLRKHDLSSLRALFLAGEPLdePTASWISEALGVPVI--- 384
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 750 NHYGPSETHVvSTYTIHPG-DPIP-ELPPIGKPIGCTDLYILNHQKQlQPCGvPGElyiSGASVARG----------YVN 817
Cdd:PRK10524 385 DNYWQTETGW-PILAIARGvEDRPtRLGSPGVPMYGYNVKLLNEVTG-EPCG-PNE---KGVLVIEGplppgcmqtvWGD 458
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1678550997 818 HDKLTSDKFSSdpFKPDVimYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQ 895
Cdd:PRK10524 459 DDRFVKTYWSL--FGRQV--YSTFDWGIRDADGYYFILGRTDDVINVAGHRLGTREIEESISSHPAVAEVAVVGVKDA 532
|
|
| FCS |
cd05921 |
Feruloyl-CoA synthetase (FCS); Feruloyl-CoA synthetase is an essential enzyme in the feruloyl ... |
490-845 |
4.79e-08 |
|
Feruloyl-CoA synthetase (FCS); Feruloyl-CoA synthetase is an essential enzyme in the feruloyl acid degradation pathway and enables some proteobacteria to grow on media containing feruloyl acid as the sole carbon source. It catalyzes the transfer of CoA to the carboxyl group of ferulic acid, which then forms feruloyl-CoA in the presence of ATP and Mg2. The resulting feruloyl-CoA is further degraded to vanillin and acetyl-CoA. Feruloyl-CoA synthetase (FCS) is a subfamily of the adenylate-forming enzymes superfamily.
Pssm-ID: 341245 [Multi-domain] Cd Length: 561 Bit Score: 58.98 E-value: 4.79e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 490 TYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPA-----DRIRYI--------- 555
Cdd:cd05921 27 TYAEALRQVRAIAQGLLDLGLSAERPLLILSGNSIEHALMALAAMYAGVPAAPVSPAYSLmsqdlAKLKHLfellkpglv 106
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 556 --------------LHDCGCSHVVSQAHLpsslEDNYIITHPEDIESKVDGSNIKSVNNA--DDLLYMIYTSGTTGKPKG 619
Cdd:cd05921 107 faqdaapfaralaaIFPLGTPLVVSRNAV----AGRGAISFAELAATPPTAAVDAAFAAVgpDTVAKFLFTSGSTGLPKA 182
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 620 VQFEHRNM-ANLLKFEYTHSGIDFEADVLQFATPsfdvcYQEIFSA-------LLKGGTLHIvpeAIKRDVPQLFAFINK 691
Cdd:cd05921 183 VINTQRMLcANQAMLEQTYPFFGEEPPVLVDWLP-----WNHTFGGnhnfnlvLYNGGTLYI---DDGKPMPGGFEETLR 254
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 692 HQTNIVflPTAFI------KMIFSERE----LANSFPDGVKHLIAAGEQLM--ISDLFQDVLRK---RGIHLHNHYGPSE 756
Cdd:cd05921 255 NLREIS--PTVYFnvpagwEMLVAALEkdeaLRRRFFKRLKLMFYAGAGLSqdVWDRLQALAVAtvgERIPMMAGLGATE 332
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 757 THVVSTYTIHPGDPIPElppIGKPIGCTDLyilnhqkQLQPCGVPGELYISGASVARGYVNHDKLTSDKFSSDPFkpdvi 836
Cdd:cd05921 333 TAPTATFTHWPTERSGL---IGLPAPGTEL-------KLVPSGGKYEVRVKGPNVTPGYWRQPELTAQAFDEEGF----- 397
|
....*....
gi 1678550997 837 mYRTGDLAR 845
Cdd:cd05921 398 -YCLGDAAK 405
|
|
| AMP-binding_C |
pfam13193 |
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to ... |
2940-3013 |
5.15e-08 |
|
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to pfam00501. It has a central beta sheet core that is flanked by alpha helices.
Pssm-ID: 463804 [Multi-domain] Cd Length: 76 Bit Score: 52.55 E-value: 5.15e-08
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 2940 EIESVIRCIKGVKDAAVVA-HVTASGQTeLSAYVVTKPG--LSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGK 3013
Cdd:pfam13193 1 EVESALVSHPAVAEAAVVGvPDELKGEA-PVAFVVLKPGveLLEEELVAHVREELGPYAVPKEVVFVDELPKTRSGK 76
|
|
| PRK06334 |
PRK06334 |
long chain fatty acid--[acyl-carrier-protein] ligase; Validated |
473-952 |
5.83e-08 |
|
long chain fatty acid--[acyl-carrier-protein] ligase; Validated
Pssm-ID: 180533 [Multi-domain] Cd Length: 539 Bit Score: 58.67 E-value: 5.83e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 473 AEKTPDAHAVIDQACSLTYRELNKAANRLARHLRMkgvVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRI 552
Cdd:PRK06334 30 SEMTTATVCWDEQLGKLSYNQVRKAVIALATKVSK---YPDQHIGIMMPASAGAYIAYFATLLSGKIPVMINWSQGLREV 106
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 553 RYILHDCGCSHVVSQAHLPSSLEDnyiiTHPEDIE---------------SKVDGSNIK----------------SVNNA 601
Cdd:PRK06334 107 TACANLVGVTHVLTSKQLMQHLAQ----THGEDAEypfsliymeevrkelSFWEKCRIGiymsipfewlmrwfgvSDKDP 182
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 602 DDLLYMIYTSGTTGKPKGVQFEHrnmANLLkfEYTHSGIDF----EADV-LQFATP----SFDVCyqEIFSaLLKGgtLH 672
Cdd:PRK06334 183 EDVAVILFTSGTEKLPKGVPLTH---ANLL--ANQRACLKFfspkEDDVmMSFLPPfhayGFNSC--TLFP-LLSG--VP 252
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 673 IVPEAIKRDVPQLFAFINKhqTNIVFLPTA--FIKMIFSERELANSFPDGVKHLIAAGeqlmisDLFQDVLRKRG----- 745
Cdd:PRK06334 253 VVFAYNPLYPKKIVEMIDE--AKVTFLGSTpvFFDYILKTAKKQESCLPSLRFVVIGG------DAFKDSLYQEAlktfp 324
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 746 -IHLHNHYGPSETHVVSTYTIHPGDPIPELppIGKPIGCTDLYILNHQKQLQ-PCGVPGELYISGASVARGYVNHD---- 819
Cdd:PRK06334 325 hIQLRQGYGTTECSPVITINTVNSPKHESC--VGMPIRGMDVLIVSEETKVPvSSGETGLVLTRGTSLFSGYLGEDfgqg 402
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 820 --KLTSDKFssdpfkpdvimYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNH---PDISEAAILIWQD 894
Cdd:PRK06334 403 fvELGGETW-----------YVTGDLGYVDRHGELFLKGRLSRFVKIGAEMVSLEALESILMEGfgqNAADHAGPLVVCG 471
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 895 QNGEHE-LCAYY---CSVQKLNTIdLRSYMASELpeyMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PRK06334 472 LPGEKVrLCLFTtfpTSISEVNDI-LKNSKTSSI---LKISYHHQVESIPMLGTGKPDYCSL 529
|
|
| AFD_CAR-like |
cd17632 |
adenylation domain of carboxylic acid reductase (CAR); This family contains the adenylation ... |
2532-2991 |
5.88e-08 |
|
adenylation domain of carboxylic acid reductase (CAR); This family contains the adenylation domain of carboxylic acid reductase enzymes (CARs), and performs an equivalent function to that of the ANL superfamily of adenylating enzymes. It takes a carboxylic acid substrate and ATP, and produces an AMP-acyl phosphoester intermediate, releasing pyrophosphate. Kinetic analysis using various substrates shows that this enzyme has a broad but similar substrate specificity, preferring electron-rich acids. This suggests that attack by the carboxylate on the alpha-phosphate of adenosine triphosphate (ATP) is the step that determines the substrate specificity and reaction kinetics. CAR is an important enzyme for use as a biocatalyst providing regiospecific route to aldehydes from their respective carboxylic acids.
Pssm-ID: 341287 [Multi-domain] Cd Length: 588 Bit Score: 58.62 E-value: 5.88e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2532 VQTISQLFEQQAARTPKASALVSGDKT--LTYQELDEWSNGIARALRSRG------------VKPDTPVGIMMHRSFSMI 2597
Cdd:cd17632 28 IATVMTGYADRPALGQRATELVTDPATgrTTLRLLPRFETITYAELWERVgavaaahdpeqpVRPGDFVAVLGFTSPDYA 107
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2598 ASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMTINEA-DLGVLADFEG-------------------------- 2650
Cdd:cd17632 108 TVDLALTRLGAVSVPLQAGASAAQLAPILAETEPRLLAVSAEHlDLAVEAVLEGgtpprlvvfdhrpevdahraalesar 187
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2651 ----------EILTIESVEEDDKSPLPQM---SSAHHLAYIIYTSGTTGRPKGVMVEHKGIANTLQWRRNAYAFNETDTI 2717
Cdd:cd17632 188 erlaavgipvTTLTLIAVRGRDLPPAPLFrpePDDDPLALLIYTSGSTGTPKGAMYTERLVATFWLKVSSIQDIRPPASI 267
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2718 -LQLFSFSFDGFITSMFTPLLSGAKAVLLheeEAKDILAIKHQLSRQRITHMIIVPVL-------YRALLD--VVQPEDV 2787
Cdd:cd17632 268 tLNFMPMSHIAGRISLYGTLARGGTAYFA---AASDMSTLFDDLALVRPTELFLVPRVcdmlfqrYQAELDrrSVAGADA 344
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2788 KT--------LRVVTLAGEAADR---------ELIArSLAICPHTELANEYGPTEnsvATTVMRhmekQAYVSIGQPIDg 2850
Cdd:cd17632 345 ETlaervkaeLRERVLGGRLLAAvcgsaplsaEMKA-FMESLLDLDLHDGYGSTE---AGAVIL----DGVIVRPPVLD- 415
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2851 tqvlilnsnHQLqpIGVA-------------GELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMADG 2917
Cdd:cd17632 416 ---------YKL--VDVPelgyfrtdrphprGELLVKTDTLFPGYYKRPEVTAEVFDEDGF------YRTGDVMAELGPD 478
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2918 TLEYLGRIDDQVKI-RGYRVETKEIESVIrcikgvKDAAVVAHVTASGQTE---LSAYVVTKP----GLSTNAVRSELQN 2989
Cdd:cd17632 479 RLVYVDRRNNVLKLsQGEFVTVARLEAVF------AASPLVRQIFVYGNSErayLLAVVVPTQdalaGEDTARLRAALAE 552
|
..
gi 1678550997 2990 KL 2991
Cdd:cd17632 553 SL 554
|
|
| FATP_chFAT1_like |
cd05937 |
Uncharacterized subfamily of bifunctional fatty acid transporter/very-long-chain acyl-CoA ... |
490-952 |
6.75e-08 |
|
Uncharacterized subfamily of bifunctional fatty acid transporter/very-long-chain acyl-CoA synthetase in fungi; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis. Members of this family are fungal FATPs, including FAT1 from Cochliobolus heterostrophus.
Pssm-ID: 341260 [Multi-domain] Cd Length: 468 Bit Score: 58.21 E-value: 6.75e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 490 TYRELNKAANRLARHLR-MKGVVRQEPVAIMMERSAAFITGVLGILKAGGAivpvdphyPAdRIRYILHDCGCSHVVsqa 568
Cdd:cd05937 7 TYSETYDLVLRYAHWLHdDLGVQAGDFVAIDLTNSPEFVFLWLGLWSIGAA--------PA-FINYNLSGDPLIHCL--- 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 569 hlpsslednyiithpediesKVdgSNIKSV-NNADDLLYMIYTSGTTGKPKGVQFEHRNMANLLKFEYTHSGIDFEADVL 647
Cdd:cd05937 75 --------------------KL--SGSRFViVDPDDPAILIYTSGTTGLPKAAAISWRRTLVTSNLLSHDLNLKNGDRTY 132
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 648 Q----FATPSFDVCyqeIFSALLKGGTLHIVPeaiKRDVPQLFAFINKHQTNIVFLPTAFIKMIFSerelANSFPDGVKH 723
Cdd:cd05937 133 TcmplYHGTAAFLG---ACNCLMSGGTLALSR---KFSASQFWKDVRDSGATIIQYVGELCRYLLS----TPPSPYDRDH 202
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 724 -LIAAGEQLMISDLFQDvLRKR-GI-HLHNHYgpSETHVVSTYTIHPGDPIPelppigkpIGCTDLY------ILNHQKQ 794
Cdd:cd05937 203 kVRVAWGNGLRPDIWER-FRERfNVpEIGEFY--AATEGVFALTNHNVGDFG--------AGAIGHHglirrwKFENQVV 271
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 795 L---------------------QPCGVPGE----LYISGASVARGYVNHDKLTSDKFSSDPFKPDVIMYRTGDLARRLED 849
Cdd:cd05937 272 LvkmdpetddpirdpktgfcvrAPVGEPGEmlgrVPFKNREAFQGYLHNEDATESKLVRDVFRKGDIYFRTGDLLRQDAD 351
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 850 GNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYCSVQK-------LNTIDLRSYMAS 922
Cdd:cd05937 352 GRWYFLDRLGDTFRWKSENVSTTEVADVLGAHPDIAEANVYGVKVPGHDGRAGCAAITLEEssavpteFTKSLLASLARK 431
|
490 500 510
....*....|....*....|....*....|
gi 1678550997 923 ELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:cd05937 432 NLPSYAVPLFLRLTEEVATTDNHKQQKGVL 461
|
|
| LCL_NRPS |
cd19538 |
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; ... |
3228-3384 |
7.41e-08 |
|
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380461 [Multi-domain] Cd Length: 432 Bit Score: 58.04 E-value: 7.41e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3228 IQQKMDLKNGPLLQAGLFHTIDGDF-LFLSAHHLVVDGISWRVLLEDLALGYRQAAGGEDIKLPPKTSSFKAYA----KK 3302
Cdd:cd19538 98 VRYPFDLSEEPPFRATLFELGENEHvLLLLLHHIAADGWSLAPLTRDLSKAYRARCKGEAPELAPLPVQYADYAlwqqEL 177
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3303 LSDYAESQQLM-KQLKYWREAEEY---QTEaLPFD-QIDGTRAHEGQrsTISFTLNDKETAALLKDANSayNTDTQDMLL 3377
Cdd:cd19538 178 LGDESDPDSLIaRQLAYWKKQLAGlpdEIE-LPTDyPRPAESSYEGG--TLTFEIDSELHQQLLQLAKD--NNVTLFMVL 252
|
....*..
gi 1678550997 3378 ASVILAL 3384
Cdd:cd19538 253 QAGFAAL 259
|
|
| PTZ00342 |
PTZ00342 |
acyl-CoA synthetase; Provisional |
1634-1905 |
8.83e-08 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 240370 [Multi-domain] Cd Length: 746 Bit Score: 58.19 E-value: 8.83e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1634 PQSLAYVIYTSGSTGMPKGVEIEHRsavNFLNSLQSRYqlKHSdmIMHKtsYSFDAsiwELFWWP----YAGASVYL-LP 1708
Cdd:PTZ00342 303 PDFITSIVYTSGTSGKPKGVMLSNK---NLYNTVVPLC--KHS--IFKK--YNPKT---HLSYLPishiYERVIAYLsFM 370
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1709 QGGE-----KEPEVIAKAIEEQKITAMHFVP-----------------------------SM--------LHAFLEHIKY 1746
Cdd:PTZ00342 371 LGGTiniwsKDINYFSKDIYNSKGNILAGVPkvfnriytnimteinnlpplkrflvkkilSLrksnnnggFSKFLEGITH 450
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1747 RSVPIKTN---RLKRVFSGGEQLGTHLVSRFYELLpNVSITNSYGPTEATveAAFF-----DCPPHEkleripIGKPV-- 1816
Cdd:PTZ00342 451 ISSKIKDKvnpNLEVILNGGGKLSPKIAEELSVLL-NVNYYQGYGLTETT--GPIFvqhadDNNTES------IGGPIsp 521
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1817 ---HHVRLYLLNQNQRMLPVgciGELYIAGAGVARGYLNRPALTEERFLEDPFypgermYKTGDVARWLPDGNVEFLGRT 1893
Cdd:PTZ00342 522 ntkYKVRTWETYKATDTLPK---GELLIKSDSIFSGYFLEKEQTKNAFTEDGY------FKTGDIVQINKNGSLTFLDRS 592
|
330
....*....|...
gi 1678550997 1894 DDQVKI-RGYRIE 1905
Cdd:PTZ00342 593 KGLVKLsQGEYIE 605
|
|
| PRK07867 |
PRK07867 |
acyl-CoA synthetase; Validated |
2533-3032 |
1.09e-07 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236120 [Multi-domain] Cd Length: 529 Bit Score: 57.77 E-value: 1.09e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2533 QTISQLFEQQAARTpkASALVSGDKTLTYQELDEWSNGIARALRSRgVKPDTP--VGIMMHRS--FSMIASILGVwkAGG 2608
Cdd:PRK07867 5 PTVAELLLPLAEDD--DRGLYFEDSFTSWREHIRGSAARAAALRAR-LDPTRPphVGVLLDNTpeFSLLLGAAAL--SGI 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2609 CYVPIDPEYPKERKRYILSDSGTKLLMTiNEADLGVLADFEG--EILTIESVEEDDK-------SPLPQMSSAHHLAYII 2679
Cdd:PRK07867 80 VPVGLNPTRRGAALARDIAHADCQLVLT-ESAHAELLDGLDPgvRVINVDSPAWADElaahrdaEPPFRVADPDDLFMLI 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2680 YTSGTTGRPKGVMVEHKGIA---NTLQWRRNAYAfnetDTILQLfsfsfdgfitSMftPLLSGAK-----AVLLHEEEAk 2751
Cdd:PRK07867 159 FTSGTSGDPKAVRCTHRKVAsagVMLAQRFGLGP----DDVCYV----------SM--PLFHSNAvmagwAVALAAGAS- 221
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2752 diLAIKHQLS---------RQRITHMIIV--PVLYrALLDVVQPEDV-KTLRVVtLAGEAADREL--IARSLAicphTEL 2817
Cdd:PRK07867 222 --IALRRKFSasgflpdvrRYGATYANYVgkPLSY-VLATPERPDDAdNPLRIV-YGNEGAPGDIarFARRFG----CVV 293
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2818 ANEYGPTENSVATTvmrHMEKQAYVSIGQPIDGTQVL-----------ILNSNHQLQPIGVAGELC-IAGTGLARGYVNL 2885
Cdd:PRK07867 294 VDGFGSTEGGVAIT---RTPDTPPGALGPLPPGVAIVdpdtgtecppaEDADGRLLNADEAIGELVnTAGPGGFEGYYND 370
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2886 PELTERaftqnpfKPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAV--VAHVTAS 2963
Cdd:PRK07867 371 PEADAE-------RMRGGVYWSGDLAYRDADGYAYFAGRLGDWMRVDGENLGTAPIERILLRYPDATEVAVyaVPDPVVG 443
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2964 GQTElsAYVVTKPGLSTNAV--------RSELQNKlpvfMHPAFIEKLDSLPLSPNGKLDRGAL-------PKPVYNHEG 3028
Cdd:PRK07867 444 DQVM--AALVLAPGAKFDPDafaeflaaQPDLGPK----QWPSYVRVCAELPRTATFKVLKRQLsaegvdcADPVWWIRR 517
|
....
gi 1678550997 3029 ERPF 3032
Cdd:PRK07867 518 LTPS 521
|
|
| AMP-binding_C |
pfam13193 |
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to ... |
873-946 |
1.95e-07 |
|
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to pfam00501. It has a central beta sheet core that is flanked by alpha helices.
Pssm-ID: 463804 [Multi-domain] Cd Length: 76 Bit Score: 51.01 E-value: 1.95e-07
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 873 EIEVTLMNHPDISEAA-ILIWQDQNGEhELCAYYCSVQKLNTI--DLRSYMASELPEYMIPAKWIWVDSIPLTPNGK 946
Cdd:pfam13193 1 EVESALVSHPAVAEAAvVGVPDELKGE-APVAFVVLKPGVELLeeELVAHVREELGPYAVPKEVVFVDELPKTRSGK 76
|
|
| PTZ00216 |
PTZ00216 |
acyl-CoA synthetase; Provisional |
2510-2925 |
2.44e-07 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 240316 [Multi-domain] Cd Length: 700 Bit Score: 56.91 E-value: 2.44e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2510 LTQEERHQLLNEFNTGQanqygvqTISQLFEQQAARTPKASAL---------------------------VSGDKTLTYQ 2562
Cdd:PTZ00216 53 VTDEEHERLRNEWYYGP-------NFLQRLERICKERGDRRALayrpvervekevvkdadgkertmevthFNETRYITYA 125
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2563 ELdeWSNGIA--RALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSD--------SGTK 2632
Cdd:PTZ00216 126 EL--WERIVNfgRGLAELGLTKGSNVAIYEETRWEWLASIYGIWSQSMVAATVYANLGEDALAYALREteckaivcNGKN 203
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2633 LLMTINEADLGVL--------------ADFEG-EILTIESVEEDDKS-----PLPQMSSAHHLAYIIYTSGTTGRPKGVM 2692
Cdd:PTZ00216 204 VPNLLRLMKSGGMpnttiiyldslpasVDTEGcRLVAWTDVVAKGHSagshhPLNIPENNDDLALIMYTSGTTGDPKGVM 283
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2693 VEHKGIA---NTLQWRRN------------------AYAFNETDTILQLFSFSFDGF-----ITSMFT-P---------- 2735
Cdd:PTZ00216 284 HTHGSLTagiLALEDRLNdligppeedetycsylplAHIMEFGVTNIFLARGALIGFgsprtLTDTFArPhgdltefrpv 363
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2736 LLSGA--------KAVllheeEAKdiLAIKHQLSRQRITHMIIVPVlyRALLD---------VV--QPEDV--KTLRVVT 2794
Cdd:PTZ00216 364 FLIGVprifdtikKAV-----EAK--LPPVGSLKRRVFDHAYQSRL--RALKEgkdtpywneKVfsAPRAVlgGRVRAML 434
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2795 LAG---EAADRELIARSLAIcphteLANEYGPTENSVATTVMR--HMEkqaYVSIGQPIDGTQVLILNSNH-----QLQP 2864
Cdd:PTZ00216 435 SGGgplSAATQEFVNVVFGM-----VIQGWGLTETVCCGGIQRtgDLE---PNAVGQLLKGVEMKLLDTEEykhtdTPEP 506
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1678550997 2865 igvAGELCIAGTGLARGYVNLPELTERAFTqnpfkpEARMYRTGDAARWMADGTLEYLGRI 2925
Cdd:PTZ00216 507 ---RGEILLRGPFLFKGYYKQEELTREVLD------EDGWFHTGDVGSIAANGTLRIIGRV 558
|
|
| hsFATP4_like |
cd05939 |
Fatty acid transport proteins (FATP), including FATP4 and FATP1, and similar proteins; Fatty ... |
1521-1983 |
2.52e-07 |
|
Fatty acid transport proteins (FATP), including FATP4 and FATP1, and similar proteins; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. At least five copies of FATPs are identified in mammalian cells. This family includes FATP4, FATP1, and homologous proteins. Each FATP has unique patterns of tissue distribution. FATP4 is mainly expressed in the brain, testis, colon and kidney. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341262 [Multi-domain] Cd Length: 474 Bit Score: 56.28 E-value: 2.52e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1521 TYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILllqsa 1600
Cdd:cd05939 5 TFRELNEYSNKVANFFQAQGYRSGDVVALFMENRLEFVALWLGLAKIGVETALINSNLRLESLLHCITVSKAKAL----- 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1601 glhvpeftgeIVYLNQTNSGLAHRLSNPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHrsavnflnslqSRY----QLKHS 1676
Cdd:cd05939 80 ----------IFNLLDPLLTQSSTEPPSQDDVNFRDKLFYIYTSGTTGLPKAAVIVH-----------SRYyriaAGAYY 138
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1677 DMIMHKTSYSFDAsiweLFWWPYAGASV---YLLPQGGEKepeVIAKaieeqKITAMHFvpsmlhaFLEHIKYRSVPI-- 1751
Cdd:cd05939 139 AFGMRPEDVVYDC----LPLYHSAGGIMgvgQALLHGSTV---VIRK-----KFSASNF-------WDDCVKYNCTIVqy 199
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1752 -----------------KTNRLKRVFSGG--EQLGTHLVSRFyellpNVS-ITNSYGPTEATVEAAFFD-----CpphEK 1806
Cdd:cd05939 200 igeicryllaqppseeeQKHNVRLAVGNGlrPQIWEQFVRRF-----GIPqIGEFYGATEGNSSLVNIDnhvgaC---GF 271
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1807 LERIPigKPVHHVRLYLLNQNQRML---PVG-CI----GElyiAGAGVAR-----------GYLNRPAlTEERFLEDPFY 1867
Cdd:cd05939 272 NSRIL--PSVYPIRLIKVDEDTGELirdSDGlCIpcqpGE---PGLLVGKiiqndplrrfdGYVNEGA-TNKKIARDVFK 345
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1868 PGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAA---VTVRTDSGEPELCAYV---EG 1941
Cdd:cd05939 346 KGDSAFLSGDVLVMDELGYLYFKDRTGDTFRWKGENVSTTEVEGILSNVLGLEDVVvygVEVPGVEGRAGMAAIVdpeRK 425
|
490 500 510 520
....*....|....*....|....*....|....*....|..
gi 1678550997 1942 LQRNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGKLDRNAL 1983
Cdd:cd05939 426 VDLDRFSAVLAKSLPPYARPQFIRLLPEVDKTGTFKLQKTDL 467
|
|
| PRK07445 |
PRK07445 |
O-succinylbenzoic acid--CoA ligase; Reviewed |
802-954 |
3.19e-07 |
|
O-succinylbenzoic acid--CoA ligase; Reviewed
Pssm-ID: 236019 [Multi-domain] Cd Length: 452 Bit Score: 56.16 E-value: 3.19e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 802 GELYISGASVARGYVNHdkltsdKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNH 881
Cdd:PRK07445 302 GNITIQAQSLALGYYPQ------ILDSQGI------FETDDLGYLDAQGYLHILGRNSQKIITGGENVYPAEVEAAILAT 369
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 882 PDISEAAILIWQDQN-GEHELCAYYCSVQKLNTIDLRSYMASELPEYMIPAKWIWVDSIPLTPNGKVDRAALPE 954
Cdd:PRK07445 370 GLVQDVCVLGLPDPHwGEVVTAIYVPKDPSISLEELKTAIKDQLSPFKQPKHWIPVPQLPRNPQGKINRQQLQQ 443
|
|
| Dip2 |
cd05905 |
Disco-interacting protein 2 (Dip2); Dip2 proteins show sequence similarity to other members of ... |
1521-1709 |
3.82e-07 |
|
Disco-interacting protein 2 (Dip2); Dip2 proteins show sequence similarity to other members of the adenylate forming enzyme family, including insect luciferase, acetyl CoA ligases and the adenylation domain of nonribosomal peptide synthetases (NRPS). However, its function may have diverged from other members of the superfamily. In mouse embryo, Dip2 homolog A plays an important role in the development of both vertebrate and invertebrate nervous systems. Dip2A appears to regulate cell growth and the arrangement of cells in organs. Biochemically, Dip2A functions as a receptor of FSTL1, an extracellular glycoprotein, and may play a role as a cardiovascular protective agent.
Pssm-ID: 341231 [Multi-domain] Cd Length: 571 Bit Score: 56.20 E-value: 3.82e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1521 TYKELNEQANRIAWELIGR-GVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSG-------- 1591
Cdd:cd05905 16 TWGKLLSRAEKIAAVLQKKvGLKPGDRVALMYPDPLDFVAAFYGCLYAGVVPIPIEPPDISQQLGFLLGTCKvrvaltve 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1592 -TNILLLQSAGLHVPefTGEIVYLN-----------QTNSGLAHRLSNPNVDVLPQSLAYVIYTSGSTGMPKGVEIEHRS 1659
Cdd:cd05905 96 aCLKGLPKKLLKSKT--AAEIAKKKgwpkildfvkiPKSKRSKLKKWGPHPPTRDGDTAYIEYSFSSDGSLSGVAVSHSS 173
|
170 180 190 200 210
....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 1660 AVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWelFWW---PYAGASVYLLPQ 1709
Cdd:cd05905 174 LLAHCRALKEACELYESRPLVTVLDFKSGLGLW--HGCllsVYSGHHTILIPP 224
|
|
| LC_FACS_bac1 |
cd17641 |
bacterial long-chain fatty acid CoA synthetase; The members of this family are bacterial ... |
1519-1940 |
4.72e-07 |
|
bacterial long-chain fatty acid CoA synthetase; The members of this family are bacterial long-chain fatty acid CoA synthetase, most of which are as yet uncharacterized. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341296 [Multi-domain] Cd Length: 569 Bit Score: 55.89 E-value: 4.72e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1519 VMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGGAYLPIDPDYPEERISFLLEDSGTNILLLQ 1598
Cdd:cd17641 11 EFTWADYADRVRAFALGLLALGVGRGDVVAILGDNRPEWVWAELAAQAIGALSLGIYQDSMAEEVAYLLNYTGARVVIAE 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1599 -----------SAGLHVPEFtgeIVYLNQTN-----------------SGLAHRLSNPNV------DVLPQSLAYVIYTS 1644
Cdd:cd17641 91 deeqvdklleiADRIPSVRY---VIYCDPRGmrkyddprlisfedvvaLGRALDRRDPGLyerevaAGKGEDVAVLCTTS 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1645 GSTGMPKGVeiehrsavnflnslqsryQLKHSDMIMHKTSY-SFD--------ASIWELfwwPYAGASVYLLPQG---GE 1712
Cdd:cd17641 168 GTTGKPKLA------------------MLSHGNFLGHCAAYlAADplgpgdeyVSVLPL---PWIGEQMYSVGQAlvcGF 226
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1713 K-----EPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYR---SVPIKT------------------------------- 1753
Cdd:cd17641 227 IvnfpeEPETMMEDLREIGPTFVLLPPRVWEGIAADVRARmmdATPFKRfmfelgmklglraldrgkrgrpvslwlrlas 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1754 -----------------NRLKRVFSGGEQLGTHlVSRFYELLpNVSITNSYGPTEAtveAAFFDCPPHEKLERIPIGKPV 1816
Cdd:cd17641 307 wladallfrplrdrlgfSRLRSAATGGAALGPD-TFRFFHAI-GVPLKQLYGQTEL---AGAYTVHRDGDVDPDTVGVPF 381
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1817 HHVRLYLLNqnqrmlpvgcIGELYIAGAGVARGYLNRPALTEERFLEDPFypgermYKTGDVARWLPDGNVEFLGRTDDQ 1896
Cdd:cd17641 382 PGTEVRIDE----------VGEILVRSPGVFVGYYKNPEATAEDFDEDGW------LHTGDAGYFKENGHLVVIDRAKDV 445
|
490 500 510 520
....*....|....*....|....*....|....*....|....*
gi 1678550997 1897 VKI-RGYRIEPGEIEAALRSIEGVREAAVTVRtdsGEPELCAYVE 1940
Cdd:cd17641 446 GTTsDGTRFSPQFIENKLKFSPYIAEAVVLGA---GRPYLTAFIC 487
|
|
| AMP-binding_C |
pfam13193 |
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to ... |
1908-1977 |
6.30e-07 |
|
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to pfam00501. It has a central beta sheet core that is flanked by alpha helices.
Pssm-ID: 463804 [Multi-domain] Cd Length: 76 Bit Score: 49.47 E-value: 6.30e-07
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 1908 EIEAALRSIEGVREAAVTVRTDS--GEpELCAYV---EGLQ--RNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGK 1977
Cdd:pfam13193 1 EVESALVSHPAVAEAAVVGVPDElkGE-APVAFVvlkPGVEllEEELVAHVREELGPYAVPKEVVFVDELPKTRSGK 76
|
|
| PLN02654 |
PLN02654 |
acetate-CoA ligase |
824-952 |
6.37e-07 |
|
acetate-CoA ligase
Pssm-ID: 215353 [Multi-domain] Cd Length: 666 Bit Score: 55.29 E-value: 6.37e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 824 DKFSSDPFKPDVIMYRTGDLARRLEDGNIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILiwqdqNGEHEL-- 901
Cdd:PLN02654 501 ERYETTYFKPFAGYYFSGDGCSRDKDGYYWLTGRVDDVINVSGHRIGTAEVESALVSHPQCAEAAVV-----GIEHEVkg 575
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 902 CAYYCSVQKLNTI----DLRSYMA----SELPEYMIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:PLN02654 576 QGIYAFVTLVEGVpyseELRKSLIltvrNQIGAFAAPDKIHWAPGLPKTRSGKIMRRIL 634
|
|
| PRK05620 |
PRK05620 |
long-chain fatty-acid--CoA ligase; |
489-952 |
7.85e-07 |
|
long-chain fatty-acid--CoA ligase;
Pssm-ID: 180167 [Multi-domain] Cd Length: 576 Bit Score: 55.17 E-value: 7.85e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 489 LTYRELNKAANRLARHLRMK-GVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYI------------ 555
Cdd:PRK05620 39 TTFAAIGARAAALAHALHDElGITGDQRVGSMMYNCAEHLEVLFAVACMGAVFNPLNKQLMNDQIVHIinhaedevivad 118
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 556 ----------LHDCGC-SHVV---------SQAHLPSSLednyiitHPEDIESKVDGSNIK---SVNNADDLLYMIYTSG 612
Cdd:PRK05620 119 prlaeqlgeiLKECPCvRAVVfigpsdadsAAAHMPEGI-------KVYSYEALLDGRSTVydwPELDETTAAAICYSTG 191
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 613 TTGKPKGVQFEHRNManllkfeYTHSgidfeadvLQF-ATPSFDVCYQEIF----------------SALLKGGTL---- 671
Cdd:PRK05620 192 TTGAPKGVVYSHRSL-------YLQS--------LSLrTTDSLAVTHGESFlccvpiyhvlswgvplAAFMSGTPLvfpg 256
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 672 ---------HIVPEAIKR---DVP----QLFAFINKHQTNivflptafiKMIFSErelansfpdgvkhLIAAGEQlmISD 735
Cdd:PRK05620 257 pdlsaptlaKIIATAMPRvahGVPtlwiQLMVHYLKNPPE---------RMSLQE-------------IYVGGSA--VPP 312
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 736 LFQDVLRKR-GIHLHNHYGPSETHVVSTYTihpgdpipeLPPIGKPIGCTDLY--------------ILN---------- 790
Cdd:PRK05620 313 ILIKAWEERyGVDVVHVWGMTETSPVGTVA---------RPPSGVSGEARWAYrvsqgrfpasleyrIVNdgqvmestdr 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 791 HQKQLQPCG--VPGELYIS-------GASVARGYVNHDklTSDKFSSDPFkpdvimYRTGDLARRLEDGNIEYIGRADNQ 861
Cdd:PRK05620 384 NEGEIQVRGnwVTASYYHSpteegggAASTFRGEDVED--ANDRFTADGW------LRTGDVGSVTRDGFLTIHDRARDV 455
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 862 VKIRGYRIEPQEIEVTLMNHPDISEAAIL-IWQDQNGEHELCAYYCSVQKLNTI----DLRSYMASELPEYMIPAKWIWV 936
Cdd:PRK05620 456 IRSGGEWIYSAQLENYIMAAPEVVECAVIgYPDDKWGERPLAVTVLAPGIEPTRetaeRLRDQLRDRLPNWMLPEYWTFV 535
|
570
....*....|....*.
gi 1678550997 937 DSIPLTPNGKVDRAAL 952
Cdd:PRK05620 536 DEIDKTSVGKFDKKDL 551
|
|
| PRK07769 |
PRK07769 |
long-chain-fatty-acid--CoA ligase; Validated |
2551-2739 |
1.77e-06 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 181109 [Multi-domain] Cd Length: 631 Bit Score: 53.96 E-value: 1.77e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2551 ALVSGDKtLTYQELD--EWSNGIARAL-------RSRGV--------KPDTPVGIMMHRSFSMIASILGVWKAGGCYVPI 2613
Cdd:PRK07769 31 AKVRGDK-LAYRFLDfsTERDGVARDLtwsqfgaRNRAVgarlqqvtKPGDRVAILAPQNLDYLIAFFGALYAGRIAVPL 109
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2614 -DPEYP--KERKRYILSDSGTKLLMTINEADLGVLADFEG-------EILTIESVEEDDKSPLPQMSSAHH-LAYIIYTS 2682
Cdd:PRK07769 110 fDPAEPghVGRLHAVLDDCTPSAILTTTDSAEGVRKFFRArpakerpRVIAVDAVPDEVGATWVPPEANEDtIAYLQYTS 189
|
170 180 190 200 210
....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 2683 GTTGRPKGVMVEHKGIA-NTLQwRRNAYAFNETDTILQLFSFSFD-GFITSMFTPLLSG 2739
Cdd:PRK07769 190 GSTRIPAGVQITHLNLPtNVLQ-VIDALEGQEGDRGVSWLPFFHDmGLITVLLPALLGH 247
|
|
| ttLC_FACS_like |
cd05915 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes ... |
490-952 |
2.68e-06 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes fatty acyl-CoA synthetases that can activate medium-chain to long-chain fatty acids. They catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family has been shown to catalyze the long-chain fatty acid, myristoyl acid, while another member in this family, the AlkK protein identified in Pseudomonas oleovorans, targets medium chain fatty acids. This family also includes an uncharacterized subgroup of FACS.
Pssm-ID: 213283 [Multi-domain] Cd Length: 509 Bit Score: 53.20 E-value: 2.68e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 490 TYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGC------SH 563
Cdd:cd05915 26 TYAEVYQRARRLMGGLRALGVGVGDRVATLGFNHFRHLEAYFAVPGMGAVLHTANPRLSPKEIAYILNHAEDkvllfdPN 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 564 VVSQAHLPSSLEDNyiITHPEDIESKVD---------GSNIKSVNNAD--DLLYMIYTSGTTGKPKGVQFEHRNM-ANLL 631
Cdd:cd05915 106 LLPLVEAIRGELKT--VQHFVVMDEKAPegylayeeaLGEEADPVRVPerAACGMAYTTGTTGLPKGVVYSHRALvLHSL 183
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 632 KFEYTHSGIDFEADVLQFATPSFDV---CYqeIFSALLKGGTLHIVPEAIKRDVpqLFAFINKHQ-TNIVFLPTAfIKMI 707
Cdd:cd05915 184 AASLVDGTALSEKDVVLPVVPMFHVnawCL--PYAATLVGAKQVLPGPRLDPAS--LVELFDGEGvTFTAGVPTV-WLAL 258
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 708 FSERE-LANSFPDGVKhLIAAGE---QLMISdlfqdvLRKRG-IHLHNHYGPSETHVVSTYTIHPgdPIPELPPIGKPIG 782
Cdd:cd05915 259 ADYLEsTGHRLKTLRR-LVVGGSaapRSLIA------RFERMgVEVRQGYGLTETSPVVVQNFVK--SHLESLSEEEKLT 329
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 783 CTDLYILNHQKQ----LQPC--GVPGE------LYISGASVARGYVNhdkltsDKFSSDPFKPDVIMYRTGDLARRLEDG 850
Cdd:cd05915 330 LKAKTGLPIPLVrlrvADEEgrPVPKDgkalgeVQLKGPWITGGYYG------NEEATRSALTPDGFFRTGDIAVWDEEG 403
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 851 NIEYIGRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHELCAYYcsvqKLNTIDLRSymaSELPEY--- 927
Cdd:cd05915 404 YVEIKDRLKDLIKSGGEWISSVDLENALMGHPKVKEAAVVAIPHPKWQERPLAVV----VPRGEKPTP---EELNEHllk 476
|
490 500 510
....*....|....*....|....*....|.
gi 1678550997 928 ------MIPAKWIWVDSIPLTPNGKVDRAAL 952
Cdd:cd05915 477 agfakwQLPDAYVFAEEIPRTSAGKFLKRAL 507
|
|
| PRK12476 |
PRK12476 |
putative fatty-acid--CoA ligase; Provisional |
2840-3018 |
5.40e-06 |
|
putative fatty-acid--CoA ligase; Provisional
Pssm-ID: 171527 [Multi-domain] Cd Length: 612 Bit Score: 52.44 E-value: 5.40e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2840 AYVSIGQPIDGTQVLILNSNHQLQ-PIGVAGELCIAGTGLARGYVNLPELTERAFtQNPFK-------------PEARMY 2905
Cdd:PRK12476 400 AHVSCGQVARSQWAVIVDPDTGAElPDGEVGEIWLHGDNIGRGYWGRPEETERTF-GAKLQsrlaegshadgaaDDGTWL 478
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2906 RTGDAARWMaDGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAHVTASGQTELSAYVVTK---------P 2976
Cdd:PRK12476 479 RTGDLGVYL-DGELYITGRIADLIVIDGRNHYPQDIEATVAEASPMVRRGYVTAFTVPAEDNERLVIVAEraagtsradP 557
|
170 180 190 200
....*....|....*....|....*....|....*....|..
gi 1678550997 2977 GLSTNAVRSELQNKLPVFMHPAFIEKLDSLPLSPNGKLDRGA 3018
Cdd:PRK12476 558 APAIDAIRAAVSRRHGLAVADVRLVPAGAIPRTTSGKLARRA 599
|
|
| ACSBG_like |
cd05933 |
Bubblegum-like very long-chain fatty acid CoA synthetase (VL-FACS); This family of very ... |
2557-2933 |
8.38e-06 |
|
Bubblegum-like very long-chain fatty acid CoA synthetase (VL-FACS); This family of very long-chain fatty acid CoA synthetase is named bubblegum because Drosophila melanogaster mutant bubblegum (BGM) has elevated levels of very-long-chain fatty acids (VLCFA) caused by a defective gene of this family. The human homolog (hsBG) has been characterized as a very long chain fatty acid CoA synthetase that functions specifically in the brain; hsBG may play a central role in brain VLCFA metabolism and myelinogenesis. VL-FACS is involved in the first reaction step of very long chain fatty acid degradation. It catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341256 [Multi-domain] Cd Length: 596 Bit Score: 51.59 E-value: 8.38e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2557 KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVWKAGGCYVPIDPEYPKERKRYILSDSGTKLLMT 2636
Cdd:cd05933 7 HTLTYKEYYEACRQAAKAFLKLGLERFHGVGILGFNSPEWFIAAVGAIFAGGIAVGIYTTNSPEACQYVAETSEANILVV 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2637 INEADLGVLADFEGEILTIESV---------------------EEDDKSPLPQ----MSS--AHHLAYIIYTSGTTGRPK 2689
Cdd:cd05933 87 ENQKQLQKILQIQDKLPHLKAIiqykeplkekepnlyswdefmELGRSIPDEQldaiISSqkPNQCCTLIYTSGTTGMPK 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2690 GVMVEHKGIANTLQWRRNAYAFNETD----TILQLFSFSFDGF-ITSMFTPLLSGAKAVLLHEEEAKDILAIkhQLSRQR 2764
Cdd:cd05933 167 GVMLSHDNITWTAKAASQHMDLRPATvgqeSVVSYLPLSHIAAqILDIWLPIKVGGQVYFAQPDALKGTLVK--TLREVR 244
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2765 ITHMIIVPVLYRALLDVVQP----------------------------------------------EDVKTL----RVVT 2794
Cdd:cd05933 245 PTAFMGVPRVWEKIQEKMKAvgaksgtlkrkiaswakgvgletnlklmggespsplfyrlakklvfKKVRKAlgldRCQK 324
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2795 LAGEAA--DRELIA--RSLAIcPHTELaneYGPTENSVATTVMRhmeKQAY--VSIGQPIDGTQVLILNSNHQLQpigva 2868
Cdd:cd05933 325 FFTGAApiSRETLEffLSLNI-PIMEL---YGMSETSGPHTISN---PQAYrlLSCGKALPGCKTKIHNPDADGI----- 392
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 2869 GELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMADGTLEYLGRIDDQVKIRG 2933
Cdd:cd05933 393 GEICFWGRHVFMGYLNMEDKTEEAIDEDGW------LHSGDLGKLDEDGFLYITGRIKELIITAG 451
|
|
| PKS_PP |
smart00823 |
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the ... |
2019-2070 |
8.40e-06 |
|
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the prosthetic group of acyl carrier proteins (ACP) in some multienzyme complexes where it serves as a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups.
Pssm-ID: 214834 [Multi-domain] Cd Length: 86 Bit Score: 46.47 E-value: 8.40e-06
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|..
gi 1678550997 2019 VGIHDNFFDRGGHSLKATALVSRITKEFDVQVPLKDVFAHPTVEGLATVIRE 2070
Cdd:smart00823 33 IDPDRPFRDLGLDSLMAVELRNRLEAATGLRLPATLVFDHPTPAALAEHLAA 84
|
|
| PRK12476 |
PRK12476 |
putative fatty-acid--CoA ligase; Provisional |
474-632 |
1.57e-05 |
|
putative fatty-acid--CoA ligase; Provisional
Pssm-ID: 171527 [Multi-domain] Cd Length: 612 Bit Score: 50.90 E-value: 1.57e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 474 EKTPDAHAVidqacSLTYREL----NKAANRLARHLRmkgvvRQEPVAIMMERSAAFITGVLGILKAGGAIVPV-DPHYP 548
Cdd:PRK12476 59 SHSAAGCAV-----ELTWTQLgvrlRAVGARLQQVAG-----PGDRVAILAPQGIDYVAGFFAAIKAGTIAVPLfAPELP 128
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 549 --ADRIRYILHDCGCSHVVSQAHLPSSLEDnYIITHPED-------IESKVD--GSNIKSVN-NADDLLYMIYTSGTTGK 616
Cdd:PRK12476 129 ghAERLDTALRDAEPTVVLTTTAAAEAVEG-FLRNLPRLrrprviaIDAIPDsaGESFVPVElDTDDVSHLQYTSGSTRP 207
|
170
....*....|....*..
gi 1678550997 617 PKGVQFEHRN-MANLLK 632
Cdd:PRK12476 208 PVGVEITHRAvGTNLVQ 224
|
|
| PRK08180 |
PRK08180 |
feruloyl-CoA synthase; Reviewed |
2533-2913 |
1.62e-05 |
|
feruloyl-CoA synthase; Reviewed
Pssm-ID: 236175 [Multi-domain] Cd Length: 614 Bit Score: 50.65 E-value: 1.62e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2533 QTISQLFEQQAARTPKASALV---SGD--KTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSF--SMIAsiLGVWK 2605
Cdd:PRK08180 39 RRLTDRLVHWAQEAPDRVFLAergADGgwRRLTYAEALERVRAIAQALLDRGLSAERPLMILSGNSIehALLA--LAAMY 116
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2606 AGGCYVPIDPEY-----PKERKRYILS---------DSGTKL---LMTINEADLGVLA----DFEGEILTIESVEEDdkS 2664
Cdd:PRK08180 117 AGVPYAPVSPAYslvsqDFGKLRHVLElltpglvfaDDGAAFaraLAAVVPADVEVVAvrgaVPGRAATPFAALLAT--P 194
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2665 PLPQMSSAH------HLAYIIYTSGTTGRPKGVMVEHKGI-ANTLQwrrnayafnetdtILQLFSFsfdgfitsmftplL 2737
Cdd:PRK08180 195 PTAAVDAAHaavgpdTIAKFLFTSGSTGLPKAVINTHRMLcANQQM-------------LAQTFPF-------------L 248
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2738 SGAKAVLLheeeakDILAIKHQLSRQRITHMII-----------------------------------VPVLYRALLDVV 2782
Cdd:PRK08180 249 AEEPPVLV------DWLPWNHTFGGNHNLGIVLynggtlyiddgkptpggfdetlrnlreisptvyfnVPKGWEMLVPAL 322
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2783 QPEDV------KTLRVVTLAGeAA------DReLIARSLAICPH-TELANEYGPTENS-VATTVMRHMEKQAYvsIGQPI 2848
Cdd:PRK08180 323 ERDAAlrrrffSRLKLLFYAG-AAlsqdvwDR-LDRVAEATCGErIRMMTGLGMTETApSATFTTGPLSRAGN--IGLPA 398
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 2849 DGTQVlilnsnhQLQPIGVAGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARW 2913
Cdd:PRK08180 399 PGCEV-------KLVPVGGKLEVRVKGPNVTPGYWRAPELTAEAFDEEGY------YRSGDAVRF 450
|
|
| ACSBG_like |
cd05933 |
Bubblegum-like very long-chain fatty acid CoA synthetase (VL-FACS); This family of very ... |
489-648 |
1.90e-05 |
|
Bubblegum-like very long-chain fatty acid CoA synthetase (VL-FACS); This family of very long-chain fatty acid CoA synthetase is named bubblegum because Drosophila melanogaster mutant bubblegum (BGM) has elevated levels of very-long-chain fatty acids (VLCFA) caused by a defective gene of this family. The human homolog (hsBG) has been characterized as a very long chain fatty acid CoA synthetase that functions specifically in the brain; hsBG may play a central role in brain VLCFA metabolism and myelinogenesis. VL-FACS is involved in the first reaction step of very long chain fatty acid degradation. It catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341256 [Multi-domain] Cd Length: 596 Bit Score: 50.43 E-value: 1.90e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 489 LTYRELNKAANRLARHLRMKGVVRQEPVAIMMERSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVV--- 565
Cdd:cd05933 9 LTYKEYYEACRQAAKAFLKLGLERFHGVGILGFNSPEWFIAAVGAIFAGGIAVGIYTTNSPEACQYVAETSEANILVven 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 566 -SQAHLPSSLEDNY-----IITHPEDIESKVDG-------------------SNIKSVNNADDLLYMIYTSGTTGKPKGV 620
Cdd:cd05933 89 qKQLQKILQIQDKLphlkaIIQYKEPLKEKEPNlyswdefmelgrsipdeqlDAIISSQKPNQCCTLIYTSGTTGMPKGV 168
|
170 180
....*....|....*....|....*...
gi 1678550997 621 QFEHRNMANLLKFEYTHSGIDfEADVLQ 648
Cdd:cd05933 169 MLSHDNITWTAKAASQHMDLR-PATVGQ 195
|
|
| PaaK |
COG1541 |
Phenylacetate-coenzyme A ligase PaaK, adenylate-forming domain family [Coenzyme transport and ... |
739-901 |
2.01e-05 |
|
Phenylacetate-coenzyme A ligase PaaK, adenylate-forming domain family [Coenzyme transport and metabolism];
Pssm-ID: 441150 [Multi-domain] Cd Length: 423 Bit Score: 50.15 E-value: 2.01e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 739 DVLRKR-----GIHLHNHYGPSET-HVVST-------YTIHPGDPIPEL--PPIGKPIgctdlyilnhqkqlqPCGVPGE 803
Cdd:COG1541 217 EEMRKEieerwGIKAYDIYGLTEVgPGVAYeceaqdgLHIWEDHFLVEIidPETGEPV---------------PEGEEGE 281
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 804 LYISGasvargyvnhdkLTSDKFssdpfkPdVIMYRTGDLARRLEDGN--------IEYI-GRADNQVKIRGYRIEPQEI 874
Cdd:COG1541 282 LVVTT------------LTKEAM------P-LIRYRTGDLTRLLPEPCpcgrthprIGRIlGRADDMLIIRGVNVFPSQI 342
|
170 180
....*....|....*....|....*..
gi 1678550997 875 EVTLMNHPDISEAAILIWQDQNGEHEL 901
Cdd:COG1541 343 EEVLLRIPEVGPEYQIVVDREGGLDEL 369
|
|
| PTZ00342 |
PTZ00342 |
acyl-CoA synthetase; Provisional |
2674-2938 |
2.02e-05 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 240370 [Multi-domain] Cd Length: 746 Bit Score: 50.49 E-value: 2.02e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2674 HLAYIIYTSGTTGRPKGVMVEHKGIANTL----QW----------------------RRNAY-AFNETDTI------LQL 2720
Cdd:PTZ00342 305 FITSIVYTSGTSGKPKGVMLSNKNLYNTVvplcKHsifkkynpkthlsylpishiyeRVIAYlSFMLGGTIniwskdINY 384
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2721 FS---FSFDGFI--------TSMFTPLLSG-AKAVLLHEEEAKDILAIKHQ-----LSR--QRITHmiivpvLYRALLDV 2781
Cdd:PTZ00342 385 FSkdiYNSKGNIlagvpkvfNRIYTNIMTEiNNLPPLKRFLVKKILSLRKSnnnggFSKflEGITH------ISSKIKDK 458
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2782 VQPedvkTLRVVtLAGEAADRELIARSLAICPHTELANEYGPTENSVATTVmRHMEKQAYVSIGQPIDGTQVLILNSNHQ 2861
Cdd:PTZ00342 459 VNP----NLEVI-LNGGGKLSPKIAEELSVLLNVNYYQGYGLTETTGPIFV-QHADDNNTESIGGPISPNTKYKVRTWET 532
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2862 LQPIGV--AGELCIAGTGLARGYVNLPELTERAFTQNPFkpearmYRTGDAARWMADGTLEYLGRIDDQVKI-RGYRVET 2938
Cdd:PTZ00342 533 YKATDTlpKGELLIKSDSIFSGYFLEKEQTKNAFTEDGY------FKTGDIVQINKNGSLTFLDRSKGLVKLsQGEYIET 606
|
|
| PRK06814 |
PRK06814 |
acyl-[ACP]--phospholipid O-acyltransferase; |
1634-1979 |
2.14e-05 |
|
acyl-[ACP]--phospholipid O-acyltransferase;
Pssm-ID: 235865 [Multi-domain] Cd Length: 1140 Bit Score: 50.73 E-value: 2.14e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1634 PQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIM------HktsySFDASiwelfwwpyAGAsvyLL 1707
Cdd:PRK06814 792 PDDPAVILFTSGSEGTPKGVVLSHRNLLANRAQVAARIDFSPEDKVFnalpvfH----SFGLT---------GGL---VL 855
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1708 PqggekepeviakAIEEQKItamHFVPSMLHaflehikYRSVP---IKTN------------------------RLKRVF 1760
Cdd:PRK06814 856 P------------LLSGVKV---FLYPSPLH-------YRIIPeliYDTNatilfgtdtflngyaryahpydfrSLRYVF 913
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1761 SGGEQLGTHlVSRFYELLPNVSITNSYGPTEATVEAAFfDCPPHEKLE---RIPIGkpVHHvrlyllnqnqRMLPVGCI- 1836
Cdd:PRK06814 914 AGAEKVKEE-TRQTWMEKFGIRILEGYGVTETAPVIAL-NTPMHNKAGtvgRLLPG--IEY----------RLEPVPGId 979
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1837 --GELYIAGAGVARGYL--NRPALTEErfledpfyPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEA- 1911
Cdd:PRK06814 980 egGRLFVRGPNVMLGYLraENPGVLEP--------PADGWYDTGDIVTIDEEGFITIKGRAKRFAKIAGEMISLAAVEEl 1051
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1912 ----------ALRSIE----GVREAAVTVRTDSGEPELCAYVEGLQRNEVraqlerllpgyMVPAYMIEMEQWPVTPSGK 1977
Cdd:PRK06814 1052 aaelwpdalhAAVSIPdarkGERIILLTTASDATRAAFLAHAKAAGASEL-----------MVPAEIITIDEIPLLGTGK 1120
|
..
gi 1678550997 1978 LD 1979
Cdd:PRK06814 1121 ID 1122
|
|
| PRK06334 |
PRK06334 |
long chain fatty acid--[acyl-carrier-protein] ligase; Validated |
1631-1985 |
2.35e-05 |
|
long chain fatty acid--[acyl-carrier-protein] ligase; Validated
Pssm-ID: 180533 [Multi-domain] Cd Length: 539 Bit Score: 50.20 E-value: 2.35e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1631 DVLPQSLAYVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIM------HktSYSFDASiwELFwwP-YAGAS 1703
Cdd:PRK06334 179 DKDPEDVAVILFTSGTEKLPKGVPLTHANLLANQRACLKFFSPKEDDVMMsflppfH--AYGFNSC--TLF--PlLSGVP 252
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1704 VYLlpQGGEKEPEVIAKAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTNRLkrVFSGGEQLGTHLVSRFYELLPNVSI 1783
Cdd:PRK06334 253 VVF--AYNPLYPKKIVEMIDEAKVTFLGSTPVFFDYILKTAKKQESCLPSLRF--VVIGGDAFKDSLYQEALKTFPHIQL 328
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1784 TNSYGPTEAT--VEAAFFDCPPHEKLeripIGKPVHHVRLYLLNQNQRM-LPVGCIGELYIAGAGVARGYL-NRPAlteE 1859
Cdd:PRK06334 329 RQGYGTTECSpvITINTVNSPKHESC----VGMPIRGMDVLIVSEETKVpVSSGETGLVLTRGTSLFSGYLgEDFG---Q 401
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1860 RFLEdpfYPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALrsIEGVREAA------VTVRTDSGEP 1933
Cdd:PRK06334 402 GFVE---LGGETWYVTGDLGYVDRHGELFLKGRLSRFVKIGAEMVSLEALESIL--MEGFGQNAadhagpLVVCGLPGEK 476
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*
gi 1678550997 1934 E-LCAYVE-GLQRNEVRAQLERL-LPGYMVPAYMIEMEQWPVTPSGKLDRNALPA 1985
Cdd:PRK06334 477 VrLCLFTTfPTSISEVNDILKNSkTSSILKISYHHQVESIPMLGTGKPDYCSLNA 531
|
|
| PaaK |
COG1541 |
Phenylacetate-coenzyme A ligase PaaK, adenylate-forming domain family [Coenzyme transport and ... |
2681-2991 |
3.34e-05 |
|
Phenylacetate-coenzyme A ligase PaaK, adenylate-forming domain family [Coenzyme transport and metabolism];
Pssm-ID: 441150 [Multi-domain] Cd Length: 423 Bit Score: 49.38 E-value: 3.34e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2681 TSGTTGRPKGVMVEHKGIANTL-QWRRNAYA--FNETDTILqlFSFSFDGFITSMFtpLLSGAKAVllheeeakDILAIK 2757
Cdd:COG1541 91 SSGTTGKPTVVGYTRKDLDRWAeLFARSLRAagVRPGDRVQ--NAFGYGLFTGGLG--LHYGAERL--------GATVIP 158
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2758 H---QLSRQ-------RITHMIIVP--VLYraLLDVVQPEDVK----TLRVVTLAGEA---ADRELIARSLAIcphtELA 2818
Cdd:COG1541 159 AgggNTERQlrlmqdfGPTVLVGTPsyLLY--LAEVAEEEGIDprdlSLKKGIFGGEPwseEMRKEIEERWGI----KAY 232
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2819 NEYGPTEnsVATTV---------MRHMEKQAYVSIGQPIDGTQVlilnsnhqlqPIGVAGELCIagTGLARgyvnlpelt 2889
Cdd:COG1541 233 DIYGLTE--VGPGVayeceaqdgLHIWEDHFLVEIIDPETGEPV----------PEGEEGELVV--TTLTK--------- 289
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2890 eraftqnpfkpEA----RmYRTGDAARWMAD----GT----LEY-LGRIDDQVKIRG---YRVetkEIESVIRCIKGVKD 2953
Cdd:COG1541 290 -----------EAmpliR-YRTGDLTRLLPEpcpcGRthprIGRiLGRADDMLIIRGvnvFPS---QIEEVLLRIPEVGP 354
|
330 340 350
....*....|....*....|....*....|....*...
gi 1678550997 2954 AAVVAHVTASGQTELSAYVVTKPGLSTNAVRSELQNKL 2991
Cdd:COG1541 355 EYQIVVDREGGLDELTVRVELAPGASLEALAEAIAAAL 392
|
|
| PLN02387 |
PLN02387 |
long-chain-fatty-acid-CoA ligase family protein |
2654-2702 |
4.58e-05 |
|
long-chain-fatty-acid-CoA ligase family protein
Pssm-ID: 215217 [Multi-domain] Cd Length: 696 Bit Score: 49.34 E-value: 4.58e-05
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....
gi 1678550997 2654 TIESVEEDDK----SPL-PQMSSAHHLAYIIYTSGTTGRPKGVMVEHKGIANTL 2702
Cdd:PLN02387 226 TVSSFSEVEKlgkeNPVdPDLPSPNDIAVIMYTSGSTGLPKGVMMTHGNIVATV 279
|
|
| PRK06814 |
PRK06814 |
acyl-[ACP]--phospholipid O-acyltransferase; |
2676-3015 |
4.84e-05 |
|
acyl-[ACP]--phospholipid O-acyltransferase;
Pssm-ID: 235865 [Multi-domain] Cd Length: 1140 Bit Score: 49.58 E-value: 4.84e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2676 AYIIYTSGTTGRPKGVMVEHKGI-ANTLQ------WRRNAYAFNetdtILQLF-SFsfdGFITSMFTPLLSGAKAVL--- 2744
Cdd:PRK06814 796 AVILFTSGSEGTPKGVVLSHRNLlANRAQvaaridFSPEDKVFN----ALPVFhSF---GLTGGLVLPLLSGVKVFLyps 868
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2745 -LH----EEEAKDILAikhqlsrqriTHMIIVPVLYRALLDVVQPEDVKTLRVVtLAG----EAADRELIARSLAIcpht 2815
Cdd:PRK06814 869 pLHyriiPELIYDTNA----------TILFGTDTFLNGYARYAHPYDFRSLRYV-FAGaekvKEETRQTWMEKFGI---- 933
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2816 ELANEYGPTENSVATTVMRHMEKQAYvSIGQPIDGTQvlilnsnHQLQPI-GV--AGELCIAGTGLARGYVnlpeLTERA 2892
Cdd:PRK06814 934 RILEGYGVTETAPVIALNTPMHNKAG-TVGRLLPGIE-------YRLEPVpGIdeGGRLFVRGPNVMLGYL----RAENP 1001
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2893 FTQNPfkPEARMYRTGDAARWMADGTLEYLGRIDDQVKIRGYRVETKEIESVIRCIKGVKDAAVVAhVTASGQTELSAYV 2972
Cdd:PRK06814 1002 GVLEP--PADGWYDTGDIVTIDEEGFITIKGRAKRFAKIAGEMISLAAVEELAAELWPDALHAAVS-IPDARKGERIILL 1078
|
330 340 350 360
....*....|....*....|....*....|....*....|....*...
gi 1678550997 2973 VTKPGLStnavRSELQ-----NKLPVFMHPAFIEKLDSLPLSPNGKLD 3015
Cdd:PRK06814 1079 TTASDAT----RAAFLahakaAGASELMVPAEIITIDEIPLLGTGKID 1122
|
|
| PTZ00216 |
PTZ00216 |
acyl-CoA synthetase; Provisional |
449-628 |
7.67e-05 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 240316 [Multi-domain] Cd Length: 700 Bit Score: 48.82 E-value: 7.67e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 449 RQLIGEITDQTPV-YETIHAMfEKQAEKTPDAHA------VIDQACSLTYRELNKAANRLARHLRMKGVVRQEPVAIMME 521
Cdd:PTZ00216 76 ERICKERGDRRALaYRPVERV-EKEVVKDADGKErtmevtHFNETRYITYAELWERIVNFGRGLAELGLTKGSNVAIYEE 154
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 522 RSAAFITGVLGILKAGGAIVPVDPHYPADRIRYILHDCGCSHVVSQAH------------------------LPSSLED- 576
Cdd:PTZ00216 155 TRWEWLASIYGIWSQSMVAATVYANLGEDALAYALRETECKAIVCNGKnvpnllrlmksggmpnttiiyldsLPASVDTe 234
|
170 180 190 200 210
....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 577 NYIITHPEDI----ESKVDGSNIKSVNNADDLLYMIYTSGTTGKPKGVQFEHRNMA 628
Cdd:PTZ00216 235 GCRLVAWTDVvakgHSAGSHHPLNIPENNDDLALIMYTSGTTGDPKGVMHTHGSLT 290
|
|
| PTZ00237 |
PTZ00237 |
acetyl-CoA synthetase; Provisional |
1639-1913 |
9.81e-05 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 240325 [Multi-domain] Cd Length: 647 Bit Score: 48.20 E-value: 9.81e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1639 YVIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLPQGGEKEPEVI 1718
Cdd:PTZ00237 258 YILYTSGTTGNSKAVVRSNGPHLVGLKYYWRSIIEKDIPTVVFSHSSIGWVSFHGFLYGSLSLGNTFVMFEGGIIKNKHI 337
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1719 A----KAIEEQKITAMHFVPSMLHAFLE--------HIKYRSvpiktNRLKRVFSGGEQLgTHLVSRFYELLPNVSITNS 1786
Cdd:PTZ00237 338 EddlwNTIEKHKVTHTLTLPKTIRYLIKtdpeatiiRSKYDL-----SNLKEIWCGGEVI-EESIPEYIENKLKIKSSRG 411
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1787 YGPTEATVeaAFFDCPPHEKLERIPIGKPVHHVRLYLLNQNQRMLPVGCIGELYIA---GAGVARGYLNRPALTEERFLE 1863
Cdd:PTZ00237 412 YGQTEIGI--TYLYCYGHINIPYNATGVPSIFIKPSILSEDGKELNVNEIGEVAFKlpmPPSFATTFYKNDEKFKQLFSK 489
|
250 260 270 280 290
....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1864 DPFYpgermYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAAL 1913
Cdd:PTZ00237 490 FPGY-----YNSGDLGFKDENGYYTIVSRSDDQIKISGNKVQLNTIETSI 534
|
|
| PLN03051 |
PLN03051 |
acyl-activating enzyme; Provisional |
1640-1983 |
1.51e-04 |
|
acyl-activating enzyme; Provisional
Pssm-ID: 215552 [Multi-domain] Cd Length: 499 Bit Score: 47.50 E-value: 1.51e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1640 VIYTSGSTGMPKGVEIEHRSAVNFLNSLQSRYQLKHSDMIMHKTSYSFDASIWELFWWPYAGASVYLLpqGGEKEPEVIA 1719
Cdd:PLN03051 124 ILFSSGTTGEPKAIPWTHLSPLRCASDGWAHMDIQPGDVVCWPTNLGWMMGPWLLYSAFLNGATLALY--GGAPLGRGFG 201
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1720 KAIEEQKITAMHFVPSMLHAFLEHIKYRSVPIKTNRLKRVFSGGEqlgthlVSRFYELLPNVSITNSYGPTeatVEAaff 1799
Cdd:PLN03051 202 KFVQDAGVTVLGLVPSIVKAWRHTGAFAMEGLDWSKLRVFASTGE------ASAVDDVLWLSSVRGYYKPV---IEY--- 269
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1800 dCPPHEKLERIPIGKPVH------------HVRLYLLNQNQRMLPVG--CIGELYIAGA--GVARGYLNrpALTEERFLE 1863
Cdd:PLN03051 270 -CGGTELASGYISSTLLQpqapgafstaslGTRFVLLNDNGVPYPDDqpCVGEVALAPPmlGASDRLLN--ADHDKVYYK 346
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1864 D-PFYP--GERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIE-AALRSIEGVRE-AAVTVRTDSGEPELCAY 1938
Cdd:PLN03051 347 GmPMYGskGMPLRRHGDIMKRTPGGYFCVQGRADDTMNLGGIKTSSVEIErACDRAVAGIAEtAAVGVAPPDGGPELLVI 426
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1939 V---------------EGLQRNEVRAQLERLLPGYMVPAYMIEMEqWPVTPSGKLDRNAL 1983
Cdd:PLN03051 427 FlvlgeekkgfdqarpEALQKKFQEAIQTNLNPLFKVSRVKIVPE-LPRNASNKLLRRVL 485
|
|
| PRK08043 |
PRK08043 |
bifunctional acyl-ACP--phospholipid O-acyltransferase/long-chain-fatty-acid--ACP ligase; |
2676-2746 |
1.78e-04 |
|
bifunctional acyl-ACP--phospholipid O-acyltransferase/long-chain-fatty-acid--ACP ligase;
Pssm-ID: 181207 [Multi-domain] Cd Length: 718 Bit Score: 47.40 E-value: 1.78e-04
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1678550997 2676 AYIIYTSGTTGRPKGVMVEHKGI-ANTLQWRRNAyAFNETD---TILQLFSfSFdGFITSMFTPLLSGAKAVL----LH 2746
Cdd:PRK08043 368 ALILFTSGSEGHPKGVVHSHKSLlANVEQIKTIA-DFTPNDrfmSALPLFH-SF-GLTVGLFTPLLTGAEVFLypspLH 443
|
|
| C_PKS-NRPS_PksJ-like |
cd20484 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
3233-3321 |
2.04e-04 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs), similar to Bacillus subtilis PksJ; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily have the typical C-domain HHxxxD motif. PksJ is involved in some intermediate steps for the synthesis of the antibiotic polyketide bacillaene which is important in secondary metabolism. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380472 [Multi-domain] Cd Length: 430 Bit Score: 46.93 E-value: 2.04e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3233 DLKNGPLLQAGLFHTIDGD-FLFLSAHHLVVDGISWRVLLEDLALGYRQAAGGEDIKLPPKTSSFKAYAKKLSDYAESQQ 3311
Cdd:cd20484 104 VLENGPLMRVHLFSRSEQEhFVLITIHHIIFDGSSSLTLIHSLLDAYQALLQGKQPTLASSPASYYDFVAWEQDMLAGAE 183
|
90
....*....|
gi 1678550997 3312 LMKQLKYWRE 3321
Cdd:cd20484 184 GEEHRAYWKQ 193
|
|
| PRK07868 |
PRK07868 |
acyl-CoA synthetase; Validated |
2525-2615 |
2.28e-04 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236121 [Multi-domain] Cd Length: 994 Bit Score: 47.40 E-value: 2.28e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2525 GQANQYGVQTISQLFEQQAARTPKASALVSGDKTLTYQELDEWSNGIARALRSRGVKPDTPVGIMMHRSFSMIASILGVW 2604
Cdd:PRK07868 439 GQINDHTRISLGRIIAEQARDAPKGEFLLFDGRVHTYEAVNRRINNVVRGLIAVGVRQGDRVGVLMETRPSALVAIAALS 518
|
90
....*....|.
gi 1678550997 2605 KAGGCYVPIDP 2615
Cdd:PRK07868 519 RLGAVAVLMPP 529
|
|
| FUM14_C_NRPS-like |
cd19545 |
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond ... |
3227-3321 |
3.52e-04 |
|
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond forming Fusarium verticillioides FUM14 protein; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) typically catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. However, some C-domains have ester-bond forming activity. This subfamily includes Fusarium verticillioides FUM14 (also known as NRPS8), a bi-domain protein with an ester-bond forming NRPS C-domain, which catalyzes linkages between an aminoacyl/peptidyl-PCP donor and a hydroxyl-containing acceptor. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. FUM14 has an altered active site motif DHTHCD instead of the typical HHxxxD motif seen in other subfamily members. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380467 [Multi-domain] Cd Length: 395 Bit Score: 46.14 E-value: 3.52e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 3227 DIQQKMDLkNGPLLQAGLF-HTIDGDFLFLSAHHLVVDGISWRVLLEDLALGYRqaagGEDIKLPPKTSSFKAYAKKLSD 3305
Cdd:cd19545 90 DRAAPMGL-GGPLVRLALVeDPDTERYFVWTIHHALYDGWSLPLILRQVLAAYQ----GEPVPQPPPFSRFVKYLRQLDD 164
|
90
....*....|....*.
gi 1678550997 3306 yAESQQlmkqlkYWRE 3321
Cdd:cd19545 165 -EAAAE------FWRS 173
|
|
| PKS_PP |
smart00823 |
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the ... |
988-1034 |
5.41e-04 |
|
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the prosthetic group of acyl carrier proteins (ACP) in some multienzyme complexes where it serves as a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups.
Pssm-ID: 214834 [Multi-domain] Cd Length: 86 Bit Score: 41.47 E-value: 5.41e-04
10 20 30 40
....*....|....*....|....*....|....*....|....*..
gi 1678550997 988 IGIQDNFFDNGGHSLKATVLMSRIAKEFHVQVSLKDIFAHPTVEGLA 1034
Cdd:smart00823 33 IDPDRPFRDLGLDSLMAVELRNRLEAATGLRLPATLVFDHPTPAALA 79
|
|
| PaaK |
cd05913 |
Phenylacetate-CoA ligase (also known as PaaK); PaaK catalyzes the first step in the aromatic ... |
835-901 |
7.16e-04 |
|
Phenylacetate-CoA ligase (also known as PaaK); PaaK catalyzes the first step in the aromatic degradation pathway, by converting phenylacetic acid (PA) into phenylacetyl-CoA (PA-CoA). Phenylacetate-CoA ligase has been found in proteobacteria as well as gram positive prokaryotes. The enzyme is specifically induced after aerobic growth in a chemically defined medium containing PA or phenylalanine (Phe) as the sole carbon source. PaaKs are members of the adenylate-forming enzyme (AFE) family. However, sequence comparison reveals divergent features of PaaK with respect to the superfamily, including a novel N-terminal sequence.
Pssm-ID: 341239 [Multi-domain] Cd Length: 425 Bit Score: 45.31 E-value: 7.16e-04
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1678550997 835 VIMYRTGDLARrLEDGN---------IEYI-GRADNQVKIRGYRIEPQEIEVTLMNHPDISEAAILIWQDQNGEHEL 901
Cdd:cd05913 290 LIRYRTRDITR-LLPGPcpcgrthrrIDRItGRSDDMLIIRGVNVFPSQIEDVLLKIPGLGPHYQLILTRQEHLDEL 365
|
|
| PLN02736 |
PLN02736 |
long-chain acyl-CoA synthetase |
2651-2700 |
7.24e-04 |
|
long-chain acyl-CoA synthetase
Pssm-ID: 178337 [Multi-domain] Cd Length: 651 Bit Score: 45.48 E-value: 7.24e-04
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|...
gi 1678550997 2651 EILTIESVEEDDK-SPLPQMSSA-HHLAYIIYTSGTTGRPKGVMVEHKG-IAN 2700
Cdd:PLN02736 197 EIVTYSKLLAQGRsSPQPFRPPKpEDVATICYTSGTTGTPKGVVLTHGNlIAN 249
|
|
| AACS |
cd05943 |
Acetoacetyl-CoA synthetase (acetoacetate-CoA ligase, AACS); AACS is a cytosolic ligase that ... |
1495-1977 |
1.31e-03 |
|
Acetoacetyl-CoA synthetase (acetoacetate-CoA ligase, AACS); AACS is a cytosolic ligase that specifically activates acetoacetate to its coenzyme A ester by a two-step reaction. Acetoacetate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is the first step of the mevalonate pathway of isoprenoid biosynthesis via isopentenyl diphosphate. Isoprenoids are a large class of compounds found in all living organisms. AACS is widely distributed in bacteria, archaea and eukaryotes. In bacteria, AACS is known to exhibit an important role in the metabolism of poly-b-hydroxybutyrate, an intracellular reserve of organic carbon and chemical energy by some microorganisms. In mammals, AACS influences the rate of ketone body utilization for the formation of physiologically important fatty acids and cholesterol.
Pssm-ID: 341265 [Multi-domain] Cd Length: 629 Bit Score: 44.57 E-value: 1.31e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1495 TLHYALEQQAEKTPDQAAVIF--EDGV---MTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGILKAGG 1569
Cdd:cd05943 69 RLNYAENLLRHADADDPAAIYaaEDGErteVTWAELRRRVARLAAALRALGVKPGDRVAGYLPNIPEAVVAMLATASIGA 148
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1570 AYLPIDPDYPE----ERIS-----FLLEDSG-----------TNILLLQsAGLhvPEFTgEIVYLNQTNSGLAHRLS-NP 1628
Cdd:cd05943 149 IWSSCSPDFGVpgvlDRFGqiepkVLFAVDAytyngkrhdvrEKVAELV-KGL--PSLL-AVVVVPYTVAAGQPDLSkIA 224
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1629 NVDVLPQSLA------------------YVIYTSGSTGMPK-------GVEIEHRSAVnflnSLQSryQLKHSDMIMHKT 1683
Cdd:cd05943 225 KALTLEDFLAtgaagelefeplpfdhplYILYSSGTTGLPKcivhgagGTLLQHLKEH----ILHC--DLRPGDRLFYYT 298
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1684 SYSfdasiWELFWWP----YAGASVYLL---PqgGEKEPEVIAKAIEEQKITAM-------------HFVP------SML 1737
Cdd:cd05943 299 TCG-----WMMWNWLvsglAVGATIVLYdgsP--FYPDTNALWDLADEEGITVFgtsakyldalekaGLKPaethdlSSL 371
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1738 HAFLE------HIKYRSVP--IKTNRLKRVFSGGeqlgTHLVSRFYELLPNVSITnsygPTE-------ATVEAafFDCP 1802
Cdd:cd05943 372 RTILStgsplkPESFDYVYdhIKPDVLLASISGG----TDIISCFVGGNPLLPVY----RGEiqcrglgMAVEA--FDEE 441
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1803 phekleripiGKPVhhvrlyllnqnqrmlpVGCIGELYIAgagvaRGYLNRPAlteeRFLEDP---------F--YPGer 1871
Cdd:cd05943 442 ----------GKPV----------------WGEKGELVCT-----KPFPSMPV----GFWNDPdgsryraayFakYPG-- 484
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1872 MYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREA-AVTVRTDSGEPELCAYV---EGLQ---- 1943
Cdd:cd05943 485 VWAHGDWIEITPRGGVVILGRSDGTLNPGGVRIGTAEIYRVVEKIPEVEDSlVVGQEWKDGDERVILFVklrEGVEldde 564
|
570 580 590
....*....|....*....|....*....|....*
gi 1678550997 1944 -RNEVRAQLERLLPGYMVPAYMIEMEQWPVTPSGK 1977
Cdd:cd05943 565 lRKRIRSTIRSALSPRHVPAKIIAVPDIPRTLSGK 599
|
|
| PRK07868 |
PRK07868 |
acyl-CoA synthetase; Validated |
1500-1580 |
2.06e-03 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236121 [Multi-domain] Cd Length: 994 Bit Score: 44.32 E-value: 2.06e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1500 LEQQAEKTPDQAAVIFEDGVMTYKELNEQANRIAWELIGRGVKPETTVAIIGKRSPEMLLGIYGI--LKAGGAYLPIDPD 1577
Cdd:PRK07868 453 IAEQARDAPKGEFLLFDGRVHTYEAVNRRINNVVRGLIAVGVRQGDRVGVLMETRPSALVAIAALsrLGAVAVLMPPDTD 532
|
...
gi 1678550997 1578 YPE 1580
Cdd:PRK07868 533 LAA 535
|
|
| PLN02654 |
PLN02654 |
acetate-CoA ligase |
1639-1924 |
2.63e-03 |
|
acetate-CoA ligase
Pssm-ID: 215353 [Multi-domain] Cd Length: 666 Bit Score: 43.73 E-value: 2.63e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1639 YVIYTSGSTGMPKGVEieHRSAvnflnslqsryqlkhSDMIMHKTS--YSFDASIWELFW------W----------PYA 1700
Cdd:PLN02654 279 FLLYTSGSTGKPKGVL--HTTG---------------GYMVYTATTfkYAFDYKPTDVYWctadcgWitghsyvtygPML 341
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1701 GASVYLLPQGGEKEPEV--IAKAIEEQKITAMHFVPSMLHAFL----EHIKYRSvpikTNRLKRVFSGGEQLGTHLVSRF 1774
Cdd:PLN02654 342 NGATVLVFEGAPNYPDSgrCWDIVDKYKVTIFYTAPTLVRSLMrdgdEYVTRHS----RKSLRVLGSVGEPINPSAWRWF 417
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 1775 YELLPN--VSITNSYGPTEAtveAAFFDCPPHEKLERIPIGK--PVHHVRLYLLNQNQRMLPVGCIGELYIAGA--GVAR 1848
Cdd:PLN02654 418 FNVVGDsrCPISDTWWQTET---GGFMITPLPGAWPQKPGSAtfPFFGVQPVIVDEKGKEIEGECSGYLCVKKSwpGAFR 494
|
250 260 270 280 290 300 310
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1678550997 1849 GYLNrpalTEERFLEDPFYPGERMYKTGDVARWLPDGNVEFLGRTDDQVKIRGYRIEPGEIEAALRSIEGVREAAV 1924
Cdd:PLN02654 495 TLYG----DHERYETTYFKPFAGYYFSGDGCSRDKDGYYWLTGRVDDVINVSGHRIGTAEVESALVSHPQCAEAAV 566
|
|
| PRK09294 |
PRK09294 |
phthiocerol/phthiodiolone dimycocerosyl transferase; |
2108-2233 |
5.22e-03 |
|
phthiocerol/phthiodiolone dimycocerosyl transferase;
Pssm-ID: 181765 [Multi-domain] Cd Length: 416 Bit Score: 42.39 E-value: 5.22e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1678550997 2108 TGYNMpavlELEGKLNPERMDRAFQELIKRHESLRTSFEQDEGGDPVQRIHDEVPFTLQttVLGARTEQEAAAAfikPFD 2187
Cdd:PRK09294 24 TGYTA----HLRGVLDIDALSDAFDALLRAHPVLAAHLEQDSDGGWELVADDLLHPGIV--VVDGDAARPLPEL---QLD 94
|
90 100 110 120
....*....|....*....|....*....|....*....|....*.
gi 1678550997 2188 LSQApLFRAQIVKVSDERHLLLVdMHHIISDGVSVNILIQEFGELY 2233
Cdd:PRK09294 95 QGVS-LLALDVVPDDGGARVTLY-IHHSIADAHHSASLLDELWSRY 138
|
|
|